PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tomasec, P; Wang, ECY; Davison, AJ; Vojtesek, B; Armstrong, M; Griffin, C; McSharry, BP; Morris, RJ; Llewellyn-Lacey, S; Rickards, C; Nomoto, A; Sinzger, C; Wilkinson, GWG				Tomasec, P; Wang, ECY; Davison, AJ; Vojtesek, B; Armstrong, M; Griffin, C; McSharry, BP; Morris, RJ; Llewellyn-Lacey, S; Rickards, C; Nomoto, A; Sinzger, C; Wilkinson, GWG			Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141	NATURE IMMUNOLOGY			English	Article							POLIOVIRUS RECEPTOR CD155; I-RELATED MOLECULES; ENDOTHELIAL-CELLS; GLYCOPROTEIN UL16; HUMAN FIBROBLASTS; CUTTING EDGE; PVR CD155; ADHESION; INFECTION; DNAM-1	Natural killer (NK) cells are crucial in the control of cytomegalovirus infections in mice and humans. Here we show that the viral UL141 gene product has an immunomodulatory function that is associated with low-passage strains of human cytomegalovirus. UL141 mediated efficient protection of cells against killing by a wide range of human NK cell populations, including interferon-alpha- stimulated bulk cultures, polyclonal NK cell lines and most NK cell clones tested. Evasion of NK cell killing was mediated by UL141 blocking surface expression of CD155, which was previously identified as a ligand for NK cell-activating receptors CD226 (DNAM-1) and CD96 (TACTILE). The breadth of the UL141-mediated effect indicates that CD155 has a key role in regulating NK cell function.	Cardiff Univ, Coll Med, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales; Inst Virol, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; Masaryk Mem Canc Inst, Brno 65653, Czech Republic; Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo, Japan; Univ Tubingen, Tubingen, Germany	Cardiff University; University of Glasgow; Masaryk Memorial Cancer Institute; University of Tokyo; Eberhard Karls University of Tubingen	Wilkinson, GWG (corresponding author), Cardiff Univ, Coll Med, Sect Infect & Immun, Tenovus Bldg,Heath Pk, Cardiff CF14 4XX, S Glam, Wales.	wilkinsongw1@cardiff.ac.uk	Moore, Melanie/AAY-3865-2021; McSharry, Brian/AAE-3351-2019; Wilkinson, Gavin WG/J-6388-2015	McSharry, Brian/0000-0003-0473-2789; Wilkinson, Gavin WG/0000-0002-5623-0126; Wang, Eddie/0000-0002-2243-4964	MRC [G0300180, G9827961] Funding Source: UKRI; Medical Research Council [G0300180, G9827961, G0500617, G0500617(74644), G0300180(65735)] Funding Source: Medline; Wellcome Trust [066749] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AOKI J, 1994, J BIOL CHEM, V269, P8431; Benedict CA, 1999, J IMMUNOL, V162, P6967; BERNHARDT G, 1994, VIROLOGY, V199, P105, DOI 10.1006/viro.1994.1102; BERSTEIN DL, 2004, NEW GENERATION VACCI, P649; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carr WH, 2002, CLIN IMMUNOL, V105, P126, DOI 10.1006/clim.2002.5273; Cerboni C, 2000, J IMMUNOL, V164, P4775, DOI 10.4049/jimmunol.164.9.4775; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Kubin M, 2001, EUR J IMMUNOL, V31, P1428, DOI 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4; Leis M, 2004, J GEN VIROL, V85, P1995, DOI 10.1099/vir.0.79818-0; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; McSharry BP, 2003, J GEN VIROL, V84, P2511, DOI 10.1099/vir.0.19298-0; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Novotny J, 2001, J MOL BIOL, V310, P1151, DOI 10.1006/jmbi.2001.4798; Oda T, 2004, BIOCHEM BIOPH RES CO, V319, P1253, DOI 10.1016/j.bbrc.2004.05.111; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Penfold MET, 1999, P NATL ACAD SCI USA, V96, P9839, DOI 10.1073/pnas.96.17.9839; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Robertson MJ, 1996, EXP HEMATOL, V24, P406; SCHOLZ M, 1992, HUM IMMUNOL, V35, P230, DOI 10.1016/0198-8859(92)90004-7; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; ZIBERT A, 1992, J VIROL, V66, P7368, DOI 10.1128/JVI.66.12.7368-7373.1992	38	208	223	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					181	188		10.1038/ni1156	http://dx.doi.org/10.1038/ni1156			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15640804	Green Accepted			2022-12-18	WOS:000226468100021
J	Chen, HD; Fraire, AE; Joris, I; Brehm, MA; Welsh, RM; Selin, LK				Chen, HD; Fraire, AE; Joris, I; Brehm, MA; Welsh, RM; Selin, LK			Memory CD8(+)T cells in heterologous antiviral immunity and immunopathology in the lung	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8 T-CELLS; BYSTANDER ACTIVATION; VACCINIA VIRUS; IN-VIVO; DIRECT VISUALIZATION; VIRAL-INFECTION; ANTIGEN; RESPONSES; MICE	A potent role for memory CD8(+) T cells in heterologous immunity was shown with a respiratory mucosal model of viral infection. Memory CD8(+) T cells generated after lymphocytic choriomeningitis virus (LCMV) infection were functionally activated in vivo to produce interferon-gamma (IFN-gamma) during acute infection with vaccinia virus (VV). Some of these antigen-specific memory cells selectively expanded in number, which resulted in modulation of the original LCMV-specific T cell repertoire. In addition, there was an organ-selective compartmental redistribution of these LCMV-specific T cells during VV infection. The presence of these LCMV-specific memory T cells correlated with enhanced VV clearance, decreased mortality and marked changes in lung immunopathology. Thus, the participation of pre-existing memory T cells specific to unrelated agents can alter the dynamics of mucosal immunity and disease course in response to a pathogen.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Selin, LK (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.			Brehm, Michael/0000-0001-6813-3262; Selin, Liisa/0000-0002-6993-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-46578] Funding Source: Medline; NIAMS NIH HHS [AR-35506] Funding Source: Medline; NIDDK NIH HHS [DK32520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; BRADLEY LM, 1993, IMMUNOL TODAY, V14, P197, DOI 10.1016/0167-5699(93)90161-D; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Elson CO, 1997, ADV EXP MED BIOL, V412, P373; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Fenner F., 1988, SMALLPOX; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; GALRIN JE, 1995, J VIROL, V69, P2297; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Haanen JBAG, 2000, NAT MED, V6, P1056, DOI 10.1038/79573; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; KHALIL N, 1989, CELL IMMUNOL, V120, P439, DOI 10.1016/0008-8749(89)90211-6; KUWANO K, 1991, MOL IMMUNOL, V28, P1; Loftus DJ, 1997, J IMMUNOL, V158, P3651; Mahalingam S, 2000, IMMUNOL REV, V177, P127, DOI 10.1034/j.1600-065X.2000.17720.x; Marrie TJ, 1998, AM J TROP MED HYG, V58, P47, DOI 10.4269/ajtmh.1998.58.47; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; PABST R, 1992, IMMUNOL TODAY, V13, P119, DOI 10.1016/0167-5699(92)90106-H; RAZVI ES, 1995, J IMMUNOL, V154, P620; Rickinson AB, 1996, VIROLOGY, P2397; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schlesinger C, 1998, Ann Diagn Pathol, V2, P321, DOI 10.1016/S1092-9134(98)80026-9; Selin Liisa K., 2000, P327; Selin LK, 1997, J IMMUNOL, V158, P5366; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Seth A, 1998, P NATL ACAD SCI USA, V95, P10112, DOI 10.1073/pnas.95.17.10112; SHIMOJO N, 1989, J IMMUNOL, V143, P2939; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; TABI Z, 1988, CELL IMMUNOL, V113, P268, DOI 10.1016/0008-8749(88)90026-3; Tay CH, 1999, J IMMUNOL, V162, P718; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; TUFARIELLO J, 1994, J VIROL, V68, P453, DOI 10.1128/JVI.68.1.453-462.1994; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; WALSH RM, 1999, ENCY VIROLOGY, P915; Walzl G, 2000, J EXP MED, V192, P1317, DOI 10.1084/jem.192.9.1317; WEINSTEIN L, 1956, ARCH INTERN MED, V98, P91, DOI 10.1001/archinte.1956.00250250097013; Welsh RM, 2000, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, P289; WHITTON JL, 1988, VIROLOGY, V162, P321, DOI 10.1016/0042-6822(88)90471-0; YANG HY, 1989, J IMMUNOL, V142, P1710; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629	57	208	208	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1067	1076		10.1038/ni727	http://dx.doi.org/10.1038/ni727			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668342				2022-12-18	WOS:000172049800021
J	Fan, QR; Long, EO; Wiley, DC				Fan, QR; Long, EO; Wiley, DC			Crystal structure of the human natural killer cell inhibitory receptor KIR2DLI-HLA-Cw4 complex	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; LEUKOCYTE ANTIGEN (HLA)-CW4; HLA-C; DIRECT BINDING; GROWTH-HORMONE; PEPTIDE; RECOGNITION; MOLECULES; LIGANDS; SPECIFICITIES	Inhibitory natural killer (NK) cell receptors down-regulate the cytotoxicity of NK cells upon recognition of specific class I major histocompatibility complex (MHC) molecules on target cells.We report here the crystal structure of the inhibitory human killer cell immunoglobulin-like receptor 2DLI (KIR2DLI) bound to its class I MHC ligand, HLA-Cw4,The KIR2DLI-HLA-Cw4 interface exhibits charge and shape complementarity. Specificity is mediated by a pocket in KIR2DLI that hosts the Lys(80) residue of HLA-Cw4. Many residues conserved in HLA-C and in KIR2DL receptors make different interactions in KIR2DLI-HLA-Cw4 and in a previously reported KIR2DLI-HLA-Cw3 complex. A dimeric aggregate of KIR-HLA-C complexes was observed in one KIR2DLI-HLA-Cw4 crystal. Most of the amino acids that differ between human and chimpanzee hips with HLA-C specificities form solvent-accessible clusters outside the KIR-HLA interface, which suggests undiscovered interactions by hips.	Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; NIAID, NIH, Immunogenet Lab, Rockville, MD 20852 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Howard Hughes Medical Institute	Wiley, DC (corresponding author), Harvard Univ, Dept Mol & Cell Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525, Z01AI000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams EJ, 1999, IMMUNOGENETICS, V49, P865; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baker BM, 1999, COLD SPRING HARB SYM, V64, P235, DOI 10.1101/sqb.1999.64.235; Barten R, 1999, IMMUNOGENETICS, V49, P731, DOI 10.1007/s002510050675; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P1200; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GUMPERZ JE, 1995, J EXP MED, V181, P113; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Long EO, 1997, CURR OPIN IMMUNOL, V9, P344, DOI 10.1016/S0952-7915(97)80080-5; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Schaiff WT, 1997, CORONARY ARTERY DIS, V8, P9, DOI 10.1097/00019501-199701000-00002; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; SIDNEY J, 1995, J IMMUNOL, V154, P247; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Westgaard IH, 1998, EUR J IMMUNOL, V28, P1839, DOI 10.1002/(SICI)1521-4141(199806)28:06<1839::AID-IMMU1839>3.0.CO;2-E; Winter CC, 1997, J IMMUNOL, V158, P4026; Yokoyama W. M., 1999, FUNDAMENTAL IMMUNOLO, P575; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	53	208	218	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					452	460		10.1038/87766	http://dx.doi.org/10.1038/87766			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323700				2022-12-18	WOS:000168549800019
J	Dror, E; Dalmas, E; Meier, DT; Wueest, S; Thevenet, J; Thienel, C; Timper, K; Nordmann, TM; Traub, S; Schulze, F; Item, F; Vallois, D; Pattou, F; Kerr-Conte, J; Lavallard, V; Berney, T; Thorens, B; Konrad, D; Boni-Schnetzler, M; Donath, MY				Dror, Erez; Dalmas, Elise; Meier, Daniel T.; Wueest, Stephan; Thevenet, Julien; Thienel, Constanze; Timper, Katharina; Nordmann, Thierry M.; Traub, Shuyang; Schulze, Friederike; Item, Flurin; Vallois, David; Pattou, Francois; Kerr-Conte, Julie; Lavallard, Vanessa; Berney, Thierry; Thorens, Bernard; Konrad, Daniel; Boni-Schnetzler, Marianne; Donath, Marc Y.			Postprandial macrophage-derived IL-1 beta stimulates insulin, and both synergistically promote glucose disposal and inflammation	NATURE IMMUNOLOGY			English	Article							BETA-CELL; NLRP3 INFLAMMASOME; DOUBLE-BLIND; ACTIVATION; OBESITY; INTERLEUKIN-1; METABOLISM; SECRETION; ISLETS; ANTIBODY	The deleterious effect of chronic activation of the 1L-1 beta system on type 2 diabetes and other metabolic diseases is well documented. However, a possible physiological role for IL-1 beta in glucose metabolism has remained unexplored. Here we found that feeding induced a physiological increase in the number of peritoneal macrophages that secreted IL-1 beta, in a glucose dependent manner. Subsequently, IL-1 beta contributed to the postprandial stimulation of insulin secretion. Accordingly, lack of endogenous IL-1 beta signaling in mice during refeeding and obesity diminished the concentration of insulin in plasma. IL-1 beta and insulin increased the uptake of glucose into macrophages, and insulin reinforced a pro-inflammatory pattern via the insulin receptor, glucose metabolism, production of reactive oxygen species, and secretion of IL-1 beta mediated by the NLRP3 inflammasome. Postprandial inflammation might be limited by normalization of glycemia, since it was prevented by inhibition of the sodium glucose cotransporter SGLT2. Our findings identify a physiological role for IL-1 beta and insulin in the regulation of both metabolism and immunity.	[Dror, Erez; Dalmas, Elise; Meier, Daniel T.; Thienel, Constanze; Timper, Katharina; Nordmann, Thierry M.; Traub, Shuyang; Schulze, Friederike; Boni-Schnetzler, Marianne; Donath, Marc Y.] Univ Basel Hosp, Clin Endocrinol Diabet & Metab, Basel, Switzerland; [Dror, Erez; Dalmas, Elise; Meier, Daniel T.; Thienel, Constanze; Timper, Katharina; Nordmann, Thierry M.; Traub, Shuyang; Schulze, Friederike; Boni-Schnetzler, Marianne; Donath, Marc Y.] Univ Basel, Dept Biomed, Basel, Switzerland; [Wueest, Stephan; Item, Flurin; Konrad, Daniel] Univ Childrens Hosp, Dept Pediat Endocrinol & Diabetol, Zurich, Switzerland; [Wueest, Stephan; Item, Flurin; Konrad, Daniel] Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland; [Thevenet, Julien; Pattou, Francois; Kerr-Conte, Julie] Univ Lille, CHU, INSERM, Lille, France; [Thevenet, Julien; Pattou, Francois; Kerr-Conte, Julie] European Genom Inst Diabet, Translat Res Diabet, Lille, France; [Vallois, David; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Lavallard, Vanessa; Berney, Thierry] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Lavallard, Vanessa; Berney, Thierry] Univ Geneva, Sch Med, Geneva, Switzerland	University of Basel; University of Basel; University Children's Hospital Zurich; University Children's Hospital Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Lausanne; University of Geneva; University of Geneva	Donath, MY (corresponding author), Univ Basel Hosp, Clin Endocrinol Diabet & Metab, Basel, Switzerland.; Donath, MY (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	marc.donath@usb.ch	Pattou, Francois/O-6151-2017; Berney, Thierry/ABE-9450-2021; Item, Flurin/GSN-0308-2022; Wüest, Stephan/AAG-9706-2020; Dror, Erez/B-2481-2017	Pattou, Francois/0000-0001-8388-3766; Berney, Thierry/0000-0002-4230-9378; Wüest, Stephan/0000-0002-0176-8906; Dalmas, Elise/0000-0003-0959-5648; Konrad, Daniel/0000-0001-9067-4356; Boni-Schnetzler, Marianne/0000-0001-5569-5506; Dror, Erez/0000-0002-9923-7600	Swiss National Research Foundation [166519]; European Genomic Institute for Diabetes [ANR-10-LABX-46]	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Genomic Institute for Diabetes	We thank R. Sharfmann (University Paris-Descartes, Institut Cochin, Paris, France) for the human beta-cell line ENDOC; technicians M. Borsigova, K. Dembinski and S. Haeuselmann for technical assistance; S. Dimeloe, E. Traunecker and D. Labes for technical advice; G. Bantug for technical and editorial advice; and the Center for Transgenic Models of the University of Basel and D. Klewe-Nebenius for supporting production of the Il1b<SUP>fl/fl</SUP> mouse. Supported by the Swiss National Research Foundation (166519 to M.Y.D.) and the European Genomic Institute for Diabetes (ANR-10-LABX-46 to F.P.).	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Benner C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-620; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caumo A, 2004, AM J PHYSIOL-ENDOC M, V287, pE371, DOI 10.1152/ajpendo.00139.2003; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; DINARELLO CA, 1986, IMMUNOBIOLOGY, V172, P301, DOI 10.1016/S0171-2985(86)80112-7; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2008, BIOCHEM SOC T, V36, P340, DOI 10.1042/BST0360340; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; GREENWOOD RH, 1976, LANCET, V1, P444; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hajmrle C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86055; Hensen J, 2013, DIABETES METAB, V39, P524, DOI 10.1016/j.diabet.2013.07.003; Herieka M, 2014, MOL NUTR FOOD RES, V58, P136, DOI 10.1002/mnfr.201300104; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Platell C, 2000, WORLD J GASTROENTERO, V6, P169; Rosa LFBPC, 1996, CELL BIOCHEM FUNCT, V14, P33, DOI 10.1002/cbf.637; Shrivastava P, 2010, WORLD J GASTROENTERO, V16, P3995, DOI 10.3748/wjg.v16.i32.3995; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; van Oostrom AJHHM, 2003, METABOLISM, V52, P199, DOI 10.1053/meta.2003.50037; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; ZAWALICH WS, 1989, AM J PHYSIOL, V256, pE19, DOI 10.1152/ajpendo.1989.256.1.E19; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	50	207	209	4	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					283	292		10.1038/ni.3659	http://dx.doi.org/10.1038/ni.3659			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28092375	Green Accepted			2022-12-18	WOS:000394413400008
J	Dwyer, DF; Barrett, NA; Austen, KF				Dwyer, Daniel F.; Barrett, Nora A.; Austen, K. Frank		Immunological Genome Project Conso	Expression profiling of constitutive mast cells reveals a unique identity within the immune system	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-E; TRICHINELLA-SPIRALIS; MESSENGER-RNA; MICE; ACTIVATION; BASOPHILS; DIFFERENTIATION; DEFENSE; RELEASE; IDENTIFICATION	Mast cells are evolutionarily ancient sentinel cells. Like basophils, mast cells express the high-affinity receptor for immunoglobulin E (IgE) and have been linked to host defense and diverse immune-system-mediated diseases. To better characterize the function of these cells, we assessed the transcriptional profiles of mast cells isolated from peripheral connective tissues and basophils isolated from spleen and blood. We found that mast cells were transcriptionally distinct, clustering independently from all other profiled cells, and that mast cells demonstrated considerably greater heterogeneity across tissues than previously appreciated. We observed minimal homology between mast cells and basophils, which shared more overlap with other circulating granulocytes than with mast cells. The derivation of mast-cell and basophil transcriptional signatures underscores their differential capacities to detect environmental signals and influence the inflammatory milieu.	[Dwyer, Daniel F.; Barrett, Nora A.; Austen, K. Frank] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Dwyer, Daniel F.; Barrett, Nora A.; Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Barrett, NA; Austen, KF (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Barrett, NA; Austen, KF (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	nbarrett@partners.org; fausten@research.bwh.harvard.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; kang, joonsoo/0000-0001-8419-7995; Colonna, Marco/0000-0001-5222-4987; Fairfax, Keke/0000-0002-8382-2960	US National Institutes of Health [R24AI072073, R01 HL120952, U19AI095219, AI095219, T32 AI007306]; Steven and Judy Kaye Young Innovators Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007306, R24AI072073, U19AI095219] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steven and Judy Kaye Young Innovators Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the other members of the ImmGen Consortium, especially C. Benoist and T. Shay, for discussions; the core ImmGen team, especially A. Rhodes and K. Rothamel, for technical assistance; and A. Chicoine for assistance with the isolation of cells. Supported by the US National Institutes of Health (R24AI072073 to the ImmGen Consortium; R01 HL120952 and U19AI095219 to N.A.B.; AI095219 to N.A.B.; and T32 AI007306 to D.F.D.) and the Steven and Judy Kaye Young Innovators Award (N.A.B.).	Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Cavalcante MCM, 2000, J BIOL CHEM, V275, P36189, DOI 10.1074/jbc.M005830200; CRAPPER RM, 1983, J IMMUNOL, V131, P923; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; DVORAK AM, 1982, BLOOD, V59, P1279; Ericson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108553; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Friend DS, 1998, J IMMUNOL, V160, P5537; Galli SJ, 2015, ADV IMMUNOL, V126, P45, DOI 10.1016/bs.ai.2014.11.002; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Gibbs BF, 1996, EUR J IMMUNOL, V26, P2493, DOI 10.1002/eji.1830261033; Gilchrist M, 1997, J IMMUNOL METHODS, V201, P207, DOI 10.1016/S0022-1759(96)00230-X; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; Kitamura Y, 2002, MOL IMMUNOL, V38, P1173, DOI 10.1016/S0161-5890(02)00058-5; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Li YP, 2015, J IMMUNOL, V194, P4328, DOI 10.4049/jimmunol.1500018; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Reber LL, 2014, ARTHRITIS RHEUMATOL, V66, P2881, DOI 10.1002/art.38747; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Siracusa MC, 2010, IMMUNOL CELL BIOL, V88, P275, DOI 10.1038/icb.2010.1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; TSAI M, 1995, AM J PATHOL, V146, P335; Vitalis T, 2003, J COMP NEUROL, V464, P392, DOI 10.1002/cne.10804; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; WARNER JA, 1989, J LEUKOCYTE BIOL, V45, P558, DOI 10.1002/jlb.45.6.558; Wong GW, 2014, BIOCHEM BIOPH RES CO, V451, P314, DOI 10.1016/j.bbrc.2014.07.124; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803	52	207	211	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					878	+		10.1038/ni.3445	http://dx.doi.org/10.1038/ni.3445			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27135604	Green Accepted, Green Submitted			2022-12-18	WOS:000378283200021
J	Halim, TYF; Hwang, YY; Scanlon, ST; Zaghouani, H; Garbi, N; Fallon, PG; McKenzie, ANJ				Halim, Timotheus Y. F.; Hwang, You Yi; Scanlon, Seth T.; Zaghouani, Habib; Garbi, Natalio; Fallon, Padraic G.; McKenzie, Andrew N. J.			Group 2 innate lymphoid cells license dendritic cells to potentiate memory T(H)2 cell responses	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; AIRWAY; LUNG; IMMUNITY; ASTHMA; INFLAMMATION; RECRUITMENT; SUFFICIENT; INDUCTION; CYTOKINES	Rapid activation of memory CD4(+) T helper 2 (T(H)2) cells during allergic inflammation requires their recruitment into the affected tissue. Here we demonstrate that group 2 innate lymphoid (ILC2) cells have a crucial role in memory T(H)2 cell responses, with targeted depletion of ILC2 cells profoundly impairing T(H)2 cell localization to the lungs and skin of sensitized mice after allergen re-challenge. ILC2-derived interleukin 13 (IL-13) is critical for eliciting production of the T(H)2 cell-attracting chemokine CCL17 by IRF4(+)CD11b(+)CD103(-) dendritic cells (DCs). Consequently, the sentinel function of DCs is contingent on ILC2 cells for the generation of an efficient memory T(H)2 cell response. These results elucidate a key innate mechanism in the regulation of the immune memory response to allergens.	[Halim, Timotheus Y. F.; Hwang, You Yi; Scanlon, Seth T.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, Cambs, England; [Zaghouani, Habib] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Garbi, Natalio] Univ Bonn, Dept Mol Immunol, Inst Mol Med, Bonn, Germany; [Garbi, Natalio] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 2, Ireland	MRC Laboratory Molecular Biology; University of Missouri System; University of Missouri Columbia; University of Bonn; University of Bonn; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, Cambs, England.	anm@mrc-lmb.cam.ac.uk	Fallon, Padraic/Y-2711-2019; Halim, Timotheus/B-3117-2018	Fallon, Padraic/0000-0002-8401-7293; Halim, Timotheus/0000-0001-9773-0023; Scanlon, Seth Thomas/0000-0002-1792-6382	UK Medical Research Council [UI05178805]; Wellcome Trust [100963]; Science Foundation Ireland; National Children's Research Centre; A-STAR; Canadian Institutes of Health Research; DFG; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805] Funding Source: researchfish; Wellcome Trust [100963/Z/13/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Children's Research Centre; A-STAR(Agency for Science Technology & Research (A*STAR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); DFG(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the MRC LMB flow core for help with flow cytometry; H.R. Rodewald (Division of Cellular Immunology, German Cancer Research Center) for Il7Ra<SUP>Cre</SUP> mice; and D. Withers (MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham) for advice with 2W1S peptide experiments. Supported by the UK Medical Research Council (UI05178805), the Wellcome Trust (100963) (A.N.J.M.), Science Foundation Ireland and National Children's Research Centre (P.G.F), A-STAR (Y.Y.H.), and the Canadian Institutes of Health Research (T.Y.F.H.). N.G. is a member of the DFG-funded ImmunoSensation Cluster of Excellence.	Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Eiwegger T, 2011, EUR J IMMUNOL, V41, P1535, DOI 10.1002/eji.201141668; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Haymaker CL, 2012, J IMMUNOL, V188, P3208, DOI 10.4049/jimmunol.1103316; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mottram JC, 2003, TRENDS PARASITOL, V19, P182, DOI 10.1016/S1471-4922(03)00038-2; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Stephens R, 2002, J IMMUNOL, V169, P5468, DOI 10.4049/jimmunol.169.10.5468; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	46	207	215	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					57	+		10.1038/ni.3294	http://dx.doi.org/10.1038/ni.3294			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26523868	Green Accepted			2022-12-18	WOS:000366675800011
J	Chen, F; Wu, WH; Millman, A; Craft, JF; Chen, E; Patel, N; Boucher, JL; Urban, JF; Kim, CC; Gause, WC				Chen, Fei; Wu, Wenhui; Millman, Ariel; Craft, Joshua F.; Chen, Eunice; Patel, Nirav; Boucher, Jean L.; Urban, Joseph F., Jr.; Kim, Charles C.; Gause, William C.			Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion	NATURE IMMUNOLOGY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; NIPPOSTRONGYLUS-BRASILIENSIS; T-CELLS; PROTECTIVE IMMUNITY; HOST PROTECTION; INNATE; MEMORY; INFECTION; MICE; RESPONSES	We examined the role of innate cells in acquired resistance to the natural murine parasitic nematode, Nippostrongylus brasiliensis. Macrophages obtained from lungs as late as 45 d after N. brasiliensis inoculation were able to transfer accelerated parasite clearance to naive recipients. Primed macrophages adhered to larvae in vitro and triggered increased mortality of parasites. Neutrophil depletion in primed mice abrogated the protective effects of transferred macrophages and inhibited their in vitro binding to larvae. Neutrophils in parasite-infected mice showed a distinct transcriptional profile and promoted alternatively activated M2 macrophage polarization through secretory factors including IL-13. Differentially activated neutrophils in the context of a type 2 immune response therefore prime a long-lived effector macrophage phenotype that directly mediates rapid nematode damage and clearance.	[Chen, Fei; Wu, Wenhui; Millman, Ariel; Patel, Nirav; Gause, William C.] Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07102 USA; [Chen, Fei; Wu, Wenhui; Millman, Ariel; Patel, Nirav; Gause, William C.] Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 07102 USA; [Craft, Joshua F.; Chen, Eunice] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Boucher, Jean L.] Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Urban, Joseph F., Jr.] USDA ARS, Beltsville Agr Res Ctr, Beltsville Human Nutr Res Ctr, Diet Gen & Immunol Lab, Beltsville, MD 20705 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Francisco; UDICE-French Research Universities; Universite Paris Cite; United States Department of Agriculture (USDA)	Gause, WC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07102 USA.	gausewc@njms.rutgers.edu	Poubelle, Patrice E/G-6537-2013	Kim, Charles/0000-0001-6474-8227; Urban, Joseph/0000-0002-1590-8869	National Institutes of Health [1R01AI107588, 5R01AI031678, R00AI085035]; Agricultural Research Service of the USDA [1235-51000-058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107588, R00AI085035, R01AI031678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agricultural Research Service of the USDA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture (USDA). The USDA is an equal opportunity provider and employer. Supported by National Institutes of Health (1R01AI107588 to W. C. G. and C. C. K.; 5R01AI031678 to W. C. G.; R00AI085035 to C. C. K.) and the Agricultural Research Service of the USDA (1235-51000-058 to J.F.U. Jr.).	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Becker HM, 2013, J IMMUNOL, V190, P4305, DOI 10.4049/jimmunol.1202097; Bonne-Annee S, 2013, INFECT IMMUN, V81, P3346, DOI 10.1128/IAI.00625-13; Bonne-Annee S, 2011, IMMUNOL RES, V51, P205, DOI 10.1007/s12026-011-8258-2; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Ckless K, 2008, J IMMUNOL, V181, P4255, DOI 10.4049/jimmunol.181.6.4255; Dent LA, 1999, INFECT IMMUN, V67, P989, DOI 10.1128/IAI.67.2.989-993.1999; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Galioto AM, 2006, INFECT IMMUN, V74, P5730, DOI 10.1128/IAI.01958-05; GAUSE WC, 1994, PCR METH APPL, V3, pS123; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gaze S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002520; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; Harvie M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00074; Harvie M, 2010, INFECT IMMUN, V78, P3753, DOI 10.1128/IAI.00502-09; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KATONA IM, 1988, J IMMUNOL, V140, P3206; King CH, 2010, ADV PARASIT, V73, P51, DOI 10.1016/S0065-308X(10)73003-7; Knott ML, 2007, INT J PARASITOL, V37, P1367, DOI 10.1016/j.ijpara.2007.04.006; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Liu Q, 2010, J IMMUNOL, V184, P5213, DOI 10.4049/jimmunol.0902879; Liu ZG, 2005, J IMMUNOL, V174, P2242, DOI 10.4049/jimmunol.174.4.2242; Maizels RM, 2012, EXP PARASITOL, V132, P76, DOI 10.1016/j.exppara.2011.08.011; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Morimoto M, 2004, J IMMUNOL, V172, P2424, DOI 10.4049/jimmunol.172.4.2424; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Oo-Puthinan S, 2008, BBA-GEN SUBJECTS, V1780, P89, DOI 10.1016/j.bbagen.2007.10.017; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rosenthal LA, 1996, INFECT IMMUN, V64, P2206, DOI 10.1128/IAI.64.6.2206-2215.1996; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Smith KA, 2012, INFECT IMMUN, V80, P3481, DOI 10.1128/IAI.00436-12; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059441; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	54	207	212	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					938	U237		10.1038/ni.2984	http://dx.doi.org/10.1038/ni.2984			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25173346	Green Accepted, Green Submitted			2022-12-18	WOS:000342564800009
J	Amin, RH; Schlissel, MS				Amin, Rupesh H.; Schlissel, Mark S.			Foxo1 directly regulates the transcription of recombination-activating genes during B cell development	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; INTERLEUKIN-7 RECEPTOR; MAMMALIAN-CELLS; DOWN-REGULATION; CUTTING EDGE; MICE LACKING; HEAVY-CHAIN; DNA-DAMAGE	Regulated expression of the recombinase RAG-1 and RAG-2 proteins is necessary for generating the vast repertoire of antigen receptors essential for adaptive immunity. Here, a retroviral cDNA library screen showed that the stress-regulated protein GADD45a activated transcription of the genes encoding RAG-1 and RAG-2 in transformed pro-B cells by a pathway requiring the transcription factor Foxo1. Foxo1 directly activated transcription of the Rag1-Rag2 locus throughout early B cell development, and a decrease in Foxo1 protein diminished the induction of Rag1 and Rag2 transcription in a model of receptor editing. We also found that transcription of Rag1 and Rag2 was repressed at the pro-B cell and immature B cell stages by the kinase Akt through its 'antagonism' of Foxo1 function. Thus, Foxo1 is a key regulator of Rag1 and Rag2 transcription in primary B cells.	[Amin, Rupesh H.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mss@berkeley.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057487] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL48702, R01 HL048702, R01 HL048702-16] Funding Source: Medline; NIAID NIH HHS [R01 AI57487, R01 AI057487-05, R01 AI057487] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BILLIPS LG, 1995, J EXP MED, V182, P973, DOI 10.1084/jem.182.4.973; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Llorian M, 2007, J IMMUNOL, V178, P1981, DOI 10.4049/jimmunol.178.4.1981; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055	50	207	211	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					613	622		10.1038/ni.1612	http://dx.doi.org/10.1038/ni.1612			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18469817	Green Accepted			2022-12-18	WOS:000256067900011
J	Shi, M; Deng, WW; Bi, EG; Mao, KR; Ji, YY; Lin, GM; Wu, XD; Tao, ZY; Li, ZH; Cai, XF; Sun, SH; Xiang, C; Sun, B				Shi, Mude; Deng, Weiwen; Bi, Enguang; Mao, Kairui; Ji, Yongyong; Lin, Guomei; Wu, Xiaodong; Tao, Zhiyun; Li, Zhenhu; Cai, Xinfen; Sun, Shuhui; Xiang, Charlie; Sun, Bing			TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; RNA INTERFERENCE; UBIQUITIN LIGASE; INNATE IMMUNITY; PROTEIN; TRAF6; PATHWAY; KINASE; EXPRESSION	Toll-like receptor (TLR) signaling is pivotal to innate and adaptive immune responses and must be tightly controlled. The mechanisms of TLR signaling have been the focus of extensive studies. Here we report that the tripartite-motif protein TRIM30 alpha, a RING protein, was induced by TLR agonists and interacted with the TAB2-TAB3-TAK1 adaptor-kinase complex involved in the activation of transcription factor NF-kappa B. TRIM30 alpha promoted the degradation of TAB2 and TAB3 and inhibited NF-kappa B activation induced by TLR signaling. In vivo studies showed that transfected or transgenic mice overexpressing TRIM30a were more resistant to endotoxic shock. Consistent with that, in vivo 'knockdown' of TRIM30a mRNA by small interfering RNA impaired lipopolysaccharide-induced tolerance. Finally, expression of TRIM30a depended on NF-kappa B activation. Our results collectively indicate that TRIM30a negatively regulates TLR-mediated NF-kappa B activation by targeting degradation of TAB2 and TAB3 by a 'feedback' mechanism.	[Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diagnosis & Treatment Infect Dis, Hangzhou 31003, Peoples R China; [Shi, Mude; Deng, Weiwen; Bi, Enguang; Mao, Kairui; Ji, Yongyong; Lin, Guomei; Wu, Xiaodong; Tao, Zhiyun; Li, Zhenhu; Cai, Xinfen; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Sun, Shuhui] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Sun, Bing] Chinese Acad Sci, Inst Pasteur, Shanghai 200025, Peoples R China; [Sun, Bing] Shanghai Univ E Inst, Div Immunol, Shanghai 200025, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiang, C (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diagnosis & Treatment Infect Dis, Hangzhou 31003, Peoples R China.	cxiang@zju.edu.cn; bsun@sibs.ac.cn	BI, ENGUANG/K-4033-2014; Deng, Weiwen/A-1646-2013	BI, ENGUANG/0000-0003-0850-8135				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Hill JA, 2003, J IMMUNOL, V171, P691, DOI 10.4049/jimmunol.171.2.691; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zeng R, 2004, J MOL BIOL, V341, P271, DOI 10.1016/j.jmb.2004.06.016	36	207	225	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					369	377		10.1038/ni1577	http://dx.doi.org/10.1038/ni1577			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18345001				2022-12-18	WOS:000254123200012
J	Saxon, A; Diaz-Sanchez, D				Saxon, A; Diaz-Sanchez, D			Air pollution and allergy: you are what you breathe	NATURE IMMUNOLOGY			English	Editorial Material							S-TRANSFERASE M1; OZONE EXPOSURE; CHALLENGE; RESPONSES	How does air pollution affect asthma and allergic rhinitis? Particulate and gaseous pollution drive proallergic inflammation through the generation of oxidative stress, which is regulated by individual genetic susceptibility.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Clin Immunol,Hart & Louis Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saxon, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Clin Immunol,Hart & Louis Lab, Los Angeles, CA 90095 USA.	ddiazsa@mednet.ucla.edu						Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Chen LL, 2004, CHEST, V125, P2328, DOI 10.1378/chest.125.6.2328; David GL, 2003, AM J RESP CRIT CARE, V168, P1199, DOI 10.1164/rccm.200305-684OC; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; DiazSanchez D, 1997, J IMMUNOL, V158, P2406; Fahy O, 2002, J IMMUNOL, V168, P5912, DOI 10.4049/jimmunol.168.11.5912; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P457, DOI 10.1164/rccm.2112064; Gilliland FD, 2004, LANCET, V363, P119, DOI 10.1016/S0140-6736(03)15262-2; Heinrich J, 2004, CURR OPIN ALLERGY CL, V4, P341, DOI 10.1097/00130832-200410000-00003; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912; LONDON SJ, 1995, J NATL CANCER I, V87, P1246, DOI 10.1093/jnci/87.16.1246; Romieu I, 2004, THORAX, V59, P8; Shore SA, 2001, AM J RESP CRIT CARE, V164, P602, DOI 10.1164/ajrccm.164.4.2001016; Takizawa H, 2004, CURR OPIN ALLERGY CL, V4, P355, DOI 10.1097/00130832-200410000-00005; Todokoro M, 2004, INFLAMMATION, V28, P105, DOI 10.1023/B:IFLA.0000033026.91221.ed; U. S. EPA, 1997, NAT AIR POLL EM TREN; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Yang IA, 2005, AM J RESP CRIT CARE, V171, P171, DOI 10.1164/rccm.200402-194OC	20	207	215	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					223	226		10.1038/ni0305-223	http://dx.doi.org/10.1038/ni0305-223			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716966				2022-12-18	WOS:000227117400002
J	Andrews, LP; Yano, H; Vignali, DAA				Andrews, Lawrence P.; Yano, Hiroshi; Vignali, Dario A. A.			Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; MHC CLASS-II; COSTIMULATORY MOLECULE; ACQUIRED-RESISTANCE; ANTITUMOR IMMUNITY; UP-REGULATION; CUTTING EDGE; LAG-3; TIM-3; EXPRESSION	Although immunotherapeutics targeting the inhibitory receptors (IRs) CTLA-4, PD-1 or PD-L1 have made substantial clinical progress in cancer, a considerable proportion of patients remain unresponsive to treatment. Targeting novel IR-ligand pathways in combination with current immunotherapies may improve clinical outcomes. New clinical immunotherapeutics target T cell-expressed IRs (LAG-3, TIM-3 and TIGIT) as well as inhibitory ligands in the B7 family (B7-H3, B7-H4 and B7-H5), although many of these targets have complex biologies and unclear mechanisms of action. With only modest clinical success in targeting these IRs, current immunotherapeutic design may not be optimal. This Review covers the biology of targeting novel IR-ligand pathways and the current clinical status of their immunotherapeutics, either as monotherapy or in combination with antibody to PD-1 or to its ligand PD-L1. Further understanding of the basic biology of these targets is imperative to the development of effective cancer immunotherapies.	[Andrews, Lawrence P.; Yano, Hiroshi; Vignali, Dario A. A.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15260 USA; [Yano, Hiroshi] Univ Pittsburgh, Sch Med, Grad Program Microbiol & Immunol, Pittsburgh, PA USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vignali, DAA (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15260 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu		Yano, Hiroshi/0000-0002-3098-2629; Vignali, Dario/0000-0002-2771-5992	US National Institutes of Health [P01 AI108545, R01 CA203689, R01 AI144422]; NCI Comprehensive Cancer Center [CA047904]; NATIONAL CANCER INSTITUTE [R01CA203689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI144422] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank C. Workman, A. Somasundaram, D. Zandberg and J. Luke for comments. Supported by the US National Institutes of Health (P01 AI108545, R01 CA203689, and R01 AI144422 to D.A.A.V.) and an NCI Comprehensive Cancer Center Support CORE grant (CA047904 to D.A.A.V.).	Aggarwal C., 2018, J IMMUNOTHER CANCER, V6, P115; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Ascierto P. A., 2017, ANN ONCOL, V28, P403; Blando J, 2019, P NATL ACAD SCI USA, V116, P1692, DOI 10.1073/pnas.1811067116; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6; Burvenich IJG, 2018, THERANOSTICS, V8, P4199, DOI 10.7150/thno.25575; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Donia M, 2015, CANCER RES, V75, P3747, DOI 10.1158/0008-5472.CAN-14-2956; Dougall WC, 2017, IMMUNOL REV, V276, P112, DOI 10.1111/imr.12518; Fourcade J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121157; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Foy SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150084; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gao JJ, 2017, NAT MED, V23, P551, DOI 10.1038/nm.4308; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; HARDING J, 2019, J CLIN ONCOL, V37; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang RY, 2015, ONCOTARGET, V6, P27359, DOI 10.18632/oncotarget.4751; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; Isshiki T, 2017, J IMMUNOL, V199, P3733, DOI 10.4049/jimmunol.1700059; Jeon H, 2014, CELL REP, V9, P1089, DOI 10.1016/j.celrep.2014.09.053; Jie HB, 2017, CANCER IMMUNOL RES, V5, P408, DOI 10.1158/2326-6066.CIR-16-0333; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jing WQ, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-014-0043-z; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kakavand H, 2017, MODERN PATHOL, V30, P1666, DOI 10.1038/modpathol.2017.89; Kaplan CD, 2017, ANN ONCOL, V28; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Kraman M, 2017, J IMMUNOTHER CANCER, V5; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Ledford H, 2018, NATURE, V562, P20, DOI 10.1038/d41586-018-06751-0; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Liang S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3074; Liu LQ, 2017, CLIN CANCER RES, V23, P1506, DOI 10.1158/1078-0432.CCR-16-0666; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Loos M, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/683875; Lucca LE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124427; Mao L, 2017, J CELL MOL MED, V21, P2199, DOI 10.1111/jcmm.13143; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Murter B, 2019, CANCER IMMUNOL RES, V7, P244, DOI 10.1158/2326-6066.CIR-18-0460; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Nishiwada S, 2015, ANTICANCER RES, V35, P2287; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Powderly J, 2017, ANN ONCOL, V28; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rader C, 2011, BLOOD, V117, P4403, DOI 10.1182/blood-2011-02-337691; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sabatos-Peyton CA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1385690; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scarpati GD, 2014, ONCOTARGETS THER, V7, P203, DOI 10.2147/OTT.S57335; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trujillo JA, 2018, CANCER IMMUNOL RES, V6, P990, DOI 10.1158/2326-6066.CIR-18-0277; Tsimberidou AM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA2553; Veenstra RG, 2015, BLOOD, V125, P3335, DOI 10.1182/blood-2014-09-603357; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Whelan S, 2019, CANCER IMMUNOL RES, V7, P257, DOI 10.1158/2326-6066.CIR-18-0442; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Xu F, 2014, CANCER RES, V74, P3418, DOI 10.1158/0008-5472.CAN-13-2690; Yan Ruhong, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P395, DOI 10.1089/mab.2013.0052; Yu MM, 2017, MOL MED REP, V15, P689, DOI 10.3892/mmr.2016.6065; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569; Zhang Y, 2017, INT IMMUNOPHARMACOL, V43, P210, DOI 10.1016/j.intimp.2016.12.024; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu YW, 2016, J EXP MED, V213, P167, DOI 10.1084/jem.20150785	100	206	217	14	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1425	1434		10.1038/s41590-019-0512-0	http://dx.doi.org/10.1038/s41590-019-0512-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31611702				2022-12-18	WOS:000492309600013
J	Liu, XG; Zhan, ZZ; Li, D; Xu, L; Ma, F; Zhang, P; Yao, HP; Cao, XT				Liu, Xingguang; Zhan, Zhenzhen; Li, Dong; Xu, Li; Ma, Feng; Zhang, Peng; Yao, Hangping; Cao, Xuetao			Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk	NATURE IMMUNOLOGY			English	Article							BRUTONS TYROSINE KINASE; MAJOR HISTOCOMPATIBILITY COMPLEX; TUMOR-NECROSIS-FACTOR; RECEPTOR; EXPRESSION; CYTOKINE; BINDING; DOMAIN; CD40; PHOSPHORYLATION	The molecular mechanisms involved in the full activation of innate immunity achieved through Toll-like receptors (TLRs) remain to be fully elucidated. In addition to their classical antigen-presenting function, major histocompatibility complex (MHC) class II molecules might mediate reverse signaling. Here we report that deficiency in MHC class II attenuated the TLR-triggered production of proinflammatory cytokines and type I interferon in macrophages and dendritic cells, which protected mice from endotoxin shock. Intracellular MHC class II molecules interacted with the tyrosine kinase Btk via the costimulatory molecule CD40 and maintained Btk activation, but cell surface MHC class II molecules did not. Then, Btk interacted with the adaptor molecules MyD88 and TRIF and thereby promoted TLR signaling. Therefore, intracellular MHC class II molecules can act as adaptors, promoting full activation of TLR-triggered innate immune responses.	[Liu, Xingguang; Zhan, Zhenzhen; Xu, Li; Zhang, Peng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Liu, Xingguang; Zhan, Zhenzhen; Xu, Li; Zhang, Peng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Li, Dong; Ma, Feng; Yao, Hangping] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Beijing 100037, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@immunol.org	Ma, Feng/E-7927-2015	Liu, Xingguang/0000-0002-1928-8847	National Key Basic Research Program of China [2007CB512403]; National 115 Key Project [2008ZX10002-008, 2009ZX09503-023]; National Natural Science Foundation of China [30721091]	National Key Basic Research Program of China(National Basic Research Program of China); National 115 Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank P. Ma, M. Jin and Y. Li for technical assistance; and N. Li, H. An, T. Chen, S. Xu and C. Han for discussions. Supported by the National Key Basic Research Program of China (2007CB512403), National 115 Key Project (2008ZX10002-008, 2009ZX09503-023) and the National Natural Science Foundation of China (30721091).	Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; APPEL SH, 1989, J SURG RES, V47, P39, DOI 10.1016/0022-4804(89)90045-0; Astiz M, 1996, J LAB CLIN MED, V128, P594, DOI 10.1016/S0022-2143(96)90132-8; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beharka AA, 1998, IN VITRO CELL DEV-AN, V34, P499; BISHOP GA, 1991, J IMMUNOL, V147, P1107; BONNEFOY JY, 1988, J EXP MED, V167, P57, DOI 10.1084/jem.167.1.57; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; Brunner C, 2002, IMMUNOBIOLOGY, V206, P432, DOI 10.1078/0171-2985-00192; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; CAMBIER JC, 1987, NATURE, V327, P629, DOI 10.1038/327629a0; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Drenou B, 1999, J IMMUNOL, V163, P4115; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; HARTON JA, 1993, J IMMUNOL, V151, P5282; HARTON JA, 1995, IMMUNITY, V3, P349, DOI 10.1016/1074-7613(95)90119-1; HAUSCHILDT S, 1993, EUR J IMMUNOL, V23, P2988, DOI 10.1002/eji.1830231139; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; LANE PJL, 1990, J IMMUNOL, V144, P3684; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Leveille C, 1999, EUR J IMMUNOL, V29, P65, DOI 10.1002/(SICI)1521-4141(199901)29:01<65::AID-IMMU65>3.0.CO;2-E; Leveille C, 1999, EUR J IMMUNOL, V29, P3516, DOI 10.1002/(SICI)1521-4141(199911)29:11<3516::AID-IMMU3516>3.3.CO;2-4; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; McDevitt HO, 2000, ANNU REV IMMUNOL, V18, P1, DOI 10.1146/annurev.immunol.18.1.1; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MOURAD W, 1990, J EXP MED, V172, P1513, DOI 10.1084/jem.172.5.1513; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Piani A, 2000, EUR J IMMUNOL, V30, P3140, DOI 10.1002/1521-4141(200011)30:11<3140::AID-IMMU3140>3.0.CO;2-O; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; SPERTINI F, 1992, J IMMUNOL, V149, P65; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TREDE NS, 1991, J IMMUNOL, V146, P2310; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742	48	206	221	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					416	U71		10.1038/ni.2015	http://dx.doi.org/10.1038/ni.2015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21441935				2022-12-18	WOS:000289666600012
J	Kim, C; Sano, Y; Todorova, K; Carlson, BA; Arpa, L; Celada, A; Lawrence, T; Otsu, K; Brissette, JL; Arthur, JSC; Park, JM				Kim, Chun; Sano, Yasuyo; Todorova, Kristina; Carlson, Bradley A.; Arpa, Luis; Celada, Antonio; Lawrence, Toby; Otsu, Kinya; Brissette, Janice L.; Arthur, J. Simon C.; Park, Jin Mo			The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; INNATE IMMUNE-RESPONSES; P38 MAP KINASE; NF-KAPPA-B; SUBSTRATE-SPECIFICITY; MACROPHAGE APOPTOSIS; INHIBITION; STRESS; INTERLEUKIN-10; PHOSPHATASE-1	The mitogen-activated protein kinase p38 mediates cellular responses to injurious stress and immune signaling. Among the many p38 isoforms, p38 alpha is the most widely expressed in adult tissues and can be targeted by various pharmacological inhibitors. Here we investigated how p38 alpha activation is linked to cell type-specific outputs in mouse models of cutaneous inflammation. We found that both myeloid and epithelial p38 alpha elicit inflammatory responses, yet p38 alpha signaling in each cell type served distinct inflammatory functions and varied depending on the mode of skin irritation. In addition, myeloid p38 alpha limited acute inflammation via activation of anti-inflammatory gene expression dependent on mitogen -and stress-activated kinases. Our results suggest a dual function for p38 alpha in the regulation of inflammation and show mixed potential for its inhibition as a therapeutic strategy.	[Kim, Chun; Sano, Yasuyo; Todorova, Kristina; Brissette, Janice L.; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Kim, Chun; Sano, Yasuyo; Todorova, Kristina; Brissette, Janice L.; Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,Natl Inst Hlth, Bethesda, MD 20892 USA; [Arpa, Luis; Celada, Antonio] Univ Barcelona, E-08028 Barcelona, Spain; [Arpa, Luis; Celada, Antonio] Inst Biomed Res, Macrophage Biol Grp, Barcelona 08028, Spain; [Lawrence, Toby] Barts & London Queen Marys Sch Med & Dent, Ctr Translat Oncol, Inst Canc, London EC1M 6BQ, England; [Lawrence, Toby] Barts & London Queen Marys Sch Med & Dent, Ctr Translat Oncol, CR UK Clin Ctr, London EC1M 6BQ, England; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Arthur, J. Simon C.] Univ Dundee, MRC, Prot Phosphorylat Unit, Sir James Black Ctr, Dundee DD1 5EH, Scotland	Harvard University; Massachusetts General Hospital; Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Royal Marsden NHS Foundation Trust; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; University of London; Queen Mary University London; Osaka University; University of Dundee	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu	Arthur, J. Simon/B-8058-2010; Lawrence, Toby/GLU-3895-2022; Celada, Antonio/I-1714-2016	Arthur, J. Simon/0000-0002-8135-1958; Lawrence, Toby/0000-0003-0967-6122; Kim, Chun/0000-0001-9497-708X; Celada, Antonio/0000-0003-3883-2171	Cutaneous Biology Research Center; US National Institutes of Health [DK043351]; Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital; Medical Research Council [MC_U127081014] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045284, R01AR055218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; MRC [MC_U127081014] Funding Source: UKRI	Cutaneous Biology Research Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Krane (Massachusetts General Hospital) for the MMP-13-specific antibody and advice on its use; D. Ginsburg (University of Michigan School of Medicine) for the PAI-2-specific antibody; R. Bravo (Bristol-Myers Squibb Pharmaceutical Research Institute) and C. Caelles (Institute for Research in Biomedicine, Barcelona) for Dusp1-KO mice; and M. Karin for discussion about Jnk-activation mechanisms in p38 alpha-deficient cells. Supported by the Cutaneous Biology Research Center through the Massachusetts General Hospital-Shiseido Agreement (J. M. P.), the US National Institutes of Health (DK043351 to D. Podolsky) and the Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital (J. M. P.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; ANANIEVA O, NAT IMMUNOL IN PRESS; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dambach DM, 2005, CURR TOP MED CHEM, V5, P929, DOI 10.2174/1568026054985911; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hale KK, 1999, J IMMUNOL, V162, P4246; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thepen T, 2000, NAT BIOTECHNOL, V18, P48, DOI 10.1038/71908; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	50	206	210	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1019	1027		10.1038/ni.1640	http://dx.doi.org/10.1038/ni.1640			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18677317	Green Accepted			2022-12-18	WOS:000258559600014
J	Corry, DB; Rishi, K; Kanellis, J; Kiss, A; Song, LZ; Xu, J; Feng, LL; Werb, Z; Kheradmand, F				Corry, DB; Rishi, K; Kanellis, J; Kiss, A; Song, LZ; Xu, J; Feng, LL; Werb, Z; Kheradmand, F			Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency	NATURE IMMUNOLOGY			English	Article							NEAR-FATAL ASTHMA; MATRIX METALLOPROTEINASES; MURINE MODEL; AIRWAY HYPERREACTIVITY; IL-13; EOSINOPHILS; MIGRATION; EXPRESSION; GELATINASE; INHIBITION	Clearance of recruited immune cells is necessary to resolve inflammatory reactions. We show here that matrix metalloproteinase 2 (MMP2), as part of an interleukin 13 (IL-13)-dependent regulatory loop, dampens inflammation by promoting the egress of inflammatory cells into the airway lumen. MMP2(-/-) mice showed a robust asthma phenotype and increased susceptibility to asphyxiation induced by allergens. However, whereas the lack of MMP2 reduced the influx of cells into bronchoalveolar lavage (BAL), numerous inflammatory cells accumulated in the lung parenchyma. BAL of MMP2(-/-) mice lacked normal chemotactic activity, whereas lung inflammatory cells from the same mice showed appropriate chemotactic responses. Thus, MMP2 establishes the chemotactic gradient required for egression of lung inflammatory cells and prevention of lethal asphyxiation.	Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco	Kheradmand, F (corresponding author), Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA.	dcorry@bcm.tmc.edu; farrahk@bcm.tmc.edu	Kanellis, John/AAD-9069-2019	Kanellis, John/0000-0002-2748-5955	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069585, K08HL003732, K08HL003344, R01HL064061] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL003344-04, K08 HL03732, R01 HL069585, R01 HL69585, R01 HL64061, R01 HL064061, K08 HL03344, K08 HL003344, K08 HL003732-02, R01 HL069585-03, R01 HL064061-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander CM, 1996, DEVELOPMENT, V122, P1723; AZZAWI M, 1992, AM REV RESPIR DIS, V145, P1477, DOI 10.1164/ajrccm/145.6.1477; Baggiolini M, 2000, IMMUNOL REV, V177, P5, DOI 10.1034/j.1600-065X.2000.17722.x; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Barnes PJ, 1996, BRIT J CLIN PHARMACO, V42, P3, DOI 10.1046/j.1365-2125.1996.03721.x; Barnes PJ, 2001, PULM PHARMACOL THER, V14, P1, DOI 10.1006/pupt.2000.0263; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; Cataldo D, 2000, INT ARCH ALLERGY IMM, V123, P259, DOI 10.1159/000024452; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; Chin JR, 1997, DEVELOPMENT, V124, P1519; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Corry DB, 1999, CURR OPIN IMMUNOL, V11, P610, DOI 10.1016/S0952-7915(99)00025-4; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; Doucet C, 1998, J CLIN INVEST, V101, P2129, DOI 10.1172/JCI741; DUBOIS GR, 1994, ANN NY ACAD SCI, V725, P268, DOI 10.1111/j.1749-6632.1994.tb39809.x; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GALARDY RE, 1994, CANCER RES, V54, P4715; GOLDSTEIN RA, 1994, ANN INTERN MED, V121, P698, DOI 10.7326/0003-4819-121-9-199411010-00011; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Haas TL, 1999, TRENDS CARDIOVAS MED, V9, P70, DOI 10.1016/S1050-1738(99)00014-6; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Holia LI, 2000, ALLERGY, V55, P900, DOI 10.1034/j.1398-9995.2000.00736.x; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; KIKUCHI Y, 1994, NEW ENGL J MED, V330, P1329, DOI 10.1056/NEJM199405123301901; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kumagai K, 1999, J IMMUNOL, V162, P4212; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Madri JA, 1996, BIOCHEM CELL BIOL, V74, P749, DOI 10.1139/o96-082; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Milik AM, 1997, J CLIN INVEST, V99, P1082, DOI 10.1172/JCI119236; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; MOLFINO NA, 1991, NEW ENGL J MED, V324, P285, DOI 10.1056/NEJM199101313240502; Murata T, 1997, BIOCHEM BIOPH RES CO, V238, P90, DOI 10.1006/bbrc.1997.7248; Okada S, 1997, AM J RESP CELL MOL, V17, P519, DOI 10.1165/ajrcmb.17.4.2877; REPONEN P, 1992, J BIOL CHEM, V267, P7856; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Savill John, 2000, Kidney and Blood Pressure Research, V23, P173; Sears MR, 2000, CLIN CHEST MED, V21, P315, DOI 10.1016/S0272-5231(05)70269-0; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	48	206	211	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					347	353		10.1038/ni773	http://dx.doi.org/10.1038/ni773			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11887181	Green Accepted			2022-12-18	WOS:000174623600015
J	Ioannidis, V; Beermann, F; Clevers, H; Held, W				Ioannidis, V; Beermann, F; Clevers, H; Held, W			The beta-catenin-TCF-I pathway ensures CD4(+)CD8(+) thymocyte survival	NATURE IMMUNOLOGY			English	Article							RECEPTOR-DEFICIENT MICE; INHIBITS MULTIPLE FORMS; CELL-DEATH; TRANSCRIPTION FACTOR; NEGATIVE SELECTION; CYCLE PROGRESSION; TUMOR-SUPPRESSOR; TRANSGENIC MICE; HMG-BOX; BCL-2	The association of trans-actingT cell factors (TCFs) or lymphoid enhancer factor I (LEF-I) with their coactivator beta -catenin mediates transient transcriptional responses to extracellular Wnt signals. We show here that T cell maturation depends on the presence of the beta -catenin-binding domain in TCF-I. This domain is necessary to mediate the survival of immature CD4+CD8+ double-positive (DP) thymocytes. Accelerated spontaneous thymocyte death in the absence of TCF-I correlates with aberrantly low expression of the anti-apoptotic protein Bcl-x(L). Increasing anti-apoptotic effectors in thymocytes by the use of a Bcl-2 transgene rescued TCF-I-deficient DP thymocytes from apoptosis. Thus, TCF-I, upon association with beta -catenin, transiently ensures the survival of immature T cells, which enables them to generate and edit T cell receptor (TCR) alpha chains and attempt TCR-mediated positive selection.	Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ Utrecht Hosp, Dept Immunol, NL-3584 CX Utrecht, Netherlands	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute Experimental Cancer Research; Utrecht University; Utrecht University Medical Center	Held, W (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.			Ioannidis, Vassilios/0000-0002-4209-2578				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CASTROP J, 1995, BLOOD, V86, P3050, DOI 10.1182/blood.V86.8.3050.bloodjournal8683050; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Grillot DAM, 1997, J IMMUNOL, V158, P4750; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; OREILLY LA, 1996, EMBO J, V15, P6970; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Schilham MW, 1998, J IMMUNOL, V161, P3984; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0	48	206	213	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					691	697		10.1038/90623	http://dx.doi.org/10.1038/90623			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477404				2022-12-18	WOS:000170230100010
J	Orr, MT; Murphy, WJ; Lanier, LL				Orr, Mark T.; Murphy, William J.; Lanier, Lewis L.			'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; COMPLEX CLASS-I; DEFICIENT HEMATOPOIETIC-CELLS; INHIBITORY RECEPTORS; MURINE CYTOMEGALOVIRUS; TYROSINE PHOSPHATASE; ACTIVATION RECEPTOR; INNATE RESISTANCE; SELF-TOLERANCE; MISSING SELF	Natural killer (NK) cells expressing inhibitory receptors that bind to self major histocompatibility complex (MHC) class I are 'licensed', or rendered functionally more responsive to stimulation, whereas 'unlicensed' NK cells lacking receptors for self MHC class I are hyporesponsive. Here we show that contrary to the licensing hypothesis, unlicensed NK cells were the main mediators of NK cell-mediated control of mouse cytomegalovirus infection in vivo. Depletion of unlicensed NK cells impaired control of viral titers, but depletion of licensed NK cells did not. The transfer of unlicensed NK cells was more protective than was the transfer of licensed NK cells. Signaling by the tyrosine phosphatase SHP-1 limited the proliferation of licensed NK cells but not that of unlicensed NK cells during infection. Thus, unlicensed NK cells are critical for protection against viral infection.	[Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Murphy, William J.] Univ Calif Davis, Dept Dermatol, Davis Hlth Syst, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Orr, Mark/0000-0003-2684-4722	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897, R01AI068129] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI066897, AI066897, R01 AI068129, R01 AI068129-10] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adam SG, 2006, J IMMUNOL, V176, P5478, DOI 10.4049/jimmunol.176.9.5478; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Clausen J, 2007, CLIN EXP IMMUNOL, V148, P520, DOI 10.1111/j.1365-2249.2007.03360.x; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; KOSZINOWSKI UH, 1990, CURR TOP MICROBIOL, V154, P189; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Merck E, 2009, J IMMUNOL, V182, P183, DOI 10.4049/jimmunol.182.1.183; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Orr MT, 2009, J EXP MED, V206, P807, DOI 10.1084/jem.20090168; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reusch U, 1999, EMBO J, V18, P1081, DOI 10.1093/emboj/18.4.1081; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sobecks RM, 2007, BONE MARROW TRANSPL, V39, P417, DOI 10.1038/sj.bmt.1705609; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; TAY CH, 1995, J IMMUNOL, V154, P780; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Tripathy SK, 2006, J VIROL, V80, P545, DOI 10.1128/JVI.80.1.545-550.2006; Velardi A, 2008, CURR OPIN IMMUNOL, V20, P581, DOI 10.1016/j.coi.2008.07.004; Wu MF, 1997, J IMMUNOL, V158, P1628; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977; Yu JL, 2009, BLOOD, V113, P3875, DOI 10.1182/blood-2008-09-177055; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	50	205	212	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					321	U29		10.1038/ni.1849	http://dx.doi.org/10.1038/ni.1849			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20190757	Green Accepted, Green Submitted			2022-12-18	WOS:000275849500011
J	Ballesteros-Tato, A; Leon, B; Lund, FE; Randall, TD				Ballesteros-Tato, Andre; Leon, Beatriz; Lund, Frances E.; Randall, Troy D.			Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza	NATURE IMMUNOLOGY			English	Article							IN-VIVO; LYMPH-NODE; ANTIGEN PRESENTATION; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; LIGAND CD70; VIRUS; INDUCTION; ACTIVATION; INFECTION	The question of which dendritic cells (DCs) respond to pulmonary antigens and cross-prime CD8(+) T cells remains controversial. We show here that influenza-specific CD8(+) T cell priming was controlled by different DCs at different times after infection. Whereas early priming was controlled by both CD103(+)CD11b(lo) and CD103-CD11b(hi) DCs, CD103-CD11b(hi) DCs dominated antigen presentation at the peak of infection. Moreover, CD103-CD11b(hi) DCs captured exogenous antigens in the lungs and directly cross-primed CD8(+) T cells in the draining lymph nodes without transferring antigen to CD8(alpha)(+) DCs. Finally, we show that CD103-CD11b(hi) DCs were the only DCs to express CD70 after influenza infection and that CD70 expression on CD103-CD11b(hi) DCs licensed them to expand CD8(+) T cell populations responding to both influenza and exogenous ovalbumin.	[Ballesteros-Tato, Andre; Leon, Beatriz; Lund, Frances E.; Randall, Troy D.] Univ Rochester, Div Allergy Immunol & Rheumatol, Rochester, NY 14627 USA	University of Rochester	Randall, TD (corresponding author), Univ Rochester, Div Allergy Immunol & Rheumatol, Rochester, NY 14627 USA.	troy_randall@urmc.rochester.edu		Ballesteros-Tato, Andre/0000-0002-4833-593X	University of Rochester and the National Institutes of Health [AI61511, HL69409, AI06856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061511] Funding Source: NIH RePORTER	University of Rochester and the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. LaMere and K. Martin for animal husbandry, and the members of the University of Rochester Medical Center Flow Cytometry Core Facility for cell sorting. Supported by the University of Rochester and the National Institutes of Health (AI61511 and HL69409 to T. D. R., and AI06856 to F. E. L.).	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Chung Y, 2007, EUR J IMMUNOL, V37, P1453, DOI 10.1002/eji.200636544; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dolfi DV, 2008, J IMMUNOL, V180, P2912, DOI 10.4049/jimmunol.180.5.2912; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Keller AM, 2009, BLOOD, V113, P5167, DOI 10.1182/blood-2008-03-148007; Keller AM, 2008, IMMUNITY, V29, P934, DOI 10.1016/j.immuni.2008.10.009; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Masten BJ, 2004, J IMMUNOL, V172, P4077, DOI 10.4049/jimmunol.172.7.4077; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368	43	205	207	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					216	U4		10.1038/ni.1838	http://dx.doi.org/10.1038/ni.1838			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20098442	Green Accepted			2022-12-18	WOS:000274605800009
J	Ebert, PJR; Jiang, S; Xie, JM; Li, QJ; Davis, MM				Ebert, Peter J. R.; Jiang, Shan; Xie, Jianming; Li, Qi-Jing; Davis, Mark M.			An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a	NATURE IMMUNOLOGY			English	Article							IN-VIVO; RECEPTOR; ANTIGEN; SELF; ACTIVATION; THYMUS; RECOGNITION; DIFFERENTIATION; PROLIFERATION; ACCUMULATION	Thymic positive selection is based on the interactions of T cell antigen receptors (TCRs) with self peptide-major histocompatibility complex (MHC) ligands, but the identity of selecting peptides for MHC class II-restricted TCRs and the functional consequences of this peptide specificity are not clear. Here we identify several endogenous self peptides that positively selected the MHC class II-restricted 5C.C7 TCR. The most potent of these also enhanced mature T cell activation, which supports the hypothesis that one function of positive selection is to produce T cells that can use particular self peptide-MHC complexes for activation and/or homeostasis. We also show that inhibiting the microRNA miR-181a resulted in maturation of T cells that overtly reacted toward these erstwhile positively selecting peptides. Therefore, miR-181a helps to guarantee the clonal deletion of particular moderate-affinity clones by modulating the TCR signaling threshold of thymocytes.	[Jiang, Shan; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA; [Ebert, Peter J. R.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Ebert, Peter J. R.; Xie, Jianming; Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Duke University; Stanford University; Howard Hughes Medical Institute; Stanford University	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.	qi-jing.li@duke.edu; mmdavis@stanford.edu	Xie, Jianming/AAC-6359-2019; Xie, Jianming/G-6567-2012	Xie, Jianming/0000-0003-4112-650X; Davis, Mark/0000-0001-6868-657X	Howard Hughes Medical Institute; Duke University; US National Institutes of Health [RO1 AIO22511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073724, R37AI022511, R01AI022511] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Duke University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Allen (Washington University) for peptide sequence data and critical discussions; C.-Z. Chen for comments on the manuscript; D. Mathis and C. Benoist (Harvard University) for Ii-deficient mice; E. W. Newell and Y. Wong for help with cell sorting; and T. Mao for help with RNA blot analysis. Supported by the Howard Hughes Medical Institute (P. J. R. E. and M. M. D.), Duke University (Q.-J. L.) and the US National Institutes of Health (RO1 AIO22511).	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Baldwin KK, 1999, J EXP MED, V189, P13, DOI 10.1084/jem.189.1.13; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chu HH, 2009, P NATL ACAD SCI USA, V106, P11241, DOI 10.1073/pnas.0902015106; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; HAYASHI H, 1992, J IMMUNOL, V149, P1223; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Leung AKL, 2006, COLD SPRING HARB SYM, V71, P29, DOI 10.1101/sqb.2006.71.049; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Okazaki N, 2003, DNA RES, V10, P35, DOI 10.1093/dnares/10.1.35; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; REAY PA, 1994, J IMMUNOL, V152, P3946; Reddy J, 2003, J IMMUNOL, V170, P870, DOI 10.4049/jimmunol.170.2.870; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; Stefanski HE, 2000, J IMMUNOL, V164, P3519, DOI 10.4049/jimmunol.164.7.3519; TOURNE S, 1995, EUR J IMMUNOL, V25, P1851, DOI 10.1002/eji.1830250709; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wu TY, 2005, J VIROL, V79, P9677, DOI 10.1128/JVI.79.15.9677-9684.2005; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	53	205	211	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1162	U44		10.1038/ni.1797	http://dx.doi.org/10.1038/ni.1797			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19801983	Green Accepted			2022-12-18	WOS:000270955900008
J	Ermolaeva, MA; Michallet, MC; Papadopoulou, N; Utermohlen, O; Kranidioti, K; Kollias, G; Tschopp, J; Pasparakis, M				Ermolaeva, Maria A.; Michallet, Marie-Cecile; Papadopoulou, Nikoletta; Utermoehlen, Olaf; Kranidioti, Ksanthi; Kollias, George; Tschopp, Juerg; Pasparakis, Manolis			Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOMAIN KINASE RIP; CELL-DEATH; TARGETED DISRUPTION; REGULATORY FACTOR-3; TNF-ALPHA; ACTIVATION; MICE; APOPTOSIS; PROTEIN	Tumor necrosis factor receptor 1 (TNFR1) and Toll-like receptors (TLRs) regulate immune and inflammatory responses. Here we show that the TNFR1-associated death domain protein (TRADD) is critical in TNFR1, TLR3 and TLR4 signaling. TRADD deficiency abrogated TNF-induced apoptosis, prevented recruitment of the ubiquitin ligase TRAF2 and ubiquitination of the adaptor RIP1 in the TNFR1 signaling complex, and considerably inhibited but did not completely abolish activation of the transcription factor NF-kappa B and mitogen-activated protein kinases 'downstream' of TNFR1. TRIF-dependent cytokine production induced by the synthetic double-stranded RNA poly(I: C) and lipopolysaccharide was lower in TRADD-deficient mice than in wild-type mice. Moreover, TRADD deficiency inhibited poly(I: C)-mediated RIP1 ubiquitination and activation of NF-kappa B and mitogen-activated protein kinase signaling in fibroblasts but not in bone marrow macrophages. Thus, TRADD is an essential component of TNFR1 signaling and has a critical but apparently cell type-specific function in TRIF-dependent TLR responses.	[Ermolaeva, Maria A.; Papadopoulou, Nikoletta; Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med, D-50674 Cologne, Germany; [Ermolaeva, Maria A.; Papadopoulou, Nikoletta; Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Ermolaeva, Maria A.; Pasparakis, Manolis] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Michallet, Marie-Cecile; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Utermoehlen, Olaf] Univ Cologne, Med Ctr, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Kranidioti, Ksanthi; Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece	University of Cologne; University of Cologne; European Molecular Biology Laboratory (EMBL); University of Lausanne; University of Cologne; Alexander Fleming Biomedical Sciences Research Center	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Kollias, George/A-7079-2012; Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019	Kollias, George/0000-0003-1867-3150; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966	European Union (MUGEN) [LSHG-CT-2005-005203]; IMDEMI [MRTN-CT-2004-005632]; Deutsche Forschungsgemeinschaft [SFB 670]; Louis-Jeantet foundation	European Union (MUGEN)(European Commission); IMDEMI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Louis-Jeantet foundation	We thank C. Uthoff-Hachenberg and U. Karow for technical assistance; B. Coornaert and N. Hermance for advice on the RIP1 ubiquitination assays; C. Libert (Flanders Institute for Biotechnology) for recombinant TNF; K. Pfeffer (Heinrich-Heine University) for mice lacking TNFR1; S. Akira (Osaka University) for mice lacking MyD88; and D. V. Goeddel (Tularik) for pRK5-TRADD. Supported by the Sixth Research Framework Programme of the European Union (MUGEN (LSHG-CT-2005-005203) and IMDEMI (MRTN-CT-2004-005632)), Deutsche Forschungsgemeinschaft (SFB 670) and the Louis-Jeantet foundation (M. E.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 1998, J EXP MED, V188, P745, DOI 10.1084/jem.188.4.745; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KELLY BS, 1979, IMMUNOLOGY, V37, P45; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasparakis Manolis, 1996, Cytokine and Growth Factor Reviews, V7, P223, DOI 10.1016/S1359-6101(96)00031-7; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	40	205	215	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1037	1046		10.1038/ni.1638	http://dx.doi.org/10.1038/ni.1638			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18641654				2022-12-18	WOS:000258559600016
J	Vennekens, R; Olausson, J; Meissner, M; Bloch, W; Mathar, I; Philipp, SE; Schmitz, F; Weissgerber, P; Nilius, B; Flockerzi, V; Freichel, M				Vennekens, Rudi; Olausson, Jenny; Meissner, Marcel; Bloch, Wilhelm; Mathar, Ilka; Philipp, Stephan E.; Schmitz, Frank; Weissgerber, Petra; Nilius, Bernd; Flockerzi, Veit; Freichel, Marc			Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4	NATURE IMMUNOLOGY			English	Article							A(3) ADENOSINE RECEPTOR; PATCH-CLAMP TECHNIQUES; CAPACITANCE MEASUREMENTS; SYNERGISTIC SIGNALS; IMMUNE-RESPONSES; RBL-2H3 CELLS; CA2+; DEPOLARIZATION; EXOCYTOSIS; PHOSPHOINOSITIDE-3-KINASE-GAMMA	Mast cells are key effector cells in allergic reactions. Aggregation of the receptor Fc epsilon RI in mast cells triggers the influx of calcium (Ca2+) and the release of inflammatory mediators. Here we show that transient receptor potential TRPM4 proteins acted as calcium-activated nonselective cation channels and critically determined the driving force for Ca2+ influx in mast cells. Trpm4(-/-) bone marrow-derived mast cells had more Ca2+ entry than did TRPM4(+/+) cells after Fc epsilon RI stimulation. Consequently, Trpm4(-/-) bone marrow-derived mast cells had augmented degranulation and released more histamine, leukotrienes and tumor necrosis factor. Trpm4(-/-) mice had a more severe IgE-mediated acute passive cutaneous anaphylactic response, whereas late-phase passive cutaneous anaphylaxis was not affected. Our results establish the physiological function of TRPM4 channels as critical regulators of Ca2+ entry in mast cells.	Katholieke Univ Leuven, Dept Mol Cell Biol, Div Physiol, Lab Ion Channel Res, B-3000 Louvain, Belgium; Univ Saarland, D-66421 Homburg, Germany; Deutsch Sporthsch, Inst Kreislaufforsch & Sportmed Mol & Zellulare S, D-50927 Cologne, Germany; Univ Saarland, Inst Anat, D-66421 Homburg, Germany	KU Leuven; Saarland University; German Sport University Cologne; Saarland University	Vennekens, R (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Div Physiol, Lab Ion Channel Res, Campus Gasthuisberg,O&N1,Herestr 49 Bus 802, B-3000 Louvain, Belgium.	rudi.vennekens@med.kuleuven.be; marc.freichel@uniklinikum-saarland.de	Vennekens, Rudi/AAQ-1664-2020; Philipp, Stephan/AAR-7519-2020	Vennekens, Rudi/0000-0002-2564-5150; Philipp, Stephan/0000-0003-1959-9167				AAAAI, 2000, ALL REP; ALI H, 1990, J BIOL CHEM, V265, P745; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; BEAVEN MA, 1984, J BIOL CHEM, V259, P7137; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fioretti B, 2005, BIOPHYS CHEM, V113, P17, DOI 10.1016/j.bpc.2004.07.037; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; INAGAKI N, 1986, INT ARCH ALLER A IMM, V81, P58, DOI 10.1159/000234108; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MARQUARDT DL, 1984, J IMMUNOL, V133, P932; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOHR FC, 1987, J CELL BIOL, V104, P783, DOI 10.1083/jcb.104.3.783; MOHR FC, 1987, J IMMUNOL, V138, P1564; Nagai H, 2000, J ALLERGY CLIN IMMUN, V106, pS91, DOI 10.1067/mai.2000.106778; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Nilius B, 2006, PFLUG ARCH EUR J PHY, V453, P313, DOI 10.1007/s00424-006-0088-z; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Petersen OH, 2002, CURR BIOL, V12, pR520, DOI 10.1016/S0960-9822(02)01027-8; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; RAMKUMAR V, 1993, J BIOL CHEM, V268, P16887; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; YOSHIMURA T, 1987, ANAL BIOCHEM, V164, P132, DOI 10.1016/0003-2697(87)90376-9; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	52	205	210	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					312	320		10.1038/ni1441	http://dx.doi.org/10.1038/ni1441			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17293867	Green Published			2022-12-18	WOS:000244275100017
J	Hahn, M; Nicholson, MJ; Pyrdol, J; Wucherpfennig, KW				Hahn, M; Nicholson, MJ; Pyrdol, J; Wucherpfennig, KW			Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; MHC CLASS-II; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; POSITIVE SELECTION; STRUCTURAL BASIS; RECOGNITION; ANTIGEN; THYMUS	Autoimmune diseases are caused by self-reactive lymphocytes that have escaped deletion. Here we have determined the structure of the trimolecular complex for a T cell receptor (TCR) from a patient with multiple sclerosis that causes autoimmunity in transgenic mice. The structure showed a TCR topology notably different from that of antimicrobial TCRs. Rather than being centered on the peptide-major histocompatibility complex, this TCR contacted only the N-terminal peptide segment and made asymmetrical interactions with the major histocompatibility complex helices. The interaction was dominated by the hypervariable complementarity-determining region 3 loops, indicating that unconventional topologies are possible because of the unique complementarity-determining region 3 sequences created during rearrangement. This topology reduces the interaction surface with peptide and alters the geometry for CD4 association. We propose that unusual TCR-binding properties can permit autoreactive T cells to escape deletion.	Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI064177] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI064177, AI045757, AI064177, P01 AI045757] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Davis M., 2003, FUNDAMENTAL IMMUNOLO, P227; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Hausmann S, 1999, J IMMUNOL, V162, P338; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; Pribyl TM, 1996, J NEUROSCI RES, V45, P812; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	49	205	210	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					490	496		10.1038/ni1187	http://dx.doi.org/10.1038/ni1187			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15821740	Green Accepted			2022-12-18	WOS:000228634300021
J	Hernandez, PP; Mahlakoiv, T; Yang, I; Schwierzeck, V; Nguyen, N; Guendel, F; Gronke, K; Ryffel, B; Holscher, C; Dumoutier, L; Renauld, JC; Suerbaum, S; Staeheli, P; Diefenbach, A				Hernandez, Pedro P.; Mahlakoiv, Tanel; Yang, Ines; Schwierzeck, Vera; Nam Nguyen; Guendel, Fabian; Gronke, Konrad; Ryffel, Bernhard; Hoelscher, Christoph; Dumoutier, Laure; Renauld, Jean-Christophe; Suerbaum, Sebastian; Staeheli, Peter; Diefenbach, Andreas			Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; BETA T-CELLS; ROR-GAMMA-T; IFN-LAMBDA; EPITHELIAL-CELLS; HOST-DEFENSE; TH17 CELLS; NK CELLS; IL-22; RECEPTOR	The epithelium is the main entry point for many viruses, but the processes that protect barrier surfaces against viral infections are incompletely understood. Here we identified interleukin 22 (IL-22) produced by innate lymphoid cell group 3 (ILC3) as an amplifier of signaling via interferon-lambda (IFN-lambda), a synergism needed to curtail the replication of rotavirus, the leading cause of childhood gastroenteritis. Cooperation between the receptor for IL-22 and the receptor for IFN-l, both of which were 'preferentially' expressed by intestinal epithelial cells (IECs), was required for optimal activation of the transcription factor STAT1 and expression of interferon-stimulated genes (ISGs). These data suggested that epithelial cells are protected against viral replication by co-option of two evolutionarily related cytokine networks. These data may inform the design of novel immunotherapy for viral infections that are sensitive to interferons.	[Hernandez, Pedro P.; Schwierzeck, Vera; Guendel, Fabian; Gronke, Konrad; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Res Ctr Immunol, D-55122 Mainz, Germany; [Hernandez, Pedro P.; Schwierzeck, Vera; Guendel, Fabian; Gronke, Konrad; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany; [Hernandez, Pedro P.; Schwierzeck, Vera; Nam Nguyen; Guendel, Fabian; Gronke, Konrad; Diefenbach, Andreas] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Dept Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Hernandez, Pedro P.; Gronke, Konrad] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Mahlakoiv, Tanel] Univ Freiburg, Med Ctr, Inst Virol, Dept Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Mahlakoiv, Tanel] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Yang, Ines; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol, Hannover, Germany; [Yang, Ines; Suerbaum, Sebastian] Hannover Med Sch, Hosp Epidemiol, Hannover, Germany; [Yang, Ines; Suerbaum, Sebastian] German Ctr Infect Res, Hannover, Germany; [Guendel, Fabian; Gronke, Konrad; Diefenbach, Andreas] Res Training Grp GRK1104 Organogenesis, Freiburg, Germany; [Ryffel, Bernhard] Univ Orleans, INEM UMR7355, Mol Immunol, Orleans, France; [Ryffel, Bernhard] CNRS, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis, ZA-7925 Cape Town, South Africa; [Hoelscher, Christoph] Res Ctr Borstel, Infect Immunol Res, Borstel, Germany; [Hoelscher, Christoph] Cluster Excellence Inflammat Interfaces, Borstel, Germany; [Dumoutier, Laure; Renauld, Jean-Christophe] Catholic Univ Louvain, Inst Canc Res, B-1200 Brussels, Belgium	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; Hannover Medical School; Hannover Medical School; German Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); University of Cape Town; Forschungszentrum Borstel; Universite Catholique Louvain	Diefenbach, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Res Ctr Immunol, D-55122 Mainz, Germany.	diefenbach@uni-mainz.de	Hölscher, Christoph/O-1732-2018; Diefenbach, Andreas/T-2589-2018; Yang, Ines/D-6904-2012; Schwierzeck, Vera/AAL-3028-2020; Hernandez, Pedro/X-2121-2019; Hernandez, Pedro P/K-4783-2015; Renauld, Jean-Christophe/B-7268-2012	Hölscher, Christoph/0000-0002-7520-9146; Diefenbach, Andreas/0000-0002-9176-9530; Yang, Ines/0000-0002-3812-2690; Schwierzeck, Vera/0000-0003-4254-3700; Hernandez, Pedro/0000-0002-2873-4298; Hernandez, Pedro P/0000-0002-2873-4298; Renauld, Jean-Christophe/0000-0003-1736-2131; Mahlakoiv, Tanel/0000-0001-9059-0486; Dumoutier, Laure/0000-0002-6645-684X	ERC [311377]; Deutsche Forschungsgemeinschaft [DI764/3, SU133/9, GRK1104, SFB900/Z1, 1656]; German Science Council [GSC-4]; Cluster of Excellence "Inflammation at Interfaces" [EXC306]	ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Science Council(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	We thank V. Sexl (University of Veterinary Medicine Vienna) for mice with a Stat3<SUP>fl</SUP> allele (provided with permission from V. Poli, Universita di Torino); M. Stemmler (Max-Planck-Institute of Immunobiology & Epigenetics, Freiburg) for Vil1-Cre mice (provided with permission from S. Robine. Institute Curie, Paris); C. Johner (Max-Planck-Institute of Immunobiology & Epigenetics, Freiburg) for Rag2<SUP>-/-</SUP> and Rag2<SUP>-/-</SUP>Il2rg<SUP>-/-</SUP> mice; D. Littman (Skirball Institute of Biomolecular Medicine) for Rorc-Cre<SUP>TG</SUP> mice; N. Ghilardi (Genentech) for Il23a<SUP>-/-</SUP> mice; M. Hornef (Hannover Medical School) for the rat IEC line IEC6 and the mouse rotavirus strain EDIM and for discussions; S. Koike (Tokyo Metropolitan Institute of Medical Science) for poliovirus type I Mahoney strain; G. Hacker for support; members of the Diefenbach laboratory for discussions; A. Triantafyllopoulou for critical reading of the manuscript; K. Oberle, S. Woltemate and Z. Fiebig for technical assistance; and M. Follo, K. Geiger and J. Bodinek-Wersing for cell sorting. Supported by ERC (311377 to A.D.), Deutsche Forschungsgemeinschaft (Priority Program 1656 "Intestinal Microbiota" DI764/3 to A.D. and SU133/9 to S.S.; GRK1104 to A.D. and F.G.; and SFB900/Z1 to S.S.) and the Excellence Initiative of the Deutsche Forschungsgemeinschaft and the German Science Council (Spemann Graduate School of Biology and Medicine (GSC-4 to T.M.); and the Cluster of Excellence "Inflammation at Interfaces" (Borstel-Kiel-Lubeck-Plon) EXC306 to C.H.).	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bachmann M, 2013, BIOCHEM PHARMACOL, V85, P396, DOI 10.1016/j.bcp.2012.11.004; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Holloway G, 2013, J GEN VIROL, V94, P1151, DOI 10.1099/vir.0.051276-0; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moon C, 2012, CURR OPIN IMMUNOL, V24, P405, DOI 10.1016/j.coi.2012.05.002; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Oksanen J, 2020, VEGAN COMMUNITY ECOL; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanos SL, 2010, METHODS MOL BIOL, V612, P505, DOI 10.1007/978-1-60761-362-6_32; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sen A, 2014, J VIROL, V88, P41, DOI 10.1128/JVI.01501-13; Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	69	204	220	0	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					698	+		10.1038/ni.3180	http://dx.doi.org/10.1038/ni.3180			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26006013	Green Accepted			2022-12-18	WOS:000356445600006
J	Gringhuis, SI; van der Vlist, M; van den Berg, LM; den Dunnen, J; Litjens, M; Geijtenbeek, TBH				Gringhuis, Sonja I.; van der Vlist, Michiel; van den Berg, Linda M.; den Dunnen, Jeroen; Litjens, Manja; Geijtenbeek, Teunis B. H.			HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LONG TERMINAL REPEAT; T-CELLS; LANGERHANS CELLS; MYCOBACTERIUM-TUBERCULOSIS; MEDIATED INTERNALIZATION; IMMUNE-RESPONSES; ACTIVATION	Pattern-recognition receptors (PRRs) elicit antiviral immune responses to human immunodeficiency virus type 1 (HIV-1). Here we show that HIV-1 required signaling by the PRRs Toll-like receptor 8 (TLR8) and DC-SIGN for replication in dendritic cells (DCs). HIV-1 activated the transcription factor NF-kappa B through TLR8 to initiate the transcription of integrated provirus by RNA polymerase II (RNAPII). However, DC-SIGN signaling was required for the generation of full-length viral transcripts. Binding of the HIV-1 envelope glycoprotein gp120 to DC-SIGN induced kinase Raf-1-dependent phosphorylation of the NF-kappa B subunit p65 at Ser276, which recruited the transcription-elongation factor pTEF-b to nascent transcripts. Transcription elongation and generation of full-length viral transcripts was dependent on pTEF-b-mediated phosphorylation of RNAPII at Ser2. Inhibition of either pathway abrogated replication and prevented HIV-1 transmission. Thus, HIV-1 subverts crucial components of the immune system for replication that might be targeted to prevent infection and dissemination.	[Gringhuis, Sonja I.; van der Vlist, Michiel; van den Berg, Linda M.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Gringhuis, Sonja I.; van der Vlist, Michiel; van den Berg, Linda M.; den Dunnen, Jeroen; Litjens, Manja; Geijtenbeek, Teunis B. H.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl	van der Vlist, Michiel/AAC-4939-2019; den Dunnen, Jeroen/K-4252-2012; van der Vlist, Michiel/B-1899-2010; Dunnen, Jeroen den/O-9760-2019	den Dunnen, Jeroen/0000-0002-7199-8619; Dunnen, Jeroen den/0000-0002-7199-8619; van der Vlist, Michiel/0000-0003-0931-8982; Gringhuis, Sonja/0000-0003-0383-4978	National Institute of Allergy and Infectious Diseases [HHSN266200400091C]; Netherlands Organisation for Scientific Research [NWO 917-46-367, NWO 912-04-025]; AIDS Foundation [2007036]; Dutch Burns Foundation [08.109]; Dutch Asthma Foundation	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); AIDS Foundation; Dutch Burns Foundation; Dutch Asthma Foundation	We thank M. Oudhoff (Academic Centre for Dentistry Amsterdam) for C. albicans; P. Gallay (The Scripps Research Institute) and C. Aiken (Vanderbilt University School of Medicine) for HIV-1 proviral plasmids; K. Kristiansen (University of Southern Denmark) for the GST-p65 expression plasmid; J. Belisle (Colorado State University; National Institute of Allergy and Infectious Diseases contract HHSN266200400091C) for M. tuberculosis; and J. Kappes and X. Wu (Tranzyme) for TZM-bl cells (obtained through the National Institutes of Health AIDS Research and Reference Reagent Program). Supported by the Netherlands Organisation for Scientific Research (NWO 917-46-367 to M. L. and NWO 912-04-025 to J. d. D.), the AIDS Foundation (2007036 to M. v. d. V.), Dutch Burns Foundation (08.109 to L. M. v. d. B) and the Dutch Asthma Foundation (3.2.03.39 to S. I. G.).	ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Chatterji U, 2005, J BIOL CHEM, V280, P40293, DOI 10.1074/jbc.M506314200; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hester RA, 2003, J WOMEN HEALTH GEN-B, V12, P487, DOI 10.1089/154099903766651612; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lawn SD, 2004, J INFECTION, V48, P1, DOI 10.1016/j.jinf.2003.09.001; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; OBRIG TG, 1971, J BIOL CHEM, V246, P174; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Publicover J, 2006, J VIROL, V80, P7028, DOI 10.1128/JVI.00478-06; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; *UNAIDS, 2005, AIDS POLICY LAW, V20, P1; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	56	204	212	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					419	U81		10.1038/ni.1858	http://dx.doi.org/10.1038/ni.1858			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20364151				2022-12-18	WOS:000276852200011
J	Olenchock, BA; Guo, R; Carpenter, JH; Jordan, M; Topham, MK; Koretzky, GA; Zhong, XP				Olenchock, Benjamin A.; Guo, Rishu; Carpenter, Jeffery H.; Jordan, Martha; Topham, Matthew K.; Koretzky, Gary A.; Zhong, Xiao-Ping			Disruption of diacylglycerol metabolism impairs the induction of T cell anergy	NATURE IMMUNOLOGY			English	Article							PHOSPHATIDIC-ACID; KINASE-ZETA; LYMPHOCYTE-PROLIFERATION; ENTEROTOXIN-B; CLONAL ANERGY; KAPPA-B; ACTIVATION; ALPHA; MECHANISM; TOLERANCE	Anergic T cells have altered diacylglycerol metabolism, but whether that altered metabolism has a causative function in the induction of T cell anergy is not apparent. To test the importance of diacylglycerol metabolism in T cell anergy, we manipulated diacylglycerol kinases ( DGKs), which are enzymes that terminate diacylglycerol-dependent signaling. Overexpression of DGK-alpha resulted in a defect in T cell receptor signaling that is characteristic of anergy. We generated DGK-alpha-deficient mice and found that DGK-alpha-deficient T cells had more diacylglycerol-dependent T cell receptor signaling. In vivo anergy induction was impaired in DGK-alpha-deficient mice. When stimulated in anergy-producing conditions, T cells lacking DGK-alpha or DGK-zeta proliferated and produced interleukin 2. Pharmacological inhibition of DGK-alpha activity in DGK-zeta-deficient T cells that received an anergizing stimulus proliferated similarly to wild-type T cells that received CD28 costimulation and prevented anergy induction. Our findings suggest that regulation of diacylglycerol metabolism is critical in determining whether activation or anergy ensues after T cell receptor stimulation.	Univ Penn, Sch Med, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Penn, Sch Med, Dept Med, Div Rheumatol, Philadelphia, PA 19104 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	University of Pennsylvania; Pennsylvania Medicine; Duke University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Pennsylvania; Duke University	Zhong, XP (corresponding author), Univ Penn, Sch Med, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	zhong001@mc.duke.edu	Koretzky, Gary/AAU-5381-2021		NATIONAL CANCER INSTITUTE [T32CA009140, R01CA095463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058019] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09140, CA95463] Funding Source: Medline; NIAID NIH HHS [R01 AI058019] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Acuto O, 2003, IMMUNOL REV, V192, P21, DOI 10.1034/j.1600-065X.2003.00034.x; Ali H, 2004, NEUROSCI LETT, V372, P190, DOI 10.1016/j.neulet.2004.09.052; Antony P, 2004, BIOCHEM SOC T, V32, P113, DOI 10.1042/BST0320113; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; BERNEY SM, 1995, J IMMUNOL METHODS, V186, P71, DOI 10.1016/0022-1759(95)00135-W; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Boonen GJJC, 1999, EUR J IMMUNOL, V29, P789; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Santos CS, 1999, CURR BIOL, V9, P437, DOI 10.1016/S0960-9822(99)80193-6; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Flores I, 1999, J IMMUNOL, V163, P708; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; JENKINS MK, 1992, IMMUNOL TODAY, V13, P69, DOI 10.1016/0167-5699(92)90137-V; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Jones A, 1997, COMPUT SECUR, V16, P595, DOI 10.1016/S0167-4048(97)80796-1; Jones DR, 1998, FEBS LETT, V433, P23, DOI 10.1016/S0014-5793(98)00875-8; JONES GA, 1993, J BIOL CHEM, V268, P20845; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; LAUENER R, 1995, BIOCHEM BIOPH RES CO, V215, P8, DOI 10.1006/bbrc.1995.2427; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; MERIDA I, 1993, DNA CELL BIOL, V12, P473, DOI 10.1089/dna.1993.12.473; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wells AD, 2003, J IMMUNOL, V170, P4127, DOI 10.4049/jimmunol.170.8.4127; Williamson P, 1993, Semin Immunol, V5, P337, DOI 10.1006/smim.1993.1040; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	56	204	222	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1174	1181		10.1038/ni1400	http://dx.doi.org/10.1038/ni1400			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17028587				2022-12-18	WOS:000241437200012
J	Fan, ZS; Beresford, PJ; Zhang, D; Xu, Z; Novina, CD; Yoshida, A; Pommier, Y; Lieberman, J				Fan, ZS; Beresford, PJ; Zhang, D; Xu, Z; Novina, CD; Yoshida, A; Pommier, Y; Lieberman, J			Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A	NATURE IMMUNOLOGY			English	Article							HUMAN APURINIC ENDONUCLEASE; BASE EXCISION-REPAIR; APURINIC/APYRIMIDINIC ENDONUCLEASE; POLY(ADP-RIBOSE) POLYMERASE; REDOX REGULATION; MAMMALIAN-CELLS; DNA-BINDING; IN-VIVO; EXPRESSION; REF-1	The cytolytic T lymphocyte protease granzyme A (GzmA) initiates a caspase-independent cell death pathway. Here we report that the rate-limiting enzyme of DNA base excision repair, apurinic endonuclease-1 (Ape1), which is also known as redox factor-1 (Ref-1), binds to GzmA and is contained in the SET complex, a macromolecular complex of 270-420 kDa that is associated with the endoplasmic reticulum and is targeted by GzmA during cell-mediated death. GzmA cleaves Ape1 after Lys31 and destroys its known oxidative repair functions. In so doing, GzmA may block cellular repair and force apoptosis. In support of this, cells with silenced Ape1 expression are more sensitive, whereas cells overexpressing noncleavable Ape1 are more resistant, to GzmA-mediated death.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.		Lieberman, Judy/A-2717-2015	ZHANG, DONG/0000-0002-1068-8334	NATIONAL CANCER INSTITUTE [ZIABC006150, Z01BC006150, ZIABC006161, Z01BC006161] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI Y, 1994, FEBS LETT, V340, P231, DOI 10.1016/0014-5793(94)80144-4; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; DUGUID JR, 1995, CANCER RES, V55, P6097; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Hall JL, 2001, CIRC RES, V88, P1247, DOI 10.1161/hh1201.091796; Hansen WK, 1998, J BIOL CHEM, V273, P756, DOI 10.1074/jbc.273.2.756; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Kakolyris S, 1997, CANCER RES, V57, P1794; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mitra S, 1997, MOL CELLS, V7, P305; Moore DH, 2000, CLIN CANCER RES, V6, P602; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; Nakamura J, 1999, CANCER RES, V59, P2522; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Prieto-Alamo MJ, 1999, CARCINOGENESIS, V20, P415, DOI 10.1093/carcin/20.3.415; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; Robertson KA, 2001, CANCER RES, V61, P2220; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	43	204	211	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					145	153		10.1038/ni885	http://dx.doi.org/10.1038/ni885			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12524539				2022-12-18	WOS:000180686500014
J	Kishimoto, H; Sprent, J				Kishimoto, H; Sprent, J			A defect in central tolerance in NOD mice	NATURE IMMUNOLOGY			English	Article							NONOBESE DIABETIC MICE; T-CELL REPERTOIRE; NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; IN-VIVO; APOPTOSIS; DEATH; ACTIVATION; THYMUS; MOUSE	The predisposition of nonobese diabetic (NOD) mice to develop autoimmune disease is usually attributed to defects in peripheral tolerance mechanisms. Here, evidence is presented that NOD mice display a defect in central tolerance (negative selection) of thymocytes. Impaired central tolerance in NOD mice was most prominent in a population of semi-mature thymocytes found in the medulla. The defect was apparent in vivo as well as in vitro, was independent of IA beta (g7) expression and affected both Fas-dependent and Fas-independent pathways of apoptosis; for Fas-dependent apoptosis, the defective tolerance of NOD thymocytes correlated with the strong T cell receptor-mediated up-regulation of caspase 8-homologous FLICE (Fas-associated death-domain-like interleukin I beta -converting enzyme)-inhibitory protein. In light of these findings, disease onset in NOD mice may reflect defects in central as well as peripheral tolerance.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sprent, J (corresponding author), Scripps Res Inst, Dept Immunol, IMM4,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NCI NIH HHS [CA38355] Funding Source: Medline; NIAID NIH HHS [AI46710, AI21487] Funding Source: Medline; NIA NIH HHS [AG01743] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038355, R37CA038355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487, R01AI046710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG001743] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; ARREAZA GA, 1997, J CLIN INVEST, V100, P8670; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cameron MJ, 1997, J IMMUNOL, V159, P4686; Cameron MJ, 1997, CRIT REV IMMUNOL, V17, P537; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gombert JM, 1996, INT IMMUNOL, V8, P1751, DOI 10.1093/intimm/8.11.1751; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Irmler M, 1997, FEBS LETT, V406, P189, DOI 10.1016/S0014-5793(97)00271-8; Izui S, 2000, Int Rev Immunol, V19, P447, DOI 10.3109/08830180009055507; JONDAL M, 1993, EUR J IMMUNOL, V23, P1246, DOI 10.1002/eji.1830230608; Kanagawa O, 1998, J IMMUNOL, V161, P4489; Kishimoto H, 2000, IMMUNOL RES, V21, P315, DOI 10.1385/IR:21:2-3:315; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Kono D H, 2000, Int Rev Immunol, V19, P367, DOI 10.3109/08830180009055504; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; McDevitt H, 1998, CURR OPIN IMMUNOL, V10, P647, DOI 10.1016/S0952-7915(98)80083-6; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Page DM, 1998, J IMMUNOL, V160, P120; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; Radons J, 1997, DIABETES, V46, P379, DOI 10.2337/diabetes.46.3.379; RAPOPORT MJ, 1993, J EXP MED, V177, P1221, DOI 10.1084/jem.177.4.1221; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; Ridgway WM, 1999, CURR OPIN IMMUNOL, V11, P638, DOI 10.1016/S0952-7915(99)00030-8; Ridgway WM, 1999, SCIENCE, V284, P749, DOI 10.1126/science.284.5415.749; Ridgway WM, 1996, J EXP MED, V183, P1657, DOI 10.1084/jem.183.4.1657; Salojin K, 1997, J EXP MED, V186, P887, DOI 10.1084/jem.186.6.887; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SERREZE DV, 1988, J IMMUNOL, V140, P3801; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; Tian J, 2001, J IMMUNOL, V166, P7144, DOI 10.4049/jimmunol.166.12.7144; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; VANANTWERP DJ, 1996, SCIENCE, V274, P786; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wicker LS, 1997, J EXP MED, V186, P973, DOI 10.1084/jem.186.7.973; WICKER LS, 1993, MOL MECH IMMUNOLOGIC, P173; Wisniewska M, 1997, CELL BIOL INT, V21, P127, DOI 10.1006/cbir.1996.0124; Xue YT, 1996, EUR J IMMUNOL, V26, P428, DOI 10.1002/eji.1830260224; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	59	204	208	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1025	1031		10.1038/ni726	http://dx.doi.org/10.1038/ni726			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11668341				2022-12-18	WOS:000172049800015
J	D'Amico, G; Frascaroli, G; Bianchi, G; Transidico, P; Doni, A; Vecchi, A; Sozzani, S; Allavena, P; Mantovani, A				D'Amico, G; Frascaroli, G; Bianchi, G; Transidico, P; Doni, A; Vecchi, A; Sozzani, S; Allavena, P; Mantovani, A			Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL MATURATION; COLONY-STIMULATING FACTOR; HUMAN MONOCYTES; POLYMORPHONUCLEAR LEUKOCYTES; II RECEPTOR; EXPRESSION; INTERLEUKIN-10; PROTEIN; LIGAND; DIFFERENTIATION	As originally demonstrated for the interleukin I (IL-1) type II receptor, some primary proinflammatory cytokines from the IL-1 and tumor necrosis factor families are regulated by decoy receptors that are structurally incapable of signaling. Here we report that concomitant exposure to proinflammatory signals and IL-10 generates functional decoy receptors in the chemokine system. Inflammatory signals, which cause dendritic cell (DC) maturation and migration to lymphoid organs, induce a chemokine receptor switch, with down-regulation of inflammatory receptors (such as CCR1,CCR2, CCR5) and induction of CCR7. Concomitant exposure to lipopolysaccharide (LPS) and IL-10 blocks the chemokine receptor switch associated with DC maturation. LPS + IL-10-treated DCs showed low expression of CCR7 and high expression of CCR1, CCR2 and CCR5. These receptors were unable to elicit migration. We provide evidence that uncoupled receptors, expressed on LPS + IL-10-treated cells, sequester and scavenge inflammatory chemokines. Similar results were obtained for monocytes exposed to activating signals and IL-10. Thus, in an inflammatory environment, IL-10 generates functional decoy receptors on DC and monocytes, which act as molecular sinks and scavengers for inflammatory chemokines.	Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, I-20157 Milan, Italy; Univ Milan, Inst Gen Pathol, I-20100 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Mantovani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Immunol & Cell Biol, Via Eritrea 62, I-20157 Milan, Italy.		Mantovani, Alberto/HCI-7449-2022; Allavena, Paola/HHM-5218-2022; D'Amico, Giovanna/AAL-3334-2020; Sozzani, Silvano/C-1447-2009; Bianchi, Giancarlo/ABF-2007-2020	Mantovani, Alberto/0000-0001-5578-236X; Allavena, Paola/0000-0002-6697-6028; D'Amico, Giovanna/0000-0001-7809-7269; Sozzani, Silvano/0000-0002-3144-8743; Doni, Andrea/0000-0001-9203-5814				Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4; ALLAVENA P, 2000, IN PRESS IMMUNOL REV; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Buelens C, 1997, EUR J IMMUNOL, V27, P756, DOI 10.1002/eji.1830270326; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Elsner J, 2000, J BIOL CHEM, V275, P7787, DOI 10.1074/jbc.275.11.7787; GAO JL, 1994, J BIOL CHEM, V269, P28539; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Horuk R, 1996, J LEUKOCYTE BIOL, V59, P29, DOI 10.1002/jlb.59.1.29; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Jenkins M, 2000, J BIOL CHEM, V275, P7988, DOI 10.1074/jbc.275.11.7988; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LLOYD AR, 1995, J BIOL CHEM, V270, P28188; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Oehen S, 1997, J IMMUNOL METHODS, V207, P33, DOI 10.1016/S0022-1759(97)00089-6; Penton-Rol G, 1998, J IMMUNOL, V160, P3869; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; RE F, 1994, J EXP MED, V179, P739, DOI 10.1084/jem.179.2.739; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Salomon B, 1998, J IMMUNOL, V160, P708; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sozzani S, 1997, J IMMUNOL, V159, P1993; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; SOZZANI S, 1995, J IMMUNOL, V155, P3292; Sozzani S, 1998, J IMMUNOL, V161, P1083; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	46	204	209	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					387	391		10.1038/80819	http://dx.doi.org/10.1038/80819			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062497				2022-12-18	WOS:000165076100010
J	Zemmour, D; Zilionis, R; Kiner, E; Klein, AM; Mathis, D; Benoist, C				Zemmour, David; Zilionis, Rapolas; Kiner, Evgeny; Klein, Allon M.; Mathis, Diane; Benoist, Christophe			Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR	NATURE IMMUNOLOGY			English	Article							FOXP3 EXPRESSION; RNA-SEQ; SIGNAL STRENGTH; DIFFERENTIATION; EFFECTOR; HOMEOSTASIS; REG; REPERTOIRE; GENERATION; POPULATION	CD4(+) T regulatory cells (T-reg) are central to immune homeostasis, their phenotypic heterogeneity reflecting the diverse environments and target cells that they regulate. To understand this heterogeneity, we combined single-cell RNA-seq, activation reporter and T cell receptor (TCR) analysis to profile thousands of T-reg or conventional CD4(+)FoxP3(-) T cells (T-cony) from mouse lymphoid organs and human blood. T-reg and T-cony pools showed areas of overlap, as resting 'furtive' T-regs with overall similarity to T-convs or as a convergence of activated states. All T-reg expressed a small core of FoxP3-dependent transcripts, onto which additional programs were added less uniformly. Among suppressive functions, ll2ra and Ctla4 were quasiconstant, inhibitory cytokines being more sparsely distributed. TCR signal intensity did not affect resting/activated T-reg proportions but molded activated T-reg programs. The main lines of T-reg heterogeneity in mice were strikingly conserved in human blood. These results reveal unexpected TCR-shaped states of activation, providing a framework to synthesize previous observations of T-reg heterogeneity.	[Zemmour, David; Kiner, Evgeny; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Zemmour, David; Kiner, Evgeny; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Zemmour, David; Kiner, Evgeny; Mathis, Diane; Benoist, Christophe] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zilionis, Rapolas; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Zilionis, Rapolas] Vilnius Univ, Inst Biotechnol, Vilnius, Lithuania	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vilnius University	Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.; Mathis, D; Benoist, C (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Mathis, D; Benoist, C (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	dm@hms.harvard.edu; cbdm@hms.harvard.edu		Zemmour, David/0000-0002-0990-217X	NIH [AI051530, AI116834, AI125603]; Boehringer Ingelheim Fonds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125603, R37AI051530, R01AI051530, R01AI116834] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Sefik for help with colon profiling and K. Hattori, C. Araneo K. Waraska, M. Thorsen and R. Steen for help with mice, profiling, sorting and sequencing. This work was supported by NIH grants AI051530, AI116834 and AI125603 to C.B./D.M. D.Z. and E.K. were supported by a PhD fellowship from the Boehringer Ingelheim Fonds.	Ashouri JF, 2017, J IMMUNOL, V198, P657, DOI 10.4049/jimmunol.1601301; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hennig C, 2015, FPC FLEXIBLE PROCEDU; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Krijthe J.H., 2015, RTSNE T DISTRIBUTED; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu YJ, 2013, NAT MED, V19, P1173, DOI 10.1038/nm.3286; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pesenacker AM, 2016, DIABETES, V65, P1031, DOI 10.2337/db15-0572; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Zemmour D, 2017, P NATL ACAD SCI USA, V114, pE3472, DOI 10.1073/pnas.1700946114; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	62	203	204	8	66	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					291	+		10.1038/s41590-018-0051-0	http://dx.doi.org/10.1038/s41590-018-0051-0			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29434354	Green Accepted			2022-12-18	WOS:000427007500018
J	Fu, WX; Ergun, A; Lu, T; Hill, JA; Haxhinasto, S; Fassett, MS; Gazit, R; Adoro, S; Glimcher, L; Chan, S; Kastner, P; Rossi, D; Collins, JJ; Mathis, D; Benoist, C				Fu, Wenxian; Ergun, Ayla; Lu, Ting; Hill, Jonathan A.; Haxhinasto, Sokol; Fassett, Marlys S.; Gazit, Roi; Adoro, Stanley; Glimcher, Laurie; Chan, Susan; Kastner, Philippe; Rossi, Derrick; Collins, James J.; Mathis, Diane; Benoist, Christophe			A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells	NATURE IMMUNOLOGY			English	Article							SUPPRESSIVE FUNCTION; FACTOR FOXP3; DIFFERENTIATION; EXPRESSION; LINEAGE; T(H)17; POPULATION; GENERATION; PROGRAM; LEADS	The transcription factor Foxp3 participates dominantly in the specification and function of Foxp3(+)CD4(+) regulatory T cells (T-reg cells) but is neither strictly necessary nor sufficient to determine the characteristic T-reg cell signature. Here we used computational network inference and experimental testing to assess the contribution of other transcription factors to this. Enforced expression of Helios or Xbp1 elicited distinct signatures, but Eos, IRF4, Satb1, Lef1 and GATA-1 elicited exactly the same outcome, acting in synergy with Foxp3 to activate expression of most of the T-reg cell signature, including key transcription factors, and enhancing occupancy by Foxp3 at its genomic targets. Conversely, the T-reg cell signature was robust after inactivation of any single cofactor. A redundant genetic switch thus 'locked in' the T-reg cell phenotype, a model that would account for several aspects of T-reg cell physiology, differentiation and stability.	[Ergun, Ayla; Lu, Ting; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Fu, Wenxian; Ergun, Ayla; Hill, Jonathan A.; Haxhinasto, Sokol; Fassett, Marlys S.; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Ergun, Ayla; Lu, Ting; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Lu, Ting] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Gazit, Roi; Rossi, Derrick] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Adoro, Stanley; Glimcher, Laurie] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Chan, Susan; Kastner, Philippe] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	Boston University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Boston University; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard T.H. Chan School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Gazit, Roi/J-3352-2017	Fu, Wenxian/0000-0003-0684-8929; Gazit, Roi/0000-0002-0548-2147	US National Institutes of Health [AI051530, AI072073, T32 DK7260, 3R24AI072073-03S1]; GlaxoSmithKline; Damon Runyon Cancer Research Foundation; American Diabetes Association [7-07-BETA-14]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530, R37AI051530, R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Damon Runyon Cancer Research Foundation; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Samstein and A. Rudensky for the unpublished ChIP-seq data; S. Smale (University of California, Los Angeles) for mouse cDNA encoding Helios; M. Calderwood and the Center for Cancer Systems Biology for expression cDNA; P. Rahl for advice on ChIP-Seq; J. Ericson, S. Davis, H. Paik and R. Cruse for genomic data analysis; H. Chen and Q. Cai for experimental support; and J. LaVecchio and G. Buruzala for sorting. This work benefited from public data generated by the Immunological Genome Project consortium. Supported by the US National Institutes of Health (AI051530 to C.B. and D.M.; AI072073 to C.B., D.M. and J.C.; training grant T32 DK7260 for support of M.S.F.; and 3R24AI072073-03S1 for support of A.E.), GlaxoSmithKline, the Damon Runyon Cancer Research Foundation (S.H.), the American Diabetes Association (7-07-BETA-14 to W.F.) and the Canadian Institutes of Health Research (J.H.).	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Battle A, 2005, J COMPUT BIOL, V12, P909, DOI 10.1089/cmb.2005.12.909; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Otsubo K, 2011, CLIN IMMUNOL, V141, P111, DOI 10.1016/j.clim.2011.06.006; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pittenger C, 1998, CR ACAD SCI III-VIE, V321, P91, DOI 10.1016/S0764-4469(97)89807-1; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	47	203	214	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					972	980		10.1038/ni.2420	http://dx.doi.org/10.1038/ni.2420			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22961053	Green Accepted, Green Submitted			2022-12-18	WOS:000309038600013
J	Smale, ST				Smale, Stephen T.			Hierarchies of NF-kappa B target-gene regulation	NATURE IMMUNOLOGY			English	Review							TISSUE-SPECIFIC ENHANCERS; BROMODOMAIN PROTEIN BRD4; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; INFLAMMATORY RESPONSE; DEPENDENT TRANSCRIPTION; LYSINE METHYLATION; IMMUNE-RESPONSES; PIONEER FACTORS; P-TEFB	Members of the NF-kappa B family of transcription factors function as dominant regulators of inducible gene expression in almost all cell types in response to a broad range of stimuli, with particularly important roles in coordinating both innate and adaptive immunity. This review summarizes the present knowledge and recent progress toward elucidating the numerous regulatory layers that confer target-gene selectivity in response to an NF-kappa B-inducing stimulus.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu			NCI NIH HHS [R01 CA127279, R01 CA127279-04] Funding Source: Medline; NIAID NIH HHS [R21 AI076921-02, R01 AI073868-05, R01 AI073868, R21 AI076921] Funding Source: Medline; NIGMS NIH HHS [R01 GM086372, R01 GM086372-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868, R21AI076921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kontaraki J, 2000, GENE DEV, V14, P2106; Lee TK, 2010, CURR OPIN GENET DEV, V20, P677, DOI 10.1016/j.gde.2010.08.005; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paszek P, 2010, CURR OPIN GENET DEV, V20, P670, DOI 10.1016/j.gde.2010.08.004; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	72	203	214	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					689	694		10.1038/ni.2070	http://dx.doi.org/10.1038/ni.2070			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772277	Green Accepted			2022-12-18	WOS:000292870700004
J	Islam, SA; Chang, DS; Colvin, RA; Byrne, MH; McCully, ML; Moser, B; Lira, SA; Charo, IF; Luster, AD				Islam, Sabina A.; Chang, Daniel S.; Colvin, Richard A.; Byrne, Mike H.; McCully, Michelle L.; Moser, Bernhard; Lira, Sergio A.; Charo, Israel F.; Luster, Andrew D.			Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5(+) T(H)2 cells	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CCR8; T-CELLS; DENDRITIC CELLS; AIRWAY INFLAMMATION; IMMUNE-RESPONSES; CUTTING EDGE; TH1 CELLS; IN-VIVO; EXPRESSION; DIFFERENTIATION	Mouse CCL8 is a CC chemokine of the monocyte chemoattractant protein (MCP) family whose biological activity and receptor usage have remained elusive. Here we show that CCL8 is highly expressed in the skin, where it serves as an agonist for the chemokine receptor CCR8 but not for CCR2. This distinguishes CCL8 from all other MCP chemokines. CCL8 responsiveness defined a population of highly differentiated, CCR8-expressing inflammatory T helper type 2 (T(H)2) cells enriched for interleukin (IL)-5. Ccr8- and Ccl8-deficient mice had markedly less eosinophilic inflammation than wild-type or Ccr4-deficient mice in a model of chronic atopic dermatitis. Adoptive transfer studies established CCR8 as a key regulator of T(H)2 cell recruitment into allergen-inflamed skin. In humans, CCR8 expression also defined an IL-5-enriched T(H)2 cell subset. The CCL8-CCR8 chemokine axis is therefore a crucial regulator of T(H)2 cell homing that drives IL-5-mediated chronic allergic inflammation.	[Islam, Sabina A.; Chang, Daniel S.; Colvin, Richard A.; Byrne, Mike H.; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol,Ctr Immunol & Inf, Boston, MA 02163 USA; [McCully, Michelle L.; Moser, Bernhard] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales; [Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Charo, Israel F.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardiff University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; The J David Gladstone Institutes	Luster, AD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol,Ctr Immunol & Inf, Boston, MA 02163 USA.	aluster@mgh.harvard.edu	McCully, Michelle/A-7705-2013; Luster, Andrew/ABE-6504-2020	McCully, Michelle/0000-0003-1543-3629; Luster, Andrew/0000-0001-9679-7912; Moser, Bernhard/0000-0002-4354-4572	US National Institutes of Health (Harvard Skin Disease Research Center Pilot & Feasibility Study) [K08-AI556663, P30AR042689, R37-AI040618]; Infectious Diseases Society of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055663, R37AI040618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health (Harvard Skin Disease Research Center Pilot & Feasibility Study)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Diseases Society of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by US National Institutes of Health grants K08-AI556663 and P30AR042689 (Harvard Skin Disease Research Center Pilot & Feasibility Study) to S. A. I. and R37-AI040618 to A. D. L., and the Infectious Diseases Society of America Young Investigator Award to S. A. I. The authors thank P. Murphy (National Institutes of Health) for 4DE4 cells, J. Pease (Imperial College London) for human CCR8 receptor transfectants, P. Shrikant (Roswell Park Cancer Institute) for transgenic Thy1.1 OTII mice, L. Lefrancois (University of Connecticut School of Medicine) for transgenic Thy1.2 OTII mice, C. Sanderson (National Institute for Medical Research, London) for Il5-transgenic mice, S. Thomas for assistance with calcium flux studies and T. Means for assistance with design and validation of QPCR primers.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO;2-A; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Drazen JM, 1996, J EXP MED, V183, P1, DOI 10.1084/jem.183.1.1; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fox JM, 2006, J BIOL CHEM, V281, P36652, DOI 10.1074/jbc.M605584200; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gonzalo JA, 2007, J IMMUNOL, V179, P1740, DOI 10.4049/jimmunol.179.3.1740; Goya I, 2003, J IMMUNOL, V170, P2138, DOI 10.4049/jimmunol.170.4.2138; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Iellem A, 2000, EUR J IMMUNOL, V30, P1030, DOI 10.1002/(SICI)1521-4141(200004)30:4<1030::AID-IMMU1030>3.0.CO;2-8; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kremer L, 2001, J IMMUNOL, V166, P218, DOI 10.4049/jimmunol.166.1.218; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Mutalithas K, 2010, CLIN EXP ALLERGY, V40, P1175, DOI 10.1111/j.1365-2222.2010.03504.x; Nomiyama H, 2003, J INTERF CYTOK RES, V23, P37, DOI 10.1089/10799900360520432; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; VanSnick J, 1996, J IMMUNOL, V157, P2570; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang G, 2007, CLIN EXP ALLERGY, V37, P151, DOI 10.1111/j.1365-2222.2006.02621.x; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xie JF, 2006, TRANSPLANTATION, V82, P1501, DOI 10.1097/01.tp.0000243167.11566.eb; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zingoni A, 1998, J IMMUNOL, V161, P547; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	50	203	209	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					167	U86		10.1038/ni.1984	http://dx.doi.org/10.1038/ni.1984			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21217759	Green Accepted			2022-12-18	WOS:000286378400011
J	Heit, B; Robbins, SM; Downey, CM; Guan, ZW; Colarusso, P; Miller, BJ; Jirik, FR; Kubes, P				Heit, Bryan; Robbins, Stephen M.; Downey, Charlene M.; Guan, Zhiwen; Colarusso, Pina; Miller, B. Joan; Jirik, Frank R.; Kubes, Paul			PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils	NATURE IMMUNOLOGY			English	Article							TUMOR-SUPPRESSOR PTEN; ACTIVATION; ROLES; PI3K; LOCALIZATION; PI(3,4,5)P-3; PI3K-GAMMA; ARTHRITIS; 3-KINASE; GAMMA	Neutrophils encounter and 'prioritize' many chemoattractants in their pursuit of bacteria. Here we tested the possibility that the phosphatase PTEN is responsible for the prioritization of chemoattractants. Neutrophils induced chemotaxis by two separate pathways, the phosphatidylinositol-3-OH kinase (PI(3)K) phosphatase and tensin homolog (PTEN) pathway, and the p38 mitogen-activated protein kinase pathway, with the p38 pathway dominating over the PI(3)K pathway. Pten(-/-) neutrophils could not prioritize chemoattractants and were 'distracted' by chemokines when moving toward bacterial chemoattractants. In opposing gradients, PTEN became distributed throughout the cell circumference, which inhibited all PI(3)K activity, thus permitting 'preferential' migration toward bacterial products via phospholipase A(2) and p38. Such prioritization was defective in Pten(-/-) neutrophils, which resulted in defective bacterial clearance in vivo. Our data identify a PTEN-dependent mechanism in neutrophils to prioritize, 'triage' and integrate responses to multiple chemotactic cues.	[Heit, Bryan; Guan, Zhiwen; Colarusso, Pina; Kubes, Paul] Univ Calgary, Immunol Res Grp, Inst Infect & Immun, Calgary, AB T2N 4N1, Canada; [Robbins, Stephen M.] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Robbins, Stephen M.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Downey, Charlene M.; Miller, B. Joan; Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Immunol Res Grp, Inst Infect & Immun, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca		Heit, Bryan/0000-0003-2392-468X				Bae YS, 2003, MOL PHARMACOL, V64, P721, DOI 10.1124/mol.64.3.721; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Khan AI, 2005, MICROCIRCULATION, V12, P421, DOI 10.1080/10739680590960368; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marino S, 2002, DEVELOPMENT, V129, P3513; Murdoch C, 2000, BLOOD, V95, P3032; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Solomon S, 2002, EUR J IMMUNOL, V32, P644, DOI 10.1002/1521-4141(200203)32:3<644::AID-IMMU644>3.0.CO;2-5; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Wu Y, 2004, BIOCHEM BIOPH RES CO, V316, P666, DOI 10.1016/j.bbrc.2004.02.107	38	203	208	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					743	752		10.1038/ni.1623	http://dx.doi.org/10.1038/ni.1623			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18536720				2022-12-18	WOS:000256904900011
J	Bardwell, PD; Woo, CJ; Wei, KC; Li, ZQ; Martin, A; Sack, SZ; Parris, T; Edelmann, W; Scharff, MD				Bardwell, PD; Woo, CJ; Wei, KC; Li, ZQ; Martin, A; Sack, SZ; Parris, T; Edelmann, W; Scharff, MD			Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice	NATURE IMMUNOLOGY			English	Article							MISMATCH REPAIR PROTEINS; IMMUNOGLOBULIN GENES; IMMUNE-RESPONSE; B-CELLS; DNA; DEFICIENT; ROLES; MSH2; AID; SPECIFICITY	The generation of protective antibodies requires somatic hypermutation (SHM) and class-switch recombination (CSR) of immunoglobulin genes. Here we show that mice mutant for exonuclease 1 (Exo1), which participates in DNA mismatch repair (MMR), have decreased CSR and changes in the characteristics of SHM similar to those previously observed in mice mutant for the MMR protein Msh2. Exo1 is thus the first exonuclease shown to be involved in SHM and CSR. The phenotype of Exo1(-/-) mice and the finding that Exo1 and Mlh1 are physically associated with mutating variable regions support the idea that Exo1 and MMR participate directly in SHM and CSR.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	scharff@aecom.yu.edu	Bardwell, Philip D./K-8442-2013; Bardwell, Philip/H-2219-2014; Martin, Alberto/B-1421-2008	Bardwell, Philip D./0000-0002-3835-255X; Bardwell, Philip/0000-0002-3835-255X; Martin, Alberto/0000-0002-0795-0418	NATIONAL CANCER INSTITUTE [R01CA072649, T32CA009173, R01CA102705, R01CA076329, R01CA093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053362] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA 09173, CA 93484, CA 76329, CA 72649, CA 102705] Funding Source: Medline; NIAID NIH HHS [AI 53362] Funding Source: Medline; PHS HHS [3T26 MO 7491] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alabyev B, 2002, J IMMUNOL, V169, P3819, DOI 10.4049/jimmunol.169.7.3819; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Evans E, 2000, MOL CELL BIOL, V20, P7839, DOI 10.1128/MCB.20.21.7839-7844.2000; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kong QZ, 2001, GENETICS, V158, P369; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sack SZ, 2001, MOL IMMUNOL, V38, P303, DOI 10.1016/S0161-5890(01)00058-X; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schrader CE, 2003, J EXP MED, V197, P1377, DOI 10.1084/jem.20022190; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Storb U, 1998, IMMUNOL REV, V162, P5, DOI 10.1111/j.1600-065X.1998.tb01424.x; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2001, P NATL ACAD SCI USA, V98, P9760, DOI 10.1073/pnas.161175998; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	50	203	205	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					224	229		10.1038/ni1031	http://dx.doi.org/10.1038/ni1031			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14716311				2022-12-18	WOS:000188512000019
J	Ellebedy, AH; Jackson, KJL; Kissick, HT; Nakaya, HI; Davis, CW; Roskin, KM; McElroy, AK; Oshansky, CM; Elbein, R; Thomas, S; Lyon, GM; Spiropoulou, CF; Mehta, AK; Thomas, PG; Boyd, SD; Ahmed, R				Ellebedy, Ali H.; Jackson, Katherine J. L.; Kissick, Haydn T.; Nakaya, Helder I.; Davis, Carl W.; Roskin, Krishna M.; McElroy, Anita K.; Oshansky, Christine M.; Elbein, Rivka; Thomas, Shine; Lyon, George M.; Spiropoulou, Christina F.; Mehta, Aneesh K.; Thomas, Paul G.; Boyd, Scott D.; Ahmed, Rafi			Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination	NATURE IMMUNOLOGY			English	Article							INFLUENZA INFECTION; VIRUS-INFECTION; GENERATION; ANTIBODIES; RESPONSES; NETWORKS	Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. ASCs (plasmablasts) have been extensively studied in humans, but less is known about B cells that become activated but do not differentiate into plasmablasts. Here we have defined the phenotype and transcriptional program of a subset of antigen-specific B cells, which we have called 'activated B cells' (ABCs), that were distinct from ASCs and were committed to the MBC lineage. We detected ABCs in humans after infection with Ebola virus or influenza virus and also after vaccination. By simultaneously analyzing antigen-specific ASCs and ABCs in human blood after vaccination against influenza virus, we investigated the clonal overlap and extent of somatic hypermutation (SHM) in the ASC (effector) and ABC (memory) lineages. Longitudinal tracking of vaccination-induced hemagglutinin (HA)-specific clones revealed no overall increase in SHM over time, which suggested that repeated annual immunization might have limitations in enhancing the quality of influenza-virus-specific antibody.	[Ellebedy, Ali H.; Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Ellebedy, Ali H.; Kissick, Haydn T.; Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Jackson, Katherine J. L.; Roskin, Krishna M.; Boyd, Scott D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA; [Nakaya, Helder I.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [McElroy, Anita K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [McElroy, Anita K.; Spiropoulou, Christina F.] US Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA USA; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Elbein, Rivka; Thomas, Shine; Lyon, George M.; Mehta, Aneesh K.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	Emory University; Emory University; Stanford University; Emory University; Emory University; Universidade de Sao Paulo; Emory University; Centers for Disease Control & Prevention - USA; St Jude Children's Research Hospital; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Boyd, SD (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	sboyd1@stanford.edu; rahmed@emory.edu	Thomas, Paul G./H-1063-2018; Jackson, Katherine/AAE-4326-2019; Kissick, Haydn/AAS-6292-2021; thomas, shine/HDN-5165-2022; Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Mehta, Aneesh/B-8054-2012	Thomas, Paul G./0000-0001-7955-0256; Kissick, Haydn/0000-0001-7624-5598; Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; McElroy, Anita/0000-0001-6764-7536; Jackson, Katherine/0000-0002-9952-7069; Mehta, Aneesh/0000-0002-6552-9162	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [HHSN266200700006C, 1P01AI097092, U19AI117891, T32AI074492, U19AI09525801, UM1AI100663, U01AI104342]; Advanced Immunization Technologies [280873]; European Union; National Center for Advancing Translational Sciences [UL1TR000454]; National Council for Scientific and Technological Development of Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092, T32AI074492, U01AI104342, UM1AI100663, U19AI117891] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Advanced Immunization Technologies; European Union(European Commission); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Karaffa and S. Durham for technical assistance. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (HHSN266200700006C, 1P01AI097092 and U19AI117891 to R.A.; T32AI074492 to A.E.; and U19AI09525801, UM1AI100663 and U01AI104342 to S.D.B.), Advanced Immunization Technologies (280873), the European Union (R.A.), the National Center for Advancing Translational Sciences (UL1TR000454 to A.K.M.) and The National Council for Scientific and Technological Development of Brazil (H.I.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health or that of the Centers for Disease Control and Prevention.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	32	202	207	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1226	+		10.1038/ni.3533	http://dx.doi.org/10.1038/ni.3533			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27525369	Green Accepted			2022-12-18	WOS:000384302900014
J	Cardone, J; Le Friec, G; Vantourout, P; Roberts, A; Fuchs, A; Jackson, I; Suddason, T; Lord, G; Atkinson, JP; Cope, A; Hayday, A; Kemper, C				Cardone, John; Le Friec, Gaelle; Vantourout, Pierre; Roberts, Andrew; Fuchs, Anja; Jackson, Ian; Suddason, Tesha; Lord, Graham; Atkinson, John P.; Cope, Andrew; Hayday, Adrian; Kemper, Claudia			Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells	NATURE IMMUNOLOGY			English	Article							COFACTOR PROTEIN MCP; INTERFERON-GAMMA; ADAPTIVE IMMUNITY; INNATE IMMUNITY; IFN-GAMMA; IN-VIVO; INTERLEUKIN-10; ACTIVATION; IL-10; LYMPHOCYTES	In this study we demonstrate a new form of immunoregulation: engagement on CD4(+) T cells of the complement regulator CD46 promoted the effector potential of T helper type 1 cells (T(H)1 cells), but as interleukin 2 (IL-2) accumulated, it switched cells toward a regulatory phenotype, attenuating IL-2 production via the transcriptional regulator ICER/CREM and upregulating IL-10 after interaction of the CD46 tail with the serine-threonine kinase SPAK. Activated CD4(+) T cells produced CD46 ligands, and blocking CD46 inhibited IL-10 production. Furthermore, CD4(+) T cells in rheumatoid arthritis failed to switch, consequently producing excessive interferon-gamma (IFN-gamma). Finally, gamma delta T cells, which rarely produce IL-10, expressed an alternative CD46 isoform and were unable to switch. Nonetheless, coengagement of T cell antigen receptor (TCR) gamma delta and CD46 suppressed effector cytokine production, establishing that CD46 uses distinct mechanisms to regulate different T cell subsets during an immune response.	[Cardone, John; Le Friec, Gaelle; Jackson, Ian; Suddason, Tesha; Lord, Graham; Hayday, Adrian; Kemper, Claudia] Guys Hosp, Div Immunol Infect & Inflammatory Dis, Kings Coll London, Med Res Council,Ctr Transplantat, London SE1 9RT, England; [Vantourout, Pierre; Roberts, Andrew; Hayday, Adrian] Canc Res UK, London Res Inst, London, England; [Vantourout, Pierre; Roberts, Andrew; Hayday, Adrian] Guys Hosp, Peter Gorer Dept Immunobiol, Kings Coll London, London SE1 9RT, England; [Fuchs, Anja] Washington Univ, Sch Med, Div Immunol & Pathol, Dept Med, St Louis, MO USA; [Jackson, Ian; Suddason, Tesha; Lord, Graham; Cope, Andrew; Hayday, Adrian] Guys Hosp, Kings Hlth Partners, Biomed Res Ctr, London SE1 9RT, England; [Atkinson, John P.] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO USA; [Cope, Andrew] Kings Coll London, Acad Dept Rheumatol, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Washington University (WUSTL); University of London; King's College London	Kemper, C (corresponding author), Guys Hosp, Div Immunol Infect & Inflammatory Dis, Kings Coll London, Med Res Council,Ctr Transplantat, London SE1 9RT, England.	claudia.kemper@kcl.ac.uk	Abraham, Sabu/E-1144-2019; Kemper, Claudia/B-1502-2015	Abraham, Sabu/0000-0002-0916-5827; Le Friec, Gaelle/0000-0002-2051-3829; HAYDAY, ADRIAN/0000-0002-9495-5793; Lord, Graham/0000-0003-2069-4743; Atkinson, John/0000-0002-2514-3441; Vantourout, Pierre/0000-0001-7287-5517; Kemper, Claudia/0000-0003-4196-1417; Cope, Andrew/0000-0001-6735-5496	American Asthma Foundation; Wellcome Trust; Cancer Research UK; US National Institutes of Health [AI037618]; Medical Research Council Centre for Transplantation, Guy's Hospital, King's College; Department of Health, National Institute for Health Research comprehensive Biomedical Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037618] Funding Source: NIH RePORTER; MRC [G0802068] Funding Source: UKRI; Medical Research Council [G0802068, G0600698B] Funding Source: researchfish	American Asthma Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Centre for Transplantation, Guy's Hospital, King's College(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health, National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Jomaa (Justus-Liebig-Universitat) for HMBPP; K. Murphy for advice and discussions; and C. Hawrylowicz for help with manuscript revision. Supported by the American Asthma Foundation (formerly Sandler Program for Asthma Research; J.P.A. and C.K.), the Wellcome Trust (A.H. and A.R.), Cancer Research UK (A.H. and P.V.), the US National Institutes of Health (AI037618 to J.P.A.), the Medical Research Council Centre for Transplantation, Guy's Hospital, King's College (G.L. and C.K.) and the Department of Health, National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (G.L.F., A.H and C.K).	Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; ASLIER AL, 2010, J IMMUNOL, V184, P685; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Caudy AA, 2007, J ALLERGY CLIN IMMUN, V119, P482, DOI 10.1016/j.jaci.2006.10.007; Chen JZ, 2009, J LEUKOCYTE BIOL, V86, P1305, DOI 10.1189/jlb.0609406; Collins Mary, 2007, Genome Biol, V8, P317, DOI 10.1186/gb-2007-8-10-317; DEL PG, 1993, J IMMUNOL, V150, P353; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; FRIEC GL, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI DOI 10.1007/S00005-009-0047-4; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Glimcher LH, 2000, GENE DEV, V14, P1693; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hunter CA, 1997, J IMMUNOL, V158, P3311; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kerekes K, 1998, INT IMMUNOL, V10, P1923, DOI 10.1093/intimm/10.12.1923; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Powell JD, 1999, J IMMUNOL, V163, P6631; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sanchez A, 2004, EUR J IMMUNOL, V34, P2439, DOI 10.1002/eji.200324259; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; White J, 2004, PROTEIN SCI, V13, P2406, DOI 10.1110/ps.03455604; Windhagen A, 1996, J IMMUNOL, V157, P1127; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	50	202	214	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					862	U123		10.1038/ni.1917	http://dx.doi.org/10.1038/ni.1917			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20694009	Green Accepted			2022-12-18	WOS:000281115500015
J	Kanda, H; Newton, R; Klein, R; Morita, Y; Gunn, MD; Rosen, SD				Kanda, Hidenobu; Newton, Rebecca; Klein, Russell; Morita, Yuka; Gunn, Michael D.; Rosen, Steven D.			Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL-CELLS; MOTILITY-STIMULATING PROTEIN; LYSOPHOSPHOLIPASE-D; L-SELECTIN; EXPRESSION PROFILE; PERTUSSIS-TOXIN; T-LYMPHOCYTES; VENULE CELLS; RECEPTOR; NODE	The extracellular lysophospholipase D autotaxin (ATX) and its product, lysophosphatidic acid, have diverse functions in development and cancer, but little is known about their functions in the immune system. Here we found that ATX had high expression in the high endothelial venules of lymphoid organs and was secreted. Chemokine-activated lymphocytes expressed receptors with enhanced affinity for ATX, which provides a mechanism for targeting the secreted ATX to lymphocytes undergoing recruitment. Lysophosphatidic acid induced chemokinesis in T cells. Intravenous injection of enzymatically inactive ATX attenuated the homing of T cells to lymphoid tissues, probably through competition with endogenous ATX and exertion of a dominant negative effect. Our results support the idea of a new and general step in the homing cascade in which the ectoenzyme ATX facilitates the entry of lymphocytes into lymphoid organs.	[Kanda, Hidenobu; Newton, Rebecca; Klein, Russell; Morita, Yuka; Rosen, Steven D.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Program Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosen, SD (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anat, Program Immunol, San Francisco, CA 94143 USA.	steven.rosen@ucsf.edu		Rosen, Steven/0000-0002-6245-701X; Gunn, Michael/0000-0003-4602-0667	NIGMS NIH HHS [R01-GM57411, R01-GM23547, R01 GM057411, R01 GM023547, R01 GM023547-32, R01 GM057411-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057411, R01GM023547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ager A, 1997, BIOCHEM SOC T, V25, P421, DOI 10.1042/bst0250421; Baekkevold ES, 1999, LAB INVEST, V79, P327; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cohen D, 2004, P NATL ACAD SCI USA, V101, P13792, DOI 10.1073/pnas.0403684101; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Fox MA, 2003, MOL CELL NEUROSCI, V23, P507, DOI 10.1016/S1044-7431(03)00073-3; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Goetzl EJ, 2000, J IMMUNOL, V164, P4996, DOI 10.4049/jimmunol.164.10.4996; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; HARRIS H, 1991, INT IMMUNOL, V3, P535, DOI 10.1093/intimm/3.6.535; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; Idzko M, 2004, J IMMUNOL, V172, P4480, DOI 10.4049/jimmunol.172.7.4480; Izawa D, 1999, INT IMMUNOL, V11, P1989, DOI 10.1093/intimm/11.12.1989; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Kitani A, 1998, J IMMUNOL, V161, P4931; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee HY, 1996, J BIOL CHEM, V271, P24408, DOI 10.1074/jbc.271.40.24408; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; MURATA J, 1994, J BIOL CHEM, V269, P30479; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Palmeri D, 2004, J LEUKOCYTE BIOL, V75, P910, DOI 10.1189/jlb.0903408; Rieken S, 2006, J BIOL CHEM, V281, P36985, DOI 10.1074/jbc.M605287200; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WILKINSON PC, 1986, IMMUNOLOGY, V57, P281; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Zheng YH, 2001, J IMMUNOL, V166, P2317, DOI 10.4049/jimmunol.166.4.2317; Zheng YH, 2000, FASEB J, V14, P2387	53	202	211	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					415	423		10.1038/ni1573	http://dx.doi.org/10.1038/ni1573			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18327261	Green Accepted			2022-12-18	WOS:000254123200017
J	Zha, YY; Marks, R; Ho, AW; Peterson, AC; Janardhan, S; Brown, I; Praveen, K; Stang, S; Stone, JC; Gajewski, TF				Zha, Yuanyuan; Marks, Reinhard; Ho, Allen W.; Peterson, Amy C.; Janardhan, Sujit; Brown, Ian; Praveen, Kesavannair; Stang, Stacey; Stone, James C.; Gajewski, Thomas F.			T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha	NATURE IMMUNOLOGY			English	Article							E3 UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; ACTIVATION; IL-2; RECEPTOR; INDUCTION; MECHANISM; SELECTION; ERK	T cell anergy has been correlated with defective signaling by the GTPase Ras, but causal and mechanistic data linking defective Ras activity with T cell anergy are lacking. Here we used adenoviral transduction to genetically manipulate nonproliferating T cells and show that active Ras restored interleukin 2 production and mitogen-activated protein kinase signaling in T cells that were made anergic in vitro or in vivo. Diacylglycerol kinases ( DGKs), which negatively regulate Ras activity, were upregulated in anergic T cells, and a DGK inhibitor restored interleukin 2 production in anergic T cells. Both anergy and DGK-alpha overexpression were associated with defective translocation of the Ras guanine nucleotide - exchange factor RasGRP1 to the plasma membrane. Our data support a causal function for excess DGK activity and defective Ras signaling in T cell anergy.	Univ Chicago, Dept Pathol, Sect Hematol & Oncol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Sect Hematol & Oncol, Chicago, IL 60637 USA; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2E1, Canada	University of Chicago; University of Chicago; University of Alberta	Gajewski, TF (corresponding author), Univ Chicago, Dept Pathol, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu	Ho, Allen/B-3017-2011; Zha, Yuanyuan/I-2890-2015	Zha, Yuanyuan/0000-0003-4323-0730; Ho, Allen/0000-0002-5861-0552	NATIONAL CANCER INSTITUTE [P01CA097296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059818] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA97296] Funding Source: Medline; NIAID NIH HHS [R01AI7919, R21AI59818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham C, 2001, J IMMUNOL, V167, P5193, DOI 10.4049/jimmunol.167.9.5193; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Crespi D, 2002, EUR J IMMUNOL, V32, P2500, DOI 10.1002/1521-4141(200209)32:9<2500::AID-IMMU2500>3.0.CO;2-S; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Fields P, 1996, J MOL MED-JMM, V74, P673, DOI 10.1007/s001090050071; Fields PE, 1998, J IMMUNOL, V161, P5268; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Frauwirth KA, 2001, J IMMUNOL, V167, P4936, DOI 10.4049/jimmunol.167.9.4936; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lin YL, 2000, FEBS LETT, V467, P184, DOI 10.1016/S0014-5793(00)01150-9; Manning TC, 1997, J IMMUNOL, V159, P4665; Marks RE, 2003, BIOCHEM BIOPH RES CO, V312, P691, DOI 10.1016/j.bbrc.2003.10.168; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; Outram SV, 2002, IMMUNOLOGY, V105, P391, DOI 10.1046/j.1365-2567.2002.01385.x; Peterson AC, 2003, EUR J IMMUNOL, V33, P2687, DOI 10.1002/eji.200324294; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; Rivas FV, 2001, J IMMUNOL, V167, P3123, DOI 10.4049/jimmunol.167.6.3123; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Telander DG, 1999, J IMMUNOL, V162, P1460; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; van Blitterswijk WJ, 1999, CHEM PHYS LIPIDS, V98, P95, DOI 10.1016/S0009-3084(99)00022-5; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	42	202	218	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1166	1173		10.1038/ni1394	http://dx.doi.org/10.1038/ni1394			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17028589				2022-12-18	WOS:000241437200011
J	Liu, B; Mink, S; Wong, KA; Stein, N; Getman, C; Dempsey, PW; Wu, H; Shuai, K				Liu, B; Mink, S; Wong, KA; Stein, N; Getman, C; Dempsey, PW; Wu, H; Shuai, K			PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA; DNA-BINDING; TARGETED DISRUPTION; STAT1; ACTIVATION; ELEMENT; TRANSCRIPTION; PHOSPHORYLATION; INVOLVEMENT; CONJUGATION	Interferon (IFN) activates the signal transducer and activator of transcription (STAT) pathway to regulate immune responses. The protein inhibitor of activated STAT (PIAS) family has been suggested to negatively regulate STAT signaling. To understand the physiological function of PIAS1, we generated Pias1(-/-) mice. Using PIAS1-deficient cells, we show that PIAS1 selectively regulates a subset of IFN-gamma- or IFN-beta-inducible genes by interfering with the recruitment of STAT1 to the gene promoter. The antiviral activity of IFN-gamma or IFN-beta was consistently enhanced by Pias1 disruption. Pias1(-/-) mice showed increased protection against pathogenic infection. Our data indicate that PIAS1 is a physiologically important negative regulator of STAT1 and CL m suggest that PIAS1 is critical for the IFN-gamma- or IFN-beta-mediated innate immune responses.	Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Shuai, K (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.	kshuai@mednet.ucla.edu			NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA009056] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Arora T, 2003, J BIOL CHEM, V278, P21327, DOI 10.1074/jbc.C300119200; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; GUYER NB, 1995, J IMMUNOL, V155, P3472; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kojima H, 1996, ONCOGENE, V12, P547; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Martinez-Guzman D, 2003, J VIROL, V77, P10488, DOI 10.1128/JVI.77.19.10488-10503.2003; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000	44	202	216	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					891	898		10.1038/ni1104	http://dx.doi.org/10.1038/ni1104			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15311277				2022-12-18	WOS:000223612500017
J	Reiser, JB; Darnault, C; Gregoire, C; Mosser, T; Mazza, G; Kearney, A; van der Merwe, PA; Fontecilla-Camps, JC; Housset, D; Malissen, B				Reiser, JB; Darnault, C; Gregoire, C; Mosser, T; Mazza, G; Kearney, A; van der Merwe, PA; Fontecilla-Camps, JC; Housset, D; Malissen, B			CDR3 loop flexibility contributes to the degeneracy of TCR recognition	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; CLASS-II MOLECULE; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; VIRAL PEPTIDE; ANTIGEN RECOGNITION; STRUCTURAL BASIS; COMPLEX; BINDING; SPECIFICITY	T cell receptor (TCR) binding degeneracy lies at the heart of several physiological and pathological phenomena, yet its structural basis is poorly understood. We determined the crystal structure of a complex involving the BM3.3 TCR and an octapeptide (VSV8) bound to the H-2K(b) major histocompatibility complex molecule at a 2.7 Angstrom resolution, and compared it with the BM3.3 TCR bound to the H-2K(b) molecule loaded with a peptide that has no primary sequence identity with VSV8. Comparison of these structures showed that the BM3.3 TCR complementarity-determining region (CDR) 3alpha could undergo rearrangements to adapt to structurally different peptide residues. Therefore, CDR3 loop flexibility helps explain TCR binding cross-reactivity.	Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, F-13288 Marseille 9, France; UJF, Inst Biol Struct JP Ebel, Cristallog & Cristallogenese Prot Lab, CNRS,CEA, F-38027 Grenoble 1, France; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Oxford	Malissen, B (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, INSERM, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.	dominique.housset@ibs.fr; bernardm@ciml.univ-mrs.fr	van der Merwe, P. Anton/F-8539-2011; Reiser, Jean-Baptiste/W-7683-2019; Mazza, Giuseppe/A-2833-2013; Malissen, Bernard/AAK-4659-2020	Reiser, Jean-Baptiste/0000-0001-6926-9137; Malissen, Bernard/0000-0003-1340-9342; HOUSSET, Dominique/0000-0003-1732-0193				Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Bongrand P, 1998, BIOESSAYS, V20, P412; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Eisen HN, 2001, ANNU REV IMMUNOL, V19, P1, DOI 10.1146/annurev.immunol.19.1.1; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gregoire C, 1996, EUR J IMMUNOL, V26, P2410, DOI 10.1002/eji.1830261022; GUIMEZANES A, 1992, EUR J IMMUNOL, V22, P1651, DOI 10.1002/eji.1830220647; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; GUIMEZANES A, UNIQUE STRUCTURAL FE; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Langman RE, 2000, MOL IMMUNOL, V37, P555, DOI 10.1016/S0161-5890(00)00083-3; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Radaev S, 2001, IMMUNITY, V15, P1039, DOI 10.1016/S1074-7613(01)00241-2; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P398, DOI 10.1073/pnas.72.1.398; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	55	202	208	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					241	247		10.1038/ni891	http://dx.doi.org/10.1038/ni891			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12563259				2022-12-18	WOS:000181201000012
J	Tellier, J; Shi, W; Minnich, M; Liao, Y; Crawford, S; Smyth, GK; Kallies, A; Busslinger, M; Nutt, SL				Tellier, Julie; Shi, Wei; Minnich, Martina; Liao, Yang; Crawford, Simon; Smyth, Gordon K.; Kallies, Axel; Busslinger, Meinrad; Nutt, Stephen L.			Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response	NATURE IMMUNOLOGY			English	Article							B-CELLS; MESSENGER-RNA; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; XBP-1; SURVIVAL; ACTIVATION; REPRESSION; GENERATION	Plasma cell differentiation requires silencing of B cell transcription, while it establishes antibody-secretory function and long-term survival. The transcription factors Blimp-1 and IRF4 are essential for the generation of plasma cells; however, their function in mature plasma cells has remained elusive. We found that while IRF4 was essential for the survival of plasma cells, Blimp-1 was dispensable for this. Blimp-l-deficient plasma cells retained their transcriptional identity but lost the ability to secrete antibody. Blimp-1 regulated many components of the unfolded protein response (UPR), including XBP-1 and ATF6. The overlap in the functions of Blimp-1 and XBP-1 was restricted to that response, with Blimp-1 uniquely regulating activity of the kinase mTOR and the size of plasma cells. Thus, Blimp-1 was required for the unique physiological ability of plasma cells that enables the secretion of protective antibody.	[Tellier, Julie; Shi, Wei; Liao, Yang; Smyth, Gordon K.; Kallies, Axel; Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Tellier, Julie; Liao, Yang; Kallies, Axel; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Minnich, Martina; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Crawford, Simon] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Melbourne; University of Melbourne	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.; Nutt, SL (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	nutt@wehi.edu.au	Smyth, Gordon/B-5276-2008; Busslinger, Meinrad J./J-1249-2016; Nutt, Stephen L/C-9256-2013	Smyth, Gordon/0000-0001-9221-2892; Busslinger, Meinrad J./0000-0002-9111-9351; Nutt, Stephen L/0000-0002-0020-6637; , Yang/0000-0002-9746-2839; Tellier, Julie/0000-0003-2787-8174; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia [361646, 575500, 1054925, 1054618, 1023454, 1049416]; Sylvia and Charles Viertel Foundation; Multiple Myeloma Research Foundation; Boehringer Ingelheim (Busslinger laboratory); European Research Council (LymphoControl for the Busslinger laboratory) [291740]; Victorian State Government Operational Infrastructure Support	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Multiple Myeloma Research Foundation; Boehringer Ingelheim (Busslinger laboratory)(Boehringer Ingelheim); European Research Council (LymphoControl for the Busslinger laboratory); Victorian State Government Operational Infrastructure Support	We thank U. Klein (Columbia University) for Irf4<SUP>fl/fl</SUP>; L. Glimcher (Weill Cornell Medical College) for Xbp1<SUP>fl/fl</SUP> mice; S. Wilcox, M. Chopin and C. Seillet for technical assistance; and J. Leahy for animal care. Supported by the National Health and Medical Research Council of Australia (G.K.S. and S.L.N.; 361646, 575500 and 1054925 to S.L.N.; 1054618 to G.K.S.; 1023454 to G.K.S. and W.S.; and 1049416 to A.K.), the Sylvia and Charles Viertel Foundation (A.K.), the Multiple Myeloma Research Foundation (S.L.N.), Boehringer Ingelheim (Busslinger laboratory) and the European Research Council (291740-LymphoControl for the Busslinger laboratory), and made possible through Victorian State Government Operational Infrastructure Support.	Bayles I, 2014, CRIT REV IMMUNOL, V34, P481, DOI 10.1615/CritRevImmunol.2014012168; Benhamron S, 2015, MOL CELL BIOL, V35, P153, DOI 10.1128/MCB.01187-14; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Brewer JW, 2014, CELL MOL LIFE SCI, V71, P1067, DOI 10.1007/s00018-013-1490-2; BRINKMANN V, 1993, CELL IMMUNOL, V152, P323, DOI 10.1006/cimm.1993.1294; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Goldfinger M, 2011, EUR J IMMUNOL, V41, P491, DOI 10.1002/eji.201040677; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Park KS, 2014, J IMMUNOL, V193, P4663, DOI 10.4049/jimmunol.1401608; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Taubenheim N, 2012, J IMMUNOL, V189, P3328, DOI 10.4049/jimmunol.1201042; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	47	201	204	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					323	330		10.1038/ni.3348	http://dx.doi.org/10.1038/ni.3348			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26779600	Green Accepted			2022-12-18	WOS:000370469300017
J	An, HZ; Hou, J; Zhou, J; Zhao, W; Xu, HM; Zheng, YJ; Yu, YZ; Liu, SX; Cao, XT				An, Huazhang; Hou, Jin; Zhou, Jun; Zhao, Wei; Xu, Hongmei; Zheng, Yuejuan; Yu, Yizhi; Liu, Shuxun; Cao, Xuetao			Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1	NATURE IMMUNOLOGY			English	Article							RECEPTOR-ASSOCIATED KINASE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INTERLEUKIN-1 RECEPTOR; TYROSINE KINASE; IMMUNE-RESPONSES; ALPHA INDUCTION; CELL ACTIVATION; ADAPTER; PROTEIN	Unbalanced production of proinflammatory cytokines and type I interferons in immune responses may lead to immunopathology; thus, the mechanisms that ensure the beneficial production of proinflammatory cytokines and type I interferons are of particular importance. Here we demonstrate that the phosphatase SHP-1 negatively regulated Toll-like receptor-mediated production of proinflammatory cytokines by inhibiting activation of the transcription factor NF-kappa B and mitogen-activated protein kinase. Simultaneously, SHP-1 increased the production of type I interferon mediated by Toll-like receptors and the helicase RIG-I by directly binding to and inhibiting activation of the kinase IRAK1. Our data demonstrate that SHP-1 contributes to immune homeostasis by balancing the production of proinflammatory cytokines and type I interferons in the innate immune response.	[An, Huazhang; Hou, Jin; Zhou, Jun; Zhao, Wei; Xu, Hongmei; Zheng, Yuejuan; Yu, Yizhi; Liu, Shuxun; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Inst Immunol, Shanghai 200433, Peoples R China	Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Inst Immunol, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn	xu, hong/GSD-8903-2022; ZHAO, WEI/C-9163-2011; Zheng, Yuejuan/AAF-5923-2020; Hou, Jin/GRY-4960-2022; yu, yizhi/ADP-7854-2022	Zhao, Wei/0000-0001-8440-2274; An, Huazhang/0000-0001-8120-9145				An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Dustin LB, 1999, J IMMUNOL, V162, P2717; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Khaled AR, 1998, CELL IMMUNOL, V185, P49, DOI 10.1006/cimm.1998.1272; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Li XX, 1999, MOL CELL BIOL, V19, P4643; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Nandan D, 1999, INFECT IMMUN, V67, P4055, DOI 10.1128/IAI.67.8.4055-4063.1999; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nguyen H, 2003, J INTERF CYTOK RES, V23, P183, DOI 10.1089/107999003765027384; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Sanaa N, 2004, J BIOL CHEM, V279, P25189, DOI 10.1074/jbc.M312431200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang N, 2006, J BIOL CHEM, V281, P21878, DOI 10.1074/jbc.M605018200; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620	35	201	210	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					542	550		10.1038/ni.1604	http://dx.doi.org/10.1038/ni.1604			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18391954				2022-12-18	WOS:000255153500016
J	Shan, B; Wang, XX; Wu, Y; Xu, C; Xia, ZX; Dai, JL; Shao, ML; Zhao, F; He, SQ; Yang, L; Zhang, ML; Nan, FJ; Li, J; Liu, JM; Liu, JF; Jia, WP; Qiu, YF; Song, BL; Han, JDJ; Rui, LY; Duan, SZ; Liu, Y				Shan, Bo; Wang, Xiaoxia; Wu, Ying; Xu, Chi; Xia, Zhixiong; Dai, Jianli; Shao, Mengle; Zhao, Feng; He, Shengqi; Yang, Liu; Zhang, Mingliang; Nan, Fajun; Li, Jia; Liu, Jianmiao; Liu, Jianfeng; Jia, Weiping; Qiu, Yifu; Song, Baoliang; Han, Jing-Dong J.; Rui, Liangyou; Duan, Sheng-Zhong; Liu, Yong			The metabolic ER stress sensor IRE1 alpha suppresses alternative activation of macrophages and impairs energy expenditure in obesity	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; ADIPOSE-TISSUE; BEIGE FAT; POLARIZATION; DISEASE; INSULIN; CELL; THERMOGENESIS; INFLAMMATION	Obesity is associated with metabolic inflammation and endoplasmic reticulum (ER) stress, both of which promote metabolic disease progression. Adipose tissue macrophages (ATMs) are key players orchestrating metabolic inflammation, and ER stress enhances macrophage activation. However, whether ER stress pathways underlie ATM regulation of energy homeostasis remains unclear. Here, we identified inositol-requiring enzyme 1 alpha (IRE1 alpha) as a critical switch governing M1-M2 macrophage polarization and energy balance. Myeloid-specific IRE1 alpha abrogation in Ern1(f/f); Lyz2-Cre mice largely reversed high-fat diet (HFD)-induced M1-M2 imbalance in white adipose tissue (WAT) and blocked HFD-induced obesity, insulin resistance, hyperlipidemia and hepatic steatosis. Brown adipose tissue (BAT) activity, WAT browning and energy expenditure were significantly higher in Ern1(f/f); Lyz2-Cre mice. Furthermore, IRE1 alpha ablation augmented M2 polarization of macrophages in a cell-autonomous manner. Thus, IRE1 alpha senses protein unfolding and metabolic and immunological states, and consequently guides ATM polarization. The macrophage IRE1 alpha pathway drives obesity and metabolic syndrome through impairing BAT activity and WAT browning.	[Shan, Bo; Wang, Xiaoxia; Wu, Ying; Dai, Jianli; Zhao, Feng; He, Shengqi; Duan, Sheng-Zhong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Xu, Chi; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Chinese Acad Sci Max Planck Partner Inst Computat, Shanghai, Peoples R China; [Xia, Zhixiong; Liu, Jianmiao; Liu, Jianfeng] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Cellular Signaling Lab, Wuhan, Peoples R China; [Shao, Mengle] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [He, Shengqi; Song, Baoliang; Liu, Yong] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China; [Yang, Liu; Zhang, Mingliang; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai, Peoples R China; [Nan, Fajun; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai, Peoples R China; [Qiu, Yifu] Peking Univ, Beijing Key Lab Cardiometab Mol Med, Acad Adv Interdisciplinary Studies, Inst Mol Med,Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Rui, Liangyou] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wuhan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Peking University; University of Michigan System; University of Michigan	Duan, SZ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.; Liu, Y (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China.	szduan@sibs.ac.cn; liuyong31279@whu.edu.cn	Li, Jia/F-9116-2011; SHAN, BO/AAC-5167-2021; li, jia/GVT-7587-2022; Shao, Mengle/AAH-8392-2019	SHAN, BO/0000-0002-1675-5809; Shao, Mengle/0000-0002-5488-9904	Ministry of Science and Technology [2016YFA0500100]; Ministry of Science and Technology (973 Program) [2012CB524900]; National Natural Science Foundation of China [81420108006, 31690102, 31230036, 31671181, 31371153, 91539107, 31671227, 91642113]; European Foundation for the Study of Diabetes/Chinese Diabetes Society/Lilly Programme	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Foundation for the Study of Diabetes/Chinese Diabetes Society/Lilly Programme	We thank S. Kajimura from UCSF for the beige preadipocytes and C. Jiang from Peking University for assistance with the macrophage depletion experiments. This work was supported by grants from the Ministry of Science and Technology (2016YFA0500100 and 973 Program 2012CB524900) and the National Natural Science Foundation of China (81420108006, 31690102 and 31230036) to Y.L.; the National Natural Science Foundation of China (31671181 and 31371153) to S.Z.D.; the National Natural Science Foundation of China (91539107) to Jianmiao Liu; and the National Natural Science Foundation of China (31671227 and 91642113) to Y.Q. This work was also supported by a research grant from the European Foundation for the Study of Diabetes/Chinese Diabetes Society/Lilly Programme to Y.L.	Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jordan MB, 2003, BLOOD, V101, P594, DOI 10.1182/blood-2001-11-0061; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang XX, 2010, MOL BIOL REP, V37, P2099, DOI 10.1007/s11033-009-9671-7; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	46	200	213	6	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					519	529		10.1038/ni.3709	http://dx.doi.org/10.1038/ni.3709			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28346409				2022-12-18	WOS:000399378700009
J	Koay, HF; Gherardin, NA; Enders, A; Loh, L; Mackay, LK; Almeida, CF; Russ, BE; Nold-Petry, CA; Nold, MF; Bedoui, S; Chen, ZJ; Corbett, AJ; Eckle, SBG; Meehan, B; d'Udekem, Y; Konstantinov, IE; Lappas, M; Liu, LG; Goodnow, CC; Fairlie, DP; Rossjohn, J; Chong, MM; Kedzierska, K; Berzins, SP; Belz, GT; McCluskey, J; Uldrich, AP; Godfrey, DI; Pellicci, DG				Koay, Hui-Fern; Gherardin, Nicholas A.; Enders, Anselm; Loh, Liyen; Mackay, Laura K.; Almeida, Catarina F.; Russ, Brendan E.; Nold-Petry, Claudia A.; Nold, Marcel F.; Bedoui, Sammy; Chen, Zhenjun; Corbett, Alexandra J.; Eckle, Sidonia B. G.; Meehan, Bronwyn; d'Udekem, Yves; Konstantinov, Igor E.; Lappas, Martha; Liu, Ligong; Goodnow, Chris C.; Fairlie, David P.; Rossjohn, Jamie; Chong, Mark M.; Kedzierska, Katherine; Berzins, Stuart P.; Belz, Gabrielle T.; McCluskey, James; Uldrich, Adam P.; Godfrey, Dale I.; Pellicci, Daniel G.			A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage	NATURE IMMUNOLOGY			English	Article							MAIT CELLS; RECEPTOR HETEROGENEITY; MR1 TETRAMERS; MOUSE; DIVERSITY; RECOGNITION; METABOLITES; ACTIVATION; PROGRAM; SUBSET	Mucosal-associated invariant T cells (MAIT cells) detect microbial vitamin B2 derivatives presented by the antigen-presenting molecule MR1. Here we defined three developmental stages and checkpoints for the MAIT cell lineage in humans and mice. Stage 1 and stage 2 MAIT cells predominated in thymus, while stage 3 cells progressively increased in abundance extrathymically. Transition through each checkpoint was regulated by MR1, whereas the final checkpoint that generated mature functional MAIT cells was controlled by multiple factors, including the transcription factor PLZF and microbial colonization. Furthermore, stage 3 MAIT cell populations were expanded in mice deficient in the antigen-presenting molecule CD1d, suggestive of a niche shared by MAIT cells and natural killer T cells (NKT cells). Accordingly, this study maps the developmental pathway and checkpoints that control the generation of functional MAIT cells.	[Koay, Hui-Fern; Gherardin, Nicholas A.; Loh, Liyen; Mackay, Laura K.; Almeida, Catarina F.; Russ, Brendan E.; Bedoui, Sammy; Chen, Zhenjun; Corbett, Alexandra J.; Eckle, Sidonia B. G.; Meehan, Bronwyn; Kedzierska, Katherine; Berzins, Stuart P.; McCluskey, James; Uldrich, Adam P.; Godfrey, Dale I.; Pellicci, Daniel G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Gherardin, Nicholas A.] Peter MacCallum Canc Ctr, Canc Immunol Res Program, East Melbourne, Australia; [Enders, Anselm; Goodnow, Chris C.] John Curtin Sch Med Res, Dept Immunol, Canberra, ACT, Australia; [Mackay, Laura K.; Uldrich, Adam P.; Godfrey, Dale I.; Pellicci, Daniel G.] Univ Melbourne, Ctr Excellence Adv Mol Imaging, Australian Res Council, Melbourne, Vic, Australia; [Nold-Petry, Claudia A.; Nold, Marcel F.] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Nold-Petry, Claudia A.; Nold, Marcel F.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [d'Udekem, Yves; Konstantinov, Igor E.] Royal Childrens Hosp, Flemington Rd, Parkville, Vic, Australia; [Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstetr Nutr & Endocrinol Grp, Heidelberg, Vic, Australia; [Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Liu, Ligong; Fairlie, David P.] Univ Queensland, Ctr Excellence Adv Mol Imaging, Australian Res Council, Brisbane, Qld, Australia; [Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff, S Glam, Wales; [Rossjohn, Jamie] Monash Univ, Ctr Excellence Adv Mol Imaging, Australian Res Council, Clayton, Vic, Australia; [Chong, Mark M.] St Vincents Inst Med Res, Fitzroy, Vic, Australia; [Chong, Mark M.] Univ Melbourne, Dept Med St Vincents, Fitzroy, Vic, Australia; [Berzins, Stuart P.] Federat Univ, Collaborat Res Network, Ballarat, Vic, Australia; [Berzins, Stuart P.] Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia; [Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Div Mol Immunol, Parkville, Vic, Australia; [Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	University of Melbourne; Peter Maccallum Cancer Center; Australian National University; John Curtin School of Medical Research; University of Melbourne; Monash University; Hudson Institute of Medical Research; Royal Children's Hospital Melbourne; University of Melbourne; University of Queensland; University of Queensland; Monash University; Cardiff University; Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; Federation University Australia; Walter & Eliza Hall Institute; University of Melbourne	Godfrey, DI; Pellicci, DG (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Godfrey, DI; Pellicci, DG (corresponding author), Univ Melbourne, Ctr Excellence Adv Mol Imaging, Australian Res Council, Melbourne, Vic, Australia.	godfrey@unimelb.edu.au; pellicci@unimelb.edu.au	Goodnow, Christopher C/V-8108-2018; McCluskey, James/A-1291-2007; Belz, Gabrielle T/C-9350-2013; Rossjohn, Jamie/F-9032-2013; Uldrich, Adam/AAX-3785-2020; d'Udekem, Yves/AAS-9642-2021; Gherardin, Nicholas/P-6853-2019; Corbett, Alexandra/A-1225-2019; Mackay, Laura K/HGC-6580-2022; Fairlie, David P/F-8865-2014; Pellicci, Daniel/AAX-8539-2020; Eckle, Sidonia BG/O-8146-2014; Enders, Anselm/B-1165-2011; liu, ligong/B-1690-2010; Chong, Mark/H-6684-2016	Goodnow, Christopher C/0000-0001-5296-6155; McCluskey, James/0000-0002-8597-815X; Belz, Gabrielle T/0000-0002-9660-9587; Rossjohn, Jamie/0000-0002-2020-7522; Corbett, Alexandra/0000-0003-1618-4337; Mackay, Laura K/0000-0002-8496-6632; Fairlie, David P/0000-0002-7856-8566; Eckle, Sidonia BG/0000-0003-0766-171X; Enders, Anselm/0000-0001-5933-6463; liu, ligong/0000-0002-2693-1896; Kedzierska, Katherine/0000-0001-6141-335X; Koay, Hui-Fern/0000-0002-3236-9609; Russ, Brendan/0000-0001-6862-5283; Dos Santos Sa E Almeida, Catarina/0000-0002-3393-4411; Chong, Mark/0000-0002-3701-7397; Loh, Liyen/0000-0002-1676-0579; Pellicci, Daniel/0000-0001-5305-2398; D'UDEKEM D'ACOZ, YVES/0000-0003-1851-7836; Godfrey, Dale/0000-0002-3009-5472; BEDOUI, SAMMY/0000-0002-7443-0543; Gherardin, Nicholas/0000-0003-4690-2571; Meehan, Bronwyn/0000-0001-7368-2979; ULDRICH, ADAM/0000-0002-6350-5976	National Health and Medical Research Council of Australia [1083942, 1013667, 1016629, CDF 1035858, ECF 1054431, 1020770, 1027369, 1047025, 1023294, 1106004]; Australian Research Council [CE140100011, LE110100106, FT140100278]; Leukaemia Foundation of Australia; National Heart Foundation of Australia; Hudson Institute; Ritchie Centre	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leukaemia Foundation of Australia; National Heart Foundation of Australia(National Heart Foundation of Australia); Hudson Institute; Ritchie Centre	We thank the staff of the University of Melbourne DMI and MBC flow cytometry facilities and M. Camilleri, D. Taylor and animal house staff for animal husbandry and assistance with genotyping; J.C. Zuniga-Pflucker (University of Toronto) for OP9 and OP9-DL1 cells; T. Hansen (Washington University School of Medicine) for the MR1-blocking antibody 8F2.F9; and the clinical research midwives G. Christophers, G. Pell and R. Murdoch and the Obstetrics and Midwifery staffs of the Mercy Hospital for Women for assistance with collection of the cord blood samples. Supported by the National Health and Medical Research Council of Australia (1083942, 1013667 and 1016629; CDF 1035858 to A.E.; ECF 1054431 to D.G.P.; Senior Principal Research Fellowships 1020770 and 1027369 to D.I.G. and D.P.F.; Australia Fellowship AF50 to J.R.; CDF2 Fellowship 1047025 to M.C.; CDF2 Fellowship 1023294 to K.K.; and CDF1 Fellowship 1106004 to L.K.M.), the Australian Research Council (CE140100011 and LE110100106; Future Fellowship FT140100278 to A.P.U.), the Leukaemia Foundation of Australia (Postgraduate Scholarship for N.A.G.), the National Heart Foundation of Australia (Future Leader Fellowship for C.A.N.-P.), the Hudson Institute (Star Recruitment Fellowship for M.F.N.) and the Ritchie Centre (Victor Yu Fellowship for M.F.N.).	Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Borg ZD, 2014, J IMMUNOL, V192, P189, DOI 10.4049/jimmunol.1301451; Chen Z., 2016, MUCOSAL IMMUNOL; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2015, J BIOL CHEM, V290, P30204, DOI 10.1074/jbc.R115.685990; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Gibbs A., 2016, MUCOSAL IMMUNOL; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leeansyah E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4143; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seach N, 2013, J IMMUNOL, V191, P6002, DOI 10.4049/jimmunol.1301212; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tsukamoto K, 2013, IMMUNOGENETICS, V65, P115, DOI 10.1007/s00251-012-0666-5; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wang J, 2015, NAT MED, V21, P820, DOI 10.1038/nm.3890; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106	42	200	201	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1300	1311		10.1038/ni.3565	http://dx.doi.org/10.1038/ni.3565			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27668799	Green Accepted, Green Published			2022-12-18	WOS:000386193200010
J	Swamy, M; Pathak, S; Grzes, KM; Damerow, S; Sinclair, LV; van Aalten, DMF; Cantrell, DA				Swamy, Mahima; Pathak, Shalini; Grzes, Katarzyna M.; Damerow, Sebastian; Sinclair, Linda V.; van Aalten, Daan M. F.; Cantrell, Doreen A.			Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy	NATURE IMMUNOLOGY			English	Article							BETA LINEAGE THYMOCYTES; C-MYC; PRE-TCR; LYMPHOCYTE-ACTIVATION; EFFECTOR RESPONSES; X-CHROMOSOME; GLCNAC; PHOSPHORYLATION; DIFFERENTIATION; PROLIFERATION	Sustained glucose and glutamine transport are essential for activated T lymphocytes to support ATP and macromolecule biosynthesis. We found that glutamine and glucose also fuel an indispensable dynamic regulation of intracellular protein O-GlcNAcylation at key stages of T cell development, transformation and differentiation. Glucose and glutamine are precursors of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), a substrate for cellular glycosyltransferases. Immune-activated T cells contained higher concentrations of UDP-GlcNAc and increased intracellular protein O-GlcNAcylation controlled by the enzyme O-linked-beta-N-acetylglucosamine (O-GlcNAc) glycosyltransferase as compared with naive cells. We identified Notch, the T cell antigen receptor and c-Myc as key controllers of T cell protein O-GlcNAcylation via regulation of glucose and glutamine transport. Loss of O-GlcNAc transferase blocked T cell progenitor renewal, malignant transformation and peripheral T cell clonal expansion. Nutrient-dependent signaling pathways regulated by O-GlcNAc glycosyltransferase are thus fundamental for T cell biology.	[Swamy, Mahima; Pathak, Shalini; Grzes, Katarzyna M.; Sinclair, Linda V.; Cantrell, Doreen A.] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [Damerow, Sebastian] Univ Dundee, Div Biol Chem & Drug Discovery, Dundee, Scotland; [van Aalten, Daan M. F.] Univ Dundee, Med Res Council Prot Phosphorylat & Ubiquitylat U, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	Swamy, Mahima/J-7046-2019	Swamy, Mahima/0000-0003-3977-3425; van Aalten, Daan/0000-0002-1499-6908	Wellcome Trust (Principal Research Fellowship) [097418/Z/11/Z]; Tenovus Scotland	Wellcome Trust (Principal Research Fellowship)(Wellcome Trust); Tenovus Scotland	We acknowledge A. Whigham and R. Clarke for cell sorting facilities, V. Borodkin for generating inhibitors, S. Thompson for assistance with the in vivo Listeria infection, E. Emslie for genotyping and managing mouse colonies, and members of the D.A.C. laboratory for critical reading of the manuscript. We thank M.A. Ferguson for help with measurement of sugar nucleotides, H. Shen (University of Pennsylvania) for the attenuated Listeria strain and J. Zuniga-Pflucker (University of Toronto) for OP9-DL1 cells. We are grateful for facilities provided by the Biological Resources unit, University of Dundee. This work was supported by the Wellcome Trust (Principal Research Fellowship 097418/Z/11/Z to D.A.C.), and by Tenovus Scotland (M.S.).	Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Boudil A, 2015, NAT IMMUNOL, V16, P397, DOI 10.1038/ni.3122; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI [10.1038/nchembio.520, 10.1038/NCHEMBIO.520]; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Hagenbeek TJ, 2008, LEUKEMIA, V22, P608, DOI 10.1038/sj.leu.2405056; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hinton HJ, 2006, FEBS LETT, V580, P5845, DOI 10.1016/j.febslet.2006.09.045; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhang J, 2011, LEUKEMIA, V25, P1857, DOI 10.1038/leu.2011.220; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339	48	200	209	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					712	+		10.1038/ni.3439	http://dx.doi.org/10.1038/ni.3439			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27111141	Green Accepted, Green Submitted			2022-12-18	WOS:000376162200016
J	Willcox, CR; Pitard, V; Netzer, S; Couzi, L; Salim, M; Silberzahn, T; Moreau, JF; Hayday, AC; Willcox, BE; Dechanet-Merville, J				Willcox, Carrie R.; Pitard, Vincent; Netzer, Sonia; Couzi, Lionel; Salim, Mahboob; Silberzahn, Tobias; Moreau, Jean-Francois; Hayday, Adrian C.; Willcox, Benjamin E.; Dechanet-Merville, Julie			Cytomegalovirus and tumor stress surveillance by binding of a human gamma delta T cell antigen receptor to endothelial protein C receptor	NATURE IMMUNOLOGY			English	Article							INFECTED CELLS; RECOGNITION; CANCER; EXPRESSION; COMPLEX; TRANSPLANTATION; IMMUNOTHERAPY; EXPANSION; RESPONSES	T cells bearing gamma delta T cell antigen receptors (TCRs) function in lymphoid stress surveillance. However, the contribution of gamma delta TCRs to such responses is unclear. Here we found that the TCR of a human V(gamma)4V(delta)5 clone directly bound endothelial protein C receptor (EPCR), which allowed gamma delta T cells to recognize both endothelial cells targeted by cytomegalovirus and epithelial tumors. EPCR is a major histocompatibility complex-like molecule that binds lipids analogously to the antigen-presenting molecule CD1d. However, the V(gamma)4V(delta)5 TCR bound EPCR independently of lipids, in an antibody-like way. Moreover, the recognition of target cells by gamma delta T cells required a multimolecular stress signature composed of EPCR and costimulatory ligand(s). Our results demonstrate how a gamma delta TCR mediates recognition of broadly stressed human cells by engaging a stress-regulated self antigen.	[Pitard, Vincent; Netzer, Sonia; Couzi, Lionel; Moreau, Jean-Francois; Dechanet-Merville, Julie] Univ Bordeaux, Unite Mixte Rech 5164, Bordeaux, France; [Willcox, Carrie R.; Salim, Mahboob; Willcox, Benjamin E.] Univ Birmingham, Sch Canc Sci, Birmingham Canc Res UK Canc Ctr, Birmingham, W Midlands, England; [Pitard, Vincent; Netzer, Sonia; Couzi, Lionel; Moreau, Jean-Francois; Dechanet-Merville, Julie] CNRS, Unite Mixte Rech 5164, Bordeaux, France; [Couzi, Lionel] CHU Bordeaux, Renal Transplantat Dept, Bordeaux, France; [Silberzahn, Tobias; Hayday, Adrian C.] Kings Coll London, Sch Med, Guys Hosp, Peter Gorer Dept Immunobiol, London, England; [Silberzahn, Tobias; Hayday, Adrian C.] Canc Res UK, London Res Inst, London, England; [Moreau, Jean-Francois] CHU Bordeaux, Dept Immunol, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Birmingham; Centre National de la Recherche Scientifique (CNRS); CHU Bordeaux; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; CHU Bordeaux	Dechanet-Merville, J (corresponding author), Univ Bordeaux, Unite Mixte Rech 5164, Bordeaux, France.	b.willcox@bham.ac.uk; julie.dechanet@u-bordeaux2.fr		HAYDAY, ADRIAN/0000-0002-9495-5793	Fondation pour la Recherche Medicate [DEQ20051205738, DEQ20110421287]; Agence Nationale de la Recherche [ANR-05-JCJC-0129-01]; Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer [A09-1-5022]; Institut National contre le Cancer Cancer Research UK [C17422-A7986, C17422-A11740]; Wellcome Trust; Boehringer Ingelheim Fonds; Cancer Research UK [19309] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0600698B, G9818340B] Funding Source: researchfish	Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National contre le Cancer Cancer Research UK; Wellcome Trust(Wellcome Trust); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M.-L. Michel, M. Swamy and F. Mohammed for contributions to this project; D. Price for discussions; and V. Venturi for analysis of TCR nontemplated nucleotide additions. Supported by Fondation pour la Recherche Medicate (DEQ20051205738 and DEQ20110421287), Agence Nationale de la Recherche (ANR-05-JCJC-0129-01), Ligue Nationale contre le Cancer, Association pour la Recherche sur le Cancer (A09-1-5022), Institut National contre le Cancer (INCa TUMOSTRESS) Cancer Research UK (C17422-A7986 and C17422-A11740 to B.E.W., supporting C.R.W. and M.S.), the Wellcome Trust (T.S. and A.C.H.) and Boehringer Ingelheim Fonds (T.S. and A.C.H.).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Born W, 1999, Adv Immunol, V71, P77; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Couzi L, 2010, J AM SOC NEPHROL, V21, P181, DOI 10.1681/ASN.2008101072; Couzi L, 2009, J INFECT DIS, V200, P1415, DOI 10.1086/644509; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Devaud C, 2009, CANCER RES, V69, P3971, DOI 10.1158/0008-5472.CAN-08-3037; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Lafarge X, 2005, EUR J IMMUNOL, V35, P1896, DOI 10.1002/eji.200425837; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maeurer M, 1995, NAT IMMUN, V14, P188; Noriega V., 2012, IMMUNOLOGIC RES, P1; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Pitard V, 2008, BLOOD, V112, P1317, DOI 10.1182/blood-2008-01-136713; Scheffer GL, 2002, EUR J CANCER, V38, P1535, DOI 10.1016/S0959-8049(02)00108-9; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Squizzato A, 2005, THROMB HAEMOSTASIS, V93, P403, DOI 10.1160/TH04-08-0523; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Tsuneyoshi N, 2001, THROMB HAEMOSTASIS, V85, P356, DOI 10.1055/s-0037-1615692; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Zarski JP, 2009, HEPATOLOGY, V50, p1031A	42	200	208	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					872	879		10.1038/ni.2394	http://dx.doi.org/10.1038/ni.2394			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22885985				2022-12-18	WOS:000307863600016
J	Chang, PP; Barral, P; Fitch, J; Pratama, A; Ma, CS; Kallies, A; Hogan, JJ; Cerundolo, V; Tangye, SG; Bittman, R; Nutt, SL; Brink, R; Godfrey, DI; Batista, FD; Vinuesa, CG				Chang, Pheh-Ping; Barral, Patricia; Fitch, Jessica; Pratama, Alvin; Ma, Cindy S.; Kallies, Axel; Hogan, Jennifer J.; Cerundolo, Vincenzo; Tangye, Stuart G.; Bittman, Robert; Nutt, Stephen L.; Brink, Robert; Godfrey, Dale I.; Batista, Facundo D.; Vinuesa, Carola G.			Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; CYTOKINE PRODUCTION; ANTIBODY-RESPONSES; GERMINAL-CENTERS; ANTIGEN; COSTIMULATION; ACTIVATION; EXPANSION; PRECURSOR; SUBSETS	Lipid antigens trigger help from natural killer T cells (NKT cells) for B cells, and direct conjugation of lipid agonists to antigen profoundly augments antibody responses. Here we show that in vivo, NKT cells engaged in stable and prolonged cognate interactions with B cells and induced the formation of early germinal centers. Mouse and human NKT cells formed CXCR5(+)PD-1(hi) follicular helper NKT cells (NKTFH cells), and this process required expression of the transcriptional repressor Bcl-6, signaling via the coreceptor CD28 and interaction with B cells. NKTFH cells provided direct cognate help to antigen-specific B cells that was dependent on interleukin 21 (IL-21). Unlike T cell-dependent germinal centers, those driven by NKTFH cells did not generate long-lived plasma cells. Our results demonstrate the existence of a Bcl-6-dependent subset of NKT cells specialized in providing help to B cells.	[Chang, Pheh-Ping; Fitch, Jessica; Pratama, Alvin; Hogan, Jennifer J.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia; [Barral, Patricia; Batista, Facundo D.] Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London, England; [Ma, Cindy S.; Tangye, Stuart G.; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Kallies, Axel; Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY USA; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Australian National University; John Curtin School of Medical Research; Cancer Research UK; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Oxford; City University of New York (CUNY) System; Queens College NY (CUNY); University of Melbourne	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Brink, Robert/B-7910-2010; Tangye, Stuart G/H-4023-2014; Nutt, Stephen L/C-9256-2013; S, Cindy/B-2340-2012	Vinuesa, Carola G/0000-0001-9799-0298; Brink, Robert/0000-0002-9586-3655; Tangye, Stuart G/0000-0002-5360-5180; Nutt, Stephen L/0000-0002-0020-6637; S, Cindy/0000-0001-5387-8413; Godfrey, Dale/0000-0002-3009-5472; Fitch, Jessica/0000-0002-8758-1359; Kallies, Axel/0000-0002-6312-6968; Chang, Pheh Ping/0000-0002-3395-4746; Barral, Patricia/0000-0003-4324-8973; Cerundolo, Vincenzo/0000-0003-0040-3793	Sylvia and Charles Viertel Charitable Foundation; European Commission [PIEF-GA-2008-220863]; Cancer Research UK; Royal Society; National Health and Medical Research Council of Australia; Australian Research Council; MRC [G1000800] Funding Source: UKRI	Sylvia and Charles Viertel Charitable Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the US National Institutes of Health Tetramer Core Facility for the allophycocyanin-conjugated mouse CD1d-alpha-GalCer tetramer; M. Kronenberg (La Jolla Institute for Allergy and Immunology) for the baculovirus construct; P. Savage (Brigham Young University) for alpha-GalCer (PBS44); M. Taniguchi (RIKEN Research Center for Allergy and Immunology) for J<INF>alpha</INF>18-deficient mice; M. Townsend for tissue sectioning; X. Hu, M. Srivastava and J. Ellyard for help with some experiments; and M. Pellegrini for infection of mice with L. monocytogenes. Supported by the Sylvia and Charles Viertel Charitable Foundation (C.G.V.), the European Commission (Seventh Framework Programme of the European Commission PIEF-GA-2008-220863 to P.B.), Cancer Research UK (F.D.B. and P.B.), the Royal Society (F.D.B.), the National Health and Medical Research Council of Australia (D.I.G., C.G.V., R.B., C.S.M. and S.G.T.) and the Australian Research Council (A.K.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chung Y, 2008, J IMMUNOL, V180, P2276, DOI 10.4049/jimmunol.180.4.2276; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; GAMMON G, 1987, IMMUNOL REV, V98, P53; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; Tonti E, 2009, BLOOD, V113, P370, DOI 10.1182/blood-2008-06-166249; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	46	200	204	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					35	U56		10.1038/ni.2166	http://dx.doi.org/10.1038/ni.2166			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22120117				2022-12-18	WOS:000298412800009
J	Orkin, SH; Zon, LI				Orkin, SH; Zon, LI			Hematopoiesis and stem cells: plasticity versus developmental heterogeneity	NATURE IMMUNOLOGY			English	Review							MURINE YOLK-SAC; COLONY-FORMING CELLS; IN-VIVO; ENDOTHELIAL-CELLS; MOUSE EMBRYO; DEFINITIVE HEMATOPOIESIS; COMMON PRECURSOR; XENOPUS-LAEVIS; BLOOD; ONTOGENY	Hematopoietic stem cells (HSCs) provide for blood formation throughout the life of the individual. Studies of HSCs form a conceptual framework for the analysis of stem cells of other organ systems. We review here the origin of HSCs during embryological development, the relationship between hematopoiesis and vascular development and the potential plasticity of HSCs and other tissue stem cells. Recent experiments in the mouse have been widely interpreted as evidence for unprecedented transdifferentiation of tissue stem cells. The use of enriched, but impure, cell populations allows for alternative interpretation. In considering these findings, we draw a distinction here between the plasticity of adult stem cells and the heterogeneity of stem cell types that pre-exist within tissues.	Dana Farber Canc Inst, Div Hematol & Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Dana Farber Canc Inst, Div Hematol & Oncol, Boston, MA 02115 USA.							Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; CHAMBORD P, 2001, HEMATOPOIESIS DEV AP, P691; CHARBORD P, 2001, HEMATOPOIESIS DEV AP, P702; CHEN XD, 1995, J IMMUNOL, V154, P2557; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Cumano A, 2000, VACCINE, V18, P1621, DOI 10.1016/S0264-410X(99)00496-X; Farrington SM, 1997, MECH DEVELOP, V62, P197, DOI 10.1016/S0925-4773(97)00664-3; FRIDENSHTEIN AY, 1982, ARK PATOL, V44, P3; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRAF T, 2002, IN PRESS BLOOD; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jordan HE, 1916, ANAT REC, V10, P417, DOI 10.1002/ar.1090100508; Kapur R, 1998, BLOOD, V91, P879, DOI 10.1182/blood.V91.3.879.879_879_889; KAU CL, 1983, J IMMUNOL, V131, P2262; Kawada H, 2001, BLOOD, V98, P2008, DOI 10.1182/blood.V98.7.2008; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kusadasi N, 2001, LEUKEMIA, V15, P1347, DOI 10.1038/sj.leu.2402204; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LASSILA O, 1978, NATURE, V272, P353, DOI 10.1038/272353a0; LASSILA O, 1982, BLOOD, V59, P377; LYDEN D, 2001, NAT MED, V11, P194; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; MAXIMOW AA, 1925, CONTRIBUTIONS EMBRYO, V80, P91; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2000, NAT MED, V6, P1212, DOI 10.1038/81303; Orkin SH, 1996, CURR OPIN GENET DEV, V6, P597, DOI 10.1016/S0959-437X(96)80089-X; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Pardanaud L, 1999, DEVELOPMENT, V126, P617; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Thiemann FT, 1998, EXP HEMATOL, V26, P612; TOLES JF, 1989, P NATL ACAD SCI USA, V86, P7456, DOI 10.1073/pnas.86.19.7456; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wood HB, 1997, BLOOD, V90, P2300; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; Yoder MC, 1999, J HEMATOTH STEM CELL, V8, P421, DOI 10.1089/152581699320180; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	71	200	213	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					323	328		10.1038/ni0402-323	http://dx.doi.org/10.1038/ni0402-323			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919568				2022-12-18	WOS:000174623600005
J	Kitagawa, Y; Ohkura, N; Kidani, Y; Vandenbon, A; Hirota, K; Kawakami, R; Yasuda, K; Motooka, D; Nakamura, S; Kondo, M; Taniuchi, I; Kohwi-Shigematsu, T; Sakaguchi, S				Kitagawa, Yohko; Ohkura, Naganari; Kidani, Yujiro; Vandenbon, Alexis; Hirota, Keiji; Kawakami, Ryoji; Yasuda, Keiko; Motooka, Daisuke; Nakamura, Shota; Kondo, Motonari; Taniuchi, Ichiro; Kohwi-Shigematsu, Terumi; Sakaguchi, Shimon			Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; SELF-TOLERANCE; TRANSCRIPTION FACTORS; EPIGENETIC CHANGES; FOXP3 EXPRESSION; CHROMATIN; DIFFERENTIATION; DISEASE; THYMUS; SATB1	Most Foxp3(+) regulatory T (T-reg) cells develop in the thymus as a functionally mature T cell subpopulation specialized for immune suppression. Their cell fate appears to be determined before Foxp3 expression; yet molecular events that prime Foxp3(-) Treg precursor cells are largely obscure. We found that Treg cell-specific super-enhancers (T-reg-SEs), which were associated with Foxp3 and other Treg cell signature genes, began to be activated in Treg precursor cells. T cell-specific deficiency of the genome organizer Satb1 impaired T-reg-SE activation and the subsequent expression of Treg signature genes, causing severe autoimmunity due to Treg cell deficiency. These results suggest that Satb1-dependent T-reg-SE activation is crucial for Treg cell lineage specification in the thymus and that its perturbation is causative of autoimmune and other immunological diseases.	[Kitagawa, Yohko; Ohkura, Naganari; Kidani, Yujiro; Hirota, Keiji; Kawakami, Ryoji; Yasuda, Keiko; Sakaguchi, Shimon] Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka, Japan; [Kitagawa, Yohko; Yasuda, Keiko; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Regenerat Sci & Engn, Lab Expt Immunol, Kyoto, Japan; [Vandenbon, Alexis] Osaka Univ, Immunogenom Res Unit, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Hirota, Keiji] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Regenerat Sci & Engn, Lab Integrat Biol Sci, Kyoto, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka, Japan; [Kondo, Motonari] Toho Univ, Sch Med, Dept Mol Immunol, Tokyo, Japan; [Taniuchi, Ichiro] RIKEN, Ctr Integrat Med Sci, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Kohwi-Shigematsu, Terumi] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA USA	Osaka University; Kyoto University; Osaka University; Kyoto University; Osaka University; Toho University; RIKEN; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Sakaguchi, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka, Japan.; Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Regenerat Sci & Engn, Lab Expt Immunol, Kyoto, Japan.	shimon@ifrec.osaka-u.ac.jp	Vandenbon, Alexis/N-4428-2019; Vandenbon, Alexis/A-8430-2017; Sakaguchi, Shimon/C-9535-2009; Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Kawakami, Ryoji/0000-0003-2253-4559; Hirota, Keiji/0000-0002-4737-0661	JSPS [261560, 15H04744]; Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE [R37CA039681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064580] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H05805] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakamura for DNA sequencing support and assistance with RNA-seq experiments, S. Kojo for providing technical advice regarding ChIP-seq experiments, and K. Chen for reading the manuscript. Bioinformatics analyses were conducted using the computer system at the Genome Information Research Center of the Research Institute for Microbial Diseases at Osaka University. This work was supported by Grants-in-Aid for Japanese Society for the Promotion of Science (JSPS) Fellows 261560 from the JSPS to Y.K. and Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency to S.S. and JSPS Grants-in-Aid for Scientific Research B 15H04744 to N.O.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cheng GY, 2013, J IMMUNOL, V190, P1567, DOI 10.4049/jimmunol.1201218; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hao B, 2015, J EXP MED, V212, P809, DOI 10.1084/jem.20142207; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2015, SEMIN IMMUNOL, V27, P10, DOI 10.1016/j.smim.2015.02.002; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Singh K, 2015, SCI REP-UK, V5, DOI 10.1038/srep07767; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Thiault N, 2015, NAT IMMUNOL, V16, P628, DOI 10.1038/ni.3150; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Waddington C H, 1957, STRATEGY GENES DISCU; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	41	199	202	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					173	183		10.1038/ni.3646	http://dx.doi.org/10.1038/ni.3646			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27992401	Green Accepted			2022-12-18	WOS:000392360900011
J	Magri, G; Miyajima, M; Bascones, S; Mortha, A; Puga, I; Cassis, L; Barra, CM; Comerma, L; Chudnovskiy, A; Gentile, M; Llige, D; Cols, M; Serrano, S; Arostegui, JI; Juan, M; Yague, J; Merad, M; Fagarasan, S; Cerutti, A				Magri, Giuliana; Miyajima, Michio; Bascones, Sabrina; Mortha, Arthur; Puga, Irene; Cassis, Linda; Barra, Carolina M.; Comerma, Laura; Chudnovskiy, Aleksey; Gentile, Maurizio; Llige, David; Cols, Montserrat; Serrano, Sergi; Ignacio Arostegui, Juan; Juan, Manel; Yaguee, Jordi; Merad, Miriam; Fagarasan, Sidonia; Cerutti, Andrea			Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; GM-CSF; DIFFERENTIATION; EXPRESSION; SUBSETS; DRIVES; GUT; REQUIREMENT; HOMEOSTASIS	Innate lymphoid cells (ILCs) regulate stromal cells, epithelial cells and cells of the immune system, but their effect on B cells remains unclear. Here we identified ROR gamma t(+) ILCs near the marginal zone (MZ), a splenic compartment that contains innate-like B cells highly responsive to circulating T cell-independent (TI) antigens. Splenic ILCs established bidirectional crosstalk with MAdCAM-1(+) marginal reticular cells by providing tumor-necrosis factor (TNF) and lymphotoxin, and they stimulated MZ B cells via B cell-activation factor (BAFF), the ligand of the costimulatory receptor CD40 (CD40L) and the Notch ligand Delta-like 1 (DLL1). Splenic ILCs further helped MZ B cells and their plasma-cell progeny by coopting neutrophils through release of the cytokine GM-CSF. Consequently, depletion of ILCs impaired both pre- and post-immune TI antibody responses. Thus, ILCs integrate stromal and myeloid signals to orchestrate innate-like antibody production at the interface between the immune system and circulatory system.	[Magri, Giuliana; Bascones, Sabrina; Puga, Irene; Cassis, Linda; Barra, Carolina M.; Comerma, Laura; Gentile, Maurizio; Llige, David; Cerutti, Andrea] Inst Hosp del Mar Invest Med, Barcelona, Spain; [Miyajima, Michio; Fagarasan, Sidonia] RIKEN Yokohama, RIKEN Ctr Integrat Med Sci, Lab Mucosal Immun, Yokohama, Kanagawa, Japan; [Mortha, Arthur; Chudnovskiy, Aleksey; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Med, Tisch Canc Inst, New York, NY USA; [Cols, Montserrat; Merad, Miriam; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Dept Med, Inst Immunol, New York, NY USA; [Serrano, Sergi] Univ Autonoma Barcelona, Hosp del Mar, Dept Pathol, E-08193 Barcelona, Spain; [Serrano, Sergi] Univ Pompeu Fabra, Barcelona, Spain; [Ignacio Arostegui, Juan; Juan, Manel; Yaguee, Jordi] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Cerutti, Andrea] Barcelona Biomed Res Pk, Catalan Inst Res & Adv Studies, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; RIKEN; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; ICREA; Pompeu Fabra University	Cerutti, A (corresponding author), Inst Hosp del Mar Invest Med, Barcelona, Spain.	acerutti@imim.es	Juan, Manel/Q-2931-2019; Fagarasan, Sidonia/A-5258-2016; Barra, Carolina/AAF-1324-2019; Blesa, Laura Comerma/AAQ-9455-2020; Cassis, Linda/K-9633-2014; Magri, Giuliana/K-6552-2014; Mortha, Arthur/ABE-6250-2020	Fagarasan, Sidonia/0000-0003-2086-6402; Barra, Carolina/0000-0002-6836-4906; Blesa, Laura Comerma/0000-0002-0249-4636; Cassis, Linda/0000-0003-4544-9816; Magri, Giuliana/0000-0002-0163-3542; Yague Ribes, Jordi/0000-0002-1935-4488; YAGUE, JORDI/0000-0001-8210-1929; Puga, Irene/0000-0003-2208-3196; Mortha, Arthur/0000-0003-2673-0485; Juan, Manel/0000-0002-3064-1648; Cerutti, Andrea/0000-0003-3026-4704; Llige, David/0000-0003-0786-6213; Arostegui, Juan Ignacio/0000-0003-4757-504X	European Research Council [ERC-2011-ADG-20110310]; Ministerio de Economia y Competitividad, Gobierno de Espana [SAF2011-25241]; European Commission [PIRG-08-GA-2010-276928]; US National Institutes of Health [R01 AI74378, R01 AI57653, U01 AI95613, U01 AI95776 IOF, P01 AI61093, U19 096187]; Ministry of Education, Culture, Sport, Science and Technology of Japan [25293118]; Integrative Medical Sciences-Research Center for Allergy and Immunology; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, U01AI095613, U19AI096187, R01AI074378, R01AI057653, P01AI061093] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Ministerio de Economia y Competitividad, Gobierno de Espana; European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Integrative Medical Sciences-Research Center for Allergy and Immunology; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Chorny, S. Casas, G.F. Sonnenberg and A. Bigas for technical assistance and help with discussions; A. Mensa for help with human samples; G. Dranoff (Dana-Farber Cancer Institute) for B16<SUP>Csf2</SUP> melanoma cells; R. Gimeno (Institut Hospital del Mar d'Investigacions Mediques) for mouse OP9 and OP9-DLL1 stromal cell lines; M. Lopez-Botet (Institut Hospital del Mar d'Investigacions Mediques) for antibody to human CD66; and E. Ramirez, E. Julia and O. Fornas for help with cell sorting. Supported by the European Research Council (ERC-2011-ADG-20110310 to A. Cerutti), Ministerio de Economia y Competitividad, Gobierno de Espana (M.G., S.B., C.M.B., I.P. and G.M.; SAF2011-25241 to A. Cerutti), the European Commission (PIRG-08-GA-2010-276928 to A. Cerutti), the US National Institutes of Health (R01 AI74378, R01 AI57653, U01 AI95613, U01 AI95776 IOF, P01 AI61093 and U19 096187 to A. Cerutti), the Ministry of Education, Culture, Sport, Science and Technology of Japan (Grant-in-Aid for Scientific Research 25293118 to S.F.) and Integrative Medical Sciences-Research Center for Allergy and Immunology (S.F.)	Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Panda S, 2013, EMBO J, V32, P2905, DOI 10.1038/emboj.2013.199; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szomolanyi-Tsuda E, 1998, CURR OPIN IMMUNOL, V10, P431, DOI 10.1016/S0952-7915(98)80117-9; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weller S, 2012, BLOOD, V120, P4992, DOI 10.1182/blood-2012-07-440776; Yeramilli VA, 2013, EUR J IMMUNOL, V43, P1484, DOI 10.1002/eji.201243205; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zindl CL, 2009, IMMUNITY, V30, P408, DOI 10.1016/j.immuni.2009.01.010	54	199	205	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					354	+		10.1038/ni.2830	http://dx.doi.org/10.1038/ni.2830			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24562309	Green Accepted, Green Submitted			2022-12-18	WOS:000333252000010
J	Sekiya, T; Kashiwagi, I; Yoshida, R; Fukaya, T; Morita, R; Kimura, A; Ichinose, H; Metzger, D; Chambon, P; Yoshimura, A				Sekiya, Takashi; Kashiwagi, Ikkou; Yoshida, Rei; Fukaya, Tomohiro; Morita, Rimpei; Kimura, Akihiro; Ichinose, Hiroshi; Metzger, Daniel; Chambon, Pierre; Yoshimura, Akihiko			Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL REQUIREMENT; FOXP3 EXPRESSION; DENDRITIC CELLS; CLONAL DELETION; NUR77; COMPLEX; SELECTION; SURVIVAL; DISEASE; ANTIGEN	Regulatory T cells (T-reg cells) develop from progenitor thymocytes after the engagement of T cell antigen receptors (TCRs) with high-affinity ligands, but the underlying molecular mechanisms are still unclear. Here we show that the Nr4a nuclear receptors, which are encoded by immediate-early genes upregulated by TCR stimulation in thymocytes, have essential roles in T-reg cell development. Mice that lacked all Nr4a factors could not produce T-reg cells and died early owing to systemic autoimmunity. Nr4a receptors directly activated the promoter of the gene encoding the transcription factor Foxp3, and forced activation of Nr4a receptors bypassed low-strength TCR signaling to drive the T-reg cell developmental program. Our results suggest that Nr4a receptors have key roles in determining CD4(+) T cell fates in the thymus and thus contribute to immune homeostasis.	[Sekiya, Takashi; Kashiwagi, Ikkou; Yoshida, Rei; Fukaya, Tomohiro; Morita, Rimpei; Kimura, Akihiro; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Metzger, Daniel; Chambon, Pierre] Univ Strasbourg, Inst Genet & Biol Mol Cellulaire, Illkirch Graffenstaden, France; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Keio University; Tokyo Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Japan Science & Technology Agency (JST)	Sekiya, T (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	t-sekiya@z7.keio.jp; yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013; Ichinose, Hiroshi/D-8986-2015	Ichinose, Hiroshi/0000-0001-6008-6860; Metzger, Daniel/0000-0002-5555-046X; Kimura, Akihiro/0000-0001-5614-8547; KASHIWAGI, IKKOH/0000-0001-5386-5719	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society of the Promotion of Science; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [22590438, 21500305] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Shimizu, S. Tsuruta, N. Shiino, Y. Noguchi and M. Asakawa for technical assistance, and Y. Ushijima for manuscript preparation. Foxp3-hCD2-hCD52-KI mice were originally from the laboratory of S. Hori (Research Center for Allergy and Immunology, RIKEN), and the Nr4a1<SUP>fl/fl</SUP> and Nr4a2<SUP>fl/fl</SUP> mice were from H. Ichinose (Tokyo Institute of Technology). Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society of the Promotion of Science, the Takeda Science Foundation, the Uehara Memorial Foundation, Mochida Memorial Foundation and the SENSHIN Medical Research Foundation.	Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; CALNAN BJ, 1995, IMMUNITY, V3, P273; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Kuang AA, 1999, EUR J IMMUNOL, V29, P3722, DOI 10.1002/(SICI)1521-4141(199911)29:11<3722::AID-IMMU3722>3.0.CO;2-N; Lahl K, 2009, J IMMUNOL, V183, P5662, DOI 10.4049/jimmunol.0803762; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	49	199	210	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					230	237		10.1038/ni.2520	http://dx.doi.org/10.1038/ni.2520			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23334790				2022-12-18	WOS:000315065400012
J	Randall, KL; Lambe, T; Johnson, A; Treanor, B; Kucharska, E; Domaschenz, H; Whittle, B; Tze, LE; Enders, A; Crockford, TL; Bouriez-Jones, T; Alston, D; Cyster, JG; Lenardo, MJ; Mackay, F; Deenick, EK; Tangye, SG; Chan, TD; Camidge, T; Brink, R; Vinuesa, CG; Batista, FD; Cornall, RJ; Goodnow, CC				Randall, Katrina L.; Lambe, Teresa; Johnson, Andy; Treanor, Bebhinn; Kucharska, Edyta; Domaschenz, Heather; Whittle, Belinda; Tze, Lina E.; Enders, Anselm; Crockford, Tanya L.; Bouriez-Jones, Tiphaine; Alston, Duncan; Cyster, Jason G.; Lenardo, Michael J.; Mackay, Fabienne; Deenick, Elissa K.; Tangye, Stuart G.; Chan, Tyani D.; Camidge, Tahra; Brink, Robert; Vinuesa, Carola G.; Batista, Facundo D.; Cornall, Richard J.; Goodnow, Christopher C.			Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production	NATURE IMMUNOLOGY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; HUMORAL IMMUNE-RESPONSES; MARGINAL ZONE; POSITIVE SELECTION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; NEGATIVE SELECTION; PLASMA-CELL; ANTIGEN; CD19	To identify genes and mechanisms involved in humoral immunity, we did a mouse genetic screen for mutations that do not affect the first wave of antibody to immunization but disrupt response maturation and persistence. The first two mutants identified had loss-of-function mutations in the gene encoding a previously obscure member of a family of Rho-Rac GTP-exchange factors, DOCK8. DOCK8-mutant B cells were unable to form marginal zone B cells or to persist in germinal centers and undergo affinity maturation. Dock8 mutations disrupted accumulation of the integrin ligand ICAM-1 in the B cell immunological synapse but did not alter other aspects of B cell antigen receptor signaling. Humoral immunodeficiency due to Dock8 mutation provides evidence that organization of the immunological synapse is critical for signaling the survival of B cell subsets required for long-lasting immunity.	[Randall, Katrina L.; Kucharska, Edyta; Domaschenz, Heather; Whittle, Belinda; Tze, Lina E.; Enders, Anselm; Vinuesa, Carola G.; Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Randall, Katrina L.] Canberra Hosp, Dept Immunol, Garran, ACT, Australia; [Lambe, Teresa; Johnson, Andy; Crockford, Tanya L.; Bouriez-Jones, Tiphaine; Alston, Duncan; Cornall, Richard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Johnson, Andy] NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD USA; [Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD USA; [Treanor, Bebhinn; Batista, Facundo D.] Lincolns Inn Fields, London Res Inst, Canc Res UK, London, England; [Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Mackay, Fabienne] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Immunol, Melbourne, Vic 3004, Australia; [Deenick, Elissa K.; Tangye, Stuart G.; Chan, Tyani D.; Camidge, Tahra; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cancer Research UK; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Monash University; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia.	richard.cornall@ndm.ox.ac.uk; chris.goodnow@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Brink, Robert/B-7910-2010; Enders, Anselm/B-1165-2011; Lambe, Teresa/E-5733-2016; Camidge, David Ross/AAG-9144-2019; Randall, Katrina L/F-1883-2013; Mackay, Fabienne/B-7440-2008; Goodnow, Christopher C/V-8108-2018; Deenick, Elissa/AAY-8998-2020; Tangye, Stuart G/H-4023-2014	Vinuesa, Carola G/0000-0001-9799-0298; Brink, Robert/0000-0002-9586-3655; Enders, Anselm/0000-0001-5933-6463; Lambe, Teresa/0000-0001-7711-897X; Mackay, Fabienne/0000-0002-6074-2693; Goodnow, Christopher C/0000-0001-5296-6155; Deenick, Elissa/0000-0002-9271-0004; Tangye, Stuart G/0000-0002-5360-5180; Chan, Tyani/0000-0001-9276-8479	Wellcome Trust; Australian Research Council; National Health and Medical Research Council; Medical Research Council; Ramaciotti Foundation; Deutsche Forschungsgemeinschaft; Cancer Research UK; Andrew McMichael Trust Fund; National Institute for Health Research Biomedical Research Centre Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052127, ZIAAI000566] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ramaciotti Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK); Andrew McMichael Trust Fund; National Institute for Health Research Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Townsend, D. Howard, H. Ferry and C. Gillespie for technical assistance; the staff of the Australian National University Bioscience Division and Oxford Biomedical Services Unit for animal husbandry; the Australian Phenomics Facility genotyping and mapping team for genetic analysis, R. Rigby, B. Balakishnan and L. Beaton (Australian National University) for advice and reagents; J. Cannons and P. Schwartzberg (National Institutes of Health) for B cell-T cell conjugation methods and SAP-deficient mice; C. Jenne, S. Watson and T. Pham (University of California, San Francisco) for collaboration; R. Schwartz (National Institutes of Health) for support with advice and reagents; and H. Su (National Institutes of Health) for sharing findings about human DOCK8 deficiency before publication. Supported by the Wellcome Trust (R.J.C. and C.C.G.), the Australian Research Council (C.C.G.), the National Health and Medical Research Council (C.C.G., R.B., S.G.T., C.G.V., F.M., K.L.R., L.E.T. and E.K.D.), the Medical Research Council (T.L. and R.J.C.), The Ramaciotti Foundation (A.E. and C.C.G.), Deutsche Forschungsgemeinschaft (A.E.), Cancer Research UK (F.D.B.), the Andrew McMichael Trust Fund (R.J.C.) and the National Institute for Health Research Biomedical Research Centre Programme (R.J.C.).	Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; NAPARSTEK Y, 1986, J EXP MED, V164, P614, DOI 10.1084/jem.164.2.614; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Okkenhaug K, 2002, SCIENCE, V297, P1031; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Schaffer AA, 2007, CURR OPIN GENET DEV, V17, P201, DOI 10.1016/j.gde.2007.04.002; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	57	199	212	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1283	U8		10.1038/ni.1820	http://dx.doi.org/10.1038/ni.1820			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19898472	Green Accepted			2022-12-18	WOS:000271872800012
J	Otero, K; Turnbull, IR; Poliani, PL; Vermi, W; Cerutti, E; Aoshi, T; Tassi, I; Takai, T; Stanley, SL; Miller, M; Shaw, AS; Colonna, M				Otero, Karel; Turnbull, Isaiah R.; Poliani, Pietro Luigi; Vermi, William; Cerutti, Elisa; Aoshi, Taiki; Tassi, Ilaria; Takai, Toshiyuki; Stanley, Samuel L.; Miller, Mark; Shaw, Andrey S.; Colonna, Marco			Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin	NATURE IMMUNOLOGY			English	Article							OSTEOPETROTIC OP/OP MICE; TOLL-LIKE RECEPTOR; FACTOR-I; OSTEOCLAST DIFFERENTIATION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; CYCLIN D1; ACTIVATION; CELL	Macrophage colony-stimulating factor (M-CSF) influences the proliferation and survival of mononuclear phagocytes through the receptor CSF-1R. The adaptor protein DAP12 is critical for the function of mononuclear phagocytes. DAP12-mutant mice and humans have defects in osteoclasts and microglia, as well as brain and bone abnormalities. Here we show DAP12 deficiency impaired the M-CSF-induced proliferation and survival of macrophages in vitro. DAP12-deficient mice had fewer microglia in defined central nervous system areas, and DAP12-deficient progenitors regenerated myeloid cells inefficiently after bone marrow transplantation. Signaling by M-CSF through CSF-1R induced the stabilization and nuclear translocation of beta-catenin, which activated genes involved in the cell cycle. DAP12 was essential for phosphorylation and nuclear accumulation of beta-catenin. Our results provide a mechanistic explanation for the many defects of DAP12-deficient mononuclear phagocytes.	[Otero, Karel; Turnbull, Isaiah R.; Cerutti, Elisa; Aoshi, Taiki; Tassi, Ilaria; Miller, Mark; Shaw, Andrey S.; Colonna, Marco] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Poliani, Pietro Luigi; Vermi, William] Univ Brescia, Dept Pathol, Spedali Civili, Brescia, Italy; [Takai, Toshiyuki] Tohoku Univ, Japan Sci & Technol Agcy, Dept Expt Immunol, Aoba Ku, Sendai, Miyagi 980, Japan; [Stanley, Samuel L.] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Brescia; Japan Science & Technology Agency (JST); Tohoku University; Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.	mcolonna@pathology.wustl.edu	Poliani, Pietro Luigi/E-8145-2010	Poliani, Pietro Luigi/0000-0002-5662-8978; Miller, Mark/0000-0001-5676-389X; tassi, ilaria/0000-0002-5803-9499; Colonna, Marco/0000-0001-5222-4987; VERMI, WILLIAM/0000-0002-2291-2997	NIAID NIH HHS [U54 AI1057160, U54 AI057160] Funding Source: Medline; NIGMS NIH HHS [R01 GM077279] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, F32AI010571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077279] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DOWNING JR, 1988, MOL CELL BIOL, V8, P1795, DOI 10.1128/MCB.8.4.1795; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Kondo Y, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-31; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Roussel MF, 1997, MOL REPROD DEV, V46, P11, DOI 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stanley E R, 1997, Methods Mol Biol, V75, P301; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Xaus J, 2001, IMMUNOBIOLOGY, V204, P543, DOI 10.1078/0171-2985-00091; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	50	199	204	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					734	U90		10.1038/ni.1744	http://dx.doi.org/10.1038/ni.1744			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19503107	Green Accepted			2022-12-18	WOS:000267142600013
J	Menager, MM; Menasche, G; Romao, M; Knapnougel, P; Ho, CH; Garfa, M; Raposo, G; Feldmann, J; Fischer, A; Basile, GD				Menager, Mickael M.; Menasche, Gael; Romao, Maryse; Knapnougel, Perrine; Ho, Chen-Hsuan; Garfa, Meriem; Raposo, Graca; Feldmann, Jerome; Fischer, Alain; de Saint Basile, Genevieve			Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; LYTIC GRANULES; T-CELLS; LYMPHOCYTES; ACTIVATION; LYSOSOMES; RAB27A; ENDOSOMES; TRANSPORT; SYNTAXIN	Cytotoxic T lymphocytes and natural killer cells exert their cytotoxic activity through the polarized secretion of cytotoxic granules at the immunological synapse. Rab27a and hMunc13-4 are critical effectors of the exocytosis of cytotoxic granules. Here we show that the cytotoxic function of lymphocytes requires the cooperation of two types of organelles: the lysosomal cytotoxic granule and the endosomal 'exocytic vesicle'. Independently of Rab27a, hMunc13-4 mediated the assembly of Rab11(+) recycling and Rab27(+) late endosomal vesicles, constituting a pool of vesicles destined for regulated exocytosis. It also primed cytotoxic granule fusion, possibly through interaction with active Rab27a. Cytotoxic T lymphocyte-target cell recognition induced rapid polarization of both types of organelles, which coalesced near the cell-cell contact area. Our data provide insight into the regulation of the generation and release of cytotoxic granules by effector cytotoxic T lymphocytes and natural killer cells.	INSERM, Lab Dev Normal & Pathol Syst Immunitaire, Unite 768, F-75015 Paris, France; Univ Paris 05, Fac Med Rene Descartes, Inst Fed Rech Necker Enfants Malades, IFR95, F-75015 Paris, France; Inst Curie, CNRS, UMR 144, F-75005 Paris, France; Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Basile, GD (corresponding author), INSERM, Lab Dev Normal & Pathol Syst Immunitaire, Unite 768, F-75015 Paris, France.	sbasile@necker.fr	Ménager, Mickaël M/L-2334-2017; menasche, gael/D-8280-2017; de Saint Basile, Genevieve/G-9731-2017	GARFA TRAORE, Meriem/0000-0001-8597-6472; Raposo, graca/0000-0001-9590-1298; de Saint Basile, Genevieve/0000-0002-1913-5269; Menager, Mickael/0000-0002-6838-2389; Menasche, Gael/0000-0001-6671-3642				Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; BURKHARDT JK, 1993, J CELL SCI, V104, P151; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Kavalali ET, 2006, NEUROSCIENTIST, V12, P57, DOI 10.1177/1073858405281852; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Manders EMM, 1996, CYTOMETRY, V23, P15; Menasche G, 2005, IMMUNOL REV, V203, P165, DOI 10.1111/j.0105-2896.2005.00224.x; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; OLSEN I, 1990, EUR J IMMUNOL, V20, P2161, DOI 10.1002/eji.1830201003; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Pfeffer S, 2001, MOL CELL, V8, P729, DOI 10.1016/S1097-2765(01)00371-9; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; RAPOSO G, 1997, HDB EXPT IMMUNOLOGY, V4, P1; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; YONEDA N, 1992, LEUKEMIA, V6, P136	47	199	210	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					257	267		10.1038/ni1431	http://dx.doi.org/10.1038/ni1431			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17237785				2022-12-18	WOS:000244275100011
J	Bischoff, V; Vignal, C; Boneca, IG; Michel, T; Hoffmann, JA; Royet, J				Bischoff, V; Vignal, C; Boneca, IG; Michel, T; Hoffmann, JA; Royet, J			Function of the drosophila pattern-recognition receptor PGRP-SD in the detection of Gram-positive bacteria	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; TOLL PATHWAY; PEPTIDOGLYCAN; PROTEIN; ACTIVATION; BINDING; SYSTEM; FAMILY	The activation of an immune response requires recognition of microorganisms by host receptors. In drosophila, detection of Gram-positive bacteria is mediated by cooperation between the peptidoglycan-recognition protein-SA (PGRP-SA) and Gram-negative binding protein 1 (GNBP1) proteins. Here we show that some Gram-positive bacterial species activate an immune response in a PGRP-SA- and GNBP1-independent manner, indicating that alternative receptors exist. Consistent with this, we noted that PGRP-SD mutants were susceptible to some Gram-positive bacteria and that a loss-of-function mutation in PGRP-SD severely exacerbated the PGRP-SA and GNBP1 mutant phenotypes. These data indicate that PGRP-SD can function as a receptor for Gram-positive bacteria and shows partial redundancy with the PGRP-SA- GNBP1 complex.	Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France; Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Royet, J (corresponding author), Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	j.royet@ibmc.u-strasbg.fr	Boneca, Ivo G/H-1677-2014; Vignal, Cecile/K-9913-2018	Boneca, Ivo G/0000-0001-8122-509X; Michel, Tatiana/0000-0002-0146-9236; Vignal, Cecile/0000-0002-4674-9565				Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Bulet P, 2003, INFEC DIS S, P89; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DEJONGE BL, 2004, J BIOL CHEM, V267, P11248; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	199	215	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1175	1180		10.1038/ni1123	http://dx.doi.org/10.1038/ni1123			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15448690				2022-12-18	WOS:000224692700015
J	Balciunaite, G; Keller, MP; Balciunaite, E; Piali, L; Zuklys, S; Mathieu, YD; Gill, J; Boyd, R; Sussman, DJ; Hollander, GA				Balciunaite, G; Keller, MP; Balciunaite, E; Piali, L; Zuklys, S; Mathieu, YD; Gill, J; Boyd, R; Sussman, DJ; Hollander, GA			Wnt glycoproteins regulate the expression of FoxNI, the gene defective in nude mice	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; SIGNALING PATHWAY; T-CELL; ACTIVATION; STEPS; AKT; DIFFERENTIATION; ANTAGONIST; PHENOTYPE; SELECTION	T cell development and selection require the fully mature and diverse epithelial microenvironment of the thymus. Acquisition of these characteristics is dependent on expression of the forkhead (also known as winged-helix) transcription factor FoxNI, as a lack of functional FoxNI results in aberrant epithelial morphogenesis and an inability to attract lymphoid precursors to the thymus primordium. However, the transcriptional control of FoxnI expression has not been elucidated. Here we report that secreted Wnt glycoproteins, expressed by thymic epithelial cells and thymocytes, regulate epithelial FoxnI expression in both autocrine and paracrine fashions. Wnt molecules therefore provide regulatory signals critical for thymic function.	Univ Basel, Dept Res, Basel, Switzerland; Univ Basel, Dept Clin Biol Sci, Basel, Switzerland; Univ Basel, Childrens Hosp, Basel, Switzerland; Monash Univ, Dept Pathol & Immunol, Prahran, Vic, Australia; Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University of Basel; University of Basel; University of Basel; Monash University; University System of Maryland; University of Maryland Baltimore	Hollander, GA (corresponding author), Univ Basel, Dept Res, Basel, Switzerland.	Georg-A.Hollaender@unibas.ch		Gill, Jason/0000-0003-0955-6470; Hollander, Georg/0000-0002-8790-0874; Mathieu, Yves/0000-0003-1366-1644				AMAGAI T, 1995, EUR J IMMUNOL, V25, P757, DOI 10.1002/eji.1830250320; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson KL, 1998, DEV COMP IMMUNOL, V22, P367, DOI 10.1016/S0145-305X(98)00011-1; Barker N, 2000, ADV CANCER RES, V77, P1; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cunliffe VT, 2002, MAMM GENOME, V13, P245, DOI 10.1007/s00335-001-3079-6; Dale TC, 1998, BIOCHEM J, V329, P209; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Howard EW, 2001, DEVELOPMENT, V128, P365; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kasai M, 1996, EUR J IMMUNOL, V26, P2101, DOI 10.1002/eji.1830260921; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kitas G, 2001, CLIN MED, V1, P18, DOI 10.7861/clinmedicine.1-1-18; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kurooka H, 1996, INT IMMUNOL, V8, P961, DOI 10.1093/intimm/8.6.961; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Millar JBA, 2002, GENOME BIOL, V3; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nelson RW, 1999, J CELL BIOL, V147, P367, DOI 10.1083/jcb.147.2.367; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	49	199	204	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1102	1108		10.1038/ni850	http://dx.doi.org/10.1038/ni850			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12379851				2022-12-18	WOS:000179073000019
J	Stoltze, L; Schirle, M; Schwarz, G; Schroter, C; Thompson, MW; Hersh, LB; Kalbacher, H; Stevanovic, S; Rammensee, HG; Schild, H				Stoltze, L; Schirle, M; Schwarz, G; Schroter, C; Thompson, MW; Hersh, LB; Kalbacher, H; Stevanovic, S; Rammensee, HG; Schild, H			Two new proteases in the MHC class I processing pathway	NATURE IMMUNOLOGY			English	Article							HUMAN BLEOMYCIN HYDROLASE; PUROMYCIN-SENSITIVE AMINOPEPTIDASE; ENDOPLASMIC-RETICULUM; ANTIGENIC PEPTIDES; CYSTEINE PROTEASE; GENERATION; EXPRESSION; ENKEPHALIN; INHIBITOR; EPITOPES	The proteasome generates exact major histocompatibility complex (MHC) class I ligands as well as NH2-terminal-extended precursor peptides, The proteases responsible for the final NH2-terminal trimming of the precursor peptides had, until now, not been determined, By using specific selective criteria we purified two cytosolic proteolytic activities, puromycin-sensitive aminopeptidase and bleomycin hydrolase,These proteases could remove NH2-terminal amino acids from the vesicular stomatitis virus nucleoprotein cytotoxic T cell epitope 52-59 (RGYVYQGL) resulting, in combination with proteasomes, in the generation of the correct epitope, Our data provide evidence for the existence of redundant systems acting downstream of the proteasome in the antigen-processing pathway for MHC class I molecules.	Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; Inst Physiol Chem, D-72076 Tubingen, Germany; Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA	Eberhard Karls University of Tubingen; University of Kentucky	Schild, H (corresponding author), Univ Tubingen, Dept Immunol, Inst Cell Biol, Morgenstelle 15, D-72076 Tubingen, Germany.			Thompson, Michael/0000-0003-1850-5579	NIDA NIH HHS [DA 02243] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anton LC, 1998, J IMMUNOL, V160, P4859; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bromme D, 1996, BIOCHEMISTRY-US, V35, P6706, DOI 10.1021/bi960092y; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; CRALU A, 1997, P NATL ACAD SCI USA, V94, P10850; DESOUZA ANC, 1991, COMP BIOCHEM PHYS C, V99, P363, DOI 10.1016/0742-8413(91)90257-T; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; EMMERICH NP, 2000, UNPUB J BIOL CHEM; ENENKEL C, 1993, J BIOL CHEM, V268, P7036; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Ferrando AA, 1997, J BIOL CHEM, V272, P33298, DOI 10.1074/jbc.272.52.33298; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; HERSH LB, 1981, BIOCHEMISTRY-US, V20, P2345, DOI 10.1021/bi00511a042; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; Koldamova RP, 1998, MOL PHARMACOL, V54, P954, DOI 10.1124/mol.54.6.954; Koldamova RP, 1998, BIOCHEMISTRY-US, V37, P2282, DOI 10.1021/bi9722204; Lobigs M, 2000, EUR J IMMUNOL, V30, P1496, DOI 10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6; Lopez D, 1997, J IMMUNOL, V159, P5769; Lopez D, 2000, J IMMUNOL, V164, P5070, DOI 10.4049/jimmunol.164.10.5070; Luckey CJ, 1998, J IMMUNOL, V161, P112; MCLELLAN S, 1988, J NEUROCHEM, V51, P1552, DOI 10.1111/j.1471-4159.1988.tb01124.x; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Thompson MW, 1999, BIOCHEM BIOPH RES CO, V258, P234, DOI 10.1006/bbrc.1999.0604; UMEZAWA H, 1974, Journal of Antibiotics (Tokyo), V27, P419; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4	32	199	206	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					413	418		10.1038/80852	http://dx.doi.org/10.1038/80852			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062501				2022-12-18	WOS:000165076100014
J	Koelwyn, GJ; Corr, EM; Erbay, E; Moore, KJ				Koelwyn, Graeme J.; Corr, Emma M.; Erbay, Ebru; Moore, Kathryn J.			Regulation of macrophage immunometabolism in atherosclerosis	NATURE IMMUNOLOGY			English	Review							LOW-DENSITY-LIPOPROTEIN; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FATTY-ACID OXIDATION; FOAM CELL-FORMATION; APOPTOTIC CELLS; PROMOTES ATHEROSCLEROSIS; CONTINUED CLEARANCE; NLRP3 INFLAMMASOME; CHOLESTEROL EFFLUX; ANALYSIS REVEALS	After activation, cells of the myeloid lineage undergo robust metabolic transitions, as well as discrete epigenetic changes, that can dictate both ongoing and future inflammatory responses. In atherosclerosis, in which macrophages play central roles in the initiation, growth, and ultimately rupture of arterial plaques, altered metabolism is a key feature that dictates macrophage function and subsequent disease progression. This Review explores how factors central to the plaque microenvironment (for example, altered cholesterol metabolism, oxidative stress, hypoxia, apoptotic and necrotic cells, and hyperglycemia) shape the metabolic rewiring of macrophages in atherosclerosis as well as how these metabolic shifts in turn alter macrophage immune-effector and tissue-reparative functions. Finally, this overview offers insight into the challenges and opportunities of harnessing metabolism to modulate aberrant macrophage responses in disease.	[Koelwyn, Graeme J.; Corr, Emma M.; Moore, Kathryn J.] NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol & Dis, Dept Med,Leon H Charney Div Cardiol, New York, NY 10003 USA; [Erbay, Ebru] Cedars Sinai Med Ctr, Dept Med, Heart Inst, Los Angeles, CA 90048 USA; [Erbay, Ebru] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Erbay, Ebru] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Erbay, Ebru] Bilkent Univ, Natl Nanotechnol Ctr, Ankara, Turkey	New York University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University	Moore, KJ (corresponding author), NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol & Dis, Dept Med,Leon H Charney Div Cardiol, New York, NY 10003 USA.	kathryn.moore@nyumc.org	Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Erbay, Ebru/0000-0001-9584-1803; Koelwyn, Graeme/0000-0002-3476-0919	National Institutes of Health [R35HL135799, P01HL131481]; Canadian Institutes of Health Research; European Research Council [336643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135799, P01HL131481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work in the laboratory of K.J.M. related to this review was supported by the National Institutes of Health (R35HL135799 and P01HL131481). G.J.K. was supported by a doctoral foreign study award from the Canadian Institutes of Health Research. E.E. was supported by an European Research Council Starting Grant (336643).	Aarup A, 2016, ARTERIOSCL THROM VAS, V36, P1782, DOI 10.1161/ATVBAHA.116.307830; Andrejeva G, 2017, CELL METAB, V26, P49, DOI 10.1016/j.cmet.2017.06.004; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bekkering S, 2016, ATHEROSCLEROSIS, V254, P228, DOI 10.1016/j.atherosclerosis.2016.10.019; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Boutens L, 2018, DIABETOLOGIA, V61, P942, DOI 10.1007/s00125-017-4526-6; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; Folco EJ, 2014, CIRC RES, V115, P875, DOI 10.1161/CIRCRESAHA.115.304437; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Gautier EL, 2013, J EXP MED, V210, P339, DOI 10.1084/jem.20121357; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE149, DOI 10.1161/01.ATV.0000133317.49796.0E; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Ham M, 2013, MOL CELL BIOL, V33, P2425, DOI 10.1128/MCB.01260-12; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Izquierdo E, 2015, J IMMUNOL, V195, P2442, DOI 10.4049/jimmunol.1403045; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Lachmandas E, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.246; Lee SJ, 2014, J NUCL MED, V55, P1699, DOI 10.2967/jnumed.114.139428; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Marsch E, 2014, ARTERIOSCL THROM VAS, V34, P2545, DOI 10.1161/ATVBAHA.114.304023; McCarthy C, 2013, EMBO MOL MED, V5, P1443, DOI 10.1002/emmm.201302587; Menegaut L, 2017, CURR OPIN LIPIDOL, V28, P19, DOI 10.1097/MOL.0000000000000370; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mogilenko DA, 2012, FASEB J, V26, P2019, DOI 10.1096/fj.11-193946; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Na YR, 2015, MOL CELL PROTEOMICS, V14, P2722, DOI 10.1074/mcp.M115.048744; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nishizawa T, 2014, CELL REP, V7, P356, DOI 10.1016/j.celrep.2014.03.028; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Ouimet M, 2017, ARTERIOSCL THROM VAS, V37, P1058, DOI 10.1161/ATVBAHA.116.308916; Ouimet M, 2016, NAT IMMUNOL, V17, P677, DOI 10.1038/ni.3434; Ouimet M, 2016, ARTERIOSCL THROM VAS, V36, P942, DOI 10.1161/ATVBAHA.116.307282; Ouimet M, 2015, J CLIN INVEST, V125, P4334, DOI 10.1172/JCI81676; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Posokhova EN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P296, DOI 10.1134/S0006297908030097; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rotllan N, 2013, ARTERIOSCL THROM VAS, V33, P1973, DOI 10.1161/ATVBAHA.113.301732; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Sergin I, 2014, CIRC RES, V115, P817, DOI 10.1161/CIRCRESAHA.114.305197; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stienstra R, 2017, CELL METAB, V26, P142, DOI 10.1016/j.cmet.2017.06.001; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tallam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149050; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tavakoli S, 2013, J NUCL MED, V54, P1661, DOI 10.2967/jnumed.112.119099; Tawakol A, 2015, ARTERIOSCL THROM VAS, V35, P1463, DOI 10.1161/ATVBAHA.115.305551; Tufanli O, 2017, P NATL ACAD SCI USA, V114, pE1395, DOI 10.1073/pnas.1621188114; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; van der Valk FM, 2016, CIRCULATION, V134, P611, DOI 10.1161/CIRCULATIONAHA.116.020838; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629; Vilne B, 2017, ATHEROSCLEROSIS, V267, P39, DOI 10.1016/j.atherosclerosis.2017.10.019; WALLACE C, 1992, METABOLISM, V41, P1016, DOI 10.1016/0026-0495(92)90130-3; Wang Y, 2017, CELL, V171, P331, DOI 10.1016/j.cell.2017.08.041; Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	114	198	214	15	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					526	537		10.1038/s41590-018-0113-3	http://dx.doi.org/10.1038/s41590-018-0113-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777212	Green Published, Green Accepted			2022-12-18	WOS:000433041500019
J	Zitvogel, L; Pietrocola, F; Kroemer, G				Zitvogel, Laurence; Pietrocola, Federico; Kroemer, Guido			Nutrition, inflammation and cancer	NATURE IMMUNOLOGY			English	Review							CALORIC RESTRICTION MIMETICS; CARDIOVASCULAR-DISEASE; NUT CONSUMPTION; CELL-FUNCTION; RISK-FACTORS; LIFE-SPAN; VITAMIN-D; OBESITY; IMMUNE; DIET	Quantitative and qualitative aspects of nutrition have a profound effect on leukocytes and thereby affect proinflammatory carcinogenic effects or anticancer immune responses. As a result, nutrition affects the incidence, natural progression and therapeutic response of malignant diseases, both in humans and in preclinical animal models. Here we discuss the molecular mechanisms through which alimentary cues modulate metabolic, microbial and neuroendocrine circuitries and thus affect the probability of developing premalignant lesions that progress to clinically manifested disease and the response to therapeutic intervention. We examine each of the connections that compose the triangle of nutrition, immunological and inflammatory reactions and cancer while focusing on the mechanistic aspects of these relationships.	[Zitvogel, Laurence; Pietrocola, Federico; Kroemer, Guido] Gustave Roussy Canc Campus, Villejuif, France; [Zitvogel, Laurence] Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT, F-1428 Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Gustave Roussy Canc Campus, Villejuif, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, Paris, France; [Pietrocola, Federico; Kroemer, Guido] INSERM, U1138, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 06, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Metabol & Cell Biol Platforms, Gustave Roussy Canc Campus, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Zitvogel, L; Kroemer, G (corresponding author), Gustave Roussy Canc Campus, Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc CICBT, F-1428 Villejuif, France.; Zitvogel, L (corresponding author), INSERM, U1015, Gustave Roussy Canc Campus, Villejuif, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Natl Canc 11, Paris, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Zitvogel, L; Kroemer, G (corresponding author), Univ Paris 06, Paris, France.; Kroemer, G (corresponding author), Metabol & Cell Biol Platforms, Gustave Roussy Canc Campus, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.	laurence.zitvogel@orange.fr; kroemer@orange.fr	Pietrocola, Federico/AAW-9621-2020; KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020	Pietrocola, Federico/0000-0002-2930-234X; KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (Equipe Labelisee); Agence National de la Recherche (ANR)-Projets Blancs; ANR; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; RHU Torino Lumiere, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	Ligue contre le Cancer (Equipe Labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)-Projets Blancs(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; RHU Torino Lumiere, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	G.K. is supported by the Ligue contre le Cancer (Equipe Labelisee); Agence National de la Recherche (ANR)-Projets Blancs; ANR, under the framework of E-Rare-2, ERA-Net for Research on Rare Diseases; Association pour la Recherche sur le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; RHU Torino Lumiere, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); and Paris Alliance of Cancer Research Institutes (PACRI).	Alicandro G., 2017, EUR J CANC PREV; Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, NEW ENGL J MED, V330, P1029, DOI DOI 10.1056/NEJM199404143301501; Aranda F, 2015, ONCOGENE, V34, P3053, DOI 10.1038/onc.2014.234; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; Batai K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00053; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bonaccio M, 2015, BRIT J NUTR, V114, P804, DOI 10.1017/S0007114515002378; Bougherara H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00500; Bruce D, 2011, J IMMUNOL, V186, P2819, DOI 10.4049/jimmunol.1003444; Buck K, 2011, J CLIN ONCOL, V29, P3730, DOI 10.1200/JCO.2011.34.6478; Cao Y, 2016, GASTROENTEROLOGY, V151, P879, DOI 10.1053/j.gastro.2016.07.030; Chen AC, 2015, NEW ENGL J MED, V373, P1618, DOI 10.1056/NEJMoa1506197; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Conroy MJ, 2016, P NUTR SOC, V75, P125, DOI 10.1017/S0029665115004176; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Doerner SK, 2016, MOL CANCER RES, V14, P953, DOI 10.1158/1541-7786.MCR-16-0153; Dou RX, 2016, BRIT J NUTR, V115, P1643, DOI 10.1017/S0007114516000696; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Elliott LA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00086; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Galluzzi L, 2012, CELL REP, V2, P257, DOI 10.1016/j.celrep.2012.06.017; Giangreco AA, 2015, J STEROID BIOCHEM, V148, P156, DOI 10.1016/j.jsbmb.2014.10.004; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Hallund J, 2008, NUTR METAB CARDIOVAS, V18, P497, DOI 10.1016/j.numecd.2007.05.007; Harmon BE, 2017, J NUTR, V147, P430, DOI 10.3945/jn.116.242529; Hodge AM, 2016, CANCER CAUSE CONTROL, V27, P907, DOI 10.1007/s10552-016-0770-1; Hopkins BD, 2016, J CLIN ONCOL, V34, P4277, DOI 10.1200/JCO.2016.67.9712; Hullar MAJ, 2014, CANCER TREAT RES, V159, P377, DOI 10.1007/978-3-642-38007-5_22; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Iyengar NM, 2016, J CLIN ONCOL, V34, P4270, DOI 10.1200/JCO.2016.67.4283; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; James BR, 2012, J IMMUNOL, V189, P1311, DOI 10.4049/jimmunol.1100587; Larriba MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023524; Karki R, 2017, CANCER IMMUNOL RES, V5, P94, DOI 10.1158/2326-6066.CIR-16-0269; Klement RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155050; Klevorn LE, 2016, TRENDS IMMUNOL, V37, P354, DOI 10.1016/j.it.2016.03.010; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Kolb R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13007; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lussier DM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2337-7; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mirsoian A, 2014, J EXP MED, V211, P2373, DOI 10.1084/jem.20140116; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mocellin S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw230; Moore LL, 2014, CANCER EPIDEM BIOMAR, V23, P2057, DOI 10.1158/1055-9965.EPI-14-0240; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pietrocola F, 2017, AUTOPHAGY, V13, P567, DOI 10.1080/15548627.2016.1271513; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Prieto I., 2016, CLIN NUTR; Protiva P, 2016, AM J CLIN NUTR, V103, P1224, DOI 10.3945/ajcn.114.105304; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Rossi EL, 2016, CANCER PREV RES, V9, P339, DOI 10.1158/1940-6207.CAPR-15-0348; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schoemaker MJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0733-1; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shivappa N., 2016, MOL NUTR FOOD RES, V61; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Siri-Tarino PW, 2015, ANNU REV NUTR, V35, P517, DOI 10.1146/annurev-nutr-071714-034449; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Song MY, 2016, GUT, V65, P296, DOI 10.1136/gutjnl-2014-308852; Steck SE, 2015, ADV NUTR, V6, P763, DOI 10.3945/an.115.009746; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; van Niekerk G, 2016, AUTOPHAGY, V12, P727, DOI 10.1080/15548627.2016.1147672; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Woolf EC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00122; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	99	198	209	9	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					843	850		10.1038/ni.3754	http://dx.doi.org/10.1038/ni.3754			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722707				2022-12-18	WOS:000405821100004
J	Choi, YS; Gullicksrud, JA; Xing, SJ; Zeng, ZH; Shan, Q; Li, FY; Love, PE; Peng, WQ; Xue, HH; Crotty, S				Choi, Youn Soo; Gullicksrud, Jodi A.; Xing, Shaojun; Zeng, Zhouhao; Shan, Qiang; Li, Fengyin; Love, Paul E.; Peng, Weiqun; Xue, Hai-Hui; Crotty, Shane			LEF-1 and TCF-1 orchestrate T-FH differentiation by regulating differentiation circuits upstream of the transcriptional repressor BcI6	NATURE IMMUNOLOGY			English	Article							FOLLICULAR HELPER-CELL; B-CELLS; ICOS; BCL6; CD4(+); GENERATION; T-HELPER-1; FATE; INDUCTION; PROMOTE	Follicular helper T cells (T-FH cells) are specialized effector CD4(+) T cells that help B cells develop germinal centers (GCs) and memory. However, the transcription factors that regulate the differentiation of T-FH cells remain incompletely understood. Here we report that selective loss of Lef1 or Tcf7 (which encode the transcription factor LEF-1 or ICE-1, respectively) resulted in T-FH cell defects, while deletion of both Lef1 and Tcf7 severely impaired the differentiation of T-FH cells and the formation of GCs. Forced expression of LEE-1 enhanced T-FH differentiation. LEF-1 and TCF-1 coordinated such differentiation by two general mechanisms. First, they established the responsiveness of naive CD4(+) T cells to T-FH cell signals. Second, they promoted early T-FH differentiation via the multipronged approach of sustaining expression of the cytokine receptors IL-61R alpha and gp130, enhancing expression of the costimulatory receptor ICOS and promoting expression of the transcriptional repressor BcI6.	[Choi, Youn Soo; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Gullicksrud, Jodi A.; Xing, Shaojun; Shan, Qiang; Li, Fengyin; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Gullicksrud, Jodi A.; Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA USA; [Zeng, Zhouhao; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Love, Paul E.] NICHD, Sect Cellular & Dev Biol, NIH, Bethesda, MD USA	La Jolla Institute for Immunology; University of Iowa; University of Iowa; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	hai-hui-xue@uiowa.edu; shane@lji.org	Crotty, Shane/AAC-6703-2019; Li, Fengyin/AAG-9476-2019; /AAI-2516-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; Peng, Weiqun/0000-0001-5521-9091; Shan, Qiang/0000-0002-7089-0278; Xue, Hai-Hui/0000-0002-9163-7669; Xing, Shaojun/0000-0003-0777-2196	American Cancer Society [RSG-11-161-01-MPC]; US National Institutes of Health [AI105351, AI112579, AI115149, AI119160, AI113806, AI109976, AI063107, AI072543, AI007485]; University of Iowa Presidential Graduate Research Fellowship program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113806, R01AI072543, T32AI007485, R01AI112579, R01AI063107, R21AI115149, R21AI119160, U19AI109976, R21AI105351] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Presidential Graduate Research Fellowship program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Yang for help with ex vivo screening of target genes obtained from RNA-seq analysis of early T<INF>FH</INF> cells and T<INF>H</INF>1 cells; Z. Fu for help with GSEA and for the generation of heat maps; the La Jolla Institute Flow Cytometry Flow Cytometry Core Facility (C. Kim, K.V. Gunst and L. Nosworthy) and the University of Iowa Flow Cytometry Core facility (J. Fishbaugh, H. Vignes and G. Rasmussen) for cell sorting; T. Takemori (RIKEN, Research Center for Integrated Medical Sciences) for Bcl6<SUP>fl/fl</SUP> mice; I. Antoshechkin (Millard and Muriel Jacobs Genetics and Genomics Laboratory at the Caltech) for Tcf7<SUP>-/-</SUP>Lef1<SUP>-/-</SUP> RNA-seq; and J.T. Harty (University of Iowa) for vaccinia virus (for the Xue laboratory). Supported by the American Cancer Society (RSG-11-161-01-MPC to H.-H.X.), the US National Institutes of Health (AI105351, AI112579, AI115149 and AI119160 to H.-H.X.; AI113806 to W.P.; AI109976, AI063107 and AI072543 to S.C.; and AI007485 for support for to JAG.) and the University of Iowa Presidential Graduate Research Fellowship program (J.A.G.).	Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Nance JP, 2015, J IMMUNOL, V194, P5599, DOI 10.4049/jimmunol.1500200; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Pratama A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7436; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	47	198	206	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					980	990		10.1038/ni.3226	http://dx.doi.org/10.1038/ni.3226			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26214741	Green Accepted			2022-12-18	WOS:000359876900016
J	Spann, NJ; Glass, CK				Spann, Nathanael J.; Glass, Christopher K.			Sterols and oxysterols in immune cell function	NATURE IMMUNOLOGY			English	Review							LIVER-X-RECEPTORS; ELEMENT-BINDING PROTEIN-1C; INHIBITS HIV-1 REPLICATION; CENTRAL-NERVOUS-SYSTEM; COENZYME-A REDUCTASE; HEPATITIS-C VIRUS; LIPID-METABOLISM; DENDRITIC CELLS; NUCLEAR RECEPTORS; LXR-ALPHA	Intermediates in the cholesterol-biosynthetic pathway and oxysterol derivatives of cholesterol regulate diverse cellular processes. Recent studies have expanded the appreciation of their roles in controlling the functions of cells of the innate and adaptive immune systems. Here we review recent literature reporting on the biological functions of sterol intermediates and oxysterols, acting through transcription factors such as the liver X receptors (LXRs), sterol regulatory element-binding proteins (SREBPs) and the G protein-coupled receptor EBI2, in regulating the differentiation and population expansion of cells of the innate and adaptive immune systems, their responses to inflammatory mediators, their effects on the phagocytic functions of macrophages and their effects on antiviral activities and the migration of immune cells. Such findings have raised many new questions about the production of endogenous bioactive sterols and oxysterols and their mechanisms of action in the immune system.	[Spann, Nathanael J.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	US National Institutes of Health [GM069338, DK091183, DK074868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Carlin for critical reading of the manuscript, and L. Bautista for assistance with manuscript preparation. Supported by the US National Institutes of Health (GM069338, DK091183 and DK074868 to C.K.G.).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bruhn KW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000886; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chaudhry MZ, 2008, SURG INFECT, V9, P183, DOI 10.1089/sur.2006.077; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Conlon P, 1999, NEUROBIOL DIS, V6, P149, DOI 10.1006/nbdi.1999.0239; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Dubrovsky L, 2012, BIOCHEM BIOPH RES CO, V419, P95, DOI 10.1016/j.bbrc.2012.01.137; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Geyeregger R, 2007, BLOOD, V109, P4288, DOI 10.1182/blood-2006-08-043422; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2000, GENE DEV, V14, P121; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hanley TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000981; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liao YH, 2013, J LEUKOCYTE BIOL, V93, P289, DOI 10.1189/jlb.0812409; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Montero MT, 2004, J IMMUNOL, V173, P4936, DOI 10.4049/jimmunol.173.8.4936; Montero MT, 2000, ATHEROSCLEROSIS, V153, P303, DOI 10.1016/S0021-9150(00)00417-2; Moog C, 1998, ANTIVIR CHEM CHEMOTH, V9, P491, DOI 10.1177/095632029800900605; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Novelli G, 2012, J INHERIT METAB DIS, V35, P917, DOI 10.1007/s10545-011-9445-y; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pezacki John Paul, 2009, BMC Chemical Biology, V9, P2, DOI 10.1186/1472-6769-9-2; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen Q, 2011, J BIOL CHEM, V286, P14554, DOI 10.1074/jbc.M110.165704; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Teunissen CE, 2003, NEUROSCI LETT, V347, P159, DOI 10.1016/S0304-3940(03)00667-0; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Walcher D, 2006, ARTERIOSCL THROM VAS, V26, P1022, DOI 10.1161/01.ATV.0000210278.67076.8f; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zeng J, 2012, ANTIVIR RES, V95, P245, DOI 10.1016/j.antiviral.2012.06.004; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005	95	198	206	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					893	900		10.1038/ni.2681	http://dx.doi.org/10.1038/ni.2681			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959186				2022-12-18	WOS:000323377700006
J	Gracias, DT; Stelekati, E; Hope, JL; Boesteanu, AC; Doering, TA; Norton, J; Mueller, YM; Fraietta, JA; Wherry, EJ; Turner, M; Katsikis, PD				Gracias, Donald T.; Stelekati, Erietta; Hope, Jennifer L.; Boesteanu, Alina C.; Doering, Travis A.; Norton, Jillian; Mueller, Yvonne M.; Fraietta, Joseph A.; Wherry, E. John; Turner, Martin; Katsikis, Peter D.			The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; CLONAL EXPANSION; MEMORY; DIFFERENTIATION; LYMPHOCYTES; IFN; PROLIFERATION; MODULATION; INFECTION; STAT3	We found upregulation of expression of the microRNA miR-155 in primary effector and effector memory CD8(+) T cells, but low miR-155 expression in naive and central memory cells. Antiviral CD8(+) T cell responses and viral clearance were impaired in miR-155-deficient mice, and this defect was intrinsic to CD8(+) T cells, as miR-155-deficient CD8(+) T cells mounted greatly diminished primary and memory responses. Conversely, miR-155 overexpression augmented antiviral CD8(+) T cell responses in vivo. Gene-expression profiling showed that miR-155-deficient CD8(+) T cells had enhanced type I interferon signaling and were more susceptible to interferon's antiproliferative effect. Inhibition of the type I interferon-associated transcription factors STAT1 or IRF7 resulted in enhanced responses of miR-155-deficient CD8(+) T cells in vivo. We have thus identified a previously unknown role for miR-155 in regulating responsiveness to interferon and CD8(+) T cell responses to pathogens in vivo.	[Gracias, Donald T.; Stelekati, Erietta; Hope, Jennifer L.; Boesteanu, Alina C.; Norton, Jillian; Mueller, Yvonne M.; Fraietta, Joseph A.; Katsikis, Peter D.] Drexel Univ, Coll Med, Ctr Immunol & Vaccine Sci, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Doering, Travis A.; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Doering, Travis A.; Wherry, E. John] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Drexel University; University of Pennsylvania; University of Pennsylvania; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Katsikis, PD (corresponding author), Drexel Univ, Coll Med, Ctr Immunol & Vaccine Sci, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	martin.turner@babraham.ac.uk; peter.katsikis@drexelmed.edu	Wherry, John/ABI-1280-2020; Gracias, Donald/G-7559-2017; Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Katsikis, Peter/0000-0001-7690-5218; Hope, Jennifer/0000-0002-2363-5442; Gracias, Donald/0000-0002-3142-9059; Mueller, Yvonne/0000-0002-4654-7509	US National Institutes of Health [U19 AI83022, U19 AI82630, R01 AI66215, R01 AI46719]; Department of Microbiology and Immunology; Biotechnology and Biological Sciences Research Council; Medical Research Council; BBSRC [BBS/E/B/000C0409, BB/J00152X/1, BBS/E/B/000C0407] Funding Source: UKRI; MRC [G1001068] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/J00152X/1, BBS/E/B/0000C206, BBS/E/B/0000C207, BBS/E/B/000C0409] Funding Source: researchfish; Medical Research Council [G1001068] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066215, U19AI082630, U19AI083022, R01AI046719] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Immunology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Gerhard (Wistar Institute) for influenza virus strain A/Puerto Rico/8/34; D. Topham (University of Rochester) for influenza virus strain A/WSN/33 expressing OVA(257-264); H. Shen (University of Pennsylvania) for OVA-expressing L. monocytogenes; E. Vigorito (Babraham Institute) for control and miR-155-expressing MigR1 vectors; G. Takaesu (Keio University) for STAT1YFIRES- GFP-pMX (DN-STAT1) and control retroviruses; B. tenOever (Mount Sinai School of Medicine) for DN-IRF7 plasmid; P. Marack (University of Colorado Health Sciences Center) for the MSCV-IRES-Thy-1.1 vector; and the Penn Molecular Profiling facility at the University of Pennsylvania for microarray assays. Some of this work was presented at the 96th Annual Meeting of the American Association of Immunologists in 2009. Supported by the US National Institutes of Health (U19 AI83022 and U19 AI82630 to E.J.W.; and R01 AI66215 and R01 AI46719), the Department of Microbiology and Immunology (P.D.K.) and the Biotechnology and Biological Sciences Research Council and Medical Research Council (M. T.)	Abate A, 2007, BIOCHEM BIOPH RES CO, V354, P757, DOI 10.1016/j.bbrc.2007.01.050; Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Borowski AB, 2007, J IMMUNOL, V179, P6494, DOI 10.4049/jimmunol.179.10.6494; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Erickson S, 1999, CELL GROWTH DIFFER, V10, P575; Erickson S, 2002, EUR J BIOCHEM, V269, P29, DOI 10.1046/j.0014-2956.2002.02626.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kashiwada M, 2006, J IMMUNOL, V176, P3958, DOI 10.4049/jimmunol.176.7.3958; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Tsai CY, 2013, J VIROL, V87, P2348, DOI 10.1128/JVI.01742-12; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsuchihashi S, 2005, TRANSPL P, V37, P1677, DOI 10.1016/j.transproceed.2005.03.080; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usherwood EJ, 1997, J GEN VIROL, V78, P2025, DOI 10.1099/0022-1317-78-8-2025; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	54	198	224	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					593	+		10.1038/ni.2576	http://dx.doi.org/10.1038/ni.2576			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23603793	Green Accepted, Green Submitted			2022-12-18	WOS:000319107600012
J	Lin, YC; Benner, C; Mansson, R; Heinz, S; Miyazaki, K; Miyazaki, M; Chandra, V; Bossen, C; Glass, CK; Murre, C				Lin, Yin C.; Benner, Christopher; Mansson, Robert; Heinz, Sven; Miyazaki, Kazuko; Miyazaki, Masaki; Chandra, Vivek; Bossen, Claudia; Glass, Christopher K.; Murre, Cornelis			Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate	NATURE IMMUNOLOGY			English	Article							CHROMOSOME CONFORMATION CAPTURE; HEAVY-CHAIN LOCUS; IMMUNOGLOBULIN REPERTOIRE; TRANSCRIPTION FACTORS; CHROMATIN; ORGANIZATION; E2A; NETWORK; COMPARTMENTALIZATION; ARCHITECTURE	The genome is folded into domains located in compartments that are either transcriptionally inert or transcriptionally permissive. Here we used genome-wide strategies to characterize domains during B cell development. Structured interaction matrix analysis showed that occupancy by the architectural protein CTCF was associated mainly with intradomain interactions, whereas sites bound by the histone acetyltransferase p300 or the transcription factors E2A or PU.1 were associated with intra-and interdomain interactions that are developmentally regulated. We identified a spectrum of genes that switched nuclear location during early B cell development. In progenitor cells, the transcriptionally inactive locus encoding early B cell factor (Ebf1) was sequestered at the nuclear lamina, which thereby preserved their multipotency. After development into the pro-B cell stage, Ebf1 and other genes switched compartments to establish new intra- and interdomain interactions associated with a B lineage-specific transcription signature.	[Benner, Christopher; Heinz, Sven; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lin, Yin C.; Mansson, Robert; Miyazaki, Kazuko; Miyazaki, Masaki; Chandra, Vivek; Bossen, Claudia; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Benner, Christopher] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Benner, C (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cbenner@salk.edu; cglass@ucsd.edu; murre@biomail.ucsd.edu	Glass, Christopher/AAI-3933-2021; Mansson, Robert/D-4372-2014; Chandra, Vivek/D-2121-2017	Glass, Christopher/0000-0003-4344-3592; Mansson, Robert/0000-0003-0738-0328; Chandra, Vivek/0000-0002-4047-015X; Heinz, Sven/0000-0002-4665-1007; Benner, Christopher/0000-0002-4618-0719; Lin, Yin/0000-0003-4925-5453	American Recovery and Reinvestment Act [ARRA PHS 3RO1AI082850]; European Molecular Biology Organization; Swiss National Science Foundation; University of California San Diego, Cancer Center [P30 CA23100]; US National Institutes of Health [AI082850A, AI00880]; NATIONAL CANCER INSTITUTE [R01CA054198, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082850, Z01AI000880, R01AI100880] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of California San Diego, Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Hardiman, C. Ludka, L. Edsall, S. Kuan, C. Espinoza, U. Wagner, J. Sprague and Z. Ye for help with Solexa DNA sequencing; J. Dixon for help during the initial phase of Hi-C analysis; B. Wold for suggesting fixation with ethylene glycol bis(succinimidylsuccinate); B. Ren for access to the Illumina Hi-Seq; and members of the Murre laboratory for comments on the manuscript. Supported by the American Recovery and Reinvestment Act (ARRA PHS 3RO1AI082850 to Y.C.L.), the European Molecular Biology Organization (C.Bo.), the Swiss National Science Foundation (C.Bo.), the University of California San Diego, Cancer Center (P30 CA23100) and the US National Institutes of Health (AI082850A and AI00880 to C.K.G. and C.M.).	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corcoran AE, 2010, SEMIN IMMUNOL, V22, P353, DOI 10.1016/j.smim.2010.08.001; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Iborra FJ, 1996, J CELL SCI, V109, P1427; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; PIENTA KJ, 1984, J CELL SCI, P123; RATTNER JB, 1985, CELL, V42, P291, DOI 10.1016/S0092-8674(85)80124-0; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sakamoto S, 2012, J IMMUNOL, V188, P5547, DOI 10.4049/jimmunol.1002346; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Welinder E, 2011, P NATL ACAD SCI USA, V108, P17402, DOI 10.1073/pnas.1111766108; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	48	198	198	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1196	+		10.1038/ni.2432	http://dx.doi.org/10.1038/ni.2432			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23064439	Green Submitted, Green Accepted			2022-12-18	WOS:000311217900013
J	Rock, KL; York, IA; Goldberg, AL				Rock, KL; York, IA; Goldberg, AL			Post-proteasomal antigen processing for major histocompatibility complex class I presentation	NATURE IMMUNOLOGY			English	Review							MHC CLASS-I; T-LYMPHOCYTE EPITOPES; DISTINCT PROTEOLYTIC PROCESSES; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; THIMET OLIGOPEPTIDASE; SIGNAL SEQUENCE; LEUCINE AMINOPEPTIDASE; TRIPEPTIDYL PEPTIDASE; PRECURSOR PEPTIDES	Peptides presented by major histocompatibility complex class I molecules are derived mainly from cytosolic oligopeptides generated by proteasomes during the degradation of intracellular proteins. Proteasomal cleavages generate the final C terminus of these epitopes. Although proteasomes may produce mature epitopes that are eight to ten residues in length, they more often generate N-extended precursors that are too long to bind to major histocompatibility complex class I molecules. Such precursors are trimmed in the cytosol or in the endoplasmic reticulum by aminopeptidases that generate the N terminus of the presented epitope. Peptidases can also destroy epitopes by trimming peptides to below the size needed for presentation. In the cytosol, endopeptidases, especially thimet oligopeptidase, and aminopeptidases degrade many proteasomal products, thereby limiting the supply of many antigenic peptides. Thus, the extent of antigen presentation depends on the balance between several proteolytic processes that may generate or destroy epitopes.	Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	York, IA (corresponding author), Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA.	ian.york@umassmed.edu	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344				ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Bury M, 2001, FOLIA HISTOCHEM CYTO, V39, P131; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldstein JS, 2002, AGEING RES REV, V1, P17, DOI 10.1016/S0047-6374(01)00367-0; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Ishii T, 1999, J IMMUNOL, V162, P1303; Kandror O, 1999, J BIOL CHEM, V274, P37743, DOI 10.1074/jbc.274.53.37743; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161; Lobigs M, 2000, EUR J IMMUNOL, V30, P1496, DOI 10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6; Lopez D, 1997, J IMMUNOL, V159, P5769; Lopez D, 2000, J IMMUNOL, V164, P5070, DOI 10.4049/jimmunol.164.10.5070; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; Mo XY, 1999, J IMMUNOL, V163, P5851; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; NEISIG A, 1995, J IMMUNOL, V154, P1273; OJCIUS DM, 1994, J IMMUNOL, V152, P2798; OJCIUS DM, 1994, FASEB J, V8, P974, DOI 10.1096/fasebj.8.12.8088463; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Wang Y, 1998, MELANOMA RES, V8, P345, DOI 10.1097/00008390-199808000-00008; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	78	198	208	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					670	677		10.1038/ni1089	http://dx.doi.org/10.1038/ni1089			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224092				2022-12-18	WOS:000222331200003
J	Willcox, BE; Thomas, LM; Bjorkman, PJ				Willcox, BE; Thomas, LM; Bjorkman, PJ			Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; HUMAN CYTOMEGALOVIRUS; INHIBITORY RECEPTOR; TRANSCRIPT-2 ILT2; CELL-RECEPTORS; MOLECULES; BINDING; SPECIFICITY; INSIGHTS; PROGRAM	Leukocyte immunoglobulin-like receptor 1 (LIR-1), an inhibitory receptor expressed on monocytes, dendritic cells and lymphocytes, regulates cellular function by binding a broad range of classical and nonclassical major histocompatibility complex (MHC) class I molecules, and the human cytomegalovirus MHC class I homolog UL18. Here we describe the 3.4-Angstrom crystal structure of a complex between the LIR-1 D1D2 domains and the MHC class I molecule HLA-A2. LIR-1 contacts the mostly conserved beta(2)-microglobulin and alpha3 domains of HLA-A2. The LIR-1 binding site comprises residues at the interdomain hinge, and a patch at the D1 tip. The structure shows how LIR-1 recognizes UL18 and diverse MHC class I molecules, and indicates that a similar mode of MHC class I recognition is used by other LIR family members.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	bjorkman@its.caltech.edu						Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Cosman D, 1999, IMMUNOL REV, V168, P177, DOI 10.1111/j.1600-065X.1999.tb01292.x; DeLano W. L, 2002, PYMOL MOL GENETICS G; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Martinez-Pena MB, 1988, ACTA GEOL HISP, V23, P81; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Willcox Benjamin E, 2002, BMC Struct Biol, V2, P6, DOI 10.1186/1472-6807-2-6; Young NT, 2001, J IMMUNOL, V166, P3933, DOI 10.4049/jimmunol.166.6.3933	40	198	211	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					913	919		10.1038/ni961	http://dx.doi.org/10.1038/ni961			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12897781				2022-12-18	WOS:000185002200019
J	Zajonc, DM; Elsliger, MA; Teyton, L; Wilson, IA				Zajonc, DM; Elsliger, MA; Teyton, L; Wilson, IA			Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 angstrom	NATURE IMMUNOLOGY			English	Article							PEPTIDE BINDING; LIPID ANTIGEN; T-CELLS; PROTEIN; RECOGNITION; REFINEMENT; PATHWAYS; PROGRAM; EMPTY; GLYCOLIPIDS	CD1 antigens bind a variety of self and foreign lipid and glycolipid antigens for presentation to CD1-restricted T cell receptors (TCRs). Here we report the crystal structure of human CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Angstrom. The lipid adopts an S-shaped conformation, with the sphingosine chain completely buried in the A' pocket and the fatty acid chain emerging from the interface of the A pocket into the more exposed F pocket. The headgroup is anchored in the A'-F' junction and protrudes into the F pocket for TCR recognition. Because the A' pocket is narrow with a fixed terminus, it can act as a molecular 'ruler' to select alkyl chains of a particular length.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Elsliger, Marc Andre/0000-0002-1989-7626	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI53725] Funding Source: Medline; NIGMS NIH HHS [GM62116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lerche MH, 1997, STRUCTURE, V5, P291, DOI 10.1016/S0969-2126(97)00186-X; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Manolova V, 2003, EUR J IMMUNOL, V33, P29, DOI 10.1002/immu.200390004; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; OBRIEN JS, 1964, J LIPID RES, V5, P329; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Rosat JP, 1999, J IMMUNOL, V162, P366; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Speir JA, 1999, IMMUNITY, V10, P51, DOI 10.1016/S1074-7613(00)80006-0; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	52	198	202	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					808	815		10.1038/ni948	http://dx.doi.org/10.1038/ni948			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12833155				2022-12-18	WOS:000184441500019
J	Lanzavecchia, A; Sallusto, F				Lanzavecchia, A; Sallusto, F			Antigen decoding by T lymphocytes: from synapses to fate determination	NATURE IMMUNOLOGY			English	Review							RECEPTOR DOWN-REGULATION; PEPTIDE-MHC COMPLEXES; SERIAL TCR ENGAGEMENT; CELLS IN-VIVO; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; AGONIST PROPERTIES; PRESENTING CELLS; MOLECULE LIGANDS	Naive T lymphocytes sense foreign antigens by establishing contacts with dendritic cells (DCs). At the immunological synapse between the T tell and a DC, T cell receptors (TCRs) are serially engaged and triggered by specific ligands. The amount and duration of TCR triggering and the efficiency of signal amplification determine T cell commitment to proliferation and differentiation. The nature and availability of DCs bearing antigen and costimulatory molecules shape the T cell response, giving rise to distinct functional outputs such as effector and memory T cell generation or T cell tolerance.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch; federica.sallusto@irb.unisi.ch						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chau LA, 1998, J EXP MED, V187, P1699, DOI 10.1084/jem.187.10.1699; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 2001, TRENDS IMMUNOL, V22, P187, DOI 10.1016/S1471-4906(01)01869-5; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO;2-B; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 1998, J IMMUNOL, V161, P553; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; INABA K, 1986, J EXP MED, V163, P247, DOI 10.1084/jem.163.2.247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itoh Y, 1999, J IMMUNOL, V162, P2073; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LIPSKY PE, 1975, J EXP MED, V141, P138, DOI 10.1084/jem.141.1.138; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Morgan DJ, 1999, J IMMUNOL, V163, P723; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Penna D, 1999, J IMMUNOL, V163, P50; Preckel T, 1997, J EXP MED, V185, P1803, DOI 10.1084/jem.185.10.1803; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; SAD S, 1994, J IMMUNOL, V153, P3514; Salio M, 1997, EUR J IMMUNOL, V27, P1769, DOI 10.1002/eji.1830270726; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Valitutti S, 1996, EUR J IMMUNOL, V26, P2012, DOI 10.1002/eji.1830260907; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1997, EUR J IMMUNOL, V27, P3080, DOI 10.1002/eji.1830271146; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WEISS A, 1987, J IMMUNOL, V138, P2169; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	107	198	205	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					487	492		10.1038/88678	http://dx.doi.org/10.1038/88678			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376334				2022-12-18	WOS:000169078000010
J	Newton, R; Priyadharshini, B; Turka, LA				Newton, Ryan; Priyadharshini, Bhavana; Turka, Laurence A.			Immunometabolism of regulatory T cells	NATURE IMMUNOLOGY			English	Review							METABOLIC CHECKPOINT; IMMUNE HOMEOSTASIS; CIS-ELEMENT; MEMORY; DIFFERENTIATION; ACTIVATION; GENERATION; EXPRESSION; INDUCTION; RECEPTOR	The bidirectional interaction between the immune system and whole-body metabolism has been well recognized for many years. Via effects on adipocytes and hepatocytes, immune cells can modulate whole-body metabolism (in metabolic syndromes such as type 2 diabetes and obesity) and, reciprocally, host nutrition and commensal-microbiota-derived metabolites modulate immunological homeostasis. Studies demonstrating the metabolic similarities of proliferating immune cells and cancer cells have helped give birth to the new field of immunometabolism, which focuses on how the cell-intrinsic metabolic properties of lymphocytes and macrophages can themselves dictate the fate and function of the cells and eventually shape an immune response. We focus on this aspect here, particularly as it relates to regulatory T cells.	[Newton, Ryan; Priyadharshini, Bhavana; Turka, Laurence A.] Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Turka, LA (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA.	lturka@partners.org			US National Institutes of Health [P01-HL018646, T32-AI007529]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Blazar, J. Bluestone, H. Chi, J. Rathmell and members of the Turka laboratory for discussions. Supported by the US National Institutes of Health (P01-HL018646 to L.A.T. and B.P., and T32-AI007529 to R.N.).	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bian L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2799; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Lee CF, 2015, CELL REP, V13, P760, DOI 10.1016/j.celrep.2015.09.036; Leone RD, 2015, COMPUT STRUCT BIOTEC, V13, P265, DOI 10.1016/j.csbj.2015.03.008; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Maloy K. J., NAT IMMUNOL; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Newton RH, 2015, BLOOD, V125, P852, DOI 10.1182/blood-2014-04-571372; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Priyadharshini B, 2015, CURR OPIN ORGAN TRAN, V20, P21, DOI 10.1097/MOT.0000000000000149; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313	86	197	214	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					618	625		10.1038/ni.3466	http://dx.doi.org/10.1038/ni.3466			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27196520	Green Accepted			2022-12-18	WOS:000376162200006
J	Yang, K; Neale, G; Green, DR; He, WF; Chi, HB				Yang, Kai; Neale, Geoffrey; Green, Douglas R.; He, Weifeng; Chi, Hongbo			The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function	NATURE IMMUNOLOGY			English	Article							KRUPPEL-LIKE FACTOR-2; KAPPA-B ACTIVATION; MTOR; DIFFERENTIATION; KINASE; MEMORY; GENE; SURVIVAL; GROWTH; COMPLEX-2	The mechanisms that regulate T cell quiescence are poorly understood. We report that the tumor suppressor Tsc1 established a quiescence program in naive T cells by controlling cell size, cell cycle entry and responses to stimulation of the T cell antigen receptor. Abrogation of quiescence predisposed Tsc1-deficient T cells to apoptosis that resulted in loss of conventional T cells and invariant natural killer T cells. Loss of Tsc1 function dampened in vivo immune responses to bacterial infection. Tsc1-deficient T cells had more activity of the serine-threonine kinase complex mTORC1 but less mTORC2 activity, and activation of mTORC1 was essential for the disruption of immune homeostasis. Therefore, Tsc1-dependent control of mTOR is crucial in actively maintaining the quiescence of naive T cells to facilitate adaptive immune function.	[Yang, Kai; Green, Douglas R.; He, Weifeng; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Yang, Kai/E-2785-2013; Green, Douglas R/N-8083-2018; Chi, Hongbo/M-9397-2018	Green, Douglas R/0000-0002-7332-1417; Chi, Hongbo/0000-0002-9997-2496	US National Institutes of Health [K01 AR053573, R01 NS064599]; Arthritis Foundation; Lupus Research Institute; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Lupus Research Institute; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Ohashi (University of Toronto) for Akt1-transgenic mice; T. Ludwig (Columbia University) for Rosa26-Cre-ER<SUP>T2</SUP> mice; R. Cross, G. Lennon and S. Morgan for cell sorting; and the National Institutes of Health Tetramer Facility for the CD1d-PBS57 tetramer. Supported by the US National Institutes of Health (K01 AR053573 and R01 NS064599), the Arthritis Foundation, the Lupus Research Institute and the American Lebanese Syrian Associated Charities (H.C.).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Glynne R, 2000, IMMUNOL REV, V176, P216; Hedrick SM, 2010, IMMUNOL REV, V236, P41, DOI 10.1111/j.1600-065X.2010.00918.x; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	197	202	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					888	U11		10.1038/ni.2068	http://dx.doi.org/10.1038/ni.2068			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21765414	Green Accepted			2022-12-18	WOS:000294461200013
J	Rossi, RL; Rossetti, G; Wenandy, L; Curti, S; Ripamonti, A; Bonnal, RJP; Birolo, RS; Moro, M; Crosti, MC; Gruarin, P; Maglie, S; Marabita, F; Mascheroni, D; Parente, V; Comelli, M; Trabucchi, E; De Francesco, R; Geginat, J; Abrignani, S; Pagani, M				Rossi, Riccardo L.; Rossetti, Grazisa; Wenandy, Lynn; Curti, Serena; Ripamonti, Anna; Bonnal, Raoul J. P.; Birolo, Roberto Sciarretta; Moro, Monica; Crosti, Maria C.; Gruarin, Paola; Maglie, Stefano; Marabita, Francesco; Mascheroni, Debora; Parente, Valeria; Comelli, Mario; Trabucchi, Emilio; De Francesco, Raffaele; Geginat, Jens; Abrignani, Sergio; Pagani, Massimiliano			Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4(+) T cells by the microRNA miR-125b	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; CENTRAL MEMORY; IMMUNE-SYSTEM; EXPRESSION; DIFFERENTIATION; SURVIVAL; LINEAGE; DICER; RNA; IDENTIFICATION	MicroRNAs are small noncoding RNAs that regulate gene expression post-transcriptionally. Here we applied microRNA profiling to 17 human lymphocyte subsets to identify microRNA signatures that were distinct among various subsets and different from those of mouse lymphocytes. One of the signature microRNAs of naive CD4(+) T cells, miR-125b, regulated the expression of genes encoding molecules involved in T cell differentiation, including IFNG, IL2RB, IL10RA and PRDM1. The expression of synthetic miR-125b and lentiviral vectors encoding the precursor to miR-125b in naive lymphocytes inhibited differentiation to effector cells. Our data provide an 'atlas' of microRNA expression in human lymphocytes, define subset-specific signatures and their target genes and indicate that the naive state of T cells is enforced by microRNA.	[Rossi, Riccardo L.; Rossetti, Grazisa; Wenandy, Lynn; Curti, Serena; Ripamonti, Anna; Bonnal, Raoul J. P.; Birolo, Roberto Sciarretta; Moro, Monica; Crosti, Maria C.; Gruarin, Paola; Maglie, Stefano; Marabita, Francesco; Mascheroni, Debora; Parente, Valeria; De Francesco, Raffaele; Geginat, Jens; Abrignani, Sergio; Pagani, Massimiliano] Ist Nazl Genet Mol, Milan, Italy; [Comelli, Mario] Univ Pavia, Dipartimento Sci Sanit Appl, I-27100 Pavia, Italy; [Trabucchi, Emilio] Pio Albergo Trivulzio, Milan, Italy; [Abrignani, Sergio] CaGranda Osped Maggiore Policlin, Ist Ricovero & Cura Carattere Sci, Milan, Italy	University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico	Abrignani, S (corresponding author), Ist Nazl Genet Mol, Milan, Italy.	abrignani@ingm.org; pagani@ingm.org	Geginat, Jens/AAA-5818-2019; Rossi, Riccardo/M-8999-2019; Marabita, Francesco/AAD-6220-2019; rossetti, grazisa/C-3722-2015; De Francesco, Raffaele/J-6003-2012; Parente, Valeria/H-7817-2016	Geginat, Jens/0000-0003-4813-0384; Rossi, Riccardo/0000-0002-4964-3264; Marabita, Francesco/0000-0001-6180-0106; rossetti, grazisa/0000-0001-6361-311X; De Francesco, Raffaele/0000-0001-8754-5123; Parente, Valeria/0000-0001-6559-9817; Bonnal, Raoul/0000-0002-2123-6536; Abrignani, Sergio/0000-0002-0794-3285; Pagani, Massimiliano/0000-0002-7017-9304	National Research Fund of Luxembourg [PDR-08-040]; Fondazione Cariplo	National Research Fund of Luxembourg(Luxembourg National Research Fund); Fondazione Cariplo(Fondazione Cariplo)	We thank P. Dellabona, P. De Candia and S. Monticelli for discussions. Supported by the National Research Fund of Luxembourg (PDR-08-040 to L.W.) and the Fondazione Cariplo.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	40	197	209	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					796	803		10.1038/ni.2057	http://dx.doi.org/10.1038/ni.2057			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21706005				2022-12-18	WOS:000292870700018
J	Fukuyama, H; Nimmerjahn, F; Ravetch, JV				Fukuyama, H; Nimmerjahn, F; Ravetch, JV			The inhibitory Fc gamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G(+) anti-DNA plasma cells	NATURE IMMUNOLOGY			English	Article							B-CELLS; CHAIN REARRANGEMENT; GENE REARRANGEMENT; TRANSGENIC MICE; DEFICIENT MICE; LUPUS; EXPRESSION; TOLERANCE; MECHANISM; REGION	Deletion of the gene encoding the Fc immunoglobulin G receptor IIB (FcgammaRIIB) results in a fulminant, lupus-like disease in C57BL/6 but not BALB/c mice. Here we have investigated this strain-specific, epistatic loss of tolerance using gene-targeted immunoglobulin variable heavy-chain (V-H) alleles 3H9 or 56R, which encode DNA-specific heavy chains, expressed on the C57BL/6 or BALB/c background. The combination of C57BL/6 and V-H 56R (B6.56R) resulted in a loss of tolerance; hybridoma and single-cell analysis indicated an FcgammaRIIB-independent difference in immunoglobulin light-chain usage, consistent with an alteration in receptor editing. FcgammaRIIB deficiency resulted in an increase in immunoglobulin G (IgG) antibodies to DNA in the serum, an increased frequency of anti-DNA-reactive IgG(+) B cells with a plasma cell phenotype and immune complex deposition in the glomeruli and renal disease in B6.56R mice. Thus, FcgammaRIIB provides a distal peripheral checkpoint to limit the accumulation of autoreactive plasma cells, thereby maintaining tolerance.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Fukuyama, Hidehiro/N-5276-2018; Nimmerjahn, Falk/J-4986-2013; Fukuyama, Hidehiro/AAY-6256-2021; Ravetch, Jeffrey/Z-1596-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Ravetch, Jeffrey/0000-0003-2024-9041; Nimmerjahn, Falk/0000-0002-5418-316X				Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; BOLLAND S, 2000, IMMUNITY; Bona CA, 2004, MOL BIOL B CELLS, P381; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Kaushik A, 1996, RES IMMUNOL, V147, P9, DOI 10.1016/0923-2494(96)81545-8; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Li YJ, 2002, J EXP MED, V196, P1543, DOI 10.1084/jem.20021560; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NISHI M, 1985, P NATL ACAD SCI USA, V82, P6399, DOI 10.1073/pnas.82.19.6399; Pearse RN, 1999, IMMUNITY, V10, P753, DOI 10.1016/S1074-7613(00)80074-6; PETER JB, 1996, AUTOANTIBODIES, P534; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RAMSDEN DA, 1994, J IMMUNOL, V153, P1150; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Sekiguchi DR, 2003, J EXP MED, V197, P27, DOI 10.1084/jem.20020737; Sekiguchi DR, 2002, J IMMUNOL, V168, P4142, DOI 10.4049/jimmunol.168.8.4142; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	38	197	206	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					99	106		10.1038/ni1151	http://dx.doi.org/10.1038/ni1151			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15592473				2022-12-18	WOS:000225888500023
J	Godfrey, DI; Koay, HF; McCluskey, J; Gherardin, NA				Godfrey, Dale, I; Koay, Hui-Fern; McCluskey, James; Gherardin, Nicholas A.			The biology and functional importance of MAIT cells	NATURE IMMUNOLOGY			English	Review							INVARIANT T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; CHRONIC HEPATITIS-B; MR1 ANTIGEN PRESENTATION; CHILDREN POSSIBLE ROLES; RECEPTOR HETEROGENEITY; PERIPHERAL-BLOOD; MOLECULAR-BASIS; INNATE; EXPRESSION	In recent years, a population of unconventional T cells called 'mucosal-associated invariant T cells' (MAIT cells) has captured the attention of immunologists and clinicians due to their abundance in humans, their involvement in a broad range of infectious and non-infectious diseases and their unusual specificity for microbial riboflavin-derivative antigens presented by the major histocompatibility complex (MHC) class I-like protein MR1. MAIT cells use a limited T cell antigen receptor (TCR) repertoire with public antigen specificities that are conserved across species. They can be activated by TCR-dependent and TCR-independent mechanisms and exhibit rapid, innate-like effector responses. Here we review evidence showing that MAIT cells are a key component of the immune system and discuss their basic biology, development, role in disease and immunotherapeutic potential.	[Godfrey, Dale, I; Koay, Hui-Fern; McCluskey, James; Gherardin, Nicholas A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Godfrey, Dale, I; Koay, Hui-Fern; Gherardin, Nicholas A.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Godfrey, DI (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia.; Godfrey, DI (corresponding author), Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Parkville, Vic, Australia.	godfrey@unimelb.edu.au	McCluskey, James/A-1291-2007	McCluskey, James/0000-0002-8597-815X; Gherardin, Nicholas/0000-0003-4690-2571; Godfrey, Dale/0000-0002-3009-5472; Koay, Hui-Fern/0000-0002-3236-9609	National Health and Medical Research Council of Australia (NHMRC) [1113293, 1140126]; Australian Research Council (ARC) [CE140100011]; Cancer Council of Victoria; NHMRC Senior Principal Research Fellowship [1117766]; NHMRC ECF Fellowship [1160333]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC ECF Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC; 1113293 and 1140126); the Australian Research Council (ARC; CE140100011) and the Cancer Council of Victoria (#). DIG is supported by NHMRC Senior Principal Research Fellowship (1117766). H-F.K is supported by an NHMRC ECF Fellowship (1160333).	Abrahamsson SV, 2013, BRAIN, V136, P2888, DOI 10.1093/brain/awt182; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Beaulieu AM, 2011, J IMMUNOL, V187, P2841, DOI 10.4049/jimmunol.1004006; Ben Youssef G, 2018, J EXP MED, V215, P459, DOI 10.1084/jem.20171739; Bernal I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02532; Beudeker BJB, 2018, LIVER INT, V38, P458, DOI 10.1111/liv.13544; Bhattacharyya A, 2018, BIOL BLOOD MARROW TR, V24, P242, DOI 10.1016/j.bbmt.2017.10.003; Boeijen LL, 2017, J INFECT DIS, V216, P969, DOI 10.1093/infdis/jix425; Bolte FJ, 2017, GASTROENTEROLOGY, V153, P1392, DOI 10.1053/j.gastro.2017.07.043; Booth JS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00466; Boudinot P, 2016, P NATL ACAD SCI USA, V113, pE2983, DOI 10.1073/pnas.1600674113; Braudeau C, 2016, J AUTOIMMUN, V70, P73, DOI 10.1016/j.jaut.2016.03.015; Brozova J, 2016, SCAND J IMMUNOL, V84, P245, DOI 10.1111/sji.12467; Buscarinu MC, 2018, NEUROTHERAPEUTICS, V15, P68, DOI 10.1007/s13311-017-0582-3; Cannizzo ES, 2019, EUR J IMMUNOL, V49, P1127, DOI 10.1002/eji.201948152; Carolan E, 2015, J IMMUNOL, V194, P5775, DOI 10.4049/jimmunol.1402945; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chandra S, 2018, J IMMUNOL, V200, P3317, DOI 10.4049/jimmunol.1800397; Chandra S, 2018, J IMMUNOL, V200, P1995, DOI 10.4049/jimmunol.1701525; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Chiba A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1257-5; Chiba A, 2012, ARTHRITIS RHEUM-US, V64, P153, DOI 10.1002/art.33314; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; D'Souza C, 2018, J IMMUNOL, V200, P1901, DOI 10.4049/jimmunol.1701512; Davanian H, 2019, INT J ORAL SCI, V11, DOI 10.1038/s41368-019-0049-y; Dias J, 2019, J HEPATOL, V71, P301, DOI 10.1016/j.jhep.2019.04.009; Dias J, 2018, P NATL ACAD SCI USA, V115, pE11513, DOI 10.1073/pnas.1812273115; Dias J, 2017, P NATL ACAD SCI USA, V114, pE5434, DOI 10.1073/pnas.1705759114; Duan M, 2019, CLIN CANCER RES, V25, P3304, DOI 10.1158/1078-0432.CCR-18-3040; Dunne MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076008; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; EBATO M, 1994, EUR J IMMUNOL, V24, P2987, DOI 10.1002/eji.1830241210; EBATO M, 1993, IMMUNOL LETT, V39, P53, DOI 10.1016/0165-2478(93)90164-W; Eberhard JM, 2016, J HEPATOL, V65, P1261, DOI 10.1016/j.jhep.2016.07.031; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Eyerich K, 2017, EUR J IMMUNOL, V47, P607, DOI 10.1002/eji.201646723; Favreau M, 2017, HAEMATOLOGICA, V102, pE266, DOI 10.3324/haematol.2017.163758; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Freeman Michael L, 2017, Pathog Immun, V2, P335, DOI 10.20411/pai.v2i3.136; Gaardbo JC, 2015, JAIDS-J ACQ IMM DEF, V70, P228, DOI 10.1097/QAI.0000000000000758; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gherardin NA, 2018, J IMMUNOL, V201, P2862, DOI 10.4049/jimmunol.1801091; Gherardin NA, 2018, IMMUNOL CELL BIOL, V96, P507, DOI 10.1111/imcb.12021; Gherardin NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22130-1; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Gibbs A, 2017, MUCOSAL IMMUNOL, V10, P35, DOI 10.1038/mi.2016.30; Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gold MC, 2013, MUCOSAL IMMUNOL, V6, P35, DOI 10.1038/mi.2012.45; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gracey E, 2016, ANN RHEUM DIS, V75, P2124, DOI 10.1136/annrheumdis-2015-208902; Greathead L, 2014, AIDS, V28, P1690, DOI 10.1097/QAD.0000000000000351; Greene JM, 2017, MUCOSAL IMMUNOL, V10, P802, DOI 10.1038/mi.2016.91; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Guggino G, 2017, EUR J IMMUNOL, V47, P2002, DOI 10.1002/eji.201747140; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Haga K, 2016, J GASTROEN HEPATOL, V31, P965, DOI 10.1111/jgh.13242; Harms RZ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02332; Harms RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117335; Harriff MJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2556; Harriff MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005524; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; Havenith SHC, 2012, INT IMMUNOL, V24, P625, DOI 10.1093/intimm/dxs069; Hayashi E, 2016, J RHEUMATOL, V43, P1695, DOI 10.3899/jrheum.151133; Hegde P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04450-y; Held K, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000107; Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447; Hiejima E, 2015, INFLAMM BOWEL DIS, V21, P1529, DOI 10.1097/MIB.0000000000000397; Hildebrandt M, 2012, TRANSFUSION, V52, P765, DOI 10.1111/j.1537-2995.2011.03351.x; Hinks TSC, 2016, AM J RESP CRIT CARE, V194, P1208, DOI 10.1164/rccm.201601-0002OC; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Howson LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02540-x; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Huang WC, 2019, TAIWAN J OBSTET GYNE, V58, P117, DOI 10.1016/j.tjog.2018.11.022; Hwang HY, 2006, MOL IMMUNOL, V43, P420, DOI 10.1016/j.molimm.2005.03.004; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Jahreis S, 2018, EUR J IMMUNOL, V48, P1698, DOI 10.1002/eji.201747312; Jesteadt E, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00117-18, 10.1128/iai.00117-18]; Jiang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32320; Jiang J, 2016, J INFECTION, V72, P338, DOI 10.1016/j.jinf.2015.11.010; Jiang X, 2018, J AUTOIMMUN, V90, P64, DOI 10.1016/j.jaut.2018.01.007; Juno JA, 2019, J IMMUNOL, V202, P2105, DOI 10.4049/jimmunol.1801405; Juno JA, 2019, CURR OPIN HIV AIDS, V14, P77, DOI [10.1097/COH.0000000000000526, 10.1097/coh.0000000000000526]; Kang SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004832; Kauffman KD, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00431-18; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kawaguchi K, 2018, INT J HEMATOL, V108, P66, DOI 10.1007/s12185-018-2442-2; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Khaitan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161786; Kim M, 2017, CYTOKINE, V99, P91, DOI 10.1016/j.cyto.2017.07.007; Kjer-Nielsen L, 2018, IMMUNOL CELL BIOL, V96, P573, DOI 10.1111/imcb.12057; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10198-w; Koay HF, 2018, IMMUNOL CELL BIOL, V96, P598, DOI 10.1111/imcb.12039; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Koppejan H, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1799-1; Kuric E, 2018, AM J PATHOL, V188, P1744, DOI 10.1016/j.ajpath.2018.04.009; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Kurioka A, 2018, J INFECT DIS, V217, P988, DOI 10.1093/infdis/jix647; Kurioka A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01031; Kwon YS, 2016, COPD, V13, P196, DOI 10.3109/15412555.2015.1069806; Kwon YS, 2015, TUBERCULOSIS, V95, P267, DOI 10.1016/j.tube.2015.03.004; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee CH, 2018, ELIFE, V7, DOI 10.7554/eLife.32532; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4143; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Leung DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003076; Lezmi G, 2018, J IMMUNOL, V200, P3317, DOI 10.4049/jimmunol.1800344; Lezmi G, 2018, CLIN IMMUNOL, V188, P7, DOI 10.1016/j.clim.2017.11.009; Li J, 2017, AUSTRALAS J DERMATOL, V58, P200, DOI 10.1111/ajd.12456; Ling LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20358; Liuzzi AR, 2016, J IMMUNOL, V197, P2195, DOI 10.4049/jimmunol.1600990; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Lopez-Sagaseta J, 2013, P NATL ACAD SCI USA, V110, pE1771, DOI 10.1073/pnas.1222678110; Maekawa T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207149; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Malka-Ruimy C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00206; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McGregor S, 2014, BLOOD, V123, P2742, DOI 10.1182/blood-2014-02-555482; McWilliam HEG, 2018, CURR OPIN IMMUNOL, V52, P108, DOI 10.1016/j.coi.2018.04.022; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Meermeier EW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12506; Meggyes M, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12805; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Meierovics AI, 2016, J EXP MED, V213, P2793, DOI 10.1084/jem.20160637; Mekinian A, 2017, SCAND J IMMUNOL, V86, P216, DOI 10.1111/sji.12585; Mendy J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03093; Mitchell J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34873-y; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Mpina M, 2017, J IMMUNOL, V199, P107, DOI 10.4049/jimmunol.1601989; Muttiah B, 2015, EUR J CLIN INVEST, V46, P170; NITTA T, 1990, SCIENCE, V249, P672, DOI 10.1126/science.2382141; Novak J, 2014, SCAND J IMMUNOL, V80, P271, DOI 10.1111/sji.12193; Paquin-Proulx D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175345; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Peterfalvi A, 2008, INT IMMUNOL, V20, P1517, DOI 10.1093/intimm/dxn111; Pincikova T, 2018, CHEST, V153, pE93, DOI 10.1016/j.chest.2018.01.020; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Renand A, 2018, HEPATOL COMMUN, V2, P972, DOI 10.1002/hep4.1202; Riegert P, 1998, J IMMUNOL, V161, P4066; Robert M, 2019, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00364; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Salerno-Goncalves R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00398; Salerno-Goncalves R, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00511; Salio M, 2017, J IMMUNOL, V199, P2631, DOI 10.4049/jimmunol.1700615; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Salou M, 2019, J EXP MED, V216, P133, DOI 10.1084/jem.20181483; Salou M, 2016, CLIN IMMUNOL, V166, P1, DOI 10.1016/j.clim.2016.03.014; Sattler A, 2015, EUR J IMMUNOL, V45, P2286, DOI 10.1002/eji.201445313; Seach N, 2013, J IMMUNOL, V191, P6002, DOI 10.4049/jimmunol.1301212; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Seshadri C, 2017, GENES IMMUN, V18, P8, DOI 10.1038/gene.2016.41; Shaler CR, 2017, CANCER IMMUNOL IMMUN, V66, P1563, DOI 10.1007/s00262-017-2050-7; Shaler CR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001930; Sharma PK, 2015, IMMUNOLOGY, V145, P443, DOI 10.1111/imm.12461; Shimamura M, 2011, IMMUNOBIOLOGY, V216, P374, DOI 10.1016/j.imbio.2010.08.003; Slichter CK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86292; Smith DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109891; Sobkowiak MJ, 2019, EUR J IMMUNOL, V49, P133, DOI 10.1002/eji.201847759; Solders M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01861; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; Spaan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159243; Sugimoto C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2923-9; Sugimoto C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121124; Sundstrom Patrik, 2019, Oncotarget, V10, P2810, DOI 10.18632/oncotarget.26866; Sundstrom P, 2015, J IMMUNOL, V195, P3472, DOI 10.4049/jimmunol.1500258; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Tastan C, 2018, MUCOSAL IMMUNOL, V11, P1591, DOI 10.1038/s41385-018-0072-x; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2898, DOI 10.1038/jid.2014.261; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tominaga K, 2017, BIOMED RES-TOKYO, V38, P111, DOI 10.2220/biomedres.38.111; Touch S, 2018, FASEB J; Toussirot E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01610; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Ussher JE, 2018, IMMUNOL CELL BIOL, V96, P630, DOI 10.1111/imcb.12008; Ussher JE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001134; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Wilgenburg B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07207-9; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Varelias A, 2018, J CLIN INVEST, V128, P1919, DOI 10.1172/JCI91646; Vinton C, 2016, J VIROL, V90, P4520, DOI 10.1128/JVI.02876-15; Voillet V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98487; Vorkas CK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121899; Walker LJ, 2014, SCAND J IMMUNOL, V80, P462, DOI 10.1111/sji.12237; Wallington JC, 2018, J ALLERGY CLIN IMMUN, V141, P2182, DOI 10.1016/j.jaci.2017.08.009; Wang HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05202-8; Wang JJ, 2016, EUR J IMMUNOL, V46, P2444, DOI 10.1002/eji.201646300; Willing A, 2018, J IMMUNOL, V200, P974, DOI 10.4049/jimmunol.1701213; Willing A, 2014, EUR J IMMUNOL, V44, P3119, DOI 10.1002/eji.201344160; Winter SJ, 2019, IMMUNOL CELL BIOL, V97, P190, DOI 10.1111/imcb.12211; Won EJ, 2016, ONCOTARGET, V7, P76274, DOI 10.18632/oncotarget.11187; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474; Yang QT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17918; Yong YK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00472; Yong YK, 2017, INNATE IMMUN-LONDON, V23, P459, DOI 10.1177/1753425917714854; Zabijak L, 2015, CANCER IMMUNOL IMMUN, V64, P1601, DOI 10.1007/s00262-015-1764-7; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zumwalde NA, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1036-5	217	196	199	6	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1110	1128		10.1038/s41590-019-0444-8	http://dx.doi.org/10.1038/s41590-019-0444-8			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31406380				2022-12-18	WOS:000482212600012
J	Sok, D; Burton, DR				Sok, Devin; Burton, Dennis R.			Recent progress in broadly neutralizing antibodies to HIV	NATURE IMMUNOLOGY			English	Review							HUMAN MONOCLONAL-ANTIBODIES; IMMUNODEFICIENCY VIRUS CHALLENGE; MUCOSAL SHIV CHALLENGE; IG KNOCKIN MICE; VACCINE DESIGN; TREATMENT INTERRUPTION; ENVELOPE TRIMER; CD4 BINDING; CELL SPREAD; IN-VIVO	In this Review, we highlight some recent developments in the discovery and application of broadly neutralizing antibodies (bnAbs) to human immunodeficiency virus (HIV); i.e., antibodies able to neutralize diverse isolates of HIV. We consider the characterization of novel bnAbs, recent data on the effects of bnAbs in vivo in humans and animal models, and the importance of both kinds of data for the application of Abs to prophylaxis and therapy and to guide vaccine design. We seek to place newly discovered bnAbs in the context of existing bnAbs, and we explore the various characteristics of the antibodies that are most desirable for different applications.	[Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Sok, Devin] Int AIDS Vaccine Initiat, New York, NY 10004 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Sok, D; Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Sok, D; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Sok, D; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Sok, D (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dsok@iavi.org; burton@scripps.edu		Burton, Dennis/0000-0001-6711-9864	US National Institute of Allergy and Infectious Diseases; IAVI; Bill and Melinda Gates Foundation; Ragon Institute; Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; United States Agency for International Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IAVI; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute; Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Wilson and W. Schief for comments on the manuscript; and L. Hangartner, C. Corbaci and B. Briney for assistance with figure preparation. Supported by the US National Institute of Allergy and Infectious Diseases (D.R.B.), IAVI (D.R.B.), the Bill and Melinda Gates Foundation (D.R.B.), the Ragon Institute (D.R.B.), the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (D.S.) and the United States Agency for International Development (D.S.). A full list of IAVI donors is available at https://www.iavi.org/what-we-do/partner/donors. Contributions from the International AIDS Vaccine Initiative do not necessarily reflect the views of USAID or the United States government.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Alam SM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7521; Andrabi R, 2017, IMMUNITY, V47, P524, DOI 10.1016/j.immuni.2017.08.006; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y; Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bournazos S, 2017, IMMUNOL REV, V275, P285, DOI 10.1111/imr.12482; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Cao LW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06121-4; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Chang HW, 2015, J VIROL, V89, P1965, DOI 10.1128/JVI.03279-14; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dingens AS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007159; Ditse Z, 2018, J VIROL, V92, DOI [10.1128/JVI.00878-18, 10.1128/jvi.00878-18]; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Freund NT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2144; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gilbert Peter B, 2017, Stat Commun Infect Dis, V9, DOI 10.1515/scid-2016-0001; Gombos RB, 2015, J VIROL, V89, P7813, DOI 10.1128/JVI.00783-15; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hessell AJ, 2015, CURR OPIN HIV AIDS, V10, P170, DOI 10.1097/COH.0000000000000152; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Irimia A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006212; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4235; Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321; Kwon YD, 2018, CELL REP, V22, P1798, DOI 10.1016/j.celrep.2018.01.023; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li H., 2017, J VIROL, V91; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Longo NS, 2016, J VIROL, V90, P10574, DOI 10.1128/JVI.01012-16; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McCoy LE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005110; Mccoy LE, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0083-y; Moldt B, 2016, AIDS, V30, P1543, DOI 10.1097/QAD.0000000000001102; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Molinos-Albert LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01154; Morris L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002436; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parsons MS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1483; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Quinn CP, 2016, CLIN VACCINE IMMUNOL, V23, P326, DOI 10.1128/CVI.00696-15; Rantalainen K, 2018, CELL REP, V23, P3249, DOI 10.1016/j.celrep.2018.05.046; Reh L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004966; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schiffner T, 2013, VACCINE, V31, P5789, DOI 10.1016/j.vaccine.2013.10.020; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shivatare VS, 2018, J AM CHEM SOC, V140, P5202, DOI 10.1021/jacs.8b00896; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Struwe WB, 2018, CELL REP, V24, P1958, DOI 10.1016/j.celrep.2018.07.080; Subbaraman H, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0433-2; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; van Gils MJ, 2014, TRENDS MICROBIOL, V22, P550, DOI 10.1016/j.tim.2014.08.006; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Webb NE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9443; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xu K, 2018, NAT MED, V24, P857, DOI 10.1038/s41591-018-0042-6; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013	107	196	204	5	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1179	1188		10.1038/s41590-018-0235-7	http://dx.doi.org/10.1038/s41590-018-0235-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333615	Green Accepted, Bronze			2022-12-18	WOS:000447632200013
J	Hammer, Q; Ruckert, T; Borst, EM; Dunst, J; Haubner, A; Durek, P; Heinrich, F; Gasparoni, G; Babic, M; Tomic, A; Pietra, G; Nienen, M; Blau, IW; Hofmann, J; Na, IK; Prinz, I; Koenecke, C; Hemmati, P; Babel, N; Arnold, R; Walter, J; Thurley, K; Mashreghi, MF; Messerle, M; Romagnani, C				Hammer, Quirin; Rueckert, Timo; Borst, Eva Maria; Dunst, Josefine; Haubner, Andre; Durek, Pawel; Heinrich, Frederik; Gasparoni, Gilles; Babic, Marina; Tomic, Adriana; Pietra, Gabriella; Nienen, Mikalai; Blau, Igor Wolfgang; Hofmann, Joerg; Na, Il-Kang; Prinz, Immo; Koenecke, Christian; Hemmati, Philipp; Babel, Nina; Arnold, Renate; Walter, Joern; Thurley, Kevin; Mashreghi, Mir-Farzin; Messerle, Martin; Romagnani, Chiara			Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells	NATURE IMMUNOLOGY			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; SEQUENCE-DERIVED PEPTIDES; HLA-E BINDS; NK CELLS; CLONAL EXPANSION; INFECTION; RECEPTOR; GENE; UL40; CD94/NKG2A	Natural killer (NK) cells are innate lymphocytes that lack antigen-specific rearranged receptors, a hallmark of adaptive lymphocytes. In some people infected with human cytomegalovirus (HCMV), an NK cell subset expressing the activating receptor NKG2C undergoes clonal-like expansion that partially resembles anti-viral adaptive responses. However, the viral ligand that drives the activation and differentiation of adaptive NKG2C(+) NK cells has remained unclear. Here we found that adaptive NKG2C(+) NK cells differentially recognized distinct HCMV strains encoding variable UL40 peptides that, in combination with pro-inflammatory signals, controlled the population expansion and differentiation of adaptive NKG2C(+) NK cells. Thus, we propose that polymorphic HCMV peptides contribute to shaping of the heterogeneity of adaptive NKG2C(+) NK cell populations among HCMV-seropositive people.	[Hammer, Quirin; Rueckert, Timo; Haubner, Andre; Babic, Marina; Romagnani, Chiara] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Innate Immun, Berlin, Germany; [Borst, Eva Maria; Tomic, Adriana; Messerle, Martin] Hannover Med Sch, Inst Virol, Hannover, Germany; [Dunst, Josefine] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Inflammat Biol, Berlin, Germany; [Durek, Pawel] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Cell Biol, Berlin, Germany; [Durek, Pawel] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Microbiota & Inflammat, Berlin, Germany; [Heinrich, Frederik; Mashreghi, Mir-Farzin] Leibniz Assoc, Therapeut Gene Regulat German Rheumatism Res Ctr, Berlin, Germany; [Gasparoni, Gilles; Walter, Joern] Univ Saarland, Dept Genet, Saarbrucken, Germany; [Pietra, Gabriella] Univ Genoa, Dept Expt Med, Genoa, Italy; [Pietra, Gabriella] Osped Policlin San Martino, Immunol, IRCCS, Genoa, Italy; [Nienen, Mikalai; Babel, Nina] Ruhr Univ Bochum, Marien Hosp Herne, Med Clin 1, Herne, Germany; [Blau, Igor Wolfgang; Na, Il-Kang; Hemmati, Philipp; Arnold, Renate] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Hofmann, Joerg] Charite, Inst Virol, Berlin, Germany; [Hofmann, Joerg] Labor Berlin Charite Vivantes GmbH, Virol, Berlin, Germany; [Na, Il-Kang] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Na, Il-Kang] BIH, Berlin, Germany; [Prinz, Immo; Koenecke, Christian] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Koenecke, Christian] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Babel, Nina] Charite, Inst Med Immunol, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Thurley, Kevin] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Syst Biol Inflammat, Berlin, Germany; [Romagnani, Chiara] Charite, Med Dept 1, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Hannover Medical School; Deutsches Rheuma-Forschungszentrum (DRFZ); Deutsches Rheuma-Forschungszentrum (DRFZ); Deutsches Rheuma-Forschungszentrum (DRFZ); Saarland University; University of Genoa; Ruhr University Bochum; St. Marien Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Hannover Medical School; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Romagnani, C (corresponding author), Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Innate Immun, Berlin, Germany.; Romagnani, C (corresponding author), Charite, Med Dept 1, Berlin, Germany.	romagnani@drfz.de	Tomic, Adriana/AAX-7203-2021; Mashreghi, Mir-Farzin/S-2911-2019; Babel, Nina/AAK-2034-2021; Babic Cac, Marina/AFO-1124-2022; Walter, Jörn/AFN-6428-2022; pietra, gabriella/J-7204-2016; Romagnani, Chiara/E-4708-2016; Cac, Marina Babic/ABH-3595-2020; Prinz, Immo/A-3026-2010	Tomic, Adriana/0000-0001-9885-3535; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Walter, Jörn/0000-0003-0563-7417; pietra, gabriella/0000-0002-7080-531X; Romagnani, Chiara/0000-0002-5167-7463; Hammer, Quirin/0000-0003-2968-6061; Ruckert, Timo/0000-0003-1433-1372; Hofmann, Joerg/0000-0003-3966-515X; Na, Il-Kang/0000-0001-9902-5424; Babel, Nina/0000-0003-3673-712X; Borst, Eva Maria/0000-0002-2589-3322; Nienen, Mikalai/0000-0002-5678-1956; Dunst, Josefine/0000-0003-0061-0901; Prinz, Immo/0000-0002-8789-9578	Leibniz Science Campus Chronic Inflammation; Leibniz Best Minds program; German Research Foundation [SFB 650, RO3565/2-1, RO3565/4-1, SFB900]; German Research Foundation (Heisenberg Program) [RO 3565/1-1]; state of Berlin; Stiftung Charite; European Regional Development Fund (ERDF); Leibniz Graduate School for Rheumatology; European Regional Development Fund [EFRE 1.8/11]	Leibniz Science Campus Chronic Inflammation; Leibniz Best Minds program; German Research Foundation(German Research Foundation (DFG)); German Research Foundation (Heisenberg Program)(German Research Foundation (DFG)); state of Berlin; Stiftung Charite; European Regional Development Fund (ERDF)(European Commission); Leibniz Graduate School for Rheumatology; European Regional Development Fund(European Commission)	We thank P. Wehler, A. Seegebarth and U. Uhlig for technical assistance; the DRFZ FCCF for cell sorting; D. Hernandez for critical reading of the manuscript; A. Moretta (University of Genoa) for antibody clone GL183; E. Weiss (Ludwig Maximilian University) for K562-HLA-E cells; J. Coligan (US National Institutes of Health) for RMA-S-HLA-E cells; G. Smith (Northwestern University) for the pGS403 plasmid; and A. Scheffold, A. Brooks and K.-J. Malmberg for comments during manuscript preparation. Supported by Leibniz Science Campus Chronic Inflammation (http://www.chronische-entzuendung.org), Leibniz Best Minds program (K.T.), the German Research Foundation (SFB 650, RO3565/2-1 and RO3565/4-1 to C.R.; SFB900 to M.M., I.P. and C.K.; and Heisenberg Program RO 3565/1-1 for C.R.), the state of Berlin (for the work of F.H. and M.-F.M.), the Stiftung Charite (for I.-K.N), the European Regional Development Fund (ERDF 2014-2020 and EFRE 1.8/11 for the work of F.H. and M.-F.M.) and the Leibniz Graduate School for Rheumatology (Q.H.).	Adam SG, 2006, J IMMUNOL, V176, P5478, DOI 10.4049/jimmunol.176.9.5478; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1999, J IMMUNOL, V162, P305; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Crnkovic-Mertens I, 1998, J VIROL, V72, P1377; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Della Chiesa M, 2014, J IMMUNOL, V192, P1471, DOI 10.4049/jimmunol.1302053; Djaoud Z, 2016, J INNATE IMMUN, V8, P374, DOI 10.1159/000445320; Elbasani E, 2014, VIRUSES-BASEL, V6, P354, DOI 10.3390/v6010354; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hammer Q, 2017, ADV IMMUNOL, V133, P171, DOI 10.1016/bs.ai.2016.10.001; Hammer Q, 2017, CYTOM PART A, V91A, P997, DOI 10.1002/cyto.a.23168; Heatley SL, 2013, J BIOL CHEM, V288, P8679, DOI 10.1074/jbc.M112.409672; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu LL, 2016, CELL REP, V15, P1088, DOI 10.1016/j.celrep.2016.04.005; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Rolle A, 2014, J CLIN INVEST, V124, P5305, DOI 10.1172/JCI77440; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; van der Ploeg K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00298; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099	75	196	200	7	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					453	+		10.1038/s41590-018-0082-6	http://dx.doi.org/10.1038/s41590-018-0082-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29632329				2022-12-18	WOS:000430562400009
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			The immunology of the allergy epidemic and the hygiene hypothesis	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; TYPE-2 IMMUNITY; AIRWAY INFLAMMATION; B-CELLS; DENDRITIC CELLS; RESPIRATORY-INFECTIONS; PROMOTES TOLERANCE; CHILDHOOD ASTHMA; EPITHELIAL-CELLS; INHALED ANTIGEN	The immunology of the hygiene hypothesis of allergy is complex and involves the loss of cellular and humoral immunoregulatory pathways as a result of the adoption of a Western lifestyle and the disappearance of chronic infectious diseases. The influence of diet and reduced microbiome diversity now forms the foundation of scientific thinking on how the allergy epidemic occurred, although clear mechanistic insights into the process in humans are still lacking. Here we propose that barrier epithelial cells are heavily influenced by environmental factors and by microbiome-derived danger signals and metabolites, and thus act as important rheostats for immunoregulation, particularly during early postnatal development. Preventive strategies based on this new knowledge could exploit the diversity of the microbial world and the way humans react to it, and possibly restore old symbiotic relationships that have been lost in recent times, without causing disease or requiring a return to an unhygienic life style.	[Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent VIB, Ctr Inflammat Res, Ghent, Belgium; [Lambrecht, Bart N.; Hammad, Hamida] Univ Hosp Ghent, Dept Resp Med, Ghent, Belgium; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN; Hammad, H (corresponding author), Univ Ghent VIB, Ctr Inflammat Res, Ghent, Belgium.; Lambrecht, BN; Hammad, H (corresponding author), Univ Hosp Ghent, Dept Resp Med, Ghent, Belgium.; Lambrecht, BN (corresponding author), ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands.	bart.lambrecht@irc.vib-ugent.be; hamida.hammad@irc.vib-ugent.be	Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603	Ghent University (Concerted Research Initiative (GOA); Scientific Research Foundation Flanders (FWO)	Ghent University (Concerted Research Initiative (GOA); Scientific Research Foundation Flanders (FWO)(FWO)	B.N.L. and H.H. are supported by Ghent University (Concerted Research Initiative (GOA) grant) and by the Scientific Research Foundation Flanders (FWO).	Akdis CA, 1997, J ALLERGY CLIN IMMUN, V99, P345, DOI 10.1016/S0091-6749(97)70052-6; Alberca-Custodio RW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00237; Amoah AS, 2013, J ALLERGY CLIN IMMUN, V132, P639, DOI 10.1016/j.jaci.2013.04.023; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Brand S, 2011, J ALLERGY CLIN IMMUN, V128, P618, DOI 10.1016/j.jaci.2011.04.035; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Danilowicz-Luebert E, 2013, INT J PARASITOL, V43, P201, DOI 10.1016/j.ijpara.2012.10.014; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Deckers J., 2017, J ALLERGY CLIN IMMUN; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; GERRARD JW, 1976, ANN ALLERGY, V37, P91; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hasegawa K, 2017, PEDIATR INT, V59, P473, DOI 10.1111/ped.13168; Holt PG, 2016, J ALLERGY CLIN IMMUN, V137, P379, DOI 10.1016/j.jaci.2015.08.044; House JS, 2017, J ALLERGY CLIN IMMUN, V140, P249, DOI 10.1016/j.jaci.2016.09.036; Hua X, 2016, EBIOMEDICINE, V3, P172, DOI 10.1016/j.ebiom.2015.11.038; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Janse JJ, 2014, PEDIAT ALLERG IMM-UK, V25, P250, DOI 10.1111/pai.12175; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Kin NW, 2012, J IMMUNOL, V189, P2246, DOI 10.4049/jimmunol.1200702; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; Loss G, 2015, J ALLERGY CLIN IMMUN, V135, P56, DOI 10.1016/j.jaci.2014.08.044; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Martin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158498; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; McFarlane A. J., J ALLERGY C IN PRESS; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; McSorley HJ, 2012, EUR J IMMUNOL, V42, P2667, DOI 10.1002/eji.201142161; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mitre E, 2005, INFECT IMMUN, V73, P4106, DOI 10.1128/IAI.73.7.4106-4111.2005; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Navarro S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8807; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Paark HK, 2012, J ASTHMA, V49, P10, DOI 10.3109/02770903.2011.637593; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; Patel PS, 2016, J IMMUNOL, V197, P3175, DOI 10.4049/jimmunol.1601039; Patel PS, 2015, J IMMUNOL, V194, P5838, DOI 10.4049/jimmunol.1500251; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rantala AK, 2015, AM J EPIDEMIOL, V182, P615, DOI 10.1093/aje/kwv093; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Rzepecka J, 2013, INT J PARASITOL, V43, P211, DOI 10.1016/j.ijpara.2012.12.001; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schmiedel Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003995; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schroder PC, 2017, ALLERGY, V72, P604, DOI 10.1111/all.13069; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Smits HH, 2016, J ALLERGY CLIN IMMUN, V137, P690, DOI 10.1016/j.jaci.2016.01.004; Steer CA, 2017, J ALLERGY CLIN IMMUN, V140, P593, DOI 10.1016/j.jaci.2016.12.984; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stephens R, 2002, J IMMUNOL, V169, P5458, DOI 10.4049/jimmunol.169.10.5458; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x; Tyagi N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004546; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Valmonte GR, 2012, ASIA PAC ALLERGY, V2, P35, DOI 10.5415/apallergy.2012.2.1.35; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; van der Vlugt LEPM, 2017, INT J PARASITOL, V47, P545, DOI 10.1016/j.ijpara.2017.02.002; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572	96	196	206	3	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1076	1083		10.1038/ni.3829	http://dx.doi.org/10.1038/ni.3829			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926539				2022-12-18	WOS:000411134000012
J	Zheng, QL; Hou, J; Zhou, Y; Li, ZY; Cao, XT				Zheng, Qingliang; Hou, Jin; Zhou, Ye; Li, Zhenyang; Cao, Xuetao			The RNA helicase DDX46 inhibits innate immunity by entrapping m(6)A-demethylated antiviral transcripts in the nucleus	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA; RIG-I; UBIQUITIN LIGASE; STEM-CELLS; NUCLEOTIDE; RETENTION; DEGRADATION; REGULATORS; ACTIVATE; SELF	DEAD-box (DDX) helicases are vital for the recognition of RNA and metabolism and are critical for the initiation of antiviral innate immunity. Modification of RNA is involved in many biological processes; however, its role in antiviral innate immunity has remained unclear. Here we found that nuclear DDX member DDX46 inhibited the production of type I interferons after viral infection. DDX46 bound Mavs, Traf3 and Traf6 transcripts (which encode signaling molecules involved in antiviral responses) via their conserved CCGGUU element. After viral infection, DDX46 recruited ALKBH5, an 'eraser' of the RNA modification N-6-methyladenosine (m(6)A), via DDX46's DEAD helicase domain to demethylate those m(6)A-modified antiviral transcripts. It consequently enforced their retention in the nucleus and therefore prevented their translation and inhibited interferon production. DDX46 also suppressed antiviral innate immunity in vivo. Thus, DDX46 inhibits antiviral innate responses by entrapping selected antiviral transcripts in the nucleus by erasing their m(6)A modification, a modification normally required for export from the nucleus and translation.	[Zheng, Qingliang; Cao, Xuetao] Chinese Acad Med Sci, CAMS Oxford Univ Int Ctr Translat Immunol, Peking Union Med Coll, Inst Basic Med Sci,Dept Immunol, Beijing, Peoples R China; [Zheng, Qingliang; Cao, Xuetao] Chinese Acad Med Sci, CAMS Oxford Univ Int Ctr Translat Immunol, Peking Union Med Coll, Inst Basic Med Sci,Ctr Immunotherapy, Beijing, Peoples R China; [Hou, Jin; Zhou, Ye; Li, Zhenyang; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Hou, Jin; Zhou, Ye; Li, Zhenyang; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Chinese Acad Med Sci, CAMS Oxford Univ Int Ctr Translat Immunol, Peking Union Med Coll, Inst Basic Med Sci,Dept Immunol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, CAMS Oxford Univ Int Ctr Translat Immunol, Peking Union Med Coll, Inst Basic Med Sci,Ctr Immunotherapy, Beijing, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.	caoxt@immunol.org	Hou, Jin/GRY-4960-2022		National Key Basic Research Program of China [2013CB530503, 2012CB518900]; National Natural Science Foundation of China [31390431, 81422037, 81671564]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]; National Key Basic Research Program of China [2013CB530503, 2012CB518900]; National Natural Science Foundation of China [31390431, 81422037, 81671564]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences	We thank T. Fang, M. Jin and Y. Li for technical assistance; X. Liu, C. Han, S. Xu, Y. Han and T. Chen for discussions; and the SIDANSAI Biotechnology Company (Shanghai, China) for helping to generate Ddx46<SUP>+/-</SUP> mice. Supported by the National Key Basic Research Program of China (2013CB530503 and 2012CB518900), the National Natural Science Foundation of China (31390431, 81422037 and 81671564) and the CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Ansari MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005019; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cordin O, 2013, RNA BIOL, V10, P83, DOI 10.4161/rna.22547; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Hirabayashi R, 2013, STEM CELLS DEV, V22, P2532, DOI 10.1089/scd.2012.0623; Hoernes TP, 2016, RNA BIOL, V13, P760, DOI 10.1080/15476286.2016.1203504; Hozumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033675; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim TW, 2016, J IMMUNOL, V197, P3348, DOI 10.4049/jimmunol.1502385; Kufel J, 2004, MOL CELL BIOL, V24, P9646, DOI 10.1128/MCB.24.21.9646-9657.2004; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Liang WW, 2015, GENE DEV, V29, P81, DOI 10.1101/gad.253708.114; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Portilho DM, 2016, CELL REP, V14, P355, DOI 10.1016/j.celrep.2015.12.039; Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sun X, 2015, SCI REP-UK, V5, DOI 10.1038/srep12521; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang X, 2014, MOL CELL, V56, P5, DOI 10.1016/j.molcel.2014.09.001; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108	50	196	217	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1094	+		10.1038/ni.3830	http://dx.doi.org/10.1038/ni.3830			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28846086				2022-12-18	WOS:000411134000014
J	Minnich, M; Tagoh, H; Bonelt, P; Axelsson, E; Fischer, M; Cebolla, B; Tarakhovsky, A; Nutt, SL; Jaritz, M; Busslinger, M				Minnich, Martina; Tagoh, Hirorni; Boenelt, Peter; Axelsson, Elin; Fischer, Maria; Cebolla, Beatriz; Tarakhovsky, Alexander; Nutt, Stephen L.; Jaritz, Markus; Busslinger, Meinrad			Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation	NATURE IMMUNOLOGY			English	Article							RNA-POLYMERASE-II; GERMINAL CENTER B; ELONGATION-FACTOR; MESSENGER-RNA; MATURE B; GENE-EXPRESSION; REPRESSION; SECRETION; PROTEIN; ELL2	The transcription factor Blimp-1 is necessary for the generation of plasma cells. Here we studied its functions in plasmablast differentiation by identifying regulated Blimp-1 target genes. Blimp-1 promoted the migration and adhesion of plasmablasts. It directly repressed genes encoding several transcription factors and Aicda (which encodes the cytidine deaminase AID) and thus silenced B cell specific gene expression, antigen presentation and class-switch recombination in plasmablasts. It directly activated genes, which led to increased expression of the plasma cell regulator IRF4 and proteins involved in immunoglobulin secretion. Blimp-1 induced the transcription of immunoglobulin genes by controlling the 3' enhancers of the loci encoding the immunoglobulin heavy chain (Igh) and K-light chain (lgk) and, furthermore, regulated the post-transcriptional expression switch from the membrane-bound form of the immunoglobulin heavy chain to its secreted form by activating EII2 (which encodes the transcription-elongation factor ELL2). Notably, Blimp-1 recruited chromatin-remodeling and histone-modifying complexes to regulate its target genes. Hence, many essential functions of plasma cells are under the control of Blimp-1.	[Minnich, Martina; Tagoh, Hirorni; Boenelt, Peter; Axelsson, Elin; Fischer, Maria; Cebolla, Beatriz; Jaritz, Markus; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA; [Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Axelsson, Elin] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1010 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Rockefeller University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria.	busslinger@imp.ac.at	Nutt, Stephen L/C-9256-2013; Busslinger, Meinrad J./J-1249-2016; Tagoh, Hiromi/B-2954-2009	Nutt, Stephen L/0000-0002-0020-6637; Busslinger, Meinrad J./0000-0002-9111-9351; Jaritz, Markus/0000-0002-9326-2047; Tagoh, Hiromi/0000-0001-9905-6992; Axelsson, Elin/0000-0003-4382-1880	Boehringer Ingelheim; European Research Council (European Union) [291740]; Austrian Industrial Research Promotion Agency; Emerald Foundation (Tarakhovsky laboratory); National Health and Medical Research Council of Australia [361646, 1054925]; Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112811] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); European Research Council (European Union)(European Research Council (ERC)European Commission); Austrian Industrial Research Promotion Agency; Emerald Foundation (Tarakhovsky laboratory); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kostanova Poliakova for technical assistance; K. Aumayr and colleagues for sorting by flow cytometry; K. Mechtler and colleagues for mass spectrometry; A. Sommer and colleagues for Illumina sequencing at the Vienna Biocenter Core Facility; H. Ekker for bioinformatics processing of ATAC-seq data; R. Kingston (Massachusetts General Hospital) for antibody to Brgl; and T. Jenuwein (Max Planck Institute of Immunobiology and Epigenetics, Freiburg) for antibody to H3K27me3. Supported by Boehringer Ingelheim, the European Research Council (European Union Seventh Framework Program: 291740-LymphoControl), the Austrian Industrial Research Promotion Agency, the Emerald Foundation (Tarakhovsky laboratory), the National Health and Medical Research Council of Australia (361646 and 1054925 for the Nutt laboratory) and the Multiple Myeloma Research Foundation (for the Nutt laboratory).	Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Benson MJ, 2012, P NATL ACAD SCI USA, V109, P16252, DOI 10.1073/pnas.1214414109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Jackson JT, 2015, BLOOD, V125, P803, DOI 10.1182/blood-2014-06-579813; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Park KS, 2014, J IMMUNOL, V193, P4663, DOI 10.4049/jimmunol.1401608; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Schulz D, 2012, J EXP MED, V209, P187, DOI 10.1084/jem.20110645; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Taubenheim N, 2012, J IMMUNOL, V189, P3328, DOI 10.4049/jimmunol.1201042; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846	53	196	200	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					331	343		10.1038/ni.3349	http://dx.doi.org/10.1038/ni.3349			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26779602	Green Accepted			2022-12-18	WOS:000370469300018
J	da Silva, RB; Laird, ME; Yatim, N; Fiette, L; Ingersoll, MA; Albert, ML				da Silva, Rosa Barreira; Laird, Melissa E.; Yatim, Nader; Fiette, Laurence; Ingersoll, Molly A.; Albert, Matthew L.			Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy	NATURE IMMUNOLOGY			English	Article							CD26/DIPEPTIDYL PEPTIDASE-IV; POSTTRANSLATIONAL MODIFICATION; CHEMOKINE ACTIVITY; CD26 EXPRESSION; CXCL10; CELLS; CANCER; ACTIVATION; TRUNCATION; PROTEINS	The success of antitumor immune responses depends on the infiltration of solid tumors by effector T cells, a process guided by chemokines. Here we show that in vivo post-translational processing of chemokines by dipeptidylpeptidase 4 (DPP4, also known as CD26) limits lymphocyte migration to sites of inflammation and tumors. Inhibition of DPP4 enzymatic activity enhanced tumor rejection by preserving biologically active CXCL10 and increasing trafficking into the tumor by lymphocytes expressing the counter-receptor CXCR3. Furthermore, DPP4 inhibition improved adjuvant-based immunotherapy, adoptive T cell transfer and checkpoint blockade. These findings provide direct in vivo evidence for control of lymphocyte trafficking via CXCL10 cleavage and support the use of DPP4 inhibitors for stabilizing biologically active forms of chemokines as a strategy to enhance tumor immunotherapy.	[da Silva, Rosa Barreira; Laird, Melissa E.; Yatim, Nader; Ingersoll, Molly A.; Albert, Matthew L.] Inst Pasteur, Lab Dendrit Cell Immunobiol, Paris, France; [da Silva, Rosa Barreira; Laird, Melissa E.; Yatim, Nader; Ingersoll, Molly A.; Albert, Matthew L.] INSERM U818, Paris, France; [Fiette, Laurence] Inst Pasteur, Human Histopathol & Anim Models, Paris, France; [Fiette, Laurence] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Albert, ML (corresponding author), Inst Pasteur, Lab Dendrit Cell Immunobiol, Paris, France.	albertm@pasteur.fr	Albert, Matthew L/C-9782-2009	Yatim, Nader/0000-0001-5326-1624	Institut Pasteur (Pasteur-Roux post-doctoral fellowship); Pasteur Foundation; Ligue Contre le Cancer; Fondation ARC pour la recherche sur le cancer; French government's Invest in the Future Program	Institut Pasteur (Pasteur-Roux post-doctoral fellowship); Pasteur Foundation; Ligue Contre le Cancer(Ligue nationale contre le cancer); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); French government's Invest in the Future Program	We thank S. Amigorena, P. Bousso, S. Turley and D. DiGregorio for critical reading of the manuscript. We also thank G. Hangoc (Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA) for providing the Dpp4<SUP>-/-</SUP> mice and C. Reis e Sousa (Immunobiology Laboratory, The Francis Crick Institute, London, UK) for the B16F10-OVA tumor cells. We thank M.A. Nicola (Plateforme d'imagerie dynamique, Institut Pasteur, Paris, France) for providing FVB CAG-luciferase transgenic mice. We acknowledge C. Hollande, D. Duffy, A. Casrouge, V. Bondet, V. Mallet, M. Buckwalter, T. Canton, M. A. Nicola and F. Cretien for advice and support. Funding was provided by the Institut Pasteur (Pasteur-Roux post-doctoral fellowship to R.B.d.S.), the Pasteur Foundation (fellowship to M.E.L.), the Ligue Contre le Cancer (M.L.A.), the Fondation ARC pour la recherche sur le cancer (M.L.A.) and the French government's Invest in the Future Program, managed by the Agence Nationale de la Recherche (LabEx Immuno-Onco (R.B.d.S., M.E.L., N.Y., M.A.I. and M.L.A.)).	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Antonsson B, 2010, PROTEOMICS, V10, P4342, DOI 10.1002/pmic.201000331; Arwert EN, 2012, ONCOGENE, V31, P992, DOI 10.1038/onc.2011.298; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; BONGERS J, 1992, BIOCHIM BIOPHYS ACTA, V1122, P147, DOI 10.1016/0167-4838(92)90317-7; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; CARBONE A, 1995, BLOOD, V86, P4617, DOI 10.1182/blood.V86.12.4617.bloodjournal86124617; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Ehlert JE, 1998, J IMMUNOL, V161, P4975; Favre-Kontula L, 2006, J IMMUNOL METHODS, V317, P152, DOI 10.1016/j.jim.2006.10.001; Forssmann U, 2008, J IMMUNOL, V181, P1120, DOI 10.4049/jimmunol.181.2.1120; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gorrell MD, 2006, ADV EXP MED BIOL, V575, P45; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kacar A, 2012, PATHOL ONCOL RES, V18, P25, DOI 10.1007/s12253-011-9412-9; Kajiyama H, 2002, ONCOLOGY-BASEL, V63, P158, DOI 10.1159/000063801; Karagiannis T, 2014, THER ADV DRUG SAF, V5, P138, DOI 10.1177/2042098614523031; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mortier A, 2012, IMMUNOL LETT, V145, P2, DOI 10.1016/j.imlet.2012.04.015; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pashenkov M, 2006, J CLIN ONCOL, V24, P5716, DOI 10.1200/JCO.2006.07.9129; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Ragab D, 2013, CYTOKINE, V63, P105, DOI 10.1016/j.cyto.2013.04.016; Riva A, 2014, HEPATOLOGY, V60, P487, DOI 10.1002/hep.27139; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schmitt TM, 2009, HUM GENE THER, V20, P1240, DOI 10.1089/hum.2009.146; Stecca BA, 1997, J HEPATOL, V27, P337, DOI 10.1016/S0168-8278(97)80180-8; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wilson MJ, 2005, J UROLOGY, V174, P1124, DOI 10.1097/01.ju.0000168621.84017.5c	51	196	199	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					850	+		10.1038/ni.3201	http://dx.doi.org/10.1038/ni.3201			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26075911				2022-12-18	WOS:000358299200012
J	Simon, V; Bloch, N; Landau, NR				Simon, Viviana; Bloch, Nicolin; Landau, Nathaniel R.			Intrinsic host restrictions to HIV-1 and mechanisms of viral escape	NATURE IMMUNOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; AICARDI-GOUTIERES SYNDROME; ANCIENT ADAPTIVE EVOLUTION; TYPE-1 VPU PROTEIN; CBF-BETA; INHIBITS HIV-1; PARTICLE RELEASE; SAMHD1 RESTRICTS; ANTIRETROVIRAL ACTIVITY; PRIMATE LENTIVIRUSES	To replicate in their hosts, viruses have to navigate the complexities of the mammalian cell, co-opting mechanisms of cellular physiology while defeating restriction factors that are dedicated to halting their progression. Primate lentiviruses devote a relatively large portion of their coding capacity to counteracting restriction factors by encoding accessory proteins dedicated to neutralizing the antiviral function of these intracellular inhibitors. Research into the roles of the accessory proteins has revealed the existence of previously undetected intrinsic defenses, provided insight into the evolution of primate lentiviruses as they adapt to new species and uncovered new targets for the development of therapeutics. This Review discusses the biology of the restriction factors APOBEC3, SAMHD1 and tetherin and the viral accessory proteins that counteract them.	[Simon, Viviana] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, Dept Microbiol, New York, NY 10029 USA; [Bloch, Nicolin; Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Icahn School of Medicine at Mount Sinai; New York University	Landau, NR (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	nathaniel.landau@med.nyu.edu	simon, viviana/A-9131-2008	simon, viviana/0000-0002-6416-5096	US National Institutes of Health/National Institute of Allergy and Infectious Disease [AI064001, AI090935, AI067059, AI058864]; Vilcek Fellowship Endowment Fund; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058864, R01AI064001, R01AI067059, P01AI090935] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Allergy and Infectious Disease; Vilcek Fellowship Endowment Fund; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Ooms and L.C.F. Mulder for critical reading of the manuscript. The work was supported by US National Institutes of Health/National Institute of Allergy and Infectious Disease grants to V.S. (AI064001, AI090935) and N.R.L. (AI067059, AI058864), the Vilcek Fellowship Endowment Fund to N.B. and the American Foundation for AIDS Research.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Albin JS, 2014, VIROLOGY, V450, P49, DOI 10.1016/j.virol.2013.11.041; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bobadilla S, 2013, GENE THER, V20, P514, DOI 10.1038/gt.2012.61; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Durand S, 2013, J VIROL, V87, P234, DOI 10.1128/JVI.01459-12; Etienne L, 2013, CELL HOST MICROBE, V14, P85, DOI 10.1016/j.chom.2013.06.002; Fourati S, 2010, AIDS, V24, P2313, DOI 10.1097/QAD.0b013e32833e515a; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hofmann H, 2013, J VIROL, V87, P11741, DOI 10.1128/JVI.02002-13; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Iwabu Yukie, 2010, Commun Integr Biol, V3, P366; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jauregui P., 2015, J VIROL; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Kim EY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004281; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kluge SF, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-32; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Krupp A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003641; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lenzi GM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0111-y; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Mlcochova P, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-25; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Norton TD, 2015, GENE THER, V22, P227, DOI 10.1038/gt.2014.117; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; SAKAI H, 1995, J GEN VIROL, V76, P2717, DOI 10.1099/0022-1317-76-11-2717; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; TRISTEM M, 1990, NATURE, V347, P341, DOI 10.1038/347341b0; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Venkatesh S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003483; Westmoreland SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084463; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019	123	196	201	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					546	553		10.1038/ni.3156	http://dx.doi.org/10.1038/ni.3156			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988886	Green Accepted			2022-12-18	WOS:000354751900002
J	Malin, S; McManus, S; Cobaleda, C; Novatchkova, M; Delogu, A; Bouillet, P; Strasser, A; Busslinger, M				Malin, Stephen; McManus, Shane; Cobaleda, Cesar; Novatchkova, Maria; Delogu, Alessio; Bouillet, Philippe; Strasser, Andreas; Busslinger, Meinrad			Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development	NATURE IMMUNOLOGY			English	Article							LIGHT-CHAIN RECOMBINATION; RECEPTOR-DEFICIENT MICE; MURINE BONE-MARROW; BCL-X; LINEAGE DIFFERENTIATION; LYMPHOID DEVELOPMENT; TRANSCRIPTION; IL-7; INTERLEUKIN-7; ACTIVATION	STAT5 and interleukin 7 (IL-7) signaling are thought to control B lymphopoiesis by regulating the expression of key transcription factors and by activating variable (V-H) gene segments at the immunoglobulin heavy-chain (Igh) locus. Using conditional mutagenesis to delete the gene encoding the transcription factor STAT5, we demonstrate that the development of pro-B cells was restored by transgenic expression of the prosurvival protein Bcl-2, which compensated for loss of the antiapoptotic protein Mcl-1. Expression of the genes encoding the B cell-specification factor EBF1 and the B cell-commitment protein Pax5 as well as V-H gene recombination were normal in STAT5- or IL-7 receptor alpha-chain (IL-7R alpha)-deficient pro-B cells rescued by Bcl-2. STAT5-expressing pro-B cells contained little or no active chromatin at most V-H genes. In contrast, rearrangements of the immunoglobulin-kappa light-chain locus (Igk) were more abundant in STAT5- or IL-7R alpha-deficient pro-B cells. Hence, STAT5 and IL-7 signaling control cell survival and the developmental ordering of immunoglobulin gene rearrangements by suppressing premature Igk recombination in pro-B cells.	[Malin, Stephen; McManus, Shane; Cobaleda, Cesar; Novatchkova, Maria; Delogu, Alessio; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Bouillet, Philippe; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Walter & Eliza Hall Institute	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria.	busslinger@imp.ac.at	Cobaleda, Cesar/D-4668-2011; Busslinger, Meinrad J./J-1249-2016; Strasser, Andreas/C-7581-2013; Delogu, Alessio/F-5033-2010; Bouillet, Philippe/E-1241-2013	Cobaleda, Cesar/0000-0003-3807-9204; Busslinger, Meinrad J./0000-0002-9111-9351; Strasser, Andreas/0000-0002-5020-4891; Delogu, Alessio/0000-0002-4414-4714; Bouillet, Philippe/0000-0002-9012-6058	Boehringer Ingelheim; Austrian Science Fund [P16701-BO9]; Austrian GEN-AU initiative (Bundesminsterium fur Bildung und Wissenschaft); European Union; NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER; Medical Research Council [G9900989] Funding Source: researchfish; MRC [G9900989] Funding Source: UKRI	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian GEN-AU initiative (Bundesminsterium fur Bildung und Wissenschaft); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Hennighausen (National Institutes of Health) for Stat5<SUP>fl/fl</SUP> and Bcl2l1<SUP>fl/fl</SUP> mice; T. Rabbitts (Leeds Institute of Molecular Medicine) for the Rag1<SUP>Cre/Cre</SUP> mouse; J. Adams (Walter and Eliza Hall Institute of Medical Research) for the Vav-Bcl2 mouse; R. Grosschedl (Max-Planck Institute Freiburg) for the Ebf1<SUP>+/-</SUP> mouse; L. Hennighausen, R. Moriggl, T. Decker and A. Rolink for discussions; M. Fuxa for advice on immunoglobulin recombination analysis; A. Ebert for help with ChIP analyses; I. Tamir for bioinformatics analysis of ChIP-on-chip data; and G. Stengl for flow cytometry sorting. Supported by Boehringer Ingelheim, the Austrian Science Fund (P16701-BO9), the Austrian GEN-AU initiative (Bundesminsterium fur Bildung und Wissenschaft) and the European Union Sixth Framework Programme (funding the Epigenome Network of Excellence and a Marie-Curie fellowship to S. Malin).	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Goetz CA, 2005, J IMMUNOL, V174, P7753, DOI 10.4049/jimmunol.174.12.7753; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GRAWUNDER U, 1993, INT IMMUNOL, V5, P1609, DOI 10.1093/intimm/5.12.1609; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hirokawa S, 2003, EUR J IMMUNOL, V33, P1824, DOI 10.1002/eji.200323974; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kieslinger M, 2000, GENE DEV, V14, P232; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8	60	196	202	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					171	U97		10.1038/ni.1827	http://dx.doi.org/10.1038/ni.1827			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	19946273	Green Accepted			2022-12-18	WOS:000273730200015
J	Ledgerwood, LG; Lal, G; Zhang, N; Garin, A; Esses, SJ; Ginhoux, F; Merad, M; Peche, H; Lira, SA; Ding, YZ; Yang, Y; He, XX; Schuchman, EH; Allende, ML; Ochando, JC; Bromberg, JS				Ledgerwood, Levi G.; Lal, Girdhari; Zhang, Nan; Garin, Alexandre; Esses, Steven J.; Ginhoux, Florent; Merad, Miriam; Peche, Helene; Lira, Sergio A.; Ding, Yaozhong; Yang, Yu; He, Xingxuan; Schuchman, Edward H.; Allende, Maria L.; Ochando, Jordi C.; Bromberg, Jonathan S.			The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics	NATURE IMMUNOLOGY			English	Article							ENDOTHELIAL-CELL LINE; TRANSENDOTHELIAL MIGRATION; TRANSCELLULAR MIGRATION; LYMPHOID ORGANS; L-SELECTIN; IN-VIVO; EXPRESSION; TRAFFICKING; SPHINGOSINE-1-PHOSPHATE; ADHESION	Although much is known about the migration of T cells from blood to lymph nodes, less is known about the mechanisms regulating the migration of T cells from tissues into lymph nodes through afferent lymphatics. Here we investigated T cell egress from nonlymphoid tissues into afferent lymph in vivo and developed an experimental model to recapitulate this process in vitro. Agonism of sphingosine 1-phosphate receptor I inhibited the entry of tissue T cells into afferent lymphatics in homeostatic and inflammatory conditions and caused the arrest, mediated at least partially by interactions of the integrin LFA-1 with its ligand ICAM-1 and of the integrin VLA-4 with its ligand VCAM-1, of polarized T cells at the basal surface of lymphatic but not blood vessel endothelium. Thus, the increased sphingosine 1-phosphate present in inflamed peripheral tissues may induce T cell retention and suppress T cell egress.	[Ledgerwood, Levi G.; Lal, Girdhari; Zhang, Nan; Garin, Alexandre; Esses, Steven J.; Ginhoux, Florent; Merad, Miriam; Peche, Helene; Lira, Sergio A.; Ding, Yaozhong; Yang, Yu; Ochando, Jordi C.; Bromberg, Jonathan S.] Mt Sinai Sch Med, Ctr Immunol, Dept Gene & Cell Med, New York, NY 10029 USA; [Yang, Yu] Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA; [Ding, Yaozhong; Yang, Yu; Bromberg, Jonathan S.] Mt Sinai Sch Med, Recanati Miller Transplant Inst, New York, NY 10029 USA; [He, Xingxuan; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; [Allende, Maria L.] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bromberg, JS (corresponding author), Mt Sinai Sch Med, Ctr Immunol, Dept Gene & Cell Med, New York, NY 10029 USA.	Jon.Bromberg@mountsinai.org	Ochando, jordi/ABE-2358-2020; Lal, Girdhari/C-1752-2012; Ochando, Jordi/B-6219-2008; Lal, Girdhari/AAU-8179-2021	Ochando, jordi/0000-0001-7037-1681; Lal, Girdhari/0000-0002-3799-3603; Ochando, Jordi/0000-0001-7037-1681; Lal, Girdhari/0000-0002-3799-3603	NIAID NIH HHS [AI41428, AI62765] Funding Source: Medline; NIDDK NIH HHS [DK67381] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI041428, R01AI062765, R01AI041428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067381] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABELLO PA, 1994, SHOCK, V2, P320, DOI 10.1097/00024382-199411000-00004; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Arbiser JL, 2000, AM J PATHOL, V156, P1469, DOI 10.1016/S0002-9440(10)65015-8; Bachmann C, 2006, GASTROENTEROLOGY, V130, P8, DOI 10.1053/j.gastro.2005.11.009; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Chang VWH, 2001, GENE, V267, P201, DOI 10.1016/S0378-1119(01)00400-0; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dejana E, 2006, NAT CELL BIOL, V8, P105, DOI 10.1038/ncb0206-105; Ebata N, 2001, TISSUE CELL, V33, P211, DOI 10.1054/tice.2000.0158; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; He XX, 2005, ANAL BIOCHEM, V340, P113, DOI 10.1016/j.ab.2005.01.058; Hsu SH, 2005, TOXICOL LETT, V159, P47, DOI 10.1016/j.toxlet.2005.04.012; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kuzmenko ES, 2004, INT J BIOCHEM CELL B, V36, P519, DOI 10.1016/j.biocel.2003.09.010; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OCONNELL KA, 1990, J IMMUNOL, V144, P521; OHH M, 1995, J CELL BIOCHEM, V59, P202, DOI 10.1002/jcb.240590210; Pabst O, 2006, J IMMUNOL, V176, P1474, DOI 10.4049/jimmunol.176.3.1474; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Perez VL, 1998, CELL IMMUNOL, V189, P31, DOI 10.1006/cimm.1998.1362; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sasaki M, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-3; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Sironi M, 2006, CELL TISSUE RES, V325, P91, DOI 10.1007/s00441-006-0171-y; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; White SJ, 2004, CIRCULATION, V109, P513, DOI 10.1161/01.CIR.0000109697.68832.5D; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Xu JC, 1996, J EXP MED, V183, P589, DOI 10.1084/jem.183.2.589; Yamaguchi H, 2003, BIOCHEM J, V374, P715, DOI 10.1042/BJ20030381; Yopp AC, 2005, J IMMUNOL, V175, P2913, DOI 10.4049/jimmunol.175.5.2913	50	196	199	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					42	53		10.1038/ni1534	http://dx.doi.org/10.1038/ni1534			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18037890				2022-12-18	WOS:000251820800010
J	Kedl, RM; Schaefer, BC; Kappler, JW; Marrack, P				Kedl, RM; Schaefer, BC; Kappler, JW; Marrack, P			T cells down-modulate peptide-MHC complexes on APCs in vivo	NATURE IMMUNOLOGY			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; CLASS-I; VIRUS-INFECTION; PRESENTING CELLS; RECEPTOR; IMMUNODOMINANCE; REPERTOIRE; SELECTION; RESPONSES; POPULATIONS	T cells compete in the response to antigen in vivo and this competition may drive the affinity maturation of a secondary T cell response. Here we show that high-affinity T cells out-competed lower affinity T cells during a response to antigenic challenge in vivo. Although competition between T cells specific for different peptide-major histocompatibility complexes (MHC) occurred, it was less efficient than competition between T cells of the same peptide-MHC specificity. In addition, high-affinity T cells efficiently induced antigen loss from the surface of antigen-presenting cells. Thus T cells that responded to the same peptide-MHC competed with each other by lowering the amount of ligand with which the cells could react. As a result, the activation of high-affinity cells was favored. This provides a mechanism for the affinity maturation of a secondary T cell response.	NatlJewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; NatlJewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kedl, RM (corresponding author), 3M Pharmaceut, 3M Ctr, Bldg 270-02-S-06, St Paul, MN 55144 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Schaefer, Brian C/0000-0001-8877-3507	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R01AI018785, R37AI017134, P01AI022295, R37AI018785, R56AI017134] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22295, AI17134, AI18785] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; COLE GA, 1994, INT IMMUNOL, V6, P1767, DOI 10.1093/intimm/6.11.1767; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fasso M, 2000, J EXP MED, V192, P1719, DOI 10.1084/jem.192.12.1719; Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO;2-B; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HORWITZ MS, 1994, J VIROL, V68, P352, DOI 10.1128/JVI.68.1.352-357.1994; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MCMICHAEL AJ, 1977, ARTHRITIS RHEUM, V20, P1037, DOI 10.1002/art.1780200501; Mitchell T, 1999, J IMMUNOL, V162, P4527; Pion S, 1997, EUR J IMMUNOL, V27, P421, DOI 10.1002/eji.1830270212; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SCHAEFER BC, 2001, UNPUB OBSERVATION AN; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Taams LS, 1998, EUR J IMMUNOL, V28, P2902, DOI 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B; Udaka K, 1996, J IMMUNOL, V157, P670; van Bergen J, 2001, EUR J IMMUNOL, V31, P646, DOI 10.1002/1521-4141(200102)31:2<646::AID-IMMU646>3.0.CO;2-5; Wolpert EZ, 1998, J IMMUNOL, V161, P4499; Yee C, 1999, J IMMUNOL, V162, P2227	33	196	199	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					27	32		10.1038/ni742	http://dx.doi.org/10.1038/ni742			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11731800				2022-12-18	WOS:000173148700011
J	Pfeifle, R; Rothe, T; Ipseiz, N; Scherer, HU; Culemann, S; Harre, U; Ackermann, JA; Seefried, M; Kleyer, A; Uderhardt, S; Haugg, B; Huebert, AJ; Daum, P; Heidkamp, GF; Ge, CR; Bohm, S; Lux, A; Schuh, W; Magorivskal, I; Nandakumar, KS; Lonnblom, E; Becker, C; Dudziak, D; Wuhrer, M; Rombouts, Y; Koeleman, CA; Toes, R; Winkler, TH; Holmdahl, R; Herrmann, M; Bluml, S; Nimmerjahn, F; Schett, G; Kronke, G				Pfeifle, Rene; Rothe, Tobias; Ipseiz, Natacha; Scherer, Hans U.; Culemann, Stephan; Harre, Ulrike; Ackermann, Jochen A.; Seefried, Martina; Kleyer, Arnd; Uderhardt, Stefan; Haugg, Benjamin; Huebert, Axel J.; Daum, Patrick; Heidkamp, Gordon F.; Ge, Changrong; Boehm, Sybille; Lux, Anja; Schuh, Wolfgang; Magorivskal, Iryna; Nandakumar, Kutty S.; Loennblom, Erik; Becker, Christoph; Dudziak, Diana; Wuhrer, Manfred; Rombouts, Yoann; Koeleman, Carolien A.; Toes, Rene; Winkler, Thomas H.; Holmdahl, Rikard; Herrmann, Martin; Blueml, Stephan; Nimmerjahn, Falk; Schett, Georg; Kroenke, Gerhard			Regulation of autoantibody activity by the IL-23-T(H)17 axis determines the onset of autoimmune disease	NATURE IMMUNOLOGY			English	Article							COLLAGEN-INDUCED ARTHRITIS; CITRULLINATED PROTEIN ANTIBODIES; RHEUMATOID-ARTHRITIS; TH17 CELLS; INDUCTION; MICE; RESPONSES; ANTIGENS; PEPTIDE; FUTURE	The checkpoints and mechanisms that contribute to autoantibody-driven disease are as yet incompletely understood. Here we identified the axis of interleukin 23 (IL-23) and the T(H)17 subset of helper T cells as a decisive factor that controlled the intrinsic inflammatory activity of autoantibodies and triggered the clinical onset of autoimmune arthritis. By instructing B cells in an IL-22- and IL-21-dependent manner, T(H)17 cells regulated the expression of beta-galactoside alpha 2,6-sialyltransferase 1 in newly differentiating antibody-producing cells and determined the glycosylation profile and activity of immunoglobulin G (IgG) produced by the plasma cells that subsequently emerged. Asymptomatic humans with rheumatoid arthritis (RA)-specific autoantibodies showed identical changes in the activity and glycosylation of autoreactive IgG antibodies before shifting to the inflammatory phase of RA; thus, our results identify an IL-23-T(H)17 cell-dependent pathway that controls autoantibody activity and unmasks a preexisting breach in immunotolerance.	[Pfeifle, Rene; Rothe, Tobias; Ipseiz, Natacha; Culemann, Stephan; Harre, Ulrike; Ackermann, Jochen A.; Kleyer, Arnd; Uderhardt, Stefan; Haugg, Benjamin; Huebert, Axel J.; Magorivskal, Iryna; Herrmann, Martin; Schett, Georg; Kroenke, Gerhard] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Pfeifle, Rene; Rothe, Tobias; Ipseiz, Natacha; Culemann, Stephan; Harre, Ulrike; Ackermann, Jochen A.; Kleyer, Arnd; Uderhardt, Stefan; Haugg, Benjamin; Huebert, Axel J.; Magorivskal, Iryna; Herrmann, Martin; Schett, Georg; Kroenke, Gerhard] Univ Hosp Erlangen, Inst Clin Immunol, Erlangen, Germany; [Pfeifle, Rene; Rothe, Tobias; Ipseiz, Natacha; Culemann, Stephan; Ackermann, Jochen A.; Seefried, Martina; Uderhardt, Stefan; Haugg, Benjamin; Daum, Patrick; Schuh, Wolfgang; Winkler, Thomas H.; Kroenke, Gerhard] Friedrich Alexander Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Erlangen, Germany; [Scherer, Hans U.; Rombouts, Yoann; Toes, Rene] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Seefried, Martina; Boehm, Sybille; Lux, Anja; Winkler, Thomas H.; Nimmerjahn, Falk] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Inst Genet, Erlangen, Germany; [Daum, Patrick; Schuh, Wolfgang] Univ Hosp Erlangen, Dept Internal Med 3, Div Mol Immunol, Erlangen, Germany; [Heidkamp, Gordon F.; Dudziak, Diana] Univ Hosp Erlangen, Dept Dermatol, Lab Dendrit Cell Biol, Erlangen, Germany; [Ge, Changrong; Nandakumar, Kutty S.; Loennblom, Erik; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Med Inflammat Res, Stockholm, Sweden; [Becker, Christoph] Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany; [Wuhrer, Manfred; Rombouts, Yoann; Koeleman, Carolien A.] Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands; [Rombouts, Yoann] Univ Toulouse, CNRS, UPS, Inst Pharmacol & Biol Struct, Toulouse, France; [Blueml, Stephan] Med Univ Vienna, Internal Med 3, Div Rheumatol, Vienna, Austria	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Karolinska Institutet; University of Erlangen Nuremberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Medical University of Vienna	Kronke, G (corresponding author), Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany.; Kronke, G (corresponding author), Univ Hosp Erlangen, Inst Clin Immunol, Erlangen, Germany.; Kronke, G (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Erlangen, Germany.	gerhard.kroenke@uk-erlangen.de	Mahorivska, Iryna/AAJ-1060-2020; Becker, Christoph/L-2996-2016; Scherer, Hans Ulrich/F-4350-2016; herrmann, martin/AAT-9836-2020; Culemann, Stephan/AAW-2778-2021; Herrmann, Martin/A-9597-2013; Uderhardt, Stefan/AAA-5224-2022; Holmdahl, Rikard/AAI-7682-2020; Krönke, Gerhard/C-6615-2014; Kleyer, Arnd/AAU-2689-2021; Nandakumar, Kutty Selva/D-5438-2011; Ipseiz, Natacha/AAG-6390-2019; Wuhrer, Manfred/ABE-9168-2020; Dudziak, Diana/B-2432-2017; Becker, Christoph/A-6694-2008	Culemann, Stephan/0000-0001-9837-2811; Herrmann, Martin/0000-0002-0258-2484; Uderhardt, Stefan/0000-0002-2489-2109; Krönke, Gerhard/0000-0002-7566-4325; Kleyer, Arnd/0000-0002-2026-7728; Nandakumar, Kutty Selva/0000-0001-7790-8197; Ipseiz, Natacha/0000-0001-5008-8889; Wuhrer, Manfred/0000-0002-0814-4995; Bluml, Stephan/0000-0002-2758-4400; Lonnblom, Erik/0000-0002-1311-2541; Steffen, Ulrike/0000-0003-2934-3202; Rombouts, Yoann/0000-0003-4482-2199; Toes, Rene/0000-0002-9618-6414; Scherer, Hans Ulrich/0000-0002-5700-5617; Dudziak, Diana/0000-0001-9358-134X; Lux, Anja/0000-0001-9475-2147; Becker, Christoph/0000-0002-1388-1041; Hueber, Axel/0000-0001-6454-1234	Deutsche Forschungsgemeinschaft [CRC1181, SPP1468-IMMUNOBONE, CRC643]; European Union [ERC StG 640087 - SOS]; European Union (MASTERSWITCH project); European Union (BTCure); Interdisciplinary Centre for Clinical Research, Erlangen [IZKF A55, A68]; Bundesministerium fur Bildung und Forschung (METARTHROS); Else-Kroner Fresenius Stiftung [2013_A274]; ELAN Fonds of the Universiatatsklinikum Erlangen [14-10-17-1]; Strategic Science Foundation; KAWallenberg Fondation; Bavarian Genome Network (BayGene)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); European Union (MASTERSWITCH project); European Union (BTCure); Interdisciplinary Centre for Clinical Research, Erlangen; Bundesministerium fur Bildung und Forschung (METARTHROS)(Federal Ministry of Education & Research (BMBF)); Else-Kroner Fresenius Stiftung; ELAN Fonds of the Universiatatsklinikum Erlangen; Strategic Science Foundation; KAWallenberg Fondation; Bavarian Genome Network (BayGene)	We thank C. Stoll, A. Klej and U. Appelt for technical assistance; Boehringer-Ingelheim for the fully mouse antibody to mouse IL-23p19; MD Bioscience for the collagen-antibody-induced arthritis 'cocktail'; and K. Ralph, D. Souza and G. Nabozny (Boehringer Ingelheim Pharmaceuticals) for technical advice and monoclonal antibody to anti-IL23. Supported by Deutsche Forschungsgemeinschaft (CRC1181 to G.K., G.S., F.N., C.B. and D.D.; SPP1468-IMMUNOBONE to G.K., G.S. and F.N.; and CRC643 to G.S., F.N. and D.D.), the European Union (ERC StG 640087 - SOS to G.K.; MASTERSWITCH project to G.S.; and BTCure to G.S. and CB.), the Interdisciplinary Centre for Clinical Research, Erlangen (IZKF A55 to G.K.; and A68 to G.K. and F.N.), the Bundesministerium fur Bildung und Forschung (METARTHROS to G.K. and G.S.), the Else-Kroner Fresenius Stiftung (2013_A274 to G.K.), the ELAN Fonds of the Universiatatsklinikum Erlangen (14-10-17-1 to G.H.), the Strategic Science Foundation (R.H.), the KAWallenberg Fondation (R.H.) and the Bavarian Genome Network (BayGene to D.D.).	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Berglin E, 2004, ARTHRITIS RES THER, V6, pR303, DOI 10.1186/ar1187; Cornelissen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057553; Corrigall VM, 2002, CRIT REV IMMUNOL, V22, P281; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Hess C, 2013, J CLIN INVEST, V123, P3788, DOI 10.1172/JCI65938; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037; Pollinger B, 2012, J MOL MED, V90, P613, DOI 10.1007/s00109-011-0841-4; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Renato GM, 2009, ANN NY ACAD SCI, V1173, P729, DOI 10.1111/j.1749-6632.2009.04626.x; Rombouts Y, 2015, ANN RHEUM DIS, V74, P234, DOI 10.1136/annrheumdis-2013-203565; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Shiozawa K, 2012, J RHEUMATOL, V39, P694, DOI 10.3899/jrheum.111152; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Ursum J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2907; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341	31	195	205	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					104	113		10.1038/ni.3579	http://dx.doi.org/10.1038/ni.3579			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27820809	Green Published, Green Accepted			2022-12-18	WOS:000390080000015
J	Bautista, JL; Lio, CWJ; Lathrop, SK; Forbush, K; Liang, YQ; Luo, JQ; Rudensky, AY; Hsieh, CS				Bautista, Jhoanne L.; Lio, Chan-Wang J.; Lathrop, Stephanie K.; Forbush, Katherine; Liang, Yuqiong; Luo, Jingqin; Rudensky, Alexander Y.; Hsieh, Chyi-Song			Intraclonal competition limits the fate determination of regulatory T cells in the thymus	NATURE IMMUNOLOGY			English	Article							RECEPTOR TRANSGENIC MICE; HOMEOSTATIC PROLIFERATION; POSITIVE SELECTION; IN-VIVO; SELF; ANTIGEN; AUTOIMMUNITY; FOXP3; EXPRESSION; NAIVE	Because the deletion of self-reactive T cells is incomplete, thymic development of natural Foxp3(+)CD4(+) regulatory T cells (T(reg) cells) is required for preventing autoimmunity. However, the function of T cell antigen receptor (TCR) specificity in thymic T(reg) cell development remains controversial. To address this issue, we generated a transgenic line expressing a naturally occurring T(reg) cell-derived TCR. Unexpectedly, we found that efficient thymic T(reg) cell development occurred only when the antigen-specific T(reg) cell precursors were present at low clonal frequency (< 1%) in a normal thymus. Using retroviral vectors and bone marrow chimeras, we observed similar activity with two other T(reg) cell-derived TCRs. Our data demonstrate that thymic T(reg) cell development is a 'TCR-instructive' process involving a niche that can be saturable at much lower clonal frequencies than is the niche for positive selection.	[Bautista, Jhoanne L.; Lio, Chan-Wang J.; Lathrop, Stephanie K.; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Forbush, Katherine; Liang, Yuqiong; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Forbush, Katherine; Liang, Yuqiong; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Luo, Jingqin] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	chsieh@dom.wustl.edu		Lio, Jerry/0000-0003-3876-6741; Bautista, Jhoanne/0000-0002-8984-1361	Arthritis Foundation; Burroughs Wellcome Fund; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079187, R01AI061478, R21AI071046] Funding Source: NIH RePORTER	Arthritis Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Santacruz and J. Hunn for technical assistance, and K. Murphy, W. Yokoyama, P. Allen, W. Swat, J. Scott-Brown and J. Fontenot for discussions and critical review of the manuscript. Supported by the Arthritis Foundation, Burroughs Wellcome Fund and the US National Institutes of Health (C.-S.H.).	Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Canelles M, 2003, NAT IMMUNOL, V4, P756, DOI 10.1038/ni953; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gough PJ, 2003, BLOOD, V101, P485, DOI 10.1182/blood-2002-07-2131; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Romagnoli P, 2005, J IMMUNOL, V175, P5751, DOI 10.4049/jimmunol.175.9.5751; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Troy AE, 2003, J IMMUNOL, V170, P672, DOI 10.4049/jimmunol.170.2.672; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; You S, 2004, P NATL ACAD SCI USA, V101, P14580, DOI 10.1073/pnas.0404870101; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	45	195	196	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					610	U74		10.1038/ni.1739	http://dx.doi.org/10.1038/ni.1739			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19430476	Green Accepted			2022-12-18	WOS:000266384100013
J	Leikina, E; Delanoe-Ayari, H; Melikov, K; Cho, MS; Chen, A; Waring, AJ; Wang, W; Xie, YM; Loo, JA; Lehrer, RI; Chernomordik, LV				Leikina, E; Delanoe-Ayari, H; Melikov, K; Cho, MS; Chen, A; Waring, AJ; Wang, W; Xie, YM; Loo, JA; Lehrer, RI; Chernomordik, LV			Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins	NATURE IMMUNOLOGY			English	Article							SEMLIKI-FOREST-VIRUS; INFLUENZA-A VIRUS; BIOLOGICAL-MEMBRANES; THETA-DEFENSINS; EARLY-STAGE; HEMAGGLUTININ; CELLS; PH; PROTEIN; LECTIN	Defensins are peptides that protect the host against microorganisms. Here we show that the theta-defensin retrocyclin 2 (RC2) inhibited influenza virus infection by blocking membrane fusion mediated by the viral hemagglutinin. RC2 was effective even after hemagglutinin attained a fusogenic conformation or had induced membrane hemifusion. RC2, a multivalent lectin, prevented hemagglutinin-mediated fusion by erecting a network of crosslinked and immobilized surface glycoproteins. RC2 also inhibited fusion mediated by Sindbis virus and baculovirus. Human beta-defensin 3 and mannan-binding lectin also blocked viral fusion by creating a protective barricade of immobilized surface proteins. This general mechanism might explain the broad-spectrum antiviral activity of many multivalent lectins of the innate immune system.	NICHHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Biochem & Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chernomordik, LV (corresponding author), NICHHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov	Melikov, Kamran/A-6604-2009; Delanoe-ayari, Helene/A-2085-2013	Delanoe-ayari, Helene/0000-0002-8658-3942	Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [RR 20004] Funding Source: Medline; NIAID NIH HHS [AI056921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001501] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056921, R21AI056921] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; CHERNOMORDIK L, 1995, J VIROL, V69, P3049, DOI 10.1128/JVI.69.5.3049-3058.1995; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DOXSEY SJ, 1985, J CELL BIOL, V101, P19, DOI 10.1083/jcb.101.1.19; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; ETCHISON J, 1971, J VIROL, V7, P155, DOI 10.1128/JVI.7.1.155-167.1971; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GOLAN DE, 1986, J CELL BIOL, V103, P819, DOI 10.1083/jcb.103.3.819; HIERHOLZER JC, 1993, J CLIN MICROBIOL, V31, P1504, DOI 10.1128/JCM.31.6.1504-1510.1993; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Kandel R, 2005, EXPERT OPIN THER TAR, V9, P1, DOI 10.1517/14728222.9.1.1; Kase T, 1999, IMMUNOLOGY, V97, P385; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Korte T, 1997, J BIOL CHEM, V272, P9764; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359; Leikina E, 2004, J BIOL CHEM, V279, P26526, DOI 10.1074/jbc.M401883200; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Mahy BWJ, 1996, VIROLOGY METHODS MAN; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Paterson RG, 1993, MOL VIROLOGY PRACTIC, P35; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/01.aids.0000096878.73209.4f, 10.1097/00002030-200311070-00001]; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sawaki K, 2002, ANTICANCER RES, V22, P2103; SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409; SCHOCH C, 1992, FEBS LETT, V311, P221, DOI 10.1016/0014-5793(92)81107-W; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Tecle T, 2005, CURR RESPIR MED REV, V1, P127, DOI 10.2174/1573398054023073; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zaitseva E, 2005, J CELL BIOL, V169, P167, DOI 10.1083/jcb.200412059	50	195	218	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					995	1001		10.1038/ni1248	http://dx.doi.org/10.1038/ni1248			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16155572				2022-12-18	WOS:000232027200018
J	Yan, MH; Marsters, SA; Grewal, IS; Wang, H; Ashkenazi, A; Dixit, VM				Yan, MH; Marsters, SA; Grewal, IS; Wang, H; Ashkenazi, A; Dixit, VM			Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; GERMINAL CENTER FORMATION; HYPER-IGM SYNDROME; HERPESVIRUS ENTRY MEDIATOR; T-CELL ACTIVATION; NF-KAPPA-B; CD40 LIGAND; AFFINITY MATURATION; FACTOR FAMILY; DEATH-DOMAIN	B lymphocyte stimulator (BLyS) is a member of the tumor necrosis factor (TNF) superfamily. BLyS stimulates proliferation of, and immunoglobulin production by, B cells. However, the relative importance of BLyS in physiological B cell activation is unclear. We identified a B cell receptor for BLyS through expression cloning as TACI, an orphan TNF receptor homologue of unknown function. Binding of BLyS to TACI activated signaling by nuclear factor-kappa B (NF-kappa). In vitro soluble TACI-Fc fusion protein blocked BLyS-induced NF-kappa B activation in B lymphoma cells and IgM production in peripheral blood B cells. In vivo treatment of immunized mice with TACI-Fc inhibited production of antigen-specific IgM and IgG I antibodies and abolished splenic germinal center (GC) formation.-rhus, BLyS activity must play a critical role in the humoral immune response.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Ashkenazi, Avi/ABG-2712-2020	dixit, vishva m/0000-0001-6983-0326; Ashkenazi, Avi/0000-0002-6890-4589; Grewal, Iqbal S/0000-0002-4775-055X				ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; ASHKENAZI A, 1991, P NATL ACAD SCI USA, V88, P10535, DOI 10.1073/pnas.88.23.10535; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; GRAY D, 1988, IMMUNOLOGY, V65, P73; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; HAN SH, 1995, J IMMUNOL, V155, P556; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; KAHRE SD, 2000, P NATL ACAD SCI USA, V97, P3372; Kato J, 1998, J IMMUNOL, V160, P4788; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PITTI RM, 1996, J BIOL CHEM, V271, P12697; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	42	195	221	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					37	41		10.1038/76889	http://dx.doi.org/10.1038/76889			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881172				2022-12-18	WOS:000089814800011
J	Ranf, S; Gisch, N; Schaffer, M; Illig, T; Westphal, L; Knirel, YA; Sanchez-Carballo, PM; Zahringer, U; Huckelhoven, R; Lee, J; Scheel, D				Ranf, Stefanie; Gisch, Nicolas; Schaeffer, Milena; Illig, Tina; Westphal, Lore; Knirel, Yuriy A.; Sanchez-Carballo, Patricia M.; Zaehringer, Ulrich; Hueckelhoven, Ralph; Lee, Justin; Scheel, Dierk			A lectin S-domain receptor kinase mediates lipopolysaccharide sensing in Arabidopsis thaliana	NATURE IMMUNOLOGY			English	Article							PLANT INNATE IMMUNITY; GENE FAMILY; PATTERN; RECOGNITION; ELICITORS; RESPONSES; ANIMALS; LPS	The sensing of microbe-associated molecular patterns (MAMPs) triggers innate immunity in animals and plants. Lipopolysaccharide (LPS) from Gram-negative bacteria is a potent MAMP for mammals, with the lipid A moiety activating proinflammatory responses via Toll-like receptor 4 (TLR4). Here we found that the plant Arabidopsis thaliana specifically sensed LPS of Pseudomonas and Xanthomonas. We isolated LPS-insensitive mutants defective in the bulb-type lectin S-domain-1 receptor-like kinase LORE (SD1-29), which were hypersusceptible to infection with Pseudomonas syringae. Targeted chemical degradation of LPS from Pseudomonas species suggested that LORE detected mainly the lipid A moiety of LPS. LORE conferred sensitivity to LPS onto tobacco after transient expression, which demonstrated a key function in LPS sensing and indicated the possibility of engineering resistance to bacteria in crop species.	[Ranf, Stefanie; Westphal, Lore; Lee, Justin; Scheel, Dierk] Leibniz Inst Plant Biochem, Stress & Dev Biol, Halle, Germany; [Ranf, Stefanie; Schaeffer, Milena; Illig, Tina; Hueckelhoven, Ralph] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Phytopathol, Freising Weihenstephan, Germany; [Gisch, Nicolas; Sanchez-Carballo, Patricia M.; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Div Immunochem Bioanalyt Chem, Prior Area Infect, Res Ctr Borstel, Borstel, Germany; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinskii Organ Chem Inst, Moscow, Russia	Leibniz Institut fur Pflanzenbiochemie; Technical University of Munich; Forschungszentrum Borstel; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Ranf, S (corresponding author), Leibniz Inst Plant Biochem, Stress & Dev Biol, Halle, Germany.	ranf@wzw.tum.de	Knirel, Yuriy A/E-2058-2014; Ranf, Stefanie/J-2474-2016; Lee, Justin/B-6096-2012; Huckelhoven, Ralph/H-6676-2013	Ranf, Stefanie/0000-0003-2262-2938; Lee, Justin/0000-0001-8269-7494; Huckelhoven, Ralph/0000-0001-5632-5451; Gisch, Nicolas/0000-0003-3260-5269; Sanchez Carballo, Patricia M./0000-0003-1061-7023	German Research Foundation [SPP1212, SFB924/TP-B10]	German Research Foundation(German Research Foundation (DFG))	We thank W. Bitter (Utrecht University) for P. alcaligenes 537 bacterial mass; B.A. Dmitriev (Gamaleya Research Institute of Epidemiology and Microbiology) for LPS of P. aeruginosa Fisher type 1; E. Glawischnig (TU Munchen) for E. salsugineum ecotype Shandong plants; K. Kawahara (The Kitasato Institute) for LPS of Burkholderia species; M. Knight (Durham University) for Col-0<SUP>AEQ</SUP> A. thaliana; U. Mamat (Research Center Borstel) for E. coli strain KPM 53; M. Quint (IPB Halle) for C. rubella seeds; K. Rudolph (Universitat Gottingen) for P. syringe pv. apii bacterial mass; S.N. Senchenkova for the isolation of X. campestris LPS; G. Stacey (University of Missouri) for T-DNA-insertion lines cerk1-2 and lyk4; C. Hemetsberger for assistance with confocal imaging; N. Bauer, B. Buske, B. Kolbl, B. Kunz, H. Moll and U. Schombel for technical assistance; H. Schempp for discussions; and C. Schwechheimer for critical reading of the manuscript. Supported by the German Research Foundation (through Priority Program SPP1212 to J.L. and D.S.; and Collaborative Research Centre SFB924/TP-B10 to S.R.).	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1177/09680519010070030101; Bedini E, 2005, J AM CHEM SOC, V127, P2414, DOI 10.1021/ja0452166; Bitter W, 2007, J BACTERIOL, V189, P2967, DOI 10.1128/JB.01583-06; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Carballo PMS, 1999, EUR J BIOCHEM, V261, P500, DOI 10.1046/j.1432-1327.1999.00299.x; Ciesielski F, 2013, BBA-BIOMEMBRANES, V1828, P1731, DOI 10.1016/j.bbamem.2013.03.029; Ciesielski F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038677; Ittig S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002667; Ivanov R, 2010, TRENDS PLANT SCI, V15, P387, DOI 10.1016/j.tplants.2010.04.010; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Kocincova D, 2011, BIOCHEMISTRY-MOSCOW+, V76, P755, DOI 10.1134/S0006297911070054; Madala NE, 2012, INNATE IMMUN-LONDON, V18, P140, DOI 10.1177/1753425910392609; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; Mclsaac S. M., 2012, J LEUKOCYTE BIOL, DOI [10.1189/jIb.0811410, DOI 10.1189/JIB.0811410]; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Ranf S, 2012, MOL PLANT, V5, P115, DOI 10.1093/mp/ssr064; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Vaid N, 2012, PLANT MOL BIOL, V80, P365, DOI 10.1007/s11103-012-9952-8; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Xing SL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-69; Zahringer U, 2014, J BIOL CHEM, V289, P23963, DOI 10.1074/jbc.M114.571489; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	40	194	213	6	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					426	433		10.1038/ni.3124	http://dx.doi.org/10.1038/ni.3124			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25729922				2022-12-18	WOS:000351333700015
J	Hammer, GE; Turer, EE; Taylor, KE; Fang, CJ; Advincula, R; Oshima, S; Barrera, J; Huang, EJ; Hou, B; Malynn, BA; Reizis, B; DeFranco, A; Criswell, LA; Nakamura, MC; Ma, A				Hammer, Gianna Elena; Turer, Emre E.; Taylor, Kimberly E.; Fang, Celia J.; Advincula, Rommel; Oshima, Shigeru; Barrera, Julio; Huang, Eric J.; Hou, Baidong; Malynn, Barbara A.; Reizis, Boris; DeFranco, Anthony; Criswell, Lindsey A.; Nakamura, Mary C.; Ma, Averil			Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; GENOME-WIDE ASSOCIATION; INFLAMMATORY DISEASE; IN-VIVO; ANKYLOSING-SPONDYLITIS; PERIPHERAL TOLERANCE; ADAPTIVE IMMUNITY	Dendritic cells (DCs), which are known to support immune activation during infection, may also regulate immune homeostasis in resting animals. Here we show that mice lacking the ubiquitin-editing molecule A20 specifically in DCs spontaneously showed DC activation and population expansion of activated T cells. Analysis of DC-specific epistasis in compound mice lacking both A20 and the signaling adaptor MyD88 specifically in DCs showed that A20 restricted both MyD88-independent signals, which drive activation of DCs and T cells, and MyD88-dependent signals, which drive population expansion of T cells. In addition, mice lacking A20 specifically in DCs spontaneously developed lymphocyte-dependent colitis, seronegative ankylosing arthritis and enthesitis, conditions stereotypical of human inflammatory bowel disease (IBD). Our findings indicate that DCs need A20 to preserve immune quiescence and suggest that A20-dependent DC functions may underlie IBD and IBD-associated arthritides.	[Hammer, Gianna Elena; Turer, Emre E.; Taylor, Kimberly E.; Fang, Celia J.; Advincula, Rommel; Oshima, Shigeru; Barrera, Julio; Huang, Eric J.; Malynn, Barbara A.; Criswell, Lindsey A.; Nakamura, Mary C.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94080 USA; [Fang, Celia J.] San Francisco VA Med Ctr, San Francisco, CA USA; [Huang, Eric J.; Nakamura, Mary C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Huang, Eric J.; Nakamura, Mary C.] VA Med Ctr, Pathol Serv, San Francisco, CA USA; [Hou, Baidong; DeFranco, Anthony] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Reizis, Boris] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94080 USA.	averil.ma@ucsf.edu	Nakamura, Mary/ABI-2887-2020; Huang, Eric J./AAH-7997-2019; Oshima, Shigeru/C-9865-2015	Nakamura, Mary/0000-0001-8127-9426; Huang, Eric J./0000-0002-5381-3801; Oshima, Shigeru/0000-0003-1186-9177; Reizis, Boris/0000-0003-1140-7853; Hammer, Gianna/0000-0001-6959-858X; Hou, Baidong/0000-0002-0892-0181	US National Institutes of Health; Crohn's and Colitis Foundation of America; Damon Runyon Cancer Research Foundation; Kenneth Rainin Foundation; UCSF Liver Center; Wellcome Trust [076113, 085475]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939, R01DK095693, T32DK007007] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Damon Runyon Cancer Research Foundation; Kenneth Rainin Foundation; UCSF Liver Center; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (A. M.), The Crohn's and Colitis Foundation of America (A. M. and S.O.), The Damon Runyon Cancer Research Foundation (G. E. H.), the Kenneth Rainin Foundation and the UCSF Liver Center and the Wellcome Trust (076113 and 085475 to the Wellcome Trust Case-Control Consortium). A full list of investigators who contributed to this work is available from the Wellcome Trust Case-Control Consortium website.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; ARCHER JR, 1995, ANN RHEUM DIS, V54, P544, DOI 10.1136/ard.54.7.544; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Breckpot K, 2009, J IMMUNOL, V182, P860, DOI 10.4049/jimmunol.182.2.860; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; D'Agostino MA, 2006, BEST PRACT RES CL RH, V20, P473, DOI 10.1016/j.berh.2006.03.007; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Duan R, 2010, ANN RHEUM DIS, V69, P1724, DOI 10.1136/ard.2009.111690; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Keller C, 2003, ANN RHEUM DIS, V62, P1128, DOI 10.1136/ard.2003.011023; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Melis L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2722; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Smith JA, 2008, ARTHRITIS RHEUM-US, V58, P1640, DOI 10.1002/art.23512; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taurog JD, 1999, IMMUNOL REV, V169, P209; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	56	194	200	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1184	U77		10.1038/ni.2135	http://dx.doi.org/10.1038/ni.2135			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22019834	Green Accepted, Green Submitted			2022-12-18	WOS:000297202700013
J	Iwasaki, H; Takeuchi, O; Teraguchi, S; Matsushita, K; Uehata, T; Kuniyoshi, K; Satoh, T; Saitoh, T; Matsushita, M; Standley, DM; Akira, S				Iwasaki, Hidenori; Takeuchi, Osamu; Teraguchi, Shunsuke; Matsushita, Kazufumi; Uehata, Takuya; Kuniyoshi, Kanako; Satoh, Takashi; Saitoh, Tatsuya; Matsushita, Mutsuyoshi; Standley, Daron M.; Akira, Shizuo			The I kappa B kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1	NATURE IMMUNOLOGY			English	Article							POSTTRANSCRIPTIONAL CONTROL; ALPHA PRODUCTION; BETA-TRCP; ACTIVATION; UBIQUITIN; PHOSPHORYLATION; INFLAMMATION; RECOGNITION; NEMO; INDUCTION	Toll-like receptor (TLR) signaling activates the inhibitor of transcription factor NF-kappa B (I kappa B) kinase (IKK) complex, which governs NF-kappa B-mediated transcription during inflammation. The RNase regnase-1 serves a critical role in preventing autoimmunity by controlling the stability of mRNAs that encode cytokines. Here we show that the IKK complex controlled the stability of mRNA for interleukin 6 (IL-6) by phosphorylating regnase-1 in response to stimulation via the IL-1 receptor (IL-1R) or TLR. Phosphorylated regnase-1 underwent ubiquitination and degradation. Regnase-1 was reexpressed in IL-1R- or TLR-activated cells after a period of lower expression. Regnase-1 mRNA was negatively regulated by regnase-1 itself via a stem-loop region present in the regnase-1 3' untranslated region. Our data demonstrate that the IKK complex phosphorylates not only I kappa B alpha, thereby activating transcription, but also regnase-1, thereby releasing a 'brake' on IL-6 mRNA expression.	[Iwasaki, Hidenori; Takeuchi, Osamu; Teraguchi, Shunsuke; Matsushita, Kazufumi; Uehata, Takuya; Kuniyoshi, Kanako; Satoh, Takashi; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Iwasaki, Hidenori; Matsushita, Mutsuyoshi] Cent Pharmaceut Res Inst, Osaka, Japan; [Takeuchi, Osamu; Kuniyoshi, Kanako; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Teraguchi, Shunsuke; Standley, Daron M.] Osaka Univ, Lab Syst Immunol, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Uehata, Takuya] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Takeuchi, O (corresponding author), Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan.	otake@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Standley, Daron/D-2343-2009; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Teraguchi, Shunsuke/0000-0002-5104-0227	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Japan Society for the Promotion of Science	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank laboratory colleagues; E. Kamada and M. Kageyama for secretarial assistance; Y. Fujiwara, M. Kumagai and N. Umano for technical assistance; M. Takahama and T. Misawa for help with experiments; A. Matsuo, T. Hata, M. Tanaka and T. Kurimoto for discussions; K. Iwai (Osaka University) for expression plasmids for Flag-tagged beta-TrCP and beta-TrCP Delta F; and D. V. Goeddel (Tularik; present affiliation, NGM Biopharmaceuticals) for the expression plasmid for IKK beta; I. Verma and M. Schmitt (Salk Institute), M. Schmidt-Supprian (Max Planck Institute) for MEFs deficient in IKK beta or both IKK alpha and IKK beta; S. Yamaoka (Tokyo Medical and Dental University) for Rat-1 and 5R cells; and F. Inagaki (Hokkaido University) for recombinant regnase-1 (amino acids 1-330). Supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare in Japan, the Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Li QT, 2000, GENE DEV, V14, P1729; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	40	194	206	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1167	U57		10.1038/ni.2137	http://dx.doi.org/10.1038/ni.2137			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22037600				2022-12-18	WOS:000297202700011
J	Ichii, H; Sakamoto, A; Hatano, M; Okada, S; Toyama, H; Taki, S; Arima, M; Kuroda, Y; Tokuhisa, T				Ichii, H; Sakamoto, A; Hatano, M; Okada, S; Toyama, H; Taki, S; Arima, M; Kuroda, Y; Tokuhisa, T			Role for Bcl-6 in the generation and maintenance of memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							GERMINAL-CENTER FORMATION; FINGER ENCODING GENE; IN-VIVO; CUTTING EDGE; NAIVE; PROLIFERATION; HOMEOSTASIS; MHC; EXPRESSION; STIMULATION	Naive T cells proliferate and differentiate into memory cells after antigenic stimulation or in a lymphopenic environment. We showed here transient increases in memory phenotype CD8(+) T cell numbers in the lymphopenic environment of spleens of very young mice. The magnitude of the increase correlated with Bcl-6 expression in the T cells. Bcl-6 controlled the generation and maintenance of antigen-specific memory phenotype CD8(+) T cells in the spleens of immunized mice. These data suggest that Bcl-6, which is essential for memory B cell development in germinal centers, is a key molecule for the establishment not only of memory T cells but also of the peripheral T cell compartment in infancy.	Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chiba 2608670, Japan; Chiba Univ, Grad Sch Med, Dept Mol Genet H1, Chiba 2608670, Japan; Kobe Univ, Sch Med, Dept Surg 1, Kobe, Hyogo 6500017, Japan	Chiba University; Chiba University; Kobe University	Tokuhisa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chiba 2608670, Japan.	tokuhisa@med.m.chiba-u.ac.jp	Ichii, Hirohito/AAV-8256-2021; Arima, Masafumi/L-1951-2018; Okada, Seiji/F-5785-2013	Arima, Masafumi/0000-0002-5169-7536; Taki, Shinsuke/0000-0001-5143-3496; Ichii, Hirohito/0000-0002-3635-5773				BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; FUKUDA T, 1995, ONCOGENE, V11, P1657; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRAY D, 1994, J EXP MED, V180, P141, DOI 10.1084/jem.180.1.141; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; HANNA MG, 1964, LAB INVEST, V13, P95; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; La Gruta NL, 2000, EUR J IMMUNOL, V30, P3380; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; LEVISKY HI, 1994, IMMUNITY, V6, P715; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Mitchell T, 1999, J IMMUNOL, V162, P4527; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; PIGUET PF, 1981, J EXP MED, V154, P581, DOI 10.1084/jem.154.3.581; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; White J, 1999, J IMMUNOL, V162, P2671; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoshida T, 1999, CARDIOVASC RES, V42, P670, DOI 10.1016/S0008-6363(99)00007-3; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	45	194	198	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					558	563		10.1038/ni802	http://dx.doi.org/10.1038/ni802			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021781				2022-12-18	WOS:000175874700015
J	Finkin, S; Yuan, DT; Stein, I; Taniguchi, K; Weber, A; Unger, K; Browning, JL; Goossens, N; Nakagawa, S; Gunasekaran, G; Schwartz, ME; Kobayashi, M; Kumada, H; Berger, M; Pappo, O; Rajewsky, K; Hoshida, Y; Karin, M; Heikenwalder, M; Ben-Neriah, Y; Pikarsky, E				Finkin, Shlomi; Yuan, Detian; Stein, Ilan; Taniguchi, Koji; Weber, Achim; Unger, Kristian; Browning, Jeffrey L.; Goossens, Nicolas; Nakagawa, Shigeki; Gunasekaran, Ganesh; Schwartz, Myron E.; Kobayashi, Masahiro; Kumada, Hiromitsu; Berger, Michael; Pappo, Orit; Rajewsky, Klaus; Hoshida, Yujin; Karin, Michael; Heikenwalder, Mathias; Ben-Neriah, Yinon; Pikarsky, Eli			Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; NODE-LIKE STRUCTURES; ADAPTIVE IMMUNITY; NECROSIS-FACTOR; LIVER; CANCER; LYMPHOTOXIN; INNATE; INFLAMMATION; EXPRESSION	Ectopic lymphoid-like structures (ELSs) are often observed in cancer, yet their function is obscure. Although ELSs signify good prognosis in certain malignancies, we found that hepatic ELSs indicated poor prognosis for hepatocellular carcinoma (HCC). We studied an HCC mouse model that displayed abundant ELSs and found that they constituted immunopathological microniches wherein malignant hepatocyte progenitor cells appeared and thrived in a complex cellular and cytokine milieu until gaining self-sufficiency. The egress of progenitor cells and tumor formation were associated with the autocrine production of cytokines previously provided by the niche. ELSs developed via cooperation between the innate immune system and adaptive immune system, an event facilitated by activation of the transcription factor NF-kappa B and abolished by depletion of T cells. Such aberrant immunological foci might represent new targets for cancer therapy.	[Finkin, Shlomi; Stein, Ilan; Berger, Michael; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Immunol & Canc Res, IL-91010 Jerusalem, Israel; [Finkin, Shlomi; Stein, Ilan; Pappo, Orit; Pikarsky, Eli] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Yuan, Detian; Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Weber, Achim] Univ Zurich, Inst Surg Pathol, Zurich, Switzerland; [Weber, Achim] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Unger, Kristian] Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Browning, Jeffrey L.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Goossens, Nicolas; Nakagawa, Shigeki; Hoshida, Yujin] Icahn Sch Med Mt Sinai, Div Liver Dis, Dept Med, Liver Canc Program,Tisch Canc Inst, New York, NY 10029 USA; [Goossens, Nicolas] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Gunasekaran, Ganesh; Schwartz, Myron E.] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, New York, NY 10029 USA; [Kobayashi, Masahiro; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Rajewsky, Klaus] Max Delbruck Ctr Mol Med, Berlin, Germany; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Zurich; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Boston University; Icahn School of Medicine at Mount Sinai; University of Geneva; Icahn School of Medicine at Mount Sinai; Toranomon Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Heikenwalder, M (corresponding author), Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany.	heikenwaelder@helmholtz-muenchen.de; yinonb@ekmd.huji.ac.il; peli@hadassah.org.il	pikarsky, eli/GXV-7099-2022; Unger, Kristian/F-3730-2018; Heikenwalder, Mathias/AAA-2269-2020; Ben-Neriah, Yinon/L-6285-2019; Hoshida, Yujin/R-7513-2019	Unger, Kristian/0000-0002-0374-2320; pikarsky, eli/0000-0003-4186-7105; Weber, Achim/0000-0003-0073-3637; Rajewsky, Klaus/0000-0002-6633-6370	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; European Research Council; Israel Science Foundation; Israel Cancer Research Fund; Helmholtz alliance "preclinical comprehensive cancer center" Graduiertenkolleg [GRK482]; Krebsliga Schweiz (Oncosuisse); Promedica Stiftung; US National Institutes of Health [CA118165, SRP ES010337, AI0043477, DK099558]; Hildyard chair for Mitochondrial and Metabolic Diseases; Japan Society for the Promotion of Science; Irma T Hirschl Trust; FLAGS foundation; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA118165, P30CA196521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Helmholtz alliance "preclinical comprehensive cancer center" Graduiertenkolleg(German Research Foundation (DFG)); Krebsliga Schweiz (Oncosuisse); Promedica Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hildyard chair for Mitochondrial and Metabolic Diseases; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Irma T Hirschl Trust; FLAGS foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank K. Kohno (Nara Institute of Science and Technology) for plasmids pBstN and p2335A-1; M.-A. Buendia (Institut Pasteur, France) for Myc-Trp53<SUP>-/-</SUP> liver tumors; V. Factor and S. Thorgeirsson (US National Institutes of Health) for anti-A6; and E. Cinnamon, M.-A. Buendia, K. Kohno, M. Ringelhan, R. Hillermann, D. Kull, I. Gat-Viks, Y. Steuerman, S. Itzkovitz and K. Bahar-Halpern for help and advice. Supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (E.P. and Y.B.-N.), the European Research Council (LIVERMICROENV to E.P.; PICHO to Y.B.-N.; and LiverCancerMechanism to M.H.), the Israel Science Foundation (E.P., Y.B.-N., LS. and O.P.), the Israel Cancer Research Fund (Y.B.-N.), the Helmholtz alliance "preclinical comprehensive cancer center" Graduiertenkolleg (GRK482 to M.H.), Krebsliga Schweiz (Oncosuisse) (AM.), Promedica Stiftung (A.W.), the US National Institutes of Health (CA118165, SRP ES010337 and AI0043477 to M.K.; and DK099558 to Y.H.), the Hildyard chair for Mitochondrial and Metabolic Diseases (M.K.), the Japan Society for the Promotion of Science (K.T.), Irma T Hirschl Trust (Y.H.), the FLAGS foundation (N.G.) and the Uehara Memorial Foundation (S.N.).	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bauer J, 2012, DIGEST DIS, V30, P453, DOI 10.1159/000341690; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Di Caro G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28850; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Drutskaya MS, 2010, IUBMB LIFE, V62, P283, DOI 10.1002/iub.309; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gerber M A, 1997, Clin Liver Dis, V1, P529, DOI 10.1016/S1089-3261(05)70319-6; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Yujin, 2009, Expert Rev Gastroenterol Hepatol, V3, P101, DOI 10.1586/egh.09.5; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; MOSNIER JF, 1993, HEPATOLOGY, V17, P366; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; SCHEUER PJ, 1992, HEPATOLOGY, V15, P567, DOI 10.1002/hep.1840150402; Schneider C, 2012, GUT, V61, P1733, DOI 10.1136/gutjnl-2011-301116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Torrecilla S, 2015, CLIN RES HEPATOL GAS, V39, pS80, DOI 10.1016/j.clinre.2015.06.016; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Wolf MJ, 2011, ADV EXP MED BIOL, V691, P231, DOI 10.1007/978-1-4419-6612-4_24; Yau TO, 2009, J PATHOL, V217, P353, DOI 10.1002/path.2451; Yu GY, 2012, MOL CELL, V48, P313, DOI 10.1016/j.molcel.2012.07.032; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8	43	193	199	6	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1235	1244		10.1038/ni.3290	http://dx.doi.org/10.1038/ni.3290			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26502405	Green Accepted, Green Submitted			2022-12-18	WOS:000365062100007
J	Shaw, AS				Shaw, Andrey S.			Lipid rafts: now you see them, now you don't	NATURE IMMUNOLOGY			English	Article							GPI-ANCHORED PROTEINS; CELL-SURFACE MOLECULES; RECEPTOR ZETA-CHAIN; PLASMA-MEMBRANE; TYROSINE KINASES; MDCK CELLS; ACTIVATION; MICRODOMAINS; CHOLESTEROL; DOMAINS	The 'lipid raft' hypothesis has been a contentious topic over the past 5 years, with much of the immunology community divided into 'believers' and 'nonbelievers'. The disagreement is due mainly to the inability to observe these membrane domains directly and to the widespread use of experimental approaches of dubious utility. As a lipid raft 'dilettante' who has dabbled in the area over the years, I view the lipid raft model with some skepticism and disinterest because of that confusion. Although progress in the field has helped clarify some of the issues, more work is still needed to formally confirm the lipid raft hypothesis and to reestablish the scientific credibility of this area.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	ashaw@wustl.edu		Shaw, Andrey/0000-0001-5685-0272				Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; Amarasinghe GK, 2005, BIOCHEMISTRY-US, V44, P15257, DOI 10.1021/bi051126h; BENZEEV A, 1979, CELL, V17, P859, DOI 10.1016/0092-8674(79)90326-X; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Burack WR, 2002, J IMMUNOL, V169, P2837, DOI 10.4049/jimmunol.169.6.2837; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; GEPPERT TD, 1991, J IMMUNOL, V146, P3298; Giocondi MC, 2000, J STRUCT BIOL, V131, P38, DOI 10.1006/jsbi.2000.4266; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865; Housden HR, 2003, EUR J BIOCHEM, V270, P2369, DOI 10.1046/j.1432-1033.2003.03604.x; Kawasaki K, 2001, BIOPHYS J, V80, P738, DOI 10.1016/S0006-3495(01)76053-5; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355; Pierce SK, 2004, NAT CELL BIOL, V6, P180, DOI 10.1038/ncb0304-180; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Radhakrishnan A, 1999, BIOPHYS J, V77, P1507, DOI 10.1016/S0006-3495(99)76998-5; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	40	193	197	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1139	1142		10.1038/ni1405	http://dx.doi.org/10.1038/ni1405			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053798				2022-12-18	WOS:000241437200007
J	Li, QJ; Dinner, AR; Qi, SY; Irvine, DJ; Huppa, JB; Davis, MM; Chakraborty, AK				Li, QJ; Dinner, AR; Qi, SY; Irvine, DJ; Huppa, JB; Davis, MM; Chakraborty, AK			CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse	NATURE IMMUNOLOGY			English	Article							PROTEIN KINASE P56LCK; SIGNAL-TRANSDUCTION; ACTIVATION; RECEPTOR; COMPLEX; RECOGNITION; MOLECULES; OLIGOMERIZATION; SURFACE; BINDING	How T cells respond with extraordinary sensitivity to minute amounts of agonist peptide and major histocompatibility complex (pMHC) molecules on the surface of antigen-presenting cells bearing large numbers of endogenous pMHC molecules is not understood. Here we present evidence that CD4 affects the responsiveness of T helper cells by controlling spatial localization of the tyrosine kinase Lck in the synapse. This finding, as well as further in silico and in vitro experiments, led us to develop a molecular model in which endogenous and agonist pMHC molecules act cooperatively to amplify T cell receptor signaling. At the same time, activation due to endogenous pMHC molecules alone is inhibited. A key feature is that the binding of agonist pMHC molecules to the T cell receptor results in CD4-mediated spatial localization of Lck, which in turn enables endogenous pMHC molecules to trigger many T cell receptors. We also discuss broader implications for T cell biology, including thymic selection, diversity of the repertoire of self pMHC molecules and serial triggering.	Stanford Univ, Dept Chem, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	Stanford University; Stanford University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Chakraborty, AK (corresponding author), Stanford Univ, Dept Chem, Berkeley, CA 94720 USA.	mdavis@cmgm.stanford.edu; arup@uclink.berkeley.edu		Davis, Mark/0000-0001-6868-657X; Huppa, Johannes/0000-0003-2634-8198				Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; COLLINS TL, 1992, J IMMUNOL, V148, P2159; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Germain RN, 2003, CURR BIOL, V13, pR137, DOI 10.1016/S0960-9822(03)00075-7; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2001, J EXP MED, V194, P1043, DOI 10.1084/jem.194.8.1043; Huang B, 1997, J IMMUNOL, V158, P216; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Krogsgaard M, 2003, SEMIN IMMUNOL, V15, P307, DOI 10.1016/j.smim.2003.09.002; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Li S, 1998, IMMUNOL TODAY, V19, P455, DOI 10.1016/S0167-5699(98)01325-5; Lindstedt R, 2001, J IMMUNOL, V166, P800, DOI 10.4049/jimmunol.166.2.800; Lynch GW, 1999, EUR J IMMUNOL, V29, P2590, DOI 10.1002/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; RIVAS A, 1988, J IMMUNOL, V140, P2912; RUDD CE, 1989, IMMUNOL REV, V111, P225, DOI 10.1111/j.1600-065X.1989.tb00548.x; SAKIHAMA T, 1995, P NATL ACAD SCI USA, V92, P6444, DOI 10.1073/pnas.92.14.6444; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; VALLITUTTI S, 1995, NATURE, V375, P148; VANKAMPEN NG, 1987, STOCHASTIC PROCESSES; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VIGNALI DAA, 1993, PHILOS T R SOC B, V342, P13, DOI 10.1098/rstb.1993.0130; Viret C, 2001, P NATL ACAD SCI USA, V98, P9243, DOI 10.1073/pnas.161274698; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N	50	193	200	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					791	799		10.1038/ni1095	http://dx.doi.org/10.1038/ni1095			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15247914				2022-12-18	WOS:000222955600010
J	Calame, KL				Calame, KL			Plasma cells: finding new light at the end of B cell development	NATURE IMMUNOLOGY			English	Review							INTERFERON REGULATORY FACTOR-4; GERMINAL-CENTER FORMATION; ANTIBODY-SECRETING CELLS; TRANSCRIPTION FACTOR; TERMINAL DIFFERENTIATION; GENE-EXPRESSION; IMMUNE-RESPONSE; MARGINAL ZONE; IN-VIVO; MEMORY	Plasma cells are cellular factories devoted entirely to the manufacture and export of a single product: soluble immunoglobulin (Ig). As the final mediators of a humoral response, plasma cells play a critical role in adaptive immunity. Although intense effort has been devoted to studying the regulation and requirements for early B cell development, little information has been available on plasma cells. However, more recent work-including studies on genetically altered mice and data from microarray analyses-has begun to identify the regulatory cascades that initiate and maintain the plasma cell phenotype. This review will summarize our current understanding of the molecules that regulate commitment to a plasma cell fate and those that mediate plasma cell function.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University	Calame, KL (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 630 W 168th St, New York, NY 10032 USA.				NIAID NIH HHS [AI43576] Funding Source: Medline; NIGMS NIH HHS [GM29361] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029361] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; CHENBETTECKEN U, 1987, IMMUNOBIOLOGY, V174, P162, DOI 10.1016/S0171-2985(87)80036-0; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DO R, 2001, CYTOKINE GROWTH F R, V199, P1; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Fagarasan S, 2000, IMMUNOL REV, V176, P205; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gado K, 2000, CELL BIOL INT, V24, P195, DOI 10.1006/cbir.2000.0497; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Gupta S, 2001, J IMMUNOL, V166, P6104, DOI 10.4049/jimmunol.166.10.6104; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; KAWANO MM, 1995, BLOOD, V85, P487; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Matthias P, 1998, SEMIN IMMUNOL, V10, P155, DOI 10.1006/smim.1998.0117; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Merville P, 1996, J EXP MED, V183, P227, DOI 10.1084/jem.183.1.227; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nutt S L, 2001, Int Rev Immunol, V20, P65, DOI 10.3109/08830180109056723; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Oliver AM, 1999, J IMMUNOL, V162, P7198; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Silvy A, 1996, EUR J IMMUNOL, V26, P517, DOI 10.1002/eji.1830260303; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tomayko MM, 1998, J IMMUNOL, V160, P107; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Usui T, 1997, J IMMUNOL, V158, P3197; Waldburger JM, 2000, IMMUNOL REV, V178, P148, DOI 10.1034/j.1600-065X.2000.17813.x; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wen XY, 1999, INT J ONCOL, V15, P173; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhang X, 2001, J IMMUNOL, V167, P49, DOI 10.4049/jimmunol.167.1.49	85	193	208	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1103	1108		10.1038/ni1201-1103	http://dx.doi.org/10.1038/ni1201-1103			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725300	Bronze			2022-12-18	WOS:000172473200011
J	Mingueneau, M; Kreslavsky, T; Gray, D; Heng, T; Cruse, R; Ericson, J; Bendall, S; Spitzer, M; Nolan, G; Kobayashi, K; von Boehmer, H; Mathis, D; Benoist, C; Best, AJ; Knell, J; Goldrath, A; Jojic, V; Koller, D; Shay, T; Regev, A; Cohen, N; Brennan, P; Brenner, M; Kim, F; Rao, TN; Wagers, A; Heng, T; Ericson, J; Rothamel, K; Ortiz-Lopez, A; Mathis, D; Bezman, NA; Sun, JC; Min-Oo, G; Kim, CC; Lanier, LL; Miller, J; Brown, B; Merad, M; Gautier, EL; Jakubzick, C; Randolph, GJ; Monach, P; Blair, DA; Dustin, ML; Shinton, SA; Hardy, RR; Laidlaw, D; Collins, J; Gazit, R; Rossi, DJ; Malhotra, N; Sylvia, K; Kang, J; Kreslavsky, T; Fletcher, A; Elpek, K; Bellemare-Pelletier, A; Malhotra, D; Turley, S				Mingueneau, Michael; Kreslavsky, Taras; Gray, Daniel; Heng, Tracy; Cruse, Richard; Ericson, Jeffrey; Bendall, Sean; Spitzer, Matt; Nolan, Garry; Kobayashi, Koichi; von Boehmer, Harald; Mathis, Diane; Benoist, Christophe; Best, Adam J.; Knell, Jamie; Goldrath, Ananda; Jojic, Vladimir; Koller, Daphne; Shay, Tal; Regev, Aviv; Cohen, Nadia; Brennan, Patrick; Brenner, Michael; Kim, Francis; Rao, Tata Nageswara; Wagers, Amy; Heng, Tracy; Ericson, Jeffrey; Rothamel, Katherine; Ortiz-Lopez, Adriana; Mathis, Diane; Bezman, Natalie A.; Sun, Joseph C.; Min-Oo, Gundula; Kim, Charlie C.; Lanier, Lewis L.; Miller, Jennifer; Brown, Brian; Merad, Miriam; Gautier, Emmanuel L.; Jakubzick, Claudia; Randolph, Gwendalyn J.; Monach, Paul; Blair, David A.; Dustin, Michael L.; Shinton, Susan A.; Hardy, Richard R.; Laidlaw, David; Collins, Jim; Gazit, Roi; Rossi, Derrick J.; Malhotra, Nidhi; Sylvia, Katelyn; Kang, Joonsoo; Kreslavsky, Taras; Fletcher, Anne; Elpek, Kutlu; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Turley, Shannon		Immunological Genome Consortium	The transcriptional landscape of alpha beta T cell differentiation	NATURE IMMUNOLOGY			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; GENE-EXPRESSION; PRE-TCR; C-MYC; CLONAL DELETION; LYMPHOCYTE DEVELOPMENT; INDUCED PROLIFERATION; THYMOCYTE SELECTION; CENTRAL TOLERANCE	The differentiation of abT cells from thymic precursors is a complex process essential for adaptive immunity. Here we exploited the breadth of expression data sets from the Immunological Genome Project to analyze how the differentiation of thymic precursors gives rise to mature T cell transcriptomes. We found that early T cell commitment was driven by unexpectedly gradual changes. In contrast, transit through the CD4(+)CD8(+) stage involved a global shutdown of housekeeping genes that is rare among cells of the immune system and correlated tightly with expression of the transcription factor c-Myc. Selection driven by major histocompatibility complex (MHC) molecules promoted a large-scale transcriptional reactivation. We identified distinct signatures that marked cells destined for positive selection versus apoptotic deletion. Differences in the expression of unexpectedly few genes accompanied commitment to the CD4(+) or CD8(+) lineage, a similarity that carried through to peripheral T cells and their activation, demonstrated by mass cytometry phosphoproteomics. The transcripts newly identified as encoding candidate mediators of key transitions help define the 'known unknowns' of thymocyte differentiation.	[Mingueneau, Michael; Cruse, Richard; Ericson, Jeffrey; Mathis, Diane; Benoist, Christophe; Heng, Tracy; Ericson, Jeffrey; Rothamel, Katherine; Ortiz-Lopez, Adriana; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA; [Kreslavsky, Taras; Kobayashi, Koichi; von Boehmer, Harald; Kreslavsky, Taras; Fletcher, Anne; Elpek, Kutlu; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Turley, Shannon] Dana Farber Canc Inst, Boston, MA USA; [Gray, Daniel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Gray, Daniel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3050, Australia; [Gray, Daniel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Heng, Tracy] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Bendall, Sean; Spitzer, Matt; Nolan, Garry] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Kobayashi, Koichi] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA; [Best, Adam J.; Knell, Jamie; Goldrath, Ananda] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Jojic, Vladimir; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Shay, Tal; Regev, Aviv] MIT, Broad Inst, Cambridge, MA 02139 USA; [Shay, Tal; Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Cohen, Nadia; Brennan, Patrick; Brenner, Michael] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Kim, Francis; Rao, Tata Nageswara; Wagers, Amy] Joslin Diabet Ctr, Boston, MA 02215 USA; [Bezman, Natalie A.; Sun, Joseph C.; Min-Oo, Gundula; Kim, Charlie C.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Miller, Jennifer; Brown, Brian; Merad, Miriam; Gautier, Emmanuel L.; Jakubzick, Claudia; Randolph, Gwendalyn J.] Mt Sinai Hosp, Icahn Med Inst, New York, NY 10029 USA; [Gautier, Emmanuel L.; Randolph, Gwendalyn J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Monach, Paul] Boston Univ, Dept Med, Boston, MA 02215 USA; [Blair, David A.; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA; [Shinton, Susan A.; Hardy, Richard R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Laidlaw, David] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Collins, Jim] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Gazit, Roi; Rossi, Derrick J.] Childrens Hosp, Program Mol Med, Boston, MA 02115 USA; [Malhotra, Nidhi; Sylvia, Katelyn; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Kreslavsky, Taras; Fletcher, Anne; Elpek, Kutlu; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Turley, Shannon] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Monash University; Stanford University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Joslin Diabetes Center, Inc.; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Boston University; New York University; Fox Chase Cancer Center; Brown University; Boston University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Bendall, Sean/AGG-0126-2022; Mingueneau, Michael/O-5313-2019; Dustin, Michael/AAM-4611-2020; Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/AAR-5712-2021; Gazit, Roi/J-3352-2017; Gray, Daniel HD/A-3293-2013; Laidlaw, David/M-4686-2019; Heng, Tracy/B-9847-2015; Nolan, Garry/AAE-7903-2019; Lanier, Lewis L/E-2139-2014	Mingueneau, Michael/0000-0002-3873-7329; Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Gray, Daniel HD/0000-0002-8457-8242; Heng, Tracy/0000-0003-4147-8986; Lanier, Lewis L/0000-0003-1308-3952; Bendall, Sean/0000-0003-1341-2453; Kobayashi, Koichi/0000-0003-2930-0114; Spitzer, Matthew/0000-0002-5291-3819; Kreslavsky, Taras/0000-0002-6672-1914; Gazit, Roi/0000-0002-0548-2147; Dustin, Michael/0000-0003-4983-6389; kang, joonsoo/0000-0001-8419-7995; Miller, Jennifer/0000-0002-3591-369X; Monach, Paul/0000-0003-4937-0515; Kim, Charles/0000-0001-6474-8227; Tata, Nageswara Rao/0000-0002-9928-5944; Nolan, Garry/0000-0002-8862-9043; Fletcher, Anne/0000-0003-1534-1142; Malhotra, Deepali/0000-0002-8215-7639	US National Institutes of Health [AI072073]; Human Frontier Science Program [HFSP-LT000096]; National Health and Medical Research Council [637353]; Australian Research Council [LP110201169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, P30DK026743] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Hattori, A. Ortiz-Lopez and N. Asinovski for technical assistance with mice and antibodies; J. Moore and A. Kressler for flow cytometry; and C. Laplace for assistance with figure preparation. Supported by the US National Institutes of Health (AI072073), the Human Frontier Science Program (HFSP-LT000096 to M. M.), the National Health and Medical Research Council (637353 to D.G.) and the Australian Research Council (LP110201169 to, T.H.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Baldwin KK, 1999, J IMMUNOL, V163, P689; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DeRyckere D, 2003, J IMMUNOL, V171, P802, DOI 10.4049/jimmunol.171.2.802; Dose M, 2006, BLOOD, V108, P2669, DOI 10.1182/blood-2006-02-005900; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Iritani BM, 2002, EMBO J, V21, P4820, DOI 10.1093/emboj/cdf492; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kisielow J, 2001, EUR J IMMUNOL, V31, P1141, DOI 10.1002/1521-4141(200104)31:4<1141::AID-IMMU1141>3.0.CO;2-R; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Miller JFAP, 2011, NAT REV IMMUNOL, V11, P489, DOI 10.1038/nri2993; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Penit C, 1997, J IMMUNOL, V159, P4848; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Rudolph B, 2000, ONCOGENE, V19, P1891, DOI 10.1038/sj.onc.1203508; Schmitz I, 2003, INT IMMUNOL, V15, P1237, DOI 10.1093/intimm/dxg125; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Thompson PK, 2011, SEMIN IMMUNOL, V23, P350, DOI 10.1016/j.smim.2011.08.007; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Viret C, 2001, J IMMUNOL, V166, P4429, DOI 10.4049/jimmunol.166.7.4429; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	92	192	196	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					619	+		10.1038/ni.2590	http://dx.doi.org/10.1038/ni.2590			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23644507	Green Submitted, Green Accepted			2022-12-18	WOS:000319107600015
J	Bezman, NA; Kim, CC; Sun, JC; Min-Oo, G; Hendricks, DW; Kamimura, Y; Best, JA; Goldrath, AW; Lanier, LL				Bezman, Natalie A.; Kim, Charles C.; Sun, Joseph C.; Min-Oo, Gundula; Hendricks, Deborah W.; Kamimura, Yosuke; Best, J. Adam; Goldrath, Ananda W.; Lanier, Lewis L.		Immunological Genome Project Conso	Molecular definition of the identity and activation of natural killer cells	NATURE IMMUNOLOGY			English	Article							HUMAN NK CELLS; GENE-EXPRESSION; T-CELL; ADAPTIVE IMMUNITY; LYMPHOID-CELLS; INNATE; MOUSE; PROTEIN; LYMPHOCYTES; SIGNATURE	Using whole-genome microarray data sets of the Immunological Genome Project, we demonstrate a closer transcriptional relationship between NK cells and T cells than between any other leukocytes, distinguished by their shared expression of genes encoding molecules with similar signaling functions. Whereas resting NK cells are known to share expression of a few genes with cytotoxic CD8(+) T cells, our transcriptome-wide analysis demonstrates that the commonalities extend to hundreds of genes, many encoding molecules with unknown functions. Resting NK cells demonstrate a 'preprimed' state compared with naive T cells, which allows NK cells to respond more rapidly to viral infection. Collectively, our data provide a global context for known and previously unknown molecular aspects of NK cell identity and function by delineating the genome-wide repertoire of gene expression of NK cells in various states.	[Bezman, Natalie A.; Min-Oo, Gundula; Hendricks, Deborah W.; Kamimura, Yosuke; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Bezman, Natalie A.; Min-Oo, Gundula; Hendricks, Deborah W.; Kamimura, Yosuke; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Kim, Charles C.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Best, J. Adam; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Heng, Tracy/AAR-5712-2021; Gazit, Roi/J-3352-2017; Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/B-9847-2015; Lanier, Lewis L/E-2139-2014	Heng, Tracy/0000-0003-4147-8986; Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Lanier, Lewis L/0000-0003-1308-3952; kang, joonsoo/0000-0001-8419-7995; Tata, Nageswara Rao/0000-0002-9928-5944; Kim, Charles/0000-0001-6474-8227; Malhotra, Deepali/0000-0002-8215-7639; Gazit, Roi/0000-0002-0548-2147; Fletcher, Anne/0000-0003-1534-1142	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R24 AI072073, R01 AI068129, T32AI060537, T32AI060536, AI072117]; American Cancer Society; Canadian Institutes of Health Research; Searle Scholars Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100874, R01AI067545, T32AI060536, R01AI068129, R24AI072073, R00AI085035, R01AI072117, T32AI060537] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Searle Scholars Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Weiss (University of California, San Francisco) for antibody to Syk; the members of the ImmGen Consortium and M. Dozmorov for discussions; the ImmGen core team (M. Painter, J. Ericson and S. Davis) for data generation and processing; J. Jarjoura and J. Arakawa-Hoyt for assistance in cell sorting; A. Beaulieu, J. Karo and S. Madera for data from MCMV infection experiments; and eBioscience, Affymetrix and Expression Analysis for support of the ImmGen Project. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R24 AI072073 and R01 AI068129; T32AI060537 to D.W.H.; T32AI060536 to JAB.; and AI072117 to A.W.G.), the American Cancer Society (L.L.L. and NAB.), the Canadian Institutes of Health Research (G.M.-O.) and the Searle Scholars Program (J.C.S.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Albrecht I, 2010, EUR J IMMUNOL, V40, P2993, DOI 10.1002/eji.201040936; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Despoix N, 2008, EUR J IMMUNOL, V38, P2855, DOI 10.1002/eji.200838469; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dybkaer K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-230; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hawiger D, 2010, NAT IMMUNOL, V11, P962, DOI 10.1038/ni.1929; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; LANIER LL, 1986, NATURE, V319, P269, DOI 10.1038/319269b0; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Pont F, 2012, EUR J IMMUNOL, V42, P228, DOI 10.1002/eji.201141870; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sun Y, 2006, NUCLEIC ACIDS RES, V34, P6314, DOI 10.1093/nar/gkl914; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wilson SB, 2001, CURR OPIN IMMUNOL, V13, P555, DOI 10.1016/S0952-7915(00)00258-2; Xue L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009229; Yamagata T, 2006, IMMUNOL REV, V210, P52, DOI 10.1111/j.0105-2896.2006.00371.x; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; Yu JH, 2011, J CLIN INVEST, V121, P1456, DOI 10.1172/JCI43242; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496	48	192	197	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					1000	1009		10.1038/ni.2395	http://dx.doi.org/10.1038/ni.2395			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22902830	Green Accepted, Green Submitted			2022-12-18	WOS:000309038600016
J	Levy, D; Kuo, AJ; Chang, YQ; Schaefer, U; Kitson, C; Cheung, P; Espejo, A; Zee, BM; Liu, CL; Tangsombatvisit, S; Tennen, RI; Kuo, AY; Tanjing, S; Cheung, R; Chua, KF; Utz, PJ; Shi, XB; Prinjha, RK; Lee, K; Garcia, BA; Bedford, MT; Tarakhovsky, A; Cheng, XD; Gozani, O				Levy, Dan; Kuo, Alex J.; Chang, Yanqi; Schaefer, Uwe; Kitson, Christopher; Cheung, Peggie; Espejo, Alexsandra; Zee, Barry M.; Liu, Chih Long; Tangsombatvisit, Stephanie; Tennen, Ruth I.; Kuo, Andrew Y.; Tanjing, Song; Cheung, Regina; Chua, Katrin F.; Utz, Paul J.; Shi, Xiaobing; Prinjha, Rab K.; Lee, Kevin; Garcia, Benjamin A.; Bedford, Mark T.; Tarakhovsky, Alexander; Cheng, Xiaodong; Gozani, Or			Lysine methylation of the NF-kappa B subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappa B signaling	NATURE IMMUNOLOGY			English	Article							EXPRESSION PROFILES; ZETA-PKC; COMPLEXES; PROTEIN; G9A; PHOSPHORYLATION; INFLAMMATION; MECHANISM; BINDING	Signaling via the methylation of lysine residues in proteins has been linked to diverse biological and disease processes, yet the catalytic activity and substrate specificity of many human protein lysine methyltransferases (PKMTs) are unknown. We screened over 40 candidate PKMTs and identified SETD6 as a methyltransferase that monomethylated chromatin-associated transcription factor NF-kappa B subunit RelA at Lys310 (RelAK310me1). SETD6-mediated methylation rendered RelA inert and attenuated RelA-driven transcriptional programs, including inflammatory responses in primary immune cells. RelAK310me1 was recognized by the ankryin repeat of the histone methyltransferase GLP, which under basal conditions promoted a repressed chromatin state at RelA target genes through GLP-mediated methylation of histone H3 Lys9 (H3K9). NF-kappa B-activation-linked phosphorylation of RelA at Ser311 by protein kinase C-zeta (PKC-zeta) blocked the binding of GLP to RelAK310me1 and relieved repression of the target gene. Our findings establish a previously uncharacterized mechanism by which chromatin signaling regulates inflammation programs.	[Levy, Dan; Kuo, Alex J.; Cheung, Peggie; Liu, Chih Long; Kuo, Andrew Y.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Chang, Yanqi; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Schaefer, Uwe; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; [Kitson, Christopher; Prinjha, Rab K.; Lee, Kevin] GlaxoSmithKline, EpiNova DPU, Immunoinflammat Grp, Stevenage, Herts, England; [Espejo, Alexsandra; Bedford, Mark T.] MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX USA; [Zee, Barry M.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Liu, Chih Long; Tangsombatvisit, Stephanie; Cheung, Regina; Utz, Paul J.] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Tennen, Ruth I.; Chua, Katrin F.] Stanford Univ, Sch Med, Dept Endocrinol Gerontol & Metab Med, Stanford, CA 94305 USA; [Tanjing, Song; Shi, Xiaobing] Univ Texas MD Anderson, Ctr Canc Epigenet, Houston, TX USA; [Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA	Stanford University; Emory University; Rockefeller University; GlaxoSmithKline; University of Texas System; UTMD Anderson Cancer Center; Princeton University; Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ogozani@stanford.edu	song, tanjing/N-7539-2013; Bedford, Mark T/E-7856-2011; Gozani, Or P/I-6157-2013; Levy, Dan/A-3226-2013; Kuo, Alex/AAL-2845-2020; Chang, Yanqi/F-7183-2011	Levy, Dan/0000-0003-0719-0305; Zee, Barry/0000-0002-3123-8375; Espejo, Alexsandra/0000-0002-8841-7219; Shi, Xiaobing/0000-0001-5242-8189; Gozani, Or/0000-0002-1365-4463; Chang, Yanqi/0000-0003-1026-8134	National Institutes of Health [DA025800, GM068680, F32AI080086]; American Society for Mass Spectrometry; National Heart, Lung and Blood Institute [HHSN-268201999934C]; National Institute of Allergy and Infectious Diseases [U19-AI082719]; Floren Family Trust; Genentech Foundation; European Molecular Biology Organization; Human Frontier Science Program; Machiah Foundation; Georgia Research Alliance; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI080086, U19AI082719, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680, R01GM079641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028867, R56AG028867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Mass Spectrometry; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Floren Family Trust; Genentech Foundation(Roche HoldingGenentech); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Machiah Foundation; Georgia Research Alliance; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Kingston and M. Simon (Harvard Medical School) for recombinant nucleosomes; J. Smith (University of Alabama Birmingham) for the PKC-zeta(ca) plasmid; W. C. Greene (University of California San Francisco) for RelA(1-431) cDNA and the kappa B-Luc luciferase reporter plasmid; D. Reinberg (New York University) for the NSD1(SET) plasmid; M. Covert (Stanford University) and T. D. Gilmore (Boston University) for the wild-type and Rela<SUP>-/-</SUP> mouse 3T3 cells; J. Moscat (University of Cincinnati College of Medicine) for the wild-type and Prkcz<SUP>-/-</SUP> MEFs; E. Engleman (Stanford University) for FL-B16 cells; E. Green for critical reading of the manuscript; and A. Alizadeh for comments. Supported by the National Institutes of Health (DA025800 to O.G. and M. T. B.; GM068680 to X. C.; and F32AI080086 to C. L. L.), the American Society for Mass Spectrometry (B. A. G.), the National Heart, Lung and Blood Institute (HHSN-268201999934C to P. J. U.), the National Institute of Allergy and Infectious Diseases (U19-AI082719 to P. J. U.), the Floren Family Trust (P. J. U.), the Genentech Foundation (A. J. K.), the European Molecular Biology Organization (D. L.), the Human Frontier Science Program (D. L.), the Machiah Foundation (D. L.), the Georgia Research Alliance (X. C.) and the Ellison Medical Foundation (O.G.)	Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Dong J, 2010, GENE DEV, V24, P1709, DOI 10.1101/gad.1958410; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kattah MG, 2008, NAT MED, V14, P1284, DOI 10.1038/nm.1755; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, pA8; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Smith L, 2000, J BIOL CHEM, V275, P40620, DOI 10.1074/jbc.M908517199; Su I, 2006, CURR OPIN IMMUNOL, V18, P152, DOI 10.1016/j.coi.2006.01.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021	48	192	204	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					29	U47		10.1038/ni.1968	http://dx.doi.org/10.1038/ni.1968			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21131967	Green Accepted			2022-12-18	WOS:000285465100010
J	Carpenter, AC; Bosselut, R				Carpenter, Andrea C.; Bosselut, Remy			Decision checkpoints in the thymus	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; THYMOCYTE POSITIVE SELECTION; DELTA LINEAGE FATE; GAMMA-DELTA; ALPHA-BETA; ZINC-FINGER; TRANSCRIPTION FACTORS; CD8 LINEAGE; PHOSPHATIDYLINOSITOL 3-KINASE; INTERLEUKIN-7 RECEPTOR	The development of T cells in the thymus involves several differentiation and proliferation events, during which hematopoietic precursors give rise to T cells ready to respond to antigen stimulation and undergo effector differentiation. This review addresses signaling and transcriptional checkpoints that control the intrathymic journey of T cell precursors. We focus on the divergence of alpha beta and gamma delta lineage cells and the elaboration of the alpha beta T cell repertoire, with special emphasis on the emergence of transcriptional programs that direct lineage decisions.	[Carpenter, Andrea C.; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov		Bohrer, Andrea/0000-0003-4268-4853	National Cancer Institute, Center for Cancer Research, US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Ashwell, A. Bhandoola, A. Gegonne, P. Love and A. Singer for their comments on the manuscript. We apologize to colleagues whose work was not directly referenced because of space constraints. Research work in the authors' laboratory is supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, US National Institutes of Health.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chi AW, 2009, CURR OPIN IMMUNOL, V21, P121, DOI 10.1016/j.coi.2009.01.012; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hayes SM, 2007, IMMUNOL REV, V215, P8, DOI 10.1111/j.1600-065X.2006.00476.x; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Jones ME, 2009, ADV EXP MED BIOL, V650, P148; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2010, CURR OPIN IMMUNOL, V22, P185, DOI 10.1016/j.coi.2009.12.006; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Matthews AGW, 2009, NAT IMMUNOL, V10, P817, DOI 10.1038/ni.1776; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Nitta T, 2008, ADV IMMUNOL, V99, P59, DOI 10.1016/S0065-2776(08)00603-2; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Robey E, 1994, Semin Immunol, V6, P207, DOI 10.1006/smim.1994.1026; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Sarafova SD, 2009, IMMUNITY, V31, P480, DOI 10.1016/j.immuni.2009.07.006; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STOCKINGER B, 2010, NAT IMMUNOL     0720, DOI DOI 10.1038/NI.1899; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon T, 2008, SEMIN IMMUNOPATHOL, V30, P383, DOI 10.1007/s00281-008-0134-3; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2010, SEMIN IMMUNOL, V22, P294, DOI 10.1016/j.smim.2010.04.013; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yu Q, 2010, IMMUNOL RES, V47, P45, DOI 10.1007/s12026-009-8137-2; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	130	192	197	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					666	673		10.1038/ni.1887	http://dx.doi.org/10.1038/ni.1887			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644572	Green Accepted			2022-12-18	WOS:000280149400004
J	Weinreich, MA; Odumade, OA; Jameson, SC; Hogquist, KA				Weinreich, Michael A.; Odumade, Oludare A.; Jameson, Stephen C.; Hogquist, Kristin A.			T cells expressing the transcription factor PLZF regulate the development of memory-like CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE PROTECTION; NKT CELLS; HOMEOSTATIC PROLIFERATION; ZINC-FINGER; IFN-GAMMA; ITK; EFFECTOR; THYMOCYTE; MICE; DEFICIENCY	Several gene-deficiency models promote the development of innate CD8(+) T cells that have diverse T cell antigen receptors (TCRs) but have a memory phenotype and rapidly produce cytokines. We demonstrate here that similar cells developed in mice deficient in the transcription factor KLF2. However, this was not due to intrinsic deficiency in KLF2 but instead was due to interleukin 4 (IL-4) produced by an expanded population of T cells expressing the transcription factor PLZF. The development of innate CD8(+) T cells in mice deficient in the tyrosine kinase Itk and coactivator CBP was also attributable to this IL-4-dependent mechanism. Finally, we show that the same mechanism drove the differentiation of innate CD8(+) T cells in BALB/c mice. Our findings identify a previously unknown mechanism of regulation of CD8(+) T cells via the production of IL-4 by PLZF(+) T cells.	[Weinreich, Michael A.; Odumade, Oludare A.; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687	US National Institutes of Health [R01 AI35296, R37 AI38903, T32 AI007313]; University of Minnesota; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R37AI038903, P01AI035296, R01AI038903, R01AI039560] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Finkelman (University of Cincinnati) for B6 Il4ra<SUP>-/-</SUP> mice; D. Kioussis (National Institute for Medical Research, London) for Vav-Cre mice; J. Lingrel (University of Cincinnati) for Kif2<SUP>fl/fl</SUP> mice; R. Proia (National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health) for S1pr1<SUP>fl/fl</SUP> mice; Y. Shimizu (University of Minnesota) for Itk<SUP>-/-</SUP> mice; R. Braun (Jackson Laboratory) for PLZF<SUP>lu/lu</SUP> mice; D. Masopust (University of Minnesota) for SMARTA TCR-transgenic mice; P. Brindle (St. Jude Children's Research Hospital) for Cbp<SUP>fl/fl</SUP>Lck-Cre bone marrow; X. Ding, J. Vevea, J. Reyes and C. Mora-Solano for technical assistance; and L. Berg and P. Schwartzberg for discussions. H. O'Donnell did initial experiments with Il4ra-/-mice. Supported by the US National Institutes of Health (R01 AI35296 to K.A.H., R37 AI38903 to S.C.J., and T32 AI007313 to M.A.W.) and the University of Minnesota (M.A.W.).	Allende ML, 2008, FASEB J, V22, P307, DOI 10.1096/fj.07-9087com; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Azuara V, 2001, EUR J IMMUNOL, V31, P205, DOI 10.1002/1521-4141(200101)31:1<205::AID-IMMU205>3.3.CO;2-#; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Dhanji S, 2006, J IMMUNOL, V177, P138, DOI 10.4049/jimmunol.177.1.138; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Lee YJ, 2009, IMMUNOL CELL BIOL, V87, P65, DOI 10.1038/icb.2008.85; LEWIS DB, 1991, J EXP MED, V173, P89, DOI 10.1084/jem.173.1.89; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Morris SC, 2009, J IMMUNOL, V182, P1429, DOI 10.4049/jimmunol.182.3.1429; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Rymarchyk SL, 2008, IMMUNOLOGY, V125, P331, DOI 10.1111/j.1365-2567.2008.02846.x; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Ueda N, 2006, INT IMMUNOL, V18, P1397, DOI 10.1093/intimm/dxl073; Ueda-Hayakawa I, 2009, J IMMUNOL, V182, P5306, DOI 10.4049/jimmunol.0804249; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Vesosky B, 2009, INFECT IMMUN, V77, P3355, DOI 10.1128/IAI.00295-09; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	48	192	194	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					709	U75		10.1038/ni.1898	http://dx.doi.org/10.1038/ni.1898			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20601952	Green Accepted			2022-12-18	WOS:000280149400012
J	Strid, J; Roberts, SJ; Filler, RB; Lewis, JM; Kwong, BY; Schpero, W; Kaplan, DH; Hayday, AC; Girardi, M				Strid, Jessica; Roberts, Scott J.; Filler, Renata B.; Lewis, Julia M.; Kwong, Bernice Y.; Schpero, William; Kaplan, Daniel H.; Hayday, Adrian C.; Girardi, Michael			Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis	NATURE IMMUNOLOGY			English	Article							DELTA-T-CELLS; V(ALPHA)14 NKT CELLS; FOLLICLE STEM-CELLS; CANCER IMMUNOSURVEILLANCE; TUMOR IMMUNOSURVEILLANCE; UL16-BINDING PROTEIN; NATURAL CYTOTOXICITY; DOWN-REGULATION; SKIN-CANCER; MIC LIGANDS	The self-encoded ligands MICA ( human) and Rae-1 ( mouse) for the cytotoxic lymphocyte activating receptor NKG2D are highly expressed in carcinomas and inflammatory lesions and have been linked to immunosurveillance and graft rejection. However, whether NKG2D ligands have an intrinsic ability to acutely regulate tissue-associated immune compartments is not known. Here we show that epidermis-specific upregulation of Rae-1 induced rapid, coincident and reversible changes in the organization of tissue-resident V gamma 5V delta 1 TCR gamma delta(+) intraepithelial T cells and Langerhans cells, swiftly followed by epithelial infiltration by unconventional ab T cells. Whereas local V gamma 5V delta 1(+) T cells limited carcinogenesis, Langerhans cells unexpectedly promoted it. These results provide unique insight into the early phases of tissue immunosurveillance and indicate that acute changes in NKG2D ligands may alone initiate a rapid, multifaceted immunosurveillance response in vivo.	[Strid, Jessica; Hayday, Adrian C.] Guys Hosp, Sch Med, Univ London Kings Coll, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Roberts, Scott J.; Filler, Renata B.; Lewis, Julia M.; Kwong, Bernice Y.; Schpero, William; Girardi, Michael] Yale Univ, Sch Med, Skin Dis Res Ctr, New Haven, CT 06511 USA; [Roberts, Scott J.; Filler, Renata B.; Lewis, Julia M.; Kwong, Bernice Y.; Schpero, William; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06511 USA; [Kaplan, Daniel H.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; Yale University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hayday, AC (corresponding author), Guys Hosp, Sch Med, Univ London Kings Coll, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk	Kaplan, Daniel H/N-2779-2013	Kaplan, Daniel H/0000-0002-7851-7320; HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343; Strid, Jessica/0000-0003-3690-2201	Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA102703] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA102703] Funding Source: Medline; Wellcome Trust [085780, 071534] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bonish B, 2000, J IMMUNOL, V165, P4076, DOI 10.4049/jimmunol.165.7.4076; Born W, 1999, Adv Immunol, V71, P77; Cameron AL, 2002, ARCH DERMATOL RES, V294, P363, DOI 10.1007/s00403-002-0349-4; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MILLER SJ, 1993, J INVEST DERMATOL, V101, P591, DOI 10.1111/1523-1747.ep12366045; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Nishibu A, 2006, J INVEST DERMATOL, V126, P787, DOI 10.1038/sj.jid.5700107; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Qin ZH, 2004, NAT IMMUNOL, V5, P3, DOI 10.1038/ni0104-3; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; Rolle A, 2003, J IMMUNOL, V171, P902, DOI 10.4049/jimmunol.171.2.902; Schreiber RD, 2004, NAT IMMUNOL, V5, P4, DOI 10.1038/ni0104-4; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160	50	192	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					146	154		10.1038/ni1556	http://dx.doi.org/10.1038/ni1556			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18176566				2022-12-18	WOS:000252503000011
J	Ranuncolo, SM; Polo, JM; Dierov, J; Singer, M; Kuo, T; Greally, J; Green, R; Carroll, M; Melnick, A				Ranuncolo, Stella Maris; Polo, Jose M.; Dierov, Jamil; Singer, Michael; Kuo, Tracy; Greally, John; Green, Roland; Carroll, Martin; Melnick, Ari			Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR	NATURE IMMUNOLOGY			English	Article							CLASS SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; DEAMINASE AID; ACTIVATION; EXPRESSION; REPLICATION; HYPERMUTATION; CHECKPOINT; DIFFERENTIATION; INFLAMMATION	Antibody specificity and diversity is generated in B cells during germinal center maturation through clonal expansion while they undergo class-switch recombination and somatic hypermutation. Here we demonstrate that the transcriptional repressor Bcl-6 mediates this phenotype by directly repressing ATR in centroblasts and lymphoma cells. ATR is critical in replication and DNA damage-sensing checkpoints. Bcl-6 allowed B cells to evade ATR-mediated checkpoints and attenuated the response of the B cells to exogenous DNA damage. Repression of ATR was necessary and sufficient for those Bcl-6 activities. CD40 signaling 'rescued' B cells from those effects by disrupting the Bcl-6 transcription-repression complex on the promoter of the gene encoding ATR. Our data demonstrate a transcriptional regulatory loop whereby Bcl-6 mediates the centroblast phenotype through transient silencing of ATR.	Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; NimbleGen Syst, Madison, WI 53711 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Roche NimbleGen; University of California System; University of California Berkeley; Yeshiva University; Albert Einstein College of Medicine	Carroll, M (corresponding author), Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA.	carroll2@mail.med.upenn.edu; amelnick@aecom.yu.edu	Melnick, Ari/AAA-5763-2020; Greally, John/AAF-9540-2019	Greally, John/0000-0001-6069-7960; Polo, Jose M/0000-0002-2531-778X; Ranuncolo, Stella/0000-0001-7775-9048	NATIONAL CANCER INSTITUTE [R01CA104348, R01CA100885] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100885, R01 CA104348] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Espinosa L, 2002, J CELL SCI, V115, P1295; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gifford LK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni024; Golay J, 1998, J IMMUNOL, V160, P2786; Ho CC, 2005, EXP CELL RES, V304, P1, DOI 10.1016/j.yexcr.2004.10.016; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; Huynh KD, 2000, GENE DEV, V14, P1810; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Margalit O, 2006, BLOOD, V107, P1599, DOI 10.1182/blood-2005-04-1629; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; Shechter D, 2005, CELL CYCLE, V4, P235; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	50	192	199	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					705	714		10.1038/ni1478	http://dx.doi.org/10.1038/ni1478			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17558410				2022-12-18	WOS:000247718100011
J	Rathinam, VAK; Zhao, Y; Shao, F				Rathinam, Vijay A. K.; Zhao, Yue; Shao, Feng			Innate immunity to intracellular LPS	NATURE IMMUNOLOGY			English	Review							GUANYLATE-BINDING-PROTEINS; NONCANONICAL INFLAMMASOME ACTIVATION; ANTHRAX LETHAL TOXIN; GASDERMIN-D; NLRP3 INFLAMMASOME; CELL-DEATH; AIM2 INFLAMMASOME; SHIGELLA-FLEXNERI; HOST-DEFENSE; IFN-GAMMA	Monitoring of the cytosolic compartment by the innate immune system for pathogen-encoded products or pathogen activities often enables the activation of a subset of caspases. In most cases, the cytosolic surveillance pathways are coupled to activation of caspase-1 via canonical inflammasome complexes. A related set of caspases, caspase-11 in rodents and caspase-4 and caspase-5 in humans, monitors the cytosol for bacterial lipopolysaccharide (LPS). Direct activation of caspase-11, caspase-4 and caspase-5 by intracellular LPS elicits the lytic cell death called 'pyroptosis', which occurs in multiple cell types. The pyroptosis is executed by the pore-forming protein GSDMD, which is activated by cleavage mediated by caspase-11, caspase-4 or caspase-5. In monocytes, formation of GSDMD pores can induce activation of the NLRP3 inflammasome for maturation of the cytokines IL-1 beta and IL-18. Caspase-11-mediated pyroptosis in response to cytosolic LPS is critical for antibacterial defense and septic shock. Here we review the emerging literature on the sensing of cytosolic LPS and its regulation and pathophysiological functions.	[Rathinam, Vijay A. K.] UConn Hlth Sch Med, Dept Immunol, Farmington, CT 06030 USA; [Zhao, Yue; Shao, Feng] Natl Inst Biol Sci, Beijing, Peoples R China	National Institute of Biological Sciences, Beijing	Rathinam, VAK (corresponding author), UConn Hlth Sch Med, Dept Immunol, Farmington, CT 06030 USA.; Shao, F (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	rathinam@uchc.edu; shaofeng@nibs.ac.cn	Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Shao, Feng/0000-0002-9562-7791	Basic Science Center Project of the National Natural Science Foundation of China [81788101]; National Key Research and Development Program of China [2016YFA0501500, 2017YFA0505900]; US National Institutes of Health [R01AI119015, R21AI 135528]	Basic Science Center Project of the National Natural Science Foundation of China; National Key Research and Development Program of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Snyder for editing the manuscript. Research in the Shao laboratory is supported by the Basic Science Center Project of the National Natural Science Foundation of China (81788101) and National Key Research and Development Program of China (2016YFA0501500 and 2017YFA0505900). Research in the Rathinam laboratory is supported by the US National Institutes of Health (R01AI119015 and R21AI 135528).	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Bitto NJ, 2018, IMMUNOL CELL BIOL, V96, P1120, DOI 10.1111/imcb.12190; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Cecil JD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01017; Chen KW, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6676; Chen SW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007240; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Chu LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03409-3; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Finethy R, 2017, MBIO, V8, DOI 10.1128/mBio.01188-17; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gu L, 2019, SHOCK, V51, P256, DOI 10.1097/SHK.0000000000001129; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Jorgensen I, 2016, J EXP MED, V213, P2113, DOI 10.1084/jem.20151613; Kang R, 2018, CELL HOST MICROBE, V24, P97, DOI 10.1016/j.chom.2018.05.009; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kanneganti A, 2018, J EXP MED, V215, P1519, DOI 10.1084/jem.20172060; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2016, NAT IMMUNOL, V17, P481, DOI 10.1038/ni.3440; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Kuang SY, 2017, P NATL ACAD SCI USA, V114, P10642, DOI 10.1073/pnas.1708194114; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lagrange B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02682-y; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Li WB, 2018, SHOCK, V50, P339, DOI 10.1097/SHK.0000000000001012; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu Z, 2018, STRUCTURE, V26, P778, DOI 10.1016/j.str.2018.03.002; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Mandal P, 2018, IMMUNITY, V49; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Napier BA, 2016, J EXP MED, V213, P2365, DOI 10.1084/jem.20160027; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Pallett MA, 2017, MUCOSAL IMMUNOL, V10, P602, DOI 10.1038/mi.2016.77; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perkins C, 1998, CANCER RES, V58, P4561; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Russo AJ, 2018, CELL HOST MICROBE, V24, P8, DOI 10.1016/j.chom.2018.06.010; Russo AJ, 2018, J MOL BIOL, V430, P207, DOI 10.1016/j.jmb.2017.10.003; Saeki N., 2011, ENDOTHELIUM EPITHELI, P193; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Wacker MA, 2017, INNATE IMMUN-LONDON, V23, P336, DOI 10.1177/1753425917695446; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Wang J, 2017, INT J MED MICROBIOL, V307, P490, DOI 10.1016/j.ijmm.2017.09.012; Wang JH, 2018, INT J INF TECHNOL SY, V11, P18, DOI 10.4018/IJITSA.2018070102; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wang W, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00350-17; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Xiao JQ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000047; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yokoyama S, 2018, ELIFE, V7, DOI 10.7554/eLife.37854; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003; Zhou P, 2018, NATURE, V561, P122, DOI 10.1038/s41586-018-0433-3; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	94	191	200	26	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					527	533		10.1038/s41590-019-0368-3	http://dx.doi.org/10.1038/s41590-019-0368-3			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30962589	Green Accepted			2022-12-18	WOS:000465084800010
J	Shinnakasu, R; Inoue, T; Kometani, K; Moriyama, S; Adachi, Y; Nakayama, M; Takahashi, Y; Fukuyama, H; Okada, T; Kurosaki, T				Shinnakasu, Ryo; Inoue, Takeshi; Kometani, Kohei; Moriyama, Saya; Adachi, Yu; Nakayama, Manabu; Takahashi, Yoshimasa; Fukuyama, Hidehiro; Okada, Takaharu; Kurosaki, Tomohiro			Regulated selection of germinal-center cells into the memory B cell compartment	NATURE IMMUNOLOGY			English	Article							CLONAL SELECTION; EXPRESSION; BACH2; PROLIFERATION; MATURATION; ANTIBODIES; EFFECTOR; DYNAMICS; BLIMP-1; NETWORK	Despite the importance of memory B cells in protection from reinfection, how such memory cells are selected and generated during germinal-center (GC) reactions remains unclear. We found here that light-zone (LZ) GC B cells with B cell antigen receptors (BCRs) of lower affinity were prone to enter the memory B cell pool. Mechanistically, cells in this memory-prone fraction had higher expression of the transcriptional repressor Bach2 than that of their counterparts with BCRs of higher affinity. Haploinsufficiency of Bach2 resulted in reduced generation of memory B cells, independently of suppression of the gene encoding the transcription factor Blimp-1. Bach2 expression in GC cells was inversely correlated with the strength of help provided by T cells. Thus, we propose an instructive model in which weak help from T cells maintains relatively high expression of Bach2, which predisposes GC cells to enter the memory pool.	[Shinnakasu, Ryo; Inoue, Takeshi; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka, Japan; [Shinnakasu, Ryo; Kometani, Kohei; Fukuyama, Hidehiro; Kurosaki, Tomohiro] RIKEN, Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan; [Moriyama, Saya; Okada, Takaharu] RIKEN, Ctr Integrat Med Sci, Lab Tissue Dynam, Yokohama, Kanagawa, Japan; [Adachi, Yu; Takahashi, Yoshimasa] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Chromosome Engn Team, Kisarazu, Chiba, Japan; [Okada, Takaharu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Saitama, Japan; [Okada, Takaharu] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 232, Japan; [Kometani, Kohei] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, Freiburg, Germany; [Moriyama, Saya] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, John & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med Coll, New York, NY 10021 USA	Osaka University; RIKEN; RIKEN; National Institute of Infectious Diseases (NIID); Kazusa DNA Research Institute; Japan Science & Technology Agency (JST); Yokohama City University; Max Planck Society; Cornell University	Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka, Japan.; Kurosaki, T (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa, Japan.	kurosaki@ifrec.osaka-u.ac.jp	Fukuyama, Hidehiro/AAY-6256-2021; Fukuyama, Hidehiro/N-5276-2018	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Takahashi, Yoshimasa/0000-0001-6342-4087; Kometani, Kohei/0000-0003-4281-4371	Ministry of Education, Culture, Sports, Science, and Technology of Japan [A212290070, A262213060, T268603430]; Japan Science and Technology (CREST) [J098501018 JST]; Grants-in-Aid for Scientific Research [16K15296, 15K19127] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology (CREST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D.L. Court (National Cancer Institute) for plasmid pSIM18 for the generation of BAC-transgenic mice; J.G. Cyster (UC San Francisco) for Hy10 mice; E. Hobeika and M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for Mb1-Cre mice; M. Nussenzweig (The Rockefeller University) for B1-8<SUP>hi</SUP> mice, anti-DEC205-OVA and anti-DEC205-CS; G.D. Victora (Whitehead Institute for Biomedical Research) for gene sets for the gene-set-enrichment analysis; O. Ohara, T. Watanabe and Y. Mochizuki for transcriptome analysis; W. Ise for discussions; M. Tochigi, C. Kawai, A. Arakawa and H. Masuda for technical assistance; P. Burrows for critical reading; and R. Brink for communicating unpublished results. Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (A212290070, A262213060 to T.K.; and T268603430 to R.S.) and Japan Science and Technology (CREST) (J098501018 JST to T.K.).	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; McHeyzer-Williams Louise J, 2004, Methods Mol Biol, V271, P173; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	48	191	191	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					861	+		10.1038/ni.3460	http://dx.doi.org/10.1038/ni.3460			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27158841				2022-12-18	WOS:000378283200019
J	Possot, C; Schmutz, S; Chea, S; Boucontet, L; Louise, A; Cumano, A; Golub, R				Possot, Cecilie; Schmutz, Sandrine; Chea, Sylvestre; Boucontet, Laurent; Louise, Anne; Cumano, Ana; Golub, Rachel			Notch signaling is necessary for adult, but not fetal, development of ROR gamma t(+) innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; NATURAL-KILLER-CELLS; INDUCER-LIKE CELLS; CD4(+)CD3(-) CELLS; GENE-EXPRESSION; RECEPTOR; NK; PROGENITORS; DISTINCT; LIGAND	The transcription factor ROR gamma t is required for the development of several innate lymphoid populations, such as lymphoid tissue-inducer cells (LTi cells) and cells that secrete interleukin 17 (IL-17) or IL-22. The progenitor cells as well as the developmental stages that lead to the emergence of ROR gamma t(+) innate lymphoid cells (ILCs) remain undefined. Here we identify the chemokine receptor CXCR6 as an additional marker of the development of ILCs and show that common lymphoid progenitors lost B cell and T cell potential as they successively acquired expression of the integrin alpha(4)beta(7) and CXCR6. Whereas fetal ROR gamma t(+) cells matured in the fetal liver environment, adult bone marrow-derived ROR gamma t(+) ILCs matured outside the bone marrow, in a Notch2-dependent manner. Therefore, fetal and adult environments influence the differentiation of ROR gamma t(+) cells differently.	[Possot, Cecilie; Schmutz, Sandrine; Chea, Sylvestre; Boucontet, Laurent; Cumano, Ana; Golub, Rachel] Inst Pasteur, Unite Lymphopoiese, Paris, France; [Possot, Cecilie; Chea, Sylvestre; Golub, Rachel] LUniv Paris Diderot, Paris, France; [Possot, Cecilie; Schmutz, Sandrine; Chea, Sylvestre; Boucontet, Laurent; Cumano, Ana; Golub, Rachel] Inst Natl Sante & Rech Med, U668, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Golub, R (corresponding author), Inst Pasteur, Unite Lymphopoiese, Paris, France.	rachel.golub@pasteur.fr	Rachel, GOLUB/M-7188-2014; VOUGNY, Marie-Christine/K-8938-2017; GOLUB, rachel/X-8717-2019	Rachel, GOLUB/0000-0002-2306-5363; GOLUB, rachel/0000-0002-2306-5363; CHEA, Sylvestre/0000-0002-0498-8429	Ministere de la Recherche; Association pour la Recherche sur le Cancer; Swiss National Science Foundation; Fondation Sante; Institut Pasteur; Universite Paris Diderot; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de Recherches	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Sante; Institut Pasteur(European Commission); Universite Paris Diderot; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de Recherches(French National Research Agency (ANR))	We thank J. Bertrand and R. Lo Man for comments on the manuscript; F. Geissmann (King's College London) for Cxcr6<SUP>GFP/+</SUP> mice; and S. Ezine (Institut National de la Sante et de la Recherche Medicale U591) for nude mice. Supported by the Ministere de la Recherche (C.P.), Association pour la Recherche sur le Cancer (C.P.), Swiss National Science Foundation (S.S.), Fondation Sante (S.S.), Institut Pasteur (A.C., L.B. and A.L.), Universite Paris Diderot (R.G., C.P. and S.C.), Institut National de la Sante et de la Recherche Medicale (A.C.) and Agence Nationale de Recherches (A.C., R.G. and S.S.).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; BORN W, 1988, J IMMUNOL, V140, P3228; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Iizuka T, 2000, J IMMUNOL, V164, P2463, DOI 10.4049/jimmunol.164.5.2463; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Kim MY, 2007, BLOOD, V109, P1602, DOI 10.1182/blood-2006-04-018465; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2003, J IMMUNOL, V171, P2208, DOI 10.4049/jimmunol.171.5.2208; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Miyagi T, 2000, J BIOL CHEM, V275, P31305, DOI 10.1074/jbc.M001269200; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	49	191	196	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					949	U54		10.1038/ni.2105	http://dx.doi.org/10.1038/ni.2105			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21909092				2022-12-18	WOS:000295084500010
J	Bustamante, J; Arias, AA; Vogt, G; Picard, C; Galicia, LB; Prando, C; Grant, AV; Marchal, CC; Hubeau, M; Chapgier, A; de Beaucoudrey, L; Puel, A; Feinberg, J; Valinetz, E; Janniere, L; Besse, C; Boland, A; Brisseau, JM; Blanche, S; Lortholary, O; Fieschi, C; Emile, JF; Boisson-Dupuis, S; Al-Muhsen, S; Woda, B; Newburger, PE; Condino-Neto, A; Dinauer, MC; Abel, L; Casanova, JL				Bustamante, Jacinta; Arias, Andres A.; Vogt, Guillaume; Picard, Capucine; Blancas Galicia, Lizbeth; Prando, Carolina; Grant, Audrey V.; Marchal, Christophe C.; Hubeau, Marjorie; Chapgier, Ariane; de Beaucoudrey, Ludovic; Puel, Anne; Feinberg, Jacqueline; Valinetz, Ethan; Janniere, Lucile; Besse, Celine; Boland, Anne; Brisseau, Jean-Marie; Blanche, Stephane; Lortholary, Olivier; Fieschi, Claire; Emile, Jean-Francois; Boisson-Dupuis, Stephanie; Al-Muhsen, Saleh; Woda, Bruce; Newburger, Peter E.; Condino-Neto, Antonio; Dinauer, Mary C.; Abel, Laurent; Casanova, Jean-Laurent			Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease	NATURE IMMUNOLOGY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PHAGOCYTE RESPIRATORY BURST; HIGH-LEVEL RECONSTITUTION; NADPH OXIDASE; FLAVOCYTOCHROME B(558); CYTOCHROME B(558); REACTIVE OXYGEN; PRIMARY IMMUNODEFICIENCIES; HUMAN-NEUTROPHILS; INTERFERON-GAMMA	Germline mutations in CYBB, the human gene encoding the gp91(phox) subunit of the phagocyte NADPH oxidase, impair the respiratory burst of all types of phagocytes and result in X-linked chronic granulomatous disease (CGD). We report here two kindreds in which otherwise healthy male adults developed X-linked recessive Mendelian susceptibility to mycobacterial disease (MSMD) syndromes. These patients had previously unknown mutations in CYBB that resulted in an impaired respiratory burst in monocyte-derived macrophages but not in monocytes or granulocytes. The macrophage-specific functional consequences of the germline mutation resulted from cell-specific impairment in the assembly of the NADPH oxidase. This 'experiment of nature' indicates that CYBB is associated with MSMD and demonstrates that the respiratory burst in human macrophages is a crucial mechanism for protective immunity to tuberculous mycobacteria.	[Bustamante, Jacinta; Picard, Capucine; Blancas Galicia, Lizbeth; Grant, Audrey V.; Hubeau, Marjorie; Chapgier, Ariane; de Beaucoudrey, Ludovic; Puel, Anne; Feinberg, Jacqueline; Janniere, Lucile; Fieschi, Claire; Boisson-Dupuis, Stephanie; Abel, Laurent; Casanova, Jean-Laurent] INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Bustamante, Jacinta; Picard, Capucine; Blancas Galicia, Lizbeth; Grant, Audrey V.; Hubeau, Marjorie; Chapgier, Ariane; de Beaucoudrey, Ludovic; Puel, Anne; Feinberg, Jacqueline; Janniere, Lucile; Fieschi, Claire; Boisson-Dupuis, Stephanie; Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Necker Med Sch, Paris, France; [Arias, Andres A.; Marchal, Christophe C.; Valinetz, Ethan; Dinauer, Mary C.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Vogt, Guillaume; Prando, Carolina; Boisson-Dupuis, Stephanie; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Study Primary Immunodeficiencies, Paris, France; [Picard, Capucine; Blanche, Stephane; Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Blancas Galicia, Lizbeth] Natl Inst Pediat, Unit Immunodeficiency, Mexico City, DF, Mexico; [Besse, Celine; Boland, Anne] Natl Genotyping Ctr, Evry, France; [Brisseau, Jean-Marie] Nantes Hosp, Dept Internal Med, Nantes, France; [Lortholary, Olivier] Hop Necker Enfants Malad, AP HP, Dept Infect Dis, Paris, France; [Fieschi, Claire] Hop St Louis, Adult Immunopathol Unit, Paris, France; [Emile, Jean-Francois] Hop Ambroise Pare, INSERM, U602, Dept Pathol, Boulogne, France; [Emile, Jean-Francois] Versailles St Quentin En Yvelines Univ, Boulogne, France; [Al-Muhsen, Saleh; Casanova, Jean-Laurent] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Dept Pediat, Riyadh 11461, Saudi Arabia; [Woda, Bruce] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Newburger, Peter E.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Condino-Neto, Antonio] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; King Saud University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Sao Paulo	Casanova, JL (corresponding author), INSERM, U980, Necker Branch, Lab Human Genet Infect Dis, Paris, France.	jean-laurent.casanova@rockefeller.edu	Al-muhsen, saleh/E-9315-2014; Bustamante, Jacinta/H-7877-2017; Valinetz, Ethan/AAA-5658-2020; Condino-Neto, Antonio/D-4762-2012; Puel, Anne/H-7305-2017; Vogt, Guillaume/L-6046-2015; Casanova, Jean-Laurent/I-3418-2017; Abel, Laurent/H-8888-2017; Boisson-Dupuis, Stéphanie/I-2040-2017; Prando, Carolina/C-4689-2015; Boisson-Dupuis, Stephanie/AAF-5066-2021; Picard, Capucine/H-3914-2017; Woda, Bruce/AAS-5898-2020	Al-muhsen, saleh/0000-0003-3698-9968; Bustamante, Jacinta/0000-0002-3439-2482; Valinetz, Ethan/0000-0003-1717-3795; Condino-Neto, Antonio/0000-0002-1069-3117; Puel, Anne/0000-0003-2603-0323; Vogt, Guillaume/0000-0001-8192-1247; Abel, Laurent/0000-0001-7016-6493; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Prando, Carolina/0000-0002-9570-9770; Picard, Capucine/0000-0001-8788-5056; Arias Sierra, Andres Augusto/0000-0002-9478-8403; Casanova, Jean-Laurent/0000-0002-7782-4169; Newburger, Peter/0000-0002-8615-673X; Chapgier, Ariane/0000-0002-1734-0744	Institut National de la Sante et de la Recherche Medicale; European Union [NEOTIM EEA05095KKA, HEALTH-F3-2008-200732]; March of Dimes [RO5050KK]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fondation BNP-Paribas; Fondation Schlumberger; Institut Universitaire de France; Agence Nationale de Recherche; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143-03]; Rockefeller University; National Institutes of Health [AI 079788, DK54369, HL045635]; Riley Children's Foundation; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI095983, R21AI079788, R01AI089970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054369] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Union(European Commission); March of Dimes(March of Dimes); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondation BNP-Paribas; Fondation Schlumberger(Schlumberger); Institut Universitaire de France; Agence Nationale de Recherche(French National Research Agency (ANR)); Rockefeller University Center for Clinical and Translational Science; Rockefeller University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the family members for participating in this study; J. Curnutte (3-V Biosciences) for EBV-B cells from CGD controls; D. Roos (University of Amsterdam) for mAb 449; F. Morel (Grenoble University) for mAb 7A2; M. Quinn (Montana State University) for mAb 54.1; all members of the two branches of the laboratory of Human Genetics of Infectious Diseases for discussions; and T. Leclerc, Y. Rose, M. de Suremain, M. Kezadi, and N. Stull for technical assistance. Supported by Institut National de la Sante et de la Recherche Medicale (J. B.), the European Union (NEOTIM EEA05095KKA to J. B., and HOMITB HEALTH-F3-2008-200732), the March of Dimes (RO5050KK to J. B.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (A.C.-N.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (A.C.-N.), Fondation BNP-Paribas, Fondation Schlumberger, Institut Universitaire de France, Agence Nationale de Recherche, The Rockefeller University Center for Clinical and Translational Science (5UL1RR024143-03), The Rockefeller University, the National Institutes of Health (AI 079788 and DK54369 to P. E. N., and HL045635 to M. C. D.), the Riley Children's Foundation (M. C. D.) and the Howard Hughes Medical Institute (J.-L.C.).	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Biberstine-Kinkade KJ, 2002, J BIOL CHEM, V277, P30368, DOI 10.1074/jbc.M203993200; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Bustamante J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043406; Bustamante J, 2007, J ALLERGY CLIN IMMUN, V120, P32, DOI 10.1016/j.jaci.2007.04.034; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; Condino-Neto A, 1998, ARCH BIOCHEM BIOPHYS, V360, P158, DOI 10.1006/abbi.1998.0958; Conley ME, 2009, ANNU REV IMMUNOL, V27, P199, DOI 10.1146/annurev.immunol.021908.132649; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Ding CJ, 1996, BLOOD, V88, P1834; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; EZEKOWITZ RAB, 1990, BLOOD, V76, P2443; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Lee PPW, 2008, PEDIATR INFECT DIS J, V27, P224, DOI 10.1097/INF.0b013e31815b494c; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MALY FE, 1993, J EXP MED, V178, P2047, DOI 10.1084/jem.178.6.2047; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370; NAKAMURA M, 1987, BLOOD, V69, P1404; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; PERKINS SL, 1991, J LEUKOCYTE BIOL, V50, P427, DOI 10.1002/jlb.50.5.427; PORTER CD, 1994, BLOOD, V84, P2767; Porter CD, 1996, BIOCHEM J, V315, P571, DOI 10.1042/bj3150571; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Reichenbach J, 2001, CURR OPIN ALLERGY CL, V1, P503, DOI 10.1097/00130832-200112000-00003; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segal BH, 1999, INFECT IMMUN, V67, P1659; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yamauchi A, 2001, MICROBIOL IMMUNOL, V45, P249, DOI 10.1111/j.1348-0421.2001.tb02614.x; Yu LX, 1999, J BIOL CHEM, V274, P4364, DOI 10.1074/jbc.274.7.4364; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	50	191	198	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					213	U47		10.1038/ni.1992	http://dx.doi.org/10.1038/ni.1992			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21278736	Green Published, Green Accepted			2022-12-18	WOS:000287354400008
J	Liao, W; Schones, DE; Oh, J; Cui, YZ; Cui, KR; Roh, TY; Zhao, K; Leonard, WJ				Liao, Wei; Schones, Dustin E.; Oh, Jangsuk; Cui, Yongzhi; Cui, Kairong; Roh, Tae-Young; Zhao, Keji; Leonard, Warren J.			Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression	NATURE IMMUNOLOGY			English	Article							IL-4 RECEPTOR; TH2 DIFFERENTIATION; UP-REGULATION; STAT5; CELLS; SUFFICIENT; MECHANISMS; GENERATION; PATHWAYS; PROTEINS	T helper type 2 (T(H)2) cells are essential for humoral immunity and host defense. Interleukin 4 (IL-4) drives T(H)2 differentiation and IL-2 augments the accessibility of Il4 chromatin. Here we demonstrate that IL-2, by inducing binding of STAT5 to the Il4ra locus, which encodes IL-4 receptor alpha-chain (IL-4R alpha), was essential for inducing and maintaining IL-4R alpha expression. Although IL-4 induced IL-4R alpha expression, T cell receptor-induced IL-4R alpha expression was normal in Il4(-/-) cells but was much lower in Il2(-/-) cells. Notably, forced IL-4R alpha expression restored the T(H)2 differentiation of Il2(-/-) cells. Moreover, genome-wide mapping by chromatin immunoprecipitation coupled with sequencing showed broad interaction of the transcription factors STAT5A and STAT5B with genes associated with T(H)2 differentiation. Our results identify a previously unappreciated function for IL-2 in 'priming' T cells for T(H)2 differentiation and in maintaining the expression of Il4ra and other genes in T(H)2-committed cells.	[Liao, Wei; Schones, Dustin E.; Oh, Jangsuk; Cui, Kairong; Roh, Tae-Young; Zhao, Keji; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Cui, Yongzhi] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022	Roh, Tae-Young/0000-0001-5833-0844	Division of Intramural Research of the National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL005402, ZIAHL005801, ZIAHL005401] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank P. Ryan (National Heart, Lung and Blood Institute, National Institutes of Health) for Il4<SUP>-/-</SUP> mice; J. X. Lin (National Heart, Lung and Blood Institute, National Institutes of Health) for discussions and real-time PCR primers; J. F. Zhu, H. H. Xue, H. P. Kim and R. Spolski for discussions and technical assistance; L. Hennighausen for support and discussions; and X. Shirley Liu for the 'model-based analysis of ChiP-seq' algorithm. Supported by the Division of Intramural Research of the National Heart, Lung, and Blood Institute, National Institutes of Health.	Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Coffman RL, 1997, J EXP MED, V185, P373, DOI 10.1084/jem.185.3.373; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; DOKTER WHA, 1992, BLOOD, V80, P2721; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kagami S, 2001, BLOOD, V97, P2358, DOI 10.1182/blood.V97.8.2358; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; RENZ H, 1991, J IMMUNOL, V146, P3049; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	41	191	194	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1288	1296		10.1038/ni.1656	http://dx.doi.org/10.1038/ni.1656			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18820682	Green Accepted			2022-12-18	WOS:000260248600016
J	Upshaw, JL; Arneson, LN; Schoon, RA; Dick, CJ; Billadeau, DD; Leibson, PJ				Upshaw, JL; Arneson, LN; Schoon, RA; Dick, CJ; Billadeau, DD; Leibson, PJ			NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells	NATURE IMMUNOLOGY			English	Article							ACTIVATING NKG2D RECEPTOR; CD8(+) T-CELLS; HUMAN NK CELLS; MEDIATED CYTOTOXICITY; CUTTING EDGE; SH3 DOMAIN; CD28; COSTIMULATION; MOUSE; GRB2	NKG2D is an important immunosurveillance receptor that responds to stress-induced ligand expression on tumors and virus-infected cells. Human natural killer cells express NKG2D and require the transmembrane adaptor DAP10 to initiate their full cytotoxic activation. However, DAP10 has no immunoreceptor tyrosine-based activation motif and thus the mechanism of recruiting 'downstream' effector proteins is unclear. We show here that binding of the p85 subunit of phosphatidylinositol-3-kinase to DAP10 could not by itself trigger cell-mediated cytotoxicity and that binding of an intermediate consisting of the DAP10 binding partner Grb2 and the effector molecule Vav1 (Grb2-Vav1) to DAP10 was sufficient to initiate tyrosine-phosphorylation events. For full calcium release and cytotoxicity to occur, both Grb2-Vav1 and p85 had to bind to DAP10. These findings identify a previously unknown mechanism by which NKG2D-DAP10 mediates cytotoxicity and provides a framework for evaluating activation by other receptor complexes that lack immunoreceptor tyrosine-based activation motifs.	Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Leibson, PJ (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	leibson.paul@mayo.edu			NCI NIH HHS [CA-47752] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047752] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AZUMA M, 1992, J IMMUNOL, V149, P1115; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chang CW, 1999, J IMMUNOL, V163, P4651; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Galea-Lauri J, 1999, J IMMUNOL, V163, P62; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; GELDHOF AB, 1995, CANCER RES, V55, P2730; Goodier MR, 2004, IMMUNOLOGY, V111, P384, DOI 10.1111/j.0019-2805.2004.01834.x; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Hunter CA, 1997, J IMMUNOL, V158, P2285; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; Lang S, 1998, EUR J IMMUNOL, V28, P780, DOI 10.1002/(SICI)1521-4141(199803)28:03<780::AID-IMMU780>3.3.CO;2-#; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; Ogasawara K, 2005, NAT IMMUNOL, V6, P938, DOI 10.1038/ni1236; Ogura K, 2002, J BIOMOL NMR, V22, P37, DOI 10.1023/A:1013868731495; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RAMOSMORALES F, 1995, ONCOGENE, V11, P1665; Rosen DB, 2004, J IMMUNOL, V173, P2470, DOI 10.4049/jimmunol.173.4.2470; RUBIN P, 1982, J IMMUNOL, V128, P2553; Sada K, 2001, BLOOD, V97, P1352, DOI 10.1182/blood.V97.5.1352; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Takaki R, 2005, J IMMUNOL, V175, P2167, DOI 10.4049/jimmunol.175.4.2167; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Wilson JL, 1999, J IMMUNOL, V163, P4207; WINDEBANK KP, 1988, J IMMUNOL, V141, P3951; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; YEH KY, 1995, CELL IMMUNOL, V165, P217, DOI 10.1006/cimm.1995.1208; Zhou H, 2005, P NATL ACAD SCI USA, V102, P10846, DOI 10.1073/pnas.0502208102; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	51	191	202	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					524	532		10.1038/ni1325	http://dx.doi.org/10.1038/ni1325			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16582911				2022-12-18	WOS:000237008800018
J	Taniguchi, M; Seino, K; Nakayama, T				Taniguchi, M; Seino, K; Nakayama, T			The NKT cell system: bridging innate and acquired immunity	NATURE IMMUNOLOGY			English	Editorial Material									RIKEN, Res Ctr Allergy & Immunol, Lab Immunoregulat, Yokohama, Kanagawa, Japan; Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba, Japan	RIKEN; Chiba University	Taniguchi, M (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Immunoregulat, Yokohama, Kanagawa, Japan.		seino, kenichiro/F-8823-2012; Nakayama, Toshinori/E-1067-2017; Taniguchi, Masaru/N-7932-2015	Nakayama, Toshinori/0000-0002-1434-2007; Taniguchi, Masaru/0000-0001-7821-7179				Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Hong SM, 1999, IMMUNOL REV, V169, P31, DOI 10.1111/j.1600-065X.1999.tb01304.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Schaible UE, 2000, SEMIN IMMUNOL, V12, P527, DOI 10.1006/smim.2000.0272; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028	11	191	205	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1164	1165		10.1038/ni1203-1164	http://dx.doi.org/10.1038/ni1203-1164			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639465				2022-12-18	WOS:000186769500008
J	Meffre, E; Casellas, R; Nussenzweig, MC				Meffre, E; Casellas, R; Nussenzweig, MC			Antibody regulation of B cell development	NATURE IMMUNOLOGY			English	Review							LYN-DEFICIENT MICE; IMMUNOGLOBULIN LIGHT-CHAIN; V(D)J RECOMBINASE ACTIVITY; KAPPA GENE REARRANGEMENT; REACTIVE LYMPHOCYTES-B; SYK TYROSINE KINASE; MOUSE BONE-MARROW; MU HEAVY-CHAIN; ALLELIC EXCLUSION; ANTIGEN-RECEPTOR	Antibodies on the surface of B lymphocytes trigger adaptive immune responses and control a series of antigen-independent checkpoints during B cell development. These physiologic processes are regulated by a complex of membrane immunoglobulin and two signal transducing proteins known as Ig alpha and Ig beta. Here we focus on the role of antibodies in governing the maturation of B cells from early antigen-independent through the final antigen-dependent stages.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019					Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; APPLEBY MW, 1995, J EXP MED, V182, P1179; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; BELL SE, 1994, EMBO J, V13, P816, DOI 10.1002/j.1460-2075.1994.tb06324.x; BERINSTEIN N, 1989, SCIENCE, V244, P337, DOI 10.1126/science.2496466; BERNARD O, 1981, P NATL ACAD SCI-BIOL, V78, P5812, DOI 10.1073/pnas.78.9.5812; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; BURNET FM, 1959, CLONAL SELECTION THE; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Cherry SR, 1999, P NATL ACAD SCI USA, V96, P10788, DOI 10.1073/pnas.96.19.10788; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; FEDDERSEN RM, 1990, J IMMUNOL, V145, P745; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; FULOP G, 1983, J IMMUNOL, V130, P644; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217; GLACHINO C, 1995, J EXP MED, V181, P1245; Gong SC, 1996, J EXP MED, V184, P2079, DOI 10.1084/jem.184.6.2079; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hertz M, 1998, NATURE, V394, P292, DOI 10.1038/28419; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hikida M, 1997, J IMMUNOL, V158, P2509; Hikida M, 1996, SCIENCE, V274, P2092, DOI 10.1126/science.274.5295.2092; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HORNE M, 1996, IMMUNITY; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; Kerr W G, 1989, Int Immunol, V1, P355, DOI 10.1093/intimm/1.4.355; KEYNA U, 1995, J IMMUNOL, V155, P5536; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; KWAN SP, 1981, CELL, V26, P57, DOI 10.1016/0092-8674(81)90033-7; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Landsteiner K, 1936, SPECIFICITY SEROLOGI; LAWTON AR, 1972, J EXP MED, V135, P277, DOI 10.1084/jem.135.2.277; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; LEVY S, 1989, J EXP MED, V170, P1, DOI 10.1084/jem.170.1.1; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; Maki K, 2000, J EXP MED, V191, P1333, DOI 10.1084/jem.191.8.1333; MANZ J, 1989, J EXP MED, V169, P2269; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; MEEK K, 1990, SCIENCE, V250, P820, DOI 10.1126/science.2237433; Meffre E, 2000, NAT IMMUNOL, V1, P207, DOI 10.1038/79739; Meffre E, 1998, J EXP MED, V188, P765, DOI 10.1084/jem.188.4.765; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571; MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; OSMOND D, 1993, IMMUNOL TODAY, V14, P68; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Papavasiliou F, 1996, J EXP MED, V184, P2025, DOI 10.1084/jem.184.5.2025; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; Papavasiliou F, 1997, SCIENCE, V278, P298, DOI 10.1126/science.278.5336.298; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; PERLMUTTER RM, 1985, SCIENCE, V227, P1597, DOI 10.1126/science.3975629; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RASSENTI LZ, 1991, J IMMUNOL, V147, P1060; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; RETH MG, 1986, EMBO J, V5, P2131, DOI 10.1002/j.1460-2075.1986.tb04476.x; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; RITCHIE KA, 1984, NATURE, V312, P517, DOI 10.1038/312517a0; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHIFF C, 2000, IN PRESS IMMUNOL REV; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Shiokawa S, 1999, J IMMUNOL, V162, P6060; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; STANHOPEBAKER P, 1996, CELL, V85, P1; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; ten Boekel E, 1998, IMMUNITY, V8, P199; tenBoekel E, 1997, IMMUNITY, V7, P357; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tornberg UC, 1998, J EXP MED, V187, P703, DOI 10.1084/jem.187.5.703; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TSAO BP, 1993, EUR J IMMUNOL, V23, P2332, DOI 10.1002/eji.1830230942; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; TSUKAMOTO A, 1984, EMBO J, V3, P975, DOI 10.1002/j.1460-2075.1984.tb01916.x; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259; Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WHITE RG, 1958, NATURE, V182, P1383, DOI [10.1038/1811419a0, 10.1038/1821383a0]; WU GE, 1986, EMBO J, V5, P3475, DOI 10.1002/j.1460-2075.1986.tb04672.x; Yamagami T, 1999, IMMUNITY, V11, P309, DOI 10.1016/S1074-7613(00)80106-5; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	192	191	193	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					379	385		10.1038/80816	http://dx.doi.org/10.1038/80816			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062496				2022-12-18	WOS:000165076100009
J	Link, TM; Park, U; Vonakis, BM; Raben, DM; Soloski, MJ; Caterina, MJ				Link, Tiffany M.; Park, Una; Vonakis, Becky M.; Raben, Daniel M.; Soloski, Mark J.; Caterina, Michael J.			TRPV2 has a pivotal role in macrophage particle binding and phagocytosis	NATURE IMMUNOLOGY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; FC-GAMMA-RECEPTORS; PLASMA-MEMBRANE; CHANNEL; ACTIVATION; TRANSLOCATION; MECHANISMS; ACIDIFICATION; CD11B/CD18; PI3-KINASE	Macrophage phagocytosis is critical for defense against pathogens. Whereas many steps of phagocytosis involve ionic flux, the underlying ion channels remain ill defined. Here we show that zymosan-, immunoglobulin G (IgG)- and complement-mediated particle binding and phagocytosis were impaired in macrophages lacking the cation channel TRPV2. TRPV2 was recruited to the nascent phagosome and depolarized the plasma membrane. Depolarization increased the synthesis of phosphatidylinositol-4,5- bisphosphate (PtdIns(4,5)P-2), which triggered the partial actin depolymerization necessary for occupancy-elicited phagocytic receptor clustering. TRPV2-deficient macrophages were also defective in chemoattractant-elicited motility. Consequently, TRPV2-deficient mice showed accelerated mortality and greater organ bacterial load when challenged with Listeria monocytogenes. Our data demonstrate the participation of TRPV2 in early phagocytosis and its fundamental importance in innate immunity.	[Link, Tiffany M.; Park, Una; Raben, Daniel M.; Caterina, Michael J.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA; [Link, Tiffany M.; Park, Una; Caterina, Michael J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Link, Tiffany M.; Park, Una; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD USA; [Vonakis, Becky M.] Johns Hopkins Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Soloski, Mark J.] Johns Hopkins Sch Med, Dept Med, Div Rheumatol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA.	caterina@jhmi.edu	Vonakis, Becky/GSN-7958-2022	Vonakis, Becky/0000-0003-4174-6514	National Institutes of Health [R01NS051551, RO1AI42287-05, AI059298, AI071117, GM059251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI071117, R01AI042287, R56AI059298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Brederson, M.-K. Chung, S. Huang, M. Meffert, C. Munns and V. Vega for suggestions; J. Wang and S. Li for technical assistance; S. Hudson for help with flow cytometry; P. Devreotes (Johns Hopkins School of Medicine) for suggestions and latrunculin A; and W. Bishai and S. Huang for critically reading the manuscript. Supported by the National Institutes of Health (R01NS051551 to MJC, RO1AI42287-05 to M. J. S.; AI059298 and AI071117 to B. M. V.; GM059251 to D. M. R.; and a Medical Scientist Training Program Award to T. M. L.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; AMES BN, 1960, J BIOL CHEM, V235, P769; Campo B, 2003, J IMMUNOL, V170, P1167, DOI 10.4049/jimmunol.170.3.1167; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Defacque H, 2002, MOL BIOL CELL, V13, P1190, DOI 10.1091/mbc.01-06-0314; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; GUER AD, 2002, J NEUROSCI, V22, P6408; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; HOLEVINSKY KO, 1995, J BIOL CHEM, V270, P8328, DOI 10.1074/jbc.270.14.8328; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Juvin V, 2007, MOL PHARMACOL, V72, P1258, DOI 10.1124/mol.107.037044; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Kowase T, 2002, ENDOCR J, V49, P349, DOI 10.1507/endocrj.49.349; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; MEDH JD, 1989, J LIPID RES, V30, P761; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Schilling T, 2009, J NEUROIMMUNOL, V216, P118, DOI 10.1016/j.jneuroim.2009.07.008; Sobota A, 2005, J IMMUNOL, V175, P4450, DOI 10.4049/jimmunol.175.7.4450; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; YOUNG JDE, 1983, P NATL ACAD SCI-BIOL, V80, P1636, DOI 10.1073/pnas.80.6.1636	39	190	203	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					232	U7		10.1038/ni.1842	http://dx.doi.org/10.1038/ni.1842			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20118928	Green Accepted			2022-12-18	WOS:000274605800011
J	Jeffrey, KL; Brummer, T; Rolph, MS; Liu, SM; Callejas, NA; Grumont, RJ; Gillieron, C; Mackay, F; Grey, S; Camps, M; Rommel, C; Gerondakis, SD; Mackay, CR				Jeffrey, KL; Brummer, T; Rolph, MS; Liu, SM; Callejas, NA; Grumont, RJ; Gillieron, C; Mackay, F; Grey, S; Camps, M; Rommel, C; Gerondakis, SD; Mackay, CR			Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE PHOSPHATASE-1; DUAL-SPECIFICITY PHOSPHATASE; TUMOR-NECROSIS-FACTOR; MAP KINASE; INDUCED ARTHRITIS; MAST-CELLS; CROSS-TALK; IN-VIVO; ACTIVATION; GENE	Mitogen-activated protein kinases facilitate many cellular processes and are essential for immune cell function. Their activity is controlled by kinases and dual-specificity phosphatases. A comprehensive microarray analysis of human leukocytes identified DUSP2 ( encoding the phosphatase PAC-1) as one of the most highly induced transcripts in activated immune cells. We generated Dusp2(-/-) mice and found considerably reduced inflammatory responses in the 'K/BxN' model of rheumatoid arthritis. PAC-1 deficiency led to increased activity of Jun kinase (Jnk) but unexpected impairment of the activity of extracellular signal-regulated kinase (Erk) and the kinase p38, reduced activity of the transcription factor Elk1 and a complex of mobilized transcription factor NFAT and the AP-1 transcription factor and decreased effector immune cell function. Thus, PAC-1 is a key positive regulator of inflammatory cell signaling and effector functions, mediated through Jnk and Erk mitogen-activated protein kinase crosstalk.	Garvan Inst Med Res, Sydney, NSW 2010, Australia; Cooperat Res Ctr Asthma, Sydney, NSW 2010, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Serono Int, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland	Garvan Institute of Medical Research; Walter & Eliza Hall Institute	Mackay, CR (corresponding author), Garvan Inst Med Res, Sydney, NSW 2010, Australia.	gerondakis@wehi.edu.au; c.mackay@garvan.org.au	Brummer, Tilman/B-6218-2016; Mackay, Fabienne/B-7440-2008; Mackay, Charles R/A-9673-2008; Grey, Shane T/B-3020-2008; Brummer, Tilman/AAA-9428-2020	Brummer, Tilman/0000-0003-4387-7905; Mackay, Fabienne/0000-0002-6074-2693; Mackay, Charles R/0000-0002-6338-7340; Grey, Shane T/0000-0003-2160-1625; Brummer, Tilman/0000-0003-4387-7905; Jeffrey, Kate/0000-0001-5746-0153; Liu, Sue Min/0000-0003-1504-1115; Camps, Montserrat/0000-0002-9849-8657				Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Bowles NE, 1996, HUM GENE THER, V7, P1735, DOI 10.1089/hum.1996.7.14-1735; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dorfman K, 1996, ONCOGENE, V13, P925; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Farooq A, 2003, STRUCTURE, V11, P155, DOI 10.1016/S0969-2126(02)00943-7; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kohno M, 2005, BLOOD, V105, P2059, DOI 10.1182/blood-2004-07-2639; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Theodosiou A, 2002, GENOME BIOL, V3; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	51	190	196	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					274	283		10.1038/ni1310	http://dx.doi.org/10.1038/ni1310			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16474395				2022-12-18	WOS:000235360400012
J	Wang, YY; Tang, YW; Teng, L; Wu, YL; Zhao, XH; Pei, G				Wang, YY; Tang, YW; Teng, L; Wu, YL; Zhao, XH; Pei, G			Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; BETA-ARRESTIN-2; ACTIVATION; KINASE; ENZYME; UBIQUITINATION; INTERLEUKIN-1; TRANSDUCTION; RESPONSES	Tumor necrosis factor receptor-associated factor 6 (TRAF6) is critical for mediating Toll-like receptor (TLR)-interleukin 1 receptor (IL-1R) signaling and subsequent activation of NF-kappa B and AP-1, transcriptional activators of innate immunity. Here we show that beta-arrestins, a family of multifunctional proteins, directly interacted with TRAF6 after TLR-IL-1R activation. Formation of the beta-arrestin- TRAF6 complex prevented autoubiquitination of TRAF6 and activation of NF-kappa B and AP-1. Endotoxin-treated beta-arrestin 2-deficient mice had higher expression of proinflammatory cytokines and were more susceptible to endotoxic shock. Thus, beta-arrestins are essential negative regulators of innate immune activation via TLR-IL-1R signaling.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Lab Mol Cell Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Acad Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Lab Mol Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Wang, Yaya/G-7587-2012; Zhao, Xiaohui/G-7626-2012					Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DUNNE A, 2003, SCI STKE, P3; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	40	190	213	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					139	147		10.1038/ni1294	http://dx.doi.org/10.1038/ni1294			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16378096				2022-12-18	WOS:000234801700014
J	Brogden, KA; Guthmiller, JM; Salzet, M; Zasloff, M				Brogden, KA; Guthmiller, JM; Salzet, M; Zasloff, M			The nervous system and innate immunity: the neuropeptide connection	NATURE IMMUNOLOGY			English	Review							MELANOCYTE-STIMULATING HORMONE; ANTIMICROBIAL PEPTIDES; ALPHA-MSH; HOST-DEFENSE; SUBSTANCE-P; HUMAN SKIN; TERMINAL FRAGMENT; CHROMAFFIN CELLS; GENE-EXPRESSION; HUMAN-MONOCYTES	Many neuropeptides and peptide hormones are very similar to antimicrobial peptides in their amino acid composition, amphipathic design, cationic charge and size. Their antimicrobial activities suggest they may also be directly involved in innate defense. Here we discuss recent advances in understanding how the mammalian nervous system, equipped with neuropeptides and peptide hormones with potent antimicrobial properties, might directly defend the host from microbial assault. As examples, we have chosen five well described, locally produced neuropeptides that may serve a previously unrecognized, direct antimicrobial, innate immune function in four anatomical sites.	Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52252 USA; Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52252 USA; Univ & Technol Lille, CNRS, UMR 8017, IFR 118,Lab Neuroimmunol Annelides, F-59650 Villeneuve Dascq, France; Georgetown Univ, Med Ctr, Sch Med, Washington, DC 20057 USA	University of Iowa; University of Iowa; Centre National de la Recherche Scientifique (CNRS); Georgetown University	Brogden, KA (corresponding author), Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52252 USA.	kim-brogden@uiowa.edu	Salzet, Michel/A-7675-2011	Salzet, Michel/0000-0003-4318-0817	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014390] Funding Source: NIH RePORTER; NIDCR NIH HHS [1 R01 DE014390-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Allaker RP, 2003, REGUL PEPTIDES, V112, P147, DOI 10.1016/S0167-0115(03)00033-8; Allaker RP, 1999, FEMS IMMUNOL MED MIC, V23, P289, DOI 10.1016/S0928-8244(98)00148-5; Andrault JB, 2003, GENOMICS, V82, P172, DOI 10.1016/S0888-7543(03)00102-2; BARTHOLD SW, 1988, ACTA NEUROPATHOL, V76, P502, DOI 10.1007/BF00686390; Bateman A, 1996, J BIOL CHEM, V271, P10654, DOI 10.1074/jbc.271.18.10654; Bayerl C, 1997, INFLAMM RES, V46, P409, DOI 10.1007/s000110050212; Bedoui S, 2003, J NEUROIMMUNOL, V134, P1, DOI 10.1016/S0165-5728(02)00424-1; BEHAR O, 1994, ENDOCRINOLOGY, V134, P475, DOI 10.1210/en.134.1.475; BENSON BJ, 1969, COMP BIOCHEM PHYSIOL, V30, P857, DOI 10.1016/0010-406X(69)90040-1; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Born W, 2002, MICROSC RES TECHNIQ, V57, P14, DOI 10.1002/jemt.10051; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Cameron VA, 1998, ENDOCRINOLOGY, V139, P2253, DOI 10.1210/en.139.5.2253; Catania A, 2000, TRENDS ENDOCRIN MET, V11, P304, DOI 10.1016/S1043-2760(00)00296-4; Chakraborty AK, 1999, ANN NY ACAD SCI, V885, P100; Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257; Chang FY, 2000, TRANSPLANTATION, V69, P70, DOI 10.1097/00007890-200001150-00014; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Elsasser TH, 1999, ENDOCRINOLOGY, V140, P5402, DOI 10.1210/en.140.11.5402; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Eto T, 2003, REGUL PEPTIDES, V112, P61, DOI 10.1016/S0167-0115(03)00023-5; Fukushi H, 2000, J NEUROVIROL, V6, P314, DOI 10.3109/13550280009030757; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X; Gibran NS, 2002, J SURG RES, V108, P122, DOI 10.1006/jsre.2002.6525; Goumon Y, 1998, J BIOL CHEM, V273, P29847, DOI 10.1074/jbc.273.45.29847; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Hook VYH, 1999, ENDOCRINOLOGY, V140, P3744, DOI 10.1210/en.140.8.3744; Ichiyama T, 2000, ANN NY ACAD SCI, V917, P221; Kapas S, 2001, PEPTIDES, V22, P1485, DOI 10.1016/S0196-9781(01)00470-3; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; Kido MA, 1999, CELL TISSUE RES, V297, P213, DOI 10.1007/s004410051349; Kowalska K, 2002, LIFE SCI, V71, P747, DOI 10.1016/S0024-3205(02)01740-X; Lever IJ, 2003, NEUROPHARMACOLOGY, V45, P1101, DOI 10.1016/S0028-3908(03)00298-3; Lipton JM, 2000, NEWS PHYSIOL SCI, V15, P192; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Lugardon K, 2002, ANN NY ACAD SCI, V971, P359, DOI 10.1111/j.1749-6632.2002.tb04496.x; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Lundy FT, 2004, CRIT REV ORAL BIOL M, V15, P82, DOI 10.1177/154411130401500203; Lundy FT, 2001, J DENT RES, V80, P1176; Machelska H, 2000, CLIN EXP PHARMACOL P, V27, P533, DOI 10.1046/j.1440-1681.2000.03287.x; Martinez A, 1997, ENDOCRINOLOGY, V138, P5597, DOI 10.1210/en.138.12.5597; Martinez A, 2001, J MOL ENDOCRINOL, V27, P31, DOI 10.1677/jme.0.0270031; Marutsuka M, 2001, EXP PHYSIOL, V86, P543, DOI 10.1113/eph8602250; Mathews M, 1999, INFECT IMMUN, V67, P2740, DOI 10.1128/IAI.67.6.2740-2745.1999; Maxwell AI, 2003, MOL IMMUNOL, V40, P413, DOI 10.1016/S0161-5890(03)00160-3; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Metz-Boutigue MH, 2003, TRENDS MICROBIOL, V11, P585, DOI 10.1016/j.tim.2003.10.001; MOR A, 1994, BIOCHEMISTRY-US, V33, P6642, DOI 10.1021/bi00187a034; Muller FB, 2003, BRIT J DERMATOL, V148, P30, DOI 10.1046/j.1365-2133.2003.05016.x; Nakayama K, 1999, ANN NEUROL, V45, P685, DOI 10.1002/1531-8249(199905)45:5<685::AID-ANA25>3.0.CO;2-6; *NAT DIAB ADV BOAR, 1980, NIH PUBL; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Olerud JE, 1999, J INVEST DERMATOL, V112, P873, DOI 10.1046/j.1523-1747.1999.00596.x; Pinter E, 2002, NEUROSCI LETT, V318, P13, DOI 10.1016/S0304-3940(01)02468-5; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Sabbadini E, 1995, NEUROIMMUNOMODULAT, V2, P184, DOI 10.1159/000097197; Salzet M, 2001, DEV COMP IMMUNOL, V25, P177, DOI 10.1016/S0145-305X(00)00047-1; Scholzen T, 1998, EXP DERMATOL, V7, P81, DOI 10.1111/j.1600-0625.1998.tb00307.x; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Shimizu M, 1998, ANTIMICROB AGENTS CH, V42, P2745, DOI 10.1128/AAC.42.10.2745; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stolzenberg ED, 1997, P NATL ACAD SCI USA, V94, P8686, DOI 10.1073/pnas.94.16.8686; STRUB JM, 1995, EUR J BIOCHEM, V229, P356, DOI 10.1111/j.1432-1033.1995.0356k.x; Sung YK, 2002, J BIOL CHEM, V277, P12762, DOI 10.1074/jbc.M106208200; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tasiemski A, 2002, BLOOD, V100, P553, DOI 10.1182/blood.V100.2.553; Taylor AW, 2000, ANN NY ACAD SCI, V917, P239; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; TOSSI A, 2005, ANTIMICROBIAL SEQUEN; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ubink R, 2000, J COMP NEUROL, V423, P13, DOI 10.1002/1096-9861(20000717)423:1<13::AID-CNE2>3.0.CO;2-P; Ubink R, 2003, TRENDS NEUROSCI, V26, P604, DOI 10.1016/j.tins.2003.09.003; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Vizioli J, 2002, TRENDS PHARMACOL SCI, V23, P494, DOI 10.1016/S0165-6147(02)02105-3; Vouldoukis I, 1996, FEBS LETT, V380, P237, DOI 10.1016/0014-5793(96)00050-6; Wikberg JES, 2000, PHARMACOL RES, V42, P393, DOI 10.1006/phrs.2000.0725; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaks-Zilberman M, 1998, INFECT IMMUN, V66, P4669, DOI 10.1128/IAI.66.10.4669-4675.1998; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	92	190	203	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					558	564		10.1038/ni1209	http://dx.doi.org/10.1038/ni1209			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908937	Green Submitted			2022-12-18	WOS:000229385900009
J	Roldan, E; Fuxa, M; Chong, W; Martinez, D; Novatchkova, M; Busslinger, M; Skok, JA				Roldan, E; Fuxa, M; Chong, W; Martinez, D; Novatchkova, M; Busslinger, M; Skok, JA			Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene	NATURE IMMUNOLOGY			English	Article							V(D)J RECOMBINASE ACTIVITY; B-CELL-DEVELOPMENT; FEEDBACK INHIBITION; KAPPA LOCUS; ENDOGENOUS IMMUNOGLOBULIN; TRANSGENIC MICE; MU-CHAIN; EXPRESSION; REARRANGEMENT; CHROMATIN	Allelic exclusion of immunoglobulin genes ensures the expression of a single antibody molecule in B cells through mostly unknown mechanisms. Large-scale contraction of the immunoglobulin heavy-chain (Igh) locus facilitates rearrangements between Igh variable (V-H) and diversity gene segments in pro-B cells. Here we show that these long-range interactions are mediated by 'looping' of individual Igh subdomains. The Igk locus also underwent contraction by looping in small pre-B and immature B cells, demonstrating that immunoglobulin loci are in a contracted state in rearranging cells. Successful Igh recombination induced the rapid reversal of locus contraction in response to pre-B cell receptor signaling, which physically separated the distal V-H genes from the proximal Igh domain, thus preventing further rearrangements. In the absence of locus contraction, only the four most proximal V-H genes escaped allelic exclusion in immature mu-transgenic B lymphocytes. Pre-B cell receptor signaling also led to rapid repositioning of one Igh allele to repressive centromeric domains in response to downregulation of interleukin 7 signaling. These data link both locus 'decontraction' and centromeric recruitment to the establishment of allelic exclusion at the Igh locus.	UCL, Dept Immunol & Mol Pathol, Div Infect & Immun, London W1T 4JF, England; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; University College London	Busslinger, M (corresponding author), UCL, Dept Immunol & Mol Pathol, Div Infect & Immun, London W1T 4JF, England.	busslinger@imp.univie.ac.at; j.skok@ucl.ac.uk	Skok, Jane/ABF-7249-2020; Martinez, Lola/L-2308-2014; Busslinger, Meinrad J./J-1249-2016; Martinez, Lola/ABG-2474-2020	Skok, Jane/0000-0002-4145-1516; Martinez, Lola/0000-0001-6273-6724; Busslinger, Meinrad J./0000-0002-9111-9351; 	Wellcome Trust [067387] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Arakawa H, 1996, INT IMMUNOL, V8, P1319, DOI 10.1093/intimm/8.8.1319; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Brown K, 2002, METHODS, V26, P10, DOI 10.1016/S1046-2023(02)00003-8; Chang Y, 1999, J EXP MED, V189, P1295, DOI 10.1084/jem.189.8.1295; Chowdhury D, 2004, CURR OPIN IMMUNOL, V16, P235, DOI 10.1016/j.coi.2004.02.003; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRANDIEN A, 1990, EUR J IMMUNOL, V20, P991, DOI 10.1002/eji.1830200507; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; IACOMINI J, 1991, INT IMMUNOL, V3, P185; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731; Kirschbaum T, 1998, EUR J IMMUNOL, V28, P1458, DOI 10.1002/(SICI)1521-4141(199805)28:05&lt;1458::AID-IMMU1458&gt;3.0.CO;2-5; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Riblet R., 2004, MOL BIOL B CELLS, P19, DOI DOI 10.1016/B978-012053641-2/50003-4; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Roschenthaler F, 2000, EUR J IMMUNOL, V30, P3349, DOI 10.1002/1521-4141(2000012)30:12&lt;3349::AID-IMMU3349&gt;3.0.CO;2-G; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; tenBoekel E, 1997, IMMUNITY, V7, P357; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; Williams GS, 2001, J IMMUNOL, V167, P257, DOI 10.4049/jimmunol.167.1.257; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	52	190	193	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					31	41		10.1038/ni1150	http://dx.doi.org/10.1038/ni1150			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15580273	Green Accepted			2022-12-18	WOS:000225888500015
J	Halverson, R; Torres, RM; Pelanda, R				Halverson, R; Torres, RM; Pelanda, R			Receptor editing is the main mechanism of B cell tolerance toward membrane antigens	NATURE IMMUNOLOGY			English	Article							LIGHT-CHAIN REARRANGEMENT; CLONAL SELECTION; ESCAPE TOLERANCE; SELF-TOLERANCE; DEFICIENT MICE; LYMPHOCYTES; ANTIBODY; DIVERSIFICATION; ELIMINATION; REPERTOIRES	Self-reactive B cells specific for ubiquitous membrane-bound autoantigens are eliminated in the bone marrow by two mechanisms of tolerance: receptor editing and clonal deletion. However, the relative contributions of clonal deletion and receptor editing to B cell tolerance in a polyclonal B cell population have not been established. Here we show that tolerance toward a membrane antigen-reactive B cell clone acts by receptor editing with very minimal cell loss. The capacity of receptor editing to rescue almost all autoreactive B cells from deletion relies on the availability of multiple joining light chain gene segments as substrate for secondary immunoglobulin light chain gene rearrangement and is independent of the affinity of the autoantigen and the presence of non-autoreactive B cells. Our data further suggest that clonal deletion is a default pathway that functions only when receptor editing has been exhausted.	Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Pelanda, R (corresponding author), Natl Jewish Med & Res Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	pelandar@njc.org			NIAID NIH HHS [AI052310, R01 AI052157, R01 AI052310, AI052157] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI052310, R01AI052157, R01AI052310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Braun U, 2000, P NATL ACAD SCI USA, V97, P7429, DOI 10.1073/pnas.050578497; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Coffman R L, 1982, Immunol Rev, V69, P5; COLIGAN J, 2000, CURRENT PROTOCOLS IM; FREITAS AA, 1995, EUR J IMMUNOL, V25, P1729, DOI 10.1002/eji.1830250636; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRANDIEN A, 1994, EUR J IMMUNOL, V24, P1345, DOI 10.1002/eji.1830240616; GRUTZMAN R, 1981, THESIS U COLOGNE GER; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; Kouskoff V, 2000, P NATL ACAD SCI USA, V97, P7435, DOI 10.1073/pnas.130182597; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Li YJ, 2004, J EXP MED, V199, P337, DOI 10.1084/jem.20031712; Louzoun Y, 2002, SEMIN IMMUNOL, V14, P169, DOI 10.1016/S1044-5323(02)00041-6; MOORE MW, 1985, P NATL ACAD SCI USA, V82, P6211, DOI 10.1073/pnas.82.18.6211; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PERSIANI DM, 1987, J EXP MED, V165, P1655, DOI 10.1084/jem.165.6.1655; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; ROES J, 1995, J IMMUNOL METHODS, V183, P231, DOI 10.1016/0022-1759(95)00059-J; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tze LE, 2000, J IMMUNOL, V165, P6796, DOI 10.4049/jimmunol.165.12.6796; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; Yachimovich N, 2002, EUR J IMMUNOL, V32, P1164, DOI 10.1002/1521-4141(200204)32:4<1164::AID-IMMU1164>3.0.CO;2-1; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7	41	190	197	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					645	650		10.1038/ni1076	http://dx.doi.org/10.1038/ni1076			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15156139				2022-12-18	WOS:000221664000024
J	Jeannin, P; Renno, T; Goetsch, L; Miconnet, I; Aubry, JP; Delneste, Y; Herbault, N; Baussant, T; Magistrelli, G; Soulas, C; Romero, P; Cerottini, JC; Bonnefoy, JY				Jeannin, P; Renno, T; Goetsch, L; Miconnet, I; Aubry, JP; Delneste, Y; Herbault, N; Baussant, T; Magistrelli, G; Soulas, C; Romero, P; Cerottini, JC; Bonnefoy, JY			OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway	NATURE IMMUNOLOGY			English	Article							OUTER-MEMBRANE PROTEIN; EXOGENOUS ANTIGENS; CARRIER PROPERTIES; APOPTOTIC CELLS; T-LYMPHOCYTES; CUTTING EDGE; RECEPTOR; IDENTIFICATION; MECHANISMS; MOLECULES	We analyzed the interaction between a bacterial cell wall protein and dendritic cells (DCs), Outer membrane protein A from Klebsiella pneumoniae (kpOmpA) specifically bound to professional antigen presenting cells and was endocytosed by immature DCs via a receptor-dependent mechanism. kpOmpA signaled through Toll like receptor 2, induced DCs to produce interleukin 12 and induced maturation of DCs,Whole antigen that was coupled to kpOmpA and injected into mice was taken up by DCs and delivered to the conventional cytosolic MHC class I presentation pathway. kpOmpA also primed antigen-specific CD8(+) CTLs in the absence of CD4(+) T cell help or adjuvant and elicited therapeutic immunity to antigen-expressing tumors. Thus, OmpA belongs to a class of proteins that are able to elicit CTL responses to exogenous antigen.	Ctr Immunol Pierre Fabre, F-74164 St Julien en Genevois, France; Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1406 Epalinges, Switzerland	Centre d'Immunologie Pierre Fabre; Ludwig Institute for Cancer Research; University of Lausanne	Jeannin, P (corresponding author), Ctr Immunol Pierre Fabre, 5 Ave Napoleon III, F-74164 St Julien en Genevois, France.	pascale.jeannin@pierre-fabre.com	DELNESTE, Yves/K-7367-2015; Delneste, Yves/O-3956-2016; JEANNIN, Pascale/K-8656-2015; Renno, Toufic/F-5564-2013; Romero, Pedro/S-6015-2017	DELNESTE, Yves/0000-0002-2142-596X; Romero, Pedro/0000-0002-9688-2882; JEANNIN, Pascale/0000-0002-3666-3856				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; FREUDENBERG MA, 1991, INFECT IMMUN, V59, P2110, DOI 10.1128/IAI.59.6.2110-2115.1991; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Haeuw JF, 1998, EUR J BIOCHEM, V255, P446, DOI 10.1046/j.1432-1327.1998.2550446.x; Heath WR, 1999, CURR OPIN IMMUNOL, V11, P314, DOI 10.1016/S0952-7915(99)80050-8; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Ke Y, 1996, J EXP MED, V184, P1179, DOI 10.1084/jem.184.3.1179; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lebecque S, 2000, VACCINE, V18, P1603, DOI 10.1016/S0264-410X(99)00493-4; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Men Y, 1999, J IMMUNOL, V162, P3566; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Muzio M, 2000, MICROBES INFECT, V2, P251, DOI 10.1016/S1286-4579(00)00303-8; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nguyen TN, 1998, GENE, V210, P93, DOI 10.1016/S0378-1119(98)00060-2; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poolman JT, 1996, NOVEL STRATEGIES DES, P73; Rauly I, 1999, INFECT IMMUN, V67, P5547, DOI 10.1128/IAI.67.11.5547-5551.1999; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rock KL, 1996, J IMMUNOL, V156, P3721; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Schild H, 1999, CURR OPIN IMMUNOL, V11, P109, DOI 10.1016/S0952-7915(99)80019-3; SEONKYEONG K, 1999, J IMMUNOL, V162, P6855; Sigal LJ, 1998, J IMMUNOL, V161, P2740; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Sjolander A, 1997, J IMMUNOL METHODS, V201, P115, DOI 10.1016/S0022-1759(96)00217-7; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; Sousa CRE, 1999, J IMMUNOL, V162, P6552; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; SU H, 1990, J EXP MED, V172, P203, DOI 10.1084/jem.172.1.203; Timmerman JM, 1999, ANNU REV MED, V50, P507; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Valmori D, 1998, J IMMUNOL, V160, P1750; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Watts C, 1999, NAT CELL BIOL, V1, pE152, DOI 10.1038/14105; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wiedlocha Antoni, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P341; WIERTZ EJHJ, 1992, J EXP MED, V176, P79, DOI 10.1084/jem.176.1.79; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; ZHOU F, 1992, CANCER RES, V52, P6287	53	190	205	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					502	509		10.1038/82751	http://dx.doi.org/10.1038/82751			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101872				2022-12-18	WOS:000165724600014
J	Gett, AV; Hodgkin, PD				Gett, AV; Hodgkin, PD			A cellular calculus for signal integration by T cells	NATURE IMMUNOLOGY			English	Article							CD28-DEFICIENT MICE; CO-STIMULATION; ACTIVATION; COSTIMULATION; IL-4; INTERLEUKIN-2; APOPTOSIS; ANTIGEN; CD28; MECHANISM	During an immune response numerous receptor-mediated signals delivered to T cells direct their proliferation, survival and differentiation. Here, we describe a quantitative model and in vitro methods for assessing the "calculus" used by T cells to process these multiple signals, The model reveals how T cells convert independently received signals into linear additive effects on division times which, in turn, amplify T cell number exponentially,These results explain why so many ligands can each appear obligatory for T cell activation and argue for a re-examination of the two-signal theory as the basis for decisions between tolerance and activation.	Univ Sydney, Centenary Inst Canc Med & Cell Biol, Med Fdn, Immune Regulat Grp, Sydney, NSW 2042, Australia	University of Sydney; Centenary Institute	Hodgkin, PD (corresponding author), Univ Sydney, Centenary Inst Canc Med & Cell Biol, Med Fdn, Immune Regulat Grp, Sydney, NSW 2042, Australia.	P.Hodgkin@centenary.usyd.edu.au		Hodgkin, Philip/0000-0002-8604-1940				Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; BROWN M, 1988, J IMMUNOL, V141, P504; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; ESTAQUIER J, 1995, J EXP MED, V182, P1759, DOI 10.1084/jem.182.6.1759; FERNANDEZBOTRAN R, 1988, J EXP MED, V168, P543, DOI 10.1084/jem.168.2.543; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; GERMANN T, 1993, EUR J IMMUNOL, V23, P1762, DOI 10.1002/eji.1830230805; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; IERZI G, 1998, IMMUNITY, V8, P89; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Kishimoto H, 1999, J IMMUNOL, V163, P1817; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MITCHELL LC, 1989, J IMMUNOL, V142, P1548; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sperling AI, 1996, IMMUNOL REV, V153, P155, DOI 10.1111/j.1600-065X.1996.tb00924.x; Sperling AI, 1996, J IMMUNOL, V157, P3909; SWAIN SL, 1990, J IMMUNOL, V145, P3796; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	48	190	193	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					239	244		10.1038/79782	http://dx.doi.org/10.1038/79782			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973282				2022-12-18	WOS:000089815100023
J	Cortez, VS; Ulland, TK; Cervantes-Barragan, L; Bando, JK; Robinette, ML; Wang, QL; White, AJ; Gilfillan, S; Cella, M; Colonna, M				Cortez, Victor S.; Ulland, Tyler K.; Cervantes-Barragan, Luisa; Bando, Jennifer K.; Robinette, Michelle L.; Wang, Qianli; White, Andrew J.; Gilfillan, Susan; Cella, Marina; Colonna, Marco			SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-beta signaling	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; T-CELLS; TISSUE RESIDENCY; MELANOMA; RECOGNITION; TIGIT; MATURATION; INSTRUCT	Among the features that distinguish type 1 innate lymphoid cells (ILC1s) from natural killer (NK) cells is a gene signature indicative of 'imprinting' by cytokines of the TGF-beta family. We studied mice in which ILC1s and NK cells lacked SMAD4, a signal transducer that facilitates the canonical signaling pathway common to all cytokines of the TGF-beta family. While SMAD4 deficiency did not affect ILC1 differentiation, NK cells unexpectedly acquired an ILC1-like gene signature and were unable to control tumor metastasis or viral infection. Mechanistically, SMAD4 restrained non-canonical TGF-beta signaling mediated by the cytokine receptor TGF beta R1 in NK cells. NK cells from a SMAD4-deficient person affected by polyposis were also hyper-responsive to TGF-beta. These results identify SMAD4 as a previously unknown regulator that restricts non-canonical TGF-beta signaling in NK cells.	[Cortez, Victor S.; Ulland, Tyler K.; Cervantes-Barragan, Luisa; Bando, Jennifer K.; Robinette, Michelle L.; Wang, Qianli; Gilfillan, Susan; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [White, Andrew J.] Washington Univ, Sch Med, Div Pediat Rheumatol, St Louis, MO USA; [White, Andrew J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu	Cella, Marina/ABA-8564-2020	White, Andrew J./0000-0001-9394-7823; Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987; Ulland, Tyler/0000-0002-6507-4989; Bando, Jennifer/0000-0002-1331-7424	US National Institutes of Health [U01 AI095542, R01 DE025884, R01 DK103039, R01 CA176695, 5T32CA009547-30]; Crohn's & Colitis Foundation of America [274415]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA176695, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis; H.-R. Rodewald (DKZF, Heidelberg, Germany) for Il7r<SUP>Cre</SUP> mice; and M. Rabinovitch (Stanford University, USA) for Bmpr2<SUP>f/f</SUP> mice. Supported by the US National Institutes of Health (U01 AI095542, R01 DE025884 and R01 DK103039 to M. Colonna; R01 CA176695 to M. Cella; and 5T32CA009547-30 to V.S.C.), the Crohn's & Colitis Foundation of America (274415) and Cancer Research Institute (J.K.B.).	Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Cella M, 2000, METH MOL B, V121, P1; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gao Y., 2017, NAT IMMUNOL; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gu AD, 2015, IMMUNITY, V42, P68, DOI 10.1016/j.immuni.2014.12.019; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Huang F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-9; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Larsen Haidle J., 1993, GENEREVIEWS, P1; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Takeda K, 2011, J LEUKOCYTE BIOL, V90, P777, DOI 10.1189/jlb.0411208; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhang Y. E., 2017, CSH PERSPEC BIOL, V9, P1	45	189	194	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					995	+		10.1038/ni.3809	http://dx.doi.org/10.1038/ni.3809			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28759002	Green Accepted			2022-12-18	WOS:000408137700009
J	Kurachi, M; Barnitz, RA; Yosef, N; Odorizzi, PM; DiIorio, MA; Lemieux, ME; Yates, K; Godec, J; Klatt, MG; Regev, A; Wherry, EJ; Haining, WN				Kurachi, Makoto; Barnitz, R. Anthony; Yosef, Nir; Odorizzi, Pamela M.; DiIorio, Michael A.; Lemieux, Madeleine E.; Yates, Kathleen; Godec, Jernej; Klatt, Martin G.; Regev, Aviv; Wherry, E. John; Haining, W. Nicholas			The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							PROBE LEVEL DATA; VIRAL-INFECTION; REGULATORY ELEMENT; CLONAL EXPANSION; IRF INTERACTIONS; MEMORY; EXPRESSION; NETWORK; T(H)17; GENOME	The transcription factor BATF is required for the differentiation of interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) and follicular helper T cells (T-FH cells). Here we identified a fundamental role for BATF in regulating the differentiation of effector of CD8(+) T cells. BATF-deficient CD8(+) T cells showed profound defects in effector population expansion and underwent proliferative and metabolic catastrophe early after encountering antigen. BATF, together with the transcription factors IRF4 and Jun proteins, bound to and promoted early expression of genes encoding lineage-specific transcription-factors (T-bet and Blimp-1) and cytokine receptors while paradoxically repressing genes encoding effector molecules (IFN-gamma and granzyme B). Thus, BATF amplifies T cell antigen receptor (TCR)-dependent expression of transcription factors and augments the propagation of inflammatory signals but restrains the expression of genes encoding effector molecules. This checkpoint prevents irreversible commitment to an effector fate until a critical threshold of downstream transcriptional activity has been achieved.	[Kurachi, Makoto; Odorizzi, Pamela M.; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurachi, Makoto; Odorizzi, Pamela M.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barnitz, R. Anthony; DiIorio, Michael A.; Yates, Kathleen; Godec, Jernej; Klatt, Martin G.; Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yosef, Nir; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA; [Haining, W. Nicholas] Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu; nicholas_haining@dfci.harvard.edu	Wherry, John/ABI-1280-2020	Klatt, Martin/0000-0001-8703-7305; Lemieux, Madeleine/0000-0001-6355-8691; Di Iorio, Michael/0000-0001-6174-5629; Barnitz, Tony/0000-0002-9634-4558	US National Institutes of Health [T32 AI00762, AI091493, AI083022, AI095608, HHSN266200500030C, AI082630]; US Government (Presidential Early Career Award for Science and Engineering); Ministry of Education, Culture, Sports, Science and Technology of Japan [22790453]; Uehara Memorial Foundation of Japan; German National Academic Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, U19AI082630, Z01AI000762, R01AI097333, R01AI091493, U01AI095608] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Government (Presidential Early Career Award for Science and Engineering); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation of Japan(Uehara Memorial Foundation); German National Academic Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Ali for animal care; K. Mansfield and J. Kurachi for technical assistance; the Center for Cancer Computational Biology Sequencing Core of the Dana-Farber Cancer Institute for sequencing services and advice; and members of the Haining and Wherry laboratories for discussions. Supported by the US National Institutes of Health (T32 AI00762 to P.M.O.; AI091493 to W.N.H.; AI083022, AI095608 and HHSN266200500030C to E.J.W.; and AI082630 to W.N.H. and E.J.W.), the US Government (Presidential Early Career Award for Science and Engineering to W.N.H.), The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Young Scientists (B) 22790453 to M.K.), the Uehara Memorial Foundation of Japan (M.K.) and the German National Academic Foundation (M.G.K.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Belz GT, 2010, CURR OPIN IMMUNOL, V22, P279, DOI 10.1016/j.coi.2010.03.008; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GY, 2008, BIOINFORMATICS, V24, P2416, DOI 10.1093/bioinformatics/btn439	64	189	193	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					373	+		10.1038/ni.2834	http://dx.doi.org/10.1038/ni.2834			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24584090	Green Submitted, Green Accepted			2022-12-18	WOS:000333252000012
J	Green, JA; Suzuki, K; Cho, B; Willison, LD; Palmer, D; Allen, CDC; Schmidt, TH; Xu, Y; Proia, RL; Coughlin, SR; Cyster, JG				Green, Jesse A.; Suzuki, Kazuhiro; Cho, Bryan; Willison, L. David; Palmer, Daniel; Allen, Christopher D. C.; Schmidt, Timothy H.; Xu, Ying; Proia, Richard L.; Coughlin, Shaun R.; Cyster, Jason G.			The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement	NATURE IMMUNOLOGY			English	Article							CLASS-SWITCH RECOMBINATION; LYMPHOCYTE EGRESS; PROTEIN-KINASE; TRANSLATIONAL CONTROL; ENDOTHELIAL-CELLS; INHIBITION; MIGRATION; AKT; SPHINGOSINE-1-PHOSPHATE; PTEN	Mice deficient in sphingosine 1-phosphate receptor type 2 (S1P(2)) develop diffuse large B cell lymphoma. However, the role of S1P(2) in normal germinal center (GC) physiology is unknown. Here we show that S1P(2)-deficient GC B cells outgrew their wild-type counterparts in chronically established GCs. We found that antagonism of the kinase Akt mediated by S1P(2) and its downstream mediators G alpha(12), Ga alpha(13) and p115RhoGEF regulated cell viability and was required for growth control in chronically proliferating GCs. Moreover, S1P(2) inhibited GC B cell responses to follicular chemoattractants and helped confine cells to the GC. In addition, S1P(2) overexpression promoted the centering of activated B cells in the follicle. We suggest that by inhibiting Akt activation and migration, S1P(2) helps restrict GC B cell survival and localization to an S1P-low niche at the follicle center.	[Green, Jesse A.; Suzuki, Kazuhiro; Cho, Bryan; Allen, Christopher D. C.; Schmidt, Timothy H.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Green, Jesse A.; Suzuki, Kazuhiro; Cho, Bryan; Allen, Christopher D. C.; Schmidt, Timothy H.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Cho, Bryan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Willison, L. David; Palmer, Daniel; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Suzuki, Kazuhiro/B-3886-2012; Palmer, Daniel/Q-7595-2016; Proia, Richard L/A-7908-2012	Palmer, Daniel/0000-0002-7954-9332; Allen, Christopher/0000-0002-1879-9047; Proia, Richard/0000-0003-0456-1270; Suzuki, Kazuhiro/0000-0002-9081-538X	National Science Foundation; Howard Hughes Medical Institute; US National Institutes of Health [HL65590, HL44907, AI45073]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL044907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056015, ZIADK056018, ZIADK056017, ZIADK056014] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23890097] Funding Source: KAKEN	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Danial (Dana-Farber) for Bad-deficient bone marrow; K. Rajewsky (Children's Hospital and Immune Disease Institute, Harvard) for mice expressing the Cr2-Cre transgene; J. Browning (Biogen Idec) for lymphotoxin-beta receptor-Fc fusion protein; J. An for help with the mouse colony; and S. Schwab for critical reading of the manuscript. Supported by the National Science Foundation (J. A. G.), Howard Hughes Medical Institute (J. G. C.) and the US National Institutes of Health (Intramural Research Program; National Institute of Diabetes and Digestive and Kidney Diseases (R. L. P.); HL65590 and HL44907 to S. R. C.; and AI45073 to J.G.C.).	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Cattoretti G, 2009, CANCER RES, V69, P8686, DOI 10.1158/0008-5472.CAN-09-1110; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Misra RS, 2010, J EXP MED, V207, P1775, DOI 10.1084/jem.20092735; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rieken S, 2006, J IMMUNOL, V177, P2985, DOI 10.4049/jimmunol.177.5.2985; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schuppel M, 2008, J INVEST DERMATOL, V128, P1747, DOI 10.1038/sj.jid.5701259; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82	50	189	194	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					672	U128		10.1038/ni.2047	http://dx.doi.org/10.1038/ni.2047			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21642988	Green Submitted, Green Accepted			2022-12-18	WOS:000291936400016
J	Huntington, ND; Puthalakath, H; Gunn, P; Naik, E; Michalak, EM; Smyth, MJ; Tabarias, H; Degli-Esposti, MA; Dewson, G; Willis, SN; Motoyama, N; Huang, DCS; Nutt, SL; Tarlinton, DM; Strasser, A				Huntington, Nicholas D.; Puthalakath, Hamsa; Gunn, Priscilla; Naik, Edwina; Michalak, Ewa M.; Smyth, Mark J.; Tabarias, Hyacinth; Degli-Esposti, Mariapia A.; Dewson, Grant; Willis, Simon N.; Motoyama, Noboru; Huang, David C. S.; Nutt, Stephen L.; Tarlinton, David M.; Strasser, Andreas			Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1	NATURE IMMUNOLOGY			English	Article							FAMILY-MEMBER BIM; BCL-2 FAMILY; BH3-ONLY PROTEINS; LYMPHOID DEVELOPMENT; APOPTOTIC RESPONSES; MICE LACKING; B-CELL; TRANSCRIPTION; HOMEOSTASIS; BAD	Interleukin 15 (IL-15) promotes the survival of natural killer (NK) cells by preventing apoptosis through mechanisms unknown at present. Here we identify Bim, Noxa and Mcl-1 as key regulators of IL-15-dependent survival of NK cells. IL-15 suppressed apoptosis by limiting Bim expression through the kinases Erk1 and Erk2 and mechanisms dependent on the transcription factor Foxo3a, while promoting expression of Mcl-1, which was necessary and sufficient for the survival of NK cells. Withdrawal of IL-15 led to upregulation of Bim and, accordingly, both Bim-deficient and Foxo3a(-/-) NK cells were resistant to cytokine deprivation. Finally, IL-15-mediated inactivation of Foxo3a and cell survival were dependent on phosphotidylinositol-3-OH kinase. Thus, IL-15 regulates the survival of NK cells at multiple steps, with Bim and Noxa being key antagonists of Mcl-1, the critical survivor factor in this process.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Peter MacCallum Canc Ctr, Sir Donald & Lady Trescowick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia; Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA 6009, Australia; Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Lions Eye Institute; University of Western Australia; National Center for Geriatrics & Gerontology	Huntington, ND (corresponding author), Inst Pasteur, Cytokine & Lymphoid Dev Unit, Dept Immunol, 25 Rue Dr Roux, F-75724 Paris, France.	nhunting@pasteur.fr; strasser@wehi.edu.au	Smyth, Mark J/H-8709-2014; Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013; Degli-Esposti, Mariapia/E-9529-2013; Puthalakath, Hamsa/B-8541-2011; dewson, grant/C-7646-2013; Degli-Esposti, Mariapia/H-9073-2014; Huntington, NICHOLAS/AAV-4704-2020; Huang, David C. S./C-7586-2013	Smyth, Mark J/0000-0001-7098-7240; Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637; dewson, grant/0000-0003-4251-8898; Huntington, NICHOLAS/0000-0002-5267-7211; Huang, David C. S./0000-0002-3101-4873; Tarlinton, David/0000-0001-9928-686X; Degli-Esposti, Mariapia/0000-0002-7808-5935; Michalak, Ewa/0000-0002-5772-2122	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA043540, CA 43540, CA 80188, R01 CA043540-21, R01 CA080188, R01 CA080188-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Andoniou CE, 2006, IMMUNOL REV, V214, P239, DOI 10.1111/j.1600-065X.2006.00465.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hunt D.J., 1998, INT J NEMATOLOGY, V7, P190; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Okkenhaug K, 2002, SCIENCE, V297, P1031; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; PUTHALAKATH H, IN PRESS CELL; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rinkenberger JL, 2000, GENE DEV, V14, P23; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	49	189	193	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					856	863		10.1038/ni1487	http://dx.doi.org/10.1038/ni1487			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17618288	Green Accepted			2022-12-18	WOS:000248169400013
J	Frahm, N; Kiepiela, P; Adams, S; Linde, CH; Hewitt, HS; Sango, K; Feeney, ME; Addo, MM; Lichterfeld, M; Lahaie, MP; Pae, E; Wurcel, AG; Roach, T; St John, MA; Altfeld, M; Marincola, FM; Moore, C; Mallal, S; Carrington, M; Heckerman, D; Allen, TM; Mullins, JI; Korber, BT; Goulder, PJR; Walker, BD; Brander, C				Frahm, N; Kiepiela, P; Adams, S; Linde, CH; Hewitt, HS; Sango, K; Feeney, ME; Addo, MM; Lichterfeld, M; Lahaie, MP; Pae, E; Wurcel, AG; Roach, T; St John, MA; Altfeld, M; Marincola, FM; Moore, C; Mallal, S; Carrington, M; Heckerman, D; Allen, TM; Mullins, JI; Korber, BT; Goulder, PJR; Walker, BD; Brander, C			Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes	NATURE IMMUNOLOGY			English	Article							HLA-B; IMMUNE ESCAPE; HIV; RESPONSES; AIDS; TRANSMISSION; PROGRESSION; VACCINE; ADAPTATION; MUTATIONS	Despite limited data supporting the superiority of dominant over subdominant responses, immunodominant epitopes represent the preferred vaccine candidates. To address the function of subdominant responses in human immunodeficiency virus infection, we analyzed cytotoxic T lymphocyte responses restricted by HLA-B*1503, a rare allele in a cohort infected with clade B, although common in one infected with clade C. HLA-B*1503 was associated with reduced viral loads in the clade B cohort but not the clade C cohort, although both shared the immunodominant response. Clade B viral control was associated with responses to several subdominant cytotoxic T lymphocyte epitopes, whereas their clade C variants were less well recognized. These data suggest that subdominant responses can contribute to in vivo viral control and that high HLA allele frequencies may drive the elimination of subdominant yet effective epitopes from circulating viral populations.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02115 USA; Univ KwaZulu Natal, ZA-4015 Durban, South Africa; Clin Ctr Natl Inst Hlth, Bethesda, MD 20892 USA; Fenway Community Hlth Ctr, Boston, MA 02115 USA; Lemuel Shattuck Hosp, Boston, MA 02115 USA; Queen Elizabeth Hosp, Bridgetown, Barbados; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Murdoch, WA 6000, Australia; Murdoch Univ, Murdoch, WA 6150, Australia; NCI, Frederick Canc Res & Dev Ctr, Lab Genom Divers, Basic Res Program, Frederick, MD 21702 USA; Microsoft Corp, Redmond, WA 98052 USA; Univ Washington, Seattle, WA 98195 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Oxford, Oxford OX1 3SY, England; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Kwazulu Natal; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Royal Perth Hospital; Murdoch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Microsoft; University of Washington; University of Washington Seattle; The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Oxford; Howard Hughes Medical Institute	Brander, C (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02115 USA.	cbrander@partners.org	Wurcel, Alysse/AAZ-6132-2020; Wurcel, Alysse/AAC-5372-2019; Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019; Lichterfeld, Mathias/B-2042-2008; Addo, Marylyn M./GNP-2548-2022; Mallal, Simon Alexander/HDM-9561-2022	Wurcel, Alysse/0000-0002-8255-8387; Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; Lichterfeld, Mathias/0000-0001-9865-8350; Mallal, Simon Alexander/0000-0002-7036-1309; Brander, Christian/0000-0002-0548-5778; Korber, Bette/0000-0002-2026-5757; Addo, Marylyn/0000-0003-2836-9224	DIVISION OF BASIC SCIENCES - NCI [Z01BC010305, Z01BC010269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067077] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL002118] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIAID NIH HHS [R01-AI-067077, N01-AI-15422] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Brander C, 2003, NAT MED, V9, P1359, DOI 10.1038/nm941; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; FRAHM N, 2003, HIV IMMUNOLOGY HIV S, V1, P3; FRAHM N, IN PRESS HIV IMMUNOL; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hanke T, 1999, IMMUNOL LETT, V66, P177, DOI 10.1016/S0165-2478(98)00164-3; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kijak GH, 2004, AIDS REV, V6, P54; KORBER B, 2001, HIV MOL IMMUNOLOGY D; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; McMichael A, 2002, SCIENCE, V296, P1410, DOI 10.1126/science.1072492; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Prilliman KR, 1999, J IMMUNOL, V162, P7277; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trachtenberg EA, 2001, HIV MOL IMMUNOLOGY 2; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611	32	189	195	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					173	178		10.1038/ni1281	http://dx.doi.org/10.1038/ni1281			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16369537				2022-12-18	WOS:000234801700018
J	Watanabe, N; Hanabuchi, S; Soumelis, V; Yuan, W; Ho, S; Malefyt, RDW; Liu, YJ				Watanabe, N; Hanabuchi, S; Soumelis, V; Yuan, W; Ho, S; Malefyt, RDW; Liu, YJ			Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4(+) T cell homeostatic expansion	NATURE IMMUNOLOGY			English	Article							SURVIVAL; NAIVE; PROLIFERATION; MEMORY; LYMPHOCYTES; COMPLEX; DIFFERENTIATION; SELECTION; DIVISION; DISTINCT	T cell homeostasis is a self-regulating process for maintaining the size of the peripheral T cell pool. Although dendritic cells (DCs) seem to be important in T cell homeostasis, the molecular regulation of DC-mediated T cell homeostasis is unknown. We show that human DCs activated by thymic stromal lymphopoietin (TSLP) induced a robust expansion of autologous CD4(+) T cell populations, which depended on self peptide-major histocompatibility complex. The proliferating T cells adopted and maintained a central memory polyclonal phenotype and could differentiate into T helper type 1 or type 2 effector cells. These results, together with findings of TSLP expression in epithelial cells of mucosal lymphoid tissues and thymus, indicate that TSLP is involved in DC-mediated CD4(+) T cell homeostasis.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; Hop Necker Enfants Malad, Dept Hematol & Bone Marrow Transplantat, F-75015 Paris, France	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Liu, YJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org	Hanabuchi, Shino/AAI-8676-2021	de Waal Malefyt, Rene/0000-0002-2663-383X				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BELL EB, 1987, J IMMUNOL, V139, P1379; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2983, DOI 10.1073/pnas.052714199; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hassan J, 1998, EUR J IMMUNOL, V28, P3057, DOI 10.1002/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.3.CO;2-Q; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; MILLER RA, 1984, J IMMUNOL, V133, P2925; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Muranski P, 2000, J IMMUNOL, V164, P3087, DOI 10.4049/jimmunol.164.6.3087; NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Piliero LM, 2004, BLOOD, V103, P1020, DOI 10.1182/blood-2003-08-2824; Pitkanen J, 2003, GENES IMMUN, V4, P12, DOI 10.1038/sj.gene.6363929; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Soares MVD, 1998, J IMMUNOL, V161, P5909; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2	51	189	204	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					426	434		10.1038/ni1048	http://dx.doi.org/10.1038/ni1048			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	14991051				2022-12-18	WOS:000220515900016
J	Kawane, K; Fukuyama, H; Yoshida, H; Nagase, H; Ohsawa, Y; Uchiyama, Y; Okada, K; Iida, T; Nagata, S				Kawane, K; Fukuyama, H; Yoshida, H; Nagase, H; Ohsawa, Y; Uchiyama, Y; Okada, K; Iida, T; Nagata, S			Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation	NATURE IMMUNOLOGY			English	Article							PROGRAMMED CELL-DEATH; ENDONUCLEASE-G; FRAGMENTATION; ACTIVATION; INTERFERON; EXPRESSION; THYMOCYTES; CASPASES; RECEPTOR; CLEAVAGE	Apoptosis is often accompanied by the degradation of chromosomal DNA. Caspase-activated DNase (CAD) is an endonuclease that is activated in dying cells, whereas DNase II is present in the lysosomes of macrophages. Here, we show that CAD(-/-) thymocytes did not undergo apoptotic DNA degradation. But, when apoptotic cells were phagocytosed by macrophages, their DNA was degraded by DNase II. The thymus of DNase II-/- CAD(-/-) embryos contained many foci carrying undigested DNA and the cellularity was severely reduced due to a block in T cell development. The interferon-beta gene was strongly up-regulated in the thymus of DNase II-/- CAD(-/-) embryos, suggesting that when the DNA of apoptotic cells is left undigested, it can activate innate immunity leading to defects in thymic development.	Osaka Univ, Dept Genet, Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Cell Biol & Neurosci, Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Bacterial Infect, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Genet Lab, Integrated Biol Labs, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Osaka Univ, Dept Genet, Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Fukuyama, Hidehiro/N-5276-2018; Fukuyama, Hidehiro/AAY-6256-2021; Nagata, Shigekazu/AAG-3203-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426; Okada, Kazuhisa/0000-0002-1225-7933; Kawane, Kohki/0000-0003-1125-9483				ARENDS MJ, 1990, AM J PATHOL, V136, P593; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bernardi G., 1971, HYDROLYSIS, P271; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Doly J, 1998, CELL MOL LIFE SCI, V54, P1109, DOI 10.1007/s000180050240; Durrieu F, 1998, EXP CELL RES, V240, P165, DOI 10.1006/excr.1997.3918; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kawane K, 1999, CELL DEATH DIFFER, V6, P745, DOI 10.1038/sj.cdd.4400547; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kondoh G, 1999, J BIOCHEM BIOPH METH, V39, P137, DOI 10.1016/S0165-022X(99)00008-1; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; McCarty JS, 1999, BIOCHEM BIOPH RES CO, V264, P181, DOI 10.1006/bbrc.1999.1498; McIlroy D, 2000, GENE DEV, V14, P549; Montgomery RA, 1997, CYTOKINE, V9, P717, DOI 10.1006/cyto.1997.0227; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAGATA S, IN PRESS CELL DEATH; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Sakahira H, 2002, J BIOL CHEM, V277, P3364, DOI 10.1074/jbc.M110071200; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Staley K, 1997, CELL DEATH DIFFER, V4, P66, DOI 10.1038/sj.cdd.4400207; Su DM, 1997, IMMUNOLOGY, V90, P543, DOI 10.1046/j.1365-2567.1997.00205.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAEGASHI Y, 1995, J EXP MED, V181, P953, DOI 10.1084/jem.181.3.953; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	53	189	197	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					138	144		10.1038/ni881	http://dx.doi.org/10.1038/ni881			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12524536				2022-12-18	WOS:000180686500013
J	Ross, TM; Xu, Y; Bright, RA; Robinson, HL				Ross, TM; Xu, Y; Bright, RA; Robinson, HL			C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge	NATURE IMMUNOLOGY			English	Article							ACQUIRED-IMMUNITY; GERMINAL-CENTERS; DNA IMMUNIZATION; RESPONSES; COMPLEMENT; VACCINES; PROTEIN	The ability of the C3d component of complement to enhance antibody responses and protective immunity to influenza virus challenges was evaluated using a DNA vaccine encoding a C3d fusion of the hemagglutinin (HA) from influenza virus, Plasmids were generated that encoded a transmembrane HA (tmHA), a secreted form of HA (sHA), or a sHA fused to three tandem copies of the murine homologue of the C3d (sHA-3C3d). Analysis of the titers, avidity maturation, and hemagglutinin-inhibition activity of raised antibody revealed that immunizations with sHA-3C3d DNA accelerated both the avidity maturation of antibody to HA and the appearance of hemagglutinin-inhibition activity. These accelerated antibody responses correlated to a more rapid appearance of protective immunity. They also correlated to complete protection from live virus challenge by a single vaccination at a dose ten times lower than the protective dose for non-C3d forms of HA.	Emory Univ, Div Microbiol & Immunol, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA	Emory University	Ross, TM (corresponding author), E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Brody Hlth Sci Bldg,600 Moye Blvd, Greenville, NC 27858 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044325, R01AI034946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034946] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI44325, R21 AI044325-02, R01 AI34946] Funding Source: Medline; NIA NIH HHS [R01 AG034946] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ANDREW ME, 1987, SCAND J IMMUNOL, V25, P21, DOI 10.1111/j.1365-3083.1987.tb01042.x; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Donnelly J J, 1998, Dev Biol Stand, V95, P43; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; GETHING MJ, 1982, NATURE, V300, P598, DOI 10.1038/300598a0; HAYNES JR, 1994, AIDS RES HUM RETROV, V10, pS43; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; MURPHY BR, 1990, VIROLOGY, P1091; Pertmer TM, 1999, VIROLOGY, V257, P406, DOI 10.1006/viro.1999.9666; PERTMER TM, 1995, VACCINE, V13, P1427, DOI 10.1016/0264-410X(95)00069-D; Portela A, 1999, ADV VIRUS RES, V54, P319, DOI 10.1016/S0065-3527(08)60370-X; POTTER CW, 1977, J INFECT DIS, V155, P423; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Rimmelzwaan GF, 1997, J GEN VIROL, V78, P757, DOI 10.1099/0022-1317-78-4-757; Robinson C. J., 1993, IEEE T REHABIL ENG, V1, P1; Robinson Harriet L., 1997, Journal of Infectious Diseases, V176, pS50, DOI 10.1086/514176; ROBINSON HL, 2000, IN PRESS ADV VIRUS R; SCHOLTISSEK S, 1987, NUCLEIC ACIDS RES, V15, P3185, DOI 10.1093/nar/15.7.3185; Seder RA, 1999, NEW ENGL J MED, V341, P277, DOI 10.1056/NEJM199907223410410; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Torres CAT, 1999, VACCINE, V18, P805, DOI 10.1016/S0264-410X(99)00345-X; ZUCKERMAN MA, 1991, J MED VIROL, V33, P133, DOI 10.1002/jmv.1890330213	26	189	227	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					127	131		10.1038/77802	http://dx.doi.org/10.1038/77802			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248804	Green Accepted			2022-12-18	WOS:000089814900012
J	Li, R; Patterson, KR; Bar-Or, A				Li, Rui; Patterson, Kristina R.; Bar-Or, Amit			Reassessing B cell contributions in multiple sclerosis	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; INTERFERON-BETA THERAPY; BLOOD MONONUCLEAR-CELLS; GLATIRAMER ACETATE COPAXONE; ANTIGEN-PRESENTING CELLS; CEREBROSPINAL-FLUID; DIMETHYL FUMARATE; PERIPHERAL-BLOOD; POTASSIUM CHANNEL; CLONAL EXPANSION	There is growing recognition that B cell contributions to normal immune responses extend well beyond their potential to become antibody-producing cells, including roles at the innate-adaptive interface and their potential to modulate the responses of other immune cells such as T cells and myeloid cells. These B cell functions can have both pathogenic and protective effects in the context of central nervous system (CNS) inflammation. Here, we review recent advances in the field of multiple sclerosis (MS), which has traditionally been viewed as primarily a T cell-mediated disease, and we consider antibody-dependent and, particularly, emerging antibody-independent functions of B cells that may be relevant in both the peripheral and CNS disease compartments.	[Bar-Or, Amit] Univ Penn, CNET, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Bar-Or, A (corresponding author), Univ Penn, CNET, Philadelphia, PA 19104 USA.	amitbar@upenn.edu	Li, Rui/O-7397-2016; Bar-Or, Amit/AIC-1416-2022	Li, Rui/0000-0002-7210-8358; 	Atara Biotherapeutics; Biogen Idec; Celgene/Receptos; Genentech/Roche; GlaxoSmithKline; MAPI; Medimmune; Merck/EMD Serono; Novartis; Sanofi-Genzyme	Atara Biotherapeutics; Biogen Idec(Biogen); Celgene/Receptos(Bristol-Myers SquibbCelgene Corporation); Genentech/Roche(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); MAPI; Medimmune(AstraZenecaMedimmune); Merck/EMD Serono; Novartis(Novartis); Sanofi-Genzyme(Sanofi-AventisGenzyme Corporation)	A.B.-O. has consulted for multiple entities involved in B cell-targeting therapies and has received consulting fees and/or grant support from Atara Biotherapeutics, Biogen Idec, Celgene/Receptos, Genentech/Roche, GlaxoSmithKline, MAPI, Medimmune, Merck/EMD Serono, Novartis and Sanofi-Genzyme. R.L. and K.R.P. have nothing to disclose.	Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; Agius MA, 2019, MULT SCLER J, V25, P235, DOI 10.1177/1352458517740641; Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Ahn YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40484; Alter A, 2003, J IMMUNOL, V170, P4497, DOI 10.4049/jimmunol.170.9.4497; Alvarez E, 2015, MULTIPLE SCLEROSIS J, V1; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Ayers CL, 2013, CLIN IMMUNOL, V147, P105, DOI 10.1016/j.clim.2013.02.015; Baker D, 2017, EBIOMEDICINE, V16, P41, DOI 10.1016/j.ebiom.2017.01.042; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Bar-Or A, 2001, J IMMUNOL, V167, P5669, DOI 10.4049/jimmunol.167.10.5669; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Bar-Or A, 2018, NEUROLOGY, V90, pE1805, DOI 10.1212/WNL.0000000000005516; Bar-Or A, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000070; Bar-Or A, 2014, DRUGS, V74, P659, DOI 10.1007/s40265-014-0212-x; Bar-Or A, 2013, NEUROLOGY, V81, P552, DOI 10.1212/WNL.0b013e31829e6fbf; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Baranzini SE, 2017, TRENDS GENET, V33, P960, DOI 10.1016/j.tig.2017.09.004; Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Berkovich R, 2015, MULT SCLER RELAT DIS, V4, P339, DOI 10.1016/j.msard.2015.06.002; Biegler BW, 2006, J NEUROIMMUNOL, V180, P159, DOI 10.1016/j.jneuroim.2006.07.015; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bjarnadottir K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34594; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Blauth K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00565; Blumenfeld S, 2016, J AUTOIMMUN, V70, P40, DOI 10.1016/j.jaut.2016.03.012; Bodhankar S., 2013, J CLIN CELL IMMUNOL, V4, P143, DOI [10.4172/2155-9899.1000143,04, DOI 10.4172/2155-9899.1000143]; Bornsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047578; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Brickshawana A, 2014, LANCET NEUROL, V13, P795, DOI 10.1016/S1474-4422(14)70141-3; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Chan A, 2005, CLIN EXP IMMUNOL, V139, P152, DOI 10.1111/j.1365-2249.2005.02653.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Claes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111115; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; Colombo M, 2003, EUR J IMMUNOL, V33, P3433, DOI 10.1002/eji.200324144; Comabella M, 2009, CLIN IMMUNOL, V130, P145, DOI 10.1016/j.clim.2008.09.010; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dhaeze T, 2015, J IMMUNOL, V195, P832, DOI 10.4049/jimmunol.1500759; Dhib-Jalbut S, 2003, J NEUROIMMUNOL, V140, P163, DOI 10.1016/S0165-5728(03)00170-X; Diebold M, 2018, J AUTOIMMUN, V86, P39, DOI 10.1016/j.jaut.2017.09.009; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Dutta R, 2014, CURR OPIN NEUROL, V27, P271, DOI 10.1097/WCO.0000000000000094; Eggers EL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92724; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fleischer V, 2018, MULT SCLER J, V24, P632, DOI 10.1177/1352458517703799; Fox EJ, 2004, NEUROLOGY, V63, pS15, DOI 10.1212/WNL.63.12_suppl_6.S15; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Gandoglia I, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000403; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Genc K, 1997, J CLIN INVEST, V99, P2664, DOI 10.1172/JCI119455; Ghadiri M, 2017, MULT SCLER J, V23, P1225, DOI 10.1177/1352458517713147; Ghadiri M, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000340; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; Glatigny S, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028977; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000183; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000289; Grutzke B, 2015, ANN CLIN TRANSL NEUR, V2, P119, DOI 10.1002/acn3.155; Hamomcioglu K, 2007, MULT SCLER J, V13, P459, DOI 10.1177/1352458506069672; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heidt S, 2012, AM J TRANSPLANT, V12, P1784, DOI 10.1111/j.1600-6143.2012.04012.x; Henn AD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00345; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Hill-Cawthorne GA, 2012, J NEUROL NEUROSUR PS, V83, P298, DOI 10.1136/jnnp-2011-300826; Hohlfeld R, 2016, LANCET NEUROL, V15, P317, DOI 10.1016/S1474-4422(15)00313-0; Hussien Y, 2004, MULT SCLER J, V10, P16, DOI 10.1191/1352458504ms979oa; Ireland SJ, 2014, JAMA NEUROL, V71, P1421, DOI 10.1001/jamaneurol.2014.1472; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kaskow BJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029025; Ketelslegers IA, 2015, MULT SCLER J, V21, P1513, DOI 10.1177/1352458514566666; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kimura K, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000210; Kinnunen T, 2013, J CLIN INVEST, V123, P2737, DOI 10.1172/JCI68775; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kitz A, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029041; Klineova S, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028928; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kowarik MC, 2011, NEUROLOGY, V76, P1214, DOI 10.1212/WNL.0b013e3182143564; Kraus V, 2014, NEUROLOGY, V82, P470, DOI 10.1212/WNL.0000000000000097; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lassmann H, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a028936; Li L, 2013, J NEUROIMMUNOL, V265, P82, DOI 10.1016/j.jneuroim.2013.10.003; Li R, 2017, J IMMUNOL, V198, P3245, DOI 10.4049/jimmunol.1601572; Li R, 2017, J IMMUNOL, V198, P691, DOI 10.4049/jimmunol.1601649; Li R, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00626; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Lin YC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000196; Lin YC, 2015, ANN CLIN TRANSL NEUR, V2, P445, DOI 10.1002/acn3.181; Lisak RP, 2017, J NEUROIMMUNOL, V309, P88, DOI 10.1016/j.jneuroim.2017.05.004; Lisak RP, 2012, J NEUROIMMUNOL, V246, P85, DOI 10.1016/j.jneuroim.2012.02.015; Longbrake EE, 2018, MULT SCLER J, V24, P728, DOI 10.1177/1352458517707069; Longbrake EE, 2016, MULT SCLER J, V22, P1061, DOI 10.1177/1352458515608961; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lucas M, 2003, NEUROCHEM INT, V42, P67, DOI 10.1016/S0197-0186(02)00057-8; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lundy SK, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000211; Ma N, 2014, J IMMUNOL, V192, P4192, DOI 10.4049/jimmunol.1302132; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mameli G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157153; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mazzola MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0460-z; MCHEYZERWILLIAMS MG, 1988, J IMMUNOL, V141, P4118; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Michel L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00636; Michell-Robinson MA, 2016, ANN CLIN TRANSL NEUR, V3, P27, DOI 10.1002/acn3.270; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; Miyazaki Y, 2018, CLIN IMMUNOL, V187, P95, DOI 10.1016/j.clim.2017.10.009; Miyazaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105421; Miyazaki Y, 2014, CLIN IMMUNOL, V151, P127, DOI 10.1016/j.clim.2014.02.001; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Monson NL, 2005, ARCH NEUROL-CHICAGO, V62, P258, DOI 10.1001/archneur.62.2.258; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Muls N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113025; Munafo A, 2007, EUR J CLIN PHARMACOL, V63, P647, DOI 10.1007/s00228-007-0311-7; Nakamura M, 2014, MULT SCLER J, V20, P1371, DOI 10.1177/1352458514523496; Nerrant E, 2014, MULT SCLER J, V20, P1699, DOI 10.1177/1352458514531086; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Nikolakopoulou AM, 2013, P NATL ACAD SCI USA, V110, P8714, DOI 10.1073/pnas.1218856110; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; O'Neill SK, 2007, J IMMUNOL, V179, P5109, DOI 10.4049/jimmunol.179.8.5109; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Piccio L, 2010, ARCH NEUROL-CHICAGO, V67, P707, DOI 10.1001/archneurol.2010.99; PIERCE SK, 1988, IMMUNOL REV, V106, P149, DOI 10.1111/j.1600-065X.1988.tb00778.x; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; PRINEAS JW, 1981, ANN NEUROL, V10, P149, DOI 10.1002/ana.410100205; Pul R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051867; Putheti P, 2003, J NEUROIMMUNOL, V144, P125, DOI 10.1016/j.jneuroim.2003.08.001; Putzki N, 2010, EUR NEUROL, V63, P311, DOI 10.1159/000302687; Putzki N, 2009, EUR NEUROL, V61, P27, DOI 10.1159/000165346; Qin YF, 2003, LAB INVEST, V83, P1081, DOI 10.1097/01.LAB.0000077008.24259.0D; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rep MHG, 1999, J NEUROIMMUNOL, V96, P92, DOI 10.1016/S0165-5728(98)00271-9; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; Rieks M, 2003, EUR NEUROL, V50, P200, DOI 10.1159/000073860; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Rizzo F, 2016, IMMUNOL CELL BIOL, V94, P886, DOI 10.1038/icb.2016.55; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Rudick RA, 1999, J NEUROIMMUNOL, V93, P8, DOI 10.1016/S0165-5728(98)00174-X; Salama HH, 2003, BRAIN, V126, P2638, DOI 10.1093/brain/awg269; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Saraste M, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000292; Satterthwaite AB, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01986; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Sellner J, 2013, CLIN EXP IMMUNOL, V173, P381, DOI 10.1111/cei.12125; Sergott RC, 2015, J NEUROL SCI, V351, P174, DOI 10.1016/j.jns.2015.02.019; Serpero LD, 2013, J NEUROIMMUNE PHARM, V8, P1106, DOI 10.1007/s11481-013-9465-5; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sievers C, 2012, CLIN IMMUNOL, V144, P70, DOI 10.1016/j.clim.2012.04.002; Smith MD, 2017, ANN CLIN TRANSL NEUR, V4, P351, DOI 10.1002/acn3.411; Sorensen PS, 2014, NEUROLOGY, V82, P573, DOI 10.1212/WNL.0000000000000125; Spencer CM, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000076; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Steri M, 2017, NEW ENGL J MED, V376, P1615, DOI 10.1056/NEJMoa1610528; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Studer V, 2014, J NEUROIMMUNOL, V276, P229, DOI 10.1016/j.jneuroim.2014.08.617; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Thomas K, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000228; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; Touil H, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1136-2; Trinschek B, 2015, INT J MOL SCI, V16, P16330, DOI 10.3390/ijms160716330; van Vollenhoven RF, 2011, ARTHRITIS RHEUM-US, V63, P1782, DOI 10.1002/art.30372; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2005, ARCH NEUROL-CHICAGO, V62, P574, DOI 10.1001/archneur.62.4.574; Villar LM, 2014, ANN NEUROL, V76, P231, DOI 10.1002/ana.24190; Vogelgesang A, 2010, ACTA NEUROL SCAND, V122, P237, DOI 10.1111/j.1600-0404.2009.01295.x; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; von Budingen HC, 2010, J NEUROIMMUNOL, V218, P134, DOI 10.1016/j.jneuroim.2009.10.005; Walters SN, 2014, J IMMUNOL, V193, P170, DOI 10.4049/jimmunol.1302519; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warnke C, 2015, MULT SCLER J, V21, P1036, DOI 10.1177/1352458514556296; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; WATSON CM, 1991, INT J IMMUNOPHARMACO, V13, P923, DOI 10.1016/0192-0561(91)90045-9; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Weber MS, 2004, BRAIN, V127, P1370, DOI 10.1093/brain/awh163; Wilk E, 2009, ARTHRITIS RHEUM-US, V60, P3563, DOI 10.1002/art.24998; Winger RC, 2016, P NATL ACAD SCI USA, V113, P7696, DOI 10.1073/pnas.1609246113; Wu HJ, 2018, CELL MOL IMMUNOL, V15, P676, DOI 10.1038/cmi.2017.133; Wu Q, 2017, J IMMUNOL, V198, P3069, DOI 10.4049/jimmunol.1601532; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zafranskaya M, 2007, IMMUNOLOGY, V121, P29, DOI 10.1111/j.1365-2567.2006.02518.x; Zan H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00631; Zeng Q, 2014, J CLIN INVEST, V124, P1052, DOI 10.1172/JCI70084; Zhang X, 2013, J IMMUNOL, V191, P5867, DOI 10.4049/jimmunol.1301926; Zhou D, 2006, P NATL ACAD SCI USA, V103, P19057, DOI 10.1073/pnas.0607242103; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	231	188	194	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					696	707		10.1038/s41590-018-0135-x	http://dx.doi.org/10.1038/s41590-018-0135-x			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925992				2022-12-18	WOS:000436341300015
J	Park, SL; Zaid, A; Hor, JL; Christo, SN; Prier, JE; Davies, B; Alexandre, YO; Gregory, JL; Russell, TA; Gebhardt, T; Carbone, FR; Tscharke, DC; Heath, WR; Mueller, SN; Mackay, LK				Park, Simone L.; Zaid, Ali; Hor, Jyh Liang; Christo, Susan N.; Prier, Julia E.; Davies, Brooke; Alexandre, Yannick O.; Gregory, Julia L.; Russell, Tiffany A.; Gebhardt, Thomas; Carbone, Francis R.; Tscharke, David C.; Heath, William R.; Mueller, Scott N.; Mackay, Laura K.			Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; NONLYMPHOID TISSUE; RM CELLS; IN-VIVO; SKIN; INFECTION; ANTIGEN; IMMUNITY; PERSISTENCE; TRIGGER	Although tissue-resident memory T cells (T-RM cells) are critical in fighting infection, their fate after local pathogen re-encounter is unknown. Here we found that skin T-RM cells engaged virus-infected cells, proliferated in situ in response to local antigen encounter and did not migrate out of the epidermis, where they exclusively reside. As a consequence, secondary T-RM cells formed from pre-existing T-RM cells, as well as from precursors recruited from the circulation. Newly recruited antigen-specific or bystander T-RM cells were generated in the skin without displacement of the pre-existing T-RM cell pool. Thus, pre-existing skin T-RM cell populations are not displaced after subsequent infections, which enables multiple T-RM cell specificities to be stably maintained within the tissue.	[Park, Simone L.; Zaid, Ali; Hor, Jyh Liang; Christo, Susan N.; Prier, Julia E.; Davies, Brooke; Alexandre, Yannick O.; Gregory, Julia L.; Gebhardt, Thomas; Carbone, Francis R.; Heath, William R.; Mueller, Scott N.; Mackay, Laura K.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Park, Simone L.; Zaid, Ali; Hor, Jyh Liang; Christo, Susan N.; Prier, Julia E.; Davies, Brooke; Alexandre, Yannick O.; Gregory, Julia L.; Gebhardt, Thomas; Carbone, Francis R.; Heath, William R.; Mueller, Scott N.; Mackay, Laura K.] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Russell, Tiffany A.; Tscharke, David C.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Heath, William R.; Mueller, Scott N.; Mackay, Laura K.] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia	University of Melbourne; Australian National University; John Curtin School of Medical Research; University of Melbourne	Mueller, SN; Mackay, LK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Mueller, SN; Mackay, LK (corresponding author), Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Mueller, SN; Mackay, LK (corresponding author), Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia.	smue@unimelb.edu.au; lkmackay@unimelb.edu.au	Mackay, Laura K/HGC-6580-2022; Tscharke, David/C-9133-2009; Carbone, Francis/ABF-2141-2020; Gregory, Julia/AAW-6017-2020; Mueller, Scott/B-1918-2012	Mackay, Laura K/0000-0002-8496-6632; Tscharke, David/0000-0001-6825-9172; Gregory, Julia/0000-0003-2408-677X; Gebhardt, Thomas/0000-0002-3768-9468; Prier, Julia/0000-0002-2653-6300; Russell, Tiffany/0000-0003-0188-9393; Alexandre, Yannick/0000-0002-6634-4098; Mueller, Scott/0000-0002-3838-3989; Park, Simone/0000-0003-1507-0864; Heath, William/0000-0001-9670-259X; Zaid, Ali/0000-0002-2528-2783	University of Melbourne; Sylvia and Charles Viertel Charitable Foundation; National Health and Medical Research Council of Australia; Australian Research Council	University of Melbourne(University of Melbourne); Sylvia and Charles Viertel Charitable Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank C. Jones, G. Davey, M. Damtsis and N. Zamudio for technical assistance. S.L.P. was supported by the University of Melbourne (Elizabeth and Vernon Puzey Postgraduate Scholarship). T.G. was supported by a fellowship from the Sylvia and Charles Viertel Charitable Foundation. This work was supported by the National Health and Medical Research Council of Australia (to S.N.M. and L.K.M.) and the Australian Research Council (to S.N.M.).	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Davies B, 2017, J IMMUNOL, V198, P2233, DOI 10.4049/jimmunol.1601367; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Macleod BL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004303; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Muschaweckh A, 2016, J EXP MED, V213, P3075, DOI 10.1084/jem.20160888; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Russell TA, 2015, J VIROL METHODS, V213, P18, DOI 10.1016/j.jviromet.2014.11.009; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Zaid A, 2017, J IMMUNOL, V199, P2451, DOI 10.4049/jimmunol.1700571; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zens KD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85832	42	188	190	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					183	+		10.1038/s41590-017-0027-5	http://dx.doi.org/10.1038/s41590-017-0027-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29311695	Green Submitted, Green Published			2022-12-18	WOS:000423435200018
J	Nomura, M; Liu, J; Rovira, II; Gonzalez-Hurtado, E; Lee, J; Wolfgang, MJ; Finkel, T				Nomura, Mitsunori; Liu, Jie; Rovira, Ilsa I.; Gonzalez-Hurtado, Elsie; Lee, Jieun; Wolfgang, Michael J.; Finkel, Toren			Fatty acid oxidation in macrophage polarization	NATURE IMMUNOLOGY			English	Letter							INFLAMMATION; ACTIVATION		[Nomura, Mitsunori; Liu, Jie; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA; [Gonzalez-Hurtado, Elsie; Lee, Jieun; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.; Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	mwolfgal@jhmi.edu; finkelt@nih.gov			NIGMS NIH HHS [R25 GM109441] Funding Source: Medline; NINDS NIH HHS [NS072241, R01 NS072241] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006185, ZIGHL006020, ZIAHL006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM109441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Namgaladze D, 2014, BBA-MOL CELL BIOL L, V1841, P1329, DOI 10.1016/j.bbalip.2014.06.007; Odegaard J.I., IMMUNITY, V38, P644; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011	7	188	193	5	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					216	217		10.1038/ni.3366	http://dx.doi.org/10.1038/ni.3366			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882249	Green Accepted			2022-12-18	WOS:000370469300002
J	Reynaud, D; Demarco, IA; Reddy, KL; Schjerven, H; Bertolino, E; Chen, ZS; Smale, ST; Winandy, S; Singh, H				Reynaud, Damien; Demarco, Ignacio A.; Reddy, Karen L.; Schjerven, Hilde; Bertolino, Eric; Chen, Zhengshan; Smale, Stephen T.; Winandy, Susan; Singh, Harinder			Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros	NATURE IMMUNOLOGY			English	Article							RECOMBINATION ACTIVATING GENE-2; TRANSCRIPTION FACTOR PAX5; DNA-BINDING PROTEINS; V(D)J RECOMBINATION; LYMPHOCYTE DEVELOPMENT; INTERLEUKIN-7 RECEPTOR; COORDINATE REGULATION; LOCUS; DIFFERENTIATION; HETEROCHROMATIN	The transcription factor Ikaros is essential for B cell development. However, its molecular functions in B cell fate specification and commitment have remained elusive. We show here that the transcription factor EBF restored the generation of CD19(+) pro-B cells from Ikaros-deficient hematopoietic progenitors. Notably, these pro-B cells, despite having normal expression of the transcription factors EBF and Pax5, were not committed to the B cell fate. They also failed to recombine variable gene segments at the immunoglobulin heavy-chain locus. Ikaros promoted heavy-chain gene rearrangements by inducing expression of the recombination-activating genes as well as by controlling accessibility of the variable gene segments and compaction of the immunoglobulin heavy-chain locus. Thus, Ikaros is an obligate component of a network that regulates B cell fate commitment and immunoglobulin heavy-chain gene recombination.	[Reynaud, Damien; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Reynaud, Damien; Demarco, Ignacio A.; Reddy, Karen L.; Bertolino, Eric; Chen, Zhengshan; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Schjerven, Hilde; Smale, Stephen T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Winandy, Susan] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hsingh@uchicago.edu	Chen, Zhengshan/J-7499-2014; Schjerven, Hilde/I-1437-2013	Schjerven, Hilde/0000-0001-9287-3375; Reddy, Karen/0000-0003-4548-5999; Reynaud, Damien/0000-0001-8765-8419	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043726] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R01 DK043726, R01 DK043726-17, R01 DK43726] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lauring J, 1999, MOL CELL BIOL, V19, P2601; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wei XC, 2005, EUR J IMMUNOL, V35, P612, DOI 10.1002/eji.200425185; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	60	188	194	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					927	936		10.1038/ni.1626	http://dx.doi.org/10.1038/ni.1626			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18568028	Green Accepted			2022-12-18	WOS:000257780700016
J	Hickman, HD; Takeda, K; Skon, CN; Murray, FR; Hensley, SE; Loomis, J; Barber, GN; Bennink, JR; Yewdell, JW				Hickman, Heather D.; Takeda, Kazuyo; Skon, Cara N.; Murray, Faith R.; Hensley, Scott E.; Loomis, Joshua; Barber, Glen N.; Bennink, Jack R.; Yewdell, Jonathan W.			Direct priming of antiviral CD8(+) T cells in the peripheral interfollicular region of lymph nodes	NATURE IMMUNOLOGY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; HIGH ENDOTHELIAL VENULES; IN-VIVO; B-CELLS; ANTIGEN PRESENTATION; SUBCAPSULAR SINUS; IMMUNE-RESPONSE; VIRUS INFECTION; ACTIVATION; TRAFFICKING	It is uncertain how antiviral lymphocytes are activated in draining lymph nodes, the site where adaptive immune responses are initiated. Here, using intravital microscopy we show that after infection of mice with vaccinia virus (a large DNA virus) or vesicular stomatitis virus (a small RNA virus), virions drained to the lymph node and infected cells residing just beneath the subcapsular sinus. Naive CD8(+) T cells rapidly migrated to infected cells in the peripheral interfollicular region and then formed tight interactions with dendritic cells, leading to complete T cell activation. Thus, antigen presentation at the lymph node periphery, not at lymphocyte exit sites in deeper lymph node venules, as dogma dictates, has a dominant function in antiviral CD8(+) T cell activation.	[Hickman, Heather D.; Takeda, Kazuyo; Skon, Cara N.; Murray, Faith R.; Hensley, Scott E.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Loomis, Joshua; Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Loomis, Joshua; Barber, Glen N.] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Miami; University of Miami	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@mail.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Hickman, Heather/0000-0003-4168-4894; Skon-Hegg, Cara/0000-0003-0703-3553	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001053, Z01AI001053] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P411, DOI 10.1111/j.1365-3083.1980.tb00085.x; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; HENDRIKS HR, 1987, EUR J IMMUNOL, V17, P1691, DOI 10.1002/eji.1830171203; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Turner DL, 2007, J VIROL, V81, P2039, DOI 10.1128/JVI.02167-06; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	41	188	190	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					155	165		10.1038/ni1557	http://dx.doi.org/10.1038/ni1557			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18193049				2022-12-18	WOS:000252503000012
J	Henson, PM				Henson, PM			Dampening inflammation	NATURE IMMUNOLOGY			English	Review							APOPTOTIC CELLS	This series of reviews addresses mechanisms whereby inflammation can be reduced, turned off or perhaps prevented, both in the context of natural dampening processes as well as possible approaches to anti-inflammatory therapy. Underlying the central issue is the implication that inflammation is indeed something inherently bad that needs to be dampened. Although this is certainly often the case and it can be argued that most human disease processes include some element of inflammation, nevertheless, inflammation is also natural, beneficial and, indeed, essential. This balance and its possible manipulation is a second theme running through the reviews.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Henson, PM (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA.	hensonp@njc.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068864, P01HL067671, P50HL067671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL67671, HL68864] Funding Source: Medline; NIGMS NIH HHS [GM61031] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Morse D., 1976, MED HIST, V20, P461; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276	9	188	200	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1179	1181		10.1038/ni1205-1179	http://dx.doi.org/10.1038/ni1205-1179			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369556				2022-12-18	WOS:000233371900002
J	Watts, C				Watts, C			The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules	NATURE IMMUNOLOGY			English	Review							MHC CLASS-II; LYSOSOMAL THIOL REDUCTASE; T-CELL SELECTION; INVARIANT CHAIN; CATHEPSIN-S; DENDRITIC CELLS; HLA-DM; ASPARAGINYL ENDOPEPTIDASE; DISULFIDE BONDS; IN-VIVO	The endosomes and lysosomes of antigen-presenting cells host the processing and assembly reactions that result in the display of peptides on major histocompatibility complex (MHC) class II molecules and lipid-linked products on CD1 molecules. This environment is potentially hostile for T cell epitope and MHC class II survival, and the influence of regulators of protease activity and specialized chaperones that assist MHC class II assembly is crucial. At present, evidence indicates that individual proteases make both constructive and destructive contributions to antigen processing for MHC class II presentation to CD4 T cells. Some features of CD1 antigen capture within the endocytic pathway are also discussed.	Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Watts, Colin/0000-0001-6183-2087				Alfonso C, 2003, J IMMUNOL, V171, P2331, DOI 10.4049/jimmunol.171.5.2331; Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bania J, 2003, P NATL ACAD SCI USA, V100, P6664, DOI 10.1073/pnas.1131604100; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; Bertho N, 2003, J IMMUNOL, V171, P5689, DOI 10.4049/jimmunol.171.11.5689; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brocke P, 2003, EUR J IMMUNOL, V33, P411, DOI 10.1002/immu.200310015; Brocke P, 2002, CURR OPIN IMMUNOL, V14, P22, DOI 10.1016/S0952-7915(01)00294-1; BROOKS AG, 1994, J IMMUNOL, V153, P5382; Brooks K, 2004, EUR J IMMUNOL, V34, P837, DOI 10.1002/eji.200324357; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Busch R, 1996, CURR OPIN IMMUNOL, V8, P51, DOI 10.1016/S0952-7915(96)80105-1; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen XJ, 2002, J EXP MED, V195, P1053, DOI 10.1084/jem.20012066; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Driessen C, 2001, EUR J IMMUNOL, V31, P1592, DOI 10.1002/1521-4141(200105)31:5<1592::AID-IMMU1592>3.0.CO;2-K; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Honey K, 2002, NAT IMMUNOL, V3, P1069, DOI 10.1038/ni844; Honey K, 2001, J BIOL CHEM, V276, P22573, DOI 10.1074/jbc.M101851200; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Jensen P E, 1995, Semin Immunol, V7, P347, DOI 10.1006/smim.1995.0039; Joyce S, 2003, CURR OPIN IMMUNOL, V15, P95, DOI 10.1016/S0952-7915(02)00012-2; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LEE P, 1988, J IMMUNOL, V140, P1063; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; Leonova T, 1996, J BIOL CHEM, V271, P17312, DOI 10.1074/jbc.271.29.17312; Li P, 2002, J IMMUNOL, V169, P2444, DOI 10.4049/jimmunol.169.5.2444; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Lindner R, 1996, EMBO J, V15, P6910, DOI 10.1002/j.1460-2075.1996.tb01083.x; Lippolis JD, 2002, J IMMUNOL, V169, P5089, DOI 10.4049/jimmunol.169.9.5089; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, P NATL ACAD SCI USA, V99, P3018, DOI 10.1073/pnas.052703299; Moody DB, 2001, IMMUNITY, V15, P861, DOI 10.1016/S1074-7613(01)00250-3; Musson JA, 2003, J BIOL CHEM, V278, P52425, DOI 10.1074/jbc.M309034200; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; NEWCOMB JR, 1993, J IMMUNOL, V151, P4153; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; OGRINC T, 1993, FEBS LETT, V336, P555, DOI 10.1016/0014-5793(93)80875-U; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Perraudeau M, 2000, EUR J IMMUNOL, V30, P2871, DOI 10.1002/1521-4141(200010)30:10<2871::AID-IMMU2871>3.0.CO;2-B; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Robinson JH, 2002, IMMUNOLOGY, V105, P252, DOI 10.1046/j.0019-2805.2001.01358.x; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; Veeraswamy RK, 2003, J IMMUNOL, V170, P5367, DOI 10.4049/jimmunol.170.11.5367; Vielhaber G, 1996, J BIOL CHEM, V271, P32438, DOI 10.1074/jbc.271.50.32438; Villadangos JA, 2000, EMBO J, V19, P882, DOI 10.1093/emboj/19.5.882; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Watts C, 2003, BIOCHEM SOC SYMP, V70, P31, DOI 10.1042/bss0700031; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WATTS C, 1989, COLD SH Q B, V54, P345; Wiendl H, 2003, J NEUROIMMUNOL, V138, P132, DOI 10.1016/S0165-5728(03)00093-6; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	131	188	191	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					685	692		10.1038/ni1088	http://dx.doi.org/10.1038/ni1088			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224094				2022-12-18	WOS:000222331200005
J	Kropshofer, H; Spindeldreher, S; Rohn, TA; Platania, N; Grygar, C; Daniel, N; Wolp, A; Langen, H; Horejsi, V; Vogt, AB				Kropshofer, H; Spindeldreher, S; Rohn, TA; Platania, N; Grygar, C; Daniel, N; Wolp, A; Langen, H; Horejsi, V; Vogt, AB			Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes	NATURE IMMUNOLOGY			English	Article							HLA-DR; MOLECULES; ANTIGEN; DM; SURFACE; TRANSPORT; MEMBRANE; DIMERS; CELLS; CDW78	Complexes of peptide and major histocompatibility complex (MHC) class 11 are expressed on the surface of antigen-presenting cells but their molecular organization is unknown. Here we show that subsets of MHC class 11 molecules localize to membrane microdomains together with tetraspan proteins, the peptide editor HLA-DM and the costimulator CD86. Tetraspan microdomains differ from other membrane areas such as lipid rafts, as they enrich MHC class 11 molecules carrying a selected set of peptide antigens. Antigen-presenting cells deficient in tetraspan microdomains have a reduced capacity to activate CD4(+) T cells. Thus, the organization of uniformly loaded peptide-MHC class 11 complexes in tetraspan domains may be a very early event that determines both the composition of the immunological synapse and the quality of the subsequent T helper cell response.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Roche Ctr Med Genom, CH-4070 Basel, Switzerland; Blood Transfus Serv, German Red Cross, D-89081 Ulm, Germany; F Hoffmann La Roche Ltd, Pharmaceut Res, CH-4070 Basel, Switzerland; AS CR, Inst Mol Genet, Prague 14220, Czech Republic	Roche Holding; Roche Holding; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kropshofer, H (corresponding author), Basel Inst Immunol, CH-4005 Basel, Switzerland.	harald.kropshofer@roche.com	Horejsi, Vaclav/G-3113-2014	Horejsi, Vaclav/0000-0003-4925-0142				ADAMS TE, 1983, IMMUNOLOGY, V50, P613; Anderson H, 2001, NAT IMMUNOL, V2, P3, DOI 10.1038/83156; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Arndt SO, 2000, EMBO J, V19, P1241, DOI 10.1093/emboj/19.6.1241; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; Chervonsky AV, 1998, P NATL ACAD SCI USA, V95, P10094, DOI 10.1073/pnas.95.17.10094; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Drbal K, 1999, INT IMMUNOL, V11, P491, DOI 10.1093/intimm/11.4.491; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hammond C, 1998, J IMMUNOL, V161, P3282; Huby R, 2001, NAT IMMUNOL, V2, P3, DOI 10.1038/83154; Huby RDJ, 1999, J BIOL CHEM, V274, P22591, DOI 10.1074/jbc.274.32.22591; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; Kropshofer H, 1998, EMBO J, V17, P2971, DOI 10.1093/emboj/17.11.2971; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lindstedt R, 2001, J IMMUNOL, V166, P800, DOI 10.4049/jimmunol.166.2.800; Maier B, 2000, EUR J IMMUNOL, V30, P448, DOI 10.1002/1521-4141(200002)30:2&lt;448::AID-IMMU448&gt;3.0.CO;2-9; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Rasmussen AM, 1997, EUR J IMMUNOL, V27, P3206, DOI 10.1002/eji.1830271218; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Roucard C, 1996, J BIOL CHEM, V271, P13993, DOI 10.1074/jbc.271.24.13993; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SCHAFER PH, 1994, IMMUNITY, V1, P699, DOI 10.1016/1074-7613(94)90040-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLACK JL, 1995, INT IMMUNOL, V7, P1087, DOI 10.1093/intimm/7.7.1087; Smith MH, 1998, MOL IMMUNOL, V35, P1033, DOI 10.1016/S0161-5890(98)00096-0; Szollosi J, 1996, J IMMUNOL, V157, P2939; TOTTERMAN TH, 1988, NOUV REV FR HEMATOL, V30, P279; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; van Lith M, 2001, J IMMUNOL, V167, P884, DOI 10.4049/jimmunol.167.2.884; Vogt AB, 2000, IMMUNOLOGIST, V8, P110; Wolpl A, 1998, TISSUE ANTIGENS, V51, P258	49	188	191	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					61	68		10.1038/ni750	http://dx.doi.org/10.1038/ni750			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11743588				2022-12-18	WOS:000173148700016
J	Macpherson, AJS; Lamarre, A; McCoy, K; Harriman, GR; Odermatt, B; Dougan, G; Hengartner, H; Zinkernagel, RM				Macpherson, AJS; Lamarre, A; McCoy, K; Harriman, GR; Odermatt, B; Dougan, G; Hengartner, H; Zinkernagel, RM			IgA production without mu or delta chain expression in developing B cells	NATURE IMMUNOLOGY			English	Article							PRE-B; COMMENSAL BACTERIA; TARGETED DELETION; GENE-EXPRESSION; DEFICIENT MICE; PEYERS-PATCHES; LYMPHOCYTES-B; SELECTION; LINE; REARRANGEMENT	Surface, membrane-bound, immunoglobulin M (IgM) or IgD expression early in B cell ontogeny is considered essential for the differentiation of antibody-producing cells in mammals; only in IgM(+) a cells is the heavy chain locus rearranged to express antibodies of other classes,We show here that IgA is selectively expressed in mu MT mice, which lack IgM or IgD expression and have a pro-B cell developmental block. mu MT IgA binds proteins of commensal intestinal bacteria and is weakly induced by Salmonella infection, although not through conventional immunization. This mu MT IgA pathway requires extrasplenic peripheral lymphoid tissues and may be an evolutionarily primitive system in which immature B cells switch to IgA production at peripheral sites.	Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Centocor Inc, Malvern, PA 19355 USA; Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Immunol, Dept Biochem, London SW7 2AZ, England	University of Zurich; University Zurich Hospital; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Imperial College London	Macpherson, AJS (corresponding author), Univ Spital Zurich, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	amacpher@pathol.unizh.ch	McCoy, Kathy/ABD-5814-2021; Lamarre, Alain/C-3006-2009					ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; Brandtzaeg P, 1994, HDB MUCOSAL IMMUNOLO, P113; BURROWS PD, 1983, NATURE, V306, P243, DOI 10.1038/306243a0; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; CLARKE BE, 1990, J GEN VIROL, V71, P1109, DOI 10.1099/0022-1317-71-5-1109; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; Harriman GR, 1999, J IMMUNOL, V162, P2521; HENDERSON PJF, 1986, METHOD ENZYMOL, V125, P387; Kim M, 1999, INT IMMUNOL, V11, P813, DOI 10.1093/intimm/11.5.813; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Londono LP, 1996, VACCINE, V14, P545; Lutz C, 1998, NATURE, V393, P797, DOI 10.1038/31716; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Matsumoto M, 1999, J IMMUNOL, V163, P1584; Melamed D, 2000, J IMMUNOL, V165, P4353, DOI 10.4049/jimmunol.165.8.4353; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NANNO M, 1994, J IMMUNOL, V153, P2014; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; ROES J, 1991, INT IMMUNOL, V3, P1367, DOI 10.1093/intimm/3.12.1367; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Tarlinton DM, 1997, INT IMMUNOL, V9, P1481, DOI 10.1093/intimm/9.10.1481; VOGLER LB, 1981, NATURE, V290, P339, DOI 10.1038/290339a0; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; YUAN D, 1988, J IMMUNOL, V140, P2808; Yuan D, 1996, J IMMUNOL, V157, P2073	36	188	197	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					625	631		10.1038/89775	http://dx.doi.org/10.1038/89775			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429547				2022-12-18	WOS:000169682100016
J	Mahmud, SA; Manlove, LS; Schmitz, HM; Xing, Y; Wang, YY; Owen, DL; Schenkel, JM; Boomer, JS; Green, JM; Yagita, H; Chi, HB; Hogquist, KA; Farrar, MA				Mahmud, Shawn A.; Manlove, Luke S.; Schmitz, Heather M.; Xing, Yan; Wang, Yanyan; Owen, David L.; Schenkel, Jason M.; Boomer, Jonathan S.; Green, Jonathan M.; Yagita, Hideo; Chi, Hongbo; Hogquist, Kristin A.; Farrar, Michael A.			Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells	NATURE IMMUNOLOGY			English	Article							C-REL; IN-VIVO; SELECTION; EXPRESSION; ANTIGEN; OX40; RESPONSES; CD28; TNF; NF-KAPPA-B1	Regulatory T cells (T-reg cells) express members of the tumor-necrosis factor (TNF) receptor superfamily (TNFRSF), but the role of those receptors in the thymic development of T-reg cells is undefined. We found here that T-reg cell progenitors had high expression of the TNFRSF members GITR, OX40 and TNFR2. Expression of those receptors correlated directly with the signal strength of the T cell antigen receptor (TCR) and required the coreceptor CD28 and the kinase TAK1. The neutralization of ligands that are members of the TNF superfamily (TNFSF) diminished the development of T-reg cells. Conversely, TNFRSF agonists enhanced the differentiation of Treg cell progenitors by augmenting responsiveness of the interleukin 2 receptor (IL-2R) and transcription factor STAT5. Costimulation with the ligand of GITR elicited dose-dependent enrichment for cells of lower TCR affinity in the T-reg cell repertoire. In vivo, combined inhibition of GITR, OX40 and TNFR2 abrogated the development of T-reg cells. Thus, expression of members of the TNFRSF on T-reg cell progenitors translated strong TCR signals into molecular parameters that specifically promoted the development of T-reg cells and shaped the T-reg cell repertoire.	[Mahmud, Shawn A.; Manlove, Luke S.; Schmitz, Heather M.; Xing, Yan; Owen, David L.; Hogquist, Kristin A.; Farrar, Michael A.] Univ Minnesota, Ctr Immunol, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Mahmud, Shawn A.; Manlove, Luke S.; Schmitz, Heather M.; Xing, Yan; Owen, David L.; Hogquist, Kristin A.; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA; [Wang, Yanyan; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Schenkel, Jason M.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Boomer, Jonathan S.; Green, Jonathan M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Green, Jonathan M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Washington University (WUSTL); Juntendo University	Farrar, MA (corresponding author), Univ Minnesota, Ctr Immunol, Mason Canc Ctr, Minneapolis, MN 55455 USA.	farra005@umn.edu	Chi, Hongbo/M-9397-2018; Farrar, Michael A/M-7802-2013; Schenkel, Jason/AAV-8184-2020	Chi, Hongbo/0000-0002-9997-2496; Schenkel, Jason/0000-0003-4641-6872; Green, Jonathan/0000-0002-7449-4387; Farrar, Michael/0000-0002-5569-0366; Hogquist, Kristin/0000-0001-9963-5687; Mahmud, Shawn/0000-0001-5169-651X; Owen, David/0000-0002-1099-0605	University of Minnesota [2T32AI007313]; University of Minnesota Medical Scientist Training Program [5T32GM008244]; US National Institutes of Health [F30DK096844, F30DK100159, HL062683, AI101407, NS64599, AI088209, CA154998, CA151845, AI061165]; US National Cancer Institute [1F31CA183226]; University of Minnesota Undergraduate Research Opportunities Program (H.M.S.); Leukemia and Lymphoma Society (M.A.F.); NATIONAL CANCER INSTITUTE [R01CA154998, R01CA151845, P30CA077598, F31CA183226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI105887, R01AI105887, R01AI088209, R01AI061165, T32AI007313, R56AI061165, R01AI101407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159, F30DK096844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); University of Minnesota Medical Scientist Training Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Minnesota Undergraduate Research Opportunities Program (H.M.S.); Leukemia and Lymphoma Society (M.A.F.)(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Riccardi (Universita Di Perugia) and E. Shevach (US National Institutes of Health) for Gitr<SUP>-/</SUP>-mice; R. Schreiber (Washington University) for neutralizing antibody to TNFR2; G. Hubbard, A. Kne and C. Reis for assistance with animal husbandry; T. Martin, J. Motl and P. Champoux for cell sorting and maintenance of the Flow Cytometry Core Facility at the University of Minnesota (5P01AI035296); and C. Katerndahl, A. Moran, A. Pagan, G. Stritesky, K. Pauken, L. Heltemes-Harris and K. Berquam-Vrieze for comments and for reviewing the manuscript. Supported by the Immunology Training Program of the University of Minnesota (2T32AI007313 to S.A.M. and J.M.S.), the University of Minnesota Medical Scientist Training Program (5T32GM008244 to S.A.M. and J.M.S.), the US National Institutes of Health (F30DK096844 and F30DK100159 to S. A. M. and J.M.S.; HL062683 to J.S.B. and J.M.G.; AI101407 and NS64599 to H.C. and Y.W.; AI088209 to K.A.H. and Y.X.; and CA154998, CA151845 and AI061165 to M.A.F.), the US National Cancer Institute (1F31CA183226 to L.S.M.), the University of Minnesota Undergraduate Research Opportunities Program (H.M.S.) and the Leukemia and Lymphoma Society (M.A.F.).	Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Coquet JM, 2013, J EXP MED, V210, P715, DOI 10.1084/jem.20112061; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hogquist KA, 2000, METH MOL B, V156, P219; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lio CWJ, 2010, J IMMUNOL, V184, P6007, DOI 10.4049/jimmunol.1000019; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakanishi T, 2010, BIOCHEM BIOPH RES CO, V393, P829, DOI 10.1016/j.bbrc.2010.02.092; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	50	187	196	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					473	+		10.1038/ni.2849	http://dx.doi.org/10.1038/ni.2849			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24633226	Green Accepted			2022-12-18	WOS:000334667900013
J	Divangahi, M; Desjardins, D; Nunes-Alves, C; Remold, HG; Behar, SM				Divangahi, Maziar; Desjardins, Danielle; Nunes-Alves, Claudio; Remold, Heinz G.; Behar, Samuel M.			Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis	NATURE IMMUNOLOGY			English	Article							T-CELL RESPONSE; DENDRITIC CELLS; IN-VIVO; INFECTED MACROPHAGES; INDUCED APOPTOSIS; ANTIGEN; SALMONELLA; ACTIVATION; IMMUNOLOGY; INDUCTION	The fate of infected macrophages has an essential role in protection against Mycobacterium tuberculosis by regulating innate and adaptive immunity. M. tuberculosis exploits cell necrosis to exit from macrophages and spread. In contrast, apoptosis, which is characterized by an intact plasma membrane, is an innate mechanism that results in lower bacterial viability. Virulent M. tuberculosis inhibits apoptosis and promotes necrotic cell death by inhibiting production of prostaglandin E-2. Here we show that by activating the 5-lipoxygenase pathway, M. tuberculosis not only inhibited apoptosis but also prevented cross-presentation of its antigens by dendritic cells, which impeded the initiation of T cell immunity. Our results explain why T cell priming in response to M. tuberculosis is delayed and emphasize the importance of early immunity.	[Divangahi, Maziar; Desjardins, Danielle; Nunes-Alves, Claudio; Remold, Heinz G.; Behar, Samuel M.] Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Behar, SM (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA.	hremold@rics.bwh.harvard.edu; sbehar@rics.bwh.harvard.edu		Behar, Samuel/0000-0002-3374-6699; Nunes-Alves, Claudio/0000-0001-9639-0477	US National Institutes of Health [AI 067731, AI072143]; Fonds de la Recherche en Sante du Quebec; Fundacao para a Ciencia e Tecnologia of Portugal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072143, R01AI067731] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Koller (University of North Carolina) for Alox<SUP>5-/-</SUP> and Ptges<SUP>-/-</SUP> mice. Supported by the US National Institutes of Health (AI 067731 to S.M.B. and AI072143 to H.G.R.), the Fonds de la Recherche en Sante du Quebec (M.D.) and Fundacao para a Ciencia e Tecnologia of Portugal (C.N.-A.).	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Brookes RH, 2003, EUR J IMMUNOL, V33, P3293, DOI 10.1002/eji.200324109; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Duan L, 2002, J IMMUNOL, V169, P5181, DOI 10.4049/jimmunol.169.9.5181; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gan HX, 2005, J INFECT DIS, V191, P1292, DOI 10.1086/428906; Haimovich B, 2006, MICROBES INFECT, V8, P568, DOI 10.1016/j.micinf.2005.08.002; Henderson RA, 1997, J IMMUNOL, V159, P635; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; John B, 2008, SCIENCE, V321, P917, DOI 10.1126/science.1162914; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lira R, 2000, INFECT IMMUN, V68, P5176, DOI 10.1128/IAI.68.9.5176-5182.2000; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Oddo M, 1998, J IMMUNOL, V160, P5448; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sadagopal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005531; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Srinivasan A, 2004, J IMMUNOL, V173, P4091, DOI 10.4049/jimmunol.173.6.4091; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tunbridge AJ, 2006, INFECT IMMUN, V74, P729, DOI 10.1128/IAI.74.1.729-733.2006; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; WALLGREN A, 1948, Tubercle, V29, P245, DOI 10.1016/S0041-3879(48)80033-4; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	50	187	197	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					751	U122		10.1038/ni.1904	http://dx.doi.org/10.1038/ni.1904			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20622882	Green Accepted			2022-12-18	WOS:000280149400017
J	Kaneider, NC; Leger, AJ; Agarwal, A; Nguyen, N; Perides, G; Derian, C; Covic, L; Kuliopulos, A				Kaneider, Nicole C.; Leger, Andrew J.; Agarwal, Anika; Nguyen, Nga; Perides, George; Derian, Claudia; Covic, Lidija; Kuliopulos, Athan			'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-C; HUMAN ENDOTHELIAL-CELLS; THROMBIN-RECEPTOR; MEDICAL PROGRESS; MOUSE MODEL; RHO; RESPONSES; PERMEABILITY; MECHANISMS; INHIBITION	Sepsis is a deadly disease characterized by considerable derangement of the proinflammatory, anti-inflammatory and coagulation responses. Protease-activated receptor 1 (PAR1), an important regulator of endothelial barrier function and blood coagulation, has been proposed to be involved in the lethal sequelae of sepsis, but it is unknown whether activation of PAR1 is beneficial or harmful. Using a cell-penetrating peptide (pepducin) approach, we provide evidence that PAR1 switched from being a vascular-disruptive receptor to a vascular-protective receptor during the progression of sepsis in mice. Unexpectedly, we found that the protective effects of PAR1 required transactivation of PAR2 signaling pathways. Our results suggest therapeutics that selectively activate PAR1-PAR2 complexes may be beneficial in the treatment of sepsis.	Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Dept Med, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Dept Biochem, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Surg, Boston, MA 02111 USA; Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA	Tufts Medical Center; Tufts Medical Center; Tufts University; Tufts Medical Center; Johnson & Johnson; Johnson & Johnson USA	Kuliopulos, A (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Dept Med, 750 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu			NCI NIH HHS [R01 CA122992-04, CA122992, CA104406, R01 CA104406, R01 CA122992] Funding Source: Medline; NHLBI NIH HHS [HL64701, R01 HL057905-12, HL57905, R01 HL064701, R01 HL057905, R01 HL064701-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA122992, R01CA104406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057905, R01HL064701] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Caunt M, 2003, J THROMB HAEMOST, V1, P2097, DOI 10.1046/j.1538-7836.2003.00426.x; CHEN J, 1994, J BIOL CHEM, V269, P16041; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kerschen EJ, 2006, BLOOD, V108, p5A; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; McCoy C, 2003, CLIN THER, V25, P396, DOI 10.1016/S0149-2918(03)80086-3; Mirza H, 1996, J CLIN INVEST, V97, P1705, DOI 10.1172/JCI118597; Moffatt JD, 2002, AM J RESP CELL MOL, V26, P680, DOI 10.1165/ajrcmb.26.6.4693; Morello S, 2005, BIOCHEM PHARMACOL, V71, P223, DOI 10.1016/j.bcp.2005.10.016; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Napoli C, 2000, P NATL ACAD SCI USA, V97, P3678, DOI 10.1073/pnas.97.7.3678; Ness TL, 2003, J IMMUNOL, V171, P3775, DOI 10.4049/jimmunol.171.7.3775; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; OKAMOTO K, 1992, HAEMOSTASIS, V22, P17; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Shi XL, 2004, MOL CANCER RES, V2, P395; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05	56	187	207	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1303	1312		10.1038/ni1525	http://dx.doi.org/10.1038/ni1525			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17965715	Green Accepted			2022-12-18	WOS:000251267000011
J	Bhakta, NR; Oh, DY; Lewis, RS				Bhakta, NR; Oh, DY; Lewis, RS			Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment	NATURE IMMUNOLOGY			English	Article							RECEPTOR TRANSGENIC MICE; T-CELL MOTILITY; 2-PHOTON MICROSCOPY; NEGATIVE SELECTION; ANTIGEN; EXPRESSION; ACTIVATION; CALCINEURIN; DURATION; SIGNALS	The three-dimensional thymic microenvironment and calcium signaling pathways are essential for driving positive selection of developing T cells. However, the nature of calcium signals and the diversity of their effects in the thymus are unknown. We describe here a thymic slice preparation for visualizing thymocyte motility and signaling in real time with two-photon microscopy. Naive thymocytes were highly motile at low intracellular calcium concentrations, but during positive selection cells became immobile and showed sustained calcium concentration oscillations. Increased intracellular calcium was necessary and sufficient to arrest thymocyte motility. The calcium dependence of motility acts to prolong thymocyte interactions with antigen-bearing stromal cells, promoting sustained signaling that may enhance the expression of genes underlying positive selection.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Lewis, RS (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	rslewis@stanford.edu		Lewis, Richard/0000-0002-6010-7403	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM45374, R01 GM045374] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi S, 2000, J BIOL CHEM, V275, P14708, DOI 10.1074/jbc.275.19.14708; Adachi S, 2002, CELL IMMUNOL, V215, P45, DOI 10.1016/S0008-8749(02)00012-6; Amasaki Y, 1998, J IMMUNOL, V160, P2324; Amasaki Y, 2002, J BIOL CHEM, V277, P25640, DOI 10.1074/jbc.M201860200; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Buxton DB, 2000, J BIOL CHEM, V275, P34772, DOI 10.1074/jbc.M004996200; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; FINKEL TH, 1987, NATURE, V330, P179, DOI 10.1038/330179a0; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hare KJ, 1999, J IMMUNOL, V162, P3978; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; Hayden-Martinez K, 2000, J IMMUNOL, V165, P3713, DOI 10.4049/jimmunol.165.7.3713; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Mariathasan S, 1998, J IMMUNOL, V161, P6030; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Merkenschlager M, 1996, EUR J IMMUNOL, V26, P892, DOI 10.1002/eji.1830260426; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Raman V, 2001, J IMMUNOL, V167, P6270, DOI 10.4049/jimmunol.167.11.6270; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	49	187	190	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					143	151		10.1038/ni1161	http://dx.doi.org/10.1038/ni1161			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15654342				2022-12-18	WOS:000226468100017
J	Bolland, DJ; Wood, AL; Johnston, CM; Bunting, SF; Morgan, G; Chakalova, L; Fraser, PJ; Corcoran, AE				Bolland, DJ; Wood, AL; Johnston, CM; Bunting, SF; Morgan, G; Chakalova, L; Fraser, PJ; Corcoran, AE			Antisense intergenic transcription in V(D)J recombination	NATURE IMMUNOLOGY			English	Article							B-CELL DIFFERENTIATION; IMMUNOGLOBULIN GENE REARRANGEMENT; GERM-LINE TRANSCRIPTION; HISTONE ACETYLATION; DJ RECOMBINATION; MICE LACKING; BONE-MARROW; REGION; RNA; ACCESSIBILITY	Antigen receptor genes undergo variable, diversity and joining(V(D)J) recombination, which requires ordered large-scale chromatin remodeling. Here we show that antisense transcription, both genic and intergenic, occurs extensively in the V region of the immunoglobulin heavy chain locus. RNA fluorescence in situ hybridization demonstrates antisense transcription is strictly developmentally regulated and is initiated during the transition from DJ(H) to VDJ(H) recombination and terminates concomitantly with VDJ(H) recombination. Our data show antisense transcription is specific to the V region and suggest transcripts extend across several genes. We propose that antisense transcription remodels the V region to facilitate V-H-to-DJ(H) recombination. These findings have wider implications for V(D)J recombination of other antigen receptor loci and developmental regulation of multigene loci.	Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England; Babraham Inst, Flow Cytometry Facil, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Corcoran, AE (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England.	anne.corcoran@bbsrc.ac.uk	Fraser, Paul J. B./D-1755-2012; Chakalova, Lyubomira/C-6810-2012; Fraser, Peter/B-7549-2009; Bolland, Daniel/AAE-5185-2020	Bolland, Daniel/0000-0003-3674-9913; Fraser, Peter/0000-0002-0041-1227	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M940, BBS/E/B/0000C163, BBS/E/B/0000H484] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Allshire R, 2002, SCIENCE, V297, P1818, DOI 10.1126/science.1075874; Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; de Krom M, 2002, MOL CELL, V9, P1319, DOI 10.1016/S1097-2765(02)00558-0; Duber S, 2003, MOL IMMUNOL, V40, P509, DOI 10.1016/S0161-5890(03)00226-8; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Haines BB, 1998, EUR J IMMUNOL, V28, P4228, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;4228::AID-IMMU4228&gt;3.0.CO;2-H; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; NELSON KJ, 1983, MOL CELL BIOL, V3, P1317, DOI 10.1128/MCB.3.7.1317; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Shendure J, 2002, GENOME BIOL, V3; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Stevenson DS, 2003, CURR BIOL, V13, pR13, DOI 10.1016/S0960-9822(02)01380-5; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	52	187	194	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					630	637		10.1038/ni1068	http://dx.doi.org/10.1038/ni1068			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15107847				2022-12-18	WOS:000221664000022
J	Yewdell, JW; Hill, AB				Yewdell, JW; Hill, AB			Viral interference with antigen presentation	NATURE IMMUNOLOGY			English	Review							MHC CLASS-I; T-CELL RESPONSES; MOUSE CYTOMEGALOVIRUS GLYCOPROTEIN; CHEMOKINE-BINDING-PROTEIN; MURINE CYTOMEGALOVIRUS; DENDRITIC CELLS; NATURAL-KILLER; ENDOPLASMIC-RETICULUM; CUTTING EDGE; HEAVY-CHAINS	CD8(+) T cells play an important role in immunity to viruses. just how important these cells are is demonstrated by the evolution of viral strategies for blocking the generation or display of peptide-major histocompatibility complex class I complexes on the surfaces of virus-infected cells. Here, we focus on viral interference with antigen presentation; in particular we consider the importance (and difficulty) of establishing the evolutionary significance (that is, the ability to enhance viral transmission) of viral gene products that interfere with antigen presentation in vitro.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Oregon Health & Science University	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.	jyewdell@nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000814, ZIAAI000814] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; AKAMI A, 2000, IMMUNOL TODAY, V21, P447; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; Bennett EM, 1999, J IMMUNOL, V162, P5049; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; BLANDEN RV, 1971, J EXP MED, V133, P1090, DOI 10.1084/jem.133.5.1090; BLANDEN RV, 1971, J EXP MED, V133, P1074, DOI 10.1084/jem.133.5.1074; BLANDEN RV, 1970, J EXP MED, V132, P1035, DOI 10.1084/jem.132.5.1035; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Cebulla CM, 2002, J IMMUNOL, V169, P167, DOI 10.4049/jimmunol.169.1.167; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Cosman D, 1999, IMMUNOL REV, V168, P177, DOI 10.1111/j.1600-065X.1999.tb01292.x; Doherty PC, 2001, PHILOS T R SOC B, V356, P581, DOI 10.1098/rstb.2000.0786; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gadola SD, 2000, CLIN EXP IMMUNOL, V121, P173, DOI 10.1046/j.1365-2249.2000.01264.x; Gilbert MJ, 1996, NATURE, V383, P720, DOI 10.1038/383720a0; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Gruhler A, 2000, TRAFFIC, V1, P318, DOI 10.1034/j.1600-0854.2000.010405.x; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hinkley S, 1998, VIRUS RES, V53, P91, DOI 10.1016/S0168-1702(97)00128-7; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kavanagh DG, 2001, J IMMUNOL, V167, P3894, DOI 10.4049/jimmunol.167.7.3894; Kavanagh DG, 2001, J EXP MED, V194, P967, DOI 10.1084/jem.194.7.967; Kerkau T, 1997, J EXP MED, V185, P1295, DOI 10.1084/jem.185.7.1295; Khanna R, 1999, P NATL ACAD SCI USA, V96, P10391, DOI 10.1073/pnas.96.18.10391; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liu XX, 2001, J BIOL CHEM, V276, P32763, DOI 10.1074/jbc.M101025200; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Munch J, 2001, J VIROL, V75, P10532, DOI 10.1128/JVI.75.21.10532-10536.2001; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; PAABO S, 1987, CELL, V50, P311, DOI 10.1016/0092-8674(87)90226-1; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; POSAVAD CM, 1994, J VIROL, V68, P4072, DOI 10.1128/JVI.68.6.4072-4074.1994; Prasad SA, 2001, J IMMUNOL, V166, P4809, DOI 10.4049/jimmunol.166.8.4809; Redpath S, 1999, J IMMUNOL, V162, P6701; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Reusch U, 1999, EMBO J, V18, P1081, DOI 10.1093/emboj/18.4.1081; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Tomazin R, 1999, NAT MED, V5, P1039, DOI 10.1038/12478; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Yewdell JW, 2001, J CELL SCI, V114, P845; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	80	187	191	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1019	1025		10.1038/ni1102-1019	http://dx.doi.org/10.1038/ni1102-1019			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407410				2022-12-18	WOS:000179073000007
J	Der, E; Suryawanshi, H; Morozov, P; Kustagi, M; Goilav, B; Ranabathou, S; Izmirly, P; Clancy, R; Belmont, HM; Koenigsberg, M; Mokrzycki, M; Rominieki, H; Graham, JA; Rocca, JP; Bornkamp, N; Jordan, N; Schulte, E; Wu, M; Pullman, J; Slowikowski, K; Raychaudhuri, S; Guthridge, J; James, J; Buyon, J; Tuschl, T; Putterman, C; Anolik, J; Apruzzese, W; Arazi, A; Berthier, C; Brenner, M; Connery, S; Cunningham, M; Dall'Era, M; Davidson, A; Fava, A; Fonseka, C; Furie, R; Goldman, D; Gupta, R; Guthridge, J; Hacohen, N; Hildeman, D; Hoover, P; Hsu, R; Kado, R; Kalunian, K; Kamen, D; Kretzler, M; Maecker, H; Massarotti, E; McCune, W; McMahon, M; Park, M; Payan-Schober, F; Pendergraft, W; Petri, M; Pichavant, M; Rao, D; Utz, P; Waguespack, D; Wofsy, D; Zhang, F				Der, Evan; Suryawanshi, Hemant; Morozov, Pavel; Kustagi, Manjunath; Goilav, Beatrice; Ranabathou, Saritha; Izmirly, Peter; Clancy, Robert; Belmont, H. Michael; Koenigsberg, Mordecai; Mokrzycki, Michele; Rominieki, Helen; Graham, Jay A.; Rocca, Juan P.; Bornkamp, Nicole; Jordan, Nicole; Schulte, Emma; Wu, Ming; Pullman, James; Slowikowski, Kamil; Raychaudhuri, Soumya; Guthridge, Joel; James, Judith; Buyon, Jill; Tuschl, Thomas; Putterman, Chaim; Anolik, Jennifer; Apruzzese, William; Arazi, Arnon; Berthier, Celine; Brenner, Michael; Connery, Sean; Cunningham, Melissa; Dall'Era, Maria; Davidson, Anne; Fava, Andrea; Fonseka, Chamith; Furie, Richard; Goldman, Dan; Gupta, Rohit; Guthridge, Joel; Hacohen, Nir; Hildeman, David; Hoover, Paul; Hsu, Raymond; Kado, Ruba; Kalunian, Kenneth; Kamen, Diane; Kretzler, Mattias; Maecker, Holden; Massarotti, Elena; McCune, William; McMahon, Maureen; Park, Meyeon; Payan-Schober, Fernanda; Pendergraft, William; Petri, Michelle; Pichavant, Mina; Rao, Deepak; Utz, Paul; Waguespack, Dia; Wofsy, David; Zhang, Fan		Accelerating Medicines Partnersh	Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways	NATURE IMMUNOLOGY			English	Article							EPITHELIAL-MYOFIBROBLAST TRANSDIFFERENTIATION; RENAL OUTCOMES; ERYTHEMATOSUS; EXPRESSION; GENE; KEGG; RECONSTRUCTION; INFLAMMATION; INTERFERON; TRANSITION	The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (scRNA-seq) to renal biopsies from patients with LN and evaluated skin biopsies as a potential source of diagnostic and prognostic markers of renal disease. Type I interferon (IFN)-response signatures in tubular cells and keratinocytes distinguished patients with LN from healthy control subjects. Moreover, a high IFN-response signature and fibrotic signature in tubular cells were each associated with failure to respond to treatment. Analysis of tubular cells from patients with proliferative, membranous and mixed LN indicated pathways relevant to inflammation and fibrosis, which offer insight into their histologic differences. In summary, we applied scRNA-seq to LN to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.	[Der, Evan; Jordan, Nicole; Schulte, Emma; Putterman, Chaim] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10467 USA; [Der, Evan; Jordan, Nicole; Schulte, Emma; Putterman, Chaim] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Suryawanshi, Hemant; Morozov, Pavel; Kustagi, Manjunath; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Goilav, Beatrice] Albert Einstein Coll Med, Childrens Hosp Montefiore, Pediat Nephrol, Bronx, NY 10467 USA; [Ranabathou, Saritha] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Pediat Nephrol, Little Rock, AR 72205 USA; [Izmirly, Peter; Clancy, Robert; Belmont, H. Michael; Bornkamp, Nicole; Wu, Ming; Buyon, Jill] NYU, Sch Med, New York, NY 10016 USA; [Koenigsberg, Mordecai] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Mokrzycki, Michele] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Nephrol, Bronx, NY 10467 USA; [Rominieki, Helen; Graham, Jay A.; Rocca, Juan P.] Montefiore Med Ctr, Montefiore Einstein Ctr Transplantat, 111 E 210th St, Bronx, NY 10467 USA; [Pullman, James] Montefiore Med Ctr, Clin Pathol, 111 E 210th St, Bronx, NY 10467 USA; [Slowikowski, Kamil; Raychaudhuri, Soumya; Arazi, Arnon; Zhang, Fan] Broad Inst MIT & Harvard, Cambridge, MA USA; [Guthridge, Joel; James, Judith] Oklahoma Med Res Fdn, Oklahoma City, OK USA; [Anolik, Jennifer] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Anolik, Jennifer] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Apruzzese, William] Brigham & Womens Hosp, Div Rheumatol, Immunol, Allergy, 75 Francis St, Boston, MA 02115 USA; [Apruzzese, William; Brenner, Michael; Cunningham, Melissa; Fonseka, Chamith; Rao, Deepak; Zhang, Fan] Harvard Med Sch, Boston, MA 02115 USA; [Berthier, Celine; Kado, Ruba; Kretzler, Mattias; McCune, William] Univ Michigan, Dept Nephrol, Internal Med, Ann Arbor, MI 48109 USA; [Connery, Sean] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Med, El Paso, TX USA; [Cunningham, Melissa] Med Univ South Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Dall'Era, Maria; Wofsy, David] Univ Calif San Francisco, Rheumatol Div, San Francisco, CA 94143 USA; [Davidson, Anne] Northwell Hlth, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA; [Fava, Andrea; Goldman, Dan; Petri, Michelle] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [Fonseka, Chamith; Zhang, Fan] Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA; [Fonseka, Chamith; Zhang, Fan] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Furie, Richard] Northwell Hlth, Div Rheumatol, Great Neck, NY USA; [Gupta, Rohit; Pichavant, Mina; Utz, Paul] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Hildeman, David] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Hildeman, David] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Hsu, Raymond] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Kalunian, Kenneth] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Maecker, Holden] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [McMahon, Maureen] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Pendergraft, William] PLLC, Integrat Med Clin North Carolina, Chapel Hill, NC USA; [Pichavant, Mina; Utz, Paul] Stanford Univ, Dept Med, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Waguespack, Dia] Univ Texas Houston, Dept Internal Med, Houston, TX USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Oklahoma Medical Research Foundation; University of Rochester; University of Rochester; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Texas Tech University System; Texas Tech University; Medical University of South Carolina; University of California System; University of California San Francisco; Northwell Health; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Northwell Health; Stanford University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco; University of California System; University of California San Diego; Stanford University; University of California System; University of California Los Angeles; Stanford University; University of Texas System; University of Texas Health Science Center Houston	Putterman, C (corresponding author), Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10467 USA.; Putterman, C (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.; Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10021 USA.; Buyon, J (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	jill.buyon@nyumc.org; ttuschl@mail.rockefeller.edu; putterman@einstein.yu.edu	Slowikowski, Kamil/K-3728-2016; Zhang, Fan/ABD-7525-2021; Morozov, Pavel/GQP-7206-2022; Fava, Andrea/AAF-8515-2019; Putterman, Chaim/AFR-0429-2022; Goilav, Beatrice/AAF-8349-2021; Rocca, Juan Pablo/AAU-3771-2020; Hildeman, David/AAA-1757-2020; Kalunian, Kenneth/AAK-6424-2020; Graham, Jay/AAL-5732-2020; Rocca, Juan/AAB-7007-2022	Slowikowski, Kamil/0000-0002-2843-6370; Zhang, Fan/0000-0002-6102-2970; Fava, Andrea/0000-0001-6738-4836; Rocca, Juan Pablo/0000-0002-1146-237X; Hildeman, David/0000-0002-0421-8483; Graham, Jay/0000-0003-2054-1253; Anolik, Jennifer/0000-0002-1450-1549; Izmirly, Peter/0000-0001-5445-2182; Belmont, Howard/0000-0003-3389-2976; Buyon, Jill/0000-0002-3852-7129; Cunningham, Melissa/0000-0002-9207-1986; Raychaudhuri, Soumya/0000-0002-1901-8265	National Center for Advancing Translational Sciences (NCATS) [UL1TR001866]; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; Arthritis Foundation; Bristol-Myers Squibb; Foundation for the National Institutes of Health, Lupus Foundation of America; Lupus Research Alliance; Merck Sharp Dohme; National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Pfizer; Rheumatology Research Foundation;  [UH2-AR067676];  [UH2-AR067677];  [UH2-AR067679];  [UH2-AR067681];  [UH2-AR067685];  [UH2-AR067688];  [UH2-AR067689];  [UH2-AR067690];  [UH2-AR067691];  [UH2-AR067694];  [UM2-AR067678]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067694, UM2AR067678, UH2AR067677, UH2AR067676, UH2AR067690, F31AR070582, UH2AR067685, UH2AR067688, UH2AR067691, UH2AR067679, UH2AR067681, UH2AR067689] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; Arthritis Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Foundation for the National Institutes of Health, Lupus Foundation of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance; Merck Sharp Dohme(Merck & Company); National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases; Pfizer(Pfizer); Rheumatology Research Foundation; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank A. Hurley and the Research Facilitation Office staff at Rockefeller University for regulatory and administrative assistance who are supported in part by grant no. UL1TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. This work was supported by the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network. AMP is a public-private partnership (AbbVie, Arthritis Foundation, Bristol-Myers Squibb, Foundation for the National Institutes of Health, Lupus Foundation of America, Lupus Research Alliance, Merck Sharp & Dohme, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Pfizer, Rheumatology Research Foundation, Sanofi and Takeda Pharmaceuticals) created to develop new ways of identifying and validating promising biological targets for diagnostics and drug development. Funding was provided through grants from the National Institutes of Health (grant nos. UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694 and UM2-AR067678). We thank the Rockefeller University Genomics Resource Center for providing access to the Fluidigm C1 system and Illumina sequencing.	Alsuwaida AO, 2013, LUPUS, V22, P1446, DOI 10.1177/0961203313507986; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; Castellano G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0588-3; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Der E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Elkon KB, 2011, J INTERF CYTOK RES, V31, P803, DOI 10.1089/jir.2011.0045; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Hsieh C, 2011, ARTHRIT CARE RES, V63, P865, DOI 10.1002/acr.20441; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim KT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0945-9; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Misra R, 2015, INT J RHEUM DIS, V18, P219, DOI 10.1111/1756-185X.12602; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; Ofengeim D, 2017, TRENDS MOL MED, V23, P563, DOI 10.1016/j.molmed.2017.04.006; Parikh SV, 2017, TRANSL RES, V182, P1, DOI [10.1016/j.trs1.2016.10.010, 10.1016/j.trsl.2016.10.010]; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116; Reich A, 2011, THER CLIN RISK MANAG, V7, P27, DOI 10.2147/TCRM.S10145; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Smith ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02709-w; Stephenson W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02659-x; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; Su Z, 2014, J INTERN MED, V276, P470, DOI 10.1111/joim.12214; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wolf G, 1997, SEMIN NEPHROL, V17, P448; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Yu F, 2010, KIDNEY INT, V77, P820, DOI 10.1038/ki.2010.13; Zhang XG, 2006, J GERONTOL A-BIOL, V61, P1130, DOI 10.1093/gerona/61.11.1130	48	186	190	6	79	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					915	+		10.1038/s41590-019-0386-1	http://dx.doi.org/10.1038/s41590-019-0386-1			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31110316	Green Submitted, Green Accepted			2022-12-18	WOS:000471891900021
J	Delconte, RB; Kolesnik, TB; Dagley, LF; Rautela, J; Shi, W; Putz, EM; Stannard, K; Zhang, JG; Teh, C; Firth, M; Ushiki, T; Andoniou, CE; Degli-Esposti, MA; Sharp, PP; Sanvitale, CE; Infusini, G; Liau, NPD; Linossi, EM; Burns, CJ; Carotta, S; Gray, DHD; Seillet, C; Hutchinson, DS; Belz, GT; Webb, AI; Alexander, WS; Li, SS; Bullock, AN; Babon, JJ; Smyth, MJ; Nicholson, SE; Huntington, ND				Delconte, Rebecca B.; Kolesnik, Tatiana B.; Dagley, Laura F.; Rautela, Jai; Shi, Wei; Putz, Eva M.; Stannard, Kimberley; Zhang, Jian-Guo; Teh, Charis; Firth, Matt; Ushiki, Takashi; Andoniou, Christopher E.; Degli-Esposti, Mariapia A.; Sharp, Phillip P.; Sanvitale, Caroline E.; Infusini, Giuseppe; Liau, Nicholas P. D.; Linossi, Edmond M.; Burns, Christopher J.; Carotta, Sebastian; Gray, Daniel H. D.; Seillet, Cyril; Hutchinson, Dana S.; Belz, Gabrielle T.; Webb, Andrew I.; Alexander, Warren S.; Li, Shawn S.; Bullock, Alex N.; Babon, Jeffery J.; Smyth, Mark J.; Nicholson, Sandra E.; Huntington, Nicholas D.			CIS is a potent checkpoint in NK cell-mediated tumor immunity	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; T-CELLS; ANTI-PD-L1 ANTIBODY; CANCER-THERAPY; PROTEIN; SUPPRESSION; ACTIVATION; IPILIMUMAB; BINDS; GENE	The detection of aberrant cells by natural killer (NK) cells is controlled by the integration of signals from activating and inhibitory ligands and from cytokines such as IL-15. We identified cytokine-inducible SH2-containing protein (CIS, encoded by Cish) as a critical negative regulator of IL-15 signaling in NK cells. Cish was rapidly induced in response to IL-15, and deletion of Cish rendered NK cells hypersensitive to IL-15, as evidenced by enhanced proliferation, survival, IFN-gamma production and cytotoxicity toward tumors. This was associated with increased JAK-STAT signaling in NK cells in which Cish was deleted. Correspondingly, CIS interacted with the tyrosine kinase JAK1, inhibiting its enzymatic activity and targeting JAK for proteasomal degradation. Cish(-/-) mice were resistant to melanoma, prostate and breast cancer metastasis in vivo, and this was intrinsic to NK cell activity. Our data uncover a potent intracellular checkpoint in NK cell-mediated tumor immunity and suggest possibilities for new cancer immunotherapies directed at blocking CIS function.	[Delconte, Rebecca B.; Kolesnik, Tatiana B.; Dagley, Laura F.; Rautela, Jai; Shi, Wei; Zhang, Jian-Guo; Teh, Charis; Firth, Matt; Ushiki, Takashi; Sharp, Phillip P.; Infusini, Giuseppe; Liau, Nicholas P. D.; Linossi, Edmond M.; Burns, Christopher J.; Carotta, Sebastian; Gray, Daniel H. D.; Seillet, Cyril; Belz, Gabrielle T.; Webb, Andrew I.; Alexander, Warren S.; Babon, Jeffery J.; Nicholson, Sandra E.; Huntington, Nicholas D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Delconte, Rebecca B.; Dagley, Laura F.; Rautela, Jai; Shi, Wei; Zhang, Jian-Guo; Teh, Charis; Firth, Matt; Ushiki, Takashi; Sharp, Phillip P.; Liau, Nicholas P. D.; Linossi, Edmond M.; Burns, Christopher J.; Carotta, Sebastian; Gray, Daniel H. D.; Seillet, Cyril; Belz, Gabrielle T.; Webb, Andrew I.; Alexander, Warren S.; Babon, Jeffery J.; Nicholson, Sandra E.; Huntington, Nicholas D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Putz, Eva M.; Stannard, Kimberley; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Andoniou, Christopher E.; Degli-Esposti, Mariapia A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Nedlands, WA 6009, Australia; [Andoniou, Christopher E.; Degli-Esposti, Mariapia A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia; [Sanvitale, Caroline E.; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford, England; [Hutchinson, Dana S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Li, Shawn S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Li, Shawn S.] Univ Western Ontario, Schulich Sch Med & Dent, Siebens Drake Med Res Inst, London, ON, Canada; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Western Australia; Lions Eye Institute; University of Western Australia; University of Oxford; Monash University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Queensland	Nicholson, SE; Huntington, ND (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.; Nicholson, SE; Huntington, ND (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia.	snicholson@wehi.edu.au; huntington@wehi.edu.au	König, Eva Maria/AAF-4041-2019; Smyth, Mark J/H-8709-2014; Stannard, Kimberley A/D-8482-2013; Belz, Gabrielle T/C-9350-2013; Gray, Daniel HD/A-3293-2013; Huntington, NICHOLAS/AAV-4704-2020; babon, jeffrey j/B-9170-2013; Seillet, Cyril/AAF-1888-2019	König, Eva Maria/0000-0002-9990-4477; Smyth, Mark J/0000-0001-7098-7240; Belz, Gabrielle T/0000-0002-9660-9587; Gray, Daniel HD/0000-0002-8457-8242; Huntington, NICHOLAS/0000-0002-5267-7211; babon, jeffrey j/0000-0002-5408-6239; Seillet, Cyril/0000-0002-0941-8679; Hutchinson, Dana/0000-0001-9947-0106; Andoniou, Christopher/0000-0003-0566-3180; Delconte, Rebecca/0000-0002-3066-4014; , Sandra/0000-0002-1314-2134; Degli-Esposti, Mariapia/0000-0002-7808-5935; Sharp, Phillip/0000-0003-4416-2303; Burns, Christopher/0000-0002-4463-4916; Liau, Nicholas/0000-0002-3887-899X; Putz, Eva Maria/0000-0002-5309-4114	National Health and Medical Research Council (NHMRC) of Australia [1027472, 1013667, 1098960, 1047903, 1016647, 1049407, 1066770, 1057852, 1078763]; NHMRC Independent Research Institute Infrastructure Support scheme grant; Victorian State Government Operational Infrastructure Scheme grant; Harry J Lloyd Charitable Trust; Leukemia Foundation scholarship; NHMRC [GNT0461276, 1058344, 545952, 1090236, 1089072, 1078671]; Australian Research Council; Menzies Foundation; Austrian Science Fund (FWF) [J-3635]; AbbVie [1097737]; Bayer PHARMA AG [1097737]; Boehringer Ingelheim [1097737]; Canada Foundation for Innovation [1097737]; Canadian Institutes for Health Research [1097737]; Genome Canada [1097737]; GlaxoSmithKline [1097737]; Janssen [1097737]; Lilly Canada [1097737]; Novartis Research Foundation [1097737]; Ontario Ministry of Economic Development and Innovation [1097737]; Pfizer [1097737]; Takeda [1097737]; Wellcome Trust [1097737, 092809/Z/10/Z]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institute Infrastructure Support scheme grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Scheme grant; Harry J Lloyd Charitable Trust; Leukemia Foundation scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Menzies Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); AbbVie(AbbVie); Bayer PHARMA AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	We wish to thank N. Nicola for helpful comments and discussion, P. Rueda and C. Quillici for technical assistance, Tracy Wilson for generating the wild-type and SH2-mutant CIS expression plasmids, R. Anderson for the E0771.LMB cells, and L. Town, K. Elder, T. Camilleri and J. Sutton for excellent animal husbandry. We are grateful to the staff of the WEHI Bioservices, Monoclonal antibody facility, Flow cytometry facility and Clinical Translational Centre. This work is supported by program and project grants from the National Health and Medical Research Council (NHMRC) of Australia (1027472 to S.C., N.D.H. and G.T.B., 1013667 and 1098960 to M.J.S., 1047903 to G.T.B., 1016647 to J.G.Z., S.E.N. and W.S.A., 1049407, 1066770 and 1057852 to N.D.H., and 1078763 to D.H.D.G.), as well as an NHMRC Independent Research Institute Infrastructure Support scheme grant and a Victorian State Government Operational Infrastructure Scheme grant. N.D.H. is a recipient of a Melanoma Research Grant from the Harry J Lloyd Charitable Trust and R.B.D. is supported by a Leukemia Foundation scholarship. This work was also supported by fellowships from the NHMRC (GNT0461276 to N.D.H., 1058344 to W.S.A., 545952 to D.S.H., 1090236 to D.H.D.G., 1089072 to C. T., Australia Fellowship 1078671 to M.J.S.), the Australian Research Council (G.T.B.) and the Menzies Foundation (N.D.H.). E.M.P. is supported by a Schroedinger Fellowship from the Austrian Science Fund (FWF): J-3635. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer PHARMA AG, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z].	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Allard B, 2013, CLIN CANCER RES, V19, P5626, DOI 10.1158/1078-0432.CCR-13-0545; Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Babon Jeffrey J, 2013, Methods Mol Biol, V967, P39, DOI 10.1007/978-1-62703-242-1_3; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Burns C. J., 2013, JAK STAT SIGNALLING, P99; Burns C.J., 2008, [No title captured], Patent No. [2008109943, WO2008109943]; Burns CJ, 2009, BIOORG MED CHEM LETT, V19, P5887, DOI 10.1016/j.bmcl.2009.08.071; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Andrade LF, 2014, CANCER RES, V74, P7298, DOI 10.1158/0008-5472.CAN-14-1339; Floros T, 2015, SEMIN ONCOL, V42, P539, DOI 10.1053/j.seminoncol.2015.05.015; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Huntington ND, 2014, IMMUNOL CELL BIOL, V92, P210, DOI 10.1038/icb.2014.1; Johnstone CN, 2015, DIS MODEL MECH, V8, P237, DOI 10.1242/dmm.017830; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Kolesnik Tatiana B, 2013, Methods Mol Biol, V967, P235, DOI 10.1007/978-1-62703-242-1_17; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Li SSC, 2009, METHODS MOL BIOL, V570, P67, DOI 10.1007/978-1-60327-394-7_3; Linossi EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070536; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Moreno BH, 2015, BRIT J CANCER, V112, P1421, DOI 10.1038/bjc.2015.124; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Palmer DC, 2015, J EXP MED, V212, P2095, DOI 10.1084/jem.20150304; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rautela J, 2015, CANCER IMMUNOL RES, V3, P1207, DOI 10.1158/2326-6066.CIR-15-0065; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Schirle M, 2012, METHODS MOL BIOL, V795, P161, DOI 10.1007/978-1-61779-337-0_11; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	61	186	197	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					816	+		10.1038/ni.3470	http://dx.doi.org/10.1038/ni.3470			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27213690	Green Submitted			2022-12-18	WOS:000378283200014
J	Goic, B; Vodovar, N; Mondotte, JA; Monot, C; Frangeul, L; Blanc, H; Gausson, V; Vera-Otarola, J; Cristofari, G; Saleh, MC				Goic, Bertsy; Vodovar, Nicolas; Mondotte, Juan A.; Monot, Clement; Frangeul, Lionel; Blanc, Herve; Gausson, Valerie; Vera-Otarola, Jorge; Cristofari, Gael; Saleh, Maria-Carla			RNA-mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila	NATURE IMMUNOLOGY			English	Article							FLOCK HOUSE VIRUS; ANTIVIRAL IMMUNITY; RECOMBINATION; REPLICATION; INFECTIONS; PARTICLES; CELLS	How persistent viral infections are established and maintained is widely debated and remains poorly understood. We found here that the persistence of RNA viruses in Drosophila melanogaster was achieved through the combined action of cellular reverse-transcriptase activity and the RNA-mediated interference (RNAi) pathway. Fragments of diverse RNA viruses were reverse-transcribed early during infection, which resulted in DNA forms embedded in retrotransposon sequences. Those virus-retrotransposon DNA chimeras produced transcripts processed by the RNAi machinery, which in turn inhibited viral replication. Conversely, inhibition of reverse transcription hindered the appearance of chimeric DNA and prevented persistence. Our results identify a cooperative function for retrotransposons and antiviral RNAi in the control of lethal acute infection for the establishment of viral persistence.	[Goic, Bertsy; Vodovar, Nicolas; Mondotte, Juan A.; Frangeul, Lionel; Blanc, Herve; Gausson, Valerie; Saleh, Maria-Carla] CNRS, URA3015, Inst Pasteur Viruses & RNA Interference, Paris, France; [Monot, Clement; Vera-Otarola, Jorge; Cristofari, Gael] Univ Nice Sophia Antipolis, CNRS, INSERM, U1081,Unite Mixte Rech 7284,Fac Med,Inst Res Canc, Nice, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Saleh, MC (corresponding author), CNRS, URA3015, Inst Pasteur Viruses & RNA Interference, Paris, France.	carla.saleh@pasteur.fr	Saleh, Maria-Carla/ABC-2527-2021; Cristofari, Gael/A-2831-2011; Frangeul, Lionel/G-3617-2015; Vodovar, Nicolas/S-2947-2019	Saleh, Maria-Carla/0000-0001-8593-4117; Cristofari, Gael/0000-0001-5620-3091; Vera-Otarola, Jorge/0000-0003-2547-4213; Vodovar, Nicolas/0000-0001-8087-387X; Dorey, valerie/0000-0002-9727-3448; Lionel, Frangeul/0000-0002-0992-8775	French Agence Nationale de la Recherche [ANR-09-JCJC-0045-01]; European Research Council [FP7/2007-2013 ERG 242703, ERG 243312]; Institut National de la Sante et de la Recherche Medicale; Institut National du Cancer; French Ministry of Research; La Fondation ARC pour la Recherche sur le Cancer; AXA Research Fund	French Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer(Institut National du Cancer (INCA) France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); La Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); AXA Research Fund(AXA Research Fund)	We thank members of the Saleh, Antoniewski and Vignuzzi laboratories for discussions and technical support; M. Vignuzzi, J. Chandler and R. van Rij for critical reading of the manuscript; A. Schneemann (The Scripps Research Institute) for antibody to FHV; P. Vargas for assistance with flow cytometry; and A. Pelisson for advice on retrotransposition. Supported by the French Agence Nationale de la Recherche (ANR-09-JCJC-0045-01 to M.-C.S.), the European Research Council (FP7/2007-2013 ERG 242703 to M.-C.S. and ERG 243312 to G.C.), Institut National de la Sante et de la Recherche Medicale and the Institut National du Cancer (G.C.), the French Ministry of Research (C.M.), La Fondation ARC pour la Recherche sur le Cancer (C.M.) and the AXA Research Fund (JAM.).	Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; DASGUPTA R, 1994, ARCH VIROL, P121; Dasgupta R, 2007, J MED ENTOMOL, V44, P102, DOI 10.1603/0022-2585(2007)44[102:ROFHVI]2.0.CO;2; Ebner PD, 2008, VIROLOGY, V381, P98, DOI 10.1016/j.virol.2008.08.024; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Flegel TW, 2007, DEV COMP IMMUNOL, V31, P217, DOI 10.1016/j.dci.2006.06.009; Flegel TW, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-32; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375; Goic B, 2012, CURR OPIN MICROBIOL, V15, P531, DOI 10.1016/j.mib.2012.06.002; Goldstone DC, 2010, CELL HOST MICROBE, V8, P248, DOI 10.1016/j.chom.2010.08.006; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Jovel J, 2011, VIROLOGY, V419, P43, DOI 10.1016/j.virol.2011.08.002; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Killip MJ, 2012, J GEN VIROL, V93, P299, DOI 10.1099/vir.0.037531-0; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; LI Y, 1993, J VIROL, V67, P3854, DOI 10.1128/JVI.67.7.3854-3860.1993; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Roekring S, 2006, DEV COMP IMMUNOL, V30, P878, DOI 10.1016/j.dci.2005.12.006; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Simon AE, 2004, ANNU REV PHYTOPATHOL, V42, P415, DOI 10.1146/annurev.phyto.42.040803.140402; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Terzian C, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-3; Tsai KN, 2007, VIRUS RES, V124, P139, DOI 10.1016/j.virusres.2006.10.013; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; ZHONG WD, 1992, P NATL ACAD SCI USA, V89, P11146, DOI 10.1073/pnas.89.23.11146	41	186	188	4	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					396	403		10.1038/ni.2542	http://dx.doi.org/10.1038/ni.2542			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23435119	Green Submitted			2022-12-18	WOS:000316648700015
J	de Jong, A; Pena-Cruz, V; Cheng, TY; Clark, RA; Van Rhijn, I; Moody, DB				de Jong, Annemieke; Pena-Cruz, Victor; Cheng, Tan-Yun; Clark, Rachael A.; Van Rhijn, Ildiko; Moody, D. Branch			CD1a-autoreactive T cells are a normal component of the human alpha beta T cell repertoire	NATURE IMMUNOLOGY			English	Article							CUTANEOUS LYMPHOCYTE ANTIGEN; ARYL-HYDROCARBON RECEPTOR; HUMAN LANGERHANS CELLS; NKT CELLS; SELF-GLYCOLIPIDS; PRESENTING CELLS; CD1D TETRAMERS; INTERLEUKIN 22; TH17 CELLS; HUMAN SKIN	CD1 activates T cells, but the function and size of the possible human T cell repertoires that recognize each of the CD1 antigen-presenting molecules remain unknown. Using an experimental system that bypasses major histocompatibility complex (MHC) restriction and the requirement for defined antigens, we show that polyclonal T cells responded at higher rates to cells expressing CD1a than to those expressing CD1b, CD1c or CD1d. Unlike the repertoire of invariant natural killer T (NKT) cells, the CD1a-autoreactive repertoire contained diverse T cell antigen receptors (TCRs). Functionally, many CD1a-autoreactive T cells homed to skin, where they produced interleukin 22 (IL-22) in response to CD1a on Langerhans cells. The strong and frequent responses among genetically diverse donors define CD1a-autoreactive cells as a normal part of the human T cell repertoire and CD1a as a target of the T(H)22 subset of helper T cells.	[de Jong, Annemieke; Cheng, Tan-Yun; Van Rhijn, Ildiko; Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Pena-Cruz, Victor] Dana Farber Canc Inst, Boston, MA 02115 USA; [Clark, Rachael A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University	Moody, DB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu		Van Rhijn, Ildiko/0000-0002-1446-5701; de Jong, Annemieke/0000-0001-6707-6585	National Institute of Arthritis, Musculoskeletal and Skin Diseases [048632, AR056720]; National Institute of Allergy and Infectious Diseases [AI071155, AI054456, AI056299]; Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund; National Psoriasis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456, R01AI071155, R01AI049313, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR048632] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Psoriasis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D.C. Barral, M. Brenner and M. Relloso (Harvard Medical School) and M. Sugita (Kyoto University) for CD1 plasmid constructs; J. Gumperz (University of Wisconsin) and M. Brigl (Harvard Medical School) for human NKT cell lines; G. Losyev for cell sorting; and K. Magalhaes, S. Huang, I.C. Ho and R. Grenningloh for technical advice. Supported by the National Institute of Arthritis, Musculoskeletal and Skin Diseases (048632 to D.B.M. and AR056720 to R.A.C.), the National Institute of Allergy and Infectious Diseases (AI071155 to D.B.M., and AI054456 and AI056299), the Damon Runyon Cancer Research Foundation (R.A.C.), the Burroughs Wellcome Fund (D.B.M.) and the National Psoriasis Foundation (A.d.J.).	Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Armerding D, 1999, INT ARCH ALLERGY IMM, V119, P212, DOI 10.1159/000024197; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; CHU A, 1982, J INVEST DERMATOL, V78, P177, DOI 10.1111/1523-1747.ep12506352; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dascher CC, 2007, CURR TOP MICROBIOL, V314, P3; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FOSTER CA, 1990, J EXP MED, V171, P997, DOI 10.1084/jem.171.4.997; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Meunier L, 1996, CYTOMETRY, V26, P260, DOI 10.1002/(SICI)1097-0320(19961215)26:4<260::AID-CYTO4>3.3.CO;2-T; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2006, ADV IMMUNOL, V89, P87, DOI 10.1016/S0065-2776(05)89003-0; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pena-Cruz V, 2001, J IMMUNOL METHODS, V255, P83, DOI 10.1016/S0022-1759(01)00432-X; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rosat JP, 1999, J IMMUNOL, V162, P366; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Roura-Mir C, 2005, J IMMUNOL, V174, P3773, DOI 10.4049/jimmunol.174.6.3773; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Strid J, 2009, SEMIN IMMUNOL, V21, P110, DOI 10.1016/j.smim.2009.03.002; Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van Beeck FAL, 2008, IMMUNOGENETICS, V60, P315, DOI 10.1007/s00251-008-0297-z; Van Rhijn I, 2006, J IMMUNOL, V176, P4888, DOI 10.4049/jimmunol.176.8.4888; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vincent MS, 2005, J IMMUNOL, V175, P6344, DOI 10.4049/jimmunol.175.10.6344; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Wang XH, 2008, BLOOD, V112, P4128, DOI 10.1182/blood-2008-05-157529; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; YU RC, 1994, BRIT J DERMATOL, V131, P843, DOI 10.1111/j.1365-2133.1994.tb08587.x; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	58	186	191	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1102	U98		10.1038/ni.1956	http://dx.doi.org/10.1038/ni.1956			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21037579	Green Accepted			2022-12-18	WOS:000284262200009
J	Katagiri, K; Imamura, M; Kinashi, T				Katagiri, Koko; Imamura, Masashi; Kinashi, Tatsuo			Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion	NATURE IMMUNOLOGY			English	Article							CASPASE-MEDIATED ACTIVATION; T-CELL ADHESION; INTEGRIN ACTIVATION; LEUKOCYTE ADHESION; AVIDITY REGULATION; SPATIAL REGULATION; HUMAN NEUTROPHILS; PLASMA-MEMBRANE; APOPTOSIS; TRAFFICKING	RAPL, a protein that binds the small GTPase Rap1, is required for efficient immune cell trafficking. Here we have identified the kinase Mst1 as a critical effector of RAPL. RAPL regulated the localization and kinase activity of Mst1. 'Knockdown' of the gene encoding Mst1 demonstrated its requirement for the induction of both a polarized morphology and integrin LFA-1 clustering and adhesion triggered by chemokines and T cell receptor ligation. RAPL and Mst1 localized to vesicular compartments and dynamically translocated with LFA-1 to the leading edge upon Rap1 activation, suggesting a regulatory function for the RAPL-Mst1 complex in intracellular transport of LFA-1. Our study demonstrates a previously unknown function for Mst1 of relaying the Rap1-RAPL signal to induce cell polarity and adhesion of lymphocytes.	Kansai Med Univ, Inst Biomed Sci, Dept Mol Genet, Osaka 5708506, Japan; Ishihara Sangyo Kaisha, Ctr Res Inst, Shiga 5250025, Japan	Kansai Medical University; Ishihara Sangyo Kaisha Ltd	Kinashi, T (corresponding author), Kansai Med Univ, Inst Biomed Sci, Dept Mol Genet, Osaka 5708506, Japan.	kinashi@takii.kmu.ac.jp						BERGER G, 1994, BRIT J HAEMATOL, V88, P372, DOI 10.1111/j.1365-2141.1994.tb05033.x; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kakeya H, 1998, CANCER RES, V58, P4888; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; PIZON V, 1994, J CELL SCI, V107, P1661; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; QUINN MT, 1992, BLOOD, V79, P1563; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; ZEMOJTEL T, 2005, LEUKEMIA	52	186	197	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					919	928		10.1038/ni1374	http://dx.doi.org/10.1038/ni1374			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16892067				2022-12-18	WOS:000239942300010
J	Jeltsch, KM; Hu, DS; Brenner, S; Zoller, J; Heinz, GA; Nagel, D; Vogel, KU; Rehage, N; Warth, SC; Edelmann, SL; Gloury, R; Martin, N; Lohs, C; Lech, M; Stehklein, JE; Geerlof, A; Kremmer, E; Weber, A; Anders, HJ; Schmitz, I; Schmidt-Supprian, M; Fu, MG; Holtmann, H; Krappmann, D; Ruland, J; Kallies, A; Heikenwalder, M; Heissmeyer, V				Jeltsch, Katharina M.; Hu, Desheng; Brenner, Sven; Zoeller, Jessica; Heinz, Gitta A.; Nagel, Daniel; Vogel, Katharina U.; Rehage, Nina; Warth, Sebastian C.; Edelmann, Stephanie L.; Gloury, Renee; Martin, Nina; Lohs, Claudia; Lech, Maciej; Stehklein, Jenny E.; Geerlof, Arie; Kremmer, Elisabeth; Weber, Achim; Anders, Hans-Joachim; Schmitz, Ingo; Schmidt-Supprian, Marc; Fu, Mingui; Holtmann, Helmut; Krappmann, Daniel; Ruland, Juergen; Kallies, Axel; Heikenwalder, Mathias; Heissmeyer, Vigo			Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; HELPER T-CELLS; MESSENGER-RNA DECAY; PHARMACOLOGICAL INHIBITION; PROTECTS MICE; PROTEASE; AUTOIMMUNITY; RECOGNITION; ACTIVATION; EXPANSION	Humoral autoimmunity paralleled by the accumulation of follicular helper T cells (T-FH cells) is linked to mutation of the gene encoding the RNA-binding protein roquin-1. Here we found that T cells lacking roquin caused pathology in the lung and accumulated as cells of the T(H)17 subset of helper T cells in the lungs. Roquin inhibited T(H)17 cell differentiation and acted together with the endoribonuclease regnase-1 to repress target mRNA encoding the T(H)17 cell promoting factors IL-6, ICOS, c-Rel, IRF4, I kappa BNS and I kappa B zeta. This cooperation required binding of RNA by roquin and the nuclease activity of regnase-1. Upon recognition of antigen by the T cell antigen receptor (TCR), roquin and regnase-1 proteins were cleaved by the paracaspase MALT1. Thus, this pathway acts as a 'rheostat' by translating TCR signal strength via graded inactivation of post-transcriptional repressors and differential derepression of targets to enhance T(H)17 differentiation.	[Jeltsch, Katharina M.; Rehage, Nina; Edelmann, Stephanie L.; Heissmeyer, Vigo] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Jeltsch, Katharina M.; Hu, Desheng; Brenner, Sven; Heinz, Gitta A.; Vogel, Katharina U.; Rehage, Nina; Warth, Sebastian C.; Edelmann, Stephanie L.; Martin, Nina; Lohs, Claudia; Stehklein, Jenny E.; Kremmer, Elisabeth; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Zoeller, Jessica; Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Nagel, Daniel; Krappmann, Daniel] Helmholtz Zentrum Munchen, Res Unit Cellular Signal Integrat, Inst Pharmacol & Toxicol, Neuherberg, Germany; [Gloury, Renee; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Lech, Maciej; Anders, Hans-Joachim] Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Geerlof, Arie] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany; [Weber, Achim] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Schmitz, Ingo] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Schmitz, Ingo] Univ Magdeburg, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Holtmann, Helmut] Hannover Med Sch, Inst Biochem, Hannover, Germany; [Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Max Planck Society; University of Missouri System; University of Missouri Kansas City; Hannover Medical School; Technical University of Munich	Heissmeyer, V (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80539 Munich, Germany.	vigo.heissmeyer@med.uni-muenchen.de	Schmidt-Supprian, Marc/F-5893-2011; Anders, Hans-Joachim/ABD-6247-2021; Heikenwalder, Mathias/AAA-2269-2020; Ruland, Jürgen/Q-6680-2018; Lech, Maciej/AAJ-7899-2021; Krappmann, Daniel/AAT-4354-2021; Schmitz, Ingo/G-2093-2013; Krappmann, Daniel/ABF-4038-2021	Schmidt-Supprian, Marc/0000-0002-8543-6166; Ruland, Jürgen/0000-0002-8381-3597; Lech, Maciej/0000-0002-4293-2733; Krappmann, Daniel/0000-0001-7640-3234; Schmitz, Ingo/0000-0002-5360-0419; Krappmann, Daniel/0000-0001-7640-3234; Heissmeyer, Vigo/0000-0002-2263-8545; Heinz, Gitta Anne/0000-0002-9330-3689; Kallies, Axel/0000-0002-6312-6968; Anders, Hans-Joachim/0000-0003-2434-2956; Weber, Achim/0000-0003-0073-3637	Deutsche Forschungsgemeinschaft [SFB 1054 TP-A03, Z02, SFB 1054 TP-B01, SFB 1054 TP-A04, SFB 1054 TP-A02, GRK1202, SFB TR36, HO1116/5-2]; PCCC; Hofschneider Foundation; Boehringer Ingelheim Fonds; Federation of European Biochemical Societies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PCCC; Hofschneider Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Federation of European Biochemical Societies	We thank H.-M. Jack and J. Wittmann (Friedrich-Alexander-Universitat Erlangen, Germany) for the cloned 3' UTR of mouse Irf4; and D. Baumjohann for critical reading of the manuscript. Supported by the Deutsche Forschungsgemeinschaft (SFB 1054 TP-A03 and Z02 to V.H.; SFB 1054 TP-B01 to J.R.; SFB 1054 TP-A04 to D.K.; SFB 1054 TP-A02 to M.S.-S; GRK1202 to H.-J.A. and M.L.; SFB TR36 to M.H. and HO1116/5-2 to H.H.) the PCCC (M.H.), the Hofschneider Foundation (M.H.), Boehringer Ingelheim Fonds (G.A.H.) and The Federation of European Biochemical Societies (K.U.V.).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brustle A, 2012, J CLIN INVEST, V122, P4698, DOI 10.1172/JCI63528; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mc Guire C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-124; Mc Guire C, 2013, J IMMUNOL, V190, P2896, DOI 10.4049/jimmunol.1201351; Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11; Nagel D, 2012, CANCER CELL, V22, P825, DOI 10.1016/j.ccr.2012.11.002; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Reinhard K, 2011, EUR J IMMUNOL, V41, P1388, DOI 10.1002/eji.201041056; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Schlundt A, 2014, NAT STRUCT MOL BIOL, V21, P671, DOI 10.1038/nsmb.2855; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhou Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082542	44	185	193	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1079	1089		10.1038/ni.3008	http://dx.doi.org/10.1038/ni.3008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25282160				2022-12-18	WOS:000343640700014
J	de Weerd, NA; Vivian, JP; Nguyen, TK; Mangan, NE; Gould, JA; Braniff, SJ; Zaker-Tabrizi, L; Fung, KY; Forster, SC; Beddoe, T; Reid, HH; Rossjohn, J; Hertzog, PJ				de Weerd, Nicole A.; Vivian, Julian P.; Nguyen, Thao K.; Mangan, Niamh E.; Gould, Jodee A.; Braniff, Susie-Jane; Zaker-Tabrizi, Leyla; Fung, Ka Yee; Forster, Samuel C.; Beddoe, Travis; Reid, Hugh H.; Rossjohn, Jamie; Hertzog, Paul J.			Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1	NATURE IMMUNOLOGY			English	Article							I INTERFERONS; ALPHA; LIPOPOLYSACCHARIDE; INDUCTION; RESPONSES; SUBUNIT; ACTIVATION; REFINEMENT; SUPPRESSOR	Type I interferons are important in regulating immune responses to pathogens and tumors. All interferons are considered to signal via the heterodimeric IFNAR1-IFNAR2 complex, yet some subtypes such as interferon-beta ( IFN-beta) can exhibit distinct functional properties, although the molecular basis of this is unclear. Here we demonstrate IFN-beta can uniquely and specifically ligate to IFNAR1 in an IFNAR2-independent manner, and we provide the structural basis of the IFNAR1-IFN-beta interaction. The IFNAR1-IFN-beta complex transduced signals that modulated expression of a distinct set of genes independently of Jak-STAT pathways. Lipopolysaccharide-induced sepsis was ameliorated in Ifnar1(-/-) mice but not Ifnar2(-/-) mice, suggesting that IFNAR1-IFN-beta signaling is pathologically relevant. Thus, we provide a molecular basis for understanding specific functions of IFN-beta.	[de Weerd, Nicole A.; Nguyen, Thao K.; Mangan, Niamh E.; Gould, Jodee A.; Braniff, Susie-Jane; Zaker-Tabrizi, Leyla; Fung, Ka Yee; Forster, Samuel C.; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [de Weerd, Nicole A.; Nguyen, Thao K.; Gould, Jodee A.; Forster, Samuel C.; Rossjohn, Jamie; Hertzog, Paul J.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic, Australia; [Vivian, Julian P.; Nguyen, Thao K.; Beddoe, Travis; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Monash University; Monash University; Monash University; Cardiff University	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.	jamie.rossjohn@monash.edu; paul.hertzog@monash.edu	Rossjohn, Jamie/F-9032-2013; Forster, Samuel C/F-4206-2014; de Weerd, Nicole/X-5886-2019; Beddoe, Travis/F-3415-2014; Hertzog, Paul J/I-7053-2013	Rossjohn, Jamie/0000-0002-2020-7522; Forster, Samuel C/0000-0003-4144-2537; de Weerd, Nicole/0000-0002-7985-189X; Beddoe, Travis/0000-0003-4550-2277; Hertzog, Paul J/0000-0002-1373-8472; Vivian, Julian/0000-0002-9400-4437; Mangan, Niamh/0000-0003-3844-0709	National Health and Medical Research Council (NHMRC); The Australian Research Council (ARC); Victorian Government's Operational Infrastructure Support Program; ARC Centre for Excellence in Structural and Functional Microbial Genomics; ARC; NHMRC; Pfizer Australia Research Fellowship; NHMRC Senior Principal Research fellowship; NHMRC Australia Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); The Australian Research Council (ARC)(Australian Research Council); Victorian Government's Operational Infrastructure Support Program; ARC Centre for Excellence in Structural and Functional Microbial Genomics(Australian Research Council); ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia Research Fellowship(PfizerPfizer Australia); NHMRC Senior Principal Research fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank R. Smith and R. Hartmann for helpful discussions and the staff at the MX1 and MX2 beamlines at the Australian synchrotron for assistance with data collection. The Endoglycosidase H clone was a gift from K. C. Garcia (Stanford University). This work is supported by funding from the National Health and Medical Research Council (NHMRC), The Australian Research Council (ARC), the Victorian Government's Operational Infrastructure Support Program and the ARC Centre for Excellence in Structural and Functional Microbial Genomics. J.P.V. is supported by an ARC Discovery Early Career Researcher Award fellowship. N.E.M. is supported by an ARC fellowship and NHMRC. T. B. is supported by a Pfizer Australia Research Fellowship. P.J.H. is supported by an NHMRC Senior Principal Research fellowship, J.R. is supported by an NHMRC Australia Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Baychelier F, 2007, CELL SIGNAL, V19, P2080, DOI 10.1016/j.cellsig.2007.05.011; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; GESSANI S, 1989, J VIROL, V63, P2785, DOI 10.1128/JVI.63.6.2785-2789.1989; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Hamilton JA, 1996, J IMMUNOL, V156, P2553; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; SENDA T, 1995, J MOL BIOL, V253, P187, DOI 10.1006/jmbi.1995.0544; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takayanagi H, 2002, ARTHRITIS RES THER, V4, pS227, DOI 10.1186/ar581; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Trajanovska S, 2003, J INTERF CYTOK RES, V23, P351, DOI 10.1089/107999003322226005; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483	52	185	187	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					901	+		10.1038/ni.2667	http://dx.doi.org/10.1038/ni.2667			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23872679				2022-12-18	WOS:000323377700007
J	Thiery, J; Keefe, D; Boulant, S; Boucrot, E; Walch, M; Martinvalet, D; Goping, IS; Bleackley, RC; Kirchhausen, T; Lieberman, J				Thiery, Jerome; Keefe, Dennis; Boulant, Steeve; Boucrot, Emmanuel; Walch, Michael; Martinvalet, Denis; Goping, Ing Swie; Bleackley, R. Chris; Kirchhausen, Tomas; Lieberman, Judy			Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells	NATURE IMMUNOLOGY			English	Article							GRANULE-MEDIATED CYTOTOXICITY; PLASMA-MEMBRANE; IMMUNOLOGICAL SYNAPSE; SERINE PROTEASE; REPAIR; DELIVERY; DEATH; ACIDIFICATION; DISRUPTION; VESICLES	How the pore-forming protein perforin delivers apoptosis-inducing granzymes to the cytosol of target cells is uncertain. Perforin induces a transient Ca2+ flux in the target cell, which triggers a process to repair the damaged cell membrane. As a consequence, both perforin and granzymes are endocytosed into enlarged endosomes called 'gigantosomes'. Here we show that perforin formed pores in the gigantosome membrane, allowing endosomal cargo, including granzymes, to be gradually released. After about 15 min, gigantosomes ruptured, releasing their remaining content. Thus, perforin delivers granzymes by a two-step process that involves first transient pores in the cell membrane that trigger the endocytosis of granzyme and perforin and then pore formation in endosomes to trigger cytosolic release.	[Thiery, Jerome; Keefe, Dennis; Boulant, Steeve; Boucrot, Emmanuel; Walch, Michael; Martinvalet, Denis; Kirchhausen, Tomas; Lieberman, Judy] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Thiery, Jerome; Keefe, Dennis; Boulant, Steeve; Boucrot, Emmanuel; Walch, Michael; Martinvalet, Denis; Kirchhausen, Tomas; Lieberman, Judy] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Thiery, Jerome; Keefe, Dennis; Walch, Michael; Martinvalet, Denis; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Boulant, Steeve; Boucrot, Emmanuel; Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Martinvalet, Denis] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Goping, Ing Swie; Bleackley, R. Chris] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Geneva; University of Alberta	Lieberman, J (corresponding author), Childrens Hosp, Immune Dis Inst, 300 Longwood Ave, Boston, MA 02115 USA.	lieberman@idi.harvard.edu	THIERY, Jerome/N-2469-2018; Boulant, Steeve/W-3754-2019; Lieberman, Judy/A-2717-2015	THIERY, Jerome/0000-0002-0998-3627; Boulant, Steeve/0000-0001-8614-4993; Walch, Michael/0000-0001-7284-3291; Boucrot, Emmanuel/0000-0001-7312-6462	US National Institutes of Health [AI063430, GM075252]; Canadian Institutes of Health Research; Canadian Cancer Society; Stiefel-Zangger Foundation; Human Frontier Science Program Organization; Harvard Digestive Diseases Center; Immune Disease Institute; GlaxoSmithKline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Stiefel-Zangger Foundation; Human Frontier Science Program Organization(Human Frontier Science Program); Harvard Digestive Diseases Center; Immune Disease Institute; GlaxoSmithKline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Jones (University of Oxford) for the mammalian expression vector pHLseq; G.M. Griffiths (Oxford University) for 2d4 mouse antibody to human perforin; and E. Marino for assistance with microscopy and image analysis. Supported by the US National Institutes of Health (AI063430 to J.L. and GM075252 to T.K.), the Canadian Institutes of Health Research (R.C.B.), the Canadian Cancer Society (RCB), the Stiefel-Zangger Foundation (M.W.), the Human Frontier Science Program Organization (E.B.), the Harvard Digestive Diseases Center (S.B.) and the Immune Disease Institute and GlaxoSmithKline Alliance (S.B.).	Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Armstrong J, 2000, INT J BIOCHEM CELL B, V32, P303, DOI 10.1016/S1357-2725(99)00112-0; Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; BLEACKLEY RC, 1988, IMMUNOL REV, V103, P5, DOI 10.1111/j.1600-065X.1988.tb00746.x; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Browne KA, 1999, MOL CELL BIOL, V19, P8604; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; DArrigo A, 1997, EUR J CELL BIOL, V72, P95; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; Katano H, 2005, BRIT J HAEMATOL, V128, P739, DOI 10.1111/j.1365-2141.2004.05305.x; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; LI GP, 1994, J BIOL CHEM, V269, P14631; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Martinvalet D, 2008, METHOD ENZYMOL, V442, P213, DOI [10.1016/S0070-6879(08)01411-0, 10.1016/S0076-6879(08)01411-0]; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; PODACK ER, 1985, ADV EXP MED BIOL, V184, P99; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Praper T, 2010, MOL IMMUNOL, V47, P2492, DOI 10.1016/j.molimm.2010.06.001; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Thiery J, 2010, CURRENT PROTOCOLS CE, V47, P37; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; TRAPANI JA, 1990, J EXP MED, V171, P545, DOI 10.1084/jem.171.2.545; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; TSCHOPP J, 1987, MOL IMMUNOL, V24, P907, DOI 10.1016/0161-5890(87)90002-2; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	49	185	193	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					770	U146		10.1038/ni.2050	http://dx.doi.org/10.1038/ni.2050			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21685908	Green Accepted			2022-12-18	WOS:000292870700015
J	Loughran, SJ; Kruse, EA; Hacking, DF; de Graaf, CA; Hyland, CD; Willson, TA; Henley, KJ; Ellis, S; Voss, AK; Metcalf, D; Hilton, DJ; Alexander, WS; Kile, BT				Loughran, Stephen J.; Kruse, Elizabeth A.; Hacking, Douglas F.; de Graaf, Carolyn A.; Hyland, Craig D.; Willson, Tracy A.; Henley, Katya J.; Ellis, Sarah; Voss, Anne K.; Metcalf, Donald; Hilton, Douglas J.; Alexander, Warren S.; Kile, Benjamin T.			The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells	NATURE IMMUNOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; ETS-RELATED GENE; GENOME-WIDE; MICE LACKING; C-MPL; MEGAKARYOBLASTIC LEUKEMIA; TARGETED DISRUPTION; PROGENITOR CELLS; MUTATIONS; FAMILY	Ets-related gene (ERG), which encodes a member of the Ets family of transcription factors, is a potent oncogene. Chromosomal rearrangements involving ERG are found in acute myeloid leukemia, acute lymphoblastic leukemia, Ewing's sarcoma and more than half of all prostate cancers; however, the normal physiological function of Erg is unknown. We did a sensitized genetic screen of the mouse for regulators of hematopoietic stem cell function and report here a germline mutation of Erg. We show that Erg is required for definitive hematopoiesis, adult hematopoietic stem cell function and the maintenance of normal peripheral blood platelet numbers.	[Loughran, Stephen J.; Kruse, Elizabeth A.; Hacking, Douglas F.; de Graaf, Carolyn A.; Willson, Tracy A.; Henley, Katya J.; Voss, Anne K.; Hilton, Douglas J.; Kile, Benjamin T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia; [Loughran, Stephen J.; Hyland, Craig D.; Metcalf, Donald; Alexander, Warren S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Canc & Hematol, Parkville, Vic 3050, Australia; [Loughran, Stephen J.; Kruse, Elizabeth A.; de Graaf, Carolyn A.; Hilton, Douglas J.; Alexander, Warren S.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Hacking, Douglas F.] Royal Womens Hosp, Neonatal Serv, Carlton, Vic 3053, Australia; [Ellis, Sarah] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center	Kile, BT (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia.	kile@wehi.edu.au	Kile, Benjamin/GNP-3246-2022; Voss, Anne K/F-5110-2013; Hilton, Douglas J/C-7250-2013; Kile, Benjamin T/F-6593-2011	Kile, Benjamin/0000-0002-8836-8947; Voss, Anne K/0000-0002-3853-9381; Hilton, Douglas J/0000-0002-7698-2392; Kile, Benjamin T/0000-0002-8836-8947; Ellis, Sarah/0000-0002-5772-6051				Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Anderson MK, 1999, DEVELOPMENT, V126, P3131; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Antonchuk J, 2004, BLOOD, V104, P1306, DOI 10.1182/blood-2004-04-1522; Baldus CD, 2004, P NATL ACAD SCI USA, V101, P3915, DOI 10.1073/pnas.0400272101; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; BODE VC, 1984, GENETICS, V108, P457; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Buttice G, 1996, ONCOGENE, V13, P2297; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; Darzynkiewicz Z., 2004, CURRENT PROTOCOLS CY; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DUTERQUECOQUILLAUD M, 1993, ONCOGENE, V8, P1865; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirsammer G, 2008, BLOOD, V111, P767, DOI 10.1182/blood-2007-04-085670; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; McLaughlin F, 2001, BLOOD, V98, P3332, DOI 10.1182/blood.V98.12.3332; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; OKADA S, 1992, BLOOD, V80, P3044; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Rainis L, 2005, CANCER RES, V65, P7596, DOI 10.1158/0008-5472.CAN-05-0147; REDDY ESP, 1991, ONCOGENE, V6, P2285; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Voss AK, 2000, DEVELOPMENT, V127, P1; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	58	185	190	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					810	819		10.1038/ni.1617	http://dx.doi.org/10.1038/ni.1617			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18500345				2022-12-18	WOS:000256904900020
J	Pongubala, JMR; Northrup, DL; Lancki, DW; Medina, KL; Treiber, T; Bertolino, E; Thomas, M; Grosschedl, R; Allman, D; Singh, H				Pongubala, Jagan M. R.; Northrup, Daniel L.; Lancki, David W.; Medina, Kay L.; Treiber, Thomas; Bertolino, Eric; Thomas, Matthew; Grosschedl, Rudolf; Allman, David; Singh, Harinder			Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5	NATURE IMMUNOLOGY			English	Article							MULTIPOTENT HEMATOPOIETIC PROGENITORS; IMMUNOGLOBULIN GENE REARRANGEMENT; COMMON LYMPHOID PROGENITORS; STEM-CELLS; INTERLEUKIN-7 RECEPTOR; IL-7 RECEPTOR; MICE LACKING; BONE-MARROW; IN-VIVO; PRO-B	Alternative lineage restriction and B cel Fl fate commitment require the transcription factor Pax5, but the function of early B cell factor (EBF) in these processes remains mostly unexplored. Here we show that in the absence of EBF, 'expandable' and clonal lymphoid progenitor cells retained considerable myeloid potential. Conversely, ectopic expression of EBF in multipotential progenitor cells directed B cell generation at the expense of myeloid cell fates. EBF induced Pax5 and antagonized expression of genes encoding the transcription factors C/EBP alpha, PU.1 and Id2. Notably, sustained expression of EBF in Pax5(-/-) hematopoietic progenitor cells was sufficient to block their myeloid and T lineage potential in vivo. Furthermore, in Pax5(-/-) pro-B cells, higher EBF expression repressed alternative lineage genes. Thus, EBF can restrict alternative lineage 'choice' and promote commitment to the B cell fate independently of Pax5.	[Pongubala, Jagan M. R.; Lancki, David W.; Medina, Kay L.; Bertolino, Eric; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Northrup, Daniel L.; Thomas, Matthew; Allman, David] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Treiber, Thomas; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cell & Mol Immunol, D-79108 Freiburg, Germany	Howard Hughes Medical Institute; University of Chicago; University of Pennsylvania; Max Planck Society	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	dallman@mail.med.upenn.edu; hsingh@uchicago.edu		Northrup, Daniel/0000-0002-2665-2686				Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; CHEN HM, 1995, ONCOGENE, V11, P1549; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Fuxa M, 2007, J IMMUNOL, V178, P3031, DOI 10.4049/jimmunol.178.5.3031; Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LI C, 2001, GENOME BIOL, V2; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Singh H, 2007, NAT IMMUNOL, V8, P119, DOI 10.1038/ni0207-119; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	65	185	189	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					203	215		10.1038/ni1555	http://dx.doi.org/10.1038/ni1555			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18176567				2022-12-18	WOS:000252503000017
J	Clark, RH; Stinchcombe, JC; Day, A; Blott, E; Booth, S; Bossi, G; Hamblin, T; Davies, EG; Griffiths, GM				Clark, RH; Stinchcombe, JC; Day, A; Blott, E; Booth, S; Bossi, G; Hamblin, T; Davies, EG; Griffiths, GM			Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse	NATURE IMMUNOLOGY			English	Article							HERMANSKY-PUDLAK-SYNDROME; CHEDIAK-HIGASHI-SYNDROME; LYSOSOME-RELATED ORGANELLES; CYTOTOXIC T-LYMPHOCYTES; AP-3 ADAPTER; MANNOSE-6-PHOSPHATE RECEPTOR; VESICLE FORMATION; BETA-3A SUBUNIT; COMPLEX AP-3; BIOGENESIS	Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease characterized by platelet defects and oculocutaneous albinism. Individuals with HPS type 2 (HPS2) lack the cytosolic adaptor protein 3 (AP-3) involved in lysosomal sorting, and are also immunodeficient. Here we characterize an HPS2 mutation and demonstrate that AP-3 deficiency leads to a loss of cytotoxic T lymphocyte (CTL)- mediated cytotoxicity. Although the lysosomal protein CD63 was mislocalized to the plasma membrane, perforin and granzymes were correctly localized to the lytic granules in AP-3-deficient CTLs. However, the lytic granules of AP-3-deficient CTLs were enlarged and were unable to move along microtubules and dock within the secretory domain of the immunological synapse. These data show that AP-3 is essential for polarized secretion from CTLs.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England; Great Ormond St Hosp Children, London WC1N 3GH, England	University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Griffiths, GM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.			stinchcombe, jane/0000-0003-1459-9299; Griffiths, Gillian/0000-0003-0434-5842				Anderson PD, 2003, HUM GENET, V113, P10, DOI 10.1007/s00439-003-0933-5; BAETZ K, 1995, J IMMUNOL, V154, P6122; Bossi G, 2002, IMMUNOL REV, V189, P152, DOI 10.1034/j.1600-065X.2002.18913.x; BURKHARDT JK, 1989, P NATL ACAD SCI USA, V86, P7128, DOI 10.1073/pnas.86.18.7128; BURKHARDT JK, 1993, J CELL SCI, V104, P151; Chiang PW, 2003, J BIOL CHEM, V278, P20332, DOI 10.1074/jbc.M300090200; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Faundez VV, 2000, MOL BIOL CELL, V11, P2591, DOI 10.1091/mbc.11.8.2591; GRIFFITHS GM, 1993, J CELL BIOL, V120, P885, DOI 10.1083/jcb.120.4.885; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Huizing M, 2002, PIGM CELL RES, V15, P405, DOI 10.1034/j.1600-0749.2002.02074.x; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; NOVAK EK, 1979, GENETICS, V92, P189; Ooi CE, 1997, EMBO J, V16, P4508; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; TAKAYAMA H, 1987, J IMMUNOL METHODS, V104, P183, DOI 10.1016/0022-1759(87)90502-3; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Ward DM, 2000, TRAFFIC, V1, P816; Yang W, 2000, J CELL SCI, V113, P4077; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	44	185	190	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1111	1120		10.1038/ni1000	http://dx.doi.org/10.1038/ni1000			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14566336				2022-12-18	WOS:000186241100015
J	Sayegh, CE; Quong, MW; Agata, Y; Murre, C				Sayegh, CE; Quong, MW; Agata, Y; Murre, C			E-proteins directly regulate expression of activation-induced deaminase in mature B cells	NATURE IMMUNOLOGY			English	Article							CLASS-SWITCH RECOMBINATION; LOOP-HELIX PROTEINS; IMMUNOGLOBULIN CLASS SWITCH; MATRIX-ATTACHMENT REGIONS; T-CELL; LYMPHOCYTE DEVELOPMENT; SAGA COMPLEX; DNA-BINDING; SOMATIC HYPERMUTATION; INTRONIC ENHANCER	Activated mature B cells in which the DNA-binding activity of E-proteins has been disrupted fail to undergo class switch recombination. Here we show that activated B cells overexpressing the antagonist helix-loop-helix protein Id3 do not induce expression of the murine Aicda gene encoding activation-induced deaminase (AID). A highly conserved intronic regulatory element in Aicda binds E-proteins both in vitro and in vivo. The transcriptional activity of this element is regulated by E-proteins. We show that the enforced expression of AID in cells overexpressing Id3 partially restores class switch recombination. Taken together, our observations link helix-loop-helix activity and Aicda gene expression in a common pathway, in which E-protein activity is required for the efficient induction of Aicda transcription.	Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA.			Agata, Yasutoshi/0000-0001-9642-6994				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bottaro A, 1998, INT IMMUNOL, V10, P799, DOI 10.1093/intimm/10.6.799; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Goldfarb AN, 1996, MOL IMMUNOL, V33, P947, DOI 10.1016/S0161-5890(96)00047-8; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; GREEVE J, IN PRESS BLOOD; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KENTER AL, 1993, J IMMUNOL, V151, P4718; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuzin II, 2000, J IMMUNOL, V164, P1451, DOI 10.4049/jimmunol.164.3.1451; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Ma LM, 1997, INT IMMUNOL, V9, P1021, DOI 10.1093/intimm/9.7.1021; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhao F, 2001, MOL CELL BIOL, V21, P6346, DOI 10.1128/MCB.21.18.6346-6357.2001; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	50	185	190	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					586	593		10.1038/ni923	http://dx.doi.org/10.1038/ni923			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12717431				2022-12-18	WOS:000183175500019
J	Mitchell, TC; Hildeman, D; Kedl, RM; Teague, TK; Schaefer, BC; White, J; Zhu, YN; Kappler, J; Marrack, P				Mitchell, TC; Hildeman, D; Kedl, RM; Teague, TK; Schaefer, BC; White, J; Zhu, YN; Kappler, J; Marrack, P			Immunological adjuvants promote activated T cell survival via induction of Bcl-3	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PERIPHERAL TOLERANCE INDUCTION; CANDIDATE PROTOONCOGENE BCL-3; TRANSCRIPTION FACTORS; IN-VIVO; CLONAL EXPANSION; DNA-BINDING; HIGH-TITER; APOPTOSIS; IMMUNITY	Injection of soluble protein antigen into animals causes abortive proliferation of the responding T cells. Immunological adjuvants boost T cell responses at least in part by increasing the survival of activated T cells during and after the initial proliferative phase of their clonal expansion,To understand how adjuvants promote T cell survival, we used gene microarrays to analyze gene expression in T cells activated either with antigen alone or in the presence of two different adjuvants. Among the genes whose expression was increased by both adjuvants was the I kappaB family member Bcl-3. Retroviral infection experiments showed that expression of Bcl-3 increased survival of activated T cells in vitro and in vivo. Adjuvants may therefore improve survival of activated T cells via induction of Bcl-3.	Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Howard Hughes Med Inst, Denver, CO 80206 USA.		Mitchell, Thomas C/B-4193-2013; Teague, T. Kent/A-2527-2008; Hildeman, David/I-4884-2015; Hildeman, David/AAA-1757-2020; Marrack, Philippa/AHE-6316-2022	Teague, T. Kent/0000-0002-4680-5440; Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI-17134, AI-18785, AI-22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018785, R37AI017134, P01AI022295, R01AI018785, R56AI017134, R01AI017134] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AOKI Y, 1994, J IMMUNOL, V153, P3611; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BHATIA K, 1991, ONCOGENE, V6, P1569; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; FENTON RG, 1988, SCIENCE, V241, P1089, DOI 10.1126/science.2970670; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maxwell JR, 1999, J IMMUNOL, V162, P2024; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; Mitchell T, 1999, J IMMUNOL, V162, P4527; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Norris PS, 1998, J VIROL METHODS, V75, P161, DOI 10.1016/S0166-0934(98)00108-6; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; ROCKEN M, 1992, NATURE, V359, P79, DOI 10.1038/359079a0; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; STYWU HK, 1996, IMMUNITY, V5, P17; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Vella AT, 1997, J IMMUNOL, V158, P4714; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WHITE DW, 1995, ONCOGENE, V10, P857; WILLIAMS AF, 1982, SCIENCE, V216, P696, DOI 10.1126/science.6177036; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0	40	185	191	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					397	402		10.1038/87692	http://dx.doi.org/10.1038/87692			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323692				2022-12-18	WOS:000168549800011
J	von Boehmer, H; Melchers, F				von Boehmer, Harald; Melchers, Fritz			Checkpoints in lymphocyte development and autoimmune disease	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGENITOR B-CELLS; V-H REPLACEMENT; NEGATIVE SELECTION; CLONAL DELETION; ALPHA-BETA; ALLELIC INCLUSION; CD4+8+ THYMOCYTES; CENTRAL TOLERANCE	Antigen receptor-controlled checkpoints in B lymphocyte development are crucial for the prevention of autoimmune diseases such as systemic lupus erythematosus. Checkpoints at the stage of pre-B cell receptor (pre-BCR) and BCR expression can eliminate certain autoreactive BCRs either by deletion of or anergy induction in cells expressing autoreactive BCRs or by receptor editing. For T cells, the picture is more complex because there are regulatory T (T-reg) cells that mediate dominant tolerance, which differs from the recessive tolerance mediated by deletion and anergy. Negative selection of thymocytes may be as essential as T-reg cell generation in preventing autoimmune diseases such as type 1 diabetes, but supporting evidence is scarce. Here we discuss several scenarios in which failures at developmental checkpoints result in autoimmunity.	[von Boehmer, Harald] Harvard Univ, Sch Med, Boston, MA 02115 USA; [von Boehmer, Harald] Dana Farber Canc Inst, Boston, MA 02115 USA; [Melchers, Fritz] Max Planck Inst Infect Biol, Berlin, Germany	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Max Planck Society	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu; fritz.melchers@unibas.ch			Deutsche Forschungsgesellschaft [ME 2764/1-1]; US National Institutes of Health [ROI AI 045846, R37 AI 053102, ROI AI 051378, POI CA 10990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI053102, R01AI051378, R01AI045846] Funding Source: NIH RePORTER	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Deutsche Forschungsgesellschaft (Koselleck grant P. S. ME 2764/1-1 to F. M.) and the US National Institutes of Health (ROI AI 045846, R37 AI 053102, ROI AI 051378 and POI CA 10990 to H. v. B.).	Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; BARBAS SM, 1995, P NATL ACAD SCI USA, V92, P2529, DOI 10.1073/pnas.92.7.2529; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Buch T, 2002, IMMUNITY, V16, P707, DOI 10.1016/S1074-7613(02)00312-6; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Carroll MC, 2004, NAT REV IMMUNOL, V4, P825, DOI 10.1038/nri1456; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; Ceredig R, 1998, INT IMMUNOL, V10, P49, DOI 10.1093/intimm/10.1.49; Chatenoud L, 2002, J CLIN INVEST, V110, P747, DOI 10.1172/JCI200216625; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Doyle CM, 2006, P NATL ACAD SCI USA, V103, P11264, DOI 10.1073/pnas.0604053103; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gerdes T, 2004, NAT IMMUNOL, V5, P1282, DOI 10.1038/ni1133; Grawunder U, 1995, INT IMMUNOL, V7, P1915, DOI 10.1093/intimm/7.12.1915; GRAWUNDER U, 1993, INT IMMUNOL, V5, P1609, DOI 10.1093/intimm/5.12.1609; Guy-Grand D, 2004, SCIENCE, V305, P185, DOI 10.1126/science.1100890; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; HASPEL MV, 1983, NATURE, V304, P73, DOI 10.1038/304073a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2005, CURR TOP MICROBIOL, V293, P25, DOI 10.1007/3-540-27702-1_2; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Khan SN, 2008, P NATL ACAD SCI USA, V105, P3861, DOI 10.1073/pnas.0800025105; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12; Liu Y, 2007, J IMMUNOL, V179, P1340, DOI 10.4049/jimmunol.179.2.1340; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lutz J, 2006, J IMMUNOL, V177, P7007, DOI 10.4049/jimmunol.177.10.7007; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Melchers F, 2006, CURR TOP MICROBIOL, V305, P1, DOI 10.1007/3-540-29714-6_1; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Nakajima PB, 2009, J IMMUNOL, V182, P3583, DOI 10.4049/jimmunol.0802533; Nemazee D, 1995, ANN NY ACAD SCI, V764, P397; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Rowley B, 2007, J AUTOIMMUN, V29, P236, DOI 10.1016/j.jaut.2007.07.020; SAITO T, 1989, J IMMUNOL, V143, P3379; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SALAUN J, 1990, SCIENCE, V247, P1471, DOI 10.1126/science.2321009; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sleckman BP, 1998, J EXP MED, V188, P1465, DOI 10.1084/jem.188.8.1465; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Suri A, 2008, CURR OPIN IMMUNOL, V20, P105, DOI 10.1016/j.coi.2007.10.007; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; tenBoekel E, 1997, IMMUNITY, V7, P357; Tung JW, 2007, CURR OPIN IMMUNOL, V19, P150, DOI 10.1016/j.coi.2007.02.012; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; von Boehmer H, 2008, NAT IMMUNOL, V9, P571, DOI 10.1038/ni0608-571; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; VONBOEHMER H, 1991, J EXP MED, V174, P1001, DOI 10.1084/jem.174.5.1001; Wack A, 1996, INT IMMUNOL, V8, P1537, DOI 10.1093/intimm/8.10.1537; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Witsch EJ, 2006, J EXP MED, V203, P1761, DOI 10.1084/jem.20060075; Xie C, 2007, INT IMMUNOL, V19, P509, DOI 10.1093/intimm/dxm017; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang ZX, 2003, IMMUNITY, V19, P21, DOI 10.1016/S1074-7613(03)00170-5; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	123	184	186	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					14	20		10.1038/ni.1794	http://dx.doi.org/10.1038/ni.1794			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016505				2022-12-18	WOS:000272855300004
J	Ghoreschi, K; Laurence, A; O'Shea, JJ				Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.			Selectivity and therapeutic inhibition of kinases: to be or not to be?	NATURE IMMUNOLOGY			English	Article							PLACEBO-CONTROLLED TRIAL; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; POLYCYTHEMIA-VERA; RHEUMATOID-ARTHRITIS; MYELOPROLIFERATIVE DISORDERS; DOUBLE-BLIND; HUMAN GENOME; MUTATION; JAK2	Protein kinases, which serve critical functions in signaling pathways in all cells, are popular therapeutic targets. At present, eight kinase inhibitors have been approved in the United States, each of which shows nanomolar potency. Although the initial goal was to generate inhibitors with a high degree of selectivity, recent experience has revealed that many of these approved compounds target more than one kinase. Surprisingly, this promiscuity is less problematic than one would have imagined; indeed, it opens new therapeutic opportunities. In this Perspective, we discuss the present status of Janus kinase inhibitors-a new class of immunosuppressive drugs-and the advantages and disadvantages of selectively inhibiting this class of kinase.	[Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Ghoreschi, K (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	ghoreschik@mail.nih.gov; osheajo@mail.nih.gov	Laurence, Arian/A-8770-2009; Laurence, Arian/H-5534-2019	Laurence, Arian/0000-0003-0942-8292; Laurence, Arian/0000-0003-0942-8292; Ghoreschi, Kamran/0000-0002-5526-7517	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041106] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AR999999] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; CHAN G, 2006, AM J TRANSPLANT, V6, pS87; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; FISCHER EH, 1966, FED PROC, V25, P1511; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kremer JM, 2006, ARTHRITIS RHEUM, V54, P4116; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manshouri T, 2008, CANCER SCI, V99, P1265, DOI 10.1111/j.1349-7006.2008.00817.x; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PAWSON T, 1995, NATURE, V373, P477, DOI 10.1038/373477a0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; van Gurp E, 2008, AM J TRANSPLANT, V8, P1711, DOI 10.1111/j.1600-6143.2008.02307.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Wilkinson B, 2008, ARTHRITIS RHEUM, V58, pS297; Williams W, 2008, ARTHRITIS RHEUM-US, V58, pS431	44	184	201	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					356	360		10.1038/ni.1701	http://dx.doi.org/10.1038/ni.1701			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295632	Green Accepted			2022-12-18	WOS:000264425800006
J	Karre, K				Karre, Klas			Natural killer cell recognition of missing self	NATURE IMMUNOLOGY			English	Editorial Material							H-2-DEFICIENT LYMPHOMA VARIANTS; TARGET-CELLS; MOUSE; RESISTANCE; REJECTION; MICE; MHC; EXPRESSION; GRAFTS; SPECIFICITY	The idea that NK cells can distinguish aberrant cells by recognizing `absence of the expected', rather than `presence of the unexpected' emerged more than 25 years ago. Klas Karre recapitulates how the idea took shape, and the first five years of experimental work to test its general predictions.	Karolinska Inst, IRIS, Dept Microbiol, Stockholm, Sweden	Karolinska Institutet	Karre, K (corresponding author), Karolinska Inst, IRIS, Dept Microbiol, Stockholm, Sweden.	klas.karre@ki.se						CUDKOWICZ G, 1971, J EXP MED, V134, P1513, DOI 10.1084/jem.134.6.1513; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; DEBAETSELIER P, 1980, NATURE, V288, P179; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; HILDEMANN WH, 1977, IMMUNOGENETICS, V5, P193, DOI 10.1007/BF01570476; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; Karre K, 1991, Semin Cancer Biol, V2, P295; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; KARRE K, 1981, THESIS KAROLINSKA I; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; KIESSLING R, 1975, INT J CANCER, V15, P933, DOI 10.1002/ijc.2910150608; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; KIESSLING R, 1977, EUR J IMMUNOL, V7, P655, DOI 10.1002/eji.1830070915; KOLB H, 1977, DEV COMP IMMUNOL, V1, P193, DOI 10.1016/S0145-305X(77)80029-3; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; POINTEK GE, 1985, J IMMUNOL, V135, P4281; QUILLET A, 1988, J IMMUNOL, V141, P17; Scofield VL, 1981, DEV COMP IMMUNOL, V5, P23; SNELL GD, 1958, JNCI-J NATL CANCER I, V21, P843; SNELL GD, 1976, TRANSPL P, V8, P147; STERN P, 1980, NATURE, V285, P341, DOI 10.1038/285341a0; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; TANIGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3405, DOI 10.1073/pnas.84.10.3405; WELSH RM, 1981, J IMMUNOL, V126, P219	28	184	185	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					477	480		10.1038/ni0508-477	http://dx.doi.org/10.1038/ni0508-477			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425103				2022-12-18	WOS:000255153500008
J	Kloetzel, PM				Kloetzel, PM			Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII	NATURE IMMUNOLOGY			English	Review							MULTICATALYTIC PROTEINASE COMPLEX; T-LYMPHOCYTE EPITOPE; NEWLY SYNTHESIZED PROTEINS; 20 S PROTEASOMES; INTERFERON-GAMMA; REGULATOR PA28; 26S PROTEASOME; CTL EPITOPE; TRIPEPTIDYL PEPTIDASE; STANDARD PROTEASOME	The proteasome is key in the cascade of proteolytic processing required for the generation of peptides presented at the cell surface to cytotoxic T lymphocytes by major histocompatibility complex class I molecules. Proteasome-dependent epitope processing is greatly improved through the interferon-gamma-induced formation of immunoproteasomes and the activator complex PA28. Tripeptidyl aminopeptidase II also has a strong effect on epitope generation. With its endoproteolytic and exoproteolytic activities, TPPII acts `downstream' of the proteasome and relies on products released by the proteasome. The antigen-processing cascade involving different proteolytic systems raises anew the question of how antigenic peptides are generated. We therefore revisit the interferon-gamma-induced immune adaptation of the proteasome and attempt to redefine its function in connection with the emerging importance of TPPII.	Humboldt Univ, Univ Med Sch Charite, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kloetzel, PM (corresponding author), Humboldt Univ, Univ Med Sch Charite, Monbijoustr 2, D-10117 Berlin, Germany.	p-m.kloetzel@charite.de						AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; Benham AM, 1998, J IMMUNOL, V161, P83; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Cardozo C, 2002, ARCH BIOCHEM BIOPHYS, V408, P103, DOI 10.1016/S0003-9861(02)00493-9; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Choppin J, 2001, J IMMUNOL, V166, P6164, DOI 10.4049/jimmunol.166.10.6164; Cruz M, 1997, GENOMICS, V45, P618, DOI 10.1006/geno.1997.4977; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Eleuteri AM, 1997, J BIOL CHEM, V272, P11824, DOI 10.1074/jbc.272.18.11824; Emmerich NPN, 2000, J BIOL CHEM, V275, P21140, DOI 10.1074/jbc.M000740200; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gileadi U, 1999, J IMMUNOL, V163, P6045; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groettrup M, 1997, P NATL ACAD SCI USA, V94, P8970, DOI 10.1073/pnas.94.17.8970; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; KAHN S, 2001, J IMMUNOL, V167, P6859; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Kuckelkorn U, 2002, J EXP MED, V195, P983, DOI 10.1084/jem.20011199; KUCKELKORN U, 1995, EUR J IMMUNOL, V25, P2605, DOI 10.1002/eji.1830250930; Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Peters B, 2002, J MOL BIOL, V318, P847, DOI 10.1016/S0022-2836(02)00167-5; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shimbara N, 1997, GENES CELLS, V2, P785, DOI 10.1046/j.1365-2443.1997.1610359.x; SIBILLE C, 1995, CURR BIOL, V5, P923, DOI 10.1016/S0960-9822(95)00182-5; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Soza A, 1997, FEBS LETT, V413, P27, DOI 10.1016/S0014-5793(97)00864-8; Stohwasser R, 2000, EUR J BIOCHEM, V267, P6221, DOI 10.1046/j.1432-1327.2000.01706.x; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Sun Y, 2002, CANCER RES, V62, P2875; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; TOMKINSON B, 1987, P NATL ACAD SCI USA, V84, P7508, DOI 10.1073/pnas.84.21.7508; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; van Hall T, 2000, J EXP MED, V192, P483, DOI 10.1084/jem.192.4.483; VAN KL, 1994, IMMUNITY, V1, P533; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897; Wang R, 1999, BIOCHEMISTRY-US, V38, P14573, DOI 10.1021/bi990826h; WHEATLEY DN, 1982, J THEOR BIOL, V98, P283, DOI 10.1016/0022-5193(82)90265-X; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; YEWDELL J, 1994, J IMMUNOL, V152, P1163; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; York L. A., 1999, IMMUNOL REV, V172, P29; ZAISS D, 2002, P NATL ACAD SCI USA, V99, P1169; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zhang SR, 1999, GENETICS, V151, P473	102	184	194	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					661	669		10.1038/ni1090	http://dx.doi.org/10.1038/ni1090			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224091				2022-12-18	WOS:000222331200002
J	Makrigiannakis, A; Zoumakis, E; Kalantaridou, S; Coutifaris, C; Margioris, AN; Coukos, G; Rice, KC; Gravanis, A; Chrousos, GP				Makrigiannakis, A; Zoumakis, E; Kalantaridou, S; Coutifaris, C; Margioris, AN; Coukos, G; Rice, KC; Gravanis, A; Chrousos, GP			Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance	NATURE IMMUNOLOGY			English	Article							ENDOMETRIAL STROMAL CELLS; I RECEPTOR ANTAGONIST; FAS LIGAND; HUMAN-PLACENTA; DEATH FACTOR; EXPRESSION; APOPTOSIS; TROPHOBLAST; CRH; FETAL	The semi-allograft embryo in the blastocyst stage implants itself in the endometrium, yet no immune rejection processes are activated. Embryonic trophoblast and maternal decidua produce corticotropin-releasing hormone (CRH) and express Fas ligand (FasL), a proapoptotic cytokine. We found that antalarmin, a CRH receptor type I antagonist, decreased FasL expression and promoted apoptosis of activated T lymphocytes, an effect which was potentiated by CRH and inhibited by antalarmin. Female rats treated with antalarmin showed a marked decrease in implantation sites and live embryos and diminished endometrial FasL expression. Embryos from mothers that lacked T cells or from syngeneic matings were not rejected when the mothers were given antalarmin. These findings suggested that locally produced CRH promotes implantation and maintenance of early pregnancy primarily by killing activated T cells.	Univ Crete, Sch Med, Iraklion 71110, Greece; Hammersmith Hosp, Imperial Coll Sch Sci & Med, Dept Reprod Med, IVF Unit, London W12, England; Onassis Fdn, Athens, Greece; Univ Penn, Med Ctr, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; NICHHD, Pediat & Reprod Endocrinol Branch, Bethesda, MD 20892 USA; NIDDKD, Med Chem Lab, Bethesda, MD 20892 USA	University of Crete; Imperial College London; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Makrigiannakis, A (corresponding author), Univ Crete, Sch Med, Iraklion 71110, Greece.		Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367; Makrigiannakis, Antonis/0000-0002-8475-1500	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK059501] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AboagyeMathiesen G, 1997, PLACENTA, V18, P155, DOI 10.1016/S0143-4004(97)90087-4; Athanassakis I, 1999, J ENDOCRINOL, V163, P221, DOI 10.1677/joe.0.1630221; Bamberger AM, 2000, AM J PATHOL, V156, P1165, DOI 10.1016/S0002-9440(10)64985-1; Bamberger AM, 1997, J CLIN ENDOCR METAB, V82, P3173, DOI 10.1210/jc.82.9.3173; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bornstein SR, 1998, ENDOCRINOLOGY, V139, P1546, DOI 10.1210/en.139.4.1546; BORTNER DM, 1995, CELL GROWTH DIFFER, V6, P1579; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan EC, 1998, ENDOCRINOLOGY, V139, P3357, DOI 10.1210/en.139.7.3357; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; CHROUSOS GP, 1984, NEW ENGL J MED, V310, P622, DOI 10.1056/NEJM198403083101004; Clifton VL, 1998, J CLIN ENDOCR METAB, V83, P3716, DOI 10.1210/jc.83.10.3716; DiBlasio AM, 1997, J CLIN ENDOCR METAB, V82, P1594, DOI 10.1210/jc.82.5.1594; FISCHER SJ, 1989, J CELL BIOL, V109, P891; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; GILL TJ, 1986, AM J REPROD IMMUNOL, V10, P116; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; GRINO M, 1987, BIOCHEM BIOPH RES CO, V148, P1208, DOI 10.1016/S0006-291X(87)80261-9; Habib KE, 2000, P NATL ACAD SCI USA, V97, P6079, DOI 10.1073/pnas.97.11.6079; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; JONES SA, 1989, J CLIN ENDOCR METAB, V68, P825, DOI 10.1210/jcem-68-4-825; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; Kauma SW, 1999, J CLIN ENDOCR METAB, V84, P2188, DOI 10.1210/jc.84.6.2188; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOCKWOOD CJ, 1994, CURR OPIN OBSTET GYN, V6, P7; LOCKWOOD CJ, 1994, ANN NY ACAD SCI, V734, P57, DOI 10.1111/j.1749-6632.1994.tb21736.x; MAKRIGIANNAKIS A, 1995, J CLIN ENDOCR METAB, V80, P185, DOI 10.1210/jc.80.1.185; MAKRIGIANNAKIS A, 1995, LIFE SCI, V57, P1869, DOI 10.1016/0024-3205(95)02167-H; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Makrigiannakis A, 2000, J CLIN ENDOCR METAB, V85, P449, DOI 10.1210/jc.85.1.449; MARTIN JN, 1993, BRIT J OBSTET GYNAEC, V100, P1095, DOI 10.1111/j.1471-0528.1993.tb15172.x; Mastorakos G, 1996, J CLIN ENDOCR METAB, V81, P1046, DOI 10.1210/jc.81.3.1046; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; MCINTYRE JA, 1986, CLIN OBSTET GYNECOL, V29, P976, DOI 10.1097/00003081-198612000-00021; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAGATA S, 1994, ADV IMMUNOL, V57, P129, DOI 10.1016/S0065-2776(08)60672-0; Nathanielsz PW, 1999, LIFE WOMB ORIGIN HLT; PETRAGLIA F, 1987, NATURE, V328, P717, DOI 10.1038/328717a0; PETRAGLIA F, 1992, J CLIN ENDOCR METAB, V74, P1427, DOI 10.1210/jc.74.6.1427; Phillips TA, 1999, J IMMUNOL, V162, P6053; Psychoyos A, 1995, HUM REPROD, V10, P30, DOI 10.1093/humrep/10.suppl_2.30; ROGERS PAW, 1992, REPROD FERT DEVELOP, V4, P261, DOI 10.1071/RD9920261; Runic R, 1996, J CLIN ENDOCR METAB, V81, P3119, DOI 10.1210/jc.81.8.3119; SAKURAGI N, 1994, J SOC GYNECOL INVEST, V1, P164, DOI 10.1177/107155769400100212; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SUDA T, 1995, J IMMUNOL, V154, P3806; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UDELSMAN R, 1986, PEPTIDES, V7, P465, DOI 10.1016/0196-9781(86)90016-1; Webster EL, 1996, ENDOCRINOLOGY, V137, P5747, DOI 10.1210/en.137.12.5747; WONG ML, 1999, LIFE SCI, V65; Zoumakis E, 2000, MOL HUM REPROD, V6, P344, DOI 10.1093/molehr/6.4.344	54	184	192	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1018	1024		10.1038/ni719	http://dx.doi.org/10.1038/ni719			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11590404				2022-12-18	WOS:000172049800014
J	Wypych, TP; Wickramasinghe, LC; Marsland, BJ				Wypych, Tomasz P.; Wickramasinghe, Lakshanie C.; Marsland, Benjamin J.			The influence of the microbiome on respiratory health	NATURE IMMUNOLOGY			English	Review							INFLAMMATORY-BOWEL-DISEASE; ARYL-HYDROCARBON RECEPTOR; ALLERGIC AIRWAY DISEASE; INNATE LYMPHOID-CELLS; CHAIN FATTY-ACIDS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; LACTOBACILLUS-CASEI; VIRUS INFECTION; BIFIDOBACTERIUM-LONGUM	The revolution in microbiota research over the past decade has provided invaluable knowledge about the function of the microbial species that inhabit the human body. It has become widely accepted that these microorganisms, collectively called 'the microbiota', engage in networks of interactions with each other and with the host that aim to benefit both the microbial members and the mammalian members of this unique ecosystem. The lungs, previously thought to be sterile, are now known to harbor a unique microbiota and, additionally, to be influenced by microbial signals from distal body sites, such as the intestine. Here we review the role of the lung and gut microbiotas in respiratory health and disease and highlight the main pathways of communication that underlie the gut-lung axis.	[Wypych, Tomasz P.; Wickramasinghe, Lakshanie C.; Marsland, Benjamin J.] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia	Monash University	Wypych, TP; Marsland, BJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia.	tomasz.wypych@monash.edu; benjamin.marsland@monash.edu	Wypych, Tomasz/AAY-9069-2020	Wypych, Tomasz/0000-0003-0558-7923; Wickramasinghe, Lakshanie C/0000-0001-8733-2945	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	T.P.W. is supported by a Postdoc Mobility Fellowship from the Swiss National Science Foundation. B.J.M. is an NHMRC Senior Research Fellow and a VESKI Innovation Fellow.	Alvarez S, 2001, J FOOD PROTECT, V64, P1768, DOI 10.4315/0362-028X-64.11.1768; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Bartley JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01164; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Becattini S, 2016, TRENDS MOL MED, V22, P458, DOI 10.1016/j.molmed.2016.04.003; Bernasconi E, 2016, AM J RESP CRIT CARE, V194, P1252, DOI 10.1164/rccm.201512-2424OC; Blumer N, 2007, CLIN EXP ALLERGY, V37, P348, DOI 10.1111/j.1365-2222.2007.02671.x; Bradley CP, 2017, CELL HOST MICROBE, V22, P697, DOI 10.1016/j.chom.2017.10.007; Bretin A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30055-y; Brown RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01803-x; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Byun MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183553; Cait A, 2018, MUCOSAL IMMUNOL, V11, P785, DOI 10.1038/mi.2017.75; Camus P, 2011, EUR RESPIR MONOGR, P163, DOI 10.1183/1025448x.10004110; Carreiro J.E., 2009, OSTEOPATHIC APPROACH; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Ceyhan BB, 2003, RESPIRATION, V70, P60, DOI 10.1159/000068407; Chua HH, 2018, GASTROENTEROLOGY, V154, P154, DOI 10.1053/j.gastro.2017.09.006; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dilantika C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-3; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; DOUGLAS JG, 1989, RESP MED, V83, P389, DOI 10.1016/S0954-6111(89)80070-8; Downward JRE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02191; Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055; Eberl G, 2016, NAT REV IMMUNOL, V16, P524, DOI 10.1038/nri.2016.75; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fastres A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122735; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Fyhrquist N, 2014, J ALLERGY CLIN IMMUN, V134, P1301, DOI 10.1016/j.jaci.2014.07.059; Gallacher DJ, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Gollwitzer ES, 2015, TRENDS IMMUNOL, V36, P684, DOI 10.1016/j.it.2015.09.009; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Gray J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9412; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Gronseth Rune, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00019-2017; Groves HT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00182; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; He Y, 2017, CRIT REV MICROBIOL, V43, P81, DOI [10.1080/1040841X.2016.1176988, 10.1080/1040841x.2016.1176988]; Hewitt RJ, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.56; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huffnagle GB, 2017, MUCOSAL IMMUNOL, V10, P299, DOI 10.1038/mi.2016.108; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Itthitaetrakool U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165798; Jartti T, 2017, J ALLERGY CLIN IMMUN, V140, P895, DOI 10.1016/j.jaci.2017.08.003; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Jung YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17487-8; Kanmani P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01613; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kawahara T, 2015, MICROBIOL IMMUNOL, V59, P1, DOI 10.1111/1348-0421.12210; Kawase M, 2010, LETT APPL MICROBIOL, V51, P6, DOI 10.1111/j.1472-765X.2010.02849.x; Kawase M, 2012, FEMS IMMUNOL MED MIC, V64, P280, DOI 10.1111/j.1574-695X.2011.00903.x; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Khailova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097861; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Koch KN, 2015, J CLIN INVEST, V125, P3297, DOI 10.1172/JCI79337; Korolkova OY, 2015, CLIN MED INSIGHTS-GA, V8, P29, DOI 10.4137/CGast.S20612; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kruisselbrink A, 2001, CLIN EXP IMMUNOL, V126, P2, DOI 10.1046/j.1365-2249.2001.01642.x; Kuhn KA, 2013, SEMIN IMMUNOL, V25, P364, DOI 10.1016/j.smim.2013.10.002; Kyburz A, 2018, J ALLERGY CLIN IMMUN, V143; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Lee SH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110429; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li NJ, 2017, RESP MED, V131, P192, DOI 10.1016/j.rmed.2017.08.016; Li X, 2018, CELL HOST MICROBE, V24, P847, DOI 10.1016/j.chom.2018.11.003; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Mackowiak Philip A, 2013, Front Public Health, V1, P52, DOI 10.3389/fpubh.2013.00052; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; MacSharry J, 2012, PULM PHARMACOL THER, V25, P325, DOI 10.1016/j.pupt.2012.05.011; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; Maizels RM, 2018, IMMUNITY, V49, P801, DOI 10.1016/j.immuni.2018.10.016; Malikowski T, 2017, CURR OPIN GASTROEN, V33, P8, DOI 10.1097/MOG.0000000000000326; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Mathieu E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01168; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Mendes E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01732; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Morita N, 2019, NATURE, V566, P110, DOI 10.1038/s41586-019-0884-1; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mouraux S, 2018, J ALLERGY CLIN IMMUN, V141, P718, DOI 10.1016/j.jaci.2017.06.022; Muhlebach MS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006798; Nakayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04638; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Park MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075368; Pattaroni C, 2018, CELL HOST MICROBE, V24, P857, DOI 10.1016/j.chom.2018.10.019; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Qian GJ, 2018, J EXP MED, V215, P2397, DOI 10.1084/jem.20172225; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Robinson PFM, 2019, J ALLERGY CLIN IMMUN, V143, P1607, DOI 10.1016/j.jaci.2018.12.985; Rondanelli M, 2017, GUT MICROBES, V8, P521, DOI 10.1080/19490976.2017.1345414; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Sagar S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-46; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samuelson DR, 2016, EXP LUNG RES, V42, P425, DOI 10.1080/01902148.2016.1258442; Scholz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084019; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Sheflin AM, 2017, GUT MICROBES, V8, P113, DOI 10.1080/19490976.2016.1270809; Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Singh R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07859-7; Skalski JH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007260; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Songur N, 2003, J CLIN GASTROENTEROL, V37, P292, DOI 10.1097/00004836-200310000-00006; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Sverrild A, 2017, J ALLERGY CLIN IMMUN, V140, P407, DOI 10.1016/j.jaci.2016.10.046; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111228; Takeda S, 2011, INT IMMUNOPHARMACOL, V11, P1976, DOI 10.1016/j.intimp.2011.08.007; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Torow N, 2017, J IMMUNOL, V198, P557, DOI 10.4049/jimmunol.1601253; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537; Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Ubags NDJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02467-2016; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Vieira AT, 2016, MICROBES INFECT, V18, P180, DOI 10.1016/j.micinf.2015.10.008; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Vogel K, 2008, J ALLERGY CLIN IMMUN, V122, P307, DOI 10.1016/j.jaci.2008.05.016; Waki N, 2014, LETT APPL MICROBIOL, V58, P87, DOI 10.1111/lam.12160; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Wang XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171721; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Wypych TP, 2018, TRENDS IMMUNOL, V39, P697, DOI 10.1016/j.it.2018.02.008; Wypych TP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060537; Xu M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02292; Yang X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9230234; Yasui H, 1999, ANTON LEEUW INT J G, V76, P383, DOI 10.1023/A:1002041616085; Yildiz S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0386-z; Young RP, 2016, AM J RESP CELL MOL, V54, P161, DOI 10.1165/rcmb.2015-0250PS; Yu GQ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1021-1; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelaya H, 2015, INFLAMM RES, V64, P589, DOI 10.1007/s00011-015-0837-6; Zelaya H, 2014, MICROBIOL IMMUNOL, V58, P416, DOI 10.1111/1348-0421.12163; Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	185	183	199	22	127	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1279	1290		10.1038/s41590-019-0451-9	http://dx.doi.org/10.1038/s41590-019-0451-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31501577				2022-12-18	WOS:000486615900012
J	Wang, HP; Flach, H; Onizawa, M; Wei, L; McManus, MT; Weiss, A				Wang, Haopeng; Flach, Henrik; Onizawa, Michio; Wei, Lai; McManus, Michael T.; Weiss, Arthur			Negative regulation of Hif1a expression and T(H)17 differentiation by the hypoxia-regulated microRNA miR-210	NATURE IMMUNOLOGY			English	Article							INDUCIBLE FACTORS; T-CELLS; TARGETS; PREDICTION; COMPLEX; GAMMA; IL-17	The microRNA miR-210 is a signature of hypoxia. We found robust increase in the abundance of miR-210 (>100-fold) in activated T cells, especially in the T(H)17 lineage of helper T cells. Hypoxia acted in synergy with stimulation via the T cell antigen receptor (TCR) and coreceptor CD28 to accelerate and increase Mir210 expression. Mir210 was directly regulated by HIF-1 alpha, a key transcriptional regulator of TH17 polarization. Unexpectedly, we identified Hif1a as a target of miR-210, which suggested negative feedback by miR-210 in inhibiting HIF-1 alpha expression. Deletion of Mir210 promoted TH17 differentiation under conditions of limited oxygen. In experimental colitis, miR-210 reduced the abundance of Hif1a transcripts and the proportion of cells that produced inflammatory cytokines and controlled disease severity. Our study identifies miR-210 as an important regulator of T cell differentiation in hypoxia, which can limit immunopathology.	[Wang, Haopeng; Flach, Henrik; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA; [Wang, Haopeng; Flach, Henrik; Weiss, Arthur] Univ Calif San Francisco, Dept Microbiol & Immunol, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA; [Wang, Haopeng; Flach, Henrik; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Onizawa, Michio] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Sun Yat Sen University; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Wang, Haopeng/0000-0002-4995-0838	Arthritis Foundation; Deutsche Forschungsgemeinschaft; National Basic Research Program of China [2013CB967002]; Keck Foundation	Arthritis Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Basic Research Program of China(National Basic Research Program of China); Keck Foundation(W.M. Keck Foundation)	We thank A. Roque for animal husbandry; R. Locksley and Z. Wang for access to the cell-sorting facility and assistance with cell sorting; J.J. O'Shea (US National Institutes of Health) for CP550690; K. Shokat (University of California, San Francisco) for GDC-0941 and MLN0128; R. Wang (St. Jude Children's Research Hospital) for organs from Hif1a<SUP>f/f</SUP>CD4-Cre mice; M. Matloubian (University of California, San Francisco) for RNA from mice infected with lymphocytic choriomeningitis virus; A. Abbas (University of California, San Francisco) for Il2<SUP>-/-</SUP> DO11.10 mice; K. Shokat (University of California, San Francisco); J.J. O'Shea (US National Institutes of Health) for kinase inhibitors; and K. Mark Ansel and L. Jeker for critical reading of the manuscript. Supported by the Arthritis Foundation (H. W.), Deutsche Forschungsgemeinschaft (H.F.), the National Basic Research Program of China (2013CB967002 to L. W.) and the Keck Foundation.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Huang X, 2014, ACTA BIOCH BIOPH SIN, V46, P220, DOI 10.1093/abbs/gmt141; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ikejiri A, 2012, INT IMMUNOL, V24, P137, DOI 10.1093/intimm/dxr111; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Mok YT, 2013, J IMMUNOL, V191, P3037, DOI 10.4049/jimmunol.1301289; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Vaupel P, 1998, ADV EXP MED BIOL, V454, P591; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Westermann J, 1999, IMMUNOL TODAY, V20, P302, DOI 10.1016/S0167-5699(99)01474-7; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yamaji O, 2012, J IMMUNOL, V188, P2524, DOI 10.4049/jimmunol.1100371; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	56	183	189	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					393	+		10.1038/ni.2846	http://dx.doi.org/10.1038/ni.2846			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24608041	Green Accepted, Green Submitted			2022-12-18	WOS:000333252000014
J	Abtin, A; Jain, R; Mitchell, AJ; Roediger, B; Brzoska, AJ; Tikoo, S; Cheng, Q; Ng, LG; Cavanagh, LL; von Andrian, UH; Hickey, MJ; Firth, N; Weninger, W				Abtin, Arby; Jain, Rohit; Mitchell, Andrew J.; Roediger, Ben; Brzoska, Anthony J.; Tikoo, Shweta; Cheng, Qiang; Ng, Lai Guan; Cavanagh, Lois L.; von Andrian, Ulrich H.; Hickey, Michael J.; Firth, Neville; Weninger, Wolfgang			Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection	NATURE IMMUNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; ALPHA-HEMOLYSIN; VENULAR WALLS; CELLS; ADAM10; EPIDEMIOLOGY; INFLAMMATION; DISINTEGRIN; VIRULENCE; RESPONSES	Transendothelial migration of neutrophils in postcapillary venules is a key event in the inflammatory response against pathogens and tissue damage. The precise regulation of this process is incompletely understood. We report that perivascular macrophages are critical for neutrophil migration into skin infected with the pathogen Staphylococcus aureus. Using multiphoton intravital microscopy we showed that neutrophils extravasate from inflamed dermal venules in close proximity to perivascular macrophages, which are a major source of neutrophil chemoattractants. The virulence factor alpha-hemolysin produced by S. aureus lyses perivascular macrophages, which leads to decreased neutrophil transmigration. Our data illustrate a previously unrecognized role for perivascular macrophages in neutrophil recruitment to inflamed skin and indicate that S. aureus uses hemolysin-dependent killing of these cells as an immune evasion strategy.	[Abtin, Arby; Jain, Rohit; Mitchell, Andrew J.; Roediger, Ben; Tikoo, Shweta; Cavanagh, Lois L.; Weninger, Wolfgang] Centenary Inst, Newtown, NSW, Australia; [Brzoska, Anthony J.; Firth, Neville] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Cheng, Qiang; Hickey, Michael J.] Monash Univ, Monash Med Ctr, Ctr Inflammatory Dis, Dept Med, Clayton, Vic 3800, Australia; [Ng, Lai Guan] Biopolis, Technol & Res A STAR, Agcy Sci, Singapore Immunol Network SIgN, Singapore, Singapore; [Cavanagh, Lois L.] Sydney Med Sch, Sydney, NSW, Australia; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Weninger, Wolfgang] Sydney Med Sch, Discipline Dermatol, Sydney, NSW, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW 2050, Australia	University of Sydney; Centenary Institute; University of Sydney; Monash University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Sydney; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Sydney; University of Sydney	Weninger, W (corresponding author), Centenary Inst, Newtown, NSW, Australia.	w.weninger@centenary.org.au	Ng, Lai Guan/E-5673-2011; Ng, Lai Guan/N-6980-2019; Tikoo, Shweta/AAX-1902-2021; Jain, Rohit/O-2015-2019; Mitchell, Alex J/P-5671-2015; Mitchell, Andrew/C-2714-2009; Hickey, Michael/A-5429-2012	Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Tikoo, Shweta/0000-0001-5850-8075; Jain, Rohit/0000-0002-4905-462X; Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Andrew/0000-0003-4454-853X; Hickey, Michael/0000-0003-2354-357X; Roediger, Ben/0000-0002-4593-091X; Weninger, Wolfgang/0000-0003-3133-8699; Firth, Neville/0000-0002-5791-7691	National Health and Medical Research Council of Australia [1030147]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Willcox (University of New South Wales, Sydney) for S. aureus strains, E. Harry (University of Technology Sydney) for S. aureus USA300, T. Graf (Center for Genomic Regulation, Barcelona, Spain) for providing Lyz2<SUP>gfp/+</SUP> mice, D. Hume (University of Edinburgh) for Csf1r-EGFP mice, M.J. Fraunholz (University of Wurzburg Biocenter) for the pmRFPmars plasmid, A. Smith, S. Allen and S. Dervish for their technical assistance, and M. Rizk and J. Qin for animal husbandry. This work was supported by grant 1030147 from the National Health and Medical Research Council of Australia (to A.A., R.J., N.F. and W.W).	BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Faust N, 2000, BLOOD, V96, P719; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; May AK, 2000, INFECT IMMUN, V68, P176, DOI 10.1128/IAI.68.1.176-183.2000; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Sumagin R, 2010, J IMMUNOL, V184, P5242, DOI 10.4049/jimmunol.0903319; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282	42	183	186	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					45	53		10.1038/ni.2769	http://dx.doi.org/10.1038/ni.2769			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24270515	Green Accepted			2022-12-18	WOS:000328800500011
J	Cui, J; Li, YY; Zhu, L; Liu, D; Zhou, SY; Wang, HLY; Wang, RF				Cui, Jun; Li, Yinyin; Zhu, Liang; Liu, Dan; Zhou Songyang; Wang, Helen Y.; Wang, Rong-Fu			NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; ANTIVIRAL IMMUNITY; INTRACELLULAR DNA; IKK-EPSILON; PATHWAYS; INDUCTION; PROTEIN; ADAPTER; NLRX1	Stringent control of the type I interferon signaling pathway is important for maintaining host immune responses and homeostasis, yet the molecular mechanisms responsible for its tight regulation are still poorly understood. Here we report that the pattern-recognition receptor NLRP4 regulated the activation of type I interferon mediated by double-stranded RNA or DNA by targeting the kinase TBK1 for degradation. NLRP4 recruited the E3 ubiquitin ligase DTX4 to TBK1 for Lys48 (K48)-linked polyubiquitination at Lys670, which led to degradation of TBK1. Knockdown of either DTX4 or NLRP4 abrogated K48-linked ubiquitination and degradation of TBK1 and enhanced the phosphorylation of TBK1 and the transcription factor IRF3. Our results identify a previously unrecognized role for NLRP4 in the regulation of type I interferon signaling and provide molecular insight into the mechanisms by which NLRP4-DTX4 targets TBK1 for degradation.	[Cui, Jun; Li, Yinyin; Zhu, Liang; Wang, Helen Y.; Wang, Rong-Fu] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Cui, Jun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Biochem, Nanjing, Jiangsu, Peoples R China; [Cui, Jun; Li, Yinyin; Wang, Helen Y.; Wang, Rong-Fu] Methodist Hosp, Ctr Inflammat & Epigenet, Res Inst, Houston, TX 77030 USA; [Li, Yinyin] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Liu, Dan; Zhou Songyang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Rong-Fu] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Wang, Rong-Fu] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Nanjing University; The Methodist Hospital System; The Methodist Hospital - Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rwang3@tmhs.org			National Natural Science Foundation of China [31000394]; National Cancer Institute; US National Institutes of Health [CA090327, CA101795, CA121191, CA116408, CA094327]; Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA101795, R01CA116408, R01CA121191, P01CA094237, R01CA090327, R01CA133249, R03CA094327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM095599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030338] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Balachandran (Fox Chase Cancer Center) for VSV-eGFP; Y.-J. Liu and Z. Zhang (The University of Texas MD Anderson Cancer Center) for the STING expression plasmid; and A.A. Ajibade for critical reading of the manuscript. Supported by the National Natural Science Foundation of China (31000394 to J.C.), the National Cancer Institute, the US National Institutes of Health (CA090327, CA101795, CA121191, CA116408 and CA094327 to R.-F.W.), the Cancer Research Institute and The Methodist Hospital Research Institute.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	32	183	202	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					387	395		10.1038/ni.2239	http://dx.doi.org/10.1038/ni.2239			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22388039	Green Accepted			2022-12-18	WOS:000301886800013
J	Sullivan, BM; Liang, HE; Bando, JK; Wu, D; Cheng, LE; McKerrow, JK; Allen, CDC; Locksley, RM				Sullivan, Brandon M.; Liang, Hong-Erh; Bando, Jennifer K.; Wu, Davina; Cheng, Laurence E.; McKerrow, James K.; Allen, Christopher D. C.; Locksley, Richard M.			Genetic analysis of basophil function in vivo	NATURE IMMUNOLOGY			English	Article							SPLENIC NON-B; NON-T CELLS; CHRONIC ALLERGIC INFLAMMATION; HELPER TYPE-2 RESPONSE; IL-4 PRODUCTION; MAST-CELL; NIPPOSTRONGYLUS-BRASILIENSIS; NEMATODE INFECTIONS; HELMINTH INFECTION; EFFECTOR FUNCTION	Contributions by basophils to allergic and helminth immunity remain incompletely defined. Using sensitive interleukin 4 (Il4) reporter alleles, we demonstrate here that basophil IL-4 production occurs by a CD4(+) T cell-dependent process restricted to the peripheral tissues affected. We genetically marked and achieved specific deletion of basophils and found that basophils did not mediate T helper type 2 (T(H)2) priming in vivo. Two-photon imaging confirmed that basophils did not interact with antigen-specific T cells in lymph nodes but engaged in prolonged serial interactions with T cells in lung tissues. Although targeted deletion of IL-4 and IL-13 in either CD4(+) T cells or basophils had a minimal effect on worm clearance, deletion from both lineages demonstrated a nonredundant role for basophil cytokines in primary helminth immunity.	[Sullivan, Brandon M.; Liang, Hong-Erh; Bando, Jennifer K.; Wu, Davina; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Sullivan, Brandon M.; Liang, Hong-Erh; Bando, Jennifer K.; Wu, Davina; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [McKerrow, James K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [McKerrow, James K.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94143 USA; [Allen, Christopher D. C.; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Allen, Christopher D. C.; Locksley, Richard M.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	chris.allen@ucsf.edu; locksley@medicine.ucsf.edu		Bando, Jennifer/0000-0002-1331-7424; Allen, Christopher/0000-0002-1879-9047	US National Institutes of Health [AI026918, AI077439]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco, San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918, R01AI026918, U19AI077439] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco, San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K.C. Lim and N. Flores for technical support; E. Thornton and M. Krummel for training in lung-slice preparation; D. Kioussis (Medical Research Council National Institute for Medical Research) for huCD2-DsRed transgenic mice; and J. Cyster (University of California, San Francisco) for mice and two-photon microscope use. Supported by the US National Institutes of Health (AI026918 and AI077439), the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at the University of California San Francisco, San Francisco.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Delmotte P, 2006, AM J RESP CELL MOL, V35, P110, DOI 10.1165/rcmb.2005-0417OC; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Lantz CS, 2008, LAB INVEST, V88, P1134, DOI 10.1038/labinvest.2008.88; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LEGROS G, 1990, J IMMUNOL, V145, P2500; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; SEDER RA, 1991, J IMMUNOL, V147, P903; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; URBAN JF, 1995, J IMMUNOL, V154, P4675; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Voehringer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-69; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	55	183	187	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					527	U243		10.1038/ni.2036	http://dx.doi.org/10.1038/ni.2036			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21552267	Green Accepted			2022-12-18	WOS:000290707100013
J	Seifert, U; Maranon, C; Shmueli, A; Desoutter, JF; Wesoloski, L; Janek, K; Henklein, P; Diescher, S; Andrieu, M; de la Salle, H; Weinschenk, T; Schild, H; Laderach, D; Galy, A; Haas, G; Kloetzel, PM; Reiss, Y; Hosmalin, A				Seifert, U; Maranon, C; Shmueli, A; Desoutter, JF; Wesoloski, L; Janek, K; Henklein, P; Diescher, S; Andrieu, M; de la Salle, H; Weinschenk, T; Schild, H; Laderach, D; Galy, A; Haas, G; Kloetzel, PM; Reiss, Y; Hosmalin, A			An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM; ANTIGENIC PEPTIDE; INTERFERON-GAMMA; HIV-1 NEF; PROTEASOME; MOLECULES; AMINOPEPTIDASE; PROTEIN; PATHWAY; PURIFICATION	Most of the peptides presented by major histocompatibility complex (MHC) class I molecules require processing by proteasomes. Tripeptidyl peptidase II (TPPII), an aminopeptidase with endoproteolytic activity, may also have a role in antigen processing. Here, we analyzed the processing and presentation of the immunodominant human immunodeficiency virus epitope HIV-Nef(73-82) in human dendritic cells. We found that inhibition of proteasome activity did not impair Nef(73-82) epitope presentation. In contrast, specific inhibition of TPPII led to a reduction of Nef(73-82) epitope presentation. We propose that TPPII can act in combination with or independent of the proteasome system and can generate epitopes that evade generation by the proteasome-system.	Humboldt Univ, Fac Med, Inst Biochem Charite, D-10117 Berlin, Germany; Inst Cochin, Dept Immunol, INSERM,U567,CNRS,UMR 8104, IFR 116, F-75014 Paris, France; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; EFS Alsace, INSERM, EP9908, F-676065 Strasbourg, France; Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; Genethon, F-91002 Evry, France; Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Tel Aviv University; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eberhard Karls University of Tubingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Kloetzel, PM (corresponding author), Humboldt Univ, Fac Med, Inst Biochem Charite, Monbijoustr 2, D-10117 Berlin, Germany.		De La Salle, Henri/H-9353-2016; Hosmalin, Anne/AAF-8561-2019; C, maranon/E-1484-2013; Galy, Anne HM/J-4439-2013	De La Salle, Henri/0000-0001-5136-0776; Hosmalin, Anne/0000-0001-9021-3488; C, maranon/0000-0002-7827-6301; Galy, Anne HM/0000-0002-0153-4392; Laderach, Diego/0000-0002-2205-0899				Andrieu M, 2003, J VIROL, V77, P1564, DOI 10.1128/JVI.77.2.1564-1570.2003; BALOW RM, 1986, J BIOL CHEM, V261, P2409; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; Benham AM, 1998, J IMMUNOL, V161, P83; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Choppin J, 2001, J IMMUNOL, V166, P6164, DOI 10.4049/jimmunol.166.10.6164; CULMANNPENCIOLELLI B, 1994, J VIROL, V68, P7336, DOI 10.1128/JVI.68.11.7336-7343.1994; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; FALK K, 1994, IMMUNOGENETICS, V40, P238, DOI 10.1007/BF00167086; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; HENDIL KB, 1991, J BIOCHEM BIOPH METH, V22, P159, DOI 10.1016/0165-022X(91)90028-U; Hilbi H, 2000, INFECT IMMUN, V68, P5502, DOI 10.1128/IAI.68.10.5502-5508.2000; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; Mo XY, 1999, J IMMUNOL, V163, P5851; Niedermann G, 1999, IMMUNOL REV, V172, P29, DOI 10.1111/j.1600-065X.1999.tb01354.x; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sewell AK, 1999, J IMMUNOL, V162, P7075; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Tanaka K, 1997, ADV IMMUNOL, V64, P1, DOI 10.1016/S0065-2776(08)60885-8; TOMKINSON B, 1987, P NATL ACAD SCI USA, V84, P7508, DOI 10.1073/pnas.84.21.7508; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897; Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	37	183	189	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					375	379		10.1038/ni905	http://dx.doi.org/10.1038/ni905			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12598896				2022-12-18	WOS:000181987700018
J	Onizawa, M; Oshima, S; Schulze-Topphoff, U; Oses-Prieto, JA; Lu, T; Tavares, R; Prodhomme, T; Duong, B; Whang, MI; Advincula, R; Agelidis, A; Barrera, J; Wu, H; Burlingame, A; Malynn, BA; Zamvil, SS; Ma, A				Onizawa, Michio; Oshima, Shigeru; Schulze-Topphoff, Ulf; Oses-Prieto, Juan A.; Lu, Timothy; Tavares, Rita; Prodhomme, Thomas; Duong, Bao; Whang, Michael I.; Advincula, Rommel; Agelidis, Alex; Barrera, Julio; Wu, Hao; Burlingame, Alma; Malynn, Barbara A.; Zamvil, Scott S.; Ma, Averil			The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; LINEAR POLYUBIQUITIN; PROGRAMMED NECROSIS; EXPRESSION; TNFAIP3; INFLAMMATION; REGULATOR; BINDING; RECOGNITION; DOWNSTREAM	A20 is an anti-inflammatory protein linked to multiple human diseases; however, the mechanisms by which A20 prevents inflammatory disease are incompletely defined. We found that A20-deficient T cells and fibroblasts were susceptible to caspase-independent and kinase RIPK3-dependent necroptosis. Global deficiency in RIPK3 significantly restored the survival of A20-deficient mice. A20-deficient cells exhibited exaggerated formation of RIPK1-RIPK3 complexes. RIPK3 underwent physiological ubiquitination at Lys5 (K5), and this ubiquitination event supported the formation of RIPK1-RIPK3 complexes. Both the ubiquitination of RIPK3 and formation of the RIPK1-RIPK3 complex required the catalytic cysteine of A20's deubiquitinating motif. Our studies link A20 and the ubiquitination of RIPK3 to necroptotic cell death and suggest additional mechanisms by which A20 might prevent inflammatory disease.	[Onizawa, Michio; Oshima, Shigeru; Lu, Timothy; Tavares, Rita; Duong, Bao; Whang, Michael I.; Advincula, Rommel; Agelidis, Alex; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schulze-Topphoff, Ulf; Prodhomme, Thomas; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Oses-Prieto, Juan A.; Burlingame, Alma] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wu, Hao] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177; Tavares, Rita/0000-0002-1654-4454; Agelidis, Alex/0000-0002-6582-1630; Whang, Michael/0000-0002-6695-6799; Oses-Prieto, Juan/0000-0003-4759-2341	Biomedical Technology Research Centers program of the National Institute of General Medical Sciences of the US National Institutes of Health [8P41GM103481]; Howard Hughes Medical Institute; US National Institutes of Health [DK071939, DK095693, AI073737, NS063008]; Kenneth Rainin Foundation; National Multiple Sclerosis Society [RG 4768, RG 5180]; Guthy Jackson Charitable Foundation; Maisin Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI045937, R01AI117908, R01AI073737, R37AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095693, T32DK007007, P30DK026743, R01DK071939, P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Biomedical Technology Research Centers program of the National Institute of General Medical Sciences of the US National Institutes of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Rainin Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Guthy Jackson Charitable Foundation; Maisin Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Wang for Ripk3<SUP>-/-</SUP> mice; J.C. Patarroyo and N. Molnarfi for assistance with EAE experiments; and S. Oakes for discussions. Mass spectrometry analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California, San Francisco, supported by funding from the Biomedical Technology Research Centers program of the National Institute of General Medical Sciences of the US National Institutes of Health (8P41GM103481) and the Howard Hughes Medical Institute. Supported by the US National Institutes of Health (DK071939 and DK095693 (A.M.), and AI073737 and NS063008 (S.S.Z.)), the Kenneth Rainin Foundation (A.M.), the National Multiple Sclerosis Society (RG 4768 and RG 5180 (S.S.Z.); and U.S.), the Guthy Jackson Charitable Foundation (S.S.Z.), the Maisin Foundation (S.S.Z.) and The Crohn's and Colitis Foundation of America (M.O. and S.O.).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Bates JS, 2009, GENES IMMUN, V10, P470, DOI 10.1038/gene.2009.31; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Heger K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001762; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Jiang XB, 2012, CLIN VACCINE IMMUNOL, V19, P1938, DOI 10.1128/CVI.00500-12; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelly C, 2013, J CYST FIBROS, V12, P411, DOI 10.1016/j.jcf.2012.10.009; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	53	182	189	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					618	+		10.1038/ni.3172	http://dx.doi.org/10.1038/ni.3172			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25939025	Green Submitted, Green Accepted			2022-12-18	WOS:000354751900014
J	Chen, HB; Ndhlovu, ZM; Liu, DF; Porter, LC; Fang, JW; Darko, S; Brockman, MA; Miura, T; Brumme, ZL; Schneidewind, A; Piechocka-Trocha, A; Cesa, KT; Sela, J; Cung, TD; Toth, I; Pereyra, F; Yu, XG; Douek, DC; Kaufmann, DE; Allen, TM; Walker, BD				Chen, Huabiao; Ndhlovu, Zaza M.; Liu, Dongfang; Porter, Lindsay C.; Fang, Justin W.; Darko, Sam; Brockman, Mark A.; Miura, Toshiyuki; Brumme, Zabrina L.; Schneidewind, Arne; Piechocka-Trocha, Alicja; Cesa, Kevin T.; Sela, Jennifer; Cung, Thai D.; Toth, Ildiko; Pereyra, Florencia; Yu, Xu G.; Douek, Daniel C.; Kaufmann, Daniel E.; Allen, Todd M.; Walker, Bruce D.			TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection	NATURE IMMUNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD8(+) T-CELLS; VIRAL LOAD; ELITE CONTROLLERS; REPLICATION CAPACITY; DISEASE PROGRESSION; LYMPHOCYTE ESCAPE; IMMUNE CONTROL; RESPONSES; EPITOPE	The human leukocyte antigens HLA-B*27 and HLA-B*57 are associated with protection against progression of disease that results from infection with human immunodeficiency virus type 1 (HIV-1), yet most people with alleles encoding HLA-B*27 and HLA-B*57 are unable to control HIV-1. Here we found that HLA-B*27-restricted CD8(+) T cells in people able to control infection with HIV-1 (controllers) and those who progress to disease after infection with HIV-1 (progressors) differed in their ability to inhibit viral replication through targeting of the immunodominant epitope of group-associated antigen (Gag) of HIV-1. This was associated with distinct T cell antigen receptor (TCR) clonotypes, characterized by superior control of HIV-1 replication in vitro, greater cross-reactivity to epitope variants and enhanced loading and delivery of perforin. We also observed clonotype-specific differences in antiviral efficacy for an immunodominant HLA-B*57-restricted response in controllers and progressors. Thus, the efficacy of such so-called 'protective alleles' is modulated by specific TCR clonotypes selected during natural infection, which provides a functional explanation for divergent HIV-1 outcomes.	[Chen, Huabiao; Ndhlovu, Zaza M.; Liu, Dongfang; Porter, Lindsay C.; Fang, Justin W.; Brockman, Mark A.; Miura, Toshiyuki; Brumme, Zabrina L.; Schneidewind, Arne; Piechocka-Trocha, Alicja; Cesa, Kevin T.; Sela, Jennifer; Cung, Thai D.; Toth, Ildiko; Pereyra, Florencia; Yu, Xu G.; Kaufmann, Daniel E.; Allen, Todd M.; Walker, Bruce D.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Chen, Huabiao; Ndhlovu, Zaza M.; Liu, Dongfang; Porter, Lindsay C.; Fang, Justin W.; Brockman, Mark A.; Miura, Toshiyuki; Brumme, Zabrina L.; Schneidewind, Arne; Piechocka-Trocha, Alicja; Cesa, Kevin T.; Sela, Jennifer; Cung, Thai D.; Toth, Ildiko; Pereyra, Florencia; Yu, Xu G.; Kaufmann, Daniel E.; Allen, Todd M.; Walker, Bruce D.] Harvard Univ, Boston, MA 02115 USA; [Chen, Huabiao; Ndhlovu, Zaza M.; Piechocka-Trocha, Alicja; Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Darko, Sam; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Schneidewind, Arne] Univ Hosp Regensburg, Dept Internal Med, Regensburg, Germany	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Simon Fraser University; University of Tokyo; University of Regensburg	Walker, BD (corresponding author), Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA.	bwalker@partners.org	Ndhlovu, Zaza/W-2437-2019; Allen, Todd/F-5473-2011; Brockman, Mark/D-1669-2016	Ndhlovu, Zaza/0000-0002-2708-3315; Allen, Todd/0000-0002-6609-1318; Brockman, Mark/0000-0001-6432-1426; Brumme, Zabrina/0000-0002-8157-1037; Liu, Dongfang/0000-0002-7295-8088	Harvard University Center for AIDS Research [5 P30 AI060354-04]; Bill and Melinda Gates Foundation; Doris Duke Charitable Foundation; US National Institutes of Health [AI030914, AI074415]; Howard Hughes Medical Institute; Mark and Lisa Schwartz Foundation; Office of AIDS Research of the US National Institutes of Health; Canadian Institutes for Health Research; Canada Research Chair in Viral Pathogenesis and Immunity; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124769, P30AI060354, P01AI074415, R01AI030914] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mark and Lisa Schwartz Foundation; Office of AIDS Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Viral Pathogenesis and Immunity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Wong (Massachusetts General Hospital) for monoclonal antibody 12F6 to CD3 and monoclonal antibody CD3: 8 bispecific for CD3 and CD8; and all study participants for their contributions. Supported by the Harvard University Center for AIDS Research (5 P30 AI060354-04), the Bill and Melinda Gates Foundation (B. D. W. and D. C. D.), the Doris Duke Charitable Foundation (B. D. W.), the US National Institutes of Health (AI030914 to B. D. W. and AI074415 to T. M. A.), the Howard Hughes Medical Institute (B. D. W.), the Mark and Lisa Schwartz Foundation (B. D. W.), the Intramural Research Program and the Office of AIDS Research of the US National Institutes of Health (D. C. D. and S. D.), the Canadian Institutes for Health Research (New Investigator Award to Z.L.B.) and the Canada Research Chair in Viral Pathogenesis and Immunity (M.A.B.).	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brockman MA, 2006, J VIROL METHODS, V131, P134, DOI 10.1016/j.jviromet.2005.08.003; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Mendoza D, 2012, J VIROL, V86, P4014, DOI 10.1128/JVI.06982-11; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Venturi V, 2011, J IMMUNOL, V186, P4285, DOI 10.4049/jimmunol.1003898; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; WILSON CC, 1995, J INFECT DIS, V172, P88, DOI 10.1093/infdis/172.1.88; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718	50	182	186	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					691	+		10.1038/ni.2342	http://dx.doi.org/10.1038/ni.2342			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22683743	Green Accepted			2022-12-18	WOS:000305483800015
J	Goto, A; Matsushita, K; Gesellchen, V; El Chamy, L; Kuttenkeuler, D; Takeuchi, O; Hoffmann, JA; Akira, S; Boutros, M; Reichhart, JM				Goto, Akira; Matsushita, Kazufumi; Gesellchen, Viola; El Chamy, Laure; Kuttenkeuler, David; Takeuchi, Osamu; Hoffmann, Jules A.; Akira, Shizuo; Boutros, Michael; Reichhart, Jean-Marc			Akirins are highly conserved nuclear proteins required for NF-kappa B-dependent gene expression in drosophila and mice	NATURE IMMUNOLOGY			English	Article							PEPTIDOGLYCAN-RECOGNITION PROTEIN; IMMUNE-RESPONSE; ANTIBACTERIAL DEFENSE; INNATE IMMUNITY; KINASE COMPLEX; HOST-DEFENSE; ACTIVATION; RELISH; MELANOGASTER; INFECTION	During a genome-wide screen with RNA-mediated interference, we isolated CG8580 as a gene involved in the innate immune response of Drosophila melanogaster. CG8580, which we called Akirin, encoded a protein that acted in parallel with the NF-kappa B transcription factor downstream of the Imd pathway and was required for defense against Gram-negative bacteria. Alkirin is highly conserved, and the human genome contains two homologs, one of which was able to rescue the loss-of-function phenotype in drosophila cells. Akirins were strictly localized to the nucleus. Knockout of both Akirin homologs in mice showed that one had an essential function downstream of the Toll-like receptor, tumor necrosis factor and interleukin (IL)-1 beta signaling pathways leading to the production of IL-6. Thus, Akirin is a conserved nuclear factor required for innate immune responses.	[Goto, Akira; El Chamy, Laure; Hoffmann, Jules A.; Reichhart, Jean-Marc] Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France; [Matsushita, Kazufumi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, ERATO, Japan Sci & Technol Agcy, Res Inst Microbial Dis,Dept Host Def, Suita, Osaka 5650871, Japan; [Gesellchen, Viola; Kuttenkeuler, David; Boutros, Michael] German Canc Res Ctr, Boveri Grp Signaling & Funct Genom, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Japan Science & Technology Agency (JST); Osaka University; Helmholtz Association; German Cancer Research Center (DKFZ)	Reichhart, JM (corresponding author), Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France.	jm.reichhart@ibmc.u-strasbg.fr	GOTO, Akira/V-7847-2017; Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011; Boutros, Michael/C-3566-2008	GOTO, Akira/0000-0003-3395-484X; Takeuchi, Osamu/0000-0002-1260-6232; Boutros, Michael/0000-0002-9458-817X; Laure, El Chamy/0000-0003-2293-5088	NIAID NIH HHS [P01 AI044220-04, AI44220, P01 AI044220, P01 AI070167, AI070167] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220, P01AI070167] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Mak TW, 2002, ARTHRITIS RES THER, V4, pS243, DOI 10.1186/ar569; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	43	182	206	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					97	104		10.1038/ni1543	http://dx.doi.org/10.1038/ni1543			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18066067	Green Accepted			2022-12-18	WOS:000251820800016
J	Jiang, N; Tan, NS; Ho, B; Ding, JL				Jiang, Naxin; Tan, Nguan Soon; Ho, Bow; Ding, Jeak Ling			Respiratory protein-generated reactive oxygen species as an antimicrobial strategy	NATURE IMMUNOLOGY			English	Article							HORSESHOE-CRAB; PSEUDOMONAS-AERUGINOSA; IMMUNE RECOGNITION; LIMULUS-POLYPHEMUS; PHENOLOXIDASE; PROPHENOLOXIDASE; HEMOCYANINS; EXPRESSION; INSECT; SYSTEM	The evolution of the host-pathogen relationship comprises a series of invasive-defensive tactics elicited by both participants. The stereotype is that the antimicrobial immune response requires multistep processes. Little is known about the primordial immunosurveillance system, which probably has components that directly link sensors and effectors. Here we found that the respiratory proteins of both the horseshoe crab and human were directly activated by microbial proteases and were enhanced by pathogen-associated molecular patterns, resulting in the production of more reactive oxygen species. Hemolytic virulent pathogens, which produce proteases as invasive factors, are more susceptible to this killing mechanism. This 'shortcut' antimicrobial strategy represents a fundamental and universal mode of immunosurveillance, which has been in existence since before the split of protostomes and deuterostomes and still persists today.	Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012; Tan, Nguan Soon/A-2220-2011	Tan, Nguan Soon/0000-0003-0136-7341				Alayash AI, 1999, NAT BIOTECHNOL, V17, P545, DOI 10.1038/9849; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENOWITZ M, 1981, ARCH BIOCHEM BIOPHYS, V210, P748, DOI 10.1016/0003-9861(81)90242-3; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P634; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chan PF, 1998, J BACTERIOL, V180, P6232; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Decker H, 2001, J BIOL CHEM, V276, P17796, DOI 10.1074/jbc.M010436200; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Ding JL, 2005, GENES IMMUN, V6, P557, DOI 10.1038/sj.gene.6364240; DING JL, 1993, BIOCHIM BIOPHYS ACTA, V1202, P149, DOI 10.1016/0167-4838(93)90076-4; Dowd PF, 1999, NAT TOXINS, V7, P337, DOI 10.1002/1522-7189(199911/12)7:6<337::AID-NT69>3.0.CO;2-O; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; FEE JA, 1981, OXYGEN OXYRADICALS C, P205; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HECK LW, 1990, J IMMUNOL, V144, P2253; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kawano T, 2002, BIOSCI BIOTECH BIOCH, V66, P1224, DOI 10.1271/bbb.66.1224; KODATI VR, 1993, BIOPHYS J, V64, P163, DOI 10.1016/S0006-3495(93)81351-1; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee SY, 2003, J BIOL CHEM, V278, P7927, DOI 10.1074/jbc.M209239200; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Nellaiappan K, 1996, COMP BIOCHEM PHYS B, V113, P163, DOI 10.1016/0305-0491(95)02047-0; Ng PML, 2004, J ENDOTOXIN RES, V10, P163, DOI 10.1179/096805104225004833; Osawa T, 2005, ANN NY ACAD SCI, V1043, P440, DOI 10.1196/annals.1333.050; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; TODER DS, 1994, INFECT IMMUN, V62, P1320, DOI 10.1128/IAI.62.4.1320-1327.1994; TWENHOFEL WH, 1935, INVERTEBRATE PALEONT, P406; Wang X.L., 2001, INT J EARLY YEARS ED, V9, P71, DOI [10.1080/09669760125651, DOI 10.1080/09669760125651, 10.1080/09669760120044204, DOI 10.1080/09669760120044204]; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Winzer K, 2001, INT J MED MICROBIOL, V291, P131, DOI 10.1078/1438-4221-00110; WRETLIND B, 1983, REV INFECT DIS, V5, pS998; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533; Zhu Y, 2006, INT IMMUNOL, V18, P1671, DOI 10.1093/intimm/dxl101	43	182	196	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1114	1122		10.1038/ni1501	http://dx.doi.org/10.1038/ni1501			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17721536				2022-12-18	WOS:000249691400026
J	Guo, J; Hawwari, A; Li, H; Sun, ZM; Mahanta, SK; Littman, DR; Krangel, MMS; He, YW				Guo, J; Hawwari, A; Li, H; Sun, ZM; Mahanta, SK; Littman, DR; Krangel, MMS; He, YW			Regulation of the TCR alpha repertoire by the survival window of CD4(+)CD8(+) thymocytes	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ROR-GAMMA-T; HISTONE ACETYLATION; POSITIVE SELECTION; SECONDARY REARRANGEMENT; ORPHAN RECEPTOR; GENE; BETA; LOCUS; ORGANIZATION	T cell receptor (TCR) alpha alleles undergo primary and secondary rearrangement in double-positive (DP) thymocytes. By analyzing TCRalpha rearrangement in orphan nuclear receptor RORgamma-deficient mice, in which the DP lifespan is shorter, and in Bcl-x(L)-transgenic mice, in which the DP lifespan is extended, we show that the progression of secondaryV(alpha) to J(alpha) rearrangements is controlled by DP thymocyte survival. In addition, because Bcl-x(L) induces a bias towards 3' J(alpha) usage in peripheral T cells, we conclude that the programmed cell death of DP thymocytes is not simply a consequence of failed positive selection. Rather, it limits the progression of rearrangement along the J(alpha) locus and the opportunities for positive selection, thereby regulating the TCRalpha repertoire.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, HHMI, New York, NY 10016 USA	Duke University; New York University; Howard Hughes Medical Institute; New York University	He, YW (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	he000004@mc.duke.edu	Hawwari, Abbas/L-1934-2019	Hawwari, Abbas/0000-0001-9643-6500	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041052, R37GM041052] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33856] Funding Source: Medline; NIGMS NIH HHS [GM41052] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Barndt R, 1999, J IMMUNOL, V163, P3331; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; Chao DT, 1997, INT IMMUNOL, V9, P1375, DOI 10.1093/intimm/9.9.1375; Davodeau F, 2001, EMBO J, V20, P4717, DOI 10.1093/emboj/20.17.4717; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; He YW, 2000, IMMUNOL RES, V22, P71, DOI 10.1385/IR:22:2-3:71; He YW, 2000, J IMMUNOL, V164, P5668, DOI 10.4049/jimmunol.164.11.5668; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Huang CY, 2001, J IMMUNOL, V166, P2597, DOI 10.4049/jimmunol.166.4.2597; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Littman DR, 1999, COLD SPRING HARB SYM, V64, P373, DOI 10.1101/sqb.1999.64.373; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Mauvieux L, 2001, EUR J IMMUNOL, V31, P2080, DOI 10.1002/1521-4141(200107)31:7<2080::AID-IMMU2080>3.3.CO;2-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Riegert P, 1999, J IMMUNOL, V162, P3471; RYTKONEN M, 1994, EUR J IMMUNOL, V24, P107, DOI 10.1002/eji.1830240117; Rytkonen MA, 1996, EUR J IMMUNOL, V26, P1892, DOI 10.1002/eji.1830260833; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; WANG K, 1994, GENOMICS, V20, P419, DOI 10.1006/geno.1994.1196; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471	46	182	184	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					469	476		10.1038/ni791	http://dx.doi.org/10.1038/ni791			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11967541				2022-12-18	WOS:000175411200016
J	Barlic, J; Andrews, JD; Kelvin, AA; Bosinger, SE; DeVries, ME; Xu, LL; Dobransky, T; Feldman, RD; Ferguson, SSG; Kelvin, DJ				Barlic, J; Andrews, JD; Kelvin, AA; Bosinger, SE; DeVries, ME; Xu, LL; Dobransky, T; Feldman, RD; Ferguson, SSG; Kelvin, DJ			Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI	NATURE IMMUNOLOGY			English	Article							SRC FAMILY KINASES; INTERLEUKIN-8 RECEPTOR-A; SIGNAL-TRANSDUCTION; HUMAN NEUTROPHILS; POLYMORPHONUCLEAR LEUKOCYTE; SECRETORY GRANULES; PROTEIN; HCK; SNAP-23; INTERNALIZATION	Chemoattractant-stimulated granule release from neutrophils, basophils and eosinophils is critical for the innate immune response against infectious bacteria. Interleukin 8 (IL-8) activation of the chemokine receptor CXCRI was found to stimulate rapid formation of beta-arrestin complexes with Hck or c-Fgr, Formation of beta-arrestin-Hck complexes led to Hck activation and trafficking of the complexes to granule-rich regions. Granulocytes expressing a dominant-negative beta-arrestin-mutant did not release granules or activate tyrosine kinases after IL-8 stimulation. Thus, beta-arrestins regulate chemokine-induced granule exocytosis, indicating a broader role for beta-arrestins in the regulation of cellular functions than was previously suspected.	John P Robarts Res Inst, Lab Mol Immunol & Inflammat, London, ON N6G 2V4, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; John P Robarts Res Inst, Neurodegenerat Dis Grp, London, ON N6G 5K8, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Pharmacol, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Toxicol, London, ON N6A 5K8, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Kelvin, DJ (corresponding author), John P Robarts Res Inst, Lab Mol Immunol & Inflammat, 1400 Western Rd, London, ON N6G 2V4, Canada.	kelvin@rri.on.ca	Feldman, Ross/G-3293-2011					Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; Berton G, 1999, Curr Opin Hematol, V6, P51, DOI 10.1097/00062752-199901000-00009; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; Borregaard N, 1995, Clin Exp Immunol, V101 Suppl 1, P6; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Chen D, 1999, BIOCHEM BIOPH RES CO, V255, P340, DOI 10.1006/bbrc.1999.0173; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Demoly P, 1997, CLIN EXP ALLERGY, V27, P672; El-Shazly A, 1999, BIOCHEM BIOPH RES CO, V264, P163, DOI 10.1006/bbrc.1999.1379; Ferguson S S, 1998, Adv Pharmacol, V42, P420; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUTKIND JS, 1989, P NATL ACAD SCI USA, V86, P8783, DOI 10.1073/pnas.86.22.8783; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Ligeti E, 1999, BIOCHEM PHARMACOL, V57, P1209, DOI 10.1016/S0006-2952(98)00377-3; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Meddows-Taylor S, 1999, CLIN DIAGN LAB IMMUN, V6, P345, DOI 10.1128/CDLI.6.3.345-351.1999; Mellado M, 1998, J IMMUNOL, V161, P805; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mocsai A, 1999, J IMMUNOL, V162, P1120; MOHN H, 1995, BIOCHEM J, V309, P657; Mollinedo F, 1997, BIOCHEM BIOPH RES CO, V231, P808, DOI 10.1006/bbrc.1997.6196; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; MURPHY PM, PHARM REV, V52, P145; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Richardson RM, 1998, J BIOL CHEM, V273, P10690, DOI 10.1074/jbc.273.17.10690; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SMITH RJ, 1992, J LEUKOCYTE BIOL, V52, P17, DOI 10.1002/jlb.52.1.17; Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613; Tapper H, 1996, EUR J HAEMATOL, V57, P191; Tapper H, 1997, J IMMUNOL, V159, P409; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Topham MK, 1998, FASEB J, V12, P733, DOI 10.1096/fasebj.12.9.733; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Welch H, 1997, J BIOL CHEM, V272, P102; Welch Heidi, 1996, Methods (Orlando), V9, P607, DOI 10.1006/meth.1996.0067; WILLEMS J, 1989, IMMUNOLOGY, V67, P540; Wong PPC, 1997, BIOCHEM BIOPH RES CO, V230, P64, DOI 10.1006/bbrc.1996.5884; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328	47	182	192	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					227	233		10.1038/79767	http://dx.doi.org/10.1038/79767			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973280				2022-12-18	WOS:000089815100021
J	Lugt, BV; Khan, AA; Hackney, JA; Agrawal, S; Lesch, J; Zhou, MJ; Lee, WP; Park, S; Xu, M; DeVoss, J; Spooner, CJ; Chalouni, C; Delamarre, L; Mellman, I; Singh, H				Lugt, Bryan Vander; Khan, Aly A.; Hackney, Jason A.; Agrawal, Smita; Lesch, Justin; Zhou, Meijuan; Lee, Wyne P.; Park, Summer; Xu, Min; DeVoss, Jason; Spooner, Chauncey J.; Chalouni, Cecile; Delamarre, Lelia; Mellman, Ira; Singh, Harinder			Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation	NATURE IMMUNOLOGY			English	Article							REGULATORY FACTOR-4; SURFACE EXPRESSION; GENE-EXPRESSION; MOLECULES; HOMEOSTASIS; SUBSETS; REVEALS; NETWORK	CD11b(+) dendritic cells (DCs) seem to be specialized for presenting antigens via major histocompatibility (MHC) class II complexes to stimulate helper T cells, but the genetic and regulatory basis for this is not established. Conditional deletion of Irf4 resulted in loss of CD11b(+) DCs, impaired formation of peptide-MHC class II complexes and defective priming of helper T cells but not of cytotoxic T lymphocyte (CTL) responses. Gene expression and chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) analyses delineated an IRF4-dependent regulatory module that programs enhanced MHC class II antigen presentation. Expression of the transcription factor IRF4 but not of IRF8 restored the ability of IRF4-deficient DCs to efficiently process and present antigen to MHC class II-restricted T cells and promote helper T cell responses. We propose that the evolutionary divergence of IRF4 and IRF8 facilitated the specialization of DC subsets for distinct modes of antigen presentation and priming of helper T cell versus CTL responses.	[Lugt, Bryan Vander; Agrawal, Smita; Spooner, Chauncey J.; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Khan, Aly A.] Univ Chicago, Inst Syst & Genom Biol, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hackney, Jason A.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Lesch, Justin; Zhou, Meijuan; Lee, Wyne P.; Park, Summer; Xu, Min; DeVoss, Jason] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Chalouni, Cecile; Delamarre, Lelia; Mellman, Ira] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; University of Chicago; University of Chicago; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Singh, H (corresponding author), Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA.	Harinder.Singh@cchmc.org	Mellman, Ira/ABG-5896-2020	Hackney, Jason/0000-0002-5922-563X				Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Smith M, 2011, POSTHUMANITIES, V16, P1; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; ten Broeke T, 2011, TRAFFIC, V12, P1025, DOI 10.1111/j.1600-0854.2011.01212.x; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	31	181	185	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					161	167		10.1038/ni.2795	http://dx.doi.org/10.1038/ni.2795			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24362890				2022-12-18	WOS:000330150600010
J	Utzschneider, DT; Legat, A; Marraco, SAF; Carrie, L; Luescher, I; Speiser, DE; Zehn, D				Utzschneider, Daniel T.; Legat, Amandine; Marraco, Silvia A. Fuertes; Carrie, Lucie; Luescher, Immanuel; Speiser, Daniel E.; Zehn, Dietmar			T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ADAPTIVE IMMUNE-RESPONSES; CHRONIC VIRAL-INFECTION; HEPATITIS-C VIRUS; MEMORY; EFFECTOR; PERSISTENCE; SUBSETS; VACCINATION; RECEPTORS	During chronic infection, pathogen-specific CD8(+) T cells upregulate expression of molecules such as the inhibitory surface receptor PD-1, have diminished cytokine production and are thought to undergo terminal differentiation into exhausted cells. Here we found that T cells with memory-like properties were generated during chronic infection. After transfer into naive mice, these cells robustly proliferated and controlled a viral infection. The reexpanded T cell populations continued to have the exhausted phenotype they acquired during the chronic infection. Thus, the cells underwent a form of differentiation that was stably transmitted to daughter cells. We therefore propose that during persistent infection, effector T cells stably differentiate into a state that is optimized to limit viral replication without causing overwhelming immunological pathology.	[Utzschneider, Daniel T.; Carrie, Lucie; Zehn, Dietmar] Swiss Vaccine Res Inst, Epalinges, Switzerland; [Utzschneider, Daniel T.; Carrie, Lucie; Zehn, Dietmar] Univ Lausanne Hosp, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland; [Legat, Amandine; Marraco, Silvia A. Fuertes; Luescher, Immanuel; Speiser, Daniel E.] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Zehn, D (corresponding author), Swiss Vaccine Res Inst, Epalinges, Switzerland.	dietmar.zehn@chuv.ch	Marraco, Silvia A Fuertes/I-2481-2014; Utzschneider, Daniel/D-5855-2016; Speiser, Daniel E./F-2173-2013; Utzschneider, Daniel/E-2563-2013	Utzschneider, Daniel/0000-0003-2205-9057; Fuertes Marraco, Silvia A/0000-0002-3456-3317	Swiss Vaccine Research Institute; Swiss National Science Foundation [CRSII3_141879]	Swiss Vaccine Research Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank S. Enouz, S. Oberle and M. Prlic for discussions and critical review of the manuscript; A. Oxenius (Institute of Microbiology, Swiss Federal Institute of Technology Zurich) for P14 alpha beta mice; P. Fink (University of Washington, Seattle) for V<INF>beta</INF>5 mice; and A. Wilson and H.R. MacDonald (Ludwig Center for Cancer Research, University of Lausanne) for antibodies specific to CD45.2 (clone 104) and CD45.1 (clone A20). Supported by the Swiss Vaccine Research Institute (D.Z.) and the Swiss National Science Foundation (CRSII3_141879 to D.Z. and D.E.S.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Baumgaertner P, 2012, INT J CANCER, V130, P2607, DOI 10.1002/ijc.26297; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; BRANDLE D, 1991, EUR J IMMUNOL, V21, P2195, DOI 10.1002/eji.1830210930; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DILLON SR, 1994, J IMMUNOL, V152, P1790; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lefrancois L, 2009, NAT IMMUNOL, V10, P369, DOI 10.1038/ni0409-369; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miller NE, 2005, J VIROL, V79, P9419, DOI 10.1128/JVI.79.15.9419-9429.2005; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pichenot M, 2012, HIV MED, V13, P148, DOI 10.1111/j.1468-1293.2011.00953.x; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Richter K, 2012, EUR J IMMUNOL, V42, P2290, DOI 10.1002/eji.201142275; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	49	181	185	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					603	+		10.1038/ni.2606	http://dx.doi.org/10.1038/ni.2606			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23644506				2022-12-18	WOS:000319107600013
J	Kincaid, EZ; Che, JW; York, I; Escobar, H; Reyes-Vargas, E; Delgado, JC; Welsh, RM; Karow, ML; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Rock, KL				Kincaid, Eleanor Z.; Che, Jenny W.; York, Ian; Escobar, Hernando; Reyes-Vargas, Eduardo; Delgado, Julio C.; Welsh, Raymond M.; Karow, Margaret L.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Rock, Kenneth L.			Mice completely lacking immunoproteasomes show major changes in antigen presentation	NATURE IMMUNOLOGY			English	Article							T-CELL REPERTOIRE; INTERFERON-GAMMA; EXPRESSION; GENERATION; MOLECULES; PEPTIDASE; PROTEINS; EPITOPE; GENES; SHAPE	The importance of immunoproteasomes to antigen presentation has been unclear because animals totally lacking immunoproteasomes had not been available. Having now developed mice lacking the three immunoproteasome catalytic subunits, we found that the dendritic cells of these mice had defects in presenting several major histocompatibility complex (MHC) class I epitopes. During viral infection in vivo, the presentation of a majority of MHC class I epitopes was markedly reduced in immunoproteasome-deficient animals compared with wild-type animals, whereas presentation of MHC class II peptides was unaffected. According to mass spectrometry, the repertoire of MHC class I-presented peptides was similar to 50% different from that in wild-type mice, and these differences were sufficient to stimulate robust transplant rejection of wild-type cells in mutant mice. These results indicated that immunoproteasomes were more important in antigen presentation than previously thought.	[Kincaid, Eleanor Z.; Che, Jenny W.; Welsh, Raymond M.; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [York, Ian] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Mol Virol & Vaccine Branch, Atlanta, GA USA; [Escobar, Hernando; Reyes-Vargas, Eduardo; Delgado, Julio C.] Univ Utah, Sch Med, Dept Pathol, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Karow, Margaret L.; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	University of Massachusetts System; University of Massachusetts Worcester; Centers for Disease Control & Prevention - USA; Utah System of Higher Education; University of Utah; ARUP Laboratories; Regeneron	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	kenneth.rock@umassmed.edu	York, Ian/X-9351-2019; Kincaid, Eleanor/AAV-3326-2021	York, Ian/0000-0002-3478-3344; escobar loaiza, hernando/0000-0001-9935-1836; Reyes-Vargas, Eduardo/0000-0003-3984-9274; Murphy, Andrew/0000-0003-4152-4081	University of Massachusetts Diabetes and Endocrinology Research Center core resources [DK32520]; US National Institutes of Health [5R01A1020248-29, 5T32A107349-19, T32CA130807-02, R37AI017672, R01AI081675, U01-AI073871]; NATIONAL CANCER INSTITUTE [T32CA130807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081675, R37AI017672, U01AI073871, R01AI020248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	University of Massachusetts Diabetes and Endocrinology Research Center core resources; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Monaco (University of Cincinnati) for beta 2i-deficient mice; L. Van Kaer (Vanderbilt University School of Medicine) for beta 1i singly deficient mice; C. Perreault (University of Montreal), with permission from H. J. Fehling (University Clinics Ulm) for beta 5i singly deficient mice; B. J. Fowlkes (US National Institutes of Health) for C57BL/6 H-Y-transgenic mice; N. Shastri (University of California, Berkeley) for11p9z cells; E. Raines (University of Washington) for plasmid pBMN-IRES-Lyt2a; M. Green (University of Massachusetts Medical School) for Phoenix cells and plasmids; Yewdell and Bennick (National Institute of Allergy and Infectious Diseases, US National Institutes of Health) for H-2K<SUP>b</SUP> exon 8-specific antiserum; F. Cruz and D. Farfan (University of Massachusetts Medical School) for the RF33.70-LUC and 12.64-CD8 alpha CD8 beta-LUC cell lines; D. Palliyaguru for doing many of the in vivo cytotoxicity experiments; and L. Stern and Z. Shen for advice and reagents for optimizing the mass spectrometry. This work was supported by University of Massachusetts Diabetes and Endocrinology Research Center core resources (DK32520; K. L. R., member) and by funding from the US National Institutes of Health (5R01A1020248-29 to K. L. R. and E. Z. K., 5T32A107349-19 and T32CA130807-02 to E. Z. K., R37AI017672 and R01AI081675 to R. M. W. and J.W.C., and U01-AI073871 to J.W.C.).	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Macagno A, 2001, EUR J IMMUNOL, V31, P3271, DOI 10.1002/1521-4141(200111)31:11<3271::AID-IMMU3271>3.0.CO;2-2; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Nil A, 2004, EUR J IMMUNOL, V34, P2681, DOI 10.1002/eji.200425032; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Osterloh P, 2006, P NATL ACAD SCI USA, V103, P5042, DOI 10.1073/pnas.0509256103; Palmowski MJ, 2006, J IMMUNOL, V177, P983, DOI 10.4049/jimmunol.177.2.983; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROCK KL, 1990, J IMMUNOL, V145, P804; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Stohwasser R, 1997, EUR J IMMUNOL, V27, P1182, DOI 10.1002/eji.1830270520; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; Van Kaer L, 2001, IMMUNOL RES, V23, P205, DOI 10.1385/IR:23:2-3:205; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4	30	181	186	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					129	135		10.1038/ni.2203	http://dx.doi.org/10.1038/ni.2203			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22197977	Green Accepted, Green Submitted			2022-12-18	WOS:000299315000009
J	Chang, M; Jin, W; Sun, SC				Chang, Mikyoung; Jin, Wei; Sun, Shao-Cong			Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; DOMAIN-CONTAINING ADAPTER; TUMOR-SUPPRESSOR CYLD; PELLINO PROTEINS; INFLAMMATORY RESPONSES; REGULATORY FACTOR-3; IMMUNE-RESPONSES; CUTTING EDGE; ACTIVATION	Toll-like receptors (TLRs) are pivotal in innate immunity and inflammation. Here we show that genetic deficiency in Peli1, an E3 ubiquitin ligase, attenuated the induction of proinflammatory cytokines by ligands of TLR3 and TLR4 and rendered mice resistant to septic shock. Peli1 was required for TLR3-induced activation of I. B kinase (IKK) and its 'downstream' target, transcription factor NF-kappa B, but was dispensable for IKK-NF-kappa B activation induced by several other TLRs and the interleukin 1 (IL-1) receptor. Notably, Peli1 bound to and ubiquitinated RIP1, a signaling molecule that mediates IKK activation induced by the TLR3 and TLR4 adaptor TRIF. Our findings suggest that Peli1 is a ubiquitin ligase needed for the transmission of TRIF-dependent TLR signals.	[Chang, Mikyoung; Jin, Wei; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org			US National Institutes of Health [AI057555, AI064639, GM84459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Texas Institute for Genomic Medicine for Peli1-knockout mice; R. Beyaert (Ghent University) for E-tag-fused Peli1 and mutants; J. Hiscott (McGill University) for GST-IRF3 (amino acids 380-427); V. Chau (Pennsylvania State University College of Medicine) for anti-ubiquitin; and M. K. Offermann and W. J. Kaiser (Emory University) for CMV14-3xFlag-TRIF, pCMV10-3XFlag-RIP1 and pcDNA3-myc-RIP1. Supported by the US National Institutes of Health (AI057555, AI064639 and GM84459).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Dejager L, 2008, CYTOKINE, V42, P55, DOI 10.1016/j.cyto.2008.01.014; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Rivera-Walsh I, 2000, J BIOL CHEM, V275, P25222, DOI 10.1074/jbc.M000444200; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; VANGURI P, 1990, J BIOL CHEM, V265, P15049; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yi AK, 1998, J IMMUNOL, V160, P5898; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	49	181	194	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1089	U66		10.1038/ni.1777	http://dx.doi.org/10.1038/ni.1777			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19734906	Green Accepted			2022-12-18	WOS:000270006900012
J	Ziegler, SF; Liu, YJ				Ziegler, SF; Liu, YJ			Thymic stromal lymphopoietin in normal and pathogenic T cell development and function	NATURE IMMUNOLOGY			English	Review							MEDIATED SIGNAL-TRANSDUCTION; IGM(+) B-CELLS; DENDRITIC CELLS; EPITHELIAL-CELLS; HASSALLS CORPUSCLES; MOLECULAR-CLONING; GROWTH-FACTOR; INTERLEUKIN-7 RECEPTOR; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS	Thymic stromal lymphopoietin, a four helix-bundle cytokine, is expressed mainly by barrier epithelial cells and is a potent activator of several cell types, particularly myeloid dendritic cells. TSLP influences the outcome of interactions between dendritic cells and CD4(+) thymocytes and T cells in many situations, such as the regulation of the positive selection of regulatory T cells, maintenance of peripheral CD4(+) T cell homeostasis and induction of CD4(+) T cell-mediated allergic inflammation.	Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA	Benaroya Research Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ziegler, SF (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org; yjliu@mdanderson.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044259, R01AI068731] Funding Source: NIH RePORTER; NIAID NIH HHS [AI068731, AI06645-01, AI44259] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; BLAU JN, 1967, IMMUNOLOGY, V12, P363; BLAU JN, 1965, NATURE, V208, P654; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fujio K, 2000, BLOOD, V95, P2204; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2983, DOI 10.1073/pnas.052714199; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Hassall AH., 1885, INHALATION TREATMENT; HE W, 1995, J IMMUNOL, V154, P3726; Hiroyama T, 2000, BIOCHEM BIOPH RES CO, V272, P224, DOI 10.1006/bbrc.2000.2764; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isaksen DE, 2002, J IMMUNOL, V168, P3288, DOI 10.4049/jimmunol.168.7.3288; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Levin SD, 1999, J IMMUNOL, V162, P677; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nanavaty U, 2001, AM J MED SCI, V321, P11, DOI 10.1097/00000441-200101000-00003; Nishio H, 2001, ACTA HISTOCHEM, V103, P89, DOI 10.1078/0065-1281-00581; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Oh JW, 2002, J ALLERGY CLIN IMMUN, V110, P460, DOI 10.1067/mai.2002.127512; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Romagnani P, 1998, BLOOD, V91, P3323, DOI 10.1182/blood.V91.9.3323.3323_3323_3332; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SENELAR R, 1976, BIOMEDICINE, V24, P112; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zaitseva M, 2002, J IMMUNOL, V168, P2609, DOI 10.4049/jimmunol.168.6.2609; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	52	181	201	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					709	714		10.1038/ni1360	http://dx.doi.org/10.1038/ni1360			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785889				2022-12-18	WOS:000238377700015
J	Sharp, LL; Jameson, JM; Cauvi, G; Havran, WL				Sharp, LL; Jameson, JM; Cauvi, G; Havran, WL			Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-I; DEXAMETHASONE-INDUCED APOPTOSIS; TRANSGENIC MICE; FACTOR RECEPTOR; IGF-I; GENE-EXPRESSION; INSULIN; LYMPHOCYTES; KERATINOCYTES; ACTIVATION	A fine balance between rates of proliferation and apoptosis in the skin provides a defensive barrier and a mechanism for tissue repair after damage. Vgamma3(+) dendritic epidermal T cells (DETCs) are primary modulators of skin immune responses. Here we show that DETCs both produce and respond to insulin-like growth factor 1 (IGF-1) after T cell receptor stimulation. Mice deficient in DETCs had a notable increase in epidermal apoptosis that was abrogated by the addition of DETCs or IGF-1. Furthermore, DETC-deficient mice had reduced IGF-1 receptor activation at wound sites. These findings indicate critical functions for DETC-mediated IGF-1 production in regulating skin homeostasis and repair.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	havran@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036964, T32AI007244] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI07244, T32AI36964] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; BIGBY M, 1993, J IMMUNOL, V151, P4465; Bitar MS, 2000, SURGERY, V127, P687, DOI 10.1067/msy.2000.105869; Blakytny Robert, 2000, Journal of Pathology, V190, P589, DOI 10.1002/(SICI)1096-9896(200004)190:5<589::AID-PATH553>3.0.CO;2-T; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boismenu R, 1996, J IMMUNOL, V157, P985; Brocardo MG, 2001, J LEUKOCYTE BIOL, V70, P297; Brown DL, 1997, AM J PATHOL, V151, P715; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; DiGiovanni J, 2000, CANCER RES, V60, P1561; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Edmondson SR, 2003, ENDOCR REV, V24, P737, DOI 10.1210/er.2002-0021; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Ghofrani A, 1999, PLAST RECONSTR SURG, V104, P470, DOI 10.1097/00006534-199908000-00020; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Havran WL, 2000, IMMUNOL RES, V21, P63, DOI 10.1385/IR:21:2-3:63; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jeschke MG, 2004, AM J PHYSIOL-REG I, V286, pR958, DOI 10.1152/ajpregu.00541.2003; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; Koshizuka S, 1997, SURG TODAY, V27, P946, DOI 10.1007/BF02388144; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NISSLEY SP, 1984, CLIN ENDOCRINOL META, V13, P43; Pifer J, 2003, MECH AGEING DEV, V124, P207, DOI 10.1016/S0047-6374(02)00141-0; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Rho O, 1996, MOL CARCINOGEN, V17, P62, DOI 10.1002/(SICI)1098-2744(199610)17:2<62::AID-MC2>3.0.CO;2-V; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116; Stentz FB, 2004, METABOLISM, V53, P117, DOI 10.1016/j.metabol.2003.07.015; Su HY, 2004, BBA-GENE STRUCT EXPR, V1676, P127, DOI 10.1016/j.bbaexp.2003.11.006; Tavakkol A, 1999, ARCH DERMATOL RES, V291, P643, DOI 10.1007/s004030050469; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Walsh PT, 2002, IMMUNOLOGY, V107, P461, DOI 10.1046/j.1365-2567.2002.01525.x; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639	44	181	192	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					73	79		10.1038/ni1152	http://dx.doi.org/10.1038/ni1152			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15592472				2022-12-18	WOS:000225888500020
J	Alberti, J; Valenzuela, JG; Carruthers, VB; Hieny, S; Andersen, J; Charest, H; Sousa, CRE; Fairlamb, A; Ribeiro, JM; Sher, A				Alberti, J; Valenzuela, JG; Carruthers, VB; Hieny, S; Andersen, J; Charest, H; Sousa, CRE; Fairlamb, A; Ribeiro, JM; Sher, A			Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells	NATURE IMMUNOLOGY			English	Article							TOXOPLASMA-GONDII; CHEMOKINE RECEPTOR; BIOCHEMICAL-CHARACTERIZATION; CYCLOPHILIN; INTERLEUKIN-12; IMMUNOPHILINS; RESISTANCE; IMMUNITY; MALARIA; ANTIGEN	Toxoplasma gondii releases factors that potently stimulate production of interleukin-12 (IL-12) from dendritic cells (DCs). Purification of this activity showed that cyclophilin-18 (C-18) was its principal component, and antibodies generated against recombinant C-18 inhibited tachyzoite extract-induced synthesis of IL-12. Recombinant C-18 showed high affinity for and triggered cell signaling through CCR5, a chemokine receptor important in parasite-induced IL-12 production by DCs. These findings suggest that the unusual potency of T gondii in inducing IL-12 from DCs results from its synthesis of a unique chemokine mimic that signals through CCR5. The ability to generate this strong protective response may benefit parasite transmission by preventing the protozoan from overwhelming its intermediate hosts.	NIAID, Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Med Entomol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Canc Res UK, London Res Inst, London WC2A 3PX, England; Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cancer Research UK; University of Dundee	Alberti, J (corresponding author), NIAID, Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Reis e Sousa, Caetano/O-1657-2014; Aliberti, Julio/G-4565-2012; Reis e Sousa, Caetano/ABD-7322-2021; Fairlamb, Alan/A-5272-2009	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Fairlamb, Alan/0000-0001-5134-0329; Carruthers, Vern/0000-0001-6859-8895; Ribeiro, Jose/0000-0002-9107-0818	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, Z01AI000810, ZIAAI000810, ZIAAI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berriman M, 1998, BIOCHEM J, V334, P437, DOI 10.1042/bj3340437; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; HACKER J, 1993, MOL MICROBIOL, V10, P445, DOI 10.1111/j.1365-2958.1993.tb00917.x; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HIGH KP, 1994, J BIOL CHEM, V269, P9105; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	20	181	195	2	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					485	490		10.1038/ni915	http://dx.doi.org/10.1038/ni915			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12665855				2022-12-18	WOS:000182665400017
J	Davis, SJ; Ikemizu, S; Evans, EJ; Fugger, L; Bakker, TR; van der Merwe, PA				Davis, SJ; Ikemizu, S; Evans, EJ; Fugger, L; Bakker, TR; van der Merwe, PA			The nature of molecular recognition by T cells	NATURE IMMUNOLOGY			English	Review							CLASS-I MOLECULES; PEPTIDE-MHC; CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; ANTIGEN RECOGNITION; LOW-AFFINITY; IMMUNOGLOBULIN SUPERFAMILY; IMMUNOLOGICAL SYNAPSE; RECEPTOR RECOGNITION; LIGAND RECOGNITION	Considerable progress has been made in characterizing four key sets of interactions controlling antigen responsiveness in T cells, involving the following: the T cell antigen receptor, its coreceptors CD4 and CD8, the costimulatory receptors CD28 and CTLA-4, and the accessory molecule CD2. Complementary work has defined the general biophysical properties of interactions between cell surface molecules. Among the major conclusions are that these interactions are structurally heterogeneous, often reflecting clear-cut functional constraints, and that, although they all interact relatively weakly, hierarchical differences in the stabilities of the signaling complexes formed by these molecules may influence the sequence of steps leading to T cell activation. Here we review these developments and highlight the major challenges remaining as the field moves toward formulating quantitative models of T cell recognition.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DU, England; Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto 8620973, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford; Kumamoto University; University of Oxford	Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.		van der Merwe, P. Anton/F-8539-2011					ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; DRISCOLL PC, 1991, NATURE, V353, P762, DOI 10.1038/353762a0; Dustin ML, 1996, J IMMUNOL, V157, P2014; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Erbe DV, 2002, J BIOL CHEM, V277, P7363, DOI 10.1074/jbc.M110162200; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gao GF, 2002, TRENDS IMMUNOL, V23, P408, DOI 10.1016/S1471-4906(02)02282-2; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; HAHN WC, 1992, P NATL ACAD SCI USA, V89, P7179, DOI 10.1073/pnas.89.15.7179; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikemizu S, 1999, P NATL ACAD SCI USA, V96, P4289, DOI 10.1073/pnas.96.8.4289; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kim M, 2001, J MOL BIOL, V312, P711, DOI 10.1006/jmbi.2001.4980; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; van der Merwe PA, 1999, CURR BIOL, V9, pR419; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; VANDERMERWE PA, IN PRESS ANN REV IMM; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WILLIAMS AF, 1984, NATURE, V308, P12, DOI 10.1038/308012a0; WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zhu BR, 2002, BIOCHEMISTRY-US, V41, P12163, DOI 10.1021/bi020296g	83	181	201	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					217	224		10.1038/ni0303-217	http://dx.doi.org/10.1038/ni0303-217			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12605231				2022-12-18	WOS:000181201000009
J	Sidorenko, SP; Clark, EA				Sidorenko, SP; Clark, EA			The dual-function CD150 receptor subfamily: the viral attraction	NATURE IMMUNOLOGY			English	Review							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC ACTIVATION MOLECULE; NATURAL-KILLER-CELLS; 2-CONTAINING INOSITOL PHOSPHATASE; PROTEIN-TYROSINE-PHOSPHATASE; MOLLUSCUM CONTAGIOSUM VIRUS; MEASLES-VIRUS; CUTTING EDGE; SH2 DOMAIN; SIGNAL-TRANSDUCTION	The CD150 subfamily within the CD2 family is a growing group of dual-function receptors that have within their cytoplasmic tails a characteristic signaling motif. The ITSM (immunoreceptor tyrosine-based switch motif) enables these receptors to bind to and be regulated by small SH2 domain adaptor proteins, including SH2D1A (SH2-containing adaptor protein SH2 domain protein 1A) and EAT-2 (EWS-activated transcript 2). A major signaling pathway through the prototypic receptor in this subfamily, CD150, leads to the activation of interferon-gamma, a key cytokine for viral immunity. As a result, many viruses have designed strategies to usurp or alter CD150 functions. Measles virus uses CD150 as a receptor and Molluscum contagiosum virus encodes proteins that are homologous to CD150. Thus, viruses use CD150 subfamily receptors to create a favorable environment to elude detection and destruction. Understanding the CD150 subfamily may lead to new strategies for vaccine development and antiviral therapies.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; NAS Ukraine, Kavetsky Inst Expt Pathol Oncol & Radiobiol, UA-03022 Kiev, Ukraine	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU	Clark, EA (corresponding author), Univ Washington, Dept Microbiol, Box 357242,1959 NE Pacific, Seattle, WA 98195 USA.	eclark@bart.rprc.washington.edu	Clark, Edward/K-3462-2012	Sidorenko, Svetlana/0000-0001-8281-8006; Clark, Edward A/0000-0001-8061-5475	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037905] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Arico M, 2001, BLOOD, V97, P1131, DOI 10.1182/blood.V97.4.1131; Aversa G, 1997, IMMUNOL CELL BIOL, V75, P202, DOI 10.1038/icb.1997.30; Benoit L, 2000, J IMMUNOL, V165, P3549, DOI 10.4049/jimmunol.165.7.3549; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Bolt G, 2002, J GEN VIROL, V83, P1157, DOI 10.1099/0022-1317-83-5-1157; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Brandau O, 1999, HUM MOL GENET, V8, P2407, DOI 10.1093/hmg/8.13.2407; Bugert JJ, 2000, VIRUS GENES, V21, P189, DOI 10.1023/A:1008187430053; Bugert JJ, 2000, VIRUS GENES, V21, P111, DOI 10.1023/A:1008140615106; Castro AG, 1999, J IMMUNOL, V163, P5860; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; Erlenhofer C, 2002, J GEN VIROL, V83, P1431, DOI 10.1099/0022-1317-83-6-1431; Fennelly JA, 2001, IMMUNOGENETICS, V53, P599, DOI 10.1007/s002510100364; Fraser CC, 2002, IMMUNOGENETICS, V53, P843, DOI 10.1007/s00251-001-0415-7; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Gold MR, 2000, IMMUNOL REV, V176, P47; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Harmer SL, 1999, J BIOL CHEM, V274, P12183, DOI 10.1074/jbc.274.17.12183; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Howie D, 2000, CURR OPIN IMMUNOL, V12, P474, DOI 10.1016/S0952-7915(00)00123-0; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Kingsbury GA, 2001, J IMMUNOL, V166, P5675, DOI 10.4049/jimmunol.166.9.5675; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Klein G, 1998, NATURE, V395, P441, DOI 10.1038/26626; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P4104, DOI 10.1073/pnas.88.10.4104; Kruse M, 2001, J IMMUNOL, V167, P1989, DOI 10.4049/jimmunol.167.4.1989; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Li SC, 1999, CURR BIOL, V9, P1355, DOI 10.1016/S0960-9822(00)80080-9; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Meroni L, 1999, CLIN IMMUNOL, V92, P276, DOI 10.1006/clim.1999.4747; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Minagawa H, 2001, J GEN VIROL, V82, P2913, DOI 10.1099/0022-1317-82-12-2913; Mori Y, 2002, J VIROL, V76, P6750, DOI 10.1128/JVI.76.13.6750-6761.2002; Morra M, 2001, BLOOD, V98, P1321, DOI 10.1182/blood.V98.5.1321; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Nagy N, 2000, INT J CANCER, V88, P439, DOI 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#; Nakajima H, 2000, HUM IMMUNOL, V61, P39, DOI 10.1016/S0198-8859(99)00170-6; Nakamura H, 2001, J IMMUNOL, V167, P2657, DOI 10.4049/jimmunol.167.5.2657; NEDELLEC P, 1994, J VIROL, V68, P4525; Nelson DL, 2000, CLIN EXP IMMUNOL, V122, P291, DOI 10.1046/j.1365-2249.2000.01400.x; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ono N, 2001, J VIROL, V75, P1594, DOI 10.1128/JVI.75.4.1594-1600.2001; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Polacino PS, 1996, J MED PRIMATOL, V25, P201, DOI 10.1111/j.1600-0684.1996.tb00017.x; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Sadelain M, 1998, NAT GENET, V20, P103, DOI 10.1038/2569; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schneider U, 2002, J VIROL, V76, P7460, DOI 10.1128/JVI.76.15.7460-7467.2002; Schneider-Schaulies S, 2002, J MOL MED-JMM, V80, P73, DOI 10.1007/s00109-001-0299-x; Schneider-Schaulies Sibylle, 2001, Current Molecular Medicine (Hilversum), V1, P163, DOI 10.2174/1566524013363960; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; SHLAPATSKA LM, 2002, LEUCOCYTE TYPING, V7, P60; SIDORENKO SP, 1992, NEOPLASMA, V39, P3; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; Strahm B, 2000, BRIT J HAEMATOL, V108, P377; Sumegi J, 2000, BLOOD, V96, P3118; Sylla BS, 2000, P NATL ACAD SCI USA, V97, P7470, DOI 10.1073/pnas.130193097; Tanaka K, 2002, ARCH VIROL, V147, P195, DOI 10.1007/s705-002-8312-0; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; Tangye SG, 2000, SEMIN IMMUNOL, V12, P149, DOI 10.1006/smim.2000.0217; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	89	181	203	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					19	24		10.1038/ni0103-19	http://dx.doi.org/10.1038/ni0103-19			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496974	Bronze			2022-12-18	WOS:000180053000009
J	Vincent, MS; Leslie, DS; Gumperz, JE; Xiong, XW; Grant, EP; Brenner, MB				Vincent, MS; Leslie, DS; Gumperz, JE; Xiong, XW; Grant, EP; Brenner, MB			CD1-dependent dendritic cell instruction	NATURE IMMUNOLOGY			English	Article							T-CELLS; RECEPTOR EXPRESSION; CUTTING EDGE; HOST-DEFENSE; NKT CELLS; IN-VIVO; RECOGNITION; LYMPHOCYTES; ANTIGEN; IL-12	Both microbial products and T cell factors influence dendritic cell (DC) maturation. However, it is not known which T cells are capable of interacting with DCs at the initiation of adaptive immunity, when foreign antigen-specific T cells are rare. We show here that self-reactive CD1-restricted T cells can promote DC maturation by recognizing CD1 in the absence of foreign antigens. T cell recognition of all four CD1 isoforms can trigger DC maturation, but their distinct mechanisms of costimulation lead to profound differences in concomitant interleukin 12 p70 production. Distinct CD1-reactive T cells may thus differentially direct DC development early in the immune response, thereby controlling subsequent polarization of acquired immunity.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Brenner, MB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 1 Jimmy Fund Way, Boston, MA 02115 USA.		Grant, Ethan/GQP-2720-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002171, R21AR048037, K08AR001996] Funding Source: NIH RePORTER; NIAID NIH HHS [R37AI29873] Funding Source: Medline; NIAMS NIH HHS [R21AR48037, K08AR01996, K08AR02171] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Benlagha K, 2000, SEMIN IMMUNOL, V12, P537, DOI 10.1006/smim.2000.0276; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2002, J IMMUNOL, V168, P1519, DOI 10.4049/jimmunol.168.4.1519; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Nieda M, 2001, IMMUNOLOGY, V102, P137, DOI 10.1046/j.1365-2567.2001.01175.x; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507	45	181	192	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1163	1168		10.1038/ni851	http://dx.doi.org/10.1038/ni851			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12415264				2022-12-18	WOS:000179467800014
J	Feau, S; Arens, R; Togher, S; Schoenberger, SP				Feau, Sonia; Arens, Ramon; Togher, Susan; Schoenberger, Stephen P.			Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells	NATURE IMMUNOLOGY			English	Article							INTERLEUKIN-2 DEFICIENT MICE; DENDRITIC CELL; CD8-T-CELL MEMORY; CD4-T-CELL HELP; SELF-ANTIGENS; IN-VIVO; RESPONSES; MOUSE; LYMPHOCYTES; ACTIVATION	Two competing theories have been put forward to explain the role of CD4(+) T cells in priming CD8(+) memory T cells: one proposes paracrine secretion of interleukin 2 (IL-2); the other proposes the activation of antigen-presenting cells (APCs) via the costimulatory molecule CD40 and its ligand CD40L. We investigated the requirement for IL-2 by the relevant three cell types in vivo and found that CD8(+) T cells, rather than CD4(+) T cells or dendritic cells (DCs), produced the IL-2 necessary for CD8(+) T cell memory. Il2(-/-) CD4(+) T cells were able to provide help only if their ability to transmit signals via CD40L was intact. Our findings reconcile contradictory elements implicit in each model noted above by showing that CD4(+) T cells activate APCs through a CD40L-dependent mechanism to enable autocrine production of IL-2 in CD8(+) memory T cells.	[Feau, Sonia; Arens, Ramon; Togher, Susan; Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA.	sps@liai.org	Arens, Ramon/V-4010-2018	Arens, Ramon/0000-0001-5058-4110	US National Institutes of Health [R01 AI076972, R01CA81261]; Leukemia and Lymphoma Society [1630-06]; Kurz Family Foundation; NATIONAL CANCER INSTITUTE [R01CA081261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076972] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Kurz Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Salek-Ardakani (La Jolla Institute for Allergy and Immunology) for vaccinia virus-OVA; M.K. Jenkins (University of Minnesota Medical School) for Act-mOVA-transgenic mice; M. Rafii-El-Idrissi for demonstrating how to produce and purify the virus; F. Lambolez for the protocol for purifying T cells from the liver; S. Trifari and M. Pipkin for advice on granzyme B expression; and C. Kim and K. Van Gunst for technical advice and assistance. Supported by the US National Institutes of Health (R01 AI076972 and R01CA81261 to S.P.S.), the Leukemia and Lymphoma Society (1630-06 to S.P.S.) and the Kurz Family Foundation.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, J IMMUNOL, V177, P999, DOI 10.4049/jimmunol.177.2.999; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Mach N, 2000, CANCER RES, V60, P3239; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445	40	180	184	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					908	U132		10.1038/ni.2079	http://dx.doi.org/10.1038/ni.2079			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21804558	Green Accepted			2022-12-18	WOS:000294461200015
J	Gonzalez, SF; Lukacs-Kornek, V; Kuligowski, MP; Pitcher, LA; Degn, SE; Kim, YA; Cloninger, MJ; Martinez-Pomares, L; Gordon, S; Turley, SJ; Carroll, MC				Gonzalez, Santiago F.; Lukacs-Kornek, Veronika; Kuligowski, Michael P.; Pitcher, Lisa A.; Degn, Soren E.; Kim, Young-A; Cloninger, Mary J.; Martinez-Pomares, Luisa; Gordon, Siamon; Turley, Shannon J.; Carroll, Michael C.			Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes	NATURE IMMUNOLOGY			English	Article							ZONE B-CELLS; SUBCAPSULAR SINUS MACROPHAGES; MANNOSE-BINDING LECTIN; SPLENIC MARGINAL ZONE; IN-VIVO DEPLETION; CAPSULAR POLYSACCHARIDE; ANTIGEN PRESENTATION; ANTIBODY-RESPONSE; GERMINAL-CENTERS; MEDIATES UPTAKE	A major pathway for B cell acquisition of lymph-borne particulate antigens relies on antigen capture by subcapsular sinus macrophages of the lymph node. Here we tested whether this mechanism is also important for humoral immunity to inactivated influenza virus. By multiple approaches, including multiphoton intravital imaging, we found that antigen capture by sinus-lining macrophages was important for limiting the systemic spread of virus but not for the generation of influenza-specific humoral immunity. Instead, we found that dendritic cells residing in the lymph node medulla use the lectin receptor SIGN-R1 to capture lymph-borne influenza virus and promote humoral immunity. Thus, our results have important implications for the generation of durable humoral immunity to viral pathogens through vaccination.	[Gonzalez, Santiago F.; Kuligowski, Michael P.; Pitcher, Lisa A.; Degn, Soren E.; Kim, Young-A; Carroll, Michael C.] Harvard Univ, Childrens Hosp, Immune Dis Inst, Sch Med,Dept Pediat, Boston, MA 02115 USA; [Gonzalez, Santiago F.; Kuligowski, Michael P.; Pitcher, Lisa A.; Degn, Soren E.; Kim, Young-A; Carroll, Michael C.] Harvard Univ, Childrens Hosp, Program Cellular & Mol Med, Sch Med,Dept Pediat, Boston, MA 02115 USA; [Gonzalez, Santiago F.; Kuligowski, Michael P.; Pitcher, Lisa A.; Degn, Soren E.; Kim, Young-A; Carroll, Michael C.] Harvard Univ, Childrens Hosp, Immune Dis Inst, Sch Med,Dept Pathol, Boston, MA 02115 USA; [Gonzalez, Santiago F.; Kuligowski, Michael P.; Pitcher, Lisa A.; Degn, Soren E.; Kim, Young-A; Carroll, Michael C.] Harvard Univ, Childrens Hosp, Program Cellular & Mol Med, Sch Med,Dept Pathol, Boston, MA 02115 USA; [Lukacs-Kornek, Veronika; Turley, Shannon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol, Boston, MA 02115 USA; [Cloninger, Mary J.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Degn, Soren E.] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Martinez-Pomares, Luisa] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Montana State University System; Montana State University Bozeman; Aarhus University; University of Nottingham; University of Oxford	Carroll, MC (corresponding author), Harvard Univ, Childrens Hosp, Immune Dis Inst, Sch Med,Dept Pediat, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu; carroll@idi.harvard.edu	Degn, Søren E/G-7936-2017	Degn, Søren E/0000-0001-5409-045X; Martinez-Pomares, Luisa/0000-0002-2331-127X; F. Gonzalez, Santiago/0000-0003-4166-7664	US National Institutes of Health [5 R01 AI039246, 1 P01 AI078897, 5 R01 AI067706, RO1 GM62444, RO1 DK074500]; European Union [220044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067706, P01AI078897, R01AI039246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062444] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nolting (Dana Farber Cancer Institute) for hemagglutinin- T cell antigen receptor- transgenic mice; M. Nussenzweig (Rockefeller University) for CD11c- eYFP mice; R. Steinman (Rockefeller University) for the anti- SIGN- R1 hybridoma; K. Rajewsky (Harvard Medical School) for B1.8 mice; W. Gerhard (Wistar Institute) for the anti- hemagglutinin hybridoma; A. Garcia- Sastre (Mount Sinai School of Medicine) for influenza A/PR/8; J. Jensenius (Aarhus University) and S. Thiel (Aarhus University) for anti- MBL and technical advice; T. Mempel for the use of microscopy facilities and technical assistance; and H. Leung, E. Marino, M. Ericsson, H. Kim and A. Gillmore for technical assistance. Supported by the US National Institutes of Health (5 R01 AI039246, 1 P01 AI078897 and 5 R01 AI067706 to M.C.C., RO1 GM62444 to M.J.C. and RO1 DK074500 to S.J.T.) and the Seventh Framework Programme of the European Union (Marie Curie International Outgoing Fellowship 220044 to S.F.G.).	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barrington RA, 2006, J IMMUNOL, V177, P1510, DOI 10.4049/jimmunol.177.3.1510; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bot A, 1998, J IMMUNOL, V160, P4500; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kawai T, 2007, J VET MED SCI, V69, P221, DOI 10.1292/jvms.69.221; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2004, P NATL ACAD SCI USA, V101, P1963, DOI 10.1073/pnas.0308490100; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Woller EK, 2002, ORG LETT, V4, P7, DOI 10.1021/ol016568+; Wykes M, 1998, J IMMUNOL, V161, P1313	54	180	181	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					427	U90		10.1038/ni.1856	http://dx.doi.org/10.1038/ni.1856			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20305659	Green Accepted			2022-12-18	WOS:000276852200012
J	Gor, DO; Rose, NR; Greenspan, NS				Gor, DO; Rose, NR; Greenspan, NS			T(H)1-T(H)2: a Procrustean paradigm	NATURE IMMUNOLOGY			English	Editorial Material							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; T-CELL CLONE; TYPE-2 IMMUNITY; IFN-GAMMA; IL-10; MICE; TH2; INDUCTION; DISEASE	Although immunologists have found the dichotomous helper T cell subset model a useful construct, it is beginning to show its age. Some suggest that proponents of the T(H)1-T(H)2 dichotomy are overzealous in making the data conform to the scheme, like Procrustes who stretched or truncated his guests so that they would fit his guest bed.	Boston Univ, Sch Med, Ctr Mol Stress Response, Boston, MA 02118 USA; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Boston University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University	Gor, DO (corresponding author), Boston Univ, Sch Med, Ctr Mol Stress Response, Boston, MA 02118 USA.		Greenspan, Neil/AAJ-4795-2020					Afanasyeva M, 2001, CIRCULATION, V104, P3145, DOI 10.1161/hc5001.100629; Afanasyeva M, 2001, AM J PATHOL, V159, P193, DOI 10.1016/S0002-9440(10)61685-9; Allen JE, 1997, IMMUNOL TODAY, V18, P387, DOI 10.1016/S0167-5699(97)01102-X; Bullens DMA, 2001, SCAND J IMMUNOL, V53, P455, DOI 10.1046/j.1365-3083.2001.00900.x; CHER DJ, 1987, J IMMUNOL, V138, P3688; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Ferber IA, 1996, J IMMUNOL, V156, P5; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; Kaya Z, 2002, J IMMUNOL, V168, P1552, DOI 10.4049/jimmunol.168.4.1552; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Liu LM, 1998, INT IMMUNOL, V10, P1017, DOI 10.1093/intimm/10.8.1017; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nagelkerken L, 1997, INT IMMUNOL, V9, P1243, DOI 10.1093/intimm/9.9.1243; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Stohlman SA, 1999, J IMMUNOL, V163, P6338; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Yip HC, 1999, J IMMUNOL, V162, P3942	18	180	203	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					503	505		10.1038/ni0603-503	http://dx.doi.org/10.1038/ni0603-503			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774069				2022-12-18	WOS:000183175500004
J	Medina, KL; Garrett, KP; Thompson, LF; Rossi, MID; Payne, KJ; Kincade, PW				Medina, KL; Garrett, KP; Thompson, LF; Rossi, MID; Payne, KJ; Kincade, PW			Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELL; B-CELL; C-KIT; PROGENITOR CELLS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; FETAL LIVER; LINEAGE; MOUSE	Estrogen is a negative regulator of lymphopoiesis and provides an experimental tool for probing relationships between lymphocyte precursors and stem cells. We found that expression of lymphocyte-associated genes and immunoglobulin (Ig) gene rearrangement occurred before CD45R acquisition. Lymphoid-restricted progenitors that were Lin-IL-7R alpha (+)c-kit(lo)TdT(+) (lineage marker-, interleukin receptor 7(alpha+), c-kit(lo) and terminal deoxynucleotidyl transferase(+)) were selectively depleted in estrogen-treated mice; within a less differentiated Lin-c-kit(hi) fraction, functional precursors of B and T, but not myeloid, cells were also selectively depleted. TdT and an Ig heavy chain transgene were detected within a hormone-regulated Lin-c-kit(hi)Sca-I(+)CD27(+)Flk-2(+)IL-7R alpha (-) subset of this multipotential progenitor population. Identification of these extremely early lymphoid precursors should facilitate investigation of the molecular mechanisms that control lineage-fate decisions in hematopoiesis.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Kincade@omrf.ouhsc.edu	Payne, Kimberly/AAS-6814-2020; Rossi, Maria Isabel D/J-4802-2012	Payne, Kimberly/0000-0002-7025-5821; Rossi, Maria Isabel D/0000-0003-3432-8453	NIAID NIH HHS [AI 20069] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Bjorck P, 1998, J IMMUNOL, V161, P5795; BRUNO S, 1992, CELL PROLIFERAT, V25, P31, DOI 10.1111/j.1365-2184.1992.tb01435.x; CHERVENAK R, 1993, J IMMUNOL, V151, P4486; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; DONSKOY E, 1992, J IMMUNOL, V148, P1604; ERNST P, 1993, MOL CELL BIOL, V13, P2982, DOI 10.1128/MCB.13.5.2982; FORD AM, 1992, P NATL ACAD SCI USA, V89, P3424, DOI 10.1073/pnas.89.8.3424; FORD AM, 1992, BLOOD, V79, P1962, DOI 10.1182/blood.V79.8.1962.bloodjournal7981962; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; JENKINSON EJ, 2000, EUR J IMMUNOL, V12, pS83; KATAYAMA N, 1993, BLOOD, V82, P2353; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Medina KL, 2000, BLOOD, V95, P2059, DOI 10.1182/blood.V95.6.2059; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; MEDINA KL, 1993, J EXP MED, V178, P1507, DOI 10.1084/jem.178.5.1507; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OKADA S, 1992, BLOOD, V80, P3044; OLSEN NJ, 1991, ENDOCRINOLOGY, V129, P2471, DOI 10.1210/endo-129-5-2471; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Osmond D G, 1990, Semin Immunol, V2, P173; PARK YH, 1989, EUR J IMMUNOL, V19, P2139, DOI 10.1002/eji.1830191125; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V36, P269; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V35, P523; Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1034/j.1600-065X.2000.017512.x; Rolink AG, 2000, CURR TOP MICROBIOL, V251, P21; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smithson G, 1998, J IMMUNOL, V161, P27; SMITHSON G, 1994, J EXP MED, V180, P717, DOI 10.1084/jem.180.2.717; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Thevenin C, 1998, J EXP MED, V188, P735, DOI 10.1084/jem.188.4.735; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; WILSON CA, 1995, BLOOD, V85, P1535, DOI 10.1182/blood.V85.6.1535.bloodjournal8561535; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422; Zinovyeva MV, 2000, EXP HEMATOL, V28, P318, DOI 10.1016/S0301-472X(99)00158-7	59	180	182	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					718	724		10.1038/90659	http://dx.doi.org/10.1038/90659			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477408				2022-12-18	WOS:000170230100014
J	Rieckmann, JC; Geiger, R; Hornburg, D; Wolf, T; Kveler, K; Jarrossay, D; Sallusto, F; Shen-Orr, SS; Lanzavecchia, A; Mann, M; Meissner, F				Rieckmann, Jan C.; Geiger, Roger; Hornburg, Daniel; Wolf, Tobias; Kveler, Ksenya; Jarrossay, David; Sallusto, Federica; Shen-Orr, Shai S.; Lanzavecchia, Antonio; Mann, Matthias; Meissner, Felix			Social network architecture of human immune cells unveiled by quantitative proteomics	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; GENE-EXPRESSION; QUANTIFICATION; SYSTEM; RESPONSES	The immune system is unique in its dynamic interplay between numerous cell types. However, a system-wide view of how immune cells communicate to protect against disease has not yet been established. We applied high-resolution mass-spectrometry-based proteomics to characterize 28 primary human hematopoietic cell populations in steady and activated states at a depth of >10,000 proteins in total. Protein copy numbers revealed a specialization of immune cells for ligand and receptor expression, thereby connecting distinct immune functions. By integrating total and secreted proteomes, we discovered fundamental intercellular communication structures and previously unknown connections between cell types. Our publicly accessible (http://www.immprot.org/) proteomic resource provides a framework for the orchestration of cellular interplay and a reference for altered communication associated with pathology.	[Rieckmann, Jan C.; Hornburg, Daniel; Meissner, Felix] Max Planck Inst Biochem, Expt Syst Immunol, Bayern, Germany; [Geiger, Roger; Wolf, Tobias; Jarrossay, David; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Geiger, Roger; Wolf, Tobias; Lanzavecchia, Antonio] ETH, Inst Microbiol, Zurich, Switzerland; [Kveler, Ksenya; Shen-Orr, Shai S.] Technion Israel Inst Technol, Dept Immunol, Fac Med, Haifa, Israel; [Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Bayern, Germany	Max Planck Society; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Max Planck Society	Meissner, F (corresponding author), Max Planck Inst Biochem, Expt Syst Immunol, Bayern, Germany.; Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Bayern, Germany.	mmann@biochem.mpg.de; meissner@biochem.mpg.de	; Meissner, Felix/C-8767-2015	Shen-Orr, Shai/0000-0002-6991-7736; Meissner, Felix/0000-0003-1000-7989; Geiger, Roger/0000-0002-8016-1669	Max Planck Society; Swiss SystemsX.ch initiative; Helmut Horten Foundation	Max Planck Society(Max Planck Society); Swiss SystemsX.ch initiative; Helmut Horten Foundation	We thank R. Scheltema for MS assistance, K. Mayr, I. Paron, S. Gabriele, S. Dewitz and M. Dodel for technical assistance, M. Wierer and P. Sinitcyn for support with RNAseq analysis, M. Oroshi and C. Schaab for computer and database support, A. Zychlinsky for critical review of the manuscript, and J. Geddes, A. Frauenstein, M. Phulphagar and L. Kuhn for helpful discussions. The work was funded by the Max Planck Society for the Advancement of Science. R.G. was supported by a grant from the Swiss SystemsX.ch initiative, evaluated by the Swiss National Science Foundation. A.L. is supported by the Helmut Horten Foundation.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Albrecht I, 2010, EUR J IMMUNOL, V40, P2993, DOI 10.1002/eji.201040936; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bieber K, 2015, IMMUNOBIOLOGY, V220, P215, DOI 10.1016/j.imbio.2014.10.025; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dembic Z., 2015, CYTOKINES IMMUNE SYS; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hotson AN, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa9303; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kim CC, 2013, CURR OPIN IMMUNOL, V25, P593, DOI 10.1016/j.coi.2013.09.013; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Meissner F, 2014, NAT IMMUNOL, V15, P112, DOI 10.1038/ni.2781; Meissner F, 2013, SCIENCE, V340, P475, DOI 10.1126/science.1232578; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Rivera A, 2016, NAT IMMUNOL, V17, P356, DOI 10.1038/ni.3375; Schaab C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014068; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shen-Orr SS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P439; Subramanian N, 2015, WIRES SYST BIOL MED, V7, P13, DOI 10.1002/wsbm.1288; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	46	179	181	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					583	593		10.1038/ni.3693	http://dx.doi.org/10.1038/ni.3693			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28263321				2022-12-18	WOS:000399378700015
J	Engel, I; Seumois, G; Chavez, L; Samaniego-Castruita, D; White, B; Chawla, A; Mock, D; Vijayanand, P; Kronenberg, M				Engel, Isaac; Seumois, Gregory; Chavez, Lukas; Samaniego-Castruita, Daniela; White, Brandie; Chawla, Ashu; Mock, Dennis; Vijayanand, Pandurangan; Kronenberg, Mitchell			Innate-like functions of natural killer T cell subsets result from highly divergent gene programs	NATURE IMMUNOLOGY			English	Article							NKT CELLS; DIFFERENTIAL EXPRESSION; INKT CELLS; ACTIVATION; NORMALIZATION; MACROPHAGE; INDUCTION; EXPANSION; RESPONSES; REQUIRES	Natural killer T cells (NKT cells) have stimulatory or inhibitory effects on the immune response that can be attributed in part to the existence of functional subsets of NKT cells. These subsets have been characterized only on the basis of the differential expression of a few transcription factors and cell-surface molecules. Here we have analyzed purified populations of thymic NKT cell subsets at both the transcriptomic level and epigenomic level and by single-cell RNA sequencing. Our data indicated that despite their similar antigen specificity, the functional NKT cell subsets were highly divergent populations with many gene-expression and epigenetic differences. Therefore, the thymus 'imprints' distinct gene programs on subsets of innate-like NKT cells that probably impart differences in proliferative capacity, homing, and effector functions.	[Engel, Isaac; Seumois, Gregory; Chavez, Lukas; Samaniego-Castruita, Daniela; White, Brandie; Chawla, Ashu; Vijayanand, Pandurangan; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Mock, Dennis] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Vijayanand, Pandurangan] Univ Southampton, Fac Med, Southampton NIHR Resp Biomed Res Unit, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Kronenberg, Mitchell] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Chavez, Lukas] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany	La Jolla Institute for Immunology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southampton; University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ)	Vijayanand, P; Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.; Vijayanand, P (corresponding author), Univ Southampton, Fac Med, Southampton NIHR Resp Biomed Res Unit, Clin & Expt Sci, Southampton SO9 5NH, Hants, England.; Kronenberg, M (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	vijay@lji.org; mitch@lji.org	Kronenberg, Mitchell/AAT-6078-2021; Kronenberg, Mitchell/B-6843-2014	Kronenberg, Mitchell/0000-0001-6318-6445; Chavez, Lukas/0000-0002-8718-8848; Seumois, Gregory/0000-0002-8164-6852	Alexander von Humboldt Foundation; William K. Bowes Jr Foundation; US National Institutes of Health [R01 HL114093, U19 AI100275, R37 AI71922, R01 AI105215]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922, U19AI100275, R01AI105215, R01AI071922] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); William K. Bowes Jr Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Kim, L. Nosworthy and K. Van Gundt for assisting with single cell sorting; J. Day for assistance with next generation sequencing; Z. Fu, A.M. Gholami and J. Greenbaum for help with processing and analysis of sequencing data; and K.M. Ansel (University of California, San Francisco) and A. Rao (La Jolla Institute for Allergy & Immunology) for HS V-deficient mice. Supported by the Alexander von Humboldt Foundation (L.C.), The William K. Bowes Jr Foundation (P.V.) and the US National Institutes of Health (R01 HL114093 to P.V.; U19 AI100275 to P.V.; and R37 AI71922 and R01 AI105215 to M.K.).	Barrett CW, 2015, J CLIN INVEST, V125, P2646, DOI 10.1172/JCI76099; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Carr T, 2015, J EXP MED, V212, P793, DOI 10.1084/jem.20141849; Chandra S, 2015, ADV IMMUNOL, V127, P145, DOI 10.1016/bs.ai.2015.03.003; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Clinton GM, 1996, P NATL ACAD SCI USA, V93, P316, DOI 10.1073/pnas.93.1.316; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Engel I, 2014, CURR TOP MICROBIOL, V381, P51, DOI 10.1007/82_2014_375; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gottschalk C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00379; Hara-Chikuma M, 2012, J EXP MED, V209, P1743, DOI 10.1084/jem.20112398; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Ledford JG, 2007, J IMMUNOL, V178, P5132, DOI 10.4049/jimmunol.178.8.5132; Ledford JG, 2012, IMMUNOL CELL BIOL, V90, P733, DOI 10.1038/icb.2011.107; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; O'Brien TF, 2016, MUCOSAL IMMUNOL, V9, P597, DOI 10.1038/mi.2015.78; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Seino K, 2004, TRENDS IMMUNOL, V25, P219, DOI 10.1016/j.it.2004.03.001; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Starr AE, 2012, J BIOL CHEM, V287, P13382, DOI 10.1074/jbc.M111.314179; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyznik AJ, 2014, J IMMUNOL, V192, P3676, DOI 10.4049/jimmunol.1300837; Uehara S, 2006, J IMMUNOL, V176, P75, DOI 10.4049/jimmunol.176.1.75; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Xu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013780; Zhao PC, 2014, J LEUKOCYTE BIOL, V95, P521, DOI 10.1189/jlb.0613331	62	179	181	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					728	+		10.1038/ni.3437	http://dx.doi.org/10.1038/ni.3437			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27089380	Green Accepted			2022-12-18	WOS:000376162200018
J	Lanna, A; Henson, SM; Escors, D; Akbar, AN				Lanna, Alessio; Henson, Sian M.; Escors, David; Akbar, Arne N.			The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE; REPLICATIVE SENESCENCE; TELOMERE EROSION; MAP KINASE; PHOSPHORYLATION; P38-ALPHA; MEMORY; INHIBITION; MECHANISM; SENSOR	In T lymphocytes, the mitogen-activated protein kinase (MAPK) p38 regulates pleiotropic functions and is activated by canonical MAPK signaling or the alternative activation pathway downstream of the T cell antigen receptor (TCR). Here we found that senescent human T cells lacked the canonical and alternative pathways for the activation of p38 but spontaneously engaged the metabolic master regulator AMPK to trigger recruitment of p38 to the scaffold protein TAB1, which caused autophosphorylation of p38. Signaling via this pathway inhibited telomerase activity, T cell proliferation and the expression of key components of the TCR signalosome. Our findings identify a previously unrecognized mode for the activation of p38 in T cells driven by intracellular changes such as low-nutrient and DNA-damage signaling (an 'intrasensory' pathway). The proliferative defect of senescent T cells was reversed by blockade of AMPK-TAB1-dependent activation of p38.	[Lanna, Alessio; Henson, Sian M.; Escors, David; Akbar, Arne N.] UCL, Div Infect & Immun, London, England; [Escors, David] Complejo Hosp Navarra, Navarrabiomed Fdn Miguel Servet, Pamplona, Spain	University of London; University College London; Navarrabiomed; Servicio Navarro de Salud - Osasunbidea	Akbar, AN (corresponding author), UCL, Div Infect & Immun, London, England.	a.akbar@ucl.ac.uk	Escors-Murugarren, David/ABG-1930-2020; Lanna, Alessio/K-2053-2018; Escors, David/C-1549-2008	Escors-Murugarren, David/0000-0003-2828-4458; Lanna, Alessio/0000-0003-2215-3748; Escors, David/0000-0003-2828-4458; Henson, Sian/0000-0003-1893-4912; Akbar, Arne/0000-0002-3763-9380	Medical Research Council; Biotechnology and Biological Science Research Council [BB/J006750/1]; Instituto de Salud Carlos III, Spain; Biotechnology and Biological Sciences Research Council [BB/J006750/1] Funding Source: researchfish; Medical Research Council [1068333, G0900950] Funding Source: researchfish; BBSRC [BB/J006750/1] Funding Source: UKRI; MRC [G0900950] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. S. Marelli for discussions. Supported by the Medical Research Council (A.L.), the Biotechnology and Biological Science Research Council (BB/J006750/1 to A.N.A. and S.M.H.) and the Instituto de Salud Carlos III, Spain (D.E.).	Akbar AN, 2004, NAT REV IMMUNOL, V4, P737, DOI 10.1038/nri1440; Akbar AN, 2007, J IMMUNOL, V178, P6689, DOI 10.4049/jimmunol.178.11.6689; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; Escors D, 2008, BLOOD, V111, P3050, DOI 10.1182/blood-2007-11-122408; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Jacquet S, 2007, CARDIOVASC RES, V76, P465, DOI 10.1016/j.cardiores.2007.08.001; Jaswal JS, 2007, AM J PHYSIOL-HEART C, V292, pH1978, DOI 10.1152/ajpheart.01121.2006; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Lanna A., 2013, J IMMUNOL; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Plunkett FJ, 2007, J IMMUNOL, V178, P7710, DOI 10.4049/jimmunol.178.12.7710; Reed JR, 2004, J EXP MED, V199, P1433, DOI 10.1084/jem.20040178; Rincon M, 2007, NAT IMMUNOL, V8, P126, DOI 10.1038/ni0207-126; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Rudd CE, 2005, NAT IMMUNOL, V6, P368, DOI 10.1038/ni0405-368; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Tangeman Larissa, 2012, J RNAi Gene Silencing, V8, P470; Tivey HSE, 2013, BIOGERONTOLOGY, V14, P47, DOI 10.1007/s10522-012-9407-2; Vallejo AN, 2005, IMMUNOL REV, V205, P158, DOI 10.1111/j.0105-2896.2005.00256.x; Warrington KJ, 2003, BLOOD, V101, P3543, DOI 10.1182/blood-2002-08-2574; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; YAN MH, 1994, NATURE, V372, P798	47	179	183	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					965	U211		10.1038/ni.2981	http://dx.doi.org/10.1038/ni.2981			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25151490	Green Accepted, Green Submitted			2022-12-18	WOS:000342564800012
J	Shiow, LR; Roadcap, DW; Paris, K; Watson, SR; Grigorova, IL; Lebet, T; An, JP; Xu, Y; Jenne, CN; Foger, N; Sorensen, RU; Goodnow, CC; Bear, JE; Puck, JM; Cyster, JG				Shiow, Lawrence R.; Roadcap, David W.; Paris, Kenneth; Watson, Susan R.; Grigorova, Irina L.; Lebet, Tonya; An, Jinping; Xu, Ying; Jenne, Craig N.; Foeger, Niko; Sorensen, Ricardo U.; Goodnow, Christopher C.; Bear, James E.; Puck, Jennifer M.; Cyster, Jason G.			The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency	NATURE IMMUNOLOGY			English	Article							T-LYMPHOCYTE TRAFFICKING; ARP2/3 COMPLEX; LEUKOCYTE MIGRATION; CELL DEFICIENCY; IN-VIVO; 16P11.2; PROTEIN; MICRODELETION; REQUIREMENT; CHEMOTAXIS	Mice carrying the recessive locus for peripheral T cell deficiency (Ptcd) have a block in thymic egress, but the mechanism responsible is undefined. Here we found that Ptcd T cells had an intrinsic migration defect, impaired lymphoid tissue trafficking and irregularly shaped protrusions. Characterization of the Ptcd locus showed a point substitution of lysine for glutamic acid at position 26 in the actin regulator coronin 1A that enhanced its inhibition of the actin regulator Arp2/3 and resulted in its mislocalization from the leading edge of migrating T cells. The discovery of another coronin 1A mutant during an N-ethyl-N-nitrosourea-mutagenesis screen for T cell-lymphopenic mice prompted us to evaluate a T cell-deficient, B cell-sufficient and natural killer cell-sufficient patient with severe combined immunodeficiency, whom we found had mutations in both CORO1A alleles. Our findings establish a function for coronin 1A in T cell egress, identify a surface of coronin involved in Arp2/3 regulation and demonstrate that actin regulation is a biological process defective in human and mouse severe combined immunodeficiency.	[Shiow, Lawrence R.; Grigorova, Irina L.; An, Jinping; Xu, Ying; Jenne, Craig N.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Shiow, Lawrence R.; Watson, Susan R.; Grigorova, Irina L.; Lebet, Tonya; An, Jinping; Xu, Ying; Jenne, Craig N.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Shiow, Lawrence R.; Puck, Jennifer M.; Cyster, Jason G.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Lebet, Tonya; Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Lebet, Tonya; Puck, Jennifer M.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Roadcap, David W.; Bear, James E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roadcap, David W.; Bear, James E.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Goodnow, Christopher C.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Paris, Kenneth; Sorensen, Ricardo U.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA; [Paris, Kenneth; Sorensen, Ricardo U.] Childrens Hosp, New Orleans, LA 70118 USA; [Foeger, Niko] Leibniz Ctr Med & Biosci, Dept Immunol & Cell Biol, D-23845 Borstel, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Australian National University; John Curtin School of Medical Research; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020; Goodnow, Christopher C/V-8108-2018	Grigorova, Irina/0000-0002-4963-7403; Goodnow, Christopher C/0000-0001-5296-6155	University of California; Genentech Sandler Family Foundation; US Immunodeficiency Network; Jeffrey Modell Foundation; Howard Hughes Medical Institute; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, R01AI074847] Funding Source: NIH RePORTER	University of California(University of California System); Genentech Sandler Family Foundation; US Immunodeficiency Network; Jeffrey Modell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patient with SCID and her family; M. Anderson, P. Beemiller, S. Cheung, G. Cinamon, M. Krummel, T. Phan, H. Phee and A. Weiss for discussions; and D. Schafer ( University of Virginia) for advice and reagents related to the pyrene actin assay. Supported by the University of California, San Francisco Medical Scientist Training Program ( L. R. S.), Genentech Sandler Family Foundation ( L. R. S.), the US Immunodeficiency Network ( J. M. P.), the Jeffrey Modell Foundation ( J. M. P.), the Howard Hughes Medical Institute ( J. G. C.) and the National Institutes of Health ( C. C. G., J. E. B. and J. G. C.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Buckley RH, 2004, J CLIN INVEST, V114, P1409, DOI 10.1172/JCI200423571; CAI L, 2008, CELL IN PRESS; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; IKEGAMI H, 1988, DIABETOLOGIA, V31, P254, DOI 10.1007/BF00290594; Kimura S, 1998, IMMUNOGENETICS, V47, P278, DOI 10.1007/s002510050358; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maltzman JS, 2005, J EXP MED, V202, P893, DOI 10.1084/jem.20051128; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; OHOTORI H, 1968, EXP ANIM (TOKYO), V17, P91; OHTORI H, 1968, EXP ANIM, V17, P91; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Puck JM, 2006, NEW ENGL J MED, V355, P1759, DOI 10.1056/NEJMp068209; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yagi H, 1996, J IMMUNOL, V157, P3412	39	179	185	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1307	1315		10.1038/ni.1662	http://dx.doi.org/10.1038/ni.1662			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18836449	Green Submitted, Green Accepted			2022-12-18	WOS:000260248600018
J	Reiley, WW; Zhang, MY; Jin, W; Losiewicz, M; Donohue, KB; Norbury, CC; Sun, SC				Reiley, WW; Zhang, MY; Jin, W; Losiewicz, M; Donohue, KB; Norbury, CC; Sun, SC			Regulation of T cell development by the deubiquitinating enzyme CYLD	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; CBL-B; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; UBIQUITIN LIGASE; DEFICIENT MICE; C-CBL; LCK; KINASE	T cell receptor signaling is essential for the generation and maturation of T lymphocyte precursors. Here we identify the deubiquitinating enzyme CYLD as a positive regulator of proximal T cell receptor signaling in thymocytes. CYLD physically interacted with active Lck and promoted recruitment of active Lck to its substrate, Zap70. CYLD also removed both Lys 48- and Lys 63-linked polyubiquitin chains from Lck. Because of a cell-autonomous defect in T cell development, CYLD-deficient mice had substantially fewer mature CD4(+) and CD8(+) single-positive thymocytes and peripheral T cells.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	sxs70@psu.edu			NATIONAL CANCER INSTITUTE [R01CA094922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056094, R01AI056094, R01AI057555] Funding Source: NIH RePORTER; NCI NIH HHS [CA94922] Funding Source: Medline; NCRR NIH HHS [C06 RR-15428-01] Funding Source: Medline; NIAID NIH HHS [AI057555, R01 AI057555, AI056094] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; BIGGS PJ, 1995, NAT GENET, V11, P441, DOI 10.1038/ng1295-441; Biggs PJ, 1996, ONCOGENE, V12, P1375; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brooke HG, 1892, BRIT J DERMATOL, V4, P269; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fischer JA, 2003, INT REV CYTOL, V229, P43, DOI 10.1016/S0074-7696(03)29002-1; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Spiegler E., 1899, ARCH DERMATOL SYPHIL, V50, P163; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TARAKHOVSKY A, 1994, EUR J IMMUNOL, V24, P1678, DOI 10.1002/eji.1830240733; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zamoyska R, 2004, CURR OPIN IMMUNOL, V16, P191, DOI 10.1016/j.coi.2004.01.001	50	179	184	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					411	417		10.1038/ni1315	http://dx.doi.org/10.1038/ni1315			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16501569				2022-12-18	WOS:000236171000015
J	Dustin, ML; Bivona, TG; Philips, MR				Dustin, ML; Bivona, TG; Philips, MR			Membranes as messengers in T cell adhesion signaling	NATURE IMMUNOLOGY			English	Review							FUNCTION-ASSOCIATED ANTIGEN-1; INTEGRIN CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; IMMUNOLOGICAL SYNAPSE; HUMAN-NEUTROPHILS; CRYSTAL-STRUCTURE; I-DOMAIN; RAP1-INDUCED ADHESION; EXTRACELLULAR SEGMENT; RAP2 PROTEINS	Talin and RapL are components of molecular pathways that regulate the avidity of the integrin lymphocyte function-associated antigen 1 (LFA-1) for its ligand, intercellular adhesion molecule 1. In this review, we discuss recent advances in our understanding of LFA-1 affinity regulation and signaling and discuss a scenario for how Talin and Rap1 might act in synergy to achieve regulation of LFA-1 that is tailored to the specific functional requirements of different situations. Speedy delivery of signals may be crucial, and membrane trafficking from endosomes and the Golgi apparatus seem to be essential in delivering the messages from spatially segregated surface receptors.	NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Dustin, ML (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Mark, Philips/0000-0002-1179-8156; Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931, R01AI044931, R01AI043542, R37AI043542] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43542, AI44931] Funding Source: Medline; NIGMS NIH HHS [GM55279] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2003, NAT IMMUNOL, V4, P725, DOI 10.1038/ni0803-725; BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Betz SF, 1998, P NATL ACAD SCI USA, V95, P7909, DOI 10.1073/pnas.95.14.7909; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Geginat J, 2000, EUR J IMMUNOL, V30, P1136, DOI 10.1002/(SICI)1521-4141(200004)30:4<1136::AID-IMMU1136>3.0.CO;2-3; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2002, CURR OPIN IMMUNOL, V14, P317, DOI 10.1016/S0952-7915(02)00334-5; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JAY PY, 1995, J CELL SCI, V108, P387; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lee SY, 2000, J CELL SCI, V113, P1883; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PARDI R, 1989, J IMMUNOL, V143, P3157; Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PIZON V, 1994, J CELL SCI, V107, P1661; Rebstein PJ, 1997, EXP CELL RES, V231, P276, DOI 10.1006/excr.1996.3466; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; TOZEREN A, 1992, J CELL BIOL, V116, P997, DOI 10.1083/jcb.116.4.997; VAN SG, 1990, J IMMUNOL, V144, P4579; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zhou XM, 2001, J BIOL CHEM, V276, P44762, DOI 10.1074/jbc.M104029200; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	107	179	182	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					363	372		10.1038/ni1057	http://dx.doi.org/10.1038/ni1057			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052266				2022-12-18	WOS:000220515900008
J	Minhas, PS; Liu, L; Moon, PK; Joshi, AU; Dove, C; Mhatre, S; Contrepois, K; Wang, Q; Lee, BA; Coronado, M; Bernstein, D; Snyder, MP; Migaud, M; Majeti, R; Mochly-Rosen, D; Rabinowitz, JD; Andreasson, KI				Minhas, Paras S.; Liu, Ling; Moon, Peter K.; Joshi, Amit U.; Dove, Christopher; Mhatre, Siddhita; Contrepois, Kevin; Wang, Qian; Lee, Brittany A.; Coronado, Michael; Bernstein, Daniel; Snyder, Michael P.; Migaud, Marie; Majeti, Ravindra; Mochly-Rosen, Daria; Rabinowitz, Joshua D.; Andreasson, Katrin I.			Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation	NATURE IMMUNOLOGY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; KYNURENINE-PATHWAY-METABOLISM; BLUE NATIVE ELECTROPHORESIS; INDOLEAMINE 2,3-DIOXYGENASE; QUINOLINIC ACID; SUCCINATE-DEHYDROGENASE; DENDRITIC CELLS; MITOCHONDRIAL; INHIBITION; PHOSPHORIBOSYLTRANSFERASE	Recent advances highlight a pivotal role for cellular metabolism in programming immune responses. Here, we demonstrate that cell-autonomous generation of nicotinamide adenine dinucleotide (NAD(+)) via the kynurenine pathway (KP) regulates macrophage immune function in aging and inflammation. Isotope tracer studies revealed that macrophage NAD(+) derives substantially from KP metabolism of tryptophan. Genetic or pharmacological blockade of de novo NAD(+) synthesis depleted NAD(+), suppressed mitochondrial NAD(+)-dependent signaling and respiration, and impaired phagocytosis and resolution of inflammation. Innate immune challenge triggered upstream KP activation but paradoxically suppressed cell-autonomous NAD(+) synthesis by limiting the conversion of downstream quinolinate to NAD(+), a profile recapitulated in aging macrophages. Increasing de novo NAD(+) generation in immune-challenged or aged macrophages restored oxidative phosphorylation and homeostatic immune responses. Thus, KP-derived NAD(+) operates as a metabolic switch to specify macrophage effector responses. Breakdown of de novo NAD(+) synthesis may underlie declining NAD(+) levels and rising innate immune dysfunction in aging and age-associated diseases.	[Minhas, Paras S.; Moon, Peter K.; Mhatre, Siddhita; Wang, Qian; Andreasson, Katrin I.] Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Minhas, Paras S.] Stanford Univ, Neurosci Grad Program, Stanford, CA 94305 USA; [Liu, Ling; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Liu, Ling; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Joshi, Amit U.; Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Dove, Christopher; Majeti, Ravindra] Stanford Sch Med, Dept Hematol, Stanford, CA USA; [Contrepois, Kevin; Lee, Brittany A.; Snyder, Michael P.] Stanford Sch Med, Dept Genet, Stanford, CA USA; [Coronado, Michael; Bernstein, Daniel] Stanford Sch Med, Dept Pediat, Stanford, CA USA; [Migaud, Marie] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA; [Andreasson, Katrin I.] Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Princeton University; Princeton University; Stanford University; Stanford University; Stanford University; Stanford University; University of South Alabama; Stanford University; Stanford University	Andreasson, KI (corresponding author), Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Stanford Neurosci Inst, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Stanford Immunol Program, Stanford, CA 94305 USA.	kandreas@stanford.edu	Mhatre, Siddhita/AAH-8051-2020; Joshi, Amit/U-3832-2018; Rabinowitz, Joshua/GPP-4019-2022	Mhatre, Siddhita/0000-0001-9939-780X; Joshi, Amit/0000-0002-2472-7672; Rabinowitz, Joshua/0000-0002-1247-4727; Bernstein, Daniel/0000-0001-7761-5853; Mochly-Rosen, Daria/0000-0002-6691-8733; Moon, Peter/0000-0002-6623-4454; Majeti, Ravindra/0000-0002-5814-0984; Snyder, Michael/0000-0003-0784-7987	Bright Focus; Paul and Daisy Soros Fellowship for New Americans; Takeda Pharmaceuticals' Science Frontier Fund; NIH [1S10RR02678001];  [RO1AG048232];  [RF1AG058047];  [1P50 AG047366];  [5T32HL094274];  [DP1DK113643];  [5U54DK10255603];  [5R01CA188055];  [R37 AA11147 MERIT]; NATIONAL CANCER INSTITUTE [R01CA188055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094274, R00HL129474, K99HL129474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK113643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047366, R01AG048232, RF1AG058047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147] Funding Source: NIH RePORTER	Bright Focus(BrightFocus Foundation); Paul and Daisy Soros Fellowship for New Americans; Takeda Pharmaceuticals' Science Frontier Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grant no. RO1AG048232 (K.I.A.), grant no. RF1AG058047 (K.I.A.), grant no. 1P50 AG047366 (K.I.A.), Bright Focus (K.I.A.), The Paul and Daisy Soros Fellowship for New Americans (P.S.M.), the Gerald J. Lieberman Fellowship (P.S.M.), grant no. DP1DK113643 (L.L. and J.D.R.), grant no. 5U54DK10255603 (K.C., B.A.L., and M.P.S.), grant no. 5R01CA188055 (C.D. and R.M.), R37 AA11147 MERIT (A.J. and D.M.R.), the Takeda Pharmaceuticals' Science Frontier Fund (D.M.R.), and grant no. 5T32HL094274 (M.C. and D.B.). The authors would like to thank L. Alexandrova at the Stanford University Mass Spectrometry Core, J. Perrino at the Stanford Microscopy Facility (supported by NIH grant no. 1S10RR02678001), and the Stanford Human Immune Monitoring Center.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; BENDER DA, 1988, BRIT J NUTR, V59, P279, DOI 10.1079/BJN19880035; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Giorgini F, 2013, J BIOL CHEM, V288, P36554, DOI 10.1074/jbc.M113.503813; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Heyes MP, 2001, BRAIN, V124, P1033, DOI 10.1093/brain/124.5.1033; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johansson JU, 2015, J CLIN INVEST, V125, P350, DOI 10.1172/JCI77487; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Lopez-Ibanez J, 2016, NUCLEIC ACIDS RES, V44, pW201, DOI 10.1093/nar/gkw253; Malik SS, 2014, PROTEINS, V82, P405, DOI 10.1002/prot.24406; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; NISHIZUKA Y, 1963, J BIOL CHEM, V238, P3369; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pellicciari R, 2018, J MED CHEM, V61, P745, DOI 10.1021/acs.jmedchem.7b01254; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Prendergast GC, 2017, CANCER RES, V77, P6795, DOI 10.1158/0008-5472.CAN-17-2285; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ryan DG, 2017, FEBS LETT, V591, P2992, DOI 10.1002/1873-3468.12744; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003; Su XY, 2017, ANAL CHEM, V89, P5941, DOI 10.1021/acs.analchem.7b00396; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06254-4; Woodling NS, 2016, BRAIN, V139, P2063, DOI 10.1093/brain/aww117; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; Youn HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19681; Zhang ZY, 2017, J AM CHEM SOC, V139, P14368, DOI 10.1021/jacs.7b08012; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	60	178	184	10	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					50	+		10.1038/s41590-018-0255-3	http://dx.doi.org/10.1038/s41590-018-0255-3			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30478397	Green Accepted			2022-12-18	WOS:000456273900014
J	Simpson, LJ; Patel, S; Bhakta, NR; Choy, DF; Brightbill, HD; Ren, X; Wang, YL; Pua, HH; Baumjohann, D; Montoya, MM; Panduro, M; Remedios, KA; Huang, XZ; Fahy, JV; Arron, JR; Woodruff, PG; Ansel, KM				Simpson, Laura J.; Patel, Sana; Bhakta, Nirav R.; Choy, David F.; Brightbill, Hans D.; Ren, Xin; Wang, Yanli; Pua, Heather H.; Baumjohann, Dirk; Montoya, Misty M.; Panduro, Marisella; Remedios, Kelly A.; Huang, Xiaozhu; Fahy, John V.; Arron, Joseph R.; Woodruff, Prescott G.; Ansel, K. Mark			A microRNA upregulated in asthma airway T cells promotes T(H)2 cytokine production	NATURE IMMUNOLOGY			English	Article							MEDIATED REGULATION; DIFFERENTIATION; MIR-17-92; INFLAMMATION; ANTAGONISM; TARGETS; AUTOIMMUNITY; SUPPRESSORS; EXPRESSION; PHENOTYPES	MicroRNAs (miRNAs) exert powerful effects on immunological function by tuning networks of target genes that orchestrate cell activity. We sought to identify miRNAs and miRNA-regulated pathways that control the type 2 helper T cell (T(H)2 cell) responses that drive pathogenic inflammation in asthma. Profiling miRNA expression in human airway-infiltrating T cells revealed elevated expression of the miRNA miR-19a in asthma. Modulating miR-19 activity altered T(H)2 cytokine production in both human and mouse T cells, and TH2 cell responses were markedly impaired in cells lacking the entire miR-17 similar to 92 cluster. miR-19 promoted T(H)2 cytokine production and amplified inflammatory signaling by direct targeting of the inositol phosphatase PTEN, the signaling inhibitor SOCS1 and the deubiquitinase A20. Thus, upregulation of miR-19a in asthma may be an indicator and a cause of increased T(H)2 cytokine production in the airways.	[Simpson, Laura J.; Patel, Sana; Baumjohann, Dirk; Montoya, Misty M.; Panduro, Marisella; Remedios, Kelly A.; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Bhakta, Nirav R.; Fahy, John V.; Woodruff, Prescott G.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Choy, David F.; Arron, Joseph R.] Genentech Inc, Immunol Tissue Growth & Repair Biomarker Discover, San Francisco, CA 94080 USA; [Brightbill, Hans D.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Ren, Xin; Wang, Yanli; Huang, Xiaozhu] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Pua, Heather H.] Univ Calif San Francisco, Dept Pathol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ansel, KM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	mark.ansel@ucsf.edu	Baumjohann, Dirk/C-9047-2009	Baumjohann, Dirk/0000-0001-8385-8288; Choy, David/0000-0003-1351-6113; Arron, Joseph/0000-0001-7677-9979	US National Institutes of Health [HL107202, HL109102]; Sandler Asthma Basic Research Center; Leukemia AMP; Lymphoma Society; US National Science Foundation predoctoral fellowship [2010101500]; Swiss Foundation for Grants in Biology and Medicine [PASMP3-142725]; National Multiple Sclerosis Society; UCSF Program for Breakthrough Biomedical Research; Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL109102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, T32AI007334] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Asthma Basic Research Center; Leukemia AMP; Lymphoma Society(Leukemia and Lymphoma Society); US National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); Swiss Foundation for Grants in Biology and Medicine; National Multiple Sclerosis Society(National Multiple Sclerosis Society); UCSF Program for Breakthrough Biomedical Research; Sandler Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M McCune, Y. Bronevetslcy and E. Krow-Lucal for help with human biospecimens, and R. Kageyama for discussion of the manuscript. Supported by the US National Institutes of Health (HL107202, HL109102), the Sandler Asthma Basic Research Center, a Scholar Award from The Leukemia & Lymphoma Society, a US National Science Foundation predoctoral fellowship (2010101500 to L.J.S.), the Swiss Foundation for Grants in Biology and Medicine (PASMP3-142725), the National Multiple Sclerosis Society and the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bhakta NR, 2011, IMMUNOL REV, V242, P220, DOI 10.1111/j.1600-065X.2011.01032.x; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Fujimoto M, 2002, INT IMMUNOL, V14, P1343, DOI 10.1093/intimm/dxf094; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Liu F, 2012, MOL MED REP, V6, P1178, DOI 10.3892/mmr.2012.1030; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; Liu Y, 2013, CLIN REV ALLERG IMMU, V45, P314, DOI 10.1007/s12016-013-8398-3; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Olive V, 2013, ELIFE, V2, DOI 10.7554/eLife.00822; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Seumois G, 2012, AM J CLIN EXP IMMUNO, V1, P70; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Srivastava N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00288; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575	50	178	185	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2014	15	12					1162	1170		10.1038/ni.3026	http://dx.doi.org/10.1038/ni.3026			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AT3NR	25362490	Green Accepted, Green Submitted			2022-12-18	WOS:000344841900013
J	Salgame, P; Yap, GS; Gause, WC				Salgame, Padmini; Yap, George S.; Gause, William C.			Effect of helminth-induced immunity on infections with microbial pathogens	NATURE IMMUNOLOGY			English	Review							ASCARIS-LUMBRICOIDES INFECTION; EXCRETORY-SECRETORY PRODUCTS; MYCOBACTERIUM-BOVIS BCG; DENDRITIC CELL-FUNCTION; REGULATORY T-CELLS; CYTOKINE RESPONSES; FILARIAL INFECTION; IN-UTERO; ALTERNATIVE ACTIVATION; INTESTINAL HELMINTHS	Helminth infections are ubiquitous worldwide and can trigger potent immune responses that differ from and potentially antagonize host protective responses to microbial pathogens. In this Review we focus on the three main killers in infectious disease-AIDS, tuberculosis and malaria-and critically assesses whether helminths adversely influence host control of these diseases. We also discuss emerging concepts for how M2 macrophages and helminth-modulated dendritic cells can potentially influence the protective immune response to concurrent infections. Finally, we present evidence advocating for more efforts to determine how and to what extent helminths interfere with the successful control of specific concurrent coinfections.	[Salgame, Padmini] Rutgers State Univ, New Jersey Med Sch, Dept Med, Ctr Emerging Pathogens, Newark, NJ 07102 USA; [Yap, George S.; Gause, William C.] Rutgers State Univ, New Jersey Med Sch, Dept Med, Ctr Immun & Inflammat, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gause, WC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Med, Ctr Immun & Inflammat, Newark, NJ 07102 USA.	gausewc@njms.rutgers.edu			US National Institutes of Health [AI031678, AIO66188, AI065663, A1069395, AI83405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083405, R01AI031678, U01AI065663, R01AI083405] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Nutman for critical comments on this manuscript. Supported by the US National Institutes of Health (AI031678 and AIO66188 to W. C. G., AI065663 and A1069395 to P. S. and AI83405 to G.S.Y.).	Adams VJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-88; Al-Riyami L, 2009, J PARASITOL, V95, P1201, DOI 10.1645/GE-2017.1; Al-Riyami Lamyaa, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P45; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Aranzamendi C, 2012, PARASITE IMMUNOL, V34, P210, DOI 10.1111/j.1365-3024.2012.01353.x; Babu S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000489; Babu S, 2009, J INFECT DIS, V200, P288, DOI 10.1086/599797; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; Bailer RT, 2000, EUR J IMMUNOL, V30, P1340, DOI 10.1002/(SICI)1521-4141(200005)30:5<1340::AID-IMMU1340>3.0.CO;2-L; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Brown M, 2005, J INFECT DIS, V191, P1648, DOI 10.1086/429668; BUCK AA, 1969, AM J TROP MED HYG, V18, P217, DOI 10.4269/ajtmh.1969.18.217; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Cervi L, 2004, J IMMUNOL, V172, P2016, DOI 10.4049/jimmunol.172.4.2016; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan DJ, 2005, CURR HIV RES, V3, P223, DOI 10.2174/1570162054368075; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Cooper PJ, 1997, T ROY SOC TROP MED H, V91, P350, DOI 10.1016/S0035-9203(97)90103-6; Courtin D, 2011, PARASITE IMMUNOL, V33, P124, DOI 10.1111/j.1365-3024.2010.01267.x; Degarege A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-291; DENIS M, 1994, AIDS RES HUM RETROV, V10, P795, DOI 10.1089/aid.1994.10.795; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Dickson JH, 2000, PHILOS T R SOC B, V355, P1843, DOI 10.1098/rstb.2000.0739; Dolo H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001890; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Dreyfuss ML, 2002, AM J CLIN NUTR, V75, P959, DOI 10.1093/ajcn/75.6.959; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; du Plessis N, 2013, MUCOSAL IMMUNOL, V6, P931, DOI 10.1038/mi.2012.131; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Elias D, 2006, TROP MED INT HEALTH, V11, P551, DOI 10.1111/j.1365-3156.2006.01578.x; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047; Elliott AM, 2003, T ROY SOC TROP MED H, V97, P103, DOI 10.1016/S0035-9203(03)90040-X; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Elliott DE, 2004, EUR J IMMUNOL, V34, P2690, DOI 10.1002/eji.200324833; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fenton A, 2008, PARASITOLOGY, V135, P841, DOI 10.1017/S0031182008000310; Frantz FG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000700; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Gaze S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002520; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Hosseinipour MC, 2007, J INFECT DIS, V195, P1278, DOI 10.1086/513274; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hubner MP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001970; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; Jankovic D, 2004, J IMMUNOL, V173, P2419, DOI 10.4049/jimmunol.173.4.2419; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; King CH, 2010, ADV PARASIT, V73, P51, DOI 10.1016/S0065-308X(10)73003-7; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Lawn SD, 2000, AIDS, V14, P2437, DOI 10.1097/00002030-200011100-00004; Le Hesran JY, 2004, T ROY SOC TROP MED H, V98, P397, DOI 10.1016/j.trstmh.2003.10.009; Li ZT, 2011, INT J PARASITOL, V41, P1129, DOI 10.1016/j.ijpara.2011.06.008; Lipner EM, 2006, AM J TROP MED HYG, V74, P841, DOI 10.4269/ajtmh.2006.74.841; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Malhotra I, 1999, J IMMUNOL, V162, P6843; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Metenou S, 2012, EUR J IMMUNOL, V42, P641, DOI 10.1002/eji.201141991; Metenou S, 2009, J IMMUNOL, V183, P916, DOI 10.4049/jimmunol.0900257; MIKOVITS JA, 1994, J LEUKOCYTE BIOL, V56, P340, DOI 10.1002/jlb.56.3.340; Mishra PK, 2013, MUCOSAL IMMUNOL, V6, P297, DOI 10.1038/mi.2012.71; Mkhize-Kwitshana ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-273; MONTANER LJ, 1993, J EXP MED, V178, P743, DOI 10.1084/jem.178.2.743; Montaner LJ, 1997, J LEUKOCYTE BIOL, V62, P126, DOI 10.1002/jlb.62.1.126; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mouser EEIM, 2012, CURR OPIN HIV AIDS, V7, P260, DOI 10.1097/COH.0b013e3283521144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; NAIF H, 1994, J LEUKOCYTE BIOL, V56, P335, DOI 10.1002/jlb.56.3.335; Ndhlovu P, 2007, T ROY SOC TROP MED H, V101, P433, DOI 10.1016/j.trstmh.2006.08.008; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; PEARLMAN E, 1993, J IMMUNOL, V151, P4857; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; Rhodes SG, 2002, TRENDS IMMUNOL, V23, P246, DOI 10.1016/S1471-4906(02)02200-7; ROUGEMONT A, 1977, LANCET, V1, P309; Roussilhon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009309; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Sacco RE, 2002, CLIN IMMUNOL, V104, P274, DOI 10.1006/clim.2002.5263; Sangare LR, 2011, PARASITOLOGY, V138, P1546, DOI 10.1017/S0031182011000357; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Segura M, 2009, INT J PARASITOL, V39, P1525, DOI 10.1016/j.ijpara.2009.08.007; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Semnani RT, 2004, J IMMUNOL, V172, P6229, DOI 10.4049/jimmunol.172.10.6229; Setiawan T, 2007, INFECT IMMUN, V75, P4655, DOI 10.1128/IAI.00358-07; Smith KA, 2011, J IMMUNOL, V186, P7098, DOI 10.4049/jimmunol.1003636; Steiner KL, 2012, VIROLOGY, V425, P23, DOI 10.1016/j.virol.2012.01.003; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Stillwaggon E, 2012, TRENDS PARASITOL, V28, P261, DOI 10.1016/j.pt.2012.04.006; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Talaat KR, 2006, J INFECT DIS, V193, P196, DOI 10.1086/498912; Tristão-Sá Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Verhagen LM, 2012, TUBERCULOSIS, V92, P505, DOI 10.1016/j.tube.2012.07.004; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Webb EL, 2012, CURR OPIN HIV AIDS, V7, P245, DOI 10.1097/COH.0b013e32835210cd; Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2; White RR, 2012, VIRULENCE, V3, P668, DOI 10.4161/viru.22832; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolday D, 2002, JAIDS-J ACQ IMM DEF, V31, P56, DOI 10.1097/00126334-200209010-00008; World Health Organization, 2012, WHO MAP PROD PUBL HL; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871	125	178	184	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1118	1126		10.1038/ni.2736	http://dx.doi.org/10.1038/ni.2736			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145791	Green Accepted			2022-12-18	WOS:000326023400008
J	Rhee, I; Veillette, A				Rhee, Inmoo; Veillette, Andre			Protein tyrosine phosphatases in lymphocyte activation and autoimmunity	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; NEGATIVE REGULATORY TYROSINE; PTPN22 ALLELIC VARIANT; SRC-FAMILY KINASES; IMMATURE B-CELLS; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; CUTTING EDGE; IMMUNE CELLS; PHOSPHOTYROSINE PHOSPHATASE	Lymphocyte activation must be tightly regulated to ensure sufficient immunity to pathogens and prevent autoimmunity. Protein tyrosine phosphatases (PTPs) serve critical roles in this regulation by controlling the functions of key receptors and intracellular signaling molecules in lymphocytes. In some cases, PTPs inhibit lymphocyte activation, whereas in others they promote it. Here we discuss recent progress in elucidating the roles and mechanisms of action of PTPs in lymphocyte activation. We also review the accumulating evidence that genetic alterations in PTPs are involved in human autoimmunity.	[Rhee, Inmoo; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Rhee, Inmoo; Veillette, Andre] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal	Veillette, A (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca			Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Canada Research Chairs program; Howard Hughes Medical Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canada Research Chairs program(Canada Research Chairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by the Canadian Institutes of Health Research (A. V.), the Canadian Cancer Society Research Institute (A. V.), The Canada Research Chairs program (A. V.) and the Howard Hughes Medical Institute (A.V.).	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Barcellos LF, 2001, NAT GENET, V29, P23, DOI 10.1038/ng722; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Benatar T, 1996, J EXP MED, V183, P329, DOI 10.1084/jem.183.1.329; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; D'Oro U, 1999, J IMMUNOL, V162, P1879; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DESAI DM, 1994, EMBO J, V13, P4002, DOI 10.1002/j.1460-2075.1994.tb06716.x; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Dupuis M, 2003, J IMMUNOL, V171, P726, DOI 10.4049/jimmunol.171.2.726; Espino-Paisan L, 2011, IMMUNOGENETICS, V63, P255, DOI 10.1007/s00251-010-0500-x; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Fowler CC, 2010, J IMMUNOL, V185, P3256, DOI 10.4049/jimmunol.1001362; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Habib T, 2012, J IMMUNOL, V188, P487, DOI 10.4049/jimmunol.1102176; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hesslein DGT, 2006, P NATL ACAD SCI USA, V103, P7012, DOI 10.1073/pnas.0601851103; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KATAGIRI T, 1995, J BIOL CHEM, V270, P27987; Katagiri T, 1999, J IMMUNOL, V163, P1321; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Kwon J, 2005, EMBO J, V24, P2331, DOI 10.1038/sj.emboj.7600706; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Morgan AR, 2010, TISSUE ANTIGENS, V76, P119, DOI 10.1111/j.1399-0039.2010.01493.x; Murphy K, 2008, IMMUNOBIOLOGY; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stepanek O, 2011, J BIOL CHEM, V286, P22101, DOI 10.1074/jbc.M110.196733; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tangye SG, 1998, J IMMUNOL, V161, P3803; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wang YN, 2005, J BIOL CHEM, V280, P14318, DOI 10.1074/jbc.M413265200; WEAVER CT, 1991, MOL CELL BIOL, V11, P4415, DOI 10.1128/MCB.11.9.4415; Weiss A, 1993, CELL, V73, P209; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Wu SD, 2009, CHEMMEDCHEM, V4, P440, DOI 10.1002/cmdc.200800375; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317; Zikherman J, 2008, IMMUNITY, V29, P839, DOI 10.1016/j.immuni.2008.12.005	95	178	181	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					439	447		10.1038/ni.2246	http://dx.doi.org/10.1038/ni.2246			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513334				2022-12-18	WOS:000303048400007
J	Wei, M; Shinkura, R; Doi, Y; Maruya, M; Fagarasan, S; Honjo, T				Wei, Min; Shinkura, Reiko; Doi, Yasuko; Maruya, Mikako; Fagarasan, Sidonia; Honjo, Tasuku			Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; SECRETORY ANTIBODIES; COMMENSAL BACTERIA; CHOLERA-TOXIN; TARGETED DELETION; IMMUNE-RESPONSES; DENDRITIC CELLS; B-CELLS; IGA	To elucidate the specific role of somatic hypermutation (SHM) in mucosal immunity, we generated mice carrying a knock-in point mutation in Aicda, which encodes activation-induced cytidine deaminase (AID), an enzyme essential to SHM and class-switch recombination (CSR). These mutant AID(G23S) mice had much less SHM but had normal amounts of immunoglobulin in both serum and intestinal secretions. AID(G23S) mice developed hyperplasia of germinal center B cells in gut-associated lymphoid tissues, accompanied by expansion of microflora in the small intestine. Moreover, AID(G23S) mice had more translocation of Yersinia enterocolitica into mesenteric lymph nodes and were more susceptible than wild-type mice to oral challenge with cholera toxin. Together our results indicate that SHM is critical in maintaining intestinal homeostasis and efficient mucosal defense.	[Wei, Min; Shinkura, Reiko; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Doi, Yasuko; Maruya, Mikako; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa, Japan	Kyoto University; RIKEN	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402	Ministry of Education, Culture, Sports, Science and Technology of Japan [17002015, 16043228]; Mitsubishi Pharma Research Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation	We thank H. Nagaoka, M. Muramatsu, K. Kinoshita and H. Ohno for critical comments, and Y. Shiraki for help in preparing the manuscript. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Specially Promoted Research 17002015, and Grant-in Aid for Scientific Research on Priority Areas 16043228) and by the Mitsubishi Pharma Research Foundation.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Arulanandam BP, 2001, J IMMUNOL, V166, P226, DOI 10.4049/jimmunol.166.1.226; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Harriman GR, 1999, J IMMUNOL, V162, P2521; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hayday AC, 2009, SEMIN IMMUNOL, V21, P99, DOI 10.1016/j.smim.2009.04.003; Honda K, 2009, MUCOSAL IMMUNOL, V2, P187, DOI 10.1038/mi.2009.8; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KELLY BS, 1979, IMMUNOLOGY, V37, P45; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Komeno Y, 2010, LEUKEMIA, V24, P1018, DOI 10.1038/leu.2010.40; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lycke N, 1999, J IMMUNOL, V163, P913; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Moore ML, 2004, J VIROL, V78, P5584, DOI 10.1128/JVI.78.11.5584-5590.2004; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peng XH, 2001, J IMMUNOL, V167, P3677, DOI 10.4049/jimmunol.167.7.3677; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Shivarov V, 2008, P NATL ACAD SCI USA, V105, P15866, DOI 10.1073/pnas.0806641105; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Uren TK, 2005, EUR J IMMUNOL, V35, P180, DOI 10.1002/eji.200425492; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x	52	178	184	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					264	U102		10.1038/ni.1991	http://dx.doi.org/10.1038/ni.1991			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21258321				2022-12-18	WOS:000287354400014
J	Aliahmad, P; de la Torre, B; Kaye, J				Aliahmad, Parinaz; de la Torre, Brian; Kaye, Jonathan			Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; HELIX INHIBITOR ID2; IL-7 RECEPTOR-ALPHA; MURINE BONE-MARROW; T-CELL; LYMPHOTOXIN-ALPHA; ORGAN DEVELOPMENT; NODE DEVELOPMENT; PEYERS-PATCHES; KEY REGULATOR	TOX is a DNA-binding factor required for development of CD4(+) T cells, natural killer T cells and regulatory T cells. Here we document that both natural killer (NK) cell development and lymphoid tissue organogenesis were also inhibited in the absence of TOX. We found that the development of lymphoid tissue-inducer cells, a rare subset of specialized cells that has an integral role in lymphoid tissue organogenesis, required TOX. Tox was upregulated considerably in immature NK cells in the bone marrow, consistent with the loss of mature NK cells in the absence of this nuclear protein. Thus, many cell lineages of the immune system share a TOX-dependent step for development.	[Kaye, Jonathan] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kaye, J (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.	kayej@cshs.org		Kaye, Jonathan/0000-0002-1634-9069	National Institutes of Health [R01AI054977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Wawrowsky for assistance with confocal microscopy; P. Lin for cell sorting; A. Kadavallore for technical assistance; and A. Seksenyan for critical reading of this manuscript. Supported by the National Institutes of Health (R01AI054977 to J.K.).	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chappaz S, 2010, J IMMUNOL, V184, P3562, DOI 10.4049/jimmunol.0901647; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; DE TP, 1994, SCIENCE, V264, P703; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X	50	178	185	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					945	U98		10.1038/ni.1930	http://dx.doi.org/10.1038/ni.1930			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20818394	Green Accepted			2022-12-18	WOS:000281926900014
J	Wearsch, PA; Cresswell, P				Wearsch, Pamela A.; Cresswell, Peter			Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; HLA CLASS-I; N-TERMINAL REGION; T-CELL EPITOPE; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; LINKED GLYCANS; TAP; BINDING; CALRETICULIN	Major histocompatibility complex (MHC) class I glycoproteins bind peptides in the endoplasmic reticulum after incorporation into the peptide-loading complex, whose core is the transporter associated with antigen processing. Other components are the chaperone calreticulin, the thiol oxidoreductase ERp57, and tapasin. Tapasin and ERp57 have been shown to exist in the peptide-loading complex as a disulfide-linked heterodimer. Here, using a cell-free system, we demonstrate that although recombinant tapasin was ineffective in recruiting MHC class I molecules and facilitating peptide binding, recombinant tapasin-ERp57 conjugates accomplished both of those functions and also 'edited' the repertoire of bound peptides to maximize their affinity. Thus, the tapasin-ERp57 conjugate is the functional unit of the peptide-loading complex that generates MHC class I molecules with stably associated peptides.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Wearsch, Pamela/K-8505-2014	Wearsch, Pamela/0000-0002-9569-3852				Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; BERTOLETTI A, 1993, J VIROL, V67, P2376, DOI 10.1128/JVI.67.4.2376-2380.1993; BURROWS SR, 1990, J EXP MED, V171, P345, DOI 10.1084/jem.171.1.345; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Garber K, 2007, J NATL CANCER I, V99, P105, DOI 10.1093/jnci/djk046; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; Owen BAL, 1999, J IMMUNOL, V162, P4677; PARHAM P, 1979, J IMMUNOL, V123, P342; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Rizvi SM, 2006, P NATL ACAD SCI USA, V103, P18220, DOI 10.1073/pnas.0605131103; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; SUTTON J, 1993, EUR J IMMUNOL, V23, P447, DOI 10.1002/eji.1830230222; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; Walker KW, 1997, J BIOL CHEM, V272, P8845; WARBURTON RJ, 1994, HUM IMMUNOL, V39, P261, DOI 10.1016/0198-8859(94)90269-0; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	48	178	179	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					873	U1		10.1038/ni1485	http://dx.doi.org/10.1038/ni1485			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17603487				2022-12-18	WOS:000248169400015
J	Reiser, JB; Darnault, C; Guimezanes, A; Gregoire, C; Mosser, T; Schmitt-Verhulst, AM; Fontecilla-Camps, JC; Malissen, B; Housset, D; Mazza, G				Reiser, JB; Darnault, C; Guimezanes, A; Gregoire, C; Mosser, T; Schmitt-Verhulst, AM; Fontecilla-Camps, JC; Malissen, B; Housset, D; Mazza, G			Crystal structure of a T cell receptor bound to an allogeneic MHC molecule	NATURE IMMUNOLOGY			English	Article							CLASS-I H-2K(B); 3-DIMENSIONAL STRUCTURE; BETA-HETERODIMER; VIRAL PEPTIDE; COMPLEX; ANTIGEN; ALLORECOGNITION; RECOGNITION; SELECTION; REPERTOIRE	Many T cell receptors (TCRs) that are selected to respond to foreign peptide antigens bound to self major histocompatibility complex (MHC) molecules ave also reactive with allelic variants of self-MHC molecules,This property, termed alloreactivity, causes graft rejection and graft-versus-host disease,The structural features of alloreactivity have yet to be defined,We now present a basis for this cross-reactivity, elucidated by the crystal structure of a complex involving the BM3.3 TCR and a naturally processed octapeptide bound to the H-2K(b) allogeneic MHC class I molecule. A distinguishing feature of this complex is that the eleven-residue-long complementarity-determining region 3 (CDR3) found in the BM3.3 TCR alpha chain folds away from the peptide binding groove and makes no contact with the bound peptide, the latter being exclusively contacted by the BM3.3 CDR3 beta. Our results formally establish that peptide-specific, alloreactive TCRs interact with allo-MHC in a register similar to the one they use to contact self-MHC molecules.	Univ Grenoble 1, CNRS, Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Prot,CEA, F-38027 Grenoble 1, France; CNRS Marseille Luminy, INSERM, Ctr Immunol, F-13288 Marseille 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Housset, D (corresponding author), Univ Grenoble 1, CNRS, Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Prot,CEA, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	housset@lccp.ibs.fr	Reiser, Jean-Baptiste/W-7683-2019; Mazza, Giuseppe/A-2833-2013; Malissen, Bernard/AAK-4659-2020	Reiser, Jean-Baptiste/0000-0001-6926-9137; HOUSSET, Dominique/0000-0003-1732-0193; Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739; Malissen, Bernard/0000-0003-1340-9342				ALBERT F, 1984, IMMUNOGENETICS, V19, P279, DOI 10.1007/BF00345401; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gregoire C, 1996, EUR J IMMUNOL, V26, P2410, DOI 10.1002/eji.1830261022; GUIMEZANES A, 1992, EUR J IMMUNOL, V22, P1651, DOI 10.1002/eji.1830220647; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Little MT, 2000, J CLIN INVEST, V105, P1679, DOI 10.1172/JCI10375; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; PULLEN JK, 1992, J IMMUNOL, V148, P953; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P398, DOI 10.1073/pnas.72.1.398; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	38	178	183	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					291	297		10.1038/79728	http://dx.doi.org/10.1038/79728			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017099				2022-12-18	WOS:000089869700010
J	Barrat, FJ; Crow, MK; Ivashkiv, LB				Barrat, Franck J.; Crow, Mary K.; Ivashkiv, Lionel B.			Interferon target-gene expression and epigenomic signatures in health and disease	NATURE IMMUNOLOGY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID DENDRITIC CELLS; MACROPHAGE ACTIVATION SYNDROME; TOLL-LIKE RECEPTORS; I INTERFERON; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MITOCHONDRIAL-DNA; PERIPHERAL-BLOOD; INNATE IMMUNITY; GAMMA	Multiple type I interferons and interferon-gamma (IFN-gamma) are expressed under physiological conditions and are increased by stress and infections, and in autoinflammatory and autoimmune diseases. Interferons activate the Jak-STAT signaling pathway and induce overlapping patterns of expression, called 'interferon signatures', of canonical interferon-stimulated genes (ISGs) encoding molecules important for antiviral responses, antigen presentation, autoimmunity and inflammation. It has now become clear that interferons also induce an 'interferon epigenomic signature' by activating latent enhancers and 'bookmarking' chromatin, thus reprogramming cell responses to environmental cues. The interferon epigenomic signature affects ISGs and other gene sets, including canonical targets of the transcription factor NF-kappa B that encode inflammatory molecules, and is involved in the priming of immune cells, tolerance and the training of innate immune memory. Here we review the mechanisms through which interferon signatures and interferon epigenomic signatures are generated, as well as the expression and functional consequences of these signatures in homeostasis and autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis.	[Barrat, Franck J.; Crow, Mary K.; Ivashkiv, Lionel B.] Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA; [Barrat, Franck J.; Crow, Mary K.; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Barrat, Franck J.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Barrat, Franck J.; Crow, Mary K.; Ivashkiv, Lionel B.] Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Crow, Mary K.; Ivashkiv, Lionel B.] Weill Cornell Med, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Ivashkiv, LB (corresponding author), Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA.; Ivashkiv, LB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.; Ivashkiv, LB (corresponding author), Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.; Ivashkiv, LB (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.	ivashkivl@hss.edu		Ivashkiv, Lionel/0000-0002-9951-0646	NIH; Scleroderma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019420] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the NIH (to F.J.B. and L.B.I.) and from the Scleroderma Research Foundation (to F.J.B.).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Ah Kioon M. D, 2018, SCI TRANSL MED, V10, DOI DOI 10.1126/SCITRANSLMED.AAM8458; Akilesh HM, 2019, SCIENCE, V363, P142, DOI 10.1126/science.aao5213; Al-Salama ZT, 2019, DRUGS, V79, P99, DOI 10.1007/s40265-018-1046-8; Almlof JC, 2019, HUM GENET, V138, P141, DOI 10.1007/s00439-018-01966-7; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau R, 2017, ANNU REV IMMUNOL, V35, P337, DOI 10.1146/annurev-immunol-051116-052225; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Boyle DL, 2015, ANN RHEUM DIS, V74, P1311, DOI 10.1136/annrheumdis-2014-206028; Bracaglia C, 2017, ANN RHEUM DIS, V76, P166, DOI 10.1136/annrheumdis-2015-209020; Briand C, 2019, ANN RHEUM DIS, V78, P431, DOI 10.1136/annrheumdis-2018-214037; BURMESTER GR, 1987, J CLIN INVEST, V80, P595, DOI 10.1172/JCI113111; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Canna SW, 2014, ARTHRITIS RHEUMATOL, V66, P1072, DOI 10.1002/art.38362; Catalina MD, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0382-x; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Crow MK, 2019, ANNU REV PATHOL-MECH, V14, P369, DOI 10.1146/annurev-pathol-020117-043952; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Daniel B, 2018, IMMUNITY, V49, P615, DOI 10.1016/j.immuni.2018.09.005; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; Der E, 2019, NAT IMMUNOL, V20, P915, DOI 10.1038/s41590-019-0386-1; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; El-Sherbiny YM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24198-1; Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; FIRESTEIN GS, 1987, ARTHRITIS RHEUM, V30, P864, DOI 10.1002/art.1780300804; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Friedberg JW, 2005, BLOOD, V105, P489, DOI 10.1182/blood-2004-06-2156; Furie R, 2019, J CLIN INVEST, V129, P1359, DOI 10.1172/JCI124466; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gerber EE, 2013, NATURE, V503, P126, DOI 10.1038/nature12614; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Guiducci C, 2009, J INTERN MED, V265, P43, DOI 10.1111/j.1365-2796.2008.02050.x; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2013, J EXP MED, V210, P2903, DOI 10.1084/jem.20131044; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Hall JC, 2012, P NATL ACAD SCI USA, V109, P17609, DOI 10.1073/pnas.1209724109; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janke M, 2009, J ALLERGY CLIN IMMUN, V123, P1026, DOI 10.1016/j.jaci.2009.02.015; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kamada R, 2018, P NATL ACAD SCI USA, V115, pE9162, DOI 10.1073/pnas.1720930115; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim H, 2016, J MOL MED, V94, P1111, DOI 10.1007/s00109-016-1465-5; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Labonte AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208132; Ladislau L, 2018, BRAIN, V141, P1609, DOI 10.1093/brain/awy105; Lanata CM, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2018-000285; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Leung YT, 2015, EPIGENETICS-US, V10, P191, DOI 10.1080/15592294.2015.1009764; Liu WF, 2017, PLACENTA, V50, P32, DOI 10.1016/j.placenta.2016.12.023; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Lounder DT, 2019, BLOOD ADV, V3, P47, DOI 10.1182/bloodadvances.2018025858; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mavragani CP, 2016, ARTHRITIS RHEUMATOL, V68, P2686, DOI 10.1002/art.39795; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Meesilpavikkai K, 2019, ARTHRITIS RHEUMATOL, V71, P829, DOI 10.1002/art.40805; Mendoza JL, 2019, NATURE, V567, P56, DOI 10.1038/s41586-019-0988-7; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Munroe ME, 2016, ANN RHEUM DIS, V75, P2014, DOI 10.1136/annrheumdis-2015-208140; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Orange DE, 2018, ARTHRITIS RHEUMATOL, V70, P690, DOI 10.1002/art.40428; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Rice GI, 2018, NEW ENGL J MED, V379, P2275, DOI 10.1056/NEJMc1810983; Rice LM, 2015, ARTHRITIS RHEUMATOL, V67, P3004, DOI 10.1002/art.39287; Ries M, 2013, J LEUKOCYTE BIOL, V94, P123, DOI 10.1189/jlb.0612278; Riggs JM, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2018-000261; Rodero MP, 2017, J EXP MED, V214, P1547, DOI 10.1084/jem.20161451; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Sarkar MK, 2018, ANN RHEUM DIS, V77, P1653, DOI 10.1136/annrheumdis-2018-213197; Schulert GS, 2015, ANNU REV MED, V66, P145, DOI 10.1146/annurev-med-061813-012806; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; SKURKOVICH SV, 1975, ANN ALLERGY, V35, P356; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; STEINBERG AD, 1969, P NATL ACAD SCI USA, V63, P1102, DOI 10.1073/pnas.63.4.1102; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Uggenti C, 2019, ANNU REV IMMUNOL, V37, P247, DOI 10.1146/annurev-immunol-042718-041257; van Bon L, 2014, NEW ENGL J MED, V370, P433, DOI 10.1056/NEJMoa1114576; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Volkmann ER, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1203-y; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wallace DJ, 2018, LANCET, V392, P222, DOI 10.1016/S0140-6736(18)31363-1; Wang A, 2019, P NATL ACAD SCI USA, V116, P2200, DOI 10.1073/pnas.1820704116; Weaver LK, 2019, ARTHRITIS RHEUMATOL, V71, P161, DOI 10.1002/art.40683; Welcher AA, 2015, ARTHRITIS RHEUMATOL, V67, P2713, DOI 10.1002/art.39248; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96; Xu M, 2016, PHARMACOL RES, V111, P152, DOI 10.1016/j.phrs.2016.05.015; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yusof MYM, 2018, ANN RHEUM DIS, V77, P1432, DOI 10.1136/annrheumdis-2018-213386; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	144	177	182	13	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1574	1583		10.1038/s41590-019-0466-2	http://dx.doi.org/10.1038/s41590-019-0466-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745335	Green Accepted			2022-12-18	WOS:000497949800012
J	Ulvmar, MH; Werth, K; Braun, A; Kelay, P; Hub, E; Eller, K; Chan, L; Lucas, B; Novitzky-Basso, I; Nakamura, K; Rulicke, T; Nibbs, RJB; Worbs, T; Forster, R; Rot, A				Ulvmar, Maria H.; Werth, Kathrin; Braun, Asolina; Kelay, Poonam; Hub, Elin; Eller, Kathrin; Chan, Li; Lucas, Beth; Novitzky-Basso, Igor; Nakamura, Kyoko; Ruelicke, Thomas; Nibbs, Robert J. B.; Worbs, Tim; Foerster, Reinhold; Rot, Antal			The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; DENDRITIC CELL; IN-VIVO; T-CELLS; CUTTING EDGE; CCX-CKR; MIGRATION; IMMUNITY; TISSUE; NOMENCLATURE	Afferent lymph borne dendritic cells essentially rely on the chemokine receptor CCR7 for their transition from the subcapsular lymph node sinus into the parenchyma, a migratory step driven by putative gradients of CCR7 ligands. We found that lymph node fringes indeed contained physiological gradients of the chemokine CCL21, which depended on the expression of CCRL1, the atypical receptor for the CCR7 ligands CCL19 and CCL21. Lymphatic endothelial cells lining the ceiling of the subcapsular sinus, but not those lining the floor, expressed CCRL1, which scavenged chemokines from the sinus lumen. This created chemokine gradients across the sinus floor and enabled the emigration of dendritic cells. In vitro live imaging revealed that spatially confined expression of CCRL1 was necessary and sufficient for the creation of functional chemokine gradients.	[Ulvmar, Maria H.; Kelay, Poonam; Hub, Elin; Eller, Kathrin; Chan, Li; Lucas, Beth; Novitzky-Basso, Igor; Nakamura, Kyoko; Rot, Antal] Univ Birmingham, Sch Immun & Infect, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Werth, Kathrin; Braun, Asolina; Worbs, Tim; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Eller, Kathrin] Graz Univ, Div Nephrol, Graz, Austria; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Nibbs, Robert J. B.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Birmingham; Hannover Medical School; University of Graz; University of Veterinary Medicine Vienna; University of Glasgow	Rot, A (corresponding author), Hannover Med Sch, Inst Immunol, Hannover, Germany.	foerster.reinhold@mh-hannover.de; antal.rot@york.ac.uk	Novitzky-Basso, Igor/GLN-4839-2022; Förster, Reinhold/D-6770-2011; Ulvmar, Maria/AAS-2245-2020; Novitzky-Basso, Igor/AAU-2356-2020	Ulvmar, Maria/0000-0002-9050-0978; Novitzky-Basso, Igor/0000-0003-3748-3117; Eller, Kathrin/0000-0002-6214-5008; Worbs, Tim/0000-0001-9945-3103; Braun, Asolina/0000-0002-2646-5362; Forster, Reinhold/0000-0001-6190-7923; Rot, Antal/0000-0002-9730-6166; Nibbs, Robert/0000-0002-8150-0044	Medical Research Council [G0802838, G9818340]; European Union Marie Curie Actions; Wellcome Trust [WT090962MA]; European Research Council [322645]; Deutsche Forschungsgemeinschaft [SFB738-B5, EXC62]; Boehringer Ingelheim Fonds; MRC [G0802838, G9818340, G0901113] Funding Source: UKRI; Medical Research Council [G0901113] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Marie Curie Actions(European Commission); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Caamano for reading the manuscript and for suggestions; C. Bleul (Novartis) for CCRL1-eGFP mice; M. Gunn (Duke University) for pit mice; and D. Kioussis (Medical Research Council, National Institute for Medical Research) for the TEP cell line. Supported by the Medical Research Council (G0802838 to A.R. and G9818340 to the Medical Research Council Centre), The European Union Marie Curie Actions (CRITICS to M.H.U. and A.R.), the Wellcome Trust (WT090962MA to I.N.-B. and A.R.), the European Research Council (322645 to RE), Deutsche Forschungsgemeinschaft (SFB738-B5 and EXC62, 'Rebirth', to R.F.) and Boehringer Ingelheim Fonds (A.B.).	Bachelerie F, 2014, NAT IMMUNOL, V15, P207, DOI 10.1038/ni.2812; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Comerford I, 2010, BLOOD, V116, P4130, DOI 10.1182/blood-2010-01-264390; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Townson JR, 2002, EUR J IMMUNOL, V32, P1230, DOI 10.1002/1521-4141(200205)32:5<1230::AID-IMMU1230>3.0.CO;2-L; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; Vander Lugt B, 2013, J IMMUNOL, V191, P3119, DOI 10.4049/jimmunol.1200938; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017	43	177	179	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					623	630		10.1038/ni.2889	http://dx.doi.org/10.1038/ni.2889			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24813163				2022-12-18	WOS:000337715600008
J	Young, LJ; Wilson, NS; Schnorrer, P; Proietto, A; ten Broeke, T; Matsuki, Y; Mount, AM; Belz, GT; O'Keeffe, M; Ohmura-Hoshino, M; Ishido, S; Stoorvogel, W; Heath, WR; Shortman, K; Villadangos, JA				Young, Louise J.; Wilson, Nicholas S.; Schnorrer, Petra; Proietto, Anna; ten Broeke, Toine; Matsuki, Yohei; Mount, Adele M.; Belz, Gabrielle T.; O'Keeffe, Meredith; Ohmura-Hoshino, Mari; Ishido, Satoshi; Stoorvogel, Willem; Heath, William R.; Shortman, Ken; Villadangos, Jose A.			Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells	NATURE IMMUNOLOGY			English	Article							IN-VIVO; T-CELLS; SURFACE EXPRESSION; IMMUNE-RESPONSES; INFLUENZA-VIRUS; CD8(+); ACTIVATION; MOUSE; IMMATURE; CD4(+)	The importance of conventional dendritic cells (cDCs) in the processing and presentation of antigen is well established, but the contribution of plasmacytoid dendritic cells (pDCs) to these processes, and hence to T cell immunity, remains unclear. Here we showed that unlike cDCs, pDCs continued to synthesize major histocompatibility complex (MHC) class II molecules and the MHC class II ubiquitin ligase MARCH1 long after activation. Sustained MHC class II-peptide complex formation, ubiquitination and turnover rendered pDCs inefficient in the presentation of exogenous antigens but enabled pDCs to continuously present endogenous viral antigens in their activated state. As the antigen-presenting abilities of cDCs and pDCs are fundamentally distinct, these two cell types may activate largely nonoverlapping repertoires of CD4(+) T cells.	[Young, Louise J.; Wilson, Nicholas S.; Schnorrer, Petra; Proietto, Anna; Mount, Adele M.; Belz, Gabrielle T.; O'Keeffe, Meredith; Heath, William R.; Shortman, Ken; Villadangos, Jose A.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Young, Louise J.; Wilson, Nicholas S.; Proietto, Anna; Mount, Adele M.; Heath, William R.; Villadangos, Jose A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Wilson, Nicholas S.; Belz, Gabrielle T.; Heath, William R.; Villadangos, Jose A.] Cooperat Res Ctr Vaccine Technol, Parkville, Vic 3050, Australia; [ten Broeke, Toine; Stoorvogel, Willem] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; [Matsuki, Yohei; Ohmura-Hoshino, Mari; Ishido, Satoshi] RIKEN, Res Ctr Allergy & Immunol, Lab Infect Immun, Kanagawa 2300045, Japan	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Utrecht University; RIKEN	Villadangos, JA (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	villadangos@wehi.edu.au	O'Keeffe, Meredith/U-9347-2017; Villadangos, Jose A/AAU-1404-2020; Belz, Gabrielle T/C-9350-2013	O'Keeffe, Meredith/0000-0002-0779-4654; Villadangos, Jose A/0000-0001-6771-8891; Belz, Gabrielle T/0000-0002-9660-9587; Heath, William/0000-0001-9670-259X	National Health and Medical Research Council of Australia; Anti-Cancer Council of Australia; Gottlieb Daimler and Karl Benz Foundation; Wellcome Trust; Howard Hughes Medical Institute; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; University of Melbourne; Leukemia and Lymphoma Society	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Anti-Cancer Council of Australia(Cancer Council AustraliaCanadian Institutes of Health Research (CIHR)Cancer Council Victoria); Gottlieb Daimler and Karl Benz Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Melbourne(University of Melbourne); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	We thank E. Unanue (Washington University) and R. Gugasyan (the Walter and Eliza Hall Institute) for antibody Aw3.18; M. Jenkins (University of Minnesota Medical School) for act- mOVA mice; E. Maraskovsky (CSL) for Alexa Fluor 488 - conjugated OVA; L. Brown (University of Melbourne, Australia) for the influenza strain A/PR/8/34; P. Benaroch for sharing unpublished information and critically reading the manuscript; and D. John, F. Kupresanin and all members of the Flow Cytometry and Animal Services facilities at The Walter and Eliza Hall Institute of Medical Research for technical assistance. Supported by the National Health and Medical Research Council of Australia (G.T.B., W.R.H. and J.A.V.), the Anti-Cancer Council of Australia (J.A.V.), the Gottlieb Daimler and Karl Benz Foundation (P.S.), the Wellcome Trust (G.T.B.), the Howard Hughes Medical Institute (G.T.B. and W. R. H.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.I.), the Japan Society for the Promotion of Science (S.I.), the University of Melbourne (L.J.Y., N.S.W. and A.M.M.) and the Leukemia and Lymphoma Society J.A.V.).	Alfonso C, 2001, J IMMUNOL, V167, P6348, DOI 10.4049/jimmunol.167.11.6348; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Barois N, 1997, J BIOL CHEM, V272, P3641, DOI 10.1074/jbc.272.6.3641; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; El-Sukkari D, 2003, J IMMUNOL, V171, P5003, DOI 10.4049/jimmunol.171.10.5003; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Morgan DJ, 1996, J IMMUNOL, V157, P978; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2005, BLOOD, V106, P3457, DOI 10.1182/blood-2004-12-4965; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Young LJ, 2007, P NATL ACAD SCI USA, V104, P17753, DOI 10.1073/pnas.0708622104; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	45	177	183	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1244	1252		10.1038/ni.1665	http://dx.doi.org/10.1038/ni.1665			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18849989				2022-12-18	WOS:000260248600011
J	Qiao, XG; He, B; Chiu, A; Knowles, DM; Chadburn, A; Cerutti, A				Qiao, XG; He, B; Chiu, A; Knowles, DM; Chadburn, A; Cerutti, A			Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; T-CELLS; HIV-1; PROTEIN; ACTIVATION; MECHANISM; ANTIGEN; VIRUS; PHOSPHORYLATION	Immunoglobulin class switching from immunoglobulin M (IgM) to IgG and IgA is central to immunity against viruses and requires the activation of B cells by T cells via CD154 (CD40 ligand) and cytokines. These molecules limit their signaling activity in immune cells by turning on negative feedback proteins, including I kappa B and SOCS. We show here that negative factor (Nef) protein, an immunosuppressive human immunodeficiency virus 1 protein expressed and released by infected cells, penetrates B cells both in vivo and in vitro. Nef suppressed immunoglobulin class-switch DNA recombination by inducing I kappa B alpha and SOCS proteins, which blocked CD154 and cytokine signaling via NF-kappa B and STAT transcription factors. Thus, human immunodeficiency virus 1 may evade protective T cell-dependent IgG and IgA responses by 'hijacking' physiological feedback inhibitors in B cells via Nef.	Cornell Univ, Dept Pathol & Lab Med, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Grad Program Immunol Microbial Pathogenesis, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Cerutti, A (corresponding author), Cornell Univ, Dept Pathol & Lab Med, Weill Med Coll, New York, NY 10021 USA.	acerutti@med.cornell.edu		Cerutti, Andrea/0000-0003-3026-4704	NIAID NIH HHS [R01 AI074378, AI057530, AI057653, R01 AI057653, R21 AI057130] Funding Source: Medline; NIAMS NIH HHS [R01 AR047872] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057530, R01AI074378, R01AI057653, R21AI057130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047872] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; James CO, 2004, J VIROL, V78, P3099, DOI 10.1128/JVI.78.6.3099-3109.2004; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kuster H, 2000, AM J PATHOL, V156, P1973, DOI 10.1016/S0002-9440(10)65070-5; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lee SB, 2005, J CELL SCI, V118, P1851, DOI 10.1242/jcs.02312; Lefevre EA, 1999, J IMMUNOL, V163, P1119; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; Peng B, 2001, IMMUNOL LETT, V78, P195, DOI 10.1016/S0165-2478(01)00250-4; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Quaranta MG, 2002, EXP CELL RES, V275, P243, DOI 10.1006/excr.2002.5497; Ravanel K, 1997, J EXP MED, V186, P269, DOI 10.1084/jem.186.2.269; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	50	177	188	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					302	310		10.1038/ni1302	http://dx.doi.org/10.1038/ni1302			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16429138				2022-12-18	WOS:000235360400015
J	Schwartz, RH				Schwartz, RH			Natural regulatory T cells and self-tolerance	NATURE IMMUNOLOGY			English	Article							RECEPTOR-ALPHA-CHAINS; CLONAL DELETION; IN-VIVO; NEGATIVE SELECTION; B-CELLS; EXPRESSION; THYMUS; ELIMINATION; LYMPHOCYTES; INDUCTION	The adaptive immune system allows individual organisms to mount defensive reactions against unanticipated pathogens by developmentally creating a diverse repertoire of clonally distributed receptors capable of recognizing a multitude of antigens and then expanding as effector cell populations those that can recognize molecules from the pathogens. To function properly, the system must deal with the problem of randomly generated receptors that can recognize self components. Most solutions to this self-tolerance problem are cell intrinsic and involve the deletion or inactivation of autoreactive cells. However, an extrinsic form of dominant tolerance has been demonstrated that takes the form of CD4(+) regulatory T cells. This perspective discusses why such a mechanism might have evolved and the problems it presents for self-non-self discrimination.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schwartz, RH (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	rschwartz@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000485, ZIAAI000485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alpan O, 2004, NAT IMMUNOL, V5, P615, DOI 10.1038/ni1077; ANDERSON D, 1951, HEREDITY, V5, P379, DOI 10.1038/hdy.1951.38; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BILLINGHAM RE, 1956, PHILOS T R SOC B, V239, P357, DOI 10.1098/rstb.1956.0006; BOYSE EA, 1973, NATURE, V244, P441, DOI 10.1038/244441a0; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caveno J, 1999, J IMMUNOL, V163, P1222; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ehrlich P, 1900, COLLECTED PAPERS P E, V37, p[453, 205]; EMERY D, 1980, TRANSPLANTATION, V29, P4, DOI 10.1097/00007890-198001000-00002; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; Modigliani Y, 1996, IMMUNOL REV, V149, P155, DOI 10.1111/j.1600-065X.1996.tb00903.x; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; ROBERTSON K, 1992, EUR J IMMUNOL, V22, P207, DOI 10.1002/eji.1830220130; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tanchot C, 2004, J IMMUNOL, V172, P4285, DOI 10.4049/jimmunol.172.7.4285; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83	59	177	195	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					327	330		10.1038/ni1184	http://dx.doi.org/10.1038/ni1184			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785757				2022-12-18	WOS:000227860000002
J	Manoury, B; Mazzeo, D; Fugger, L; Viner, N; Ponsford, M; Streeter, H; Mazza, G; Wraith, DC; Watts, C				Manoury, B; Mazzeo, D; Fugger, L; Viner, N; Ponsford, M; Streeter, H; Mazza, G; Wraith, DC; Watts, C			Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS PATIENTS; ALTERED PEPTIDE LIGAND; CLASS-II MOLECULES; ANTIGEN; MHC; RECOGNITION; BINDING; TOLERANCE; ENCEPHALOMYELITIS	Little is known about the processing of putative human autoantigens and why tolerance is established to some T cell epitopes but not others. Here we show that a principal human HLA-DR2-restricted epitope-amino acids 85-99 of myelin basic protein, MBP(85-99)-contains a processing site for the cysteine protease asparagine endopeptidase (AEP). Presentation of this epitope by human antigen-presenting cells is inversely proportional to the amount of cellular AEP activity: inhibition of AEP in living cells greatly enhances presentation of the MBP(85-99) epitope, whereas overexpression of AEP diminishes presentation. These results indicate that central tolerance to this encephalitogenic MBP epitope may not be established because destructive processing limits its display in the thymus. Consistent with this hypothesis, AEP is expressed abundantly in thymic antigen-presenting cells.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol, Dundee DD1 5EH, Scotland; Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8200 Aarhus, Denmark; Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England	University of Dundee; Aarhus University; University of Bristol	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol, Dundee DD1 5EH, Scotland.			Manoury, Benedicte/0000-0001-7784-3389; Wraith, David/0000-0003-2147-5614; Watts, Colin/0000-0001-6183-2087				Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderton S, 1999, IMMUNOL REV, V169, P123, DOI 10.1111/j.1600-065X.1999.tb01311.x; Anderton SM, 2001, J EXP MED, V193, P1, DOI 10.1084/jem.193.1.1; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Bates IR, 2000, PROTEIN EXPRES PURIF, V20, P285, DOI 10.1006/prep.2000.1307; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; DAVIDSON HW, 1990, J IMMUNOL, V144, P4101; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Heath VL, 1998, J AUTOIMMUN, V11, P309, DOI 10.1006/jaut.1998.0210; Hewitt EW, 1997, J IMMUNOL, V159, P4693; JARAQUEMADA D, 1990, J IMMUNOL, V145, P2880; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kissler S, 2001, J AUTOIMMUN, V16, P303, DOI 10.1006/jaut.2000.0498; Knight AM, 1997, EMBO J, V16, P3842, DOI 10.1093/emboj/16.13.3842; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MARTENSON RE, 1975, J IMMUNOL, V114, P592; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; MARTIN R, 1990, J IMMUNOL, V145, P540; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; McAdam SN, 2001, J EXP MED, V193, P1239, DOI 10.1084/jem.193.11.1239; Moudgil K D, 2000, Rev Immunogenet, V2, P26; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Ridsdale RA, 1997, J BIOL CHEM, V272, P4269, DOI 10.1074/jbc.272.7.4269; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; Vergelli M, 1997, J NEUROIMMUNOL, V77, P195, DOI 10.1016/S0165-5728(97)00075-1; Volkmann A, 1997, J IMMUNOL, V158, P693; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	41	177	179	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					169	174		10.1038/ni754	http://dx.doi.org/10.1038/ni754			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812994				2022-12-18	WOS:000173562400017
J	Herblot, S; Steff, AM; Hugo, P; Aplan, PD; Hoang, T				Herblot, S; Steff, AM; Hugo, P; Aplan, PD; Hoang, T			SCL and LMOI alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR SCL; CELL DEVELOPMENT; TRANSGENIC MICE; LYMPHOCYTE DEVELOPMENT; B-LYMPHOCYTE; PROTEIN LMO2; GENE; E2A; ENHANCER	Cooperation between the stem cell leukemia (SCL) transcription factor and its nuclear partners LMO1 or LMO2 induces aggressive T cell acute lymphoblastic leukemia when inappropriately expressed in T cells. This study examined the cellular and molecular targets of the SCL-LMO complex at the preleukemic stage. We show that SCL and its partners are coexpressed in the most primitive thymocytes. Maturation to the pre-T cell stage is associated with a down-regulation of SCL and LMO1 and LMO2, and a concomitant up-regulation of E2A and HEB expression. Moreover, enforced expression of SCL-LMO1 inhibits T cell differentiation and recapitulates a loss of HEB function, causing a deregulation of the transition checkpoint from the CD4(-)CD8(-) to CD4(+)CD8(+) stages. Finally, we identify the gene encoding pT alpha as a downstream target of HEB that is specifically repressed by the SCL-LMO complex.	Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Procrea Biosci Inc, Montreal, PQ H4P 2R2, Canada; NCI, Dept Genet, Med Branch, Div Clin Sci, Gaithersburg, MD 20877 USA; Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Program Mol Biol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universite de Montreal; Universite de Montreal; Universite de Montreal	Hoang, T (corresponding author), Clin Res Inst Montreal, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	hoangt@ircm.qc.ca	Aplan, Peter D/K-9064-2016	Steff, Ann-Muriel/0000-0002-9817-6164				Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Barndt R, 1999, J IMMUNOL, V163, P3331; Begley CG, 1999, BLOOD, V93, P2760; Blom B, 1999, EMBO J, V18, P2793, DOI 10.1093/emboj/18.10.2793; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Chervinsky DS, 1999, MOL CELL BIOL, V19, P5025; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Condorelli GL, 1996, CANCER RES, V56, P5113; DONG WF, 1995, LEUKEMIA, V9, P1812; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; HAWLEY RG, 1994, GENE THER, V1, P136; Henning SW, 1998, J EXP MED, V188, P931, DOI 10.1084/jem.188.5.931; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; HSU HL, 1994, P NATL ACAD SCI USA, V91, P3181, DOI 10.1073/pnas.91.8.3181; HUGO P, 1991, INT IMMUNOL, V3, P265, DOI 10.1093/intimm/3.3.265; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Keller JH, 1996, PLASMA SOURCES SCI T, V5, P166, DOI 10.1088/0963-0252/5/2/008; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Kim D, 1999, MOL CELL BIOL, V19, P8240; Krosl G, 1998, J EXP MED, V188, P439, DOI 10.1084/jem.188.3.439; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; MCGUIRE EA, 1992, MOL CELL BIOL, V12, P4186, DOI 10.1128/MCB.12.9.4186; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; MOUTHON MA, 1993, BLOOD, V81, P647; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Smith KS, 1999, MOL CELL BIOL, V19, P4443; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	50	177	178	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					138	144		10.1038/77819	http://dx.doi.org/10.1038/77819			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248806				2022-12-18	WOS:000089814900014
J	Sun, DX; Ding, AH				Sun, DX; Ding, AH			MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENTS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; DOMAIN-CONTAINING ADAPTER; NITRIC-OXIDE SYNTHASE-2; IFN-REGULATORY FACTOR-3; PROTEIN-KINASE P38; MAP KINASE; SIGNALING PATHWAYS; BINDING PROTEIN	The MyD88 adaptor protein is critical in Toll-like receptor and interleukin 1 receptor (IL-1R) signaling, but has not been linked to interferon-gamma receptor (IFN-gamma R) signaling. Here we demonstrate that MyD88 increased the half-life but not the synthesis of IFN-gamma-induced mRNA transcripts encoding tumor necrosis factor and IFN-gamma-inducible protein 10. IFN-gamma stimulation triggered a physical association between the IFN-gamma R1 and MyD88. Transcript stabilization required activation of mixed-lineage kinase 3 and p38 mitogen-activated protein kinase and the presence of an adenine-uridine-rich element in the transcript's 3' untranslated region. These results demonstrate a MyD88-dependent post-transcriptional mechanism through which IFN-gamma can enhance the expression of genes encoding proinflammatory molecules.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Ding, AH (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	ahding@med.cornell.edu			NIAID NIH HHS [AI30165] Funding Source: Medline; NIGMS NIH HHS [GM61710] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030165, R29AI030165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta S, 2004, J IMMUNOL, V173, P2755, DOI 10.4049/jimmunol.173.4.2755; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gingerich Timothy J., 2004, Animal Health Research Reviews, V5, P49, DOI [10.1079/AHR200460, 10.1079/AHRR200460]; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Gouble A, 2002, CANCER RES, V62, P1489; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lam LT, 2001, GENOME BIOL, V2; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	56	176	183	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					375	381		10.1038/ni1308	http://dx.doi.org/10.1038/ni1308			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16491077				2022-12-18	WOS:000236171000011
J	Shih, TAY; Roederer, M; Nussenzweig, MC				Shih, TAY; Roederer, M; Nussenzweig, MC			Role of antigen receptor affinity in T cell-independent antibody responses in vivo	NATURE IMMUNOLOGY			English	Article							SIGNAL-TRANSDUCTION MOLECULE; GERMINAL CENTER FORMATION; LYN-DEFICIENT MICE; HEAVY-CHAIN GENE; B-CELL; IMMUNE-RESPONSE; PNEUMOCOCCAL POLYSACCHARIDE; C57BL-6 MICE; MOUSE; CD19	To examine how B cell receptor affinity affects clonal selection in thymus-independent type 2 (T1-2) immune responses, we produced mice with antibodies that showed a 40-fold difference in affinity for the hapten (4-hydroxy-3-nitrophenyl) acetyl (NP). The difference in the responses of high- and low-affinity B cells to NP-Ficoll was only twofold. However, in competition experiments only the high-affinity B cells responded to antigen. CD19 deficiency increased the affinity threshold of T1-2 responses, whereas Lyn deficiency enhanced clonal expansion but abrogated B cell terminal differentiation. Thus, in T1-2 immune responses, large differences in affinity produce only small differences in the intrinsic ability of B cells to respond to antigen, and selection for high- affinity clones is due to clonal competition during the earliest stages of the response.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; National Institutes of Health (NIH) - USA; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019; Roederer, Mario/G-1887-2011		NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; BAKER PJ, 1971, J IMMUNOL, V107, P719; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P1314; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fehr T, 1998, J EXP MED, V188, P145, DOI 10.1084/jem.188.1.145; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HAN S, 1996, SCIENCE, V274, P2097; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HUMPHREY JH, 1981, EUR J IMMUNOL, V11, P212, DOI 10.1002/eji.1830110310; JACK RS, 1977, EUR J IMMUNOL, V7, P559, DOI 10.1002/eji.1830070813; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JERNE N K, 1951, Acta Pathol Microbiol Scand Suppl, V87, P1; Kato J, 1998, J IMMUNOL, V160, P4788; KLAUS GGB, 1974, EUR J IMMUNOL, V4, P370, DOI 10.1002/eji.1830040513; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROEDERER M, 1999, CONJUGATION MONOCLON; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Watanabe D, 1995, INT IMMUNOL, V7, P1949, DOI 10.1093/intimm/7.12.1949	56	176	180	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					399	406		10.1038/ni776	http://dx.doi.org/10.1038/ni776			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11896394				2022-12-18	WOS:000174623600022
J	Moser, JM; Gibbs, J; Jensen, PE; Lukacher, AE				Moser, JM; Gibbs, J; Jensen, PE; Lukacher, AE			CD94-NKG2A receptors regulate antiviral CD8+T cell responses	NATURE IMMUNOLOGY			English	Article							CD8(+) T-CELLS; POLYOMA-VIRUS; INHIBITORY RECEPTORS; VIRAL PERSISTENCE; MOLECULE QA-1(B); TUMOR-INDUCTION; KIR EXPRESSION; MIDDLE-T; IN-VIVO; LYMPHOCYTES	CD8(+) T lymphocytes mediate immunosurveillance against persistent virus infections and virus-induced neoplasia. Polyoma virus, a highly oncogenic natural mouse DNA virus, establishes persistent infection, but only a few mice are highly susceptible to tumors induced by the virus. Mature antiviral CD8(+) T cells expand in tumor-susceptible mice, but their cytotoxic effector activity is nonfunctional in vivo. Here we show that the natural killer cell inhibitory receptor, CD94-NKG2A, is up-regulated by antiviral CD8(+) T cells during acute polyoma infection and is responsible for down-regulating their antigen-specific cytotoxicity during both viral clearance and virus-induced oncogenesis.	Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lukacher, AE (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000814, Z01AI000814] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad A, 2000, J VIROL, V74, P7196, DOI 10.1128/JVI.74.16.7196-7203.2000; Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000; Bergmann CC, 1999, J IMMUNOL, V163, P3379; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brawand P, 2000, J IMMUNOL, V165, P1871, DOI 10.4049/jimmunol.165.4.1871; Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Chun T, 1998, IMMUNOLOGY, V94, P64; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; DeMaria A, 1997, P NATL ACAD SCI USA, V94, P10285, DOI 10.1073/pnas.94.19.10285; Deng YP, 1997, J IMMUNOL, V158, P1507; Drake DR, 1998, VIROLOGY, V252, P275, DOI 10.1006/viro.1998.9455; FREUND R, 1992, VIROLOGY, V191, P716, DOI 10.1016/0042-6822(92)90247-M; GROSS L, 1983, ONCOGENIC VIRUSES, P737; Huard B, 2000, NATURE, V403, P325, DOI 10.1038/35002105; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Lukacher AE, 1999, J IMMUNOL, V163, P3369; LUKACHER AE, 1995, J EXP MED, V181, P1683, DOI 10.1084/jem.181.5.1683; Lukacher AE, 1998, J IMMUNOL, V160, P1724; LUKACHER AE, 1993, VIROLOGY, V196, P241, DOI 10.1006/viro.1993.1472; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; Moser JM, 2001, J EXP MED, V193, P595, DOI 10.1084/jem.193.5.595; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Roger J, 2001, J IMMUNOL, V167, P6, DOI 10.4049/jimmunol.167.1.6; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; TRANSY C, 1987, J EXP MED, V166, P341, DOI 10.1084/jem.166.2.341; Ugolini S, 2001, NAT IMMUNOL, V2, P430, DOI 10.1038/87740; Ugolini S, 2000, CURR OPIN IMMUNOL, V12, P295, DOI 10.1016/S0952-7915(00)00090-X; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Vetter CS, 2000, J INVEST DERMATOL, V114, P941, DOI 10.1046/j.1523-1747.2000.00958.x; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19; Wirth JJ, 1997, J VIROL, V71, P1072, DOI 10.1128/JVI.71.2.1072-1078.1997; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Zajac AJ, 1999, J IMMUNOL, V163, P5526	47	176	186	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					189	195		10.1038/ni757	http://dx.doi.org/10.1038/ni757			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812997				2022-12-18	WOS:000173562400020
J	Sunyer, JO				Sunyer, J. Oriol			Fishing for mammalian paradigms in the teleost immune system	NATURE IMMUNOLOGY			English	Article							TROUT ONCORHYNCHUS-MYKISS; PHAGOCYTIC B-CELLS; RAINBOW-TROUT; ANTIBODY REPERTOIRE; PERITONEAL-CAVITY; ADAPTIVE IMMUNITY; CHANNEL CATFISH; DENDRITIC CELLS; INNATE IMMUNITY; LAMINA PROPRIA	Recent years have witnessed a renaissance in the study of fish immune systems. Such studies have greatly expanded the knowledge of the evolution and diversification of vertebrate immune systems. Several findings in those studies have overturned old paradigms about the immune system and led to the discovery of novel aspects of mammalian immunity. Here I focus on how findings pertaining to immunity in teleost (bony) fish have led to major new insights about mammalian B cell function in innate and adaptive immunity. Additionally, illustrate how the discovery of the most ancient mucosal immunoglobulin described thus far will help resolve unsettled paradigms of mammalian mucosal immunity.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Sunyer, JO (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	sunyer@vet.upenn.edu			National Science Foundation [NSF-MCB-0719599]; US National Institutes of Health [R01GM085207-01]; US Department of Agriculture [USDA-NRI 2006-01619, USDA-NRI 2007-01719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085207] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank L. King and D. Parra for critical reading and editing of the manuscript. Supported by the National Science Foundation (NSF-MCB-0719599), the US National Institutes of Health (R01GM085207-01), the US Department of Agriculture (USDA-NRI 2006-01619 and USDA-NRI 2007-01719).	Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Cain KD, 2002, DEV COMP IMMUNOL, V26, P181, DOI 10.1016/S0145-305X(01)00063-5; Cain KD, 2000, FISH SHELLFISH IMMUN, V10, P651, DOI 10.1006/fsim.2000.0280; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Edholm ES, 2011, DEV COMP IMMUNOL, V35, P1309, DOI 10.1016/j.dci.2011.03.002; Edholm ES, 2010, J IMMUNOL, V185, P4082, DOI 10.4049/jimmunol.1000631; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Gao JX, 2012, EUR J IMMUNOL, V42, P982, DOI 10.1002/eji.201141519; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hastings WD, 2006, EUR J IMMUNOL, V36, P1114, DOI 10.1002/eji.200535142; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Herzenberg L. A., 1992, ANN N Y ACAD SCI, V651, P1, DOI 10.1111/j.1749-6632.1992.tb24588.x; Hoehlig K, 2008, ADV IMMUNOL, V98, P1, DOI 10.1016/S0065-2776(08)00401-X; Hoffmann J, 2007, NAT IMMUNOL, V8, P543, DOI 10.1038/ni0607-543; Itakura A, 2005, J IMMUNOL, V175, P7170, DOI 10.4049/jimmunol.175.11.7170; Kaattari S, 1998, IMMUNOL REV, V166, P133, DOI 10.1111/j.1600-065X.1998.tb01258.x; Kaattari SL, 2002, DEV COMP IMMUNOL, V26, P191, DOI 10.1016/S0145-305X(01)00064-7; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Litman GW, 2007, NAT IMMUNOL, V8, P547, DOI 10.1038/ni0607-547; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Maki JL, 2003, CLIN DIAGN LAB IMMUN, V10, P876, DOI 10.1128/CDLI.10.5.876-881.2003; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Neumann NF, 2001, DEV COMP IMMUNOL, V25, P807, DOI 10.1016/S0145-305X(01)00037-4; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramirez-Gomez F, 2012, J IMMUNOL, V188, P1341, DOI 10.4049/jimmunol.1101938; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Saunders HL, 2010, DEV COMP IMMUNOL, V34, P669, DOI 10.1016/j.dci.2010.01.013; Solem ST, 2006, DEV COMP IMMUNOL, V30, P57, DOI 10.1016/j.dci.2005.06.007; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Sunyer JO, 2011, DEV COMP IMMUNOL, V35, P1193, DOI 10.1016/j.dci.2011.09.006; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; Vasta GR, 2011, DEV COMP IMMUNOL, V35, P1388, DOI 10.1016/j.dci.2011.08.011; Viau M, 2005, CLIN IMMUNOL, V114, P17, DOI 10.1016/j.clim.2004.08.019; Warr GW, 1997, DEV BIOLOGICALS, V90, P15; Wu Y, 2009, J IMMUNOL, V183, P5622, DOI 10.4049/jimmunol.0901772; Ye JM, 2011, DEV COMP IMMUNOL, V35, P1273, DOI 10.1016/j.dci.2011.03.005; Ye JM, 2010, J IMMUNOL, V184, P844, DOI 10.4049/jimmunol.0902364; Yoder JA, 2011, IMMUNOGENETICS, V63, P123, DOI 10.1007/s00251-010-0506-4; Zapata A, 2000, CURR TOP MICROBIOL, V248, P67; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002; Zimmerman LM, 2010, BIOL LETTERS, V6, P270, DOI 10.1098/rsbl.2009.0692	73	175	180	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					320	326		10.1038/ni.2549	http://dx.doi.org/10.1038/ni.2549			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23507645	Green Accepted			2022-12-18	WOS:000316648700006
J	Reis, BS; Rogoz, A; Costa-Pinto, FA; Taniuchi, I; Mucida, D				Reis, Bernardo Sgarbi; Rogoz, Aneta; Costa-Pinto, Frederico Azevedo; Taniuchi, Ichiro; Mucida, Daniel			Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity	NATURE IMMUNOLOGY			English	Article							RETINOIC ACID; TGF-BETA; INTRAEPITHELIAL LYMPHOCYTES; HELPER 17; DIFFERENTIATION; LINEAGE; T(H)17; INFLAMMATION; REPRESSION; REACTIVITY	The gut mucosa hosts large numbers of activated lymphocytes that are exposed to stimuli from the diet, microbiota and pathogens. Although CD4(+) T cells are crucial for defense, intestinal homeostasis precludes exaggerated responses to luminal contents, whether they are harmful or not. We investigated mechanisms used by CD4(+) T cells to avoid excessive activation in the intestine. Using genetic tools to label and interfere with T cell development transcription factors, we found that CD4(+) T cells acquired the CD8-lineage transcription factor Runx3 and lost the CD4-lineage transcription factor ThPOK and their differentiation into the T(H)17 subset of helper T cells and colitogenic potential, in a manner dependent on transforming growth factor-beta (TGF-beta) and retinoic acid. Our results demonstrate considerable plasticity in the CD4(+) T cell lineage that allows chronic exposure to luminal antigens without pathological inflammation.	[Reis, Bernardo Sgarbi; Rogoz, Aneta; Costa-Pinto, Frederico Azevedo; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10021 USA; [Costa-Pinto, Frederico Azevedo] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Taniuchi, Ichiro] RIKEN Res Ctr Allergy & Immunol, Lab Transcript Regulat, Yokohama, Kanagawa, Japan	Rockefeller University; Universidade de Sao Paulo; RIKEN	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.	mucida@rockefeller.edu	Costa-Pinto, Frederico/F-7571-2010; Taniuchi, Ichiro/N-6399-2015; Reis, Bernardo S/E-3448-2012	Costa-Pinto, Frederico/0000-0003-1135-2354; Taniuchi, Ichiro/0000-0002-9853-9068; Reis, Bernardo S/0000-0002-6841-116X; Mucida, Daniel/0000-0002-0000-0452	Ellison Medical Foundation; Irma T. Hirschl Trust; Crohn's & Colitis Foundation of America; US National Institutes of Health [R01 DK093674-01]; Leona M. and Harry B. Helmsley Charitable Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093674] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Irma T. Hirschl Trust; Crohn's & Colitis Foundation of America; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Velinzon and Y. Shatalina for sorting cells; members of the Nussenzweig, Steinman, Marraffini and Tavazoie laboratories and employees of the The Rockefeller University for assistance; R. Noelle (Dartmouth University) for dnRara<SUP>lsl/Isl</SUP> mice; D. Littman (New York University) for Runx3-YFP mice; L. Glimcher (Cornell University) for Tbx21 vectors; and L. Marraffini, S. Tavazoie, G. Kim, M. Kronenberg, H. Cheroutre and members of the Mucida laboratory, particularly L. Feighery, for discussions and critical reading and editing of the manuscript. Supported by the Ellison Medical Foundation (D.M.), the Irma T. Hirschl Trust (D.M.), the Crohn's & Colitis Foundation of America (D.M.), the US National Institutes of Health (R01 DK093674-01 to D.M.), the Leona M. and Harry B. Helmsley Charitable Trust (D.M.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (F.A.C.-P.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (F.A.C.-P.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D., 2013, NAT IMMUNOL, DOI [10.1038/ni2523, DOI 10.1038/NI2523]; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Mucida D, 2009, SEMIN IMMUNOL, V21, P14, DOI 10.1016/j.smim.2008.08.001; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ono Y, 2012, GASTROENTEROLOGY, V143, P1288, DOI 10.1053/j.gastro.2012.07.108; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shi MJ, 1998, J IMMUNOL, V161, P6751; Sujino T, 2011, GASTROENTEROLOGY, V141, P1014, DOI 10.1053/j.gastro.2011.05.052; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	42	175	180	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					271	280		10.1038/ni.2518	http://dx.doi.org/10.1038/ni.2518			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23334789	Green Accepted			2022-12-18	WOS:000315065400017
J	Lazarevic, V; Glimcher, LH				Lazarevic, Vanja; Glimcher, Laurie H.			T-bet in disease	NATURE IMMUNOLOGY			English	Review							COLLAGEN-INDUCED ARTHRITIS; IFN-GAMMA PRODUCTION; TRANSCRIPTION-FACTOR; INTERFERON-GAMMA; CELL-DIFFERENTIATION; MULTIPLE-SCLEROSIS; TGF-BETA; LISTERIA-MONOCYTOGENES; ALLOGRAFT-REJECTION; MONONUCLEAR-CELLS	The activation of immune-defense mechanisms in response to a microbial attack must be robust and appropriately tailored to fight particular types of pathogens. Infection with intracellular microorganisms elicits a type 1 inflammatory response characterized by mobilization of T helper type 1 (T(H)1) cells to the site of infection, where they are responsible for the recruitment and activation of macrophages. At the center of the type 1 inflammatory response is the transcription factor T-bet, a critical regulator of the T(H)1 differentiation program. T-bet induces the production of interferon-gamma ( IFN-gamma) and orchestrates the T(H)1 cell-migratory program by regulating the expression of chemokines and chemokine receptors. However, tight regulation of the type 1 inflammatory response is essential for the prevention of immunopathology and the development of organ-specific autoimmunity. In this review, we discuss how T-bet expression drives autoaggressive and inflammatory processes and how its function in vivo must be delicately balanced to avoid disease.	[Lazarevic, Vanja; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard & MIT, Ragon Inst MGH, Boston, MA USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Lazarevic, Vanja/B-1160-2009	Lazarevic, Vanja/0000-0002-5783-7130	US National Institutes of Health [P01 NS038037, CA112663]; Danone Group; Cancer Research Institute; NATIONAL CANCER INSTITUTE [ZIABC011431, R01CA112663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danone Group(Danone Nutricia); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the US National Institutes of Health (P01 NS038037 and CA112663 to L. H. G.), the Danone Group and the Cancer Research Institute (V.L.).	Abromson-Leeman S, 2009, J NEUROIMMUNOL, V215, P10, DOI 10.1016/j.jneuroim.2009.07.007; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bending D, 2011, J IMMUNOL, V186, P3373, DOI 10.4049/jimmunol.1003216; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Burrell BE, 2008, J IMMUNOL, V181, P3906, DOI 10.4049/jimmunol.181.6.3906; CANNON GW, 1989, ARTHRITIS RHEUM, V32, P964, DOI 10.1002/anr.1780320805; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Drulovic J, 2009, J NEUROIMMUNOL, V215, P90, DOI 10.1016/j.jneuroim.2009.07.010; Durrant DM, 2009, J IMMUNOL, V183, P5293, DOI 10.4049/jimmunol.0803109; Esensten JH, 2009, J IMMUNOL, V183, P75, DOI 10.4049/jimmunol.0804154; Ferber IA, 1996, J IMMUNOL, V156, P5; Finotto S, 2005, INT IMMUNOL, V17, P993, DOI 10.1093/intimm/dxh281; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frisullo G, 2007, CLIN IMMUNOL, V124, P284, DOI 10.1016/j.clim.2007.05.011; Frisullo G, 2006, J NEUROSCI RES, V84, P1027, DOI 10.1002/jnr.20995; Furuta S, 2008, J IMMUNOL, V180, P6656, DOI 10.4049/jimmunol.180.10.6656; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gerth AJ, 2003, INT IMMUNOL, V15, P937, DOI 10.1093/intimm/dxg093; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Guo SQ, 2009, J IMMUNOL, V182, P6179, DOI 10.4049/jimmunol.0803821; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; Hultgren OH, 2004, MICROBES INFECT, V6, P529, DOI 10.1016/j.micinf.2004.02.005; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kiwamoto T, 2006, AM J RESP CRIT CARE, V174, P142, DOI 10.1164/rccm.200601-079OC; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Munthe-Kaas MC, 2008, J ALLERGY CLIN IMMUN, V121, P51, DOI 10.1016/j.jaci.2007.07.068; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Nos C, 2004, MULT SCLER J, V10, P413, DOI 10.1191/1352458504ms1068oa; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Plevy SE, 1997, J IMMUNOL, V159, P6276; Raby BA, 2006, AM J RESP CRIT CARE, V173, P64, DOI 10.1164/rccm.200503-505OC; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ravindran R, 2005, J IMMUNOL, V175, P4603, DOI 10.4049/jimmunol.175.7.4603; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; Sasaki Y, 2004, HUM GENET, V115, P177, DOI 10.1007/s00439-004-1146-2; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Skurkovich S, 2001, MULT SCLER, V7, P277, DOI 10.1177/135245850100700502; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; TARGAN SR, 1995, J IMMUNOL, V154, P664; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vermeire K, 1997, J IMMUNOL, V158, P5507; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Way SS, 2004, J IMMUNOL, V173, P5918, DOI 10.4049/jimmunol.173.10.5918; Werneck MBF, 2008, J IMMUNOL, V180, P8004, DOI 10.4049/jimmunol.180.12.8004; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yuan XL, 2008, J EXP MED, V205, P3133, DOI 10.1084/jem.20081937; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	120	175	187	1	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					597	606		10.1038/ni.2059	http://dx.doi.org/10.1038/ni.2059			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685955	Green Accepted			2022-12-18	WOS:000291936400007
J	Hinterberger, M; Aichinger, M; da Costa, OP; Voehringer, D; Hoffmann, R; Klein, L				Hinterberger, Maria; Aichinger, Martin; da Costa, Olivia Prazeres; Voehringer, David; Hoffmann, Reinhard; Klein, Ludger			Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance	NATURE IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; DENDRITIC CELLS; SELF-TOLERANCE; RNA INTERFERENCE; ANTIGEN; SELECTION; THYMOCYTES; CIITA; MICROENVIRONMENT; DIFFERENTIATION	Medullary thymic epithelial cells (mTECs) serve an essential function in central tolerance by expressing peripheral-tissue antigens. These antigens may be transferred to and presented by dendritic cells (DCs). Therefore, it is unclear whether mTECs, in addition to being an antigen reservoir, also serve a mandatory function as antigen-presenting cells. Here we diminished major histocompatibility complex (MHC) class II on mTECs through transgenic expression of a 'designer' microRNA specific for the MHC class II transactivator CIITA (called 'C2TA' here). This resulted in an enlarged polyclonal CD4(+) single-positive compartment and, among thymocytes specific for model antigens expressed in mTECs, enhanced selection of regulatory T cells (T-reg cells) at the expense of deletion. Our data document an autonomous contribution of mTECs to both dominant and recessive mechanisms of CD4(+) T cell tolerance and support an avidity model of T-reg cell development versus deletion.	[Hinterberger, Maria; Aichinger, Martin; Voehringer, David; Klein, Ludger] Univ Munich, Inst Immunol, D-8000 Munich, Germany; [da Costa, Olivia Prazeres; Hoffmann, Reinhard] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany	University of Munich; Technical University of Munich	Klein, L (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-8000 Munich, Germany.	ludger.klein@med.uni-muenchen.de	Klein, Ludger/G-8785-2011; Voehringer, David/K-2776-2019; Hoffmann, Reinhard/I-8748-2018	Hoffmann, Reinhard/0000-0003-1514-1183; Klein, Ludger/0000-0003-2054-071X	Deutsche Forschungsgemeinschaft [KL 1228/3-1, SFB 455, VO 944/2-2]; Austrian National Science Fund [SFB23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian National Science Fund(Austrian Science Fund (FWF))	We thank B. Kyewski for critical reading of the manuscript; C. Federle and S. Hoeflinger for technical assistance; C. Theussl for BAC injections; M. S. Anderson (University of California, San Francisco) for Adig mice; K. Karjalainen (Nanyang Technological University) for A5 hybridoma cells; and H. S. Scott (University of Adelaide) for monoclonal antibody to Aire. Supported by the Deutsche Forschungsgemeinschaft (KL 1228/3-1 to L. K. and M. H.; SFB 455 to L. K. and M. A.; and VO 944/2-2 to D. V.) and the Austrian National Science Fund (SFB23).	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bot A, 1996, J IMMUNOL, V157, P3436; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Otten LA, 2006, EUR J IMMUNOL, V36, P1548, DOI 10.1002/eji.200535687; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Spence PJ, 2008, P NATL ACAD SCI USA, V105, P973, DOI 10.1073/pnas.0709071105; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	54	175	177	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					512	U80		10.1038/ni.1874	http://dx.doi.org/10.1038/ni.1874			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20431619				2022-12-18	WOS:000277821300012
J	Quann, EJ; Merino, E; Furuta, T; Huse, M				Quann, Emily J.; Merino, Ernesto; Furuta, Toshiaki; Huse, Morgan			Localized diacylglycerol drives the polarization of the microtubule-organizing center in T cells	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; DEPENDENT MECHANISM; RECEPTOR; ANTIGEN; ACTIVATION; POLARITY; PROTEIN; TCR; CHEMOTAXIS; SECRETION	The reorientation of the T cell microtubule-organizing center (MTOC) toward the antigen-presenting cell enables the directional secretion of cytokines and lytic factors. By single-cell photoactivation of the T cell antigen receptor, we show that MTOC polarization is driven by localized accumulation of diacylglycerol (DAG). MTOC reorientation was closely preceded first by production of DAG and then by recruitment of the microtubule motor protein dynein. Blocking DAG production or disrupting the localization of DAG impaired MTOC recruitment. Localized DAG accumulation was also required for cytotoxic T cell-mediated killing. Furthermore, photoactivation of DAG itself was sufficient to induce transient polarization. Our data identify a DAG-dependent pathway that signals through dynein to control microtubule polarity in T cells.	[Quann, Emily J.; Merino, Ernesto; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Furuta, Toshiaki] Toho Univ, Dept Biomol Sci, Chiba 2748510, Japan	Memorial Sloan Kettering Cancer Center; Toho University	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	husem@mskcc.org	Furuta, Toshiaki/F-1363-2011	Furuta, Toshiaki/0000-0001-8532-1775	Spanish Ministry of Science and Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Searle Scholars Program; Cancer Research Institute	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Searle Scholars Program; Cancer Research Institute	We thank G. Altan-Bonnet (Memorial Sloan-Kettering Cancer Center) and O. Feinerman (Memorial Sloan-Kettering Cancer Center) for assistance with MATLAB programming, RMA-s cells and other reagents; T. Pentcheva-Hoang (Memorial Sloan-Kettering Cancer Center) and J. Allison (Memorial Sloan-Kettering Cancer Center) for CH12 cells and help with imaging experiments; Q. Li (Duke University) for helper T cell cDNA; W. Sha (University of California, Berkeley) and M. S. Kuhns (Stanford University) for pMSCV; R. Tsien (University of California, San Diego) and M. W. Davidson (Florida State University) for Tag-RFP-T; S. S. Yi and the Sloan-Kettering Institute Microchemistry Core Facility for peptide synthesis; D. Sant'Angelo, G. Altan-Bonnet, A. Hall, P. Abeyweera, D. A. Schaer and K. Pham for advice and critical reading of the manuscript; B. Driscoll for technical assistance; the laboratories of M. O. Li and B. Dupont for reagents and comments; and M. M. Davis for advice and support at the start of this project. Supported by the Spanish Ministry of Science and Innovation (E. M.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (T. F.), the Searle Scholars Program (M. H.) and the Cancer Research Institute (M. H.).	Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Ebinu JO, 2000, BLOOD, V95, P3199; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Huang XP, 1996, BIOPHYS J, V70, P2448, DOI 10.1016/S0006-3495(96)79816-8; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irie A, 2006, INT IMMUNOL, V18, P1737, DOI 10.1093/intimm/dxl108; JONES GA, 1993, J BIOL CHEM, V268, P20845; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Resnick MS, 1998, J BIOL CHEM, V273, P27654, DOI 10.1074/jbc.273.42.27654; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Suzuki AZ, 2003, ORG LETT, V5, P4867, DOI 10.1021/ol0359362; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x	41	175	176	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					627	U96		10.1038/ni.1734	http://dx.doi.org/10.1038/ni.1734			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19430478				2022-12-18	WOS:000266384100015
J	Cherry, S; Silverman, N				Cherry, Sara; Silverman, Neal			Host-pathogen interactions in drosophila: new tricks from an old friend	NATURE IMMUNOLOGY			English	Review							COMPLEMENT-LIKE PROTEIN; RNAI SCREEN REVEALS; IMMUNE-RESPONSE; ANTIVIRAL RESPONSE; RECOGNITION; PHAGOCYTOSIS; VIRUS; INTERFERENCE; INFECTION; CELLS	Insects rely solely on innate immune responses to combat a wide array of pathogens. With its powerful genetics, drosophila has proven especially powerful for the study of humoral innate immunity, characterized by the rapid induction of antimicrobial peptides. The two signaling pathways involved, Toll and Imd, have been studied intensely, but other aspects of the drosophila immune response are less well understood. A flurry of reports has focused on the mechanisms of phagocytosis, antiviral immunity and viral pathogenesis in drosophila. These studies have taken advantage of genome- wide RNA-mediated interference screening in drosophila cells, as well as more traditional genetic tools available in the fly. This review discusses advances in these exciting new areas of drosophila immunity.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Massachusetts, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	neal.silverman@umassmed.edu		cherry, sara/0000-0003-3956-6610; Silverman, Neal/0000-0002-4259-456X	NIAID NIH HHS [AI060025] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060025, R01AI060025] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Berkhout B, 2006, FEBS LETT, V580, P2896, DOI 10.1016/j.febslet.2006.02.070; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; BRUN G, 1980, GENET BIOL DROSOPHIL, P625; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haasnoot J, 2006, HANDB EXP PHARM, V173, P117; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyano-Kurosaki N, 2006, HANDB EXP PHARM, V173, P151; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Reavy B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-18; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schmucker D, 2004, NEURON, V44, P219, DOI 10.1016/j.neuron.2004.10.004; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wayne ML, 1996, MOL BIOL EVOL, V13, P191, DOI 10.1093/oxfordjournals.molbev.a025555; Xie ZF, 2005, CHINESE MED J-PEKING, V118, P6; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	58	175	191	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					911	917		10.1038/ni1388	http://dx.doi.org/10.1038/ni1388			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924255				2022-12-18	WOS:000239942300009
J	Garbi, N; Tanaka, S; Momburg, F; Hammerling, GJ				Garbi, N; Tanaka, S; Momburg, F; Hammerling, GJ			Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; ER CHAPERONE; TAPASIN; MOLECULES; BINDING; CELLS; TAP	The thiol-oxidoreductase ERp57 is an integral component of the peptide-loading complex of the major histocompatibility complex (MHC) class I pathway, but its function is unknown. To investigate its function in antigen presentation, we generated ERp57-deficient mice. Death in utero caused by ubiquitous ERp57 deletion was prevented by specific deletion in the B cell compartment. We demonstrate that ERp57 was central for recruitment of MHC class I molecules into the loading complex. In ERp57-deficient cells, we found short-lived interaction of MHC class I molecules with the loading complex. Thus, in the steady state, very few MHC class I molecules were present in the loading complex. Surface H-2K(b)-peptide expression and stability were reduced, and presentation of a model antigen was decreased. Our results indicate that ERp57 does not influence the redox state of MHC class I molecules but is an essential structural component required for stable assembly of the peptide-loading complex.	German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hammerling, GJ (corresponding author), German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany.	hammerling@dkfz.de	Garbi, Natalio/B-9147-2009; Garbi, Natalio/H-7666-2014					ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Antoniou AN, 2003, CURR OPIN IMMUNOL, V15, P75, DOI 10.1016/S0952-7915(02)00010-9; Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; Brocke P, 2003, EUR J IMMUNOL, V33, P411, DOI 10.1002/immu.200310015; Brocke P, 2002, CURR OPIN IMMUNOL, V14, P22, DOI 10.1016/S0952-7915(01)00294-1; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Cresswell P, 2001, CURR OPIN IMMUNOL, V13, P11, DOI 10.1016/S0952-7915(00)00174-6; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Eufemi M, 2004, BIOCHEM BIOPH RES CO, V323, P1306, DOI 10.1016/j.bbrc.2004.09.009; Farmery MR, 2000, J BIOL CHEM, V275, P14933, DOI 10.1074/jbc.275.20.14933; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Hammerling GJ, 1998, RES IMMUNOL, V149, P863, DOI 10.1016/S0923-2494(99)80013-3; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; NEEFJES JJ, 1992, EUR J IMMUNOL, V22, P1609, DOI 10.1002/eji.1830220639; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WANG H, 1994, J BIOL CHEM, V269, P22276; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7	61	175	180	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					93	102		10.1038/ni1288	http://dx.doi.org/10.1038/ni1288			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16311600				2022-12-18	WOS:000234139700023
J	Tolar, P; Sohn, HW; Pierce, SK				Tolar, P; Sohn, HW; Pierce, SK			The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer	NATURE IMMUNOLOGY			English	Article							LIPID RAFTS; CYTOPLASMIC DOMAIN; LIVE CELLS; TRANSDUCTION; FRET; ACTIVATION; PROTEIN; PHOSPHORYLATION; LYMPHOCYTES; INHIBITION	Binding of antigen to the B cell antigen receptor (BCR) triggers signaling that ultimately leads to B cell activation. Using quantitative fluorescence resonance energy transfer imaging, we provide evidence here that the BCR is a monomer on the surface of resting cells. Binding of multivalent antigen clustered the BCR, resulting in the simultaneous phosphorylation of and a conformational change in the BCR cytoplasmic domains from a closed to an open form. Notably, the open conformation required immunoreceptor tyrosine-activation motif and continuous Src family kinase activity but not binding of the kinase Syk. Thus, the initiation of BCR signaling is a very dynamic process accompanied by reversible conformational changes induced by Src family kinase activity.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	spierce@nih.gov		Tolar, Pavel/0000-0003-4693-7299	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000898, ZIAAI000898] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi T, 2001, J BIOL CHEM, V276, P26648, DOI 10.1074/jbc.M100997200; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Pao LI, 1997, J IMMUNOL, V158, P1116; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Vilen BJ, 2002, J IMMUNOL, V168, P4344, DOI 10.4049/jimmunol.168.9.4344; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, CURR OPIN IMMUNOL, V16, P674, DOI 10.1016/j.coi.2004.07.018; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	41	175	180	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1168	1176		10.1038/ni1262	http://dx.doi.org/10.1038/ni1262			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16200067				2022-12-18	WOS:000232833300018
J	Muppidi, JR; Siegel, RM				Muppidi, JR; Siegel, RM			Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVATION; SIGNALING COMPLEX; LYMPHOCYTE APOPTOSIS; IN-VIVO; BCL-2; MICRODOMAINS; MECHANISM; RESPONSES; PATHWAYS; LIVE	Clonotypic elimination of activated T cells through Fas-Fas ligand (CD95-CD95L) interactions is one mechanism of peripheral self-tolerance. T cell receptor (TCR) stimuli trigger FasL synthesis but also sensitize activated T cells to Fas-mediated apoptosis through an unknown mechanism. Here we show that TCR restimulation of activated human CD4(+) T cells resulted in Fas translocation into lipid raft microdomains before binding FasL, rendering these cells sensitive to apoptosis after stimulation with bivalent antibody or FasL. Disruption of lipid rafts reduced sensitivity to Fas-mediated apoptosis after TCR restimulation. Thus, the redistribution of Fas and other tumor necrosis factor family receptors into and out of lipid rafts may dynamically regulate the efficiency and outcomes of signaling by these receptors.	NIAMSD, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Siegel, RM (corresponding author), NIAMSD, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893; Muppidi, Jagan/0000-0002-2639-4226	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NIEHS NIH HHS [5T32 ES 007079] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Combadiere B, 1998, IMMUNITY, V9, P305, DOI 10.1016/S1074-7613(00)80613-5; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Garofalo T, 2003, J BIOL CHEM, V278, P8309, DOI 10.1074/jbc.M207618200; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hornung F, 1997, J IMMUNOL, V159, P3816; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; SEDWICK CE, 2002, SCI STKE, pRE2; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Wong B, 1997, J EXP MED, V186, P1939, DOI 10.1084/jem.186.11.1939; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	34	175	190	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					182	189		10.1038/ni1024	http://dx.doi.org/10.1038/ni1024			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14745445				2022-12-18	WOS:000188512000014
J	Zhong, XP; Hainey, EA; Olenchock, BA; Jordan, MS; Maltzman, JS; Nichols, KE; Shen, H; Koretzky, GA				Zhong, XP; Hainey, EA; Olenchock, BA; Jordan, MS; Maltzman, JS; Nichols, KE; Shen, H; Koretzky, GA			Enhanced T cell responses due to diacylglycerol kinase xi deficiency	NATURE IMMUNOLOGY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SMOOTH-MUSCLE CELLS; KAPPA-B ACTIVATION; GROWTH-FACTOR; PHORBOL ESTER; PHOSPHOLIPASE C-GAMMA-1; NUCLEAR-LOCALIZATION; SIGNAL-TRANSDUCTION; C1 DOMAIN	Much is known about how T cell receptor (TCR) engagement leads to T cell activation; however, the mechanisms terminating TCR signaling remain less clear. Diacylglycerol, generated after TCR ligation, is essential in T cells. Its function must be controlled tightly to maintain normal T cell homeostasis. Previous studies have shown that diacylglycerol kinase zeta (DGKzeta), which converts diacylglycerol to phosphatidic acid, can inhibit TCR signaling. Here we show that DGKzeta-deficient T cells are hyperresponsive to TCR stimulation both ex vivo and in vivo. Furthermore, DGKzeta-deficient mice mounted a more robust immune response to lymphocytic choriomeningitis virus infection than did wild-type mice. These results demonstrate the importance of DGKzeta as a physiological negative regulator of TCR signaling and T cell activation.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Signal Transduct Program, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Immunol Grad Grp, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Pediat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Koretzky, GA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Signal Transduct Program, Philadelphia, PA 19104 USA.		Nichols, Kim/E-9353-2016; Nichols, Kim/AAP-8592-2020; Koretzky, Gary/AAU-5381-2021	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555; 				ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; BERRIDGE MJ, 1984, BIOCHEM J, V222, P195, DOI 10.1042/bj2220195; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bregoli L, 2001, J BIOL CHEM, V276, P23288, DOI 10.1074/jbc.M101501200; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cutrupi S, 2000, EMBO J, V19, P4614, DOI 10.1093/emboj/19.17.4614; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Du XN, 2001, BIOCHEM J, V357, P275, DOI 10.1042/0264-6021:3570275; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; Flores I, 1999, J IMMUNOL, V163, P708; GOTO K, 1992, MOL BRAIN RES, V16, P75, DOI 10.1016/0169-328X(92)90196-I; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; Hashimoto K, 2001, MOL NEUROBIOL, V23, P69; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; INUI H, 1994, BIOCHEM BIOPH RES CO, V205, P1338, DOI 10.1006/bbrc.1994.2812; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jung S, 1999, CURR OPIN IMMUNOL, V11, P319, DOI 10.1016/S0952-7915(99)80051-X; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Liu ZT, 2001, J BIOL CHEM, V276, P5900, DOI 10.1074/jbc.M007311200; LYNCH DH, 1995, IMMUNOL TODAY, V16, P569, DOI 10.1016/0167-5699(95)80079-4; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nagaya H, 2002, MOL BIOL CELL, V13, P302, DOI 10.1091/mbc.01-05-0255; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; PARK DJ, 1992, J BIOL CHEM, V267, P1496; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; SCHULZ M, 1989, EUR J IMMUNOL, V19, P1657, DOI 10.1002/eji.1830190921; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	75	175	188	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					882	890		10.1038/ni958	http://dx.doi.org/10.1038/ni958			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12883552				2022-12-18	WOS:000185002200015
J	Kim, MS; Byun, MJ; Oh, BH				Kim, MS; Byun, MJ; Oh, BH			Crystal structure of peptidoglycan recognition protein LB from Drosophila melanogaster	NATURE IMMUNOLOGY			English	Article							POSITIVE BACTERIAL-INFECTIONS; IMMUNE-RESPONSE REQUIRES; GRAM-NEGATIVE BACTERIA; KAPPA-B KINASE; INNATE IMMUNITY; ANTIBACTERIAL DEFENSE; HOST-DEFENSE; BOMBYX-MORI; TOLL; SYSTEM	The family of peptidoglycan recognition proteins (PGRPs) are associated with the recognition of the peptidoglycan of microbes and subsequent activation of signaling pathways for immune response. Here the crystal structure of Drosophila PGRP-LB is determined at a resolution of 2.0 Angstrom and shows an active-site cleft with a zinc cage. Poor conservation of surface residues at the cleft predicts a widely varying individual specificity of PGRPs for molecular patterns on microbial cell walls. At the back of this cleft is a putatively conserved distinctive groove. The location and mainly hydrophobic nature of the groove indicate that the back face serves for subsequent signaling after clustering of PGRP molecules by binding to polymeric cell wall components.	Pohang Univ Sci & Technol, Dept Life Sci, Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea.		Oh, Byung-Ha/C-2061-2011	Byun, Minji/0000-0002-2830-4079				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; COOPER S, 1991, MICROBIOL REV, V55, P649, DOI 10.1128/MMBR.55.4.649-674.1991; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Ibrahim HR, 2001, FEBS LETT, V506, P27, DOI 10.1016/S0014-5793(01)02872-1; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; ROGERS HJ, 1980, MICROBACTERIAL CELL; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; SCHLEIFER KH, 1983, ANNU REV MICROBIOL, V37, P143, DOI 10.1146/annurev.mi.37.100183.001043; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	45	175	189	0	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					787	793		10.1038/ni952	http://dx.doi.org/10.1038/ni952			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12845326				2022-12-18	WOS:000184441500016
J	Costello, PS; Gallagher, M; Cantrell, DA				Costello, PS; Gallagher, M; Cantrell, DA			Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; ANTIGEN-PRESENTING CELLS; PROTEIN-KINASE-B; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; TRANSGENIC MICE; D PKD; RECEPTOR; LOCALIZATION; NAIVE	T cell activation is triggered by several hours of contact with peptide-major histocompatibility (MHC) complexes on the surface of antigen-presenting cells (APCs). The nature and location of the sustained signal transduction pathways required for T cell activation are unknown. We show here that the production of phosphatidylinositol (3,4,5)triphosphate (PIP3) was dynamically sustained for hours as T cells responded to antigen. In addition, sustained elevation of PIP3 was essential for T cell proliferation. There was PIP3 accumulation in the T cell-APC contact zone and at the antipodal pole of the cell. The immune synapse is thus not the sole site of sustained signal transduction in activated T cells.	Cancer Res UK, London Res Inst, Lymphocyte Activat Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Cantrell, DA (corresponding author), Cancer Res UK, London Res Inst, Lymphocyte Activat Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	doreen.cantrell@cancer.org.uk		Cantrell, Doreen/0000-0001-7525-3350				Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Astoul E, 1999, J CELL BIOL, V145, P1511, DOI 10.1083/jcb.145.7.1511; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Cantrell DA, 2001, J CELL SCI, V114, P1439; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Lafont V, 2000, FEBS LETT, V486, P38, DOI 10.1016/S0014-5793(00)02235-3; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lanzavecchia A, 1997, J EXP MED, V185, P1717, DOI 10.1084/jem.185.10.1717; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meyer T, 2000, METHOD ENZYMOL, V327, P500, DOI 10.1016/S0076-6879(00)27298-4; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ni HT, 2001, J IMMUNOL, V166, P6523, DOI 10.4049/jimmunol.166.11.6523; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; Okkenhaug K, 2002, SCIENCE, V297, P1031; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Singbartl K, 2001, J IMMUNOL, V166, P7520, DOI 10.4049/jimmunol.166.12.7520; Sperling AI, 1998, J IMMUNOL, V161, P6459; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Teruel MN, 2002, SCIENCE, V295, P1910, DOI 10.1126/science.1065028; van der Merwe PA, 2002, SCIENCE, V295, P1479, DOI 10.1126/science.1069896; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	50	175	178	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1082	1089		10.1038/ni848	http://dx.doi.org/10.1038/ni848			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12389042				2022-12-18	WOS:000179073000016
J	Bergsbaken, T; Bevan, MJ				Bergsbaken, Tessa; Bevan, Michael J.			Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8(+) T cells responding to infection	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CXCR3; YERSINIA-PSEUDOTUBERCULOSIS; PESTIS INFECTION; DENDRITIC CELLS; ORAL INFECTION; EFFECTOR-CELLS; MEMORY; MIGRATION; ANTIGEN; GENERATION	We report that oral infection with Yersinia pseudotuberculosis results in the development of two distinct populations of pathogen-specific CD8(+) tissue-resident memory T cells (T-RM cells) in the lamina propria. CD103(-) T cells did not require transforming growth factor-beta (TGF-beta) signaling but were true resident memory cells. Unlike CD103(+)CD8(+) T cells, which were TGF-beta dependent and were scattered in the tissue, CD103(-)CD8(+) T cells clustered with CD4(+) T cells and CX3CR1(+) macrophages and/or dendritic cells around areas of bacterial infection. CXCR3-dependent recruitment of cells to inflamed areas was critical for development of the CD103(-) population and pathogen clearance. Our studies have identified the 'preferential' development of CD103(-) T-RM cells in inflammatory microenvironments within the lamina propria and suggest that this subset has a critical role in controlling infection.	[Bevan, Michael J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@uw.edu		Bergsbaken, Tessa/0000-0001-8841-8185	Howard Hughes Medical Institute; US National Institutes of Health [AI-19335]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019335, R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Chase and X. Cun-Pan for technical assistance and N. Zhang for critical reading of the manuscript. Supported by the Howard Hughes Medical Institute, the US National Institutes of Health (AI-19335 to M.J.B.) and the Cancer Research Institute (T.B.).	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; AUTENRIETH IB, 1992, INFECT IMMUN, V60, P1140, DOI 10.1128/IAI.60.3.1140-1149.1992; Barnes PD, 2006, J EXP MED, V203, P1591, DOI 10.1084/jem.20060905; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; DePaolo RW, 2012, J EXP MED, V209, P1437, DOI 10.1084/jem.20112339; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Jung C, 2012, J CLIN INVEST, V122, P2239, DOI 10.1172/JCI58147; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lin JS, 2011, J IMMUNOL, V187, P897, DOI 10.4049/jimmunol.1100174; Logsdon LK, 2003, INFECT IMMUN, V71, P4595, DOI 10.1128/IAI.71.8.4595-4607.2003; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Melton-Witt JA, 2012, INFECT IMMUN, V80, P720, DOI 10.1128/IAI.05958-11; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Philipovskiy AV, 2007, INFECT IMMUN, V75, P878, DOI 10.1128/IAI.01529-06; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wiedig CA, 2005, VACCINE, V23, P4984, DOI 10.1016/j.vaccine.2005.05.027; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang Y, 2012, INFECT IMMUN, V80, P206, DOI 10.1128/IAI.05971-11; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	47	174	176	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					406	414		10.1038/ni.3108	http://dx.doi.org/10.1038/ni.3108			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25706747	Green Accepted			2022-12-18	WOS:000351333700013
J	Cremasco, V; Woodruff, MC; Onder, L; Cupovic, J; Nieves-Bonilla, JM; Schildberg, FA; Chang, J; Cremasco, F; Harvey, CJ; Wucherpfennig, K; Ludewig, B; Carroll, MC; Turley, SJ				Cremasco, Viviana; Woodruff, Matthew C.; Onder, Lucas; Cupovic, Jovana; Nieves-Bonilla, Janice M.; Schildberg, Frank A.; Chang, Jonathan; Cremasco, Floriana; Harvey, Christopher J.; Wucherpfennig, Kai; Ludewig, Burkhard; Carroll, Michael C.; Turley, Shannon J.			B cell homeostasis and follicle confines are governed by fibroblastic reticular cells	NATURE IMMUNOLOGY			English	Article							SECONDARY LYMPHOID ORGANS; BETA-DEFICIENT MICE; DENDRITIC CELLS; HUMORAL IMMUNITY; STROMAL CELLS; NODES; ANTIGEN; ORGANOGENESIS; ACTIVATION; MATURATION	Fibroblastic reticular cells (FRCs) are known to inhabit T cell-rich areas of lymphoid organs, where they function to facilitate interactions between T cells and dendritic cells. However, in vivo manipulation of FRCs has been limited by a dearth of genetic tools that target this lineage. Here, using a mouse model to conditionally ablate FRCs, we demonstrated their indispensable role in antiviral T cell responses. Unexpectedly, loss of FRCs also attenuated humoral immunity due to impaired B cell viability and follicular organization. Follicle-resident FRCs established a favorable niche for B lymphocytes via production of the cytokine BAFF. Thus, our study indicates that adaptive immunity requires an intact FRC network and identifies a subset of FRCs that control B cell homeostasis and follicle identity.	[Cremasco, Viviana; Nieves-Bonilla, Janice M.; Schildberg, Frank A.; Chang, Jonathan; Cremasco, Floriana; Harvey, Christopher J.; Wucherpfennig, Kai; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA; [Woodruff, Matthew C.; Carroll, Michael C.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Woodruff, Matthew C.; Chang, Jonathan] Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA; [Onder, Lucas; Cupovic, Jovana; Ludewig, Burkhard] Kantonal Hosp St Gallen, Inst Immunol, St Gallen, Switzerland; [Cremasco, Floriana] Univ Milan, Dept Pharmacol, Milan, Italy; [Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Kantonsspital St. Gallen; University of Milan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Turley, SJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	michael.carroll@childrens.harvard.edu; turley.shannon@gene.com		Nieves-Bonilla, Janice/0000-0001-6543-3681; Woodruff, Matthew/0000-0002-5252-7539	US National Institutes of Health [5R01 DK074500-08, 2P01AI045757-15, R21 CA182598-01, R01 AI039246, P01 AI078897, R37 AI054636, T32 CA 070083-15]; Barr Foundation; Cancer Research Institute; Vontobel Foundation; Helmut Horten Foundation; NATIONAL CANCER INSTITUTE [R21CA182598, T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barr Foundation; Cancer Research Institute; Vontobel Foundation; Helmut Horten Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Cameron for technical assistance at the Dana-Farber cancer Institute Confocal Imaging core. Supported by the US National Institutes of Health (5R01 DK074500-08, 2P01AI045757-15, R21 CA182598-01 to S.J.T.; R01 AI039246, P01 AI078897 and R37 AI054636 to M.C.C.; and T32 CA 070083-15 to V.C.), the Barr Foundation (S.J.T.), the Cancer Research Institute (V.C.), the Vontobel Foundation (to B.L.) and the Helmut Horten Foundation (to B.L.).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Boulianne B, 2013, J IMMUNOL, V191, P4521, DOI 10.4049/jimmunol.1300769; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cervantes-Barragan L., 2010, MBIO, V1, P4, DOI DOI 10.1128/MBI0.00171-10; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cupovic J., 2014, THESIS EIDGENOSSISCH; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Cyster JG, 2000, IMMUNOL REV, V176, P181; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Katakai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00200; Khan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026138; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	44	174	176	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					973	U222		10.1038/ni.2965	http://dx.doi.org/10.1038/ni.2965			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25151489	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-18	WOS:000342564800013
J	Bermejo, DA; Jackson, SW; Gorosito-Serran, M; Acosta-Rodriguez, EV; Amezcua-Vesely, MC; Sather, BD; Singh, AK; Khim, S; Mucci, J; Liggitt, D; Campetella, O; Oukka, M; Gruppi, A; Rawlings, DJ				Bermejo, Daniela A.; Jackson, Shaun W.; Gorosito-Serran, Melisa; Acosta-Rodriguez, Eva V.; Amezcua-Vesely, Maria C.; Sather, Blythe D.; Singh, Akhilesh K.; Khim, Socheath; Mucci, Juan; Liggitt, Denny; Campetella, Oscar; Oukka, Mohamed; Gruppi, Adriana; Rawlings, David J.			Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR gamma t and Ahr that leads to IL-17 production by activated B cells	NATURE IMMUNOLOGY			English	Article							CAMPYLOBACTER-JEJUNI; RECEPTOR; INFECTION; ANTIGEN; DIFFERENTIATION; EXPRESSION; IMMUNITY; SIALYLTRANSFERASE; IDENTIFICATION; GLYCOSYLATION	Here we identified B cells as a major source of rapid, innate-like production of interleukin 17 (IL-17) in vivo in response to infection with Trypanosoma cruzi. IL-17(+) B cells had a plasmablast phenotype, outnumbered cells of the T(H)17 subset of helper T cells and were required for an optimal response to this pathogen. With both mouse and human primary B cells, we found that exposure to parasite-derived trans-sialidase in vitro was sufficient to trigger modification of the cell-surface mucin CD45, which led to signaling dependent on the kinase Btk and production of IL-17A or IL-17F via a transcriptional program independent of the transcription factors ROR gamma t and Ahr. Our combined data suggest that the generation of IL-17(+) B cells may be a previously unappreciated feature of innate immune responses required for pathogen control or IL-17-mediated autoimmunity.	[Bermejo, Daniela A.; Gorosito-Serran, Melisa; Acosta-Rodriguez, Eva V.; Amezcua-Vesely, Maria C.; Gruppi, Adriana] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol, RA-5000 Cordoba, Argentina; [Jackson, Shaun W.; Sather, Blythe D.; Singh, Akhilesh K.; Khim, Socheath; Oukka, Mohamed; Rawlings, David J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Jackson, Shaun W.; Sather, Blythe D.; Singh, Akhilesh K.; Khim, Socheath; Oukka, Mohamed; Rawlings, David J.] Seattle Childrens Res Inst, Seattle, WA USA; [Mucci, Juan; Campetella, Oscar] Univ Nacl San Martin, Inst Invest Biotecnol, San Martin, Argentina; [Liggitt, Denny] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Oukka, Mohamed; Rawlings, David J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rawlings, DJ (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.	agruppi@fcq.unc.edu.ar; drawling@u.washington.edu	Mucci, Juan/N-2335-2017; Rawlings, David/CAI-4751-2022	Mucci, Juan/0000-0002-7394-709X; Campetella, Oscar/0000-0002-7018-375X; AMEZCUA VESELY, MARIA CAROLINA/0000-0001-9631-1249; Acosta Rodriguez, Eva/0000-0001-5871-2391	US National Institutes of Health [HD037091, HL075453, AI084457, AI071163, AI 075589, 5T32AR007108, K12HD043376]; Rheumatology Research Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043376] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI071163, R56AI084457, R01AI071163, R01AI075589, R01AI084457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007108] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Norris (University of Pittsburgh) for T. cruzi, Y strain; A. Weiss (University of California at San Francisco) for Cd45<SUP>-/-</SUP> mice; G. Sonnenberg (University of Pennsylvania) and D. Artis (University of Pennsylvania) for Il17a<SUP>-/-</SUP> mice; O. Campetella (Universidad de San Martin) for the trans-sialidase-neutralizing mAb (hybridoma 13G9); T. Burris (The Scripps Research Institute) for the inhibitor SR1001; N. Scharping and F. Fiocca-Vernengo for technical assistance; K. Sommer and M. Schwartz and other members of the Rawlings laboratory for suggestions and discussions; P. Abadie and MP Crespo for cell sorting; and F. Navarro for animal care in Argentina. Supported by the US National Institutes of Health (HD037091, HL075453, AI084457 and AI071163 to D.J.R.; AI 075589 to O.C.; and 5T32AR007108 and K12HD043376 to S.W.J.), the Rheumatology Research Foundation (S.W.J.), Consejo Nacional de Investigaciones Cientificas y Tecnicas, Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica) and Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (A. G.) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (D. A. B., M. C. A.-V. and M.G.-S.).	Acosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493; Alvarez P, 2001, INFECT IMMUN, V69, P7946, DOI 10.1128/IAI.69.12.7946-7949.2001; Andrews SF, 2009, J IMMUNOL, V182, P2868, DOI 10.4049/jimmunol.0802368; Bermejo DA, 2011, IMMUNOLOGY, V132, P123, DOI 10.1111/j.1365-2567.2010.03347.x; Bermejo DA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000679; Bryan MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000733; Buschiazzo A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002474; CAMPETELLA OE, 1994, MOL BIOCHEM PARASIT, V64, P337, DOI 10.1016/0166-6851(94)00036-0; Cheng JS, 2008, GLYCOBIOLOGY, V18, P686, DOI 10.1093/glycob/cwn047; Cheng JS, 2010, GLYCOBIOLOGY, V20, P260, DOI 10.1093/glycob/cwp172; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Dong C, 2011, EXP MOL MED, V43, P1, DOI 10.3858/emm.2011.43.1.007; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gao W, 2002, INT IMMUNOL, V14, P299, DOI 10.1093/intimm/14.3.299; Gao W, 2001, EUR J IMMUNOL, V31, P1503, DOI 10.1002/1521-4141(200105)31:5&lt;1503::AID-IMMU1503&gt;3.0.CO;2-W; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Leguizamon MS, 1999, J INFECT DIS, V180, P1398, DOI 10.1086/315001; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer-Bahlburg A, 2012, FRONT BIOSCI-LANDMRK, V17, P1499, DOI 10.2741/4000; Minoprio P, 1989, Int Immunol, V1, P176, DOI 10.1093/intimm/1.2.176; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Moreno-Garcia ME, 2006, ADV EXP MED BIOL, V584, P89; Mou ZR, 2010, INFECT IMMUN, V78, P5271, DOI 10.1128/IAI.00168-10; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Muia RP, 2010, GLYCOBIOLOGY, V20, P833, DOI 10.1093/glycob/cwq037; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; Norris KA, 1997, INFECT IMMUN, V65, P349, DOI 10.1128/IAI.65.2.349-357.1997; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Rawlings DJ, 1999, CLIN IMMUNOL, V91, P243, DOI 10.1006/clim.1999.4732; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Risso MG, 2007, PARASITOLOGY, V134, P503, DOI 10.1017/S0031182006001752; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Zuniga E, 2001, J LEUKOCYTE BIOL, V70, P73	54	174	187	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					514	+		10.1038/ni.2569	http://dx.doi.org/10.1038/ni.2569			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23563688	Green Accepted, Green Published			2022-12-18	WOS:000317732100017
J	Sheridan, BS; Lefrancois, L				Sheridan, Brian S.; Lefrancois, Leo			Regional and mucosal memory T cells	NATURE IMMUNOLOGY			English	Review							HERPES-SIMPLEX-VIRUS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; IL-7 RECEPTOR-ALPHA; INTESTINAL DENDRITIC CELLS; EPITHELIAL M-CELLS; IN-VIVO; RETINOIC-ACID; ANTIGEN PRESENTATION; NONLYMPHOID TISSUES; PERIPHERAL-TISSUES	After infection, most antigen-specific memory T cells reside in nonlymphoid tissues. Tissue-specific programming during priming leads to directed migration of T cells to the appropriate tissue, which promotes the development of tissue-resident memory in organs such as intestinal mucosa and skin. Mechanisms that regulate the retention of tissue-resident memory T cells include transforming growth factor-beta (TGF-beta)-mediated induction of the E-cadherin receptor CD103 and downregulation of the chemokine receptor CCR7. These pathways enhance protection in internal organs, such as the nervous system, and in the barrier tissues-the mucosa and skin. Memory T cells that reside at these surfaces provide a first line of defense against subsequent infection, and defining the factors that regulate their development is critical to understanding organ-based immunity.	[Sheridan, Brian S.; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Ctr Integrated Immunol & Vaccine Res, Dept Immunol, Farmington, CT USA	University of Connecticut	Sheridan, BS (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Integrated Immunol & Vaccine Res, Dept Immunol, Farmington, CT USA.	bsheridan@uchc.edu; llefranc@neuron.uchc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172, R01AI041576, R01AI076457] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI076457, R01 AI041576, R01 AI041576-15, P01 AI056172-07, R01 AI041576-14, R01 AI076457-04, P01 AI056172] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agace W, 2010, IMMUNOL LETT, V128, P21, DOI 10.1016/j.imlet.2009.09.012; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; BERG EL, 1989, IMMUNOL REV, V108, P5, DOI 10.1111/j.1600-065X.1989.tb00010.x; Briskin M, 1997, AM J PATHOL, V151, P97; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Chakrabarti LA, 2010, CURR OPIN IMMUNOL, V22, P488, DOI 10.1016/j.coi.2010.06.006; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Croom HA, 2011, EUR J IMMUNOL, V41, P682, DOI 10.1002/eji.201040625; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Disson O, 2009, NAT PROTOC, V4, P799, DOI 10.1038/nprot.2009.66; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fontoura P, 2010, MABS-AUSTIN, V2, P670, DOI 10.4161/mabs.2.6.13270; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Himmelein Susanne, 2011, Herpesviridae, V2, P5, DOI 10.1186/2042-4280-2-5; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Khanna KM, 2008, EUR J IMMUNOL, V38, P3304, DOI 10.1002/eji.200838602; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kim SK, 1999, J IMMUNOL, V163, P4125; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Kim SK, 1997, J IMMUNOL, V159, P4295; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Klonowski KD, 2006, J IMMUNOL, V177, P6738, DOI 10.4049/jimmunol.177.10.6738; Klonowski KD, 2006, J IMMUNOL, V177, P4247, DOI 10.4049/jimmunol.177.7.4247; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; LEFRANCOIS L, 1994, EUR J IMMUNOL, V24, P635, DOI 10.1002/eji.1830240322; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; LIU LM, 1993, J EXP MED, V177, P1299, DOI 10.1084/jem.177.5.1299; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reenaers Catherine, 2010, Therap Adv Gastroenterol, V3, P99, DOI 10.1177/1756283X09356872; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schlickum S, 2008, BLOOD, V112, P619, DOI 10.1182/blood-2008-01-134833; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schon MP, 1999, J IMMUNOL, V162, P6641; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sheridan BS, 2006, J IMMUNOL, V177, P8356, DOI 10.4049/jimmunol.177.12.8356; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Soderberg KA, 2004, J IMMUNOL, V173, P1908, DOI 10.4049/jimmunol.173.3.1908; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; TRIPP RA, 1995, J IMMUNOL, V154, P5870; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	113	174	178	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					485	491		10.1038/ni.2029	http://dx.doi.org/10.1038/ni.2029			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739671	Green Accepted			2022-12-18	WOS:000290707100006
J	Hamilton, SE; Wolkers, MC; Schoenberger, SP; Jameson, SC				Hamilton, SE; Wolkers, MC; Schoenberger, SP; Jameson, SC			The generation of protective memory-like CD8(+) T cells during homeostatic proliferation requires CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							LISTERIA-MONOCYTOGENES; POSITIVE SELECTION; LYMPHOPENIC HOSTS; CD8-T-CELL MEMORY; CD4-T-CELL HELP; ACUTE INFECTION; DEFICIENT MICE; LYMPHOCYTES; EXPANSION; APOPTOSIS	Antigen-specific memory T cells are a critical component of protective immunity because of their increased frequency and enhanced reactivity after restimulation. However, it is unclear whether 'memory-like' T cells generated during lymphopenia-induced homeostatic proliferation can also offer protection against pathogens. Here we show that homeostatic proliferation induced memory (HP-memory) CD8(+) T cells controlled bacterial infection as effectively as 'true' memory CD8(+) T cells, but their protective capacity required the presence of CD4(+) T cells during homeostatic proliferation. The necessity for CD4 help was overcome, however, if the HP-memory CD8(+) T cells lacked expression of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand; also called Apo-2L). Thus, like conventional CD8(+) memory T cells, the protective function of HP-memory CD8(+) T cells shows dependence on CD4(+) T cell help.	Univ Minnesota, Med Ctr, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	University of Minnesota System; University of Minnesota Twin Cities; La Jolla Institute for Immunology	Jameson, SC (corresponding author), Univ Minnesota, Med Ctr, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Wolkers, Monika/0000-0003-3242-1363	NCI NIH HHS [T32 CA009138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hagen KA, 2004, J IMMUNOL, V173, P3909, DOI 10.4049/jimmunol.173.6.3909; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu HM, 2002, CANCER RES, V62, P3914; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kieper WC, 2001, J IMMUNOL, V166, P5515, DOI 10.4049/jimmunol.166.9.5515; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Stockinger B, 2004, CURR OPIN IMMUNOL, V16, P775, DOI 10.1016/j.coi.2004.09.003; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tanchot C, 2001, EUR J IMMUNOL, V31, P2256, DOI 10.1002/1521-4141(200108)31:8<2256::AID-IMMU2256>3.0.CO;2-8; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wrzesinski C, 2005, CURR OPIN IMMUNOL, V17, P195, DOI 10.1016/j.coi.2005.02.002; Zheng SJ, 2004, J IMMUNOL, V173, P5652, DOI 10.4049/jimmunol.173.9.5652	44	174	178	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					475	481		10.1038/ni1326	http://dx.doi.org/10.1038/ni1326			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16604076				2022-12-18	WOS:000237008800012
J	Hammer, GE; Gonzalez, F; Champsaur, M; Cado, D; Shastri, N				Hammer, GE; Gonzalez, F; Champsaur, M; Cado, D; Shastri, N			The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules	NATURE IMMUNOLOGY			English	Article							LEUCYL-SPECIFIC AMINOPEPTIDASE; EPITOPE PRECURSOR PEPTIDES; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; EXPRESSION CLONING; PRESENTED PEPTIDES; CELLS; GENERATION; IDENTIFICATION; TAPASIN	Major histocompatibility complex (MHC) class I molecules present thousands of peptides to allow CD8(+) T cells to detect abnormal intracellular proteins. The antigen-processing pathway for generating peptides begins in the cytoplasm, and the MHC molecules are loaded in the endoplasmic reticulum. However, the nature of peptide pool in the endoplasmic reticulum and the proteolytic events that occur in this compartment are unclear. We addressed these issues by generating mice lacking the endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP). We found that loss of ERAAP disrupted the generation of naturally processed peptides in the endoplasmic reticulum, decreased the stability of peptide-MHC class I complexes and diminished CD8(+) T cell responses. Thus, trimming of antigenic peptides by ERAAP in the endoplasmic reticulum is essential for the generation of the normal repertoire of processed peptides.	Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu		Hammer, Gianna/0000-0001-6959-858X				Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Bhattacharya D, 2002, P NATL ACAD SCI USA, V99, P8838, DOI 10.1073/pnas.132274799; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; LANDER MR, 1978, J NATL CANCER I, V60, P477; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; Mo XY, 1999, J IMMUNOL, V163, P5851; NEISIG A, 1995, J IMMUNOL, V154, P1273; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Rammensee HG, 1997, MOL B INT U, P1; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	40	174	178	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					103	112		10.1038/ni1286	http://dx.doi.org/10.1038/ni1286			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16299505				2022-12-18	WOS:000234139700024
J	Rossi, FMV; Corbel, SY; Merzaban, JS; Carlow, DA; Gossens, K; Duenas, J; So, L; Yi, L; Ziltener, HJ				Rossi, FMV; Corbel, SY; Merzaban, JS; Carlow, DA; Gossens, K; Duenas, J; So, L; Yi, L; Ziltener, HJ			Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1	NATURE IMMUNOLOGY			English	Article							CORE 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; COMMON LYMPHOID PROGENITORS; HEMATOPOIETIC STEM-CELLS; T-CELL; BONE-MARROW; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; MICE; INFLAMMATION; EXPRESSION	The molecular mechanisms that direct the migration of early T lymphocyte progenitors to the thymus are unknown. We show here that P-selectin is expressed by thymic endothelium and that lymphoid progenitors in bone marrow and thymus bind P-selectin. Parabiosis, competitive thymus reconstitution and short-term homing assays indicated that P-selectin and its ligand PSGL-1 are functionally important components of the thymic homing process. Accordingly, thymi of mice lacking PSGL-1 contained fewer early thymic progenitors and had increased empty niches for prothymocytes compared with wild-type mice. Furthermore, the number of resident thymic progenitors controls thymic expression of P-selectin, suggesting that regulation of P-selectin expression by a thymic 'niche occupancy sensor' may be used to direct progenitor access.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Fabio@brc.ubc.ca; Hermann@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013; Merzaban, Jasmeen/V-3147-2018	Rossi, Fabio MV/0000-0002-0368-2620; Merzaban, Jasmeen/0000-0002-7276-2907				Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Blais ME, 2004, BLOOD, V103, P3102, DOI 10.1182/blood-2003-09-3311; Borges E, 1997, J BIOL CHEM, V272, P28786, DOI 10.1074/jbc.272.45.28786; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LENTER M, 1994, J CELL BIOL, V125, P471, DOI 10.1083/jcb.125.2.471; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Merzaban JS, 2005, J IMMUNOL, V174, P4051, DOI 10.4049/jimmunol.174.7.4051; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; TOOTHILL VJ, 1990, J IMMUNOL, V145, P283; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Winkler IG, 2004, BLOOD, V103, P1685, DOI 10.1182/blood-2003-06-1921; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215	42	174	179	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					626	634		10.1038/ni1203	http://dx.doi.org/10.1038/ni1203			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15880112				2022-12-18	WOS:000229385900018
J	Kunikata, T; Yamane, H; Segi, E; Matsuoka, T; Sugimoto, Y; Tanaka, S; Tanaka, H; Nagai, H; Ichikawa, A; Narumiya, S				Kunikata, T; Yamane, H; Segi, E; Matsuoka, T; Sugimoto, Y; Tanaka, S; Tanaka, H; Nagai, H; Ichikawa, A; Narumiya, S			Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3	NATURE IMMUNOLOGY			English	Article							EPITHELIAL-CELLS; AIRWAY HYPERRESPONSIVENESS; PROSTANOID RECEPTORS; MICE LACKING; EXPRESSION; HISTAMINE; IGE; OVERPRODUCTION; INTERVENTION; INHIBITION	Prostaglandins, including PGD(2) and PGE(2), are produced during allergic reactions. Although PGD(2) is an important mediator of allergic responses, aspirin-like drugs that inhibit prostaglandin synthesis are generally ineffective in allergic disorders, suggesting that another prostaglandin-mediated pathway prevents the development of allergic reactions. Here we show that such a pathway may be mediated by PGE(2) acting at the prostaglandin E receptor EP3. Mice lacking EP3 developed allergic inflammation that was much more pronounced than that in wild-type mice or mice deficient in other prostaglandin E receptor subtypes. Conversely, an EP3-selective agonist suppressed the inflammation. This suppression was effective when the agonist was administered 3 h after antigen challenge and was associated with inhibition of allergy-related gene expression. Thus, the PGE(2)-EP3 pathway is an important negative modulator of allergic reactions.	Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Fac Med, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan; Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5020003, Japan	Kyoto University; Kyoto University; Kyoto University; Gifu Pharmaceutical University	Narumiya, S (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Sugimoto, Yukihiko/AAV-6470-2021; Tanaka, Satoshi/H-6800-2019; TANAKA, Satoshi/B-1624-2011	Sugimoto, Yukihiko/0000-0001-6973-932X; Tanaka, Satoshi/0000-0002-3468-7694; TANAKA, Satoshi/0000-0002-3468-7694; Segi-Nishida, Eri/0000-0002-0803-6513				Arshad SH, 2001, CLIN EXP ALLERGY, V31, P1344, DOI 10.1046/j.1365-2222.2001.01162.x; Berin MC, 2001, AM J RESP CELL MOL, V24, P382, DOI 10.1165/ajrcmb.24.4.4360; Chan CL, 2000, BRIT J PHARMACOL, V129, P589, DOI 10.1038/sj.bjp.0703072; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V105, P211, DOI 10.1016/S0091-6749(00)90068-X; Corry DB, 1999, NATURE, V402, pB18; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; Gauvreau GM, 1999, AM J RESP CRIT CARE, V159, P31, DOI 10.1164/ajrccm.159.1.9804030; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; GURISH MF, 2001, J EXP MED, V194, P1; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Howarth PH, 1997, ALLERGY, V52, P12, DOI 10.1111/j.1398-9995.1997.tb04878.x; Inagaki N, 1999, EUR J PHARMACOL, V367, P361, DOI 10.1016/S0014-2999(98)00974-1; Irkec M, 2003, CURR ALLERGY ASTHM R, V3, P352, DOI 10.1007/s11882-003-0098-2; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; King NE, 2004, AM J RESP CELL MOL, V31, P257, DOI 10.1165/rcmb.2004-0026OC; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Martin JG, 2002, J IMMUNOL, V169, P3963, DOI 10.4049/jimmunol.169.7.3963; Matsukura S, 2001, AM J RESP CELL MOL, V24, P755, DOI 10.1165/ajrcmb.24.6.4351; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Nagai H, 1999, J PHARMACOL EXP THER, V288, P43; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Oguma T, 2004, NEW ENGL J MED, V351, P1752, DOI 10.1056/NEJMoa031785; PAVORD ID, 1993, AM REV RESPIR DIS, V148, P87, DOI 10.1164/ajrccm/148.1.87; Pawankar R, 2003, CURR OPIN ALLERGY CL, V3, P1, DOI 10.1097/01.all.0000053260.61007.d6; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Pouladi MA, 2004, AM J RESP CELL MOL, V30, P84, DOI 10.1165/rcmb.2003-0051OC; POWELL WS, 1982, METHOD ENZYMOL, V86, P467; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; STEVENS RL, 1987, FASEB J, V46, P1915; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Szczeklik A, 1999, J ALLERGY CLIN IMMUN, V104, P5, DOI 10.1016/S0091-6749(99)70106-5; Takahashi Y, 2002, BRIT J PHARMACOL, V137, P315, DOI 10.1038/sj.bjp.0704872; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; ZUHDI AM, 2000, AM J RESP CELL MOL B, V22, P253	44	174	180	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					524	531		10.1038/ni1188	http://dx.doi.org/10.1038/ni1188			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15806106	Green Submitted			2022-12-18	WOS:000228634300025
J	Perez, OD; Mitchell, D; Jager, GC; South, S; Murriel, C; McBride, J; Herzenberg, LA; Kinoshita, S; Nolan, GP				Perez, OD; Mitchell, D; Jager, GC; South, S; Murriel, C; McBride, J; Herzenberg, LA; Kinoshita, S; Nolan, GP			Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1	NATURE IMMUNOLOGY			English	Article							MODULATE AP-1 ACTIVITY; PROTEIN-KINASE; INTEGRIN LFA-1; MOLECULAR TRANSPORTERS; ADHESION DEFICIENCY; CYTOKINE PRODUCTION; MAP KINASE; COSTIMULATION; DELIVERY; LIGAND	Leukocyte functional antigen 1 (LFA-1), with intercellular adhesion molecule ligands, mediates T cell adhesion, but the signaling pathways and functional effects imparted by LFA-1 are unclear. Here, intracellular phosphoprotein staining with 13-dimensional flow cytometry showed that LFA-1 activation induced phosphorylation of the 2 integrin chain and release of Jun-activating binding protein 1 (JAB-1), and mediated signaling of kinase Erk1/2 through cytohesin-1. Dominant negatives of both JAB-1 and cytohesin-1 inhibited interleukin 2 production and impaired T helper type 1 differentiation. LFA-1 stimulation lowered the threshold of T cell activation. Thus, LFA-1 signaling contributes to T cell activation and effects T cell differentiation.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Baxter Lab Genet Pharmacol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA; Univ Texas, SW Med Ctr, Dept Dermatol, Ctr Immunol, Dallas, TX 75390 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.		Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039646, R01AI035304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR062227] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-281831] Funding Source: Medline; NIAID NIH HHS [AI35304, P01-AI39646] Funding Source: Medline; NIAMS NIH HHS [AR44656, N01-AR-6-2227] Funding Source: Medline; NIH HHS [A1/GF41520-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abraham C, 1999, J IMMUNOL, V162, P4399; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Borovsky Z, 2002, J BIOL CHEM, V277, P21529, DOI 10.1074/jbc.M201613200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; DAMLE NK, 1993, CELL IMMUNOL, V148, P144, DOI 10.1006/cimm.1993.1097; Dierks H, 2001, J BIOL CHEM, V276, P37472, DOI 10.1074/jbc.M101502200; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Glimcher LH, 2000, GENE DEV, V14, P1693; Griffiths EK, 2002, CURR OPIN IMMUNOL, V14, P317, DOI 10.1016/S0952-7915(02)00334-5; GRIFFITHS EK, 2002, SCI STKE, pRE3; Hogg N, 1999, J CLIN INVEST, V103, P97, DOI 10.1172/JCI3312; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kliche S, 2001, MOL CELL, V7, P833, DOI 10.1016/S1097-2765(01)00227-1; Koike T, 2003, J BIOL CHEM, V278, P15685, DOI 10.1074/jbc.M210829200; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li W, 2001, J IMMUNOL, V167, P827, DOI 10.4049/jimmunol.167.2.827; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Porter JC, 2002, J IMMUNOL, V168, P6330, DOI 10.4049/jimmunol.168.12.6330; Ragazzo JL, 2001, P NATL ACAD SCI USA, V98, P241, DOI 10.1073/pnas.011397798; Rothbard JB, 2002, J MED CHEM, V45, P3612, DOI 10.1021/jm0105676; Rovere P, 1996, J IMMUNOL, V156, P2273; Salomon B, 1998, J IMMUNOL, V161, P5138; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Weber KSC, 2001, CURR BIOL, V11, P1969, DOI 10.1016/S0960-9822(01)00597-8; WEISS A, 1987, J IMMUNOL, V138, P2169; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Winquist RJ, 2001, EUR J PHARMACOL, V429, P297, DOI 10.1016/S0014-2999(01)01328-0; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Yu TK, 2000, J IMMUNOL, V164, P6244, DOI 10.4049/jimmunol.164.12.6244; Zola H, 2000, J BIOL REG HOMEOS AG, V14, P218	49	174	182	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1083	1092		10.1038/ni984	http://dx.doi.org/10.1038/ni984			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14528303				2022-12-18	WOS:000186241100012
J	Hu, XY; Herrero, C; Li, WP; Antoniv, TT; Falck-Pedersen, E; Koch, AE; Woods, JM; Haines, GK; Ivashkiv, LB				Hu, XY; Herrero, C; Li, WP; Antoniv, TT; Falck-Pedersen, E; Koch, AE; Woods, JM; Haines, GK; Ivashkiv, LB			Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation	NATURE IMMUNOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; STIMULATED JAK/STAT PATHWAY; EXPRESSING INTERFERON-GAMMA; RECEPTOR-BETA CHAIN; RHEUMATOID-ARTHRITIS; TRANSGENIC MICE; TARGETED DISRUPTION; CROSS-TALK; T-CELLS; CYTOKINE	A general paradigm in signal transduction is ligand-induced feedback inhibition and the desensitization of signaling. We found that subthreshold concentrations of interferon-gamma (IFN-gamma), which did not activate macrophages, increased their sensitivity to subsequent IFN-gamma stimulation; this resulted in increased signal transducer and activator of transcription 1 (STAT1) activation and increased IFN-gamma-dependent gene activation. Sensitization of IFN-gamma signaling was mediated by the induction of STAT1 expression by low doses of IFN-gamma that did not effectively induce feedback inhibition. IFN-gamma signaling was sensitized in vivo after IFN-gamma injection, and STAT1 expression was increased after injection of lipopolysaccharide and in rheumatoid arthritis synovial cells. These results identify a mechanism that sensitizes macrophages to low concentrations of IFN-gamma and regulates IFN-gamma responses in acute and chronic inflammation.	Cornell Univ, Grad Program Immunol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Grad Program Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Hosp Special Surg, Dept Med, New York, NY 10021 USA; Vet Adm Chicago Healthcare Syst, Lakeside Div, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	Cornell University; Cornell University; Northwestern University; Northwestern University	Ivashkiv, LB (corresponding author), Cornell Univ, Grad Program Immunol, Weill Grad Sch Med Sci, New York, NY 10021 USA.		Hu, Xiaoyu/D-5403-2017; Koch, Alisa E/B-6894-2011	Hu, Xiaoyu/0000-0002-4289-6998; Herrero, Carmen/0000-0001-6465-2073; Herrero, Carmen/0000-0002-9509-8033	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040987, R01AI046712, R01AI040987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58695] Funding Source: Medline; NIAID NIH HHS [AI46712, AI40987] Funding Source: Medline; NIAMS NIH HHS [AR46713] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Deon D, 2001, J IMMUNOL, V167, P5395, DOI 10.4049/jimmunol.167.9.5395; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; GREENE WC, 1986, ANN INTERN MED, V105, P560, DOI 10.7326/0003-4819-105-4-560; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Herrero C, 2001, J CLIN INVEST, V107, P485, DOI 10.1172/JCI11696; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Ivashkiv LB, 1996, J IMMUNOL, V157, P1415; Ivashkiv LB, 1996, ADV IMMUNOL, V63, P337, DOI 10.1016/S0065-2776(08)60859-7; Jouanguy E, 1997, J INTERF CYTOK RES, V17, P583, DOI 10.1089/jir.1997.17.583; KOCH AE, 1992, CLIN IMMUNOL IMMUNOP, V65, P23, DOI 10.1016/0090-1229(92)90243-H; KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; KOCH AE, 1992, PATHOBIOLOGY, V60, P59, DOI 10.1159/000163699; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Massa PT, 1996, J IMMUNOL, V157, P5139; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(01)00269-0; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; NARUMI S, 1991, J IMMUNOL, V146, P3038; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Seery JP, 1997, J EXP MED, V186, P1451, DOI 10.1084/jem.186.9.1451; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Stoiber D, 1999, J IMMUNOL, V163, P2640; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Woldman I, 2001, J BIOL CHEM, V276, P45722, DOI 10.1074/jbc.M105320200; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416	51	174	181	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					859	866		10.1038/ni828	http://dx.doi.org/10.1038/ni828			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12172544				2022-12-18	WOS:000177694900015
J	Flodstrom, M; Maday, A; Balakrishna, D; Cleary, MM; Yoshimura, A; Sarvetnick, N				Flodstrom, M; Maday, A; Balakrishna, D; Cleary, MM; Yoshimura, A; Sarvetnick, N			Target cell defense prevents the development of diabetes after viral infection	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; NITRIC-OXIDE SYNTHASE; COXSACKIE B VIRUSES; PANCREATIC-ISLETS; T-CELLS; ENTEROVIRUS INFECTION; ALPHA-INTERFERON; GENE-EXPRESSION; TRANSGENIC MICE; BETA-CELLS	The mechanisms that regulate susceptibility to virus-induced autoimmunity remain undefined. We establish here a fundamental link between the responsiveness of target pancreatic beta cells to interferons (IFNs) and prevention of coxsackievirus B4 ( CVB4)-induced diabetes. We found that an intact beta cell response to IFNs was critical in preventing disease in infected hosts. The antiviral defense, raised by beta cells in response to IFNs, resulted in a reduced permissiveness to infection and subsequent natural killer (NK) cell dependent death. These results show that beta cell defenses are critical for beta cell survival during CVB4 infection and suggest an important role for IFNs in preserving NK cell tolerance to beta cells during viral infection. Thus, alterations in target cell defenses can critically influence susceptibility to disease.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Scripps Research Institute; Kyushu University	Sarvetnick, N (corresponding author), Scripps Res Inst, Dept Immunol, IMM-23,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noras@scripps.edu	Yoshimura, Akihiko/K-5515-2013	Flodstrom Tullberg, Malin/0000-0003-2685-2052	NIAID NIH HHS [R01AI42231] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042231] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Andreoletti L, 1998, CLIN DIAGN VIROL, V9, P125, DOI 10.1016/S0928-0197(98)00011-7; Bach JF, 2000, CLIN REV ALLERG IMMU, V19, P217, DOI 10.1385/CRIAI:19:3:217; Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1997, J INFECT DIS, V175, P697, DOI 10.1093/infdis/175.3.697; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; CHAMPSAUR H, 1980, LANCET, V1, P251, DOI 10.1016/S0140-6736(80)90731-X; Chehadeh W, 2000, J VIROL, V74, P10153, DOI 10.1128/JVI.74.21.10153-10164.2000; Cottet S, 2001, J BIOL CHEM, V276, P25862, DOI 10.1074/jbc.M103235200; DOHERTY PC, 1987, CELL IMMUNOL, V107, P1, DOI 10.1016/0008-8749(87)90259-0; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Flodstrom M, 1997, ENDOCRINOLOGY, V138, P2747, DOI 10.1210/en.138.7.2747; Flodstrom M, 2001, VIROLOGY, V281, P205, DOI 10.1006/viro.2000.0801; FOULIS AK, 1987, LANCET, V2, P1423; Foulis AK, 1997, DIABETOLOGIA, V40, P53, DOI 10.1007/s001250050642; Frisk G, 2000, Int J Exp Diabetes Res, V1, P165, DOI 10.1155/EDR.2000.165; Frisk G, 2001, J VIROL METHODS, V98, P161, DOI 10.1016/S0166-0934(01)00363-9; FRISK G, 1994, VIRUS RES, V33, P229, DOI 10.1016/0168-1702(94)90105-8; GLADISCH R, 1976, Z KARDIOL, V65, P837; GODENY EK, 1987, J IMMUNOL, V139, P913; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Graves PM, 1997, DIABETES, V46, P161, DOI 10.2337/diabetes.46.2.161; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; HARADA M, 1995, CELL IMMUNOL, V161, P42, DOI 10.1006/cimm.1995.1007; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Hiltunen M, 1997, J INFECT DIS, V175, P554, DOI 10.1093/infdis/175.3.554; Horwitz MS, 1999, J VIROL, V73, P1756, DOI 10.1128/JVI.73.3.1756-1766.1999; Horwitz MS, 1999, IMMUNOL REV, V169, P241, DOI 10.1111/j.1600-065X.1999.tb01319.x; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Hyoty H, 1998, CLIN DIAGN VIROL, V9, P77, DOI 10.1016/S0928-0197(98)00007-5; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Imagawa A, 2000, ANN MED, V32, P539, DOI 10.3109/07853890008998833; JENSON AB, 1980, LANCET, V2, P354; KASAI M, 1981, NATURE, V291, P334, DOI 10.1038/291334a0; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Kile BT, 2001, INT J HEMATOL, V73, P292, DOI 10.1007/BF02981953; Knip M, 1999, EXP CLIN ENDOCR DIAB, V107, pS93, DOI 10.1055/s-0029-1212160; Kukreja A, 2000, CELL MOL LIFE SCI, V57, P534, DOI 10.1007/PL00000715; Le Page C, 2000, Rev Immunogenet, V2, P374; Lee U, 1996, JPN J CANCER RES, V87, P429, DOI 10.1111/j.1349-7006.1996.tb00241.x; Lonnrot M, 2000, DIABETES, V49, P1314, DOI 10.2337/diabetes.49.8.1314; Ludewig B, 2001, CURR OPIN IMMUNOL, V13, P657, DOI 10.1016/S0952-7915(01)00275-8; Luppi P, 2000, DIABETOLOGIA, V43, P1484, DOI 10.1007/s001250051559; Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000; Mena I, 2000, VIROLOGY, V271, P276, DOI 10.1006/viro.2000.0332; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; NIGRO G, 1986, EUR J PEDIATR, V145, P557, DOI 10.1007/BF02429065; PARKER SE, 1988, J IMMUNOGENET, V15, P215; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Ramsingh AI, 1999, J VIROL, V73, P3080, DOI 10.1128/JVI.73.4.3080-3086.1999; Ramsingh AI, 1997, BIOESSAYS, V19, P793, DOI 10.1002/bies.950190909; RHODES CJ, 1985, BIOCHEM J, V228, P87, DOI 10.1042/bj2280087; RHODES CJ, 1984, DIABETOLOGIA, V27, P601, DOI 10.1007/BF00276977; Robles DT, 2001, J AUTOIMMUN, V16, P355, DOI 10.1006/jaut.2000.0483; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Rueckert R., 1996, FIELDS VIROLOGY, P609; Sakamoto H, 2000, LEUKEMIA LYMPHOMA, V38, P49, DOI 10.3109/10428190009060318; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; SHIMIZU F, 1985, ENDOCRINOLOGY, V117, P2081, DOI 10.1210/endo-117-5-2081; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; SOMOZA N, 1994, J IMMUNOL, V153, P1360; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; SZOPA TM, 1986, CELL BIOCHEM FUNCT, V4, P181, DOI 10.1002/cbf.290040304; SZOPA TM, 1989, DIABETIC MED, V6, P314, DOI 10.1111/j.1464-5491.1989.tb01171.x; Tay CH, 1998, CURR TOP MICROBIOL, V230, P193; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Torres A, 1984, Bol Asoc Med P R, V76, P49; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VELLA C, 1992, J GEN VIROL, V73, P1379, DOI 10.1099/0022-1317-73-6-1379; Vreugdenhil GR, 2000, CLIN INFECT DIS, V31, P1025, DOI 10.1086/318159; Whitton JL, 1999, CURR OPIN MICROBIOL, V2, P392; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; WILTROUT RH, 1985, J BIOL RESP MODIF, V4, P512; YOON JW, 1980, J EXP MED, V152, P878, DOI 10.1084/jem.152.4.878; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	86	174	179	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					373	382		10.1038/ni771	http://dx.doi.org/10.1038/ni771			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919579				2022-12-18	WOS:000174623600019
J	Fukao, T; Yamada, T; Tanabe, M; Terauchi, Y; Ota, T; Takayama, T; Asano, T; Takeuchi, T; Kadowaki, T; Hata, J; Koyasu, S				Fukao, T; Yamada, T; Tanabe, M; Terauchi, Y; Ota, T; Takayama, T; Asano, T; Takeuchi, T; Kadowaki, T; Hata, J; Koyasu, S			Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; CONNECTIVE-TISSUE-TYPE; C-KIT LIGAND; TRICHINELLA-SPIRALIS; STRONGYLOIDES-VENEZUELENSIS; CARDIOPULMONARY ALTERATIONS; P85-ALPHA SUBUNIT; DEFICIENT W/WV; EXPRESSION; ANAPHYLAXIS	Mice that lack the p85alpha regulatory subunit of phosphatidylinositol-3 kinase (PI3K) are deficient in gastrointestinal and peritoneal mast cells but have dermal mast cells. Accordingly, these mice show impaired bacterial clearance in response to acute septic peritonitis and are highly susceptible to infection by the intestinal nematode Strongyloides venezuelensis. Systemic anaphylactic shock responses, however, are intact. We found that although reconstitution of PI3K(-/-) mice with bone marrow-derived mast cells (BMMCs) restored anti-bacterial immunity, only T helper type 2 (T(H)2)-conditioned BMMCs, not "standard" BMMCs, were able to restore anti-nematode immunity. This finding highlights the importance of the T(H)2 response in the control of nematode infection. Thus, PI3K likely plays an essential role in host immune responses by regulating both the development and induction of mast cells.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	Keio University; Keio University; Keio University; University of Tokyo	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	koyasu@sc.itc.keio.ac.jp	Koyasu, Shigeo/J-5583-2015; Terauchi, Yasuo/AAO-4347-2020; Fukao, Taro/I-3246-2014; Ota, Takayuki/Q-5528-2017	Koyasu, Shigeo/0000-0001-9585-3038; Ota, Takayuki/0000-0001-6249-0664				ABE T, 1988, PARASITOL RES, V74, P484, DOI 10.1007/BF00535150; ABE T, 1987, PARASITE IMMUNOL, V9, P31, DOI 10.1111/j.1365-3024.1987.tb00486.x; BOCHNER BS, 1991, NEW ENGL J MED, V324, P1785, DOI 10.1056/NEJM199106203242506; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FINKELMAN FD, 1994, J EXP MED, V179, P1563, DOI 10.1084/jem.179.5.1563; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; Galli S J, 1994, Curr Opin Hematol, V1, P33; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; GALLI SJ, 1987, AM J PATHOL, V127, P191; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; GHILDYAL N, 1992, J BIOL CHEM, V267, P8473; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; Godfraind C, 1998, J IMMUNOL, V160, P3989; GURISH MF, 2001, J EXP MED, V194, P1; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JACOBY W, 1984, J INVEST DERMATOL, V83, P302, DOI 10.1111/1523-1747.ep12340431; KHAN AI, 1993, INT J PARASITOL, V23, P551, DOI 10.1016/0020-7519(93)90159-V; Khan WI, 2001, INFECT IMMUN, V69, P838, DOI 10.1128/IAI.69.2.838-844.2001; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; KITAMURA Y, 1978, BLOOD, V52, P447; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kobayashi T, 1998, PARASITE IMMUNOL, V20, P279, DOI 10.1046/j.1365-3024.1998.00142.x; LANTZ CS, 1995, J IMMUNOL, V155, P4024; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; MEKORI YA, 1993, J IMMUNOL, V151, P3775; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NAWA Y, 1994, PARASITE IMMUNOL, V16, P333, DOI 10.1111/j.1365-3024.1994.tb00358.x; OKUDA K, 1992, BLOOD, V79, P2880; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; SATO Y, 1990, INT J PARASITOL, V20, P63, DOI 10.1016/0020-7519(90)90174-L; Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Suzuki K, 2000, BLOOD, V96, P2172, DOI 10.1182/blood.V96.6.2172.h8002172_2172_2180; TAKEISHI T, 1991, J CLIN INVEST, V88, P598, DOI 10.1172/JCI115344; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663	59	174	177	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					295	304		10.1038/ni768	http://dx.doi.org/10.1038/ni768			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11850627				2022-12-18	WOS:000174074000019
J	Larregina, AT; Morelli, AE; Spencer, LA; Logar, AJ; Watkins, SC; Thomson, AW; Falo, LD				Larregina, AT; Morelli, AE; Spencer, LA; Logar, AJ; Watkins, SC; Thomson, AW; Falo, LD			Dermal-resident CD14(+) cells: differentiate into Langerhans cells	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; NECROSIS-FACTOR-ALPHA; NORMAL HUMAN-SKIN; DENDRITIC CELLS; T-LYMPHOCYTES; IN-VITRO; GENERATION; MIGRATION; ANTIGENS; LOCALIZATION	Epidermal Langerhans cells (LCs) show extraordinary immunostimulatory capacity and play a key role in the initiation and regulation of immune responses. Studies of LC biology are currently the focus of efforts to engineer immune responses and to better understand the immunopathology of cutaneous diseases. Here we identified and characterized a population of LC precursors that were resident in human skin. These immediate precursors expressed CD14, langerin and functional CCR6. When cultured with transforming growth factor-beta1 alone, they had the potential to differentiate into epidermal LCs; when cultured in the presence of granulocyte macrophage-colony-stimulating factor and interleukin 4 they differentiated into functionally mature dendritic cells. Identification and characterization of these LC precursors provided insight into LC biology and the mechanism(s) through which LCs repopulate the epidermis.	Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Ctr Biol Imaging, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Larregina, AT (corresponding author), Univ Pittsburgh, Med Ctr, Dept Dermatol, Pittsburgh, PA 15213 USA.		Falo, Louis/ABD-1499-2020; Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	NCI NIH HHS [P01 CA73743] Funding Source: Medline; NIAID NIH HHS [R01 AI43916, R01 AI41011] Funding Source: Medline; NIDDK NIH HHS [R01 DK49745] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA073743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043916, R01AI041011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049745] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BIRBECK MS, 1961, J INVEST DERMATOL, V37, P51, DOI 10.1038/jid.1961.80; Borkowski TA, 1997, J CLIN INVEST, V100, P575, DOI 10.1172/JCI119567; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Caux C, 1996, BLOOD, V87, P2376, DOI 10.1182/blood.V87.6.2376.bloodjournal8762376; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CERIO R, 1989, BRIT J DERMATOL, V121, P421, DOI 10.1111/j.1365-2133.1989.tb15509.x; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x; DEZUTTERDAMBUYA.C, 1984, BRIT J DERMATOL, V3, P1; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ito T, 1999, J IMMUNOL, V163, P1409; KANG KF, 1994, J IMMUNOL, V153, P5256; KOSZIK F, 1994, J INVEST DERMATOL, V102, P773, DOI 10.1111/1523-1747.ep12377706; Larregina AT, 1997, IMMUNOLOGY, V91, P303, DOI 10.1046/j.1365-2567.1997.00250.x; Larregina AT, 2000, HUM GENE THER, V11, P2301, DOI 10.1089/104303400750035852; LARREGINA AT, 2001, DENDRITIC CELLS BIOL, P301; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; MEUNIER L, 1995, J INVEST DERMATOL, V105, P782, DOI 10.1111/1523-1747.ep12326032; Morelli A, 1996, IMMUNOLOGY, V89, P126, DOI 10.1046/j.1365-2567.1996.d01-701.x; MORI M, 1994, HISTOPATHOLOGY, V24, P311, DOI 10.1111/j.1365-2559.1994.tb00531.x; MURPHY GF, 1986, AM J PATHOL, V123, P401; NESTLE FO, 1995, J CUTAN PATHOL, V22, P385, DOI 10.1111/j.1600-0560.1995.tb00753.x; NESTLE FO, 1993, J IMMUNOL, V151, P6535; POLIT FD, 1996, DATA ANAL STAT NURSI, P156; POPE M, 1995, J INVEST DERMATOL, V104, P11, DOI 10.1111/1523-1747.ep12613452; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Riedl E, 1997, J IMMUNOL, V158, P1591; RUCO LP, 1989, AM J CLIN PATHOL, V92, P273, DOI 10.1093/ajcp/92.3.273; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; STROBEL H, 1997, IMMUNOBIOLOGY, V198, P588; STROBL H, 1996, BLOOD, V90, P1425; Strunk D, 1996, BLOOD, V87, P1292, DOI 10.1182/blood.V87.4.1292.bloodjournal8741292; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0	41	174	177	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1151	1158		10.1038/ni731	http://dx.doi.org/10.1038/ni731			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11702065				2022-12-18	WOS:000172473200018
J	Piskurich, JF; Lin, KI; Lin, Y; Wang, Y; Ting, JPY; Calame, K				Piskurich, JF; Lin, KI; Lin, Y; Wang, Y; Ting, JPY; Calame, K			BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells	NATURE IMMUNOLOGY			English	Article							INVARIANT CHAIN GENE; IFN-GAMMA; MICE LACKING; B-CELLS; C-MYC; ACTIVE SUPPRESSION; SECRETING CELLS; MHC; CIITA; PROMOTER	Class II transactivator (CIITA), a coactivator required for class II major histocompatibility complex (MHC) transcription, is expressed in B cells but extinguished in plasma cells,This report identifies B lymphocyte-induced maturation protein I (BLIMP-I), a transcriptional repressor that is capable of triggering plasma cell differentiation, as a developmentally regulated repressor of CIITA transcription. BLIMP-I represses the B cell-specific promoter of the human gene that encodes CI ITA (MHC2TA) in a binding site-dependent manner. Decreased CIITA correlates with increased BLIMP-I during plasma cell differentiation in cultured cells. Ectopic expression of BLIMP I represses endogenous mRNA for CIITA and the CIITA targets, class II MHC, invariant chain and H2-DM (the murine equivalent of HLA-DM) in primary splenic B cells as well as 18-81 pre-B cells. Thus, the BLIMP-I program of B cell differentiation includes loss of antigen presentation via extinction of CIITA expression.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	University of North Carolina; University of North Carolina Chapel Hill; Columbia University	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.		Lin, KUO-I/C-6928-2009		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043567, R56AI029564, P01AI041580, R01AI029564, R01AI041751, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034190] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29564, AI41580, AI43567, AI41751] Funding Source: Medline; NIGMS NIH HHS [GM29361] Funding Source: Medline; NINDS NIH HHS [NS34190] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSSON J, 1974, EUR J IMMUNOL, V4, P715, DOI 10.1002/eji.1830041103; Angelin-Duclos C, 1998, MOL CELL BIOL, V18, P6253, DOI 10.1128/MCB.18.11.6253; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BROWN AM, 1993, J BIOL CHEM, V268, P26328; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Burrows P D, 1990, Semin Immunol, V2, P189; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHANG CH, 1992, J EXP MED, V176, P1465, DOI 10.1084/jem.176.5.1465; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; DELLABONA P, 1989, J IMMUNOL, V142, P2902; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Ghosh N, 1999, J BIOL CHEM, V274, P32342, DOI 10.1074/jbc.274.45.32342; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; HALPER J, 1978, J IMMUNOL, V120, P1480; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KARA CJ, 1993, EMBO J, V12, P187, DOI 10.1002/j.1460-2075.1993.tb05644.x; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; LALA PK, 1979, J IMMUNOL, V122, P334; LATRON F, 1988, P NATL ACAD SCI USA, V85, P2229, DOI 10.1073/pnas.85.7.2229; Lee YJ, 1997, J IMMUNOL, V158, P2065; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; LIN KI, 2000, IN PRESS MOL CELL BI, V20; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; MIKI N, 1992, J IMMUNOL, V149, P801; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nandan D, 1997, J IMMUNOL, V158, P1095; NATKUNAM Y, 1994, J IMMUNOL, V153, P3476; Nikcevich KM, 1999, J NEUROIMMUNOL, V99, P195, DOI 10.1016/S0165-5728(99)00117-4; Piskurich JF, 1998, J IMMUNOL, V160, P233; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; ROSA F, 1983, EMBO J, V2, P1585, DOI 10.1002/j.1460-2075.1983.tb01628.x; Sartoris S, 1996, EUR J IMMUNOL, V26, P2456, DOI 10.1002/eji.1830261028; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Ting JPY, 1997, J IMMUNOL, V159, P5457; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wilson IA, 1996, SCIENCE, V272, P973, DOI 10.1126/science.272.5264.973; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	52	174	182	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					526	532		10.1038/82788	http://dx.doi.org/10.1038/82788			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101876				2022-12-18	WOS:000165724600018
J	Carr, EJ; Dooley, J; Garcia-Perez, JE; Lagou, V; Lee, JC; Wouters, C; Meyts, I; Goris, A; Boeckxstaens, G; Linterman, MA; Liston, A				Carr, Edward J.; Dooley, James; Garcia-Perez, Josselyn E.; Lagou, Vasiliki; Lee, James C.; Wouters, Carine; Meyts, Isabelle; Goris, An; Boeckxstaens, Guy; Linterman, Michelle A.; Liston, Adrian			The cellular composition of the human immune system is shaped by age and cohabitation	NATURE IMMUNOLOGY			English	Article							THYMIC INVOLUTION; INFLUENZA; INFLAMMATION; CONCORDANCE; VACCINATION; MICROBIOTA; PHENOTYPE; RESPONSES; PATTERNS; HEALTH	Detailed population-level description of the human immune system has recently become achievable. We used a 'systems-level' approach to establish a resource of cellular immune profiles of 670 healthy individuals. We report a high level of interindividual variation, with low longitudinal variation, at the level of cellular subset composition of the immune system. Despite the profound effects of antigen exposure on individual antigen-specific clones, the cellular subset structure proved highly elastic, with transient vaccination-induced changes followed by a return to the individual's unique baseline. Notably, the largest influence on immunological variation identified was cohabitation, with 50% less immunological variation between individuals who share an environment (as parents) than between people in the wider population. These results identify local environmental conditions as a key factor in shaping the human immune system.	[Carr, Edward J.; Linterman, Michelle A.] Babraham Inst, Lymphocyte Signaling & Dev ISP, Cambridge, England; [Dooley, James; Garcia-Perez, Josselyn E.; Lagou, Vasiliki; Liston, Adrian] VIB, Translat Immunol Lab, Leuven, Belgium; [Dooley, James; Garcia-Perez, Josselyn E.; Lagou, Vasiliki; Wouters, Carine; Meyts, Isabelle; Liston, Adrian] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lagou, Vasiliki; Goris, An] Univ Leuven, Dept Neurosci, Leuven, Belgium; [Lee, James C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Lee, James C.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Boeckxstaens, Guy] Univ Leuven, Dept Expt Med, Leuven, Belgium	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Cambridge; University of Cambridge; KU Leuven	Liston, A (corresponding author), VIB, Translat Immunol Lab, Leuven, Belgium.; Liston, A (corresponding author), Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	adrian.liston@vib.be	Boeckxstaens, Guy/AAP-2502-2020; Lee, James/ABD-5920-2020; Linterman, Michelle/AAN-4210-2021; Meyts, Isabelle/Z-3295-2019; Goris, An/L-5852-2019	Lee, James/0000-0001-5711-9385; Linterman, Michelle/0000-0001-6047-1996; Goris, An/0000-0002-1276-6682; Lagou, Vasiliki/0000-0003-3165-8940; Carr, Edward/0000-0001-9343-4593; Wouters, Carine/0000-0002-6426-8845; Dooley, James/0000-0003-3154-4708	National Institute for Health Research Cambridge Biomedical Research Centre; European Research Council; NIHR; Biotechnology and Biological Sciences Research Council; Research Fund KU Leuven [OT/11/087]; Research Foundation Flanders [G073415N]; Wellcome Trust [105920/Z/14/Z]; BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0407] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0409] Funding Source: researchfish; National Institute for Health Research [ACF-2014-14-003] Funding Source: researchfish	National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); NIHR(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Fund KU Leuven(KU Leuven); Research Foundation Flanders(FWO); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all volunteers for their participation; the Cambridge BioResource staff for help with volunteer recruitment; members of the Cambridge BioResource SAB and Management Committee for support of this study; and A. Nuygen, D. Franckaert, D. Danso-Abeam and L. Van Eyck (KUL-VIB) for technical assistance. Supported by the National Institute for Health Research Cambridge Biomedical Research Centre; the European Research Council (Start Grant IMMUNO to A. L. and Start Grant TWILIGHT to M.A.L.). the NIHR (E.J.C.), the Biotechnology and Biological Sciences Research Council (M.A.L.), Research Fund KU Leuven (OT/11/087 to A.G.), Research Foundation Flanders (G073415N to A.G.) and the Wellcome Trust (105920/Z/14/Z to J.C.L.).	AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Csiszar A, 2012, J GERONTOL A-BIOL, V67, P811, DOI 10.1093/gerona/glr228; Damluji AA, 2015, HEART, V101, P436, DOI 10.1136/heartjnl-2014-306649; Davis MM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003385; De Jager PL, 2015, SEMIN IMMUNOL, V27, P51, DOI 10.1016/j.smim.2015.03.003; DeMarco MM, 2011, AM J EPIDEMIOL, V174, P790, DOI 10.1093/aje/kwr167; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Falba TA, 2008, HEALTH SERV RES, V43, P96, DOI 10.1111/j.1475-6773.2007.00754.x; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Franckaert D, 2015, EUR J IMMUNOL, V45, P1535, DOI 10.1002/eji.201445277; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Graham K, 1999, ADDICT BEHAV, V24, P839, DOI 10.1016/S0306-4603(99)00059-3; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; Johnson PLF, 2012, P NATL ACAD SCI USA, V109, P21432, DOI 10.1073/pnas.1209283110; Kort R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-41; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; R Development Core Team, 2014, R FDN STAT COMP; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Song Y, 2012, ARTERIOSCL THROM VAS, V32, P103, DOI 10.1161/ATVBAHA.111.236349; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; Spielmann G, 2014, CLIN EXP IMMUNOL, V176, P246, DOI 10.1111/cei.12267; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Van de Voorde J, 2014, CURR VASC PHARMACOL, V12, P403; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	40	173	176	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					461	+		10.1038/ni.3371	http://dx.doi.org/10.1038/ni.3371			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26878114	Green Accepted, Green Submitted			2022-12-18	WOS:000372508000021
J	Duerkop, BA; Hooper, LV				Duerkop, Breck A.; Hooper, Lora V.			Resident viruses and their interactions with the immune system	NATURE IMMUNOLOGY			English	Article							HUMAN GUT VIROME; CYCLIC GMP-AMP; BACTERIOPHAGE PARTICLES; DENDRITIC CELLS; CYTOSOLIC DNA; HUMAN FECES; MICROBIOTA; INFECTION; DIVERSITY; HOST	The human body is colonized with a diverse resident microflora that includes viruses. Recent studies of metagenomes have begun to characterize the composition of the human 'virobiota' and its associated genes (the 'virome'), and have fostered the emerging field of host-virobiota interactions. In this Perspective, we explore how resident viruses interact with the immune system. We review recent findings that highlight the role of the immune system in shaping the composition of the virobiota and consider how resident viruses may impact host immunity. Finally, we discuss the implications of virobiota-immune system interactions for human health.	[Duerkop, Breck A.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Duerkop, Breck/I-2460-2019	Duerkop, Breck/0000-0003-4030-9822	Ruth L. Kirschstein National Research Service Award [F32 DK089718]; Howard Hughes Medical Institute; US National Institutes of Health [R01 DK070855]; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK089718, R01DK070855] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a Ruth L. Kirschstein National Research Service Award F32 DK089718 (to B. A. D.), The Howard Hughes Medical Institute (to L. V. H.), US National Institutes of Health grant R01 DK070855 (to L. V. H.) and a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases award (to L.V.H.).	BARFOOT R, 1989, IMMUNOLOGY, V68, P233; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; DEMARINI DM, 1992, MUTAT RES, V267, P1, DOI 10.1016/0027-5107(92)90106-C; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109; Duerr DM, 2004, J VIROL METHODS, V116, P177, DOI 10.1016/j.jviromet.2003.11.012; Eriksson F, 2009, J IMMUNOL, V182, P3105, DOI 10.4049/jimmunol.0800224; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gorski A, 2006, TRANSPL P, V38, P331, DOI 10.1016/j.transproceed.2005.12.073; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Hamzeh-Mivehroud M, 2008, EUR J PHARM BIOPHARM, V70, P577, DOI 10.1016/j.ejpb.2008.06.005; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; INCHLEY CJ, 1969, CLIN EXP IMMUNOL, V5, P189; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; KELLER R, 1958, P SOC EXP BIOL MED, V98, P577, DOI 10.3181/00379727-98-24112; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mori K, 1996, ANTIVIR RES, V31, P79, DOI 10.1016/0166-3542(96)00951-5; NELSON J, 1980, CLIN EXP IMMUNOL, V42, P234; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Pride DT, 2012, ENVIRON MICROBIOL, V14, P2564, DOI 10.1111/j.1462-2920.2012.02775.x; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; White DW, 2012, IMMUNOL REV, V245, P189, DOI 10.1111/j.1600-065X.2011.01074.x; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	57	173	184	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					654	659		10.1038/ni.2614	http://dx.doi.org/10.1038/ni.2614			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778792	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000320509100003
J	Ilani, T; Vasiliver-Shamis, G; Vardhana, S; Bretscher, A; Dustin, ML				Ilani, Tal; Vasiliver-Shamis, Gaia; Vardhana, Santosh; Bretscher, Anthony; Dustin, Michael L.			T cell antigen receptor signaling and immunological synapse stability require myosin IIA	NATURE IMMUNOLOGY			English	Article							ACTIN CYTOSKELETON; IMMUNE SYNAPSE; ACTIVATION; RECRUITMENT; PHOSPHORYLATION; MICROCLUSTERS; MOLECULES; ADHESION; CYTOKINESIS; LYMPHOCYTES	Immunological synapses are initiated by signaling in discrete T cell antigen receptor microclusters and are important for the differentiation and effector functions of T cells. Synapse formation involves the orchestrated movement of microclusters toward the center of the contact area with the antigen-presenting cell. Microcluster movement is associated with centripetal actin flow, but the function of motor proteins is unknown. Here we show that myosin IIA was necessary for complete assembly and movement of T cell antigen receptor microclusters. In the absence of myosin IIA or its ATPase activity, T cell signaling was interrupted 'downstream' of the kinase Lck and the synapse was destabilized. Thus, T cell antigen receptor signaling and the subsequent formation of immunological synapses are active processes dependent on myosin IIA.	[Ilani, Tal; Bretscher, Anthony] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Vasiliver-Shamis, Gaia; Vardhana, Santosh; Dustin, Michael L.] NYU, Sch Med, Mol Pathogenesis Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY USA	Cornell University; New York University	Bretscher, A (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	apb5@cornell.edu; michael.dustin@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Vardhana, Santosha/0000-0002-3100-1298; Dustin, Michael/0000-0003-4983-6389; Ilani, Tal/0000-0003-2806-4455	European Molecular Biology Organization; US National Institutes of Health [GM36652, AI44931]; Nanomedicine Development Center [EY16586]; NATIONAL EYE INSTITUTE [PN2EY016586, PN1EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044931, R56AI044931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036652] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nanomedicine Development Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Garbett for help with data analysis with Volocity and for comments, and D. W. Pruyne for help in setting up DIC microscopy. Supported by the European Molecular Biology Organization (T. I.) and the US National Institutes of Health (GM36652 to A. B.; and AI44931 and Nanomedicine Development Center EY16586 to M. L. D.).	Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Blanchard N, 2004, J IMMUNOL, V173, P3062, DOI 10.4049/jimmunol.173.5.3062; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CHAKRABORTY AK, 2002, SCI STKE, pPE10; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Davis MM, 2007, IMMUNITY, V27, P179, DOI 10.1016/j.immuni.2007.08.005; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Janeway C A Jr, 1996, Semin Immunol, V8, P108; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MAUPIN P, 1994, J CELL SCI, V107, P3077; MESCHER MF, 1992, J IMMUNOL, V149, P2402; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vasiliver-Shamis G, 2008, J VIROL, V82, P9445, DOI 10.1128/JVI.00835-08; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	50	173	176	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					531	539		10.1038/ni.1723	http://dx.doi.org/10.1038/ni.1723			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19349987	Green Accepted			2022-12-18	WOS:000265394400015
J	Cannarile, MA; Lind, NA; Rivera, R; Sheridan, AD; Camfield, KA; Wu, BB; Cheung, KP; Ding, ZQ; Goldrath, AW				Cannarile, Michael A.; Lind, Nicholas A.; Rivera, Richard; Sheridan, Alison D.; Camfield, Kristin A.; Wu, Bei Bei; Cheung, Kitty P.; Ding, Zhaoqing; Goldrath, Ananda W.			Transcriptional regulator Id2 mediates CD8(+) T cell immunity	NATURE IMMUNOLOGY			English	Article							HELIX INHIBITOR ID2; LYMPHOCYTE DEVELOPMENT; SECONDARY EXPANSION; MICE LACKING; MEMORY; PROTEINS; EFFECTOR; E2A; DIFFERENTIATION; PROLIFERATION	Transcriptional programs that initiate and sustain the proliferation, differentiation and survival of CD8(+) T cells during immune responses are not completely understood. Here we show that inhibitor of DNA binding 2 (Id2), an antagonist of E protein transcription factors, was upregulated in CD8(+) T cells during infection and that expression of Id2 was maintained in memory CD8(+) T cells. Although Id2-deficient naive CD8(+) T cells recognized antigen and proliferated normally early after infection, effector CD8+ T cells did not accumulate because the cells were highly susceptible to apoptosis. Id2-deficient CD8(+) T cells responding to infection had changes in the expression of genes that influence survival and had altered memory formation. Our data emphasize the importance of ld2 in regulating gene expression by CD8+ T cells and the magnitude of effector responses, suggesting a mechanism involving Id protein- and E protein-mediated survival and differentiation of mature T cells.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu		Sheridan, Alison/0000-0002-6831-0668	NIAID NIH HHS [AI067545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067545] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Fukunaga A, 2002, RRD MAT SCI, V3, P31; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Goldfarb AN, 1996, MOL IMMUNOL, V33, P947, DOI 10.1016/S0161-5890(96)00047-8; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kim JK, 2004, GUT, V53, P480, DOI 10.1136/gut.2003.022293; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Pan LH, 2004, IMMUNOLOGY, V111, P147, DOI 10.1111/j.0019-2805.2003.01802.x; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Sugai M, 2004, J MOL MED, V82, P592, DOI 10.1007/s00109-004-0562-z; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yokota Y, 2000, CURR TOP MICROBIOL, V251, P35; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	38	173	177	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1317	1325		10.1038/ni1403	http://dx.doi.org/10.1038/ni1403			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17086188				2022-12-18	WOS:000242125200014
J	Tesselaar, K; Arens, R; van Schijndel, GMW; Baars, PA; van der Valk, MA; Borst, J; van Oers, MHJ; van Lier, RAW				Tesselaar, K; Arens, R; van Schijndel, GMW; Baars, PA; van der Valk, MA; Borst, J; van Oers, MHJ; van Lier, RAW			Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions	NATURE IMMUNOLOGY			English	Article							RECEPTOR FAMILY-MEMBERS; TNF-RECEPTOR; INTERFERON-GAMMA; HIV-1 INFECTION; 4-1BB LIGAND; MURINE CD70; B-CELL; VIRUS; MICE; EXPRESSION	It has been proposed that HIV-1, in addition to directly infecting and killing CD4(+) T cells, causes T cell dysfunction and T cell loss by chronic immune activation. We analyzed the effects of chronic immune activation in mice that constitutively expressed CD70, the ligand for the tumor necrosis factor receptor family member CD27, on B cells. CD70 transgenic (CD70 Tg) mice showed a progressive conversion of naive T cells into effector-memory cells, which culminated in the depletion of naive T cells from lymph nodes and spleen. T cell changes depended on continuous CD27-CD70 interactions and T cell antigen receptor stimulation. Despite this hyperactive immune system, CD70 Tg mice died aged 6-8 months from Pneumocystis carinii infection, a hallmark of T cell immunodeficiency. Thus, persistent delivery of costimulatory signals via CD27-CD70 interactions, as may occur during chronic active viral infections, can exhaust the T cell pool and is sufficient to induce lethal immunodeficiency.	Acad Med Ctr, Expt Immunol Lab, NL-1100 DD Amsterdam, Netherlands; Acad Med Ctr, Dept Hematol, NL-1100 DD Amsterdam, Netherlands; Acad Med Ctr, Dept Immunobiol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Lab Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	van Lier, RAW (corresponding author), Acad Med Ctr, Expt Immunol Lab, POB 22700, NL-1100 DD Amsterdam, Netherlands.	R.vanLier@AMC.UVA.NL	Arens, Ramon/V-4010-2018	Arens, Ramon/0000-0001-5058-4110; Tesselaar, Kiki/0000-0002-9847-0814; Borst, Jannie/0000-0002-8043-5009; van Lier, Rene/0000-0002-3201-7144				Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gravestein LA, 1998, SEMIN IMMUNOL, V10, P423, DOI 10.1006/smim.1998.0144; Green EA, 1998, IMMUNITY, V9, P733, DOI 10.1016/S1074-7613(00)80670-6; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; HINTZEN RQ, 1994, J IMMUNOL, V152, P1762; KASLOW RA, 1987, ANN INTERN MED, V107, P474, DOI 10.7326/0003-4819-107-4-474; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Tan JT, 1999, J IMMUNOL, V163, P4859; Tesselaar K, 1997, J IMMUNOL, V159, P4959; Wolthers KC, 1996, EUR J IMMUNOL, V26, P1700, DOI 10.1002/eji.1830260806; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	35	173	187	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					49	54		10.1038/ni869	http://dx.doi.org/10.1038/ni869			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12469117	Bronze			2022-12-18	WOS:000180053000014
J	Geiger, H; Van Zant, G				Geiger, H; Van Zant, G			The aging of lympho-hematopoietic stem cells	NATURE IMMUNOLOGY			English	Review							LONG-TERM; BONE-MARROW; REPLICATIVE SENESCENCE; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; MOUSE STRAINS; IMMUNE-SYSTEM; DNA-DAMAGE; AGE; MICE	The extensive self-renewal capacity of hematopoietic stem cells (HSCs) implies that this cell population may not age and thus may provide undiminished replenishment of blood cells throughout the lifespan of an organism. In contrast, accumulating experimental evidence supports the premise that HSCs show signs of aging and may have a limited functional lifespan. We summarize here the evidence for HSC aging, discuss the possible molecular mechanisms that may be involved and show evidence of a genetic connection between the effects of age on blood-forming cells and the longevity of mice. We speculate that age-related functional decline in adult tissue HSCs limits longevity in mammals.	Univ Kentucky, Dept Med, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Van Zant, G (corresponding author), Univ Kentucky, Dept Med, Lexington, KY 40536 USA.				NATIONAL INSTITUTE ON AGING [R01AG016653] Funding Source: NIH RePORTER; NIA NIH HHS [AG16653] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355; Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223; Aspinall R, 2001, CELL IMMUNOL, V212, P150, DOI 10.1006/cimm.2001.1848; Aspinall R, 2000, BIOGERONTOLOGY, V1, P273, DOI 10.1023/A:1010046532657; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399; Bohr V, 1998, TOXICOL LETT, V103, P47; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; CASHMAN J, 1985, BLOOD, V66, P1002; Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; CHERTKOV JL, 1981, EXP GERONTOL, V16, P195, DOI 10.1016/0531-5565(81)90045-0; de Haan G, 2000, BLOOD, V96, P1374, DOI 10.1182/blood.V96.4.1374.h8001374_1374_1379; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Effros RB, 1998, AM J HUM GENET, V62, P1003, DOI 10.1086/301845; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; Globerson A, 1997, ARCH GERONTOL GERIAT, V24, P141, DOI 10.1016/S0167-4943(96)00747-9; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARRISON DE, 1972, NATURE-NEW BIOL, V237, P220, DOI 10.1038/newbio237220a0; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; Harrison DE, 1997, EXP HEMATOL, V25, P293; HARRISON DE, 1989, J IMMUNOL, V142, P3833; Hasty P, 2001, MECH AGEING DEV, V122, P1651, DOI 10.1016/S0047-6374(01)00294-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; HOTTA T, 1980, EXP HEMATOL, V8, P933; Hsu HC, 2001, MECH AGEING DEV, V122, P305, DOI 10.1016/S0047-6374(00)00247-5; Imai T, 2001, P NATL ACAD SCI USA, V98, P4581, DOI 10.1073/pnas.071056098; JACOBSON LO, 1949, J LAB CLIN MED, V34, P1538; JIANG DZ, 1992, EXP HEMATOL, V20, P1216; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MAUCH P, 1982, BLOOD, V60, P245; MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214; Miller RA, 2000, VACCINE, V18, P1654, DOI 10.1016/S0264-410X(99)00502-2; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MINTZ B, 1967, SCIENCE, V158, P1484, DOI 10.1126/science.158.3807.1484; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; PLOEMACHER RE, 1988, EXP HEMATOL, V16, P21; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; VANZANT G, 1992, EXP HEMATOL, V20, P470; VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zhao Y, 2000, BLOOD, V96, P3016	65	173	184	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					329	333		10.1038/ni0402-329	http://dx.doi.org/10.1038/ni0402-329			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919569				2022-12-18	WOS:000174623600006
J	Beatson, R; Tajadura-Ortega, V; Achkova, D; Picco, G; Tsourouktsoglou, TD; Klausing, S; Hillier, M; Maher, J; Noll, T; Crocker, PR; Taylor-Papadimitriou, J; Burchell, JM				Beatson, Richard; Tajadura-Ortega, Virginia; Achkova, Daniela; Picco, Gianfranco; Tsourouktsoglou, Theodora-Dorita; Klausing, Sandra; Hillier, Matthew; Maher, John; Noll, Thomas; Crocker, Paul R.; Taylor-Papadimitriou, Joyce; Burchell, Joy M.			The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; BREAST-CANCER; T-CELLS; DENDRITIC CELLS; NK CELLS; METASTASIS; MACROPHAGES; ST3GAL-I; EXPRESSION; DIFFERENTIATION	Siglec-9 is a sialic-acid-binding lectin expressed predominantly on myeloid cells. Aberrant glycosylation occurs in essentially all types of cancers and results in increased sialylation. Thus, when the mucin MUC1 is expressed on cancer cells, it is decorated by multiple short, sialylated O-linked glycans (MUC1-ST). Here we found that this cancer-specific MUC1 glycoform, through engagement of Siglec-9, 'educated' myeloid cells to release factors associated with determination of the tumor microenvironment and disease progression. Moreover, MUC1-ST induced macrophages to display a tumor-associated macrophage (TAM)-like phenotype, with increased expression of the checkpoint ligand PD-L1. Binding of MUC1-ST to Siglec-9 did not activate the phosphatases SHP-1 or SHP-2 but, unexpectedly, induced calcium flux that led to activation of the kinases MEK-ERK. This work defines a critical role for aberrantly glycosylated MUC1 and identifies an activating pathway that follows engagement of Siglec-9.	[Beatson, Richard; Tajadura-Ortega, Virginia; Picco, Gianfranco; Tsourouktsoglou, Theodora-Dorita; Hillier, Matthew; Taylor-Papadimitriou, Joyce; Burchell, Joy M.] Kings Coll London, Div Canc Studies, Breast Canc Biol Grp, Guys Hosp, London, England; [Tajadura-Ortega, Virginia; Maher, John] Kings Coll London, Guys Hosp, Div Canc Studies, CAR Mech Grp, London, England; [Klausing, Sandra; Noll, Thomas] Univ Bielefeld, Cell Culture Technol Grp, Bielefeld, Germany; [Crocker, Paul R.] Univ Dundee, Sch Life Sci, Dundee, Scotland	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Bielefeld; University of Dundee	Burchell, JM (corresponding author), Kings Coll London, Div Canc Studies, Breast Canc Biol Grp, Guys Hosp, London, England.	joy.burchell@kcl.ac.uk	Noll, Thomas/A-3539-2012; Beatson, Richard/AAB-8945-2021; Beatson, Richard/AAB-1029-2021	Noll, Thomas/0000-0003-0748-3423; Beatson, Richard/0000-0002-0411-932X; Maher, John/0000-0001-8275-8488; Burchell, Joy/0000-0003-0413-3823	Breast Cancer Now [2011NovPR-43]; Medical Research Council [MR/J007196/1]; Department the Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC [MR/J007196/1] Funding Source: UKRI	Breast Cancer Now; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department the Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank V. Corrigall (King's College London) for tocilizumab; and N. O'Reilly for the lyophilization of samples. Supported by Breast Cancer Now (2011NovPR-43), the Medical Research Council (MR/J007196/1), the Department the Experimental Cancer Medicine Centre at King's College London, the National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; Bauerle KT, 2014, J CLIN ENDOCR METAB, V99, pE1436, DOI 10.1210/jc.2013-3636; Beatson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125994; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chen H, 2015, SURGERY, V158, P1705, DOI 10.1016/j.surg.2015.04.053; Christo SN, 2015, IMMUNOL CELL BIOL, V93, P694, DOI 10.1038/icb.2015.34; Correa I, 2005, INT J CANCER, V115, P760, DOI 10.1002/ijc.20949; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Hudak JE, 2014, NAT CHEM BIOL, V10, P69, DOI [10.1038/NCHEMBIO.1388, 10.1038/nchembio.1388]; Jandus C, 2014, J CLIN INVEST, V124, P1810, DOI 10.1172/JCI65899; Julien S, 2007, J IMMUNOL, V179, P5701, DOI 10.4049/jimmunol.179.9.5701; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Laubli H, 2014, P NATL ACAD SCI USA, V111, P14211, DOI 10.1073/pnas.1409580111; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mungul A, 2004, INT J ONCOL, V25, P937; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Oosterhoff D, 2012, ONCOIMMUNOLOGY, V1, P649, DOI 10.4161/onci.20365; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paul SP, 2000, BLOOD, V96, P483; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rughetti A, 2005, J IMMUNOL, V174, P7764, DOI 10.4049/jimmunol.174.12.7764; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Sproviero D, 2012, J BIOL CHEM, V287, P44490, DOI 10.1074/jbc.M112.427827; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; Thapa B, 2014, BIOCHEM BIOPH RES CO, V450, P1696, DOI 10.1016/j.bbrc.2014.07.070; Thompson PA, 2015, CARCINOGENESIS, V36, pS232, DOI 10.1093/carcin/bgv038; Xuan QJ, 2014, PATHOL ONCOL RES, V20, P619, DOI 10.1007/s12253-013-9740-z; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	50	172	178	7	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1273	1281		10.1038/ni.3552	http://dx.doi.org/10.1038/ni.3552			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27595232	Green Submitted, Green Accepted			2022-12-18	WOS:000386193200007
J	Su, XD; Yu, YP; Zhong, Y; Giannopoulou, EG; Hu, XY; Liu, H; Cross, JR; Ratsch, G; Rice, CM; Ivashkiv, LB				Su, Xiaodi; Yu, Yingpu; Zhong, Yi; Giannopoulou, Eugenia G.; Hu, Xiaoyu; Liu, Hui; Cross, Justin R.; Raetsch, Gunnar; Rice, Charles M.; Ivashkiv, Lionel B.			Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSES; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; BACTERIAL PATHOGENS; I INTERFERON; MTOR; PATHWAY; POLARIZATION; EXPRESSION; KINASE	Interferon-gamma (IFN-gamma) primes macrophages for enhanced microbial killing and inflammatory activation by Toll-like receptors (TLRs), but little is known about the regulation of cell metabolism or mRNA translation during this priming. We found that IFN-gamma regulated the metabolism and mRNA translation of human macrophages by targeting the kinases mTORC1 and MNK, both of which converge on the selective regulator of translation initiation eIF4E. Physiological downregulation of mTORC1 byIFN-gamma was associated with autophagy and translational suppression of repressors of inflammation such as HES1. Genome-wide ribosome profiling in TLR2-stimulated macrophages showed thatIFN-gamma selectively modulated the macrophage translatome to promote inflammation, further reprogram metabolic pathways and modulate protein synthesis. These results show thatIFN-gamma-mediated metabolic reprogramming and translational regulation are key components of classical inflammatory macrophage activation.	[Su, Xiaodi; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA; [Su, Xiaodi; Giannopoulou, Eugenia G.; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Su, Xiaodi; Giannopoulou, Eugenia G.; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, New York, NY 10021 USA; [Yu, Yingpu; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA; [Zhong, Yi; Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Dept, New York, NY 10021 USA; [Giannopoulou, Eugenia G.] CUNY, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY 11210 USA; [Liu, Hui; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rockefeller University; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Memorial Sloan Kettering Cancer Center	Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017; Giannopoulou, Evgenia/K-9576-2019; Rätsch, Gunnar/O-5914-2017	Hu, Xiaoyu/0000-0002-4289-6998; Rätsch, Gunnar/0000-0001-5486-8532; Cross, Justin/0000-0002-6356-057X	NIH; Leonard Tow Foundation; Greenberg Medical Research Institute; Starr Foundation; European Commission [EU PITN-GA-2012-316861]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR050401] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leonard Tow Foundation; Greenberg Medical Research Institute; Starr Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Weill Cornell Medical College Genomics Core for advice about RNA-Seq, J. Schulze (UC Davis Proteomics Core) for advice about amino acid measurements, B. Zhao and L. Donlin for review of the manuscript, K. Park-Min (Hospital for Special Surgery, New York, New York, USA) for providing Myc inhibitor and siRNA oligos, and S. Park and Y. Qiao for discussion about bioinformatic analysis. This work was supported by the NIH (grants to L.B.I. and C.M.R.), the Leonard Tow Foundation (grant to the David Z. Rosensweig Genomics Research Center), the Greenberg Medical Research Institute, the Starr Foundation (grant to C.M.R.) and the European Commission (EU PITN-GA-2012-316861 to Y.Z.).	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Cortese M, 2014, CELL METAB, V19, P737, DOI 10.1016/j.cmet.2014.04.012; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; Lemaitre B, 2013, NAT REV MICROBIOL, V11, P365, DOI 10.1038/nrmicro3029; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; O'Neill LAJ, 2014, NAT IMMUNOL, V15, P314, DOI 10.1038/ni.2852; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	50	172	175	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					838	+		10.1038/ni.3205	http://dx.doi.org/10.1038/ni.3205			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26147685	Green Submitted, Green Accepted			2022-12-18	WOS:000358299200011
J	Sun, DX; Novotny, M; Bulek, K; Liu, CN; Li, XX; Hamilton, T				Sun, Dongxu; Novotny, Michael; Bulek, Katarzyna; Liu, Caini; Li, Xiaoxia; Hamilton, Thomas			Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; POSTTRANSCRIPTIONAL CONTROL; NEUTROPHIL INFILTRATION; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; FACTOR ASF/SF2; RECEPTOR; STABILIZATION; STABILITY	Interleukin 17 (IL-17) promotes the expression of chemokines and cytokines via the induction of gene transcription and post-transcriptional stabilization of mRNA. We show here that IL-17 enhanced the stability of chemokine CXCL1 mRNA and other mRNAs through a pathway that involved the adaptor Act1, the adaptors TRAF2 or TRAF5 and the splicing factor SF2 (also known as alternative splicing factor (ASF)). TRAF2 and TRAF5 were necessary for IL-17 to signal the stabilization of CXCL1 mRNA. Furthermore, IL-17 promoted the formation of complexes of TRAF5-TRAF2, Act1 and SF2 (ASF). Overexpression of SF2 (ASF) shortened the half-life of CXCL1 mRNA, whereas depletion of SF2 (ASF) prolonged it. SF2 (ASF) bound chemokine mRNA in unstimulated cells, whereas the SF2 (ASF)-mRNA interaction was much lower after stimulation with IL-17. Our findings define an IL-17-induced signaling pathway that links to the stabilization of selected mRNA species through Act1, TRAF2-TRAF5 and the RNA-binding protein SF2 (ASF).	[Sun, Dongxu; Novotny, Michael; Bulek, Katarzyna; Liu, Caini; Li, Xiaoxia; Hamilton, Thomas] Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hamilton, T (corresponding author), Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hamiltt@ccf.org	Bulek, Katarzyna/L-7517-2015	Hamilton, Thomas/0000-0002-9817-242X	US Public Health Service [R01CA039621, R01HL098935]; American Asthma Foundation; David and Lindsay Morgenthaler Endowment; NATIONAL CANCER INSTITUTE [R01CA039621] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098935, P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Asthma Foundation; David and Lindsay Morgenthaler Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Nakano (Juntendo University School of Medicine) for MEFs deficient in both TRAF2 and TRAF5 and reconstituted TRAF2- and TRAF5-deficient MEFs; and X. Fu (University of California, San Diego) for inducible Tet-Off SF2 (ASF) MEFs. Supported by the US Public Health Service (R01CA039621 to T.H. and R01HL098935 to X.L.), the American Asthma Foundation (X.L.) and the David and Lindsay Morgenthaler Endowment (D.S.).	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Endlich B, 2002, J IMMUNOL, V168, P3586, DOI 10.4049/jimmunol.168.7.3586; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hamilton T, 2010, CYTOKINE, V52, P116, DOI 10.1016/j.cyto.2010.04.003; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Novotny M, 2005, J BIOL CHEM, V280, P30166, DOI 10.1074/jbc.M502280200; OHMORI Y, 1995, J IMMUNOL, V155, P3593; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e	48	172	179	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					853	U70		10.1038/ni.2081	http://dx.doi.org/10.1038/ni.2081			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21822258	Green Accepted			2022-12-18	WOS:000294461200009
J	Angkasekwinai, P; Chang, SH; Thapa, M; Watarai, H; Dong, C				Angkasekwinai, Pornpimon; Chang, Seon Hee; Thapa, Manoj; Watarai, Hiroshi; Dong, Chen			Regulation of IL-9 expression by IL-25 signaling	NATURE IMMUNOLOGY			English	Article							ALLERGIC AIRWAY INFLAMMATION; PULMONARY INFLAMMATION; T-HELPER-2 CELLS; IMMUNE-RESPONSES; ADAPTER PROTEIN; TRANSGENIC MICE; T-LYMPHOCYTES; TGF-BETA; IN-VIVO; HYPERRESPONSIVENESS	The physiological regulation of the expression of interleukin (IL)-9, a cytokine traditionally regarded as being T(H)2 associated, remains unclear. Here, we show that IL-9-expressing T cells generated in vitro in the presence of transforming growth factor-beta and IL-4 express high levels of mRNA for IL-17 receptor B (IL-17RB), the receptor for IL-25. Treatment of these cells with IL-25 enhances IL-9 expression in vitro. Moreover, transgenic and retroviral overexpression of IL-17RB in T cells results in IL-25-induced IL-9 production that is IL-4 independent. In vivo, the IL-25-IL-17RB pathway regulates IL-9 expression in allergic airway inflammation. Thus, IL-25 is a newly identified regulator of IL-9 expression.	[Angkasekwinai, Pornpimon; Chang, Seon Hee; Thapa, Manoj; Dong, Chen] Univ Texas, Dept Immunol, Houston, TX USA; [Angkasekwinai, Pornpimon; Chang, Seon Hee; Thapa, Manoj; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Angkasekwinai, Pornpimon] Thammasat Univ, Dept Med Technol, Fac Allied Hlth Sci, Pathum Thani, Thailand; [Watarai, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Kanagawa, Japan	University of Texas System; University of Texas System; UTMD Anderson Cancer Center; Thammasat University; RIKEN	Dong, C (corresponding author), Univ Texas, Dept Immunol, Houston, TX USA.	cdong@mdanderson.org	dong, chen/B-3181-2009; Thapa, Manoj/AAW-3311-2020; Watarai, Hiroshi/G-9894-2012; Angkasekwinai, Pornpimon/AAX-6124-2020; Chang, Seon Hee/AAQ-9521-2020	dong, chen/0000-0002-0084-9130; Watarai, Hiroshi/0000-0003-1511-2593; Chang, Seon Hee/0000-0002-9389-508X; Angkasekwinai, Pornpimon/0000-0003-0303-9544	NIH; Royal Thai government; Trust Fellow of the MD Anderson Cancer Center; Leukemia and Lymphoma Society Scholar; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772, RC2AR059010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai government; Trust Fellow of the MD Anderson Cancer Center; Leukemia and Lymphoma Society Scholar(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Rivera, S. J. Kuschert and J. Parker-Thornburg for their help in generation of knockout and transgenic animals, D. Littman (New York University School of Medicine) for the CD4 mini-gene plasmid, K. Murphy for GFP-RV vector, Amgen for IL-17-receptor deficient mice, J. van Snick for an anti-IL-9 staining antibody, B. Stockinger and M. Veldhoen for suggestions and the Dong lab members for their help and discussion. The work is supported by research grants from NIH (to C. D.). P. A. receives a fellowship from Royal Thai government and C. D. is a Trust Fellow of the MD Anderson Cancer Center and a Leukemia and Lymphoma Society Scholar.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; ELSE KJ, 1992, IMMUNOLOGY, V75, P232; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; HOUSSIAU FA, 1992, J IMMUNOL, V148, P3147; Kung TT, 2001, AM J RESP CELL MOL, V25, P600, DOI 10.1165/ajrcmb.25.5.4533; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; McLane MP, 1998, AM J RESP CELL MOL, V19, P713, DOI 10.1165/ajrcmb.19.5.3457; Monteyne P, 1997, J IMMUNOL, V159, P2616; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Ying S, 2002, CLIN EXP ALLERGY, V32, P866, DOI 10.1046/j.1365-2222.2002.01376.x	26	172	189	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					250	U9		10.1038/ni.1846	http://dx.doi.org/10.1038/ni.1846			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20154671	Green Accepted			2022-12-18	WOS:000274605800013
J	Mueller, DL				Mueller, DL			E3 ubiquitin ligases as T cell anergy factors	NATURE IMMUNOLOGY			English	Review							KAPPA-B-ALPHA; CLONAL ANERGY; C-CBL; NEGATIVE REGULATION; IL-2 GENE; MEDIATED RESISTANCE; CYCLE PROGRESSION; IN-VITRO; V-CBL; ACTIVATION	E3 ubliquitin ligases have emerged as key molecular regulators of immune cell function. Three families of proteins with ubiquitin ligase activity have been described (the HECT, RING and U-box proteins), and each may be involved in the regulation of immune responses during infection by targeting specific inhibitory molecules for proteolytic destruction. Several HECT and RING E3 proteins have now also been linked to the induction and maintenance of immune self-tolerance: c-Cbl, Cbl-b, GRAIL, Itch and Nedd4 each negatively regulate T cell growth factor production and proliferation. This review will discuss the relationship between the ubiquitination of select components of the antigen-sensing signaling apparatus in T cells and the development and maintenance of the clonal anergy state.	Univ Minnesota, Sch Med, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Mueller, DL (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA.	muell002@umn.edu		Mueller, Daniel/0000-0003-1621-0419	NIAID NIH HHS [P01 AI35296, P01 AI50162] Funding Source: Medline; NIGMS NIH HHS [R01 GM54706] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI050162, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; BHANDOOLA A, 1993, J IMMUNOL, V151, P2355; BLAKE TJ, 1991, ONCOGENE, V6, P653; Borchers AGM, 2002, DEV BIOL, V251, P395, DOI 10.1006/dbio.2002.0814; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Dillon TJ, 2003, J BIOL CHEM, V278, P35940, DOI 10.1074/jbc.M301506200; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jenkins R., 1987, POWDER DIFFR, V2, P84; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mondino A, 1996, J IMMUNOL, V157, P2048; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pape KA, 1998, J IMMUNOL, V160, P4719; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Powell JD, 1999, J IMMUNOL, V162, P2775; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; QUILL H, 1987, J IMMUNOL, V138, P3704; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shao Y, 2003, EMBO REP, V4, P425, DOI 10.1038/sj.embor.embor813; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Telander DG, 1999, J IMMUNOL, V162, P1460; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vanasek TL, 2001, J IMMUNOL, V167, P5636, DOI 10.4049/jimmunol.167.10.5636; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhang WY, 2003, J BIOL CHEM, V278, P23978, DOI 10.1074/jbc.M212671200	72	172	182	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					883	890		10.1038/ni1106	http://dx.doi.org/10.1038/ni1106			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334084				2022-12-18	WOS:000223612500016
J	Shinkura, R; Ito, S; Begum, NA; Nagaoka, H; Muramatsu, M; Kinoshita, K; Sakakibara, Y; Hijikata, H; Honjo, T				Shinkura, R; Ito, S; Begum, NA; Nagaoka, H; Muramatsu, M; Kinoshita, K; Sakakibara, Y; Hijikata, H; Honjo, T			Separate domains of AID are required for somatic hypermutation and class-switch recombination	NATURE IMMUNOLOGY			English	Article							SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; ANTIBODY DIVERSIFICATION; REGION; ENZYME; URACIL; GLYCOSYLASE; FIBROBLASTS; MECHANISM; CELLS	Activation-induced cytidine deaminase (AID) is essential for class-switch recombination (CSR) and somatic hypermutation (SHM). Mutants with changes in the C-terminal region of AID retain SHM but lose CSR activity. Here we describe five mutants with alterations in the N-terminal region of AID that caused selective deficiency in SHM but retained CSR, suggesting that the CSR and SHM activities of AID may dissociate via interaction of CSR- or SHM-specific cofactors with different domains of AID. Unlike cells expressing C-terminal AID mutants, B cells expressing N-terminal AID mutants had mutations in the switch mu region, indicating that such mutations are generated by reactions involved in CSR but not SHM. Thus, we propose that separate domains of AID interact with specific cofactors to regulate these two distinct genetic events in a target-specific way.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Begum, Nasim/0000-0001-7177-188X				Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	31	172	178	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					707	712		10.1038/ni1086	http://dx.doi.org/10.1038/ni1086			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15195091				2022-12-18	WOS:000222331200023
J	Buckley, AF; Kuo, CT; Leiden, JM				Buckley, AF; Kuo, CT; Leiden, JM			Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway	NATURE IMMUNOLOGY			English	Article							KRUPPEL-LIKE FACTOR; ACTIVATION; EXPRESSION; SURVIVAL; PROMOTER; IDENTIFICATION; ELONGATION; CYTOKINES; MOLECULE; ARREST	T lymphocytes circulate in a quiescent state until they encounter cognate antigen bound to the surface of an antigen-presenting cell. The molecular pathways that regulate T cell quiescence remain largely unknown. Here we show that forced expression of the lung Kruppel-like transcription factor (LKLF) in jurkat T cells is sufficient to program a quiescent phenotype characterized by decreased proliferation, reduced cell size and protein synthesis and decreased surface expression of activation markers. Conversely, LKLF-deficient peripheral T cells produced by gene targeting showed increased proliferation, increased cell size and enhanced expression of surface activation markers in vivo. LKLF appeared to function, at least in part, by decreasing expression of the proto-oncogene encoding c-Myc. Forced expression of LKLF was associated with markedly decreased c-Myc expression. In addition, many effects of LKLF expression were mimicked by expression of the dominant-negative MadMyc protein and rescued by overexpression of c-Myc. Thus, LKLF is both necessary and sufficient to program quiescence in T cells and functions, in part, by negatively regulating a c-Myc-dependent pathway.	Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; Harvard University; Harvard T.H. Chan School of Public Health; University of Chicago	Buckley, AF (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.			Buckley, Anne/0000-0003-1209-5791				Abbas AK, 1994, CELLULAR MOL IMMUNOL; Aizawa S, 1997, J BIOL CHEM, V272, P2042; Berns K, 1997, ONCOGENE, V15, P1347, DOI 10.1038/sj.onc.1201280; Brunner T, 2000, J BIOL CHEM, V275, P9767, DOI 10.1074/jbc.275.13.9767; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; CAZZOLA M, 1990, BLOOD, V75, P1903; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; ELLIS TM, 1993, J IMMUNOL, V151, P2380; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gilfillan MC, 1998, J IMMUNOL, V160, P2180; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gregory S, 2000, HUM IMMUNOL, V61, P427, DOI 10.1016/S0198-8859(00)00107-5; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Perkins A, 1999, INT J BIOCHEM CELL B, V31, P1175, DOI 10.1016/S1357-2725(99)00083-7; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; Schober SL, 1999, J IMMUNOL, V163, P3662; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; SUSSMAN DJ, 1991, NUCLEIC ACIDS RES, V19, P5045, DOI 10.1093/nar/19.18.5045; TRIPATHY SK, 1994, P NATL ACAD SCI USA, V91, P11557, DOI 10.1073/pnas.91.24.11557; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676	29	172	177	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					698	704		10.1038/90633	http://dx.doi.org/10.1038/90633			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477405				2022-12-18	WOS:000170230100011
J	Wang, HP; Franco, F; Tsui, YC; Xie, X; Trefny, MP; Zappasodi, R; Mohmood, SR; Fernandez-Garcia, J; Tsai, CH; Schulze, I; Picard, F; Meylan, E; Silverstein, R; Goldberg, I; Fendt, SM; Wolchok, JD; Merghoub, T; Jandus, C; Zippelius, A; Ho, PC				Wang, Haiping; Franco, Fabien; Tsui, Yao-Chen; Xie, Xin; Trefny, Marcel P.; Zappasodi, Roberta; Mohmood, Syed Raza; Fernandez-Garcia, Juan; Tsai, Chin-Hsien; Schulze, Isabell; Picard, Florence; Meylan, Etienne; Silverstein, Roy; Goldberg, Ira; Fendt, Sarah-Maria; Wolchok, Jedd D.; Merghoub, Taha; Jandus, Camilla; Zippelius, Alfred; Ho, Ping-Chih			CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors	NATURE IMMUNOLOGY			English	Article							MACROPHAGE; DEPLETION; TREGS; REPROGRAMS; THERAPY; FITNESS; MUSCLE; FOXP3	Depleting regulatory T cells (T-reg cells) to counteract immunosuppressive features of the tumor microenvironment (TME) is an attractive strategy for cancer treatment; however, autoimmunity due to systemic impairment of their suppressive function limits its therapeutic potential. Elucidating approaches that specifically disrupt intratumoral T-reg cells is direly needed for cancer immunotherapy. We found that CD36 was selectively upregulated in intrautumoral T-reg cells as a central metabolic modulator. CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-beta signaling, programming T-reg cells to adapt to a lactic acid-enriched TME. Genetic ablation of Cd36 in T-reg cells suppressed tumor growth accompanied by a decrease in intratumoral T-reg cells and enhancement of antitumor activity in tumor-infiltrating lymphocytes without disrupting immune homeostasis. Furthermore, CD36 targeting elicited additive antitumor responses with anti-programmed cell death protein 1 therapy. Our findings uncover the unexplored metabolic adaptation that orchestrates the survival and functions of intratumoral T-reg cells, and the therapeutic potential of targeting this pathway for reprogramming the TME. Tumor environments are highly acidic due to high concentrations of lactic acid. Ho and colleagues report that tumor-infiltrating regulatory T cells adapt to this tumor environment by upregulating expression of CD36, which allows them to use fatty acids to fuel their metabolism.	[Wang, Haiping; Franco, Fabien; Tsui, Yao-Chen; Tsai, Chin-Hsien; Picard, Florence; Jandus, Camilla; Ho, Ping-Chih] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Wang, Haiping; Franco, Fabien; Tsui, Yao-Chen; Tsai, Chin-Hsien; Picard, Florence; Jandus, Camilla; Ho, Ping-Chih] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Xie, Xin; Mohmood, Syed Raza] NYU Abu Dhabi, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Trefny, Marcel P.; Zippelius, Alfred] Univ Hosp, Lab Canc Immunol, Dept Biomed, Basel, Switzerland; [Trefny, Marcel P.; Zippelius, Alfred] Univ Basel, Basel, Switzerland; [Zappasodi, Roberta; Schulze, Isabell; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat & Swim Amer Lab, 1275 York Ave, New York, NY 10021 USA; [Zappasodi, Roberta; Schulze, Isabell; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA; [Fernandez-Garcia, Juan; Fendt, Sarah-Maria] VIB KU Leuven Ctr Canc Biol, Lab Cellular Metab & Metab Regulat, Leuven, Belgium; [Fernandez-Garcia, Juan; Fendt, Sarah-Maria] Katholieke Univ Leuven, Dept Oncol, Lab Cellular Metab & Metab Regulat, Leuven, Belgium; [Fernandez-Garcia, Juan; Fendt, Sarah-Maria] Leuven Canc Inst, Leuven, Belgium; [Meylan, Etienne] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Silverstein, Roy] Med Coll Wisconsin, Dept Med, Wauwatosa, WI USA; [Goldberg, Ira] NYU Langone Hlth, Dept Med, New York, NY USA; [Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Wolchok, Jedd D.] Weill Cornell Med, New York, NY USA; [Zippelius, Alfred] Univ Hosp Basel, Med Oncol, Basel, Switzerland	University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Basel; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Flanders Institute for Biotechnology (VIB); KU Leuven; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Medical College of Wisconsin; NYU Langone Medical Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of Basel	Ho, PC (corresponding author), Univ Lausanne, Dept Oncol, Lausanne, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland.	ping-chih.ho@unil.ch	Merghoub, Taha/ABD-8362-2021	Ho, Ping-Chih/0000-0003-3078-3774; Fendt, Sarah-Maria/0000-0001-6018-9296; Meylan, Etienne/0000-0002-0899-2230; Fernandez Garcia, Juan/0000-0003-3422-3627; Trefny, Marcel Philipp/0000-0001-6755-7899; Xie, Xin/0000-0002-6784-4860	SNSF [31003A_163204, 31003A_182470, PMPDP3_129022, PZ00P3_161459, 320030_162575]; Swiss Cancer Foundation [KFS-3949-08-2016]; Swiss Institute for Experimental Cancer Research [ISREC 26075483]; European Research Council [802773-MitoGuide]; Cancer Research Institute Clinic and Laboratory Integration Program award; SITC-MRA Young Investigator Award; Cancer League Switzerland [KFS-3394-02-2014]; NIH [P01 HL46403, P01 HL087018, R01 HL142152, HL45095, HL073029, P30 CA008748, R01 CA056821]; Swiss Cancer Research Foundation [KFS-3681-08-2015-R]; FWO; KU Leuven Methusalem; Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Electron Microscopy Facility at the University of Lausanne; Biomedical Sequencing Facility at the Research Center for Molecular Medicine of the Austrian Academy of Sciences	SNSF(Swiss National Science Foundation (SNSF)); Swiss Cancer Foundation; Swiss Institute for Experimental Cancer Research; European Research Council(European Research Council (ERC)European Commission); Cancer Research Institute Clinic and Laboratory Integration Program award; SITC-MRA Young Investigator Award; Cancer League Switzerland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Cancer Research Foundation; FWO(FWO); KU Leuven Methusalem(KU Leuven); Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Electron Microscopy Facility at the University of Lausanne; Biomedical Sequencing Facility at the Research Center for Molecular Medicine of the Austrian Academy of Sciences	We thank L.-F. Lu and W.-L. Lo for critical reading and comments. We also thank Y. Maeda and H. Nishikawa for helpful discussion. P.-C.H. was supported in part by the SNSF (project grants 31003A_163204 and 31003A_182470), the Swiss Cancer Foundation (KFS-3949-08-2016), the Swiss Institute for Experimental Cancer Research (ISREC 26075483), a European Research Council Staring Grant (802773-MitoGuide), the Cancer Research Institute Clinic and Laboratory Integration Program award and the SITC-MRA Young Investigator Award. C.J. is supported by the SNSF (project grants PMPDP3_129022 and PZ00P3_161459). A.Z. is supported by the SNSF (project grant 320030_162575) and Cancer League Switzerland (KFS-3394-02-2014). R.S. and I.G. are supported by NIH funding (P01 HL46403, P01 HL087018 and R01 HL142152 to R.S. and HL45095 and HL073029 to I.G.). E.M. acknowledges funding from the Swiss Cancer Research Foundation (KFS-3681-08-2015-R). S.-M.F. acknowledges funding from an FWO grant and projects, as well as KU Leuven Methusalem co-funding. J.F.-G. is supported by an FWO postdoctoral fellowship. J.D.W and T.M. are supported by NIH funding (P30 CA008748 and R01 CA056821), Swim Across America, the Ludwig Institute for Cancer Research, the Parker Institute for Cancer Immunotherapy and the Breast Cancer Research Foundation. R.Z. is supported by the Parker Institute for Cancer Immunotherapy Bridge Scholar Award. We also appreciate the support provided by the Electron Microscopy Facility at the University of Lausanne and the Biomedical Sequencing Facility at the Research Center for Molecular Medicine of the Austrian Academy of Sciences.	Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Cheng WC, 2019, NAT IMMUNOL, V20, P206, DOI 10.1038/s41590-018-0290-0; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Curtin JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001983; Dammone G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072044; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; He NH, 2017, P NATL ACAD SCI USA, V114, P12542, DOI 10.1073/pnas.1715363114; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Ho PC, 2014, CANCER RES, V74, P3205, DOI 10.1158/0008-5472.CAN-13-3461; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Ladanyi A, 2018, ONCOGENE, V37, P2285, DOI 10.1038/s41388-017-0093-z; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Liu PS, 2018, MITOCHONDRION, V41, P45, DOI 10.1016/j.mito.2017.11.002; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Miska J, 2019, CELL REP, V27, P226, DOI 10.1016/j.celrep.2019.03.029; Morino K, 2012, DIABETES, V61, P877, DOI 10.2337/db11-1391; Nelson JW, 2017, BIOINFORMATICS, V33, P447, DOI 10.1093/bioinformatics/btw624; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Pacella I, 2018, P NATL ACAD SCI USA, V115, pE6546, DOI 10.1073/pnas.1720113115; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Piconese S, 2014, HEPATOLOGY, V60, P1494, DOI 10.1002/hep.27188; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Roychoudhuri R, 2015, CURR OPIN IMMUNOL, V33, P101, DOI 10.1016/j.coi.2015.02.003; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Son NH, 2018, J CLIN INVEST, V128, P4329, DOI [10.1172/JCI99315, 10.1172/jci99315]; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Vannini N, 2019, CELL STEM CELL, V24, P405, DOI 10.1016/j.stem.2019.02.012; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Wang HP, 2017, TRENDS CANCER, V3, P583, DOI 10.1016/j.trecan.2017.06.005; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Zappasodi R, 2019, NAT MED, V25, P759, DOI 10.1038/s41591-019-0420-8; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	54	171	175	18	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					298	+		10.1038/s41590-019-0589-5	http://dx.doi.org/10.1038/s41590-019-0589-5		FEB 2020	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066953	Green Accepted			2022-12-18	WOS:000514067400009
J	Monticelli, LA; Buck, MD; Flamar, AL; Saenz, SA; Wojno, EDT; Yudanin, NA; Osborne, LC; Hepworth, MR; Tran, SV; Rodewald, HR; Shah, H; Cross, JR; Diamond, JM; Cantu, E; Christie, JD; Pearce, EL; Artis, D				Monticelli, Laurel A.; Buck, Michael D.; Flamar, Anne-Laure; Saenz, Steven A.; Wojno, Elia D. Tait; Yudanin, Naomi A.; Osborne, Lisa C.; Hepworth, Matthew R.; Tran, Sara V.; Rodewald, Hans-Reimer; Shah, Hardik; Cross, Justin R.; Diamond, Joshua M.; Cantu, Edward; Christie, Jason D.; Pearce, Erika L.; Artis, David			Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation	NATURE IMMUNOLOGY			English	Article							L-ARGININE; AIRWAYS; INFECTION; PATHOGENESIS; HOMEOSTASIS; INDUCTION; BALANCE; BIOLOGY; ASTHMA	Group 2 innate lymphoid cells (ILC2s) regulate tissue inflammation and repair after activation by cell-extrinsic factors such as host-derived cytokines. However, the cell-intrinsic metabolic pathways that control ILC2 function are undefined. Here we demonstrate that expression of the enzyme arginase-1 (Arg1) during acute or chronic lung inflammation is a conserved trait of mouse and human ILC2s. Deletion of mouse ILC-intrinsic Arg1 abrogated type 2 lung inflammation by restraining ILC2 proliferation and dampening cytokine production. Mechanistically, inhibition of Arg1 enzymatic activity disrupted multiple components of ILC2 metabolic programming by altering arginine catabolism, impairing polyamine biosynthesis and reducing aerobic glycolysis. These data identify Arg1 as a key regulator of ILC2 bioenergetics that controls proliferative capacity and proinflammatory functions promoting type 2 inflammation.	[Monticelli, Laurel A.; Flamar, Anne-Laure; Saenz, Steven A.; Wojno, Elia D. Tait; Yudanin, Naomi A.; Osborne, Lisa C.; Hepworth, Matthew R.; Tran, Sara V.; Artis, David] Cornell Univ, Joan & Sanford I Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA; [Buck, Michael D.; Pearce, Erika L.] Max Plank Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany; [Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany; [Shah, Hardik; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Diamond, Joshua M.; Cantu, Edward; Christie, Jason D.] Univ Penn, Perelman Sch Med, Ctr Translat Lung Biol, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Saenz, Steven A.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Wojno, Elia D. Tait] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Wojno, Elia D. Tait] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Osborne, Lisa C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Hepworth, Matthew R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Biogen; Cornell University; Cornell University; University of British Columbia; University of Manchester	Artis, D (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.	dartis@med.cornell.edu	Yudanin, Naomi/U-2757-2019; Osborne, Lisa/K-3027-2015	Yudanin, Naomi/0000-0002-5019-2851; Osborne, Lisa/0000-0002-7170-3235; Christie, Jason/0000-0003-0519-218X; Cross, Justin/0000-0002-6356-057X; Tait Wojno, Elia/0000-0003-2822-296X; Hepworth, Matthew/0000-0002-9613-7858; Shah, Hardik/0000-0001-8408-5686; Artis, David/0000-0002-1753-4100; Buck, Michael/0000-0002-9611-1199	National Institutes of Health (NIH) [AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI097333, T32-AI007532, CA181125, AI091965, HL087115, HL081619, HL096845, HL115354, HL114626, HL116656, HL090021, K23-HL121406]; Burroughs Wellcome Fund; Crohn's AMP; Colitis Foundation of America; Edmond J. Safra Foundation/Cancer Research Institute; National Science Foundation [DGE-1143954]; Robert Wood Johnson Foundation [AMFDP 70640]; Thoracic Surgery Foundation; German Research Foundation (DFG-project 11) [SFB 873]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA181125] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL135227, K23HL116656, R01HL096845, R01HL087115, K12HL090021, K24HL115354, K23HL121406, R01HL081619, R01HL114626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095608, R01AI074878, R01AI061570, R01AI095466, R01AI102942, P01AI106697, R01AI097333, R21AI087990, T32AI007532, R01AI091965, R21AI083480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109630] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's AMP; Colitis Foundation of America; Edmond J. Safra Foundation/Cancer Research Institute; National Science Foundation(National Science Foundation (NSF)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Thoracic Surgery Foundation; German Research Foundation (DFG-project 11)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the D. Artis and G.F. Sonnenberg laboratories for critical reading of this manuscript. We thank R.M. Locksley (University of California, San Francisco, San Francisco, California, USA) for generously providing the Arg1<SUP>YFP</SUP> mice and B. Vallance (University of British Columbia, Vancouver, British Columbia, Canada) for providing Citrobacter rodentium. This work was supported by the National Institutes of Health (NIH) (grants AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942 and AI097333 to D.A.; T32-AI007532 to L.A.M.; CA181125 and AI091965 to E.L.P.; HL087115, HL081619, HL096845, HL115354 and HL114626 to J.D.C.; HL116656 to E.C.; and HL090021 and K23-HL121406 to J.M.D.), the Burroughs Wellcome Fund (D.A. and E.L.P.), the Crohn's & Colitis Foundation of America (D.A. and M.R.H.), the Edmond J. Safra Foundation/Cancer Research Institute (L.C.O.), the National Science Foundation (grant DGE-1143954 to M.D.B.), the Robert Wood Johnson Foundation (grant AMFDP 70640 to E.C.), the Thoracic Surgery Foundation (E.C.) and the German Research Foundation (DFG SFB 873-project 11 to H.-R.R.). We thank the Mucosal Immunology Studies Team (MIST) of the NIH NIAID for shared expertise and resources.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barron L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061961; Bergeron C, 2007, J ALLERGY CLIN IMMUN, V119, P391, DOI 10.1016/j.jaci.2006.10.030; Bratt JM, 2011, J BIOMED RES, V25, P299, DOI 10.1016/S1674-8301(11)60041-9; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cloots RHE, 2013, AM J PHYSIOL-LUNG C, V305, pL364, DOI 10.1152/ajplung.00341.2012; Demkow U, 2010, EUR J MED RES, V15, P27; Fujita M, 2007, MED SCI MONITOR, V13, pRA19; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Knippenberg S, 2015, EUR J IMMUNOL, V45, P1716, DOI 10.1002/eji.201445419; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Marsland BJ, 2008, EUR J IMMUNOL, V38, P479, DOI 10.1002/eji.200737827; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Tadie JM, 2008, AM J PHYSIOL-LUNG C, V294, pL489, DOI 10.1152/ajplung.00109.2007; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Vonk JM, 2010, PHARMACOGENET GENOM, V20, P179, DOI 10.1097/FPC.0b013e328336c7fd; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595	50	171	180	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					656	+		10.1038/ni.3421	http://dx.doi.org/10.1038/ni.3421			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27043409	Green Accepted			2022-12-18	WOS:000376162200010
J	Reeves, RK; Li, HY; Jost, S; Blass, E; Li, HL; Schafer, JL; Varner, V; Manickam, C; Eslamizar, L; Altfeld, M; von Andrian, UH; Barouch, DH				Reeves, R. Keith; Li, Haiying; Jost, Stephanie; Blass, Eryn; Li, Hualin; Schafer, Jamie L.; Varner, Valerie; Manickam, Cordelia; Eslamizar, Leila; Altfeld, Marcus; von Andrian, Ulrich H.; Barouch, Dan H.			Antigen-specific NK cell memory in rhesus macaques	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; ADAPTIVE IMMUNITY; LYMPHOID-CELLS; CUTTING EDGE; VIRUS; HIV-1; INFECTION; ACTIVATION; RESPONSES; EXPRESSION	Natural killer (NK) cells have traditionally been considered nonspecific components of innate immunity, but recent studies have shown features of antigen-specific memory in mouse NK cells. However, it has remained unclear whether this phenomenon also exists in primates. We found that splenic and hepatic NK cells from SHIVSF162p3-infected and SIVmac251-infected macaques specifically lysed Gag- and Env-pulsed dendritic cells in an NKG2-dependent fashion, in contrast to NK cells from uninfected macaques. Moreover, splenic and hepatic NK cells from Ad26-vaccinated macaques efficiently lysed antigen-matched but not antigen-mismatched targets 5 years after vaccination. These data demonstrate that robust, durable, antigen-specific NK cell memory can be induced in primates after both infection and vaccination, and this finding could be important for the development of vaccines against HIV-1 and other pathogens.	[Reeves, R. Keith; Li, Haiying; Blass, Eryn; Li, Hualin; Schafer, Jamie L.; Varner, Valerie; Manickam, Cordelia; Eslamizar, Leila; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Reeves, R. Keith; Li, Haiying] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Immunol, Southborough, MA 01772 USA; [Jost, Stephanie; Altfeld, Marcus; von Andrian, Ulrich H.; Barouch, Dan H.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA USA; [Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Heinrich Pette Institute; Harvard University; Harvard Medical School	Reeves, RK (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	rreeves@bidmc.harvard.edu; dbarouch@bidmc.harvard.edu	Altfeld, Marcus/AAE-7306-2019; Barouch, Dan/Y-3918-2019	Altfeld, Marcus/0000-0001-5972-2997; Reeves, R. Keith/0000-0003-3157-2557	National Institutes of Health [AI078526, AI096040, AI095985, AI069259, AI111595, AI112521, AI067031, AI118468]; American Foundation for AIDS Research [108547-53-RGRL]; Harvard Center for AIDS Research [AI060354]; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, U19AI096040, R01AI111595, U19AI095985, R01AI067031, P30AI060354, U19AI078526, R56AI120828, P01AI112521, R21AI118468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research; Harvard Center for AIDS Research; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grants AI078526, AI096040 and AI095985 to D.H.B.; AI069259, AI111595 and AI112521 to U.H.v.A.; AI067031 to MA.; and AI118468 to R.K.R.), the American Foundation for AIDS Research (grant 108547-53-RGRL to R.K.R.), the Harvard Center for AIDS Research (grant AI060354 to R.K.R.) and the Ragon Institute of MGH, MIT and Harvard (S.J., M.A., D.H.B. and U.H.v.A.).	Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; BANDYOPADHYAY S, 1990, CLIN EXP IMMUNOL, V79, P430, DOI 10.1111/j.1365-2249.1990.tb08107.x; Banks ND, 2002, AIDS RES HUM RETROV, V18, P1197, DOI 10.1089/08892220260387940; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Bostik P, 2009, J IMMUNOL, V182, P3638, DOI 10.4049/jimmunol.0803580; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Eisenhardt M, 2014, AIDS, V28, P1879, DOI 10.1097/QAD.0000000000000355; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Fehniger TA, 1998, J IMMUNOL, V161, P6433; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Marras F, 2013, P NATL ACAD SCI USA, V110, P11970, DOI 10.1073/pnas.1302090110; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rouzaire P, 2012, EUR J IMMUNOL, V42, P80, DOI 10.1002/eji.201141820; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Shang L, 2014, J IMMUNOL, V193, P277, DOI 10.4049/jimmunol.1400417; Shieh TM, 2001, J NEUROVIROL, V7, P11; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takahashi Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003929; Thomas R, 2012, AIDS RES HUM RETROV, V28, P844, DOI [10.1089/aid.2011.0253, 10.1089/AID.2011.0253]; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; VOWELS BR, 1990, AIDS RES HUM RETROV, V6, P905, DOI 10.1089/aid.1990.6.905; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	48	171	178	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					927	932		10.1038/ni.3227	http://dx.doi.org/10.1038/ni.3227			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26193080	Green Accepted, Green Submitted			2022-12-18	WOS:000359876900010
J	Volkman, HE; Stetson, DB				Volkman, Hannah E.; Stetson, Daniel B.			The enemy within: endogenous retroelements and autoimmune disease	NATURE IMMUNOLOGY			English	Review							AICARDI-GOUTIERES-SYNDROME; CYCLIC GMP-AMP; RESTRICTION FACTOR SAMHD1; INNATE IMMUNE SENSOR; EXONUCLEASE TREX1; DNA SENSOR; ANTIVIRAL RESPONSE; HIV-INFECTION; CELL-DEATH; MUTATIONS	Inappropriate or chronic detection of self nucleic acids by the innate immune system underlies many human autoimmune diseases. We discuss here an unexpected source of endogenous immunostimulatory nucleic acids: the reverse-transcribed cDNA of endogenous retroelements. The interplay between innate immune sensing and clearance of retroelement cDNA has important implications for the understanding of immune responses to infectious retroviruses such as human immunodeficiency virus (HIV). Furthermore, the detection of cDNA by the innate immune system reveals an evolutionary tradeoff: selection for a vigorous, sensitive response to infectious retroviruses may predispose the inappropriate detection of endogenous retroelements. We propose that this tradeoff has placed unique constraints on the sensitivity of the DNA-activated antiviral response, with implications for the interactions of DNA viruses and retroviruses with their hosts. Finally, we discuss how better understanding of the intersection of retroelement biology and innate immunity can guide the way to novel therapies for specific autoimmune diseases.	[Volkman, Hannah E.; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	stetson@uw.edu			Jane Coffin Childs Fund (H.E.V.); Rita Allen Foundation (D.B.S.); National Institute of Allergy and Infectious Diseases [AI084914]; European Union Seventh Framework Programme [241779]; Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084914] Funding Source: NIH RePORTER	Jane Coffin Childs Fund (H.E.V.); Rita Allen Foundation (D.B.S.); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union Seventh Framework Programme(European Commission); Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Stetson laboratory for discussions; R, Medzhitov for helpful comments on the manuscript; and Y. Crow for continued collaborations. Supported by the Jane Coffin Childs Fund (H.E.V.), the Rita Allen Foundation (D. B. S.), the National Institute of Allergy and Infectious Diseases (AI084914), the European Union Seventh Framework Programme 2007-2013 (241779; Nuclease Immune Mediated Brain and Lupus-like conditions) and the Lupus Research Institute.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Doehle BP, 2012, J VIROL, V86, P8499, DOI 10.1128/JVI.00424-12; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hughes JF, 2004, P NATL ACAD SCI USA, V101, P1668, DOI 10.1073/pnas.0307885100; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li T, 2013, CELL HOST MICROBE, V14, P591, DOI 10.1016/j.chom.2013.10.007; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	97	171	172	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					415	422		10.1038/ni.2872	http://dx.doi.org/10.1038/ni.2872			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747712	Green Accepted			2022-12-18	WOS:000334667900006
J	Dejean, AS; Beisner, DR; Ch'en, IL; Kerdiles, YM; Babour, A; Arden, KC; Castrillon, DH; DePinho, RA; Hedrick, SM				Dejean, Anne S.; Beisner, Daniel R.; Ch'en, Irene L.; Kerdiles, Yann M.; Babour, Anna; Arden, Karen C.; Castrillon, Diego H.; DePinho, Ronald A.; Hedrick, Stephen M.			Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells	NATURE IMMUNOLOGY			English	Article							TRYPTOPHAN CATABOLISM; OXIDATIVE STRESS; MLL GENE; IN-VIVO; SURVIVAL; AUTOIMMUNITY; ACTIVATION; PROTEINS; FAMILY; CTLA-4	Foxo transcription factors regulate cell cycle progression, cell survival and DNA-repair pathways. Here we demonstrate that deficiency in Foxo3 resulted in greater expansion of T cell populations after viral infection. This exaggerated expansion was not T cell intrinsic. Instead, it was caused by the enhanced capacity of Foxo3-deficient dendritic cells to sustain T cell viability by producing more interleukin 6. Stimulation of dendritic cells mediated by the coinhibitory molecule CTLA-4 induced nuclear localization of Foxo3, which in turn inhibited the production of interleukin 6 and tumor necrosis factor. Thus, Foxo3 acts to constrain the production of key inflammatory cytokines by dendritic cells and to control T cell survival.	[Dejean, Anne S.; Beisner, Daniel R.; Ch'en, Irene L.; Kerdiles, Yann M.; Babour, Anna; Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, San Diego, CA 92103 USA; [Dejean, Anne S.; Beisner, Daniel R.; Ch'en, Irene L.; Kerdiles, Yann M.; Babour, Anna; Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Arden, Karen C.] Univ Calif, San Diego Sch Med, Ludwig Inst Canc Res, La Jolla, CA USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst,Dept Adult Oncol, Ctr Appl Canc Sci,Belfer Inst Innovat Canc Sci, Boston, MA 02115 USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst,Dept Med, Ctr Appl Canc Sci,Belfer Inst Innovat Canc Sci, Boston, MA 02115 USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst,Dept Genet, Ctr Appl Canc Sci,Belfer Inst Innovat Canc Sci, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Hedrick, SM (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, San Diego, CA 92103 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010; kerdiles, yann/U-2190-2018; Dejean, Anne S/K-6739-2014	kerdiles, yann/0000-0002-8605-1073; Babour, Anna/0000-0002-0212-3528; Dejean, Anne S./0000-0002-8846-1113; Hedrick, Stephen/0000-0002-6345-8751; DePinho, Ronald/0000-0002-5625-577X	American Cancer Society; Robert A. and Renee E. Belfer Institute for Innovative Cancer Research; US National Cancer Institute; Division of Biological Sciences of the University of California, San Diego; Fondation pour la Recherche Medicale; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073885] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Robert A. and Renee E. Belfer Institute for Innovative Cancer Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Biological Sciences of the University of California, San Diego; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. P. Allison (Sloan-Kettering Memorial Hospital) and J. A. Bluestone (University of California at San Diego) for CTLA-4-specific blocking antibodies; A. Brunet (Stanford University) for Foxo3-specific antibody; L. Lefranc, ois (University of Connecticut Health Center) for OVA-expressing vesicular stomatitis virus; L. Mack and E. Zuniga for assistance with virus titers; and M. Niwa for microscope facility use. Supported by the American Cancer Society (R. A. D.), the Robert A. and Renee E. Belfer Institute for Innovative Cancer Research (R. A. D.), the US National Cancer Institute (R. A. D.), the Division of Biological Sciences of the University of California, San Diego (S. M. H.) and the Fondation pour la Recherche Medicale (A. S. D.).	Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; CORRAL J, 1993, P NATL ACAD SCI USA, V90, P8538, DOI 10.1073/pnas.90.18.8538; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hara T, 2008, IMMUNOL LETT, V116, P95, DOI 10.1016/j.imlet.2007.11.016; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, P83; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Rochman I, 2005, J IMMUNOL, V174, P4761, DOI 10.4049/jimmunol.174.8.4761; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Santiago-Raber ML, 2001, J IMMUNOL, V167, P4067, DOI 10.4049/jimmunol.167.7.4067; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Teague TK, 1997, J IMMUNOL, V158, P5791; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030	45	171	178	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					504	513		10.1038/ni.1729	http://dx.doi.org/10.1038/ni.1729			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19363483	Green Accepted			2022-12-18	WOS:000265394400012
J	Tynan, FE; Reid, HH; Kjer-Nielsen, L; Miles, JJ; Wilce, MCJ; Kostenko, L; Borg, NA; Williamson, NA; Beddoe, T; Purcell, AW; Burrows, SR; McCluskey, J; Rossjohn, J				Tynan, Fleur E.; Reid, Hugh H.; Kjer-Nielsen, Lars; Miles, John J.; Wilce, Matthew C. J.; Kostenko, Lyudmila; Borg, Natalie A.; Williamson, Nicholas A.; Beddoe, Travis; Purcell, Anthony W.; Burrows, Scott R.; McCluskey, James; Rossjohn, Jamie			A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule	NATURE IMMUNOLOGY			English	Article							STRUCTURAL BASIS; MHC RESTRICTION; VIRAL PEPTIDE; RECOGNITION; BINDING; CRYSTALLIZATION; THERMODYNAMICS; IMMUNOGENICITY; IDENTIFICATION; DEGENERACY	Plasticity of the T cell receptor (TCR) is a hallmark of major histocompatibility complex (MHC)-restricted T cell recognition. However, it is unclear whether interactions of TCR and peptide-MHC class I ( pMHCI) always conform to this paradigm. Here we describe the structure of a TCR, ELS4, in its non-ligand-bound form and in complex with a prominent 'bulged' Epstein-Barr virus peptide bound to HLA-B*3501. This complex was atypical of previously characterized TCR-pMHCI interactions in that a rigid face of the TCR crumpled the bulged antigenic determinant. This peptide 'bulldozing' created a more featureless pMHCI determinant, allowing the TCR to maximize MHC class I contacts essential for MHC class I restriction of TCR recognition. Our findings represent a mechanism of antigen recognition whereby the plasticity of the T cell response is dictated mainly by adjustments in the MHC-bound peptide.	Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia; Univ Melbourne, Dept Biochem, Parkville, Vic 3010, Australia	Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Melbourne	McCluskey, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Williamson, Nicholas A/O-9812-2016; Miles, John/H-4975-2011; Miles, John J/ABC-1105-2020; Beddoe, Travis/F-3415-2014; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019; Burrows, Scott/G-2050-2011	Williamson, Nicholas A/0000-0002-2173-3452; Miles, John J/0000-0001-5506-6304; Beddoe, Travis/0000-0003-4550-2277; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Burrows, Scott/0000-0002-1430-0472; Kostenko, Lyudmila/0000-0002-8466-7966; Borg, Natalie/0000-0002-8677-9056				ASTILA TP, 1999, SCIENCE, V286, P958; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Davis MM, 2003, NAT IMMUNOL, V4, P649, DOI 10.1038/ni0703-649; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrieu C, 2003, RADIAT RES, V159, P268, DOI 10.1667/0033-7587(2003)159[0268:FCAOGR]2.0.CO;2; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GARBOCZI DN, 1994, J MOL BIOL, V239, P581, DOI 10.1006/jmbi.1994.1398; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maverakis E, 2001, J AUTOIMMUN, V16, P201, DOI 10.1006/jaut.2000.0493; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Webb AI, 2004, J IMMUNOL, V173, P402, DOI 10.4049/jimmunol.173.1.402; Williamson NA, 2005, EXPERT REV PROTEOMIC, V2, P367, DOI 10.1586/14789450.2.3.367; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	50	171	173	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					268	276		10.1038/ni1432	http://dx.doi.org/10.1038/ni1432			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17259989				2022-12-18	WOS:000244275100012
J	Krogsgaard, M; Davis, MM				Krogsgaard, M; Davis, MM			How T cells 'see' antigen	NATURE IMMUNOLOGY			English	Review							PEPTIDE-MHC COMPLEXES; CLASS-II; STRUCTURAL BASIS; IMMUNOLOGICAL SYNAPSE; RECEPTOR RECOGNITION; CRYSTAL-STRUCTURE; CD3-EPSILON-GAMMA HETERODIMER; LIGAND RECOGNITION; NEGATIVE SELECTION; TCR BINDING	T lymphocytes bearing alphabeta T cell receptors are pivotal in the immune response of most vertebrates. For example, helper T cells orchestrate antibody production by B cells as well as stimulating other cells, whereas cytotoxic T cells kill virally infected or abnormal cells. Regulatory T cells act to dampen responsiveness, and natural killer-like T cells monitor lipid metabolism. The specificity of these cells is governed by the alphabeta T cell receptors - antibody-like heterodimeric receptors that detect antigenic fragments (peptides) or lipids bound to histocompatibility molecules. Intriguing clues as to how these peculiar ligands are recognized have gradually emerged over the years and tell a remarkable story of biochemical and cellular novelty. Here we summarize some of the more recent work on alphabeta T cell receptor recognition and discuss the implications for activation.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu		Davis, Mark/0000-0001-6868-657X				Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; LECKBAND D, 1995, BIOPHYS J, V69, P1162, DOI 10.1016/S0006-3495(95)79990-8; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; NANDA NK, 1995, J EXP MED, V182, P531, DOI 10.1084/jem.182.2.531; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Peterson DA, 1999, J IMMUNOL, V162, P3117; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Seed B, 1995, Semin Immunol, V7, P3, DOI 10.1016/1044-5323(95)90002-0; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Ulrich HD, 1997, NATURE, V389, P271, DOI 10.1038/38470; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	77	171	178	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					239	245		10.1038/ni1173	http://dx.doi.org/10.1038/ni1173			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716973				2022-12-18	WOS:000227117400015
J	Holdorf, AD; Lee, KH; Burack, WR; Allen, PM; Shaw, AS				Holdorf, AD; Lee, KH; Burack, WR; Allen, PM; Shaw, AS			Regulation of Lck activity by CD4 and CD28 in the immunological synapse	NATURE IMMUNOLOGY			English	Article							TYROSINE-PROTEIN-KINASE; T-CELL-RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHATASE CD45; ANTIGEN RECEPTOR; CROSS-LINKING; C-SRC; ACTIVATION; PHOSPHORYLATION; DOMAIN	Although the Src family tyrosine kinase Lck is essential for T cell receptor (TCR) signaling, whether or how Lck is activated is unknown. Using a phosphospecific antiserum to Lck, we show here that Lck becomes autophosphorylated when T cells are stimulated by antigen-presenting cells (APCs). We found that TCR cross-linking alone could not stimulate Lck autophosphorylation and CD45 was not required or this process. Instead, the T cell accessory molecules CD4 and CD28 cooperated to induce autophosphorylation of Lck. CD4 recruited Lck to the T cell-APC interface, whereas CD28 sustained Lck activation. These data show how the multiple interactions afforded by the immunological synapse drive efficient and highly specific signaling.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid,Campus Box 8118, St Louis, MO 63110 USA.	shaw@immunology.wustl.edu		Shaw, Andrey/0000-0001-5685-0272; Holdorf, Amy/0000-0001-5699-4081				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; DANIELIAN S, 1989, EUR J IMMUNOL, V19, P2183, DOI 10.1002/eji.1830191202; DEANS JP, 1992, EUR J IMMUNOL, V22, P661, DOI 10.1002/eji.1830220308; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; DESAI DM, 1994, EMBO J, V13, P4002, DOI 10.1002/j.1460-2075.1994.tb06716.x; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Holdorf A D, 2000, Rev Immunogenet, V2, P175; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; RUDD CE, 1991, ADV EXP MED BIOL, V292, P85; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Shaw A S, 1995, Semin Immunol, V7, P13, DOI 10.1016/1044-5323(95)90003-9; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SOULA M, 1993, J BIOL CHEM, V268, P27420; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; van Oers NSC, 1999, SEMIN IMMUNOL, V11, P227, DOI 10.1006/smim.1999.0179; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1990, ONCOGENE, V5, P1455; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; Vidal K, 1999, J IMMUNOL, V163, P4811; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	47	171	177	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					259	264		10.1038/ni761	http://dx.doi.org/10.1038/ni761			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11828322				2022-12-18	WOS:000174074000014
J	Moss, P				Moss, Paul			The T cell immune response against SARS-CoV-2	NATURE IMMUNOLOGY			English	Review							ACUTE RESPIRATORY SYNDROME; COVID-19; REVEALS; VACCINE; PROTECTION; INFECTION; ANTIBODY; DISEASE; IMMUNOGENICITY; REACTOGENICITY	Paul Moss reviews the current knowledge of T cell immunity in the control of SARS-CoV-2. The adaptive immune response is a major determinant of the clinical outcome after SARS-CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and correlate with protection but are relatively impaired in severe disease and are associated with intense activation and lymphopenia. A subset of T cells primed against seasonal coronaviruses cross reacts with SARS-CoV-2 and may contribute to clinical protection, particularly in early life. T cell memory encompasses broad recognition of viral proteins, estimated at around 30 epitopes within each individual, and seems to be well sustained so far. This breadth of recognition can limit the impact of individual viral mutations and is likely to underpin protection against severe disease from viral variants, including Omicron. Current COVID-19 vaccines elicit robust T cell responses that likely contribute to remarkable protection against hospitalization or death, and novel or heterologous regimens offer the potential to further enhance cellular responses. T cell immunity plays a central role in the control of SARS-CoV-2 and its importance may have been relatively underestimated thus far.	[Moss, Paul] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Moss, P (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	p.moss@bham.ac.uk	Moss, Paul/D-1728-2009	Moss, Paul/0000-0002-6895-1967				Adamo S, NATURE, DOI [10.1038/s41586-021-04280-x(2021), DOI 10.1038/S41586-021-04280-X(2021)]; [Anonymous], 2020, PFIZ BIONTECH ANN VA; Antunes RD, 2021, J INFECT DIS, V224, P70, DOI 10.1093/infdis/jiab176; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Bange EM, 2021, NAT MED, V27, P1280, DOI 10.1038/s41591-021-01386-7; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Bergamaschi L, 2021, IMMUNITY, V54, P1257, DOI 10.1016/j.immuni.2021.05.010; Bieberich Florian, 2021, Front Immunol, V12, P701085, DOI 10.3389/fimmu.2021.701085; Bilich T, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf7517; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Boppana S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009761; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cohen B, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.11.006; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Cromer D, 2021, NAT REV IMMUNOL, V21, P395, DOI 10.1038/s41577-021-00550-x; de Silva TI, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103353; Deinhardt-Emmer S, 2021, ELIFE, V10, DOI 10.7554/eLife.60361; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dowell AC, 2022, NAT IMMUNOL, V23, P40, DOI 10.1038/s41590-021-01089-8; Dykema AG, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146922; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Fischer W, 2021, CELL HOST MICROBE, V29, P1093, DOI 10.1016/j.chom.2021.05.012; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Gao ML, 2021, J LEUKOCYTE BIOL, V109, P91, DOI 10.1002/JLB.5COVA0720-421RR; Gorse GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1875, DOI 10.1128/CVI.00278-10; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; Grifoni A, 2021, CELL HOST MICROBE, V29, P1076, DOI 10.1016/j.chom.2021.05.010; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Heitmann JS, 2022, NATURE, V601, P617, DOI 10.1038/s41586-021-04232-5; Hillaire MLB, 2013, CURR OPIN VIROL, V3, P430, DOI 10.1016/j.coviro.2013.05.002; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jung JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24377-1; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lehner PJ, 2003, IMMUNITY, V18, P315, DOI 10.1016/S1074-7613(03)00061-X; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lucas C, 2021, NAT MED, V27, P1178, DOI 10.1038/s41591-021-01355-0; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Madden EA, 2022, CURR OPIN VIROL, V52, P30, DOI 10.1016/j.coviro.2021.11.002; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Maurice NJ, 2021, J IMMUNOL, V206, P455, DOI 10.4049/jimmunol.2000937; Mazzoni A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149150; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Meade P, 2020, MBIO, V11, DOI 10.1128/mBio.03243-19; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Murchu EO, 2022, REV MED VIROL, V32, DOI 10.1002/rmv.2260; Nagler A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109305; Nathan A, 2021, CELL, V184, P4401, DOI 10.1016/j.cell.2021.06.029; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ng Kevin W, 2020, Science, V370, P1339, DOI 10.1126/science.abe1107; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Notarbartolo S, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5021; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Ogbe A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21856-3; Parry H, 2021, LANCET HEALTH LONGEV, V2, pE554, DOI 10.1016/S2666-7568(21)00169-0; Parry H, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00246-9; Peng Y., 2020, NAT IMMUNOL, V21, P1336, DOI DOI 10.1038/s41590-020-0782-6; Peng YC, 2022, NAT IMMUNOL, V23, P50, DOI 10.1038/s41590-021-01084-z; Pozzetto B, 2021, NATURE, V600, P701, DOI 10.1038/s41586-021-04120-y; Pujadas E, 2020, LANCET RESP MED, V8, pE70, DOI 10.1016/S2213-2600(20)30354-4; Quadeer AA, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100312; Redd Andrew D, 2021, medRxiv, DOI [10.1093/ofid/ofab143, 10.1101/2021.02.11.21251585]; Rha MS, 2021, IMMUNITY, V54, P44, DOI 10.1016/j.immuni.2020.12.002; Rice A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94364-5; Robson F, 2020, MOL CELL, V79, P710, DOI 10.1016/j.molcel.2020.07.027; Routhu NK, 2021, IMMUNITY, V54, P542, DOI 10.1016/j.immuni.2021.02.001; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; Russell CD, 2017, CLIN MICROBIOL REV, V30, P481, DOI 10.1128/CMR.00090-16; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Sahin U, 2021, NATURE, V595, P572, DOI 10.1038/s41586-021-03653-6; Saletti G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78506-9; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01158-2, 10.1016/S0140-6736(21)01115-6]; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Shoukat MS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100192; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Singer J, COV GLUE; Skelly DT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25167-5; Song JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17240-2; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stephenson E, 2021, NAT MED, V27, P904, DOI 10.1038/s41591-021-01329-2; Stuart ASV, 2022, LANCET, V399, P36, DOI 10.1016/S0140-6736(21)02718-5; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Szabo PA, 2021, IMMUNITY, V54, P797, DOI 10.1016/j.immuni.2021.03.005; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Verhagen J, 2021, CLIN EXP IMMUNOL, V205, P363, DOI 10.1111/cei.13627; Weingarten-Gabbay S, 2021, CELL, V184, P3962, DOI 10.1016/j.cell.2021.05.046; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wheatley AK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21444-5; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woldemeskel BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149335; Woolthuis RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33334; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Yang JR, 2020, J MED VIROL, V92, P1681, DOI 10.1002/jmv.25940; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yu KKQ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.146242; Zeng C, 2022, P NATL ACAD SCI USA, V119, DOI [10.1101/2021.06.01.446579, 10.1073/pnas.2111400119]; Zhang YW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024202118; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	129	170	170	38	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					186	193		10.1038/s41590-021-01122-w	http://dx.doi.org/10.1038/s41590-021-01122-w		FEB 2022	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35105982	Bronze			2022-12-18	WOS:000749438100008
J	Yu, F; Sharma, S; Edwards, J; Feigenbaum, L; Zhu, JF				Yu, Fang; Sharma, Suveena; Edwards, Julie; Feigenbaum, Lionel; Zhu, Jinfang			Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; FACTOR FOXP3; DIFFERENTIATION; ACTIVATION; PROGRAM; INFLAMMATION; INSTABILITY; MECHANISMS; GENERATION; INFECTION	Regulatory T cells (T-reg cells) can express the transcription factors T-bet and GATA-3, but the function of this expression and whether such cells represent stable subsets is still unknown. By using various reporter tools, we found that the expression of T-bet and GATA-3 in T-reg cells was dynamically influenced by the cytokine environment. T-reg cell-specific deletion of the gene encoding either T-bet (Tbx21) or GATA-3 (Gata3) alone did not result in loss of T-reg cell function; however, mice with combined deficiency in both genes in T-reg cells developed severe autoimmune-like diseases. Loss of T-reg cell function correlated with upregulation of expression of the transcription factor ROR gamma t and reduced expression of the transcription factor Foxp3. Thus, in the steady state, activated T-reg cells transiently upregulated either T-bet or GATA-3 to maintain T cell homeostasis.	[Yu, Fang; Sharma, Suveena; Edwards, Julie; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	Division of Intramural Research of the NIAID (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID (US National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.D. Engel (University of Michigan) for GATA-3-GFP reporter mice on the C57BL/6 background; S. Reiner (University of Columbia) for Tbx21<SUP>fl/fl</SUP> mice; A. Rudensky (Memorial Sloan Kettering Cancer Center) for Foxp3-IRES-YFP-Cre mice; D. Jankovic (National Institute of Allergy and Infectious Diseases (NIAID)) for Stat1<SUP>-/-</SUP> mice; E. Shevach, Y. Belkaid and W. Paul for critical reading of the manuscript and discussions; A. Thornton for discussions; L. Guo for the help with enzyme-linked immunosorbent assay experiments; N. Cereb and S.Y. Yang (Histogenetics) and S. Reiner (Columbia University) for constructing and providing Tbx21fl/fl mice; and the flow cytometry core facility of the NIAID for cell sorting. Supported by the Division of Intramural Research of the NIAID (US National Institutes of Health).	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	170	175	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					197	+		10.1038/ni.3053	http://dx.doi.org/10.1038/ni.3053			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25501630	Green Accepted			2022-12-18	WOS:000348143100012
J	Paust, S; von Andrian, UH				Paust, Silke; von Andrian, Ulrich H.			Natural killer cell memory	NATURE IMMUNOLOGY			English	Review							CHEMOKINE RECEPTOR EXPRESSION; IMMUNOGLOBULIN-LIKE RECEPTORS; MOUSE LYMPHOID-CELLS; T-CELLS; NK CELLS; DENDRITIC CELLS; IFN-GAMMA; CYTOTOXIC REACTIVITY; CONTACT SENSITIVITY; SCAVENGER RECEPTOR	Natural killer (NK) cells are bone marrow-derived granular lymphocytes that have a key role in immune defense against viral and bacterial infections and malignancies. NK cells are traditionally defined as cells of the innate immune response because they lack RAG recombinase-dependent clonal antigen receptors. However, evidence suggests that specific subsets of mouse NK cells can nevertheless develop long-lived and highly specific memory to a variety of antigens. Here we review published evidence of NK cell-mediated, RAG-independent adaptive immunity. We also compare and contrast candidate mechanisms for mammalian NK cell memory and antigen recognition with other examples of RAG-independent pathways that generate antigen receptor diversity in non-mammalian species and discuss NK cell memory in the context of lymphocyte evolution.	[Paust, Silke; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Paust, Silke] MGH, Ragon Inst, MIT, Charlestown, MA USA; [von Andrian, Ulrich H.] Immune Dis Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	uva@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008	Paust, Silke/0000-0002-0526-3999	Cancer Research Institute; Ragon Institute of MGH, MIT and Harvard; US National Institutes of Health [AI069259, AI072252, AI1078897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, R01AI072252] Funding Source: NIH RePORTER	Cancer Research Institute; Ragon Institute of MGH, MIT and Harvard; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Cancer Research Institute (S.P.), the Ragon Institute of MGH, MIT and Harvard (S.P. and U.H.v.A.) and the US National Institutes of Health (AI069259, AI072252 and AI1078897 to U.H.v.A.).	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; Aslanian AM, 2006, CIRCULATION, V114, P583, DOI 10.1161/CIRCULATIONAHA.105.540583; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Boehncke WH, 2005, EXP DERMATOL, V14, P70, DOI 10.1111/j.0906-6705.2005.290b.x; Bouazzaoui A, 2009, GENES IMMUN, V10, P687, DOI 10.1038/gene.2009.49; Buentke E, 2002, J INVEST DERMATOL, V119, P850, DOI 10.1046/j.1523-1747.2002.00132.x; Calabresi PA, 2002, J NEUROIMMUNOL, V127, P96, DOI 10.1016/S0165-5728(02)00106-6; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carbone T, 2010, J IMMUNOL, V184, P1102, DOI 10.4049/jimmunol.0902518; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; CROWLE AJ, 1959, SCIENCE, V130, P159, DOI 10.1126/science.130.3368.159; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; FernandezBusquets X, 1997, J BIOL CHEM, V272, P27839, DOI 10.1074/jbc.272.44.27839; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Gao N, 2001, J IMMUNOL, V167, P2011, DOI 10.4049/jimmunol.167.4.2011; Garcia GE, 2007, AM J PATHOL, V170, P1485, DOI 10.2353/ajpath.2007.060065; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gorbachev AV, 2001, CRIT REV IMMUNOL, V21, P451; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Gutwein P, 2009, EUR J CANCER, V45, P478, DOI 10.1016/j.ejca.2008.10.023; Hedman M, 2008, CLIN EXP IMMUNOL, V153, P360, DOI 10.1111/j.1365-2249.2008.03720.x; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hunger RE, 1999, BRIT J DERMATOL, V141, P565; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Ivakine EA, 2006, J IMMUNOL, V176, P2976, DOI 10.4049/jimmunol.176.5.2976; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Jiang XF, 2005, J IMMUNOL, V175, P2051, DOI 10.4049/jimmunol.175.4.2051; Jinushi M, 2007, IMMUNOLOGY, V120, P73, DOI 10.1111/j.1365-2567.2006.02479.x; Joly E, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-3; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim JV, 2010, J IMMUNOL METHODS, V352, P89, DOI 10.1016/j.jim.2009.09.007; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lunemann A, 2009, MOL MED, V15, P352, DOI 10.2119/molmed.2009.00035; MACDOUGALL JR, 1990, CELL IMMUNOL, V130, P106, DOI 10.1016/0008-8749(90)90165-N; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martini G, 2008, CLIN IMMUNOL, V129, P268, DOI 10.1016/j.clim.2008.06.014; Matsumura K, 2008, RADIAT MED, V26, P133, DOI 10.1007/s11604-007-0207-6; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Momot T, 2004, ARTHRITIS RHEUM-US, V50, P1561, DOI 10.1002/art.20216; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Namekawa T, 2000, J IMMUNOL, V165, P1138, DOI 10.4049/jimmunol.165.2.1138; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Nicotra ML, 2009, CURR BIOL, V19, P583, DOI 10.1016/j.cub.2009.02.040; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Oh ST, 2009, DERM-ENDOCRINOL, V1, P114, DOI 10.4161/derm.1.2.7750; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; PHANUPHAK P, 1974, J IMMUNOL, V112, P115; PHANUPHAK P, 1974, J IMMUNOL, V112, P849; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Scalzo AA, 2005, IMMUNOL CELL BIOL, V83, P144, DOI 10.1111/j.1440-1711.2005.01311.x; Seidl H, 2007, HUM PATHOL, V38, P768, DOI 10.1016/j.humpath.2006.11.013; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Suzuki Y, 2004, J INVEST DERMATOL, V122, P1133, DOI 10.1111/j.0022-202X.2004.22517.x; Teramoto K, 2008, J PHARMACOL SCI, V106, P56, DOI 10.1254/jphs.FP0071337; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Uinuk-ool TS, 2003, SCAND J IMMUNOL, V58, P436, DOI 10.1046/j.1365-3083.2003.01322.x; Uinuk-ool TS, 2003, IMMUNOGENETICS, V55, P38, DOI 10.1007/s00251-003-0548-y; van der Voort R, 2005, ARTHRITIS RHEUM-US, V52, P1381, DOI 10.1002/art.21004; van der Voort R, 2010, J LEUKOCYTE BIOL, V87, P1029, DOI 10.1189/jlb.0709482; Vermijlen D, 2004, EUR J IMMUNOL, V34, P2529, DOI 10.1002/eji.200324712; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zucchetti I, 2008, DIFFERENTIATION, V76, P267, DOI 10.1111/j.1432-0436.2007.00214.x	106	170	177	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					500	508		10.1038/ni.2032	http://dx.doi.org/10.1038/ni.2032			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739673				2022-12-18	WOS:000290707100008
J	Maritano, D; Sugrue, ML; Tininini, S; Dewilde, S; Strobl, B; Fu, XP; Murray-Tait, V; Chiarle, R; Poli, V				Maritano, D; Sugrue, ML; Tininini, S; Dewilde, S; Strobl, B; Fu, XP; Murray-Tait, V; Chiarle, R; Poli, V			The STAT3 isoforms and have unique and specific functions	NATURE IMMUNOLOGY			English	Article							ACUTE-PHASE RESPONSE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CHRONIC ENTEROCOLITIS; STAT3-DEFICIENT MICE; NEGATIVE REGULATOR; SIGNAL TRANSDUCER; IL-10 GENE; IN-VIVO; C-JUN	Signal transducer and activator of transcription 3 (STAT3) is the main mediator of interleukin 6 (IL-6)-type cytokine signaling. It exists in two isoforms: the full-length STAT3 and the truncated STAT3, generally thought to act as a dominant negative factor. To assess their relative functions, we ablated the expression of either isoform by gene targeting. We show here that in vivo STAT3 is not a dominant negative factor. Its expression can rescue the embryonic lethality of a STAT3-null mutation and it can by itself induce the expression of specific STAT3 target genes. Nevertheless, STAT3 has nonredundant roles such as modulation of cellular responses to IL-6 and mediation of IL-10 function in macrophages.	Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Canc Res United Kingdom London Res Inst, London WC2A 3PX, England; Univ Turin, Dept Biomed Sci & Human Oncol, Turin, Italy; Ctr Expt Res & Med Studies, Turin, Italy	University of Turin; University of Dundee; Cancer Research UK; University of Turin	Poli, V (corresponding author), Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy.	valeria.poli@unito.it	Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966; Strobl, Birgit/0000-0001-5716-3212; CHIARLE, Roberto/0000-0003-1564-8531				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aberger F, 2001, GENOMICS, V77, P50, DOI 10.1006/geno.2001.6623; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Cappelletti M, 1996, CELL DEATH DIFFER, V3, P29; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DOYLE AG, 1996, WEIRS HDB EXPT IMMUN; Duncan SA, 1997, DEV DYNAM, V208, P190, DOI 10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; MACKIEWICZ A, 1995, CYTOKINE, V7, P142, DOI 10.1006/cyto.1995.1019; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Strobl B, 2001, EMBO J, V20, P5431, DOI 10.1093/emboj/20.19.5431; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	44	170	181	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					401	409		10.1038/ni1052	http://dx.doi.org/10.1038/ni1052			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15021879				2022-12-18	WOS:000220515900013
J	Martin, CH; Aifantis, I; Scimone, ML; von Andrian, UH; Reizis, B; von Boehmer, H; Gounari, F				Martin, CH; Aifantis, I; Scimone, ML; von Andrian, UH; Reizis, B; von Boehmer, H; Gounari, F			Efficient thymic immigration of B220(+) lymphoid-restricted bone marrow cells with T precursor potential	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; LINEAGE; EXPRESSION; MICE; LYMPHOPOIESIS; NOTCH1; FATE; GENE; DIFFERENTIATION	Using a human CD25 reporter transgene controlled by regulatory sequences from the gene encoding pre-T cell receptor alpha, we identified a common lymphocyte precursor (CLP-2) population that, in contrast to the previously identified CLP-1 population, was c-Kit(-)B220(+). In short-term culture, the CLP-2 could be derived from the CLP-1 subset, and contained cells that in clonogenic assays were assessed to be bipotent precursors of T and B cells. Intravenous injection of bone marrow cells yielded a selective accumulation of CLP-2 thymic immigrants that in thymic organ culture generated mature alphabeta T cells. Although the CLP-2 subset may represent the most differentiated population with T cell potential before commitment to the B cell lineage, other subsets of thymic immigrants capable of generating T cells may exist.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.		von Andrian, Ulrich H/A-5775-2008	Reizis, Boris/0000-0003-1140-7853	PHS HHS [R01A147281, R01A145846] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; ASENSI V, 1989, IMMUNOLOGY, V68, P204; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DEJBAKHSHJONES S, 1995, J IMMUNOL, V155, P3338; DOMIATISAAD R, 1993, J IMMUNOL, V151, P5936; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0; Okada T, 2003, EUR J IMMUNOL, V33, P1012, DOI 10.1002/eji.200323616; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Schlueter AJ, 1997, J IMMUNOL, V158, P4211; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793	35	170	174	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					866	873		10.1038/ni965	http://dx.doi.org/10.1038/ni965			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12925850				2022-12-18	WOS:000185002200013
J	Cauwels, A; Janssen, B; Waeytens, A; Cuvelier, C; Brouckaert, P				Cauwels, A; Janssen, B; Waeytens, A; Cuvelier, C; Brouckaert, P			Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2	NATURE IMMUNOLOGY			English	Article							INDUCED ENTEROCYTE APOPTOSIS; ARACHIDONIC-ACID RELEASE; DOMAIN KINASE RIP; DEATH DOMAIN; SIGNAL-TRANSDUCTION; CELL APOPTOSIS; TNF-ALPHA; ACTIVATION; MICE; FAS	Dysregulated apoptotic cell death contributes to many pathological conditions, including sepsis, prompting the suggestion that caspase inhibition to block apoptosis could have useful therapeutic applications. Because the cytokine tumor necrosis factor (TNF, also known as TNF-alpha) is both proapoptotic and pro-inflammatory and is involved in septic shock, we tested whether caspase inhibition would alleviate TNF-induced toxicity in vivo. General caspase inhibition by the protease inhibitor zVAD-fmk exacerbated TNF toxicity by enhancing oxidative stress and mitochondrial damage, resulting in hyperacute hemodynamic collapse, kidney failure and death. Thus, survival of TNF toxicity depends on caspase-dependent processes. Our results demonstrated the pathophysiological relevance of caspase-independent, ROS-mediated pathways in response to lethal TNF-induced shock in mice. In addition, survival of TNF toxicity seemed to require a caspase-dependent protective feedback on excessive reactive oxygen species (ROS) formation and phospholipase A2 activation.	State Univ Ghent, Dept Mol Biomed Res, Mol Pathophysiol & Expt Therapy Unit, B-9000 Ghent, Belgium; Flanders Interuniv Inst Biotechnol VIB, B-9000 Ghent, Belgium; Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands; State Univ Ghent, Dept Pathol, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Maastricht University; Ghent University	Cauwels, A (corresponding author), State Univ Ghent, Dept Mol Biomed Res, Mol Pathophysiol & Expt Therapy Unit, KL Ledeganckstr 35, B-9000 Ghent, Belgium.							Adam-Klages S, 1998, J IMMUNOL, V161, P5687; Ameloot P, 2002, EUR J IMMUNOL, V32, P2759, DOI 10.1002/1521-4141(2002010)32:10<2759::AID-IMMU2759>3.0.CO;2-L; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Ayala A, 2003, INT J BIOCHEM CELL B, V35, P7, DOI 10.1016/S1357-2725(02)00099-7; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Beyaert R, 2002, INT REV CYTOL, V214, P225; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Cauwels A, 2000, IMMUNITY, V13, P223, DOI 10.1016/S1074-7613(00)00022-4; Denson DD, 2001, J BIOL CHEM, V276, P7136, DOI 10.1074/jbc.M009566200; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henshall DC, 2001, J NEUROCHEM, V77, P886, DOI 10.1046/j.1471-4159.2001.00291.x; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jaeschke H, 1998, J IMMUNOL, V160, P3480; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kronke M, 2002, FEBS LETT, V531, P18, DOI 10.1016/S0014-5793(02)03407-5; Kunstle G, 1997, IMMUNOL LETT, V55, P5, DOI 10.1016/S0165-2478(96)02642-9; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; ODONNELL VB, 1995, BIOCHEM J, V310, P133, DOI 10.1042/bj3100133; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Piguet PF, 1999, LAB INVEST, V79, P495; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; ROSENTHAL MD, 1989, BIOCHIM BIOPHYS ACTA, V1001, P1, DOI 10.1016/0005-2760(89)90299-3; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Schoonbroodt S, 2000, BIOCHEM PHARMACOL, V60, P1075, DOI 10.1016/S0006-2952(00)00371-3; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Worrell RT, 2001, AM J PHYSIOL-CELL PH, V281, pC147, DOI 10.1152/ajpcell.2001.281.1.C147; Yamashita K, 1999, BLOOD, V93, P674, DOI 10.1182/blood.V93.2.674.402k26_674_685; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	44	170	176	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					387	393		10.1038/ni914	http://dx.doi.org/10.1038/ni914			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12652297				2022-12-18	WOS:000181987700020
J	Holler, PD; Chlewicki, LK; Kranz, DM				Holler, PD; Chlewicki, LK; Kranz, DM			TCRs with high affinity for foreign pMHC show self-reactivity	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; YEAST SURFACE-DISPLAY; MAJOR HISTOCOMPATIBILITY COMPLEXES; PEPTIDE-MHC; ALPHA-BETA; ANTIGEN RECOGNITION; POSITIVE SELECTION; NEGATIVE SELECTION; STRUCTURAL BASIS; LIGAND AFFINITY	T cells with high-affinity T cell receptors (TCRs) for a foreign peptide-major histocompatibility complex (pMHC) appear to be negatively selected, even though they have never seen the foreign antigen. To examine how this process operates, we used in vitro yeast display to isolate high-affinity TCRs from the T cell clone 2C. The TCRs showed fast on-rates, which were consistent with reduced CDR (complementarity determining region) flexibility, and cross-reactivity with other cognate pMHCs. T cell hybridomas transfected with a high-affinity TCR were stimulated by endogenous self-pMHC, which suggested that T cells bearing the TCR would be negatively selected. The immune system appears to maintain a repertoire of flexible, low-affinity TCRs at the expense of more effective high-affinity TCRs.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.		Calabrese, Massimiliano/I-6195-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM55767] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; Eisen HN, 2001, ANNU REV IMMUNOL, V19, P1, DOI 10.1146/annurev.immunol.19.1.1; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia K C, 1999, Rev Immunogenet, V1, P75; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; GASCOIGNE NRJ, 2001, EXP REV MOL MED 0212; GEITZ RD, 1995, YEAST, V11, P355; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2001, J EXP MED, V194, P1043, DOI 10.1084/jem.194.8.1043; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kieke MC, 1997, PROTEIN ENG, V10, P1303, DOI 10.1093/protein/10.11.1303; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Manning TC, 1996, J IMMUNOL METHODS, V192, P125, DOI 10.1016/0022-1759(96)00048-8; Manning TC, 1999, J EXP MED, V189, P461, DOI 10.1084/jem.189.3.461; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; OHerrin SM, 1997, J EXP MED, V186, P1333, DOI 10.1084/jem.186.8.1333; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; Sherman LA, 2000, IMMUNOL RES, V21, P305, DOI 10.1385/IR:21:2-3:305; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	47	170	181	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					55	62		10.1038/ni863	http://dx.doi.org/10.1038/ni863			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12469116				2022-12-18	WOS:000180053000015
J	Garaude, J; Acin-Perez, R; Martinez-Cano, S; Enamorado, M; Ugolini, M; Nistal-Villan, E; Hervas-Stubbs, S; Pelegrin, P; Sander, LE; Enriquez, JA; Sancho, D				Garaude, Johan; Acin-Perez, Rebeca; Martinez-Cano, Sarai; Enamorado, Michel; Ugolini, Matteo; Nistal-Villan, Estanislao; Hervas-Stubbs, Sandra; Pelegrin, Pablo; Sander, Leif E.; Enriquez, Jose A.; Sancho, David			Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense	NATURE IMMUNOLOGY			English	Article							COMPLEX-I; INNATE; DEHYDROGENASE; SUCCINATE; CELL; ACTIVATION; CASPASE-1; IL-1-BETA; INDUCTION; KINASES	Macrophages tightly scale their core metabolism after being activated, but the precise regulation of the mitochondrial electron-transport chain (ETC) and its functional implications are currently unknown. Here we found that recognition of live bacteria by macrophages transiently decreased assembly of the ETC complex I (CI) and Cl-containing super-complexes and switched the relative contributions of CI and CII to mitochondria! respiration. This was mediated by phagosomal NADPH oxidase and the reactive oxygen species (ROS)-dependent tyrosine kinase Fgr. It required Toll-like receptor signaling and the NLRP3 inflammasome, which were both connected to bacterial viability specific immune responses. Inhibition of CII during infection with Escherichia coli normalized serum concentrations of interleukin 1 beta (IL-1 beta) and IL-10 to those in mice treated with dead bacteria and impaired control of bacteria. We have thus identified ETC adaptations as an early immunological-metabolic checkpoint that adjusts innate immune responses to bacterial infection.	[Garaude, Johan; Acin-Perez, Rebeca; Martinez-Cano, Sarai; Enamorado, Michel; Enriquez, Jose A.; Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Garaude, Johan] INSERM, Inst Regenerat Med & Biotherapies, U1183, F-U1183 Montpellier, France; [Ugolini, Matteo; Sander, Leif E.] Charite Hosp Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Nistal-Villan, Estanislao; Hervas-Stubbs, Sandra] Univ Navarra, Ctr Invest Med Aplicada, Pamplona, Spain; [Hervas-Stubbs, Sandra] Recinto Complejo Hosp Navarra, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain; [Pelegrin, Pablo] Hosp Clin Univ Virgen Arrixaca, Unidad Inflamac & Cirugia Expt, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Inst Murciano Invest Biosanitaria Arrixaca, Murcia, Spain; [Enriquez, Jose A.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Nistal-Villan, Estanislao] Univ CEU San Pablo, Microbiol Sect, Dept Pharmaceut & Hlth Sci, Fac Pharm, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca; University of Zaragoza; San Pablo CEU University	Garaude, J; Enriquez, JA; Sancho, D (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Garaude, J (corresponding author), INSERM, Inst Regenerat Med & Biotherapies, U1183, F-U1183 Montpellier, France.; Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.	johan.garaude@inserm.fr; jaenriquez@cnic.es; dsancho@cnic.es	Sander, Leif Erik/AAI-8619-2020; Nistal-Villan, Estanislao/GWM-7994-2022; Pelegrin, Pablo/M-2007-2014; Sancho, David/D-3433-2009; Acin-Perez, Rebeca/AAU-4913-2020; Enríquez, J.A./M-8468-2016; Nistal-Villán, Estanislao/AAM-8029-2020; Hervas-Stubbs, Sandra/C-9053-2018	Pelegrin, Pablo/0000-0002-9688-1804; Sancho, David/0000-0003-2890-3984; Acin-Perez, Rebeca/0000-0001-9553-8337; Enríquez, J.A./0000-0002-3671-2961; Nistal-Villán, Estanislao/0000-0003-2458-8833; Hervas-Stubbs, Sandra/0000-0003-3391-1516; Sander, Leif Erik/0000-0002-0476-9947; Garaude, Johan/0000-0001-7789-7715; Enamorado Escalona, Neris Michel/0000-0001-7748-454X	European Community [332881, ERC-2010-StG 260414, 635122-PROCROP H2020, UE0/MCA1108, UE0/MCA1201]; French association 'La Ligue Contre le Cancer-comite du Gard' [CG/59-2013]; Spanish Ministry of Economy and Competitiveness [SAF-2013-42920R, SAF2012-1207, RyC2011-07826]; Comunidad de Madrid [CAM/API1009]; German research council (DFG grant) [SA1940/2-1, SFB-TR84 TP-C08]; MINECO; Pro-CNIC Foundation	European Community(European Commission); French association 'La Ligue Contre le Cancer-comite du Gard'; Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); German research council (DFG grant)(German Research Foundation (DFG)); MINECO(Spanish Government); Pro-CNIC Foundation	We thank A. Hidalgo for critical reading of the manuscript; S. Akira (Oska University) for Ips1<SUP>-/-</SUP> mice; J. Magarian Blander (Mount Sinai School of Medicine) for Myd88<SUP>-/-</SUP>, Trif<SUP>-/-</SUP> and Trif<SUP>-/-</SUP> Myd88<SUP>-/-</SUP> mice; F. Norel-Bozouklian (Institut Pasteur) for S. thyphimurium SL1344; S. Trombetta (New York University) for the plasmid encoding GFP-OT; S. Bartlett for English editing; and M. Fernandez-Monreal, M. Villalba, F. Ruperez-Pascualena and members of the Sancho and Enriquez laboratories for discussions and support. Supported by the European Community (FP7-Marie Curie-CIG#332881 to J.G.; ERC-2010-StG 260414 and 635122-PROCROP H2020 to D.S.; and UE0/MCA1108 and UE0/MCA1201 to J.A.E), the French association 'La Ligue Contre le Cancer-comite du Gard' (CG/59-2013 to J.G.), the Spanish Ministry of Economy and Competitiveness (SAF-2013-42920R to D.S.; SAF2012-1207 to J.A.E.; and RyC2011-07826 to R.A.-P.), the Comunidad de Madrid (CAM/API1009 to J.A.E.), the German research council (DFG grant SA1940/2-1 and SFB-TR84 TP-C08 to L.E.S.). CNIC is supported by the MINECO and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, CELL METAB, V19, P1020, DOI 10.1016/j.cmet.2014.04.015; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Benard G, 2008, INT J BIOCHEM CELL B, V40, P1543, DOI 10.1016/j.biocel.2007.11.023; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; GUTMAN M, 1978, MOL CELL BIOCHEM, V20, P41; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Nath AK, 2015, CELL REP, V10, P694, DOI 10.1016/j.celrep.2015.01.010; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pan H, 2012, BIOCHEM BIOPH RES CO, V420, P685, DOI 10.1016/j.bbrc.2012.03.069; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sokolovska A, 2013, NAT IMMUNOL, V14, P543, DOI 10.1038/ni.2595; Speijer D, 2011, BIOESSAYS, V33, P88, DOI 10.1002/bies.201000097; Stanley IA, 2014, TRENDS CELL BIOL, V24, P118, DOI 10.1016/j.tcb.2013.07.010; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	41	169	172	4	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1037	1045		10.1038/ni.3509	http://dx.doi.org/10.1038/ni.3509			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27348412	Green Accepted			2022-12-18	WOS:000381832000007
J	Pierson, W; Cauwe, B; Policheni, A; Schlenner, SM; Franckaert, D; Berges, J; Humblet-Baron, S; Schonefeldt, S; Herold, MJ; Hildeman, D; Strasser, A; Bouillet, P; Lu, LF; Matthys, P; Freitas, AA; Luther, RJ; Weaver, CT; Dooley, J; Gray, DHD; Liston, A				Pierson, Wim; Cauwe, Benedicte; Policheni, Antonia; Schlenner, Susan M.; Franckaert, Dean; Berges, Julien; Humblet-Baron, Stephanie; Schonefeldt, Susann; Herold, Marco J.; Hildeman, David; Strasser, Andreas; Bouillet, Philippe; Lu, Li-Fan; Matthys, Patrick; Freitas, Antonio A.; Luther, Rita J.; Weaver, Casey T.; Dooley, James; Gray, Daniel H. D.; Liston, Adrian			Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							BH3-ONLY PROTEINS; DENDRITIC CELLS; LIFE-SPAN; HOMEOSTASIS; RECEPTOR; FAMILY; LIMITS; DEATH; INFLAMMATION; AUTOIMMUNITY	Foxp3(+) regulatory T (T-reg)cells are a crucial immunosuppressive population of CD4(+) T cells, yet the homeostatic processes and survival programs that maintain the T-reg cell pool are poorly understood. Here we report that peripheral T-reg cells markedly alter their proliferative and apoptotic rates to rapidly restore numerical deficit through an interleukin 2-dependent and costimulation-dependent process. By contrast, excess T-reg cells are removed by attrition, dependent on the Bim-initiated Bak- and Bax-dependent intrinsic apoptotic pathway. The antiapoptotic proteins Bcl-x(L) and Bcl-2 were dispensable for survival of T-reg cells, whereas Mcl-1 was critical for survival of T-reg cells, and the loss of this antiapoptotic protein caused fatal autoimmunity. Together, these data define the active processes by which T-reg cells maintain homeostasis via critical survival pathways.	[Pierson, Wim; Cauwe, Benedicte; Schlenner, Susan M.; Franckaert, Dean; Humblet-Baron, Stephanie; Schonefeldt, Susann; Dooley, James; Liston, Adrian] VIB, Autoimmune Genet Lab, Louvain, Belgium; [Pierson, Wim; Cauwe, Benedicte; Schlenner, Susan M.; Franckaert, Dean; Humblet-Baron, Stephanie; Schonefeldt, Susann; Dooley, James; Liston, Adrian] Univ Louvain, Dept Microbiol & Immunol, Louvain, Belgium; [Policheni, Antonia; Herold, Marco J.; Strasser, Andreas; Bouillet, Philippe; Gray, Daniel H. D.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Policheni, Antonia; Herold, Marco J.; Strasser, Andreas; Bouillet, Philippe; Gray, Daniel H. D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Berges, Julien; Freitas, Antonio A.] Inst Pasteur, Dept Immunol, Unite Biol Populat Lymphocytaires, F-75724 Paris, France; [Berges, Julien; Freitas, Antonio A.] CNRS, Unite Rech Associee 1961, Paris, France; [Hildeman, David] Univ Cincinnati, Coll Med, Div Immunobiol, Cincinnati, OH USA; [Hildeman, David] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Matthys, Patrick] Univ Louvain, Rega Inst, Immunobiol Lab, Louvain, Belgium; [Luther, Rita J.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Flanders Institute for Biotechnology (VIB); Walter & Eliza Hall Institute; University of Melbourne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Diego; KU Leuven; University of Alabama System; University of Alabama Birmingham	Liston, A (corresponding author), VIB, Autoimmune Genet Lab, Louvain, Belgium.	dgray@wehi.edu.au; adrian.liston@vib.be	Gray, Daniel HD/A-3293-2013; Bouillet, Philippe/E-1241-2013; Hildeman, David/AAA-1757-2020; freitas, antonio/A-2482-2013; Liston, Adrian/G-8606-2013; Hildeman, David/I-4884-2015; Herold, Marco J/C-8039-2013; Strasser, Andreas/C-7581-2013; Matthys, Patrick/B-4813-2018; Schlenner, Susan/P-7905-2017	Gray, Daniel HD/0000-0002-8457-8242; Bouillet, Philippe/0000-0002-9012-6058; Hildeman, David/0000-0002-0421-8483; Liston, Adrian/0000-0002-6272-4085; Hildeman, David/0000-0002-0421-8483; Herold, Marco J/0000-0001-7539-7581; Strasser, Andreas/0000-0002-5020-4891; Matthys, Patrick/0000-0002-9685-6836; Dooley, James/0000-0003-3154-4708; Lu, Li-Fan/0000-0002-9727-0036; Schlenner, Susan/0000-0002-8553-3388; Pierson, Wim/0000-0003-1369-4606; Weaver, Casey/0000-0002-2180-1793; freitas, antonio/0000-0001-6392-7178; Humblet-Baron, Stephanie/0000-0003-4684-069X	VIB; Marie Curie; European Research Council (IMMUNO); Interuniversity Attraction Poles [VII/39]; QSIS; Australian National Health and Medical Research Council (CDF-1) [637353]; Agentschap voor Innovatie door Wetenschap en Technologie; Fonds Wetenschappelijk Onderzoek; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033057] Funding Source: NIH RePORTER	VIB; Marie Curie(European Commission); European Research Council (IMMUNO); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); QSIS; Australian National Health and Medical Research Council (CDF-1)(National Health and Medical Research Council (NHMRC) of Australia); Agentschap voor Innovatie door Wetenschap en Technologie; Fonds Wetenschappelijk Onderzoek(FWO); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Fink (University of Washington, Seattle) for providing Rag2-GFP-Tg mice backcrossed to the B6 background, L. Hennighausen (US National Institutes of Health) for providing Bcl2l1<SUP>fx</SUP> mice, A. Rudensky (Memorial Sloan-Kettering Cancer Center) for providing Foxp3<SUP>GFP</SUP>, Foxp3<SUP>Cre</SUP>, Foxp3<SUP>Thy1.1</SUP> and Foxp3<SUP>DTR</SUP> mice, G. Kelly and S. Grabow (Walter and Eliza Hall Institute of Medical Research) for CreERT2Mcl1<SUP>fl</SUP> and CreERT2Bcl2l1<SUP>flox</SUP> mice and Bcl2<SUP>-/-</SUP> fetal liver samples, F. Kupresanin, G. Siciliano, G.-F. Dabrowski, K. Humphreys and E. Lanera (Walter and Eliza Hall Institute of Medical Research) for technical assistance, S. Korsmeyer (Harvard Medical School) for BaxflBak1<SUP>-/-</SUP> mice, and A. Kallies for critical feedback on the manuscript. This work was supported by grants from the VIB, Marie Curie (TREG to A. L.), European Research Council (IMMUNO to A. L.), Interuniversity Attraction Poles (VII/39 to A. L and P. M.), QSIS (to A. A. F.) and the Australian National Health and Medical Research Council (CDF-1 #637353 to D. H. D. G.). W. P. is funded by Agentschap voor Innovatie door Wetenschap en Technologie. B. C., S. M. S. and S.H.-B. are funded by the Fonds Wetenschappelijk Onderzoek. This work was made possible through Victorian State Government Operational Infrastructure Support and the Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Baba J, 2012, BLOOD, V120, P2417, DOI 10.1182/blood-2012-02-411124; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chougnet CA, 2011, J IMMUNOL, V186, P156, DOI 10.4049/jimmunol.1001505; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Dzhagalov I, 2008, J IMMUNOL, V181, P521, DOI 10.4049/jimmunol.181.1.521; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Liu N, 2011, INT IMMUNOPHARMACOL, V11, P212, DOI 10.1016/j.intimp.2010.11.021; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; McNeill A, 2007, SCAND J IMMUNOL, V65, P63, DOI 10.1111/j.1365-3083.2006.01870.x; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Raynor J., FRONT IMMUN IN PRESS; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Tai X., 2013, IMMUNITY IN PRESS; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Tischner D, 2012, J AUTOIMMUN, V38, P59, DOI 10.1016/j.jaut.2011.12.008; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Walker LSK, 2004, IMMUNOLOGY, V111, P129, DOI 10.1111/j.0019-2805.2003.01788.x; Wang X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.9; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhan YF, 2011, J IMMUNOL, V187, P1566, DOI 10.4049/jimmunol.1100027; Zheng LJ, 2007, J IMMUNOL, V179, P8035, DOI 10.4049/jimmunol.179.12.8035	59	169	176	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					959	+		10.1038/ni.2649	http://dx.doi.org/10.1038/ni.2649			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23852275	Green Accepted			2022-12-18	WOS:000323377700013
J	Oestreich, KJ; Mohn, SE; Weinmann, AS				Oestreich, Kenneth J.; Mohn, Sarah E.; Weinmann, Amy S.			Molecular mechanisms that control the expression and activity of BcI-6 in T(H)1cells to regulate flexibility with a T-FH-like gene profile	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; FOLLICULAR HELPER-CELL; LINEAGE COMMITMENT; ANTIBODY-RESPONSES; BET; DIFFERENTIATION; BCL6; CD4; PLASTICITY; BLIMP-1	The transcription factors T-bet and BcI-6 are required for the establishment of a T helper type 1 cell (T(H)1 cell) and follicular helper T cell (T-FH cell) gene-expression profile, respectively. Here we found that high concentrations of interleukin 2 (IL-2) inhibited BcI-6 expression in polarized T(H)1 cells. Mechanistically, the low concentrations of BcI-6 normally found in effector T(H)1 cells did not repress its target genes because a T-bet BcI-6 complex masked the BcI-6 DNA-binding domain. T(H)1 cells increased their BcI-6/T-bet ratio in response to limiting IL-2 conditions, which allowed excess BcI-6 to repress its direct target Prdm1 (which encodes the transcriptional repressor Blimp-1). The BcI-6-dependent repression of Blimp-1 effectively induced a partial T-FH profile because Blimp-1 directly repressed a subset of T-FH signature genes, including Cxcr5. Thus, IL-2-signaling regulates the BcI-6-Blimp-1 axis in T(H)1 cells to maintain flexibility with a T-FH cell like gene profile.	[Oestreich, Kenneth J.; Mohn, Sarah E.; Weinmann, Amy S.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weinmann, AS (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	weinmann@u.washington.edu			National Institute of Allergy and Infectious Diseases [AI061061, AI07272]; American Cancer Society [RSG-09-045-01-DDC]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society)	We thank the National Cancer Institute preclinical repository for IL-2 and anti-IL-4; members of the Weinmann laboratory for discussions; and M. Wijaranakula for technical assistance. Supported by the National Institute of Allergy and Infectious Diseases (AI061061 and AI07272 to A.S.W.) and the American Cancer Society (RSG-09-045-01-DDC to A.S.W.).	Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Lewis MD, 2007, MOL CELL BIOL, V27, P8510, DOI 10.1128/MCB.01615-07; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Peng SL, 2006, CELL MOL IMMUNOL, V3, P87; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Reinhardt RL, 2006, CURR OPIN IMMUNOL, V18, P271, DOI 10.1016/j.coi.2006.03.003; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	169	179	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					405	411		10.1038/ni.2242	http://dx.doi.org/10.1038/ni.2242			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22406686	Green Accepted			2022-12-18	WOS:000301886800015
J	Rooijakkers, SHM; Wu, J; Ruyken, M; van Domselaar, R; Planken, KL; Tzekou, A; Ricklin, D; Lambris, JD; Janssen, BJC; van Strijp, JAG; Gros, P				Rooijakkers, Suzan H. M.; Wu, Jin; Ruyken, Maartje; van Domselaar, Robert; Planken, Karel L.; Tzekou, Apostolia; Ricklin, Daniel; Lambris, John D.; Janssen, Bert J. C.; van Strijp, Jos A. G.; Gros, Piet			Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor	NATURE IMMUNOLOGY			English	Article							FACTOR-B; C5 CONVERTASE; CONFORMATIONAL-CHANGES; PROVIDES INSIGHTS; CRYSTAL-STRUCTURE; BINDING-SITE; A DOMAIN; ACTIVATION; SYSTEM; C3-CONVERTASE	Activation of the complement system generates potent chemoattractants and leads to the opsonization of cells for immune clearance. Short-lived protease complexes cleave complement component C3 into anaphylatoxin C3a and opsonin C3b. Here we report the crystal structure of the C3 convertase formed by C3b and the protease fragment Bb, which was stabilized by the bacterial immune-evasion protein SCIN. The data suggest that the proteolytic specificity and activity depend on the formation of dimers of C3 with C3b of the convertase. SCIN blocked the formation of a productive enzyme-substrate complex. Irreversible dissociation of the complex of C3b and Bb is crucial to complement regulation and was determined by slow binding kinetics of the Mg2+-adhesion site in Bb. Understanding the mechanistic basis of the central complement-activation step and microbial immune evasion strategies targeting this step will aid in the development of complement therapeutics.	[Wu, Jin; Janssen, Bert J. C.; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Rooijakkers, Suzan H. M.; Ruyken, Maartje; van Domselaar, Robert; van Strijp, Jos A. G.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Planken, Karel L.] Univ Utrecht, Vant Hoff Lab Phys & Colloid Chem, Utrecht, Netherlands; [Tzekou, Apostolia; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Pennsylvania	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, Utrecht, Netherlands.	p.gros@uu.nl	Ricklin, Daniel/F-5104-2011; Lambris, John/Q-5633-2018; Gros, Piet/I-5569-2016; van Strijp, Jos A.G./J-9549-2014; Gros, Piet/AAD-6452-2019; Janssen, Bert/I-3338-2016	Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776; Gros, Piet/0000-0002-7782-2585; van Strijp, Jos A.G./0000-0001-6253-0830; Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370	NIAID NIH HHS [P01 AI068730-029001, R01 AI072106, P01 AI068730, R01 AI072106-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, P01AI068730] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Brookes E, 2008, COLLOID POLYM SCI, V286, P139, DOI 10.1007/s00396-007-1714-9; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISHELSON Z, 1983, J BIOL CHEM, V258, P7411; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; HORIUCHI T, 1991, J IMMUNOL, V147, P584; Hourcade DE, 1999, J IMMUNOL, V162, P2906; Hourcade DE, 2002, J BIOL CHEM, V277, P1107, DOI 10.1074/jbc.M109322200; Hourcade DE, 1999, IMMUNOPHARMACOLOGY, V42, P167, DOI 10.1016/S0162-3109(99)00005-3; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; KAM CM, 1987, J BIOL CHEM, V262, P3444; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; KERR MA, 1980, BIOCHEM J, V189, P173, DOI 10.1042/bj1890173; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Krishnan V, 2007, J MOL BIOL, V367, P224, DOI 10.1016/j.jmb.2006.12.039; LAMBRIS JD, 1980, J EXP MED, V152, P1625, DOI 10.1084/jem.152.6.1625; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Law SKA, 1997, PROTEIN SCI, V6, P263; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; PRYZDIAL ELG, 1987, J BIOL CHEM, V262, P1519; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2001, INT IMMUNOPHARMACOL, V1, P415, DOI 10.1016/S1567-5769(00)00039-4; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Tuckwell DS, 1997, BIOCHEMISTRY-US, V36, P6605, DOI 10.1021/bi963155l; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	49	169	171	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					721	U72		10.1038/ni.1756	http://dx.doi.org/10.1038/ni.1756			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19503103	Green Accepted			2022-12-18	WOS:000267142600011
J	Blanchard, N; Gonzalez, F; Schaeffer, M; Joncker, NT; Cheng, T; Shastri, AJ; Robey, EA; Shastri, N				Blanchard, Nicolas; Gonzalez, Federico; Schaeffer, Marie; Joncker, Nathalie T.; Cheng, Tiffany; Shastri, Anjali J.; Robey, Ellen A.; Shastri, Nilabh			Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; IFN-GAMMA PRODUCTION; PARASITOPHOROUS VACUOLE; T-CELLS; AMINOPEPTIDASE ERAAP; PEPTIDE REPERTOIRE; PRESENTING CELLS; HOST-CELLS; INFECTION; RESISTANCE	The parasite Toxoplasma gondii replicates in a specialized intracellular vacuole and causes disease in many species. Protection from toxoplasmosis is mediated by CD8(+) T cells, but the T. gondii antigens and host genes required for eliciting protective immunity are poorly defined. Here we identified GRA6, a polymorphic protein secreted in the parasitophorous vacuole, as the source of the immunodominant and protective decapeptide HF10 presented by the H-2L(d) major histocompatibility complex class I molecule. Presentation of the HF10-H-2L(d) ligand required proteolysis by ERAAP, the endoplasmic reticulum aminopeptidase associated with antigen processing. Consequently, expansion of protective CD8(+) T cell populations was impaired in T. gondii-infected ERAAP-deficient mice, which were more susceptible to toxoplasmosis. Thus, endoplasmic reticulum proteolysis is critical for eliciting protective immunity to a vacuolar parasite.	[Blanchard, Nicolas; Gonzalez, Federico; Schaeffer, Marie; Joncker, Nathalie T.; Cheng, Tiffany; Shastri, Anjali J.; Robey, Ellen A.; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Blanchard, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nicolasblanchard@berkeley.edu; nshastri@berkeley.edu	Blanchard, Nicolas/AAD-6601-2020; Schaeffer, Marie/C-9815-2019; Blanchard, Nicolas/I-5255-2014	Blanchard, Nicolas/0000-0002-4924-2161; Schaeffer, Marie/0000-0002-2063-5324; Blanchard, Nicolas/0000-0002-4924-2161	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039548, R37AI060040, T32AI007290, R01AI026604] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI060040, R01 AI039548, R01 AI026604, T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blanchard N, 2008, CURR OPIN IMMUNOL, V20, P82, DOI 10.1016/j.coi.2007.12.004; BROWN CR, 1995, IMMUNOLOGY, V85, P419; BuzoniGatel D, 1997, J IMMUNOL, V158, P5883; Cesbron-Delauw MF, 2008, TRAFFIC, V9, P657, DOI 10.1111/j.1600-0854.2008.00728.x; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1993, J IMMUNOL, V151, P3672; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KHAN IA, 1994, J IMMUNOL, V152, P1856; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kirisits MJ, 2000, INT J PARASITOL, V30, P149, DOI 10.1016/S0020-7519(00)00009-6; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Kwok LY, 2003, J IMMUNOL, V170, P1949, DOI 10.4049/jimmunol.170.4.1949; LECORDIER L, 1995, MOL BIOCHEM PARASIT, V70, P85, DOI 10.1016/0166-6851(95)00010-X; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lutjen S, 2006, INFECT IMMUN, V74, P5790, DOI 10.1128/IAI.00098-06; Martinez-Aran A, 2006, BIPOLAR DISORD, V8, P2; Mendoza LM, 2000, METH MOL B, V156, P255; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrot A, 2004, INT J PARASITOL, V34, P1529, DOI 10.1016/j.ijpara.2004.10.001; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; PARKER SJ, 1991, CLIN EXP IMMUNOL, V84, P207, DOI 10.1111/j.1365-2249.1991.tb08150.x; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Reichmann G, 1999, J IMMUNOL, V163, P3354; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Schluter D, 2003, J IMMUNOL, V170, P6172, DOI 10.4049/jimmunol.170.12.6172; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; SUZUKI Y, 1988, J IMMUNOL, V140, P3943; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103	49	169	174	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					937	944		10.1038/ni.1629	http://dx.doi.org/10.1038/ni.1629			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18587399	Green Accepted			2022-12-18	WOS:000257780700017
J	Hu, QS; Ye, YQ; Chan, LC; Li, YJ; Liang, K; Lin, AF; Egranov, SD; Zhang, YH; Xia, WY; Gong, J; Pan, YH; Chatterjee, SS; Yao, J; Evans, KW; Nguyen, TK; Park, PK; Liu, JW; Coarfa, C; Donepudi, SR; Putluri, V; Putluri, N; Sreekumar, A; Ambati, CR; Hawke, DH; Marks, JR; Gunaratne, PH; Caudle, AS; Sahin, AA; Hortobagyi, GN; Meric-Bernstam, F; Chen, LP; Yu, DH; Hung, MC; Curran, MA; Han, L; Lin, CR; Yang, LQ				Hu, Qingsong; Ye, Youqiong; Chan, Li-Chuan; Li, Yajuan; Liang, Ke; Lin, Aifu; Egranov, Sergey D.; Zhang, Yaohua; Xia, Weiya; Gong, Jing; Pan, Yinghong; Chatterjee, Sujash S.; Yao, Jun; Evans, Kurt W.; Nguyen, Tina K.; Park, Peter K.; Liu, Jiewei; Coarfa, Cristian; Donepudi, Sri Ramya; Putluri, Vasanta; Putluri, Nagireddy; Sreekumar, Arun; Ambati, Chandrashekar R.; Hawke, David H.; Marks, Jeffrey R.; Gunaratne, Preethi H.; Caudle, Abigail S.; Sahin, Aysegul A.; Hortobagyi, Gabriel N.; Meric-Bernstam, Funda; Chen, Lieping; Yu, Dihua; Hung, Mien-Chie; Curran, Michael A.; Han, Leng; Lin, Chunru; Yang, Liuqing			Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression	NATURE IMMUNOLOGY			English	Article							NEGATIVE BREAST-CANCER; TRANSGENIC MICE; G-PROTEINS; T-CELL; MUTATION; COMPLEX; P53; PHOSPHORYLATION; IMMUNOTHERAPY; RESISTANCE	How tumor cells genetically lose antigenicity and evade immune checkpoints remains largely elusive. We report that tissue-specific expression of the human long noncoding RNA LINK-A in mouse mammary glands initiates metastatic mammary gland tumors, which phenotypically resemble human triple-negative breast cancer (TNBC). LINK-A expression facilitated crosstalk between phosphatidylinositol-(3,4,5)-trisphosphate and inhibitory G-protein-coupled receptor (GPCR) pathways, attenuating protein kinase A-mediated phosphorylation of the E3 ubiquitin ligase TRIM71. Consequently, LINK-A expression enhanced K48-polyubiquitination-mediated degradation of the antigen peptide-loading complex (PLC) and intrinsic tumor suppressors Rb and p53. Treatment with LINK-A locked nucleic acids or GPCR antagonists stabilized the PLC components, Rb and p53, and sensitized mammary gland tumors to immune checkpoint blockers. Patients with programmed ccll death protein-1(PD-1) blockade-resistant TNBC exhibited elevated LINK-A levels and downregulated PLC components. Hence we demonstrate lncRNA-dependent downregulation of antigenicity and intrinsic tumor suppression, which provides the basis for developing combinational immunotherapy treatment regimens and early TNBC prevention.	[Hu, Qingsong; Chan, Li-Chuan; Li, Yajuan; Liang, Ke; Lin, Aifu; Egranov, Sergey D.; Zhang, Yaohua; Xia, Weiya; Yao, Jun; Nguyen, Tina K.; Park, Peter K.; Yu, Dihua; Lin, Chunru; Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ye, Youqiong; Gong, Jing; Liu, Jiewei; Han, Leng] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chan, Li-Chuan; Yu, Dihua; Lin, Chunru; Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Pan, Yinghong; Chatterjee, Sujash S.; Gunaratne, Preethi H.] Univ Houston, Dept Biochem & Biol, Houston, TX USA; [Evans, Kurt W.; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Coarfa, Cristian; Putluri, Nagireddy; Sreekumar, Arun; Gunaratne, Preethi H.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Donepudi, Sri Ramya; Putluri, Vasanta; Putluri, Nagireddy; Sreekumar, Arun; Ambati, Chandrashekar R.] Baylor Coll Med, Alkek Ctr Mol Discovery, Adv Technol Core, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Marks, Jeffrey R.] Duke Univ, Sch Med, Div Surg Sci, Dept Surg, Durham, NC USA; [Caudle, Abigail S.] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Sahin, Aysegul A.] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Dept Pathol, Houston, TX 77030 USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Breast Med Oncol, Houston, TX 77030 USA; [Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Hung, Mien-Chie] China Med Univ, Taichung, Taiwan; [Curran, Michael A.] Univ Texas MD Anderson Canc Ctr, Div Basic Sci, Dept Immunol, Houston, TX 77030 USA; [Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Non Coding RNAs, Houston, TX 77030 USA; [Lin, Aifu] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Pan, Yinghong] UPMC Genome Ctr, Pittsburgh, PA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Duke University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Lin, CR; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Han, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Lin, CR; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Non Coding RNAs, Houston, TX 77030 USA.	leng.han@uth.tmc.edu; clin2@mdanderson.org; lyang7@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Han, Leng/HCH-3491-2022; ambati, chandra shekar reddy/G-1908-2017; Chan, Li-Chuan/T-3530-2018	Hung, Mien-Chie/0000-0003-4317-4740; Han, Leng/0000-0002-7380-2640; ambati, chandra shekar reddy/0000-0001-5413-6745; Pan, Yinghong/0000-0001-7334-1787; Putluri, Nagireddy/0000-0003-4488-7400; Chan, Li-Chuan/0000-0002-2665-637X; Ye, Youqiong/0000-0001-8332-4710; Yu, Dihua/0000-0001-6231-9381; Donepudi, Sri Ramya/0000-0002-2845-1212; Egranov, Sergey/0000-0002-6806-281X; Curran, Michael/0000-0003-4996-7207	Cancer Prevention Research Institute of Texas (CPRIT) [RP130397]; National Institutes of Health (NIH) grant [1S10OD012304-01]; University of Houston; UH Division of Research; UH College of NSM; UH Small Core Equipment Program [P30CA125123]; CPRIT Proteomics and Metabolomics Core Facility [RP170005]; Dan L. Duncan Cancer Center [R01CA216426, R01CA220297, U01CA214263]; NIH [127430-RSG-15-105-01-CNE]; American Cancer Society; NIH T32 Training Grant in Cancer Biology [5T32CA186892]; Cancer Prevention & Research Institute of Texas grant [RR150085]; NIH R01 awards [1R01CA218025-01, 1R01CA231011-01]; CPRIT individual investigator research award [RP150094, RP180259]; Department of Defense Breakthrough award [BC151465]; NIH R01 award [1R01CA218036-01]; CPRIT First-time Faculty Recruitment Award [R1218]; American Association for Cancer Research-Bayer Innovation and Discovery Grant [18-80-44]; Andrew Sabin Family Foundation Fellows Award; NATIONAL CANCER INSTITUTE [U01CA214263, R01CA231011, R01CA220297, T32CA186892, R01CA218036, R01CA216426, R01CA218025, P30CA125123, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas (CPRIT); National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Houston; UH Division of Research; UH College of NSM; UH Small Core Equipment Program; CPRIT Proteomics and Metabolomics Core Facility; Dan L. Duncan Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH T32 Training Grant in Cancer Biology; Cancer Prevention & Research Institute of Texas grant; NIH R01 awards; CPRIT individual investigator research award; Department of Defense Breakthrough award; NIH R01 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT First-time Faculty Recruitment Award; American Association for Cancer Research-Bayer Innovation and Discovery Grant; Andrew Sabin Family Foundation Fellows Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Proteomics and Metabolomics Facility was supported in part by a Cancer Prevention Research Institute of Texas (CPRIT) grant (no. RP130397) and a National Institutes of Health (NIH) grant (no. 1S10OD012304-01 to D.H.H.). This project is partially supported by University of Houston (UH) Seq-N-Edit Core with funding from UH Division of Research; UH College of NSM and Department of Biology & Biochemistry; NRUF MINOR CORE 17 Grant (to P.H.G.) and UH Small Core Equipment Program Grant (to P.H.G.). We thank the core facilities at BCM: Metabolomics Core (NIH grant no. P30CA125123), CPRIT Proteomics and Metabolomics Core Facility (grant no. RP170005 to N.P.) and Dan L. Duncan Cancer Center. This work was supported by grant nos. R01CA216426, R01CA220297 and U01CA214263 from NIH and 127430-RSG-15-105-01-CNE from the American Cancer Society (to N.P.). This project was partially supported by the NIH T32 Training Grant in Cancer Biology (grant no. 5T32CA186892 to L.-C.C.). This project was also supported by Cancer Prevention & Research Institute of Texas grant (no. RR150085 to L.H.). This work was supported by NIH R01 awards (nos. 1R01CA218025-01 and 1R01CA231011-01), CPRIT individual investigator research award (nos. RP150094 and RP180259) and Department of Defense Breakthrough award (no. BC180196 to C.L.). This work was supported by an NIH R01 award (no. 1R01CA218036-01), CPRIT First-time Faculty Recruitment Award (no. R1218), Department of Defense Breakthrough award (no. BC151465), The American Association for Cancer Research-Bayer Innovation and Discovery Grant (no. 18-80-44) and Andrew Sabin Family Foundation Fellows Award (to L.Y.).	ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Deng JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01730-x; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Nguyen DTT, 2017, CELL DEATH DIFFER, V24, P1063, DOI 10.1038/cdd.2017.54; Fan Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1029-6; Felices M, 2007, ADV IMMUNOL, V93, P145, DOI 10.1016/S0065-2776(06)93004-1; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Harriff MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005524; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu QS, 2019, CELL RES, V29, P286, DOI 10.1038/s41422-018-0134-3; Hulpke S, 2013, TRENDS BIOCHEM SCI, V38, P412, DOI 10.1016/j.tibs.2013.06.003; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Jia HY, 2017, DRUG RESIST UPDATE, V32, P1, DOI 10.1016/j.drup.2017.07.002; Johnsen AK, 1999, J IMMUNOL, V163, P4224; Kanaan YM, 2014, CANCER GENOM PROTEOM, V11, P279; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Lin AF, 2017, NAT CELL BIOL, V19, P238, DOI 10.1038/ncb3473; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Loedige I, 2013, NUCLEIC ACIDS RES, V41, P518, DOI 10.1093/nar/gks1032; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; NIELSEN LL, 1991, CANCER RES, V51, P3762; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Pattabiraman DR, 2016, SCIENCE, V351, P1042, DOI 10.1126/science.aad3680; PERRY BD, 1981, EUR J PHARMACOL, V76, P461, DOI 10.1016/0014-2999(81)90123-0; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; PIETILAINEN T, 1995, EUR J CANCER, V31A, P329, DOI 10.1016/0959-8049(94)00463-F; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Vianello F, 2006, J IMMUNOL, V176, P2902, DOI 10.4049/jimmunol.176.5.2902; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Ye YQ, 2018, CELL SYST, V6, P314, DOI 10.1016/j.cels.2018.01.013	61	168	176	7	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					835	+		10.1038/s41590-019-0400-7	http://dx.doi.org/10.1038/s41590-019-0400-7			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31160797	Green Accepted			2022-12-18	WOS:000471891900015
J	Yang, Q; Li, FY; Harly, C; Xing, SJ; Ye, LY; Xia, XF; Wang, HK; Wang, XX; Yu, SY; Zhou, XY; Cam, M; Xue, HH; Bhandoola, A				Yang, Qi; Li, Fengyin; Harly, Christelle; Xing, Shaojun; Ye, Longyun; Xia, Xuefeng; Wang, Haikun; Wang, Xinxin; Yu, Shuyang; Zhou, Xinyuan; Cam, Maggie; Xue, Hai-Hui; Bhandoola, Avinash			TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELL; TRANSCRIPTION FACTOR; RECEPTOR; NOTCH; DIFFERENTIATION; FACTOR-1; ADULT; ALPHA; NFIL3; SPECIFICATION	The cellular and molecular events that drive the early development of innate lymphoid cells (ILCs) remain poorly understood. We show that the transcription factor TCF-1 is required for the efficient generation of all known adult ILC subsets and their precursors. Using novel reporter mice, we identified a new subset of early ILC progenitors (EILPs) expressing high amounts of TCF-1. EILPs lacked efficient T and B lymphocyte potential but efficiently gave rise to NK cells and all known adult helper ILC lineages, indicating that they are the earliest ILC-committed progenitors identified so far. Our results suggest that upregulation of TCF-1 expression denotes the earliest stage of ILC fate specification. The discovery of EILPs provides a basis for deciphering additional signals that specify ILC fate.	[Yang, Qi; Harly, Christelle; Ye, Longyun; Bhandoola, Avinash] NCI, T Cell Biol & Dev Unit, Lab Genome Integr, Ctr Canc Res, Bethesda, MD 20892 USA; [Yang, Qi; Xia, Xuefeng; Wang, Haikun; Wang, Xinxin] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Li, Fengyin; Xing, Shaojun; Yu, Shuyang; Zhou, Xinyuan; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Cam, Maggie] NCI, CCR Collaborat Bioinformat Resource, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bhandoola, A (corresponding author), NCI, T Cell Biol & Dev Unit, Lab Genome Integr, Ctr Canc Res, Bethesda, MD 20892 USA.	hai-hui-xue@uiowa.edu; avinash.bhandoola@nih.gov	Wang, Xin/GYU-1129-2022; Li, Fengyin/AAG-9476-2019; Zhou, Xinyuan/AFS-9817-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Xue, Hai-Hui/0000-0002-9163-7669; Harly, Christelle/0000-0002-8045-9166; Zhou, Xinyuan/0000-0002-1374-8240; Xing, Shaojun/0000-0003-0777-2196	American Cancer Society [RSG-11-161-01-MPC]; National Institutes of Health [AI105351, AI112579, AI115149, AI119160, AI059621, AI098428, HL11074103]; National Institutes of Health, the National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059621, R21AI115149, R21AI105351, R56AI059621, R21AI119160, R21AI098428, R01AI112579] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, the National Cancer Institute; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Greene and G. Massey for essential support. We thank the laboratories of A. Haczku, Y. Belkaid, R. Bosselut and D. Artis for technical and scientific advice. OP9-DL1 stromal cell lines were obtained from J.C. Zuniga-Pflucker (University of Toronto, Toronto, Ontario, Canada). Reagents for recombineering were kindly provided by D.L. Court (National Cancer Institute, Frederick, Maryland, USA) and N.G. Copeland (Houston Methodist Research Institute, Houston, Texas, USA). We thank T.L. Saunders at the University of Michigan for blastocyst injection of Tcf7-GFP<SUP>+</SUP> embryonic stem cells. We also thank Y. Yokota (University of Fukui, Fukui, Japan) for Id2<SUP>-/-</SUP> mice. This work was supported by the American Cancer Society (RSG-11-161-01-MPC to H.-H.X.) and the National Institutes of Health (AI105351, AI112579, AI115149 and AI119160 to H.-H.X.; AI059621, AI098428 and HL11074103 to A.B.). A.B. is supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, and the Center for Cancer Research.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Chi AWS, 2011, BLOOD, V118, P2723, DOI 10.1182/blood-2010-09-309989; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; De Obaldia ME, 2013, NAT IMMUNOL, V14, P1277, DOI 10.1038/ni.2760; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goetz CA, 2005, J IMMUNOL, V174, P7753, DOI 10.4049/jimmunol.174.12.7753; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; Held W, 1999, IMMUNITY, V11, P433, DOI 10.1016/S1074-7613(00)80118-1; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Ioannidis V, 2003, J IMMUNOL, V171, P769, DOI 10.4049/jimmunol.171.2.769; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kolde R., PHEATMAP PRETTY HEAT; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	49	168	171	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1044	+		10.1038/ni.3248	http://dx.doi.org/10.1038/ni.3248			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26280998	Green Accepted			2022-12-18	WOS:000361686500009
J	Hogquist, KA; Jameson, SC				Hogquist, Kristin A.; Jameson, Stephen C.			The self-obsession of T cells: how TCR signaling thresholds affect fate 'decisions' and effector function	NATURE IMMUNOLOGY			English	Review							NEGATIVE SELECTION; THYMIC SELECTION; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; DEVELOPMENT REQUIRES; CLONAL DELETION; NAIVE; PEPTIDE; REPERTOIRE; SURVIVAL	Self-reactivity was once seen as a potential characteristic of T cells that was eliminated by clonal selection to protect the host from autoimmune pathology. It is now understood that the T cell repertoire is in fact broadly self-reactive, even self-centered. The strength with which a T cell reacts to self ligands and the environmental context in which this reaction occurs influence almost every aspect of T cell biology, from development to differentiation to effector function. Here we highlight recent advances and discoveries that relate to T cell self-reactivity, with a particular emphasis on T cell antigen receptor (TCR) signaling thresholds.	[Hogquist, Kristin A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu; james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687	US National Institutes of Health [PO1 AI35296, RO1 AI088209, R37 AI39560, R01 AI75168, R37 AI38903]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903, R37AI039560, R01AI088209, P01AI035296, R01AI075168] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (PO1 AI35296, RO1 AI088209 and R37 AI39560 to K.A.H., and R01 AI75168 and R37 AI38903 to S.C.J.).	Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bains I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003102; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Becker AM, 2010, J IMMUNOL, V184, P6822, DOI 10.4049/jimmunol.0902058; Bedel R, 2014, P NATL ACAD SCI USA, V111, pE119, DOI 10.1073/pnas.1320777110; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chu HH, 2010, J IMMUNOL, V185, P4705, DOI 10.4049/jimmunol.1002276; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dyall R, 1999, J EXP MED, V190, P757, DOI 10.1084/jem.190.6.757; Dzhagalov IL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001566; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Garcia KC, 2012, IMMUNITY, V36, P887, DOI 10.1016/j.immuni.2012.05.018; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Gascoigne NRJ, 2010, CURR TOP MICROBIOL, V340, P171, DOI 10.1007/978-3-642-03858-7_9; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; Hoerter JAH, 2013, J EXP MED, V210, P1807, DOI 10.1084/jem.20122528; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hu Q, 2009, J IMMUNOL, V183, P7761, DOI 10.4049/jimmunol.0902181; Huynh A, 2014, IMMUNOL REV, V258, P117, DOI 10.1111/imr.12148; Johnson LDS, 2010, J IMMUNOL, V184, P5604, DOI 10.4049/jimmunol.1000109; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Lai YG, 1999, J IMMUNOL, V163, P5843; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Leignadier J, 2008, P NATL ACAD SCI USA, V105, P20440, DOI 10.1073/pnas.0806289106; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lo WL, 2014, ELIFE, V3, DOI 10.7554/eLife.01457; Lo WL, 2013, MOL IMMUNOL, V55, P186, DOI 10.1016/j.molimm.2012.10.028; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Pauken KE, 2013, J IMMUNOL, V191, P4913, DOI 10.4049/jimmunol.1301927; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Ross JO, 2014, P NATL ACAD SCI USA, V111, pE2550, DOI 10.1073/pnas.1408482111; Saini M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000702; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Sinclair C, 2014, J IMMUNOL, V192, P5151, DOI 10.4049/jimmunol.1303085; Sinclair C, 2013, P NATL ACAD SCI USA, V110, pE2905, DOI 10.1073/pnas.1304859110; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Suen AYW, 2012, P NATL ACAD SCI USA, V109, P893, DOI 10.1073/pnas.1114834109; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; Wang D, 2012, NAT IMMUNOL, V13, P560, DOI 10.1038/ni.2301; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	84	168	171	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					815	823		10.1038/ni.2938	http://dx.doi.org/10.1038/ni.2938			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137456	Green Accepted			2022-12-18	WOS:000340739400005
J	Quintana, FJ; Jin, HL; Burns, EJ; Nadeau, M; Yeste, A; Kumar, D; Rangachari, M; Zhu, C; Xiao, S; Seavitt, J; Georgopoulos, K; Kuchroo, VK				Quintana, Francisco J.; Jin, Hulin; Burns, Evan J.; Nadeau, Meghan; Yeste, Ada; Kumar, Deepak; Rangachari, Manu; Zhu, Chen; Xiao, Sheng; Seavitt, John; Georgopoulos, Katia; Kuchroo, Vijay K.			Aiolos promotes T(H)17 differentiation by directly silencing Il2 expression	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; TH17 CELLS; HELPER-CELLS; ROR-GAMMA; IN-VIVO; INTERLEUKIN-2; TRANSCRIPTION; GENE; IL-2	CD4(+) interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) are instrumental in the immune response to pathogens. However, an overactive T(H)17 response results in tissue inflammation and autoimmunity, and therefore it is important to identify the molecular mechanisms that control the development of T(H)17 cells. IL-2 suppresses such development, but how IL-2 production is actively suppressed during T(H)7 differentiation is not understood. Here we report that under T(H)17-polarizing conditions, the transcription factors STAT3 and AhR upregulated the expression of Aiolos, a member of the Ikaros family of transcription factors. Using Aiolos-deficient mice, we demonstrated that Aiolos silenced the Il2 locus, promoting T(H)17 differentiation in vitro and in vivo. Thus, we have identified a module in the transcriptional program of T(H)17 cells that actively limits IL-2 production and promotes their differentiation.	[Quintana, Francisco J.; Jin, Hulin; Burns, Evan J.; Nadeau, Meghan; Yeste, Ada; Rangachari, Manu; Zhu, Chen; Xiao, Sheng; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Kumar, Deepak] Harvard Univ, Sch Med, Boston, MA USA; [Seavitt, John; Georgopoulos, Katia] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		US National Institutes of Health [P01AI073748, P01NS038037, P01AI056299, R01NS030843, AI075285, AI093903]; National Multiple Sclerosis Society [RG4111A1, FG1850-A-1]; Harvard Medical School Office for Diversity and Community Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, R01AI093903, R00AI075285, P01AI073748, P01AI056299, K99AI075285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843, P01NS038037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Harvard Medical School Office for Diversity and Community Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for cell sorting, and B. Waksman and I.R. Cohen for discussions. Supported by the US National Institutes of Health (P01AI073748, P01NS038037, P01AI056299 and R01NS030843 to V.K.K.; and AI075285 and AI093903 to F.J.Q.), the National Multiple Sclerosis Society (RG4111A1 to F.J.Q.), the Harvard Medical School Office for Diversity and Community Partnership (F.J.Q.) and the National Multiple Sclerosis Society (FG1850-A-1 to H.J.).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jeon MS, 2000, J IMMUNOL, V165, P6975, DOI 10.4049/jimmunol.165.12.6975; Kameyama K, 2010, EUR J IMMUNOL, V40, P2423, DOI 10.1002/eji.200939764; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liu SM, 2011, J CLIN INVEST, V121, P4303, DOI 10.1172/JCI46187; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	45	168	185	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					770	+		10.1038/ni.2363	http://dx.doi.org/10.1038/ni.2363			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22751139	Green Accepted			2022-12-18	WOS:000306569600013
J	Garcia, KC; Adams, JJ; Feng, D; Ely, LK				Garcia, K. Christopher; Adams, Jarrett J.; Feng, Dan; Ely, Lauren K.			The molecular basis of TCR germline bias for MHC is surprisingly simple	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN RECOGNITION; DOCKING ORIENTATION; CRYSTAL-STRUCTURES; HIGH-AFFINITY; PEPTIDE-MHC; AMINO-ACIDS; BINDING; SELECTION	The elusive etiology of germline bias of the T cell receptor (TCR) for major histocompatibility complex (MHC) has been clarified by recent 'proof-of-concept' structural results demonstrating the conservation of specific TCR-MHC interfacial contacts in complexes bearing common variable segments and MHC allotypes. We suggest that each TCR variable-region gene product engages each type of MHC through a 'menu' of structurally coded recognition motifs that have arisen through coevolution. The requirement for MHC-restricted T cell recognition during thymic selection and peripheral surveillance has necessitated the existence of such a coded recognition system. Given these findings, a reconsideration of the TCR-peptide-MHC structural database shows that not only have the answers been there all along but also they were predictable by the first principles of physical chemistry.	[Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI048540] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Borg NA, 2007, ADV EXP MED BIOL, V598, P20; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; GANJU RK, 1992, P NATL ACAD SCI USA, V89, P11552, DOI 10.1073/pnas.89.23.11552; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Inman J., 1978, THEORETICAL IMMUNOLO, P243; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Wilson IA, 2005, NAT IMMUNOL, V6, P434, DOI 10.1038/ni0505-434; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; [No title captured]	53	168	177	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					143	147		10.1038/ni.f.219	http://dx.doi.org/10.1038/ni.f.219			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148199	Green Accepted			2022-12-18	WOS:000263178500007
J	Gauld, SB; Benschop, RJ; Merrell, KT; Cambier, JC				Gauld, SB; Benschop, RJ; Merrell, KT; Cambier, JC			Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling	NATURE IMMUNOLOGY			English	Article							REACTIVE LYMPHOCYTES-B; COSTIMULATORY MOLECULES; DISSOCIATION KINETICS; IMMUNOGLOBULIN-E; TRANSGENIC MICE; SELF-TOLERANCE; ACTIVATION; EXPRESSION; POPULATION; INDUCTION	Immunological tolerance can be mediated by anergy, in which self-reactive B cells persist in the periphery yet remain unresponsive to immunogen. Whether anergy is induced after transient exposure to self antigen and is 'remembered' or requires continuous antigen receptor occupancy and transduction of signals remains unclear. We have explored this using an immunoglobulin-transgenic mouse in which B cells were hapten specific (arsonate) yet cross-reacted with a self antigen that induced anergy in vivo. Many features of anergic cells were rapidly reversed after dissociation of self antigen using hapten competition and these cells regained antigen responsiveness. Our findings indicate that continuous binding of antigen and subsequent receptor signaling are essential for the maintenance of anergy.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 4200 E 9th Ave, Denver, CO 80206 USA.	cambierj@njc.org		Cambier, John/0000-0002-7803-242X	NIAID NIH HHS [R01-AI020519] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020519] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Cook MC, 1998, EUR J IMMUNOL, V28, P2549, DOI 10.1002/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DING L, 1995, J IMMUNOL, V155, P5124; ERICKSON JW, 1991, BIOCHEMISTRY-US, V30, P2357, DOI 10.1021/bi00223a009; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Glynne R, 2000, IMMUNOL REV, V176, P216; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRANDIEN A, 1994, EUR J IMMUNOL, V24, P1345, DOI 10.1002/eji.1830240616; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; LANE P, 1995, BEHRING I MITT, V96, P7; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013; POSNER RG, 1991, BIOCHEMISTRY-US, V30, P2348, DOI 10.1021/bi00223a008; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Vilen BJ, 1997, J IMMUNOL, V159, P231; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wither JE, 2000, CLIN IMMUNOL, V94, P51, DOI 10.1006/clim.1999.4806; Wither JE, 2000, EUR J IMMUNOL, V30, P356, DOI 10.1002/1521-4141(200002)30:2&lt;356::AID-IMMU356&gt;3.0.CO;2-H	32	168	170	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1160	1167		10.1038/ni1256	http://dx.doi.org/10.1038/ni1256			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16200069				2022-12-18	WOS:000232833300017
J	Cavanagh, LL; Bonasio, R; Mazo, IB; Halin, C; Cheng, GY; van der Velden, AWM; Cariappa, A; Chase, C; Russell, P; Starnbach, MN; Koni, PA; Pillai, S; Weninger, W; von Andrian, UH				Cavanagh, LL; Bonasio, R; Mazo, IB; Halin, C; Cheng, GY; van der Velden, AWM; Cariappa, A; Chase, C; Russell, P; Starnbach, MN; Koni, PA; Pillai, S; Weninger, W; von Andrian, UH			Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells	NATURE IMMUNOLOGY			English	Article							LYMPH-NODES; IN-VIVO; ADHESION MOLECULE-1; ENDOTHELIAL SELECTINS; MIGRATORY PROPERTIES; IMMUNE-RESPONSES; THORACIC DUCT; MOUSE; BLOOD; MICE	Dendritic cells (DCs) carry antigen from peripheral tissues via lymphatics to lymph nodes. We report here that differentiated DCs can also travel from the periphery into the blood. Circulating DCs migrated to the spleen, liver and lung but not lymph nodes. They also homed to the bone marrow, where they were retained better than in most other tissues. Homing of DCs to the bone marrow depended on constitutively expressed vascular cell adhesion molecule 1 and endothelial selectins in bone marrow microvessels. Two-photon intravital microscopy in bone marrow cavities showed that DCs formed stable antigen-dependent contacts with bone marrow - resident central memory T cells. Moreover, using this previously unknown migratory pathway, antigen-pulsed DCs were able to trigger central memory T cell - mediated recall responses in the bone marrow.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University System of Georgia; Augusta University	von Andrian, UH (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Bonasio, Roberto/P-1356-2014; Koni, Pandelakis/A-3349-2008	Bonasio, Roberto/0000-0002-0767-0889; Weninger, Wolfgang/0000-0003-3133-8699; Koni, Pandelakis/0000-0002-0892-4764; Halin, Cornelia/0000-0002-7899-2850	NHLBI NIH HHS [R01 HL054936, HL54936, HL56949, HL62524, P01 HL056949] Funding Source: Medline; NIAID NIH HHS [R01 AI061663, AI061663] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062524, P01HL056949, R01HL054936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; BOAK JL, 1965, NATURE, V205, P396, DOI 10.1038/205396a0; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Di Rosa F, 2002, EUR J IMMUNOL, V32, P1873; Donnenberg VS, 2001, TRANSPLANTATION, V72, P1946, DOI 10.1097/00007890-200112270-00014; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Feuerer M, 2001, NAT MED, V7, P452, DOI 10.1038/86523; FOSSUM S, 1988, SCAND J IMMUNOL, V27, P97, DOI 10.1111/j.1365-3083.1988.tb02326.x; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; GESNER BM, 1962, BRIT J EXP PATHOL, V43, P424; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632; Lappin MB, 1999, IMMUNOLOGY, V98, P181; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; O'Keeffe M, 2003, BLOOD, V101, P1453, DOI 10.1182/blood-2002-03-0974; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Racanelli V, 2004, IMMUNITY, V20, P47, DOI 10.1016/S1074-7613(03)00353-4; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Robert C, 2003, GENE THER, V10, P1479, DOI 10.1038/sj.gt.3302008; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; Saiki T, 2001, TRANSPLANTATION, V71, P1806, DOI 10.1097/00007890-200106270-00017; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	50	168	180	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1029	1037		10.1038/ni1249	http://dx.doi.org/10.1038/ni1249			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16155571	Green Accepted			2022-12-18	WOS:000232027200022
J	Kang, SJ; Cresswell, P				Kang, SJ; Cresswell, P			Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells	NATURE IMMUNOLOGY			English	Article							ACTIVATOR PROTEIN; CYTOPLASMIC TAIL; ALPHA-GALACTOSYLCERAMIDE; PRESENTING MOLECULES; ENZYMATIC-HYDROLYSIS; LIPOGLYCAN ANTIGENS; SELF-GLYCOLIPIDS; CD1 MOLECULES; NKT CELLS; RECOGNITION	Members of the CD1 family present antigenic lipids to T lymphocytes. CD1 molecules survey endocytic compartments for lipid antigens that are sorted into these vesicles after incorporation into the membrane bilayer, and extraction from the bilayer is likely to be a critical step for lipid association. We hypothesized that lysosomal saposins, which are cofactors required for sphingolipid degradation, might be involved in this process. Here we show that saposins, although not required for the autoreactive recognition of CD1d by natural killer T cells, are indispensable for the binding of an exogenous lipid antigen, alpha-galactosylceramide, to CD1d in the endocytic pathway. We suggest that saposins mobilize monomeric lipids from lysosomal membranes and facilitate their association with CD1d.	Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, POB 208011, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Kang, Suk-Jo/C-1796-2011					AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1998, J IMMUNOL, V160, P3681; Brossay L, 1998, J IMMUNOL, V161, P5124; Burdin N, 1998, J IMMUNOL, V161, P3271; Burkhardt JK, 1997, EUR J CELL BIOL, V73, P10; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; FISCHER G, 1977, BIOCHIM BIOPHYS ACTA, V481, P561, DOI 10.1016/0005-2744(77)90288-1; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LI SC, 1988, J BIOL CHEM, V263, P6588; Moody DB, 1999, IMMUNOL LETT, V65, P85, DOI 10.1016/S0165-2478(98)00129-1; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Sandhoff K., 2001, METABOLIC ANDMOLECUL, P3371; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Turvy DN, 1998, J IMMUNOL METHODS, V212, P9, DOI 10.1016/S0022-1759(97)00206-8; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948	50	168	180	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					175	181		10.1038/ni1034	http://dx.doi.org/10.1038/ni1034			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14716312				2022-12-18	WOS:000188512000013
J	Cerundolo, V; Hermans, IF; Salio, M				Cerundolo, V; Hermans, IF; Salio, M			Dendritic cells: a journey from laboratory to clinic	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; MELANOMA PATIENTS; METASTATIC MELANOMA; IMMUNE-RESPONSE; IN-VIVO; MULTIPEPTIDE VACCINE; TUMOR-REGRESSION; PEPTIDE; ANTIGEN; ADJUVANT	Dendritic cell-based vaccines have been rapidly transferred from the laboratory to the clinic. As the full potential of these cells has not yet been entirely exploited, many strategies could improve the immunogenicity of these vaccines.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Tumor Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Cerundolo, V (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Tumor Immunol Unit, Oxford OX3 9DS, England.		Hermans, Ian/I-3961-2013	Hermans, Ian/0000-0002-7584-887X; Cerundolo, Vincenzo/0000-0003-0040-3793; Salio, Mariolina/0000-0002-4821-3801				Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Karanikas V, 2003, J IMMUNOL, V171, P4898, DOI 10.4049/jimmunol.171.9.4898; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee KH, 1999, J IMMUNOL, V163, P6292; Lee P, 2001, J CLIN ONCOL, V19, P3836, DOI 10.1200/JCO.2001.19.18.3836; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Pullarkat V, 2003, CLIN CANCER RES, V9, P1301; Salio M, 2003, EUR J IMMUNOL, V33, P1052, DOI 10.1002/eji.200323676; Schaed SG, 2002, CLIN CANCER RES, V8, P967; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Smith JW, 2003, J CLIN ONCOL, V21, P1562, DOI 10.1200/JCO.2003.09.020; Speiser DE, 2002, EUR J IMMUNOL, V32, P731, DOI 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669	23	168	183	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					7	10		10.1038/ni0104-7	http://dx.doi.org/10.1038/ni0104-7			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14699398	Bronze			2022-12-18	WOS:000187635800004
J	Hunziker, L; Recher, M; Macpherson, AJ; Ciurea, A; Freigang, S; Hengartner, H; Zinkernagel, RM				Hunziker, L; Recher, M; Macpherson, AJ; Ciurea, A; Freigang, S; Hengartner, H; Zinkernagel, RM			Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; B-CELL RESPONSE; T-CELLS; DENDRITIC CELLS; HEPATITIS-C; MICE; ANTIBODY; ANTIGEN; IMMUNE; DISRUPTION	Polyclonal hypergammaglobulinemia is a characteristic of chronic inflammatory conditions, including persisting viral infections and autoimmune diseases. Here we have studied hypergammaglobulinemia in mice infected with lymphocytic choriomeningitis virus (LCMV), which induces nonspecific immunoglobulins as a result of switching natural IgM specificities to IgG. The process is dependent on help from CD4(+) T cells that specifically recognize LCMV peptides presented by B cells on major histocompatibility complex class II molecules. Thus, hypergammaglobulinemia may arise when specific helper T cells recognize B cells that have processed viral antigens irrespective of the B cell receptor specificity. This nonspecific B cell activation may contribute to antibody-mediated autoimmunity.	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Univ Basel Hosp, CH-4021 Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel	Hunziker, L (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Freigang, Stefan/A-8682-2013	Freigang, Stefan/0000-0003-4438-7828; Hunziker, Lukas/0000-0003-0081-8518; Recher, Mike/0000-0002-9121-6936; Ciurea, Adrian/0000-0002-7870-7132				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; CASATO M, 1991, LANCET, V337, P1047, DOI 10.1016/0140-6736(91)92715-E; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Choudhury A, 2000, J IMMUNOL, V164, P1713, DOI 10.4049/jimmunol.164.4.1713; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; COUTELIER JP, 1994, J AUTOIMMUN, V7, P589, DOI 10.1006/jaut.1994.1043; COUTELIER JP, 1990, J VIROL, V64, P5383, DOI 10.1128/JVI.64.11.5383-5388.1990; Hirano T, 1989, Prog Growth Factor Res, V1, P133, DOI 10.1016/0955-2235(89)90007-0; HIRANO T, 1987, P NATL ACAD SCI USA, V84, P228, DOI 10.1073/pnas.84.1.228; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; KAWAMOTO H, 1993, ACTA MED OKAYAMA, V47, P305; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; LEVY M, 1979, LANCET, V1, P113; LIEBERMAN R, 1974, J EXP MED, V139, P983, DOI 10.1084/jem.139.4.983; Lutz C, 1998, NATURE, V393, P797, DOI 10.1038/31716; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OLDSTONE MB, 1969, J EXP MED, V129, P483, DOI 10.1084/jem.129.3.483; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Oxenius A, 1997, J IMMUNOL, V158, P5717; PLAGEMANN PG, 1966, P SOC EXP BIOL MED, V121, P1147; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; RIVIERE Y, 1985, J VIROL, V55, P704, DOI 10.1128/JVI.55.3.704-709.1985; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Sullivan Kathleen E., 1998, Current Opinion in Pediatrics, V10, P600; Thomsen AR, 1996, J IMMUNOL, V157, P3074; TIRELLI U, 1986, AIDS RES HUM RETROV, V2, P227, DOI 10.1089/aid.1.1986.2.227; TSIANOS EV, 1990, AM J GASTROENTEROL, V85, P1005; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wykes M, 1998, J IMMUNOL, V161, P1313	41	168	171	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					343	349		10.1038/ni911	http://dx.doi.org/10.1038/ni911			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12627229				2022-12-18	WOS:000181987700013
J	Skok, JA; Brown, KE; Azuara, V; Caparros, ML; Baxter, J; Takacs, K; Dillon, N; Gray, D; Perry, RP; Merkenschlager, M; Fisher, AG				Skok, JA; Brown, KE; Azuara, V; Caparros, ML; Baxter, J; Takacs, K; Dillon, N; Gray, D; Perry, RP; Merkenschlager, M; Fisher, AG			Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes	NATURE IMMUNOLOGY			English	Article							HEAVY-CHAIN; CENTROMERIC HETEROCHROMATIN; MESSENGER-RNA; GENE; CELLS; LOCUS; TRANSCRIPTION; LOCALIZATION; SELECTION; REGION	Individual B lymphocytes normally express immunoglobulin (Ig) proteins derived from single Ig heavy chain (H) and light chain (L) alleles. Allelic exclusion ensures monoallelic expression of Ig genes by each B cell to maintain single receptor specificity. Here we provide evidence that at later stages of B cell development, additional mechanisms may contribute to prioritizing expression of single IgH and IgL alleles. Fluorescent in situ hybridization analysis of primary splenic B cells isolated from normal and genetically manipulated mice showed that endogenous IgH, kappa and lambda alleles localized to different subnuclear environments after activation and had differential expression patterns. However, this differential recruitment and expression of Ig alleles was not typically seen among transformed B cell lines. These data raise the possibility that epigenetic factors help maintain the monoallelic expression of Ig.	Hammersmith Hosp, Imperial Coll Sch Med, MRC, Clin Sci Ctr,Lymphocyte Dev Grp, London W12 0NN, England; Hammersmith Hosp, Imperial Coll Sch Med, MRC, Clin Sci Ctr,Gene Regulat & Chromatin Grp, London W12 0NN, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Imperial College London; Imperial College London; University of Edinburgh; Fox Chase Cancer Center	Fisher, AG (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, MRC, Clin Sci Ctr,Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.		Gray, David/L-8295-2013; Skok, Jane/ABF-7249-2020	Gray, David/0000-0003-3785-4934; Skok, Jane/0000-0002-4145-1516; Azuara, Veronique/0000-0003-4608-3713; Merkenschlager, Matthias/0000-0003-2889-3288				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; BERNIER GM, 1964, SCIENCE, V144, P1590, DOI 10.1126/science.144.3626.1590; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Elenich LA, 1997, J IMMUNOL, V158, P4564; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FISHER AG, 1995, INT IMMUNOL, V7, P415, DOI 10.1093/intimm/7.3.415; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; GEORGOPOUOS K, 1994, CELL, V79, P43; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; HONJO T, 1995, IMMUNOGLOBULIN GENES; HOOD L, 1969, DEV ASPECTS ANTIBODY, V1, P283; KELLEY DE, 1986, NUCLEIC ACIDS RES, V14, P5431, DOI 10.1093/nar/14.13.5431; KIM KJ, 1979, J IMMUNOL, V122, P549; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; LENNON GG, 1989, IMMUNOGENETICS, V30, P383, DOI 10.1007/BF02425279; LIU CP, 1980, SCIENCE, V209, P1348, DOI 10.1126/science.6774414; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Mainville CA, 1996, J IMMUNOL, V156, P1038; NELSON KJ, 1984, NUCLEIC ACIDS RES, V12, P1911, DOI 10.1093/nar/12.4.1911; NELSON KJ, 1983, MOL CELL BIOL, V3, P1317, DOI 10.1128/MCB.3.7.1317; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RATCLIFFE MJH, 1982, EUR J IMMUNOL, V12, P634, DOI 10.1002/eji.1830120803; ROLINK A, 1993, CURR OPIN IMMUNOL, V5, P207, DOI 10.1016/0952-7915(93)90006-E; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schubeler D, 2000, GENE DEV, V14, P940; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; WEISS S, 1987, EMBO J, V6, P927, DOI 10.1002/j.1460-2075.1987.tb04840.x; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	38	168	172	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					848	854		10.1038/ni0901-848	http://dx.doi.org/10.1038/ni0901-848			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526401				2022-12-18	WOS:000170781200025
J	Bohn, T; Rapp, S; Luther, N; Klein, M; Bruehl, TJ; Kojima, N; Lopez, PA; Hahlbrock, J; Muth, S; Endo, S; Pektor, S; Brand, A; Renner, K; Popp, V; Gerlach, K; Vogel, D; Lueckel, C; Arnold-Schild, D; Pouyssegur, J; Kreutz, M; Huber, M; Koenig, J; Weigmann, B; Probst, HC; von Stebut, E; Becker, C; Schild, H; Schmitt, E; Bopp, T				Bohn, Toszka; Rapp, Steffen; Luther, Natascha; Klein, Matthias; Bruehl, Till-Julius; Kojima, Nobuhiko; Lopez, Pamela Aranda; Hahlbrock, Jennifer; Muth, Sabine; Endo, Shogo; Pektor, Stefanie; Brand, Almut; Renner, Kathrin; Popp, Vanessa; Gerlach, Katharina; Vogel, Dennis; Lueckel, Christina; Arnold-Schild, Danielle; Pouyssegur, Jacques; Kreutz, Marina; Huber, Magdalena; Koenig, Jochem; Weigmann, Benno; Probst, Hans-Christian; von Stebut, Esther; Becker, Christian; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias			Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages	NATURE IMMUNOLOGY			English	Article							SERUM LACTATE-DEHYDROGENASE; PROTEIN-COUPLED RECEPTORS; CAMP EARLY REPRESSOR; NF-KAPPA-B; LACTIC-ACID; INFLAMMATORY RESPONSES; SOLID TUMORS; IN-VITRO; IMMUNE; PROGRESSION	Many tumors evolve sophisticated strategies to evade the immune system, and these represent major obstacles for efficient antitumor immune responses. Here we explored a molecular mechanism of metabolic communication deployed by highly glycolytic tumors for immunoevasion. In contrast to colon adenocarcinomas, melanomas showed comparatively high glycolytic activity, which resulted in high acidification of the tumor microenvironment. This tumor acidosis induced Gprotein-coupled receptor-dependent expression of the transcriptional repressor ICER in tumor-associated macrophages that led to their functional polarization toward a non-inflammatory phenotype and promoted tumor growth. Collectively, our findings identify a molecular mechanism of metabolic communication between non-lymphoid tissue and the immune system that was exploited by high-glycolytic-rate tumors for evasion of the immune system.	[Bohn, Toszka; Klein, Matthias; Bruehl, Till-Julius; Hahlbrock, Jennifer; Muth, Sabine; Lueckel, Christina; Arnold-Schild, Danielle; Probst, Hans-Christian; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Mainz, Germany; [Rapp, Steffen] Johannes Gutenberg Univ Mainz, Mol Genet, Mainz, Germany; [Luther, Natascha; Becker, Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dermatol, Mainz, Germany; [Kojima, Nobuhiko] Toyo Univ, Fac Life Sci, Gunma, Japan; [Lopez, Pamela Aranda] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin 3, Mainz, Germany; [Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Neurosci Res Team, Tokyo, Japan; [Pektor, Stefanie] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Nucl Med, Mainz, Germany; [Brand, Almut; Renner, Kathrin; Kreutz, Marina] Univ Regensburg, Internal Med 3, Regensburg, Germany; [Renner, Kathrin; Kreutz, Marina] RCI, Regensburg, Germany; [Popp, Vanessa; Gerlach, Katharina; Weigmann, Benno] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Vogel, Dennis; Lueckel, Christina; Huber, Magdalena] Univ Marburg, Inst Med Microbiol, Marburg, Germany; [Vogel, Dennis; Lueckel, Christina; Huber, Magdalena] Univ Marburg, Hosp Hyg, Marburg, Germany; [Pouyssegur, Jacques] Univ Nice Sophia Antipolis, Inst Res Canc & Aging, Nice, France; [Pouyssegur, Jacques; Becker, Christian] CSM, Med Biol Dept, Monaco, Monaco; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany; [Probst, Hans-Christian; Becker, Christian; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany; [von Stebut, Esther] Univ Med Ctr Cologne, Dermatol & Venereol, Cologne, Germany; [Schild, Hansjoerg; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Univ Canc Ctr, Mainz, Germany; [Bopp, Tobias] German Canc Consortium DKTK, Heidelberg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Toyo University; Johannes Gutenberg University of Mainz; Tokyo Metropolitan Institute of Gerontology; Johannes Gutenberg University of Mainz; University of Regensburg; University of Erlangen Nuremberg; Philipps University Marburg; Philipps University Marburg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Cologne; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ)	Bopp, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Mainz, Germany.; Bopp, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Mainz, Germany.; Bopp, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Univ Canc Ctr, Mainz, Germany.; Bopp, T (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	boppt@uni-mainz.de	Becker, Christian/GLS-0862-2022; Renner, Kathrin/H-3211-2013; Huber, Magdalena/ABD-1810-2020	Becker, Christian/0000-0002-1716-7208; Huber, Magdalena/0000-0002-2963-0693; PROBST, Hans Christian/0000-0002-7926-0651; Renner, Kathrin/0000-0002-7116-1368; Gerlach, Katharina/0000-0001-5855-7205	Deutsche Forschungsgemeinschaft (DFG) [SFB 1292]; DFG [BO 3306/1-1, SCHM 1014/7-1, SCHM 1014/5-1, SFB 1066, TR SFB 156]; Universitares Centrum fur Tumorerkrankungen; Forschungszentrum Immuntherapie, core facility Histology, of the University Medical Center, Johannes Gutenberg University Mainz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Universitares Centrum fur Tumorerkrankungen; Forschungszentrum Immuntherapie, core facility Histology, of the University Medical Center, Johannes Gutenberg University Mainz	We are grateful to C.J.M. Melief for critical reading of our manuscript. We thank C. Braun, S. Fischer and S. Hesse-Kerolli for expert technical help. We thank M. Diken (Translationale Onkologie, University Medical Center, Johannes Gutenberg University Mainz) for OVA-expressing B16F10 (B16) melanoma cells; and K. Rajalingam (Institute for Immunology, University Medical Center, Johannes Gutenberg University Mainz) for LLC1 cells. This work was supported by Deutsche Forschungsgemeinschaft (DFG) SFB 1292 TP01 (T.Bopp and E.S.), TP13 (H.S. and H.-C.P.) and TP15 (E.v.S.); by DFG grants BO 3306/1-1, SCHM 1014/7-1, SCHM 1014/5-1, SFB 1066 projects B13 (E.S.) and B8 (T.Bopp and C.B.) and TR SFB 156 (E.v.S., H.-C.P. and H.S.); and by the Universitares Centrum fur Tumorerkrankungen and the Forschungszentrum Immuntherapie, core facility Histology, of the University Medical Center, Johannes Gutenberg University Mainz (E.v.S., E.S. and T.Bopp).	Auguie B., 2017, GRIDEXTRA MISCELLANE; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Carmona-Fontaine C, 2017, P NATL ACAD SCI USA, V114, P2934, DOI 10.1073/pnas.1700600114; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diem S, 2016, BRIT J CANCER, V114, P256, DOI 10.1038/bjc.2015.467; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Earle WR, 1943, J NATL CANCER I, V4, P165; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gerweck LE, 1996, CANCER RES, V56, P1194; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Ho PC, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0109-1; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Oliveros J. C., 2015, VENNY INTERACTIVE TO; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Petrelli F, 2015, ACTA ONCOL, V54, P961, DOI 10.3109/0284186X.2015.1043026; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Sanderlin EJ, 2015, CELL HEALTH CYTOSKEL, V7, P99, DOI 10.2147/CHC.S60508; Selleri S, 2016, ONCOTARGET, V7, P30193, DOI 10.18632/oncotarget.8623; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zeh HJ, 1999, J IMMUNOL, V162, P989; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09800	51	167	171	12	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1319	+		10.1038/s41590-018-0226-8	http://dx.doi.org/10.1038/s41590-018-0226-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30397348				2022-12-18	WOS:000452873000013
J	Liu, BY; Zhang, M; Chu, HL; Zhang, HH; Wu, HF; Song, GH; Wang, P; Zhao, K; Hou, JX; Wang, X; Zhang, L; Gao, CJ				Liu, Bingyu; Zhang, Meng; Chu, Honglei; Zhang, Honghai; Wu, Haifeng; Song, Guanhua; Wang, Peng; Zhao, Kai; Hou, Jinxiu; Wang, Xueer; Zhang, Lei; Gao, Chengjiang			The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INTERFERON; PROTEIN; RECOGNITION; DEGRADATION; RECEPTORS; MECHANISM; PATHWAY; SENSOR	The signaling adaptor MAVS forms prion-like aggregates to activate an innate antiviral immune response after viral infection. However, the molecular mechanisms that regulate MAVS aggregation are poorly understood. Here we identified TRIM31, an E3 ubiquitin ligase of the TRIM family of proteins, as a regulator of MAVS aggregation. TRIM31 was recruited to mitochondria after viral infection and specifically regulated antiviral signaling mediated by RLR pattern-recognition receptors. TRIM31-deficient mice were more susceptible to infection with RNA virus than were wild-type mice. TRIM31 interacted with MAVS and catalyzed the Lys63 (K63)-linked polyubiquitination of Lys10, Lys311 and Lys461 on MAVS. This modification promoted the formation of prion-like aggregates of MAVS after viral infection. Our findings reveal new insights in the molecular regulation of MAVS aggregation and the cellular antiviral response through TRIM31-mediated K63-linked polyubiquitination of MAVS.	[Liu, Bingyu; Chu, Honglei; Zhang, Honghai; Wu, Haifeng; Song, Guanhua; Wang, Peng; Zhao, Kai; Hou, Jinxiu; Wang, Xueer; Zhang, Lei; Gao, Chengjiang] Shandong Univ, Sch Basic Med Sci, Dept Immunol, Jinan, Peoples R China; [Liu, Bingyu; Chu, Honglei; Zhang, Honghai; Wu, Haifeng; Song, Guanhua; Wang, Peng; Zhao, Kai; Hou, Jinxiu; Wang, Xueer; Zhang, Lei; Gao, Chengjiang] Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China; [Zhang, Meng] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Zhang, Meng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Gao, CJ (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Immunol, Jinan, Peoples R China.; Gao, CJ (corresponding author), Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China.	cgao@sdu.edu.cn	WANG, Peng/GSN-5263-2022	Zhao, Kai/0000-0003-1894-5347; Gao, Chengjiang/0000-0002-9365-4497	Natural Science Foundation of China [81525012, 81273219, 81471538]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130131130010]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	We thank Z. Jiang (Peking University) for Mays<SUP>-/-</SUP> MEFs; D. Guo (Wuhan University) for Ddx58<SUP>-/-</SUP> MEFs; K.A. Fitzgerald (University of Massachusetts Medical School) for the human IFNB1 promoter reporter and its mutated reporter; and B. Sun and F. Hou (Shanghai Institutes for Biological Sciences) for the expression plasmids for TRIM30-alpha and MAVS(M56R). Supported by the Natural Science Foundation of China (81525012, 81273219 and 81471538 to C.G.) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20130131130010 to C.G.).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Heaton SM, 2016, J EXP MED, V213, P1, DOI 10.1084/jem.20151531; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Pan Y, 2014, J IMMUNOL, V192, P4758, DOI 10.4049/jimmunol.1302632; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sugiura T, 2011, CELL BIOL INT, V35, P657, DOI 10.1042/CBI20100772; Sugiura T, 2008, J CELL BIOCHEM, V105, P1081, DOI 10.1002/jcb.21908; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Wang YT, 2012, J IMMUNOL, V189, P5304, DOI 10.4049/jimmunol.1201445; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhou X, 2012, CELL RES, V22, P717, DOI 10.1038/cr.2011.184	35	167	178	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					214	224		10.1038/ni.3641	http://dx.doi.org/10.1038/ni.3641			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	27992402				2022-12-18	WOS:000392360900015
J	Mortimer, L; Moreau, F; MacDonald, JA; Chadee, K				Mortimer, Leanne; Moreau, France; MacDonald, Justin A.; Chadee, Kris			NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations	NATURE IMMUNOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; PROSTAGLANDIN E-2; EP4 RECEPTOR; PROSTANOID RECEPTORS; HUMAN MACROPHAGES; ACTIVATION; CAMP; EXPRESSION; GENE; CIAS1	Inflammasomes are positioned to rapidly escalate the intensity of inflammation by activating interleukin (IL)-1 beta, IL-18 and cell death by pyroptosis. However, negative regulation of inflammasomes remains poorly understood, as is the signaling cascade that dampens inflammasome activity. We found that rapid NLRP3 inflammasome activation was directly inhibited by protein kinase A (PKA), which was induced by prostaglandin E-2 (PGE(2)) signaling via the PGE2 receptor E-prostanoid 4 (EP4). PKA directly phosphorylated the cytoplasmic receptor NLRP3 and attenuated its ATPase function. We found that Ser295 in human NLRP3 was critical for rapid inhibition and PKA phosphorylation. Mutations in NLRP3-encoding residues adjacent to Ser295 have been linked to the inflammatory disease CAPS (cryopyrin-associated periodic syndromes). NLRP3-S295A phenocopied the human CAPS mutants. These data suggest that negative regulation at Ser295 is critical for restraining the NLRP3 inflammasome and identify a molecular basis for CAPS-associated NLRP3 mutations.	[Mortimer, Leanne; Moreau, France; Chadee, Kris] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [MacDonald, Justin A.] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary	Chadee, K (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.	kchadee@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473	Canadian Institute of Health Research [MOP-340405]; Natural Sciences and Engineering Research Council of Canada [RGPIN-04023]; Alberta Innovates Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Health Solutions	We thank Y. Shi (University of Calgary) for MSU and silica. Supported by the Canadian Institute of Health Research (MOP-340405 to K.C.; Tier 1 Canada Research Chair in Gastrointestinal Inflammation to K.C.; Team Grant in Health Challenges in Chronic Inflammation to J.A.M.), the Natural Sciences and Engineering Research Council of Canada (RGPIN-04023 to K.C.; and Canada Graduate Scholarship to L.M.) and Alberta Innovates Health Solutions (J.A.M. and L.M.).	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arostegui JI, 2004, ARTHRITIS RHEUM-US, V50, P4045, DOI 10.1002/art.20633; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Dey I, 2009, BRIT J PHARMACOL, V156, P475, DOI 10.1111/j.1476-5381.2008.00056.x; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; He Y, 2014, J BIOL CHEM, V289, P1142, DOI 10.1074/jbc.M113.515080; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hirata T, 2011, CHEM REV, V111, P6209, DOI 10.1021/cr200010h; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Kanariou M, 2009, KLIN PADIATR, V221, P379, DOI 10.1055/s-0029-1239572; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; KUNKEL SL, 1986, J IMMUNOL, V136, P186; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Leinonen M., 2014, PEDIAT RHEUMATOL S1, V12, P76; Lejeune M, 2010, AM J PHYSIOL-GASTR L, V299, pG1097, DOI 10.1152/ajpgi.00280.2010; MAROTTA P, 1992, BRIT J PHARMACOL, V107, P640, DOI 10.1111/j.1476-5381.1992.tb14499.x; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Schmitz T, 2007, PEDIATR RES, V61, P421, DOI 10.1203/pdr.0b013e318030d141; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Susuki-Miyata S, 2015, P NATL ACAD SCI USA, V112, pE1800, DOI 10.1073/pnas.1418716112; Takaishi O, 1999, DIGEST DIS SCI, V44, P2405, DOI 10.1023/A:1026614400820; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047	45	167	177	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1176	+		10.1038/ni.3538	http://dx.doi.org/10.1038/ni.3538			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27548431				2022-12-18	WOS:000384302900009
J	Orme, IM; Robinson, RT; Cooper, AM				Orme, Ian M.; Robinson, Richard T.; Cooper, Andrea M.			The balance between protective and pathogenic immune responses in the TB-infected lung	NATURE IMMUNOLOGY			English	Review							MYCOBACTERIUM-TUBERCULOSIS INFECTION; DENDRITIC CELLS; CUTTING EDGE; PULMONARY TUBERCULOSIS; IL-1-BETA PRODUCTION; IFN-GAMMA; INNATE; MACROPHAGE; TRIGGERS; SUSCEPTIBILITY	Tuberculosis is a disease of the lung, and efficient transmission is dependent on the generation of a lesion in the lung, which results in a bacterium-laden cough. Mycobacterium tuberculosis (Mtb) is able to manipulate both the innate and acquired immune response of the host. This manipulation results in an effective CD4(+) T cell response that limits disease throughout the body but can also promote the development of progressively destructive lesions in the lung. In this way Mtb infection can result in an ambulatory individual who has a lesion in the lung capable of transmitting Mtb. The inflammatory environment within the lung lesion is manipulated by Mtb throughout infection and can limit the expression of acquired immunity by a variety of pathways.	[Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Robinson, Richard T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Cooper, Andrea M.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Colorado State University; Medical College of Wisconsin; Trudeau Institute	Cooper, AM (corresponding author), Trudeau Inst Inc, Saranac Lake, NY 12983 USA.	acooper@trudeauinstitute.org		Robinson, Richard/0000-0002-4699-515X; Cooper, Andrea/0000-0001-6050-3863	Trudeau Institute, Inc.; US National Institutes of Health NIAID [AI69121, AI73564, AI67723, AI099661]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067723, R21AI099661, R01AI073564, R01AI069121] Funding Source: NIH RePORTER	Trudeau Institute, Inc.; US National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Trudeau Institute, Inc., and the US National Institutes of Health NIAID (AI69121, AI73564 and AI67723 to A.M.C.; AI099661 R.T.R.).	Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Arcos J, 2011, J IMMUNOL, V187, P372, DOI 10.4049/jimmunol.1100823; Arlehamn CL, 2014, J IMMUNOL, V193, P2931, DOI 10.4049/jimmunol.1401151; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bhatt K, 2004, J IMMUNOL, V172, P2748, DOI 10.4049/jimmunol.172.5.2748; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P58, DOI 10.1038/cmi.2012.46; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cooper AM, 2002, TRENDS MICROBIOL, V10, P221, DOI 10.1016/S0966-842X(02)02344-2; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gomes MS, 1999, J IMMUNOL, V162, P6734; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Keeton R, 2014, J CLIN INVEST, V124, P1537, DOI 10.1172/JCI45005; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; Pearl JE, 2012, EUR J IMMUNOL, V42, P3267, DOI 10.1002/eji.201142158; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Rich AR., 1944, PATHOGENESIS TUBERCU; Robinson RT, 2010, J EXP MED, V207, P591, DOI 10.1084/jem.20091085; Rothchild AC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003805; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schreiber HA, 2011, J CLIN INVEST, V121, P3902, DOI 10.1172/JCI45113; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Srivastava S, 2013, J IMMUNOL, V191, P1016, DOI 10.4049/jimmunol.1301236; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	82	167	175	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					57	63		10.1038/ni.3048	http://dx.doi.org/10.1038/ni.3048			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521685	Bronze			2022-12-18	WOS:000346494200009
J	Watchmaker, PB; Lahl, K; Lee, M; Baumjohann, D; Mortont, J; Kim, SJ; Zeng, R; Dent, A; Anse, KM; Diamond, B; Hadeiba, H; Butcher, EC				Watchmaker, Payal B.; Lahl, Katharina; Lee, Mike; Baumjohann, Dirk; Morton, John; Kim, Sun Jung; Zeng, Ruizhu; Dent, Alexander; Anse, K. Mark; Diamond, Betty; Hadeiba, Husein; Butcher, Eugene C.			Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice	NATURE IMMUNOLOGY			English	Article							CD103(+)CD11B(+) DENDRITIC CELLS; LAMINA PROPRIA; INFLAMMATION; MACROPHAGES; EXPRESSION; IMMUNITY; BLIMP-1; SUBSETS; LYMPH; GUT	Dendritic cells (DCs) that orchestrate mucosal immunity have been studied in mice. Here we characterized human gut DC populations and defined their relationship to previously studied human and mouse DCs. CD103(+)Sirp alpha(-) DCs were related to human blood CD141(+) DCs and to mouse intestinal CD103(+)CD11b(-) DCs and expressed markers of cross-presenting DCs. CD103(+)Sirp alpha(+) DCs aligned with human blood CD1c(+) DCs and mouse intestinal CD103(+)CD11b(+) DCs and supported the induction of regulatory T cells. Both CD103(+) DC subsets induced the T(H)17 subset of helper T cells, while CD103-Sirp alpha(+) DCs induced the T(H)17 subset of helper T cells. Comparative analysis of transcriptomes revealed conserved transcriptional programs among CD103(+) DC subsets and identified a selective role for the transcriptional repressors BcI-6 and Blimp-1 in the specification of CD103(+)CD11b(-) DCs and intestinal CD103(+)CD11b(+) DCs, respectively. Our results highlight evolutionarily conserved and divergent programming of intestinal DCs.	[Watchmaker, Payal B.; Lahl, Katharina; Lee, Mike; Zeng, Ruizhu; Butcher, Eugene C.] Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Watchmaker, Payal B.; Lahl, Katharina; Lee, Mike; Zeng, Ruizhu; Hadeiba, Husein; Butcher, Eugene C.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA USA; [Baumjohann, Dirk; Anse, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, Dept Microbiol & Immunol, San Francisco, CA USA; [Morton, John] Stanford Univ, Sch Med, Dept Surg, Stanford, CA USA; [Kim, Sun Jung; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, New York, NY USA; [Dent, Alexander] Indiana Univ, Sch Med, Dept Immunol & Microbiol, Indianapolis, IN USA; [Hadeiba, Husein; Butcher, Eugene C.] Palo Alto Inst Res & Educ, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California San Francisco; Stanford University; Northwell Health; Indiana University System; Indiana University-Purdue University Indianapolis	Lahl, K (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	katharina.lahl@gmail.com	Baumjohann, Dirk/C-9047-2009; Lahl, Katharina/AAA-1909-2021	Baumjohann, Dirk/0000-0001-8385-8288; Lahl, Katharina/0000-0003-4919-331X	US National Institutes of Health [R01 AI093981, R01 DK084647, R37 AI047822, 5T32AI007290-25, K01 AR59378, AI07290]; US Department of Veterans Affairs; Digestive Disease Center of Stanford University [P30 DK056339]; German Research Foundation; Crohn's and Colitis Foundation of America; Stanford Institute for Immunity, Transplantation and Infection; Agency for Science, Technology And Research of Singapore; Swiss National Science Foundation [PBBEP3-133516]; Swiss Foundation for Grants in Biology and Medicine [PASMP3-142725]; Leukemia & Lymphoma Society; California Institute for Regenerative Medicine; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, R01AI093981, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR059378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339, R01DK084647] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Digestive Disease Center of Stanford University; German Research Foundation(German Research Foundation (DFG)); Crohn's and Colitis Foundation of America; Stanford Institute for Immunity, Transplantation and Infection; Agency for Science, Technology And Research of Singapore(Agency for Science Technology & Research (A*STAR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Okada (RIKEN, Japan) for YFP-BcI-6 mice<SUP>52</SUP>; E. Meffre (Yale University) for Blimp-l-YFP mice<SUP>53</SUP>; J. Sweere and H. Kiefel for critical reading of the manuscript; L. Rott for assistance with flow cytometry and cell sorting; E. Resurreccion for assistance with immunohistochemistry; K. Bhat for writing Python scripts; all members of the Butcher laboratory for discussions; and the Immunological Genome Project and the Merad laboratory (Mount Sinai School of Medicine) for generating the publicly available microarray data of sorted mouse intestinal DC. Supported by the US National Institutes of Health (R01 AI093981, R01 DK084647 and R37 AI047822 to E.C.B.; 5T32AI007290-25 to M.L.; K01 AR59378 to S.J.K.; and AI07290 to H.H.), the US Department of Veterans Affairs (E.C.B.), the Digestive Disease Center of Stanford University (under P30 DK056339), the German Research Foundation (K.L.), the Crohn's and Colitis Foundation of America (K.L. and M.L.), The Stanford Institute for Immunity, Transplantation and Infection (K.L.), the Agency for Science, Technology And Research of Singapore (R.Z.), the Swiss National Science Foundation (PBBEP3-133516 to D.B.), the Swiss Foundation for Grants in Biology and Medicine (PASMP3-142725 to D.B.), the Leukemia & Lymphoma Society (K.M.A.), the California Institute for Regenerative Medicine (H.H.) and the Arthritis Foundation (H.H.).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Baumgart DC, 2005, GUT, V54, P228, DOI 10.1136/gut.2004.040360; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bouloc A, 2000, EUR J IMMUNOL, V30, P3132, DOI 10.1002/1521-4141(200011)30:11<3132::AID-IMMU3132>3.0.CO;2-E; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Milling S, 2010, IMMUNOL REV, V234, P259, DOI 10.1111/j.0105-2896.2009.00866.x; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Takeuchi A, 2009, J IMMUNOL, V183, P4220, DOI 10.4049/jimmunol.0901248; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013	47	167	172	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					98	108		10.1038/ni.2768	http://dx.doi.org/10.1038/ni.2768			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24292363	Green Submitted, Green Accepted			2022-12-18	WOS:000328800500017
J	Huang, LR; Wohlleber, D; Reisinger, F; Jenne, CN; Cheng, RL; Abdullah, Z; Schildberg, FA; Odenthal, M; Dienes, HP; van Rooijen, N; Schmitt, E; Garbi, N; Croft, M; Kurts, C; Kubes, P; Protzer, U; Heikenwalder, M; Knolle, PA				Huang, Li-Rung; Wohlleber, Dirk; Reisinger, Florian; Jenne, Craig N.; Cheng, Ru-Lin; Abdullah, Zeinab; Schildberg, Frank A.; Odenthal, Margarete; Dienes, Hans-Peter; van Rooijen, Nico; Schmitt, Edgar; Garbi, Natalio; Croft, Michael; Kurts, Christian; Kubes, Paul; Protzer, Ulrike; Heikenwalder, Mathias; Knolle, Percy A.			Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+T cells and successful immunotherapy against chronic viral liver infection	NATURE IMMUNOLOGY			English	Article							EFFECTOR FUNCTION; T-CELLS; ANTIGEN; LYMPHOCYTES; MONOCYTES	Chronic infection is difficult to overcome because of exhaustion or depletion of cytotoxic effector CD8+ T cells (cytotoxic T lymphoytes (CTLs)). Here we report that signaling via Toll-like receptors (TLRs) induced intrahepatic aggregates of myeloid cells that enabled the population expansion of CTLs (iMATEs: 'intrahepatic myeloid-cell aggregates for T cell population expansion') without causing immunopa thology. In the liver, CTL proliferation was restricted to iMATEs that were composed of inflammatory monocyte-derived CD11b(+) cells. Signaling via tumor-necrosis factor (TNF) caused iMATE formation that facilitated costimulation dependent on the receptor OX40 for expansion of the CTL population. The iMATEs arose during acute viral infection but were absent during chronic viral infection, yet they were still induced by TLR signaling. Such hepatic expansion of the CTL population controlled chronic viral infection of the liver after vaccination with DNA. Thus, iMATEs are dynamic structures that overcome regulatory cues that limit the population expansion of CTLs during chronic infection and can be used in new therapeutic vaccination strategies.	[Huang, Li-Rung; Wohlleber, Dirk; Cheng, Ru-Lin; Abdullah, Zeinab; Schildberg, Frank A.; Garbi, Natalio; Kurts, Christian; Knolle, Percy A.] Univ Bonn, Inst Mol Med, Bonn, Germany; [Huang, Li-Rung; Wohlleber, Dirk; Cheng, Ru-Lin; Abdullah, Zeinab; Schildberg, Frank A.; Garbi, Natalio; Kurts, Christian; Knolle, Percy A.] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Reisinger, Florian; Protzer, Ulrike; Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany; [Jenne, Craig N.; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada; [Odenthal, Margarete; Dienes, Hans-Peter] Univ Cologne, Inst Pathol, Cologne, Germany; [van Rooijen, Nico] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, Mainz, Germany; [Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA; [Knolle, Percy A.] Tech Univ Munich, Inst Virol, D-80290 Munich, Germany; [Knolle, Percy A.] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Calgary; University of Cologne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johannes Gutenberg University of Mainz; La Jolla Institute for Immunology; Technical University of Munich; Technical University of Munich	Knolle, PA (corresponding author), Univ Bonn, Inst Mol Med, Bonn, Germany.	heikenwalder@helmholtz-muenchen.de; percy.knolle@ukb.uni-bonn.de	Protzer, Ulrike/D-5915-2015; Van Rooijen, Nico/Z-1578-2019; Garbi, Natalio/H-7666-2014; Jenne, Craig/HCH-3413-2022; Wohlleber, Dirk/J-2549-2017; Heikenwalder, Mathias/AAA-2269-2020	Protzer, Ulrike/0000-0002-9421-1911; Wohlleber, Dirk/0000-0003-3861-5150; Knolle, Percy A./0000-0003-2983-0414	Helmholtz Association; Hofschneider Foundation; European Research Council (LiverCancerMech); Helmholtz Alliance Preclinical Comprehensive Cancer Center; Sonderforschungsbereich [36, 704, TR57, 670]; Helmholtz Alliance on Immunotherapy of Cancer; Bundesministerium fur Bildung und Forschung projects Virtual Liver and PeTra; Excellence Cluster ImmunoSensation	Helmholtz Association(Helmholtz Association); Hofschneider Foundation; European Research Council (LiverCancerMech); Helmholtz Alliance Preclinical Comprehensive Cancer Center; Sonderforschungsbereich(German Research Foundation (DFG)); Helmholtz Alliance on Immunotherapy of Cancer; Bundesministerium fur Bildung und Forschung projects Virtual Liver and PeTra; Excellence Cluster ImmunoSensation	We thank D. Kull, R. Hillermann, O. Seelbach, N. Simonavicius, M. Wolf and the flow cytometry core facility of the Institutes of Molecular Medicine and Experimental Immunology, University of Bonn for technical support. Supported by the Helmholtz Association (M.H.), the Hofschneider Foundation (M.H.), the European Research Council (LiverCancerMech; M.H.), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (M.H.), Sonderforschungsbereich (36 to M. H., and 704, TR57 and 670 to P.K.), the Helmholtz Alliance on Immunotherapy of Cancer (P.K.), the Bundesministerium fur Bildung und Forschung projects Virtual Liver and PeTra (P.K.) and the Excellence Cluster ImmunoSensation (P.K.).	Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Huang LR, 2012, GASTROENTEROLOGY, V142, P1447, DOI 10.1053/j.gastro.2012.03.006; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lee SW, 2003, J IMMUNOL, V170, P2456, DOI 10.4049/jimmunol.170.5.2456; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; MacGregor JN, 2006, CANCER RES, V66, P4913, DOI 10.1158/0008-5472.CAN-05-3507; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Sacher T, 2002, EUR J IMMUNOL, V32, P3628, DOI 10.1002/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stabenow D, 2010, HEPATOLOGY, V51, P1430, DOI 10.1002/hep.23575; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wohlleber D, 2012, CELL REP, V2, P478, DOI 10.1016/j.celrep.2012.08.001; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wong P, 2003, IMMUNITY, V18, P499, DOI 10.1016/S1074-7613(03)00081-5	38	167	173	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					574	+		10.1038/ni.2573	http://dx.doi.org/10.1038/ni.2573			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23584070				2022-12-18	WOS:000319107600010
J	Cullen, BR				Cullen, Bryan R.			MicroRNAs as mediators of viral evasion of the immune system	NATURE IMMUNOLOGY			English	Review							TRANSLATION INITIATION; HERPESVIRUS MICRORNA; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; VIRUS MICRORNA; MESSENGER-RNA; TARGET; MIR-155; RECOGNITION; LATENT	Cellular microRNAs serve key roles in the post-transcriptional regulation of almost every cellular gene-regulatory pathway, and it therefore is not surprising that viruses have found ways to subvert this process. Several viruses encode microRNAs that directly downregulate the expression of factors of the innate immune system, including proteins involved in promoting apoptosis and recruiting effector cells of the immune system. Viruses have also evolved the ability to downregulate or upregulate the expression of specific cellular miRNAs to enhance their replication. This Review provides an overview of the present knowledge of the complex interactions of viruses with the microRNA machinery of cells.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	bryan.cullen@duke.edu			US National Institutes of Health [R01-AI0973376, R01-AI067968, R01-DA030086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968, R01AI097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030086] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the US National Institutes of Health (R01-AI0973376, R01-AI067968 and R01-DA030086).	Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cai XZ, 2006, J VIROL, V80, P10890, DOI 10.1128/JVI.01175-06; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Davis M, 2008, J VIROL, V82, P11824, DOI 10.1128/JVI.01078-08; Dolken L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001150; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim S, 2011, NAT IMMUNOL, V12, P984, DOI 10.1038/ni.2097; Kim Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002577; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lei XF, 2012, J VIROL, V86, P11698, DOI 10.1128/JVI.06855-11; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lin YT, 2011, P NATL ACAD SCI USA, V108, P11229, DOI 10.1073/pnas.1105799108; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nikitin PA, 2011, FUTURE VIROL, V6, P813, DOI 10.2217/FVL.11.55; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	89	167	180	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					205	210		10.1038/ni.2537	http://dx.doi.org/10.1038/ni.2537			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416678	Green Accepted			2022-12-18	WOS:000315065400009
J	Tibbetts, MD; Zheng, LX; Lenardo, MJ				Tibbetts, MD; Zheng, LX; Lenardo, MJ			The death effector domain protein family: regulators of cellular homeostasis	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; SIGNALING COMPLEX; KINASE-C; CASPASE-8 ACTIVATION; APOPTOSIS REGULATOR; RECEPTOR SIGNALS; FADD; FAS; FLIP	The death effector domain (DED) occurs in proteins that regulate programmed cell death. Both pro- and anti-apoptotic proteins containing DEDs have been identified. For Fas and possibly other death receptors, homotypic DIED interactions connect the Fas-associated death domain (FADD) protein to caspase-8 and caspase-10 to mediate formation of the death-inducing signal complex. This complex can be inhibited by other DED-containing proteins. Accumulating evidence now suggests that DED-containing proteins have additional roles in controlling pathways of cellular activation and proliferation. Thus, the DED defines a family of proteins that may be pivotal to cellular homeostasis by establishing a 'cell renewal set point' that coregulates proliferation and apoptosis in parallel.	NIAID, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000718, ZIAAI000718] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; ALDERSON MR, 1993, J EXP MED, V178, P1891; ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Garvey TL, 2002, VIROLOGY, V300, P217, DOI 10.1006/viro.2002.1518; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; HOLLER P, 1989, MAR GEOTECHNOL, V8, P1, DOI 10.1080/10641198909379855; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1993, J BIOL CHEM, V268, P10932; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kaufmann M, 2002, FEBS LETT, V527, P250, DOI 10.1016/S0014-5793(02)03146-0; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kitsberg D, 1999, J NEUROSCI, V19, P8244; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kubes M, 1998, J NEUROCHEM, V71, P1307; Lee JC, 2002, J CELL BIOL, V158, P1051, DOI 10.1083/jcb.200112124; Lee SW, 2000, MOL MICROBIOL, V35, P1540, DOI 10.1046/j.1365-2958.2000.01824.x; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; MACKERT JR, 1986, DENT MATER, V2, P32, DOI 10.1016/S0109-5641(86)80067-7; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Roth W, 2002, J BIOL CHEM, V277, P7501, DOI 10.1074/jbc.M110749200; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Thomas RK, 2002, AM J PATHOL, V160, P1521, DOI 10.1016/S0002-9440(10)62578-3; THORNE M, 1997, NATURE, V386, P517; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	74	167	171	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					404	409		10.1038/ni0503-404	http://dx.doi.org/10.1038/ni0503-404			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719729				2022-12-18	WOS:000182665400003
J	Wang, H; Marsters, SA; Baker, T; Chan, B; Lee, WP; Fu, L; Tumas, D; Yan, MH; Dixit, VM; Ashkenazi, A; Grewal, IS				Wang, H; Marsters, SA; Baker, T; Chan, B; Lee, WP; Fu, L; Tumas, D; Yan, MH; Dixit, VM; Ashkenazi, A; Grewal, IS			TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR FAMILY; ANTI-TNF-ALPHA; RHEUMATOID-ARTHRITIS; II COLLAGEN; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; LYMPHOCYTE-T; KAPPA-B; RECEPTOR; MEMBER	Interactions of the tumor necrosis factor superfamily members B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) with their receptors-transmembrane activator and CAML interactor (TACI) and B cell maturation molecule (BCMA)-on B cells play an important role in the humoral immune response. Whereas BCMA is restricted to B cells,TACI is also expressed on activated T cells; we show here that TACI-Fc blocks the activation of T cells in vitro and inhibits antigen-specific T cell activation and priming in vivo. In a mouse model for rheumatoid arthritis (RA), an autoimmune disease that involves both B and T cell components,TACI-Fc treatment substantially inhibited inflammation, bone and cartilage destruction and disease development. Thus, BLyS and/or APRIL are important not only for B cell function but for T cell-mediated immune responses. Inhibition of these ligands might have therapeutic benefits for autoimmune diseases, such as RA, that involve both B and T cells.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Grewal, IS (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	aa@gene.com; iqbal@gene.com	dixit, vishva m/A-4496-2012; Ashkenazi, Avi/ABG-2712-2020	dixit, vishva m/0000-0001-6983-0326; Ashkenazi, Avi/0000-0002-6890-4589; Grewal, Iqbal S/0000-0002-4775-055X				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; CATHCART ES, 1986, LAB INVEST, V54, P26; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; HOLMDAHL R, 1986, AGENTS ACTIONS, V19, P295, DOI 10.1007/BF01971231; Joosten LAB, 1996, ARTHRITIS RHEUM, V39, P797, DOI 10.1002/art.1780390513; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MAINI RN, 1995, IMMUNOL REV, V144, P195, DOI 10.1111/j.1600-065X.1995.tb00070.x; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; MORIMOTO C, 1988, AM J MED, V84, P817, DOI 10.1016/0002-9343(88)90058-7; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; PITZALIS C, 1988, EUR J IMMUNOL, V18, P1397, DOI 10.1002/eji.1830180915; POTOCNIK AJ, 1990, SCAND J IMMUNOL, V31, P213, DOI 10.1111/j.1365-3083.1990.tb02762.x; RICHARD KG, 2000, J EXP MED, V192, P953; RIDLEY MG, 1990, BRIT J RHEUMATOL, V29, P84; SEKI N, 1992, J IMMUNOL, V148, P3093; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; THOMAS R, 1994, J IMMUNOL, V152, P2613; Thomas R, 1996, J IMMUNOL, V156, P3074; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35; WERNICK RM, 1985, ARTHRITIS RHEUM, V28, P742, DOI 10.1002/art.1780280704; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889	33	167	208	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					632	637		10.1038/89782	http://dx.doi.org/10.1038/89782			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429548				2022-12-18	WOS:000169682100017
J	Smyth, MJ; Godfrey, DI				Smyth, MJ; Godfrey, DI			NKT cells and tumor immunity - a double-edged sword	NATURE IMMUNOLOGY			English	News Item							T-CELLS; IL-13		Peter MacCallum Canc Inst, Trescowthick Labs, Melbourne, Vic 8006, Australia; Alfred Hosp, Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia	Peter Maccallum Cancer Center; Florey Institute of Neuroscience & Mental Health; Monash University	Smyth, MJ (corresponding author), Peter MacCallum Canc Inst, Trescowthick Labs, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	m.smyth@pmci.unimelb.edu.au	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Godfrey, Dale/0000-0002-3009-5472				Eberl G, 1999, J IMMUNOL, V162, P6410; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Hoshino T, 1999, J IMMUNOL, V162, P5070; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Leitenberg D, 1998, J IMMUNOL, V161, P1194; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; MOODYCLIFFE AM, NATURE IMMUNOL, V1, P521; Nishimura T, 2000, INT IMMUNOL, V12, P987, DOI 10.1093/intimm/12.7.987; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Singh N, 1999, J IMMUNOL, V163, P2373; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; TERABE M, NATURE IMMUNOL, V1, P515; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X	15	167	191	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					459	460		10.1038/82698	http://dx.doi.org/10.1038/82698			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101862				2022-12-18	WOS:000165724600005
J	Assmann, N; O'Brien, KL; Donnelly, RP; Dyck, L; Zaiatz-Bittencourt, V; Loftus, RM; Heinrich, P; Oefner, PJ; Lynch, L; Gardiner, CM; Dettmer, K; Finlay, DK				Assmann, Nadine; O'Brien, Katie L.; Donnelly, Raymond P.; Dyck, Lydia; Zaiatz-Bittencourt, Vanessa; Loftus, Roisin M.; Heinrich, Paul; Oefner, Peter J.; Lynch, Lydia; Gardiner, Clair M.; Dettmer, Katja; Finlay, David K.			Srebp-controlled glucose metabolism is essential for NK cell functional responses	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; ELEMENT-BINDING PROTEINS; FATTY-ACID SYNTHESIS; T-CELLS; EFFECTOR FUNCTION; LIPID-SYNTHESIS; METHYL-ESTERS; ACTIVATION; MEMORY; GENE	Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokineinduced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-gamma and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.	[Assmann, Nadine; O'Brien, Katie L.; Donnelly, Raymond P.; Dyck, Lydia; Zaiatz-Bittencourt, Vanessa; Loftus, Roisin M.; Lynch, Lydia; Gardiner, Clair M.; Finlay, David K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Heinrich, Paul; Oefner, Peter J.; Dettmer, Katja] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Finlay, David K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland	Trinity College Dublin; University of Regensburg; Trinity College Dublin	Finlay, DK (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.; Finlay, DK (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.	finlayd@tcd.ie	Dettmer, Katja/D-6218-2018; Lynch, Lydia/ABD-5598-2021; Assmann, Nadine/AAC-5201-2020; Finlay, David/H-5840-2018	Dettmer, Katja/0000-0001-7337-2380; Finlay, David/0000-0003-2716-6679; Lynch, Lydia/0000-0002-4273-4681; Gardiner, Clair/0000-0001-5643-9432; Zaiatz Bittencourt, Vanessa/0000-0003-0567-3223; Loftus, Roisin/0000-0001-9137-6625	Science Foundation Ireland [12/IP/1286, 13/CDA/2161]; Irish Cancer Society (Children's Leukaemia Research Project) [CRS15OBR]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [BEX 13446134]; Deutsche Forschungsgemeinschaft [KFO-262]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Cancer Society (Children's Leukaemia Research Project); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Comparative Medicine Unit, Trinity College Dublin for use of their facilities. Supported by Science Foundation Ireland (12/IP/1286 and 13/CDA/2161 for the D.K.F. laboratory); Irish Cancer Society (research scholarship CRS15OBR to K.L.O'B. which includes support from the Children's Leukaemia Research Project), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (research scholarship BEX 13446134 to V.Z.B.) and Deutsche Forschungsgemeinschaft (KFO-262 for K.D.).	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bertolotti M, 2012, NUTR METAB CARDIOVAS, V22, P823, DOI 10.1016/j.numecd.2011.02.009; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dettmer K, 2014, ANAL BIOANAL CHEM, V406, P4931, DOI 10.1007/s00216-014-7919-0; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eibinger G, 2013, EXP CELL RES, V319, P1828, DOI 10.1016/j.yexcr.2013.03.025; Fernandez-Sanchez A, 2013, EPIGENETICS-US, V8, P66, DOI 10.4161/epi.23115; Gardiner CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01061; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Infantino V, 2007, BIOCHEM BIOPH RES CO, V356, P249, DOI 10.1016/j.bbrc.2007.02.114; Keating SE, 2016, J IMMUNOL, V196, P2552, DOI 10.4049/jimmunol.1501783; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Laue Tobias, 2015, BMC Obes, V2, P1, DOI 10.1186/s40608-014-0033-1; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Miyake T, 2010, P NATL ACAD SCI USA, V107, P17680, DOI 10.1073/pnas.1012977107; Moon YA, 2000, J BIOL CHEM, V275, P30280, DOI 10.1074/jbc.M001066200; Murakami H, 2000, LIPIDS, V35, P333, DOI 10.1007/s11745-000-0530-1; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Sun TJ, 2010, J BIOL CHEM, V285, P27418, DOI 10.1074/jbc.M109.078667; Sun Y, 2016, INFECT DIS-NOR, V48, P813, DOI 10.1080/23744235.2016.1201721; van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; York AG, 2013, J EXP MED, V210, P1653, DOI 10.1084/jem.20131335	56	166	169	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1197	+		10.1038/ni.3838	http://dx.doi.org/10.1038/ni.3838			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	28920951				2022-12-18	WOS:000413457300006
J	Park, JH; Adoro, S; Guinter, T; Erman, B; Alag, AS; Catalfamo, M; Kimura, MY; Cui, YZ; Lucas, PJ; Gress, RE; Kubo, M; Hennighausen, L; Feigenbaum, L; Singer, A				Park, Jung-Hyun; Adoro, Stanley; Guinter, Terry; Erman, Batu; Alag, Amala S.; Catalfamo, Marta; Kimura, Motoko Y.; Cui, Yongzhi; Lucas, Philip J.; Gress, Ronald E.; Kubo, Masato; Hennighausen, Lothar; Feigenbaum, Lionel; Singer, Alfred			Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells	NATURE IMMUNOLOGY			English	Article							DOUBLE-POSITIVE THYMOCYTES; TRANSCRIPTION FACTORS; NEGATIVE SELECTION; DISTINCT FUNCTIONS; RUNX PROTEINS; THPOK; COMMITMENT; IL-7; EXPRESSION; DIRECTS	Immature CD4(+) CD8(+) (double-positive (DP)) thymocytes are signaled via T cell antigen receptors (TCRs) to undergo positive selection and become responsive to intrathymic cytokines such as interleukin 7 (IL-7). We report here that cytokine signaling is required for positively selected thymocytes to express the transcription factor Runx3, specify CD8 lineage choice and differentiate into cytotoxic-lineage T cells. In DP thymocytes genetically engineered to be cytokine responsive, IL-7 signaling induced TCR-unsignaled DP thymocytes to express Runx3 and to differentiate into mature CD8(+) T cells, completely circumventing positive selection. We conclude that TCR-mediated positive selection converts DP cells into cytokine-responsive thymocytes, but it is subsequent signaling by intrathymic cytokines that specifies CD8 lineage choice and promotes differentiation into cytotoxic-lineage T cells.	[Park, Jung-Hyun; Adoro, Stanley; Guinter, Terry; Alag, Amala S.; Kimura, Motoko Y.; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Erman, Batu] Sabanci Univ, Biol Sci & Bioengn Program, Fac Engn & Nat Sci, Istanbul, Turkey; [Catalfamo, Marta] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA; [Cui, Yongzhi; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD USA; [Lucas, Philip J.; Gress, Ronald E.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Lab Signal Network, Res Ctr Allergy & Immunol, Kanagawa, Japan; [Feigenbaum, Lionel] NCI, Sci Applicat Int Corp Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sabanci University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); RIKEN; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@mail.nih.gov	erman, batu/AAE-1963-2020; Kubo, Masato/A-5918-2016; Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055; Hennighausen, Lothar/0000-0001-8319-9841	US National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011111, ZIABC009273, ZIABC010525, ZIABC011214, ZICBC009255, ZIABC011106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Bosselut, N. El Kassar, R. Hodes, D. Singer and N. Taylor for critical reading of the manuscript; S. Habu (Tokai University) for mouse Runx3 cDNA; A. Weiss (University of California San Francisco) for fluorescein isothiocyanate-conjugated monoclonal antibody to Syk (5F5); J. Ihle (St. Jude Children's Research Hospital) for Socs1<SUP>+/-</SUP> Ifng<SUP>-/-</SUP> mice; and S. Sharrow, A. Adams and L. Granger for flow cytometry. Supported by the Intramural Research Program of the US National Institutes of Health, the National Cancer Institute and the Center for Cancer Research.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Chu DH, 1999, J IMMUNOL, V163, P2610; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Egawa T, 2009, BLOOD CELL MOL DIS, V43, P27, DOI 10.1016/j.bcmd.2009.03.004; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Metcalf D, 1999, EXP HEMATOL, V27, P1715, DOI 10.1016/S0301-472X(99)00120-4; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; VERNACHIO J, 1989, J IMMUNOL, V142, P48; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	50	166	168	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					257	U10		10.1038/ni.1840	http://dx.doi.org/10.1038/ni.1840			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20118929	Green Accepted			2022-12-18	WOS:000274605800014
J	Dahl, ME; Dabbagh, K; Liggitt, D; Kim, S; Lewis, DB				Dahl, ME; Dabbagh, K; Liggitt, D; Kim, S; Lewis, DB			Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells	NATURE IMMUNOLOGY			English	Article							A VIRUS-INFECTION; TH2 IMMUNE-RESPONSES; INFLUENZA-VIRUS; AIRWAY SENSITIZATION; INTERFERON-GAMMA; ANTIGEN; INDUCTION; MICE; ASTHMA; HYPERRESPONSIVENESS	It is widely accepted that T helper type 1 (T(H)1) cytokines such as interferon-gamma(IFN-gamma) antagonize allergic diseases mediated by T(H)2 cytokines. The 'hygiene hypothesis' has also proposed that decreased childhood exposure to pathogen-derived T(H)1 cytokines may underlie the recent increased prevalence of asthma, a T(H)2-mediated disease. We show here that influenza A viral infection, which induces large amounts of intrapulmonary IFN-gamma production, unexpectedly enhanced later allergen-specific asthma and promoted dual allergen-specific T(H)1 and T(H)2 responses. Pulmonary dendritic cells obtained from the lung after viral clearance and resolution of acute inflammation conferred enhanced allergic disease and concurrent T(H)1 and T(H)2 immune responses, and these effects were dependent on IFN-gamma secreted during the acute viral infection. Thus, respiratory viral infection and the acute T(H)1 response can positively regulate T(H)2-dependent allergic pulmonary disease in vivo, at least in part, by altering pulmonary dendritic cell function.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	Stanford University; Stanford University; University of Washington; University of Washington Seattle	Lewis, DB (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	dblewis@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044699] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 44699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Doyle AG, 1999, J EXP MED, V190, P1081, DOI 10.1084/jem.190.8.1081; EICHELBERGER MC, 1991, J GEN VIROL, V72, P1695, DOI 10.1099/0022-1317-72-7-1695; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Gern JE, 2002, NAT REV IMMUNOL, V2, P132, DOI 10.1038/nri725; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Hussell T, 1996, J GEN VIROL, V77, P2447, DOI 10.1099/0022-1317-77-10-2447; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; KOLOPPSARDA MN, 1994, ANAT REC, V239, P150, DOI 10.1002/ar.1092390205; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lewis DB, 2002, CURR OPIN IMMUNOL, V14, P644, DOI 10.1016/S0952-7915(02)00388-6; Lloyd CM, 2001, ADV IMMUNOL, V77, P263, DOI 10.1016/S0065-2776(01)77019-8; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; MARRACK P, 1983, J EXP MED, V158, P1635, DOI 10.1084/jem.158.5.1635; Martinez Fernando D, 2002, Paediatr Respir Rev, V3, P193, DOI 10.1016/S1526-0542(02)00188-4; MO XY, 1995, J VIROL, V69, P1288, DOI 10.1128/JVI.69.2.1288-1291.1995; Morel PA, 1998, CRIT REV IMMUNOL, V18, P275, DOI 10.1615/CritRevImmunol.v18.i4.10; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Redd SC, 2002, ENVIRON HEALTH PERSP, V110, P557, DOI 10.1289/ehp.02110s4557; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; SARAWAR SR, 1994, J IMMUNOL, V153, P1246; Schwarze J, 1999, J IMMUNOL, V163, P5729; Schwarze J, 1999, J IMMUNOL, V162, P4207; Schwarze J, 2002, EUR RESPIR J, V19, P341, DOI 10.1183/09031936.02.00254302; Schwarze J, 1999, J IMMUNOL, V162, P2997; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsitoura DC, 2000, J IMMUNOL, V165, P3484, DOI 10.4049/jimmunol.165.6.3484; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Yamamoto N, 2000, EUR J IMMUNOL, V30, P316, DOI 10.1002/1521-4141(200001)30:1<316::AID-IMMU316>3.0.CO;2-0; Yamamoto N, 2001, J VIROL, V75, P499, DOI 10.1128/JVI.75.1.499-505.2001	49	166	175	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					337	343		10.1038/ni1041	http://dx.doi.org/10.1038/ni1041			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14973436				2022-12-18	WOS:000189344600017
J	Sawant, DV; Yano, H; Chikina, M; Zhang, QX; Liao, MT; Liu, C; Callahan, DJ; Sun, Z; Sun, T; Tabib, T; Pennathur, A; Corry, DB; Luketich, JD; Lafyatis, R; Chen, W; Poholek, AC; Bruno, TC; Workman, CJ; Vignali, DAA				Sawant, Deepali, V; Yano, Hiroshi; Chikina, Maria; Zhang, Qianxia; Liao, Mengting; Liu, Chang; Callahan, Derrick J.; Sun, Zhe; Sun, Tao; Tabib, Tracy; Pennathur, Arjun; Corry, David B.; Luketich, James D.; Lafyatis, Robert; Chen, Wei; Poholek, Amanda C.; Bruno, Tullia C.; Workman, Creg J.; Vignali, Dario A. A.			Adaptive plasticity of IL-10(+) and IL-35(+) T-reg cells cooperatively promotes tumor T cell exhaustion	NATURE IMMUNOLOGY			English	Article							RECEPTOR; DISTINCT; EXPRESSION; SEQUENCE; TCR; REQUIREMENT; ACTIVATION; AUTOIMMUNE; INDUCTION; IMMUNITY	Regulatory T cells (T-reg cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. T-reg cells subvert beneficial anti-tumor immunity by modulating inhibitory receptor expression on tumor-infiltrating lymphocytes (TILs); however, the underlying mediators and mechanisms have remained elusive. Here, we found that the cytokines IL-10 and IL-35 (Ebi3-IL-12 alpha heterodimer) were divergently expressed by T-reg cell subpopulations in the tumor microenvironment (TME) and cooperatively promoted intratumoral T cell exhaustion by modulating several inhibitory receptor expression and exhaustion-associated transcriptomic signature of CD8(+) TILs. While expression of BLIMP1 (encoded by Prdm1) was a common target, IL-10 and IL-35 differentially affected effector T cell versus memory T cell fates, respectively, highlighting their differential, partially overlapping but non-redundant regulation of anti-tumor immunity. Our results reveal previously unappreciated cooperative roles for T-reg cell-derived IL-10 and IL-35 in promoting BLIMP1-dependent exhaustion of CD8(+) TILs that limits effective anti-tumor immunity.	[Sawant, Deepali, V; Yano, Hiroshi; Zhang, Qianxia; Liao, Mengting; Liu, Chang; Callahan, Derrick J.; Poholek, Amanda C.; Bruno, Tullia C.; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA; [Yano, Hiroshi; Callahan, Derrick J.] Univ Pittsburgh, Program Microbiol & Immunol, Sch Med, Pittsburgh, PA USA; [Chikina, Maria] Univ Pittsburgh, Dept Computat & Syst Biol, Sch Med, Pittsburgh, PA USA; [Sun, Zhe; Sun, Tao; Chen, Wei] Univ Pittsburgh, Dept Biostat, Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Tabib, Tracy; Lafyatis, Robert] Univ Pittsburgh, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15213 USA; [Pennathur, Arjun; Luketich, James D.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA; [Pennathur, Arjun; Luketich, James D.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Poholek, Amanda C.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Bruno, Tullia C.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Bruno, Tullia C.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA; [Sawant, Deepali, V] Amgen Inc, Dept Inflammat & Oncol, Discovery Res, San Francisco, CA USA; [Zhang, Qianxia] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Zhang, Qianxia] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Zhang, Qianxia] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Liao, Mengting] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Amgen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Central South University	Vignali, DAA (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	luketich, james/AAY-6230-2020; Zhang, Qianxia/D-7689-2011; Liao, Mengting/GSJ-2298-2022; Sawant, Deepali/K-1088-2015	Zhang, Qianxia/0000-0002-2885-2147; Sun, Tao/0000-0003-4447-3005; Sawant, Deepali/0000-0002-8119-1106; Yano, Hiroshi/0000-0002-3098-2629; Chen, Wei/0000-0001-7196-8703	National Institutes of Health [R01 CA203689, P01 AI108545]; NCI Comprehensive Cancer Center Support CORE grant [CA047904]; NIH [1S10OD011925-01]; SRA from Tizona Therapeutics;  [P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA203689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI108545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SRA from Tizona Therapeutics; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank H. Shen, D. Falkner and A. Yates from the Immunology Flow Core for cell sorting; E. Brunazzi and the staff of the Division of Laboratory Animals for animal husbandry; A. Cillo for helpful suggestions regarding scRNAseq analysis; W. Horne, J. Kolls and the University of Pittsburgh HSCRF Genomics Research Core for assistance with sequencing and A. Menk and G. Delgoffe at the Universtiy of Pittsburgh for generation and provision of the BrafPten (clone 24) cell line for tumor growth experiments. The authors also wish to thank the Department of Cardiothoracic Surgery at the University of Pittsburgh, in particular, J. Ward for her help in coordination and gathering patient consents, as well as the Department of Cardiothoracic Surgery at the University of Colorado and the University of Colorado SPORE for providing some samples. This work was supported by the National Institutes of Health (grant nos. R01 CA203689 and P01 AI108545 to D.A.A.V.), NCI Comprehensive Cancer Center Support CORE grant (no. CA047904 to D.A.A.V.) and an SRA from Tizona Therapeutics. This work also benefitted from the Immunology Department Flow Cytometry Core SPECIAL BD LSR FORTESSA funded by NIH grant no. 1S10OD011925-01 (L. Borghesi, Department of Immunology). This project also used the Hillman Cancer Center Immunologic Monitoring and Cellular Products Laboratory that is supported in part by award no. P30 CA047904.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Genard G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00828; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu C, 2016, FEBS J, V283, P2731, DOI 10.1111/febs.13656; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Poholek AC, 2016, SCI IMMUNOLOGY, V1, P5, DOI DOI 10.1126/SCIIMMUN0L.AAF8612; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sawant DV, 2015, J INTERF CYTOK RES, V35, P499, DOI 10.1089/jir.2015.0015; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Seo W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41351; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Shitara K, 2018, ANN NY ACAD SCI, V1417, P104, DOI 10.1111/nyas.13625; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wei XD, 2017, CELL REP, V21, P1853, DOI 10.1016/j.celrep.2017.10.090; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Xin A, 2011, ADV EXP MED BIOL, V780, P85, DOI 10.1007/978-1-4419-5632-3_8; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	52	165	173	10	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					724	+		10.1038/s41590-019-0346-9	http://dx.doi.org/10.1038/s41590-019-0346-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	30936494	Green Accepted			2022-12-18	WOS:000468505100015
J	Pobezinskaya, YL; Kim, YS; Choksi, S; Morgan, MJ; Li, T; Liu, CY; Liu, ZG				Pobezinskaya, Yelena L.; Kim, You-Sun; Choksi, Swati; Morgan, Michael J.; Li, Tao; Liu, Chengyu; Liu, Zhenggang			The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; DOMAIN KINASE RIP; TNF RECEPTOR; MEDIATED APOPTOSIS; ACTIVATION; PROTEIN; TRANSDUCTION; RECRUITMENT; HEPATITIS	The physiological function of the adaptor protein TRADD remains unclear because of the unavailability of a TRADD-deficient animal model. By generating TRADD-deficient mice, we found here that TRADD serves an important function in tumor necrosis factor receptor 1 (TNFR1) signaling by orchestrating the formation of TNFR1 signaling complexes. TRADD was essential for TNFR1 signaling in mouse embryonic fibroblasts but was partially dispensable in macrophages; abundant expression of the adaptor RIP in macrophages may have allowed some transmission of TNFR1 signals in the absence of TRADD. Although morphologically normal, TRADD-deficient mice were resistant to toxicity induced by TNF, lipopolysaccharide and polyinosinic-polycytidylic acid. TRADD was also required for TRIF-dependent Toll-like receptor signaling in mouse embryonic fibroblasts but not macrophages. Our findings definitively establish the biological function of TRADD in TNF signaling.	[Pobezinskaya, Yelena L.; Kim, You-Sun; Choksi, Swati; Morgan, Michael J.; Li, Tao; Liu, Zhenggang] NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core Facil, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Liu, ZG (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	zgliu@helix.nih.gov		Li, Tao/0000-0002-0746-8322	Center for Cancer Research (US National Cancer Institute); NATIONAL CANCER INSTITUTE [ZIASC010376] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005907] Funding Source: NIH RePORTER	Center for Cancer Research (US National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank W. C. Yeh and T. W. Mak (University of Toronto, Canada) for Traf2<SUP>-/-</SUP> MEFs; H. Nakano (Juntento University, Japan) for Traf5<SUP>-/-</SUP> and Traf2<SUP>-/-</SUP> Traf5<SUP>-/-</SUP> MEFs; L. Tessarollo (US National Cancer Institute) for the pLTM260 vector; A. Singer (US National Cancer Institute) for the pKO Scrambler 917 TK vector; and L. Pobezinsky for suggestions. Supported by the Intramural Research Program of Center for Cancer Research (US National Cancer Institute).	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Dejager L, 2008, CYTOKINE, V42, P55, DOI 10.1016/j.cyto.2008.01.014; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; FRESHNEY IR, 1994, CULTURE ANIMAL CELLS, P131; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KIM Y, 2007, MOL CELL, V26, P769; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nowak M, 2000, AM J PHYSIOL-REG I, V278, pR1202, DOI 10.1152/ajpregu.2000.278.5.R1202; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TIEGS G, 1989, BIOCHEM PHARMACOL, V38, P627, DOI 10.1016/0006-2952(89)90208-6; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wesemann DR, 2004, NAT IMMUNOL, V5, P199, DOI 10.1038/ni1025; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	40	165	170	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1047	1054		10.1038/ni.1639	http://dx.doi.org/10.1038/ni.1639			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18641653	Green Accepted			2022-12-18	WOS:000258559600017
J	Feng, D; Bond, CJ; Ely, LK; Maynard, J; Garcia, KC				Feng, Dan; Bond, Christopher J.; Ely, Lauren K.; Maynard, Jennifer; Garcia, K. Christopher			Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; ALANINE-SCANNING MUTAGENESIS; MHC CLASS-II; PEPTIDE-MHC; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSGENIC MICE; HYPERVARIABLE REGIONS; MOLECULAR REPLACEMENT; CANONICAL STRUCTURES; CRYSTAL-STRUCTURE	All complexes of T cell receptors (TCRs) bound to peptide-major histocompatibility complex (pMHC) molecules assume a stereotyped binding 'polarity', despite wide variations in TCR-pMHC docking angles. However, existing TCR-pMHC crystal structures have failed to show broadly conserved pairwise interaction motifs. Here we determined the crystal structures of two TCRs encoded by the variable beta-chain 8.2 (V(beta)8.2), each bound to the MHC class II molecule I-A(u), and did energetic mapping of V-alpha and V-beta contacts with I-A(u). Together with two previously solved structures of V(beta)8.2-containing TCR-MHC complexes, we found four TCR-I-A complexes with structurally superimposable interactions between the V-beta loops and the I-A alpha-helix. This examination of a narrow 'slice' of the TCR-MHC repertoire demonstrates what is probably one of many germline-derived TCR-MHC interaction 'codons'.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol,Dept Struct Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol,Dept Struct Biol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, T32AI007290, R56AI048540] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48540, T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeLano W. L, 2002, PYMOL MOL GENETICS G; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Li HM, 1997, J MOL BIOL, V269, P385, DOI 10.1006/jmbi.1997.1047; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RUDOLPH MG, 2006, ANNU REV IMMUNOL, V24, P149; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1987, J IMMUNOL, V139, P1075; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	49	165	171	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					975	983		10.1038/ni1502	http://dx.doi.org/10.1038/ni1502			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17694060				2022-12-18	WOS:000248918200021
J	Guarda, G; Hons, M; Soriano, SF; Huang, AY; Polley, R; Martin-Fontecha, A; Stein, JV; Germain, RN; Lanzavecchia, A; Sallusto, F				Guarda, Greta; Hons, Miroslav; Soriano, Silvia F.; Huang, Alex Y.; Polley, Rosalind; Martin-Fontecha, Alfonso; Stein, Jens V.; Germain, Ronald N.; Lanzavecchia, Antonio; Sallusto, Federica			L-selectin-negative CCR7(-) effector and memory CD8(+) T cells enter reactive lymph nodes and kill dendritic cells	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; IN-VIVO; NK CELLS; LISTERIA-MONOCYTOGENES; DEPENDENT ELIMINATION; LEUKOCYTE ADHESION; PERIPHERAL-TISSUES; IFN-GAMMA; LYMPHOCYTES; MIGRATION	T lymphocytes lacking the lymph node-homing receptors L-selectin and CCR7 do not migrate to lymph nodes in the steady state. Instead, we found here that lymph nodes draining sites of mature dendritic cells or adjuvant inoculation recruited L-selectin- negative CCR7(-) effector and memory CD8(+) T cells. This recruitment required CXCR3 expression on T cells and occurred through high endothelial venules in concert with lumenal expression of the CXCR3 ligand CXCL9. In reactive lymph nodes, recruited T cells established stable interactions with and killed antigen-bearing dendritic cells, limiting the ability of these dendritic cells to activate naive CD4(+) and CD8(+) T cells. The inducible recruitment of blood-borne effector and memory T cells to lymph nodes may represent a mechanism for terminating primary and limiting secondary immune responses.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; NIAID, NIH, Bethesda, MD 20892 USA	Universita della Svizzera Italiana; University of Bern; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sallusto, F (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch	Germain, Ronald/ABE-7090-2020; Huang, Alex Y./ABG-8182-2021; Germain, Ronald N./Z-1945-2019; Hons, Miroslav/AAK-5115-2021; Guarda, Greta/G-1921-2011; Hons, Miroslav/I-2197-2018; Pinos, Jakub/D-6536-2015	Huang, Alex Y./0000-0002-5701-4521; Hons, Miroslav/0000-0002-6625-3348; Hons, Miroslav/0000-0002-6625-3348; Stein, Jens V/0000-0002-8199-9586; Guarda, Greta/0000-0001-9243-6116; Pinos, Jakub/0000-0001-6993-8660	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545, ZIAAI000545] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Badovinac VP, 2000, J IMMUNOL, V164, P6444, DOI 10.4049/jimmunol.164.12.6444; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; HADIDA F, 1992, J CLIN INVEST, V89, P53, DOI 10.1172/JCI115585; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; Hosmalin A, 2001, BLOOD, V97, P2695, DOI 10.1182/blood.V97.9.2695; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; KYBURZ D, 1993, J IMMUNOL, V150, P5051; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Ronchese F, 2001, J EXP MED, V194, pF23, DOI 10.1084/jem.194.5.F23; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; TRAUNECKER A, 1991, TRENDS BIOTECHNOL, V9, P109, DOI 10.1016/0167-7799(91)90038-J; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wilson JL, 1999, J IMMUNOL, V163, P6365; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983	54	165	169	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					743	752		10.1038/ni1469	http://dx.doi.org/10.1038/ni1469			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17529983				2022-12-18	WOS:000247718100015
J	Schwarz, BA; Bhandoola, A				Schwarz, BA; Bhandoola, A			Circulating hematopoietic progenitors with T lineage potential	NATURE IMMUNOLOGY			English	Article							COMMON LYMPHOID PROGENITORS; ADULT-MOUSE THYMUS; MURINE FETAL BLOOD; STEM-CELLS; BONE-MARROW; THYMOCYTE PRECURSORS; C-KIT; MICE; KINETICS; DIFFERENTIATION	The thymus is seeded via the blood, but the identity of hematopoietic progenitors with access to the circulation in adult mice is unknown. We report here that the only progenitors in blood with efficient T lineage potential were lineage negative with high expression of stem cell antigen 1 and c-Kit (LSK cells). The blood LSK population, like its counterpart in the bone marrow, contained hematopoietic stem cells and nonrenewing, multipotent progenitors, including early lymphoid progenitors and CD62L(+) cells previously described as efficient T lineage progenitors. Common lymphoid progenitors could not be identified in the circulation, suggesting they are not physiological T lineage precursors. We conclude that blood LSK cells are the principal circulating progenitors with T lineage potential.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Schwarz, Benjamin/A-1069-2007		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059621, T32AI055428] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI-055428, AI059621, T32 AI055428] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Donskoy E, 2003, J IMMUNOL, V171, P3568, DOI 10.4049/jimmunol.171.7.3568; Dunon D, 1999, BLOOD, V93, P2234, DOI 10.1182/blood.V93.7.2234.407k11_2234_2243; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Harrison DE, 1997, BLOOD, V90, P174; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; KADISH JL, 1976, J EXP MED, V143, P1082, DOI 10.1084/jem.143.5.1082; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; MILLER JFA, 1967, PHYSIOL REV, V47, P437, DOI 10.1152/physrev.1967.47.3.437; Montecino-Rodriguez E, 2003, NAT IMMUNOL, V4, P100, DOI 10.1038/ni0203-100; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; OKADA S, 1991, BLOOD, V78, P1706; Papayannopoulou T, 1999, ANN NY ACAD SCI, V872, P187, DOI 10.1111/j.1749-6632.1999.tb08464.x; Pear WS, 2003, SEMIN IMMUNOL, V15, P69, DOI 10.1016/S1044-5323(03)00003-4; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; To LB, 1997, BLOOD, V89, P2233, DOI 10.1182/blood.V89.7.2233; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yamamoto Y, 1996, BLOOD, V88, P445, DOI 10.1182/blood.V88.2.445.bloodjournal882445; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	51	165	168	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					953	960		10.1038/ni1101	http://dx.doi.org/10.1038/ni1101			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15300246				2022-12-18	WOS:000223612500024
J	Hasbold, J; Corcoran, LM; Tarlinton, DM; Tangye, SG; Hodgkin, PD				Hasbold, J; Corcoran, LM; Tarlinton, DM; Tangye, SG; Hodgkin, PD			Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation	NATURE IMMUNOLOGY			English	Article							PRIMARY IMMUNE-RESPONSE; LIVED PLASMA-CELLS; DIACETATE SUCCINIMIDYL ESTER; ANTIBODY-FORMING-CELLS; MEMORY B-CELLS; CD40 LIGAND; IN-SITU; DIVISION; PROLIFERATION; SURVIVAL	Naive B lymphocytes undergo isotype switching and develop into immunoglobulin-secreting cells to generate the appropriate class and amount of antibody necessary for effective immunity. Although this seems complex, we report here that the generation of immunoglobulin G-secreting cells from naive precursors is highly predictable. The probabilities of isotype switching and development into secreting cells change with successive cell divisions and interleave independently. Cytokines alter the probability of each differentiation event, while leaving intact their independent assortment. As a result, cellular heterogeneity arises automatically as the cells divide. Stochastic division-linked regulation of heterogeneity challenges the conventional paradigms linking distinct phenotypes to unique combinations of signals and has the potential to simplify our concept of immune complexity considerably.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia	Walter & Eliza Hall Institute; University of Sydney; Centenary Institute	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.		Tangye, Stuart G/H-4023-2014; Corcoran, Lynn M/C-9316-2013	Tangye, Stuart G/0000-0002-5360-5180; Tarlinton, David/0000-0001-9928-686X; Hodgkin, Philip/0000-0002-8604-1940				BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Deenick EK, 1999, J IMMUNOL, V163, P4707; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Hasbold J, 1999, IMMUNOL CELL BIOL, V77, P516, DOI 10.1046/j.1440-1711.1999.00874.x; Hasbold J, 1999, J IMMUNOL, V163, P4175; HO F, 1986, EUR J IMMUNOL, V16, P1297, DOI 10.1002/eji.1830161018; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; HODGKIN PD, 1996, WEIRS HDB EXPT IMMUN, V89; HOLLENBAUGH D, 1994, IMMUNOL REV, V138, P23, DOI 10.1111/j.1600-065X.1994.tb00845.x; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Janas ML, 1999, J IMMUNOL, V163, P4192; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; JELINEK DF, 1983, J IMMUNOL, V130, P2597; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; KELSO A, 1991, IMMUNOL REV, V123, P85, DOI 10.1111/j.1600-065X.1991.tb00607.x; Kopper L, 2000, LEUKEMIA LYMPHOMA, V38, P271, DOI 10.3109/10428190009087018; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALISZEWSKI CR, 1993, EUR J IMMUNOL, V23, P1044, DOI 10.1002/eji.1830230510; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Rush JS, 2002, J IMMUNOL, V168, P2676, DOI 10.4049/jimmunol.168.6.2676; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; SEDGWICK JD, 1986, J IMMUNOL METHODS, V87, P37, DOI 10.1016/0022-1759(86)90341-8; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; SNAPPER CM, 1995, J IMMUNOL, V154, P1177; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Takagi M, 1998, ENERGY WATCH SER, V9, P35; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Tangye SG, 2002, J IMMUNOL, V169, P4298, DOI 10.4049/jimmunol.169.8.4298; VANROOIJEN N, 1986, IMMUNOL TODAY, V7, P193, DOI 10.1016/0167-5699(86)90100-3	42	165	166	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					55	63		10.1038/ni1016	http://dx.doi.org/10.1038/ni1016			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14647274				2022-12-18	WOS:000187635800014
J	Chiu, YH; Park, SH; Benlagha, K; Forestier, C; Jayawardena-Wolf, J; Savage, PB; Teyton, L; Bendelac, A				Chiu, YH; Park, SH; Benlagha, K; Forestier, C; Jayawardena-Wolf, J; Savage, PB; Teyton, L; Bendelac, A			Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CDId	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; COMPLEX CLASS-I; DIFFERENT INTRACELLULAR COMPARTMENTS; CD1 MOLECULES; PRESENTING MOLECULES; POSITIVE SELECTION; LIPID ANTIGENS; MOUSE CD1; RECOGNITION; LYMPHOCYTES	For members of the CD I family of beta(2)-microglobulin-associated lipid-presenting molecules, tyrosine-based motifs in the cytoplasmic tail and invariant chain (Ii) govern glycoprotein trafficking through endosomal compartments. Little is known about the intracellular pathways of CDI trafficking and antigen presentation. However, in vitro studies with cells transfected with mutant CDI that had a truncated cytoplasmic tail have suggested a role for these tyrosine motifs in some, but not all, antigenic systems. By introducing a deletion of the tyrosine motif into the germ line, and through homologous recombination in embryonic stem cells, we now describe knock-in mice with the CDId cytoplasmic tail deleted. Despite adequate surface CDId expression and the presence of Ii, these mutant mice showed multiple and selective abnormalities in intracellular trafficking, antigen presentation and T cell development, demonstrating the critical functions of the CDId cytoplasmic tail motif in vivo.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Brigham Young Univ, Dept Chem & Biochem, Provo, UT USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Princeton University; Korea University; Brigham Young University; Scripps Research Institute	Park, SH (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Savage, Paul B/HGB-3414-2022; Benlagha, Kamel/I-5035-2016; Savage, Paul B/E-1448-2011; Benlagha, Kamel/GLQ-8342-2022	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; benlagha, kamel/0000-0002-3251-9195				Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Brossay L, 1998, J IMMUNOL, V160, P3681; Burdin N, 1998, J IMMUNOL, V161, P3271; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Chen YH, 1999, J IMMUNOL, V162, P4560; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; JAYAWARDENAWOLF.J, 2001, IN PRESS IMMUNITY, V15; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Park SH, 1998, J IMMUNOL, V160, P3128; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Roark JH, 1998, J IMMUNOL, V160, P3121; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349	33	165	171	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					55	60		10.1038/ni740	http://dx.doi.org/10.1038/ni740			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11731798				2022-12-18	WOS:000173148700015
J	Cayrol, C; Duval, A; Schmitt, P; Roga, S; Camus, M; Stella, A; Burlet-Schiltz, O; Gonzalez-de-Peredo, A; Girard, JP				Cayrol, Corinne; Duval, Anais; Schmitt, Pauline; Roga, Stephane; Camus, Mylene; Stella, Alexandre; Burlet-Schiltz, Odile; Gonzalez-de-Peredo, Anne; Girard, Jean-Philippe			Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33	NATURE IMMUNOLOGY			English	Article							PROTEASE ALLERGEN; EPITHELIAL-CELLS; INTERLEUKIN-33; RESPONSES; TYPE-2; ASTHMA; ACTIVATION; CYTOKINE; CONTRIBUTE; INITIATION	Allergic inflammation has crucial roles in allergic diseases such as asthma. It is therefore important to understand why and how the immune system responds to allergens. Here we found that full-length interleukin 33 (IL-33(FL) ), an alarmin cytokine with critical roles in type 2 immunity and asthma, functioned as a protease sensor that detected proteolytic activities associated with various environmental allergens across four kingdoms, including fungi, house dust mites, bacteria and pollens. When exposed to allergen proteases, IL-33(FL) was rapidly cleaved in its central 'sensor' domain, which led to activation of the production of type 2 cytokines in group 2 innate lymphoid cells. Preventing cleavage of IL-33(FL) reduced allergic airway inflammation. Our findings reveal a molecular mechanism for the rapid induction of allergic type 2 inflammation following allergen exposure, with important implications for allergic diseases.	[Cayrol, Corinne; Duval, Anais; Schmitt, Pauline; Roga, Stephane; Camus, Mylene; Stella, Alexandre; Burlet-Schiltz, Odile; Gonzalez-de-Peredo, Anne; Girard, Jean-Philippe] Univ Toulouse, CNRS, UPS, IPBS, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cayrol, C; Girard, JP (corresponding author), Univ Toulouse, CNRS, UPS, IPBS, Toulouse, France.	corinne.cayrol@ipbs.fr; jean-philippe.girard@ipbs.fr	CAYROL, Corinne/C-2106-2011; GIRARD, Jean-Philippe/F-5229-2010	CAYROL, Corinne/0000-0002-7813-4397; GIRARD, Jean-Philippe/0000-0002-9154-1691; Gonzalez de Peredo, Anne/0000-0001-6152-6311; Schiltz, Odile/0000-0002-3606-2356				Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Beausejour A, 1998, INFECT IMMUN, V66, P676; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Cheng ZY, 2015, NATURE, V521, P213, DOI 10.1038/nature14243; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Florsheim E, 2015, J IMMUNOL, V194, P4621, DOI 10.4049/jimmunol.1402493; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hara K, 2014, J IMMUNOL, V192, P4032, DOI 10.4049/jimmunol.1400110; Jarrett R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6833; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kouzaki H, 2017, AM J RESP CRIT CARE, V195, P737, DOI 10.1164/rccm.201603-0529OC; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; Osbourn M, 2017, IMMUNITY, V47, P739, DOI 10.1016/j.immuni.2017.09.015; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Rosenstein RK, 2014, P NATL ACAD SCI USA, V111, pE4963, DOI 10.1073/pnas.1418959111; Smith D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006659; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stewart GA, 1996, CLIN EXP ALLERGY, V26, P1020, DOI 10.1111/j.1365-2222.1996.tb00641.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145	53	164	168	5	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					375	+		10.1038/s41590-018-0067-5	http://dx.doi.org/10.1038/s41590-018-0067-5			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29556000				2022-12-18	WOS:000428151000017
J	Holm, CK; Jensen, SB; Jakobsen, MR; Cheshenko, N; Horan, KA; Moeller, HB; Gonzalez-Dosal, R; Rasmussen, SB; Christensen, MH; Yarovinsky, TO; Rixon, FJ; Herold, BC; Fitzgerald, KA; Paludan, SR				Holm, Christian K.; Jensen, Soren B.; Jakobsen, Martin R.; Cheshenko, Natalia; Horan, Kristy A.; Moeller, Hanne B.; Gonzalez-Dosal, Regina; Rasmussen, Simon B.; Christensen, Maria H.; Yarovinsky, Timur O.; Rixon, Frazer J.; Herold, Betsy C.; Fitzgerald, Katherine A.; Paludan, Soren R.			Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING	NATURE IMMUNOLOGY			English	Article							RECOGNITION; INFLAMMASOME; ACTIVATION; LIPOSOMES; INFECTION	The innate immune system senses infection by detecting either evolutionarily conserved molecules essential for the survival of microbes or the abnormal location of molecules. Here we demonstrate the existence of a previously unknown innate detection mechanism induced by fusion between viral envelopes and target cells. Virus-cell fusion specifically stimulated a type I interferon response with expression of interferon-stimulated genes, in vivo recruitment of leukocytes and potentiation of signaling via Toll-like receptor 7 (TLR7) and TLR9. The fusion-dependent response was dependent on the stimulator of interferon genes STING but was independent of DNA, RNA and viral capsid. We suggest that membrane fusion is sensed as a danger signal with potential implications for defense against enveloped viruses and various conditions of giant-cell formation.	[Holm, Christian K.; Jensen, Soren B.; Jakobsen, Martin R.; Horan, Kristy A.; Moeller, Hanne B.; Gonzalez-Dosal, Regina; Rasmussen, Simon B.; Christensen, Maria H.; Paludan, Soren R.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Holm, Christian K.; Jakobsen, Martin R.; Paludan, Soren R.] Aarhus Univ, Aarhus Res Ctr Innate Immunol, Aarhus, Denmark; [Jensen, Soren B.; Fitzgerald, Katherine A.] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Cheshenko, Natalia; Herold, Betsy C.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Yarovinsky, Timur O.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Rixon, Frazer J.] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland	Aarhus University; Aarhus University; University of Massachusetts System; University of Massachusetts Worcester; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yale University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow	Paludan, SR (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	srp@microbiology.au.dk	Fitzgerald, Katherine/ABE-6317-2020; Cheshenko, Natalia/ABF-5896-2021	Holm, Christian/0000-0002-2655-3362; Fitzgerald, Kate/0000-0003-3175-609X; Herold, Betsy/0000-0001-9974-0786; , Martin/0000-0001-8847-9201	Danish Medical Research Council [09-072636, 10-081986]; Novo Nordisk Foundation; Velux Foundation; Christian d. Tiendes Fond; Aase og Ejnar Danielsens Fond; Fhv. Direktor Leo Nielsen og hustru Karen Margrethe Nielsen's legat for Laegevidenskabelig Grundforskning; Lundbeck Foundation [R17-A1526, R34-3855]; Elvira og Rasmus Riisforts almenvelgorende Fond; Aarhus University Research Foundation; Kathrine og Vigo Skovgaards Fond; US National Institutes of Health [AI061679, AI083713, AI067497]; Faculty of Health Sciences of Aarhus Univeristy; European Union; UK Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061679, R56AI067497, R01AI067497, R01AI061679, R01AI083713, R37AI067497] Funding Source: NIH RePORTER; Medical Research Council [MC_U130115834] Funding Source: researchfish; MRC [MC_U130115834] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Velux Foundation(Velux Fonden); Christian d. Tiendes Fond; Aase og Ejnar Danielsens Fond; Fhv. Direktor Leo Nielsen og hustru Karen Margrethe Nielsen's legat for Laegevidenskabelig Grundforskning; Lundbeck Foundation(Lundbeckfonden); Elvira og Rasmus Riisforts almenvelgorende Fond; Aarhus University Research Foundation; Kathrine og Vigo Skovgaards Fond; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Health Sciences of Aarhus Univeristy; European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A.R. Thomsen (Copenhagen University) for mice deficient in the receptor for type I interferon (Ifnar1<SUP>-/-</SUP> mice); J. Sodroski (Dana Farber Cancer Institute) for the pSVIII-ADA Env plasmid (obtained via P. Gorry); and P. Gorry (Burnet Institute) for the fusion-deficient construct pSVIII-ADA Y552F. Supported by The Danish Medical Research Council (09-072636 and 10-081986), The Novo Nordisk Foundation, The Velux Foundation, Christian d. Tiendes Fond, Aase og Ejnar Danielsens Fond, Fhv. Direktor Leo Nielsen og hustru Karen Margrethe Nielsen's legat for Laegevidenskabelig Grundforskning, The Lundbeck Foundation (R17-A1526 and R34-3855), Elvira og Rasmus Riisforts almenvelgorende Fond, Aarhus University Research Foundation, Kathrine og Vigo Skovgaards Fond, the US National Institutes of Health (AI061679 to B. C. H., and AI083713 and AI067497 to K. A. F.), the Faculty of Health Sciences of Aarhus Univeristy (S. B. J. and S. B. R.), the European Union Seventh Framework Programme Marie Curie Action (K. A. H.) and the UK Medical Research Council (F.J.R.).	Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Csiszar A, 2010, BIOCONJUGATE CHEM, V21, P537, DOI 10.1021/bc900470y; DARGAN DJ, 1995, J VIROL, V69, P4924, DOI 10.1128/JVI.69.8.4924-4932.1995; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Herschke F, 2007, J VIROL, V81, P12859, DOI 10.1128/JVI.00078-07; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Murthy M, 2010, DEVELOPMENT, V137, P2773, DOI 10.1242/dev.048330; Nordborg C, 2009, SCAND J RHEUMATOL, V38, P144, DOI 10.1080/03009740802448841; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; SZILAGYI JF, 1991, J GEN VIROL, V72, P661, DOI 10.1099/0022-1317-72-3-661; Tanaka T, 2008, EUR J IMMUNOL, V38, P1351, DOI 10.1002/eji.200737998; Tiwari V, 2010, J GEN VIROL, V91, P3002, DOI 10.1099/vir.0.024166-0; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	32	164	169	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					737	+		10.1038/ni.2350	http://dx.doi.org/10.1038/ni.2350			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22706339	Green Accepted, Green Submitted			2022-12-18	WOS:000306569600009
J	Barral, P; Polzella, P; Bruckbauer, A; van Rooijen, N; Besra, GS; Cerundolo, V; Batista, FD				Barral, Patricia; Polzella, Paolo; Bruckbauer, Andreas; van Rooijen, Nico; Besra, Gurdyal S.; Cerundolo, Vincenzo; Batista, Facundo D.			CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; SUBCAPSULAR SINUS MACROPHAGES; DENDRITIC CELLS; B-CELLS; RESPONSES; DYNAMICS; INFECTION; MECHANISM; IMMUNITY	Invariant natural killer T cells (iNKT cells) are involved in the host defense against microbial infection. Although it is known that iNKT cells recognize glycolipids presented by CD1d, how and where they encounter antigen in vivo remains unclear. Here we used multiphoton microscopy to visualize the dynamics and activation of iNKT cells in lymph nodes. After antigen administration, iNKT cells became confined in a CD1d-dependent manner in close proximity to subcapsular sinus CD169(+) macrophages. These macrophages retained, internalized and presented lipid antigen and were required for iNKT cell activation, cytokine production and population expansion. Thus, CD169(+) macrophages can act as true antigen-presenting cells controlling early iNKT cell activation and favoring the fast initiation of immune responses.	[Polzella, Paolo; Cerundolo, Vincenzo] John Radcliffe Hosp, Weatherall Inst Mol Med, Tumor Immunol Grp, Oxford OX3 9DU, England; [Barral, Patricia; Bruckbauer, Andreas; Batista, Facundo D.] London Res Inst, Canc Res UK, Lymphocyte Interact Lab, London, England; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Fac Med, Amsterdam, Netherlands; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Oxford; Cancer Research UK; Vrije Universiteit Amsterdam; University of Birmingham	Cerundolo, V (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Tumor Immunol Grp, Oxford OX3 9DU, England.	vincenzo.cerundolo@imm.ox.ac.uk; facundo.batista@cancer.org.uk	Bruckbauer, Andreas/A-9598-2008; Van Rooijen, Nico/Z-1578-2019	Bruckbauer, Andreas/0000-0003-1419-9674; Besra, Gurdyal/0000-0002-5605-0395; Barral, Patricia/0000-0003-4324-8973; Cerundolo, Vincenzo/0000-0003-0040-3793	Cancer Research UK [C399/A2291, C5255/A10339]; European Molecular Biology Organization Young Investigator Programme; Royal Society; Wellcome Trust [084923]; Ministerio de Education from Spain [2007-0148]; European Commission [PIEF-GA-2008220863, MRTN-CT-2006-035946]; Medical Research Council [MC_U137884181] Funding Source: researchfish; MRC [MC_U137884181] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Ministerio de Education from Spain; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kronenberg (La Jolla Institute for Allergy & Immunology) and C.-H. Wong (Scripps Laboratories) for GSL-1'; L. Van Kaer (Vanderbilt University School of Medicine) for CD1d-deficient mice; and A. Bendelac (University of Chicago) for DN32. D3 cells. Supported by Cancer Research UK (F. D. B., and C399/A2291 and C5255/A10339 to V. C.), the European Molecular Biology Organization Young Investigator Programme (F. D. B), the Royal Society (F. D. B.), The Wellcome Trust (084923 to V. C., G. B. and F. D. B.), the Ministerio de Education from Spain (2007-0148 to P. B.) and the European Commission (Seventh Framework Programme of the European Commission PIEF-GA-2008220863 to P. B. and Immunanomap MRTN-CT-2006-035946 to P. P.).	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berzins SP, 2005, CURR OPIN IMMUNOL, V17, P448, DOI 10.1016/j.coi.2005.05.012; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2008, CHEM BIOL, V15, P654, DOI 10.1016/j.chembiol.2008.05.012; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Laloux W, 2002, J IMMUNOL, V168, P3251, DOI 10.4049/jimmunol.168.7.3251; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; TILNEY NL, 1971, J ANAT, V109, P369; Tripp CH, 2009, J IMMUNOL, V182, P7644, DOI 10.4049/jimmunol.0900134; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Veerapen N, 2009, BIOORG MED CHEM LETT, V19, P4288, DOI 10.1016/j.bmcl.2009.05.095; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024	51	164	165	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					303	U48		10.1038/ni.1853	http://dx.doi.org/10.1038/ni.1853			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20228797	Green Accepted, Green Submitted			2022-12-18	WOS:000275849500009
J	Capasso, M; Bhamrah, MK; Henley, T; Boyd, RS; Langlais, C; Cain, K; Dinsdale, D; Pulford, K; Khan, M; Musset, B; Cherny, VV; Morgan, D; Gascoyne, RD; Vigorito, E; DeCoursey, TE; MacLennan, ICM; Dyer, MJS				Capasso, Melania; Bhamrah, Mandeep K.; Henley, Tom; Boyd, Robert S.; Langlais, Claudia; Cain, Kelvin; Dinsdale, David; Pulford, Karen; Khan, Mahmood; Musset, Boris; Cherny, Vladimir V.; Morgan, Deri; Gascoyne, Randy D.; Vigorito, Elena; DeCoursey, Thomas E.; MacLennan, Ian C. M.; Dyer, Martin J. S.			HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species	NATURE IMMUNOLOGY			English	Article							B-CELL LINES; PROTEIN-TYROSINE PHOSPHATASES; GATED PROTON CHANNEL; ANTIGEN RECEPTOR; RESPIRATORY BURST; HUMAN-LYMPHOCYTES; OXIDATIVE STRESS; VOLTAGE SENSOR; PLASMA-CELL; SURFACE IG	Voltage-gated proton currents regulate generation of reactive oxygen species (ROS) in phagocytic cells. In B cells, stimulation of the B cell antigen receptor (BCR) results in the production of ROS that participate in B cell activation, but the involvement of proton channels is unknown. We report here that the voltage-gated proton channel HVCN1 associated with the BCR complex and was internalized together with the BCR after activation. BCR-induced generation of ROS was lower in HVCN1-deficient B cells, which resulted in attenuated BCR signaling via impaired BCR-dependent oxidation of the tyrosine phosphatase SHP-1. This resulted in less activation of the kinases Syk and Akt, impaired mitochondrial respiration and glycolysis and diminished antibody responses in vivo. Our findings identify unanticipated functions for proton channels in B cells and demonstrate the importance of ROS in BCR signaling and downstream metabolism.	[Capasso, Melania; Bhamrah, Mandeep K.; Boyd, Robert S.; Langlais, Claudia; Cain, Kelvin; Dinsdale, David; Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Henley, Tom; Vigorito, Elena] Babraham Inst, Cambridge, England; [Pulford, Karen] Leukemia Res Lymphoma Antigens Grp, Oxford, England; [Khan, Mahmood; MacLennan, Ian C. M.] Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; [Musset, Boris; Cherny, Vladimir V.; Morgan, Deri; DeCoursey, Thomas E.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Gascoyne, Randy D.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	University of Leicester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Oxford; University of Birmingham; Rush University; British Columbia Cancer Agency	Dyer, MJS (corresponding author), Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England.	mjsd1@le.ac.uk	Pulford, Karen/B-3609-2009; DeCoursey, Thomas/A-6820-2009; Musset, Boris/AAD-4158-2022; Musset, Boris/J-2520-2013; Dyer, Martin/F-2691-2014	Pulford, Karen/0000-0002-2989-789X; DeCoursey, Thomas/0000-0002-4263-180X; Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817; Capasso, Melania/0000-0001-8659-9867; Dyer, Martin/0000-0002-5033-2236	Medical Research Council [G0802524]; Medical Research Council; Lymphoma Research Foundation (USA); US National Institutes of Health [HL-61437]; MRC [MC_U132670597, G8402371, G0700287] Funding Source: UKRI; Medical Research Council [MC_U132670597, G8402371, G0700287, G9818340B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lymphoma Research Foundation (USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Klein for discussions; S.-D. Zhang for assistance with statistical analysis; the laboratories of P. Nicotera, G. Cohen, P. Salomoni (Medical Research Council Toxicology Unit) for reagents and discussions; K. Young for help in the acquisition and analysis of data; A. Tobin, I. Forsythe, E. Tulchinsky, M. Kriajevska, E. Raven, J. Basran and K. Brown (University of Leicester) for reagents and use of equipment; F. Batista (Cancer Research UK) and A. Knight (University of Newcastle) for the HEL-specific B cell lines A20 D1.3 and LK35.2 HyHEL10; R. Snowden and K. Topping for assistance with flow cytometry and sorting; and the Medical Research Council (G0802524) for sorter funding. Supported by the Medical Research Council, the Lymphoma Research Foundation (USA), Philip Morris and the US National Institutes of Health (HL-61437).	Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Boyd RS, 2009, MOL CELL PROTEOMICS, V8, P1501, DOI 10.1074/mcp.M800515-MCP200; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dustin LB, 1999, J IMMUNOL, V162, P2717; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; JONES OTG, 1995, PROTOPLASMA, V184, P1; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kodiha M, 2009, FEBS LETT, V583, P1987, DOI 10.1016/j.febslet.2009.05.011; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; LECA G, 1991, J IMMUNOL, V146, P3542; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MALY FE, 1990, SCAND J IMMUNOL, V32, P661, DOI 10.1111/j.1365-3083.1990.tb03208.x; MALY FE, 1989, J IMMUNOL, V142, P1260; MALY FE, 1988, J IMMUNOL, V140, P2334; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Reth M, 2004, NAT REV IMMUNOL, V4, P269, DOI 10.1038/nri1335; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schilling T, 2002, J PHYSIOL-LONDON, V545, P93, DOI 10.1113/jphysiol.2002.028878; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; VOLKMAN DJ, 1984, J IMMUNOL, V133, P3006; WEIBEL ER, 1963, LAB INVEST, V12, P131; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	53	164	164	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					265	U12		10.1038/ni.1843	http://dx.doi.org/10.1038/ni.1843			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20139987	Green Accepted			2022-12-18	WOS:000274605800015
J	Shinkura, R; Tian, M; Smith, M; Chua, K; Fujiwara, Y; Alt, FW				Shinkura, R; Tian, M; Smith, M; Chua, K; Fujiwara, Y; Alt, FW			The influence of transcriptional orientation on endogenous switch region function	NATURE IMMUNOLOGY			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; SOMATIC HYPERMUTATION; ANTIBODY DIVERSIFICATION; DNA DEAMINATION; DEFICIENT MICE; IGH LOCI; RECOMBINATION; RNA; EXPRESSION	Immunoglobulin heavy chain (IgH) class switch recombination (CSR) takes place between large switch (S) regions that precede exons of the constant region. The precise functions of the S region are controversial, although transcription of the S region targets CSR. We have tested the effects of deletion, inversion and replacement of the endogenous 12-kilobase S-gamma1 region on CSR in vivo. Here we show that S-gamma1 is required for CSR, that CSR is effected by a 1-kilobase sequence that generates a G-rich transcript, and that inversion of S-gamma1 or the G-rich sequence decreases CSR. We conclude that S-gamma1 function is dependent on orientation and lacks an absolute requirement for common S region motifs. We propose that single-stranded DNA stabilized by transcription-dependent, higher order structures is a primary substrate of CSR.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.				NIAID NIH HHS [AI07512, AI31541] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; CHAUDHURI J, IN PRESS NATURE; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0; COLLINS JT, 1993, INT IMMUNOL, V5, P885, DOI 10.1093/intimm/5.8.885; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Harriman GR, 1996, J CLIN INVEST, V97, P477, DOI 10.1172/JCI118438; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; HUMMEL M, 1987, J IMMUNOL, V138, P3539; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; JUNG S, 1994, J EXP MED, V179, P2023, DOI 10.1084/jem.179.6.2023; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; Lee CG, 1998, CURR BIOL, V8, P227, DOI 10.1016/S0960-9822(98)70087-9; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Ma LM, 2002, J IMMUNOL, V168, P2835, DOI 10.4049/jimmunol.168.6.2835; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; RADBRUCH A, 1986, P NATL ACAD SCI USA, V83, P3954, DOI 10.1073/pnas.83.11.3954; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672, DOI 10.1128/MCB.10.4.1672; ROTHMAN P, 1990, INT IMMUNOL, V2, P621, DOI 10.1093/intimm/2.7.621; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SCHULTZ C, 1990, J IMMUNOL, V144, P363; Seidl KJ, 1998, INT IMMUNOL, V10, P1683, DOI 10.1093/intimm/10.11.1683; Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365; Sleckman BP, 1998, J EXP MED, V188, P1465, DOI 10.1084/jem.188.8.1465; Stavnezer J, 2002, TRENDS GENET, V18, P541, DOI 10.1016/S0168-9525(02)02799-3; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; Storb U, 2002, CURR BIOL, V12, pR725, DOI 10.1016/S0960-9822(02)01247-2; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; VONSCHWEDLER U, 1990, NEW BIOL, V8, P657; Weill JC, 2002, ADV IMMUNOL, V80, P183, DOI 10.1016/S0065-2776(02)80015-3; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; Xu M, 1990, Dev Immunol, V1, P11, DOI 10.1155/1990/47659; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; YU K, 2003, NATURE IMMUNOLO 0407; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	58	164	168	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					435	441		10.1038/ni918	http://dx.doi.org/10.1038/ni918			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12679811				2022-12-18	WOS:000182665400010
J	Okkenhaug, K; Wu, L; Garza, KM; La Rose, J; Khoo, W; Odermatt, B; Mak, TW; Ohashi, PS; Rottapel, R				Okkenhaug, K; Wu, L; Garza, KM; La Rose, J; Khoo, W; Odermatt, B; Mak, TW; Ohashi, PS; Rottapel, R			A point mutation in CD28 distinguishes proliferative signals from survival signals	NATURE IMMUNOLOGY			English	Article							JURKAT T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE ASSOCIATION; COSTIMULATORY RECEPTOR CD28; PROTEIN-TYROSINE KINASE; CD28-MEDIATED COSTIMULATION; CYTOPLASMIC DOMAIN; PHOSPHOINOSITIDE 3-KINASES; ADAPTER PROTEIN; IL-2 PRODUCTION; ACTIVATION	Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines, One tyrosine in particular (Y-170 in mouse CD28, Y-173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-x(L), rendering the T cells move susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.	Univ Toronto, Dept Immunol, Toronto, ON M5S 1A2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A2, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A2, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Amgen Inst, Toronto, ON, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Zurich; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rottapel, R (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A2, Canada.	rottapel@uhnres.utoronto.ca	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Ohashi, Pamela S./0000-0003-2915-9317; Rottapel, Robert/0000-0002-6024-5558				AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; Barz C, 1998, J IMMUNOL, V161, P5366; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Cefai D, 1998, J IMMUNOL, V160, P2223; Collette Y, 1997, EUR J IMMUNOL, V27, P3283, DOI 10.1002/eji.1830271227; CROOKS MEC, 1995, MOL CELL BIOL, V15, P6820; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; Downward J, 1996, CANCER SURV, V27, P87; Ellis JH, 2000, J IMMUNOL, V164, P5805, DOI 10.4049/jimmunol.164.11.5805; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; King PD, 1997, J IMMUNOL, V158, P580; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; LAHESMAA R, 1995, J IMMUNOL, V155, P3815; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; LU YL, 1995, EUR J IMMUNOL, V25, P533, DOI 10.1002/eji.1830250234; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Okkenhaug K, 1998, J BIOL CHEM, V273, P21194, DOI 10.1074/jbc.273.33.21194; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Sadra A, 1999, J IMMUNOL, V162, P1966; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shi J, 1997, J IMMUNOL, V158, P4688; Sperling AI, 1996, J IMMUNOL, V157, P3909; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Truitt KE, 1996, J IMMUNOL, V156, P4539; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; TRUITT KE, 1995, J IMMUNOL, V155, P4702; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WARD SG, 1995, EUR J IMMUNOL, V25, P526, DOI 10.1002/eji.1830250233; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Zell T, 1996, J IMMUNOL, V156, P883; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	164	169	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					325	332		10.1038/86327	http://dx.doi.org/10.1038/86327			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276203				2022-12-18	WOS:000167982900013
J	Kohlgruber, AC; Gal-Oz, ST; LaMarche, NM; Shimazaki, M; Duquette, D; Nguyen, HN; Mina, AI; Paras, T; Tavakkoli, A; von Andrian, U; Banks, AS; Shay, T; Brenner, MB; Lynch, L				Kohlgruber, Ayano C.; Gal-Oz, Shani T.; LaMarche, Nelson M.; Shimazaki, Moto; Duquette, Danielle; Nguyen, Hung N.; Mina, Amir I.; Paras, Tyler; Tavakkoli, Ali; von Andrian, Ulrich; Banks, Alexander S.; Shay, Tal; Brenner, Michael B.; Lynch, Lydia			gamma delta T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID TYPE-2; PLZF CONTROLS; TISSUE; IL-33; FAT; ACCUMULATION; GENE; ACTIVATION; EXPRESSION; PHENOTYPE	gamma delta T cells are situated at barrier sites and guard the body from infection and damage. However, little is known about their roles outside of host defense in nonbarrier tissues. Here, we characterize a highly enriched tissue-resident population of gamma delta T cells in adipose tissue that regulate age-dependent regulatory T cell (T-reg) expansion and control core body temperature in response to environmental fluctuations. Mechanistically, innate PLZF(+) gamma delta T cells produced tumor necrosis factor and interleukin (IL) 17 A and determined PDGFR alpha(+) and Pdpn(+) stromal-cell production of IL-33 in adipose tissue. Mice lacking gamma delta T cells or IL-17A exhibited decreases in both ST2(+) T-reg cells and IL-33 abundance in visceral adipose tissue. Remarkably, these mice also lacked the ability to regulate core body temperature at thermoneutrality and after cold challenge. Together, these findings uncover important physiological roles for resident gamma delta T cells in adipose tissue immune homeostasis and body-temperature control.	[Kohlgruber, Ayano C.; LaMarche, Nelson M.; Shimazaki, Moto; Nguyen, Hung N.; Paras, Tyler; Brenner, Michael B.; Lynch, Lydia] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Kohlgruber, Ayano C.; LaMarche, Nelson M.; von Andrian, Ulrich] Harvard Med Sch, Div Med Sci, Boston, MA USA; [Gal-Oz, Shani T.; Shay, Tal] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Duquette, Danielle; Mina, Amir I.; Banks, Alexander S.; Lynch, Lydia] Brigham & Womens Hosp, Dept Med, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA; [Tavakkoli, Ali] Brigham & Womens Hosp, Dept Gen & Gastrointestinal Surg, 75 Francis St, Boston, MA 02115 USA; [von Andrian, Ulrich] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA USA; [Lynch, Lydia] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ben Gurion University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Trinity College Dublin	Brenner, MB; Lynch, L (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Lynch, L (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA.; Lynch, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	mbrenner@research.bwh.harvard.edu; llynch@bwh.harvard.edu	Gal-Oz, Shani Talia/AAE-9478-2019; Shay, Tal/J-4028-2016; Lynch, Lydia/ABD-5598-2021	Gal-Oz, Shani Talia/0000-0001-7775-2006; Shay, Tal/0000-0003-0755-1350; Mina, Amir I./0000-0002-1231-1696; Koay, Hui-Fern/0000-0002-3236-9609; ULDRICH, ADAM/0000-0002-6350-5976	NIH [R01 AI11304603]; ERC Starting Grant [679173]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Starting Grant	We thank A. T. Chicoine, flow cytometry core manager at the Human Immunology Center at BWH, for flow cytometry sorting. We thank D. Sant'Angelo (Rutgers Cancer Institute) for providing Zbtb16<SUP>-/-</SUP> mice and R. O'Brien (National Jewish Health) for providing Vg4/6<SUP>-/-</SUP> mice. This research was supported by NIH grant R01 AI11304603 (to M.B.B.) and ERC Starting Grant 679173 (to L.L.).	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cipolletta D, 2014, IMMUNOLOGY, V142, P517, DOI 10.1111/imm.12262; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Hepworth MR, 2017, TRENDS IMMUNOL, V38, P873, DOI 10.1016/j.it.2017.09.003; Jackson-Jones LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12651; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; Lynch L, 2016, CELL METAB, V24, P510, DOI 10.1016/j.cmet.2016.08.003; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Mathis D, 2016, CELL, V166, P794, DOI 10.1016/j.cell.2016.07.051; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Okada K, 2016, MOL METAB, V5, P340, DOI 10.1016/j.molmet.2016.02.002; Paget C, 2015, IMMUNOL CELL BIOL, V93, P198, DOI 10.1038/icb.2014.94; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wei YL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00118; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Zeyda M, 2013, INT J OBESITY, V37, P658, DOI 10.1038/ijo.2012.118; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	47	163	165	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					464	+		10.1038/s41590-018-0094-2	http://dx.doi.org/10.1038/s41590-018-0094-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670241	Green Accepted			2022-12-18	WOS:000430562400010
J	Beura, LK; Mitchell, JS; Thompson, EA; Schenkel, JM; Mohammed, J; Wijeyesinghe, S; Fonseca, R; Burbach, BJ; Hickman, HD; Vezys, V; Fife, BT; Masopust, D				Beura, Lalit K.; Mitchell, Jason S.; Thompson, Emily A.; Schenkel, Jason M.; Mohammed, Javed; Wijeyesinghe, Sathi; Fonseca, Raissa; Burbach, Brandon J.; Hickman, Heather D.; Vezys, Vaiva; Fife, Brian T.; Masopust, David			Intravital mucosal imaging of CD8(+) resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory	NATURE IMMUNOLOGY			English	Article							PROLIFERATIVE CAPACITY; PROTECTIVE IMMUNITY; LOCAL ANTIGEN; RM CELLS; MIGRATION; DIFFERENTIATION; LYMPHOCYTES; PERSISTENCE; ACTIVATION; INFECTION	CD8(+) T cell immunosurveillance dynamics influence the outcome of intracellular infections and cancer. Here we used two-photon intravital microscopy to visualize the responses of CD8(+) resident memory T cells (T-RM cells) within the reproductive tracts of live female mice. We found that mucosal T-RM cells were highly motile, but paused and underwent in situ division after local antigen challenge. T-RM cell reactivation triggered the recruitment of recirculating memory T cells that underwent antigen-independent T-RM cell differentiation in situ. However, the proliferation of pre-existing T-RM cells dominated the local mucosal recall response and contributed most substantially to the boosted secondary T-RM cell population. We observed similar results in skin. Thus, T-RM cells can autonomously regulate the expansion of local immunosurveillance independently of central memory or proliferation in lymphoid tissue.	[Beura, Lalit K.; Thompson, Emily A.; Schenkel, Jason M.; Wijeyesinghe, Sathi; Fonseca, Raissa; Vezys, Vaiva; Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Beura, Lalit K.; Mitchell, Jason S.; Thompson, Emily A.; Schenkel, Jason M.; Wijeyesinghe, Sathi; Fonseca, Raissa; Burbach, Brandon J.; Vezys, Vaiva; Fife, Brian T.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Mitchell, Jason S.; Burbach, Brandon J.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Mohammed, Javed] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Hickman, Heather D.] NIAID, Viral Immun & Pathogenesis Unit, Lab Clin Immunol & Microbiol, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Fife, Brian T.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA.; Masopust, D (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN USA.	masopust@umn.edu	Fonseca, Raissa/AAF-8940-2021; Schenkel, Jason/AAV-8184-2020; Vezys, Vaiva/N-3144-2013; Beura, Lalit/W-6281-2019; masopust, david/B-5027-2008; Fife, Brian/D-2042-2013	Schenkel, Jason/0000-0003-4641-6872; Fonseca, Raissa/0000-0001-8202-4871; Burbach, Brandon/0000-0003-0922-7722; Wijeyesinghe, Sathi/0000-0002-8819-2654; Hickman, Heather/0000-0003-4168-4894; Fife, Brian/0000-0001-9826-5637	Howard Hughes Medical Institute Faculty Scholars program; US National Institutes of Health [R01AI111671, R01AI084913, R21AI123600]; US National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, ZIAAI001225, R01AI084913, R21AI123600, R01AI111671] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Faculty Scholars program(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Masopust laboratory for helpful discussions. This work was funded by the Howard Hughes Medical Institute Faculty Scholars program (D.M.) and the US National Institutes of Health (grants R01AI111671 and R01AI084913 to D.M.; grant R21AI123600 to B.J.B.). H.D.H. was funded by the Intramural Research Program of the US National Institute of Allergy and Infectious Diseases.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; EBERT EC, 1986, CLIN EXP IMMUNOL, V65, P148; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gaylo A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00428; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; MOWAT AM, 1989, IMMUNOLOGY, V66, P398; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Posavad CM, 2017, MUCOSAL IMMUNOL, V10, P1259, DOI 10.1038/mi.2016.118; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thompson EA, 2016, J IMMUNOL, V196, P3054, DOI 10.4049/jimmunol.1501797; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	46	163	162	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					173	+		10.1038/s41590-017-0029-3	http://dx.doi.org/10.1038/s41590-017-0029-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29311694	Green Accepted			2022-12-18	WOS:000423435200017
J	Astarita, JL; Cremasco, V; Fu, JX; Darnell, MC; Peck, JR; Nieves-Bonilla, JM; Song, K; Kondo, Y; Woodruff, MC; Gogineni, A; Onder, L; Ludewig, B; Weimer, RM; Carroll, MC; Mooney, DJ; Xia, LJ; Turley, SJ				Astarita, Jillian L.; Cremasco, Viviana; Fu, Jianxin; Darnell, Max C.; Peck, James R.; Nieves-Bonilla, Janice M.; Song, Kai; Kondo, Yuji; Woodruff, Matthew C.; Gogineni, Alvin; Onder, Lucas; Ludewig, Burkhard; Weimer, Robby M.; Carroll, Michael C.; Mooney, David J.; Xia, Lijun; Turley, Shannon J.			The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture	NATURE IMMUNOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DENDRITIC CELLS; RECEPTOR CLEC-2; TUMOR INVASION; T-CELLS; PODOPLANIN; GROWTH; HOMEOSTASIS; IMMUNITY; T1-ALPHA/PODOPLANIN	In lymph nodes, fibroblastic reticular cells (FRCs) form a collagen-based reticular network that supports migratory dendritic cells (DCs) and T cells and transports lymph. A hallmark of FRCs is their propensity to contract collagen, yet this function is poorly understood. Here we demonstrate that podoplanin (PDPN) regulates actomyosin contractility in FRCs. Under resting conditions, when FRCs are unlikely to encounter mature DCs expressing the PDPN receptor CLEC-2, PDPN endowed FRCs with contractile function and exerted tension within the reticulum. Upon inflammation, CLEC-2 on mature DCs potently attenuated PDPN-mediated contractility, which resulted in FRC relaxation and reduced tissue stiffness. Disrupting PDPN function altered the homeostasis and spacing of FRCs and T cells, which resulted in an expanded reticular network and enhanced immunity.	[Astarita, Jillian L.; Woodruff, Matthew C.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Astarita, Jillian L.; Cremasco, Viviana; Peck, James R.; Nieves-Bonilla, Janice M.; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Fu, Jianxin; Song, Kai; Kondo, Yuji; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Fu, Jianxin; Song, Kai; Kondo, Yuji; Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Darnell, Max C.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Darnell, Max C.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Woodruff, Matthew C.; Carroll, Michael C.] Harvard Univ, Childrens Hosp Boston, Sch Med, Program Cellular & Mol Med, Boston, MA USA; [Gogineni, Alvin; Weimer, Robby M.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA USA; [Onder, Lucas; Ludewig, Burkhard] Kantonal Hosp, Inst Immunobiol, St Gallen, Switzerland; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA USA; [Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Roche Holding; Genentech; Kantonsspital St. Gallen; Harvard University; Harvard Medical School; Roche Holding; Genentech	Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	turley.shannon@gene.com		Darnell, Max/0000-0003-2411-5403; Fu, Jianxin/0000-0002-3067-8539; Nieves-Bonilla, Janice/0000-0001-6543-3681; Woodruff, Matthew/0000-0002-5252-7539; Mooney, David/0000-0001-6299-1194	US National Institutes of Health [R0I DK074500, P01 AI045757, R21 CA182598, 5R01 AI039246, P01 HL085607, GM103441]; American Cancer Society; Claudia Adams Barr Program in Innovative Cancer Research; Cancer Research Institute; American Heart Association [SDG7410022]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039246, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Claudia Adams Barr Program in Innovative Cancer Research; Cancer Research Institute; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Cameron for assistance at the Dana-Farber Cancer Institute confocal microscopy core, and R. Gelman for help with statistical analyses. Supported by the US National Institutes of Health (R0I DK074500, P01 AI045757 and R21 CA182598 to S.J.T.; 5R01 AI039246 to M.C.C.; and P01 HL085607 and GM103441 to L.X.), the American Cancer Society (S.J.T.), the Claudia Adams Barr Program in Innovative Cancer Research (S.J.T.), the Cancer Research Institute (to V.C.), the American Heart Association (SDG7410022 to J.F.) and the National Science Foundation (J.L.A.).	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Andersson K., 2010, NATURE PRECEDINGS; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Fehon R. G., 2010, NAT REV MOL CELL BIO, V11, P1; Fernandez-Munoz B, 2011, INT J BIOCHEM CELL B, V43, P886, DOI 10.1016/j.biocel.2011.02.010; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Khan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026138; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Navarro A, 2008, AM J PHYSIOL-LUNG C, V295, pL543, DOI 10.1152/ajplung.90262.2008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Suzuki-Inoue K, 2011, J THROMB HAEMOST, V9, P44, DOI 10.1111/j.1538-7836.2011.04335.x; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Tzeng TC, 2010, J IMMUNOL, V184, P4247, DOI 10.4049/jimmunol.0902914; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	50	163	175	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					75	+		10.1038/ni.3035	http://dx.doi.org/10.1038/ni.3035			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25347465	Green Accepted, Green Submitted			2022-12-18	WOS:000346494200011
J	Semmling, V; Lukacs-Kornek, V; Thaiss, CA; Quast, T; Hochheiser, K; Panzer, U; Rossjohn, J; Perlmutter, P; Cao, J; Godfrey, DI; Savage, PB; Knolle, PA; Kolanus, W; Forster, I; Kurts, C				Semmling, Verena; Lukacs-Kornek, Veronika; Thaiss, Christoph A.; Quast, Thomas; Hochheiser, Katharina; Panzer, Ulf; Rossjohn, Jamie; Perlmutter, Patrick; Cao, Jia; Godfrey, Dale I.; Savage, Paul B.; Knolle, Percy A.; Kolanus, Waldemar; Foerster, Irmgard; Kurts, Christian			Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; CHEMOKINE RECEPTOR EXPRESSION; DENDRITIC CELLS; IN-VIVO; AIRWAY HYPERREACTIVITY; MEDIATED ACTIVATION; CD8(+); CD4(+); CCR4; IMMUNITY	Cross-priming allows dendritic cells (DCs) to induce cytotoxic T cell (CTL) responses to extracellular antigens. DCs require cognate 'licensing' for cross-priming, classically by helper T cells. Here we demonstrate an alternative mechanism for cognate licensing by natural killer T (NKT) cells recognizing microbial or synthetic glycolipid antigens. Such licensing caused cross-priming CD8(alpha)(+) DCs to produce the chemokine CCL17, which attracted naive CTLs expressing the chemokine receptor CCR4. In contrast, DCs licensed by helper T cells recruited CTLs using CCR5 ligands. Thus, depending on the type of antigen they encounter, DCs can be licensed for cross-priming by NKT cells or helper T cells and use at least two independent chemokine pathways to attract naive CTLs. Because these chemokines acted synergistically, this can potentially be exploited to improve vaccinations.	[Foerster, Irmgard] Univ Dusseldorf, Inst Umwelmed Forsch, Dusseldorf, Germany; [Semmling, Verena; Lukacs-Kornek, Veronika; Thaiss, Christoph A.; Hochheiser, Katharina; Knolle, Percy A.; Kurts, Christian] Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, Life & Med Sci Inst, D-5300 Bonn, Germany; [Panzer, Ulf] Univ Klinikum Hamburg Eppendorf, Med Klin 3, Hamburg, Germany; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Perlmutter, Patrick; Cao, Jia] Monash Univ, Dept Chem, Clayton, Vic 3168, Australia; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Heinrich Heine University Dusseldorf; University of Bonn; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Monash University; Monash University; University of Melbourne; Brigham Young University	Forster, I (corresponding author), Univ Dusseldorf, Inst Umwelmed Forsch, Dusseldorf, Germany.	irmgard.foerster@uni-duesseldorf.de; ckurts@web.de	Rossjohn, Jamie/F-9032-2013; Savage, Paul B/E-1448-2011; Förster, Irmgard/P-8545-2016; Savage, Paul B/HGB-3414-2022	Rossjohn, Jamie/0000-0002-2020-7522; Savage, Paul B/0000-0002-4642-6109; Förster, Irmgard/0000-0002-7644-5642; Savage, Paul B/0000-0002-4642-6109; Knolle, Percy A./0000-0003-2983-0414; Perlmutter, Patrick/0000-0003-4105-4526; Godfrey, Dale/0000-0002-3009-5472				Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; de Lavareille A, 2001, EUR J IMMUNOL, V31, P1037, DOI 10.1002/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Du W, 2007, CHEM COMMUN, P2336, DOI 10.1039/b702551c; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Freeman CM, 2006, J IMMUNOL, V177, P4149, DOI 10.4049/jimmunol.177.6.4149; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gonzalo JA, 1999, J IMMUNOL, V163, P403; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kondo T, 2009, INT IMMUNOL, V21, P523, DOI 10.1093/intimm/dxp019; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.3.CO;2-P; Long XT, 2007, NAT CHEM BIOL, V3, P559, DOI 10.1038/nchembio.2007.19; Lukacs-Kornek V, 2008, J IMMUNOL, V180, P706, DOI 10.4049/jimmunol.180.2.706; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Meyer EH, 2007, J IMMUNOL, V179, P4661, DOI 10.4049/jimmunol.179.7.4661; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stober D, 2003, J IMMUNOL, V170, P2540, DOI 10.4049/jimmunol.170.5.2540; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	51	163	166	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					313	U57		10.1038/ni.1848	http://dx.doi.org/10.1038/ni.1848			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20190758				2022-12-18	WOS:000275849500010
J	Ivashkiv, LB				Ivashkiv, Lionel B.			Cross-regulation of signaling by ITAM-associated receptors	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; ADAPTER PROTEIN CARD9; FC-ALPHA-RI; DENDRITIC CELLS; GAMMA-CHAIN; IFN-ALPHA; OSTEOCLAST DIFFERENTIATION; FEEDBACK INHIBITION; IMMUNE-RESPONSES; KINASE PATHWAY	An important function of receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs) is to regulate signaling by heterologous receptors. This review describes mechanisms by which ITAM-associated receptors modulate signaling by Toll-like receptors (TLRs), tumor necrosis factor receptor family members and cytokine receptors that use the Jak-STAT signaling pathway, and the biological importance of this signal transduction cross-talk. ITAM-mediated cross-regulation can either augment or dampen signaling by other receptors. Conversely, TLRs and cytokines modulate ITAM-mediated signaling, by means including activation of beta 2 integrins that are coupled to the ITAM-containing adaptors DAP12 and FcR gamma. Integration of ITAM signaling into signaling networks through cross-talk with other signal transduction pathways results in tight regulation and fine tuning of cellular responses to various extracellular stimuli and contributes to induction of specific activation and differentiation pathways.	Hosp Special Surg, Arthrit & Tissue Degenerat Program, Immunol & Microbial Pathogenesis Program, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Immunol & Microbial Pathogenesis Program, Weill Cornell Grad Sch Med Sci, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu			US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712, R01AI059636, R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	I thank M. Nakamura for discussions and X. Hu and K.-H. Park-Min for critical review of the manuscript. Supported by the US National Institutes of Health.	Abram C.L., 2007, SCI STKE, V2007, pre2; Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Bekeredjian-Ding I, 2008, J IMMUNOL, V181, P8267, DOI 10.4049/jimmunol.181.12.8267; Belostocki K, 2008, ARTHRITIS RHEUM, V58, P384, DOI 10.1002/art.23200; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Bode JG, 2001, BIOL CHEM, V382, P1447, DOI 10.1515/BC.2001.178; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Cuzzola M, 2000, J IMMUNOL, V164, P5871, DOI 10.4049/jimmunol.164.11.5871; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kanamaru Y, 2008, J IMMUNOL, V180, P2669, DOI 10.4049/jimmunol.180.4.2669; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu Y, 2005, J LEUKOCYTE BIOL, V77, P767, DOI 10.1189/jlb.0904532; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Radhakrishnan S, 2008, J IMMUNOL, V181, P7863, DOI 10.4049/jimmunol.181.11.7863; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	97	163	167	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					340	347		10.1038/ni.1706	http://dx.doi.org/10.1038/ni.1706			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295630	Green Accepted			2022-12-18	WOS:000264425800004
J	Guimond, M; Veenstra, RG; Grindler, DJ; Zhang, H; Cui, YZ; Murphy, RD; Kim, SY; Na, RS; Hennighausen, L; Kurtulus, S; Erman, B; Matzinger, P; Merchant, MS; Mackall, CL				Guimond, Martin; Veenstra, Rachelle G.; Grindler, David J.; Zhang, Hua; Cui, Yongzhi; Murphy, Ryan D.; Kim, Su Young; Na, Risu; Hennighausen, Lothar; Kurtulus, Sema; Erman, Batu; Matzinger, Polly; Merchant, Melinda S.; Mackall, Crystal L.			Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; MHC CLASS-II; IL-7 INCREASES; POTENTIAL ROLE; NAIVE; SURVIVAL; CD8(+); TCR; EXPRESSION; RECOVERY	Interleukin 7 (IL-7) and T cell antigen receptor signals have been proposed to be the main drivers of homeostatic T cell proliferation. However, it is not known why CD4(+) T cells undergo less-efficient homeostatic proliferation than CD8(+) T cells do. Here we show that systemic IL-7 concentrations increased during lymphopenia because of diminished use of IL-7 but that IL-7 signaling on IL-7 receptor-alpha-positive (IL-7R alpha(+)) dendritic cells (DCs) in lymphopenic settings paradoxically diminished the homeostatic proliferation of CD4(+) T cells. This effect was mediated at least in part by IL-7-mediated downregulation of the expression of major histocompatibility complex class II on IL-7R alpha(+) DCs. Our results indicate that IL-7R alpha(+) DCs are regulators of the peripheral CD4(+) T cell niche and that IL-7 signals in DCs prevent uncontrolled CD4(+) T cell population expansion in vivo.	[Guimond, Martin; Veenstra, Rachelle G.; Grindler, David J.; Zhang, Hua; Cui, Yongzhi; Murphy, Ryan D.; Kim, Su Young; Merchant, Melinda S.; Mackall, Crystal L.] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Na, Risu; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA; [Erman, Batu] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Kurtulus, Sema] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Matzinger, Polly] NIAID, Ghost Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Sabanci University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mackall, CL (corresponding author), NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.	mackallc@mail.nih.gov	erman, batu/AAE-1963-2020	Hennighausen, Lothar/0000-0001-8319-9841	Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011069, Z01SC010281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, ZIAAI000868] Funding Source: NIH RePORTER	Intramural Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Kapoor and N. Voong for flow cytometry expertise; M. A. Caligiuri (Ohio State University) for Flt3 ligand; S. Durum (National Cancer Institute) for Rag1<SUP>-/-</SUP> Il7<SUP>-/-</SUP> mice; and S. Durum, A. Singer and R. Gress for review of the manuscript. Supported by the Intramural Program of the National Cancer Institute.	Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bourgeois C, 2005, J IMMUNOL, V174, P5316, DOI 10.4049/jimmunol.174.9.5316; Boursalian TE, 1999, J IMMUNOL, V162, P3795; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dion ML, 2007, BLOOD, V109, P2912, DOI 10.1182/blood-2006-09-047308; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Dumont-Girard F, 1998, BLOOD, V92, P4464, DOI 10.1182/blood.V92.11.4464.423k32_4464_4471; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Fry TJ, 2004, BLOOD, V104, P2794, DOI 10.1182/blood-2003-11-3789; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; Giraud S, 2005, J INTERF CYTOK RES, V25, P135, DOI 10.1089/jir.2005.25.135; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI22492; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Heitger A, 1997, BLOOD, V90, P850, DOI 10.1182/blood.V90.2.850.850_850_857; Iwata M, 2002, BLOOD, V100, P1318, DOI 10.1182/blood-2002-01-0062; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Min B, 2004, P NATL ACAD SCI USA, V101, P3874, DOI 10.1073/pnas.0400606101; Mohty M, 2005, LEUKEMIA, V19, P1, DOI 10.1038/sj.leu.2403558; Moniuszko M, 2004, J VIROL, V78, P9740, DOI 10.1128/JVI.78.18.9740-9749.2004; Moschella F, 2001, BRIT J HAEMATOL, V114, P444, DOI 10.1046/j.1365-2141.2001.02953.x; Muthukumar A, 2004, BLOOD, V103, P973, DOI 10.1182/blood-2003-03-0874; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pillai M, 2004, LEUKEMIA LYMPHOMA, V45, P2403, DOI 10.1080/10428190412331283189; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vasir B, 2005, J IMMUNOL, V174, P2376, DOI 10.4049/jimmunol.174.4.2376; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70	48	163	168	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					149	157		10.1038/ni.1695	http://dx.doi.org/10.1038/ni.1695			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19136960	Green Accepted			2022-12-18	WOS:000263178500008
J	Skokos, D; Shakhar, G; Varma, R; Waite, JC; Cameron, TO; Lindquist, RL; Schwickert, T; Nussenzweig, MC; Dustin, ML				Skokos, Dimitris; Shakhar, Guy; Varma, Rajat; Waite, Janelle C.; Cameron, Thomas O.; Lindquist, Randall L.; Schwickert, Tanja; Nussenzweig, Michel C.; Dustin, Michael L.			Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes	NATURE IMMUNOLOGY			English	Article							IN-VIVO; RECEPTOR-LIGAND; IMMUNOLOGICAL SYNAPSE; POSITIVE SELECTION; ANTIGEN RECEPTOR; TRANSGENIC MICE; IMMUNE-SYSTEM; B-CELLS; ACTIVATION; MOTILITY	T cells survey antigen-presenting dendritic cells (DCs) by migrating through DC networks, arresting and maintaining contact with DCs for several hours after encountering high-potency complexes of peptide and major histocompatibility complex (pMHC), leading to T cell activation. The effects of low-potency pMHC complexes on T cells in vivo, however, are unknown, as is the mechanism controlling T cell arrest. Here we evaluated T cell responses in vivo to high-, medium- and low-potency pMHC complexes and found that regardless of potency, pMHC complexes induced upregulation of CD69, anergy and retention of T cells in lymph nodes. However, only high-potency pMHC complexes expressed by DCs induced calcium-dependent T cell deceleration and calcineurin-dependent anergy. The pMHC complexes of lower potency instead induced T cell anergy by a biochemically distinct process that did not affect T cell dynamics.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; NYU, Sch Med, Program Mol Pathogenesis, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, Skirball Inst Biomol Med, New York, NY 10016 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; New York University; New York University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.	nussen@mail.rockefeller.edu; dustin@saturn.med.nyu.edu	Varma, Rajat/I-1209-2012; Nussenzweig, Michel/AAE-7292-2019; Dustin, Michael/AAM-4611-2020	Varma, Rajat/0000-0001-5131-0402; Schwickert, Tanja/0000-0002-3371-2376; Dustin, Michael/0000-0003-4983-6389	NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lyman MA, 2005, J IMMUNOL, V174, P2563, DOI 10.4049/jimmunol.174.5.2563; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Mangues R, 1998, CANCER RES, V58, P1253; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Pei XY, 2005, CLIN CANCER RES, V11, P4589, DOI 10.1158/1078-0432.CCR-04-2346; Powell JD, 2005, TRANSPLANTATION, V80, P1541, DOI 10.1097/01.tp.0000185299.72295.90; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Rogers PR, 1998, J IMMUNOL, V160, P3698; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SLOANLANCASTER J, 1995, CURR OPIN IMMUNOL, V7, P103, DOI 10.1016/0952-7915(95)80035-2; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; VANIER LE, 1992, J EXP MED, V176, P37, DOI 10.1084/jem.176.1.37; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zollner TM, 2002, J CLIN INVEST, V109, P671, DOI 10.1172/JCI200212736	61	163	163	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					835	844		10.1038/ni1490	http://dx.doi.org/10.1038/ni1490			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17632517				2022-12-18	WOS:000248169400011
J	Krmpotic, A; Busch, DH; Bubic, I; Gebhardt, F; Hengel, H; Hasan, M; Scalzo, AA; Koszinowski, UH; Jonjic, S				Krmpotic, A; Busch, DH; Bubic, I; Gebhardt, F; Hengel, H; Hasan, M; Scalzo, AA; Koszinowski, UH; Jonjic, S			MCMV glycoprotein gp40 confers virus resistance to CD8(+) T cells and NK cells in vivo	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; MOUSE CYTOMEGALOVIRUS GLYCOPROTEIN; CLASS-I MOLECULES; MURINE CYTOMEGALOVIRUS; GENE-COMPLEX; NKG2D RECEPTOR; ANTIGEN PRESENTATION; IMMUNE-EVASION; HLA-E; INFECTION	The susceptibility of certain inbred mouse strains to murine cytomegalovirus (MCMV) is related to their inability to generate a strong natural killer (NK) cell response. We addressed here whether the MCMV susceptibility of the BALB/c strain is due to viral functions that control NK cell activation in a strain-specific manner. MCMV expresses two proteins, gp48 and gp40, that are encoded by the genes m06 and m152, respectively; they down-regulate major histocompatibility complex (MHC) class I expression at the plasma membrane. Using MCMV deletion mutants and revertants, we found that gp40 but not gp48 controls NK cell activation. Absence of gp40 improved antiviral NK cell control in BALB/c, but not C57BL/6, mice. Down-regulation of H-60, the high-affinity ligand for the NKG2D receptor, was the mechanism by which gp40 modulates NK cell activation. Thus, a single herpesvirus protein has a dual function in inhibiting both the adaptive as well as the innate immune response.	Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; Tech Univ Munich, Inst Microbiol Immunol & Hyg, D-8000 Munich, Germany; Robert Koch Inst, D-1000 Berlin, Germany; Univ Western Australia, Dept Microbiol, Nedlands, WA 6009, Australia; Max von Pettenkofer Inst, D-8000 Munich, Germany	University of Rijeka; Technical University of Munich; Robert Koch Institute; University of Western Australia; University of Munich	Jonjic, S (corresponding author), Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia.		Krmpotic, Astrid/U-6224-2017; Bubic, Ivan/GZL-2338-2022; Jonjic, Stipan/C-5657-2016; Hasan, Milena/AAO-6610-2021	Krmpotic, Astrid/0000-0001-5470-5370; Jonjic, Stipan/0000-0001-5003-3108; Hasan, Milena/0000-0002-0879-7099				Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; ARASE H, 2002, SCIENCE         0411; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Crnkovic-Mertens I, 1998, J VIROL, V72, P1377; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; DEL VM, 1991, CELL, V66, P1145; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GRUNDY JE, 1981, INFECT IMMUN, V32, P277, DOI 10.1128/IAI.32.1.277-286.1981; GUTERMANN A, 2002, IN PRESS CURR TOP MI; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kavanagh DG, 2001, J EXP MED, V194, P967, DOI 10.1084/jem.194.7.967; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Peng YF, 2001, J VIROL, V75, P4540, DOI 10.1128/JVI.75.10.4540-4550.2001; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; Reusch U, 1999, EMBO J, V18, P1081, DOI 10.1093/emboj/18.4.1081; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Scalzo AA, 1999, IMMUNOGENETICS, V49, P238, DOI 10.1007/s002510050486; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; SCALZO AA, 1995, IMMUNOGENETICS, V41, P148, DOI 10.1007/BF00182328; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3	51	163	167	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					529	535		10.1038/ni799	http://dx.doi.org/10.1038/ni799			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021778				2022-12-18	WOS:000175874700011
J	Rankin, LC; Girard-Madoux, MJH; Seillet, C; Mielke, LA; Kerdiles, Y; Fenis, A; Wieduwild, E; Putoczki, T; Mondot, S; Lantz, O; Demon, D; Papenfuss, AT; Smyth, GK; Lamkanfi, M; Carotta, S; Renauld, JC; Shi, W; Carpentier, S; Soos, T; Arendt, C; Ugolini, S; Huntington, ND; Bez, GT; Vivier, E				Rankin, Lucille C.; Girard-Madoux, Mathilde J. H.; Seillet, Cyril; Mielke, Lisa A.; Kerdiles, Yann; Fenis, Aurore; Wieduwild, Elisabeth; Putoczki, Tracy; Mondot, Stanislas; Lantz, Olivier; Demon, Dieter; Papenfuss, Anthony T.; Smyth, Gordon K.; Lamkanfi, Mohamed; Carotta, Sebastian; Renauld, Jean-Christophe; Shi, Wei; Carpentier, Sabrina; Soos, Tim; Arendt, Christopher; Ugolini, Sophie; Huntington, Nicholas D.; Bez, Gabrielle T.; Vivier, Eric			Complementarity and redundancy of IL-22-producing innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELL; COMMENSAL BACTERIA; IL-22 PRODUCTION; HOST-DEFENSE; INTERLEUKIN-22; INFLAMMATION; LYMPHOCYTES; INFECTION	Intestinal T cells and group 3 innate lymphoid cells (ILC3 cells) control the composition of the microbiota and gut immune responses. Within the gut, ILC3 subsets coexist that either express or lack the natural cytoxicity receptor (NCR) NKp46. We identified here the transcriptional signature associated with the transcription factor T-bet-dependent differentiation of NCR- ILC3 cells into NCR+ ILC3 cells. Contrary to the prevailing view, we found by conditional deletion of the key ILC3 genes Stat3, 1122, Tbx21 and Mcl1 that NCR+ ILC3 cells were redundant for the control of mouse colonic infection with Citrobacter rodentium in the presence of T cells. However, NCR+ ILC3 cells were essential for cecal homeostasis. Our data show that interplay between intestinal ILC3 cells and adaptive lymphocytes results in robust complementary failsafe mechanisms that ensure gut homeostasis.	[Rankin, Lucille C.; Seillet, Cyril; Mielke, Lisa A.; Putoczki, Tracy; Papenfuss, Anthony T.; Smyth, Gordon K.; Carotta, Sebastian; Shi, Wei; Huntington, Nicholas D.; Bez, Gabrielle T.; Vivier, Eric] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Rankin, Lucille C.; Seillet, Cyril; Mielke, Lisa A.; Putoczki, Tracy; Papenfuss, Anthony T.; Smyth, Gordon K.; Carotta, Sebastian; Shi, Wei; Huntington, Nicholas D.; Bez, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Girard-Madoux, Mathilde J. H.; Kerdiles, Yann; Fenis, Aurore; Wieduwild, Elisabeth; Ugolini, Sophie; Vivier, Eric] Univ Aix Marseille, Ctr Immunol Marseille Luminy, CNRS, Inserm,U1104,UMR7280,UM2, Marseille, France; [Mondot, Stanislas] Inst Pasteur, Labex Milieu Interieur, Paris, France; [Lantz, Olivier] Inst Curie, Lab Immunol, Paris, France; [Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Demon, Dieter; Lamkanfi, Mohamed] Univ Ghent, VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium; [Demon, Dieter; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Carotta, Sebastian] Boehringer Ingelheim RCV, Vienna, Austria; [Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels, Belgium; [Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, Brussels, Belgium; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Carpentier, Sabrina] Aix Marseille Univ, MI mAbs Consortium, Ctr Immunol Marseille Luminy, Marseille, France; [Soos, Tim] SANOFI, Bioinnovat, Boston, MA USA; [Vivier, Eric] Hop Conception, AP HP, Immunol, Marseille, France; [Rankin, Lucille C.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Melbourne; Boehringer Ingelheim; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Cornell University	Bez, GT; Vivier, E (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Bez, GT (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	belz@wehi.edu.au; vivier@ciml.univ-mrs.fr	Papenfuss, Anthony T/C-6297-2008; Smyth, Gordon/B-5276-2008; Seillet, Cyril/AAF-1888-2019; Vivier, Eric/F-8939-2010; Belz, Gabrielle T/C-9350-2013; Huntington, NICHOLAS/AAV-4704-2020; kerdiles, yann/U-2190-2018; Renauld, Jean-Christophe/B-7268-2012	Papenfuss, Anthony T/0000-0002-1102-8506; Smyth, Gordon/0000-0001-9221-2892; Seillet, Cyril/0000-0002-0941-8679; Vivier, Eric/0000-0001-7022-8287; Belz, Gabrielle T/0000-0002-9660-9587; Huntington, NICHOLAS/0000-0002-5267-7211; kerdiles, yann/0000-0002-8605-1073; Rankin, Lucille/0000-0002-3699-1569; Mielke, Lisa/0000-0002-9522-9320; Mondot, Stanislas/0000-0003-3668-3168; Renauld, Jean-Christophe/0000-0003-1736-2131; Lantz, olivier/0000-0003-3161-7719; Girard-Madoux, Mathilde/0000-0002-8840-2623; Ugolini, Sophie/0000-0003-4041-0103; Wieduwild, Elisabeth/0000-0002-8550-7665	National Health and Medical Research Council of Australia; Dora Lush Postgraduate Research Scholarship; Australian Research Council; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrustructure Support; European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee); INSERM; CNRS; Aix-Marseille University; Institut Universitaire de France	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Postgraduate Research Scholarship; Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrustructure Support(National Health and Medical Research Council (NHMRC) of Australia); European Research Council (THINK Advanced Grant); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Institut Universitaire de France	We thank M. Camilleri, J. Vella, E. Loza and L. Inglis and the staff of the animal and flow cytometry facilities of The Walter and Eliza Hall Institute of Medical Research and the Centre d'Immunologie de Marseille-Luminy for technical assistance; S. Kaech (Yale University) for mice with loxP-flanked alleles encoding T-bet; and L. Chasson and C. Laprie (Centre d'Immunologie de Marseille-Luminy) for expertise in histology and for assigning scores to tissue sections. Supported by the National Health and Medical Research Council of Australia (G.T.B., Se.C. and N.H.; Dora Lush Postgraduate Research Scholarship to L.C.R.); the Australian Research Council (Future Fellowship to G.T.B.); the Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institutes Infrustructure Support; the European Research Council (THINK Advanced Grant), the Ligue Nationale contre le Cancer (Equipe Labellisee), INSERM, CNRS and Aix-Marseille University to Centre d'Immunologie de Marseille-Luminy (all for the E.V. laboratory); and the Institut Universitaire de France (E.V.).	Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Frisch M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b716; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Smith HF, 2009, J EVOLUTION BIOL, V22, P1984, DOI 10.1111/j.1420-9101.2009.01809.x; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; van de Pavert S.A., INT IMMUNOL, DOI [10.1093/intimm/dxv052, DOI 10.1093/INTIMM/DXV052]; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Xu X, 2014, J IMMUNOL, V192, P1778, DOI 10.4049/jimmunol.1300039; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	41	162	166	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					179	186		10.1038/ni.3332	http://dx.doi.org/10.1038/ni.3332			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26595889	Green Submitted, Green Accepted			2022-12-18	WOS:000368571500011
J	Hamazaki, Y; Fujita, H; Kobayashi, T; Choi, Y; Scott, HS; Matsumoto, M; Minato, N				Hamazaki, Yoko; Fujita, Harumi; Kobayashi, Takashi; Choi, Yongwon; Scott, Hamish S.; Matsumoto, Mitsuru; Minato, Nagahiro			Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin	NATURE IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; TIGHT JUNCTION STRANDS; CENTRAL TOLERANCE; SELF-TOLERANCE; DEFICIENT MICE; ANTIGEN; DIFFERENTIATION; AUTOIMMUNITY; PROGENITOR	The autoimmune regulator Aire is expressed in a small proportion of medullary thymic epithelial cells (mTECs) and is crucial in the induction of central T cell tolerance. The origin and development of Aire(+) mTECs, however, are not well understood. Here we demonstrate that the tight-junction components claudin-3 and claudin-4 (Cld3,4) were 'preferentially' expressed in Aire+ mTECs. In early ontogeny, Cld3,4(hi) TECs derived from the most apical layer of the stratified thymic anlage first expressed known mTEC markers such as UEA-1 ligand and MTS10. We provide evidence that such Cld3,4(hi) UEA-1(+) TECs represented the initial progenitors specified for Aire(+) mTECs, whose development crucially required NF-kappa B-inducing kinase and the adaptor molecule TRAF6. Our results suggest that Aire(+) mTECs represent terminally differentiated cells in a unique lineage arising during thymic organogenesis.	Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan	Kyoto University; Kyoto University; Kyushu University; University of Pennsylvania; Walter & Eliza Hall Institute; Tokushima University	Minato, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	minato@imm.med.kyoto-u.ac.jp	Scott, Hamish/B-2122-2009; Hamazaki, Y*/Q-3076-2019	Scott, Hamish/0000-0002-5813-631X; Hamazaki, Y*/0000-0001-5866-7340; Fujita, Harumi/0000-0003-2133-845X				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; ANDERSON G, 1994, J EXP MED, V179, P2027, DOI 10.1084/jem.179.6.2027; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Gillard GO, 2005, J EXP MED, V202, P15, DOI 10.1084/jem.20050976; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Zhang MF, 2003, J IMMUNOL, V170, P3954, DOI 10.4049/jimmunol.170.8.3954; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	49	162	163	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					304	311		10.1038/ni1438	http://dx.doi.org/10.1038/ni1438			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17277780				2022-12-18	WOS:000244275100016
J	Welte, S; Kuttruff, S; Waldhauer, I; Steinle, A				Welte, Stefan; Kuttruff, Sabrina; Waldhauer, Inja; Steinle, Alexander			Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction	NATURE IMMUNOLOGY			English	Article							NK GENE-COMPLEX; DENDRITIC CELLS; CUTTING EDGE; PLASMODIUM-FALCIPARUM; NKG2D RECEPTOR; MISSING SELF; T-CELLS; IN-VIVO; LIGANDS; EXPRESSION	Receptors encoded by the natural killer (NK) cell gene complex (such as NKG2D) govern the reactivity of NK cells. However, the function and ligand(s) of the NK cell gene complex-encoded human NK cell receptor NKp80 remain elusive. Here we demonstrate that NKp80 binds to the genetically linked 'orphan' receptor AICL, which, like NKp80, is absent from rodents. We defined AICL as a myeloid-specific activating receptor that is upregulated by Toll-like receptor stimulation. AICL-NKp80 interactions promoted NK cell-mediated cytolysis of malignant myeloid cells. In addition, during crosstalk between NK cells and monocytes, NKp80 stimulated the release of proinflammatory cytokines from both cell types. Thus, by specifically bridging NK cells and myeloid cells, NKp80-AICL interactions may contribute to the initiation and maintenance of immune responses at sites of inflammation.	Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Steinle, A (corresponding author), Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany.	alexander.steinle@uni-tuebingen.de	Steinle, Alexander/E-6131-2012	Steinle, Alexander/0000-0001-5081-8503				AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Biassoni R, 2005, J IMMUNOL, V174, P5695, DOI 10.4049/jimmunol.174.9.5695; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cooper GJS, 2001, AUST J DAIRY TECHNOL, V56, P97; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hamann J, 1997, IMMUNOGENETICS, V45, P295, DOI 10.1007/s002510050208; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Korbel DS, 2005, J IMMUNOL, V175, P7466, DOI 10.4049/jimmunol.175.11.7466; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roda-Navarro P, 2000, EUR J IMMUNOL, V30, P568, DOI 10.1002/1521-4141(200002)30:2<568::AID-IMMU568>3.0.CO;2-Y; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vankayalapati R, 2005, J IMMUNOL, V175, P4611, DOI 10.4049/jimmunol.175.7.4611; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhang RJ, 2006, J IMMUNOL, V176, P2610, DOI 10.4049/jimmunol.176.4.2610	44	162	169	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1334	1342		10.1038/ni1402	http://dx.doi.org/10.1038/ni1402			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17057721				2022-12-18	WOS:000242125200016
J	Xiao, X; Balasubramanian, S; Liu, WT; Chu, XF; Wang, HB; Taparowsky, EJ; Fu, YX; Choi, Y; Walsh, MC; Li, XC				Xiao, Xiang; Balasubramanian, Savithri; Liu, Wentao; Chu, Xiufeng; Wang, Haibin; Taparowsky, Elizabeth J.; Fu, Yang-Xin; Choi, Yongwon; Walsh, Matthew C.; Li, Xian Chang			OX40 signaling favors the induction of T(H)9 cells and airway inflammation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; T-CELLS; FAMILY-MEMBERS; NUCLEAR-FACTOR; MAST-CELLS; TGF-BETA; EXPRESSION; IL-9; MICE; COSTIMULATION	The mechanisms that regulate the T(H)9 subset of helper T cells and diseases mediated by T(H)9 cells remain poorly defined. Here we found that the costimulatory receptor OX40 was a powerful inducer of T(H)9 cells in vitro and T(H)9 cell-dependent airway inflammation in vivo. In polarizing conditions based on transforming growth factor-beta (TGF-beta), ligation of OX40 inhibited the production of induced regulatory T cells and the T(H)17 subset of helper T cells and diverted CD4(+)Foxp3(-) T cells to a T(H)9 phenotype. Mechanistically, OX40 activated the ubiquitin ligase TRAF6, which triggered induction of the kinase NIK in CD4(+) T cells and the noncanonical transcription factor NF-kappa B pathway; this subsequently led to the generation of T(H)9 cells. Thus, our study identifies a previously unknown mechanism for the induction of T(H)9 cells and may have important clinical implications in allergic inflammation.	[Xiao, Xiang; Liu, Wentao; Chu, Xiufeng; Li, Xian Chang] Harvard Univ, Brigham & Womens Hosp, Transplant Res Ctr, Sch Med, Boston, MA 02115 USA; [Xiao, Xiang; Liu, Wentao; Chu, Xiufeng; Li, Xian Chang] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Balasubramanian, Savithri] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med, Boston, MA 02215 USA; [Wang, Haibin] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Allergy & Inflammat,Med Sch, Boston, MA 02215 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Dept Biol Sci, Lafayette, IN USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Choi, Yongwon; Walsh, Matthew C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Purdue University System; Purdue University; University of Chicago; University of Pennsylvania	Li, XC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Transplant Res Ctr, Sch Med, Boston, MA 02115 USA.	xli28@partners.org		fu, yang-xin/0000-0001-8441-6617; Li, Xian Chang/0000-0002-5981-2762; xiao, xiang/0000-0001-6644-6118	US National Institutes of Health; Juvenile Diabetes Research Foundation International; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064909, R01AI070315, R56AI070315] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Ishii (Tohoku University) for OX40L-transgenic mice; A. McKenzie (MRC Laboratory of Molecular Biology) for IL-9-deficient mice; M. Alegre (University of Chicago) for I kappa B alpha Delta N-transgenic mice; and D. Tenen (Harvard Medical School) for SfpI<SUP>f/f</SUP> mice. Supported by the US National Institutes of Health and the Juvenile Diabetes Research Foundation International.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Demirci G, 2008, CURR OPIN ORGAN TRAN, V13, P26, DOI 10.1097/MOT.0b013e3282f3def3; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Jash A, 2012, J BIOL CHEM, V287, P15445, DOI 10.1074/jbc.M112.340356; Kaur D, 2012, CHEST, V141, P494, DOI 10.1378/chest.11-1730; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Li XC, 2009, IMMUNOL REV, V229, P271, DOI 10.1111/j.1600-065X.2009.00781.x; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Tan C, 2012, CRIT REV IMMUNOL, V32, P1; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vu MD, 2006, J IMMUNOL, V176, P1394, DOI 10.4049/jimmunol.176.3.1394; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Zhan YF, 2008, J IMMUNOL, V181, P5405, DOI 10.4049/jimmunol.181.8.5405; Zhou P, 2005, J IMMUNOL, V174, P3447, DOI 10.4049/jimmunol.174.6.3447	43	161	173	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					981	990		10.1038/ni.2390	http://dx.doi.org/10.1038/ni.2390			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22842344	Green Accepted, Green Submitted			2022-12-18	WOS:000309038600014
J	Jabara, HH; McDonald, DR; Janssen, E; Massaad, MJ; Ramesh, N; Borzutzky, A; Rauter, I; Benson, H; Schneider, L; Baxi, S; Recher, M; Notarangelo, LD; Wakim, R; Dbaibo, G; Dasouki, M; Al-Herz, W; Barlan, I; Baris, S; Kutukculer, N; Ochs, HD; Plebani, A; Kanariou, M; Lefranc, G; Reisli, I; Fitzgerald, KA; Golenbock, D; Manis, J; Keles, S; Ceja, R; Chatila, TA; Geha, RS				Jabara, Haifa H.; McDonald, Douglas R.; Janssen, Erin; Massaad, Michel J.; Ramesh, Narayanaswamy; Borzutzky, Arturo; Rauter, Ingrid; Benson, Halli; Schneider, Lynda; Baxi, Sachin; Recher, Mike; Notarangelo, Luigi D.; Wakim, Rima; Dbaibo, Ghassan; Dasouki, Majed; Al-Herz, Waleed; Barlan, Isil; Baris, Safa; Kutukculer, Necil; Ochs, Hans D.; Plebani, Alessandro; Kanariou, Maria; Lefranc, Gerard; Reisli, Ismail; Fitzgerald, Katherine A.; Golenbock, Douglas; Manis, John; Keles, Sevgi; Ceja, Reuben; Chatila, Talal A.; Geha, Raif S.			DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation	NATURE IMMUNOLOGY			English	Article							SYK TYROSINE KINASE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; IMMUNE-RESPONSES; ANTIBODY-RESPONSES; HUMORAL IMMUNITY; STAT3 ACTIVATION; CPG ODN; INDUCTION; MYD88	The adaptors DOCK8 and MyD88 have been linked to serological memory. Here we report that DOCK8-deficient patients had impaired antibody responses and considerably fewer CD27(+) memory B cells. B cell proliferation and immunoglobulin production driven by Toll-like receptor 9 (TLR9) were considerably lower in DOCK8-deficient B cells, but those driven by the costimulatory molecule CD40 were not. In contrast, TLR9-driven expression of AICDA (which encodes the cytidine deaminase AID), the immunoglobulin receptor CD23 and the costimulatory molecule CD86 and activation of the transcription factor NF-kappa B, the kinase p38 and the GTPase Rac1 were intact. DOCK8 associated constitutively with MyD88 and the tyrosine kinase Pyk2 in normal B cells. After ligation of TLR9, DOCK8 became tyrosine-phosphorylated by Pyk2, bound the Src-family kinase Lyn and linked TLR9 to a Src-kinase Syk-transcription factor STAT3 cascade essential for TLR9-driven B cell proliferation and differentiation. Thus, DOCK8 functions as an adaptor in a TLR9-MyD88 signaling pathway in B cells.	[Jabara, Haifa H.; McDonald, Douglas R.; Janssen, Erin; Massaad, Michel J.; Ramesh, Narayanaswamy; Borzutzky, Arturo; Rauter, Ingrid; Benson, Halli; Schneider, Lynda; Baxi, Sachin; Recher, Mike; Notarangelo, Luigi D.; Geha, Raif S.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; [Jabara, Haifa H.; McDonald, Douglas R.; Janssen, Erin; Massaad, Michel J.; Ramesh, Narayanaswamy; Borzutzky, Arturo; Rauter, Ingrid; Benson, Halli; Schneider, Lynda; Baxi, Sachin; Recher, Mike; Notarangelo, Luigi D.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wakim, Rima; Dbaibo, Ghassan] Amer Univ Beirut, Beirut, Lebanon; [Dasouki, Majed] Univ Kansas, Med Ctr, Dept Pediat, Div Genet Endocrinol & Metab, Kansas City, KS 66103 USA; [Dasouki, Majed] Univ Kansas, Med Ctr, Dept Internal Med, Div Genet Endocrinol & Metab, Kansas City, KS 66103 USA; [Al-Herz, Waleed] Al Sabah Hosp, Allergy & Clin Immunol Unit, Dept Pediat, Kuwait, Kuwait; [Barlan, Isil; Baris, Safa] Marmara Univ, Div Pediat Allergy & Immunol, Istanbul, Turkey; [Kutukculer, Necil] Ege Univ, Dept Pediat Immunol, Izmir, Turkey; [Ochs, Hans D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Angelo Nocivelli Inst Mol Med, Brescia, Italy; [Kanariou, Maria] Agia Sophia Childrens Hosp, Athens, Greece; [Lefranc, Gerard] Univ Montpellier, Unite Propre Rech 1142, CNRS, Inst Med Genet, F-34059 Montpellier, France; [Reisli, Ismail; Keles, Sevgi] Selcuk Univ, Meram Med Fac, Div Pediat Allergy & Immunol, Konya, Turkey; [Fitzgerald, Katherine A.; Golenbock, Douglas] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Manis, John] Childrens Hosp, Dept Transfus Med, Boston, MA 02115 USA; [Keles, Sevgi; Ceja, Reuben; Chatila, Talal A.] Univ Calif Los Angeles, Div Allergy & Immunol, Los Angeles, CA USA; [Keles, Sevgi; Ceja, Reuben; Chatila, Talal A.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; American University of Beirut; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Al Sabah Hospital; Marmara University; Ege University; University of Washington; University of Washington Seattle; University of Brescia; University of Brescia; The Aghia Sophia Children's Hospital; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Selcuk University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Geha, RS (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	Dbaibo, Ghassan S./X-2978-2019; Baris, Safa/AAH-1932-2019; Fitzgerald, Katherine/ABE-6317-2020; Notarangelo, Luigi D/F-9718-2016	Baris, Safa/0000-0002-4730-9422; Notarangelo, Luigi D/0000-0002-8335-0262; Chatila, Talal/0000-0001-7439-2762; Fitzgerald, Kate/0000-0003-3175-609X; Janssen, Erin/0000-0002-0687-2550; Borzutzky, Arturo/0000-0002-7904-262X; Recher, Mike/0000-0002-9121-6936	US Public Health Service [P01AI076210, T32AI007512, R01AI083503, R21AI087627, K08AI076625]; Dubai Harvard Foundation for Medical Research; Swiss National Science Foundation [PASMP3-127678/1]; Clinical Immunology Society; Manton Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087627, R03AI094017, R01AI100315, P01AI076210, R01AI065617, T32AI007512, K08AI076625, R01AI083503, R21AI080002] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Dubai Harvard Foundation for Medical Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Immunology Society; Manton Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Uckun (University of Southern California, Los Angeles) for SYKINH-61; R. Treisman (Cancer Research UK) for hemagglutinin-tagged MRTF-A;J.-L. Casanova (The Rockefeller University), A. Puel and C. Picard (Hopital Necker-Enfants Malades, France) for the MyD88-deficient EBV-B cell line; K. Eurich for technical assistance; A. Rambhatla and A. Chen for help in DNA sequencing; members of the Geha laboratory for discussions; J. Kagan and H. Oettgen for comments on the manuscript; and the patients and their families for donating blood. Supported by the US Public Health Service (P01AI076210, T32AI007512 and R01AI083503 to R. S. G.; R21AI087627 to T. A. C.; and K08AI076625 to D. R. M.), the Dubai Harvard Foundation for Medical Research (R. S. G. and L.D.N.), the Swiss National Science Foundation (PASMP3-127678/1 to M. R.), the Clinical Immunology Society (E.J.) and the Manton Foundation (E.J. and L.D.N.).	Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Bonnette PC, 2010, J PROTEOMICS, V73, P1306, DOI 10.1016/j.jprot.2010.01.011; Boudot C, 2003, BIOCHEM BIOPH RES CO, V300, P437, DOI 10.1016/S0006-291X(02)02866-8; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Carpenter EL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-93; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2006, J IMMUNOL, V176, P1978, DOI 10.4049/jimmunol.176.3.1978; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Giordani L, 2009, J LEUKOCYTE BIOL, V86, P261, DOI 10.1189/jlb.0908560; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Guay HM, 2007, J IMMUNOL, V178, P5124, DOI 10.4049/jimmunol.178.8.5124; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jabara HH, 2001, J CLIN INVEST, V107, P371, DOI 10.1172/JCI10168; Jiang W, 2007, EUR J IMMUNOL, V37, P2205, DOI 10.1002/eji.200636984; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lim W, 2002, J IMMUNOL, V168, P1759, DOI 10.4049/jimmunol.168.4.1759; MATSUDA T, 1994, BLOOD, V83, P3457; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Park SM, 2008, J IMMUNOL, V181, P6447, DOI 10.4049/jimmunol.181.9.6447; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Seibert SA, 2010, IMMUNOL LETT, V127, P126, DOI 10.1016/j.imlet.2009.10.008; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Sin JI, 2011, VACCINE, V29, P4125, DOI 10.1016/j.vaccine.2011.03.098; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Uckun FM, 2010, P NATL ACAD SCI USA, V107, P2902, DOI 10.1073/pnas.0909086107; Weeratna RD, 2005, VACCINE, V23, P5263, DOI 10.1016/j.vaccine.2005.06.024; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhang XQ, 2007, J IMMUNOTHER, V30, P469, DOI 10.1097/CJI.0b013e31802fd8c6	54	161	167	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					612	+		10.1038/ni.2305	http://dx.doi.org/10.1038/ni.2305			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22581261	Green Accepted, Green Submitted			2022-12-18	WOS:000304203900016
J	Honke, N; Shaabani, N; Cadeddu, G; Sorg, UR; Zhang, DE; Trilling, M; Klingel, K; Sauter, M; Kandolf, R; Gailus, N; van Rooijen, N; Burkart, C; Baldus, SE; Grusdat, M; Lohning, M; Hengel, H; Pfeffer, K; Tanaka, M; Haussinger, D; Recher, M; Lang, PA; Lang, KS				Honke, Nadine; Shaabani, Namir; Cadeddu, Giuseppe; Sorg, Ursula R.; Zhang, Dong-Er; Trilling, Mirko; Klingel, Karin; Sauter, Martina; Kandolf, Reinhard; Gailus, Nicole; van Rooijen, Nico; Burkart, Christoph; Baldus, Stephan E.; Grusdat, Melanie; Loehning, Max; Hengel, Hartmut; Pfeffer, Klaus; Tanaka, Masato; Haeussinger, Dieter; Recher, Mike; Lang, Philipp A.; Lang, Karl S.			Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus	NATURE IMMUNOLOGY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; MARGINAL ZONE MACROPHAGES; T-CELL-ACTIVATION; DENDRITIC CELLS; I-INTERFERON; QUANTITATIVE-ANALYSIS; LYMPH-NODE; B-CELLS; INFECTION; RESPONSES	The innate immune system limits viral replication via type I interferon and also induces the presentation of viral antigens to cells of the adaptive immune response. Using infection of mice with vesicular stomatitis virus, we analyzed how the innate immune system inhibits viral propagation but still allows the presentation of antigen to cells of the adaptive immune response. We found that expression of the gene encoding the inhibitory protein Usp18 in metallophilic macrophages led to lower type I interferon responsiveness, thereby allowing locally restricted replication of virus. This was essential for the induction of adaptive antiviral immune responses and, therefore, for preventing the fatal outcome of infection. In conclusion, we found that enforced viral replication in marginal zone macrophages was an immunological mechanism that ensured the production of sufficient antigen for effective activation of the adaptive immune response.	[Honke, Nadine; Shaabani, Namir; Gailus, Nicole; Grusdat, Melanie; Haeussinger, Dieter; Lang, Philipp A.; Lang, Karl S.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Cadeddu, Giuseppe; Baldus, Stephan E.] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Sorg, Ursula R.; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Zhang, Dong-Er; Burkart, Christoph] Univ Calif San Diego, Dept Pathol, Div Biol Sci, La Jolla, CA 92093 USA; [Zhang, Dong-Er; Burkart, Christoph] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA; [Trilling, Mirko; Hengel, Hartmut] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Klingel, Karin; Sauter, Martina; Kandolf, Reinhard] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Fac Med, Amsterdam, Netherlands; [Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Loehning, Max] German Rheumatism Res Ctr, Berlin, Germany; [Tanaka, Masato] RIKEN Res Ctr Allergy & Immunol, Lab Innate Cellular Immun, Yokohama, Kanagawa, Japan; [Recher, Mike] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; [Lang, Philipp A.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Lang, Karl S.] Univ Essen Gesamthsch, Inst Immunol, Essen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of California System; University of California San Diego; University of California System; University of California San Diego; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); RIKEN; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Duisburg Essen	Lang, KS (corresponding author), Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.	philipp.lang@gmx.net; karlsebastian.lang@uk-essen.de	Lang, Karl S/R-2505-2016; Trilling, Mirko/AAL-3533-2021; Van Rooijen, Nico/Z-1578-2019; Löhning, Max/AAL-2967-2021	Trilling, Mirko/0000-0003-3659-3541; Löhning, Max/0000-0001-6382-7281; Grusdat, Melanie/0000-0003-0708-0077; Pfeffer, Klaus/0000-0002-5652-6330; Honke, Nadine/0000-0002-2220-6806; Lang, Karl/0000-0001-9783-7605; Recher, Mike/0000-0002-9121-6936	Alexander von Humboldt Foundation [SKA-2008, SKA-2010]; Collaborative Research Center [SFB575]; Deutsche Forschungsgemeinschaft [LA1419/3-1, SFB-TR19, FOR729]; MOI Manchot Graduate School (Jurgen Manchot Foundation); Swiss National Science Foundation [PASMP3-127678/1]; US National Institutes of Health [R01 HL091549]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091549] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390095] Funding Source: KAKEN	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Collaborative Research Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MOI Manchot Graduate School (Jurgen Manchot Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D. Kolakofsky (University of Geneva) for VSV; and K. Schattel for technical support. Supported by the Alexander von Humboldt Foundation (SKA-2008 to K.S.L. and SKA-2010 to P.A.L.), Collaborative Research Center SFB575, Experimental Hepatology (coordinator, D.H.; Deutsche Forschungsgemeinschaft grant LA1419/3-1 to K.S.L. and SFB-TR19 to K.K. and R.K.; FOR729 to K.P.; SFB/Transregio 60 (coordinator, M. Roggendorf), the MOI Manchot Graduate School (Jurgen Manchot Foundation), the Swiss National Science Foundation (PASMP3-127678/1 to M.R.) and the US National Institutes of Health (R01 HL091549 for Usp18-related work in the D.-E.Z. laboratory).	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; BACHMANN MF, 1993, J VIROL, V67, P3917, DOI 10.1128/JVI.67.7.3917-3922.1993; BACHMANN MF, 1994, MED MICROBIOL IMMUN, V183, P95, DOI 10.1007/BF00277160; Battegay M, 1996, CELL IMMUNOL, V167, P115, DOI 10.1006/cimm.1996.0014; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fink K, 2006, EUR J IMMUNOL, V36, P2094, DOI 10.1002/eji.200635993; FREER G, 1995, EUR J IMMUNOL, V25, P1410, DOI 10.1002/eji.1830250541; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Junt T, 2006, EUR J IMMUNOL, V36, P2061, DOI 10.1002/eji.200626255; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KRAAL G, 1989, EUR J IMMUNOL, V19, P675, DOI 10.1002/eji.1830190416; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NONACS R, 1992, J EXP MED, V176, P519, DOI 10.1084/jem.176.2.519; Oetke C, 2006, IMMUNOL LETT, V106, P96, DOI 10.1016/j.imlet.2006.04.004; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; OGRA PL, 1971, NEW ENGL J MED, V285, P1333, DOI 10.1056/NEJM197112092852401; OHASHI PS, 1993, J IMMUNOL, V150, P5185; PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Seiler P, 1997, EUR J IMMUNOL, V27, P2626, DOI 10.1002/eji.1830271023; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Steiniger B., 2000, ADV ANAT EMBRYOL, DOI [10.1007/978-3-642-57088-9, DOI 10.1007/978-3-642-57088-9]; WARDLE EN, 1987, LIVER, V7, P63; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Yoshimura A, 2005, CLIN REV ALLERG IMMU, V28, P205, DOI 10.1385/CRIAI:28:3:205; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	51	161	163	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					51	U131		10.1038/ni.2169	http://dx.doi.org/10.1038/ni.2169			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22101728				2022-12-18	WOS:000298412800011
J	Stadanlick, JE; Kaileh, M; Karnell, FG; Scholz, JL; Miller, JP; Quinn, WJ; Brezski, RJ; Treml, LS; Jordan, KA; Monroe, JG; Sen, R; Cancro, MP				Stadanlick, Jason E.; Kaileh, Mary; Karnell, Fredrick G.; Scholz, Jean L.; Miller, Juli P.; Quinn, William J., III; Brezski, Randall J.; Treml, Laura S.; Jordan, Kimberly A.; Monroe, John G.; Sen, Ranjan; Cancro, Michael P.			Tonic B cell antigen receptor signals supply an NF-kappa B substrate for prosurvival BLyS signaling	NATURE IMMUNOLOGY			English	Article							TYROSINE KINASE INHIBITOR; NECROSIS-FACTOR FAMILY; MARGINAL ZONE; LYMPHOCYTE STIMULATOR; MEMBRANE CHOLESTEROL; CUTTING EDGE; BAFF-R; ACTIVATION; SURVIVAL; NF-KAPPA-B2	The survival of transitional and mature B cells requires both the B cell antigen receptor (BCR) and BLyS receptor 3 (BR3), which suggests that these receptors send signals that are nonredundant or that engage in crosstalk with each other. Here we show that BCR signaling induced production of the nonclassical transcription factor NF-kappa B pathway substrate p100, which is required for transmission of BR3 signals and thus B cell survival. The capacity for sustained p100 production emerged during transitional B cell differentiation, the stage at which BCR signals begin to mediate survival rather than negative selection. Our findings identify a molecular mechanism for the reliance of primary B cells on continuous BR3 and BCR signaling, as well as for the gradual resistance to negative selection that is acquired during B cell maturation.	[Stadanlick, Jason E.; Karnell, Fredrick G.; Scholz, Jean L.; Miller, Juli P.; Quinn, William J., III; Brezski, Randall J.; Treml, Laura S.; Monroe, John G.; Cancro, Michael P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kaileh, Mary; Sen, Ranjan] NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; [Jordan, Kimberly A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania	Cancro, MP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	cancro@mail.med.upenn.edu	Quinn, William/K-1889-2019; Scholz, Jean L/AAJ-2333-2020	Brezski, Randall/0000-0003-4028-4741; Cancro, Michael/0000-0002-8659-3227; Quinn, William/0000-0002-3642-584X	US Public Health Service [R01AI073939, R01AI0545488, T32HL07971, T32AI055428, R01AI032592]; National Institute on Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, R01AI073939, R01AI054488, R01AI032592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000375] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. May, L. Solt and the University of Pennsylvania Flow Cytometry Core for assistance and advice; C. A. Hunter (University of Pennsylvania School of Veterinary Medicine) for NF-kappa B p50-deficient mice; C. Thompson (University of Pennsylvania) for mice with B cell-specific expression of the Bcl-xL transgene; V. Dixit (Genentech) for pRK5B-hBR3; and J.M. Stadanlick for critical reading of this manuscript. Supported by the US Public Health Service (R01AI073939 and R01AI0545488 to M. P. C.; T32HL07971 to J.E. S.; T32AI055428 to F. G. K.; and R01AI032592 to J.G.M.) and the Intramural Research Program of the National Institute on Aging.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Amanna IJ, 2003, J IMMUNOL, V170, P4593, DOI 10.4049/jimmunol.170.9.4593; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brezski RJ, 2007, J IMMUNOL, V179, P4464, DOI 10.4049/jimmunol.179.7.4464; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chung JB, 2002, INT IMMUNOL, V14, P157, DOI 10.1093/intimm/14.2.157; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Francis DA, 1998, INT IMMUNOL, V10, P285, DOI 10.1093/intimm/10.3.285; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hondowicz BD, 2007, INT IMMUNOL, V19, P465, DOI 10.1093/intimm/dxm011; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Karnell FG, 2005, J BIOL CHEM, V280, P25621, DOI 10.1074/jbc.M503162200; Lai JYQ, 2003, BIOORG MED CHEM LETT, V13, P3111, DOI 10.1016/S0960-894X(03)00658-9; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pear W., 2001, CURR PROTOC MOL BIOL; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Weil R, 2004, CURR OPIN IMMUNOL, V16, P374, DOI 10.1016/j.coi.2004.03.003; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X	50	161	163	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1379	1387		10.1038/ni.1666	http://dx.doi.org/10.1038/ni.1666			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18978795	Green Accepted			2022-12-18	WOS:000260888700013
J	Ahmed, R; Oldstone, MBA; Palese, P				Ahmed, Rafi; Oldstone, Michael B. A.; Palese, Peter			Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; CHRONIC VIRAL-INFECTION; IMMUNOLOGICAL MEMORY; SMALLPOX VACCINATION; PARTICLE VACCINE; HUMORAL IMMUNITY; PLASMA-CELLS; B-CELL; VIRUS; MORTALITY	The influenza pandemic of 1918 killed nearly 50 million people worldwide and was characterized by an atypical W-shaped mortality curve, where adults between the ages of 30-60 years fared better than younger adults aged 18-30 years. In this review, we will discuss why this influenza virus strain was so virulent and how immunological memory to the 1918 virus may have shaped the W mortality curve. We will end on the topic of the 'honeymoon' period of infectious diseases - the clinically documented period between the ages of 4-13 years during which children demonstrate less morbidity and/or mortality to infectious diseases, in general, compared with young adults.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Scripps Res Inst, Viral Immunobiol Lab, Mol & Integrat Neurosci Lab, La Jolla, CA 92037 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Emory University; Emory University; Scripps Research Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	ra@microbio.emory.edu		Palese, Peter/0000-0002-0337-5823				Ahmed R, 2006, IMMUNOL REV, V211, P5, DOI 10.1111/j.0105-2896.2006.00424.x; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Crosby A., 1989, AM FORGOTTEN PANDEMI; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; FEIGIN RD, 2004, TXB PEDIAT INFECTIOU; Finlay BB, 2004, NAT REV MICROBIOL, V2, P602, DOI 10.1038/nrmicro930; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Giuliano AR, 2007, J INFECT DIS, V196, P1153, DOI 10.1086/521679; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Langford C, 2002, MED HIST, V46, P1; Linder Forrest, 1947, VITAL STAT RATES US; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Oldstone M B, 1994, Curr Top Microbiol Immunol, V189, P1; Palese P, 2006, IMMUNITY, V24, P121, DOI 10.1016/j.immuni.2006.01.007; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Palese P., 2007, FIELDS VIROLOGY; PLOTKIN SA, 2004, VACCINE; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; SVITIL KA, 2003, DISCOVER        0801; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	50	161	175	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1188	1193		10.1038/ni1530	http://dx.doi.org/10.1038/ni1530			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952044	Green Published, Bronze			2022-12-18	WOS:000250338900009
J	Weskamp, G; Ford, JW; Sturgill, J; Martin, S; Docherty, AJP; Swendeman, S; Broadway, N; Hartmann, D; Saftig, P; Umland, S; Sehara-Fujisawa, A; Black, RA; Ludwig, A; Becherer, JD; Conrad, DH; Blobel, CP				Weskamp, Gisela; Ford, Jill W.; Sturgill, Jamie; Martin, Steve; Docherty, Andrew J. P.; Swendeman, Steven; Broadway, Neil; Hartmann, Dieter; Saftig, Paul; Umland, Shelby; Sehara-Fujisawa, Atsuko; Black, Roy A.; Ludwig, Andreas; Becherer, J. David; Conrad, Daniel H.; Blobel, Carl P.			ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RII; METALLOPROTEASE-DISINTEGRIN MDC9; REGULATES MONOCYTE ACTIVATION; COLLAGEN-INDUCED ARTHRITIS; AMYLOID PRECURSOR PROTEIN; CELL-CELL ADHESION; IGE PRODUCTION; SOLUBLE CD23; CATALYTIC-ACTIVITY; EXPRESSION	CD23, the low-affinity immunoglobulin E receptor, is an important modulator of the allergic response and of diseases such as rheumatoid arthritis. The proteolytic release of CD23 from cells is considered a key event in the allergic response. Here we used loss-of-function and gain-of-function experiments with cells lacking or overexpressing candidate CD23-releasing enzymes (ADAM8, ADAM9, ADAM10, ADAM12, ADAM15, ADAM17, ADAM19 and ADAM33), ADAM-knockout mice and a selective inhibitor to identify ADAM10 as the main CD23-releasing enzyme in vivo. Our findings provide a likely target for the treatment 5 of allergic reactions and set the stage for further studies of the involvement of ADAM10 in CD23-dependent pathologies.	Cornell Univ, Weill Med Coll, Hosp Special Surg, Arthrit & Tissue Regenerat Program, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; Virginia Commonwealth Univ, Dept Immunol & Microbiol, Richmond, VA 23298 USA; GlaxoSmithKline, Discovery Res, Stevenage SG1 2NY, Herts, England; Celltech Ltd, Slough SL1 4EN, Berks, England; Katholieke Univ Leuven VIB, Dept Human Genet, B-3000 Louvain, Belgium; Univ Kiel, Inst Biochem, D-24089 Kiel, Germany; Schering Plough Corp, Inst Res, Kenilworth, NJ 07033 USA; Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto 6068507, Japan; Amgen Inc, Seattle, WA 98119 USA; Rhein Westphalian Tech Univ, Inst Mol Cardiovasc Res, Aachen, Germany; GlaxoSmithKline, Dept Biochem & Analyt Pharmacol, Res Triangle Pk, NC 27709 USA	Cornell University; Cornell University; Cornell University; Virginia Commonwealth University; GlaxoSmithKline; Celltech Group Ltd; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Kiel; Merck & Company; Schering Plough Corporation; Kyoto University; Amgen; RWTH Aachen University; GlaxoSmithKline	Blobel, CP (corresponding author), Cornell Univ, Weill Med Coll, Hosp Special Surg, Arthrit & Tissue Regenerat Program, New York, NY 10021 USA.	blobelc@hss.edu	Saftig, Paul/A-7966-2010; Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986; Sturgill, Jamie/0000-0001-8856-3227	NCRR NIH HHS [C06-RR12538-01] Funding Source: Medline; NIAID NIH HHS [R01 AI018697, AI18697, T32 AI07407] Funding Source: Medline; NIGMS NIH HHS [GM64750] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018697, T32AI007407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Caven TH, 2005, CELL IMMUNOL, V238, P123, DOI 10.1016/j.cellimm.2006.03.001; Christie G, 1997, EUR J IMMUNOL, V27, P3228, DOI 10.1002/eji.1830271221; CONRAD DH, 1984, J IMMUNOL, V132, P796; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Gu B, 1998, BLOOD, V92, P946; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huissoon AP, 2000, SCAND J RHEUMATOL, V29, P154; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; KEEGAN AD, 1989, J IMMUNOL, V142, P3868; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Kilmon MA, 2004, J IMMUNOL, V172, P1065, DOI 10.4049/jimmunol.172.2.1065; Kilmon MA, 2001, J IMMUNOL, V167, P3139, DOI 10.4049/jimmunol.167.6.3139; Kleinau S, 1999, J IMMUNOL, V162, P4266; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LecoanetHenchoz S, 1997, EUR J IMMUNOL, V27, P2290, DOI 10.1002/eji.1830270924; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marolewski AE, 1998, BIOCHEM J, V333, P573, DOI 10.1042/bj3330573; Mayer RJ, 2000, CLIN EXP ALLERGY, V30, P719; Molica S, 1996, HAEMATOLOGICA, V81, P428; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Payet ME, 1999, J IMMUNOL, V163, P217; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; PENE J, 1988, EUR J IMMUNOL, V18, P929, DOI 10.1002/eji.1830180615; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PLATERZYBERK C, 1995, NAT MED, V1, P781, DOI 10.1038/nm0895-781; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Ribbens C, 2000, CLIN EXP IMMUNOL, V120, P194, DOI 10.1046/j.1365-2249.2000.01198.x; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sarfati M, 1996, BLOOD, V88, P4259; Schwartz W., 2004, BIOPROCESSING J, V3, P53; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Umland SP, 2003, AM J RESP CELL MOL, V29, P571, DOI 10.1165/rcmb.2003-0028OC; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	46	161	166	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1293	1298		10.1038/ni1399	http://dx.doi.org/10.1038/ni1399			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17072319				2022-12-18	WOS:000242125200011
J	Martin, SW; Goodnow, CC				Martin, SW; Goodnow, CC			Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory	NATURE IMMUNOLOGY			English	Article							B-CELL ACTIVATION; LYMPHOCYTES-B; ANTIGEN RECEPTORS; SURFACE-IMMUNOGLOBULIN; IMMUNOLOGICAL MEMORY; CLONAL EXPANSION; TRANSGENIC MICE; IN-VIVO; T-CELLS; EXPRESSION	The basis of immune memory leading to heightened secondary antibody responses is a longstanding unanswered issue. Here we show that a single irreversible molecular change in the B cell antigen receptor, which is brought about by immunoglobulin M (IgM) to IgG isotype switching, is sufficient to greatly increase the extrafollicular proliferative burst of antigen-specific B cells. The unique membrane-spanning regions of IgG do not alter the T cell-dependent activation and proliferation of antigen-specific B cells in vivo, but markedly increase the number of progeny cells and plasmablasts that accumulate. These results establish a key molecular determinant of immunological memory and define an unexpected cellular basis by which it enhances the magnitude of secondary antibody responses.	Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, ACRF Genet Lab, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, ACRF Genet Lab, POB 334,Mills Rd, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155; Martin, Stephen/0000-0002-7981-524X				Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; BRUNET FM, 1959, CLONAL DELECTION THE; CELADA F, 1971, PROG ALLERGY, V15, P223; COFFMAN RL, 1977, J IMMUNOL, V118, P1806; DIXON FJ, 1954, J IMMUNOL, V72, P179; Doyle AM, 2001, J EXP MED, V194, P893, DOI 10.1084/jem.194.7.893; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; HILL SW, 1975, EUR J IMMUNOL, V5, P317, DOI 10.1002/eji.1830050506; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Knight AM, 1997, EMBO J, V16, P3842, DOI 10.1093/emboj/16.13.3842; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Nussenzweig MC, 1997, CURR BIOL, V7, pR355, DOI 10.1016/S0960-9822(06)00173-4; POGUE SL, 1994, J IMMUNOL, V152, P3925; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tierens A, 1999, BLOOD, V93, P226, DOI 10.1182/blood.V93.1.226.401a30_226_234; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Vora KA, 1998, J IMMUNOL, V160, P728; Warren HS, 1999, IMMUNOL CELL BIOL, V77, P544, DOI 10.1046/j.1440-1711.1999.00865.x; WEISER P, 1994, EUR J IMMUNOL, V24, P665, DOI 10.1002/eji.1830240327; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; YEFENOF E, 1986, J IMMUNOL, V137, P85; YUAN D, 1977, J EXP MED, V145, P1421, DOI 10.1084/jem.145.6.1421	42	161	169	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					182	188		10.1038/ni752	http://dx.doi.org/10.1038/ni752			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812996				2022-12-18	WOS:000173562400019
J	Zuo, JM; Dowell, AC; Pearce, H; Verma, K; Long, HM; Begum, J; Aiano, F; Amin-Chowdhury, Z; Hallis, B; Stapley, L; Borrow, R; Linley, E; Ahmad, S; Parker, B; Horsley, A; Amirthalingam, G; Brown, K; Ramsay, ME; Ladhani, S; Moss, P				Zuo, Jianmin; Dowell, Alexander C.; Pearce, Hayden; Verma, Kriti; Long, Heather M.; Begum, Jusnara; Aiano, Felicity; Amin-Chowdhury, Zahin; Hallis, Bassam; Stapley, Lorrain; Borrow, Ray; Linley, Ezra; Ahmad, Shazaad; Parker, Ben; Horsley, Alex; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary E.; Ladhani, Shamez; Moss, Paul			Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection	NATURE IMMUNOLOGY			English	Article							RESPONSES; MEMORY; CORONAVIRUS; PROTECTION; ANTIBODIES	The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern that waning immunity may predispose to reinfection. We analyzed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at 6 months following infection. T cell responses were present by ELISPOT and/or intracellular cytokine staining analysis in all donors and characterized by predominant CD4(+) T cell responses with strong interleukin (IL)-2 cytokine expression. Median T cell responses were 50% higher in donors who had experienced a symptomatic infection, indicating that the severity of primary infection establishes a 'set point' for cellular immunity. T cell responses to spike and nucleoprotein/membrane proteins were correlated with peak antibody levels. Furthermore, higher levels of nucleoprotein-specific T cells were associated with preservation of nucleoprotein-specific antibody level although no such correlation was observed in relation to spike-specific responses. In conclusion, our data are reassuring that functional SARS-CoV-2-specific T cell responses are retained at 6 months following infection. The contribution of T cells to the SARS-CoV-2 response remains an important and unresolved question. Moss and colleagues examine T cell and antibody kinetics in a large cohort of patients with COVID-19 and find robust and durable T cell responses.	[Zuo, Jianmin; Dowell, Alexander C.; Pearce, Hayden; Verma, Kriti; Long, Heather M.; Begum, Jusnara; Moss, Paul] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Aiano, Felicity; Amin-Chowdhury, Zahin; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary E.; Ladhani, Shamez] Natl Infect Serv, Immunisat & Countermeasures Div, London, England; [Hallis, Bassam; Stapley, Lorrain] Natl Infect Serv, Immunoassay Lab, Porton Down, England; [Borrow, Ray; Linley, Ezra] Manchester Royal Infirm, Manchester Med Microbiol Partnership, Publ Hlth Lab Manchester, Publ Hlth England,Seroepidemiol Unit, Manchester, Lancs, England; [Ahmad, Shazaad] Manchester Acad, Hlth Sci Ctr, Manchester Fdn Trust, Manchester Med Microbiol Partnership,Dept Virol, Manchester, Lancs, England; [Parker, Ben; Horsley, Alex] Manchester Univ NHS Fdn Trust, NIHR Manchester Clin Res Facil, Manchester, Lancs, England; [Parker, Ben] Manchester Univ NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Kellgren Ctr Rheumatol, Manchester, Lancs, England; [Horsley, Alex] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Ladhani, Shamez] St Georges Univ London SGUL, Paediatr Infect Dis Res Grp PIDRG, London, England	University of Birmingham; Public Health England; University of Manchester; University of Manchester; St Georges University London	Moss, P (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Ladhani, S (corresponding author), Natl Infect Serv, Immunisat & Countermeasures Div, London, England.; Ladhani, S (corresponding author), St Georges Univ London SGUL, Paediatr Infect Dis Res Grp PIDRG, London, England.	Shamez.Ladhani@phe.gov.uk; P.Moss@bham.ac.uk	Zuo, Jianmin/AAU-6491-2021; Moss, Paul/D-1728-2009	Zuo, Jianmin/0000-0002-8341-465X; Moss, Paul/0000-0002-6895-1967; Parker, Ben/0000-0001-7959-6529; Dowell, Alexander/0000-0002-1909-7047; Horsley, Alex/0000-0003-1828-0058; Pearce, Hayden/0000-0002-8380-8122; Verma, Kriti/0000-0002-7368-8171	UK Research and Innovation/National Institute for Health Research (NIHR) through the UK Coronavirus Immunology Consortium (UK-CIC); Blood Cancer UK [17009]; Medical Research Council [MR/R011230/1]; NIHR Manchester Clinical Research Facility; NIHR Manchester Biomedical Research Centre	UK Research and Innovation/National Institute for Health Research (NIHR) through the UK Coronavirus Immunology Consortium (UK-CIC); Blood Cancer UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Manchester Clinical Research Facility; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was partly funded by UK Research and Innovation/National Institute for Health Research (NIHR) through the UK Coronavirus Immunology Consortium (UK-CIC). K.V. is supported by Blood Cancer UK (grant no. 17009) and A.D. is supported by the Medical Research Council (grant no. MR/R011230/1). This research was carried out with the support of the NIHR Manchester Clinical Research Facility. B.P. and A.H. are supported by the NIHR Manchester Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the Department of Health.	Altmann Daniel M, 2020, Oxf Open Immunol, V1, piqaa003, DOI 10.1093/oxfimm/iqaa003; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Berretta AA, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110622; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fan YY, 2009, ARCH VIROL, V154, P1093, DOI 10.1007/s00705-009-0409-6; Figueiredo-Campos P, 2020, EUR J IMMUNOL, V50, P2025, DOI 10.1002/eji.202048970; Forner G, 2016, J CLIN MICROBIOL, V54, P2149, DOI 10.1128/JCM.00561-16; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guthmiller JJ, 2021, MBIO, V12, DOI 10.1128/mBio.02940-20; Harris R.J., SEROLOGICAL SURVEILL, DOI [10.1101/2020.10.21.20216689, DOI 10.1101/2020.10.21.20216689]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Iwasaki A, 2021, LANCET INFECT DIS, V21, P3, DOI 10.1016/S1473-3099(20)30783-0; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Martin-Gayo E, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89574; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Meckiff Benjamin J, 2020, SSRN, P3641939, DOI [10.1101/2020.06.12.148916, 10.2139/ssrn.3641939]; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Payne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Reynolds C.J., 2020, HEALTHCARE WORKERS M, DOI [10.1101/2020.10.13.20211763, DOI 10.1101/2020.10.13.20211763]; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Savic M, 2016, IMMUNOLOGY, V147, P165, DOI 10.1111/imm.12548; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Thieme CJ, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100092; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wu LP, 2007, EMERG INFECT DIS, V13, P1562, DOI 10.3201/eid1310.070576; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443	39	160	165	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					620	+		10.1038/s41590-021-00902-8	http://dx.doi.org/10.1038/s41590-021-00902-8		MAR 2021	14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33674800	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-18	WOS:000625624300001
J	Papotto, PH; Ribot, JC; Silva-Santos, B				Papotto, Pedro H.; Ribot, Julie C.; Silva-Santos, Bruno			IL-17(+) gamma delta T cells as kick-starters of inflammation	NATURE IMMUNOLOGY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LISTERIA-MONOCYTOGENES INFECTION; PSORIASIFORM SKIN INFLAMMATION; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; TH17 CELLS; PROINFLAMMATORY IL-17(+); RECEPTOR REPERTOIRE; INTERFERON-GAMMA; INNATE IMMUNITY	Shortly after the discovery of interleukin 17 (IL-17)-producing CD4(+) helper T cells (T(H)17 cells), it was found that gamma delta T cells can also secrete large amounts of this pro-inflammatory cytokine. A decade later, it is now known that IL-17(+) gamma delta T cells (gamma delta 17 T cells) are often the main providers of IL-17A in various models of inflammatory diseases, while they also contribute to protective immune responses to infectious organisms. Due to an intricate thymic program of differentiation, gamma delta 17 T cells are able to respond faster than T(H)17 cells do and thus predominate in the early stages of inflammatory responses. Here we review the current knowledge of the development, activation and pathophysiological functions of gamma delta 17 T cells, aiming to increase the awareness in the community of the therapeutic potential of this 'other side' of IL-17-mediated immune responses.	[Papotto, Pedro H.; Ribot, Julie C.; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal	Universidade de Lisboa	Silva-Santos, B (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	bssantos@medicina.ulisboa.pt	; Ribot, Julie/D-5487-2014	Papotto, Pedro/0000-0002-2488-7182; Ribot, Julie/0000-0002-7852-343X; Silva-Santos, Bruno/0000-0003-4141-9302	European Research Council [CoG_646701]; Fundacao para a Ciencia e Tecnologia [PD/BD/105855/2014, IF/00013/2014]	European Research Council(European Research Council (ERC)European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Supported by the European Research Council (CoG_646701 to B.S.-S.) and Fundacao para a Ciencia e Tecnologia (PD/BD/105855/2014 to P.H.P.; IF/00013/2014 to J.C.R.).	Adamski MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097755; Akitsu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8464; Barros-Martins J, 2016, J IMMUNOL, V196, P3642, DOI 10.4049/jimmunol.1501921; Bekiaris V, 2013, IMMUNITY, V39, P1082, DOI 10.1016/j.immuni.2013.10.017; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blink SE, 2014, CELL IMMUNOL, V290, P39, DOI 10.1016/j.cellimm.2014.04.013; Boismenu R, 1996, J IMMUNOL, V157, P985; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen JM, 2014, DEMENT GERIATR COGN, V38, P321, DOI 10.1159/000360606; Chien YH, 2013, TRENDS IMMUNOL, V34, P151, DOI 10.1016/j.it.2012.11.004; Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504; Colpitts SL, 2015, P NATL ACAD SCI USA, V112, P9692, DOI 10.1073/pnas.1420741112; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Fay NS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00210; Fujikado N, 2016, IMMUNITY, V45, P999, DOI 10.1016/j.immuni.2016.10.023; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hartwig T, 2015, EUR J IMMUNOL, V45, P3022, DOI 10.1002/eji.201545883; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HVAS J, 1993, J NEUROIMMUNOL, V46, P225, DOI 10.1016/0165-5728(93)90253-U; Imai Y, 2015, J IMMUNOL, V195, P421, DOI 10.4049/jimmunol.1500448; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kashani E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7477; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Li FL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13839; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mair F, 2015, ELIFE, V4, DOI 10.7554/eLife.10087; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Malik S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00014; Markle JGM, 2013, J IMMUNOL, V190, P5392, DOI 10.4049/jimmunol.1203502; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Misiak A, 2017, J IMMUNOL, V198, P363, DOI 10.4049/jimmunol.1601024; Moens E, 2011, J LEUKOCYTE BIOL, V89, P743, DOI 10.1189/jlb.0910501; Munoz-Ruiz M., 2017, TRENDS IMMUNOL; Munoz-Ruiz M, 2016, NAT IMMUNOL, V17, P721, DOI 10.1038/ni.3424; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Nakamura M, 2015, J IMMUNOL, V194, P243, DOI 10.4049/jimmunol.1401619; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Nitta T, 2015, EMBO REP, V16, P638, DOI 10.15252/embr.201540096; O'Brien RL, 2015, CELL IMMUNOL, V296, P62, DOI 10.1016/j.cellimm.2015.01.011; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pikor NB, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00657; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Qian X, 2017, CYTOKINE, V89, P34, DOI 10.1016/j.cyto.2015.09.011; Rajan AJ, 1996, J IMMUNOL, V157, P941; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Rei M, 2014, P NATL ACAD SCI USA, V111, pE3562, DOI 10.1073/pnas.1403424111; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Ribot JC, 2014, J IMMUNOL, V192, P2237, DOI 10.4049/jimmunol.1303119; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Romagnoli PA, 2016, P NATL ACAD SCI USA, V113, P8502, DOI 10.1073/pnas.1600713113; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Schmolka N, 2015, SEMIN IMMUNOL, V27, P19, DOI 10.1016/j.smim.2015.01.001; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Serre K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00431; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shibata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8687; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Silva-Santos B, 2011, BLOOD, V118, P3, DOI 10.1182/blood-2011-05-351726; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	113	160	164	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					604	611		10.1038/ni.3726	http://dx.doi.org/10.1038/ni.3726			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28518154				2022-12-18	WOS:000401520900005
J	Chen, L; Wilson, JE; Koenigsknecht, MJ; Chou, WC; Montgomery, SA; Truax, AD; Brickey, WJ; Packey, CD; Maharshak, N; Matsushima, GK; Plevy, SE; Young, VB; Sartor, RB; Ting, JPY				Chen, Liang; Wilson, Justin E.; Koenigsknecht, Mark J.; Chou, Wei-Chun; Montgomery, Stephanie A.; Truax, Agnieszka D.; Brickey, W. June; Packey, Christopher D.; Maharshak, Nitsan; Matsushima, Glenn K.; Plevy, Scott E.; Young, Vincent B.; Sartor, R. Balfour; Ting, Jenny P-Y			NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; INTESTINAL MICROBIOTA; GUT MICROBIOTA; NOD2; MACROPHAGES; SUSCEPTIBILITY; METABOLITES; MONARCH-1; MUCOSA	Inflammatory bowel diseases involve the dynamic interaction of host genetics, the microbiome and inflammatory responses. Here we found lower expression of NLRP12 (which encodes a negative regulator of innate immunity) in human ulcerative colitis, by comparing monozygotic twins and other patient cohorts. In parallel, Nlrp12 deficiency in mice caused increased basal colonic inflammation, which led to a less-diverse microbiome and loss of protective gut commensal strains (of the family Lachnospiraceae) and a greater abundance of colitogenic strains (of the family Erysipelotrichaceae). Dysbiosis and susceptibility to colitis associated with Nlrp12 deficency were reversed equally by treatment with antibodies targeting inflammatory cytokines and by the administration of beneficial commensal Lachnospiraceae isolates. Fecal transplants from mice reared in specific-pathogen-free conditions into germ-free Nlrp12-deficient mice showed that NLRP12 and the microbiome each contributed to immunological signaling that culminated in colon inflammation. These findings reveal a feed-forward loop in which NLRP12 promotes specific commensals that can reverse gut inflammation, while cytokine blockade during NLRP12 deficiency can reverse dysbiosis.	[Chen, Liang; Brickey, W. June; Matsushima, Glenn K.; Ting, Jenny P-Y] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Chen, Liang; Koenigsknecht, Mark J.; Montgomery, Stephanie A.; Truax, Agnieszka D.; Brickey, W. June; Ting, Jenny P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Justin E.; Chou, Wei-Chun; Truax, Agnieszka D.; Ting, Jenny P-Y] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koenigsknecht, Mark J.] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Montgomery, Stephanie A.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Packey, Christopher D.] Columbia Univ, Div Digest & Liver Dis, Med Ctr, New York, NY USA; [Maharshak, Nitsan] Tel Aviv Univ, Dept Gastroenterol, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Tel Aviv, Israel; [Matsushima, Glenn K.] Univ North Carolina Chapel Hill, UNC Neurosci Ctr, Chapel Hill, NC USA; [Matsushima, Glenn K.] Univ North Carolina Chapel Hill, Integrat Program Biol Genome Sci, Chapel Hill, NC USA; [Plevy, Scott E.] Janssen Pharmaceut, Immunol Res & Dev, Spring House, PA USA; [Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol, Chapel Hill, NC USA; [Wilson, Justin E.] Univ N Carolina, Dept Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Columbia University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Young, Vincent B/B-3179-2009; , Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022; Core, UNC Microbiome/AAB-3304-2022; Young, Vincent Bensan/M-9916-2019; , Pathology Services Core/CEZ-2246-2022	Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364; 	US National Institute of Health (National Cancer Institute) [RO1-CA156330]; US National Institute of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [P01 DK094779, P30 DK034987, F32-DK088417-01, F32-DK098916]; US National Institute of Health (National Institute of Allergy and Infectious Disease) [U19-AI067798, R37 AI029564, U19 AI090871]; US National Institute of Health (Office of the Director) [P40 OD010995]; American Cancer Society [PF-13-401-01-TBE]; Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society [FG 1968-A-1]; NATIONAL CANCER INSTITUTE [R01CA156330, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871, U19AI067798, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK094779, F32DK088417, F32DK098916, P30DK034987] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	US National Institute of Health (National Cancer Institute); US National Institute of Health (National Institute of Diabetes and Digestive and Kidney Diseases); US National Institute of Health (National Institute of Allergy and Infectious Disease); US National Institute of Health (Office of the Director); American Cancer Society(American Cancer Society); Crohn's and Colitis Foundation of America; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the following for core and technical support: the University of North Carolina (UNC)-North Carolina State University Center for Gastrointestinal Biology and Disease; the UNC Microbiome Core Facility; S.L. Tonkonogy and the Gnotobiotic Core at North Carolina State University; M.A. Bower and J.W. Herzog at the National Gnotobiotic Rodent Resource Center and Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility at UNC; the UNC Lineberger Comprehensive Cancer Center Animal Histopathology Core Facility and Animal Studies Core Facility; and the UNC Flow Cytometry Core Facility. Supported by the US National Institute of Health (RO1-CA156330 to J.P.-Y.T. (National Cancer Institute); P01 DK094779 to J.P.-Y.T., P30 DK034987 to R.B.S., F32-DK088417-01 to J.E.W. and F32-DK098916 to A.D.T. (National Institute of Diabetes and Digestive and Kidney Diseases); U19-AI067798 and R37 AI029564 to J.P.-Y.T. and U19 AI090871 to V.B.Y. (National Institute of Allergy and Infectious Disease); and P40 OD010995 to R.B.S. (Office of the Director)), the American Cancer Society (PF-13-401-01-TBE to J.E.W.), the Crohn's and Colitis Foundation of America (R.B.S.) and the National Multiple Sclerosis Society (FG 1968-A-1 to W-C.C.).	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Handley SA, 2016, CELL HOST MICROBE, V19, P323, DOI 10.1016/j.chom.2016.02.010; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peyrin-Biroulet L, 2010, Minerva Gastroenterol Dietol, V56, P233; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	44	160	162	8	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					541	551		10.1038/ni.3690	http://dx.doi.org/10.1038/ni.3690			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28288099	Green Accepted, Green Submitted			2022-12-18	WOS:000399378700011
J	Rossy, J; Owen, DM; Williamson, DJ; Yang, ZM; Gaus, K				Rossy, Jeremie; Owen, Dylan M.; Williamson, David J.; Yang, Zhengmin; Gaus, Katharina			Conformational states of the kinase Lck regulate clustering in early T cell signaling	NATURE IMMUNOLOGY			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; PLASMA-MEMBRANE MICRODOMAINS; CD45 TYROSINE PHOSPHATASE; SRC-FAMILY KINASES; RECEPTOR MICROCLUSTERS; ACTIVATION; DOMAINS; CONDENSATION; ORGANIZATION; MOLECULES	Phosphorylation of the T cell antigen receptor (TCR) by the tyrosine kinase Lck is an essential step in the activation of T cells. Because Lck is constitutively active, spatial organization may regulate TCR signaling. Here we found that Lck distributions on the molecular level were controlled by the conformational states of Lck, with the open, active conformation inducing clustering and the closed, inactive conformation preventing clustering. In contrast, association with lipid domains and protein networks were not sufficient or necessary for Lck clustering. Conformation-driven Lck clustering was highly dynamic, so that TCR triggering resulted in Lck clusters that contained phosphorylated TCRs but excluded the phosphatase CD45. Our data suggest that Lck conformational states represent an intrinsic mechanism for the intermolecular organization of early T cell signaling.	[Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Gaus, K (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	k.gaus@unsw.edu.au	Williamson, David J/G-2265-2012; Rossy, Jeremie/N-8554-2016	Williamson, David J/0000-0002-6222-6297; Rossy, Jeremie/0000-0002-5128-5283; Gaus, Katharina/0000-0002-8009-9658	Australian Research Council; National Health and Medical Research Council of Australia; Human Frontier Science Program	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program)	We thank T. Harder (University of Oxford) for mammalian expression constructs encoding full-length wild-type human Lck and Lck(Y505F); O. Acuto (University of Oxford) for Lck(Y394F) and Lck(R273A); J. Wiedenmann (University of Southampton) for the mEos2 expression construct; and K. Nika and O. Acuto for discussions. Supported by the Australian Research Council, the National Health and Medical Research Council of Australia and the Human Frontier Science Program.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; D'Oro U, 1999, J IMMUNOL, V162, P1879; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Gan WX, 2009, PROTEINS, V74, P996, DOI 10.1002/prot.22209; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2010, MOL CELL BIOL, V30, P3421, DOI 10.1128/MCB.00160-10; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabouridis PS, 2011, MOL MEMBR BIOL, V28, P487, DOI 10.3109/09687688.2011.624990; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; Laham LE, 2000, ONCOGENE, V19, P3961, DOI 10.1038/sj.onc.1203738; LeeFruman KK, 1996, J BIOL CHEM, V271, P25003, DOI 10.1074/jbc.271.40.25003; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rossy J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00167; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Wong NKY, 2008, J IMMUNOL, V181, P7033, DOI 10.4049/jimmunol.181.10.7033; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108	49	160	161	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					82	89		10.1038/ni.2488	http://dx.doi.org/10.1038/ni.2488			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23202272				2022-12-18	WOS:000312433800013
J	King, IL; Fortier, A; Tighe, M; Dibble, J; Watts, GFM; Veerapen, N; Haberman, AM; Besra, GS; Mohrs, M; Brenner, MB; Leadbetter, EA				King, Irah L.; Fortier, Anne; Tighe, Michael; Dibble, John; Watts, Gerald F. M.; Veerapen, Natacha; Haberman, Ann M.; Besra, Gurdyal S.; Mohrs, Markus; Brenner, Michael B.; Leadbetter, Elizabeth A.			Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner	NATURE IMMUNOLOGY			English	Article							CXC CHEMOKINE RECEPTOR-5; MARGINAL ZONE; NKT CELLS; ANTIBODY-RESPONSES; CUTTING EDGE; IN-VIVO; IMMUNOGLOBULIN; IL-21; DIFFERENTIATION; ACTIVATION	Mouse invariant natural killer T cells (iNKT cells) provide cognate and noncognate help for lipid and protein-specific B cells, respectively. However, the long-term outcome for B cells after cognate help is provided by iNKT cells is unknown at present. Here we found that cognate iNKT cell help resulted in a B cell differentiation program characterized by extrafollicular plasmablasts, germinal-center formation, affinity maturation and a robust primary immunoglobulin G (IgG) antibody response that was uniquely dependent on iNKT cell-derived interleukin 21 (IL-21). However, cognate help from iNKT cells did not generate an enhanced humoral memory response. Thus, cognate iNKT cell help for lipid-specific B cells induces a unique signature that is a hybrid of classic T cell-dependent and T cell-independent type 2 B cell responses.	[King, Irah L.; Fortier, Anne; Tighe, Michael; Dibble, John; Mohrs, Markus; Leadbetter, Elizabeth A.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Watts, Gerald F. M.; Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol, Boston, MA 02115 USA; [Veerapen, Natacha; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Trudeau Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Birmingham; Yale University	Leadbetter, EA (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	eleadbetter@trudeauinstitute.org		Besra, Gurdyal/0000-0002-5605-0395; Watts, Gerald/0000-0003-2276-1524	Trudeau Institute; US National Institutes of Health [AI028973-23, AI063428-06, T32 A1049823-10]; Royal Society; Wellcome Trust [084923/B/08/Z]; Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028973, T32AI049823, R01AI076479, R37AI028973, R56AI063428, R01AI063428] Funding Source: NIH RePORTER	Trudeau Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Nussenzweig (Rockefeller University) for B6.SJL B1-8<SUP>hi</SUP> mice; M. Exley (Dana Farber Cancer Institute) for C57BL/6 V<INF>alpha</INF>14-transgenic mice and C57BL/6 J<INF>alpha</INF>18-deficient mice; K. Rajewsky (Center for Blood Research) for B1-8f mice; M. Rincon (University of Vermont) for IL-21-deficient mice; and the US National Institutes of Health Tetramer Core for mouse CD1d-PBS57 tetramers and unloaded CD1d tetramers. Supported by the Trudeau Institute (E.A.L.), the US National Institutes of Health (AI028973-23 and AI063428-06 to M.B.B. and T32 A1049823-10 to I.L.K.), J. Bardrick (G.S.B.), the Royal Society (G.S.B.), The Wellcome Trust (084923/B/08/Z to G.S.B.) and the Medical Research Council (G.S.B.).	Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Belperron AA, 2005, J IMMUNOL, V174, P5681, DOI 10.4049/jimmunol.174.9.5681; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Bialecki E, 2009, J IMMUNOL, V182, P6105, DOI 10.4049/jimmunol.0802273; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859; Devera TS, 2008, EUR J IMMUNOL, V38, P1001, DOI 10.1002/eji.200738000; Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; King IL, 2010, J IMMUNOL, V185, P6138, DOI 10.4049/jimmunol.1001703; Kobrynski LJ, 2005, J IMMUNOL, V174, P1787, DOI 10.4049/jimmunol.174.4.1787; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Roark JH, 1998, J IMMUNOL, V160, P3121; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	44	160	165	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					44	U64		10.1038/ni.2172	http://dx.doi.org/10.1038/ni.2172			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22120118	Green Accepted			2022-12-18	WOS:000298412800010
J	Jacobelli, J; Friedman, RS; Conti, MA; Lennon-Dumenil, AM; Piel, M; Sorensen, CM; Adelstein, RS; Krummel, MF				Jacobelli, Jordan; Friedman, Rachel S.; Conti, Mary Anne; Lennon-Dumenil, Ana-Maria; Piel, Matthieu; Sorensen, Caitlin M.; Adelstein, Robert S.; Krummel, Matthew F.			Confinement-optimized three-dimensional T cell amoeboid motility is modulated via myosin IIA-regulated adhesions	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; LYMPHOCYTE MOTILITY; LEUKOCYTE MIGRATION; CHEMOTAXIS; MICROSCOPY; DEFECTS; BINDING; ICAM-1; MODES; SPEED	During trafficking through tissues, T cells fine-tune their motility to balance the extent and duration of cell-surface contacts versus the need to traverse an entire organ. Here we show that in vivo, myosin IIA-deficient T cells had a triad of defects, including overadherence to high-endothelial venules, less interstitial migration and inefficient completion of recirculation through lymph nodes. Spatiotemporal analysis of three-dimensional motility in microchannels showed that the degree of confinement and myosin IIA function, rather than integrin adhesion (as proposed by the haptokinetic model), optimized motility rate. This motility occurred via a myosin IIA-dependent rapid 'walking' mode with multiple small and simultaneous adhesions to the substrate, which prevented spurious and prolonged adhesions. Adhesion discrimination provided by myosin IIA is thus necessary for the optimization of motility through complex tissues.	[Jacobelli, Jordan; Friedman, Rachel S.; Sorensen, Caitlin M.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Conti, Mary Anne; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Lennon-Dumenil, Ana-Maria; Piel, Matthieu] Inst Curie, Inst Natl Sante Rech Med, U653, Paris, France	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Lennon-Dumenil, Ana-Maria/I-6716-2016	Adelstein, Robert/0000-0002-8683-2144	National Institutes of Health [AI52116]; Larry L. Hillblom Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Beemiller for help with two-photon data analysis with Imaris and Matlab software; S. Peck for assistance in maintenance of microscopes; M. Tang (Stanford Microfabrication Center) for Silicon Masters; S. Jiang for technical assistance with cell sorting; O. Khan and M. Werner for help with mouse genotyping; M. Heuze for assistance in setting up the microchannel system; and B. Sauer (Stowers Institute for Medical Research) for the pBS479 vector. Supported by the National Institutes of Health (AI52116 to M.F.K.) and the Larry L. Hillblom Foundation (R.S.F.).	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Hara T, 2006, INT IMMUNOL, V18, P301, DOI 10.1093/intimm/dxh369; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; JAY PY, 1995, J CELL SCI, V108, P387; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; VON ANDRIAN UH, 2003, NAT REV IMMUNOL, V3, P867; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725	40	160	160	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					953	U110		10.1038/ni.1936	http://dx.doi.org/10.1038/ni.1936			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20835229	Green Accepted			2022-12-18	WOS:000281926900015
J	Pereira, JP; An, JP; Xu, Y; Huang, Y; Cyster, JG				Pereira, Joao P.; An, Jinping; Xu, Ying; Huang, Yong; Cyster, Jason G.			Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids	NATURE IMMUNOLOGY			English	Article							IN-VIVO PERFUSION; ADHESION MOLECULE-1; CHEMOKINE SDF-1; STEM-CELLS; LYMPHOCYTE; EXPRESSION; BETA-1-INTEGRIN; CXCR4; RESPONSIVENESS; LOCALIZATION	Immature B cells developing in the bone marrow are found in the parenchyma and sinusoids. The mechanisms that control the positioning of B cells in the sinusoids are not understood. Here we show that the integrin alpha(4)beta(1) (VLA-4) and its ligand VCAM-1 were required, whereas the chemokine receptor CXCR4 was dispensable, for sinusoidal retention of B cells. Instead, cannabinoid receptor 2 (CB2), a G alpha(i) protein-coupled receptor upregulated in immature B cells, was required for sinusoidal retention. Using two-photon microscopy, we found immature B cells entering and crawling in sinusoids; these immature B cells were displaced by CB2 antagonism. Moreover, CB2-deficient mice had a lower frequency of immunoglobulin lambda-chain-positive B cells in the peripheral blood and spleen. Our findings identify unique requirements for the retention of B cells in the bone marrow sinusoidal niche and suggest involvement of CB2 in the generation of the B cell repertoire.	[Pereira, Joao P.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Pereira, Joao P.; An, Jinping; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Huang, Yong] Univ Calif San Francisco, Drug Studies Unit, Dept Biopharmaceut Sci, San Francisco, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Pereira, Joao/0000-0002-5694-4938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098, N01AI40098, R37AI040098] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI040098, N01AI40098, R37 AI040098-13] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Estalilla OC, 1999, AM J CLIN PATHOL, V112, P248; Fedyk ER, 1999, J LEUKOCYTE BIOL, V66, P667, DOI 10.1002/jlb.66.4.667; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Jacobsen K, 1996, BLOOD, V87, P73; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; Jorda MA, 2002, BLOOD, V99, P2786; KAMINSKI NE, 1994, BIOCHEM PHARMACOL, V48, P1899, DOI 10.1016/0006-2952(94)90588-6; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kuwata N, 1999, J IMMUNOL, V163, P6355; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Oberdoerffer P, 2003, J EXP MED, V197, P1165, DOI 10.1084/jem.20030402; OSMOND DG, 1984, AM J ANAT, V170, P349, DOI 10.1002/aja.1001700310; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; SCHATZ AR, 1993, IMMUNOPHARMACOLOGY, V26, P129, DOI 10.1016/0162-3109(93)90005-B; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; Tanikawa T, 2007, MICROBIOL IMMUNOL, V51, P1013, DOI 10.1111/j.1348-0421.2007.tb03985.x; TAVASSOLI M, 1983, BONE MARROW STRUCTUR, P1; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Vela JL, 2008, IMMUNITY, V28, P161, DOI 10.1016/j.immuni.2007.12.011; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; YOFFEY JM, 1965, J ANAT, V99, P841; Ziring D, 2006, IMMUNOGENETICS, V58, P714, DOI 10.1007/s00251-006-0138-x; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	160	161	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					403	411		10.1038/ni.1710	http://dx.doi.org/10.1038/ni.1710			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19252491	Green Accepted			2022-12-18	WOS:000264425800014
J	Hammer, GE; Gonzalez, F; James, E; Nolla, H; Shastri, N				Hammer, Gianna Elena; Gonzalez, Federico; James, Edward; Nolla, Hector; Shastri, Nilabh			In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PROCESSING PATHWAY; ENDOPLASMIC-RETICULUM; T-CELLS; COMPLEX; REPERTOIRE; GENERATION; PROTEIN; MICE; DEGRADATION; LYMPHOCYTES	Immunosurveillance by cytotoxic T cells requires that cells generate a diverse spectrum of peptides for presentation by major histocompatibility complex ( MHC) class I molecules. Those peptides are generated by proteolysis, which begins in the cytoplasm and continues in the endoplasmic reticulum by the unique aminopeptidase ERAAP. The overall extent to which trimming by ERAAP modifies the peptide pool and the immunological consequences of ERAAP deficiency are unknown. Here we show that the peptide-MHC repertoire of ERAAP-deficient mice was missing many peptides. Furthermore, ERAAP-deficient cells presented many unstable and structurally unique peptide-MHC complexes, which elicited potent CD8(+) T cell and B cell responses. Thus, ERAAP is a 'quintessential editor' of the peptide-MHC repertoire and, paradoxically, its absence enhances immunogenicity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	nshastri@berkeley.edu		Hammer, Gianna/0000-0001-6959-858X; James, Edward/0000-0001-8638-7928				COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Green KJ, 2004, EUR J IMMUNOL, V34, P2510, DOI 10.1002/eji.200425193; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Rammensee HG, 1997, MOL B INT U, P1; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Roopenian D, 2002, IMMUNOL REV, V190, P86, DOI 10.1034/j.1600-065X.2002.19007.x; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	34	160	163	3	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					101	108		10.1038/ni1409	http://dx.doi.org/10.1038/ni1409			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17128277				2022-12-18	WOS:000242934400019
J	Chen, Q; Fisher, DT; Clancy, KA; Gauguet, JMM; Wang, WC; Unger, E; Rose-John, S; von Andrian, UH; Baumann, H; Evans, SS				Chen, Qing; Fisher, Daniel T.; Clancy, Kristen A.; Gauguet, Jean-Marc M.; Wang, Wan-Chao; Unger, Emily; Rose-John, Stefan; von Andrian, Ulrich H.; Baumann, Heinz; Evans, Sharon S.			Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interieukin 6 trans-signaling mechanism	NATURE IMMUNOLOGY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; L-SELECTIN; IMMUNE-RESPONSE; CELLS; HYPERTHERMIA; NODES; CHEMOKINES; MIGRATION; RECEPTOR; INFLAMMATION	Fever is an evolutionarily conserved response during acute inflammation, although its physiological benefit is poorly understood. Here we show thermal stress in the range of fever temperatures increased the intravascular display of two 'gatekeeper' homing molecules, intercellular adhesion molecule 1 (ICAM-1) and CCL21 chemokine, exclusively in high endothelial venules (HEVs) that are chief portals for the entry of blood-borne lymphocytes into lymphoid organs. Enhanced endothelial expression of ICAM-1 and CCL21 was linked to increased lymphocyte trafficking across HEVs. A bifurcation in the mechanisms controlling HEV adhesion was demonstrated by evidence that the thermal induction of ICAM-1 but not of CCL21 involved an interleukin 6 trans. signaling pathway. Our findings identify the 'HEV axis' as a thermally sensitive alert system that heightens immune surveillance during inflammation by amplifying lymphocyte trafficking to lymphoid organs.	Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; Roswell Pk Canc Inst, Rochester, NY 14623 USA	Roswell Park Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Kiel; Roswell Park Cancer Institute	Evans, SS (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	sharon.evans@roswellpark.org	Rose-John, Stefan/A-7998-2010; von Andrian, Ulrich H/A-5775-2008	Rose-John, Stefan/0000-0002-7519-3279; 	NATIONAL CANCER INSTITUTE [R01CA079765, P30CA016056, P01CA094045, R01CA085580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663, R01AI069259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033886] Funding Source: NIH RePORTER; NCI NIH HHS [CA79765, CA16056, CA094045, CA85580] Funding Source: Medline; NIAID NIH HHS [AI069259, AI061663] Funding Source: Medline; NIAMS NIH HHS [P30 AR 42689] Funding Source: Medline; NIDDK NIH HHS [DK33886] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramoff M.D., 2004, BIOPHOT INT, V11, P36; Appenheimer MM, 2005, IMMUNOL INVEST, V34, P295, DOI 10.1081/IMM-200064501; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen Q, 2006, CANCER IMMUNOL IMMUN, V55, P299, DOI 10.1007/s00262-005-0022-9; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Choi J, 2004, ANNU REV IMMUNOL, V22, P683, DOI 10.1146/annurev.immunol.22.012703.104639; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Evans SS, 2000, INT J HYPERTHER, V16, P45, DOI 10.1080/026567300285411; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Gerwin N, 1999, IMMUNITY, V10, P9, DOI 10.1016/S1074-7613(00)80002-3; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; Hasday JD, 2001, J APPL PHYSIOL, V90, P90, DOI 10.1152/jappl.2001.90.1.90; Izawa D, 1999, INT IMMUNOL, V11, P1989, DOI 10.1093/intimm/11.12.1989; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Lehmann JCU, 2003, J IMMUNOL, V171, P2588, DOI 10.4049/jimmunol.171.5.2588; MACKAY CR, 1992, EUR J IMMUNOL, V22, P2205, DOI 10.1002/eji.1830220904; McEvoy LM, 1997, BLOOD, V90, P3587, DOI 10.1182/blood.V90.9.3587; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Ostberg JR, 2006, CANCER IMMUNOL IMMUN, V55, P292, DOI 10.1007/s00262-005-0689-y; Ostberg JR, 2001, J IMMUNOL, V167, P2666, DOI 10.4049/jimmunol.167.5.2666; Pachynski RK, 1998, J IMMUNOL, V161, P952; REILLY PL, 1995, J IMMUNOL, V155, P529; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Sarantos MR, 2005, J BIOL CHEM, V280, P28290, DOI 10.1074/jbc.M501662200; Shah A, 2002, INT J HYPERTHER, V18, P534, DOI 10.1080/02656730210157843; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; STEVENS SK, 1982, J IMMUNOL, V128, P844; Tedla N, 1998, J IMMUNOL, V161, P5663; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wang WC, 1998, J IMMUNOL, V160, P961; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953	51	160	168	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1299	1308		10.1038/ni1406	http://dx.doi.org/10.1038/ni1406			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17086187				2022-12-18	WOS:000242125200012
J	van Loo, G; De Lorenzi, R; Schmidt, H; Huth, M; Mildner, A; Schmidt-Supprian, M; Lassmann, H; Prinz, MR; Pasparakis, M				van Loo, Geert; De Lorenzi, Rossana; Schmidt, Hauke; Huth, Marion; Mildner, Alexander; Schmidt-Supprian, Marc; Lassmann, Hans; Prinz, Marco R.; Pasparakis, Manolis			Inhibition of transcription factor NF-kappa B in the central nervous system ameliorates autoimmune encephalomyelitis in mice	NATURE IMMUNOLOGY			English	Article							CELL-ADHESION MOLECULE-1; MULTIPLE-SCLEROSIS LESIONS; DEFICIENT MICE; ANIMAL-MODEL; ASTROCYTES; GENE; EXPRESSION; INFLAMMATION; ACTIVATION; ROLES	Activation of transcription factor NF-kappa B in the central nervous system (CNS) has been linked to autoimmune demyelinating disease; however, it remains unclear whether its function is protective or pathogenic. Here we show that CNS-restricted ablation of 'upstream' NF-kappa B activators NEMO or IKK2 but not IKK1 ameliorated disease pathology in a mouse model of multiple sclerosis, suggesting that 'canonical' NF-kappa B activation in cells of the CNS has a mainly pathogenic function in autoimmune demyelinating disease. NF-kappa B inhibition prevented the expression of proinflammatory cytokines, chemokines and the adhesion molecule VCAM-1 from CNS-resident cells. Thus, NF-kappa B-dependent gene expression in non-microglial cells of the CNS provides a permissive proinflammatory milieu that is critical for CNS inflammation and tissue damage in autoimmune demyelinating disease.	European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Vienna, Brain Res Inst, A-1090 Vienna, Austria; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	European Molecular Biology Laboratory (EMBL); University of Gottingen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Vienna; University of Cologne	Pasparakis, M (corresponding author), European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy.	pasparakis@uni-koeln.de	mildner, alexander/AAF-9451-2022; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AFK-2161-2022; Pasparakis, Manolis/H-9292-2017; mildner, alexander/GQA-3761-2022; Schmidt-Supprian, Marc/F-5893-2011; Pasparakis, Manolis/N-4350-2019; van Loo, Geert/C-1505-2009; , van Loo Geert/AAD-1220-2019; Lassmann, Hans/Z-2269-2019	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Pasparakis, Manolis/0000-0002-9870-0966; mildner, alexander/0000-0002-2019-8427; Schmidt-Supprian, Marc/0000-0002-8543-6166; Pasparakis, Manolis/0000-0002-9870-0966; , van Loo Geert/0000-0002-8427-4775; Lassmann, Hans/0000-0001-8617-5052				Bechmann I, 2002, J NEUROIMMUNOL, V132, P60, DOI 10.1016/S0165-5728(02)00311-9; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; CARLOS TM, 1990, BLOOD, V76, P965; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; De Keyser J, 2003, ARCH NEUROL-CHICAGO, V60, P132, DOI 10.1001/archneur.60.1.132; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gimenez MAT, 2004, J NEUROIMMUNOL, V151, P116, DOI 10.1016/j.jneuroim.2004.02.012; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hilliard B, 1999, J IMMUNOL, V163, P2937; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kwon D, 2006, NEUROSCI RES, V54, P338, DOI 10.1016/j.neures.2005.12.011; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROSENMAN SJ, 1995, J IMMUNOL, V154, P1888; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722	45	160	162	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					954	961		10.1038/ni1372	http://dx.doi.org/10.1038/ni1372			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16892069				2022-12-18	WOS:000239942300014
J	Chin, RK; Lo, JC; Kim, O; Blink, SE; Christiansen, PA; Peterson, P; Wang, Y; Ware, C; Fu, YX				Chin, RK; Lo, JC; Kim, O; Blink, SE; Christiansen, PA; Peterson, P; Wang, Y; Ware, C; Fu, YX			Lymphotoxin pathway directs thymic Aire expression	NATURE IMMUNOLOGY			English	Article							NONOBESE DIABETIC MICE; NF-KAPPA-B; BETA-RECEPTOR; NEGATIVE SELECTION; AUTOIMMUNE-DISEASE; LYMPHOID-TISSUES; GENE-EXPRESSION; RELB-DEFICIENT; MOUSE; CELLS	The autoimmune regulator Aire is a key mediator of central tolerance for peripherally restricted antigens. Its absence in human patients results in autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. The cellular signals that regulate Aire expression are undefined. We show here that lymphotoxin signaling is necessary for the expression of Aire and its downstream target genes. The failure of Aire induction in the thymi of lymphotoxin-deficient and lymphotoxin- receptor-deficient mice contributes to overt autoimmunity against self antigens normally protected by Aire. Conversely, stimulation of lymphotoxin- receptor by agonistic antibody leads to increased expression of Aire and tissue-restricted antigens in both intact thymi and cultured thymic epithelial cell line. These findings define the essential cross-talk between thymocytes and thymic stroma that is required for central tolerance.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Tampere, Inst Med Technol, Tampere 33014, Finland; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	University of Chicago; University of Chicago; Tampere University; La Jolla Institute for Immunology	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Lo, James/GYR-1149-2022; Peterson, Pärt/A-5788-2009	Lo, James/0000-0003-0244-1670; Peterson, Pärt/0000-0001-6755-791X; fu, yang-xin/0000-0001-8441-6617	NIAID NIH HHS [AI 33068] Funding Source: Medline; NICHD NIH HHS [HD-37104] Funding Source: Medline; NIDDK NIH HHS [DK-58891] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07281] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R01AI033068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Agyekum S, 2003, J PATHOL, V199, P115, DOI 10.1002/path.1249; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BANKS TA, 1995, J IMMUNOL, V155, P1685; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Browning JL, 1997, J IMMUNOL, V159, P3288; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Ettinger R, 2001, J EXP MED, V193, P1333, DOI 10.1084/jem.193.11.1333; FAAS SJ, 1993, EUR J IMMUNOL, V23, P1201, DOI 10.1002/eji.1830230602; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Grech A P, 2000, Dev Immunol, V8, P61, DOI 10.1155/2000/13492; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Murumagi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200; Peterson P, 1998, IMMUNOL TODAY, V19, P384, DOI 10.1016/S0167-5699(98)01293-6; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; VUKMANOVIC S, 1994, INT IMMUNOL, V6, P239, DOI 10.1093/intimm/6.2.239; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Weih F, 1996, J IMMUNOL, V157, P3974; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	31	160	162	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1121	1127		10.1038/ni982	http://dx.doi.org/10.1038/ni982			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14517552				2022-12-18	WOS:000186241100016
J	Osorio, F; Tavernier, SJ; Hoffmann, E; Saeys, Y; Martens, L; Vetters, J; Delrue, I; De Rycke, R; Parthoens, E; Pouliot, P; Iwawaki, T; Janssens, S; Lambrecht, BN				Osorio, Fabiola; Tavernier, Simon J.; Hoffmann, Eik; Saeys, Yvan; Martens, Liesbet; Vetters, Jessica; Delrue, Iris; De Rycke, Riet; Parthoens, Eef; Pouliot, Philippe; Iwawaki, Takao; Janssens, Sophie; Lambrecht, Bart N.			The unfolded-protein-response sensor IRE-1 alpha regulates the function of CD8 alpha(+) dendritic cells	NATURE IMMUNOLOGY			English	Article							CROSS-PRESENTATION; MESSENGER-RNAS; STEADY-STATE; STRESS; ACTIVATION; RECEPTOR; XBP-1; DIFFERENTIATION; IDENTIFICATION; INFLUENZA	The role of the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress in homeostasis of the immune system is incompletely understood. Here we found that dendritic cells (DCs) constitutively activated the UPR sensor IRE-1 alpha and its target, the transcription factor XBP-1, in the absence of ER stress. Loss of XBP-1 in CD11c(+) cells led to defects in phenotype, ER homeostasis and antigen presentation by CD8 alpha(+) conventional DCs, yet the closely related CD11b(+) DCs were unaffected. Whereas the dysregulated ER in XBP-1-deficient DCs resulted from loss of XBP-1 transcriptional activity, the phenotypic and functional defects resulted from regulated IRE-1 alpha-dependent degradation (RIDD) of mRNAs, including those encoding CD18 integrins and components of the major histocompatibility complex (MHC) class I machinery. Thus, a precisely regulated feedback circuit involving IRE-1 alpha and XBP-1 controls the homeostasis of CD8 alpha(+) conventional DCs.	[Osorio, Fabiola; Tavernier, Simon J.; Saeys, Yvan; Martens, Liesbet; Vetters, Jessica; Delrue, Iris; Pouliot, Philippe; Janssens, Sophie; Lambrecht, Bart N.] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Osorio, Fabiola; Tavernier, Simon J.; Hoffmann, Eik; Saeys, Yvan; Martens, Liesbet; Vetters, Jessica; Delrue, Iris; Pouliot, Philippe; Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, GRP ID Consortium, B-9000 Ghent, Belgium; [Osorio, Fabiola; Tavernier, Simon J.; Hoffmann, Eik; Saeys, Yvan; Martens, Liesbet; Vetters, Jessica; Delrue, Iris; Pouliot, Philippe; Janssens, Sophie; Lambrecht, Bart N.] Univ Hosp, Ghent, Belgium; [Osorio, Fabiola; Tavernier, Simon J.; Saeys, Yvan; Martens, Liesbet; Vetters, Jessica; Delrue, Iris; Pouliot, Philippe; Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium; [Hoffmann, Eik] VIB Inflammat Res Ctr, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [De Rycke, Riet; Parthoens, Eef] VIB Inflammat Res Ctr, Microscopy Core Facil, Ghent, Belgium; [Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Gunma University; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, Ghent, Belgium.	bart.lambrecht@irc.vib-ugent.be	Osorio, Fabiola/H-4529-2014; Saeys, Yvan/C-1311-2009; Hoffmann, Eik/T-5428-2018; Hoffmann, Eik/Y-2297-2019; Tavernier, Simon/L-9949-2019; Lambrecht, Bart N/K-2484-2014; Janssens, Sophie/HHN-1756-2022	Osorio, Fabiola/0000-0001-5306-7856; Saeys, Yvan/0000-0002-0415-1506; Hoffmann, Eik/0000-0003-4224-1091; Hoffmann, Eik/0000-0003-4224-1091; Tavernier, Simon/0000-0003-2514-5655; Lambrecht, Bart N/0000-0003-4376-6834; Martens, Liesbet/0000-0001-9180-7456; Vetters, Jessica/0000-0001-5817-0086	European Research Council; European Union Seventh Framework Programme; Fonds Wetenschappelijk Onderzoek Vlaanderen program; Ghent University; Marie Curie Actions; Federation of European Biochemical Societies; Agentschap voor Innovatie door Wetenschap en Techniek; Grants-in-Aid for Scientific Research [24390049] Funding Source: KAKEN	European Research Council(European Research Council (ERC)European Commission); European Union Seventh Framework Programme(European Commission); Fonds Wetenschappelijk Onderzoek Vlaanderen program; Ghent University(Ghent University); Marie Curie Actions(European Commission); Federation of European Biochemical Societies; Agentschap voor Innovatie door Wetenschap en Techniek; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank L. Glimcher (Cornell University) for Xbp1<SUP>f1/f1</SUP> mice; B. Reizis (Columbia University) for Itgax-Cre mice; B. Malissen (Aix Marseille University) for H-Y mice; J. Magalhaes (Institut Curie) for advice and protocols; D. Jankovic and A. Sher (National Institute of Allergy and Infectious Diseases) for T gondii extracts; C. Reis e Sousa (Cancer Research UK) for bm1 T OVA cells; the VIB Microarray Facility for doing the microarray experiments; the IRC Microscopy Core Facility and, more specifically, A. Kremers, S. Lippens and C. Guerin for help with the imaging of XBP-1-deficient CD8 alpha<SUP>+</SUP> cDCs by focused ion beam-scanning electron microscopy. Supported by the European Research Council (B.N.L.), the European Union Seventh Framework Programme (B.N.L.), the Fonds Wetenschappelijk Onderzoek Vlaanderen program (B.N.L. and S.J.), Ghent University (B.N.L. and S.J.), Marie Curie Actions (F.O. and E.H.), The Federation of European Biochemical Societies (F.O.) and the Agentschap voor Innovatie door Wetenschap en Techniek (S.J.T.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Varadarajan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056603; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644	39	159	163	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					248	257		10.1038/ni.2808	http://dx.doi.org/10.1038/ni.2808			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24441789				2022-12-18	WOS:000331683100010
J	Nutt, SL; Tarlinton, DM				Nutt, Stephen L.; Tarlinton, David M.			Germinal center B and follicular helper T cells: siblings, cousins or just good friends?	NATURE IMMUNOLOGY			English	Review							CXC CHEMOKINE RECEPTOR-5; PLASMA-CELLS; TRANSCRIPTIONAL PROGRAM; DENDRITIC CELLS; IL-21 RECEPTOR; MEMORY; DIFFERENTIATION; EXPRESSION; GENE; BCL6	Humoral immunity requires interaction between specialized populations of B cells and CD4(+) T cells, called follicular helper T cells (T-FH cells), in the germinal center (GC) to produce memory B cells and long-lived plasma cells. Molecular crosstalk between GC B cells and T-FH cells influences the survival, proliferation and differentiation of each cell type. This pairing of GC B cells and T-FH cells also occurs at the transcriptional level as the Bcl-6-IRF4-Blimp-1 axis, which is crucial for B cell differentiation, is also essential for the T-FH cell identity. Less is known about the memory B cells that arise from the GC pool, as they seem to be distinctly 'programmed' on the basis of their antigen receptor affinity to enter the long-lived memory pool.	[Nutt, Stephen L.; Tarlinton, David M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Nutt, Stephen L.; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au; tarlinton@wehi.edu.au	Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637; Tarlinton, David/0000-0001-9928-686X	Pfizer Australia; Australian Research Council; National Health and Medical Research Council of Australia	Pfizer Australia(PfizerPfizer Australia); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by Pfizer Australia (S.L.N.), the Australian Research Council (S.L.N.) and the National Health and Medical Research Council of Australia (D.M.T.).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Holmes ML, 2008, IMMUNOL CELL BIOL, V86, P47, DOI 10.1038/sj.icb.7100134; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; King IL, 2010, J IMMUNOL, V185, P6138, DOI 10.4049/jimmunol.1001703; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nutt SL, 2010, NAT IMMUNOL, V11, P464, DOI 10.1038/ni0610-464; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Rankin AL, 2011, J IMMUNOL, V186, P667, DOI 10.4049/jimmunol.0903207; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	94	159	161	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					472	477		10.1038/ni.2019	http://dx.doi.org/10.1038/ni.2019			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739669				2022-12-18	WOS:000290707100004
J	Farez, MF; Quintana, FJ; Gandhi, R; Izquierdo, G; Lucas, M; Weiner, HL				Farez, Mauricio F.; Quintana, Francisco J.; Gandhi, Roopali; Izquierdo, Guillermo; Lucas, Miguel; Weiner, Howard L.			Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; INNATE IMMUNITY; PROTEIN MICROARRAYS; IFN-GAMMA; ACTIVATION; DISEASE; INTERLEUKIN-12; DEMYELINATION	Multiple sclerosis is an inflammatory disease of the central nervous system that begins as a relapsing-remitting disease (RRMS) and is followed by a progressive phase (SPMS). The progressive phase causes the greatest disability and has no effective therapy, but the processes that drive SPMS are mostly unknown. Here we found higher serum concentrations of 15 alpha-hydroxicholestene (15-HC) in patients with SPMS and in mice with secondary progressive experimental autoimmune encephalomyelitis (EAE) but not in patients with RRMS. In mice, 15-HC activated microglia, macrophages and astrocytes through a pathway involving Toll-like receptor 2 (TLR2) and poly(ADP-ribose) polymerase 1 (PARP-1). PARP-1 activity was higher in monocytes of patients with SPMS, and PARP-1 inhibition suppressed the progression of EAE. Thus, the TLR2-PARP-1 pathway is a potential new therapeutic target in SPMS.	[Farez, Mauricio F.; Quintana, Francisco J.; Gandhi, Roopali; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Izquierdo, Guillermo; Lucas, Miguel] Univ Seville, Mol Biol Serv, Seville, Spain; [Izquierdo, Guillermo] Univ Seville, Multiple Sclerosis Unit, Seville, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sevilla; University of Sevilla	Weiner, HL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		US National Institutes of Health [AI435801, NS38037]; US National Multiple Sclerosis Society [PP1289]; Human Frontiers of Science Program Organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043458, R01AI064430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Human Frontiers of Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. S. Basso (Universidade Federal de Sao Paulo) for discussions, and M. Oukka (Harvard Medical School) for TLR2-deficient mice. Supported by the US National Institutes of Health (AI435801 and NS38037), the US National Multiple Sclerosis Society (PP1289 to H. L. W.) and the Human Frontiers of Science Program Organization (F. J. Q.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balashov KE, 2000, NEUROLOGY, V55, P192, DOI 10.1212/WNL.55.2.192; Balashov KE, 1997, P NATL ACAD SCI USA, V94, P599, DOI 10.1073/pnas.94.2.599; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; BONGARZONE ER, 1995, J NEUROSCI RES, V41, P213, DOI 10.1002/jnr.490410209; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Comabella M, 1998, J CLIN INVEST, V102, P671, DOI 10.1172/JCI3125; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Karni A, 2006, J IMMUNOL, V177, P4196, DOI 10.4049/jimmunol.177.6.4196; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Quintana FJ, 2004, P NATL ACAD SCI USA, V101, P14615, DOI 10.1073/pnas.0404848101; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; SUTO MJ, 1991, ANTI-CANCER DRUG DES, V6, P107; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8	35	159	169	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					958	U44		10.1038/ni.1775	http://dx.doi.org/10.1038/ni.1775			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19684606	Green Accepted			2022-12-18	WOS:000269120900009
J	Jacobelli, J; Chmura, SA; Buxton, DB; Davis, MM; Krummel, MF				Jacobelli, J; Chmura, SA; Buxton, DB; Davis, MM; Krummel, MF			A single class II myosin modulates T cell motility and stopping, but not synapse formation	NATURE IMMUNOLOGY			English	Article							HEAVY-CHAIN PHOSPHORYLATION; NONMUSCLE MYOSIN; IMMUNOLOGICAL SYNAPSE; IMMUNE INTERACTIONS; ANTIGEN; ACTIVATION; DICTYOSTELIUM; MIGRATION; GENE; CYTOKINESIS	Upon encountering an antigen, motile T cells stop crawling, change morphology and ultimately form an 'immunological synapse'. Although myosin motors are thought to mediate various aspects of this process, the molecules involved and their exact roles are not defined. Here we show that nonmuscle myosin heavy chain IIA, or MyH9, is the only class II myosin expressed in T cells and is associated with the uropod during crawling. MyH9 function is required for maintenance of the uropod and for T cell motility but is dispensable for synapse formation. Phosphorylation of MyH9 in its multimerization domain by T cell receptor-generated signals indicates that inactivation of this motor may be a key step in the 'stop' response during antigen recognition.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 93143 USA; NHLBI, Mol Cardiol Lab, Bethesda, MD 20892 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; Howard Hughes Medical Institute; Stanford University	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave, San Francisco, CA 93143 USA.	krummel@itsa.ucsf.edu		Buxton, Denis/0000-0003-3077-6435	NIAID NIH HHS [R01 AI052116, R01-AI52116-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Buxton DB, 2000, J BIOL CHEM, V275, P34772, DOI 10.1074/jbc.M004996200; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; DOOLITTLE KW, 1995, DEV BIOL, V167, P118, DOI 10.1006/dbio.1995.1011; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; FORD HL, 1995, ONCOGENE, V11, P2067; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heidemann SR, 1998, J CELL BIOL, V141, P1, DOI 10.1083/jcb.141.1.1; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Levi S, 2002, CELL MOTIL CYTOSKEL, V53, P177, DOI 10.1002/cm.10068; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MCFARLAN.W, 1965, NATURE, V205, P887, DOI 10.1038/205887a0; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Redowicz MJ, 2001, J MUSCLE RES CELL M, V22, P163; Rey M, 2002, J IMMUNOL, V169, P5410, DOI 10.4049/jimmunol.169.10.5410; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	44	159	166	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					531	538		10.1038/ni1065	http://dx.doi.org/10.1038/ni1065			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15064761				2022-12-18	WOS:000221101100018
J	Mak, TW; Shahinian, A; Yoshinaga, SK; Wakeham, A; Boucher, LM; Pintilie, M; Duncan, G; Gajewska, BU; Gronski, M; Eriksson, U; Odermatt, B; Ho, A; Bouchard, D; Whorisky, JS; Jordana, M; Ohashi, PS; Pawson, T; Bladt, F; Tafuri, A				Mak, TW; Shahinian, A; Yoshinaga, SK; Wakeham, A; Boucher, LM; Pintilie, M; Duncan, G; Gajewska, BU; Gronski, M; Eriksson, U; Odermatt, B; Ho, A; Bouchard, D; Whorisky, JS; Jordana, M; Ohashi, PS; Pawson, T; Bladt, F; Tafuri, A			Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER FORMATION; ALLERGIC AIRWAY DISEASE; IMMUNE-RESPONSES; AFFINITY MATURATION; DEFICIENT MICE; MOLECULE ICOS; CD40 LIGAND; IN-VIVO; ACTIVATION; RECEPTOR	Costimulation through the inducible costimulator (ICOS) and its ligand (ICOSL) is essential for T cell-dependent B cell responses, but the cellular and temporal dynamics underlying its in vivo effects are poorly defined. Here we have shown that Icosl(-/-) and Icos(-/-) mice had similar phenotypes and that ICOS-ICOSL costimulation modulated the early but not late phases of IgG1 affinity maturation. Exploiting the adoptive transfer of T or B cells from primed Icosl(-)/(-) mice, we provided genetic evidence that costimulation through ICOSL was essential for primary but not secondary helper T cell responses and for the control of both T and B cell activities, resulting in T cell-dependent IgG1 production.	Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA; McMaster Univ, Div Resp Dis & Allergy, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; Amgen; McMaster University; University of Zurich; University Zurich Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Mak, TW (corresponding author), Adv Med Discovery Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Pawson, Tony J/E-4578-2013	Boucher, Louis-Martin/0000-0003-2802-2124; Gronski, Matthew/0000-0003-4779-5720; Eriksson, Urs/0000-0003-1217-9696; Ohashi, Pamela S./0000-0003-2915-9317				Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2000, AM J RESP CRIT CARE, V162, pS179, DOI 10.1164/ajrccm.162.supplement_3.15tac8; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong HD, 1999, NAT MED, V5, P1365; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Hudson L, 1980, PRACTICAL IMMUNOLOGY, V2nd; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jaiswal AI, 1997, J IMMUNOL, V159, P2282; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liang L, 2002, J EXP MED, V196, P97, DOI 10.1084/jem.20020298; Liu XL, 2001, J EXP MED, V194, P1339, DOI 10.1084/jem.194.9.1339; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Reiter R, 2002, IMMUNOLOGY, V106, P222, DOI 10.1046/j.1365-2567.2002.01405.x; Rennert P, 1997, INT IMMUNOL, V9, P805, DOI 10.1093/intimm/9.6.805; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Sperling AI, 2001, CLIN IMMUNOL, V100, P261, DOI 10.1006/clim.2001.5084; Sporici RA, 2001, CLIN IMMUNOL, V100, P263, DOI 10.1006/clim.2001.5093; Sporici RA, 2001, CLIN IMMUNOL, V100, P277, DOI 10.1006/clim.2001.5074; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tarlinton DM, 1998, CURR TOP MICROBIOL, V229, P71; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yoshinaga SK, 2000, INT IMMUNOL, V12, P1439, DOI 10.1093/intimm/12.10.1439; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	48	159	168	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					765	772		10.1038/ni947	http://dx.doi.org/10.1038/ni947			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12833154				2022-12-18	WOS:000184441500013
J	Serwold, T; Gaw, S; Shastri, N				Serwold, T; Gaw, S; Shastri, N			ER aminopeptidases generate a unique pool of peptides for MHC class I molecules	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM; CELL-PROTEINS; COMPLEX; DEGRADATION; PROTEASOME; MOTIFS; TAP; SELF; VIVO; IDENTIFICATION	We define here the specificity and significance of proteases in the endoplasmic reticulum (ER) that generate peptides for presentation by major histocompatibility complex (MHC) class molecules. We show that aminopeptidases efficiently trimmed all residues except proline that flank the NH2-termini of antigenic precursors in the ER and caused an accumulation of X-P-X-n peptides. An aminopeptidase inhibitor blocked peptide trimming in the ER and, consequently, the generation of peptide-loaded MHC molecules. Peptide trimming in the ER is therefore a key step in the MHC class I antigen-processing pathway and also explains the paradox of why many MHC class molecules display peptides with the X-P-X. motif despite the inability of the transporter associated with antigen processing to transport such peptides from the cytoplasm.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu	Gaw, Stephanie/K-4592-2019	Gaw, Stephanie/0000-0003-0891-6964				ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; Anton LC, 1997, J IMMUNOL, V158, P2535; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; DICK LR, 1994, J IMMUNOL, V152, P3884; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FALK K, 1994, IMMUNOGENETICS, V39, P230; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MALARKANNAN S, 1995, J EXP MED, V182, P1739, DOI 10.1084/jem.182.6.1739; Malarkannan S, 1996, P NATL ACAD SCI USA, V93, P13991, DOI 10.1073/pnas.93.24.13991; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; Mendoza LM, 2001, J IMMUNOL, V166, P4438, DOI 10.4049/jimmunol.166.7.4438; MENTLEIN R, 1988, FEBS LETT, V234, P251, DOI 10.1016/0014-5793(88)80092-9; NEISIG A, 1995, J IMMUNOL, V154, P1273; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Serwold T, 1999, J IMMUNOL, V162, P4712; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHASTRI N, 1995, J IMMUNOL, V155, P4339; SHASTRI N, 1995, J BIOL CHEM, V270, P1088, DOI 10.1074/jbc.270.3.1088; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1997, J EXP MED, V186, P1087, DOI 10.1084/jem.186.7.1087; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; WALTER P, 1983, METHOD ENZYMOL, V96, P84; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; YellenShaw AJ, 1997, J EXP MED, V186, P1655, DOI 10.1084/jem.186.10.1655; YellenShaw AJ, 1997, J IMMUNOL, V158, P3227; Zuberi AR, 1998, IMMUNITY, V9, P687, DOI 10.1016/S1074-7613(00)80666-4	50	159	159	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					644	651		10.1038/89800	http://dx.doi.org/10.1038/89800			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429550				2022-12-18	WOS:000169682100019
J	Liu, BY; Ye, BQ; Yang, LL; Zhu, XX; Huang, GL; Zhu, PP; Du, Y; Wu, JY; Qin, XW; Chen, RS; Tian, Y; Fan, ZS				Liu, Benyu; Ye, Buqing; Yang, Liuliu; Zhu, Xiaoxiao; Huang, Guanling; Zhu, Pingping; Du, Ying; Wu, Jiayi; Qin, Xiwen; Chen, Runsheng; Tian, Yong; Fan, Zusen			Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; SELF-RENEWAL; NKP46(+) CELLS; STEM-CELLS; DIFFERENTIATION; SATB1; TRANSCRIPTION; INFLAMMATION; COMMITMENT; LINEAGES	Innate lymphoid cells (ILCs) communicate with other hematopoietic and nonhematopoietic cells to regulate immunity, inflammation and tissue homeostasis. How ILC lineages develop and are maintained remains largely unknown. In this study we observed that a divergent long noncoding RNA (lncRNA), lncKdm2b, was expressed at high levels in intestinal group 3 ILCs (ILC3s). LncKdm2b deficiency in the hematopoietic system led to reductions in the number and effector functions of ILC3s. LncKdm2b expression sustained the maintenance of ILC3s by promoting their proliferation through activation of the transcription factor Zfp292. Mechanistically, lncKdm2b recruited the chromatin organizer Satb1 and the nuclear remodeling factor (NURF) complex onto the Zfp292 promoter to initiate its transcription. Deletion of Zfp292 or Bptf also abrogated the maintenance of ILC3s, leading to susceptibility to bacterial infection. Therefore, our findings reveal that lncRNAs may represent an additional layer of regulation of ILC development and function.	[Liu, Benyu; Ye, Buqing; Yang, Liuliu; Huang, Guanling; Zhu, Pingping; Du, Ying; Wu, Jiayi; Qin, Xiwen; Fan, Zusen] Chinese Acad Sci, Ctr Excellence Biomacromol, Key Lab Infect & Immun, Inst Biophys, Beijing, Peoples R China; [Liu, Benyu; Yang, Liuliu; Huang, Guanling; Wu, Jiayi; Qin, Xiwen; Chen, Runsheng; Tian, Yong; Fan, Zusen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xiaoxiao; Chen, Runsheng; Tian, Yong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Ctr Excellence Biomacromol, Key Lab Infect & Immun, Inst Biophys, Beijing, Peoples R China.; Chen, RS; Tian, Y; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, RS; Tian, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, Beijing, Peoples R China.	crs@sun5.ibp.ac.cn; ytian@ibp.ac.cn; fanz@moon.ibp.ac.cn	TIAN, YONG/L-2414-2019; TIAN, YONG/ABF-4406-2021; 吴, 家怡/GSI-7419-2022; Chen, Runsheng/S-9834-2017; Zhu, Xiaoxiao/AAD-1561-2019; Huang, Guanling/AAE-3779-2020	TIAN, YONG/0000-0002-8790-1148; Chen, Runsheng/0000-0001-6049-8347; Yang, Liuliu/0000-0003-0121-4214; Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [91640203, 31530093, 91419308, 31470864, 31670886, 31601189]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDB19030203, XDA12020219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences	We thank D. R. Littman (New York University, New York, New York, USA) for providing pMIGR plasmid, and P. Zhu (Institute of Biophysics, CAS, Beijing, China) for pcDNA4/TO-mSatb1 plasmid. C. rodentium was a gift from B. Ge (Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China). We thank J. Li (Cnkingbio Company Ltd., Beijing, China) for technical support. We also thank S. Meng, D. Fan, X. Wu, L. Zhou, Y. Teng and J. Jia for technical support. This work was supported by the National Natural Science Foundation of China (grants 91640203, 31530093, and 91419308 to Z.F.; 31470864 and 31670886 to B.Y.; and 31601189 to X.Z.) and the Strategic Priority Research Programs of the Chinese Academy of Sciences (grants XDB19030203 and XDA12020219 to Z.F.).	Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Song HY, 2009, EMBO REP, V10, P1140, DOI 10.1038/embor.2009.157; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608; Zhu PP, 2016, NAT STRUCT MOL BIOL, V23, P631, DOI 10.1038/nsmb.3235	49	158	166	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					499	508		10.1038/ni.3712	http://dx.doi.org/10.1038/ni.3712			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28319097				2022-12-18	WOS:000399378700007
J	Jellusova, J; Cato, MH; Apgar, JR; Ramezani-Rad, P; Leung, CR; Chen, CD; Richardson, AD; Conner, EM; Benschop, RJ; Woodgett, JR; Rickert, RC				Jellusova, Julia; Cato, Matthew H.; Apgar, John R.; Ramezani-Rad, Parham; Leung, Charlotte R.; Chen, Cindi; Richardson, Adam D.; Conner, Elaine M.; Benschop, Robert J.; Woodgett, James R.; Rickert, Robert C.			Gsk3 is a metabolic checkpoint regulator in B cells	NATURE IMMUNOLOGY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GERMINAL CENTER; C-MYC; PHOSPHORYLATION; HYPOXIA; GROWTH; INACTIVATION; LYMPHOCYTES; PATHWAY; INSULIN	B cells predominate in a quiescent state until an antigen is encountered, which results in rapid growth, proliferation and differentiation of the B cells. These distinct cell states are probably accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (Gsk3) is a metabolic sensor that promotes the survival of naive recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, Gsk3 was selectively required for regulation of B cell size, mitochondrial biogenesis, glycolysis and production of reactive oxygen species (ROS), in a manner mediated by the co-stimulatory receptor CD40. Gsk3 was required to prevent metabolic collapse and ROS-induced apoptosis after glucose became limiting, functioning in part by repressing growth dependent on the myelocytomatosis oncoprotein c-Myc. Notably, we found that Gsk3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment.	[Jellusova, Julia; Cato, Matthew H.; Apgar, John R.; Ramezani-Rad, Parham; Leung, Charlotte R.; Chen, Cindi; Rickert, Robert C.] Sanford Burnham Prebys Med Discovery Inst SBP, Tumor Microenvironm & Canc Immunol Program, La Jolla, CA 92037 USA; [Jellusova, Julia; Cato, Matthew H.; Apgar, John R.; Ramezani-Rad, Parham; Leung, Charlotte R.; Chen, Cindi; Richardson, Adam D.; Rickert, Robert C.] NCI, Sanford Burnham Prebys Med Discovery Inst, Designated Canc Ctr, La Jolla, CA 92037 USA; [Conner, Elaine M.; Benschop, Robert J.] Eli Lilly & Co, La Jolla, CA USA; [Woodgett, James R.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; Eli Lilly; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Rickert, RC (corresponding author), Sanford Burnham Prebys Med Discovery Inst SBP, Tumor Microenvironm & Canc Immunol Program, La Jolla, CA 92037 USA.; Rickert, RC (corresponding author), NCI, Sanford Burnham Prebys Med Discovery Inst, Designated Canc Ctr, La Jolla, CA 92037 USA.	robert@sbpdiscovery.org	Woodgett, Jim/F-1087-2010; Richardson, Adam D/N-7845-2014	Woodgett, Jim/0000-0003-3731-5797; Richardson, Adam D/0000-0003-3646-2584	US National Institutes of Health [R01AI41649]; Lilly Research Award Program; Deutsche Forschungsgemeinschaft; Cancer Centers Council (C3); Arthritis National Research Foundation; Canadian Institutes of Health Research; NCI award [5P30CA030199]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Research Award Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Centers Council (C3); Arthritis National Research Foundation(National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the SBP vivarium staff for animal care, M. Shlomchik (University of Pittsburgh) for providing the hCD20-Tam<SUP>Cre</SUP> mice, D. Kitamura (Tokyo University of Science) for providing the CD40LB cell line and C. Lyssiotis (University of Michigan) for discussions. Supported by US National Institutes of Health grant R01AI41649 (R.C.R.), the Lilly Research Award Program (R.C.R.), fellowships from the Deutsche Forschungsgemeinschaft (J.J.) and the Cancer Centers Council (C3) (P.R.-R.) and grants from the Arthritis National Research Foundation (J.J.) and the Canadian Institutes of Health Research (J.W.). The Animal Resources and Cancer Metabolism Cores at SBP are supported by NCI award 5P30CA030199.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Azoulay-Alfaguter I, 2015, ONCOGENE, V34, P4613, DOI 10.1038/onc.2014.390; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacobs K.M, 2012, INT J CELL BIOL, V2012; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stretton C, 2015, BIOCHEM J, V470, P207, DOI 10.1042/BJ20150404; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	37	158	159	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					303	312		10.1038/ni.3664	http://dx.doi.org/10.1038/ni.3664			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28114292	Green Accepted			2022-12-18	WOS:000394413400010
J	Liu, XW; Ma, B; Malik, AB; Tang, HY; Yang, T; Sun, B; Wang, G; Minshall, RD; Li, Y; Zhao, Y; Ye, RD; Xu, JS				Liu, Xiaowen; Ma, Bo; Malik, Asrar B.; Tang, Haiyang; Yang, Tao; Sun, Bo; Wang, Gang; Minshall, Richard D.; Li, Yan; Zhao, Yong; Ye, Richard D.; Xu, Jingsong			Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases	NATURE IMMUNOLOGY			English	Article							FORMYL PEPTIDE RECEPTOR; SIGNALING PATHWAYS; CELL-MIGRATION; CHEMOTAXIS; POLARITY; ALPHA; BETA; PHOSPHORYLATION; DESENSITIZATION; SPECIFICITY	To kill invading bacteria, neutrophils must interpret spatial cues, migrate and reach target sites. Although the initiation of chemotactic migration has been extensively studied, little is known about its termination. Here we found that two mitogen-activated protein kinases (MAPKs) had opposing roles in neutrophil trafficking. The extracellular signal-regulated kinase Erk potentiated activity of the G protein-coupled receptor kinase GRK2 and inhibited neutrophil migration, whereas the MAPK p38 acted as a noncanonical GRK that phosphorylated the formyl peptide receptor FPR1 and facilitated neutrophil migration by blocking GRK2 function. Therefore, the dynamic balance between Erk and p38 controlled neutrophil 'stop' and 'go' activity, which ensured that neutrophils reached their final destination as the first line of host defense.	[Liu, Xiaowen; Tang, Haiyang; Sun, Bo; Wang, Gang; Ye, Richard D.; Xu, Jingsong] Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60680 USA; [Liu, Xiaowen; Malik, Asrar B.; Tang, Haiyang; Sun, Bo; Wang, Gang; Minshall, Richard D.; Ye, Richard D.; Xu, Jingsong] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Ma, Bo; Yang, Tao; Sun, Bo; Zhao, Yong] Chinese Acad Sci, Inst Zool, Grad Sch, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA; [Li, Yan] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shanghai Jiao Tong University	Xu, JS (corresponding author), Univ Illinois, Coll Med, Dept Dermatol, Chicago, IL 60680 USA.	yer@uic.edu; jingsong@uic.edu	TANG, HAIYANG/J-4006-2013; Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020; ma, bo/B-1163-2019	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; ma, bo/0000-0003-0816-6630; Malik, Asrar/0000-0002-8205-7128	US National Institutes of Health [HL095716, AI033503]; Chinese Academy of Sciences [KSCX-W-R-66, KSCX2-YW-R-156]; Natural Science Foundation of China [30630037, 31070956]; National Basic Research Program of China [2010CB945301, 2011CB710900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, R01HL095716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI033503, R01AI033503] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Du, B. Gantner (University of Illinois at Chicago), S. Wang (Peking University) and S. Chen (University of Iowa) for discussions, E. R. Prossnitz (University of New Mexico) for the FPR1-Delta ST construct and K. Otsu (Osaka University) for permission to use mice with loxP-flanked Mapk14. Supported by the US National Institutes of Health (HL095716 and AI033503), the Chinese Academy of Sciences (KSCX-W-R-66 and KSCX2-YW-R-156), the Natural Science Foundation of China (30630037 and 31070956) and the National Basic Research Program of China (2010CB945301 and 2011CB710900).	Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Hale KK, 1999, J IMMUNOL, V162, P4246; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; MCLEISH KR, 1989, MOL PHARMACOL, V36, P384; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; SULLIVAN SJ, 1980, J CELL BIOL, V85, P703, DOI 10.1083/jcb.85.3.703; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Theilade J, 2005, BIOCHEM BIOPH RES CO, V330, P685, DOI 10.1016/j.bbrc.2005.03.044; Theilade J, 2002, FEBS LETT, V518, P195, DOI 10.1016/S0014-5793(02)02701-1; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; Zu YL, 1998, J IMMUNOL, V160, P1982	36	158	159	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					457	464		10.1038/ni.2258	http://dx.doi.org/10.1038/ni.2258			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22447027	Green Accepted			2022-12-18	WOS:000303048400009
J	Eisenring, M; vom Berg, J; Kristiansen, G; Saller, E; Becher, B				Eisenring, Maya; vom Berg, Johannes; Kristiansen, Glen; Saller, Elisabeth; Becher, Burkhard			IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; NK CELLS; IL-12-MEDIATED REJECTION; ANTITUMOR-ACTIVITY; EFFECTOR-CELLS; IFN-GAMMA; INNATE; INTERLEUKIN-12; IMMUNITY; CANCER	The potent tumoricidal activity of interleukin 12 (IL-12) is thought to be mediated by the activation and polarization of natural killer (NK) cells and T helper type 1 (T(H)1) cells, respectively. By systematic analysis of the IL-12-induced immune response to subcutaneous melanoma (B16), we found that tumor suppression was mediated independently of T lymphocytes or NK cells. IL-12 initiated local antitumor immunity by stimulating a subset of NKp46(+) lymphoid tissue-inducer (LTi) cells dependent on the transcription factor ROR gamma t. The presence of these NKp46(+) LTi cells induced upregulation of adhesion molecules in the tumor vasculature and resulted in more leukocyte invasion. Thus, this innate cell type is responsive to IL-12 and is a powerful mediator of tumor suppression.	[Eisenring, Maya; vom Berg, Johannes; Saller, Elisabeth; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Kristiansen, Glen] Univ Zurich Hosp, Dept Pathol, Inst Clin Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	burkhard.becher@neuroimm.uzh.ch	Berg, Johannes vom/B-8983-2018; Becher, Burkhard/ABE-4225-2020	Berg, Johannes vom/0000-0002-4086-1564; Becher, Burkhard/0000-0002-1541-7867	Swiss National Science Foundation; Swiss Cancer League; Center for Neurosciences Zurich; Marie Heim-Vogtlin Programme	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Center for Neurosciences Zurich; Marie Heim-Vogtlin Programme(Swiss National Science Foundation (SNSF))	We thank S. Bulfone-Paus (Research Center Borstel) for Il15ra<SUP>-/-</SUP> mice; A. Diefenbach (University Hospital Freiburg) for Rorc-eYFP mice; Y. Iwakura (University of Tokyo) for Il17a<SUP>-/-</SUP> mice; J.C. Renauld (Ludwig Institute Brussels) for Il22<SUP>-/-</SUP> mice; R. Zinkernagel (University Hospital of Zurich) for anti-CD4 and anti-CD8; M. Kopf and A. Diefenbach for discussions; and V. Tosevski, S. Burkhard, B. Sobotka, V. Wortmann and S. Behnke for technical assistance. Supported by the Swiss National Science Foundation (B.B.), the Swiss Cancer League (B.B.), the Center for Neurosciences Zurich (M.E.) and the Marie Heim-Vogtlin Programme (E.S.).	[Anonymous], 1995, Science, V268, P1555; Beadling C, 2006, ARCH IMMUNOL THER EX, V54, P15, DOI 10.1007/s00005-006-0002-6; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; KINLEN LJ, 1979, BRIT MED J, V2, P1461, DOI 10.1136/bmj.2.6203.1461; Kodama T, 1999, EUR J IMMUNOL, V29, P1390, DOI 10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.3.CO;2-3; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Nishimura T, 1999, J EXP MED, V190, P617, DOI 10.1084/jem.190.5.617; Noguchi Y, 1996, P NATL ACAD SCI USA, V93, P11798, DOI 10.1073/pnas.93.21.11798; Park SH, 2003, J IMMUNOL, V170, P1197, DOI 10.4049/jimmunol.170.3.1197; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Ryschich E, 2002, INT J CANCER, V97, P719, DOI 10.1002/ijc.10074; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schmidt SR, 2009, IDRUGS, V12, P284; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Schrama D, 2001, IMMUNITY, V14, P111, DOI 10.1016/S1074-7613(09)00094-6; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; TAHARA H, 1994, CANCER RES, V54, P182; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	49	158	172	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1030	U83		10.1038/ni.1947	http://dx.doi.org/10.1038/ni.1947			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20935648				2022-12-18	WOS:000283127800013
J	Tanigaki, K; Honjo, T				Tanigaki, Kenji; Honjo, Tasuku			Regulation of lymphocyte development by Notch signaling	NATURE IMMUNOLOGY			English	Review							ZONE B-CELLS; HEMATOPOIETIC PROGENITOR CELLS; MARGINAL ZONE; ALPHA-BETA; T-CELLS; TRANSCRIPTIONAL REPRESSION; LINEAGE SPECIFICATION; NEGATIVE REGULATION; IN-VITRO; DIFFERENTIATION	Notch molecules are well conserved from Drosophila melanogaster to mammals and regulate a broad spectrum of various cell lineage commitment processes. Recent studies using inhibitors, transgenic mice and conditional loss-of-function approaches have demonstrated essential roles for Notch signaling in the differentiation of thymocytes and peripheral T cells, as well as B cells. Here we highlight parallels in the developmental regulation of mammalian lymphocytes and the D. melanogaster nervous system through Notch cooperation with the transcriptional regulators RBP-J (Su( H)), MINT (Hairless) and E2A (Ac-Sc-Da).	Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan; Shiga Med Ctr, Res Inst, Shiga 5248524, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016					Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Engel I, 2002, P NATL ACAD SCI USA, V99, P11322, DOI 10.1073/pnas.162373999; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hoebeke I, 2006, BLOOD, V107, P2879, DOI 10.1182/blood-2005-05-1815; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tanigaki K, 2003, SEMIN IMMUNOL, V15, P113, DOI 10.1016/S1044-5323(03)00008-3; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8	73	158	170	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					451	456		10.1038/ni1453	http://dx.doi.org/10.1038/ni1453			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440450				2022-12-18	WOS:000245831600005
J	Gupta, N; Wollscheid, B; Watts, JD; Scheer, B; Aebersold, R; DeFranco, AL				Gupta, Neetu; Wollscheid, Bernd; Watts, Julian D.; Scheer, Barbara; Aebersold, Ruedi; DeFranco, Anthony L.			Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics	NATURE IMMUNOLOGY			English	Article							CODED AFFINITY TAGS; ERM PROTEINS; MASS-SPECTROMETRY; IMMUNOLOGICAL SYNAPSE; STATISTICAL-MODEL; T-LYMPHOCYTES; MEMBRANE; ACTIVATION; COMPLEX; MOESIN	Ligation of the B cell antigen receptor (BCR) with antigen induces lipid raft coalescence, a process that occurs after crosslinking of a variety of signaling receptors and is thought to potentiate cellular activation. To investigate lipid raft dynamics during BCR signaling, we quantitatively analyzed the B cell lipid raft proteome. BCR engagement induced dissociation of the adaptor protein ezrin from lipid rafts as well as threonine dephosphorylation of ezrin and its concomitant detachment from actin, indicating a transient uncoupling of lipid rafts from the actin cytoskeleton. Expression of constitutively active ezrin chimeras inhibited the BCR-induced coalescence of lipid rafts. Our data demonstrate that the release of ezrin from lipid rafts acts as a critical trigger that regulates lipid raft dynamics during BCR signaling.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Inst Syst Biol, Seattle, WA 98103 USA; Univ Zurich, Fac Nat Sci, CH-8057 Zurich, Switzerland	University of California System; University of California San Francisco; Institute for Systems Biology (ISB); University of Zurich	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	defranco@cgl.ucsf.edu	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610	DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020038, R01AI020038, R01AI041109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK068292] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HV-28179] Funding Source: Medline; NIAID NIH HHS [AI41109, AI20038] Funding Source: Medline; NIDDK NIH HHS [DK068292] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Tomas EM, 2002, IMMUNOL LETT, V83, P143, DOI 10.1016/S0165-2478(02)00075-5; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhou Huilin, 2004, Methods Mol Biol, V261, P511	42	158	162	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					625	633		10.1038/ni1337	http://dx.doi.org/10.1038/ni1337			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16648854				2022-12-18	WOS:000237751200018
J	Matthias, LJ; Yam, PTW; Jiang, XM; Vandegraaff, N; Li, P; Poumbourios, P; Donoghue, N; Hogg, PJ				Matthias, LJ; Yam, PTW; Jiang, XM; Vandegraaff, N; Li, P; Poumbourios, P; Donoghue, N; Hogg, PJ			Disulfide exchange in domain 2 of CD4 is required for entry of HIV-I	NATURE IMMUNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BETA-SHEET CONFORMATION; MONOCLONAL-ANTIBODY; PLASMA THIOREDOXIN; CRYSTAL-STRUCTURE; N-ACETYLCYSTEINE; CYSTINE PEPTIDES; NEOPLASTIC-CELLS; SOLUBLE FORM; INHIBITION	CD4, a member of the immunoglobulin superfamily of receptors that mediates cell-cell interactions in the immune system, is the primary receptor for HIV-1. The extracellular portion of CD4 is a concatenation of four immunoglobulin-like domains, D1 to D4. The D1, D2 and D4 domains each contain a disulfide bond. We show here that the D2 disulfide bond is redox-active. The redox state of the thiols (disulfide versus dithiol) appeared to be regulated by thioredoxin, which is secreted by CD4(+) T cells. Locking the CD4 and the thioredoxin active-site dithiols in the reduced state with a hydrophilic trivalent arsenical blocked entry of HIV-1 into susceptible cells. These findings indicate that redox changes in CD4 D2 are important for HIV-1 entry and represent a new target for HIV-1 entry inhibitors.	Univ New S Wales, Sch Med Sci, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia; Inst Med & Vet Sci, Infect Dis Labs, Natl Ctr HIV Virol Res, Adelaide, SA 5000, Australia; St Vincents Inst Med Res, Virol Unit, Fitzroy, Vic 3065, Australia	University of New South Wales Sydney; Institute Medical & Veterinary Science Australia; St. Vincent's Institute of Medical Research	Hogg, PJ (corresponding author), Univ New S Wales, Sch Med Sci, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au		Yam, Patricia/0000-0002-3631-3151; Hogg, Philip/0000-0001-6486-2863				BACHELDER RE, 1995, J VIROL, V69, P5734, DOI 10.1128/JVI.69.9.5734-5742.1995; BERGAMINI A, 1994, J CLIN INVEST, V93, P2251, DOI 10.1172/JCI117223; Bergamini A, 1996, J INFECT DIS, V174, P214, DOI 10.1093/infdis/174.1.214; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; BURKLY LC, 1992, J IMMUNOL, V149, P1779; CHANDRA P, 1986, ARZNEIMITTEL-FORSCH, V36-1, P184; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; DROGE W, 1992, IMMUNOL TODAY, V13, P211, DOI 10.1016/0167-5699(92)90156-2; HARRIS RJ, 1990, EUR J BIOCHEM, V188, P291, DOI 10.1111/j.1432-1033.1990.tb15402.x; HO WZ, 1995, AIDS RES HUM RETROV, V11, P451, DOI 10.1089/aid.1995.11.451; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; INGALLS HM, 1986, P NATL ACAD SCI USA, V83, P4779, DOI 10.1073/pnas.83.13.4779; JAUHIAINEN M, 1988, J BIOL CHEM, V263, P6525; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KARLE IL, 1989, INT J PEPT PROT RES, V34, P37; KARLE IL, 1988, J AM CHEM SOC, V110, P1958, DOI 10.1021/ja00214a049; KATZ BA, 1986, J BIOL CHEM, V261, P5480; KIRSZBAUM L, 1989, J IMMUNOL, V142, P3931; Konig R, 2002, CURR OPIN IMMUNOL, V14, P75, DOI 10.1016/S0952-7915(01)00300-4; LaBranche CC, 1999, J VIROL, V73, P10310, DOI 10.1128/JVI.73.12.10310-10319.1999; LI P, 1992, AIDS RES HUM RETROV, V8, P253, DOI 10.1089/aid.1992.8.253; Lynch GW, 1999, EUR J IMMUNOL, V29, P2590, DOI 10.1002/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MARTIN H, 1991, BIOCHEM BIOPH RES CO, V175, P123, DOI 10.1016/S0006-291X(05)81209-4; MOORE JP, 1992, J VIROL, V66, P4784, DOI 10.1128/JVI.66.8.4784-4793.1992; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; NAKASHIMA I, 1994, J IMMUNOL, V152, P1064; PACE CN, 1988, J BIOL CHEM, V263, P11820; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROEDERER M, 1992, AIDS RES HUM RETROV, V8, P209, DOI 10.1089/aid.1992.8.209; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Sanejouand YH, 1996, PROTEIN ENG, V9, P671, DOI 10.1093/protein/9.8.671; SCHULOF RS, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1531; Soderberg A, 2000, CANCER RES, V60, P2281; Sodroski JG, 1999, CELL, V99, P243, DOI 10.1016/S0092-8674(00)81655-4; SOWERBY DB, 1994, CHEM ORGANIC ARSENIC, P25; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TONISSEN K, 1993, J BIOL CHEM, V268, P22485; Vandegraaff N, 2001, ANTIMICROB AGENTS CH, V45, P2510, DOI 10.1128/AAC.45.9.2510-2516.2001; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WILLIAMS AF, 1989, COLD SPRING HARB SYM, V54, P637; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015	50	158	176	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					727	732		10.1038/ni815	http://dx.doi.org/10.1038/ni815			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12089508				2022-12-18	WOS:000177118500011
J	Esterhazy, D; Loschko, J; London, M; Jove, V; Oliveira, TY; Mucida, D				Esterhazy, Daria; Loschko, Jakob; London, Mariya; Jove, Veronica; Oliveira, Thiago Y.; Mucida, Daniel			Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T-reg cells and tolerance	NATURE IMMUNOLOGY			English	Article							ORAL TOLERANCE; REGULATORY FACTOR-4; TGF-BETA; DIFFERENTIATION; MACROPHAGES; EXPRESSION; ICSBP; DEFICIENCY; GENERATION; MONOCYTES	Oral tolerance prevents pathological inflammatory responses to innocuous foreign antigens by peripheral regulatory T cells (pT(reg) cells). However, whether a particular subset of antigen-presenting cells (APCs) is required during dietary antigen exposure for the 'instruction' of naive CD4(+) T cells to differentiate into pT(reg) cells has not been defined. Using myeloid lineage-specific APC depletion in mice, we found that monocyte-derived APCs were dispensable, while classical dendritic cells (cDCs) were critical, for pT(reg) cell induction and oral tolerance. CD11b(-) cDCs from the gut-draining lymph nodes efficiently induced pT(reg) cells and, conversely, loss of transcription factor IRF8-dependent CD11b(-) cDCs impaired their polarization, although oral tolerance remained intact. These data reveal the hierarchy of cDC subsets in the induction of pT(reg) cells and their redundancy during the development of oral tolerance.	[Esterhazy, Daria; London, Mariya; Jove, Veronica; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Loschko, Jakob; Oliveira, Thiago Y.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.	mucida@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Jove, Veronica/0000-0002-1454-2228; Mucida, Daniel/0000-0002-0000-0452	Swiss National Foundation; US National Institutes of Health [1R56AI119062]; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI119062] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Amoury and L. Cohn for thoughts for the beginning of the project; M. Nussenzweig (The Rockefeller University) for Csf1r<SUP>LsL-DTR</SUP>, zDC<SUP>DTR</SUP> and zDC<SUP>Cre</SUP> knock-in mice and conceptual input; S. Mazmanian (California Institute of Technology) for germ-free C57BL/6 mice; B. Reis and V. Pedicord for assistance in mouse-dissection experiments, critical discussions and help in preparing the manuscript; K. Velinzon and N. Thomas for assistance in cell sorting; The Rockefeller University Genomics Center; A. Rogoz, T. Rendon, S. Gonzalez and the Rockefeller University Comparative Bioscience Center for animal care and genotyping; and the New York University histology core for lung histological staining. Supported by the Swiss National Foundation (D.E.), The US National Institutes of Health (1R56AI119062 to D.M.) and the Leona M. and Harry B. Helmsley Charitable Trust (D.E. and D.M.).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Loschko J., J EXP MED IN PRESS; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Wang YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008442; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	50	157	164	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					545	+		10.1038/ni.3408	http://dx.doi.org/10.1038/ni.3408			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27019226	Green Accepted			2022-12-18	WOS:000374323100014
J	McHeyzer-Williams, LJ; Milpied, PJ; Okitsu, SL; McHeyzer-Williams, MG				McHeyzer-Williams, Louise J.; Milpied, Pierre J.; Okitsu, Shinji L.; McHeyzer-Williams, Michael G.			Class-switched memory B cells remodel BCRs within secondary germinal centers	NATURE IMMUNOLOGY			English	Article							CLONAL SELECTION; PLASMA-CELLS; ANTIBODY; HYPERMUTATION; REVEALS; RECOMBINATION; MATURATION; MUTATIONS; DYNAMICS; ANTIGEN	Effective vaccines induce high-affinity memory B cells and durable antibody responses through accelerated mechanisms of natural selection. Secondary changes in antibody repertoires after vaccine boosts suggest progressive rediversification of B cell receptors (BCRs), but the underlying mechanisms remain unresolved. Here, the integrated specificity and function of individual memory B cell progeny revealed ongoing evolution of polyclonal antibody specificities through germinal center (GC)-specific transcriptional activity. At the clonal and subclonal levels, single-cell expression of the genes encoding the costimulatory molecule CD83 and the DNA polymerase Pol eta segregated the secondary GC transcriptional program into four stages that regulated divergent mechanisms of memory BCR evolution. Our studies demonstrate that vaccine boosts reactivate a cyclic program of GC function in class-switched memory B cells to remodel existing antibody specificities and enhance durable immunological protection.	[McHeyzer-Williams, Louise J.; Milpied, Pierre J.; Okitsu, Shinji L.; McHeyzer-Williams, Michael G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu	Milpied, Pierre J/Q-1380-2015	Milpied, Pierre J/0000-0003-1873-5358	Foundation Bettencourt-Schueller; Swiss National Science Foundation; Novartis Jubliaeumsstiftung; Roche Research Foundation; US National Institutes of Health [AI047231, AI040215, AI071182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071182, R01AI047231, R01AI040215] Funding Source: NIH RePORTER	Foundation Bettencourt-Schueller; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Jubliaeumsstiftung(Novartis); Roche Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Foundation Bettencourt-Schueller (P.J.M.), the Swiss National Science Foundation (S.L.O.), the Novartis Jubliaeumsstiftung (S.L.O.), the Roche Research Foundation (S.L.O.) and the US National Institutes of Health (AI047231, AI040215 and AI071182 to M.G.M.-W.). This is The Scripps Research Institute manuscript number 26086.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Benson MJ, 2009, J EXP MED, V206, P2013, DOI 10.1084/jem.20090667; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Kaji T, 2013, INT IMMUNOL, V25, P683, DOI 10.1093/intimm/dxt030; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Zabel F, 2014, J IMMUNOL, V192, P5499, DOI 10.4049/jimmunol.1400065; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	50	157	158	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					296	U129		10.1038/ni.3095	http://dx.doi.org/10.1038/ni.3095			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25642821	Green Accepted			2022-12-18	WOS:000349842100013
J	Janssens, S; Pulendran, B; Lambrecht, BN				Janssens, Sophie; Pulendran, Bali; Lambrecht, Bart N.			Emerging functions of the unfolded protein response in immunity	NATURE IMMUNOLOGY			English	Review							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; REGULATED IRE1-DEPENDENT DECAY; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; INDUCED GENE-EXPRESSION; ER STRESS; TRANSLATIONAL CONTROL; MESSENGER-RNA; INFLAMMATORY RESPONSE	The unfolded protein response (UPR) has traditionally been viewed as an adaptive response triggered by the accumulation of unfolded proteins in the endoplasmic reticulum (ER) and aimed at restoring ER function. The UPR can also be an anticipatory response that is activated well before the disruption of protein homeostasis. UPR signaling intersects at many levels with the innate and adaptive immune responses. In some types of cells of the immune system, such as dendritic cells (DCs) and B cells, particular sensors that detect the UPR seem to be constitutively active in the absence of induction of the traditional UPR gene program and are necessary for antigen presentation and immunoglobulin synthesis. The UPR also influences signaling via Toll-like receptors (TLRs) and activation of the transcription factor NF-kappa B, and some pathogens subvert the UPR. This Review summarizes these emerging noncanonical functions of the UPR in immunity.	[Janssens, Sophie; Lambrecht, Bart N.] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, Univ Hosp, Ghent Researchers Unfolded Prot Inflammat & Dis C, B-9000 Ghent, Belgium; [Janssens, Sophie; Lambrecht, Bart N.] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium; [Pulendran, Bali] Emory Univ, Yerkes Natl Primate Ctr, Emory Vaccine Ctr, Dept Pathol, Atlanta, GA 30322 USA; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University Hospital; Ghent University; Emory University; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, Ghent, Belgium.	bart.lambrecht@irc.vib-ugent.be	Janssens, Sophie/HHN-1756-2022; Lambrecht, Bart N/K-2484-2014; Pulendran, Bali/AAW-9550-2021	Lambrecht, Bart N/0000-0003-4376-6834; Pulendran, Bali/0000-0001-6517-4333	European Research Council; Fonds Wetenschappelijk Onderzoek; University of Ghent Multidisciplinary Research Platform; US National Institutes of Health [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048638, U19AI090023, R37AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Fonds Wetenschappelijk Onderzoek(FWO); University of Ghent Multidisciplinary Research Platform; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank F. Martinon, P. de Bleser, P. Hulpiau and L. Martens for comments on the bioinformatics analysis. Supported by the European Research Council (B.N.L.), Fonds Wetenschappelijk Onderzoek (B.N.L. and S.J.), University of Ghent Multidisciplinary Research Platform (B.N.L and S.J.), the US National Institutes of Health (R37 DK057665, R37 AI048638, U19 AI090023 and U19 AI057266 to B.P.) and the Bill & Melinda Gates Foundation (B.P.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Adolph TE, 2012, DIGEST DIS, V30, P341, DOI 10.1159/000338121; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Anderson P, 2014, NEW LEFT REV, P39; Araki Kazutaka, 2012, Cold Spring Harb Perspect Biol, V4, pa015438, DOI 10.1101/cshperspect.a015438; Arensdorf AM, 2013, J CELL SCI, V126, P4026, DOI 10.1242/jcs.130757; Askew DS, 2014, VIRULENCE, V5, P331, DOI 10.4161/viru.28051; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Benhamron S, 2014, EUR J IMMUNOL, V44, P867, DOI 10.1002/eji.201343953; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Clavarino G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002708; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dalod M, 2011, EUR J IMMUNOL, V41, P898, DOI 10.1002/eji.201141497; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Engin F, 2013, SCI TRANSL MED, V5; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Gora S, 2010, FASEB J, V24, P3284, DOI 10.1096/fj.09-146852; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hassan I, 2014, J BIOL CHEM, V289, P7537, DOI 10.1074/jbc.M113.510594; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lemaitre B, 2013, NAT REV MICROBIOL, V11, P365, DOI 10.1038/nrmicro3029; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Ma YJ, 2003, NAT IMMUNOL, V4, P310, DOI 10.1038/ni0403-310; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Marjon PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-4; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Osorio F, 2013, SEMIN IMMUNOPATHOL, V35, P293, DOI 10.1007/s00281-013-0368-6; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Roy CR, 2006, NAT REV IMMUNOL, V6, P136, DOI 10.1038/nri1775; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stahl S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003544; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Tateda C, 2008, J PLANT RES, V121, P603, DOI 10.1007/s10265-008-0185-5; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zheng Y, 2005, J MICROBIOL, V43, P529	140	157	162	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					910	919		10.1038/ni.2991	http://dx.doi.org/10.1038/ni.2991			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232821	Green Accepted			2022-12-18	WOS:000342564800006
J	Seiler, MP; Mathew, R; Liszewski, MK; Spooner, C; Barr, K; Meng, FY; Singh, H; Bendelac, A				Seiler, Michael P.; Mathew, Rebecca; Liszewski, Megan K.; Spooner, Chauncey; Barr, Kenneth; Meng, Fanyong; Singh, Harinder; Bendelac, Albert			Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling	NATURE IMMUNOLOGY			English	Article							DELTA T-CELLS; PLZF; GENE; REGULATOR; MATURATION; SURVIVAL; PROGRAM; NFAT; RECOGNITION; LYMPHOCYTES	Interactions driven by the T cell antigen receptor (TCR) determine the lineage fate of CD4(+)CD8(+) thymocytes, but the molecular mechanisms that induce the lineage-determining transcription factors are unknown. Here we found that TCR-induced transcription factors Egr2 and Egr1 had higher and more-prolonged expression in precursors of the natural killer T (NKT) than in cells of conventional lineages. Chromatin immunoprecipitation followed by deep sequencing showed that Egr2 directly bound and activated the promoter of Zbtb16, which encodes the NKT lineage-specific transcription factor PLZF. Egr2 also bound the promoter of Il2rb, which encodes the interleukin 2 (IL-2) receptor beta-chain, and controlled the responsiveness to IL-15, which signals the terminal differentiation of the NKT lineage. Thus, we propose that persistent higher expression of Egr2 specifies the early and late stages of NKT lineage differentiation, providing a discriminating mechanism that enables TCR signaling to 'instruct' a thymic lineage.	[Seiler, Michael P.; Mathew, Rebecca; Liszewski, Megan K.; Spooner, Chauncey; Barr, Kenneth; Meng, Fanyong; Singh, Harinder; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Seiler, Michael P.; Mathew, Rebecca; Liszewski, Megan K.; Spooner, Chauncey; Barr, Kenneth; Meng, Fanyong; Singh, Harinder; Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Mathew, Rebecca/H-7154-2013	Zilla, Megan/0000-0003-2473-4474; Barr, Kenneth/0000-0002-0769-7053	US National Institutes of Health [AI038339, AI053725, T32AI0709030]; Digestive Disease Research Core Center [P30 DK42086]; Cancer Research Institute; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053725, R37AI038339, R01AI038339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center; Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Charnay (Institut National de la Sante et de la Recherche Medicale) for Egr1-Egr2-deficient mice; E. Bartom for help with analysis of ChIP-seq data; M. Wang for help with statistical analyses; the University of Chicago Animal Resource Center, Core Flow Cytometry Facility, DNA Sequencing Facility; the National Institute of Allergy and Infectious Diseases tetramer facility for CD1d tetramers; and the ImmGen Consortium for data assembly. Supported by the US National Institutes of Health (AI038339 and AI053725; and T32AI0709030 to M.P.S.), the Digestive Disease Research Core Center (P30 DK42086), the Cancer Research Institute (R.M.) and the Howard Hughes Medical Institute (A.B.).	Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Castillo EF, 2010, BLOOD, V116, P2494, DOI 10.1182/blood-2010-03-277103; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hu TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019890; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Lambolez F, 2007, IMMUNOL REV, V215, P178, DOI 10.1111/j.1600-065X.2006.00488.x; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Valouev A, 2008, NAT METHODS, V5, P829, DOI [10.1038/nmeth.1246, 10.1038/NMETH.1246]; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	50	157	157	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					264	271		10.1038/ni.2230	http://dx.doi.org/10.1038/ni.2230			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22306690	Green Accepted			2022-12-18	WOS:000300510600013
J	Yu, Q; Sharma, A; Oh, SY; Moon, HG; Hossain, MZ; Salay, TM; Leeds, KE; Du, HS; Wu, BB; Waterman, ML; Zhu, Z; Sen, JM				Yu, Qing; Sharma, Archna; Oh, Sun Young; Moon, Hyung-Geun; Hossain, M. Zulfiquer; Salay, Theresa M.; Leeds, Karen E.; Du, Hansen; Wu, Beibei; Waterman, Marian L.; Zhu, Zhou; Sen, Jyoti Misra			T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma	NATURE IMMUNOLOGY			English	Article							BETA-CATENIN; LINEAGE COMMITMENT; PROSTAGLANDIN E-2; GENE-EXPRESSION; IMMUNE-SYSTEM; COLON-CANCER; TH2 CELLS; IN-VITRO; WNT; RESPONSES	The differentiation of activated CD4(+) T cells into the T helper type 1 (T(H)1) or T(H)2 fate is regulated by cytokines and the transcription factors T-bet and GATA-3. Whereas interleukin 12 (IL-12) produced by antigen-presenting cells initiates the T(H)1 fate, signals that initiate the T(H)2 fate are not completely characterized. Here we show that early GATA-3 expression, required for T(H)2 differentiation, was induced by T cell factor 1 (TCF-1) and its cofactor beta-catenin, mainly from the proximal Gata3 promoter upstream of exon 1b. This activity was induced after T cell antigen receptor (TCR) stimulation and was independent of IL-4 receptor signaling through the transcription factor STAT6. Furthermore, TCF-1 blocked T(H)1 fate by negatively regulating interferon-gamma (IFN-gamma) expression independently of beta-catenin. Thus, TCF-1 initiates T(H)2 differentiation of activated CD4(+) T cells by promoting GATA-3 expression and suppressing IFN-gamma expression.	[Yu, Qing; Sharma, Archna; Hossain, M. Zulfiquer; Salay, Theresa M.; Leeds, Karen E.; Du, Hansen; Sen, Jyoti Misra] NIA, Lymphocyte Dev Unit, Immunol Lab, NIH, Baltimore, MD 21224 USA; [Oh, Sun Young; Moon, Hyung-Geun; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Div Clin Immunol & Allergy, Baltimore, MD USA; [Wu, Beibei; Waterman, Marian L.] Univ Calif Irvine, Irvine, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; University of California System; University of California Irvine	Sen, JM (corresponding author), NIA, Lymphocyte Dev Unit, Immunol Lab, NIH, Baltimore, MD 21224 USA.	jyoti-sen@nih.gov	Sharma, Archna/R-9377-2016; Wu, Beibei/B-5169-2010; Wu, Beibei/B-7463-2011	Sharma, Archna/0000-0003-4745-0220; 	Intramural Research Program of the National Institute on Aging of the National Institutes of Health; Oak Ridge Institute for Science and Education's Research Associates Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000772] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oak Ridge Institute for Science and Education's Research Associates Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Wersto and team for cell sorting; the animal facility of the National Institute on Aging for maintaining animals; S. Luo and team for genotyping; H. Clevers (Hubrecht Institute) for TCF-1-deficient mice; W. Pear (University of Pennsylvania) for the dnMAML retroviral construct; and N. Taylor, A. Singer, R. Bosselut, R. Sen and A. Bhandoola for critically reading the manuscript. Supported by the Intramural Research Program of the National Institute on Aging of the National Institutes of Health and the Oak Ridge Institute for Science and Education's Research Associates Program of the National Institutes of Health.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Glimcher LH, 2000, GENE DEV, V14, P1693; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hossain MZ, 2008, INT IMMUNOL, V20, P925, DOI 10.1093/intimm/dxn051; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; vonderWeid T, 1996, J IMMUNOL, V157, P4421; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2007, J IMMUNOL, V178, P5028, DOI 10.4049/jimmunol.178.8.5028; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	49	157	166	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					992	U85		10.1038/ni.1762	http://dx.doi.org/10.1038/ni.1762			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19648923	Green Accepted			2022-12-18	WOS:000269120900013
J	Tan, JB; Visan, I; Yuan, JS; Guidos, CJ				Tan, JB; Visan, I; Yuan, JS; Guidos, CJ			Requirement for Notch1 signals at sequential early stages of intrathymic T cell development	NATURE IMMUNOLOGY			English	Article							COMMON LYMPHOID PROGENITORS; SELF-RENEWAL CAPACITY; ADULT-MOUSE THYMUS; BONE-MARROW; LINEAGE DECISION; DENDRITIC-CELL; STEM-CELLS; PRECURSOR CELLS; ALPHA-BETA; PRE-TCR	Signaling through the transmembrane Notch1 receptor directs thymus-seeding progenitors (TSPs) to suppress their B cell potential and 'choose' the T cell fate. Present paradigms suggest that TSPs are contained in the multipotent early T lineage precursor (ETP) subset of thymocytes. However, we show here that the B cell potential of ETPs was not augmented in microenvironments that limited Notch1 activation. Furthermore, low-threshold Notch1 signals suppressed B cell production by TSPs before they reached the ETP stage. Notch1 signals of a higher threshold were needed to drive proliferation of ETPs and development into CD4(+)CD8(+) double-positive thymocytes. Thus, TSPs can be differentiated from all previously identified early T cell progenitors by their robust B cell potential and exquisite sensitivity to Notch1 signals.	Hosp Sick Children, Inst Res, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Guidos, CJ (corresponding author), Hosp Sick Children, Inst Res, Program Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cynthia.guidos@sickkids.ca						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BALCIUNAITE G, 2004, BLOOD; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Donskoy E, 2003, J IMMUNOL, V171, P3568, DOI 10.4049/jimmunol.171.7.3568; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hardy RR, 2000, IMMUNOL REV, V175, P23, DOI 10.1111/j.1600-065X.2000.imr017517.x; HARMAN BC, 2005, BLOOD; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Ikawa T, 2004, BLOOD, V103, P530, DOI 10.1182/blood-2003-06-1797; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Koch U, 2003, SEMIN IMMUNOL, V15, P99, DOI 10.1016/S1044-5323(03)00006-X; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lee CK, 2001, J IMMUNOL, V166, P5964, DOI 10.4049/jimmunol.166.10.5964; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834	56	157	160	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					671	679		10.1038/ni1217	http://dx.doi.org/10.1038/ni1217			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15951812				2022-12-18	WOS:000229975500010
J	Anzelon, AN; Wu, H; Rickert, RC				Anzelon, AN; Wu, H; Rickert, RC			Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function	NATURE IMMUNOLOGY			English	Article							PHOSPHOINOSITIDE 3-KINASE; CELL-DEVELOPMENT; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CYCLIN D2; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; TYROSINE KINASE; ACTIVATION; PROLIFERATION	Phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog (PTEN) phosphatase serve essential functions in the regulation of cell growth, differentiation and survival by modulating intracellular phosphatidylinositol-3,4,5-trisphosphate (P1-3,4,5-P3) concentrations. Here we show that the conditional deletion of Pten in B cells led to the preferential generation of marginal zone (MZ) B cells and B1 cells. PTEN-deficient B cells were hyperproliferative in response to mitogenic stimuli, and exhibited a lower threshold for activation through the B cell antigen receptor. Inactivation of PTEN rescued germinal center, MZ B and B1 cell formation in CD19(-/-) mice, arguing that recruitment and activation of PI3K are the dominant roles for CD19 in these B cell subpopulations. These findings establish the central role of PI-3,4,5-P3 regulation in the differentiation of peripheral B cell subsets.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rickert, RC (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr,MC 0322, La Jolla, CA 92093 USA.	rrickert@ucsd.edu			NIAID NIH HHS [AI41649] Funding Source: Medline; NIGMS NIH HHS [GM07246] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buhl AM, 1999, J IMMUNOL, V162, P4438; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; DEL PL, 1997, SCIENCE, V278, P687; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fujimoto M, 2002, J IMMUNOL, V168, P5465, DOI 10.4049/jimmunol.168.11.5465; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glassford J, 2001, J BIOL CHEM, V276, P41040, DOI 10.1074/jbc.M105305200; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Helgason CD, 2000, J EXP MED, V191, P781, DOI 10.1084/jem.191.5.781; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2002, SCIENCE, V297, P1031; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Otero DC, 2001, J BIOL CHEM, V276, P1474, DOI 10.1074/jbc.M003918200; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Schwartz MA, 2001, J CELL SCI, V114, P2553; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751	52	157	159	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					287	294		10.1038/ni892	http://dx.doi.org/10.1038/ni892			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12563260				2022-12-18	WOS:000181201000019
J	Valujskikh, A; Lantz, O; Celli, S; Matzinger, P; Heeger, PS				Valujskikh, A; Lantz, O; Celli, S; Matzinger, P; Heeger, PS			Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway	NATURE IMMUNOLOGY			English	Article							MURINE CARDIAC ALLOGRAFTS; CLASS-I EXPRESSION; MINOR H-ANTIGENS; ENDOTHELIAL-CELLS; TRANSPLANTATION ANTIGEN; VASCULAR ENDOTHELIUM; EXOGENOUS ANTIGEN; SKIN-GRAFTS; IFN-GAMMA; MHC	To prevent bystander destruction of healthy host tissues, cytotoxic CD8(+) T lymphocytes are fitted with specific receptors that direct their destructive forces specifically against chosen targets. We show here, however, that anti-H-Y monospecific, H-2(b)-restricted MataHari CD8(+) T cells reject H-2(k) male skin grafts, with which they cannot directly interact. Such rejection is interferon-gamma-dependent and only occurs if the recipient endothelium expresses H-2(b). The findings suggest an alternate indirect effector pathway that requires processing and presentation of the donor H-Y antigen by recipient endothelium and have implications for both transplantation and autoimmune disease.	Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA; Inst Curie, Immunol Lab, F-75005 Paris, France; Inst Curie, Unite 520, INSERM, F-75005 Paris, France; NIAID, Ghost Lab, LCMI, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; Case Western Reserve University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Heeger, PS (corresponding author), Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Celli, Susanna/M-7138-2014; Lantz, Olivier J/J-4960-2012	Lantz, Olivier J/0000-0003-3161-7719	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, Z01AI000581, R01AI043578] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-43578-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BILLINGHAM RE, 1960, J IMMUNOL, V85, P14; BYRNE JA, 1984, J IMMUNOL, V133, P433; CHAN SY, 1995, TRANSPLANTATION, V59, P1155, DOI 10.1097/00007890-199504270-00014; Colucci F, 1999, J IMMUNOL, V162, P2761; DESQUENNECLARK L, 1992, TRANSPLANTATION, V54, P916, DOI 10.1097/00007890-199211000-00028; DESQUENNECLARK L, 1987, DEV GENET, V8, P189, DOI 10.1002/dvg.1020080403; DEWAAL RMW, 1986, TRANSPLANTATION, V42, P178, DOI 10.1097/00007890-198608000-00015; DEWAAL RMW, 1983, NATURE, V303, P426, DOI 10.1038/303426a0; DOODY DP, 1994, J EXP MED, V179, P1645, DOI 10.1084/jem.179.5.1645; EPPERSON DE, 1992, J IMMUNOL, V149, P3297; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Hancock WW, 1998, NAT MED, V4, P1392, DOI 10.1038/3982; Hasegawa S, 1998, AM J PATHOL, V153, P69, DOI 10.1016/S0002-9440(10)65547-2; HAYRY P, 1970, SCIENCE, V168, P133, DOI 10.1126/science.168.3927.133; Heeger PS, 2000, J IMMUNOL, V165, P1278, DOI 10.4049/jimmunol.165.3.1278; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; JAKOBSEN MK, 1995, J IMMUNOTHER, V17, P222, DOI 10.1097/00002371-199505000-00004; Jones ND, 2001, J IMMUNOL, V166, P2824, DOI 10.4049/jimmunol.166.4.2824; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Kreisel D, 2001, J IMMUNOL METHODS, V254, P31, DOI 10.1016/S0022-1759(01)00371-4; LANCKI DW, 1984, IMMUNOL REV, V81, P65, DOI 10.1111/j.1600-065X.1984.tb01105.x; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; LAPIERRE LA, 1988, J EXP MED, V167, P794, DOI 10.1084/jem.167.3.794; LASSILA O, 1988, NATURE, V334, P253, DOI 10.1038/334253a0; Lee RS, 1997, TRANSPLANTATION, V63, P1123, DOI 10.1097/00007890-199704270-00012; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Ma WL, 1997, J BIOL CHEM, V272, P16585, DOI 10.1074/jbc.272.26.16585; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MARINCOLA FM, 1994, J IMMUNOL, V153, P1225; Matesic D, 1998, TRANSPLANTATION, V65, P906, DOI 10.1097/00007890-199804150-00008; MATZINGER P, 1977, CELL IMMUNOL, V33, P92, DOI 10.1016/0008-8749(77)90137-X; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; MINTZ B, 1967, SCIENCE, V158, P1484, DOI 10.1126/science.158.3807.1484; Miura M, 2001, J IMMUNOL, V167, P3494, DOI 10.4049/jimmunol.167.6.3494; Morgan DJ, 1998, J IMMUNOL, V160, P643; PATTEN PA, 1993, J IMMUNOL, V150, P2281; Plautz GE, 2000, J IMMUNOL, V165, P3656, DOI 10.4049/jimmunol.165.7.3656; POBER JS, 1982, P NATL ACAD SCI-BIOL, V79, P6641, DOI 10.1073/pnas.79.21.6641; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROSENBERG AS, 1988, P NATL ACAD SCI USA, V85, P7739, DOI 10.1073/pnas.85.20.7739; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; SILVERS WK, 1968, NATURE, V220, P401, DOI 10.1038/220401a0; SINGER A, 1984, J IMMUNOL, V132, P2199; Valujskikh A, 1998, J CLIN INVEST, V101, P1398, DOI 10.1172/JCI893; Vella JP, 1999, TRANSPLANTATION, V67, P1523, DOI 10.1097/00007890-199906270-00005; Wigginton JM, 2001, J CLIN INVEST, V108, P51	55	157	160	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					844	851		10.1038/ni831	http://dx.doi.org/10.1038/ni831			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12172545				2022-12-18	WOS:000177694900013
J	Hidaka, T; Ogawa, E; Kobayashi, EH; Suzuki, T; Funayama, R; Nagashima, T; Fujimura, T; Aiba, S; Nakayama, K; Okuyama, R; Yamamoto, M				Hidaka, Takanori; Ogawa, Eisaku; Kobayashi, Eri H.; Suzuki, Takafumi; Funayama, Ryo; Nagashima, Takeshi; Fujimura, Taku; Aiba, Setsuya; Nakayama, Keiko; Okuyama, Ryuhei; Yamamoto, Masayuki			The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; ULTRAFINE PARTICLES; SENSORY NEURONS; NC/NGA MICE; SKIN; ITCH; EXPRESSION; DISEASES; PRURITUS; TRANSCRIPTION	Atopic dermatitis is increasing worldwide in correlation with air pollution. Various organic components of pollutants activate the transcription factor AhR (aryl hydrocarbon receptor). Through the use of AhR-CA mice, whose keratinocytes express constitutively active AhR and that develop atopic-dermatitis-like phenotypes, we identified Artn as a keratinocyte-specific AhR target gene whose product (the neurotrophic factor artemin) was responsible for epidermal hyper-innervation that led to hypersensitivity to pruritus. The activation of AhR via air pollutants induced expression of artemin, alloknesis, epidermal hyper-innervation and inflammation. AhR activation and ARTN expression were positively correlated in the epidermis of patients with atopic dermatitis. Thus, AhR in keratinocytes senses environmental stimuli and elicits an atopic-dermatitis pathology. We propose a mechanism of air-pollution-induced atopic dermatitis via activation of AhR.	[Hidaka, Takanori; Kobayashi, Eri H.; Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Hidaka, Takanori; Fujimura, Taku; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi, Japan; [Ogawa, Eisaku; Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano, Japan; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Cell Proliferat, Sendai, Miyagi, Japan; [Yamamoto, Masayuki] Tohoku Med Megabank Org, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Shinshu University; Tohoku University	Kobayashi, EH; Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan.; Yamamoto, M (corresponding author), Tohoku Med Megabank Org, Sendai, Miyagi, Japan.	erik@med.tohoku.ac.jp; erik@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Takafumi/ABC-6582-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Takafumi/0000-0002-3425-8208; xing zhi, shi zhi/0000-0003-3289-5681; Fujimura, Taku/0000-0001-6809-5833	Japan Society for the Promotion of Science [KAKENHI 25840001, 15K08257, 25461688, 22118002, 24249015, 26111002]; Japan Society for the Promotion of Science (AMED-CREST (chronic inflammation)); Mitsubishi Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (AMED-CREST (chronic inflammation)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank K. Kuroda for bioinformatics support; M. Nakagawa, M. Kikuchi, M. Tsuda, S. Inomata, A. Gotoh and A. Uchiyama for technical assistance; the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support; J. Takeda (Osaka University) for Krt5-Cre mice; N. E. Fusenig (Deutsches Krebsforschungszentrum) for HaCaT keratinocytes; S. Ikawa (Tohoku University) for adenoviral vectors; and M. Sagai (Aomori University of Health and Welfare) for DEPs. Supported by the Japan Society for the Promotion of Science (KAKENHI 25840001 and 15K08257 to E.H.K.; 25461688 to E.O.; 22118002, 24249015 and 26111002 to M.Y.; and AMED-CREST (chronic inflammation) to M.Y.), the Mitsubishi Foundation (M.Y.) and the Takeda Science Foundation (M.Y.).	Abramovits W, 2005, J AM ACAD DERMATOL, V53, pS70, DOI 10.1016/j.jaad.2005.04.032; Akiyama T, 2012, J INVEST DERMATOL, V132, P1886, DOI 10.1038/jid.2012.52; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Chu I, 1996, FOOD CHEM TOXICOL, V34, P267, DOI 10.1016/0278-6915(95)00112-3; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Farmahin R, 2016, BIOCHEM PHARMACOL, V115, P134, DOI 10.1016/j.bcp.2016.06.005; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hashimoto Y, 2004, LIFE SCI, V76, P783, DOI 10.1016/j.lfs.2004.07.022; Hong J, 2011, SEMIN CUTAN MED SURG, V30, P71, DOI 10.1016/j.sder.2011.05.002; Ikoma A, 2003, ARCH DERMATOL, V139, P1475, DOI 10.1001/archderm.139.11.1475; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Jedrychowski W, 2011, INT ARCH ALLERGY IMM, V155, P275, DOI 10.1159/000320376; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; KAO J, 1985, TOXICOL APPL PHARM, V81, P502, DOI 10.1016/0041-008X(85)90421-1; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kim HO, 2014, EXP DERMATOL, V23, P278, DOI 10.1111/exd.12350; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kopec AK, 2010, TOXICOL SCI, V118, P286, DOI 10.1093/toxsci/kfq236; Kuriyama S, 2016, J EPIDEMIOL, V26, P493, DOI 10.2188/jea.JE20150268; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li RS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-6; Lo R, 2012, TOXICOL SCI, V130, P349, DOI 10.1093/toxsci/kfs253; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Murota H, 2012, J ALLERGY CLIN IMMUN, V130, P671, DOI 10.1016/j.jaci.2012.05.027; Ricci G, 2006, J AM ACAD DERMATOL, V55, P765, DOI 10.1016/j.jaad.2006.04.064; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; SANDERS CL, 1984, ENVIRON RES, V33, P353, DOI 10.1016/0013-9351(84)90033-1; Song S, 2011, ENVIRON RES, V111, P394, DOI 10.1016/j.envres.2010.10.010; Tamari M, 2014, J DERMATOL, V41, P213, DOI 10.1111/1346-8138.12321; Tauchi M, 2005, MOL CELL BIOL, V25, P9360, DOI 10.1128/MCB.25.21.9360-9368.2005; Tominaga M, 2007, J DERMATOL SCI, V46, P199, DOI 10.1016/j.jdermsci.2007.02.002; Tominaga M, 2014, J DERMATOL, V41, P205, DOI 10.1111/1346-8138.12317; Totlandsdal AI, 2012, TOXICOL LETT, V208, P262, DOI 10.1016/j.toxlet.2011.10.025; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; WAHLGREN CF, 1991, ACTA DERM-VENEREOL, V71, P488; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yoshida N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-41	48	156	163	6	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					64	73		10.1038/ni.3614	http://dx.doi.org/10.1038/ni.3614			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB	27869817				2022-12-18	WOS:000390080000011
J	Chang, VT; Fernandes, RA; Ganzinger, KA; Lee, SF; Siebold, C; McColl, J; Jonsson, P; Palayret, M; Harlos, K; Coles, CH; Jones, EY; Lui, Y; Huang, E; Gilbert, RJC; Klenerman, D; Aricescu, AR; Davis, SJ				Chang, Veronica T.; Fernandes, Ricardo A.; Ganzinger, Kristina A.; Lee, Steven F.; Siebold, Christian; McColl, James; Jonsson, Peter; Palayret, Matthieu; Harlos, Karl; Coles, Charlotte H.; Jones, E. Yvonne; Lui, Yuan; Huang, Elizabeth; Gilbert, Robert J. C.; Klenerman, David; Aricescu, A. Radu; Davis, Simon J.			Initiation of T cell signaling by CD45 segregation at 'close contacts'	NATURE IMMUNOLOGY			English	Article							ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RECEPTOR; PROTEIN; RECOGNITION; ACTIVATION; DIMENSIONS; EXPRESSION; ANTIGEN	It has been proposed that the local segregation of kinases and the tyrosine phosphatase CD45 underpins T cell antigen receptor (TCR) triggering, but how such segregation occurs and whether it can initiate signaling is unclear. Using structural and biophysical analysis, we show that the extracellular region of CD45 is rigid and extends beyond the distance spanned by TCR-ligand complexes, implying that sites of TCR-ligand engagement would sterically exclude CD45. We also show that the formation of 'close contacts', new structures characterized by spontaneous CD45 and kinase segregation at the submicron-scale, initiates signaling even when TCR ligands are absent. Our work reveals the structural basis for, and the potent signaling effects of, local CD45 and kinase segregation. TCR ligands have the potential to heighten signaling simply by holding receptors in close contacts.	[Chang, Veronica T.; Fernandes, Ricardo A.; Lui, Yuan; Huang, Elizabeth; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England; [Chang, Veronica T.; Fernandes, Ricardo A.; Lui, Yuan; Huang, Elizabeth; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Ganzinger, Kristina A.; Lee, Steven F.; McColl, James; Jonsson, Peter; Palayret, Matthieu; Klenerman, David] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Chang, Veronica T.; Siebold, Christian; Harlos, Karl; Coles, Charlotte H.; Jones, E. Yvonne; Gilbert, Robert J. C.; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England.; Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DU, England.; Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.; Aricescu, AR (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England.	dk10012@cam.ac.uk; radu@strubi.ox.ac.uk; simon.davis@imm.ox.ac.uk	Jones, Yvonne/J-2293-2016; Fernandes, Ricardo/AAB-8165-2019; Jones, Yvonne/N-8111-2019; Ganzinger, Kristina/AAD-5584-2020; Jönsson, Peter/C-3351-2009	Jones, Yvonne/0000-0002-3834-1893; Fernandes, Ricardo/0000-0001-5343-3334; Jones, Yvonne/0000-0002-3834-1893; Ganzinger, Kristina/0000-0001-9106-9406; Jönsson, Peter/0000-0003-2994-8017; Aricescu, Alexandru ARadu/0000-0003-3783-1388; Klenerman, David/0000-0001-7116-6954; Siebold, Christian/0000-0002-6635-3621; McColl, James/0000-0002-6692-3663; Coles, Charlotte/0000-0003-4525-7144; Gilbert, Robert/0000-0001-9336-5604; Palayret, Matthieu/0000-0002-5343-8378	Wellcome Trust [098274/Z/12/Z, 090532/Z/09/Z, 090708/Z/09/Z]; UK Medical Research Council [G0700232]; Royal Society [UF120277]; Cancer Research UK [C20724/A14414, C375/A10976]; Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award [090532/Z/09/Z]; Instruct, an ESFRI Landmark Project; Wellcome Trust JIF award [060208/Z/00/Z]; MRC [G0900084, G0700232, MR/L017776/1, G9900061, MR/M000141/1, MR/L009609/1, MC_UU_12010/4] Funding Source: UKRI; Cancer Research UK [10976, 14414] Funding Source: researchfish; Medical Research Council [MR/L009609/1, MR/L017776/1, MR/M000141/1, G0900084, G0700232, G9900061, MC_UU_12010/4] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award; Instruct, an ESFRI Landmark Project; Wellcome Trust JIF award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank R.A. Cornall, M.L. Dustin and P.A. van der Merwe for comments on the manuscript and S. Ikemizu for useful discussions about the structure. We also thank W. Lu and T. Walter for technical support with protein expression and crystallization, the staff at Diamond Light Source beamlines I02, I03 and I04-1 (proposal mx10627) and European Synchrotron Radiation Facility beamlines ID23EH1 and ID23EH2 for assistance at the synchrotrons, G. Sutton for assistance with MALS experiments, and M. Fritzsche for advice on the calcium analysis. This work was funded by the Wellcome Trust (098274/Z/12/Z to S.J.D.; 090532/Z/09/Z to R.J.C.G.; 090708/Z/09/Z to D.K.), the UK Medical Research Council (G0700232 to A.R.A.), the Royal Society (UF120277 to S.F.L.) and Cancer Research UK (C20724/A14414 to C.S.; C375/A10976 to E.Y.J.). The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award Grant Number 090532/Z/09/Z. We acknowledge financial support from Instruct, an ESFRI Landmark Project. The OPIC electron microscopy facility was funded by a Wellcome Trust JIF award (060208/Z/00/Z).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bricogne G., 2011, BUSTER VERSION 2 11; Burroughs NJ, 2006, BIOPHYS J, V91, P1619, DOI 10.1529/biophysj.105.080044; Burroughs NJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002076; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; COCKETT MI, 1990, BIO-TECHNOL, V8, P662, DOI 10.1038/nbt0790-662; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Crocker JC, 1996, PHYS REV LETT, V77, P1897, DOI 10.1103/PhysRevLett.77.1897; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FISCHER EH, 1992, CIBA F SYMP, V164, P132; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Jonsson P, 2012, P NATL ACAD SCI USA, V109, P10328, DOI 10.1073/pnas.1202858109; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MCCALL MN, 1992, IMMUNOLOGY, V76, P310; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Olveczky BP, 1997, BIOPHYS J, V73, P2836, DOI 10.1016/S0006-3495(97)78312-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Symons A, 1999, PROTEIN ENG, V12, P885, DOI 10.1093/protein/12.10.885; Tan YX, 2013, COLD SH Q B, V78, P131, DOI 10.1101/sqb.2013.78.020347; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Weimann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064287; Williams A.F., 1986, HDB EXPT IMMUNOLOGY; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	69	156	160	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					574	+		10.1038/ni.3392	http://dx.doi.org/10.1038/ni.3392			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26998761	Green Accepted			2022-12-18	WOS:000374323100017
J	Beresford, GW; Boss, JM				Beresford, GW; Boss, JM			CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter	NATURE IMMUNOLOGY			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; BARE LYMPHOCYTE SYNDROME; TRANSACTIVATOR GENE CIITA; INVARIANT CHAIN GENE; CREB BINDING-PROTEIN; NF-Y; ACETYLTRANSFERASE ACTIVITY; INTERFERON-GAMMA; BOX-BINDING	We present here an in vivo view of major histocompatibility complex (MHC) class II promoter assembly, nucleosome modifications and gene expression mediated by the class II transactivator (CIITA). Acetylation and deacetylation of histones H3 and H4 at the HLA-DRA promoter were found to occur during a time-course that depended on CIITA expression and binding. Expression of a CIITA mutant, which lacked the activation domain, induced H4 but not H3 histone acetylation. This suggested that multiple histone acetyltransferase activities are associated with MHC class II expression. H4 acetylation was mapped to Lys(8), which implicated several histone acetyltransferases as possible modulators of this activity.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.		Beresford, Guy/C-6548-2016	Beresford, Guy/0000-0001-5312-6262	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI034000, R01AI034000, R21AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34000] Funding Source: Medline; NIGMS NIH HHS [GM47310] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; Boss JM, 1999, MICROBES INFECT, V1, P847, DOI 10.1016/S1286-4579(99)00234-8; BROWN H, 1995, MENT HANDICAP RES, V8, P1; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHANG CH, 1992, J EXP MED, V176, P1465, DOI 10.1084/jem.176.5.1465; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLIGAN JE, 1991, CURRENT PROTOCOLS IM, V1; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; DeSandro AM, 2000, MOL CELL BIOL, V20, P6587, DOI 10.1128/MCB.20.17.6587-6599.2000; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Griscelli C, 1989, Immunodefic Rev, V1, P135; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LISOWSKAGROSPIERRE B, 1994, HUM MOL GENET, V3, P953, DOI 10.1093/hmg/3.6.953; LOWE LAB, 1989, J CLIN INVEST, V84, P613; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MARTIN BK, 1997, IMMUNITY, V6, P581; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Nagarajan UM, 2000, J IMMUNOL, V164, P3666, DOI 10.4049/jimmunol.164.7.3666; RADLEY E, 1994, J BIOL CHEM, V269, P18834; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; Reith W, 1999, MICROBES INFECT, V1, P839; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; RILEY JL, 1993, J IMMUNOL, V151, P6942; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SEIDL C, 1992, J IMMUNOL, V148, P1576; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Westerheide SD, 1997, J IMMUNOL, V158, P4812; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; WRIGHT KL, 1992, P NATL ACAD SCI USA, V89, P7601, DOI 10.1073/pnas.89.16.7601; Wright KL, 1998, P NATL ACAD SCI USA, V95, P6267, DOI 10.1073/pnas.95.11.6267; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	60	156	158	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					652	657		10.1038/89810	http://dx.doi.org/10.1038/89810			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429551				2022-12-18	WOS:000169682100020
J	Garbi, N; Tan, P; Diehl, AD; Chambers, BJ; Ljunggren, HG; Momburg, F; Hammerling, GJ				Garbi, N; Tan, P; Diehl, AD; Chambers, BJ; Ljunggren, HG; Momburg, F; Hammerling, GJ			Impaired immune responses and altered peptide repertoire in tapasin-deficient mice	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; CYTOTOXIC T-LYMPHOCYTES; NATURAL-KILLER-CELLS; ANTIGEN PRESENTATION; REVEALS POLYMORPHISM; DENDRITIC CELLS; INSECT CELLS; MUTANT MICE; BONE-MARROW; LINE .220	Tapasin is a component of the major histocompatibility complex (MHC) class I antigen-loading complex. Here we show that mice with a disrupted tapasin gene display reduced MHC class I expression. Cytotoxic T cell (CTL) responses to viruses are impaired, and dendritic cells of tapasin-deficient mice do not cross-present protein antigen via the MHC class I pathway, indicating a defect in antigen processing. Natural killer (NK) cells from tapasin-deficient mice have an altered repertoire and are self-tolerant. In addition, the repertoire of class I-bound peptides is altered towards less stably binding ones. Thus tapasin plays a role in CTL and NK immune responses and in optimal peptide selection.	German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany; Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet	Hammerling, GJ (corresponding author), German Canc Res Ctr, Div Mol Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Garbi, Natalio/B-9147-2009; Garbi, Natalio/H-7666-2014; Diehl, Alexander/G-9883-2016	Diehl, Alexander/0000-0001-9990-8331; Chambers, Benedict/0000-0003-0437-8441				ALDRICH CJ, 1994, P NATL ACAD SCI USA, V91, pS652; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; Deng YP, 1998, J IMMUNOL, V161, P1677; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Grandea AG, 1998, IMMUNOGENETICS, V48, P260, DOI 10.1007/s002510050430; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; Kropshofer H, 1999, IMMUNOL REV, V172, P267, DOI 10.1111/j.1600-065X.1999.tb01371.x; Kropshofer H, 1998, EMBO J, V17, P2971, DOI 10.1093/emboj/17.11.2971; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Lauvau G, 1999, J BIOL CHEM, V274, P31349, DOI 10.1074/jbc.274.44.31349; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1998, EUR J IMMUNOL, V28, P3214, DOI 10.1002/(SICI)1521-4141(199810)28:10<3214::AID-IMMU3214>3.3.CO;2-3; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LJUNGGREN HG, 1994, P NATL ACAD SCI USA, V91, P6520, DOI 10.1073/pnas.91.14.6520; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Miller JFAP, 1998, IMMUNOL REV, V165, P267, DOI 10.1111/j.1600-065X.1998.tb01244.x; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; NEEFJES JJ, 1992, EUR J IMMUNOL, V22, P1609, DOI 10.1002/eji.1830220639; Neisig A, 1996, J IMMUNOL, V156, P3196; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; ORTIZNAVARRETE V, 1991, P NATL ACAD SCI USA, V88, P3594, DOI 10.1073/pnas.88.9.3594; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Salcedo M, 1996, CHEM IMMUNOL, V64, P44; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; SANDERSON S, 1994, INT IMMUNOL, V6, P6369; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; ZHOU XZ, 1993, EUR J IMMUNOL, V23, P1796, DOI 10.1002/eji.1830230810	42	156	162	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					234	238		10.1038/79775	http://dx.doi.org/10.1038/79775			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973281				2022-12-18	WOS:000089815100022
J	Shulman, Z; Stern-Ginossar, N				Shulman, Ziv; Stern-Ginossar, Noam			The RNA modification N-6-methyladenosine as a novel regulator of the immune system	NATURE IMMUNOLOGY			English	Review							PRE-MESSENGER-RNA; SINGLE-NUCLEOTIDE-RESOLUTION; HEMATOPOIETIC STEM; M(6)A RNA; NUCLEAR-RNA; STRUCTURAL BASIS; AORTIC ENDOTHELIUM; IL-2 RECEPTOR; YTH DOMAIN; T-CELLS	The RNA modification N-6-methyladenosine (m(6)A) plays an essential role in the regulation of immunity. Here, Shulman and Stern-Ginossar review the roles of m(6)A in controlling immune recognition, activation of innate and adaptive immune responses, and cell fate decisions. Protection from harmful pathogens depends on activation of the immune system, which relies on tight regulation of gene expression. Recently, the RNA modification N-6-methyladenosine (m(6)A) has been found to play an essential role in such regulation. Here, we summarize newly discovered functions of m(6)A in controlling various aspects of immunity, including immune recognition, activation of innate and adaptive immune responses, and cell fate decisions. We then discuss some of the current challenges in the field and describe future directions for uncovering the immunological functions of m(6)A and its mechanisms of action.	[Shulman, Ziv] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Stern-Ginossar, Noam] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shulman, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ziv.shulman@weizmann.ac.il; noam.stern-ginossar@weizmann.ac.il		Shulman, Ziv/0000-0002-9604-212X; , Noam/0000-0003-3583-5932	European Research Council [StG-2014-638142]; Minerva foundation; ERC grant [StG-2015-677713]; Human Frontiers of Science Program [CDA-00023/2016]; Israel Science Foundation (ISF) [1090/18]; Morris Kahn Institute for Human Immunology	European Research Council(European Research Council (ERC)European Commission); Minerva foundation; ERC grant; Human Frontiers of Science Program(Human Frontier Science Program); Israel Science Foundation (ISF)(Israel Science Foundation); Morris Kahn Institute for Human Immunology	We thank Igor Ulitsky, Schraga Schwartz, Michal Schwartz and Amalie Grenov for providing valuable feedback. Work in the Stern-Ginossar lab on m<SUP>6</SUP>A is supported by a European Research Council starting grant (grant no. StG-2014-638142) and by the Minerva foundation. The Shulman lab is supported by the ERC grant (grant no. StG-2015-677713), Human Frontiers of Science Program (grant no. CDA-00023/2016), Israel Science Foundation (ISF) grant no. 1090/18 and the Morris Kahn Institute for Human Immunology. N.S.-G is an incumbent of the Skirball New Scientist Chair. N.S.-G. and Z.S. are members of the European Molecular Biology Organization (EMBO) Young Investigator Program.	Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alloatti A, 2016, IMMUNOL REV, V272, P97, DOI 10.1111/imr.12432; Arguello AE, 2017, J AM CHEM SOC, V139, P17249, DOI 10.1021/jacs.7b09213; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Bailey AS, 2017, ELIFE, V6, DOI 10.7554/eLife.26116; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bokar JA, 1997, RNA, V3, P1233; Boulias K, 2019, MOL CELL, V75, P631, DOI 10.1016/j.molcel.2019.06.006; Burbage M, 2019, NAT IMMUNOL, V20, P518, DOI 10.1038/s41590-019-0371-8; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Chen YG, 2019, MOL CELL, V76, P96, DOI 10.1016/j.molcel.2019.07.016; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Cheng YM, 2019, CELL REP, V28, P1703, DOI 10.1016/j.celrep.2019.07.032; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Choe J, 2018, NATURE, V561, P556, DOI 10.1038/s41586-018-0538-8; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Darnell RR, 2018, RNA, V24, P262, DOI 10.1261/rna.065219.117; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Durbin AF, 2016, MBIO, V7, DOI 10.1128/mBio.00833-16; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Gama-Norton L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9510; Gao YM, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-119699; Garcia-Campos MA, 2019, CELL, V178, P731, DOI 10.1016/j.cell.2019.06.013; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Grozhik AV, 2017, METHODS MOL BIOL, V1562, P55, DOI 10.1007/978-1-4939-6807-7_5; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019; Imaeda A, 2019, NUCLEOS NUCLEOT NUCL, V38, P972, DOI 10.1080/15257770.2019.1641205; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jain D, 2018, ELIFE, V7, DOI 10.7554/eLife.30919; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kasowitz SD, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007412; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Knuckles P, 2018, GENE DEV, V32, P415, DOI 10.1101/gad.309146.117; Kretschmer J, 2018, RNA, V24, P1339, DOI 10.1261/rna.064238.117; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Labi V, 2019, GENE DEV, V33, P1673, DOI 10.1101/gad.330134.119; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Lesbirel S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32310-8; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Li ZR, 2018, CELL RES, V28, P904, DOI 10.1038/s41422-018-0072-0; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11713-9; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468; Lizama CO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8739; Lorenz DA, 2020, RNA, V26, P19, DOI 10.1261/rna.072785.119; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lu MJ, 2020, NAT MICROBIOL, V5, P584, DOI 10.1038/s41564-019-0653-9; Lv JH, 2018, CELL RES, V28, P249, DOI 10.1038/cr.2017.143; Ma HH, 2019, NAT CHEM BIOL, V15, P549, DOI 10.1038/s41589-019-0233-6; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer KD, 2019, NAT METHODS, V16, P1275, DOI 10.1038/s41592-019-0570-0; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Peng SM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau7116; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Price A.M., 2019, DIRECT RNA SEQUENCIN, DOI [10.1101/865485, DOI 10.1101/865485]; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Ringeard M, 2019, NATURE, V565, P500, DOI 10.1038/s41586-018-0841-4; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Rubio RM, 2018, GENE DEV, V32, P1472, DOI 10.1101/gad.319475.118; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seki Y, 2007, J IMMUNOL, V178, P262, DOI 10.4049/jimmunol.178.1.262; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; SOMMER S, 1978, J MOL BIOL, V124, P487, DOI 10.1016/0022-2836(78)90183-3; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Sprent J, 2017, IMMUNOL CELL BIOL, V95, P855, DOI 10.1038/icb.2017.67; Sun HX, 2019, CELL RES, V29, P80, DOI 10.1038/s41422-018-0117-4; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang H, 2018, CELL RES, V28, P1035, DOI 10.1038/s41422-018-0082-y; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang L, 2019, SCIENCE, V365, P656, DOI 10.1126/science.aav0758; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2017, NATURE, V542, P260, DOI 10.1038/nature21073; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Wesselhoeft RA, 2019, MOL CELL, V74, P508, DOI 10.1016/j.molcel.2019.02.015; Williams GD, 2019, ANNU REV VIROL, V6, P235, DOI 10.1146/annurev-virology-092818-015559; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilusz JE, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1478; Winkler R, 2019, NAT IMMUNOL, V20, P243, DOI 10.1038/s41590-019-0314-4; Wojtas MN, 2017, MOL CELL, V68, P374, DOI 10.1016/j.molcel.2017.09.021; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu C, 2015, J BIOL CHEM, V290, P24902, DOI 10.1074/jbc.M115.680389; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yao QJ, 2018, CELL RES, V28, P952, DOI 10.1038/s41422-018-0062-2; Yue YA, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0019-0; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang CX, 2017, NATURE, V549, P273, DOI 10.1038/nature23883; Zhang PP, 2015, CELL RES, V25, P1093, DOI 10.1038/cr.2015.109; Zhang Y, 2019, P NATL ACAD SCI USA, V116, P976, DOI 10.1073/pnas.1812536116; Zhang Z, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0250; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng QL, 2017, NAT IMMUNOL, V18, P1361, DOI 10.1038/ni1217-1361a; Zhou J, 2018, MOL CELL, V69, P636, DOI 10.1016/j.molcel.2018.01.019; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	144	155	160	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					501	512		10.1038/s41590-020-0650-4	http://dx.doi.org/10.1038/s41590-020-0650-4		APR 2020	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32284591				2022-12-18	WOS:000526627600004
J	Dainichi, T; Kitoh, A; Otsuka, A; Nakajima, S; Nomura, T; Kaplan, DH; Kabashima, K				Dainichi, Teruki; Kitoh, Akihiko; Otsuka, Atsushi; Nakajima, Saeko; Nomura, Takashi; Kaplan, Daniel H.; Kabashima, Kenji			The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis	NATURE IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; GENOME-WIDE ASSOCIATION; INFLAMMATORY DENDRITIC CELLS; JANUS KINASE INHIBITOR; NATURAL HELPER-CELLS; LANGERHANS CELLS; T-CELLS; SKIN INFLAMMATION; INTERLEUKIN-23 PRODUCTION; EPIDERMAL HYPERPLASIA	The skin provides both a physical barrier and an immunologic barrier to external threats. The protective machinery of the skin has evolved to provide situation-specific responses to eliminate pathogens and to provide protection against physical dangers. Dysregulation of this machinery can give rise to the initiation and propagation of inflammatory loops in the epithelial micro-environment that result in inflammatory skin diseases in susceptible people. A defective barrier and microbial dysbiosis drive an interleukin 4 (IL-4) loop that underlies atopic dermatitis, while in psoriasis, disordered keratinocyte signaling and predisposition to type 17 responses drive a pathogenic IL-17 loop. Here we discuss the pathogenesis of atopic dermatitis and psoriasis in terms of the epithelial immune microenvironment-the microbiota, keratinocytes and sensory nerves-and the resulting inflammatory loops.	[Dainichi, Teruki; Kitoh, Akihiko; Otsuka, Atsushi; Nakajima, Saeko; Nomura, Takashi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Immunol, Cutaneous Biol Res Core, Pittsburgh, PA USA; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Inst Med Biol, Singapore, Singapore	Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Dainichi, T; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.; Kabashima, K (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.; Kabashima, K (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	dainichi@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Dainichi, Teruki/AAL-5400-2020; Nakajima, Saeko/AAB-1577-2021; Kabashima, Kenji/G-2521-2014	Dainichi, Teruki/0000-0002-9497-0029; Otsuka, Atsushi/0000-0001-7365-947X; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554				Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Amaya M, 2007, J DERMATOL, V34, P619, DOI 10.1111/j.1346-8138.2007.00343.x; Anbunathan H, 2017, J INVEST DERMATOL, V137, pE113, DOI 10.1016/j.jid.2016.03.047; Armstrong AW, 2013, J AM ACAD DERMATOL, V68, P654, DOI 10.1016/j.jaad.2012.08.015; Atzeni F, 2005, LUPUS, V14, P723, DOI 10.1191/0961203305lu2208oa; Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48; Bissonnette R, 2016, BRIT J DERMATOL, V175, P902, DOI 10.1111/bjd.14871; Bissonnette R, 2015, BRIT J DERMATOL, V172, P1395, DOI 10.1111/bjd.13551; BJERKE JR, 1982, ACTA DERM-VENEREOL, V62, P93; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen WJ, 2017, J DERMATOL SCI, V85, P115, DOI 10.1016/j.jdermsci.2016.11.011; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cornelissen C, 2012, J ALLERGY CLIN IMMUN, V129, P426, DOI 10.1016/j.jaci.2011.10.042; Cowden JM, 2010, J INVEST DERMATOL, V130, P1023, DOI 10.1038/jid.2009.358; Dainichi T, 2014, J DERMATOL SCI, V76, P81, DOI 10.1016/j.jdermsci.2014.08.010; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Doebel T, 2017, TRENDS IMMUNOL, V38, P817, DOI 10.1016/j.it.2017.06.008; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Egawa G, 2016, J ALLERGY CLIN IMMUN, V138, P350, DOI 10.1016/j.jaci.2016.06.002; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; ELLIS CN, 1986, JAMA-J AM MED ASSOC, V256, P3110, DOI 10.1001/jama.256.22.3110; England BR, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1036; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; FAULDS D, 1993, DRUGS, V45, P953, DOI 10.2165/00003495-199345060-00007; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fujita H, 2013, J DERMATOL SCI, V72, P3, DOI 10.1016/j.jdermsci.2013.04.028; Furue M, 2011, J DERMATOL, V38, P353, DOI 10.1111/j.1346-8138.2011.01209.x; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Grinberg-Bleyer Y, 2015, J IMMUNOL, V194, P2472, DOI 10.4049/jimmunol.1402608; Gutowska-Owsiak D, 2012, EXP DERMATOL, V21, P104, DOI 10.1111/j.1600-0625.2011.01412.x; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Guttman-Yassky E, 2018, J AM ACAD DERMATOL, V78, P872, DOI 10.1016/j.jaad.2018.01.016; Ha C, 2009, AM J GASTROENTEROL, V104, P1445, DOI 10.1038/ajg.2009.81; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; HAMMAR H, 1984, J INVEST DERMATOL, V83, P416, DOI 10.1111/1523-1747.ep12273499; Hidaka T, 2017, NAT IMMUNOL, V18, P64, DOI 10.1038/ni.3614; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Joseph T, 2005, BRIT J DERMATOL, V152, P185, DOI 10.1111/j.1365-2133.2005.06330.x; Junghans V, 1996, Exp Dermatol, V5, P316, DOI 10.1111/j.1600-0625.1996.tb00135.x; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kasraie S, 2013, ALLERGY, V68, P739, DOI 10.1111/all.12152; Kido-Nakahara M, 2017, IMMUNOL ALLERGY CLIN, V37, P113, DOI 10.1016/j.iac.2016.08.007; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lambert S, 2017, J INVEST DERMATOL, V137, P1501, DOI 10.1016/j.jid.2016.12.032; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Langan EA, 2018, BRIT J DERMATOL, V178, P1020, DOI 10.1111/bjd.16081; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Lee HM, 2009, CELL MICROBIOL, V11, P678, DOI 10.1111/j.1462-5822.2009.01285.x; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Loesche MA, 2018, J INVEST DERMATOL, V138, P1973, DOI 10.1016/j.jid.2018.03.1501; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Maruyama K, 2017, CELL REP, V19, P2730, DOI 10.1016/j.celrep.2017.06.002; Matsumoto R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121175; McAleer MA, 2015, J ALLERGY CLIN IMMUN, V136, P1268, DOI 10.1016/j.jaci.2015.05.002; Mollanazar NK, 2016, CLIN REV ALLERG IMMU, V51, P263, DOI 10.1007/s12016-015-8488-5; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nakagawa H, 2018, BRIT J DERMATOL, V178, P424, DOI 10.1111/bjd.16014; Nakajima K, 2013, J INVEST DERMATOL, V133, P2555, DOI 10.1038/jid.2013.199; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nash M S, 2000, J Spinal Cord Med, V23, P111; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Oldhoff JM, 2005, ALLERGY, V60, P693, DOI 10.1111/j.1398-9995.2005.00791.x; Paller AS, 2017, J ALLERGY CLIN IMMUN, V140, P633, DOI 10.1016/j.jaci.2017.07.006; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Papp K, 2015, BRIT J DERMATOL, V173, P767, DOI 10.1111/bjd.13745; Papp KA, 2016, BRIT J DERMATOL, V174, P1266, DOI 10.1111/bjd.14403; Papp KA, 2017, NEW ENGL J MED, V376, P1551, DOI 10.1056/NEJMoa1607017; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Punwani N, 2012, J AM ACAD DERMATOL, V67, P658, DOI 10.1016/j.jaad.2011.12.018; Rabeony H, 2015, EUR J IMMUNOL, V45, P2847, DOI 10.1002/eji.201445215; Ray-Jones H, 2016, J INVEST DERMATOL, V136, P567, DOI 10.1016/j.jid.2015.11.025; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Rubin-Asher D, 2005, SPINAL CORD, V43, P175, DOI 10.1038/sj.sc.3101697; Ruiz-Romeu E, 2018, J INVEST DERMATOL, V138, P580, DOI 10.1016/j.jid.2017.08.048; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shibata S, 2013, J INVEST DERMATOL, V133, P479, DOI 10.1038/jid.2012.313; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; TAGAMI H, 1985, ARCH DERMATOL, V121, P642, DOI 10.1001/archderm.121.5.642; Takahashi H, 2014, J DERMATOL, V41, P144, DOI 10.1111/1346-8138.12393; Takemoto A, 2015, J DERMATOL, V42, P166, DOI 10.1111/1346-8138.12739; Tamari M, 2014, J DERMATOL, V41, P213, DOI 10.1111/1346-8138.12321; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Tsai YC, 2017, THER ADV MUSCULOSKEL, V9, P277, DOI 10.1177/1759720X17735756; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsunemi Y, 2002, J DERMATOL SCI, V30, P100, DOI 10.1016/S0923-1811(02)00065-8; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Volpe E, 2014, J ALLERGY CLIN IMMUN, V134, P373, DOI 10.1016/j.jaci.2014.04.022; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Williams MR, 2017, CELL HOST MICROBE, V22, P579, DOI 10.1016/j.chom.2017.10.015; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Wu L, 2015, J EXP MED, V212, P1571, DOI 10.1084/jem.20150204; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Yuki T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161759; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zanchi M, 2008, J EUR ACAD DERMATOL, V22, P431, DOI 10.1111/j.1468-3083.2007.02457.x; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021; Zhu HY, 2017, EMBO MOL MED, V9, P589, DOI 10.15252/emmm.201607027	158	155	162	6	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2018	19	12					1286	1298		10.1038/s41590-018-0256-2	http://dx.doi.org/10.1038/s41590-018-0256-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HD9HQ	30446754				2022-12-18	WOS:000452873000010
J	Ravens, S; Schultze-Florey, C; Raha, S; Sandrock, I; Drenker, M; Oberdorfer, L; Reinhardt, A; Ravens, I; Beck, M; Geffers, R; von Kaisenberg, C; Heuser, M; Thol, F; Ganser, A; Forster, R; Koenecke, C; Prinz, I				Ravens, Sarina; Schultze-Florey, Christian; Raha, Solaiman; Sandrock, Inga; Drenker, Melanie; Oberdoerfer, Linda; Reinhardt, Annika; Ravens, Inga; Beck, Maleen; Geffers, Robert; von Kaisenberg, Constantin; Heuser, Michael; Thol, Felicitas; Ganser, Arnold; Foerster, Reinhold; Koenecke, Christian; Prinz, Immo			Human gamma delta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection	NATURE IMMUNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; RECEPTOR REPERTOIRE; PERIPHERAL-BLOOD; ANTIGEN RECEPTOR; CYTOMEGALOVIRUS; POPULATION; LYMPHOCYTES; INNATE; MEMORY; SUBSET	To investigate how the human gamma delta T cell pool is shaped during ontogeny and how it is regenerated after transplantation of hematopoietic stem cells (HSCs), we applied an RNA-based next-generation sequencing approach to monitor the dynamics of the repertoires of gamma delta T cell antigen receptors (TCRs) before and after transplantation in a prospective cohort study. We found that repertoires of rearranged genes encoding gamma delta TCRs (TRG and TRD) in the peripheral blood of healthy adults were stable over time. Although a large fraction of human TRG repertoires consisted of public sequences, the TRD repertoires were private. In patients undergoing HSC transplantation, gamma delta T cells were quickly reconstituted; however, they had profoundly altered TCR repertoires. Notably, the clonal proliferation of individual virus-reactive gamma delta TCR sequences in patients with reactivation of cytomegalovirus revealed strong evidence for adaptive anti-viral gamma delta T cell immune responses.	[Ravens, Sarina; Schultze-Florey, Christian; Raha, Solaiman; Sandrock, Inga; Oberdoerfer, Linda; Reinhardt, Annika; Ravens, Inga; Beck, Maleen; Foerster, Reinhold; Koenecke, Christian; Prinz, Immo] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Schultze-Florey, Christian; Drenker, Melanie; Beck, Maleen; Heuser, Michael; Thol, Felicitas; Ganser, Arnold; Koenecke, Christian] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Schultze-Florey, Christian; Koenecke, Christian; Prinz, Immo] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany; [von Kaisenberg, Constantin] Hannover Med Sch, Dept Obstet Gynecol & Reprod Med, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Prinz, I (corresponding author), Hannover Med Sch, Inst Immunol, Hannover, Germany.; Prinz, I (corresponding author), Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Hannover, Germany.	prinz.immo@mh-hannover.de	Heuser, Michael/S-2363-2017; von Kaisenberg, Constantin/AAR-2756-2021; Koenecke, Christian/C-3138-2009; Prinz, Immo/A-3026-2010	Heuser, Michael/0000-0001-5318-9044; Koenecke, Christian/0000-0001-7025-1735; Ravens, Sarina/0000-0002-3265-6341; Forster, Reinhold/0000-0001-6190-7923; Prinz, Immo/0000-0002-8789-9578	Deutsche Forschungsgemeinschaft [SFB900/B8, PR727/4-1]; German Federal Ministry of Education and Research [01EO1302]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank E. Hage and T. Schulz for assistance from the central project Z1, an NGS core facility of Collaborative Research Centre SFB900; C. Struckmann and M. Ballmaier for technical guidance and single-cell sorting; the Hannover Unified Biobank of Hannover Medical School; A. Krueger for reading and criticizing the manuscript; and J. Blume for help in cord-blood preparation. Supported by Deutsche Forschungsgemeinschaft, (SFB900/B8 to C.K. and I.P.; and PR727/4-1 to I.P.) and the German Federal Ministry of Education and Research (01EO1302 to C.S.-F., C.K. and I.P.).	Airoldi I, 2015, BLOOD, V125, P2349, DOI 10.1182/blood-2014-09-599423; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; BELDJORD K, 1993, J EXP MED, V178, P121, DOI 10.1084/jem.178.1.121; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Caccamo N, 2006, J LEUKOCYTE BIOL, V79, P663, DOI 10.1189/jlb.1105640; Cairo C, 2010, HUM IMMUNOL, V71, P968, DOI 10.1016/j.humimm.2010.06.014; CASORATI G, 1989, J EXP MED, V170, P1521, DOI 10.1084/jem.170.5.1521; Chaudhry S, 2013, AIDS, V27, P1557, DOI 10.1097/QAD.0b013e3283611888; Chien YH, 2006, CELL MOL LIFE SCI, V63, P2089, DOI 10.1007/s00018-006-6020-z; CHOWERS Y, 1994, J EXP MED, V180, P183, DOI 10.1084/jem.180.1.183; DAVODEAU F, 1993, EUR J IMMUNOL, V23, P804, DOI 10.1002/eji.1830230405; Dechanet J, 1999, J CLIN INVEST, V103, P1437, DOI 10.1172/JCI5409; Dechanet J, 1999, J INFECT DIS, V179, P1, DOI 10.1086/314568; Dimova T, 2015, P NATL ACAD SCI USA, V112, pE556, DOI 10.1073/pnas.1412058112; Evans PS, 2001, IMMUNOLOGY, V104, P19, DOI 10.1046/j.1365-2567.2001.01282.x; Fujishima N, 2007, CLIN EXP IMMUNOL, V149, P70, DOI 10.1111/j.1365-2249.2007.03388.x; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Harden Jamie L, 2015, F1000Res, V4, P460, DOI 10.12688/f1000research.6756.1; Hartwig T, 2015, EUR J IMMUNOL, V45, P3022, DOI 10.1002/eji.201545883; HINZ T, 1994, EUR J IMMUNOL, V24, P3044, DOI 10.1002/eji.1830241219; Hirokawa M, 2000, BONE MARROW TRANSPL, V26, P177, DOI 10.1038/sj.bmt.1702478; HOLTMEIER W, 1995, J CLIN INVEST, V96, P1108, DOI 10.1172/JCI118097; Hviid L, 2000, INT IMMUNOL, V12, P797, DOI 10.1093/intimm/12.6.797; Kabelitz D, 2016, CLIN IMMUNOL, V172, P90, DOI 10.1016/j.clim.2016.07.012; Kashani E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7477; Khairallah C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004702; Knight A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068729; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Lang P, 2015, BONE MARROW TRANSPL, V50, pS6, DOI 10.1038/bmt.2015.87; MCVAY LD, 1991, EMBO J, V10, P83, DOI 10.1002/j.1460-2075.1991.tb07923.x; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Pauza CD, 2015, CELL IMMUNOL, V296, P22, DOI 10.1016/j.cellimm.2015.02.010; Prinz I, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-14; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Scheper W, 2014, LEUKEMIA, V28, P1181, DOI 10.1038/leu.2013.378; Scheper W, 2013, LEUKEMIA, V27, P1328, DOI 10.1038/leu.2012.374; Scheper W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00601; Schumacher JA, 2014, AM J CLIN PATHOL, V141, P348, DOI 10.1309/AJCP5TYGBVW4ZITR; Sell S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004481; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; SHERWOOD AM, 2011, SCI TRANSL MED, V90, pRA61; VANDERHARST D, 1991, BLOOD, V78, P1875; Vermijlen D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00486; Vermijlen D, 2010, J EXP MED, V207, P807, DOI 10.1084/jem.20090348; VILLERS D, 1994, BONE MARROW TRANSPL, V13, P19; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394	52	155	158	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					393	+		10.1038/ni.3686	http://dx.doi.org/10.1038/ni.3686			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28218745				2022-12-18	WOS:000396815800007
J	Chun, TW; Moir, S; Fauci, AS				Chun, Tae-Wook; Moir, Susan; Fauci, Anthony S.			HIV reservoirs as obstacles and opportunities for an HIV cure	NATURE IMMUNOLOGY			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; BROADLY NEUTRALIZING ANTIBODIES; HISTONE DEACETYLASE INHIBITORS; VIRAL RESERVOIR; LATENT RESERVOIR; HIV-1-INFECTED PATIENTS; ANTIVIRAL THERAPY; EXTENDED PERIODS; RHESUS-MONKEYS	The persistence of HIV reservoirs remains a formidable obstacle to achieving sustained virologic remission in HIV-infected individuals after antiretroviral therapy (ART) is discontinued, even if plasma viremia has been successfully suppressed for prolonged periods of time. Numerous approaches aimed at eradicating the virus, as well as maintaining its prolonged suppression in the absence of ART, have had little success. A better understanding of the pathophysiologic nature of HIV reservoirs and the impact of various interventions on their persistence is essential for the development of successful therapeutic strategies against HIV or the long-term control of infection. Here, we discuss the persistent HIV reservoir as a barrier to cure as well as the current therapeutic strategies aimed at eliminating or controlling the virus in the absence of ART.	[Chun, Tae-Wook; Moir, Susan; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chun, TW (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twchun@nih.gov	Moir, Susan/AAC-3676-2020; Chun, Tae-Wook/W-9187-2019; Chun, Tae-Wook/AAC-3101-2020	Chun, Tae-Wook/0000-0001-5153-7340; 	National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI000851] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Carcelain G, 2013, IMMUNOL REV, V254, P355, DOI 10.1111/imr.12083; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Cory TJ, 2013, CURR OPIN HIV AIDS, V8, P190, DOI 10.1097/COH.0b013e32835fc68a; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hutter G, 2014, NEW ENGL J MED, V371, P2437, DOI 10.1056/NEJMc1412279; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Moir S, 2011, NAT STRUCT MOL BIOL, V18, P1317, DOI 10.1038/nsmb.2194; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Stone D, 2013, CURR OPIN HIV AIDS, V8, P217, DOI 10.1097/COH.0b013e32835f736c; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	63	155	161	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					584	589		10.1038/ni.3152	http://dx.doi.org/10.1038/ni.3152			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25990814				2022-12-18	WOS:000354751900007
J	Egawa, T; Littman, DR				Egawa, Takeshi; Littman, Dan R.			ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; THYMOCYTE DIFFERENTIATION; DROSOPHILA HEMATOPOIESIS; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; INTERMEDIATE STEPS; GENE-EXPRESSION; DEFICIENT MICE; REGULATES CD4; TYPE-1 CELLS	The transcription factor ThPOK is required and sufficient for the generation of CD4(+) CD8(-) thymocytes, yet the mechanism by which ThPOK orchestrates differentiation into the CD4(+) helper T cell lineage remains unclear. Here we used reporter mice to track the expression of transcription factors in developing thymocytes. Distal promoter-driven expression of the gene encoding the transcription factor Runx3 was restricted to major histocompatibility complex (MHC) class I-selected thymocytes. In ThPOK-deficient mice, such expression was derepressed in MHC class II-selected thymocytes, which contributed to their redirection to the CD8(+) T cell lineage. In the absence of both ThPOK and Runx, redirection was prevented and cells potentially belonging to the CD4(+) lineage, presumably specified independently of ThPOK, were generated. Our results suggest that MHC class II-selected thymocytes are directed toward the CD4(+) lineage independently of ThPOK but require ThPOK to prevent Runx-dependent differentiation toward the CD8(+) lineage.	[Egawa, Takeshi; Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program,Helen & Martin Kimmel Ct, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med,Helen & Martin Kimmel Ct, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Egawa, T (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program,Helen & Martin Kimmel Ct, New York, NY 10016 USA.	egawa@saturn.med.nyu.edu; littman@saturn.med.nyu.edu			Leukemia and Lymphoma Society; Howard Hughes Medical Institute	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Rockefeller University Gene Targeting Facility for the generation of ThPOK mutant mice with B6-C2J embryonic stem cells; J. H. Dong, A. Auerbach and W. Ho for microinjection; members of the laboratory for discussion; and J. Huh, M. Chong, A. Collins and S. Schwab for critical reading of the manuscript. Supported by the Leukemia and Lymphoma Society (T. E.) and the Howard Hughes Medical Institute (D. R. L.).	Barthlott T, 1997, EUR J IMMUNOL, V27, P2024, DOI 10.1002/eji.1830270829; Chan S, 1998, J EXP MED, V188, P2321, DOI 10.1084/jem.188.12.2321; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fossett N, 2003, P NATL ACAD SCI USA, V100, P11451, DOI 10.1073/pnas.1635050100; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; KYDD R, 1995, J IMMUNOL, V155, P3806; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2004, ADV IMMUNOL, V83, P91; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	39	155	158	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1131	1139		10.1038/ni.1652	http://dx.doi.org/10.1038/ni.1652			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18776905	Green Accepted			2022-12-18	WOS:000259315600011
J	Wang, L; Wildt, KF; Zhu, JF; Zhang, XY; Feigenbaum, L; Tessarollo, L; Paul, WE; Fowlkes, BJ; Bosselut, R				Wang, Lie; Wildt, Kathryn F.; Zhu, Jinfang; Zhang, Xianyu; Feigenbaum, Lionel; Tessarollo, Lino; Paul, William E.; Fowlkes, B. J.; Bosselut, Remy			Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							CD4-CD8 LINEAGE DIFFERENTIATION; ZINC-FINGER PROTEINS; TRANSGENIC MICE; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; ANTIGEN RECEPTOR; TH2 CELLS; C-MYB; EXPRESSION; CD8	The transcription factors GATA-3 and ThPOK are required for intrathymic differentiation of CD4(+) T cells, but their precise functions in this process remain unclear. Here we show that, contrary to previous findings, Gata3 disruption blocked differentiation into the CD4(+) T cell lineage before commitment to the CD4(+) lineage and in some contexts permitted the 'redirection' of major histocompatibility complex class II-restricted thymocytes into the CD8(+) lineage. GATA-3 promoted ThPOK expression and bound to a region of the locus encoding ThPOK established as being critical for ThPOK expression. Finally, ThPOK promoted differentiation into the CD4(+) lineage in a way dependent on GATA-3 but inhibited differentiation into the CD8(+) lineage independently of GATA-3. We propose that GATA-3 acts as a specification factor for the CD4(+) lineage 'upstream' of the ThPOK-controlled CD4(+) commitment checkpoint.	[Wang, Lie; Wildt, Kathryn F.; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhu, Jinfang; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Zhang, Xianyu; Fowlkes, B. J.] NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Sci Applicat Int Corp, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	Intramural Research Programs of the National Cancer Institute, Center for Cancer Research; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010904, ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, ZIAAI000486, ZIAAI000926] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Xiong, R. Jenkinson and J. Rozenberg for assistance with ChIP assays; E. Southon for embryonic stem cell recombination; M. Pellegrini and A. Nussenzweig for assistance with recombination-mediated genetic engineering; E. Castro and G. Sanchez for mouse technical assistance; B. Taylor and S. Banerjee for cell sorting; and A. Ge gonne and A. Singer for reading the manuscript. Supported by the Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, and of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Laky K, 2005, CURR OPIN IMMUNOL, V17, P116, DOI 10.1016/j.coi.2005.02.004; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Ling KW, 2007, EUR J IMMUNOL, V37, P1043, DOI 10.1002/eji.200636485; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Ma WB, 2003, CANCER RES, V63, P5320; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	50	155	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1122	1130		10.1038/ni.1647	http://dx.doi.org/10.1038/ni.1647			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18776904	Green Accepted			2022-12-18	WOS:000259315600010
J	Katagiri, K; Ohnishi, N; Kabashima, K; Iyoda, T; Takeda, N; Shinkai, Y; Inaba, K; Kinashi, T				Katagiri, K; Ohnishi, N; Kabashima, K; Iyoda, T; Takeda, N; Shinkai, Y; Inaba, K; Kinashi, T			Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; SPLENIC MARGINAL ZONE; T-CELL; INTEGRIN ACTIVATION; SMALL GTPASE; IN-VIVO; MIGRATION; ANTIGEN; ADHESION; THYMUS	Immunosurveillance requires the coordinated regulation of chemokines and adhesion molecules to guide immune cell migration. However, the critical molecule for governing the high trafficking capability of immune cells is not clear. Here we show that the effector molecule RAPL is indispensable in the integrin-mediated adhesion and migration of lymphocytes and dendritic cells. RAPL deficiency caused defective chemokine-triggered lymphocyte adhesion and migration to secondary lymphoid organs, resulting in atrophic lymphoid follicles and deficient marginal zone B cells, concomitant with increased immature B cells in the blood. Furthermore, splenic dendritic cells were diminished and defective in adhesion. After being activated with inflammatory stimuli, skin and splenic dendritic cells failed to migrate into either the draining lymph nodes or the white pulp of the spleen. Thus, RAPL is a crucial immune cell trafficking regulator essential for immunosurveillance.	Kyoto Univ, Grad Sch Med, Dept Mol Immunol & Allergy, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Grad Sch Biostudies,Div Systemic Life Sci, Dept Anim Dev & Physiol,Lab Immunobiol, Kyoto 6068502, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kumamoto University; Kyoto University	Kinashi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Immunol & Allergy, Kyoto 6068501, Japan.	tkinashi@mfour.med.kyoto-u.ac.jp	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554				Amsen D, 2000, EUR J IMMUNOL, V30, P2832, DOI 10.1002/1521-4141(200010)30:10<2832::AID-IMMU2832>3.0.CO;2-D; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kitajima T, 1996, J CLIN INVEST, V98, P142, DOI 10.1172/JCI118759; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Pribila JT, 2004, J IMMUNOL, V172, P282, DOI 10.4049/jimmunol.172.1.282; Price AA, 1997, J EXP MED, V186, P1725, DOI 10.1084/jem.186.10.1725; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Schneeberger EE, 2000, J IMMUNOL, V164, P2472, DOI 10.4049/jimmunol.164.5.2472; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Xu H, 2001, EUR J IMMUNOL, V31, P3085, DOI 10.1002/1521-4141(2001010)31:10<3085::AID-IMMU3085>3.0.CO;2-B; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	46	155	160	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1045	1051		10.1038/ni1111	http://dx.doi.org/10.1038/ni1111			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15361866				2022-12-18	WOS:000224156600028
J	Weiner, HL				Weiner, HL			The mucosal milieu creates tolerogenic dendritic cells and TRI and T(H)3 regulatory cells	NATURE IMMUNOLOGY			English	News Item							ORAL TOLERANCE; INDUCTION; RESPONSES	Certain types of regulatory T cells are preferentially induced at mucosal surfaces to maintain tolerance. However, the mechanisms involved in their induction are unclear. New evidence suggests DCs orchestrate this mucosal tolerogenic immune response.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur,HIM 720, Boston, MA 02115 USA.	weiner@cnd.bwh.harvard.edu						Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cohn L, 2001, AM J RESP CELL MOL, V24, P509, DOI 10.1165/ajrcmb.24.5.f207; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Haneda K, 1997, J IMMUNOL, V159, P4484; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SPALDING DM, 1984, J EXP MED, V160, P941, DOI 10.1084/jem.160.3.941; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Viney JL, 1998, J IMMUNOL, V160, P5815; Zhang X, 2000, FASEB J, V14, pA1198	14	155	168	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					671	672		10.1038/90604	http://dx.doi.org/10.1038/90604			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477400				2022-12-18	WOS:000170230100007
J	Pedotti, R; Mitchell, D; Wedemeyer, J; Karpuj, M; Chabas, D; Hattab, EM; Tsai, M; Galli, SJ; Steinman, L				Pedotti, R; Mitchell, D; Wedemeyer, J; Karpuj, M; Chabas, D; Hattab, EM; Tsai, M; Galli, SJ; Steinman, L			An unexpected version of horror autotoxicus: anaphylactic shock to a self peptide	NATURE IMMUNOLOGY			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MAST-CELL DEGRANULATION; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; FC-GAMMA-RIII; MULTIPLE-SCLEROSIS; T-CELLS; PROTEOLIPID PROTEIN	EAE can refer either to experimental autoimmune encephalomyelitis or experimental allergic encephalomyelitis. Although EAE is classically a prototypicT helper I (THI) cell-mediated autoimmune disease, it can also be induced by T(H)2 cells. Characteristically, the most severe manifestation of allergy, anaphylaxis, is associated with exposure to a foreign antigen that is often derived from medication, insect venom or food. We report here that, after self-tolerance to myelin is destroyed, anaphylaxis may be triggered by a self-antigen, in this case a myelin peptide. "Horror autotoxicus", which was initially described by Ehrlich, may not only include autoimmunity to self, it may also encompass immediate hypersensitivity to self, which leads to shock and rapid death.	Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; Univ Milan, IRCCS Osped Maggiore Policlin, Inst Clin Neurol, Milan, Italy	Stanford University; Stanford University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Steinman, L (corresponding author), Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.		Messier, Claude/A-2322-2008; Hattab, Eyas M/E-9342-2016	Messier, Claude/0000-0002-4791-1763; Hattab, Eyas M/0000-0002-3660-6261; Tsai, Mindy/0000-0002-8421-4721; Steinman, Lawrence/0000-0002-2437-2250				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Bebo BF, 1996, IMMUNOL CELL BIOL, V74, P225, DOI 10.1038/icb.1996.41; Begolka WS, 1998, J IMMUNOL, V161, P4437; BOCHNER BS, 1991, NEW ENGL J MED, V324, P1785, DOI 10.1056/NEJM199106203242506; BOVE JR, 1988, TRANSFUSION, V28, P603, DOI 10.1046/j.1537-2995.1988.28689059042.x; BRENNER T, 1994, J NEUROL SCI, V122, P210, DOI 10.1016/0022-510X(94)90300-X; BROSNAN CF, 1988, J NEUROIMMUNOL, V18, P87, DOI 10.1016/0165-5728(88)90137-3; DAVIS HM, 1990, THROMB HAEMOSTASIS, V63, P386; DIETSCH GN, 1989, J IMMUNOL, V142, P1476; Dines KC, 1997, J NEUROPATH EXP NEUR, V56, P627; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Encinas JA, 1996, J NEUROSCI RES, V45, P655; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; GALLI SJ, 1999, FUNDAMENTAL IMMUNOLO, P1137; Genain CP, 1996, SCIENCE, V274, P2054, DOI 10.1126/science.274.5295.2054; HURTENBACH U, 1993, J EXP MED, V177, P1499, DOI 10.1084/jem.177.5.1499; ISHIZAKA T, 1984, PROG ALLERGY, V34, P188; Jensen MA, 1999, J AUTOIMMUN, V12, P73, DOI 10.1006/jaut.1998.0263; JOHNSON D, 1988, BRAIN RES, V444, P195, DOI 10.1016/0006-8993(88)90929-8; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kim R, 1993, Del Med J, V65, P17; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; KRUGER PG, 1990, ACTA NEUROL SCAND, V81, P31; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; LINTHICUM DS, 1982, J EXP MED, V156, P31, DOI 10.1084/jem.156.1.31; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; LINTHICUM DS, 1982, IMMUNOBIOLOGY, V162, P211, DOI 10.1016/S0171-2985(11)80001-X; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; MOTA I, 1969, LIFE SCI PT 1 PHYSI, V8, P813, DOI 10.1016/0024-3205(69)90099-X; OLSSON Y, 1974, ACTA NEUROL SCAND, V50, P611; Oro AS, 1996, J ALLERGY CLIN IMMUN, V97, P1402, DOI 10.1016/S0091-6749(96)70210-5; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Radu CG, 2000, INT IMMUNOL, V12, P1553, DOI 10.1093/intimm/12.11.1553; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; SCHERNTHANER G, 1993, DIABETES CARE, V16, P155, DOI 10.2337/diacare.16.3.155; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shopnick RI, 1996, TRANSFUSION, V36, P358, DOI 10.1046/j.1537-2995.1996.36496226153.x; SOLOWAY P, 1991, J EXP MED, V174, P847, DOI 10.1084/jem.174.4.847; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Steinman L, 2000, NAT MED, V6, P15, DOI 10.1038/71466; STEINMAN L, 1982, NATURE, V299, P738, DOI 10.1038/299738a0; TOMS R, 1990, J NEUROIMMUNOL, V30, P169, DOI 10.1016/0165-5728(90)90101-R; TUOHY VK, 1989, J IMMUNOL, V142, P1523; VANDENBARK AA, 1985, J IMMUNOL, V135, P229; Waisman A, 1996, NAT MED, V2, P899, DOI 10.1038/nm0896-899; WERSHIL BK, 1988, J IMMUNOL, V140, P2356; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; ZELENIKA D, 1993, J NEUROCHEM, V60, P1574, DOI 10.1111/j.1471-4159.1993.tb03325.x	55	155	160	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					216	222		10.1038/85266	http://dx.doi.org/10.1038/85266			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224520				2022-12-18	WOS:000167413800013
J	Gerondalds, S; Fulford, TS; Messina, NL; Grumont, RJ				Gerondalds, Steve; Fulford, Thomas S.; Messina, Nicole L.; Grumont, Raelene J.			NF-kappa B control of T cell development	NATURE IMMUNOLOGY			English	Review							THYMIC EPITHELIAL-CELLS; KINASE-C-THETA; ROR-GAMMA-T; NUCLEAR-FACTOR; DIFFERENTIAL REQUIREMENT; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; LIVER DEGENERATION; NEGATIVE SELECTION; SIGNAL STRENGTH	The NF-kappa B signal transduction pathway is best known as a major regulator of innate and adaptive immune responses, yet there is a growing appreciation of its importance in immune cell development, particularly of T lineage cells. In this Review, we discuss how the temporal regulation of NF-kappa B controls the stepwise differentiation and antigen-dependent selection of conventional and specialized subsets of T cells in response to T cell receptor and costimulatory, cytokine and growth factor signals.	[Gerondalds, Steve] Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; Monash Univ, Cent Clin Sch, Dept Clin Hematol, Melbourne, Vic 3004, Australia	Monash University; Monash University	Gerondalds, S (corresponding author), Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia.	steven.gerondakis@monash.edu		Messina, Nicole/0000-0001-8404-4462	National Health and Medical Research Council of Australia [1016701, 1029822]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge support from the National Health and Medical Research Council of Australia (program grant 1016701 and project grant 1029822 to S.G.).	Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Akashi K, 1999, COLD SPRING HARB SYM, V64, P1, DOI 10.1101/sqb.1999.64.1; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Akiyama T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00278; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Chang JH, 2012, NAT IMMUNOL, V13, P481, DOI 10.1038/ni.2267; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; Cheng J, 2011, IMMUNOL RES, V50, P113, DOI 10.1007/s12026-011-8216-z; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Ferreira LMR, 2013, INT REV IMMUNOL, V32, P223, DOI 10.3109/08830185.2013.783831; Finlay DK, 2010, J IMMUNOL, V185, P5973, DOI 10.4049/jimmunol.1000827; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Grigoriadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026851; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Gugasyan R, 2012, EMBO J, V31, P692, DOI 10.1038/emboj.2011.435; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Kingeter LM, 2008, J IMMUNOL, V181, P6244, DOI 10.4049/jimmunol.181.9.6244; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008675; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mandal M, 2005, J EXP MED, V201, P603, DOI 10.1084/jem.20041924; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Proietto AI, 2009, IMMUNOL CELL BIOL, V87, P39, DOI 10.1038/icb.2008.86; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Stankovic S, 2011, IMMUNOL CELL BIOL, V89, P294, DOI 10.1038/icb.2010.93; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Strasser A, 1999, EUR J IMMUNOL, V29, P928, DOI 10.1002/(SICI)1521-4141(199903)29:03<928::AID-IMMU928>3.3.CO;2-G; Taniuchi I, 2009, CURR OPIN IMMUNOL, V21, P127, DOI 10.1016/j.coi.2009.03.012; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vallabhapurapu S, 2008, EUR J IMMUNOL, V38, P3508, DOI 10.1002/eji.200737830; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Yamamoto H, 1998, J IMMUNOL, V161, P4753; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	106	154	168	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					15	25		10.1038/ni.2785	http://dx.doi.org/10.1038/ni.2785			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24352326				2022-12-18	WOS:000328800500008
J	Wakim, LM; Gupta, N; Mintern, JD; Villadangos, JA				Wakim, Linda M.; Gupta, Nishma; Mintern, Justine D.; Villadangos, Jose A.			Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3	NATURE IMMUNOLOGY			English	Article							WEST NILE VIRUS; PROTEINS; ANTIGEN	Infection with influenza virus results in the deposition of anti-influenza CD8(+) resident memory T cells (T-RM cells) in the lung. As a consequence of their location in the lung mucosal tissue, these cells are exposed to cytopathic pathogens over the life of the organism and may themselves be susceptible to infection. Here we found that lung T-RM cells selectively maintained expression of the interferon-induced transmembrane protein IFITM3, a protein that confers broad resistance to viral infection. Lung T-RM cells that lacked IFITM3 expression were more susceptible to infection than were their normal counterparts and were selectively lost during a secondary bout of infection. Thus, lung T-RM cells were programmed to retain IFITM3 expression, which facilitated their survival and protection from viral infection during subsequent exposures.	[Wakim, Linda M.; Gupta, Nishma; Mintern, Justine D.; Villadangos, Jose A.] Walter & Eliza Hall Inst Med Res, Div Inflammat, Melbourne, Vic 3050, Australia; [Wakim, Linda M.; Villadangos, Jose A.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Mintern, Justine D.; Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Wakim, LM (corresponding author), Walter & Eliza Hall Inst Med Res, Div Inflammat, Melbourne, Vic 3050, Australia.	wakiml@unimelb.edu.au; j.villadangos@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891; Mintern, Justine/0000-0002-3797-8577; Gupta, Nishma/0000-0002-1278-0337; Wakim, Linda/0000-0003-1752-9579	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank P. Crack (University of Melbourne) and P. Hertzog (Monash Institute of Medical Research) for mice deficient in the receptor for type I interferon; S. Elledge (Harvard Medical School) for the pINDUCER constructs; F. Carbone (University of Melbourne) for the influenza virus flu-OVA (wsn-OVA); S. Turner (University of Melbourne) for the influenza viruses Pr8-OVA and x31-OVA; and A. Brooks (University of Melbourne) for influenza viruses Pr8 and x31. Supported by the National Health and Medical Research Council of Australia.	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Ariotti S, 2012, ADV IMMUNOL, V114, P203, DOI 10.1016/B978-0-12-396548-6.00008-1; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Scott R, 2011, J INTERF CYTOK RES, V31, P601, DOI 10.1089/jir.2010.0134; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	25	154	167	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					238	245		10.1038/ni.2525	http://dx.doi.org/10.1038/ni.2525			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23354485				2022-12-18	WOS:000315065400013
J	Ludin, A; Itkin, T; Gur-Cohen, S; Mildner, A; Shezen, E; Golan, K; Kollet, O; Kalinkovich, A; Porat, Z; D'Uva, G; Schajnovitz, A; Voronov, E; Brenner, DA; Apte, RN; Jung, S; Lapidot, T				Ludin, Aya; Itkin, Tomer; Gur-Cohen, Shiri; Mildner, Alexander; Shezen, Elias; Golan, Karin; Kollet, Orit; Kalinkovich, Alexander; Porat, Ziv; D'Uva, Gabriele; Schajnovitz, Amir; Voronov, Elena; Brenner, David A.; Apte, Ron N.; Jung, Steffen; Lapidot, Tsvee			Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow	NATURE IMMUNOLOGY			English	Article							PROGENITOR CELLS; STEM-CELLS; STROMAL CELLS; PROSTAGLANDIN-E2; MYELOPOIESIS; MOBILIZATION; MODULATION; INHIBITION; NICHES	Hematopoietic stem and progenitor cells (HSPCs) are regulated by various bone marrow stromal cell types. Here we identified rare activated bone marrow monocytes and macrophages with high expression of a-smooth muscle actin (alpha-SMA) and the cyclooxygenase COX-2 that were adjacent to primitive HSPCs. These myeloid cells resisted radiation-induced cell death and further upregulated COX-2 expression under stress conditions. COX-2-derived prostaglandin E-2 (PGE(2)) prevented HSPC exhaustion by limiting the production of reactive oxygen species (ROS) via inhibition of the kinase Akt and higher stromal-cell expression of the chemokine CXCL12, which is essential for stem-cell quiescence. Our study identifies a previously unknown subset of alpha-SMA(+) activated monocytes and macrophages that maintain HSPCs and protect them from exhaustion during alarm situations.	[Ludin, Aya; Itkin, Tomer; Gur-Cohen, Shiri; Mildner, Alexander; Shezen, Elias; Golan, Karin; Kollet, Orit; Kalinkovich, Alexander; D'Uva, Gabriele; Schajnovitz, Amir; Jung, Steffen; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Porat, Ziv] Weizmann Inst Sci, Flow Cytometry Unit, Dept Biol Serv, IL-76100 Rehovot, Israel; [Voronov, Elena; Apte, Ron N.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Brenner, David A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Weizmann Institute of Science; Weizmann Institute of Science; Ben Gurion University; University of California System; University of California San Diego	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Kollet, Orit/A-6861-2008; Mildner, Alexander/ABG-6122-2020; Jung, Steffen/K-1409-2012; mildner, alexander/AFK-2161-2022; D'Uva, Gabriele/A-6252-2015; Porat, Ziv/K-1672-2012; Lapidot, Tsvee/A-1812-2010; mildner, alexander/AAF-9451-2022; mildner, alexander/GQA-3761-2022	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; D'Uva, Gabriele/0000-0001-9622-9288; Porat, Ziv/0000-0003-3059-181X; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Brenner, David/0000-0003-2573-525X; Gur-Cohen, Shiri/0000-0002-6372-2284	Israeli Science Foundation [ISF 544/09]; European Commission [CELL-PID FP7-261387]; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G.N. Enikolopov (Cold Spring Harbor Laboratory) for nestin-G FP mice; Y. Yarden (Weizmann Institute of Science) for the 3T3 cell line; N. Iscove for guidance during the study and for critical review of the manuscript; H. Perlman for help in the characterization of myeloid cells; J. Hanna for use of the FACSAria; and D. Shafritz, J. Canaani, K. Lapid and Y. Ovadia for critical review of the manuscript. Supported by the Israeli Science Foundation (ISF 544/09), the European Commission (CELL-PID FP7-261387) and the Leona M. and Harry B. Helmsley Charitable Trust.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GENTILE PS, 1988, J IMMUNOL, V141, P2714; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hoggatt J., 2010, 52 ANN M AM SOC HEM, V116, P1088; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Huang YL, 2009, CELL SIGNAL, V21, P954, DOI 10.1016/j.cellsig.2009.02.005; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirouac DC, 2006, CURR OPIN BIOTECH, V17, P538, DOI 10.1016/j.copbio.2006.07.003; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PELUS LM, 1989, IMMUNOL RES, V8, P176, DOI 10.1007/BF02918143; Porter RL, 2010, BLOOD, V116, P181; RIESE J, 1994, J LEUKOCYTE BIOL, V55, P476, DOI 10.1002/jlb.55.4.476; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	49	154	161	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1072	1082		10.1038/ni.2408	http://dx.doi.org/10.1038/ni.2408			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	22983360				2022-12-18	WOS:000310091700010
J	Xue, LQ; Morris, SW; Orihuela, C; Tuomanen, E; Cui, XL; Wen, RR; Wang, DM				Xue, LQ; Morris, SW; Orihuela, C; Tuomanen, E; Cui, XL; Wen, RR; Wang, DM			Defective development and function of Bcl10-deficient follicular, marginal zone and B1B cells	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; FAMILY MEMBER; MALT LYMPHOMA; BCL10; RECRUITMENT; ACTIVATION; PROTEIN; MUTATIONS; REGULATOR	Bcl10 is an intracellular protein essential for nuclear factor (NF)-kappaB activation after lymphocyte antigen receptor stimulation. Using knockout mice, we show that absence of Bcl10 impeded conversion from transitional type 2 to mature follicular B cells and caused substantial decreases in marginal zone and B1 B cells. Bcl10-deficient B cells showed no excessive apoptosis. However, both Bcl10-deficient follicular and marginal zone B cells failed to proliferate normally, although Bcl10-deficient marginal zone B cells uniquely failed to activate NF-kappaB efficiently after stimulation with lipopolysaccharide. Bcl10-deficient marginal zone B cells did not capture antigens, and Bcl10-deficient (Bcl10(-/-)) mice failed to initiate humoral responses, leading to an inability to clear blood-borne bacteria. Thus, Bcl10 is essential for the development of all mature B cell subsets.	St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA; Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA; Nanjing Univ, Model Anim Res Ctr, Nanjing, Peoples R China; Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Versiti Blood Center of Wisconsin; Nanjing University; Medical College of Wisconsin	Morris, SW (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	steve.morris@stjude.org; dwang@bcsew.edu	Tuomanen, Elaine I/N-3081-2018; Wang, Demin/AAX-4449-2020	Tuomanen, Elaine I/0000-0003-0349-8716; Wang, Demin/0000-0001-5549-3795	NCI NIH HHS [CA21765] Funding Source: Medline; NHLBI NIH HHS [R01 HL073284] Funding Source: Medline; NIAID NIH HHS [R01 AI52327] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052327] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lentz VM, 1996, J IMMUNOL, V157, P598; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Martinez-Cruz B, 2002, MOL ECOL NOTES, V2, P323, DOI 10.1046/j.1471-8286.2002.00231.x; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Spencer J, 1998, IMMUNOL TODAY, V19, P421, DOI 10.1016/S0167-5699(98)01308-5; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THORNE M, 2002, CURR BIOL, V12, pR45; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wotherspoon AC, 2002, CURR OPIN HEMATOL, V9, P50, DOI 10.1097/00062752-200201000-00009; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; Yui D, 2001, ONCOGENE, V20, P4317, DOI 10.1038/sj.onc.1204576; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	45	154	162	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					857	865		10.1038/ni963	http://dx.doi.org/10.1038/ni963			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12910267				2022-12-18	WOS:000185002200012
J	Gounari, F; Aifantis, I; Khazaie, K; Hoeflinger, S; Harada, N; Taketo, MM; von Boehmer, H				Gounari, F; Aifantis, I; Khazaie, K; Hoeflinger, S; Harada, N; Taketo, MM; von Boehmer, H			Somatic activation of beta-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; LYMPHOCYTE DEVELOPMENT; GAMMA-CHAIN; ALPHA GENE; BCL-2; MICE; DIFFERENTIATION; PROGENITORS; EXPRESSION; DEFICIENT	Mutation or ablation of T cell factor I and lymphocyte enhancer factor I indicated involvement of the Wnt pathway in thymocyte development. The central effector of the Wnt pathway is beta -catenin, which undergoes stabilization upon binding of Wnt ligands to frizzled receptors. We report here that conditional stabilization of beta -catenin in immature thymocytes resulted in the generation of single positive T cells that lacked the alpha beta TCR and developed in the absence of pre-TCR signaling and TCR selection. Although active beta -catenin induced differentiation in the absence of TCRs, its action was associated with reduced proliferation and survival when compared to developmental changes induced by the pre-TCR or the alpha beta TCR.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Merck, Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Merck & Company; Kyoto University	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu	Harada, Naomoto/Y-4591-2019	Harada, Naomoto/0000-0003-1083-7253	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047281, R01AI045846] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI45846, R01AI47281] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALFANTIS I, 1998, IMMUNITY, V9, P649; Alfantis I, 2001, NATURE IMMUNOL, V2, P403; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; de Lau W, 2001, NAT GENET, V28, P3, DOI 10.1038/88233; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE NC, 1994, IMMUNOLOGY, V81, P115; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nakajima H, 1999, J IMMUNOL, V162, P782; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Schilham MW, 1998, J IMMUNOL, V161, P3984; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; VONBOEHMER H, 2001, GREAT EXPT BIOL; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	34	154	160	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					863	869		10.1038/ni0901-863	http://dx.doi.org/10.1038/ni0901-863			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526403				2022-12-18	WOS:000170781200027
J	Xu, LF; Cao, Y; Xie, ZY; Huang, QZ; Bai, Q; Yang, X; He, R; Hao, YX; Wang, HQ; Zhao, TT; Fan, ZL; Qin, AJ; Ye, JQ; Zhou, XY; Ye, LL; Wu, YZ				Xu, Lifan; Cao, Yi; Xie, Zhunyi; Huang, Qizhao; Bai, Qiang; Yang, Xia; He, Ran; Hao, Yaxing; Wang, Haoqiang; Zhao, Tingting; Fan, Zhonglei; Qin, Aijian; Ye, Jianqiang; Zhou, Xinyuan; Ye, Lilin; Wu, Yuzhang			The transcription factor TCF-1 initiates the differentiation of T-FH cells during acute viral infection	NATURE IMMUNOLOGY			English	Article							CXC CHEMOKINE RECEPTOR-5; FOLLICULAR HELPER; B-CELLS; NEGATIVE REGULATOR; BETA-CATENIN; BCL6; CD4; FATE; ROLES; TH1	Induction of the transcriptional repressor BcI-6 in CD4(+) T cells is critical for the differentiation of follicular helper T cells (T-FH cells), which are essential for B cell mediated immunity. In contrast, the transcription factor Blimp1 (encoded by Prdm1) inhibits T-FH differentiation by antagonizing BcI-6. Here we found that the transcription factor TCF-1 was essential for both the initiation of TFH differentiation and the effector function of differentiated T-FH cells during acute viral infection. Mechanistically, TCF-1 bound directly to the Bcl6 promoter and Prdm1 5' regulatory regions, which promoted BcI-6 expression but repressed Blimp1 expression. ICE-1-null T-FH cells upregulated genes associated with non-T-FH cell lineages. Thus, TCF-1 functions as an important hub upstream of the Bcl-6-Blimp1 axis to initiate and secure the differentiation of T-FH cells during acute viral infection.	[Xu, Lifan; Cao, Yi; Xie, Zhunyi; Huang, Qizhao; Bai, Qiang; Yang, Xia; He, Ran; Hao, Yaxing; Wang, Haoqiang; Zhao, Tingting; Zhou, Xinyuan; Ye, Lilin; Wu, Yuzhang] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China; [Fan, Zhonglei; Qin, Aijian; Ye, Jianqiang] Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou, Peoples R China; [Fan, Zhonglei; Qin, Aijian; Ye, Jianqiang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Army Medical University; Yangzhou University	Ye, LL (corresponding author), Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China.	xinyuanzhou@tmmu.edu.cn; yelilinlcmv@tmmu.edu.cn; wuyuzhang@tmmu.edu.cn	ye, jianqiang/ABH-8988-2020; Zhou, Xinyuan/AFS-9817-2022; BAI, Qiang/O-1069-2019	BAI, Qiang/0000-0001-7423-0712; Wu, Yuzhang/0000-0002-4049-0214; Ye, Lilin/0000-0003-0778-3311; Zhou, Xinyuan/0000-0002-1374-8240	National Basic Research Program of China (973 Program) [2013CB531500]; National Natural Science Foundation of China [31470870, 81471624, 31000631]; China1000 Talent Plan Program; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China1000 Talent Plan Program; Priority Academic Program Development of Jiangsu Higher Education Institutions	We thank the Institut Clinique de la Souris (part of the International Knockout Mouse Consortium) for permission to use the mouse with conditional knockout of Tcf7; H.H. Xue (University of Iowa) for Tcf7<SUP>fl/fl</SUP> mice and retroviral vectors; R. Ahmed (Emory University) for SMARTA mice and retroviral vectors; CapitalBio for performing microarray experiments and data analysis; and the core facility center of Third Military Medical University for cell sorting. Supported by the National Basic Research Program of China (973 Program, 2013CB531500, to L.Y. and X.Z.), the National Natural Science Foundation of China (31470870 to X.Z., 81471624 to L.Y. and 31000631 to Z.X.), the China1000 Talent Plan Program (L.Y.) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (A.Q.).	[Anonymous], 2013, VACCINES; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Choi YS, 2013, CURR OPIN IMMUNOL, V25, P366, DOI 10.1016/j.coi.2013.04.003; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Regadas I, 2014, BBA-GENE REGUL MECH, V1839, P1121, DOI 10.1016/j.bbagrm.2014.08.007; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Steinke FC, 2014, IMMUNOL RES, V59, P45, DOI 10.1007/s12026-014-8545-9; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	43	153	165	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					991	999		10.1038/ni.3229	http://dx.doi.org/10.1038/ni.3229			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26214740				2022-12-18	WOS:000359876900017
J	Baumjohann, D; Kageyama, R; Clingan, JM; Morar, MM; Patel, S; de Kouchkovsky, D; Bannard, O; Bluestone, JA; Matloubian, M; Ansel, KM; Jeker, LT				Baumjohann, Dirk; Kageyama, Robin; Clingan, Jonathan M.; Morar, Malika M.; Patel, Sana; de Kouchkovsky, Dimitri; Bannard, Oliver; Bluestone, Jeffrey A.; Matloubian, Mehrdad; Ansel, K. Mark; Jeker, Lukas T.			The microRNA cluster miR-17 similar to 92 promotes T-FH cell differentiation and represses subset-inappropriate gene expression	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; BCL6; PLASTICITY; RESPONSES; EFFECTOR; ROBUSTNESS; REGULATORS; SIGNALS; TARGETS; ANTIGEN	Follicular helper T cells (T-FH cells) are the prototypic helper T cell subset specialized to enable B cells to form germinal centers (GCs) and produce high-affinity antibodies. We found that expression of microRNAs (miRNAs) by T cells was essential for T-FH cell differentiation. More specifically, we show that after immunization of mice with protein, the miRNA cluster miR-17 similar to 92 was critical for robust differentiation and function of T-FH cells in a cell-intrinsic manner that occurred regardless of changes in proliferation. In a viral infection model, miR-17 similar to 92 restrained the expression of genes 'inappropriate' to the T-FH cell subset, including the direct miR-17 similar to 92 target Rora. Removal of one Rora allele partially 'rescued' the inappropriate gene signature in miR-17 similar to 92-deficient T-FH cells. Our results identify the miR-17 similar to 92 cluster as a critical regulator of T cell-dependent antibody responses, TFH cell differentiation and the fidelity of the T-FH cell gene-expression program.	[Baumjohann, Dirk; Kageyama, Robin; Patel, Sana; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Clingan, Jonathan M.; Matloubian, Mehrdad] Univ Calif San Francisco, Div Rheumatol, Dept Med, San Francisco, CA 94143 USA; [Clingan, Jonathan M.; Matloubian, Mehrdad] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Clingan, Jonathan M.] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Morar, Malika M.; de Kouchkovsky, Dimitri; Bluestone, Jeffrey A.; Jeker, Lukas T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Morar, Malika M.; de Kouchkovsky, Dimitri; Bluestone, Jeffrey A.; Jeker, Lukas T.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bannard, Oliver] Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Bluestone, Jeffrey A.; Jeker, Lukas T.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jeker, LT (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	mark.ansel@ucsf.edu; ljeker@diabetes.ucsf.edu	Baumjohann, Dirk/C-9047-2009	Baumjohann, Dirk/0000-0001-8385-8288; de Kouchkovsky, Dimitri/0000-0002-9609-3226	Burroughs Wellcome Fund [CABS 1006173]; US National Institutes of Health [R01 HL109102, P01 HL107202, P01 AI35297, U19 AI056388, P30 DK63720]; Juvenile Diabetes Research Foundation; Swiss National Science Foundation [PBBEP3-133516]; Swiss Foundation for Grants in Biology and Medicine [PASMP3-142725, PASMP3-124274/1]; National Science Foundation; Wellcome Trust; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL109102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056388, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Panduro for technical assistance; R. Blelloch (University of California, San Francisco) for Dgcr8<SUP>fl/fl</SUP> mice; R. Barbeau, J. Pollack, A. Barczak and D. Erle for assistance with microarray experiments; the 'miRNA in lymphocytes interest group' of the University of California, San Francisco, for discussions; D. Fuentes for animal husbandry; and D. Le for help with genotyping. Supported by the Burroughs Wellcome Fund (CABS 1006173 to K.M.A.), the US National Institutes of Health (R01 HL109102 and P01 HL107202 to K.M.A.; P01 AI35297 and U19 AI056388 to J.A.B.; and P30 DK63720 for core support), Juvenile Diabetes Research Foundation (J.A.B.), the Swiss National Science Foundation (PBBEP3-133516 to D. B.), the Swiss Foundation for Grants in Biology and Medicine (PASMP3-142725 to D.B.; and PASMP3-124274/1 to L.T.J.), the National Science Foundation (J.M.C.) and the Wellcome Trust (O.B.).	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Baumjohann D., 2013, NAT PROTOC, DOI [org/10.1038/protex.2013.060, DOI 10.1038/PR0TEX.2013.060]; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Kouchkovsky D., J IMMUNOL IN PRESS; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	52	153	163	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					840	+		10.1038/ni.2642	http://dx.doi.org/10.1038/ni.2642			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23812098	Green Accepted, Green Submitted			2022-12-18	WOS:000322010600013
J	Bender, TP; Kremer, CS; Kraus, M; Buch, T; Rajewsky, K				Bender, TP; Kremer, CS; Kraus, M; Buch, T; Rajewsky, K			Critical functions for c-Myb at three checkpoints during thymocyte development	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; DIFFERENTIAL EXPRESSION; GENE REARRANGEMENT; TRANSGENIC MICE; ALPHA; PHOSPHORYLATION; ACCESSIBILITY; ACTIVATION; SELECTION; ENHANCER	The transcription factor c-Myb is expressed throughout T cell development in the thymus. However, little is understood about c-Myb function because of the embryonic lethality of traditional Myb-null mutations. Using tissue-specific deletion to abrogate c-Myb expression at distinct stages of T cell development, we identify three points at which c-Myb activity is required for normal T cell differentiation: transition through the double-negative 3 stage, survival of preselection CD4(+)CD8(+) thymocytes, and differentiation of CD4 thymocytes. Thus, c-Myb is essential at several stages during T cell development in the thymus.	Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany	University of Virginia; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cologne	Bender, TP (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	tpb3e@virginia.edu	Buch, Thorsten/P-1659-2019	Buch, Thorsten/0000-0002-2236-9074; Rajewsky, Klaus/0000-0002-6633-6370	FIC NIH HHS [TW02297, F06 TW002297] Funding Source: Medline; NCI NIH HHS [CA85842, R01 CA085842] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW002297] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Ess KC, 1999, ONCOGENE, V18, P1103, DOI 10.1038/sj.onc.1202387; Fehling H J, 1999, Adv Immunol, V71, P1; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; HSIANG YHH, 1995, J IMMUNOL, V154, P5195; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JACOBS SM, 1994, ONCOGENE, V9, P227; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; LAVU S, 1986, NUCLEIC ACIDS RES, V14, P5309, DOI 10.1093/nar/14.13.5309; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MCCLINTON D, 1990, MOL CELL BIOL, V10, P705, DOI 10.1128/MCB.10.2.705; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pearson R, 2000, EMBO J, V19, P6112, DOI 10.1093/emboj/19.22.6112; PENIT C, 1995, J IMMUNOL, V154, P5103; RAMSAY RG, 1995, ONCOGENE, V11, P2113; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Torres RM, 1997, LAB PROTOCOLS CONDIT; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820	47	153	156	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					721	729		10.1038/ni1085	http://dx.doi.org/10.1038/ni1085			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15195090				2022-12-18	WOS:000222331200025
J	Song, JX; Salek-Ardakani, S; Rogers, PR; Cheng, M; Van Parijs, L; Croft, M				Song, JX; Salek-Ardakani, S; Rogers, PR; Cheng, M; Van Parijs, L; Croft, M			The costimulation-regulated duration of PKB activation controls T cell longevity	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; GLYCOGEN-SYNTHASE KINASE-3; IN-VIVO; CLONAL EXPANSION; BCL-2 EXPRESSION; DENDRITIC CELLS; CD4 MEMORY; SURVIVAL; AKT	A brief antigenic stimulus can promote T cell proliferation, but the duration and nature of intracellular signals required for survival are unclear. Here we show that in the absence of OX40 costimulation, antigen-activated CD4(+) cells are short-lived because the activity of protein kinase B (PKB; also known as Akt) is not maintained over time. Activated T cells that express a dominant-negative variant of PKB also undergo apoptosis, reproducing the OX40-deficient phenotype. In contrast, an active form of PKB prevents downregulation of antiapoptotic proteins in OX40-deficient T cells, rescues antigen-induced cell survival in vivo, and controls inflammation in recall responses. Thus, sustained and periodic PKB signaling has an integral role in regulating T cell longevity.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	La Jolla Institute for Immunology; Massachusetts Institute of Technology (MIT)	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	mick@liai.org			NCI NIH HHS [CA 91827] Funding Source: Medline; NIAID NIH HHS [AI 50498] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI050498] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Arimura Y, 2002, INT IMMUNOL, V14, P555, DOI 10.1093/intimm/dxf022; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cooper D, 2002, EUR J IMMUNOL, V32, P521, DOI 10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO;2-X; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Gramaglia I, 2000, J IMMUNOL, V165, P3043, DOI 10.4049/jimmunol.165.6.3043; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Parsons MJ, 2001, J IMMUNOL, V167, P42, DOI 10.4049/jimmunol.167.1.42; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; WEISS A, 1987, J IMMUNOL, V138, P2169; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	48	153	164	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					150	158		10.1038/ni1030	http://dx.doi.org/10.1038/ni1030			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14730361				2022-12-18	WOS:000188512000010
J	Orange, JS; Fassett, MS; Koopman, LA; Boyson, JE; Strominger, JL				Orange, JS; Fassett, MS; Koopman, LA; Boyson, JE; Strominger, JL			Viral evasion of natural killer cells	NATURE IMMUNOLOGY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I HOMOLOG; CHEMOKINE BINDING-PROTEIN; VIRUS-INFECTED CELLS; HLA-E BINDS; HUMAN CYTOMEGALOVIRUS; DOWN-REGULATION; MURINE CYTOMEGALOVIRUS; NK CELLS; GLYCOPROTEIN UL16	Viruses have evolved mechanisms to avoid the host immune system, including means of escaping detection by both the innate and adaptive immune responses. Natural killer (NK) cells are a central component of the innate immune system and are crucial in defense against certain viruses. To attain a state of chronic infection, some successful viruses have developed specific mechanisms to evade detection by and activation of NK cells. These NK cell-specific evasion mechanisms fall into distinct mechanistic categories used in numerous virus families.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Strominger, JL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jlstrom@fas.harvard.edu	Orange, Jordan S/D-5239-2009	orange, jordan/0000-0001-7117-7725	NIAID NIH HHS [AI-50207, AI-07512] Funding Source: Medline; NICHD NIH HHS [F32 HD008515-03, F32 HD008515-02, F32 HD008515, F32 HD008515-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, R01AI050207] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcami A, 1998, J IMMUNOL, V160, P624; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BALLAS ZK, 1990, J ALLERGY CLIN IMMUN, V85, P453, DOI 10.1016/0091-6749(90)90155-W; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CHEHIMI J, 1991, J VIROL, V65, P1812, DOI 10.1128/JVI.65.4.1812-1822.1991; Cho YS, 2001, FEBS LETT, V501, P139, DOI 10.1016/S0014-5793(01)02652-7; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Cretney E, 1999, J EXP MED, V190, P435, DOI 10.1084/jem.190.3.435; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Fleming P, 1999, J VIROL, V73, P6800, DOI 10.1128/JVI.73.8.6800-6809.1999; Fletcher JM, 1998, J IMMUNOL, V161, P2365; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Huard B, 2000, EUR J IMMUNOL, V30, P509, DOI 10.1002/1521-4141(200002)30:2<509::AID-IMMU509>3.0.CO;2-H; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jun Y, 2000, J IMMUNOL, V164, P805, DOI 10.4049/jimmunol.164.2.805; Kavanagh DG, 2001, J EXP MED, V194, P967, DOI 10.1084/jem.194.7.967; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kloover JS, 2002, ARCH VIROL, V147, P813, DOI 10.1007/s007050200028; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Kubin M, 2001, EUR J IMMUNOL, V31, P1428, DOI 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4; Kubota A, 1999, CELL IMMUNOL, V191, P145, DOI 10.1006/cimm.1998.1424; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lee SJ, 2001, J IMMUNOL, V167, P497, DOI 10.4049/jimmunol.167.1.497; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; Lopez-Botet M, 2001, IMMUNOL REV, V181, P193, DOI 10.1034/j.1600-065X.2001.1810116.x; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Machold RP, 1997, J EXP MED, V185, P363, DOI 10.1084/jem.185.2.363; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; MELERO I, 1993, EUR J IMMUNOL, V23, P1859, DOI 10.1002/eji.1830230819; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Park B, 2002, J IMMUNOL, V168, P3464, DOI 10.4049/jimmunol.168.7.3464; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pietra G, 2000, J MED VIROL, V62, P354; Poggi A, 2002, J IMMUNOL, V168, P95, DOI 10.4049/jimmunol.168.1.95; Reyburn HT, 1997, NATURE, V386, P514, DOI 10.1038/386514a0; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Schust DJ, 1998, J EXP MED, V188, P497, DOI 10.1084/jem.188.3.497; Senkevich TG, 1998, VIROLOGY, V250, P397, DOI 10.1006/viro.1998.9390; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smith HRC, 2001, IMMUNOL REV, V181, P115, DOI 10.1034/j.1600-065X.2001.1810109.x; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; Swigut T, 2000, J VIROL, V74, P5691, DOI 10.1128/JVI.74.12.5691-5701.2000; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; Wack A, 2001, EUR J IMMUNOL, V31, P166, DOI 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L; Wang ECY, 2002, P NATL ACAD SCI USA, V99, P7570, DOI 10.1073/pnas.112680099; Wendland T, 2000, IMMUNOL LETT, V72, P75, DOI 10.1016/S0165-2478(00)00169-3; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; YORK IA, 1993, J INFECT DIS, V168, P1127, DOI 10.1093/infdis/168.5.1127; ZHENG ZY, 1992, J IMMUNOL, V148, P3679; Zocchi MR, 1998, J IMMUNOL, V161, P2938	72	153	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1006	1012		10.1038/ni1102-1006	http://dx.doi.org/10.1038/ni1102-1006			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407408	Bronze			2022-12-18	WOS:000179073000005
J	Mohrs, M; Blankespoor, CM; Wang, ZE; Loots, GG; Afzal, V; Hadeiba, H; Shinkai, K; Rubin, EM; Locksley, RM				Mohrs, M; Blankespoor, CM; Wang, ZE; Loots, GG; Afzal, V; Hadeiba, H; Shinkai, K; Rubin, EM; Locksley, RM			Deletion of a coordinate regulator of type 2 cytokine expression in mice	NATURE IMMUNOLOGY			English	Article							CELL-SPECIFIC DEMETHYLATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CUTTING EDGE; MAST-CELLS; T-CELLS; INTERLEUKIN-4 PROMOTER; LINEAGE COMMITMENT; CHAIN ENHANCER; TH1 CELLS	Mechanisms that underlie the patterning of cytokine expression in T helper (T-H) cell subsets remain incompletely defined. An evolutionarily conserved similar to 400.bp noncoding sequence in the intergenic region between the genes Il4 and III3, designated conserved noncoding sequence I (CNS-1), was deleted in mice. The capacity to develop T(H)2 cells was compromised in vitro and in vivo in the absence of CNS-1. Despite the profound effect in T cells, mast cells from CNS-1(-/-) mice maintained their capacity to produce interleukin 4. AT cell-specific element critical for the optimal expression of type 2 cytokines may represent the evolution of a regulatory sequence exploited by adaptive immunity.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genome Sci Dept, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Loots, Gabriela G/AGA-4868-2022	Loots, Gabriela G/0000-0001-9546-5561	NHLBI NIH HHS [HL56385, HL66671] Funding Source: Medline; NIAID NIH HHS [AI30663] Funding Source: Medline; NIGMS NIH HHS [GM07618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056385, P01HL056385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; BRUHN KW, 1993, P NATL ACAD SCI USA, V90, P9707, DOI 10.1073/pnas.90.20.9707; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; GROSSCHEDL R, 1988, CELL, V55, P645, DOI 10.1016/0092-8674(88)90223-1; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; LEDERER JA, 1994, J IMMUNOL, V152, P77; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PASZTY C, 1995, NAT GENET, V11, P33, DOI 10.1038/ng0995-33; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; ROONEY JW, 1995, IMMUNITY, V2, P545; Sherman MA, 1999, J IMMUNOL, V163, P1733; Sherman MA, 1999, EUR J IMMUNOL, V29, P1235, DOI 10.1002/(SICI)1521-4141(199904)29:04<1235::AID-IMMU1235>3.3.CO;2-S; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wenner CA, 1997, J IMMUNOL, V158, P765; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZON LI, 1991, J BIOL CHEM, V266, P22948	49	153	154	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					842	847		10.1038/ni0901-842	http://dx.doi.org/10.1038/ni0901-842			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526400	Green Submitted			2022-12-18	WOS:000170781200024
J	Hu, H; Huston, G; Duso, D; Lepak, N; Roman, E; Swain, SL				Hu, H; Huston, G; Duso, D; Lepak, N; Roman, E; Swain, SL			CD4(+) T cell effectors can become memory cells with high efficiency and without further division	NATURE IMMUNOLOGY			English	Article							GAMMA PROMOTER DEMETHYLATION; IN-VIVO PERSISTENCE; IMMUNOLOGICAL MEMORY; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; CUTTING EDGE; IFN-GAMMA; ANTIGEN; GENERATION; NAIVE	Whether memory T lymphocytes are derived directly from effector T cells or via a separately controlled pathway has long been debated. Here we present evidence that, after adoptive transfer, a large fraction of in vitro-derived effector CD4(+)T cells have the potential to become memory T cells and that this transition can occur without further division. This data supports a linear pathway from effector to memory cells and suggests that most properties of memory cells are predetermined during effector generation. We suggest, therefore, that evaluation of vaccine efficacy in the induction of memory CD4(+)T cells should focus on the effector stage.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Swain, SL (corresponding author), Trudeau Inst Inc, 100 Algonquin Ave, Saranac Lake, NY 12983 USA.							Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ahmadzadeh M, 1999, J IMMUNOL, V163, P3053; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Cerwenka A, 1998, J IMMUNOL, V161, P97; Cerwenka A, 1999, J IMMUNOL, V163, P5535; DUBEY C, 1995, J IMMUNOL, V155, P45; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Farber DL, 1998, J IMMUNOL, V160, P535; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; HARBERTSON J, 2001, UNPUB J EXP MED; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; HWITMIRE JK, 2000, PHIL T R SOC LOND B, V355, P373; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Rogers PR, 1998, J IMMUNOL, V161, P3844; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Sprent J, 1997, CURR OPIN IMMUNOL, V9, P371, DOI 10.1016/S0952-7915(97)80084-2; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Swain SL, 1996, IMMUNOL REV, V150, P143, DOI 10.1111/j.1600-065X.1996.tb00700.x; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Topham DJ, 1996, J IMMUNOL, V157, P2947; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zhang ZP, 1998, CHINESE PHYS LETT, V15, P591, DOI 10.1088/0256-307X/15/8/017	46	153	162	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					705	710		10.1038/90643	http://dx.doi.org/10.1038/90643			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477406				2022-12-18	WOS:000170230100012
J	Shi, FD; Wang, HB; Li, HL; Hong, S; Taniguchi, M; Link, H; Van Kaer, L; Ljunggren, HG				Shi, FD; Wang, HB; Li, HL; Hong, S; Taniguchi, M; Link, H; Van Kaer, L; Ljunggren, HG			Natural killer cells determine the out-come of B cell-mediated autoimmunity	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; CD4(+) T-CELLS; MYASTHENIA-GRAVIS; NK-CELLS; TGF-BETA; MULTIPLE-SCLEROSIS; IFN-GAMMA; MICE; INDUCTION; LYMPHOCYTES	Natural killer (NK) cells can affect the outcome of adaptive immune responses. NK cells, but not NK1.1(+)T cells, were found to participate in the development of myasthenia gravis (a T cell-dependent, B cell- and antibody-mediated autoimmune disease) in C57BL/6 mice. The requirement for NK cells was reflected by the lack of a type I helper T cell response and antibodies to the acetylcholine receptor in both NK1.1(+) cell-depleted and NK cell-deficient IL-18(-/-) mice. These findings establish a previously unrecognized link between NK cells and autoreactive T and B cells.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Div Neurol, S-14186 Stockholm, Sweden; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Nashville, TN 37232 USA; Chiba Univ, Sch Med, Ctr Biomed Sci, Div Mol Immunol,Chuo Ku, Chiba 260, Japan	Karolinska Institutet; Karolinska Institutet; Howard Hughes Medical Institute; Vanderbilt University; Chiba University	Ljunggren, HG (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.	hans-gustaf.ljunggren@mtc.ki.se	Taniguchi, Masaru/N-7932-2015; Van Kaer, Luc/H-1033-2015	Taniguchi, Masaru/0000-0001-7821-7179; Van Kaer, Luc/0000-0001-5275-2309				Balasa B, 1997, J EXP MED, V186, P385, DOI 10.1084/jem.186.3.385; BERMAN PW, 1980, J EXP MED, V151, P204, DOI 10.1084/jem.151.1.204; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DALAKAS MC, 1995, ANN NEUROL, V37, P806, DOI 10.1002/ana.410370615; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DASCH JR, 1989, J IMMUNOL, V142, P1536; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DOUGLAS TF, 1996, SCIENCE, V272, P50; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Fort MM, 1998, J IMMUNOL, V161, P3256; GARCIASUAREZ J, 1995, BRIT J HAEMATOL, V89, P653, DOI 10.1111/j.1365-2141.1995.tb08382.x; Gray JD, 1998, J IMMUNOL, V160, P2248; GRAY JD, 1994, J EXP MED, V180, P1937, DOI 10.1084/jem.180.5.1937; Hong SM, 1999, IMMUNOL REV, V169, P31, DOI 10.1111/j.1600-065X.1999.tb01304.x; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Lindstrom J, 1981, Methods Enzymol, V74 Pt C, P432; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; Matsumoto Y, 1998, EUR J IMMUNOL, V28, P1681, DOI 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T; Mendola JF, 1997, CELL TRANSPLANT, V6, P69, DOI 10.1016/S0963-6897(96)00092-9; Moiola M, 1998, EUR J IMMUNOL, V28, P2487, DOI 10.1002/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; RAUCH HC, 1985, IMMUNOL INVEST, V14, P427, DOI 10.3109/08820138509047611; RIDDERSTAD A, 1995, INT IMMUNOL, V7, P459, DOI 10.1093/intimm/7.3.459; ROMAGNANI S, 1992, IMMUNOL TODAY, V13, P379, DOI 10.1016/0167-5699(92)90083-J; SEAMAN WE, 1987, J IMMUNOL, V138, P4539; Shi FD, 1998, EUR J IMMUNOL, V28, P3587, DOI 10.1002/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.3.CO;2-P; Shi FD, 1999, J IMMUNOL, V162, P5757; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; VRANES Z, 1989, J NEUROL SCI, V94, P115, DOI 10.1016/0022-510X(89)90222-0; YUAN D, 1994, FASEB J, V8, P1012, DOI 10.1096/fasebj.8.13.7926365; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	39	153	159	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					245	251		10.1038/79792	http://dx.doi.org/10.1038/79792			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973283				2022-12-18	WOS:000089815100024
J	Zheng, M; Karki, R; Williams, EP; Yang, D; Fitzpatrick, E; Vogel, P; Jonsson, CB; Kanneganti, TD				Zheng, Min; Karki, Rajendra; Williams, Evan Peter; Yang, Dong; Fitzpatrick, Elizabeth; Vogel, Peter; Jonsson, Colleen Beth; Kanneganti, Thirumala-Devi			TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines	NATURE IMMUNOLOGY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; INNATE IMMUNE-RESPONSES; KAPPA-B; RECEPTOR; CELLS; ACTIVATION; INFECTION; MICE	The innate sensors of SARS-CoV-2 are still being determined. Kanneganti and colleagues find that SARS-CoV-2 envelope protein is sensed by TLR2 and this drives pathogenic inflammatory cytokine production. The innate immune response is critical for recognizing and controlling infections through the release of cytokines and chemokines. However, severe pathology during some infections, including SARS-CoV-2, is driven by hyperactive cytokine release, or a cytokine storm. The innate sensors that activate production of proinflammatory cytokines and chemokines during COVID-19 remain poorly characterized. In the present study, we show that both TLR2 and MYD88 expression were associated with COVID-19 disease severity. Mechanistically, TLR2 and Myd88 were required for beta-coronavirus-induced inflammatory responses, and TLR2-dependent signaling induced the production of proinflammatory cytokines during coronavirus infection independent of viral entry. TLR2 sensed the SARS-CoV-2 envelope protein as its ligand. In addition, blocking TLR2 signaling in vivo provided protection against the pathogenesis of SARS-CoV-2 infection. Overall, our study provides a critical understanding of the molecular mechanism of beta-coronavirus sensing and inflammatory cytokine production, which opens new avenues for therapeutic strategies to counteract the ongoing COVID-19 pandemic.	[Zheng, Min; Karki, Rajendra; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Williams, Evan Peter; Jonsson, Colleen Beth] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Yang, Dong; Fitzpatrick, Elizabeth] Univ Tennessee, Hlth Sci Ctr, UTHSC Reg Biocontainment Lab, Memphis, TN USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Jonsson, Colleen/GPC-4424-2022; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Jonsson, Colleen/0000-0002-2640-7672; Vogel, Peter/0000-0002-7535-0545; Karki, Rajendra/0000-0003-4436-9128	US NIH [AI101935, AI124346, AR056296, CA253095]; American Lebanese Syrian Associated Charities	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	We thank all the members of the Kanneganti laboratory for their comments and suggestions during the development of this article. We thank A. Burton (St Jude Children's Research Hospital) for her technical support. We also thank R. Tweedell for scientific editing and writing support and S. Surendrathanan for technical assistance. Work from our laboratory is supported by the US NIH (grant nos. AI101935, AI124346, AR056296 and CA253095 to T.-D.K.) and the American Lebanese Syrian Associated Charities (to T.-D.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The following reagents were deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, NR-52281, and Heat Inactivated, NR-52286.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amarante-Mendes GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02379; Barrat FJ, 2018, J EXP MED, V215, P2964, DOI 10.1084/jem.20181899; Briard B, 2020, PHYSIOLOGY, V35, P112, DOI 10.1152/physiol.00022.2019; Brownlie J, 2017, FENNER'S VETERINARY VIROLOGY, 5TH EDITION, P435, DOI 10.1016/B978-0-12-800946-8.00024-6; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Cabanski M, 2009, AM J PHYSIOL-LUNG C, V297, pL608, DOI 10.1152/ajplung.90433.2008; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Ghosh S, 2020, CELL, V183, P1520, DOI 10.1016/j.cell.2020.10.039; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Kampf G, 2020, J HOSP INFECT, V105, P348, DOI 10.1016/j.jhin.2020.03.025; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee J, 2020, J VIROL, V94, DOI 10.1128/JVI.00317-20; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lythgoe MP, 2020, TRENDS PHARMACOL SCI, V41, P363, DOI 10.1016/j.tips.2020.03.006; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Oladunni FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19891-7; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Schickli JH, 1997, J VIROL, V71, P9499, DOI 10.1128/JVI.71.12.9499-9507.1997; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Slaats J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005973; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang DM, 2021, MILITARY MED RES, V8, DOI [10.1101/2021.02.10.430677, 10.1186/s40779-021-00340-5]; Zalinger ZB, 2015, J VIROL, V89, P12330, DOI 10.1128/JVI.01470-15; Zhao WM, 2019, INT J BIOL SCI, V15, P1571, DOI 10.7150/ijbs.34211; Zheng M, 2020, J BIOL CHEM, V295, P14040, DOI 10.1074/jbc.RA120.015036; Zhou HX, 2010, MBIO, V1, DOI 10.1128/mBio.00219-10	51	152	153	6	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					829	+		10.1038/s41590-021-00937-x	http://dx.doi.org/10.1038/s41590-021-00937-x		MAY 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	33963333	Bronze, Green Accepted			2022-12-18	WOS:000648307900001
J	Zou, Q; Jin, J; Hu, HB; Li, HYS; Romano, S; Xiao, YC; Nakaya, M; Zhou, XF; Cheng, XH; Yang, PR; Lozano, G; Zhu, CM; Watowich, SS; Ullrich, SE; Sun, SC				Zou, Qiang; Jin, Jin; Hu, Hongbo; Li, Haiyan S.; Romano, Simona; Xiao, Yichuan; Nakaya, Mako; Zhou, Xiaofei; Cheng, Xuhong; Yang, Peirong; Lozano, Guillermina; Zhu, Chengming; Watowich, Stephanie S.; Ullrich, Stephen E.; Sun, Shao-Cong			USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses	NATURE IMMUNOLOGY			English	Article							UBIQUITIN LIGASES; P53; ROLES; UBIQUITYLATION; ONCOGENESIS; ACTIVATION; EXPRESSION; PROTEINS; PATHWAY; FINGER	Deubiquitinases (DUBs) are a new class of drug targets, although the physiological function of only few DUBs has been characterized. Here we identified the DUB USP15 as a crucial negative regulator of T cell activation. USP15 stabilized the E3 ubiquitin ligase MDM2, which in turn negatively regulated T cell activation by targeting the degradation of the transcription factor NFATc2. USP15 deficiency promoted T cell activation in vitro and enhanced T cell responses to bacterial infection and tumor challenge in vivo. USP15 also stabilized MDM2 in cancer cells and regulated p53 function and cancer-cell survival. Our results suggest that inhibition of USP15 may both induce tumor cell apoptosis and boost antitumor T cell responses.	[Zou, Qiang; Jin, Jin; Hu, Hongbo; Li, Haiyan S.; Romano, Simona; Xiao, Yichuan; Nakaya, Mako; Zhou, Xiaofei; Cheng, Xuhong; Zhu, Chengming; Watowich, Stephanie S.; Ullrich, Stephen E.; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Romano, Simona] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Yang, Peirong; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Lozano, Guillermina; Zhu, Chengming; Watowich, Stephanie S.; Ullrich, Stephen E.; Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Naples Federico II; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	zhou, xiaofei/A-9844-2013; Hu, Hongbo/J-8059-2016	Hu, Hongbo/0000-0002-8177-7641; Zou, Qiang/0000-0002-1362-2007; Watowich, Stephanie/0000-0003-1969-659X; Jin, Jin/0000-0001-7887-5972	US National Institutes of Health or National Cancer Insitute at The MD Anderson Cancer Center [P30CA016672]; US National Institutes of Health [AI057555, AI064639, GM84459, AI104519, AI098099]; Sister Institution Network Fund; Center for Inflammation and Cancer at the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA047296, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI104519, R21AI098099, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health or National Cancer Insitute at The MD Anderson Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sister Institution Network Fund; Center for Inflammation and Cancer at the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Gu for expression vectors, B. Vogelstein for HCT116 derivative cell lines, S. Hao for recombinant L. monocytogenesis, Q. Ti for B16 cell line, L.A. Donehower for Trp53<SUP>-/-</SUP> mice, and the personnel from the US National Institutes of Health or National Cancer Insitute-supported resources (flow cytometry, DNA analysis and animal facilities) under award number P30CA016672 at The MD Anderson Cancer Center. This study was supported by grants from US National Institutes of Health (AI057555, AI064639, GM84459 and AI104519 to S.-C.S. and AI098099 to S.S.W.) and partially supported by a Sister Institution Network Fund and a seed fund from the Center for Inflammation and Cancer at the MD Anderson Cancer Center.	Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheok CF, 2010, CELL DEATH DIFFER, V17, P1486, DOI 10.1038/cdd.2010.18; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Kitagaki J, 2008, MOL CANCER THER, V7, P2445, DOI 10.1158/1535-7163.MCT-08-0063; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Loch CM, 2012, BBA-MOL CELL RES, V1823, P2069, DOI 10.1016/j.bbamcr.2012.05.006; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Take Y, 1996, BIOCHEM BIOPH RES CO, V221, P207, DOI 10.1006/bbrc.1996.0575; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vos RM, 2009, J VIROL, V83, P8885, DOI 10.1128/JVI.00605-09; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	37	152	157	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					562	570		10.1038/ni.2885	http://dx.doi.org/10.1038/ni.2885			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24777531	Green Accepted			2022-12-18	WOS:000336419300013
J	Kaufmann, SHE				Kaufmann, Stefan H. E.			Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff	NATURE IMMUNOLOGY			English	Article								One hundred years ago the birth of immunology was made official by the Nobel Prize award to Elie Metchnikoff and Paul Ehrlich. Metchnikoff discovered phagocytosis by macrophages and microphages as a critical host-defense mechanism and thus is considered the father of cellular innate immunity. Ehrlich described the side-chain theory of antibody formation and the mechanisms of how antibodies neutralize toxins and induce bacterial lysis with the help of complement and thus is considered one of the fathers of humoral adaptive immunity. Despite many discordant discussions in the initial phase after these discoveries, innate and adaptive responses are now known to be complementary partners in producing robust immunity.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268				[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; BEHRING E, 1967, NOBEL LECT PHYSL MED; Bordet J, 1899, ANN I PASTEUR, V13, P273; BORDET J, 1909, STUDIES IMMUNITY, P1; Bordet J., 1898, ANN I PASTEUR PARIS, V12, P688; Bordet J., 1896, ANN I PASTEUR PARIS, V10, P193; Breinl F., 1930, Z PHYSL CHEM, V192, P45; BUCHNER H, 1889, PARASITENKUNDE, V6, P561; BUCHNER H, 1891, T 7 INT C HYG DEM, V1, P124; BUCHNER H, 1889, PARASITENKUNDE, V6, P1; BUCHNER H, 1889, PARASITENKUNDE, V5, P817; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM, 1964, NOBEL LECT PHYSL MED; COHNHEIM J, 1873, NEUERE UNTERSUCHUNGE, P1; EHRLICH G, 1956, J PHYS CHEM SOLIDS, V1, P1; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P979, DOI [10.1055/s-0029-1206682, DOI 10.1055/S-0029-1206682]; Ehrlich P, 1967, NOBEL LECT PHYSL MED; EHRLICH P, 1904, GESAMMELTE ARBEITEN, P1; EHRLICH P, 1957, COLLECTED PAPERS P E, V2, P1; EHRLICH P, 1960, COLLECTED PAPERS P E, V3, P1; Ehrlich P., 1891, DEUT MED WOCHENSCHR, V17, P1218, DOI DOI 10.1055/S-0029-1206825; GROTJAHN V, 1903, WOCHENSCHR, V24, P307; Hodgkin PD, 2007, NAT IMMUNOL, V8, P1019, DOI 10.1038/ni1007-1019; JERNE N, 1993, NOBEL LECT PHYSL MED; Koch R., 1876, COH BEIT BIOL PFLAN, V2, P277; Kuhn T. S., 1970, STRUCTURE SCI REVOLU; Mechnikov I, 1967, NOBEL LECT PHYSL MED; MECZNIKOW E, 1866, B ACAD IMP SCI STPET, V5, P433; Metchnikoff E., 1883, BIOL ZBL, V3, P560; METCHNIKOFF E, 1903, NATURE MAN STUDIES O, P1; Metchnikoff E, 1884, VIRCHOWS ARCH, V96, P177; METCHNIKOFF E, 1907, PROLONGATION LIFE OP, P1; Metchnikoff Olga, 1921, LIFE ELIE METCHNIKOF; Metschnikoff E, 1880, ZOOL ANZ, V3, P261; Metschnikoff E, 1888, VIRCHOWS ARCH PATH A, V113, P63; Metschnikoff E, 1887, VIRCHOWS ARCH, V107, P209, DOI DOI 10.1007/BF01926053; Metschnikoff E, 1878, ZOOL ANZ, V1, P387; METSCHNIKOFF E, 1884, ZOOL STAT TRIEST, V5, P141; METSCHNIKOFF E, 1908, RUSSK VEDOMOSTI, V302; METSCHNIKOFF E, 1884, VIRCHOWS ARCH PATH A, V97, P502; METSCHNIKOFF E, 1884, FORTSCHR MED, V2, P558; Metschnikoff E, 1884, ALLG WEIN MED ZTG, V27, P307; Metschnikoff E, 1886, ARB ZOOL I U WIEN, V6, P237; METSCHNIKOFF E, 1902, IMMUNITAT INFEKTIONS, P1; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PFEIFFER R, 1894, DEUT MED WOCHENSCHR, V20, P698; ROUX E, 1891, T 7 INT C HYG DEM, V1, P110; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; Tonegawa S, 1993, NOBEL LECT PHYSL MED; VENZMER G, 1948, P EHRLICH LEBEN WIRK, P33; Wright AE, 1903, P R SOC LONDON, V72, P357, DOI 10.1098/rspl.1903.0062; 1891, NATURE, V44, P419	52	152	154	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					705	712		10.1038/ni0708-705	http://dx.doi.org/10.1038/ni0708-705			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18563076				2022-12-18	WOS:000256904900003
J	Taghon, T; Yui, MA; Rothenberg, EV				Taghon, Tom; Yui, Mary A.; Rothenberg, Ellen V.			Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3	NATURE IMMUNOLOGY			English	Article							ENFORCED EXPRESSION; LYMPHOID PROGENITORS; HEMATOPOIETIC-CELLS; DENDRITIC CELLS; CUTTING EDGE; MOUSE THYMUS; BONE-MARROW; PAX5 MUTANT; C/EBP-ALPHA; DIFFERENTIATION	GATA-3 is essential for T cell development from the earliest stages. However, abundant GATA-3 can drive T lineage precursors to a non-T cell fate, depending on Notch signaling and developmental stage. Here, overexpression of GATA-3 blocked the survival of pro-T cells when Notch-Delta signals were present but enhanced viability in their absence. In fetal thymocytes at the doublenegative 1 (DN1) stage and DN2 stage but not those at the DN3 stage, overexpression of GATA-3 rapidly induced respecification to the mast cell lineage with high frequency by direct transcriptional 'reprogramming'. Normal DN2 thymocytes also showed mast cell potential when interleukin 3 and stem cell factor were added in the absence of Notch signaling. Our results suggest a close relationship between the pro-T cell and mast cell programs and a previously unknown function for Notch in T lineage fidelity.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	California Institute of Technology; Ghent University; Ghent University Hospital	Rothenberg, EV (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	evroth@its.caltech.edu	Taghon, Tom/M-9111-2018	Taghon, Tom/0000-0002-5781-0288; Rothenberg, Ellen/0000-0002-3901-347X; Yui, Mary/0000-0002-3136-2181	NCI NIH HHS [R01 CA090233-06A1, R01 CA98925, R01 CA090233-05, R01 CA098925-04, R01 CA098925, R01 CA090233, R01 CA90233] Funding Source: Medline; NIAID NIH HHS [R01 AI064590, R01 AI064590-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098925, R01CA090233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson MK, 2002, DEV BIOL, V246, P103, DOI 10.1006/dbio.2002.0674; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Babina M, 2005, CELL MOL LIFE SCI, V62, P214, DOI 10.1007/s00018-004-4480-6; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Burnet F M, 1977, Cell Immunol, V30, P358, DOI 10.1016/0008-8749(77)90079-X; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Chen D, 2001, EXP HEMATOL, V29, P971, DOI 10.1016/S0301-472X(01)00670-1; Crivellato E, 2005, ANAT EMBRYOL, V209, P243, DOI 10.1007/s00429-004-0439-5; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Mohtashami M, 2006, J IMMUNOL, V176, P730, DOI 10.4049/jimmunol.176.2.730; MURPHY M, 1992, J IMMUNOL, V149, P2506; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Nishiyama C, 2005, INT IMMUNOL, V17, P847, DOI 10.1093/intimm/dxh278; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; Shortman K, 1998, IMMUNOL REV, V165, P39, DOI 10.1111/j.1600-065X.1998.tb01228.x; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon T, 2001, J IMMUNOL, V167, P4468, DOI 10.4049/jimmunol.167.8.4468; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; WISE WS, 1976, ARCH PATHOL LAB MED, V100, P283; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	49	152	156	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					845	855		10.1038/ni1486	http://dx.doi.org/10.1038/ni1486			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17603486	Green Accepted			2022-12-18	WOS:000248169400012
J	Hodges, A; Sharrocks, K; Edelmann, M; Baban, D; Moris, A; Schwartz, O; Drakesmith, H; Davies, K; Kessler, B; McMichael, A; Simmons, A				Hodges, Ashleigh; Sharrocks, Katherine; Edelmann, Mariola; Baban, Dilair; Moris, Arnaud; Schwartz, Olivier; Drakesmith, Hal; Davies, Kay; Kessler, Benedikt; McMichael, Andrew; Simmons, Alison			Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication	NATURE IMMUNOLOGY			English	Article							OLIGONUCLEOTIDE ARRAY DATA; EPIDERMAL-GROWTH-FACTOR; C-TYPE LECTINS; T-CELLS; IMMUNOLOGICAL SYNAPSE; ANTIGEN PRESENTATION; INFECTIOUS SYNAPSE; IMMUNE-RESPONSES; LYMPH-NODE; IN-VIVO	DC-SIGN, a C-type lectin expressed on dendritic cells (DCs), can sequester human immunodeficiency virus (HIV) virions in multivesicular bodies. Here, using large-scale gene expression profiling and tyrosine-phosphorylated proteome analyses, we characterized signaling mediated by DC-SIGN after activation by either HIV or a DC-SIGN-specific antibody. Activation of DC-SIGN resulted in downregulation of genes encoding major histocompatibility complex class II, Jagged 1 and interferon-response molecules and upregulation of the gene encoding transcription factor ATF3. Phosphorylated proteome analysis showed that HIV-or antibody-stimulated DC-SIGN signaling was mediated by the Rho guanine nucleotide-exchange factor LARG and led to increased Rho-GTPase activity. Activation of LARG in DCs exposed to HIV was required for the formation of virus-T cell synapses. Thus, HIV sequestration by and stimulation of DC- SIGN helps HIV evade immune responses and spread to cells.	John Radcliffe Hosp, Westherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England; Univ Oxford, Oxford OX3 7BN, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England; Inst Pasteur, Grp Virus & Imunite, F-75724 Paris 15, France; John Radcliffe Hosp, Westherall Inst Mol Med, Mol Immunol Grp, Oxford OX3 9DS, England	University of Oxford; University of Oxford; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford	Simmons, A (corresponding author), John Radcliffe Hosp, Westherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	asimmons@hammer.imm.ox.ac.uk	Schwartz, Olivier/AAZ-3765-2021; Kessler, Benedikt/AAY-8614-2021	Schwartz, Olivier/0000-0002-0729-1475; Kessler, Benedikt/0000-0002-8160-2446; Edelmann, Mariola/0000-0003-0459-7716; Simmons, Alison/0000-0003-3454-0710; Moris, Arnaud/0000-0002-5052-1678	Medical Research Council [MC_U137761449, MC_U137884177] Funding Source: Medline; MRC [MC_U137761449, MC_U137884177] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Deckert M, 2005, CURR TOP MICROBIOL, V291, P61; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Eun SY, 2006, J IMMUNOL, V177, P4271, DOI 10.4049/jimmunol.177.7.4271; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Harman AN, 2006, J IMMUNOL, V177, P7103, DOI 10.4049/jimmunol.177.10.7103; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jefford M, 2003, BLOOD, V102, P1753, DOI 10.1182/blood-2002-12-3854; KINTHER M, 2000, PROTIN SEQUENCING ID; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Loomis RJ, 2006, TRAFFIC, V7, P1643, DOI 10.1111/j.1600-0854.2006.00503.x; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; ODA K, 2006, MOL SYST BIOL, V2, pNI137; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Suwa A, 2002, J BIOL CHEM, V277, P13053, DOI 10.1074/jbc.M108644200; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Tao L, 2002, BIOCHEM J, V363, P175, DOI 10.1042/0264-6021:3630175; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b	44	152	159	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					569	577		10.1038/ni1470	http://dx.doi.org/10.1038/ni1470			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17496896				2022-12-18	WOS:000246703300010
J	Allie, SR; Bradley, JE; Mudunuru, U; Schultz, MD; Graf, BA; Lund, FE; Randall, TD				Allie, S. Rameeza; Bradley, John E.; Mudunuru, Uma; Schultz, Michael D.; Graf, Beth A.; Lund, Frances E.; Randall, Troy D.			The establishment of resident memory B cells in the lung requires local antigen encounter	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER SELECTION; MAINTENANCE; PERSISTENCE; MATURATION; ANTIBODIES; INFECTION; SUBSET	Memory B cells are found in lymphoid and non-lymphoid tissues, suggesting that some may be tissue-resident cells. Here we show that pulmonary influenza infection elicited lung-resident memory B cells (BRM cells) that were phenotypically and functionally distinct from their systemic counterparts. BRM cells were established in the lung early after infection, in part because their placement required local antigen encounter. Lung BRM cells, but not systemic memory B cells, contributed to early plasmablast responses following challenge infection. Following secondary infection, antigen-specific BRM cells differentiated in situ, whereas antigen-non-specific BRM cells were maintained as memory cells. These data demonstrate that BRM cells are an important component of immunity to respiratory viruses such as influenza virus and suggest that vaccines designed to elicit BRM cells must deliver antigen to the lungs.	[Allie, S. Rameeza; Bradley, John E.; Mudunuru, Uma; Randall, Troy D.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL 35294 USA; [Schultz, Michael D.; Graf, Beth A.; Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Randall, TD (corresponding author), Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Dept Med, Birmingham, AL 35294 USA.	randallt@uab.edu		Randall, Troy/0000-0003-0643-0311	NIH [HL69409, AI100127, AI097357, AI109962, AI120508];  [AI078907]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI120508, R01AI097357, U19AI109962, T32AI007051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank U. Mudunuru and S. Simpler for animal husbandry and the Rheumatic Diseases Core Center flow cytometry facility, which is supported by AI078907. This work was supported by NIH grants HL69409, AI100127, AI097357, AI109962 to T.D.R. and AI120508 to S.R.A.	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Bannard O, 2017, CURR OPIN IMMUNOL, V45, P21, DOI 10.1016/j.coi.2016.12.004; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Van V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10875; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hwang JY, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00258; Jaimes MC, 2004, J VIROL, V78, P10967, DOI 10.1128/JVI.78.20.10967-10976.2004; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Lee FEH, 2011, J IMMUNOL, V186, P5514, DOI 10.4049/jimmunol.1002932; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McMaster SR, 2018, MUCOSAL IMMUNOL, V11, P1071, DOI 10.1038/s41385-018-0003-x; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Phan TG, 2017, CURR OPIN IMMUNOL, V45, P132, DOI 10.1016/j.coi.2017.03.005; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	30	151	154	7	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					97	+		10.1038/s41590-018-0260-6	http://dx.doi.org/10.1038/s41590-018-0260-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30510223	Green Accepted			2022-12-18	WOS:000456273900018
J	Garcia-Beltran, WF; Holzemer, A; Martrus, G; Chung, AW; Pacheco, Y; Simoneau, CR; Rucevic, M; Lamothe-Molina, PA; Pertel, T; Kim, TE; Dugan, H; Alter, G; Dechanet-Merville, J; Jost, S; Carrington, M; Altfeld, M				Garcia-Beltran, Wilfredo F.; Hoelzemer, Angelique; Martrus, Gloria; Chung, Amy W.; Pacheco, Yovana; Simoneau, Camille R.; Rucevic, Marijana; Lamothe-Molina, Pedro A.; Pertel, Thomas; Kim, Tae-Eun; Dugan, Haley; Alter, Galit; Dechanet-Merville, Julie; Jost, Stephanie; Carrington, Mary; Altfeld, Marcus			Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; NATURAL-KILLER-CELLS; CLASS-I; CUTTING EDGE; SURFACE EXPRESSION; PROTEIN; PROGRESSION; COMPLEX; GENE; ANTIBODIES	The activating natural killer (NK)-cell receptor KIR3DS1 has been linked to the outcome of various human diseases, including delayed progression of disease caused by human immunodeficiency virus type 1 (HIV-1), yet a ligand that would account for its biological effects has remained unknown. We screened 100 HLA class I proteins and found that KIR3DS1 bound to HLA-F, a result we confirmed biochemically and functionally. Primary human KIR3DS1(+) NK cells degranulated and produced antiviral cytokines after encountering HLA-F and inhibited HIV-1 replication in vitro. Activation of CD4(+) T cells triggered the transcription and surface expression of HLA-F mRNA and HLA-F protein, respectively, and induced binding of KIR3DS1. HIV-1 infection further increased the transcription of HLA-F mRNA but decreased the binding of KIR3DS1, indicative of a mechanism for evading recognition by KIR3DS1(+) NK cells. Thus, we have established HLA-F as a ligand of KIR3DS1 and have demonstrated cell-context-dependent expression of HLA-F that might explain the widespread influence of KIR3DS1 in human disease.	[Garcia-Beltran, Wilfredo F.; Hoelzemer, Angelique; Chung, Amy W.; Pacheco, Yovana; Simoneau, Camille R.; Rucevic, Marijana; Lamothe-Molina, Pedro A.; Kim, Tae-Eun; Dugan, Haley; Alter, Galit; Jost, Stephanie; Carrington, Mary; Altfeld, Marcus] MGH MIT & Harvard, Ragon Inst, Cambridge, MA USA; [Hoelzemer, Angelique; Martrus, Gloria; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Hoelzemer, Angelique] Univ Med Ctr Eppendorf, Dept Internal Med 1, Hamburg, Germany; [Pacheco, Yovana] Univ Nuestra Senora Rosario, Fac Ciencias, Dept Maternat, Bogota, Colombia; [Pertel, Thomas] Harvard Med Sch, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA USA; [Dechanet-Merville, Julie] Univ Bordeaux, CNRS, UMR 5164, Bordeaux, France; [Carrington, Mary] Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Leidos Biomed Res, Frederick, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Altfeld, M (corresponding author), MGH MIT & Harvard, Ragon Inst, Cambridge, MA USA.; Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	marcus.altfeld@hpi.uni-hamburg.de	Altfeld, Marcus/AAE-7306-2019; Pacheco Nieva, Yovana/J-2932-2018	Altfeld, Marcus/0000-0001-5972-2997; Lamothe, Pedro/0000-0001-9262-2920; Martrus, Gloria/0000-0003-2879-3201; Pacheco Nieva, Yovana/0000-0002-0722-546X; Chung, Amy/0000-0003-0020-9704; Pertel, Thomas/0000-0002-2286-6011	Ragon Institute Flow Cytometry Core and Virology Core; US National Institutes of Health [R01-AI067031-08, P01-AI104715, F31AI116366]; US National Institutes of Health (Intramural Research Program, Frederick National Lab, Center for Cancer Research); National Institute of General Medical Sciences [T32GM007753]; Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Heinrich-Pette Institute-Leibniz Institute for Experimental Virology (Program Area Antiviral Targets and Strategies); German Center for Infection Research; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067031, F31AI116366, P01AI104715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Ragon Institute Flow Cytometry Core and Virology Core; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Intramural Research Program, Frederick National Lab, Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ragon Institute of MGH; Ragon Institute of MIT; Ragon Institute of Harvard; Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Heinrich-Pette Institute-Leibniz Institute for Experimental Virology (Program Area Antiviral Targets and Strategies); German Center for Infection Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Korner and A. Crespo for advice and discussions; D. Campana (St. Jude Children's Research Hospital) for K562 cells expressing mbIL-15 and CD137L; C. Brander (Ragon Institute of MGH, MIT, and Harvard) for 721.221 cells transduced to express HLA; J. Strominger (Harvard University) for 721.221-HLA-G cells; F. Zhang (Broad Institute of MIT and Harvard) for the lentiCas9-Blast plasmid; L. Ferreira (Harvard University) and T. Meissner (Harvard University) for beta<INF>2</INF>m-targeting single-guide RNA plasmid; and the Ragon Institute Flow Cytometry Core and Virology Core for support and assistance. Supported by the US National Institutes of Health (R01-AI067031-08 and P01-AI104715; F31AI116366 to W.F.G.-B.; the Intramural Research Program, Frederick National Lab, Center for Cancer Research), the National Institute of General Medical Sciences (T32GM007753), the Ragon Institute of MGH, MIT and Harvard, the Frederick National Laboratory for Cancer Research (HHSN261200800001E), the Heinrich-Pette Institute-Leibniz Institute for Experimental Virology (Program Area Antiviral Targets and Strategies) and the German Center for Infection Research. The content is solely the responsibility of the authors and does not necessarily represent the official views or policies of the National Institute of General Medical Sciences, the National Institutes of Health, or the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Besson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000406; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Derrien M, 2004, J GEN VIROL, V85, P1945, DOI 10.1099/vir.0.79867-0; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Gagne K, 2009, BIOL BLOOD MARROW TR, V15, P1366, DOI 10.1016/j.bbmt.2009.06.015; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Jiang YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-405; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lee N, 2003, J IMMUNOL, V171, P5264, DOI 10.4049/jimmunol.171.10.5264; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Noguchi K, 2004, ANTICANCER RES, V24, P3387; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; O'Connor GM, 2015, J VIROL, V89, P5213, DOI 10.1128/JVI.03586-14; Pan FH, 2013, INT J IMMUNOGENET, V40, P369, DOI 10.1111/iji.12047; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Rajalingam Raja, 2011, Korean J Hematol, V46, P216, DOI 10.5045/kjh.2011.46.4.216; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061992; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Trydzenskaya H, 2013, KIDNEY INT, V84, P359, DOI 10.1038/ki.2013.59; Venstrom JM, 2010, BLOOD, V115, P3162, DOI 10.1182/blood-2009-08-236943; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Vivier E, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00018; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wainwright SD, 2000, J IMMUNOL, V164, P319, DOI 10.4049/jimmunol.164.1.319	50	151	153	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1067	1074		10.1038/ni.3513	http://dx.doi.org/10.1038/ni.3513			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27455421	Green Accepted			2022-12-18	WOS:000381832000010
J	Herzner, AM; Hagmann, CA; Goldeck, M; Wolter, S; Kubler, K; Wittmann, S; Gramberg, T; Andreeva, L; Hopfner, KP; Mertens, C; Zillinger, T; Jin, T; Xiao, TS; Bartok, E; Coch, C; Ackermann, D; Hornung, V; Ludwig, J; Barchet, W; Hartmann, G; Schlee, M				Herzner, Anna-Maria; Hagmann, Cristina Amparo; Goldeck, Marion; Wolter, Steven; Kuebler, Kirsten; Wittmann, Sabine; Gramberg, Thomas; Andreeva, Liudmila; Hopfner, Karl-Peter; Mertens, Christina; Zillinger, Thomas; Jin, Tengchuan; Xiao, Tsan Sam; Bartok, Eva; Coch, Christoph; Ackermann, Damian; Hornung, Veit; Ludwig, Janos; Barchet, Winfried; Hartmann, Gunther; Schlee, Martin			Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSE; CYTOSOLIC DNA; INTRACELLULAR DNA; I INTERFERON; BACTERIAL-DNA; RNA; 2ND-MESSENGER; INFLAMMASOME	Cytosolic DNA that emerges during infection with a retrovirus or DNA virus triggers antiviral type I interferon responses. So far, only double-stranded DNA (dsDNA) over 40 base pairs (bp) in length has been considered immunostimulatory. Here we found that unpaired DNA nucleotides flanking short base-paired DNA stretches, as in stem-loop structures of single-stranded DNA (ssDNA) derived from human immunodeficiency virus type 1 (HIV-1), activated the type I interferon-inducing DNA sensor cGAS in a sequence-dependent manner. DNA structures containing unpaired guanosines flanking short (12-to 20-bp) dsDNA (Y-form DNA) were highly stimulatory and specifically enhanced the enzymatic activity of cGAS. Furthermore, we found that primary HIV-1 reverse transcripts represented the predominant viral cytosolic DNA species during early infection of macrophages and that these ssDNAs were highly immunostimulatory. Collectively, our study identifies unpaired guanosines in Y-form DNA as a highly active, minimal cGAS recognition motif that enables detection of HIV-1 ssDNA.	[Herzner, Anna-Maria; Hagmann, Cristina Amparo; Goldeck, Marion; Wolter, Steven; Mertens, Christina; Zillinger, Thomas; Bartok, Eva; Coch, Christoph; Ludwig, Janos; Barchet, Winfried; Hartmann, Gunther; Schlee, Martin] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Kuebler, Kirsten] Univ Bonn, Dept Obstet & Gynecol, Ctr Integrated Oncol, Bonn, Germany; [Wittmann, Sabine; Gramberg, Thomas] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Andreeva, Liudmila; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Zillinger, Thomas; Barchet, Winfried] German Ctr Infect Dis, Cologne, Germany; [Jin, Tengchuan] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ackermann, Damian] Univ Bonn, LIMES Inst, Chem Biol, Bonn, Germany; [Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, Bonn, Germany	University of Bonn; University of Bonn; University of Erlangen Nuremberg; University of Munich; German Center for Infection Research; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Case Western Reserve University; University of Bonn; University of Bonn	Herzner, AM (corresponding author), Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.	aherzner@uni-bonn.de; martin.schlee@uni-bonn.de	Hornung, Veit/C-3565-2012; Goldeck, Marion/AAX-5599-2020; Bartok, Eva/AAM-6274-2020; Schlee, Martin/AAL-1238-2021; Coch, Christoph/AAW-5336-2021; Hartmann, Gunther/P-7492-2017; Xiao, Tsan Sam/A-8590-2010; Ludwig, Janos/I-3544-2013; Gramberg, Thomas/AAW-8706-2020; Zillinger, Thomas/AAD-7320-2020; Hopfner, Karl-Peter/B-6864-2014; Jin, Tengchuan/B-5883-2014	Hornung, Veit/0000-0002-4150-194X; Bartok, Eva/0000-0003-0556-1950; Hartmann, Gunther/0000-0003-1021-2018; Xiao, Tsan Sam/0000-0001-9688-475X; Zillinger, Thomas/0000-0002-0866-4835; Hopfner, Karl-Peter/0000-0002-4528-8357; Jin, Tengchuan/0000-0002-1395-188X; Barchet, Winfried/0000-0002-6745-6606; Kubler, Kirsten/0000-0002-0342-5579; Schlee, Martin/0000-0003-3671-7639; Andreeva, Liudmila/0000-0003-3421-7438; Goldeck, Marion/0000-0003-1899-4763	Deutsche Forschungsgemeinschaft [SFB670, DFG SCHL1930/1-1, SFB704, SFB832, KFO177]; Deutsche Forschungsgemeinschaft Excellence Cluster ImmunoSensation; BONFOR of the University of Bonn; German Center of Infectious Disease	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft Excellence Cluster ImmunoSensation; BONFOR of the University of Bonn; German Center of Infectious Disease	We thank C. Siering for help with circular dichroism spectroscopy, and S. Schmitt for discussions. Supported by Deutsche Forschungsgemeinschaft (SFB670 to M.S., W.B., V.H. and G.H.; DFG SCHL1930/1-1 to M.S.; SFB704 to G.H., V.H. and W.B.; and SFB832 and KFO177 to C. C. and G.H.), the Deutsche Forschungsgemeinschaft Excellence Cluster ImmunoSensation (G.H., M.S., V.H., E.B. and W.B.), BONFOR of the University of Bonn (E.B.) and the German Center of Infectious Disease (G.H., V.H. and W.B.).	Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Bagashev A, 2010, J INTERF CYTOK RES, V30, P843, DOI 10.1089/jir.2010.0017; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fisher TS, 2003, J VIROL, V77, P5837, DOI 10.1128/JVI.77.10.5837-5845.2003; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Galvis AE, 2014, J VIROL, V88, P7054, DOI 10.1128/JVI.00704-14; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Hagmann CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062872; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobsen MR, 2014, CYTOKINE GROWTH F R, V25, P649, DOI 10.1016/j.cytogfr.2014.06.004; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suzuki K, 1999, P NATL ACAD SCI USA, V96, P2285, DOI 10.1073/pnas.96.5.2285; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; van Hemert FJ, 2013, RNA BIOL, V10, P211, DOI 10.4161/rna.22896; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoh SM, 2015, CELL, V161, P1293, DOI 10.1016/j.cell.2015.04.050; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	55	151	160	4	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1025	+		10.1038/ni.3267	http://dx.doi.org/10.1038/ni.3267			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26343537	Green Accepted			2022-12-18	WOS:000361686500007
J	Leon, B; Ballesteros-Tato, A; Browning, JL; Dunn, R; Randall, TD; Lund, FE				Leon, Beatriz; Ballesteros-Tato, Andre; Browning, Jeffrey L.; Dunn, Robert; Randall, Troy D.; Lund, Frances E.			Regulation of T(H)2 development by CXCR5(+) dendritic cells and lymphotoxin-expressing B cells	NATURE IMMUNOLOGY			English	Article							MICE LACKING EXPRESSION; FOLLICULAR HELPER-CELLS; TUMOR-NECROSIS-FACTOR; CD4 T-CELLS; IN-VIVO; LYMPHOID ORGANS; IMMUNE-RESPONSES; CHEMOKINE RECEPTOR; DEPENDENT FASHION; INDUCED ARTHRITIS	Although cognate encounters between antigen-bearing dendritic cells (DCs) that express the chemokine receptor CCR7 and CCR7(+) naive T cells take place in the T cell zone of lymph nodes, it is unknown whether the colocalization of DCs and T cells in the T cell area is required for the generation of effector cells. Here we found that after infection with an intestinal nematode, antigen-bearing DCs and CD4(+) T cells upregulated the chemokine receptor CXCR5 and localized together outside the T cell zone by a mechanism dependent on the chemokine CXCL13, B cells and lymphotoxin. Notably, lymphotoxin-expressing B cells, CXCR5-expressing DCs and T cells, and CXCL13 were also necessary for development of interleukin 4 (IL-4)-producing type 2 helper T cells (T(H)2 cells), which suggests that T(H)2 differentiation can initiate outside the T cell zone.	[Leon, Beatriz; Ballesteros-Tato, Andre; Randall, Troy D.; Lund, Frances E.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Browning, Jeffrey L.] Biogen Idec Inc, Cambridge, MA USA; [Dunn, Robert] Biogen Idec Inc, San Diego, CA USA	University of Rochester; Biogen; Biogen	Lund, FE (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	flund@uab.edu		Browning, Jeffrey/0000-0001-9168-5233; Ballesteros-Tato, Andre/0000-0002-4833-593X	University of Rochester; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [AI068056, AI078907, AI061511]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072689, R01AI068056, R01AI061511, P01AI078907] Funding Source: NIH RePORTER	University of Rochester; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. LaMere, A. Bucher and K. Martin for management of animal breeding and genotyping; the University of Rochester Flow Facility Core for cell sorting; the tetramer facility of the US National Institutes of Health for influenza virus nucleoprotein-specific CD4 tetramers; M. Mohrs (Trudeau Institute) for B6 4get (IL-4 reporter) and 4get mu MT mice; J. Kearney (University of Alabama-Birmingham) for MD4 mu MT mice; and J. Cyster (University of California, San Francisco) for plt mice. Supported by the University of Rochester and the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (AI068056 and AI078907 to F. E. L., and AI061511 to T.D.R.).	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2000, CURR BIOL, V10, pR30, DOI 10.1016/S0960-9822(99)00253-5; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matsuura J, 2010, INFLAMM RES, V59, P123, DOI 10.1007/s00011-009-0078-7; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	44	151	157	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2012	13	7					681	+		10.1038/ni.2309	http://dx.doi.org/10.1038/ni.2309			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	961QZ	22634865	Green Accepted			2022-12-18	WOS:000305483800014
J	Di, AK; Gao, XP; Qian, F; Kawamura, T; Han, J; Hecquet, C; Ye, RD; Vogel, SM; Malik, AB				Di, Anke; Gao, Xiao-Pei; Qian, Feng; Kawamura, Takeshi; Han, Jin; Hecquet, Claudie; Ye, Richard D.; Vogel, Stephen M.; Malik, Asrar B.			The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation	NATURE IMMUNOLOGY			English	Article							PLATELET-ACTIVATING-FACTOR; GATED PROTON CHANNELS; NADPH OXIDASE; OXIDATIVE STRESS; VOLTAGE-DEPENDENCE; RESPIRATORY BURST; ION-CHANNEL; DEPOLARIZATION; SELECTIVITY; NEUTROPHILS	The NADPH oxidase activity of phagocytes and its generation of reactive oxygen species (ROS) is critical for host defense, but ROS overproduction can also lead to inflammation and tissue injury. Here we report that TRPM2, a nonselective and redox-sensitive cation channel, inhibited ROS production in phagocytic cells and prevented endotoxin-induced lung inflammation in mice. TRPM2-deficient mice challenged with endotoxin (lipopolysaccharide) had an enhanced inflammatory response and diminished survival relative to that of wild-type mice challenged with endotoxin. TRPM2 functioned by dampening NADPH oxidase-mediated ROS production through depolarization of the plasma membrane in phagocytes. As ROS also activate TRPM2, our findings establish a negative feedback mechanism for the inactivation of ROS production through inhibition of the membrane potential-sensitive NADPH oxidase.	[Di, Anke; Gao, Xiao-Pei; Qian, Feng; Kawamura, Takeshi; Han, Jin; Hecquet, Claudie; Ye, Richard D.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA; [Di, Anke; Gao, Xiao-Pei; Qian, Feng; Kawamura, Takeshi; Han, Jin; Hecquet, Claudie; Ye, Richard D.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60680 USA.	abmalik@uic.edu	Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Malik, Asrar/0000-0002-8205-7128; Han, Jin/0000-0003-0662-006X	Francis Families Foundation; US National Institutes of Health [P01 HL77806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, P01HL060678] Funding Source: NIH RePORTER	Francis Families Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. E. DeCoursey, N. Demaurex, J.D. Lambeth and M.C. Dinauer for insights; B.A. Miller (Pennsylvania State University School of Medicine) for Trpm2<SUP>-/-</SUP> C57BL/6 mice; and G. Liu and G. Wang for technical assistance. Supported by the Francis Families Foundation (Parker B. Francis Fellowship Program, 2007-2010) and the US National Institutes of Health (P01 HL77806).	Bankers-Fulbright JL, 2003, J CELL SCI, V116, P3221, DOI 10.1242/jcs.00627; Buckley JF, 2006, CARDIOVASC RES, V72, P220, DOI 10.1016/j.cardiores.2006.07.011; Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2010, PHYSIOLOGY, V25, P27, DOI 10.1152/physiol.00039.2009; Demaurex N, 2010, J PHYSIOL-LONDON, V588, P4659, DOI 10.1113/jphysiol.2010.194225; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Iles KE, 2002, IMMUNOL RES, V26, P95, DOI 10.1385/IR:26:1-3:095; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Khan SJ, 2010, AM J PHYSIOL-HEART C, V298, pH66, DOI 10.1152/ajpheart.00501.2009; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Murphy R, 2006, BBA-BIOENERGETICS, V1757, P996, DOI 10.1016/j.bbabio.2006.01.005; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Petheo GL, 2005, BIOCHEM J, V388, P485, DOI 10.1042/BJ20041889; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; RANDRIAMAMPITA C, 1989, FEBS LETT, V249, P199, DOI 10.1016/0014-5793(89)80624-6; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; SUTO MJ, 1991, ANTI-CANCER DRUG DES, V6, P107; Swain SD, 1998, J LEUKOCYTE BIOL, V64, P817, DOI 10.1002/jlb.64.6.817; Umans JG, 1998, KIDNEY INT, V54, P1063, DOI 10.1046/j.1523-1755.1998.00090.x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zorn-Pauly K, 2007, SHOCK, V28, P655, DOI 10.1097/shk.0b013e31812386bf	50	151	158	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					29	U130		10.1038/ni.2171	http://dx.doi.org/10.1038/ni.2171			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22101731	Green Accepted, Green Submitted			2022-12-18	WOS:000298412800008
J	Wencker, M; Turchinovich, G; Barros, RD; Deban, L; Jandke, A; Cope, A; Hayday, AC				Wencker, Melanie; Turchinovich, Gleb; Barros, Rafael Di Marco; Deban, Livija; Jandke, Anett; Cope, Andrew; Hayday, Adrian C.			Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness	NATURE IMMUNOLOGY			English	Article							LYMPHOID STRESS-SURVEILLANCE; INTERFERON-GAMMA; CUTTING EDGE; SELECTION; ACTIVATION; INDUCTION; ANERGY; INTERLEUKIN-17; IDENTIFICATION; LOCALIZATION	The subclassification of immunology into innate and adaptive immunity is challenged by innate-like T lymphocytes that use innate receptors to respond rapidly to stress despite expressing T cell antigen receptors (TCRs), a hallmark of adaptive immunity. In studies that explain how such cells can straddle innate and adaptive immunity, we found that signaling via antigen receptors, whose conventional role is to facilitate clonal T cell activation, was critical for the development of innate-like T cells but then was rapidly attenuated, which accommodated the cells' innate responsiveness. These findings permitted the identification of a previously unknown innate-like T cell subset and indicate that T cell hyporesponsiveness, a state traditionally linked to tolerance, may be fundamental to T cells entering the innate compartment and thereby providing lymphoid stress surveillance.	[Wencker, Melanie; Turchinovich, Gleb; Barros, Rafael Di Marco; Deban, Livija; Jandke, Anett; Hayday, Adrian C.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Wencker, Melanie; Turchinovich, Gleb; Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London, England; [Barros, Rafael Di Marco] UCL, London, England; [Cope, Andrew] Kings Coll London, Ctr Mol & Cell Biol Inflammat, London, England	Cancer Research UK; University of London; King's College London; University of London; University College London; University of London; King's College London	Hayday, AC (corresponding author), Canc Res UK London Res Inst, London WC2A 3PX, England.	adrian.hayday@kcl.ac.uk	Jandke, Anett/AAK-4545-2021; Di Marco Barros, Rafael/GXZ-6688-2022; Wencker, Mélanie/M-3849-2014	Wencker, Mélanie/0000-0003-4200-0079; Jandke, Anett/0000-0002-7681-7952; Di Marco Barros, Rafael/0000-0002-6484-2317; Cope, Andrew/0000-0001-6735-5496; HAYDAY, ADRIAN/0000-0002-9495-5793	Cancer Research UK; Marie Curie Actions; University College London MBPhD programme; Wellcome Trust; Cancer Research UK [19309] Funding Source: researchfish; Medical Research Council [1415536] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Marie Curie Actions(European Commission); University College London MBPhD programme; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Sakaguchi (Osaka University) for SKG mice; K. Hogquist (University of Minnesota) for Nur77-GFP mice; and our colleagues, including M.-L. Michel, P. Vantourout, O. Sobolev, R. Hart, M. Swamy, B. Silva-Santos, D. Pennington, G. LeClercq, P. Parker and M. Saini and the staff of the flow cytometry and biological services units of the London Research Institute and of the Peter Gorer Department of Immunobiology, King's College London, for help and discussions. Supported by Cancer Research UK, Marie Curie Actions (L.D.), the University College London MBPhD programme (R.D.M.B.) and the Wellcome Trust (A.C.H.).	Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hannier S, 1998, J IMMUNOL, V161, P4058; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jin Y, 2010, J IMMUNOL, V185, P7156, DOI 10.4049/jimmunol.1002781; Kisielow J, 2011, BLOOD, V118, P6591, DOI 10.1182/blood-2011-05-352732; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MallickWood CA, 1996, P NATL ACAD SCI USA, V93, P9704, DOI 10.1073/pnas.93.18.9704; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; OSBORNE BA, 1994, IMMUNOL REV, V142, P301, DOI 10.1111/j.1600-065X.1994.tb00894.x; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vahl JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001589; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; Weber KS, 2008, J IMMUNOL, V180, P1442, DOI 10.4049/jimmunol.180.3.1442; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Wong GW, 2010, SEMIN IMMUNOL, V22, P228, DOI 10.1016/j.smim.2010.04.005; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zheng Y, 2013, MOL IMMUNOL, V55, P283, DOI 10.1016/j.molimm.2013.03.006; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	52	150	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					80	87		10.1038/ni.2773	http://dx.doi.org/10.1038/ni.2773			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24241693	Green Accepted			2022-12-18	WOS:000328800500015
J	Rudra, D; Egawa, T; Chong, MMW; Treuting, P; Littman, DR; Rudensky, AY				Rudra, Dipayan; Egawa, Takeshi; Chong, Mark M. W.; Treuting, Piper; Littman, Dan R.; Rudensky, Alexander Y.			Runx-CBF beta complexes control expression of the transcription factor Foxp3 in regulatory T cells	NATURE IMMUNOLOGY			English	Article							RECEPTOR-DELTA-ENHANCER; HELPER TYPE-1 CELLS; CORE-BINDING-FACTOR; GENE-EXPRESSION; TARGET GENES; C-MYB; PROTEINS; AUTOIMMUNITY; HYPERTENSION; RECOGNITION	The transcription factor Foxp3 has an indispensable role in establishing stable transcriptional and functional programs of regulatory T cells (T-reg cells). Loss of Foxp3 expression in mature T-reg cells results in a failure of suppressor function, yet the molecular mechanisms that ensure steady, heritable Foxp3 expression in the T-reg cell lineage remain unknown. Using T-reg cell-specific gene targeting, we found that complexes of the transcription factors Runx and CBF beta were required for maintenance of Foxp3 mRNA and protein expression in T-reg cells. Consequently, mice lacking CBF beta exclusively in the T-reg cell lineage had a moderate lymphoproliferative syndrome. Thus, Runx-CBF beta complexes maintain stable high expression of Foxp3 and serve as an essential determinant of T-reg cell lineage stability.	[Rudra, Dipayan; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Egawa, Takeshi; Chong, Mark M. W.; Littman, Dan R.] NYU, Sch Med, New York, NY USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Rudra, Dipayan; Chong, Mark M. W.; Littman, Dan R.; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; New York University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org	Chong, Mark/H-6684-2016; Treuting, Piper M./AAB-2721-2019; Rudra, Dipayan/AAZ-5426-2020; Rudra, Dipayan/B-6660-2012	Chong, Mark/0000-0002-3701-7397; Treuting, Piper M./0000-0002-1812-1519; Rudra, Dipayan/0000-0002-9667-5891; 	National Institutes of Health; Arthritis Foundation; Leukemia and Lymphoma Society; Helen and Martin Kimmel Center for Stem Cell Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI061816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Helen and Martin Kimmel Center for Stem Cell Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tone (University of Pennsylvania) for the reporter construct containing the Foxp3 promoter; K. Forbush, T. Chu and L. Karpik for managing the mouse colony; and I. Taniuchi, Y. Tone and M. Tone for advice. Supported by the National Institutes of Health (A. Y. R.), the Arthritis Foundation (D. R.), the Leukemia and Lymphoma Society (T. E.), the Helen and Martin Kimmel Center for Stem Cell Biology (M. M. W. C.) and the Howard Hughes Medical Institute (A. Y. R. and D. R. L).	Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Speck NA, 2001, CURR OPIN HEMATOL, V8, P192, DOI 10.1097/00062752-200107000-00002; SUN WW, 1995, J VIROL, V69, P4941, DOI 10.1128/JVI.69.8.4941-4949.1995; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taraseviciene-Stewart L, 2007, AM J RESP CRIT CARE, V175, P1280, DOI 10.1164/rccm.200608-1189OC; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	34	150	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1170	U53		10.1038/ni.1795	http://dx.doi.org/10.1038/ni.1795			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19767756	Green Accepted			2022-12-18	WOS:000270955900009
J	Sapoznikov, A; Pewzner-Jung, Y; Kalchenko, V; Krauthgamer, R; Shachar, I; Jung, S				Sapoznikov, Anita; Pewzner-Jung, Yael; Kalchenko, Vyacheslav; Krauthgamer, Rita; Shachar, Idit; Jung, Steffen			Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches	NATURE IMMUNOLOGY			English	Article							MIGRATION INHIBITORY FACTOR; CD8(+) T-CELLS; INDEPENDENT RESPONSES; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; DEFICIENT MICE; MEMORY; ACTIVATION; DIFFERENTIATION; PROLIFERATION	Beyond its established function in hematopoiesis, the bone marrow hosts mature lymphocytes and acts as a secondary lymphoid organ in the initiation of T cell and B cell responses. Here we report the characterization of bone marrow-resident dendritic cells (bmDCs). Multiphoton imaging showed that bmDCs were organized into perivascular clusters that enveloped blood vessels and were seeded with mature B lymphocytes and T lymphocytes. Conditional ablation of bmDCs in these bone marrow immune niches led to the specific loss of mature B cells, a phenotype that could be reversed by overexpression of the antiapoptotic factor Bcl-2 in B cells. The presence of bmDCs promoted the survival of recirculating B cells in the bone marrow through the production of macrophage migration-inhibitory factor. Thus, bmDCs are critical for the maintenance of recirculating B cells in the bone marrow.	[Sapoznikov, Anita; Pewzner-Jung, Yael; Krauthgamer, Rita; Shachar, Idit; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Kalchenko, Vyacheslav] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Kalchenko, Vyacheslav/F-2924-2012; Jung, Steffen/K-1409-2012; Pewzner, Faivish/I-6225-2017	Jung, Steffen/0000-0003-4290-5716; Pewzner, Faivish/0000-0002-7490-8121; Kalchenko, Vyacheslav/0000-0002-3166-7049; Sapoznikov, Anita/0000-0002-2543-7837				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Feuerer M, 2004, INT J ONCOL, V25, P867; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Floyd H, 2000, IMMUNOLOGY, V101, P342, DOI 10.1046/j.1365-2567.2000.00103.x; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	56	150	154	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					388	395		10.1038/ni1571	http://dx.doi.org/10.1038/ni1571			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18311142				2022-12-18	WOS:000254123200014
J	Gallo, EM; Cante-Barrett, K; Crabtree, GR				Gallo, EM; Cante-Barrett, K; Crabtree, GR			Lymphocyte calcium signaling from membrane to nucleus	NATURE IMMUNOLOGY			English	Review							ALDRICH-SYNDROME PROTEIN; B-CELL DEVELOPMENT; MICROTUBULE-ORGANIZING CENTER; CD28 COSTIMULATORY SIGNAL; T-CELLS; ANTIGEN RECEPTOR; IMMUNOLOGICAL SYNAPSE; TRANSCRIPTION FACTOR; KINASE-IV; MOLECULAR CHARACTERIZATION	Ca2+ signals control a variety of lymphocyte responses, ranging from short-term cytoskeletal modifications to long-term changes in gene expression. The identification of molecules and channels that modulate Ca2+ entry into T and B lymphocytes has both provided details of the molecular events leading to immune responses and raised controversy. Here we review studies of the pathways that allow Ca2+ entry, the function of Ca2+ in the regulation of cell polarity and motility and the principles by which Ca2+-dependent transcription regulates lymphocyte function.	Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Program Immunol, Stanford, CA 94305 USA.	crabtree@stanford.edu		Cante-Barrett, Kirsten/0000-0003-0418-8445	NIAID NIH HHS [AI-60037] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akha AAS, 1996, J BIOL CHEM, V271, P7297, DOI 10.1074/jbc.271.13.7297; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brunner MC, 1999, J IMMUNOL, V162, P5813; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Eddy RJ, 2000, J CELL SCI, V113, P1287; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Esser MT, 1998, J EXP MED, V187, P1057, DOI 10.1084/jem.187.7.1057; Esser MT, 1996, J EXP MED, V183, P1697, DOI 10.1084/jem.183.4.1697; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FREEDMAN BD, 1992, J IMMUNOL, V149, P3784; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gamberucci A, 2002, BIOCHEM J, V364, P245, DOI 10.1042/bj3640245; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Gomes B, 2004, CRIT REV IMMUNOL, V24, P425, DOI 10.1615/CritRevImmunol.v24.i6.30; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang W, 2005, J IMMUNOL, V174, P2602, DOI 10.4049/jimmunol.174.5.2602; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; Janssen E, 2004, J IMMUNOL, V172, P6810, DOI 10.4049/jimmunol.172.11.6810; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; Koonpaew S, 2004, J BIOL CHEM, V279, P11229, DOI 10.1074/jbc.M311394200; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Makowska A, 2000, EUR J BIOCHEM, V267, P877, DOI 10.1046/j.1432-1327.2000.01066.x; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mandeville JTH, 1997, J CELL PHYSIOL, V171, P168, DOI 10.1002/(SICI)1097-4652(199705)171:2<168::AID-JCP7>3.0.CO;2-M; Matsushita T, 2004, BIOCHEM BIOPH RES CO, V325, P1163, DOI 10.1016/j.bbrc.2004.10.147; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Miletic AV, 2003, CURR OPIN IMMUNOL, V15, P261, DOI 10.1016/S0952-7915(03)00054-2; Mills JW, 2000, EXP CELL RES, V261, P209, DOI 10.1006/excr.2000.5032; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; PREMACK BA, 1994, J IMMUNOL, V152, P5226; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Randriamampita C, 2004, BIOL CELL, V96, P69, DOI 10.1016/j.biolcel.2003.10.008; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; SERAFINI AT, 1995, IMMUNITY, V3, P239, DOI 10.1016/1074-7613(95)90093-4; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Stankunas K, 1999, COLD SPRING HARB SYM, V64, P505, DOI 10.1101/sqb.1999.64.505; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Turner M, 2002, BIOCHEM SOC T, V30, P812, DOI 10.1042/bst0300812; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	165	150	159	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					25	32		10.1038/ni1295	http://dx.doi.org/10.1038/ni1295			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357855				2022-12-18	WOS:000234139700015
J	Zuniga, EI; McGavern, DB; Pruneda-Paz, JL; Teng, C; Oldstone, MBA				Zuniga, EI; McGavern, DB; Pruneda-Paz, JL; Teng, C; Oldstone, MBA			Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; IFN REGULATORY FACTOR-2; ADAPTIVE IMMUNITY; LYMPHOCYTE INTERACTIONS; PREDENDRITIC CELLS; I INTERFERON; FLT3 LIGAND; B CELLS; MOUSE; PROGENITORS	Two subsets of dendritic cell (DCs), plasmacytoid (p) and myeloid (m) DCs, have been described in humans and mice. These subsets are known to have divergent roles during an immune response, but their developmental course is unclear. Here we report that virus infection induces bone marrow pDCs to differentiate into mDCs, thereby undergoing profound phenotypic and functional changes including the acquisition of enhanced antigen-presenting capacity and the ability to recognize different microbial structures through Toll-like receptor 4. The conversion of pDCs into mDCs is also induced by the injection of double-stranded RNA and requires type I interferons. Our results establish a precursor-product developmental relationship between these two DC subsets and highlight unexpected plasticity of bone marrow pDCs.	Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Scripps Research Institute	Zuniga, EI (corresponding author), Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA.	ezuniga@scripps.edu	McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927, R37AI009484, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048866] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045927, AI45927, AI09484, R01 AI009484] Funding Source: Medline; NINDS NIH HHS [R21 NS048866] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED R, 1988, J EXP MED, V167, P1719, DOI 10.1084/jem.167.5.1719; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Ardavin Carlos, 2004, Immunity, V20, P17, DOI 10.1016/S1074-7613(03)00352-2; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Beignon AS, 2003, NAT IMMUNOL, V4, P939, DOI 10.1038/ni1003-939; Bjorck P, 1998, J IMMUNOL, V161, P5795; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Cerundolo V, 2004, NAT IMMUNOL, V5, P7, DOI 10.1038/ni0104-7; Chaperot L, 2001, BLOOD, V97, P3210, DOI 10.1182/blood.V97.10.3210; Comeau MR, 2002, J IMMUNOL, V169, P75, DOI 10.4049/jimmunol.169.1.75; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kadowaki N, 2002, HUM IMMUNOL, V63, P1126, DOI 10.1016/S0198-8859(02)00751-6; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; KOO CH, 1990, AM J CLIN PATHOL, V93, P822, DOI 10.1093/ajcp/93.6.822; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee CK, 2001, J IMMUNOL, V166, P5964, DOI 10.4049/jimmunol.166.10.5964; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Mazzoni A, 2004, J LEUKOCYTE BIOL, V75, P721, DOI 10.1189/jlb.1003482; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; OLDSTONE MBA, 1988, VIROLOGY, V164, P507, DOI 10.1016/0042-6822(88)90565-X; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152	44	150	157	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1227	1234		10.1038/ni1136	http://dx.doi.org/10.1038/ni1136			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15531885	Green Accepted			2022-12-18	WOS:000225353500011
J	Doucey, MA; Scarpellino, L; Zimmer, J; Guillaume, P; Luescher, IF; Bron, C; Held, W				Doucey, MA; Scarpellino, L; Zimmer, J; Guillaume, P; Luescher, IF; Bron, C; Held, W			Cis association of Ly49A with MHC class I restricts natural killer cell inhibition	NATURE IMMUNOLOGY			English	Article							RECEPTOR LY49A; NK CELLS; HEMATOPOIETIC-CELLS; MISSING SELF; RECOGNITION; EXPRESSION; MOLECULES; BINDING; LIGAND; ACTIVATION	Natural killer (NK) cell function is negatively regulated by inhibitory receptors interacting with major histocompatibility complex class I molecules expressed on target cells. Here we show that the inhibitory Ly49A NK cell receptor not only binds to its H-2D(d) ligand expressed on potential target cells (in trans) but also is constitutively associated with H-2D(d) in cis (on the same cell). Cis association and trans interaction occur through the same binding site. Consequently, cis association restricts the number of Ly49A receptors available for binding of H-2D(d) on target cells and reduces NK cell inhibition through Ly49A. By lowering the threshold at which NK cell activation exceeds NK cell inhibition, cis interaction allows optimal discrimination of normal and abnormal host cells.	Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne	Held, W (corresponding author), Ludwig Inst Canc Res, Lausanne Branch, Ch Boveresses 155, CH-1066 Epalinges, Switzerland.	wheld@isrec.unil.ch		Zimmer, Jacques/0000-0002-7118-6944				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Dorfman JR, 1996, EUR J IMMUNOL, V26, P151, DOI 10.1002/eji.1830260123; GLAS R, 1992, P NATL ACAD SCI USA, V89, P11381, DOI 10.1073/pnas.89.23.11381; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kase A, 1998, J IMMUNOL, V161, P6133; KVIST S, 1978, SCAND J IMMUNOL, V7, P265, DOI 10.1111/j.1365-3083.1978.tb00454.x; Labelle JL, 2002, LEUKEMIA LYMPHOMA, V43, P1637, DOI 10.1080/1042819021000002974; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lowin-Kropf B, 2000, J IMMUNOL, V165, P91, DOI 10.4049/jimmunol.165.1.91; Lowin-Kropf B, 2002, EUR J IMMUNOL, V32, P773, DOI 10.1002/1521-4141(200203)32:3<773::AID-IMMU773>3.0.CO;2-U; Matsumoto N, 1998, IMMUNITY, V8, P245, DOI 10.1016/S1074-7613(00)80476-8; Matsumoto N, 2001, INT IMMUNOL, V13, P615, DOI 10.1093/intimm/13.5.615; Matsumoto N, 2001, J EXP MED, V193, P147, DOI 10.1084/jem.193.2.147; Michaelsson J, 2001, J IMMUNOL, V166, P7327, DOI 10.4049/jimmunol.166.12.7327; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Sentman C L, 1995, Semin Immunol, V7, P109, DOI 10.1006/smim.1995.0015; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; STORKUS WJ, 1993, J IMMUNOL, V151, P3719; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Waldenstrom M, 1998, EUR J IMMUNOL, V28, P2872, DOI 10.1002/(SICI)1521-4141(199809)28:09<2872::AID-IMMU2872>3.0.CO;2-3; Wang J, 2002, J BIOL CHEM, V277, P1433, DOI 10.1074/jbc.M110316200; Wilson CS, 1999, J IMMUNOL, V162, P3933; Wu MF, 1997, J IMMUNOL, V158, P1628; Zimmer J, 2001, J EXP MED, V194, P1531, DOI 10.1084/jem.194.10.1531	48	150	151	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					328	336		10.1038/ni1043	http://dx.doi.org/10.1038/ni1043			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14973437				2022-12-18	WOS:000189344600016
J	Hernanz-Falcon, P; Rodriguez-Frade, JM; Serrano, A; Juan, D; del Sol, A; Soriano, SF; Roncal, F; Gomez, L; Valencia, A; Martinez-A, C; Mellado, M				Hernanz-Falcon, P; Rodriguez-Frade, JM; Serrano, A; Juan, D; del Sol, A; Soriano, SF; Roncal, F; Gomez, L; Valencia, A; Martinez-A, C; Mellado, M			Identification of amino acid residues crucial for chemokine receptor dimerization	NATURE IMMUNOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; ENERGY-TRANSFER FRET; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; CORRELATED MUTATIONS; GABA(B) RECEPTOR; HIV-1 INFECTION; ACTIVATION; DOMAIN; CCR5	Chemokines coordinate leukocyte trafficking by promoting oligomerization and signaling by G protein-coupled receptors; however, it is not known which amino acid residues of the receptors participate in this process. Bioinformatic analysis predicted that Ile52 in transmembrane region-1 (TM1) and Val150 in TM4 of the chemokine receptor CCR5 are key residues in the interaction surface between CCR5 molecules. Mutation of these residues generated nonfunctional receptors that could not dimerize or trigger signaling. In vitro and in vivo studies in human cell lines and primary T cells showed that synthetic peptides containing these residues blocked responses induced by the CCR5 ligand CCL5. Fluorescence resonance energy transfer showed the presence of preformed, ligand-stabilized chemokine receptor oligomers. This is the first description of the residues involved in chemokine receptor dimerization, and indicates a potential target for the modification of chemokine responses.	Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain; Natl Biotechnol Ctr, Prot Design Grp, E-28049 Madrid, Spain		Martinez-A, C (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, Campus Univ Cantoblanco, E-28049 Madrid, Spain.	cmartineza@cnb.uam.es	Valencia, Alfonso/I-3127-2015; Frade, Jose Miguel Rodriguez/K-4266-2014; Mellado, Mario/M-9893-2014; Juan, David/AAA-2614-2020; del Sol, Antonio/M-7431-2017	Valencia, Alfonso/0000-0002-8937-6789; Frade, Jose Miguel Rodriguez/0000-0002-7753-1462; Mellado, Mario/0000-0001-6325-1630; Juan, David/0000-0003-1912-9667; Serrano, Antonio/0000-0003-1993-640X; del Sol, Antonio/0000-0002-9926-617X				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.97.7.3684; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Filizola M, 2002, BIOPOLYMERS, V66, P317, DOI 10.1002/bip.10311; Filizola M, 2002, PROTEIN ENG, V15, P881, DOI 10.1093/protein/15.11.881; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Gu C, 2002, EUR J BIOCHEM, V269, P413, DOI 10.1046/j.0014-2956.2001.02708.x; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Mellado M, 1998, J IMMUNOL, V161, P805; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Milligan G, 2001, J CELL SCI, V114, P1265; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Onuffer JJ, 2002, TRENDS PHARMACOL SCI, V23, P459, DOI 10.1016/S0165-6147(02)02064-3; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Rodriguez-Frade JM, 2001, TRENDS IMMUNOL, V22, P612, DOI 10.1016/S1471-4906(01)02036-1; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Vakser IA, 2002, METHOD ENZYMOL, V343, P313; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	54	150	158	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					216	223		10.1038/ni1027	http://dx.doi.org/10.1038/ni1027			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14716309				2022-12-18	WOS:000188512000018
J	Flemming, A; Brummer, T; Reth, M; Jumaa, H				Flemming, A; Brummer, T; Reth, M; Jumaa, H			The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion	NATURE IMMUNOLOGY			English	Article							SURROGATE LIGHT-CHAIN; MOUSE BONE-MARROW; ANTIGEN-RECEPTOR; SIGNAL-TRANSDUCTION; DEVELOPMENTAL PROGRESSION; ALLELIC EXCLUSION; TYROSINE KINASE; LINKER PROTEIN; ACTIVATED RAS; SH2 DOMAIN	Mice deficient in the adaptor protein SLP-65 (also known as BLNK) have reduced numbers of mature B cells, but an increased pre-B cell compartment. We show here that compared to wild-type cells, SLP-65(-/-) pre-B cells show an enhanced ex vivo proliferative capacity. This proliferation requires interleukin 7 and expression of the pre-B cell receptor (pre-BCR). In addition, SLP-65(-/-) mice have a high incidence of pre-B cell lymphoma. Reintroduction of SLP-65 into SLP-65(-/-) pre-B cells led to preBCR down-regulation and enhanced differentiation. Our results indicate that SLP-65 regulates a developmental program that promotes differentiation and limits pre-B cell expansion, thereby acting as a tumor suppressor.	Univ Freiburg, Inst Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Reth, M (corresponding author), Univ Freiburg, Inst Biol 3, Stuebeweg 51, D-79108 Freiburg, Germany.		Brummer, Tilman/B-6218-2016; Brummer, Tilman/AAA-9428-2020	Brummer, Tilman/0000-0003-4387-7905; Brummer, Tilman/0000-0003-4387-7905				Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; Craxton A, 1999, ADV IMMUNOL, V73, P79, DOI 10.1016/S0065-2776(08)60786-5; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Gugasyan R, 2000, IMMUNOL REV, V176, P134; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; Karasuyama H, 1997, IMMUNOL CELL BIOL, V75, P209, DOI 10.1038/icb.1997.32; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Martensson IL, 2000, IMMUNOLOGY, V101, P435, DOI 10.1046/j.1365-2567.2000.00151.x; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; Nagaoka H, 2000, J EXP MED, V192, P171, DOI 10.1084/jem.192.2.171; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ray RJ, 1998, J IMMUNOL, V160, P5886; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Shaw AC, 1999, J EXP MED, V189, P123, DOI 10.1084/jem.189.1.123; Stephan RP, 2001, J IMMUNOL, V167, P3734, DOI 10.4049/jimmunol.167.7.3734; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; ten Boekel E, 1998, IMMUNITY, V8, P199; Tomlinson MG, 2000, IMMUNOL TODAY, V21, P584, DOI 10.1016/S0167-5699(00)01716-3; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	49	150	152	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					38	43		10.1038/ni862	http://dx.doi.org/10.1038/ni862			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12436112				2022-12-18	WOS:000180053000012
J	Cannon, JP; Haire, RN; Litman, GW				Cannon, JP; Haire, RN; Litman, GW			Identification of diversified genes that contain immunoglobulin-like variable regions in a protochordate	NATURE IMMUNOLOGY			English	Article							CHITIN-BINDING ACTIVITY; T-CELL; RECEPTOR GENES; ANTIMICROBIAL PEPTIDES; MULTIGENE FAMILY; IMMUNE-SYSTEM; SUPERFAMILY; EVOLUTION; PROTEIN; MEMBER	The evolutionary origin of adaptive immune receptors is not understood below the phylogenetic level of the jawed vertebrates. We describe here a strategy for the selective cloning of cDNAs encoding secreted or transmembrane proteins that uses a bacterial plasmid (Amptrap) with a defective lactamase gene. This method requires knowledge of only a single target motif that corresponds to as few as three amino acids; it was validated with major histocompatibility complex genes from a cartilaginous fish. Using this approach, we identified families of genes encoding secreted proteins with two diversified immunoglobulin-like variable (V) domains and a chitin-binding domain in amphioxus, a protochordate. Thus, multigenic families encoding diversified V regions exist in a species lacking an adaptive immune response.	H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA; Univ S Florida, Coll Med, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Litman, GW (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, 12902 Magnolia Ave, Tampa, FL 33612 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI023338, R37AI023338, R01AI023338] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23338] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; CHENCHIK A, 1998, GENE CLONING ANAL RT, P305; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hawke NA, 1997, BIOTECHNIQUES, V23, P619, DOI 10.2144/97234bm13; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Iwanaga S, 1998, J BIOCHEM, V123, P1; JACKSON DG, 1992, EUR J IMMUNOL, V22, P1157, DOI 10.1002/eji.1830220508; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Laird DJ, 2000, P NATL ACAD SCI USA, V97, P6924, DOI 10.1073/pnas.97.13.6924; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Okamura K, 1997, IMMUNITY, V7, P777, DOI 10.1016/S1074-7613(00)80396-9; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pancer Z, 1998, GENE, V207, P227, DOI 10.1016/S0378-1119(97)00631-8; Pancer Z, 1997, DNA CELL BIOL, V16, P801, DOI 10.1089/dna.1997.16.801; Pancer Z, 1996, IMMUNOGENETICS, V45, P69, DOI 10.1007/s002510050169; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; RAST JP, 1995, IMMUNOGENETICS, V42, P204, DOI 10.1007/BF00191226; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sarwal MM, 1996, GENOME RES, V6, P1207, DOI 10.1101/gr.6.12.1207; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; Strong SJ, 1999, P NATL ACAD SCI USA, V96, P15080, DOI 10.1073/pnas.96.26.15080; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasta GR, 2001, ADV EXP MED BIOL, V484, P275; WILKINSON DG, 1999, IN SITU HYBRIDIZATIO; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Yoder JA, 2001, P NATL ACAD SCI USA, V98, P6771, DOI 10.1073/pnas.121101598; Zhang SM, 2001, IMMUNOGENETICS, V53, P684, DOI 10.1007/s00251-001-0386-8	40	150	158	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1200	1207		10.1038/ni849	http://dx.doi.org/10.1038/ni849			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12415263				2022-12-18	WOS:000179467800019
J	Doody, GM; Bell, SE; Vigorito, E; Clayton, E; McAdam, S; Tooze, R; Fernandes, C; Lee, IJ; Turner, M				Doody, GM; Bell, SE; Vigorito, E; Clayton, E; McAdam, S; Tooze, R; Fernandes, C; Lee, IJ; Turner, M			Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation	NATURE IMMUNOLOGY			English	Article							EXCHANGE FACTOR VAV; HEAT-STABLE ANTIGEN(HI); T-CELL; DEFICIENT MICE; RHO GTPASES; LYMPHOCYTE; FAMILY; REGULATOR; LACKING; IMMUNOGLOBULIN	B and T lymphocytes develop normally in mice lacking the guanine nucleotide exchange factor Vav-2, However, the immune responses to type II thymus-independent antigen as well as the primary response to thymus-dependent (TD) antigen are defective. Vav-2-deficient mice are also defective in their ability to switch immunoglobulin class, form germinal centers and generate secondary immune responses to TD antigens, Mice lacking both Vav-1 and Vav-2 contain reduced numbers of B lymphocytes and display a maturational block in the development of mature B cells. B cells from Vav-1(-/-)Vav-2(-/-) mice respond poorly to antigen receptor triggering, both in terms of proliferation and calcium release. These studies show the importance of Vav-2 in humoral immune responses and B cell maturation.	Babraham Inst, Mol Immunol Programme, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England; Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; NIAAA, Neurogenet Lab, NIH, Rockville, MD 20906 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Turner, M (corresponding author), Babraham Inst, Mol Immunol Programme, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England.	martin.turner@bbsrc.ac.uk	Turner, Martin/N-9976-2014; Doody, Gina/AAN-8246-2021	Turner, Martin/0000-0002-3801-9896; Doody, Gina/0000-0003-0665-6759; Tooze, Reuben/0000-0003-2915-7119				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Bachmann MF, 1999, J IMMUNOL, V163, P137; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gardby E, 2000, EUR J IMMUNOL, V30, P1861, DOI 10.1002/1521-4141(200007)30:7<1861::AID-IMMU1861>3.0.CO;2-A; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Henning SW, 1998, CURR OPIN IMMUNOL, V10, P322, DOI 10.1016/S0952-7915(98)80171-4; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Sato S, 1997, J IMMUNOL, V158, P4662; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Schuebel KE, 1996, ONCOGENE, V13, P363; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	39	150	152	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					542	547		10.1038/88748	http://dx.doi.org/10.1038/88748			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376342				2022-12-18	WOS:000169078000018
J	Montecino-Rodriguez, E; Leathers, H; Dorshkind, K				Montecino-Rodriguez, E; Leathers, H; Dorshkind, K			Bipotential B-macrophage progenitors are present in adult bone marrow	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE FETAL LIVER; DENDRITIC CELLS; LYMPHOCYTE-B; MONOCLONAL-ANTIBODIES; STROMAL CELLS; PRO-B; LINEAGE; DIFFERENTIATION; EXPRESSION	According to the current model of adult hematopoiesis, differentiation of pluripotential hematopoietic stem cells into common myeloid- and lymphoid-committed progenitors establishes an early separation between the myeloid and lymphoid lineages. This report describes a rare and previously unidentified CD45R-CD19(+) B cell progenitor population in postnatal bone marrow that can also generate macrophages. In addition to the definition of this B-lineage intermediate, the data indicate that a developmental relationship between the B and macrophage lineages is retained during postnatal hematopoiesis.	Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu		Montecino Rodriguez, Encarnacion/0000-0002-2826-7503	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060658] Funding Source: NIH RePORTER; NCI NIH HHS [CA16042] Funding Source: Medline; NHLBI NIH HHS [HL60658] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Bjorck P, 1998, J IMMUNOL, V161, P5795; Borrello MA, 1996, IMMUNOL TODAY, V17, P471, DOI 10.1016/0167-5699(96)20031-B; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; DAVIDSON WF, 1992, ANN NY ACAD SCI, V651, P112; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DORSHKIND K, 1986, J IMMUNOL, V136, P422; DZIERZAK E, 1990, MOL BIOL B CELL T CE, P3; GREAVES MF, 1986, BLOOD, V67, P1; HARA H, 1990, INT IMMUNOL, V2, P691, DOI 10.1093/intimm/2.8.691; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HESTDAL K, 1991, J IMMUNOL, V147, P22; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; JOHNSON A, 1986, BLOOD, V68, P1348; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kelleher P, 1998, INT IMMUNOL, V10, P749, DOI 10.1093/intimm/10.6.749; KIERNEY PC, 1987, BLOOD, V70, P1418; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; MARTIN PA, 1995, APPL NURS RES, V8, P50; MCKEARN JP, 1984, J IMMUNOL, V132, P332; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; MILLER BA, 1985, J IMMUNOL, V134, P3286; MOORE T, 1994, J IMMUNOL, V153, P4978; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PHILLIPS RA, 1988, CURR TOP MICROBIOL, V141, P11; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; WEILBAECHER K, 1991, BLOOD, V78, P945; WHITLOCK C, 1982, P NATL ACAD SCI USA, V79, P308; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; WINEMAN JP, 1992, BLOOD, V80, P1717	50	150	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					83	88		10.1038/83210	http://dx.doi.org/10.1038/83210			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135583				2022-12-18	WOS:000166261500019
J	Geng, J; Sun, XF; Wang, P; Zhang, SH; Wang, XZ; Wu, HT; Hong, LX; Xie, CC; Li, X; Zhao, H; Liu, QX; Jiang, MT; Chen, QH; Zhang, JJ; Li, Y; Song, SY; Wang, HR; Zhou, RB; Johnson, RL; Chien, KY; Lin, SC; Han, JH; Avruch, J; Chen, LF; Zhou, DW				Geng, Jing; Sun, Xiufeng; Wang, Ping; Zhang, Shihao; Wang, Xiaozhen; Wu, Hongtan; Hong, Lixin; Xie, Changchuan; Li, Xun; Zhao, Hao; Liu, Qingxu; Jiang, Mingting; Chen, Qinghua; Zhang, Jinjia; Li, Yang; Song, Siyang; Wang, Hong-Rui; Zhou, Rongbin; Johnson, Randy L.; Chien, Kun-Yi; Lin, Sheng-Cai; Han, Jiahuai; Avruch, Joseph; Chen, Lanfen; Zhou, Dawang			Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; HIPPO PATHWAY; SIGNALING PATHWAY; PROTEIN-KINASE; RAC GTPASE; T-CELLS; IMMUNODEFICIENCY; PHOSPHORYLATION; RECOGNITION; ACTIVATION	Mitochondria need to be juxtaposed to phagosomes for the synergistic production of ample reactive oxygen species (ROS) in phagocytes to kill pathogens. However, how phagosomes transmit signals to recruit mitochondria has remained unclear. Here we found that the kinases Mst1 and Mst2 functioned to control ROS production by regulating mitochondrial trafficking and mitochondrion-phagosome juxtaposition. Mst1 and Mst2 activated the GTPase Rac to promote Toll-like receptor (TLR)-triggered assembly of the TRAF6-ECSIT complex that is required for the recruitment of mitochondria to phagosomes. Inactive forms of Rac, including the human Rac2(D57N) mutant, disrupted the TRAF6-ECSIT complex by sequestering TRAF6 and substantially diminished ROS production and enhanced susceptibility to bacterial infection. Our findings demonstrate that the TLR-Mst1-Mst2-Rac signaling axis is critical for effective phagosome-mitochondrion function and bactericidal activity.	[Geng, Jing; Sun, Xiufeng; Wang, Ping; Zhang, Shihao; Wang, Xiaozhen; Wu, Hongtan; Hong, Lixin; Xie, Changchuan; Zhao, Hao; Liu, Qingxu; Jiang, Mingting; Chen, Qinghua; Zhang, Jinjia; Li, Yang; Song, Siyang; Wang, Hong-Rui; Lin, Sheng-Cai; Han, Jiahuai; Chen, Lanfen; Zhou, Dawang] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen, Peoples R China; [Li, Xun] Xiamen Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Xiamen, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, Inst Immunol, Hefei 230026, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Innovat Ctr Cell Signaling Network, Sch Life Sci, Hefei 230026, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, Med Ctr, Hefei 230026, Peoples R China; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chien, Kun-Yi] Chang Gung Univ, Coll Med, Kwei Shan, Taiwan; [Avruch, Joseph] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Xiamen University; Xiamen University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Texas System; UTMD Anderson Cancer Center; Chang Gung University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Zhou, DW (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen, Peoples R China.	chenlanfen@xmu.edu.cn; dwzhou@xmu.edu.cn	Geng, Jing/I-7130-2018; xie, chang/GYJ-2493-2022; Han, J/G-4671-2010; Zhou, Rongbin/B-1430-2013; Chen, Lanfen/B-7975-2016; Li, Terytty Yang/HCI-2446-2022	Geng, Jing/0000-0002-0568-7345; Chen, Lanfen/0000-0002-9413-1284; Zhou, Dawang/0000-0002-9053-5249; Li, Terytty Yang/0000-0003-3684-7935; Wang, Hong-Rui/0000-0002-2916-8849	National Basic Research Program (973) of China [2015CB910502]; China's 1000 Young Talents Program; 111 Projects [B12001, B06016]; Fundamental Research Funds for the Central Universities of China-Xiamen University [CXB2014004, 20720140551, 2013121034, 20720140537]; National Natural Science Foundation of China [31270918, 81222030, J1310027, 81372617, 81422018, U1405225, 81472229, 81302529]; Natural Science Foundation of Fujian [2013106011, 2014D007]; US National Institutes of Health [RO1 CA136567]; Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA136567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER	National Basic Research Program (973) of China(National Basic Research Program of China); China's 1000 Young Talents Program; 111 Projects(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities of China-Xiamen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Basic Research Program (973) of China (2015CB910502 to L.C.), China's 1000 Young Talents Program (D.Z. and L.C.), the 111 Projects (B12001 and B06016), the Fundamental Research Funds for the Central Universities of China-Xiamen University (CXB2014004 to J.Z.; 20720140551 to L.C.; and 2013121034 and 20720140537 to D.Z.), the National Natural Science Foundation of China (31270918, 81222030 and J1310027 to D.Z.; 81372617, 81422018 and U1405225 to L.C.; 81472229 to L.H.; and 81302529 to XL.), the Natural Science Foundation of Fujian (2013106011 to D.Z. and 2014D007 to X.L.), the US National Institutes of Health (RO1 CA136567 for J.A.) and institutional funds from Massachusetts General Hospital (for J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Del Re DP, 2014, MOL CELL, V54, P639, DOI 10.1016/j.molcel.2014.04.007; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Ueda Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2105; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Williams DA, 2000, BLOOD, V96, P1646; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	48	149	167	6	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1142	1152		10.1038/ni.3268	http://dx.doi.org/10.1038/ni.3268			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26414765	Green Submitted, Green Accepted			2022-12-18	WOS:000363096000008
J	Zhang, ZQ; Bao, MS; Lu, N; Weng, LY; Yuan, B; Liu, YJ				Zhang, Zhiqiang; Bao, Musheng; Lu, Ning; Weng, Leiyun; Yuan, Bin; Liu, Yong-Jun			The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; RIG-I; AIM2 INFLAMMASOME; CYTOSOLIC DNA; ADAPTER; RNA; RECOGNITION; SENSOR; INTERFERON; HELICASES	DDX41 is a sensor of intracellular double-stranded DNA (dsDNA) in myeloid dendritic cells (mDCs) that triggers a type I interferon response via the signaling adaptor STING. We identified the E3 ligase TRIM21 as a DDX41-interacting protein and found that knockdown of or deficiency in TRIM21 resulted in enhanced type I interferon responses to intracellular dsDNA and DNA viruses. Overexpression of TRIM21 resulted in more degradation of DDX41 and less production of interferon-beta (IFN-beta) In response to intracellular dsDNA. The SPRY-PRY domain of TRIM21 interacted with the DEADc domain of DDX41. Lys9 and Lys115 of DDX41 were the targets of TRIM21-mediated ubiquitination. TRIM21 is therefore an interferon-inducible E3 ligase that induces the Lys48 (K48)-linked ubiquitination and degradation of DDX41 and negatively regulates the innate immune response to intracellular dsDNA.	[Zhang, Zhiqiang; Bao, Musheng; Weng, Leiyun; Liu, Yong-Jun] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Lu, Ning; Yuan, Bin] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Immunol, Houston, TX 77030 USA	Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Liu, YJ (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	yong-jun.liu@baylorhealth.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI091947] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI091947] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	40	149	157	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					172	178		10.1038/ni.2492	http://dx.doi.org/10.1038/ni.2492			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23222971	Green Accepted			2022-12-18	WOS:000313918400012
J	Barbet, G; Demion, M; Moura, IC; Serafini, N; Leger, T; Vrtovsnik, F; Monteiro, RC; Guinamard, R; Kinet, JP; Launay, P				Barbet, Gaetan; Demion, Marie; Moura, Ivan C.; Serafini, Nicolas; Leger, Thibaut; Vrtovsnik, Francois; Monteiro, Renato C.; Guinamard, Romain; Kinet, Jean-Pierre; Launay, Pierre			The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CCR7; SIGNALING MECHANISMS; IMMUNE-RESPONSE; TYROSINE KINASE; MICE LACKING; OSCILLATIONS; EXPRESSION; ANTIGEN; HSP70	Dendritic cell (DC) maturation and migration are events critical for the initiation of immune responses. After encountering pathogens, DCs upregulate the expression of costimulatory molecules and subsequently migrate to secondary lymphoid organs. Calcium (Ca2+) entry governs the functions of many hematopoietic cell types, but the role of Ca2+ entry in DC biology remains unclear. Here we report that the Ca2+-activated nonselective cation channel TRPM4 was expressed in and controlled the Ca2+ homeostasis of mouse DCs. The absence of TRPM4, which elicited Ca2+ overload, did not influence DC maturation but did considerably impair chemokine-dependent DC migration. Our results establish TRPM4-regulated Ca2+ homeostasis as crucial for DC mobility but not maturation and emphasize that DC maturation and migration are independently regulated.	[Barbet, Gaetan; Demion, Marie; Moura, Ivan C.; Serafini, Nicolas; Leger, Thibaut; Vrtovsnik, Francois; Monteiro, Renato C.; Launay, Pierre] Univ Paris 07, INSERM, U699, F-75018 Paris, France; [Barbet, Gaetan; Demion, Marie; Serafini, Nicolas; Leger, Thibaut; Launay, Pierre] Univ Paris 07, INSERM, Equipe Avenir, F-75018 Paris, France; [Barbet, Gaetan; Demion, Marie; Moura, Ivan C.; Serafini, Nicolas; Leger, Thibaut; Vrtovsnik, Francois; Monteiro, Renato C.; Launay, Pierre] Univ Paris 07, Fac Med, F-75018 Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, Serv Nephrol, F-75018 Paris, France; [Guinamard, Romain] Univ Caen, Lab Physiol Cellulaire, EA 3212, F-14032 Caen, France; [Kinet, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Kinet, Jean-Pierre] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Launay, P (corresponding author), Univ Paris 07, INSERM, U699, F-75018 Paris, France.	pierre.launay@inserm.fr	Léger, Thibaut/GPP-5828-2022; Moura, Ivan C/A-9510-2013; Monteiro, Renato C/U-8633-2017; Barbet, Gaetan/AAJ-1675-2021; SERAFINI, nicolas/S-5675-2019; marie, Demion/Q-8215-2016; Barbet, Gaetan/ABB-5618-2020; Launay, Pierre/AAH-7076-2019; Cruz Moura, Ivan/A-9510-2013	Moura, Ivan C/0000-0002-2977-0354; Monteiro, Renato C/0000-0001-5202-5646; Barbet, Gaetan/0000-0002-0152-3650; SERAFINI, nicolas/0000-0002-7440-4353; Leger, Thibaut/0000-0002-6304-3433; Vrtovsnik, Francois/0000-0003-1554-314X; Cruz Moura, Ivan/0000-0002-8418-2803; Demion, Marie/0000-0003-4777-0654	Association pour la Recherche sur le Cancer; Institut National de la Sante et de la Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche, Universite Paris 7; Fondation pour la Recherche Medicale; Action Concertee Incitative Jeunes Chercheurs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046734] Funding Source: NIH RePORTER	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche, Universite Paris 7; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Action Concertee Incitative Jeunes Chercheurs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Y. Lin (ABgenomics) and B. Koller (University of North Carolina) for help with generation of Trpm4<SUP>-/-</SUP> mice; C. S. Zuker (University of California, San Diego) for Trpm5<SUP>-/-</SUP> mice; E. Ferrary for help with the patch- clamp setup; M. Benhamou and U. Blank for advice and critical reading of the manuscript; and J. Bex, A. Bouhalfai " a and E. Couchi for help in animal care. Supported by the Association pour la Recherche sur le Cancer (G. B.), Institut National de la Sante et de la Recherche Medicale (M. D. and P. L.), Ministere de l'Enseignement Superieur et de la Recherche, Universite Paris 7 (N. S.), Fondation pour la Recherche Medicale ( T. L. and P. L.) and Action Concertee Incitative Jeunes Chercheurs (P. L.).	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Del Prete A, 2007, BLOOD, V109, P626, DOI 10.1182/blood-2006-02-003665; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; DONNADIEU E, 1995, PFLUG ARCH EUR J PHY, V429, P546, DOI 10.1007/BF00704160; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; ten Brinke A, 2007, VACCINE, V25, P7145, DOI 10.1016/j.vaccine.2007.07.031; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	43	149	152	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1148	1156		10.1038/ni.1648	http://dx.doi.org/10.1038/ni.1648			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18758465	Green Accepted			2022-12-18	WOS:000259315600013
J	Mackay, CR				Mackay, Charles R.			Moving targets: cell migration inhibitors as new anti-inflammatory therapies	NATURE IMMUNOLOGY			English	Review							CHEMOKINE RECEPTOR; IN-VIVO; NEUTROPHIL RECRUITMENT; PI3K-GAMMA INHIBITION; AIRWAY INFLAMMATION; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; DENDRITIC CELLS; INFLAMED JOINTS; MURINE MODEL	The pharmaceutical industry has targeted various types of molecules to subdue inflammatory diseases. Drugs that disrupt cell migration appear particularly promising in clinical trials and in many animal models of inflammatory disease. Cell migration inhibitors not only interfere with migration of cells to a tissue, but also can affect other necessary processes such as mediator release and angiogenesis. However, the question is whether drugs that target adhesion molecules or chemoattractant receptors will prove superior to drugs that target other molecular types. This review proclaims the virtues of targeting cell migration-related molecules for development of new anti-inflammatory and anti-tumor based drugs. It is likely that cell migration inhibitors will transform the way in which many human inflammatory diseases and cancers are treated.	St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Mackay, CR (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	c.mackay@mac.com	Mackay, Charles R/A-9673-2008	Mackay, Charles R/0000-0002-6338-7340	Australian National Health and Medical Research Council; Cooperative Research Center for Asthma and Airways	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Center for Asthma and Airways	I thank A. Rot, J.-C. Gutierrez Ramos and I. Mackay for helpful suggestions. Supported by the Australian National Health and Medical Research Council and the Cooperative Research Center for Asthma and Airways.	Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Bogunia-Kubik K, 2006, HAEMATOLOGICA, V91, P1628; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Chiba K, 1998, J IMMUNOL, V160, P5037; De Lucca GV, 2005, J MED CHEM, V48, P2194, DOI 10.1021/jm049530m; Diaz-Gonzalez F, 2007, ANN RHEUM DIS, V66, P628, DOI 10.1136/ard.2006.062554; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Fischereder M, 2001, LANCET, V357, P1758, DOI 10.1016/S0140-6736(00)04898-4; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Fulkerson PC, 2006, P NATL ACAD SCI USA, V103, P16418, DOI 10.1073/pnas.0607863103; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; GLADUE R, 2007, CHEMOKINE BIOL BASIC, V2, P103; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; GOODMAN A, 2008, NEUROL TODAY, V8, P16; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Hesterberg PE, 1996, GASTROENTEROLOGY, V111, P1373, DOI 10.1053/gast.1996.v111.pm8898653; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Laan M, 1999, J IMMUNOL, V162, P2347; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; Leonardi C, 2008, BRIT J DERMATOL, V158, P1107, DOI 10.1111/j.1365-2133.2008.08548.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mahler DA, 2004, CHEST, V126, P926, DOI 10.1378/chest.126.3.926; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mihara K, 2005, EUR J IMMUNOL, V35, P2573, DOI 10.1002/eji.200526021; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; NEOTE K, 2007, CHEMOKINE BIOL BASIC, V2; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Podolin PL, 2002, J IMMUNOL, V169, P6435, DOI 10.4049/jimmunol.169.11.6435; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Prosser HM, 2002, DRUG DEVELOP RES, V55, P197, DOI 10.1002/ddr.10044; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Saita Y, 2005, EUR J PHARMACOL, V518, P227, DOI 10.1016/j.ejphar.2005.06.010; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Sawicka E, 2003, J IMMUNOL, V171, P6206, DOI 10.4049/jimmunol.171.11.6206; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427, DOI 10.2174/15680266106061427; Valdes AM, 2002, ARTERIOSCL THROM VAS, V22, P1924, DOI 10.1161/01.ATV.0000038486.48400.E7; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang L, 2008, INT J IMMUNOGENET, V35, P45, DOI 10.1111/j.1744-313X.2007.00734.x; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wheeler J, 2007, ANTIVIR THER, V12, P233; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Wong AK, 1998, J MED CHEM, V41, P3417, DOI 10.1021/jm9800651; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	94	149	162	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					988	998		10.1038/ni.f.210	http://dx.doi.org/10.1038/ni.f.210			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711436				2022-12-18	WOS:000258559600007
J	Croxford, JL; Miyake, S; Huang, YY; Shimamura, M; Yamamura, T				Croxford, J. Ludovic; Miyake, Sachiko; Huang, Yi-Ying; Shimamura, Michio; Yamamura, Takashi			Invariant V(alpha)19i T cells regulate autoimmune inflammation	NATURE IMMUNOLOGY			English	Article							TCR ALPHA-CHAIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; CENTRAL-NERVOUS-SYSTEM; NKT CELLS; B-CELLS; EXPRESSION; GALACTOSYLCERAMIDE; ACTIVATION; PREVENTS	T cells expressing an invariant V(alpha)19-J(alpha)33 T cell receptor alpha-chain (V(alpha)19i TCR) are restricted by the nonpolymorphic major histocompatibility complex class Ib molecule MR1. Whether V(alpha)19i T cells are involved in autoimmunity is not understood. Here we demonstrate that T cells expressing the V(alpha)19i TCR transgene inhibited the induction and progression of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. Similarly, EAE was exacerbated in MR1-deficient mice, which lack V(alpha)19i T cells. EAE suppression was accompanied by reduced production of inflammatory mediators and increased secretion of interleukin 10. Interleukin 10 production occurred at least in part through interactions between B cells and V(alpha)19i T cells mediated by the ICOS costimulatory molecule. These results suggest an immunoregulatory function for V(alpha)19i T cells.	Natl Inst Neurosci, Dept Immunol, Natl Ctr Neurol & Psychiat, Tokyo 1878502, Japan; Mitsubishi Kagaku Inst Life Sci, Dev Immunol Unit, Tokyo 1948511, Japan	National Center for Neurology & Psychiatry - Japan; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Yamamura, T (corresponding author), Natl Inst Neurosci, Dept Immunol, Natl Ctr Neurol & Psychiat, Tokyo 1878502, Japan.	yamamura@ncnp.go.jp						Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chiba A, 2005, ARTHRITIS RHEUM-US, V52, P1941, DOI 10.1002/art.21056; Cognasse F, 2005, INT J IMMUNOPATH PH, V18, P65, DOI 10.1177/039463200501800108; Croxford JL, 1998, J IMMUNOL, V160, P5181; Croxford JL, 2001, J IMMUNOL, V166, P4124, DOI 10.4049/jimmunol.166.6.4124; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikarashi Y, 2001, J EXP MED, V194, P1179, DOI 10.1084/jem.194.8.1179; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Kaneda H, 2005, BIOCHEM BIOPH RES CO, V327, P201, DOI 10.1016/j.bbrc.2004.12.004; Kaneko M, 2005, IMMUNOLOGY, V116, P64, DOI 10.1111/j.1365-2567.2005.02198.x; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Miyake Sachiko, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P315, DOI 10.2174/1568008054863772; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Muhlen KA, 2004, J IMMUNOL, V172, P3034, DOI 10.4049/jimmunol.172.5.3034; Okamoto N, 2005, CHEM BIOL, V12, P677, DOI 10.1016/j.chembiol.2005.04.014; Pal E, 2001, J IMMUNOL, V166, P662, DOI 10.4049/jimmunol.166.1.662; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Riegert P, 1998, J IMMUNOL, V161, P4066; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shimamura M, 2002, FEBS LETT, V516, P97, DOI 10.1016/S0014-5793(02)02509-7; Song F, 1999, J IMMUNOL, V162, P2275; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Wagner MJD, 2005, J IMMUNOL, V174, P6764, DOI 10.4049/jimmunol.174.11.6764; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	44	149	150	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					987	994		10.1038/ni1370	http://dx.doi.org/10.1038/ni1370			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16878136				2022-12-18	WOS:000239942300018
J	Schaller, M; Burton, DR; Ditzel, HJ				Schaller, M; Burton, DR; Ditzel, HJ			Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease	NATURE IMMUNOLOGY			English	Article							AUTOCRINE MOTILITY FACTOR; ENDOTHELIAL GROWTH-FACTOR; PHOSPHOHEXOSE ISOMERASE; MONOCLONAL-ANTIBODY; NEUROTROPHIC FACTOR; MOLECULAR MIMICRY; CELL RECOGNITION; NEUROLEUKIN; AUTOIMMUNITY; EXPRESSION	In K/BxN T cell receptor-transgenic mice, spontaneous inflammatory arthritis exhibiting many of the features of human rheumatoid arthritis (RA) is initiated by T cells, but is almost entirely sustained by antibodies to the self-antigen glucose-6-phosphate isomerase (GPI). The relevance of these observations to human disease has been questioned. Here we show that 64% of humans with RA, but not controls, had increased concentrations of anti-GPI immunoglobulin G (IgG) in serum and synovial fluid. In addition, the concentrations of soluble GPI in the sera and synovial fluids of RA patients were also elevated, which led to immune complex formation. Using phage-display methods, we cloned a panel of specific high-affinity human monoclonal anti-GPI IgGs from a patient with RA. These antibodies were highly somatically mutated, which was indicative of an affinity-matured response that was antigen driven. Immunohistochemistry of RA synovium showed high concentrations of GPI on the surface of the synovial lining and on the endothelial cell surface of arterioles; this indicated a mechanism by which antibodies to GPI may precipitate joint disease. The results indicate that the immunological events that lead to the development of autoimmune disease in the K/BxN mouse model may also occur in human RA. This data may be used to develop new strategies for therapeutic intervention.	Scripps Res Inst, Dept Immunol, IMM2, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Ditzel, HJ (corresponding author), Scripps Res Inst, Dept Immunol, IMM2, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hditzel@scripps.edu		Ditzel, Henrik J./0000-0003-3927-5135; Schaller, Monica/0000-0002-5002-2238				BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P10164, DOI 10.1073/pnas.89.21.10164; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BAUMANN M, 1988, CANCER RES, V48, P2998; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; BURTON DR, 1992, ADV IMMUNOL, V51, P118; Caton AJ, 1996, J EXP MED, V183, P13, DOI 10.1084/jem.183.1.13; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DITZEL HJ, 1995, J IMMUNOL, V154, P893; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FILELLA X, 1991, TUMOR BIOL, V12, P360, DOI 10.1159/000217737; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOMM SA, 1988, BRIT J CANCER, V58, P797, DOI 10.1038/bjc.1988.312; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GURNEY ME, 1986, SCIENCE, V234, P574, DOI 10.1126/science.3020690; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; HOLMDAHL R, 1990, IMMUNOL REV, V118, P193, DOI 10.1111/j.1600-065X.1990.tb00817.x; Jackson JR, 1997, J RHEUMATOL, V24, P1253; JALKANEN S, 1986, SCIENCE, V233, P556, DOI 10.1126/science.3726548; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; PHILLIPS TL, 1976, BIOCHIM BIOPHYS ACTA, V429, P624, DOI 10.1016/0005-2744(76)90311-9; ROCKEN M, 1992, NATURE, V359, P79, DOI 10.1038/359079a0; ROWAN RM, 1978, MED LAB SCI, V35, P155; Silletti S, 1996, CURR TOP MICROBIOL, V213, P137; Watanabe H, 1996, CANCER RES, V56, P2960; WATANABE H, 1991, J BIOL CHEM, V266, P13442; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; [No title captured]	40	149	180	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					746	753		10.1038/90696	http://dx.doi.org/10.1038/90696			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477412				2022-12-18	WOS:000170230100018
J	Diskin, B; Adam, S; Cassini, MF; Sanchez, G; Liria, M; Aykut, B; Buttar, C; Li, E; Sundberg, B; Salas, RD; Chen, RN; Wang, JJ; Kim, M; Farooq, MS; Nguy, S; Fedele, C; Tang, KH; Chen, T; Wang, W; Hundeyin, M; Rossi, JAK; Kurz, E; Ul Haq, MI; Karlen, J; Kruger, E; Sekendiz, Z; Wu, DL; Shadaloey, SAA; Baptiste, G; Werba, G; Selvaraj, S; Loomis, C; Wong, KK; Leinwand, J; Miller, G				Diskin, Brian; Adam, Salma; Cassini, Marcelo F.; Sanchez, Gustavo; Liria, Miguel; Aykut, Berk; Buttar, Chandan; Li, Eric; Sundberg, Belen; Salas, Ruben D.; Chen, Ruonan; Wang, Junjie; Kim, Mirhee; Farooq, Mohammad Saad; Nguy, Susanna; Fedele, Carmine; Tang, Kwan Ho; Chen, Ting; Wang, Wei; Hundeyin, Mautin; Rossi, Juan A. Kochen; Kurz, Emma; Ul Haq, Muhammad Israr; Karlen, Jason; Kruger, Emma; Sekendiz, Zennur; Wu, Dongling; Shadaloey, Sorin A. A.; Baptiste, Gillian; Werba, Gregor; Selvaraj, Shanmugapriya; Loomis, Cynthia; Wong, Kwok-Kin; Leinwand, Joshua; Miller, George			PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer	NATURE IMMUNOLOGY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PANCREATIC-CANCER; EXPRESSION; STAT3; ONCOGENESIS; ACTIVATION; INDUCTION; BLOCKADE; PATHWAY; AXIS	Programmed cell death protein 1 (PD-1) ligation delimits immunogenic responses in T cells. However, the consequences of programmed cell death 1 ligand 1 (PD-L1) ligation in T cells are uncertain. We found that T cell expression of PD-L1 in cancer was regulated by tumor antigen and sterile inflammatory cues. PD-L1(+) T cells exerted tumor-promoting tolerance via three distinct mechanisms: (1) binding of PD-L1 induced STAT3-dependent 'back-signaling' in CD4(+) T cells, which prevented activation, reduced T(H)1-polarization and directed T(H)17-differentiation. PD-L1 signaling also induced an anergic T-bet(-)IFN-gamma(-) phenotype in CD8(+) T cells and was equally suppressive compared to PD-1 signaling; (2) PD-L1(+) T cells restrained effector T cells via the canonical PD-L1-PD-1 axis and were sufficient to accelerate tumorigenesis, even in the absence of endogenous PD-L1; (3) PD-L1(+) T cells engaged PD-1(+) macrophages, inducing an alternative M2-like program, which had crippling effects on adaptive antitumor immunity. Collectively, we demonstrate that PD-L1(+) T cells have diverse tolerogenic effects on tumor immunity. PD-L1 on tumor cells exerts an important dampening effect on T cells via their expression of PD-1. Miller and colleagues find that PD-L1 'back-signaling' into T cells and macrophages can also dampen immune responses within the tumor microenvironment.	[Diskin, Brian; Adam, Salma; Cassini, Marcelo F.; Sanchez, Gustavo; Liria, Miguel; Aykut, Berk; Buttar, Chandan; Li, Eric; Sundberg, Belen; Salas, Ruben D.; Chen, Ruonan; Wang, Junjie; Kim, Mirhee; Farooq, Mohammad Saad; Wang, Wei; Hundeyin, Mautin; Rossi, Juan A. Kochen; Kurz, Emma; Ul Haq, Muhammad Israr; Karlen, Jason; Kruger, Emma; Sekendiz, Zennur; Wu, Dongling; Shadaloey, Sorin A. A.; Baptiste, Gillian; Werba, Gregor; Leinwand, Joshua; Miller, George] NYU, Dept Surg, Sch Med, S Arthur Localio Lab, New York, NY 10016 USA; [Nguy, Susanna] NYU, Sch Med, Dept Radiat Oncol, New York, NY USA; [Fedele, Carmine; Tang, Kwan Ho; Chen, Ting; Selvaraj, Shanmugapriya; Loomis, Cynthia] NYU, Sch Med, Dept Pathol, New York, NY USA; [Loomis, Cynthia; Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Wong, Kwok-Kin] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University; New York University; New York University	Miller, G (corresponding author), NYU, Dept Surg, Sch Med, S Arthur Localio Lab, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	george.miller@nyumc.org	Hundeyin, Mautin/AAU-6792-2020	Chen, Ting/0000-0003-1725-7956; Werba, Gregor/0000-0003-1464-9065; Salas Parra, Ruben Dario/0000-0002-8960-266X; Tang, Kwan Ho/0000-0001-7729-5159; Chen, Ruonan/0000-0003-1758-6151; Wu, Dongling/0000-0003-1966-8257; chen, ting/0000-0001-8414-6346; wong, kwok kin/0000-0001-6323-235X	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NIH [S10 OD021747, CA168611, CA203105, CA215471, CA19311, DK106025]; American College of Surgeons Resident Research Fellowship	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Resident Research Fellowship	We acknowledge the use of the Genome Technology, Experimental Pathology and Flow Cytometry core facilities at NYU School of Medicine. These shared resources are partially supported by the Cancer Center Support Grant, P30CA016087, at the Laura and Isaac Perlmutter Cancer Center. The Vectra3 imaging system was purchased through NIH Shared Instrument Grant S10 OD021747. This work was supported by the American College of Surgeons Resident Research Fellowship (B.D.) and NIH grants CA168611 (G.M.), CA203105 (G.M.), CA215471 (G.M.), CA19311 (G.M.) and DK106025 (G.M.).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Blogowski W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097613; Chen CL, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1373234; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Coffre M, 2016, CELL REP, V17, P2271, DOI 10.1016/j.celrep.2016.11.006; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gato-Canas M, 2017, CELL REP, V20, P1818, DOI 10.1016/j.celrep.2017.07.075; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Greco SH, 2016, J LEUKOCYTE BIOL, V100, P185, DOI 10.1189/jlb.3A0515-185R; Horlad H, 2016, CANCER SCI, V107, P1696, DOI 10.1111/cas.13065; Jenkins RW, 2018, CANCER DISCOV, V8, P196, DOI 10.1158/2159-8290.CD-17-0833; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kythreotou A, 2018, J CLIN PATHOL, V71, P189, DOI 10.1136/jclinpath-2017-204853; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep36722; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Melton AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058966; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Oh HM, 2012, J BIOL CHEM, V287, P30436, DOI 10.1074/jbc.M112.359661; Procaccia S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43078; Pulko V, 2011, J IMMUNOL, V187, P5606, DOI 10.4049/jimmunol.1003976; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Rehman A, 2013, J IMMUNOL, V190, P4640, DOI 10.4049/jimmunol.1202312; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; Thorn M, 2016, CANCER GENE THER, V23, P188, DOI 10.1038/cgt.2016.19; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006; Winograd R, 2015, CANCER IMMUNOL RES, V3, P399, DOI 10.1158/2326-6066.CIR-14-0215; Yang B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/623759; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162	47	148	153	13	77	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					442	+		10.1038/s41590-020-0620-x	http://dx.doi.org/10.1038/s41590-020-0620-x		MAR 2020	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32152508				2022-12-18	WOS:000518737000002
J	Beyer, M; Thabet, Y; Muller, RU; Sadlon, T; Classen, S; Lahl, K; Basu, S; Zhou, XY; Bailey-Bucktrout, SL; Krebs, W; Schonfeld, EA; Bottcher, J; Golovina, T; Mayer, CT; Hofmann, A; Sommer, D; Debey-Pascher, S; Endl, E; Limmer, A; Hippen, KL; Blazar, BR; Balderas, R; Quast, T; Waha, A; Mayer, G; Famulok, M; Knolle, PA; Wickenhauser, C; Kolanus, W; Schermer, B; Bluestone, JA; Barry, SC; Sparwasser, T; Riley, JL; Schultze, JL				Beyer, Marc; Thabet, Yasser; Mueller, Roman-Ulrich; Sadlon, Timothy; Classen, Sabine; Lahl, Katharina; Basu, Samik; Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Krebs, Wolfgang; Schoenfeld, Eva A.; Boettcher, Jan; Golovina, Tatiana; Mayer, Christian T.; Hofmann, Andrea; Sommer, Daniel; Debey-Pascher, Svenja; Endl, Elmar; Limmer, Andreas; Hippen, Keli L.; Blazar, Bruce R.; Balderas, Robert; Quast, Thomas; Waha, Andreas; Mayer, Guenter; Famulok, Michael; Knolle, Percy A.; Wickenhauser, Claudia; Kolanus, Waldemar; Schermer, Bernhard; Bluestone, Jeffrey A.; Barry, Simon C.; Sparwasser, Tim; Riley, James L.; Schultze, Joachim L.			Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; TARGET GENES; BINDING PROTEIN; MULTIPLE GENES; TGF-BETA; IN-VIVO; EXPRESSION; PLASTICITY; IDENTIFICATION; DISRUPTION	Regulatory T cells (T-reg cells) are essential for self-tolerance and immune homeostasis. Lack of effector T cell (T-eff cell) function and gain of suppressive activity by T-reg cells are dependent on the transcriptional program induced by Foxp3. Here we report that repression of SATB1, a genome organizer that regulates chromatin structure and gene expression, was crucial for the phenotype and function of T-reg cells. Foxp3, acting as a transcriptional repressor, directly suppressed the SATB1 locus and indirectly suppressed it through the induction of microRNAs that bound the SATB1 39 untranslated region. Release of SATB1 from the control of Foxp3 in T-reg cells caused loss of suppressive function, establishment of transcriptional T-eff cell programs and induction of T-eff cell cytokines. Our data support the proposal that inhibition of SATB1-mediated modulation of global chromatin remodeling is pivotal for maintaining T-reg cell functionality.	[Beyer, Marc; Thabet, Yasser; Classen, Sabine; Krebs, Wolfgang; Schoenfeld, Eva A.; Hofmann, Andrea; Sommer, Daniel; Debey-Pascher, Svenja; Schultze, Joachim L.] Univ Bonn, Lab Genom & Immunoregulat, Life & Med Sci Inst, D-5300 Bonn, Germany; [Mueller, Roman-Ulrich; Schermer, Bernhard] Univ Cologne, Div Renal, Dept Med, Cologne, Germany; [Mueller, Roman-Ulrich; Schermer, Bernhard] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Sadlon, Timothy; Barry, Simon C.] Univ Adelaide, Discipline Paediat, Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia; [Lahl, Katharina; Mayer, Christian T.; Sparwasser, Tim] Hannover Med Sch, Inst Infect Immunol, TWINCORE, Ctr Expt & Clin Infect Res, D-3000 Hannover, Germany; [Lahl, Katharina; Mayer, Christian T.; Sparwasser, Tim] Helmholtz Ctr Infect Res, Hannover, Germany; [Basu, Samik; Golovina, Tatiana; Riley, James L.] Univ Penn, Dept Microbiol, Translat Res Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Boettcher, Jan; Endl, Elmar; Limmer, Andreas; Knolle, Percy A.] Univ Hosp Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Cancer Ctr, Minneapolis, MN USA; [Hippen, Keli L.; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Balderas, Robert] BD Biosci Pharmingen, San Diego, CA USA; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, Life & Med Sci Inst, Lab Mol Immunol, D-5300 Bonn, Germany; [Waha, Andreas] Univ Hosp Bonn, Dept Neuropathol, Bonn, Germany; [Mayer, Guenter; Famulok, Michael] Univ Bonn, Life & Med Sci Inst, Biol Chem Lab, D-5300 Bonn, Germany; [Wickenhauser, Claudia] Univ Hosp Leipzig, Dept Diagnost, Inst Pathol, Leipzig, Germany	University of Bonn; University of Cologne; University of Cologne; University of Adelaide; Womens & Childrens Hospital Australia; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bonn; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Bonn; University of Bonn; University of Bonn; Leipzig University	Schultze, JL (corresponding author), Univ Bonn, Lab Genom & Immunoregulat, Life & Med Sci Inst, D-5300 Bonn, Germany.	j.schultze@uni-bonn.de	Schermer, Bernhard/E-9972-2014; Beyer, Marc/ABE-1408-2021; barry, simon/Y-4529-2019; Müller, Roman-Ulrich/AAK-3493-2021; Sparwasser, Tim/AAF-7085-2019; Sparwasser, Tim D/AAA-4306-2022; Schultze, Joachim L/D-7794-2011; Lahl, Katharina/AAA-1909-2021; Zhou, Xuyu/L-7422-2019; Schultze, Joachim L./ABA-8176-2020	Schermer, Bernhard/0000-0002-5194-9000; Beyer, Marc/0000-0001-9704-148X; barry, simon/0000-0002-0597-7609; Müller, Roman-Ulrich/0000-0001-6910-0745; Sparwasser, Tim/0000-0001-5645-902X; Schultze, Joachim L/0000-0003-2812-9853; Lahl, Katharina/0000-0003-4919-331X; Zhou, Xuyu/0000-0002-6626-0898; Schultze, Joachim L./0000-0003-2812-9853; Riley, James/0000-0002-1057-576X; Knolle, Percy A./0000-0003-2983-0414; Bottcher, Jan/0000-0002-8163-8107	German Research Foundation [Sonderforschungsbereich 832, SFB 704, INST 217/576-1, INST 217/577-1, SCHE 1562, SFB832]; Wilhelm-Sander-Foundation; German Cancer Aid; German Jose-Carreras-Foundation; Federal Ministry of Education and Research; Leukemia and Lymphoma Society of America [R6029-07]; Juvenile Diabetes Research Foundation [16-2008-643]; University of California, San Francisco, Autoimmunity Center of Excellence; National Health and Medical Research Council [339123, 565314]; Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy; Juvenile Diabetes Research Foundation Center on Cord Blood Therapies for Type 1 Diabetes; NATIONAL CANCER INSTITUTE [P01CA142106, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034495, P01AI056299] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Wilhelm-Sander-Foundation; German Cancer Aid(Deutsche Krebshilfe); German Jose-Carreras-Foundation; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of California, San Francisco, Autoimmunity Center of Excellence(University of California System); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation Center on Cord Blood Therapies for Type 1 Diabetes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Mai, M. Kraut, S. Keller, N. Kuhn, J. Birke, I. Buchmann, A. Dolf and P. Wurst for technical assistance; M. Hoch, M. Pankratz, S. Burgdorf, A. Popov and A. Staratschek-Jox, as well as all other laboratory members, for discussions; and J. Oldenburg for blood samples from healthy subjects. Supported by the German Research Foundation (Sonderforschungsbereich 832, SFB 704, INST 217/576-1 and INST 217/577-1 to J.L.S. and M.B.), the Wilhelm-Sander-Foundation (J.L.S. and M.B.), the German Cancer Aid (J.L.S.), the German Jose-Carreras-Foundation (J.L.S. and M.B.), the Federal Ministry of Education and Research (Nationale Genomforschungsnetz 2 to J.L.S.), the Humboldt Foundation (J.L.S.), the Leukemia and Lymphoma Society of America (R6029-07 to B.R.B. and K.L.H.), the Juvenile Diabetes Research Foundation (16-2008-643 to X.Z., S.L.B.-B. and J.A.B.), the University of California, San Francisco, Autoimmunity Center of Excellence (X.Z., S.L.B.-B. and J.A.B.), the National Health and Medical Research Council (339123, 565314 to S.C.B.), the German Research Foundation (SCHE 1562 and SFB832 to B.S.), the Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy (S.B., T.G. and J.L.R.) and the Juvenile Diabetes Research Foundation Center on Cord Blood Therapies for Type 1 Diabetes (S.B., T.G. and J.L.R.).	Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Classen S, 2007, J IMMUNOL, V178, P6931, DOI 10.4049/jimmunol.178.11.6931; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2009, J IMMUNOL, V183, P5662, DOI 10.4049/jimmunol.0803762; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	54	148	157	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					898	U125		10.1038/ni.2084	http://dx.doi.org/10.1038/ni.2084			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21841785	Green Accepted, Green Published			2022-12-18	WOS:000294461200014
J	Bulek, K; Liu, CN; Swaidani, S; Wang, LW; Page, RC; Gulen, MF; Herjan, T; Abbadi, A; Qian, W; Sun, DX; Lauer, M; Hascall, V; Misra, S; Chance, M; Aronica, M; Hamilton, T; Li, XX				Bulek, Katarzyna; Liu, Caini; Swaidani, Shadi; Wang, Liwen; Page, Richard C.; Gulen, Muhammet F.; Herjan, Tomasz; Abbadi, Amina; Qian, Wen; Sun, Dongxu; Lauer, Mark; Hascall, Vincent; Misra, Saurav; Chance, Mark; Aronica, Mark; Hamilton, Thomas; Li, Xiaoxia			The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation	NATURE IMMUNOLOGY			English	Article							MESSENGER-RNA STABILIZATION; ACTIVATED PROTEIN-KINASE; AIRWAY EPITHELIAL-CELLS; SWISS-MODEL REPOSITORY; KAPPA-B ACTIVATION; IL-17 RECEPTOR; T-CELLS; TISSUE INFLAMMATION; STRUCTURAL BASIS; TH17 CELLS	Interleukin 17 (IL-17) is critical in the pathogenesis of inflammatory and autoimmune diseases. Here we report that Act1, the key adaptor for the IL-17 receptor (IL-7R), formed a complex with the inducible kinase IKKi after stimulation with IL-17. Through the use of IKKi-deficient mice, we found that IKKi was required for IL-17-induced expression of genes encoding inflammatory molecules in primary airway epithelial cells, neutrophilia and pulmonary inflammation. IKKi deficiency abolished IL-17-induced formation of the complex of Act1 and the adaptors TRAF2 and TRAF5, activation of mitogen-activated protein kinases (MAPKs) and mRNA stability, whereas the Act1-TRAF6-transcription factor NF-kappa B axis was retained. IKKi was required for IL-17-induced phosphorylation of Act1 on Ser311, adjacent to a putative TRAF-binding motif. Substitution of the serine at position 311 with alanine impaired the IL-17-mediated Act1-TRAF2-TRAF5 interaction and gene expression. Thus, IKKi is a kinase newly identified as modulating IL-17 signaling through its effect on Act1 phosphorylation and consequent function.	[Bulek, Katarzyna; Liu, Caini; Swaidani, Shadi; Gulen, Muhammet F.; Herjan, Tomasz; Abbadi, Amina; Qian, Wen; Sun, Dongxu; Hamilton, Thomas; Li, Xiaoxia] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Wang, Liwen; Chance, Mark] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH USA; [Page, Richard C.; Misra, Saurav] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Lauer, Mark; Hascall, Vincent] Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Aronica, Mark] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Bulek, Katarzyna/L-7517-2015; Herjan, Tomasz/AAM-9625-2020; Hamilton, Thomas A/A-7756-2009	Hamilton, Thomas/0000-0002-9817-242X; Gulen, Muhammet/0000-0002-7139-6781; Misra, Saurav/0000-0002-1385-8554; Page, Richard/0000-0002-3006-3171; Swaidani, Shadi/0000-0003-1506-4472	American Asthma Foundation; US National Institutes of Health [R01HL098935-01A1]; American Heart Association [09POST2010041]; NATIONAL CANCER INSTITUTE [R01CA039621] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, R01HL098935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER	American Asthma Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Maniatis (Harvard University) for IKKi-deficient and wild-type C57BL/6 control mice; and the High Performance Computing Resource in the Core Facility for Advanced Research Computing and Center of Proteomics and Bioinformatics at Case Western Reserve University. Supported by the American Asthma Foundation (X.L.), the US National Institutes of Health (R01HL098935-01A1 to X.L.) and the American Heart Association (09POST2010041 to R.C.P.).	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kolls J, 2010, SEMIN IMMUNOPATHOL, V32, P1, DOI 10.1007/s00281-010-0198-8; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	50	148	161	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					844	U61		10.1038/ni.2080	http://dx.doi.org/10.1038/ni.2080			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21822257	Green Accepted			2022-12-18	WOS:000294461200008
J	Borg, NA; Ely, LK; Beddoe, T; Macdonald, WA; Reid, HH; Clements, CS; Purcell, AW; Kjer-Nielsen, L; Miles, JJ; Burrows, SR; McCluskey, J; Rossjohn, J				Borg, NA; Ely, LK; Beddoe, T; Macdonald, WA; Reid, HH; Clements, CS; Purcell, AW; Kjer-Nielsen, L; Miles, JJ; Burrows, SR; McCluskey, J; Rossjohn, J			The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition	NATURE IMMUNOLOGY			English	Article							EPSTEIN-BARR-VIRUS; STRUCTURAL BASIS; ANTIGEN RECOGNITION; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; TCR BINDING; HOT-SPOT; CLASS-II; IN-VIVO; COMPLEX	The energetic bases of T cell recognition are unclear. Here, we studied the 'energetic landscape' of peptide-major histocompatibility complex (pMHC) recognition by an immunodominant alphabeta T cell receptor (TCR). We quantified and evaluated the effect of natural and systematic substitutions in the complementarity-determining region (CDR) loops on ligand binding in the context of the structural detail of each component of the immunodominant TCR-pMHC complex. The CDR1 and CDR2 loops contributed minimal energy through direct recognition of the antigen and instead had a chief function in stabilizing the ligated CDR3 loops. The underlying energetic basis for recognition lay in the CDR3 loops. Therefore the energetic burden of the CDR loops in the TCR-pMHC interaction is variable among TCRs, reflecting the inherent adaptability of the TCR in ligating different ligands.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Monash Ctr Synchrotron Sci,Prot Crystallog Unit, Clayton, Vic 3800, Australia; Queensland Inst Med Res, Cellular Immunol Lab, Brisbane, Qld 4029, Australia	University of Melbourne; Monash University; QIMR Berghofer Medical Research Institute	Rossjohn, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamie.rossjohn@med.monash.edu.au	Burrows, Scott/G-2050-2011; Miles, John/H-4975-2011; Purcell, Anthony/AAH-1942-2019; Miles, John J/ABC-1105-2020; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014	Burrows, Scott/0000-0002-1430-0472; Purcell, Anthony/0000-0003-0532-8331; Miles, John J/0000-0001-5506-6304; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Borg, Natalie/0000-0002-8677-9056				Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Baxter TK, 2004, J BIOL CHEM, V279, P29175, DOI 10.1074/jbc.M403372200; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590; CALLAN MFC, 1995, EUR J IMMUNOL, V25, P1529, DOI 10.1002/eji.1830250609; Callan MFC, 1999, SPRINGER SEMIN IMMUN, V21, P37, DOI 10.1007/s002810050051; Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.3.CO;2-Q; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JAMESON SC, 1990, J IMMUNOL, V145, P1324; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1999, J EXP MED, V189, P461, DOI 10.1084/jem.189.3.461; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mongkolsapaya J, 1999, J VIROL, V73, P67, DOI 10.1128/JVI.73.1.67-71.1999; PANZARA MA, 1992, BIOTECHNIQUES, V12, P728; PARHAM P, 1979, J IMMUNOL, V123, P342; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sim BC, 1998, J IMMUNOL, V160, P1204; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wang ZC, 2002, J IMMUNOL, V169, P3146, DOI 10.4049/jimmunol.169.6.3146; Webb AI, 2004, J IMMUNOL, V173, P402, DOI 10.4049/jimmunol.173.1.402; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	57	148	155	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					171	180		10.1038/ni1155	http://dx.doi.org/10.1038/ni1155			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15640805				2022-12-18	WOS:000226468100020
J	Schaeffer, EM; Yap, GS; Lewis, CM; Czar, MJ; McVicar, DW; Cheever, AW; Sher, A; Schwartzberg, PL				Schaeffer, EM; Yap, GS; Lewis, CM; Czar, MJ; McVicar, DW; Cheever, AW; Sher, A; Schwartzberg, PL			Mutation of Tec family kinase alters T helper cell differentiation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; IN-VIVO; PEPTIDE LIGANDS; TYROSINE KINASE; TH2 DEVELOPMENT; MICE LACKING; NFAT FAMILY; EXPRESSION; CD4; ANTIGEN	The Tec kinases RIk and Itk are critical for full T cell receptor (TCR)-induced activation of phospholipase C-gamma and mitogen-activated protein kinase. We show here that the mutation of RIk and Itk impaired activation of the transcription factors NFAT and AP-1 and production of both T helper type I (T(H)1) and T(H)2 cytokines. Consistent with these biochemical defects, Itk(-/-) mice did not generate effective T(H)2 responses when challenged with Schistosoma mansoni eggs. Paradoxically, the more severely impaired RIk(-/-)Itk(-/-) mice were able to mount a T(H)2 response and produced T(H)2 cytokines in response to this challenge. In addition, RIk(-/-)Itk(-/-) cells showed impaired TCR-induced repression of the T(H)2-inducing transcription factor GATA-3, suggesting a potential mechanism for T(H)2 development in these hyporesponsive cells. Thus, mutations that affect Tec kinases lead to complex alterations in CD4(+)T(H) cell differentiation.	NHGRI, NIH, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; Biomed Res Inst, Rockville, MD 20852 USA; Brown Univ, Dept Med Microbiol & Immunol, Providence, RI 02912 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Brown University	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.		McVicar, Daniel/G-1970-2015	McVicar, Daniel/0000-0002-1112-5111	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579, Z01AI000579] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; BANCROFT AJ, 1994, EUR J IMMUNOL, V24, P3113, DOI 10.1002/eji.1830241230; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Brown DR, 1997, J EXP MED, V186, P101, DOI 10.1084/jem.186.1.101; Brown DR, 1996, J EXP MED, V184, P803, DOI 10.1084/jem.184.3.803; COFFMAN RL, 1988, MONOGR ALLERGY, V24, P96; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Foucras G, 2000, J EXP MED, V191, P683, DOI 10.1084/jem.191.4.683; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grakoui A, 1999, J IMMUNOL, V162, P1923; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; HULI J, 1989, J IMMUNOL, V142, P800; Jankovic D, 1999, J IMMUNOL, V163, P337; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kashiwakura J, 1999, J EXP MED, V190, P1147, DOI 10.1084/jem.190.8.1147; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Smith JA, 1998, J IMMUNOL, V160, P4841; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; WYNN TA, 1993, J IMMUNOL, V151, P1430; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	45	148	158	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1183	1188		10.1038/ni734	http://dx.doi.org/10.1038/ni734			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11702066				2022-12-18	WOS:000172473200022
J	Xie, XM; Shi, Q; Wu, P; Zhang, XY; Kambara, H; Su, JY; Yu, HB; Park, SY; Guo, RX; Ren, Q; Zhang, SD; Xu, YF; Silberstein, LE; Cheng, T; Ma, FX; Li, C; Luo, HBR				Xie, Xuemei; Shi, Qiang; Wu, Peng; Zhang, Xiaoyu; Kambara, Hiroto; Su, Jiayu; Yu, Hongbo; Park, Shin-Young; Guo, Rongxia; Ren, Qian; Zhang, Sudong; Xu, Yuanfu; Silberstein, Leslie E.; Cheng, Tao; Ma, Fengxia; Li, Cheng; Luo, Hongbo R.			Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection	NATURE IMMUNOLOGY			English	Article							BONE-MARROW NEUTROPHILS; HEMATOPOIETIC STEM; LINEAGE COMMITMENT; AGED NEUTROPHILS; R PACKAGE; GRANULES; PROGENITOR; DIFFERENTIATION; GRANULOPOIESIS; IDENTIFICATION	Luo and colleagues use single-cell RNA sequencing to provide a comprehensive transcriptional landscape of neutrophil maturation, function and fate decision in their steady state and during bacterial infection. The full neutrophil heterogeneity and differentiation landscape remains incompletely characterized. Here, we profiled >25,000 differentiating and mature mouse neutrophils using single-cell RNA sequencing to provide a comprehensive transcriptional landscape of neutrophil maturation, function and fate decision in their steady state and during bacterial infection. Eight neutrophil populations were defined by distinct molecular signatures. The three mature peripheral blood neutrophil subsets arise from distinct maturing bone marrow neutrophil subsets. Driven by both known and uncharacterized transcription factors, neutrophils gradually acquire microbicidal capability as they traverse the transcriptional landscape, representing an evolved mechanism for fine-tuned regulation of an effective but balanced neutrophil response. Bacterial infection reprograms the genetic architecture of neutrophil populations, alters dynamic transitions between subpopulations and primes neutrophils for augmented functionality without affecting overall heterogeneity. In summary, these data establish a reference model and general framework for studying neutrophil-related disease mechanisms, biomarkers and therapeutic targets at single-cell resolution.	[Xie, Xuemei; Wu, Peng; Zhang, Xiaoyu; Guo, Rongxia; Ren, Qian; Zhang, Sudong; Xu, Yuanfu; Cheng, Tao; Ma, Fengxia] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Tianjin, Peoples R China; [Xie, Xuemei; Zhang, Xiaoyu; Kambara, Hiroto; Su, Jiayu; Park, Shin-Young; Silberstein, Leslie E.; Luo, Hongbo R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Xie, Xuemei; Zhang, Xiaoyu; Kambara, Hiroto; Su, Jiayu; Park, Shin-Young; Silberstein, Leslie E.; Luo, Hongbo R.] Boston Childrens Hosp, Dept Lab Med, Stem Cell Program, Boston, MA 02115 USA; [Xie, Xuemei; Zhang, Xiaoyu; Kambara, Hiroto; Su, Jiayu; Park, Shin-Young; Silberstein, Leslie E.; Luo, Hongbo R.] Dana Farber Harvard Canc Ctr, Boston, MA 02215 USA; [Shi, Qiang; Su, Jiayu; Li, Cheng] Peking Univ, Ctr Bioinformat, Ctr Stat Sci, Sch Life Sci, Beijing, Peoples R China; [Yu, Hongbo] VA Boston Healthcare Syst, Dept Pathol & Lab Med, Boston, MA USA; [Yu, Hongbo] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Yu, Hongbo] Harvard Med Sch, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Peking University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ma, FX (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Tianjin, Peoples R China.; Luo, HBR (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.; Luo, HBR (corresponding author), Boston Childrens Hosp, Dept Lab Med, Stem Cell Program, Boston, MA 02115 USA.; Luo, HBR (corresponding author), Dana Farber Harvard Canc Ctr, Boston, MA 02215 USA.; Li, C (corresponding author), Peking Univ, Ctr Bioinformat, Ctr Stat Sci, Sch Life Sci, Beijing, Peoples R China.	mafengxia@ihcams.ac.cn; cheng_li@pku.edu.cn; Hongbo.Luo@childrens.harvard.edu	Ma, Fengxia/AAI-1653-2021; su, jiayu/GZK-9305-2022	Su, Jiayu/0000-0002-8997-9272; Shi, Qiang/0000-0003-1851-773X; Xie, Xuemei/0000-0001-7966-2733; Cheng, Tao/0000-0002-5925-2769	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2017-I2M-1-015, 2016-I2M-1-017, 2016-12M-1-003]; Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2018RC31002, 2018PT32034, 2017PT31033]; National Natural Science Foundation of China [31871266, 81970107, 81421002]; Natural Science Foundation of Tianjin City [18JCYBJC25700]; Chinese National Key Projects of Research and Development [2016YFA0100103]; NSFC [71532001]; National Institutes of Health [1 R01 AI142642, 1 R01 AI145274, 1 R01 AI141386, R01HL092020, P01 HL095489]; FAMRI [CIA 123008]	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); Chinese National Key Projects of Research and Development; NSFC(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI	The authors thank A. Hidalgo, L. G. Ng, J. Manis and L. Chai for helpful discussions and suggestions. F.M., Y.X. and T.C. are supported by grants from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2017-I2M-1-015, 2016-I2M-1-017 and 2016-12M-1-003), the Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2018RC31002, 2018PT32034 and 2017PT31033), the National Natural Science Foundation of China (81970107 and 81421002) and the Natural Science Foundation of Tianjin City (18JCYBJC25700). Q.S. and C.L. were supported by the National Natural Science Foundation of China (31871266), Chinese National Key Projects of Research and Development (2016YFA0100103) and NSFC Key Research Grant 71532001. H.R.L. is supported by National Institutes of Health grants (1 R01 AI142642, 1 R01 AI145274, 1 R01 AI141386, R01HL092020 and P01 HL095489) and a grant from FAMRI (CIA 123008). Part of the data analysis was performed on the High Performance Computing Platform of the Center for Life Sciences, Peking University.	Adlung L, 2018, NAT REV IMMUNOL, V18, P597, DOI 10.1038/s41577-018-0050-2; Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Benaglia T, 2009, J STAT SOFTW, V32, P1; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hoogendijk AJ, 2019, CELL REP, V29, P2505, DOI 10.1016/j.celrep.2019.10.082; Hou QM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aal4045; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Karatepe K, 2018, STEM CELL REP, V11, P1092, DOI 10.1016/j.stemcr.2018.10.004; Kim MH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39804; KJELDSEN L, 1993, BLOOD, V82, P3183; Kolaczkowska E, 2016, BLOOD, V128, P2280, DOI 10.1182/blood-2016-09-739680; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Kwak HJ, 2015, IMMUNITY, V42, P159, DOI 10.1016/j.immuni.2014.12.017; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Ley K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat4579; Loison F, 2014, J CLIN INVEST, V124, P4445, DOI 10.1172/JCI76246; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Muench DE, 2020, NATURE, V582, P109, DOI 10.1038/s41586-020-2227-7; Mullen K.M., 2012, NNLS LAWSON HANSON A; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Sorensen O, 1997, BLOOD, V90, P2796; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yvan-Charvet L, 2019, TRENDS IMMUNOL, V40, P598, DOI 10.1016/j.it.2019.05.004; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	69	147	150	12	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1119	+		10.1038/s41590-020-0736-z	http://dx.doi.org/10.1038/s41590-020-0736-z		JUL 2020	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32719519	Green Accepted, Green Submitted			2022-12-18	WOS:000553242700001
J	Song, WM; Colonna, M				Song, Wilbur M.; Colonna, Marco			The identity and function of microglia in neurodegeneration	NATURE IMMUNOLOGY			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA DEPOSITION; INNATE IMMUNE RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOUSE MODEL; MYELOID CELLS; TRANSGENIC MICE; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE	The predominant type of immune cell in the brain is the microglia, a type of tissue-resident macrophage. In a variety of neurodegenerative settings, microglia alter their transcriptional profile, morphology and function in similar ways; thus, these activated cells have been called 'degeneration-or disease-associated microglia' (DAM). These activated microglia can perform different functions and exert both positive effects and negative effects in different mouse disease models. In humans, mutations in genes expressed in microglia are linked to various neurodegenerative diseases. Here we provide an overview of the common microglial response to neurodegeneration and key contributing pathways; delineate the multifaceted functions of activated microglia spanning various diseases; and discuss insights from the study of human disease-associated genes. We argue that strong evidence from both mouse models and human genetics causally links the function of activated microglia to neurodegeneration.	[Song, Wilbur M.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu		Colonna, Marco/0000-0001-5222-4987				Acharya MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31545; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bialas AR, 2017, NATURE, V546, P539, DOI 10.1038/nature22821; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Chakrabarty P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-16; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dagher NN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0366-9; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haure-Mirande JV, 2017, ACTA NEUROPATHOL, V134, P769, DOI 10.1007/s00401-017-1737-3; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hong S., 2015, SCIENCE, V33, P395; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jiang T, 2016, NEUROBIOL AGING, V42, DOI 10.1016/j.neurobiolaging.2016.02.023; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kobayashi M, 2016, J NEUROSCI, V36, P11138, DOI 10.1523/JNEUROSCI.1238-16.2016; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lampron A, 2015, J EXP MED, V212, P481, DOI 10.1084/jem.20141656; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liao F, 2018, J CLIN INVEST, V128, P2144, DOI 10.1172/JCI96429; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim JE, 2011, AM J PATHOL, V179, P1095, DOI 10.1016/j.ajpath.2011.05.045; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Lund H, 2018, NAT IMMUNOL, V19, P435, DOI 10.1038/s41590-018-0091-5; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Main BS, 2016, GLIA, V64, P1590, DOI 10.1002/glia.23028; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Martinez-Muriana A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25663; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Minter MR, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0341-4; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Papageorgiou IE, 2016, P NATL ACAD SCI USA, V113, P212, DOI 10.1073/pnas.1513853113; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pottier C, 2016, NEUROBIOL AGING, V48, DOI 10.1016/j.neurobiolaging.2016.07.028; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Pridans C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03013; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prokop S, 2015, J EXP MED, V212, P1811, DOI 10.1084/jem.20150479; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Raj DDA, 2014, NEUROBIOL AGING, V35, P2147, DOI 10.1016/j.neurobiolaging.2014.03.025; Rangaraju S, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0254-8; REBECK GW, 1993, NEURON, V11, P575; Reichenbach N, 2018, J EXP MED, V215, P1649, DOI 10.1084/jem.20171487; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Sims R., NAT GENET; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Spiller KJ, 2018, NAT NEUROSCI, V21, P329, DOI 10.1038/s41593-018-0083-7; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Sudom A, 2018, J BIOL CHEM, V293, P12634, DOI 10.1074/jbc.RA118.002352; Tada M, 2016, ANN NEUROL, V80, P554, DOI 10.1002/ana.24754; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Ulrich JD, 2018, J EXP MED, V215, P1047, DOI 10.1084/jem.20171265; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Varvel NH, 2015, J EXP MED, V212, P1803, DOI 10.1084/jem.20150478; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Weitz TM, 2014, AM J PATHOL, V184, P2855, DOI 10.1016/j.ajpath.2014.07.004; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wong K, 2017, NAT IMMUNOL, V18, P633, DOI 10.1038/ni.3743; Wu PJ, 2017, NEUROIMMUNOMODULAT, V24, P29, DOI 10.1159/000477092; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031	176	147	150	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1048	1058		10.1038/s41590-018-0212-1	http://dx.doi.org/10.1038/s41590-018-0212-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30250185				2022-12-18	WOS:000445968600011
J	Rodrigues, PF; Alberti-Servera, L; Eremin, A; Grajales-Reyes, GE; Ivanek, R; Tussiwand, R				Rodrigues, Patrick Fernandes; Alberti-Servera, Llucia; Eremin, Anna; Grajales-Reyes, Gary E.; Ivanek, Robert; Tussiwand, Roxane			Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells	NATURE IMMUNOLOGY			English	Article							INTERFERON-PRODUCING CELLS; TRANSCRIPTION FACTOR E2-2; IN-VIVO; BONE-MARROW; HEMATOPOIETIC PROGENITOR; COMMITTED PROGENITORS; CLONOGENIC PROGENITOR; REGULATORY FACTOR-4; SUBSET DEVELOPMENT; REPRESSING ID2	Plasmacytoid dendritic cells (pDCs) are an immune subset devoted to the production of high amounts of type 1 interferons in response to viral infections. Whereas conventional dendritic cells (cDCs) originate mostly from a common dendritic cell progenitor (CDP), pDCs have been shown to develop from both CDPs and common lymphoid progenitors. Here, we found that pDCs developed predominantly from IL-7R(+) lymphoid progenitor cells. Expression of SiglecH and Ly6D defined pDC lineage commitment along the lymphoid branch. Transcriptional characterization of SiglecH(+) Ly6D(+) precursors indicated that pDC development requires high expression of the transcription factor IRF8, whereas pDC identity relies on TCF4. RNA sequencing of IL-7R(+) lymphoid and CDP-derived pDCs mirrored the heterogeneity of mature pDCs observed in single-cell analysis. Both mature pDC subsets are able to secrete type 1 interferons, but only myeloid-derived pDCs share with cDCs their ability to process and present antigen.	[Rodrigues, Patrick Fernandes; Alberti-Servera, Llucia; Eremin, Anna; Ivanek, Robert; Tussiwand, Roxane] Univ Basel, Dept Biomed, Basel, Switzerland; [Alberti-Servera, Llucia] Dept Human Genet, Leuven, Belgium; [Alberti-Servera, Llucia] VIB Ctr Biol Dis, Leuven, Belgium; [Grajales-Reyes, Gary E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ivanek, Robert] Swiss Inst Bioinformat, Basel, Switzerland	University of Basel; Flanders Institute for Biotechnology (VIB); Washington University (WUSTL); Swiss Institute of Bioinformatics	Tussiwand, R (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	r.tussiwand@unibas.ch		Tussiwand, Roxane/0000-0002-1712-868X; Ivanek, Robert/0000-0002-8403-056X; Rodrigues, Patrick/0000-0002-0214-0627	SNF [PP00P3_150714]; Novartis Foundation for medical biological research [16A052]	SNF; Novartis Foundation for medical biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. G. Rolink (DBM University of Basel), K. M. Murphy (Washington University in St. Louis), and P. Tsapogas (DBM University of Basel) for sharing reagents, expertise and discussions; B. Lambrecht and M. Guilliams ( VIB-UG-ent Center for Inflammation Research) for sharing data and reagents; M. Busslinger (Research Institute of Molecular Pathology IMP, Vienna) for kindly providing us with EbfhCD2 reporter mice; D. Schreiner and C King, for constant input and critical reading of the;manuscript; D. Lobes (DBM University of Basel), K. Eschbach and C. Beisel (Department of Biosystems Science and Engineering (D-BSSE.) University of Zurich, Basel) for excellent technical support; the DBM Microscopy Core Facility; A. Brulhart and all the animal caretakers of WRO1060; and C. Cannavo for IT support. This study was supported by SNF project number PP00P3_150714 and by the Novartis Foundation for medical biological research n.16A052. This work is dedicated to the memory of Ton Rolink.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Grajkowska LT, 2017, IMMUNITY, V46, P65, DOI 10.1016/j.immuni.2016.11.006; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano T, SCIENCE, V265; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tel J, 2013, CANCER RES, V73, P1063, DOI 10.1158/0008-5472.CAN-12-2583; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114	65	147	149	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					711	+		10.1038/s41590-018-0136-9	http://dx.doi.org/10.1038/s41590-018-0136-9			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925996				2022-12-18	WOS:000436341300016
J	Lanna, A; Gomes, DCO; Muller-Durovic, B; McDonnell, T; Escors, D; Gilroy, DW; Lee, JH; Karin, M; Akbar, AN				Lanna, Alessio; Gomes, Daniel C. O.; Muller-Durovic, Bojana; McDonnell, Thomas; Escors, David; Gilroy, Derek W.; Lee, Jun Hee; Karin, Michael; Akbar, Arne N.			A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging	NATURE IMMUNOLOGY			English	Article							PREVENT HERPES-ZOSTER; KINASE ACTIVATION; SENESCENCE; MTORC1; IDENTIFICATION; EXPRESSION; REGULATOR; PATHWAYS; STRESS; SYSTEM	Mitogen-activated protein kinases (MAPKs) including Erk, Jnk and p38 regulate diverse cellular functions and are thought to be controlled by independent upstream activation cascades. Here we show that the sestrins bind to and coordinate simultaneous Erk, Jnk and p38 MAPK activation in T lymphocytes within a new immune-inhibitory complex (sestrin MAPK activation complex. (sMAC)). Whereas sestrin ablation resulted in broad reconstitution of immune function in stressed T cells, inhibition of individual MAPKs allowed only partial functional recovery. T cells from old humans (>65 years old) or mice (16-20 months old) were more likely to form the sMAC, and disruption of this complex restored antigen-specific functional responses in these cells. Correspondingly, sestrin deficiency or simultaneous inhibition of all three MAPKs enhanced vaccine responsiveness in old mice. Thus, disruption of sMAC provides a foundation for rejuvenating immunity during aging.	[Lanna, Alessio; Gomes, Daniel C. O.; Muller-Durovic, Bojana; McDonnell, Thomas; Escors, David; Akbar, Arne N.] UCL, Div Infect & Immun, London, England; [Lanna, Alessio] Univ Oxford, Nuffield Dept Med, Oxford, England; [Gomes, Daniel C. O.] UFES, Nucleo Doencas Infecciosas, Nucleo Biotecnol, Vitoria, Spain; [Escors, David] IdisNA, Fdn Miguel Servet, Navarrabiomed Biomed Res Ctr, Complejo Hosp Navarra, Pamplona, Spain; [Gilroy, Derek W.] UCL, Div Med, London, England; [Lee, Jun Hee] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, San Diego Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Karin, Michael] Univ Calif San Diego, Dept Pathol, San Diego Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of London; University College London; University of Oxford; Navarrabiomed; Servicio Navarro de Salud - Osasunbidea; University of London; University College London; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Lanna, A; Akbar, AN (corresponding author), UCL, Div Infect & Immun, London, England.; Lanna, A (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	alessio.lanna@kennedy.ox.ac.uk; a.akbar@ucl.ac.uk	Escors-Murugarren, David/ABG-1930-2020; Muller-Durovic, Bojana/AAY-1699-2021; Lanna, Alessio/K-2053-2018; Escors, David/C-1549-2008; McDonnell, Thomas/Z-2464-2019; Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020	Escors-Murugarren, David/0000-0003-2828-4458; Lanna, Alessio/0000-0003-2215-3748; Escors, David/0000-0003-2828-4458; Gilroy, Derek/0000-0003-3476-0844; Muller-Durovic, Bojana/0000-0002-9672-3750; Akbar, Arne/0000-0002-3763-9380; Lee, Jun Hee/0000-0002-2200-6011; McDonnell, Thomas/0000-0002-1712-9957	Wellcome Trust [AZR00630]; Biotechnology and Biological Science Research Council [BB/L005328/1]; Coordination for the Improvement of Higher Education Personnel (CAPES Brazil) [99999.006198/2014-07]; Swiss National Foundation [P300PB_161092, P2BSP3_151877]; NIHR BRC; Miguel Servet Fellowship [CP12/03114]; FIS project from the Instituto de Salud Carlos III, Spain [PI14/00579]; Ellison Medical Foundation [AG-SS-2440-10]; NIH [R21AG045432]; M.L. Dustin (University of Oxford); BBSRC [BB/J006750/1, BB/L005328/1, BB/L005336/1, BB/E019188/1] Funding Source: UKRI; MRC [MR/N017749/1, MR/M003833/1, MR/P00184X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L005336/1, BB/E019188/1, BB/J006750/1] Funding Source: researchfish; Medical Research Council [MR/M003833/1, MR/P00184X/1, MR/N017749/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R21AG045432] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Coordination for the Improvement of Higher Education Personnel (CAPES Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NIHR BRC; Miguel Servet Fellowship; FIS project from the Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.L. Dustin (University of Oxford); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Sewell, D. Mosser and O. Franzese for discussions. Supported by the Wellcome Trust (AZR00630 to AL.) and the Biotechnology and Biological Science Research Council (BB/L005328/1 to A.N.A.). D.C.O.G. was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES Brazil) (grant number 99999.006198/2014-07). B.M.-D. was supported by the Swiss National Foundation (P300PB_161092 and P2BSP3_151877); T.M.D. was supported by an NIHR BRC grant; D.E. was supported by a Miguel Servet Fellowship (CP12/03114) and a FIS project (PI14/00579) from the Instituto de Salud Carlos III, Spain. Mouse Sestrin 1 studies were supported by the Ellison Medical Foundation (AG-SS-2440-10 to M.K.) and the NIH (R21AG045432 to J.H.L.). A.L. is a recipient of a Sir Henry Wellcome Trust Fellowship sponsored by M.L. Dustin (University of Oxford).	Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hay N, 2008, CELL METAB, V8, P184, DOI 10.1016/j.cmet.2008.08.010; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lanna A, 2013, J IMMUNOL, V191, P3744, DOI 10.4049/jimmunol.1301409; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Levin MJ, 2012, CURR OPIN IMMUNOL, V24, P494, DOI 10.1016/j.coi.2012.06.002; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Muller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011	37	147	149	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					354	363		10.1038/ni.3665	http://dx.doi.org/10.1038/ni.3665			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28114291	Green Submitted, Green Accepted			2022-12-18	WOS:000394413400015
J	Zeissig, S; Blumberg, RS				Zeissig, Sebastian; Blumberg, Richard S.			Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; GUT MICROBIOME; CHILDHOOD ASTHMA; ALLERGIC-ASTHMA; IMMUNE-SYSTEM; DELIVERY MODE; EXPOSURE; MICE; RISK; DIFFERENTIATION	This Commentary discusses how treatment with antibiotics in infancy shapes host immunity and influences susceptibility later in life to diseases mediated by the immune system.	[Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med, Kiel, Germany; [Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	University of Kiel; Schleswig Holstein University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zeissig, S (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Internal Med, Kiel, Germany.	rblumberg@partners.org	Zeissig, Sebastian/B-6297-2012	Zeissig, Sebastian/0000-0001-5124-0897	US National Institutes of Health [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK0034854]; European Research Council [336528]; European Commission [256363]; Deutsche Forschungsgemeinschaft [ZE814/4-1, ZE814/5-1, ZE814/6-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362, R37DK044319, R01DK053056, R01DK088199, P30DK034854, R01DK044319] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the US National Institutes of Health (DK044319, DK051362, DK053056 and DK088199 to R.S.B.), the Harvard Digestive Diseases Center (DK0034854 to R.S.B.), the European Research Council (Starting Grant Agreement 336528 to S.Z.), Deutsche Forschungsgemeinschaft (ZE814/4-1, ZE814/5-1 and ZE814/6-1, and the Excellence Cluster 'Inflammation at Interfaces', to S.Z.) and the European Commission (Marie Curie International Reintegration Grant 256363 to S.Z.).	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fohr C, 2005, BRIT J DERMATOL, V152, P202, DOI [10.1111/J.1365-2133.2005.06436.X, 10.1111/j.1365-2133.2004.06436.x]; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Norgaard M, 2011, AM J EPIDEMIOL, V174, P945, DOI 10.1093/aje/kwr201; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Oyama N, 2001, J ALLERGY CLIN IMMUN, V107, P153, DOI 10.1067/mai.2001.111142; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sudo N, 1997, J IMMUNOL, V159, P1739; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	47	147	155	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					307	310		10.1038/ni.2847	http://dx.doi.org/10.1038/ni.2847			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646587				2022-12-18	WOS:000333252000001
J	Call, ME; Wucherpfennig, KW; Chou, JJ				Call, Matthew E.; Wucherpfennig, Kai W.; Chou, James J.			The structural basis for intramembrane assembly of an activating immunoreceptor complex	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; IMMUNE RECEPTORS; HIV-1 PROTEASE; CHEMICAL-SHIFT; GXXXG MOTIF; PROTEINS; MEMBRANE; ASSOCIATION; EXPRESSION; RESIDUES	Many receptors that activate cells of the immune system are multisubunit membrane protein complexes in which ligand recognition and signaling functions are contributed by separate protein modules. Receptors and signaling subunits assemble through contacts among basic and acidic residues in their transmembrane domains to form the functional complexes. Here we report the nuclear magnetic resonance (NMR) structure of the membrane-embedded, heterotrimeric assembly formed by association of the DAP12 signaling module with the natural killer (NK) cell-activating receptor NKG2C. The main intramembrane contact site is formed by a complex electrostatic network involving five hydrophilic transmembrane residues. Functional mutagenesis demonstrated that similar polar intramembrane motifs are also important for assembly of the NK cell-activating NKG2D-DAP10 complex and the T cell antigen receptor (TCR)-invariant signaling protein CD3 complex. This structural motif therefore lies at the core of the molecular organization of many activating immunoreceptors.	[Call, Matthew E.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu; chou@cmcd.hms.harvard.edu	Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022	Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344; Call, Matthew/0000-0001-5846-6469	Helen Hay Whitney Foundation; Charles A. King Trust; US National Institutes of Health [R01AI054520, R01HL084329, EB002026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079388] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Charles A. King Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.C. Blacklow (Harvard Medical School) for pMM-LR6 vector; M.J. Call and members of the Chou lab for reading the manuscript and discussions; and J. Pyrdol for assistance with initial construct design and expression trials. Supported by the Helen Hay Whitney Foundation (M.E.C.), the Charles A. King Trust (M.E.C.) and the US National Institutes of Health (R01AI054520 to K.W.W., R01HL084329 to J.J.C. and EB002026 to the Center for Magnetic Resonance at the Massachusetts Institute of Technology, where NMR data were collected).	BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Exley M, 1991, Semin Immunol, V3, P283; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Keller RLJ, 2004, COMPUTER AIDED RESON; KUSTER H, 1990, J BIOL CHEM, V265, P6448; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Smith R, 1996, NAT STRUCT BIOL, V3, P946, DOI 10.1038/nsb1196-946; SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Trylska J, 1999, PROTEIN SCI, V8, P180; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	35	147	152	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1023	U73		10.1038/ni.1943	http://dx.doi.org/10.1038/ni.1943			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20890284	Green Accepted			2022-12-18	WOS:000283127800012
J	Grigorova, IL; Schwab, SR; Phan, TG; Pham, THM; Okada, T; Cyster, JG				Grigorova, Irina L.; Schwab, Susan R.; Phan, Tri Giang; Pham, Trung H. M.; Okada, Takaharu; Cyster, Jason G.			Cortical sinus probing, S1P(1)-dependent entry and flow-based capture of egressing T cells	NATURE IMMUNOLOGY			English	Article							LYMPH-NODE; SPHINGOSINE 1-PHOSPHATE; ENDOTHELIAL-CELLS; DEEP CORTEX; RECEPTORS; MACROPHAGES; EXPRESSION; TRAFFICKING; CHEMOKINES; MIGRATION	The cellular dynamics of the egress of lymphocytes from lymph nodes are poorly defined. Here we visualized the branched organization of lymph node cortical sinuses and found that after entry, some T cells were retained, whereas others returned to the parenchyma. T cells deficient in sphingosine 1-phosphate receptor type 1 probed the sinus surface but failed to enter the sinuses. In some sinuses, T cells became rounded and moved unidirectionally. T cells traveled from cortical sinuses into macrophage-rich sinus areas. Many T cells flowed from medullary sinuses into the subcapsular space. We propose a multistep model of lymph node egress in which cortical sinus probing is followed by entry dependent on sphingosine 1-phosphate receptor type 1, capture of cells in a sinus region with flow, and transport to medullary sinuses and the efferent lymph.	[Grigorova, Irina L.; Schwab, Susan R.; Phan, Tri Giang; Pham, Trung H. M.; Okada, Takaharu; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Grigorova, Irina L.; Schwab, Susan R.; Phan, Tri Giang; Pham, Trung H. M.; Okada, Takaharu; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020; Okada, Takaharu/N-7931-2015; Phan, Tri Giang/G-3937-2012	Grigorova, Irina/0000-0002-4963-7403; Phan, Tri Giang/0000-0002-4909-2984; Schwab, Susan/0000-0002-0834-0822; Pham, Trung/0000-0003-2724-2547	Cancer Research Institute; Irvington Institute for Immunological Research; National Health and Medical Research Council; American Australian Association; Boyer Graduate Program in the Biochemical Sciences; Howard Hughes Medical Institute; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847, R01AI045073] Funding Source: NIH RePORTER	Cancer Research Institute; Irvington Institute for Immunological Research; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Australian Association; Boyer Graduate Program in the Biochemical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Bullen and M. Krummel for help with the two-photon microscope; R. Proia ( US National Cancer Institute) for S1P<INF>1</INF>-deficient mice; L. Shiow for help with movie preparation; and J. An for colony management. Supported by the Cancer Research Institute ( I. L. G.), the Irvington Institute for Immunological Research ( S. R. S.), the National Health and Medical Research Council and American Australian Association ( T. G. P.), the Boyer Graduate Program in the Biochemical Sciences ( T. H. M. P.), the Howard Hughes Medical Institute ( J. G. C.) and the National Institutes of Health.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; BELISLE C, 1981, ANAT REC, V199, P213, DOI 10.1002/ar.1091990206; COMPTON CC, 1985, ANAT RECORD, V212, P408, DOI 10.1002/ar.1092120412; Crivellato E, 1998, J SUBMICR CYTOL PATH, V30, P495; Dahan A, 2007, EUR J PHARM SCI, V32, P367, DOI 10.1016/j.ejps.2007.09.005; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Dickstein JB, 2000, SLEEP, V23, P185; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; ENGESET A, 1977, LYMPHOLOGY, V10, P198; FROST P, 1974, IMMUNOLOGY, V27, P609; HE Y, 1985, ARCH HISTOL JAPON, V48, P1, DOI 10.1679/aohc.48.1; HEATH TJ, 1987, J ANAT, V155, P177; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; KELLY RH, 1975, INT ARCH ALLER A IMM, V48, P836, DOI 10.1159/000231371; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NICANDER L, 1991, J ANAT, V178, P203; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; PICKER LJ, 1999, FUNDAMENTAL IMMUNOLO, V4, P479; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; YAMADA S, 1988, JPN J PHYSIOL, V38, P729, DOI 10.2170/jjphysiol.38.729	39	147	148	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					58	65		10.1038/ni.1682	http://dx.doi.org/10.1038/ni.1682			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19060900	Green Accepted, Green Submitted			2022-12-18	WOS:000261788800012
J	Lizee, G; Basha, G; Tiong, J; Julien, JP; Tian, MM; Biron, KE; Jefferies, WA				Lizee, G; Basha, G; Tiong, J; Julien, JP; Tian, MM; Biron, KE; Jefferies, WA			Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; MEDIATED PHAGOCYTOSIS; ANTIGEN PRESENTATION; PROCESSING PATHWAYS; EXOGENOUS ANTIGENS; SORTING SIGNAL; SENDAI-VIRUS; MOLECULES; PEPTIDE; EXPRESSION	Dendritic cells (DCs) can present extracellularly derived antigens in the context of major histocompatibility complex (MHC) class I molecules, a process called cross-presentation. Although recognized to be important for priming of T cell responses to many viral, bacterial and tumor antigens, the mechanistic details of this alternative antigen-presentation pathway are poorly understood. We demonstrate here the existence of an endolysosomal compartment in DCs where exogenously derived peptides can be acquired for presentation to T cells, and show that the MHC class I cytoplasmic domain contains a tyrosine-based targeting signal required for routing MHC class I molecules through these compartments. We also report that transgenic mice expressing H-2K(b) with a tyrosine mutation mount inferior H-2K(b)-restricted cytotoxic T lymphocyte responses against two immunodominant viral epitopes, providing evidence of a crucial function for cross-priming in antiviral immunity.	Univ British Columbia, Biomed Res Ctr, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; McGill University	Jefferies, WA (corresponding author), Univ British Columbia, Biomed Res Ctr, Biotechnol Lab, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wilf@brc.ubc.ca		Lizee, Gregory/0000-0003-4449-7461				Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Andrieu M, 2001, AIDS RES HUM RETROV, V17, P1365, DOI 10.1089/08892220152596623; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; GUILD BC, 1984, J BIOL CHEM, V259, P9235; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; LIU TM, 1995, J IMMUNOL, V154, P3147; Liu TM, 1997, J IMMUNOL, V159, P5364; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; MOTAL UMA, 1995, EUR J IMMUNOL, V25, P1121, DOI 10.1002/eji.1830250441; MURRE C, 1984, NATURE, V307, P432, DOI 10.1038/307432a0; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Park B, 2001, IMMUNITY, V15, P213, DOI 10.1016/S1074-7613(01)00179-0; Pathak SS, 2000, TRAFFIC, V1, P561, DOI 10.1034/j.1600-0854.2000.010706.x; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; ROSENTHAL KL, 1981, J IMMUNOL, V126, P446; Schirmbeck R, 1997, EUR J IMMUNOL, V27, P2016, DOI 10.1002/eji.1830270828; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Svensson M, 1999, EUR J IMMUNOL, V29, P180, DOI 10.1002/(SICI)1521-4141(199901)29:01<180::AID-IMMU180>3.0.CO;2-W; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Watts C, 2002, CURR BIOL, V12, pR666, DOI 10.1016/S0960-9822(02)01163-6; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; ZUNIGA MC, 1983, CELL, V34, P535, DOI 10.1016/0092-8674(83)90386-0	50	147	156	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1065	1073		10.1038/ni989	http://dx.doi.org/10.1038/ni989			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14566337				2022-12-18	WOS:000186241100010
J	Rui, LX; Vinuesa, CG; Blasioli, J; Goodnow, CC				Rui, LX; Vinuesa, CG; Blasioli, J; Goodnow, CC			Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling	NATURE IMMUNOLOGY			English	Article							BACTERIAL-DNA; RHEUMATOID-FACTOR; TRANSGENIC MICE; SELF-TOLERANCE; LYMPHOCYTES-B; POSITIVE SELECTION; T-LYMPHOCYTES; B-1 CELLS; ANTIBODIES; ACTIVATION	CpG sequences in self-DNA are an important potential trigger for autoantibody secretion in systemic lupus and other systemic autoimmune disorders. It is not known how this ubiquitous threat may be controlled by active mechanisms for maintaining self tolerance. Here we show that two distinct mechanisms oppose autoantibody secretion induced by CpG DNA in anergic B cells that are constantly binding self-antigen. Uncoupling of the antigen receptor (BCR) from a calcineurin-dependent pathway prevents signals that synergize with CpG DNA for proliferation. The BCR does not become desensitized by activating the extracellular response kinase (ERK) MAP kinase pathway, however, and continuous self-antigen signaling to ERK inhibits CpG DNA-induced plasma cell differentiation. These two mechanisms seem to act as a general control against autoantibody production elicited by Toll-like receptors, and their regulation of T cell-independent responses to Toll-like receptor 9 (TLR9) is probably crucial for resistance to systemic autoimmunity.	Australian Natl Univ, ACRF Genet Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia	Australian National University; Australian National University; John Curtin School of Medical Research	Goodnow, CC (corresponding author), Australian Natl Univ, ACRF Genet Lab, GPO Box 4, Canberra, ACT 2601, Australia.		rui, li/GYR-3791-2022; Goodnow, Christopher C/V-8108-2018; li, rui/GSD-4367-2022; Vinuesa, Carola G/B-1108-2010	Goodnow, Christopher C/0000-0001-5296-6155; Vinuesa, Carola G/0000-0001-9799-0298				Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bowes T, 2002, INFECT IMMUN, V70, P5008, DOI 10.1128/IAI.70.9.5008-5018.2002; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; COUTINHO A, 1974, SCAND J IMMUNOL, V3, P133, DOI 10.1111/j.1365-3083.1974.tb01241.x; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; DESAI DD, 1993, J IMMUNOL, V151, P1614; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DRESSER DW, 1978, NATURE, V274, P480, DOI 10.1038/274480a0; EAST J, 1967, LANCET, V1, P755; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; GILKESON GS, 1989, J IMMUNOL, V142, P1482; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goeckeritz BE, 1999, INT IMMUNOL, V11, P1693, DOI 10.1093/intimm/11.10.1693; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; IZUI S, 1979, J IMMUNOL, V122, P2096; Julien S, 2002, J IMMUNOL, V169, P4198, DOI 10.4049/jimmunol.169.8.4198; Jung J, 2002, J IMMUNOL, V169, P2368, DOI 10.4049/jimmunol.169.5.2368; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MOLLER G, 1976, J EXP MED, V143, P1429, DOI 10.1084/jem.143.6.1429; MURAKAMI M, 1994, J EXP MED, V180, P111, DOI 10.1084/jem.180.1.111; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Nguyen KAT, 1997, J IMMUNOL, V159, P2633; Pisetsky DS, 2001, ISRAEL MED ASSOC J, V3, P850; PRIMI D, 1977, J EXP MED, V145, P21, DOI 10.1084/jem.145.1.21; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rifkin IR, 2000, J IMMUNOL, V165, P1626, DOI 10.4049/jimmunol.165.3.1626; Seo Su-jean, 2003, Curr Dir Autoimmun, V6, P1; STEELE EJ, 1978, NATURE, V274, P483, DOI 10.1038/274483a0; STOLLAR BD, 1986, CRC CR REV BIOCH MOL, V20, P1, DOI 10.3109/10409238609115899; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; TSAO BP, 1993, EUR J IMMUNOL, V23, P2332, DOI 10.1002/eji.1830230942; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; Wang HW, 1997, J IMMUNOL, V159, P1125; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247	52	147	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					594	600		10.1038/ni924	http://dx.doi.org/10.1038/ni924			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12740574				2022-12-18	WOS:000183175500020
J	Colucci, F; Di Santo, JP; Leibson, PJ				Colucci, F; Di Santo, JP; Leibson, PJ			Natural killer cell activation in mice and men: different triggers for similar weapons?	NATURE IMMUNOLOGY			English	Review							PROTEIN-TYROSINE KINASE; HUMAN NK CELLS; CUTTING EDGE; MEDIATED CYTOTOXICITY; MURINE CYTOMEGALOVIRUS; INHIBITORY RECEPTORS; SIGNAL-TRANSDUCTION; FUNCTIONAL-ROLE; IMMUNE-SYSTEM; GENE-PRODUCT	The signaling pathways that regulate B and T lymphocytes are remarkably conserved between humans and mice. However, recent evidence suggests that the pathways regulating natural killer (NK) cell activation may actually differ between these two species. We discuss the controversies in the field and propose that this divergence could be deceptive: despite some clear differences between human and mouse NK cell receptors, the many ways of activating NK cells and their functions may well be conserved.	Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Inst Pasteur, Unit Cytokines & Lymphoid Dev, Paris, France	Mayo Clinic; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Colucci, F (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	cecco@pasteur.fr	Di Santo, James P/M-4298-2014; Colucci, Francesco/F-2844-2010	Di Santo, James P/0000-0002-7146-1862; Colucci, Francesco/0000-0001-5193-6376				Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; Basse P H, 2001, Int Rev Immunol, V20, P439, DOI 10.3109/08830180109054416; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Binstadt BA, 1998, J BIOL CHEM, V273, P27518, DOI 10.1074/jbc.273.42.27518; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Boles KS, 2001, IMMUNOL REV, V181, P234, DOI 10.1034/j.1600-065X.2001.1810120.x; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Colucci F, 1999, J IMMUNOL, V163, P1769; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Fehniger T A, 2001, Int Rev Immunol, V20, P503, DOI 10.3109/08830180109054417; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Gismondi A, 2000, J IMMUNOL, V164, P2272, DOI 10.4049/jimmunol.164.5.2272; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; HERCEND T, 1988, IMMUNOL TODAY, V9, P291, DOI 10.1016/0167-5699(88)91317-5; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jevremovic D, 1999, J IMMUNOL, V162, P2453; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Karre K, 1991, Semin Cancer Biol, V2, P295; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Krmpotic A, 2002, NAT IMMUNOL, V3, P529, DOI 10.1038/ni799; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Long EO, 2001, IMMUNOL REV, V181, P223, DOI 10.1034/j.1600-065X.2001.1810119.x; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Perussia B, 2000, NAT IMMUNOL, V1, P372, DOI 10.1038/80808; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Smith KM, 1998, J IMMUNOL, V161, P7; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tangye SG, 1999, J IMMUNOL, V162, P6981; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Williams NS, 1999, J IMMUNOL, V163, P2648; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yamada H, 1996, J IMMUNOL, V157, P1523; Yoder JA, 2001, P NATL ACAD SCI USA, V98, P6771, DOI 10.1073/pnas.121101598; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	72	147	151	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					807	813		10.1038/ni0902-807	http://dx.doi.org/10.1038/ni0902-807			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205470				2022-12-18	WOS:000177694900008
J	Faili, A; Aoufouchi, S; Gueranger, Q; Zober, C; Leon, A; Bertocci, B; Weill, JC; Reynaud, CA				Faili, A; Aoufouchi, S; Gueranger, Q; Zober, C; Leon, A; Bertocci, B; Weill, JC; Reynaud, CA			AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line	NATURE IMMUNOLOGY			English	Article							CYTIDINE DEAMINASE AID; IG GENE HYPERMUTATION; IMMUNOGLOBULIN GENES; BREAKS; POLYMERASE; SUGGESTS; INDUCTION; SEQUENCES; MUTATION; PATHWAY	Immunoglobulin (Ig) gene hypermutation can be induced in the BL2 Burkitt's lymphoma cell line by IgM cross-linking and coculture with normal or transformed T helper clones. We describe here a T cell-independent in vitro induction assay, by which hypermutation is induced in BL2 cells through simultaneous aggregation of three surface receptors: IgM, CD19 and CD21. The mutations arise as a post-transcriptional event within 90 min. They are stably introduced in the G1 phase of the cell cycle, occurring in one of the two variable gene DNA strands, and eventually become fixed by replication in one of the daughter cells. Inactivation of AID (activation-induced cytidine deaminase) by homologous recombination in BL2 cells completely inhibits the process, thus validating this induction procedure as a model for the in vivo mechanism.	Fac Med Necker Enfants Malad, INSERM, U373, Paris, France; EFS, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Reynaud, CA (corresponding author), Fac Med Necker Enfants Malad, INSERM, U373, Paris, France.	reynaud@necker.fr	Aoufouchi, Said/I-2985-2016; AOUFOUCHI, Said/P-9926-2019; Bertocci, Barbara/L-9115-2018	AOUFOUCHI, Said/0000-0001-6547-2664; Gueranger, Quentin/0000-0002-9507-8315				Aoufouchi S, 1997, HYBRIDOMA, V16, P583; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bachl J, 1996, P NATL ACAD SCI USA, V93, P851, DOI 10.1073/pnas.93.2.851; Bertocci B, 1998, IMMUNITY, V9, P257, DOI 10.1016/S1074-7613(00)80608-1; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Denepoux S, 2000, J IMMUNOL, V164, P1306, DOI 10.4049/jimmunol.164.3.1306; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; DINZ M, 2002, CURR OPIN IMMUNOL, V14, P235; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Kong QZ, 2001, GENETICS, V158, P369; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; MITTRUCKER HW, 1993, INT IMMUNOL, V5, P985, DOI 10.1093/intimm/5.8.985; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 1996, CURR TOP MICROBIOL, V212, P7; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Weill JC, 2002, ADV IMMUNOL, V80, P183, DOI 10.1016/S0065-2776(02)80015-3; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang W, 2001, INT IMMUNOL, V13, P1175, DOI 10.1093/intimm/13.9.1175	43	147	152	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					815	821		10.1038/ni826	http://dx.doi.org/10.1038/ni826			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12145648				2022-12-18	WOS:000177694900009
J	Tedford, K; Nitschke, L; Girkontaite, I; Charlesworth, A; Chan, G; Sakk, V; Barbacid, M; Fischer, KD				Tedford, K; Nitschke, L; Girkontaite, I; Charlesworth, A; Chan, G; Sakk, V; Barbacid, M; Fischer, KD			Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling	NATURE IMMUNOLOGY			English	Article							XID-LIKE IMMUNODEFICIENCY; EXCHANGE FACTOR VAV; T-CELL; NEGATIVE SELECTION; POSITIVE SELECTION; TYROSINE KINASE; ADAPTER PROTEIN; LINKER PROTEIN; DEFICIENT MICE; SH2 DOMAIN	Vav-1 and Vav-2 are closely related Dbl-homology CTP exchange factors (GEFs) for Rho GTPases. Mutation of Vav-1 disrupts T cell development and T cell antigen receptor-induced activation, but has comparatively little effect on B cells. We found that combined deletion of both Vav-1 and Vav-2 in mice resulted in a marked reduction in mature B lymphocyte numbers. Vav-1(-/-)Vav-2(-/-) B cells were unresponsive to B cell antigen receptor (BCR)-driven proliferation in vitro and to thymus-independent antigen in vivo. BCR-stimulated intracellular calcium mobilization was greatly impaired in Vav1(-/-)Vav-2(-/-) B cells. These findings establish a role for Vav-2 in BCR calcium signaling and reveal that the Vav family of GEFs is critical to B cell development and function.	Univ Ulm, Abt Physiol Chem, D-89069 Ulm, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany; Univ Chicago, Dept Med, Chicago, IL 60637 USA; M Barbacid Ctr Nacl Invest Oncol Carlos III, Madrid 28220, Spain	Ulm University; University of Wurzburg; University of Wurzburg; University of Chicago	Fischer, KD (corresponding author), Univ Ulm, Abt Physiol Chem, Albert Einstein Allee 11, D-89069 Ulm, Germany.	klaus.fischer@medizin.uni-ulm.de	Girkontaite, Irute/K-9017-2013	Girkontaite, Irute/0000-0002-3659-3202				Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Bachmann MF, 1999, J IMMUNOL, V163, P137; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fu C, 1997, J BIOL CHEM, V272, P27362, DOI 10.1074/jbc.272.43.27362; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gulbranson-Judge A, 1999, EUR J IMMUNOL, V29, P477, DOI 10.1002/(SICI)1521-4141(199902)29:02&lt;477::AID-IMMU477&gt;3.0.CO;2-V; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kelly ME, 2000, CURR OPIN IMMUNOL, V12, P267, DOI 10.1016/S0952-7915(00)00086-8; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Klaus GGB, 1997, EUR J IMMUNOL, V27, P2749, DOI 10.1002/eji.1830271102; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schuebel KE, 1996, ONCOGENE, V13, P363; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; WENG WK, 1994, J BIOL CHEM, V269, P32514; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wu J, 1997, J EXP MED, V185, P1877, DOI 10.1084/jem.185.10.1877; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZMUIDZINAS A, 1995, EMBO J, V14, P1	57	147	148	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					548	555		10.1038/88756	http://dx.doi.org/10.1038/88756			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376343				2022-12-18	WOS:000169078000019
J	Srikanth, S; Woo, JS; Wu, BB; El-Sherbiny, YM; Leung, J; Chupradit, K; Rice, L; Seo, GJ; Calmettes, G; Ramakrishna, C; Cantin, E; An, DS; Sun, R; Wu, TT; Jung, JU; Savic, S; Gwack, Y				Srikanth, Sonal; Woo, Jin Seok; Wu, Beibei; El-Sherbiny, Yasser M.; Leung, Jennifer; Chupradit, Koollawat; Rice, Laura; Seo, Gil Ju; Calmettes, Guillaume; Ramakrishna, Chandran; Cantin, Edouard; An, Dong Sung; Sun, Ren; Wu, Ting-Ting; Jung, Jae U.; Savic, Sinisa; Gwack, Yousang			The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum	NATURE IMMUNOLOGY			English	Article							CYCLIC GMP-AMP; ACTIVATION; MUTATIONS; PROTEIN; IMMUNODEFICIENCY; TRANSLOCATION; INFECTION; CHANNELS; ORAI1; CELL	Stimulator of interferon genes (STING) is an endoplasmic reticulum (ER) signaling adaptor that is essential for the type I interferon response to DNA pathogens. Aberrant activation of STING is linked to the pathology of autoimmune and autoinflammatory diseases. The rate-limiting step for the activation of STING is its translocation from the ER to the ER-Golgi intermediate compartment. Here, we found that deficiency in the Ca2+ sensor stromal interaction molecule 1 (STIM1) caused spontaneous activation of STING and enhanced expression of type I interferons under resting conditions in mice and a patient with combined immunodeficiency. Mechanistically, STIM1 associated with STING to retain it in the ER membrane, and coexpression of full-length STIM1 or a STING-interacting fragment of STIM1 suppressed the function of dominant STING mutants that cause autoinflammatory diseases. Furthermore, deficiency in STIM1 strongly enhanced the expression of type I interferons after viral infection and prevented the lethality of infection with a DNA virus in vivo. This work delineates a STIM1-STING circuit that maintains the resting state of the STING pathway.	[Srikanth, Sonal; Woo, Jin Seok; Wu, Beibei; Leung, Jennifer; Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [El-Sherbiny, Yasser M.; Savic, Sinisa] St James Univ Hosp, Leeds Biomed Res Ctr, Natl Inst Hlth Res, Wellcome Trust Brenner Bldg, Leeds, W Yorkshire, England; [El-Sherbiny, Yasser M.] St James Univ Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Wellcome Trust Brenner Bldg, Leeds, W Yorkshire, England; [El-Sherbiny, Yasser M.] Mansoura Univ, Clin Pathol Dept, Fac Med, Mansoura, Egypt; [El-Sherbiny, Yasser M.] Nottingham Trent Univ, Sch Sci & Technol, Dept Biosci, Nottingham, England; [Chupradit, Koollawat; An, Dong Sung] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Chupradit, Koollawat; An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Chupradit, Koollawat; An, Dong Sung] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Rice, Laura] Univ Leeds, Leeds Inst Biomed & Clin Sci, St Jamess Univ Hosp, Wellcome Trust Brenner Bldg, Leeds, W Yorkshire, England; [Seo, Gil Ju; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Calmettes, Guillaume] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Los Angeles, CA 90095 USA; [Ramakrishna, Chandran; Cantin, Edouard] City Hope Beckman Res Inst, Dept Mol Immunol, Duarte, CA USA; [Sun, Ren; Wu, Ting-Ting] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Savic, Sinisa] St James Univ Hosp, Dept Clin Immunol & Allergy, Leeds, W Yorkshire, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Leeds Biomedical Research Centre; Saint James's University Hospital; Saint James's University Hospital; Egyptian Knowledge Bank (EKB); Mansoura University; Nottingham Trent University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Saint James's University Hospital; University of Leeds; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; Saint James's University Hospital	Srikanth, S; Gwack, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	ssrikanth@mednet.ucla.edu; ygwack@mednet.ucla.edu	El-Sherbiny, Yasser M/I-4055-2013; Savic, Sinisa/Q-6217-2019	El-Sherbiny, Yasser M/0000-0003-4791-3475; Savic, Sinisa/0000-0001-7910-0554; Woo, Jin Seok/0000-0001-8921-2832	National Institutes of Health [AI083432, DE028432, AI130653]; Fletcher Jones Foundation; Whittier Foundation;  [CA180779];  [CA200422];  [AI073099];  [AI116585];  [AI129496];  [AI140705];  [DE023926];  [DE027888]; NATIONAL CANCER INSTITUTE [R35CA200422, P01CA180779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073099, R01AI083432, R21AI130653, R01AI140705, R21AI129496, R01AI116585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE027888, R21DE028269, R01DE023926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fletcher Jones Foundation; Whittier Foundation; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S. Bensinger (UCLA) for sharing THP1 cells, and X. Liu and S. Smale (UCLA) for BMDM differentiation protocols and reagents. We thank N.-H. Park, K.-H. Shin, M.K. Kang, R. Kim, Y. Wang, and T.M. Vondriska for sharing their confocal imaging facilities. We thank J.-L. Casanova (Rockefeller University) for providing STIM1 patient B cell line. This work was supported by the National Institutes of Health grants AI083432 and DE028432 (Y.G.) and AI130653 (S. Srikanth). This work was also supported in part by CA180779, CA200422, AI073099, AI116585, AI129496, AI140705, DE023926, DE027888, the Fletcher Jones Foundation, and the Whittier Foundation (J.U.J.).	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Baba Y, 2016, CURR TOP MICROBIOL, V393, P143, DOI 10.1007/82_2015_477; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Li T., 2018, J EXP MED, V17, P1142; Li Y, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0159-2; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Notarangelo LD, 2016, NAT REV IMMUNOL, V16, P234, DOI 10.1038/nri.2016.28; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rice A., 2018, PREPRINT, DOI [10.31219/osf.io/4duxt, DOI 10.31219/OSF.IO/4DUXT]; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shang YF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005037; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Srikanth S, 2017, ADV EXP MED BIOL, V993, P397, DOI 10.1007/978-3-319-57732-6_21; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	40	146	148	6	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					152	+		10.1038/s41590-018-0287-8	http://dx.doi.org/10.1038/s41590-018-0287-8			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643259	Green Accepted, Green Submitted			2022-12-18	WOS:000456279100013
J	Guy, CS; Vignali, KM; Temirov, J; Bettini, ML; Overacre, AE; Smeltzer, M; Zhang, H; Huppa, JB; Tsai, YH; Lobry, C; Xie, JM; Dempsey, PJ; Crawford, HC; Aifantis, I; Davis, MM; Vignali, DAA				Guy, Clifford S.; Vignali, Kate M.; Temirov, Jamshid; Bettini, Matthew L.; Overacre, Abigail E.; Smeltzer, Matthew; Zhang, Hui; Huppa, Johannes B.; Tsai, Yu-Hwai; Lobry, Camille; Xie, Jianming; Dempsey, Peter J.; Crawford, Howard C.; Aifantis, Iannis; Davis, Mark M.; Vignali, Dario A. A.			Distinct TCR signaling pathways drive proliferation and cytokine production in T cells	NATURE IMMUNOLOGY			English	Article							IN-VIVO; ADAPTER PROTEINS; C-MYC; NOTCH; ACTIVATION; ACTIN; LINKS; VAV; NCK; MICROCLUSTERS	The physiological basis and mechanistic requirements for a large number of functional immunoreceptor tyrosine-based activation motifs (ITAMs; high ITAM multiplicity) in the complex of the T cell antigen receptor (TCR) and the invariant signaling protein CD3 remain obscure. Here we found that whereas a low multiplicity of TCR-CD3 ITAMs was sufficient to engage canonical TCR-induced signaling events that led to cytokine secretion, a high multiplicity of TCR-CD3 ITAMs was required for TCR-driven proliferation. This was dependent on the formation of compact immunological synapses, interaction of the adaptor Vav1 with phosphorylated CD3 ITAMs to mediate the recruitment and activation of the oncogenic transcription factor Notch1 and, ultimately, proliferation induced by the cell-cycle regulator c-Myc. Analogous mechanistic events were also needed to drive proliferation in response to weak peptide agonists. Thus, the TCR-driven pathways that initiate cytokine secretion and proliferation are separable and are coordinated by the multiplicity of phosphorylated ITAMs in TCR-CD3.	[Guy, Clifford S.; Vignali, Kate M.; Bettini, Matthew L.; Overacre, Abigail E.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Temirov, Jamshid] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Smeltzer, Matthew; Zhang, Hui] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Huppa, Johannes B.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Immune Recognit Unit, Vienna, Austria; [Tsai, Yu-Hwai; Dempsey, Peter J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Lobry, Camille; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, Howard Hughes Med Inst, New York, NY USA; [Lobry, Camille; Aifantis, Iannis] NYU, NYU Canc Inst, New York, NY USA; [Xie, Jianming; Davis, Mark M.] Stanford Sch Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Palo Alto, CA USA; [Crawford, Howard C.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Medical University of Vienna; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; New York University; New York University; Howard Hughes Medical Institute; Stanford University; Mayo Clinic	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	lobry, camille/A-6188-2015; Zhang, Hui/E-8112-2010; Huppa, Johannes Bernhard/AAY-9471-2021; Xie, Jianming/AAC-6359-2019	lobry, camille/0000-0003-0550-4921; Huppa, Johannes Bernhard/0000-0003-2634-8198; Xie, Jianming/0000-0003-4112-650X; Smeltzer, Matthew/0000-0003-1366-9267; Overacre, Abigail/0000-0003-4027-3487; Davis, Mark/0000-0001-6868-657X; Zhang, Hui/0000-0001-6825-5649	SJCRH; National Cancer Institute (SJCRH) [P30 CA021765]; Department of Immunology Imaging Facility (SJCRH); US National Institutes of Health [R01 AI052199]; St. Jude National Cancer Institute Comprehensive Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA149655, R03CA129579, R01CA159222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022511, R01AI052199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093697] Funding Source: NIH RePORTER	SJCRH; National Cancer Institute (SJCRH); Department of Immunology Imaging Facility (SJCRH); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Jude National Cancer Institute Comprehensive Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P.J. Dempsey (University of Michigan) for Adam10<SUP>fl/fl</SUP> mice; I. Aifantis (New York University School of Medicine) for Notch1<SUP>fl/fl</SUP> mice; D. Green (SJCRH) for tamoxifen-inducible c-Myc and for critical review of the manuscript; R. Kubo (CytelCorp) for antibody H146-968 (to CD3 zeta); D. Littman (New York University School of Medicine) for constitutively active Lck; J. Gray (SJCRH) for the third-generation lentiviral vector pCML20; K. Forbes and A. McKenna for the maintenance, breeding and genotyping of mouse colonies; members of the Vignali laboratory for assistance with bone marrow collection; and R.Cross, S. Morgan and G. Lennon of the Department of Immunology Flow Lab (SJCRH) for cell sorting; the staff of the Shared Animal Resource Center (SJCRH) for animal husbandry; and the Hartwell Center for Biotechnology and Bioinformatics (SJCRH) for the synthesis of primers and probes for real-time PCR. Images were acquired at the Cell & Tissue Imaging Center (supported by SJCRH and the National Cancer Institute (P30 CA021765)) and the Department of Immunology Imaging Facility (both at SJCRH). Supported by the US National Institutes of Health (R01 AI052199 to D.A.A.V.), the St. Jude National Cancer Institute Comprehensive Cancer Center (CA21765 to D.A.A.V.) and the American Lebanese Syrian Associated Charities (D.A.A.V.).	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Finco TS, 1999, COLD SPRING HARB SYM, V64, P265, DOI 10.1101/sqb.1999.64.265; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Guy CS, 2009, IMMUNOL REV, V232, P7, DOI 10.1111/j.1600-065X.2009.00843.x; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Hsieh EH, 2012, DEV COMP IMMUNOL, V37, P306, DOI 10.1016/j.dci.2012.04.003; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Luty WH, 2007, J IMMUNOL, V179, P819, DOI 10.4049/jimmunol.179.2.819; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rogers PR, 1998, J IMMUNOL, V160, P3698; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	44	146	155	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					262	270		10.1038/ni.2538	http://dx.doi.org/10.1038/ni.2538			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23377202	Green Accepted			2022-12-18	WOS:000315065400016
J	Wang, F; Ma, YY; Barrett, JW; Gao, XJ; Loh, J; Barton, E; Virgin, HW; McFadden, G				Wang, F; Ma, YY; Barrett, JW; Gao, XJ; Loh, J; Barton, E; Virgin, HW; McFadden, G			Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier	NATURE IMMUNOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; GENE-EXPRESSION; MICE REVEALS; KAPPA-B; CELLS; REQUIREMENT; INHIBITION; RECEPTORS; RESPONSES	Myxoma virus, a member of the poxvirus family, causes lethal infection only in rabbits, but the mechanism underlying the strict myxoma virus species barrier is not known. Here we show that myxoma virus infection of primary mouse embryo fibroblasts elicited extracellular signal-regulated kinase (Erk) signaling, which was integrated to interferon regulatory factor 3 activation and type I interferon induction. We further show that Erk inactivation or disruption of interferon signaling mediated by the transcription factor STAT1 broke the cellular blockade to myxoma virus multiplication. Moreover, STAT1 deficiency rendered mice highly susceptible to lethal myxoma virus infection. Thus, the Erk-interferon-STAT1 signaling cascade elicited by myxoma virus in nonpermissive primary mouse embryo fibroblasts mediates an innate cellular barrier to poxvirus infection.	Univ Western Ontario, Robarts Res Inst, London, ON N6G 2V4, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Washington University (WUSTL); Washington University (WUSTL)	McFadden, G (corresponding author), Univ Western Ontario, Robarts Res Inst, London, ON N6G 2V4, Canada.	mcfadden@robarts.ca		McFadden, Grant/0000-0002-2556-3526; Virgin, Herbert/0000-0001-8580-7628				Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Booth JL, 2004, J VIROL, V78, P4156, DOI 10.1128/JVI.78.8.4156-4164.2004; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Egerton M, 1998, INT IMMUNOL, V10, P223, DOI 10.1093/intimm/10.2.223; Esposito JJ, 2001, FIELDS VIROLOGY, P2885; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fenner F., 1965, MYXOMATOSIS; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kerr P, 2002, VIRAL IMMUNOL, V15, P229, DOI 10.1089/08828240260066198; Knipe Condit R. C., 2001, FIELDS VIROLOGY, V1, P19; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li Y, 1997, J VIROL, V71, P9557, DOI 10.1128/JVI.71.12.9557-9562.1997; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Maruoka S, 2000, AM J RESP CRIT CARE, V161, P922, DOI 10.1164/ajrccm.161.3.9906059; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Moss B, 2007, FIELDS VIROLOGY, P2849; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Planz O, 2001, J VIROL, V75, P4871, DOI 10.1128/JVI.75.10.4871-4877.2001; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Robinson CJM, 1996, BIOCHEM J, V320, P123, DOI 10.1042/bj3200123; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	50	146	154	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1266	1274		10.1038/ni1132	http://dx.doi.org/10.1038/ni1132			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15502830				2022-12-18	WOS:000225353500016
J	Hingley-Wilson, SM; Sambandamurthy, VK; Jacobs, WR				Hingley-Wilson, SM; Sambandamurthy, VK; Jacobs, WR			Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis	NATURE IMMUNOLOGY			English	Review							MICROBIAL ENUMERATION TECHNIQUE; BACILLUS-CALMETTE-GUERIN; RECEPTOR-BETA-1 DEFICIENCY; BCG VACCINATION; MOUSE TISSUES; SIGMA-FACTOR; VIRULENCE; MACROPHAGES; PERSISTENCE; GROWTH	Studying defined mutants of Mycobacterium tuberculosis in the mouse model of infection has led to the discovery of attenuated mutants that fall into several phenotypic classes. These mutants are categorized by their growth characteristics compared with those of wild-type M. tuberculosis, and include severe growth in vivo mutants, growth in vivo mutants, persistence mutants, pathology mutants and dissemination mutants. Here, examples of each of these mutant phenotypes are described and classified accordingly. Defining the importance of mycobacterial gene products responsible for in vivo growth, persistence and the induction of immunopathology will lead to a greater understanding of the host-pathogen interaction and potentially to new antimycobacterial treatment options.	Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Jacobs, WR (corresponding author), Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA.	jacobsw@hhmi.org		Jacobs, William/0000-0003-3321-3080; Hingley-Wilson, Suzie/0000-0002-6514-1424	NIAID NIH HHS [AI 26170] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R01AI026170, R22AI026170] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Barnes Peter F., 1994, P417; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS DM, 1995, P NATL ACAD SCI USA, V92, P8036, DOI 10.1073/pnas.92.17.8036; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dannenberg Arthur M. Jr., 1994, P459; de Mendonca-Lima L, 2001, MICROBIOL-SGM, V147, P2315, DOI 10.1099/00221287-147-8-2315; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Doffinger R, 2002, MOL IMMUNOL, V38, P903, DOI 10.1016/S0161-5890(02)00017-2; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; FINE PEM, 2002, ISSUES RELATING USE; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hess J, 1998, P NATL ACAD SCI USA, V95, P5299, DOI 10.1073/pnas.95.9.5299; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Huebner RE, 1996, CURR TOP MICROBIOL, V215, P263; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Jacobs WR, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P1; Johansen KA, 1996, INFECT IMMUN, V64, P3259, DOI 10.1128/IAI.64.8.3259-3266.1996; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; KOCH R, 1882, AETIOLOGY TUBERCULOS; Lichtenauer-Kaligis EGR, 2003, EUR J IMMUNOL, V33, P59, DOI 10.1002/immu.200390008; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MIDDLEBROOK G, 1954, AM REV TUBERC PULM, V69, P471; Mueller-Ortiz SL, 2002, INFECT IMMUN, V70, P6751, DOI 10.1128/IAI.70.12.6751-6760.2002; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; North RJ, 1999, INFECT IMMUN, V67, P5483, DOI 10.1128/IAI.67.10.5483-5485.1999; Noss EH, 2000, CELL IMMUNOL, V201, P63, DOI 10.1006/cimm.2000.1633; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; RATON JA, 1992, MED J AUSTRALIA, V156, P286; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; REYNES JPC, 2000, LANCET, V356, P2133; Rosenfeldt V, 1997, SCAND J INFECT DIS, V29, P526, DOI 10.3109/00365549709011871; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; SMITH E, 1992, SCAND J INFECT DIS, V24, P109, DOI 10.3109/00365549209048409; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642; Ting LM, 1999, J IMMUNOL, V163, P3898; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; WRIGHT SD, 1983, J EXP MED, V158, P2016, DOI 10.1084/jem.158.6.2016; XU SM, 1994, J IMMUNOL, V153, P2568; Young DB, 2003, TUBERCULOSIS, V83, P77, DOI 10.1016/S1472-9792(02)00081-1; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	73	146	151	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					949	955		10.1038/ni981	http://dx.doi.org/10.1038/ni981			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515128				2022-12-18	WOS:000185590100010
J	Lohr, J; Knoechel, B; Jiang, SW; Sharpe, AH; Abbas, AK				Lohr, J; Knoechel, B; Jiang, SW; Sharpe, AH; Abbas, AK			The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; IN-VIVO; AUTOIMMUNE-DISEASE; CTLA-4 ENGAGEMENT; CD40 LIGAND; ACTIVATION; TOLERANCE; INDUCTION; EXPRESSION; ROLES	When antigen-presenting cells (APCs) encounter inflammatory stimuli, they up-regulate their expression of B7. A small amount of B7 is also constitutively expressed on resting APCs, but its function is unclear. Here we show that initiation of T cell responses requires the expression of B7 on immunizing APCs, but the responses are much greater in the absence of basal B7 expression. Transfer of antigen-specific CD4(+)CD25(+) cells reverses the increased responsiveness, and tolerance to a self-protein is broken by immunization in the absence of basal B7, thereby inducing autoimmunity. Similar loss of self-tolerance is seen on depletion of CD25(+) cells. Thus, constitutively expressed B7 costimulators function to suppress T cell activation and maintain self-tolerance, principally by sustaining a population of regulatory T cells.	Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Abbas, AK (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA.							Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Camacho SA, 2001, NAT IMMUNOL, V2, P523, DOI 10.1038/88720; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; DEBOER M, 1993, EUR J IMMUNOL, V23, P3120, DOI 10.1002/eji.1830231212; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Laurie KL, 2002, IMMUNOL CELL BIOL, V80, P567, DOI 10.1046/j.1440-1711.2002.01127.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McAdam AJ, 1998, IMMUNOL REV, V165, P231; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Onizuka S, 1999, CANCER RES, V59, P3128; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	40	146	154	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					664	669		10.1038/ni939	http://dx.doi.org/10.1038/ni939			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12766766				2022-12-18	WOS:000183952500014
J	Zompi, S; Hamerman, JA; Ogasawara, K; Schweighoffer, E; Tybulewicz, VLJ; Di Santo, JP; Lanier, LL; Colucci, F				Zompi, S; Hamerman, JA; Ogasawara, K; Schweighoffer, E; Tybulewicz, VLJ; Di Santo, JP; Lanier, LL; Colucci, F			NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CUTTING EDGE; T-CELLS; IN-VIVO; ACTIVATION; RECEPTOR; MICE; REJECTION; DISTINCT; LIGANDS	In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. Here we show that cytotoxicity, but not cytokine production, is triggered by NKG2D in activated NK cells lacking either DAP12 or the Syk family members Syk and ZAP70. Inhibition of PI3K blocks this cytotoxicity, suggesting that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells. Our results highlight signaling divergence in the effector functions of NKG2D and indicate that alternative associations between a receptor and its adaptors may provide a single receptor with a dual 'on-switch', giving mouse NK cells more choices through which to trigger cytotoxicity.	Inst Pasteur, Dept Immunol, F-75015 Paris, France; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Francisco; MRC National Institute for Medical Research	Colucci, F (corresponding author), Inst Pasteur, Dept Immunol, 25-28 Rue Dr Roux, F-75015 Paris, France.		Colucci, Francesco/F-2844-2010; Ogasawara, Kouetsu/G-9892-2011; Lanier, Lewis L/E-2139-2014; Di Santo, James P/M-4298-2014	Colucci, Francesco/0000-0001-5193-6376; Lanier, Lewis L/0000-0003-1308-3952; Di Santo, James P/0000-0002-7146-1862; Tybulewicz, Victor/0000-0003-2439-0798	NCI NIH HHS [R01 CA89294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089294] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BILLADEAU DD, 2003, NAT IMMUNOL; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Colucci F, 1999, J IMMUNOL, V162, P2761; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HALD J, 1995, CANCER IMMUNOL IMMUN, V41, P243, DOI 10.1007/s002620050224; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Karre K, 1991, Semin Cancer Biol, V2, P295; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Long EO, 2002, NAT IMMUNOL, V3, P1119, DOI 10.1038/ni1202-1119; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Martin-Fontecha A, 1999, J IMMUNOL, V162, P5910; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059	39	146	149	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					565	572		10.1038/ni930	http://dx.doi.org/10.1038/ni930			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12740576	Green Submitted			2022-12-18	WOS:000183175500016
J	Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S				Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S			Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; CD4+ T-CELLS; INTERFERON-GAMMA; NATURAL-KILLER; LISTERIA-MONOCYTOGENES; GENE-EXPRESSION; ALPHA-CHAIN; BETA-CHAIN; CYTOKINE; MICE	Activation of dendritic cells (DCs) and macrophages by infectious agents leads to secretion of interleukin 12 (IL-12), which subsequently induces interferon-gamma (IFN-gamma) production by multiple cell types that include DCs and macrophages. In turn, IFN-gamma acts on macrophages to augment IL-12 secretion and to produce nitric oxide (NO), which eradicates infected microbes. We show here that in cytokine common gamma subunit-deficient and/or IL-2 receptor beta -deficient mice, production of IL-12, IFN-gamma and NO by DCs and macrophages was severely impaired, as was up-regulation of major histocompatibility complex class II and CD40. Similar phenotypes were observed in DCs and macrophages from IL-15-deficient mice but not in those from IL-2-deficient mice. This shows that the IL-15-IL-15R interaction is critical in early activation of antigen-presenting cells and plays an important role in the innate immune system.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	koyasu@microb.med.keio.ac.jp	Koyasu, Shigeo/J-5583-2015; Ota, Takayuki/Q-5528-2017	Koyasu, Shigeo/0000-0001-9585-3038; Ota, Takayuki/0000-0001-6249-0664; Suzue, Kazutomo/0000-0002-8959-5746				ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BOSCO MC, 1994, BLOOD, V83, P2995, DOI 10.1182/blood.V83.10.2995.2995; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Dai WJ, 1997, J IMMUNOL, V158, P5297; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DIMARZIO P, 1994, J EXP MED, V179, P1731, DOI 10.1084/jem.179.5.1731; ESPINOZADELGADO I, 1990, J EXP MED, V171, P1821, DOI 10.1084/jem.171.5.1821; Fehniger TA, 2000, J IMMUNOL, V164, P1643, DOI 10.4049/jimmunol.164.4.1643; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Fukao T, 2000, EUR J IMMUNOL, V30, P1453, DOI 10.1002/(SICI)1521-4141(200005)30:5<1453::AID-IMMU1453>3.0.CO;2-W; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; JACOBSEN FW, 1993, J EXP MED, V178, P1777, DOI 10.1084/jem.178.5.1777; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nishimura H, 2000, J EXP MED, V191, P157, DOI 10.1084/jem.191.1.157; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; Puddu P, 1997, J IMMUNOL, V159, P3490; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Song F, 1996, J IMMUNOL, V156, P2979; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0	46	146	161	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1138	1143		10.1038/ni729	http://dx.doi.org/10.1038/ni729			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11702064				2022-12-18	WOS:000172473200016
J	Ugolini, S; Arpin, C; Anfossi, N; Walzer, T; Cambiaggi, A; Forster, R; Lipp, M; Toes, REM; Melief, CJ; Marvel, J; Vivier, E				Ugolini, S; Arpin, C; Anfossi, N; Walzer, T; Cambiaggi, A; Forster, R; Lipp, M; Toes, REM; Melief, CJ; Marvel, J; Vivier, E			Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; TRANSGENIC MICE; LYMPHOKINE PRODUCTION; RECEPTORS; LYMPHOCYTES; EXPRESSION; ANTIGEN; CYTOTOXICITY; TOLERANCE; RESPONSES	Inhibitory natural killer receptors (NKRs) such as killer cell immunoglobulin-like receptors (KIRs) in humans and Ly49 molecules in mice are expressed on NK cells and recognize multiple major histocompatibility (MHC) class I proteins. In humans and mice, a subset of CD8(+)T cells also expresses NKRs and harbors a memory phenotype. Using mice that are transgenic for KIR2DL3 and its cognate HLA-Cw3 ligand, we show that engagement of inhibitory NKRs selectively drives the in vivo accumulation of a subset of memory-phenotype CD8(+) T cells that express the beta chain of the interleukin 2 receptor. In vitro, recognition of MHC class I molecules by inhibitory NKRs on T cells down-regulated activation-induced cell death. These results unveil an MHC class I-dependent pathway that promotes the survival of a subset of memory-phenotype CD8(+)T cells and also reveal an unexpected biological function for inhibitory NKRs on T cells.	CNRS Marseille Luminy, INSERM, Ctr Immuno, F-13288 Marseille 09, France; INSERM, U503, CERVI, Lyon, France; Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; Max Delbruck Ctr Mol Med, Berlin, Germany; Leiden Univ, Ctr Med, Dept Immunohaematol & Bloodbank, Leiden, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leiden University; Leiden University - Excl LUMC	Vivier, E (corresponding author), CNRS Marseille Luminy, INSERM, Ctr Immuno, Case 906, F-13288 Marseille 09, France.		Walzer, Thierry/L-9418-2014; Förster, Reinhold/D-6770-2011; Lipp, Martin/G-2235-2010; Arpin, Christophe/M-3862-2014; Vivier, Eric/F-8939-2010; marvel, jacqueline/H-8638-2014	Walzer, Thierry/0000-0002-0857-8179; Arpin, Christophe/0000-0003-0915-5554; Vivier, Eric/0000-0001-7022-8287; marvel, jacqueline/0000-0001-6241-459X; Ugolini, Sophie/0000-0003-4041-0103; Toes, Rene/0000-0002-9618-6414; Lipp, Martin/0000-0002-0087-2672; Forster, Reinhold/0000-0001-6190-7923				ANFOSSI N, 2001, IN PRESS IMMUNOL REV, V181; Bieganowska K, 1999, J IMMUNOL, V162, P1765; Borges L, 1999, CURR TOP MICROBIOL, V244, P123; BUDD RC, 1987, J IMMUNOL, V138, P3583; Cambiaggi A, 1999, BLOOD, V94, P2396, DOI 10.1182/blood.V94.7.2396.419k17_2396_2402; Cambiaggi A, 1997, P NATL ACAD SCI USA, V94, P8088, DOI 10.1073/pnas.94.15.8088; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; DAndrea A, 1996, J EXP MED, V184, P789, DOI 10.1084/jem.184.2.789; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Marti F, 1998, P NATL ACAD SCI USA, V95, P11810, DOI 10.1073/pnas.95.20.11810; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; Mingari MC, 1997, INT IMMUNOL, V9, P485, DOI 10.1093/intimm/9.4.485; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; Oehen S, 1998, J IMMUNOL, V161, P5338; Ortaldo JR, 1998, J IMMUNOL, V160, P1158; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; WALUNAS TL, 1995, J IMMUNOL, V155, P1873	29	146	149	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					430	435		10.1038/87740	http://dx.doi.org/10.1038/87740			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323697				2022-12-18	WOS:000168549800016
J	Cimmino, L; Dawlaty, MM; Ndiaye-Lobry, D; Yap, YS; Bakogianni, S; Yu, YT; Bhattacharyya, S; Shaknovich, R; Geng, H; Lobry, C; Mullenders, J; King, B; Trimarchi, T; Aranda-Orgilles, B; Liu, C; Shen, S; Verma, AK; Jaenisch, R; Aifantis, I				Cimmino, Luisa; Dawlaty, Meelad M.; Ndiaye-Lobry, Delphine; Yap, Yoon Sing; Bakogianni, Sofia; Yu, Yiting; Bhattacharyya, Sanchari; Shaknovich, Rita; Geng, Huimin; Lobry, Camille; Mullenders, Jasper; King, Bryan; Trimarchi, Thomas; Aranda-Orgilles, Beatriz; Liu, Cynthia; Shen, Steven; Verma, Amit K.; Jaenisch, Rudolf; Aifantis, Iannis			TET1 is a tumor suppressor of hematopoietic malignancy	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL LYMPHOMA; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; DNA METHYLATION; HODGKIN-LYMPHOMA; GENE-EXPRESSION; MAMMALIAN DNA; GENOME; 5-HYDROXYMETHYLCYTOSINE	The methylcytosine dioxygenase TET1 ('ten-eleven translocation 1') is an important regulator of 5-hydroxymethylcytosine (5hmC) in embryonic stem cells. The diminished expression of TET proteins and loss of 5hmC in many tumors suggests a critical role for the maintenance of this epigenetic modification. Here we found that deletion of Tet1 promoted the development of B cell lymphoma in mice. TET1 was required for maintenance of the normal abundance and distribution of 5hmC, which prevented hypermethylation of DNA, and for regulation of the B cell lineage and of genes encoding molecules involved in chromosome maintenance and DNA repair. Whole-exome sequencing of TET1-deficient tumors revealed mutations frequently found in non-Hodgkin B cell lymphoma (B-NHL), in which TET1 was hypermethylated and transcriptionally silenced. Our findings provide in vivo evidence of a function for TET1 as a tumor suppressor of hematopoietic malignancy.	[Cimmino, Luisa; Ndiaye-Lobry, Delphine; Yap, Yoon Sing; Bakogianni, Sofia; Lobry, Camille; Mullenders, Jasper; King, Bryan; Trimarchi, Thomas; Aranda-Orgilles, Beatriz; Liu, Cynthia; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA; [Cimmino, Luisa; Ndiaye-Lobry, Delphine; Yap, Yoon Sing; Bakogianni, Sofia; Lobry, Camille; Mullenders, Jasper; King, Bryan; Trimarchi, Thomas; Aranda-Orgilles, Beatriz; Liu, Cynthia; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Cimmino, Luisa; Ndiaye-Lobry, Delphine; Yap, Yoon Sing; Bakogianni, Sofia; Lobry, Camille; Mullenders, Jasper; King, Bryan; Trimarchi, Thomas; Aranda-Orgilles, Beatriz; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY USA; [Cimmino, Luisa; Ndiaye-Lobry, Delphine; Yap, Yoon Sing; Bakogianni, Sofia; Lobry, Camille; Mullenders, Jasper; King, Bryan; Trimarchi, Thomas; Aranda-Orgilles, Beatriz; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY USA; [Dawlaty, Meelad M.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA USA; [Dawlaty, Meelad M.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yu, Yiting; Bhattacharyya, Sanchari; Verma, Amit K.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Hemato Oncol, Bronx, NY 10467 USA; [Shaknovich, Rita] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Geng, Huimin] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Shen, Steven] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Cornell University; University of California System; University of California San Francisco; New York University	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10012 USA.	jaenisch@wi.mit.edu; iannis.aifantis@nyumc.org	lobry, camille/A-6188-2015; Mullenders, Jasper/J-2398-2015	lobry, camille/0000-0003-0550-4921; Mullenders, Jasper/0000-0003-3737-6901; Shen, Steven/0000-0001-7725-1260	Damon Runyon Cancer Research Foundation; US National Institutes of Health [5RO1HD045022, 5R37CA084198, 1R01CA169784, 1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636]; Simons Foundation; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society (TRP) [6340-11]; Leukemia & Lymphoma Society (LLS) [6373-13]; Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; National Health and Medical Research Council; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA105129, R01CA173636, R01CA149655, R37CA084198, P30CA013330, R01CA133379, R01CA194923, R01CA169784, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society (TRP)(Leukemia and Lymphoma Society); Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Chemotherapy Foundation; V Foundation for Cancer Research; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Baldrick's Cancer Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank members of the Aifantis laboratory for discussions; M. Xu and F. Yang for help and advice; L. Pasqualucci (Columbia University) for control antibodies and control tissue sections for immunohistochemistry of mouse B cell lymphomas and expertise; K. Ganz, R. Flannery, D. Fu and T. Adil for help with animal husbandry and tissue collection; A. Heguy and I. Dolgalev for assistance with microarray experiments, RNA-seq and exome sequencing; the NYU Flow Cytometry facility for cell sorting; the NYU Histology Core; and E. Oricchio for assistance with analysis of data from patients with FL. Supported by the Damon Runyon Cancer Research Foundation (M. M. D.), the US National Institutes of Health (5RO1HD045022 and 5R37CA084198 for work in the laboratory of R.J.; and 1R01CA169784, 1R01CA133379, 1R01CA105129, 1R01CA149655 and 5R01CA173636 for the Aifantis laboratory), the Simons Foundation (for work in the laboratory of R.J.), the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society (TRP#6340-11 and LLS#6373-13), The Chemotherapy Foundation, The V Foundation for Cancer Research, the Alex's Lemonade Stand Foundation for Childhood Cancer, the St. Baldrick's Cancer Research Foundation, the National Health and Medical Research Council (L.C.) and the Howard Hughes Medical Institute (I.A.).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Asmar F, 2013, HAEMATOLOGICA, V98, P1912, DOI 10.3324/haematol.2013.088740; Bhattacharyya S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt601; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Chan WC, 1997, BLOOD, V89, P3909; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Geng HM, 2012, CANCER DISCOV, V2, P1004, DOI 10.1158/2159-8290.CD-12-0208; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guo JY, 2005, AM J CLIN PATHOL, V124, P430, DOI 10.1309/LCGNV77J464LNFD6; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ittel A, 2013, HAEMATOLOGICA, V98, pE166, DOI 10.3324/haematol.2013.096750; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li HX, 2014, BLOOD, V123, P1487, DOI 10.1182/blood-2013-05-500264; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Matsuda I, 2014, J CLIN EXP HEMATOP, V54, P67, DOI 10.3960/jslrt.54.67; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Shaknovich R, 2010, BLOOD, V116, pE81, DOI 10.1182/blood-2010-05-285320; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Weigert O, 2012, CANCER DISCOV, V2, P47, DOI 10.1158/2159-8290.CD-11-0208; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	58	145	148	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					653	+		10.1038/ni.3148	http://dx.doi.org/10.1038/ni.3148			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25867473	Green Submitted, Green Accepted			2022-12-18	WOS:000354751900018
J	Bertin, S; Aoki-Nonaka, Y; de Jong, PR; Nohara, LL; Xu, HJ; Stanwood, SR; Srikanth, S; Lee, J; To, K; Abramson, L; Yu, T; Han, T; Touma, R; Li, XL; Gonzalez-Navajas, JM; Herdman, S; Corr, M; Fu, G; Dong, H; Gwack, Y; Franco, A; Jefferies, WA; Raz, E				Bertin, Samuel; Aoki-Nonaka, Yukari; de Jong, Petrus Rudolf; Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Srikanth, Sonal; Lee, Jihyung; To, Keith; Abramson, Lior; Yu, Timothy; Han, Tiffany; Touma, Ranim; Li, Xiangli; Gonzalez-Navajas, Jose M.; Herdman, Scott; Corr, Maripat; Fu, Guo; Dong, Hui; Gwack, Yousang; Franco, Alessandra; Jefferies, Wilfred A.; Raz, Eyal			The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							CAPSAICIN RECEPTOR; TYROSINE KINASE; GENE-EXPRESSION; CALCIUM; POTENT; MICE; MEMBRANE; STIM	TRPV1 is a Ca2+-permeable channel studied mostly as a pain receptor in sensory neurons. However, its role in other cell types is poorly understood. Here we found that TRPV1 was functionally expressed in CD4+ T cells, where it acted as a non-store-operated Ca2+ channel and contributed to T cell antigen receptor (TCR)-induced Ca2+ influx, TCR signaling and T cell activation. In models of T cell-mediated colitis, TRPV1 promoted colitogenic T cell responses and intestinal inflammation. Furthermore, genetic and pharmacological inhibition of TRPV1 in human CD4+ T cells recapitulated the phenotype of mouse Trpvl(-/-) CD4+ T cells. Our findings suggest that inhibition of TRPV1 could represent a new therapeutic strategy for restraining proinflammatory T cell responses.	[Bertin, Samuel; Aoki-Nonaka, Yukari; de Jong, Petrus Rudolf; Lee, Jihyung; To, Keith; Abramson, Lior; Yu, Timothy; Han, Tiffany; Li, Xiangli; Gonzalez-Navajas, Jose M.; Herdman, Scott; Corr, Maripat; Dong, Hui; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Aoki-Nonaka, Yukari] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Niigata, Japan; [Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada; [Nohara, Lilian L.; Xu, Hongjian; Stanwood, Shawna R.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Srikanth, Sonal; Gwack, Yousang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Touma, Ranim; Franco, Alessandra] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Fu, Guo] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Fu, Guo] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Biol, Sch Life Sci, Xiamen, Fujian, Peoples R China	University of California System; University of California San Diego; Niigata University; University of British Columbia; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Scripps Research Institute; Xiamen University	Jefferies, WA (corresponding author), Univ British Columbia, Dept Med Genet, Dept Microbiol & Immunol, Michael Smith Labs,Ctr Blood Res,Brain Res Ctr, Vancouver, BC, Canada.	wilf@msl.ubc.ca; eraz@ucsd.edu	González-Navajas, Jose Manuel/AAB-1575-2019	González-Navajas, Jose Manuel/0000-0002-1591-939X; Bertin, Samuel/0000-0003-2340-959X; de Jong, Petrus/0000-0003-2321-1153	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health [P30 NS047101]; US National Institutes of Health [U01 AI095623, P01 DK35108, AI083432]; Canadian Institutes of Health Research [MOP-102698]; Broad Foundation [IBD-0342R]; Crohn's & Colitis Foundation of America [SRA 3038, RFA 3574, RFA 2927]; European Molecular Biology Organization [ALTF 288-2009]; Fulbright Association; Philippe Foundation; Japan Society for the Promotion of Science	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Broad Foundation; Crohn's & Colitis Foundation of America; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fulbright Association; Philippe Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank C. Conche and K. Sauer for help with measurements of Ca<SUP>2+</SUP>; A. Patapoutian (The Scripps Research Institute) for Chinese hamster ovary cells transfected to express TRPV1; E. Garcia and T. Snutch for access to electrophysiological equipment; J. Lee and C. Quinley for discussions; M. Scholl for animal breeding; T. Rambaldo for cell sorting; S. Shenouda for tissue processing; N. Varki and L. Eckmann for help with histological evaluations; and J. Santini for technical assistance with confocal imaging at the Neuroscience microscopy shared facility of the University of California San Diego (supported by the National Institute of Neurological Disorders and Stroke of the US National Institutes of Health (P30 NS047101)). Supported by the US National Institutes of Health (U01 AI095623 and P01 DK35108 to E.R., and AI083432 to Y.G.), the Canadian Institutes of Health Research (MOP-102698 to W.A.J.), the Broad Foundation (IBD-0342R to E.R.), the Crohn's & Colitis Foundation of America (SRA 3038 to E.R., RFA 3574 to S.B., and RFA 2927 to P.R.d.J.), the European Molecular Biology Organization (ALTF 288-2009 to S.B.), the Fulbright Association (S.B.), the Philippe Foundation (S.B.) and the Japan Society for the Promotion of Science (Y.A.-N.).	Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Armstrong DL, 2010, METHOD CELL BIOL, V99, P183, DOI [10.1016/S0091-679X(10)99007-9, 10.1016/B978-0-12-374841-6.00007-4]; Bachiocco V, 2011, CLIN J PAIN, V27, P631, DOI 10.1097/AJP.0b013e3182119356; Barr VA, 2009, IMMUNOL REV, V231, P148, DOI 10.1111/j.1600-065X.2009.00812.x; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Gad M, 2009, INFLAMM BOWEL DIS, V15, P1174, DOI 10.1002/ibd.20902; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Omilusik KD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00164; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Saunders CIM, 2007, MOL IMMUNOL, V44, P1429, DOI 10.1016/j.molimm.2006.04.027; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Schwarz E. C., 2007, V179, P445; Shin JS, 2001, NEUROSCI LETT, V299, P135, DOI 10.1016/S0304-3940(00)01777-8; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Spinsanti G, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-51; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voolstra O, 2014, CELLS-BASEL, V3, P258, DOI 10.3390/cells3020258; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	40	145	151	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1055	1063		10.1038/ni.3009	http://dx.doi.org/10.1038/ni.3009			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25282159	Green Accepted			2022-12-18	WOS:000343640700011
J	Laurenti, E; Doulatov, S; Zandi, S; Plumb, I; Chen, J; April, C; Fan, JB; Dick, JE				Laurenti, Elisa; Doulatov, Sergei; Zandi, Sasan; Plumb, Ian; Chen, Jing; April, Craig; Fan, Jian-Bing; Dick, John E.			The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; B-CELL; LINEAGE COMMITMENT; EXPRESSION; BCL6; MAP; PROGENITORS; BCL11A; STATES	Understanding how differentiation programs originate from the gene-expression 'landscape' of hematopoietic stem cells (HSCs) is crucial for the development of new clinical therapies. We mapped the transcriptional dynamics underlying the first steps of commitment by tracking transcriptome changes in human HSCs and eight early progenitor populations. We found that transcriptional programs were extensively shared, extended across lineage-potential boundaries and were not strictly lineage affiliated. Elements of stem, lymphoid and myeloid programs were retained in multilymphoid progenitors (MLPs), which reflected a hybrid transcriptional state. By functional single cell analysis, we found that the transcription factors Bcl-11A, Sox4 and TEAD1 (TEF1) governed transcriptional networks in MLPs, which led to B cell specification. Overall, we found that integrated transcriptome approaches can be used to identify previously unknown regulators of multipotency and show additional complexity in lymphoid commitment.	[Laurenti, Elisa; Doulatov, Sergei; Zandi, Sasan; Plumb, Ian; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Chen, Jing; April, Craig; Fan, Jian-Bing] Illumina, San Diego, CA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Illumina	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON, Canada.	jdick@uhnresearch.ca		Zandi, Sasan/0000-0002-8448-094X; Laurenti, Elisa/0000-0002-9917-9092; Dick, John/0000-0002-9527-8317	Swiss National Science Foundation; Roche; Fondation Suisse pour les Bourses en Medecine et Biologie; Swedish Research Council; Genome Canada (through the Ontario Genomics Institute); Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research; Canada Research Chairs Program; Princess Margaret Hospital Foundation; Terry Fox Research Institute; Canadian Cancer Society Research Institute; Ontario Ministry of Health and Long Term Care	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche(Roche Holding); Fondation Suisse pour les Bourses en Medecine et Biologie; Swedish Research Council(Swedish Research CouncilEuropean Commission); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Princess Margaret Hospital Foundation; Terry Fox Research Institute; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We thank the obstetrics unit of Trillium Hospital for cord blood samples; P. A. Penttil, A. Khandi, L. Jamieson and S. Zhao at the SickKids Flow Cytometry Facility for cell sorting; V. Voisin and G. Bader for advice on bioinformatics and critical review of the manuscript; S. Bashir for statistical advice; A. Neumann for help with cloning and plasmids; M. Doedens for help with intrafemoral injections; and O. Gan for critical review of the manuscript. Supported by the Swiss National Science Foundation (E. L.), Roche (E. L.), the Fondation Suisse pour les Bourses en Medecine et Biologie (E. L.), the Swedish Research Council (S.Z.), Genome Canada (through the Ontario Genomics Institute), Ontario Institute for Cancer Research with funds from the province of Ontario, the Canadian Institutes for Health Research, Canada Research Chairs Program, the Princess Margaret Hospital Foundation, the Terry Fox Research Institute, Canadian Cancer Society Research Institute and the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Fan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030794; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; ITOH K, 1989, EXP HEMATOL, V17, P145; Jansson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032013; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Santos PM, 2011, CURR OPIN IMMUNOL, V23, P163, DOI 10.1016/j.coi.2010.11.014; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Zandi S, 2010, IMMUNOL REV, V238, P47, DOI 10.1111/j.1600-065X.2010.00950.x; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang QZ, 2012, CURR OPIN IMMUNOL, V24, P196, DOI 10.1016/j.coi.2011.12.007; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	47	145	146	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					756	+		10.1038/ni.2615	http://dx.doi.org/10.1038/ni.2615			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23708252	Green Accepted, Green Submitted			2022-12-18	WOS:000320509100018
J	Van Rhijn, I; Kasmar, A; de Jong, A; Gras, S; Bhati, M; Doorenspleet, ME; de Vries, N; Godfrey, DI; Altman, JD; de Jager, W; Rossjohn, J; Moody, DB				Van Rhijn, Ildiko; Kasmar, Anne; de Jong, Annemieke; Gras, Stephanie; Bhati, Mugdha; Doorenspleet, Marieke E.; de Vries, Niek; Godfrey, Dale I.; Altman, John D.; de Jager, Wilco; Rossjohn, Jamie; Moody, D. Branch			A conserved human T cell population targets mycobacterial antigens presented by CD1b	NATURE IMMUNOLOGY			English	Article							LIPID ANTIGENS; RECOGNITION; EXPRESSION; RESPONSES; MEMORY; LYMPHOCYTES	Human T cell antigen receptors (TCRs) pair in millions of combinations to create complex and unique T cell repertoires for each person. Through the use of tetramers to analyze TCRs reactive to the antigen-presenting molecule CD1b, we detected T cells with highly stereotyped TCR alpha-chains present among genetically unrelated patients with tuberculosis. The germline-encoded, mycolyl lipid-reactive (GEM) TCRs had an alpha-chain bearing the variable (V) region TRAV1-2 rearranged to the joining (J) region TRAJ9 with few nontemplated (N)-region additions. Analysis of TCRs by high-throughput sequencing, binding and crystallography showed linkage of TCR alpha sequence motifs to high-affinity recognition of antigen. Thus, the CD1-reactive TCR repertoire is composed of at least two compartments: high-affinity GEM TCRs, and more-diverse TCRs with low affinity for CD1b-lipid complexes. We found high interdonor conservation of TCRs that probably resulted from selection by a nonpolymorphic antigen-presenting molecule and an immunodominant antigen.	[Van Rhijn, Ildiko; Kasmar, Anne; de Jong, Annemieke; Moody, D. Branch] Harvard Univ, Sch Med, Dept Rheumatol & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Gras, Stephanie; Bhati, Mugdha; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Doorenspleet, Marieke E.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1012 WX Amsterdam, Netherlands; [Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Altman, John D.] NIH Tetramer Core Facil, Emory Vaccine Ctr, Atlanta, GA USA; [de Jager, Wilco] Univ Utrecht, Med Ctr, Dept Pediat Immunol, Utrecht, Netherlands; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University; Monash University; University of Amsterdam; Academic Medical Center Amsterdam; University of Melbourne; Emory University; National Institutes of Health (NIH) - USA; Utrecht University; Cardiff University	Moody, DB (corresponding author), Harvard Univ, Sch Med, Dept Rheumatol & Immunol, Brigham & Womens Hosp, Boston, MA 02115 USA.	i.vanrhijn@uu.nl; bmoody@rics.bwh.harvard.edu	gras, stephanie/C-8307-2013; Rossjohn, Jamie/F-9032-2013; de Vries, Niek/J-9348-2013	Rossjohn, Jamie/0000-0002-2020-7522; de Vries, Niek/0000-0002-6257-8604; gras, stephanie/0000-0001-7416-038X; Godfrey, Dale/0000-0002-3009-5472; de Jong, Annemieke/0000-0001-6707-6585; de Jager, Wilco/0000-0002-0014-0682; Van Rhijn, Ildiko/0000-0002-1446-5701	US National Institute of Allergy and Infectious Diseases [AI04393, AR048632, K08 AI089858]; Burroughs Wellcome Fund; Nederlands Wetenschappelijk Onderzoek (Meervoud) [836.08.001]; National Health and Medical Research Council; Australian Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089858, R01AI049313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Nederlands Wetenschappelijk Onderzoek (Meervoud); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the Tetramer Core Facility of the US National Institutes of Health for CD1b protein; M. Turner, C. Seshadri and the Shattuck Hospital for clinical collaboration; L. Tan for technical help; and the beamline staff at the Australian synchrotron for assistance with data collection. Supported by the US National Institute of Allergy and Infectious Diseases (AI04393, AR048632 to D. B. M., and K08 AI089858 to A. K.) the Burroughs Wellcome Fund, Nederlands Wetenschappelijk Onderzoek (Meervoud 836.08.001 to I. V. R.), the National Health and Medical Research Council (D. I. G. and J.R.) and the Australian Research Council (S.G.).	BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Cohen NR, 2013, NAT IMMUNOL, V14, P90, DOI 10.1038/ni.2490; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Han M, 1999, TISSUE ANTIGENS, V54, P122, DOI 10.1034/j.1399-0039.1999.540202.x; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Ly D, 2013, J EXP MED, V210, P729, DOI 10.1084/jem.20120624; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mongkolsapaya J, 1999, J VIROL, V73, P67, DOI 10.1128/JVI.73.1.67-71.1999; Montamat-Sicotte DJ, 2011, J CLIN INVEST, V121, P2493, DOI 10.1172/JCI46216; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Van Rhijn I, 2009, EUR J IMMUNOL, V39, P3031, DOI 10.1002/eji.200939619; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Vincent MS, 2005, J IMMUNOL, V175, P6344, DOI 10.4049/jimmunol.175.10.6344; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141	48	145	145	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					706	+		10.1038/ni.2630	http://dx.doi.org/10.1038/ni.2630			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23727893	Green Accepted, Green Submitted			2022-12-18	WOS:000320509100012
J	Sokolovska, A; Becker, CE; Ip, WKE; Rathinam, VAK; Brudner, M; Paquette, N; Tanne, A; Vanaja, SK; Moore, KJ; Fitzgerald, KA; Lacy-Hulbert, A; Stuart, LM				Sokolovska, Anna; Becker, Christine E.; Ip, W. K. Eddie; Rathinam, Vijay A. K.; Brudner, Matthew; Paquette, Nicholas; Tanne, Antoine; Vanaja, Sivapriya K.; Moore, Kathryn J.; Fitzgerald, Katherine A.; Lacy-Hulbert, Adam; Stuart, Lynda M.			Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR; INNATE IMMUNE-SYSTEM; H+-ATPASE ACTIVITY; PROTEOLYTIC CLEAVAGE; STAPHYLOCOCCUS-AUREUS; NALP3 INFLAMMASOME; BACTERIAL LIGANDS; DENDRITIC CELLS; MATURATION; ACIDIFICATION	Phagocytosis is a fundamental cellular process that is pivotal for immunity as it coordinates microbial killing, innate immune activation and antigen presentation. An essential step in this process is phagosome acidification, which regulates many functions of these organelles that allow phagosomes to participate in processes that are essential to both innate and adaptive immunity. Here we report that acidification of phagosomes containing Gram-positive bacteria is regulated by the NLRP3 inflammasome and caspase-1. Active caspase-1 accumulates on phagosomes and acts locally to control the pH by modulating buffering by the NADPH oxidase NOX2. These data provide insight into a mechanism by which innate immune signals can modify cellular defenses and establish a new function for the NLRP3 inflammasome and caspase-1 in host defense.	[Sokolovska, Anna; Becker, Christine E.; Ip, W. K. Eddie; Brudner, Matthew; Paquette, Nicholas; Tanne, Antoine; Lacy-Hulbert, Adam; Stuart, Lynda M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sokolovska, Anna; Becker, Christine E.; Ip, W. K. Eddie; Brudner, Matthew; Paquette, Nicholas; Tanne, Antoine; Lacy-Hulbert, Adam; Stuart, Lynda M.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Sokolovska, Anna; Becker, Christine E.; Ip, W. K. Eddie; Brudner, Matthew; Paquette, Nicholas; Tanne, Antoine; Lacy-Hulbert, Adam; Stuart, Lynda M.] Harvard Univ, Sch Med, Boston, MA USA; [Rathinam, Vijay A. K.; Vanaja, Sivapriya K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Moore, Kathryn J.] NYU, Med Ctr, Dept Med, New York, NY 10016 USA; [Moore, Kathryn J.] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Stuart, Lynda M.] Broad Inst Harvard & MIT, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; New York University; New York University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Stuart, LM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	asokolovska@partners.org; lstuart@partners.org	Fitzgerald, Katherine/ABE-6317-2020; Moore, Kathryn/ABE-6416-2020; Rathinam, Vijay/ABE-7544-2020; Ip, W. K. Eddie/C-3042-2012	Moore, Kathryn/0000-0003-2505-2547; Rathinam, Vijay/0000-0002-8009-3977; Ip, W. K. Eddie/0000-0003-1953-972X; Fitzgerald, Kate/0000-0003-3175-609X; Lacy-Hulbert, Adam/0000-0003-2162-0156	US National Institutes of Health; National Institute of Allergy and Infectious Diseases [RO1 AI079198, RO1 AI093752]; National Institutes of Health National Institute on Aging [RO1 AG020255]; Crohns' and Colitis and Hood foundations; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK093695]; Massachusetts General Hospital Executive Committee on Research; New England Regional Center of Excellence-Biodefense and Emerging Infectious Diseases [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI093752, R01AI079198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093695, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Crohns' and Colitis and Hood foundations; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Massachusetts General Hospital Executive Committee on Research; New England Regional Center of Excellence-Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from US National Institutes of Health National Institute of Allergy and Infectious Diseases to L.M.S. (RO1 AI079198) and K.A.F. (RO1 AI093752), National Institutes of Health National Institute on Aging to K.J.M. (RO1 AG020255), grants from the Crohns' and Colitis and Hood foundations and National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to A.L.-H. (RO1 DK093695), and postdoctoral fellowships from Massachusetts General Hospital Executive Committee on Research to A.S. and New England Regional Center of Excellence-Biodefense and Emerging Infectious Diseases (U54 AI057159 to N.P.). Electron microscopy was performed by M. McKee in the Microscopy Core of the Center for Systems Biology.	Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Foubert TR, 2001, J BIOL CHEM, V276, P38852, DOI 10.1074/jbc.M104373200; Grabarek J, 2002, EXP HEMATOL, V30, P982, DOI 10.1016/S0301-472X(02)00886-X; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Ramachandra Lakshmi, 2008, V445, P353, DOI 10.1007/978-1-59745-157-4_23; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sokolovska A., 2012, CURR PROTOC IMMUNOL, P30; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Zhang BL, 2003, MOL CELL BIOL, V23, P5716, DOI 10.1128/MCB.23.16.5716-5725.2003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	55	145	148	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					543	+		10.1038/ni.2595	http://dx.doi.org/10.1038/ni.2595			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23644505	Green Accepted, Green Submitted			2022-12-18	WOS:000319107600007
J	Facciotti, F; Ramanjaneyulu, GS; Lepore, M; Sansano, S; Cavallari, M; Kistowska, M; Forss-Petter, S; Ni, GH; Colone, A; Singhal, A; Berger, J; Xia, CF; Mori, L; De Libero, G				Facciotti, Federica; Ramanjaneyulu, Gundimeda S.; Lepore, Marco; Sansano, Sebastiano; Cavallari, Marco; Kistowska, Magdalena; Forss-Petter, Sonja; Ni, Guanghui; Colone, Alessia; Singhal, Amit; Berger, Johannes; Xia, Chengfeng; Mori, Lucia; De Libero, Gennaro			Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus	NATURE IMMUNOLOGY			English	Article							NKT CELLS; CD1D; BIOSYNTHESIS; RECOGNITION; LIGANDS; MICE; GLYCOSPHINGOLIPIDS; PLASMALOGENS; INFLAMMATION; SELECTION	The development and maturation of semi-invariant natural killer T cells (iNKT cells) rely on the recognition of self antigens presented by CD1d restriction molecules in thymus. The nature of the stimulatory thymic self lipids remains elusive. We isolated lipids from thymocytes and found that ether-bonded mono-alkyl glycerophosphates and the precursors and degradation products of plasmalogens stimulated iNKT cells. Synthetic analogs showed high potency in activating thymic and peripheral iNKT cells. Mice deficient in the peroxisomal enzyme glyceronephosphate O-acyltransferase (GNPAT), essential for the synthesis of ether lipids, had significant alteration of the thymic maturation of iNKT cells and fewer iNKT cells in both thymus and peripheral organs, which confirmed the role of ether-bonded lipids as iNKT cell antigens. Thus, peroxisome-derived lipids are nonredundant self antigens required for the generation of a full iNKT cell repertoire.	[Facciotti, Federica; Ramanjaneyulu, Gundimeda S.; Lepore, Marco; Sansano, Sebastiano; Cavallari, Marco; Kistowska, Magdalena; Mori, Lucia; De Libero, Gennaro] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Forss-Petter, Sonja; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Ni, Guanghui; Xia, Chengfeng] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China; [Colone, Alessia; Singhal, Amit; Mori, Lucia; De Libero, Gennaro] Agcy Sci Technol & Res, Singapore Immunol Network, Biopolis, Singapore	University of Basel; Medical University of Vienna; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	De Libero, G (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	gennaro_delibero@immunol.a-star.edu.sg	Berger, Johannes/A-9122-2014; Gundimeda, Seeta ramanjaneyulu/D-8645-2013; Facciotti, Federica/AAA-3518-2019; De Libero, Gennaro/P-2694-2017	Berger, Johannes/0000-0003-0182-2658; Gundimeda, Seeta ramanjaneyulu/0000-0001-9705-0159; Facciotti, Federica/0000-0002-2541-9428; Lepore, Marco/0000-0003-1353-8224; Singhal, Amit/0000-0003-3913-8798; De Libero, Gennaro/0000-0003-0853-7868	Swiss National Foundation [3100AO-122464/1, Sinergia CRS133-124819]; Yunnan High-End Technology Professionals Introduction Program [2010CI117]; Oncosuisse	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Yunnan High-End Technology Professionals Introduction Program; Oncosuisse	We thank W. Just (University of Heidelberg) for Gnpat<SUP>-/-</SUP> mice; J. Mattner (Cincinnati Children's Hospital) for S. paucimobilis; P. Seeberger (Max Plank Institute of Colloids and Interfaces, Potsdam) for GSL-1; E. Palmer, K. Karjalainen and P. Dellabona for discussions; P. Cullen for proofreading the manuscript; and L. Angman for technical assistance. Supported by the Swiss National Foundation (3100AO-122464/1 and Sinergia CRS133-124819 to G. D. L., and Oncosuisse to L. M. and G. D. L.) and the Yunnan High-End Technology Professionals Introduction Program (2010CI117 to C.X.).	Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bodennec J, 2000, J LIPID RES, V41, P1524; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Darmoise A, 2010, IMMUNITY, V33, P216, DOI 10.1016/j.immuni.2010.08.003; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gapin L, 2010, NAT REV IMMUNOL, V10, P272, DOI 10.1038/nri2743; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Haig NA, 2011, J BIOL CHEM, V286, P37692, DOI 10.1074/jbc.M111.267948; Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kyriakakis E, 2010, EUR J IMMUNOL, V40, P3268, DOI 10.1002/eji.201040619; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; MacDonald HR, 2007, CURR TOP MICROBIOL, V314, P195; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Meyer EH, 2008, ANNU REV MED, V59, P281, DOI 10.1146/annurev.med.59.061506.154139; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Schumann J, 2007, EUR J IMMUNOL, V37, P1431, DOI 10.1002/eji.200737160; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	51	145	146	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					474	U73		10.1038/ni.2245	http://dx.doi.org/10.1038/ni.2245			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22426352				2022-12-18	WOS:000303048400011
J	Rutz, S; Noubade, R; Eidenschenk, C; Ota, N; Zeng, WW; Zheng, Y; Hackney, J; Ding, JB; Singh, H; Ouyang, WJ				Rutz, Sascha; Noubade, Rajkumar; Eidenschenk, Celine; Ota, Naruhisa; Zeng, Wenwen; Zheng, Yan; Hackney, Jason; Ding, Jiabing; Singh, Harinder; Ouyang, Wenjun			Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells	NATURE IMMUNOLOGY			English	Article							ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; INTERLEUKIN 22; HOST-DEFENSE; DIFFERENTIATION; EXPRESSION; CYTOKINE; IL-10; INFLAMMATION; GENERATION	Interleukin 22 (IL-22), which is produced by cells of the T(H)17 subset of helper T cells and other leukocytes, not only enhances proinflammatory innate defense mechanisms in epithelial cells but also provides crucial protection to tissues from damage caused by inflammation and infection. In T(H)17 cells, transforming growth factor-beta (TGF-beta) regulates IL-22 and IL-17 differently. IL-6 alone induces T cells to produce only IL-22, whereas the combination of IL-6 and high concentrations of TGF-beta results in the production of IL-17 but not IL-22 by T cells. Here we identify the transcription factor c-Maf, which is induced by TGF-beta, as a downstream repressor of Il22. We found that c-Maf bound to the Il22 promoter and was both necessary and sufficient for the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells.	[Rutz, Sascha; Noubade, Rajkumar; Eidenschenk, Celine; Ota, Naruhisa; Zeng, Wenwen; Zheng, Yan; Ding, Jiabing; Singh, Harinder; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Hackney, Jason] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020; Zeng, Wenwen/D-7276-2017; Zheng, Yan/A-6993-2008	Zeng, Wenwen/0000-0001-8544-3318; Zheng, Yan/0000-0002-7002-277X; Ouyang, Wenjun/0000-0002-1811-5864; Hackney, Jason/0000-0002-5922-563X				Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Hale TK, 2000, J BIOL CHEM, V275, P17991, DOI 10.1074/jbc.M000921200; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; Hiramatsu Y, 2010, J LEUKOCYTE BIOL, V87, P703, DOI 10.1189/jlb.0909639; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantei A, 2008, EUR J IMMUNOL, V38, P2616, DOI 10.1002/eji.200738075; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2010, CYTOKINE GROWTH F R, V21, P435, DOI 10.1016/j.cytogfr.2010.10.007; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	51	145	155	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1238	U136		10.1038/ni.2134	http://dx.doi.org/10.1038/ni.2134			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22001828				2022-12-18	WOS:000297202700019
J	Kufer, TA; Sansonetti, PJ				Kufer, Thomas A.; Sansonetti, Philippe J.			NLR functions beyond pathogen recognition	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INDUCIBLE INFLAMMATORY MEDIATOR; AUTOIMMUNE ADDISONS-DISEASE; STEM-CELL TRANSPLANTATION; GENE-EXPRESSION PATTERNS; GENOME-WIDE ASSOCIATION; INNATE IMMUNE RECEPTORS; NECROSIS-FACTOR-ALPHA; FAMILY-MEMBER NLRC5; NOD-LIKE RECEPTORS	The last 10 years have witnessed the identification of a new class of intracellular pattern-recognition molecules-the nucleotide-binding domain and leucine-rich repeat-containing family (NLR). Members of this family garnered interest as pattern-recognition receptors able to trigger inflammatory responses against pathogens. Many studies support a pathogen-recognition function for human NLR proteins and shed light on their role in the broader control of adaptive immunity and various disease states. Other evidence suggests that NLRs function in processes unrelated to pathogen detection. Here we discuss recent advances in our understanding of the biology of the human NLR proteins and their non-pathogen-recognition function in tissue homeostasis, apoptosis, graft-versus-host disease and early development.	[Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Sansonetti, Philippe J.] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, F-75231 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Cologne; UDICE-French Research Universities; PSL Research University Paris; College de France	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	philippe.sansonetti@pasteur.fr	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412	German Research Foundation (DFG) [SFB670]	German Research Foundation (DFG)(German Research Foundation (DFG))	We apologize to authors whose work could not be cited due to space limitations. We thank V. Hornung (University of Bonn) for insightful comments, K. Lautz for critical reading of the manuscript and H. Bielig for help with graphic design. P.J.S. is a Howard Hughes Medical Institute foreign scholar. T. A. K. is supported by the German Research Foundation (DFG) within the collaborative research centre SFB670.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; DASILVA CJ, 2006, P NATL ACAD SCI USA, V103, P1840, DOI DOI 10.1073/PNAS.0509228103; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Fontalba A, 2007, J IMMUNOL, V179, P8519, DOI 10.4049/jimmunol.179.12.8519; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Granell M, 2008, BLOOD, V112, P4337, DOI 10.1182/blood-2007-12-129247; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Ji S, 2009, INFECT IMMUN, V77, P1044, DOI 10.1128/IAI.00449-08; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu J, 2008, MOL PLANT, V1, P411, DOI 10.1093/mp/ssn010; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Maraldi T, 2009, MOL HUM REPROD, V15, P499, DOI 10.1093/molehr/gap048; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McDaniel P, 2009, MOL REPROD DEV, V76, P151, DOI 10.1002/mrd.20937; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mitroulis I, 2010, EUR J INTERN MED, V21, P157, DOI 10.1016/j.ejim.2010.03.005; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Moreira LO, 2008, VACCINE, V26, P5808, DOI 10.1016/j.vaccine.2008.08.038; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nguyen Y, 2010, BLOOD, V115, P3625, DOI 10.1182/blood-2009-09-243840; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Perco P, 2009, TRANSPLANTATION, V87, P290, DOI 10.1097/TP.0b013e318191b4c0; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Watanabe H, 2008, J IMMUNOL, V180, P5826, DOI 10.4049/jimmunol.180.9.5826; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zurawek M, 2010, HUM IMMUNOL, V71, P530, DOI 10.1016/j.humimm.2010.02.004	122	145	149	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					121	128		10.1038/ni.1985	http://dx.doi.org/10.1038/ni.1985			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21245903				2022-12-18	WOS:000286378400005
J	Hodson, DJ; Janas, ML; Galloway, A; Bell, SE; Andrews, S; Li, CM; Pannell, R; Siebel, CW; MacDonald, HR; De Keersmaecker, K; Ferrando, AA; Grutz, G; Turner, M				Hodson, Daniel J.; Janas, Michelle L.; Galloway, Alison; Bell, Sarah E.; Andrews, Simon; Li, Cheuk M.; Pannell, Richard; Siebel, Christian W.; MacDonald, H. Robson; De Keersmaecker, Kim; Ferrando, Adolfo A.; Grutz, Gerald; Turner, Martin			Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia	NATURE IMMUNOLOGY			English	Article							AU-RICH ELEMENT; PRE-TCR SIGNALS; THYMOCYTE DIFFERENTIATION; CELL DEVELOPMENT; BETA-SELECTION; MESSENGER-RNAS; KINASE-B; NOTCH; TRISTETRAPROLIN; MICE	ZFP36L1 and ZFP36L2 are RNA-binding proteins (RBPs) that interact with AU-rich elements in the 3' untranslated region of mRNA, which leads to mRNA degradation and translational repression. Here we show that mice that lacked ZFP36L1 and ZFP36L2 during thymopoiesis developed a T cell acute lymphoblastic leukemia (T-ALL) dependent on the oncogenic transcription factor Notch1. Before the onset of T-ALL, thymic development was perturbed, with accumulation of cells that had passed through the beta-selection checkpoint without first expressing the T cell antigen receptor beta-chain (TCR beta). Notch1 expression was higher in untransformed thymocytes in the absence of ZFP36L1 and ZFP36L2. Both RBPs interacted with evolutionarily conserved AU-rich elements in the 3' untranslated region of Notch1 and suppressed its expression. Our data establish a role for ZFP36L1 and ZFP36L2 during thymocyte development and in the prevention of malignant transformation.	[Hodson, Daniel J.; Janas, Michelle L.; Galloway, Alison; Bell, Sarah E.; Li, Cheuk M.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Pannell, Richard] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Siebel, Christian W.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [MacDonald, H. Robson] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [De Keersmaecker, Kim; Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Grutz, Gerald] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Grutz, Gerald] GKSS, Ctr Biomat Dev, Polymer Res Inst, Teltow, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC Laboratory Molecular Biology; Roche Holding; Genentech; Ludwig Institute for Cancer Research; University of Lausanne; Columbia University; Columbia University; Columbia University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	martin.turner@bbsrc.ac.uk	Turner, Martin/N-9976-2014; Ferrando, Adolfo A/Q-7026-2016; De Keersmaecker, Kim/W-9702-2018; Hodson, Daniel J/K-6817-2016	Turner, Martin/0000-0002-3801-9896; De Keersmaecker, Kim/0000-0002-7420-9531; Hodson, Daniel J/0000-0001-6225-2033; Galloway, Alison/0000-0001-8780-0382	Cancer Research UK; Addenbrooke's Charitable Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council [BB/C506121/1]; US National Institutes of Health [R01CA120196, R01CA129382]; European College of Obstetrics and Gynaecology tumor bank [U24 CA114737]; Leukemia & Lymphoma Society; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Belgian American Educational Foundation; BBSRC [BB/F02066X/1, BBS/E/B/0000H190] Funding Source: UKRI; MRC [G0601618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F02066X/1, BBS/E/B/0000M983, BBS/E/B/0000H190] Funding Source: researchfish; Medical Research Council [G0601618] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U24CA114737, R01CA120196, R01CA129382] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Addenbrooke's Charitable Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European College of Obstetrics and Gynaecology tumor bank; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Belgian American Educational Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Clark (Kennedy Institute of Rheumatology, London) for the pcDNA3. myc. WT ZFP36L1 expression construct and pFLAG.CMV2-ZFP36L2; and J. Zuniga-Pflucker (University of Toronto) for OP9-DL1 stromal cells. Supported by Cancer Research UK (D.J.H.), the Addenbrooke's Charitable Trust (D.J.H.), the Medical Research Council (M.T., and a Collaborative Award in Science and Engineering to A.G.), the Biotechnology and Biological Sciences Research Council (BB/C506121/1 to M.T.), the US National Institutes of Health (R01CA120196 and R01CA129382 to A.A.F.), the European College of Obstetrics and Gynaecology tumor bank (U24 CA114737), the Leukemia & Lymphoma Society (A.A.F.), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (K.D.K.) and the Belgian American Educational Foundation (K.D.K.).	Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Baou M, 2009, LEUKEMIA, V23, P986, DOI 10.1038/leu.2008.340; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Campese AF, 2006, BLOOD, V108, P305, DOI 10.1182/blood-2006-01-0143; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Galante PAF, 2009, RNA BIOL, V6, P426, DOI 10.4161/rna.6.4.8841; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Gonsalves FC, 2007, P NATL ACAD SCI USA, V104, P531, DOI 10.1073/pnas.0609851104; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jackson RS, 2006, CELL CYCLE, V5, P2889, DOI 10.4161/cc.5.24.3539; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Michie AM, 2007, INT IMMUNOL, V19, P1421, DOI 10.1093/intimm/dxm113; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	49	145	148	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					717	U84		10.1038/ni.1901	http://dx.doi.org/10.1038/ni.1901			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20622884	Green Accepted, Green Submitted			2022-12-18	WOS:000280149400013
J	Gan, HX; Lee, JH; Ren, FC; Chen, MJ; Kornfeld, H; Remold, HG				Gan, Huixian; Lee, Jinhee; Ren, Fucheng; Chen, Minjian; Kornfeld, Hardy; Remold, Heinz G.			Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence	NATURE IMMUNOLOGY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; TUMOR-NECROSIS-FACTOR; ALPHA-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; ALVEOLAR MACROPHAGES; LIPOCORTIN-I; TISSUE TRANSGLUTAMINASE; MURINE MACROPHAGES; CORNIFIED ENVELOPE; HOST MACROPHAGES	Macrophages infected with attenuated Mycobacterium tuberculosis strain H37Ra become apoptotic, which limits bacterial replication and facilitates antigen presentation. Here we demonstrate that cells infected with H37Ra became apoptotic after the formation of an apoptotic envelope on their surface was complete. This process required exposure of phosphatidylserine on the cell surface, followed by deposition of the phospholipid-binding protein annexin-1 and then transglutaminase-mediated crosslinking of annexin-1 through its amino-terminal domain. In macrophages infected with the virulent strain H37Rv, in contrast, the amino-terminal domain of annexin-1 was removed by proteolysis, thus preventing completion of the apoptotic envelope, which resulted in macrophage death by necrosis. Virulent M. tuberculosis therefore avoids the host defense system by blocking formation of the apoptotic envelope, which leads to macrophage necrosis and dissemination of infection in the lung.	[Gan, Huixian; Chen, Minjian; Remold, Heinz G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gan, Huixian; Chen, Minjian; Remold, Heinz G.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lee, Jinhee; Ren, Fucheng; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Remold, HG (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	hremold@rics.bwh.harvard.edu	Kornfeld, Hardy/AAS-2903-2021		US National Institutes of Health [AI50216, HL064884]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050216, R21AI050216] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. F. Rosenberg (National Institute of Allergy and Infectious Diseases) for mice with deletion of the gene encoding PAI2; E. Remold- O'Donnell and T. Vallerskog for discussions; and S. Remold for help with Supplementary Figure 6. Supported by US National Institutes of Health (AI50216 and HL064884).	ANDO Y, 1989, BIOCHEM BIOPH RES CO, V163, P944, DOI 10.1016/0006-291X(89)92313-9; ANDO Y, 1991, J BIOL CHEM, V266, P1101; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Ciaramella A, 2004, J INFECT DIS, V190, P1167, DOI 10.1086/423850; Costelloe EO, 1999, J LEUKOCYTE BIOL, V66, P172, DOI 10.1002/jlb.66.1.172; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Dickinson JL, 1998, CELL DEATH DIFFER, V5, P163, DOI 10.1038/sj.cdd.4400324; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fratazzi C, 1997, J IMMUNOL, V158, P4320; GAN HX, 1995, J IMMUNOL, V155, P1304; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; JENSEN PH, 1993, EUR J BIOCHEM, V214, P141, DOI 10.1111/j.1432-1033.1993.tb17906.x; JENSEN PJ, 1995, EXP CELL RES, V217, P65, DOI 10.1006/excr.1995.1064; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; KNIGHT RL, 1993, EUR J CELL BIOL, V60, P210; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; KRUITHOF EKO, 1986, J BIOL CHEM, V261, P1207; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; LEVITT ML, 1990, CANCER RES, V50, P120; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oddo M, 1998, J IMMUNOL, V160, P5448; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SCHLAEPFER DD, 1987, J BIOL CHEM, V262, P6931; SCHWARTZ BS, 1992, J BIOL CHEM, V267, P7089; SIEFRING GE, 1978, BIOCHEMISTRY-US, V17, P2598, DOI 10.1021/bi00606a022; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Traverso V, 1998, J CELL SCI, V111, P1405; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003	59	145	152	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1189	1197		10.1038/ni.1654	http://dx.doi.org/10.1038/ni.1654			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18794848	Green Accepted, Green Submitted			2022-12-18	WOS:000259315600018
J	Ramalingam, TR; Pescel, JT; Sheikh, F; Cheever, AW; Mentink-Kane, MM; Wilson, MS; Stevens, S; Valenzuela, DM; Murphy, AJ; Yancopoulos, GD; Urban, JF; Donnelly, RP; Wynn, TA				Ramalingam, Thirumalai R.; Pescel, John T.; Sheikh, Faruk; Cheever, Allen W.; Mentink-Kane, Margaret M.; Wilson, Mark S.; Stevens, Sean; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Urban, Joseph F., Jr.; Donnelly, Raymond P.; Wynn, Thomas A.			Unique functions of the type 11 interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha 1 chain	NATURE IMMUNOLOGY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; IL-13 INDUCES PROLIFERATION; GRANULOMATOUS PATHOLOGY; TH2 CYTOKINES; IN-VIVO; CELLS; EXPRESSION; INDUCTION; FIBROSIS; SURVIVAL	The interleukin 4 receptor (IL-4R) is a central mediator of T helper type 2 (T(H)2)-mediated disease and associates with either the common gamma-chain to form the type I IL-4R or with the IL-13R alpha 1 chain (IL-13R alpha 1) to form the type II IL-4R. Here we used II13ral(-/-) mice to characterize the distinct functions of type I and type II IL-4 receptors in vivo. In contrast to II4ra(-/-) mice, which have weak T(H)2 responses, II13ra1(-/-) mice had exacerbated T(H)2 responses. II13ra1(-/-) mice showed much less mortality after infection with Schistosoma mansoni and much more susceptibility to Nippostrongylus brasiliensis. IL-13R alpha 1 was essential for allergen-induced airway hyperreactivity and mucus hypersecretion but not for fibroblast or alternative macrophage activation. Thus, type I and II IL-4 receptors exert distinct effects on immune responses.	[Ramalingam, Thirumalai R.; Pescel, John T.; Mentink-Kane, Margaret M.; Wilson, Mark S.; Wynn, Thomas A.] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; [Sheikh, Faruk; Donnelly, Raymond P.] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA; [Cheever, Allen W.] Inst Biomed Res, Rockville, MD 20892 USA; [Stevens, Sean; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Urban, Joseph F., Jr.] USDA, BHNRC, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Regeneron; United States Department of Agriculture (USDA)	Wynn, TA (corresponding author), NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/C-2797-2011; Wynn, Thomas A/AAO-3523-2021; Donnelly, Raymond P./AFT-8600-2022	Wynn, Thomas A/0000-0002-7244-8731; Donnelly, Raymond P./0000-0002-0695-5276; Murphy, Andrew/0000-0003-4152-4081; Urban, Joseph/0000-0002-1590-8869	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001019, Z01AI000829] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI001019-01, Z01 AI000829-10] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adams NC, 2006, PRIN PRACT, P131; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Brunet LR, 1997, J IMMUNOL, V159, P777; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Doucet C, 2002, EUR J IMMUNOL, V32, P2437, DOI 10.1002/1521-4141(200209)32:9<2437::AID-IMMU2437>3.0.CO;2-N; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grunig G, 2002, CHEST, V121, p88S, DOI 10.1378/chest.121.3_suppl.88S; Guo LY, 2001, NAT IMMUNOL, V2, P461, DOI 10.1038/87778; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herrick CA, 2003, J IMMUNOL, V170, P2488, DOI 10.4049/jimmunol.170.5.2488; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hoffmann KF, 2001, FASEB J, V15, P2545, DOI 10.1096/fj.01-0306fje; Jankovic D, 1999, J IMMUNOL, V163, P337; KATONA IM, 1983, J IMMUNOL, V130, P350; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Lai YH, 1999, J IMMUNOL, V162, P78; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li LQ, 2004, IMMUNITY, V20, P429, DOI 10.1016/S1074-7613(04)00072-X; Loke P, 2000, EUR J IMMUNOL, V30, P2669, DOI 10.1002/1521-4141(200009)30:9&lt;2669::AID-IMMU2669&gt;3.0.CO;2-1; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; Murata T, 1999, INT J HEMATOL, V69, P13; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; PUNNONEN J, 1994, J IMMUNOL, V152, P1094; Richter L, 2001, SENSOR MATER, V13, P385; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang ZJ, 2004, J ELECTROCERAM, V13, P41, DOI 10.1007/s10832-004-5073-4; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yang M, 2006, J IMMUNOL, V177, P5595, DOI 10.4049/jimmunol.177.8.5595; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; ZURAWSKI G, 1994, STEM CELLS, V12, P169, DOI 10.1002/stem.5530120204	49	145	151	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					25	33		10.1038/ni1544	http://dx.doi.org/10.1038/ni1544			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18066066	Green Accepted			2022-12-18	WOS:000251820800008
J	Krummel, MF; Macara, I				Krummel, Matthew F.; Macara, Ian			Maintenance and modulation of T cell polarity	NATURE IMMUNOLOGY			English	Review							IMMUNOLOGICAL SYNAPSE FORMATION; LARGE TUMOR-SUPPRESSOR; ACTIN POLYMERIZATION; DYNAMIC RECRUITMENT; MEDIATED ACTIVATION; MAMMALIAN HOMOLOG; LYMPHOCYTE ARREST; ANTIGEN RECEPTOR; BOUND CHEMOKINES; EXCHANGE FACTOR	As T cells move through the lymphatics and tissues, chemokine receptors, adhesion molecules, costimulatory molecules and antigen receptors engage their ligands in the microenvironment and contribute to establishing and maintaining cell polarity. Cytoskeletal assemblies, surface proteins and vesicle traffic are essential components of polarity and probably stabilize the activity of lymphocytes that must negotiate their 'noisy' environment. An additional component of polarity is a family of polarity proteins in T cells that includes DIg, Scrib and LgI, as well as a complex of partitioning-defective proteins. Ultimately, the strength of a T cell response may rely on correct T cell polarization. Therefore, loss of polarity regulators or guidance cues may interfere with T cell activation.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of California System; University of California San Francisco; University of Virginia	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu; igm9c@virginia.edu						Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Batista A, 2004, J IMMUNOL, V172, P6709, DOI 10.4049/jimmunol.172.11.6709; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; delPozo MA, 1997, J CELL BIOL, V137, P493; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Moss WC, 2002, P NATL ACAD SCI USA, V99, P15024, DOI 10.1073/pnas.192573999; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Russell S, 2006, IMMUNOL CELL BIOL, V84, P107, DOI 10.1111/j.1440-1711.2005.01415.x; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Tibaldi EV, 2002, P NATL ACAD SCI USA, V99, P7582, DOI 10.1073/pnas.112212699; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Volinsky N, 2006, BIOCHEM J, V397, P213, DOI 10.1042/BJ20051655; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	85	145	146	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1143	1149		10.1038/ni1404	http://dx.doi.org/10.1038/ni1404			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053799				2022-12-18	WOS:000241437200008
J	Hou, WS; Van Parijs, L				Hou, WS; Van Parijs, L			A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; TUMOR-NECROSIS-FACTOR; IN-VIVO; T-CELLS; ANTIGEN PRESENTATION; FAMILY-MEMBER; CUTTING EDGE; SURVIVAL; ACTIVATION; APOPTOSIS	The lifespan of antigen-bearing dendritic cells (DCs) is determined by signals from pathogens and T cells. These signals regulate DC survival by modulating expression of Bcl-2 family proteins. Toll-like receptors and T cell costimulatory molecules both trigger a DC survival pathway that is dependent on Bcl-x(L). However, Toll-like receptors uniquely increase expression of Bim and trigger cell death by a pathway that is blocked by Bcl-2. This pathway serves as a molecular 'timer' that sets the lifespan of DCs and regulates the magnitude of T cell responses in vivo. Thus, signals derived from the innate and acquired immune systems control DC lifespan and immunogenicity by distinct molecular mechanisms.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Van Parijs, L (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	lukvp@mit.edu						Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; De Smedt T, 1998, J IMMUNOL, V161, P4476; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; Klinman Dennis M, 2003, Expert Rev Vaccines, V2, P305, DOI 10.1586/14760584.2.2.305; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Mintern J, 1999, IMMUNOL CELL BIOL, V77, P539, DOI 10.1046/j.1440-1711.1999.00868.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nopora A, 2002, J IMMUNOL, V169, P3006, DOI 10.4049/jimmunol.169.6.3006; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P	36	145	164	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					583	589		10.1038/ni1071	http://dx.doi.org/10.1038/ni1071			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15133508				2022-12-18	WOS:000221664000016
J	Trambas, CM; Griffiths, GM				Trambas, CM; Griffiths, GM			Delivering the kiss of death	NATURE IMMUNOLOGY			English	Review							CHEDIAK-HIGASHI-SYNDROME; NATURAL-KILLER-CELLS; MICROTUBULE-ORGANIZING CENTER; LYTIC GRANULE EXOCYTOSIS; CYTOTOXIC T-LYMPHOCYTES; TARGET-CELLS; PERFORIN GENE; GRANZYME-B; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MYOSIN VA	Cytotoxic T lymphocytes and natural killer cells kill their targets by secreting specialized granules that contain potent cytotoxic molecules. Through the study of rare immunodeficiency diseases in which this granule pathway of killing is impaired, proteins such as Rab27a have been identified as components of the secretory machinery of these killer cells. Recent evidence suggests that the destruction of activated lymphocytes through granule-mediated killing may be an important mechanism of immunological homeostasis. Although the process by which this occurs is not yet known, it is possible that events taking place at the immunological synapse may render the killer cell susceptible to fratricidal attack by other killer cells.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Griffiths, GM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gillion.griffiths@path.ox.ac.uk		Griffiths, Gillian/0000-0003-0434-5842				Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Arico M, 2002, BRIT J HAEMATOL, V119, P180, DOI 10.1046/j.1365-2141.2002.03773.x; BAETZ K, 1995, J IMMUNOL, V154, P6122; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; BETKAR SS, 2002, IMMUNITY, V16, P417; Browne KA, 1999, MOL CELL BIOL, V19, P8604; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; de Saint Basile G, 2001, CURR OPIN IMMUNOL, V13, P549, DOI 10.1016/S0952-7915(00)00257-0; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Ericson KG, 2001, AM J HUM GENET, V68, P590, DOI 10.1086/318796; Espinosa E, 2002, J IMMUNOL, V168, P6336, DOI 10.4049/jimmunol.168.12.6336; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GARTUNG C, 1985, EMBO J, V4, P1725, DOI 10.1002/j.1460-2075.1985.tb03842.x; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Griffiths Gillian M., 2002, Current Molecular Medicine (Hilversum), V2, P479, DOI 10.2174/1566524023362258; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; HENKART MP, 1982, ADV EXP MED BIOL, V146, P227; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kataoka T, 1998, J IMMUNOL, V161, P3936; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER A, 1985, J MOL CELL IMMUNOL, V2, P37; KUPFER A, 1986, J EXP MED, V163, P489, DOI 10.1084/jem.163.3.489; Kuroda TS, 2002, BIOCHEM BIOPH RES CO, V293, P899, DOI 10.1016/S0006-291X(02)00320-0; KUTA AE, 1989, J IMMUNOL, V142, P4378; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MILLARD PJ, 1984, J IMMUNOL, V132, P3197; Moretta L, 2000, IMMUNOL TODAY, V21, P593, DOI 10.1016/S0167-5699(00)01731-X; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; SANDERSON CJ, 1976, PROC R SOC SER B-BIO, V192, P221, DOI 10.1098/rspb.1976.0010; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Stinchcombe JC, 2000, TRAFFIC, V1, P435, DOI 10.1034/j.1600-0854.2000.010508.x; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Suga N, 2002, BRIT J HAEMATOL, V116, P346, DOI 10.1046/j.1365-2141.2002.03266.x; Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO;2-Y; Tchernev VT, 2002, MOL MED, V8, P56, DOI 10.1007/BF03402003; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; van der Merwe PA, 2002, CURR OPIN IMMUNOL, V14, P293, DOI 10.1016/S0952-7915(02)00350-3; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Ward DM, 2000, TRAFFIC, V1, P816; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Winkler U, 1997, BIOCHEM BIOPH RES CO, V236, P34, DOI 10.1006/bbrc.1997.6899; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595	85	145	152	4	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					399	403		10.1038/ni0503-399	http://dx.doi.org/10.1038/ni0503-399			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719728				2022-12-18	WOS:000182665400002
J	Marie, JC; Astier, AL; Rivailler, P; Rabourdin-Combe, C; Wild, TF; Horvat, B				Marie, JC; Astier, AL; Rivailler, P; Rabourdin-Combe, C; Wild, TF; Horvat, B			Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation	NATURE IMMUNOLOGY			English	Article							MEMBRANE COFACTOR PROTEIN; MEASLES-VIRUS INFECTION; TYROSINE-PHOSPHATASE SHP-1; NITRIC-OXIDE PRODUCTION; PREFERENTIAL EXPRESSION; CONTACT SENSITIVITY; MEDIATED-IMMUNITY; MOLECULAR-CLONING; MOUSE MACROPHAGES; DOWN-REGULATION	CD46 is a widely expressed transmembrane protein that was initially identified as binding and inactivating C3b and C4b complement products. We used mice that were transgenic for one of two human CD46 isoforms that differ in their cytoplasmic domains (termed CD46-1 and CD46-2) to analyze the effect of CD46 stimulation on the immune response. We show here that CD46 can regulate inflammatory responses, either by inhibiting (CD46-1) or increasing (CD46-2) the contact hypersensitivity reaction. We found that engagement of CD46-1 or CD46-2 differentially affected CD8(+) T cell cytotoxicity, CD4(+) T cell proliferation, interleukin 2 (IL-2) and IL-10 production as well as tyrosine phosphorylation of Vav in T lymphocytes. These results indicate that CD46 plays a role in regulating the T cell-induced inflammatory reaction and in fine-tuning the cellular immune response by bridging innate and acquired immunity.	CERVI, INSERM, U404, F-69365 Lyon 07, France; CERVI, INSERM, U503, F-69365 Lyon 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Horvat, B (corresponding author), CERVI, INSERM, U404, 21 Ave Tony Garnier, F-69365 Lyon 07, France.	horvat@cervi-lyon.inserm.fr	Astier, Anne L/A-1641-2008; Marie, Julien/I-5084-2016; Horvat, Branka/M-3504-2014	Astier, Anne L/0000-0002-0144-3431; Horvat, Branka/0000-0003-0578-7765; Marie, Julien/0000-0001-6713-7923				ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Buchholz CJ, 1996, VIROLOGY, V217, P349, DOI 10.1006/viro.1996.0122; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Clark DA, 2000, REV MED VIROL, V10, P155, DOI 10.1002/(SICI)1099-1654(200005/06)10:3&lt;155::AID-RMV277&gt;3.0.CO;2-6; Devaux P, 1997, J VIROL, V71, P4157, DOI 10.1128/JVI.71.5.4157-4160.1997; Devaux P, 1996, J GEN VIROL, V77, P1477, DOI 10.1099/0022-1317-77-7-1477; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Evlashev A, 2000, J VIROL, V74, P1373, DOI 10.1128/JVI.74.3.1373-1382.2000; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; FERGUSON TA, 1994, J EXP MED, V179, P1597, DOI 10.1084/jem.179.5.1597; Fernandez-Centeno E, 2000, J IMMUNOL, V164, P4533, DOI 10.4049/jimmunol.164.9.4533; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Ghali M, 1998, J NEUROVIROL, V4, P521, DOI 10.3109/13550289809113496; GRIFFIN DE, 1994, J INFECT DIS, V170, pS24, DOI 10.1093/infdis/170.Supplement_1.S24; Hirano A, 1999, J VIROL, V73, P4776, DOI 10.1128/JVI.73.6.4776-4785.1999; HOLMES CH, 1992, EUR J IMMUNOL, V22, P1579, DOI 10.1002/eji.1830220635; Horvat B, 1996, J VIROL, V70, P6673, DOI 10.1128/JVI.70.10.6673-6681.1996; Hosokawa M, 1996, J IMMUNOL, V157, P4946; Imani F, 1999, J IMMUNOL, V162, P1597; IWATA K, 1995, J BIOL CHEM, V270, P15148, DOI 10.1074/jbc.270.25.15148; JOHNSTONE RW, 1993, MOL IMMUNOL, V30, P1231, DOI 10.1016/0161-5890(93)90038-D; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Katayama Y, 2000, J VIROL, V74, P1252, DOI 10.1128/JVI.74.3.1252-1257.2000; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Kurita-Taniguchi M, 2000, J IMMUNOL, V165, P5143, DOI 10.4049/jimmunol.165.9.5143; Kurita-Taniguchi M, 2002, MOL IMMUNOL, V38, P689, DOI 10.1016/S0161-5890(01)00100-6; LISZEWSKI MK, 1994, J BIOL CHEM, V269, P10776; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Manchester M, 1997, VIROLOGY, V233, P174, DOI 10.1006/viro.1997.8581; Manchester M, 2000, J VIROL, V74, P3967, DOI 10.1128/JVI.74.9.3967-3974.2000; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NANICHE D, 1993, J GEN VIROL, V74, P1073, DOI 10.1099/0022-1317-74-6-1073; Raab M, 2001, IMMUNITY, V15, P921, DOI 10.1016/S1074-7613(01)00248-5; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; SCHNORR JJ, 1995, EUR J IMMUNOL, V25, P976, DOI 10.1002/eji.1830250418; Thorley BR, 1997, EUR J IMMUNOL, V27, P726, DOI 10.1002/eji.1830270322; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; VILLIERS MB, 1991, SCAND J IMMUNOL, V34, P585, DOI 10.1111/j.1365-3083.1991.tb01582.x; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; WARD BJ, 1990, CLIN IMMUNOL IMMUNOP, V55, P315, DOI 10.1016/0090-1229(90)90107-2; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	54	145	149	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					659	666		10.1038/ni810	http://dx.doi.org/10.1038/ni810			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055630				2022-12-18	WOS:000176441700016
J	Tsokos, GC				Tsokos, George C.			Autoimmunity and organ damage in systemic lupus erythematosus	NATURE IMMUNOLOGY			English	Review							B-CELL TOLERANCE; HELPER T-CELLS; DENDRITIC CELLS; NUCLEIC-ACIDS; IFN-ALPHA; PROMOTE; DISEASE; EXPRESSION; RESPONSES; SLE	Impressive progress has been made over the last several years toward understanding how almost every aspect of the immune system contributes to the expression of systemic autoimmunity. In parallel, studies have shed light on the mechanisms that contribute to organ inflammation and damage. New approaches that address the complicated interaction between genetic variants, epigenetic processes, sex and the environment promise to enlighten the multitude of pathways that lead to what is clinically defined as systemic lupus erythematosus. It is expected that each patient owns a unique 'interactome', which will dictate specific treatment. Tsokos reviews how the genetic, epigenetic and microbial environments influence innate and adaptive immune cells to drive immunopathology and organ damage in systemic lupus erythematosus.	[Tsokos, George C.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	Tsokos, George/O-3360-2013	Tsokos, George/0000-0001-9589-2360	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank my colleagues current and past who have helped me acquire a better understanding of this formidable disease known as lupus. I want to thank M. Tsokos for her support and feedback during the preparation of this report and N. Plummer for helping with the assembly of references. The work in my laboratory has been supported by the NIH.	Acosta-Herrera M, 2019, ANN RHEUM DIS, V78, P311, DOI 10.1136/annrheumdis-2018-214127; Afeltra A, 2015, INTERN EMERG MED, V10, P677, DOI 10.1007/s11739-015-1212-x; Amarilyo G, 2014, J IMMUNOL, V193, P540, DOI 10.4049/jimmunol.1400931; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2019, NAT IMMUNOL, V20, P1574, DOI 10.1038/s41590-019-0466-2; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Buie JJ, 2017, J IMMUNOL, V199, P1979, DOI 10.4049/jimmunol.1600108; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Caielli S, 2019, NAT MED, V25, P75, DOI 10.1038/s41591-018-0254-9; Carlucci PM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99276; Castillejo-Lopez C, 2012, ANN RHEUM DIS, V71, P136, DOI 10.1136/annrheumdis-2011-200085; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chen XJ, 2018, SCIENCE, V362, P700, DOI 10.1126/science.aap9310; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Christophersen A, 2019, NAT MED, V25, P734, DOI 10.1038/s41591-019-0403-9; Coit P, 2016, CLIN IMMUNOL, V170, P70, DOI 10.1016/j.clim.2016.07.026; Comte D, 2017, ARTHRITIS RHEUMATOL, V69, P808, DOI 10.1002/art.40014; Crispin JC, 2017, CRIT REV IMMUNOL, V37, P39, DOI 10.1615/CritRevImmunol.2018025213; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Davidson A, 2019, CURR OPIN RHEUMATOL, V31, P682, DOI 10.1097/BOR.0000000000000642; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Deligianni C, 2012, EMBO REP, V13, P819, DOI 10.1038/embor.2012.112; Deng GM, 2015, NAT REV RHEUMATOL, V11, P663, DOI 10.1038/nrrheum.2015.106; Deng Y, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0695-z; Deng Y, 2014, CURR OPIN RHEUMATOL, V26, P482, DOI 10.1097/BOR.0000000000000086; Der E, 2019, NAT IMMUNOL, V20, P1556, DOI 10.1038/s41590-019-0529-4; DiStasio MM, 2019, ANN NEUROL, V86, P885, DOI 10.1002/ana.25610; Dorner T, 2019, LANCET, V393, P2344, DOI 10.1016/S0140-6736(19)30546-X; Dorner T, 2016, NAT REV RHEUMATOL, V12, P645, DOI 10.1038/nrrheum.2016.158; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Durcan L, 2019, LANCET, V393, P2332, DOI 10.1016/S0140-6736(19)30237-5; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Finsterbusch M, 2016, P NATL ACAD SCI USA, V113, pE5172, DOI 10.1073/pnas.1606253113; Flores-Mendoza G, 2018, TRENDS MOL MED, V24, P364, DOI 10.1016/j.molmed.2018.02.003; Frangou E, 2019, ANN RHEUM DIS, V78, P238, DOI 10.1136/annrheumdis-2018-213181; Freedman BI, 2014, ARTHRITIS RHEUMATOL, V66, P390, DOI 10.1002/art.38220; Furie R, 2019, J CLIN INVEST, V129, P1359, DOI 10.1172/JCI124466; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Ge Y, 2013, J EXP MED, V210, P2387, DOI 10.1084/jem.20130731; Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385; Greiling TM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2306; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; Hedrich CM, 2019, ANN RHEUM DIS, V78, P1293, DOI 10.1136/annrheumdis-2019-215957; Hedrich CM, 2017, EPIGENOMICS-UK, V9, P505, DOI 10.2217/epi-2016-0096; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hedrich CM, 2013, J BIOL CHEM, V288, P31880, DOI 10.1074/jbc.M113.508655; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Henault J, 2016, NAT IMMUNOL, V17, P196, DOI 10.1038/ni.3326; Heneka MT, 2020, NATURE, V577, P322, DOI 10.1038/d41586-019-03892-8; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Jacquemin C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122167; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jin FF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02381; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Katsuyama E, 2020, CELL REP, V30, P112, DOI 10.1016/j.celrep.2019.12.014; Kim K, 2012, ANN RHEUM DIS, V71, P1809, DOI 10.1136/annrheumdis-2011-201110; Kim SJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01793; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Kinloch AJ, 2014, ARTHRITIS RHEUMATOL, V66, P3359, DOI 10.1002/art.38888; Kottyan LC, 2015, HUM MOL GENET, V24, P582, DOI 10.1093/hmg/ddu455; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kuriakose J, 2019, J CLIN INVEST, V129, P2251, DOI 10.1172/JCI125116; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Li H, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120880; Li H, 2015, J CLIN INVEST, V125, P2877, DOI 10.1172/JCI81059; Li J, 2016, CIRC RES, V118, P1540, DOI 10.1161/CIRCRESAHA.116.308648; Liang Y, 2017, NAT IMMUNOL, V18, P152, DOI 10.1038/ni.3643; Liarski VM, 2019, NAT IMMUNOL, V20, P503, DOI 10.1038/s41590-019-0315-3; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Liszewski MK, 2017, ANNU REV PATHOL-MECH, V12, P25, DOI 10.1146/annurev-pathol-012615-044145; Liu YD, 2018, CURR OPIN RHEUMATOL, V30, P441, DOI 10.1097/BOR.0000000000000528; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; Lu XM, 2015, AM J HUM GENET, V96, P731, DOI 10.1016/j.ajhg.2015.03.002; Maeda K, 2018, J CLIN INVEST, V128, P3445, DOI 10.1172/JCI99507; Mande P, 2018, J CLIN INVEST, V128, P2966, DOI 10.1172/JCI98219; Manni M, 2018, NAT IMMUNOL, V19, P407, DOI 10.1038/s41590-018-0056-8; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Martens HA, 2009, ANN RHEUM DIS, V68, P715, DOI 10.1136/ard.2007.085688; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Menke J, 2008, J IMMUNOL, V181, P7367, DOI 10.4049/jimmunol.181.10.7367; Mizui M, 2014, J IMMUNOL, V193, P2168, DOI 10.4049/jimmunol.1400977; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Molineros JE, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008092; Moulton VR, 2017, TRENDS MOL MED, V23, P615, DOI 10.1016/j.molmed.2017.05.006; Moulton VR, 2015, J CLIN INVEST, V125, P2220, DOI 10.1172/JCI78087; Moulton VR, 2012, CLIN IMMUNOL, V144, P53, DOI 10.1016/j.clim.2012.04.003; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Odhams CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10106-2; Oh SH, 2011, CLIN EXP DERMATOL, V36, P512, DOI 10.1111/j.1365-2230.2010.03996.x; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Pelikan RC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05328-9; Peng SL, 1996, J IMMUNOL, V156, P4041; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Ryu H, 2018, NAT IMMUNOL, V19, P1036, DOI 10.1038/s41590-018-0158-3; Sahu R, 2014, ARTHRITIS RHEUMATOL, V66, P1596, DOI 10.1002/art.38410; Salmond RJ, 2014, NAT IMMUNOL, V15, P875, DOI 10.1038/ni.2958; Scharer CD, 2019, NAT IMMUNOL, V20, P1071, DOI 10.1038/s41590-019-0419-9; Schwarting A, 2005, J AM SOC NEPHROL, V16, P3264, DOI 10.1681/ASN.2004111014; Schwartz N, 2019, NAT REV RHEUMATOL, V15, P137, DOI 10.1038/s41584-018-0156-8; Sharabi A, 2020, NAT REV RHEUMATOL, V16, P100, DOI 10.1038/s41584-019-0356-x; Sharabi A, 2018, NAT REV DRUG DISCOV, V17, P823, DOI 10.1038/nrd.2018.148; Shinde R, 2018, NAT IMMUNOL, V19, P571, DOI 10.1038/s41590-018-0107-1; Smith E, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4081; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Stock AD, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124203; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Suurmond J, 2019, J ALLERGY CLIN IMMUN, V143, P1586, DOI 10.1016/j.jaci.2018.10.041; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Teruel M, 2016, CURR OPIN RHEUMATOL, V28, P506, DOI 10.1097/BOR.0000000000000310; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; Tilstra JS, 2018, J CLIN INVEST, V128, P4884, DOI 10.1172/JCI120859; Tipton CM, 2018, IMMUNOL REV, V284, P120, DOI 10.1111/imr.12660; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Thai TH, 2013, P NATL ACAD SCI USA, V110, P20194, DOI 10.1073/pnas.1317632110; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1589, DOI 10.1002/art.33488; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zegarra-Ruiz DF, 2019, CELL HOST MICROBE, V25, P113, DOI 10.1016/j.chom.2018.11.009; Zhao J, 2017, NAT GENET, V49, P433, DOI 10.1038/ng.3782; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632; Zhou H, 2013, J AM SOC NEPHROL, V24, P1073, DOI 10.1681/ASN.2012080849; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhuang HY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00291; Zumaquero E, 2019, ELIFE, V8, DOI 10.7554/eLife.41641	152	144	151	6	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					605	614		10.1038/s41590-020-0677-6	http://dx.doi.org/10.1038/s41590-020-0677-6		MAY 2020	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32367037	Green Accepted			2022-12-18	WOS:000530283200001
J	Luo, WW; Li, S; Li, C; Lian, H; Yang, Q; Zhong, B; Shu, HB				Luo, Wei-Wei; Li, Shu; Li, Chen; Lian, Huan; Yang, Qing; Zhong, Bo; Shu, Hong-Bing			iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING	NATURE IMMUNOLOGY			English	Article							CELLULAR ANTIVIRAL RESPONSE; CYCLIC GMP-AMP; CYTOSOLIC DNA; INTRACELLULAR DNA; DENDRITIC CELLS; SENSOR; RECOGNITION; ACTIVATION; INDUCTION; PATHWAY	STING is a central adaptor in the innate immune response to DNA viruses. However, the manner in which STING activity is regulated remains unclear. We identified iRhom2 (Inactive rhomboid protein 2') as a positive regulator of DNA-virus-triggered induction of type I interferons. iRhom2 deficiency markedly impaired DNA-virus- and intracellular-DNA-induced signaling in cells, and iRhom2-deficient mice were more susceptible to lethal herpes simplex virus type 1 (HSV-1) infection. iRhom2 was constitutively associated with STING and acted in two distinct processes to regulate STING activity. iRhom2 recruited the translocon-associated protein TRAP beta to the STING complex to facilitate trafficking of STING from the endoplasmic reticulum to perinuclear microsomes. iRhom2 also recruited the deubiquitination enzyme EIF3S5 to maintain the stability of STING through removal of its K48-linked polyubiquitin chains. These results suggest that iRhom2 is essential for STING activity, as it regulates TRAP beta-mediated translocation and EIF3S5-mediated deubiquitination of STING.	[Luo, Wei-Wei; Li, Shu; Li, Chen; Yang, Qing; Zhong, Bo; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Lian, Huan; Zhong, Bo; Shu, Hong-Bing] Wuhan Univ, Med Res Inst, Sch Med, Collaborat Innovat Ctr Viral Immunol, Wuhan, Peoples R China	Wuhan University; Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China.; Shu, HB (corresponding author), Wuhan Univ, Med Res Inst, Sch Med, Collaborat Innovat Ctr Viral Immunol, Wuhan, Peoples R China.	shuh@whu.edu.cn			Ministry of Science and Technology of China [2014CB910103, 2012CB910201]; National Natural Science Foundation of China [31521091, 91429304]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the Ministry of Science and Technology of China (2014CB910103 and 2012CB910201) and the National Natural Science Foundation of China (31521091 and 91429304).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shu HB, 2014, IMMUNITY, V41, P871, DOI 10.1016/j.immuni.2014.12.002; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	36	144	150	3	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1057	1066		10.1038/ni.3510	http://dx.doi.org/10.1038/ni.3510			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27428826				2022-12-18	WOS:000381832000009
J	Zook, EC; Kee, BL				Zook, Erin C.; Kee, Barbara L.			Development of innate lymphoid cells	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELL; TRANSCRIPTION FACTOR BCL11B; TISSUE-INDUCER CELL; NK CELLS; T-BET; FACTOR GATA3; FACTOR E4BP4; TYPE-2; DIFFERENTIATION; LINEAGE	Innate lymphoid cells (ILCs) are a family of immune effector cells that have important roles in host defense, metabolic homeostasis and tissue repair but can also contribute to inflammatory diseases such as asthma and colitis. These cells can be categorized into three groups on the basis of the transcription factors that direct their function and the cytokines they produce, which parallel the effector functions of T lymphocytes. The hierarchy of cell-fate-restriction events that occur as common lymphoid progenitors become committed to each of the ILC lineages further underscores the relationship between these innate immune cells and T lymphocytes. In this Review we discuss the developmental program of ILCs and transcription factors that guide ILC lineage specification and commitment.	[Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Comm Canc Biol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu		Kee, Barbara/0000-0001-7014-1982	US National Institutes of Health [F32CA177235, R01 AI106352, R21 AI115338]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Sun and members of the Kee laboratory for discussions, and A. Sperling for comments on this manuscript. Supported by the US National Institutes of Health (F32CA177235 for E.C.Z., and R01 AI106352 and R21 AI115338 for work in the laboratory of B.L.K.).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cichocki F, 2011, J INNATE IMMUN, V3, P242, DOI 10.1159/000323929; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cording S, 2014, FEBS LETT, V588, P4176, DOI 10.1016/j.febslet.2014.03.034; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Crotta S, 2014, J IMMUNOL, V192, P2677, DOI 10.4049/jimmunol.1302765; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Foley B, 2014, IMMUNOL REV, V258, P45, DOI 10.1111/imr.12157; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gasteiger G, 2013, J EXP MED, V210, P1167, DOI 10.1084/jem.20122462; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Gentek R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00334; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Juelke K, 2016, CURR OPIN IMMUNOL, V38, P75, DOI 10.1016/j.coi.2015.11.005; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kim BS, 2013, CURR OPIN IMMUNOL, V25, P738, DOI 10.1016/j.coi.2013.07.013; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Parikh BA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005323; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2013, SEMIN IMMUNOPATHOL, V35, P657, DOI 10.1007/s00281-013-0393-5; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spits H., 2016, NAT IMMUNOL; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Tanaka H, 2014, CURR TOP MICROBIOL, V373, P113, DOI 10.1007/82_2013_323; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van de Pavert SA, 2016, INT IMMUNOL, V28, P35, DOI 10.1093/intimm/dxv052; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Vosshenrich CAJ, 2013, CURR OPIN IMMUNOL, V25, P130, DOI 10.1016/j.coi.2013.02.002; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2016, CURR OPIN IMMUNOL, V39, P114, DOI 10.1016/j.coi.2016.01.006; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	110	144	153	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					775	782		10.1038/ni.3481	http://dx.doi.org/10.1038/ni.3481			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328007				2022-12-18	WOS:000378283200009
J	Gray, EE; Ramirez-Valle, F; Xu, Y; Wu, S; Wu, ZH; Karjalainen, KE; Cyster, JG				Gray, Elizabeth E.; Ramirez-Valle, Francisco; Xu, Ying; Wu, Shuang; Wu, Zhihao; Karjalainen, Klaus E.; Cyster, Jason G.			Deficiency in IL-17-committed V(gamma)4(+) gamma delta T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis	NATURE IMMUNOLOGY			English	Article							ALPHA-BETA; SKIN; PROTEIN; IDENTIFICATION; THYMUS; IL-17; INFLAMMATION; LYMPHOCYTES; THYMOCYTES; EXPRESSION	Interleukin 17 (IL-17)-committed gamma delta T cells (gamma delta T17 cells) participate in many immune responses, but their developmental requirements and subset specific functions remain poorly understood. Here we report that a commonly used CD45.1(+) congenic C57BL/6 mouse substrain is characterized by selective deficiency in V(gamma)4(+) gamma delta T17 cells. This trait was due to a spontaneous mutation in the gene encoding the transcription factor Sox13 that caused an intrinsic defect in development of those cells in the neonatal thymus. The gdT17 cells migrated from skin to lymph nodes at low rates. In a model of psoriasis-like dermatitis, the V(gamma)4(+) gamma delta T17 cell subset expanded considerably in lymph nodes and homed to inflamed skin. Sox13-mutant mice were protected from psoriasis-like skin changes, which identified a role for Sox13-dependent gamma delta T17 cells in this inflammatory condition.	[Gray, Elizabeth E.; Ramirez-Valle, Francisco; Xu, Ying; Wu, Shuang; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Gray, Elizabeth E.; Ramirez-Valle, Francisco; Xu, Ying; Wu, Shuang; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Gray, Elizabeth E.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Ramirez-Valle, Francisco] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wu, Zhihao; Karjalainen, Klaus E.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Karjalainen, Klaus/A-2206-2011	Wu, Zhihao/0000-0001-8099-6693	US National Institutes of Health [T32 AR007175, AI045073]; Dermatology Foundation; Biomedical Research Council [06/1/22/19/469]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007175] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A.-K. Hadjantonakis and S. Nowotschin (Memorial Sloan-Kettering) for making KikGR mice available; A. Weiss and K. Skrzypczynska (University of California San Francisco) for Ptprc<SUP>-/-</SUP> mice; L. Coussens (University of California San Francisco and Oregon Health Sciences University) for FVB/N mice; Q. Tang and A. Mahne (University of California San Francisco) for mice of the nonobese diabetic strain; A. Reboldi, Y. Han and J. Kang for discussions; and J. An for technical assistance. Supported by the US National Institutes of Health (T32 AR007175 to F.R.-V., and AI045073 to J.G.C.), the Dermatology Foundation (F.R.V.), the Biomedical Research Council (06/1/22/19/469 to Z. W. and K. E. K.) and the Howard Hughes Medical Institute (J.G.C.).	Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; Kido S, 1998, GENE, V208, P201, DOI 10.1016/S0378-1119(97)00667-7; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Ma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024768; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roose J, 1999, GENOMICS, V57, P301, DOI 10.1006/geno.1999.5779; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Zebedee S L, 1991, Dev Immunol, V1, P243, DOI 10.1155/1991/52686	50	144	149	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					584	+		10.1038/ni.2585	http://dx.doi.org/10.1038/ni.2585			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23624556	Green Accepted, Green Submitted			2022-12-18	WOS:000319107600011
J	Ring, AM; Lin, JX; Feng, D; Mitra, S; Rickert, M; Bowman, GR; Pande, VS; Li, P; Moraga, I; Spolski, R; Ozkan, E; Leonard, WJ; Garcia, KC				Ring, Aaron M.; Lin, Jian-Xin; Feng, Dan; Mitra, Suman; Rickert, Mathias; Bowman, Gregory R.; Pande, Vijay S.; Li, Peng; Moraga, Ignacio; Spolski, Rosanne; Oezkan, Engin; Leonard, Warren J.; Garcia, K. Christopher			Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15	NATURE IMMUNOLOGY			English	Article							ALPHA-RECEPTOR; DIFFERENTIAL REGULATION; MOLECULAR SIMULATION; FAMILY CYTOKINES; CELL-SURVIVAL; T-CELLS; INTERLEUKIN-2; BINDING; KINETICS; COMPLEX	Interleukin 15 (IL-15) and IL-2 have distinct immunological functions even though both signal through the receptor subunit IL-2R beta and the common gamma-chain (gamma(c)). Here we found that in the structure of the IL-15-IL-15R alpha-IL-2R beta-gamma(c) quaternary complex, IL-15 binds to IL-2R beta and gamma(c) in a heterodimer nearly indistinguishable from that of the IL-2-IL-2R alpha-IL-2R beta-gamma(c) complex, despite their different receptor-binding chemistries. IL-15R alpha substantially increased the affinity of IL-15 for IL-2R beta, and this allostery was required for IL-15 trans signaling. Consistent with their identical IL-2R beta-gamma(c) dimer geometries, IL-2 and IL-15 showed similar signaling properties in lymphocytes, with any differences resulting from disparate receptor affinities. Thus, IL-15 and IL-2 induced similar signals, and the cytokine specificity of IL-2R alpha versus IL-15R alpha determined cellular responsiveness. Our results provide new insights for the development of specific immunotherapeutics based on IL-15 or IL-2.	[Ring, Aaron M.; Feng, Dan; Rickert, Mathias; Moraga, Ignacio; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ring, Aaron M.; Feng, Dan; Rickert, Mathias; Moraga, Ignacio; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Feng, Dan; Rickert, Mathias; Moraga, Ignacio; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Mitra, Suman; Li, Peng; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Bowman, Gregory R.; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Leonard, Warren/AAA-1397-2022; Pande, Vijay/ABE-8145-2020	Ring, Aaron/0000-0003-3699-2446; Moraga, Ignacio/0000-0001-9909-0701; Ozkan, Engin/0000-0002-0263-6729	US National Institutes of Health [R01 AI51321, R01 GM062868]; National Research Service Award [NIH-F30DK094541]; American Recovery and Reinvestment Act [MRI-R2]; Division of Intramural Research of the National Heart, Lung and Blood Institute (US National Institutes of Health); Stanford Medical Scientist Training Program [NIH-GM07365]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005401, ZIAHL005402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321, R37AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868, T32GM007365] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Division of Intramural Research of the National Heart, Lung and Blood Institute (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Medical Scientist Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Long, M. Rubinstein and members of the Leonard and Garcia laboratories for advice and discussions; and N. Goriatcheva, D. Waghray and S. Fischer for technical assistance. Supported by the US National Institutes of Health (R01 AI51321 to K.C.G.; R01 GM062868 to V.S.P.; and National Research Service Award NIH-F30DK094541 to A.M.R.), the American Recovery and Reinvestment Act of 2009 (Public Law 111-5; MRI-R2 to V.S.P.), the Division of Intramural Research of the National Heart, Lung and Blood Institute (US National Institutes of Health; W.J.L., J.-X.L., P.L., S.M. and R.S.), the Stanford Medical Scientist Training Program (NIH-GM07365 to A.M.R.) and the Howard Hughes Medical Institute (K.C.G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; BALASUBRAMANIAN S, 1995, INT IMMUNOL, V7, P1839, DOI 10.1093/intimm/7.11.1839; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bessard A, 2009, MOL CANCER THER, V8, P2736, DOI 10.1158/1535-7163.MCT-09-0275; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Bowman GR, 2010, CELL RES, V20, P622, DOI 10.1038/cr.2010.57; Bowman GR, 2009, METHODS, V49, P197, DOI 10.1016/j.ymeth.2009.04.013; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Castro I, 2011, J IMMUNOL, V187, P5170, DOI 10.4049/jimmunol.1003961; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; COLLINS L, 1988, P NATL ACAD SCI USA, V85, P7709, DOI 10.1073/pnas.85.20.7709; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; DARDEN T, 1995, J CHEM PHYS, V103, P3014; Demirci G, 2004, CELL MOL IMMUNOL, V1, P123; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hanick NA, 2007, BIOCHEMISTRY-US, V46, P9453, DOI 10.1021/bi700652f; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lindemann MJ, 2008, J BIOL CHEM, V283, P14100, DOI 10.1074/jbc.M801357200; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Pettit DK, 1997, J BIOL CHEM, V272, P2312; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sneller MC, 2011, BLOOD, V118, P6845, DOI 10.1182/blood-2011-09-377804; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Zambricki E, 2005, AM J TRANSPLANT, V5, P2623, DOI 10.1111/j.1600-6143.2005.01075.x; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	50	144	173	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1187	+		10.1038/ni.2449	http://dx.doi.org/10.1038/ni.2449			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23104097	Green Accepted			2022-12-18	WOS:000311217900012
J	Narayan, K; Sylvia, KE; Malhotra, N; Yin, CC; Martens, G; Vallerskog, T; Kornfeld, H; Xiong, N; Cohen, NR; Brenner, MB; Berg, LJ; Kang, J				Narayan, Kavitha; Sylvia, Katelyn E.; Malhotra, Nidhi; Yin, Catherine C.; Martens, Gregory; Vallerskog, Therese; Kornfeld, Hardy; Xiong, Na; Cohen, Nadia R.; Brenner, Michael B.; Berg, Leslie J.; Kang, Joonsoo		Immunological Genome Project	Intrathymic programming of effector fates in three molecularly distinct gamma delta T cell subtypes	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; INTERFERON-GAMMA; UP-REGULATION; DIFFERENTIATION; SELECTION; RECEPTOR; THYMUS; THYMOCYTES; INHIBITOR; IMMUNITY	Innate gamma delta T cells function in the early phase of immune responses. Although innate gamma delta T cells have often been studied as one homogenous population, they can be functionally classified into effector subsets on the basis of the production of signature cytokines, analogous to adaptive helper T cell subsets. However, unlike the function of adaptive T cells, gamma delta effector T cell function correlates with genomically encoded T cell antigen receptor (TCR) chains, which suggests that clonal TCR selection is not the main determinant of the differentiation of gamma delta effector cells. A high-resolution transcriptome analysis of all emergent gamma delta thymocyte subsets segregated on the basis of use of the TCR gamma-chain or delta-chain indicated the existence of three separate subtypes of gamma delta effector cells in the thymus. The immature gamma delta subsets were distinguished by unique transcription-factor modules that program effector function.	[Narayan, Kavitha; Sylvia, Katelyn E.; Malhotra, Nidhi; Yin, Catherine C.; Berg, Leslie J.; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Martens, Gregory; Vallerskog, Therese; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Xiong, Na] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Cohen, Nadia R.; Brenner, Michael B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Cohen, Nadia R.; Brenner, Michael B.] Harvard Univ, Sch Med, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kang, J (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	joonsoo.kang@umassmed.edu	Gautier, Emmanuel L./E-2259-2017; Heng, Tracy/B-9847-2015; Gazit, Roi/J-3352-2017; Heng, Tracy/AAR-5712-2021; Kornfeld, Hardy/AAS-2903-2021	Gautier, Emmanuel L./0000-0003-2976-7566; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Gazit, Roi/0000-0002-0548-2147	Core resources supported by the Diabetes Endocrinology Research Center [DK32520]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R24 AI072073, CA100382]; eBioscience; Affymetrix; Expression Analysis; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA100382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084987, R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Core resources supported by the Diabetes Endocrinology Research Center; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); eBioscience; Affymetrix; Expression Analysis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Mohrs (Trudeau Institute) for IL-4-GFP reporter mice; H. Birchmeier (Max-Delbruck-Center for Molecular Medicine Berlin) for Axin2 reporter mice; V. Lefebvre (Cleveland Clinic) for Sox5 reporter mice; K. Rock (University of Massachusetts Medical School) for Ctsl<SUP>-/-</SUP> mice; E. Huseby (University of Massachusetts Medical School) for Cd74<SUP>-/-</SUP> mice; S. Davis (Harvard Medical School) for the ConsolidateProbeSets module and PopulationDistances PCA program; A. Hayday (King's College, London) for anti-V<INF>delta</INF>1 (17D1); members of the ImmGen Consortium for discussions; the ImmGen core team (M. Painter, J. Ericson and S. Davis) for help with data generation and processing; and eBioscience, Affymetrix and Expression Analysis for support of the ImmGen Project. Core resources supported by the Diabetes Endocrinology Research Center (DK32520) were used. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R24 AI072073 to the ImmGen group, and CA100382 to J.K.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Andrews DM, 2011, IMMUNOL CELL BIOL, V89, P739, DOI 10.1038/icb.2010.168; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Livak F, 1999, J IMMUNOL, V162, P2575; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pereira P, 2004, J IMMUNOL, V173, P3261, DOI 10.4049/jimmunol.173.5.3261; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	51	144	147	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					511	U116		10.1038/ni.2247	http://dx.doi.org/10.1038/ni.2247			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22473038	Green Submitted, Green Accepted			2022-12-18	WOS:000303048400015
J	Biton, M; Levin, A; Slyper, M; Alkalay, I; Horwitz, E; Mor, H; Kredo-Russo, S; Avnit-Sagi, T; Cojocaru, G; Zreik, F; Bentwich, Z; Poy, MN; Artis, D; Walker, MD; Hornstein, E; Pikarsky, E; Ben-Neriah, Y				Biton, Moshe; Levin, Avi; Slyper, Michal; Alkalay, Irit; Horwitz, Elad; Mor, Hagar; Kredo-Russo, Sharon; Avnit-Sagi, Tali; Cojocaru, Gady; Zreik, Farid; Bentwich, Zvi; Poy, Matthew N.; Artis, David; Walker, Michael D.; Hornstein, Eran; Pikarsky, Eli; Ben-Neriah, Yinon			Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk	NATURE IMMUNOLOGY			English	Article							KRUPPEL-LIKE FACTOR-4; GOBLET CELLS; ENZYME DICER; STEM-CELLS; EXPRESSION; DIFFERENTIATION; SYSTEM; COLON; MICE; GENE	Colonic homeostasis entails epithelium-lymphocyte cooperation, yet many participants in this process are unknown. We show here that epithelial microRNAs mediate the mucosa-immune system crosstalk necessary for mounting protective T helper type 2 (T(H)2) responses. Abolishing the induction of microRNA by gut-specific deletion of Dicer1 (Dicer1(Delta gut)), which encodes an enzyme involved in microRNA biogenesis, deprived goblet cells of RELM beta, a key T(H)2 antiparasitic cytokine; this predisposed the host to parasite infection. Infection of Dicer1(Delta gut) mice with helminths favored a futile T(H)1 response with hallmarks of inflammatory bowel disease. Interleukin 13 (IL-13) induced the microRNA miR-375, which regulates the expression of TSLP, a T(H)2-facilitating epithelial cytokine; this indicated a T(H)2-amplification loop. We found that miR-375 was required for RELM beta expression in vivo; miR-375-deficient mice had significantly less intestinal RELM beta, which possibly explains the greater susceptibility of Dicer1(Delta gut) mice to parasites. Our findings indicate that epithelial microRNAs are key regulators of gut homeostasis and mucosal immunity.	[Biton, Moshe; Levin, Avi; Slyper, Michal; Alkalay, Irit; Horwitz, Elad; Mor, Hagar; Cojocaru, Gady; Pikarsky, Eli; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91010 Jerusalem, Israel; [Levin, Avi] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Gastroenterol, Div Med, Jerusalem, Israel; [Kredo-Russo, Sharon; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Avnit-Sagi, Tali; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Zreik, Farid; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel; [Bentwich, Zvi] Rosetta Genom, Rehovot, Israel; [Poy, Matthew N.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Artis, David] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Pikarsky, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91010 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	Poy, Matthew/F-6914-2017; HORNSTEIN, ERAN/K-1340-2012; Ben-Neriah, Yinon/L-6285-2019; pikarsky, eli/GXV-7099-2022	Poy, Matthew/0000-0002-4904-2426; HORNSTEIN, ERAN/0000-0002-5534-1924; pikarsky, eli/0000-0003-4186-7105; Levin, Avraham/0000-0002-7544-5077; Biton, Moshe/0000-0001-8330-1674; Artis, David/0000-0002-1753-4100	Israel Science Foundation; Israel Cancer Research Fund; Hadassah Medical Center; German-Israeli Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Crohn's & Colitis Foundation of America	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Hadassah Medical Center; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Crohn's & Colitis Foundation of America	We thank S. Robine (Institut Curie, Centre National de la Recherche Scientifique) for Villin Cre-ER<SUP>T2</SUP> mice; C.J. Tabin (Harvard Medical School) for Dicer1<SUP>fl/fl</SUP> mice; P. P. Pandolfi (Harvard Medical School) for Pten<SUP>fl/fl</SUP> mice; K. Rajewsky (Harvard Medical School) for antibody to Dicer; I. Ben-Porath (Hebrew University) for reagents; H. Clevers for IEC-isolation protocols; Y. Smith for assistance in genomic data analysis; M. Leshets and I. Burstain for handling the confocal microscopy; and R. Goldstein for critical review of the manuscript. Supported by the Israel Science Foundation, Israel Cancer Research Fund, Hadassah Medical Center (A. L.), the German-Israeli Foundation, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Crohn's & Colitis Foundation of America.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; AUGERON C, 1984, CANCER RES, V44, P3961; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hauber HP, 2010, J CYST FIBROS, V9, P277, DOI 10.1016/j.jcf.2010.05.002; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kida Y, 2008, JAMA-J AM MED ASSOC, V299, P2628, DOI 10.1001/jama.299.22.2628-a; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; PANESAR TS, 1981, Z PARASITENKD, V66, P163, DOI 10.1007/BF00925723; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; VELCICH A, 1995, CELL GROWTH DIFFER, V6, P749; Wang ML, 2008, AM J PHYSIOL-GASTR L, V295, pG1122, DOI 10.1152/ajpgi.90430.2008; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wynn TA, 2009, NAT IMMUNOL, V10, P679, DOI 10.1038/ni0709-679; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	50	144	154	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					239	U75		10.1038/ni.1994	http://dx.doi.org/10.1038/ni.1994			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21278735				2022-12-18	WOS:000287354400011
J	Tenzer, S; Wee, E; Burgevin, A; Stewart-Jones, G; Friis, L; Lamberth, K; Chang, CH; Harndahl, M; Weimershaus, M; Gerstoft, J; Akkad, N; Klenerman, P; Fugger, L; Jones, EY; McMichael, AJ; Buus, S; Schild, H; van Endert, P; Iversen, AKN				Tenzer, Stefan; Wee, Edmund; Burgevin, Anne; Stewart-Jones, Guillaume; Friis, Lone; Lamberth, Kasper; Chang, Chih-hao; Harndahl, Mikkel; Weimershaus, Mirjana; Gerstoft, Jan; Akkad, Nadja; Klenerman, Paul; Fugger, Lars; Jones, E. Yvonne; McMichael, Andrew J.; Buus, Soren; Schild, Hansjoerg; van Endert, Peter; Iversen, Astrid K. N.			Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; QUANTITATIVE-ANALYSIS; PEPTIDE-BINDING; CELL RESPONSES; VIRUS; ESCAPE; EPITOPE; IDENTIFICATION; GAG; TRANSMISSION	Although cytotoxic T lymphocytes (CTLs) in people infected with human immunodeficiency virus type 1 can potentially target multiple virus epitopes, the same few are recognized repeatedly. We show here that CTL immunodominance in regions of the human immunodeficiency virus type 1 group-associated antigen proteins p17 and p24 correlated with epitope abundance, which was strongly influenced by proteasomal digestion profiles, affinity for the transporter protein TAP, and trimming mediated by the endoplasmatic reticulum aminopeptidase ERAAP, and was moderately influenced by HLA affinity. Structural and functional analyses demonstrated that proteasomal cleavage 'preferences' modulated the number and length of epitope-containing peptides, thereby affecting the response avidity and clonality of T cells. Cleavage patterns were affected by both flanking and intraepitope CTL-escape mutations. Our analyses show that antigen processing shapes CTL response hierarchies and that viral evolution modifies cleavage patterns and suggest strategies for in vitro vaccine optimization.	[Wee, Edmund; Stewart-Jones, Guillaume; Friis, Lone; Chang, Chih-hao; Fugger, Lars; McMichael, Andrew J.; Iversen, Astrid K. N.] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford, England; [Tenzer, Stefan; Akkad, Nadja; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany; [Burgevin, Anne; Weimershaus, Mirjana; van Endert, Peter] INSERM, U580, Paris, France; [Burgevin, Anne; Weimershaus, Mirjana; van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Lamberth, Kasper; Harndahl, Mikkel; Buus, Soren] Univ Copenhagen, Expt Immunol Lab, Copenhagen, Denmark; [Gerstoft, Jan] Natl Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Peter Medawar Bldg Pathogen Res, Oxford, England; [Fugger, Lars] Univ Oxford, Dept Clin Neurol, John Radcliffe Hosp, Oxford, England; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Struct Biol Grp, Oxford, England	University of Oxford; Johannes Gutenberg University of Mainz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Iversen, AKN (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford, England.	astrid.iversen@imm.ox.ac.uk	Jones, Yvonne/N-8111-2019; Tenzer, Stefan/AAE-2180-2020; Jones, Yvonne/J-2293-2016; Buus, Soren/F-5446-2010; Stewart-Jones, Guillaume/E-7013-2013; van Endert, Peter/R-4606-2017	Jones, Yvonne/0000-0002-3834-1893; Tenzer, Stefan/0000-0003-3034-0017; Jones, Yvonne/0000-0002-3834-1893; van Endert, Peter/0000-0003-3782-0750; CHANG, CHIH-HAO/0000-0002-0139-7439; Buus, Soren/0000-0001-8363-1999; klenerman, paul/0000-0003-4307-9161	Novo Nordisk Foundation; Danish AIDS foundation; Deutsche Forschungsgemeinschaft; Genomes2Vaccines Specific Targeted Research Project; Sixth Framework Programme [LSHB-CT-2003-503231]; Hochschulbauforderungsgesetz Program [HBFG-122-605]; Forschungszentrum Immunologie at the University of Mainz; Nuffield Dominions Trust; Cancer Research UK; European Union [LSHG-CT-2006-031220, LSHC-CT-2006-518234, HEALTH-2007-222773]; Wellcome Trust; James Martin 21st Century School at the University of Oxford; National Institute for Health; UK Medical Research Council; Medical Research Council [MC_U137884177, MC_U137884178, G9900061] Funding Source: researchfish; MRC [G9900061, MC_U137884178, MC_U137884177] Funding Source: UKRI	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish AIDS foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Genomes2Vaccines Specific Targeted Research Project; Sixth Framework Programme(European Commission); Hochschulbauforderungsgesetz Program; Forschungszentrum Immunologie at the University of Mainz; Nuffield Dominions Trust; Cancer Research UK(Cancer Research UK); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); James Martin 21st Century School at the University of Oxford; National Institute for Health; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients for donating samples; B. Baadegaard and L. P. Jensen for patient management; D. Hass, T. Rostron, J. Frankland and J. Forsch for technical assistance; and N. Willcox for discussions. Supported by the Novo Nordisk Foundation, the Danish AIDS foundation, the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 490, E6, Z3), the Genomes2Vaccines Specific Targeted Research Project, Sixth Framework Programme (LSHB-CT-2003-503231), the Hochschulbauforderungsgesetz Program (HBFG-122-605), the Forschungszentrum Immunologie at the University of Mainz, the Nuffield Dominions Trust, Cancer Research UK, the European Union (LSHG-CT-2006-031220, LSHC-CT-2006-518234 and HEALTH-2007-222773), the Wellcome Trust, The James Martin 21st Century School at the University of Oxford, the National Institute for Health Research Biomedical Research Centre Programme, and the UK Medical Research Council.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; BOUILLOT M, 1989, NATURE, V339, P473, DOI 10.1038/339473a0; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Burgevin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002402; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; HUET S, 1990, INT IMMUNOL, V2, P311, DOI 10.1093/intimm/2.4.311; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Martinez-Hackert E, 2006, J BIOL CHEM, V281, P20205, DOI 10.1074/jbc.M601934200; Milicic A, 2005, J IMMUNOL, V175, P4618, DOI 10.4049/jimmunol.175.7.4618; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shimbara N, 1998, J BIOL CHEM, V273, P23062, DOI 10.1074/jbc.273.36.23062; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tenzer S, 2004, J IMMUNOL, V172, P1083, DOI 10.4049/jimmunol.172.2.1083; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zimbwa P, 2007, J VIROL, V81, P2031, DOI 10.1128/JVI.00968-06; 2006, HIV MOL IMMUNOLOGY 2, P53	50	144	147	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					636	U109		10.1038/ni.1728	http://dx.doi.org/10.1038/ni.1728			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19412183				2022-12-18	WOS:000266384100016
J	Maekawa, Y; Minato, Y; Ishifune, C; Kurihara, T; Kitamura, A; Kojima, H; Yagita, H; Sakata-Yanagimoto, M; Saito, T; Taniuchi, I; Chiba, S; Sone, S; Yasutomo, K				Maekawa, Yoichi; Minato, Yoshiaki; Ishifune, Chieko; Kurihara, Takeshi; Kitamura, Akiko; Kojima, Hidefumi; Yagita, Hideo; Sakata-Yanagimoto, Mamiko; Saito, Toshiki; Taniuchi, Ichiro; Chiba, Shigeru; Sone, Saburo; Yasutomo, Koji			Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity	NATURE IMMUNOLOGY			English	Article							GATA3 EXPRESSION; CROSS-TALK; DIFFERENTIATION; MEMORY; EFFECTOR; RESPONSES; PATHWAY; PROLIFERATION; EOMESODERMIN; ACTIVATION	The acquisition of cytotoxic effector function by CD8(+) T cells is crucial for the control of intracellular infection and tumor invasion. However, it remains unclear which signaling pathways are required for the differentiation of CD8(+) cytotoxic T lymphocytes. We show here that Notch2-deficient T cells had impaired differentiation into cytotoxic T lymphocytes. In addition, dendritic cells with lower expression of the Notch ligand Delta-like 1 induced the differentiation of cytotoxic T lymphocytes less efficiently. We found that the intracellular domain of Notch2 interacted with a phosphorylated form of the transcription factor CREB1, and together these proteins bound the transcriptional coactivator p300 to form a complex on the promoter of the gene encoding granzyme B. Our results suggest that the highly regulated, dynamic control of T cell cytotoxicity depends on the integration of Notch2 and CREB1 signals.	[Maekawa, Yoichi; Minato, Yoshiaki; Ishifune, Chieko; Kurihara, Takeshi; Kitamura, Akiko; Yasutomo, Koji] Univ Tokushima, Grad Sch, Dept Immunol & Parasitol 1, Inst Hlth Biosci, Tokushima 7708503, Japan; [Minato, Yoshiaki; Sone, Saburo] Univ Tokushima, Grad Sch, Dept Resp Med & Rheumatol, Inst Hlth Biosci, Tokushima 7708503, Japan; [Kojima, Hidefumi] Dokkyo Med Univ, Dept Immunol, Mibu, Tochigi 3210293, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Sakata-Yanagimoto, Mamiko; Saito, Toshiki; Chiba, Shigeru] Univ Tokyo, Dept Cell Therapy & Transplantat Med 5, Tokyo 1138655, Japan; [Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Clin & Expt Hematol, Tsukuba, Ibaraki 3058575, Japan; [Taniuchi, Ichiro] RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Yokohama, Kanagawa 2300045, Japan	Tokushima University; Tokushima University; Dokkyo Medical University; Juntendo University; University of Tokyo; University of Tsukuba; RIKEN	Yasutomo, K (corresponding author), Univ Tokushima, Grad Sch, Dept Immunol & Parasitol 1, Inst Hlth Biosci, Tokushima 7708503, Japan.	yasutomo@basic.med.tokushima-u.ac.jp	Taniuchi, Ichiro/N-6399-2015; Saito, Takashi/C-9684-2009; Mamiko, Sakata-yanagimoto/AAP-3298-2020	Taniuchi, Ichiro/0000-0002-9853-9068; Saito, Takashi/0000-0001-9495-3547; Yasutomo, Koji/0000-0003-0411-2037; Maekawa, Yoichi/0000-0002-3879-5713	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Sumitomo Foundation; Mochida Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Mochida Memorial Foundation	We thank T. Kitamura (Tokyo University), S. Reiner (University of Pennsylvania) and J. Fujisawa (Kansai Medical University) for reagents; R. Germain (US National Institutes of Health) for the DCEK cell line and for discussions; K. Ikuta for critical review of the manuscript; C. Kinouchi for technical assistance; and K. Yamakawa for secretarial assistance. Supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (S)), The Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Priority Areas), the Takeda Science Foundation, the Sumitomo Foundation and the Mochida Memorial Foundation.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Clarke SRM, 2000, J LEUKOCYTE BIOL, V67, P607, DOI 10.1002/jlb.67.5.607; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Muller U, 2003, EUR J IMMUNOL, V33, P70, DOI 10.1002/immu.200390009; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pear WS, 2003, SEMIN IMMUNOL, V15, P69, DOI 10.1016/S1044-5323(03)00003-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wong KK, 2003, J CLIN INVEST, V112, P1741, DOI 10.1172/JCI18020; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	41	144	147	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1140	1147		10.1038/ni.1649	http://dx.doi.org/10.1038/ni.1649			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18724371				2022-12-18	WOS:000259315600012
J	van Vliet, SJ; Gringhuis, SI; Geijtenbeek, TBH; van Kooyk, Y				van Vliet, Sandra J.; Gringhuis, Sonja I.; Geijtenbeek, Teunis B. H.; van Kooyk, Yvette			Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45	NATURE IMMUNOLOGY			English	Article							TYROSINE-PHOSPHATASE CD45; DENDRITIC CELLS; IN-VITRO; DC-SIGN; RECEPTOR; RESPONSES; LYMPHOCYTES; EXPRESSION; ADHESION; GLYCOSYLATION	Homeostatic control of T cells involves tight regulation of effector T cells to prevent excessive activation that can cause tissue damage and autoimmunity. Little is known, however, about whether antigen-presenting cells ( APCs) are also involved in maintaining immune system homeostasis once effector T cells are stimulated. Here we found that immature APCs downregulated effector T cell function by a mechanism involving the C-type lectin MGL expressed by APCs. Glycosylation-dependent interactions of MGL with CD45 on effector T cells negatively regulated T cell receptor - mediated signaling and T cell dependent cytokine responses, which in turn decreased T cell proliferation and increased T cell death. Thus, regulation of effector T cells by MGL expressed on APCs may provide a target for regulating chronic inflammatory and autoimmune diseases.	Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Kooyk, Y (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	y.vankooyk@vumc.nl	Van Vliet, Sandra/AAO-9534-2020; Geijtenbeek, Teunis/C-2229-2009	van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665; Gringhuis, Sonja/0000-0003-0383-4978				Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Fortin M, 2002, J IMMUNOL, V168, P6084, DOI 10.4049/jimmunol.168.12.6084; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia GG, 2005, EUR J IMMUNOL, V35, P622, DOI 10.1002/eji.200425538; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gregori S, 2005, J EXP MED, V201, P1293, DOI 10.1084/jem.20040912; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; HINTZEN RQ, 1993, J IMMUNOL, V151, P2426; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Klaus SJ, 1996, J IMMUNOL, V156, P2743; Kumamoto Y, 2004, J BIOL CHEM, V279, P49274, DOI 10.1074/jbc.M409300200; Latinis KM, 1997, J IMMUNOL, V158, P4602; Lesage S, 1997, J IMMUNOL, V159, P4762; Liu Z, 2006, INT IMMUNOL, V18, P959, DOI 10.1093/intimm/dxl032; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Luke P. P. W., 2001, Current Molecular Medicine (Hilversum), V1, P533, DOI 10.2174/1566524013363348; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; OHTA T, 1994, BIOCHEM BIOPH RES CO, V200, P1283, DOI 10.1006/bbrc.1994.1590; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Piemonti L, 1999, J IMMUNOL, V162, P6473; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; ROGERS PR, 1992, J IMMUNOL, V148, P4054; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; ZAPATA JM, 1994, J IMMUNOL, V152, P3852	50	144	148	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1200	1208		10.1038/ni1390	http://dx.doi.org/10.1038/ni1390			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	16998493				2022-12-18	WOS:000241437200015
J	Loza, MJ; Perussia, B				Loza, MJ; Perussia, B			Final steps of natural killer cell maturation: a model for type 1 type 2 differentiation?	NATURE IMMUNOLOGY			English	Article							STIMULATORY FACTOR INTERLEUKIN-12; HUMAN NK-CELL; CUTTING EDGE; BONE-MARROW; T-CELLS; CYTOKINE; EXPRESSION; DEFINITION; IMMATURE; SUBSET	Analysis of cytokine and differentiation antigen expression in human natural killer (NK) cells revealed that interleukin 13 (IL-13) and interferon gamma (IFN-gamma) are produced at sequential stages during irreversible IL-12-induced differentiation. In human NK cell clones, polyclonal CD3(-)CD161(+)CD56(-) cells and peripheral lymphocytes, IL-4 induced the proliferation of both IL-13. NK and T cells, whereas IL-12 allowed a proliferation-independent accumulation of IFN-gamma (+) cells. These data disproved the NK1-NK2 hypothesis and challenge the current T helper 1 (THI)-T(H)2 paradigm. We propose that the cytokine environment regulates a type 2 -->0 -->1 developmental progression, with IL-12 needed for terminal differentiation and IL-4 delaying this process, rather than a type 1 versus type 2 decision of a type 0 cell.	Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Perussia, B (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	Bice.Perussia@mail.tju.edu		Loza, Matthew/0000-0002-8609-118X				ASTEAMEZAGA M, 1994, CELL IMMUNOL, V156, P480, DOI 10.1006/cimm.1994.1192; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Cella M, 2000, METH MOL B, V121, P1; CUTURI MC, 1989, J EXP MED, V169, P569, DOI 10.1084/jem.169.2.569; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; ISHIZUKA T, 1995, INFLAMMATION, V19, P627, DOI 10.1007/BF01534567; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; Peritt D, 1998, J IMMUNOL, V161, P5821; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; PERUSSIA B, 1992, J IMMUNOL, V149, P3495; PERUSSIA B, 1983, J IMMUNOL, V131, P223; PERUSSIA B, 1991, CURR OPIN IMMUNOL, V3, P49, DOI 10.1016/0952-7915(91)90076-D; PERUSSIA B, 1983, J IMMUNOL, V130, P2133; POGGI A, 1993, P NATL ACAD SCI USA, V90, P4465, DOI 10.1073/pnas.90.10.4465; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sandel PC, 2001, J IMMUNOL, V166, P5935, DOI 10.4049/jimmunol.166.10.5935; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; Smits HH, 2001, EUR J IMMUNOL, V31, P1055, DOI 10.1002/1521-4141(200104)31:4<1055::AID-IMMU1055>3.0.CO;2-7; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TASWELL C, 1981, J IMMUNOL, V126, P1614; Trotta R, 1998, J IMMUNOL, V161, P6648; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	31	144	152	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					917	924		10.1038/ni1001-917	http://dx.doi.org/10.1038/ni1001-917			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577347				2022-12-18	WOS:000171361500010
J	Aifantis, I; Gounari, F; Scorrano, L; Borowski, C; von Boehmer, H				Aifantis, I; Gounari, F; Scorrano, L; Borowski, C; von Boehmer, H			Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-kappa B and NFAT	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ALLELIC EXCLUSION; THYMOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; BETA-CHAIN; GENE-EXPRESSION; CALCIUM CURRENT; ALPHA; BCL-2; CALCINEURIN	Pre-T cell antigen receptor (pre-TCR) signaling plays a crucial role in the development of immature T cells,Although certain aspects of proximal pre-TCR signaling have been studied, the intermediate signal transducers and the distal transcription modulators have been poorly characterized. We report here a correlation between pre-TCR signaling and a biphasic rise in the cytosolic Ca2+ concentration. In addition, we show that constitutive pre-TCR signaling is associated with an increased rate of Ca2+ influx through store-operated plasma membrane Ca2+ channels,We show also that the biphasic nature of the observed pre-TCR-induced rise in cytosolic Ca2+ differentially modulates the activities of the transcription factors NF-kappaB and NFAT in developing T cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, 44 Binney St, Boston, MA 02115 USA.	Harald_von_Boehmer@dfci.harvard.edu	Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045846] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI45846] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aifantis I, 1999, J EXP MED, V190, P1093, DOI 10.1084/jem.190.8.1093; Aifantis I, 1997, IMMUNITY, V7, P601, DOI 10.1016/S1074-7613(00)80381-7; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; Amasaki Y, 1998, J IMMUNOL, V160, P2324; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bakker TR, 1999, J IMMUNOL, V162, P3456; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feuillard J, 2000, INT IMMUNOL, V12, P613, DOI 10.1093/intimm/12.5.613; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Porcellini S, 1999, EUR J IMMUNOL, V29, P2476, DOI 10.1002/(SICI)1521-4141(199908)29:08<2476::AID-IMMU2476>3.0.CO;2-1; Putney JW, 1999, BIOESSAYS, V21, P38; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; SCHROEDER J, 1989, SIGNAL PROCESS, V17, P19, DOI 10.1016/0165-1684(89)90069-8; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Tuosto L, 2000, EUR J IMMUNOL, V30, P2445, DOI 10.1002/1521-4141(200009)30:9<2445::AID-IMMU2445>3.0.CO;2-4; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VASSILOPOULOS D, 1995, CLIN IMMUNOL IMMUNOP, V77, P59, DOI 10.1016/0090-1229(95)90137-X; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Voll RE, 1999, COLD SPRING HARB SYM, V64, P485, DOI 10.1101/sqb.1999.64.485; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; von Boehmer H, 1999, COLD SPRING HARB SYM, V64, P283, DOI 10.1101/sqb.1999.64.283; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wang J, 1998, MATH COMPUT MODEL, V28, P1, DOI 10.1016/S0895-7177(98)00087-9; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	59	144	146	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					403	409		10.1038/87704	http://dx.doi.org/10.1038/87704			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323693				2022-12-18	WOS:000168549800012
J	Kee, BL; Rivera, RR; Murre, C				Kee, BL; Rivera, RR; Murre, C			Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX PROTEIN; CELL DEVELOPMENT; T-CELL; DOWN-REGULATION; GATA-3 EXPRESSION; E2A PROTEINS; GENE; ACTIVATION; APOPTOSIS; INDUCTION	E proteins function in many developmental processes and are essential for the formation of lymphocyte progenitors. However, it is not known whether E proteins regulate lymphocyte survival, proliferation or differentiation or how their activity is regulated during lymphocyte development. We show here a role for Id3, an inhibitor of E protein activity, in the induction of apoptosis and growth arrest, Id3 is induced in response to transforming growth factor beta (TGF-beta), a pleiotropic cytokine that inhibits the growth and survival of normal and transformed lymphocyte progenitors. In the absence of ld3, the response of lymphocyte progenitors to TGF-beta is perturbed, which indicates that Id3 is a mediator of this response. Our data show a key role for E proteins in lymphocyte survival and link the activity of E proteins, and their antagonists, to members of the TGF-beta family of cytokines.	Univ Calif San Diego, Dept Biol MC0366, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kee, BL (corresponding author), Univ Calif San Diego, Dept Biol MC0366, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Baker JC, 1997, CURR OPIN GENET DEV, V7, P467, DOI 10.1016/S0959-437X(97)80072-X; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Buske C, 1998, EXP HEMATOL, V26, P1155; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; CHANG ES, 1989, ADV CELL CULT, V7, P19; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Douglas RS, 1997, BLOOD, V89, P941, DOI 10.1182/blood.V89.3.941; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heath VL, 2000, EUR J IMMUNOL, V30, P2639, DOI 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Kamesaki H, 1998, J IMMUNOL, V160, P770; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE G, 1989, J IMMUNOL, V142, P3875; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; LOTZ M, 1994, J EXP MED, V179, P999, DOI 10.1084/jem.179.3.999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazaki M, 1998, BIOCHEM BIOPH RES CO, V246, P873, DOI 10.1006/bbrc.1998.8712; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pan LH, 1999, MOL CELL BIOL, V19, P5969; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Saltzman A, 1998, EXP CELL RES, V242, P244, DOI 10.1006/excr.1998.4096; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wu M, 1999, J IMMUNOL, V163, P6530; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	52	144	157	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					242	247		10.1038/85303	http://dx.doi.org/10.1038/85303			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224524				2022-12-18	WOS:000167413800017
J	Farrar, JD; Smith, JD; Murphy, TL; Leung, S; Stark, GR; Murphy, KM				Farrar, JD; Smith, JD; Murphy, TL; Leung, S; Stark, GR; Murphy, KM			Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse STAT2	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX VIRUS; CD4+ T-CELLS; ALPHA-INTERFERON; IFN-ALPHA; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; GAMMA PRODUCTION; INTERLEUKIN-12; RECEPTOR; PROTEIN	The use of murine systems to model pathogen-induced human diseases presumes that general immune mechanisms between these species ave conserved. One important immunoregulatory mechanism involves linkage of innate and adaptive immunity to direct the development of T helper subsets, for example toward subset I (THI) development through STAT4 activation. In analyzing type I interferon signaling, we uncovered a difference between murine and human cells which may affect how these two species control linkage between innate and adaptive immunity. We show that in humans, type I interferons induce THI development and can activate STAT4 by recruitment to the IFN-alpha receptor complex specifically via the carboxy-terminus of STAT2. However, the mouse Stat2 gene harbors a minisatellite insertion that has altered the carboxy-terminus and selectively disrupted its capacity to activate STAT4, but not other STATs. This defect in murine Stat2 suggests that the signals leading to STAT4 activation and THI development in CD4(+)T cells are different between mice and humans.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA; Berlex Biosci, Dept Immunol, Richmond, CA 94804 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Cleveland Clinic Foundation	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, 660 S Euclid, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034580, U19AI034580] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56419] Funding Source: Medline; NIAID NIH HHS [AI34580] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Cho SS, 1996, J IMMUNOL, V157, P4781; de Jong R, 1998, SCIENCE, V280, P1435; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Guler ML, 1997, J IMMUNOL, V159, P1767; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jacobson S, 1988, Ann N Y Acad Sci, V540, P352, DOI 10.1111/j.1749-6632.1988.tb27096.x; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Naeger LK, 1999, J BIOL CHEM, V274, P1875, DOI 10.1074/jbc.274.4.1875; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rogge L, 1998, J IMMUNOL, V161, P6567; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SCHMID DS, 1991, REV INFECT DIS, V13, pS946; SCHMID DS, 1988, J IMMUNOL, V140, P3610; SCHMID DS, 1992, CURR TOP MICROBIOL, V179, P57; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Wenner CA, 1996, J IMMUNOL, V156, P1442; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057	44	144	146	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					65	69		10.1038/76932	http://dx.doi.org/10.1038/76932			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881177				2022-12-18	WOS:000089814800016
J	Drissen, R; Buza-Vidas, N; Woll, P; Thongjuea, S; Gambardella, A; Giustacchini, A; Mancini, E; Zriwil, A; Lutteropp, M; Grover, A; Mead, A; Sitnicka, E; Jacobsen, SEW; Nerlov, C				Drissen, Roy; Buza-Vidas, Natalija; Woll, Petter; Thongjuea, Supat; Gambardella, Adriana; Giustacchini, Alice; Mancini, Elena; Zriwil, Alya; Lutteropp, Michael; Grover, Amit; Mead, Adam; Sitnicka, Ewa; Jacobsen, Sten Eirik W.; Nerlov, Claus			Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; PRIMED MULTIPOTENT PROGENITORS; TRANSCRIPTION FACTOR GATA-1; MURINE FETAL LIVER; MOUSE BONE-MARROW; LINEAGE COMMITMENT; EOSINOPHIL LINEAGE; C/EBP-BETA; B-CELL; T-CELL	According to current models of hematopoiesis, lymphoid-primed multi-potent progenitors (LMPPs) (Lin(-)Sca-1(+)c-Kit(+)CD34(+)Flt3(hi)) and common myeloid progenitors (CMPs) (Lin(-)Sca-1(+)c-Kit(+)CD34(+)CD41(hi)) establish an early branch point for separate lineage-commitment pathways from hematopoietic stem cells, with the notable exception that both pathways are proposed to generate all myeloid innate immune cell types through the same myeloid-restricted pre-granulocyte-macrophage progenitor (pre-GM) (Lin(-)Sca-1(-)c-Kit(+)CD41(-)Fc gamma RII/III(-)CD150(-)CD105(-)). By single-cell transcriptome profiling of pre-GMs, we identified distinct myeloid differentiation pathways: a pathway expressing the gene encoding the transcription factor GATA-1 generated mast cells, eosinophils, megakaryocytes and erythroid cells, and a pathway lacking expression of that gene generated monocytes, neutrophils and lymphocytes. These results identify an early hematopoietic-lineage bifurcation that separates the myeloid lineages before their segregation from other hematopoietic-lineage potential.	[Drissen, Roy; Woll, Petter; Thongjuea, Supat; Gambardella, Adriana; Giustacchini, Alice; Lutteropp, Michael; Grover, Amit; Mead, Adam; Jacobsen, Sten Eirik W.; Nerlov, Claus] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England; [Drissen, Roy; Buza-Vidas, Natalija; Gambardella, Adriana; Grover, Amit; Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland; [Woll, Petter; Giustacchini, Alice; Lutteropp, Michael; Mead, Adam; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford, England; [Mancini, Elena; Grover, Amit; Nerlov, Claus] EMBL Mouse Biol Program, Monterotondo, Italy; [Zriwil, Alya; Sitnicka, Ewa] Lund Univ, Div Mol Hematol, Lund, Sweden	University of Oxford; University of Edinburgh; University of Oxford; European Molecular Biology Laboratory (EMBL); Lund University	Jacobsen, SEW; Nerlov, C (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England.; Nerlov, C (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Edinburgh, Midlothian, Scotland.; Jacobsen, SEW (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford, England.; Nerlov, C (corresponding author), EMBL Mouse Biol Program, Monterotondo, Italy.	sten.jacobsen@imm.ox.ac.uk; claus.nerlov@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Drissen, Roy/Z-4298-2019; Mead, Adam/A-8796-2012; Giustacchini, Alice/D-4074-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Drissen, Roy/0000-0002-8574-5014; Mead, Adam/0000-0001-8522-1002; Giustacchini, Alice/0000-0002-8733-8594; Zriwil, Alya/0000-0001-6262-7253; Thongjuea, Supat/0000-0002-9129-4694; Woll, Petter S./0000-0002-2340-2526	Wellcome Trust Equipment Grant [WT087371MA]; WIMM; Medical Research Council Grants [MC_UU_12009, MC_UU_12025, G0902418]; Association for International Cancer Research [11-0724]; Medical Research Council (UK Program Grant) [G0801073, MC_UU_12009/5]; European Commission FP7 (CardioCell project); European Commission FP7 (EuroSyStem project);  [G0701761];  [G0900892];  [MC_UU_12009/7]; EPSRC [EP/H018921/1] Funding Source: UKRI; MRC [G0701761, MR/L012766/1, MC_UU_12009/5, G0900892, MR/M00919X/1, MC_UU_12009/7, MR/L006340/1, MC_PC_12020, MC_UU_12009/16, G0801073, G0501838] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H018921/1, 1104521] Funding Source: researchfish; Medical Research Council [MC_UU_12009/16, G0801073, MC_UU_12009/7, MC_UU_12009/5, MC_PC_12020, G0900892, MR/L006340/1, MR/M00919X/1, G0501838, MR/L012766/1, G0701761] Funding Source: researchfish; Worldwide Cancer Research [11-0724] Funding Source: researchfish	Wellcome Trust Equipment Grant(Wellcome Trust); WIMM; Medical Research Council Grants(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research; Medical Research Council (UK Program Grant)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission FP7 (CardioCell project); European Commission FP7 (EuroSyStem project); ; ; ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	We thank A. Cumano (Pasteur Institute, Paris) for OP9 and OP9-DL1 stroma cells; the EMBL Monterotondo Gene Expression Service and Transgenic Core Facility for generating the Gata1-EGFP bacterial artificial chromosome and the corresponding transgenic mouse line, and flow cytometry facilities at the ISCR (supported by Wellcome Trust Equipment Grant WT087371MA (C.N.) and WIMM (supported by Medical Research Council Grants MC_UU_12009, MC_UU_12025 and G0902418) for flow cytometry and cell sorting. Supported by the Association for International Cancer Research (11-0724 to C.N.), the Medical Research Council (UK Program Grant G0801073 and Unit Grant MC_UU_12009/5 to S.E.W.J.; Strategic Grant G0701761, Program Grant G0900892 and Unit Grant MC_UU_12009/7 to C.N.) and the European Commission FP7 (CardioCell project (C.N.) and EuroSyStem project (S.E.W.J.)).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544; Chi AWS, 2011, BLOOD, V118, P2723, DOI 10.1182/blood-2010-09-309989; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drissen R, 2010, BLOOD, V115, P3463, DOI 10.1182/blood-2009-07-232876; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jasinski M, 2001, BLOOD, V98, P2248, DOI 10.1182/blood.V98.7.2248; KANAKURA Y, 1988, BLOOD, V71, P573; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koenderman L, 2014, IMMUNOL LETT, V162, P95, DOI 10.1016/j.imlet.2014.10.010; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Luc S, 2007, ANN NY ACAD SCI, V1106, P89, DOI 10.1196/annals.1392.023; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mancini E, 2012, EMBO J, V31, P351, DOI 10.1038/emboj.2011.390; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Moreira Pedro N., 2006, V349, P151; Nagasawa T., 2014, FRONT IMMUNOL, V5, P445, DOI DOI 10.3389/FIMMU.2014.00445; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI 10.1128/MCB.01524-13; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sadrzadeh H, 2011, DISCOV MED, V12, P481; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	58	143	144	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					666	+		10.1038/ni.3412	http://dx.doi.org/10.1038/ni.3412			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27043410	Green Accepted, Green Submitted			2022-12-18	WOS:000376162200011
J	Meller, S; Di Domizio, J; Voo, KS; Friedrich, HC; Chamilos, G; Ganguly, D; Conrad, C; Gregorio, J; Le Roy, D; Roger, T; Ladbury, JE; Homey, B; Watowich, S; Modlin, RL; Kontoyiannis, DP; Liu, YJ; Aroldl, ST; Gilliet, M				Meller, Stephan; Di Domizio, Jeremy; Voo, Kui S.; Friedrich, Heike C.; Chamilos, Georgios; Ganguly, Dipyaman; Conrad, Curdin; Gregorio, Josh; Le Roy, Didier; Roger, Thierry; Ladbury, John E.; Homey, Bernhard; Watowich, Stanley; Modlin, Robert L.; Kontoyiannis, Dimitrios P.; Liu, Yong-Jun; Aroldl, Stefan T.; Gilliet, Michel			T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; GROWTH-FACTOR-BETA; I INTERFERON; ANTIMICROBIAL PEPTIDES; CRYSTAL-STRUCTURE; INDUCTION; DIFFERENTIATION; SUSCEPTIBILITY; RECRUITMENT; DEFICIENCY	Interleukin 17-producing helper T cells (T(H)17 cells) have a major role in protection against infections and in mediating autoimmune diseases, yet the mechanisms involved are incompletely understood. We found that interleukin 26 (IL-26), a human T(H)17 cell-derived cytokine, is a cationic amphipathic protein that kills extracellular bacteria via membrane-pore formation. Furthermore, T(H)17 cell-derived IL-26 formed complexes with bacterial DNA and self-DNA released by dying bacteria and host cells. The resulting IL-26-DNA complexes triggered the production of type I interferon by plasmacytoid dendritic cells via activation of Toll-like receptor 9, but independently of the IL-26 receptor. These findings provide insights into the potent antimicrobial and proinflammatory function of T(H)17 cells by showing that IL-26 is a natural human antimicrobial that promotes immune sensing of bacterial and host cell death.	[Meller, Stephan; Voo, Kui S.; Chamilos, Georgios; Ganguly, Dipyaman; Gregorio, Josh; Gilliet, Michel] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Meller, Stephan; Friedrich, Heike C.; Homey, Bernhard] Univ Dusseldorf, Fac Med, Dept Dermatol, Dusseldorf, Germany; [Di Domizio, Jeremy; Conrad, Curdin; Gilliet, Michel] CHU Vaudois, Univ Hosp, Dept Dermatol, CH-1011 Lausanne, Switzerland; [Chamilos, Georgios; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Le Roy, Didier; Roger, Thierry] CHU Vaudois, Univ Hosp, Dept Infect Dis, CH-1011 Lausanne, Switzerland; [Ladbury, John E.] Univ Leeds, Sch Mol & Cell Biol, Leeds, W Yorkshire, England; [Watowich, Stanley] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; [Liu, Yong-Jun] MedImmune, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [Aroldl, Stefan T.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	University of Texas System; UTMD Anderson Cancer Center; Heinrich Heine University Dusseldorf; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Texas System; UTMD Anderson Cancer Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Leeds; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; AstraZeneca; Medimmune; King Abdullah University of Science & Technology	Gilliet, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	Michel.gilliet@chuv.ch	Hawerkamp, Heike C./S-8303-2019; Modlin, Robert L/M-7941-2014; Di Domizio, Jeremy/L-1777-2019; Ganguly, Dipyaman/GON-3988-2022; Roger, Thierry/G-2007-2012; Meller, Stephan/GYA-5568-2022	Hawerkamp, Heike C./0000-0002-3990-8230; Modlin, Robert L/0000-0003-4720-031X; Ganguly, Dipyaman/0000-0002-7786-1795; Roger, Thierry/0000-0002-9358-0109; Conrad, Curdin/0000-0002-2547-3440; Ladbury, John/0000-0002-6328-7200; Chamilos, Georgios/0000-0002-7987-4055; LE ROY, Didier/0000-0001-8954-5442; Arold, Stefan T/0000-0001-5278-0668	Swiss National Science Foundation [144072, 149511]; National Cancer Institute [CA128913]; DANA Foundation; German Research Foundation; research commission of the Medical Faculty of the University of Dusseldorf; King Abdullah University of Science and Technology (KAUST); NATIONAL CANCER INSTITUTE [P30CA016672, P01CA128913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868, R01AI022553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020, R01AR040312] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DANA Foundation; German Research Foundation(German Research Foundation (DFG)); research commission of the Medical Faculty of the University of Dusseldorf; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Dunner for scanning electron microscopy at the HREM Facility, MD Anderson Cancer Center. We thank L. Bover and the Monoclonal Antibody Core Facility staff at the MD Anderson Cancer Center for assistance in generating monoclonal antibodies to IL-26. We thank the Berkeley Laboratory Advanced Light Source and the SIBYLS beamline staff at 12.3.1 for assistance with the collection of small-angle X-ray scattering data, and we thank K. Dyer for the mail-in service provided by SIBYLS. This work was funded by the Swiss National Science Foundation (grant 144072), the National Cancer Institute (PO1 grant CA128913) and the DANA Foundation (all to M.G.). S.M. was partly supported by the German Research Foundation and the research commission of the Medical Faculty of the University of Dusseldorf. Research by S.T.A. was supported by the King Abdullah University of Science and Technology (KAUST). T.R. is supported by the Swiss National Science Foundation (grant 149511).	Baumgart DC, 2011, CLIN EXP IMMUNOL, V166, P46, DOI 10.1111/j.1365-2249.2011.04439.x; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Corvaisier M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001395; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; Goris A, 2001, GENES IMMUN, V2, P284, DOI 10.1038/sj.gene.6363772; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2015, EUR J IMMUNOL, V45, P203, DOI 10.1002/eji.201344277; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Luft T, 1998, J IMMUNOL, V161, P1947; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; OPDENAKKER G, 1995, FASEB J, V9, P453, DOI 10.1096/fasebj.9.5.7896019; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236; Venet F, 2010, AM J PATHOL, V176, P764, DOI 10.2353/ajpath.2010.090765; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang Guangshun, 2012, Curr Biotechnol, V1, P72; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	48	143	150	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					970	979		10.1038/ni.3211	http://dx.doi.org/10.1038/ni.3211			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26168081	Green Submitted, Green Accepted			2022-12-18	WOS:000359876900015
J	Natsuaki, Y; Egawa, G; Nakamizo, S; Ono, S; Hanakawa, S; Okada, T; Kusuba, N; Otsuka, A; Kitoh, A; Honda, T; Nakajima, S; Tsuchiya, S; Sugimoto, Y; Ishii, KJ; Tsutsui, H; Yagita, H; Iwakura, Y; Kubo, M; Ng, LG; Hashimoto, T; Fuentes, J; Guttman-Yassky, E; Miyachi, Y; Kabashima, K				Natsuaki, Yohei; Egawa, Gyohei; Nakamizo, Satoshi; Ono, Sachiko; Hanakawa, Sho; Okada, Takaharu; Kusuba, Nobuhiro; Otsuka, Atsushi; Kitoh, Akihiko; Honda, Tetsuya; Nakajima, Saeko; Tsuchiya, Soken; Sugimoto, Yukihiko; Ishii, Ken J.; Tsutsui, Hiroko; Yagita, Hideo; Iwakura, Yoichiro; Kubo, Masato; Ng, Lai Guan; Hashimoto, Takashi; Fuentes, Judilyn; Guttman-Yassky, Emma; Miyachi, Yoshiki; Kabashima, Kenji			Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin	NATURE IMMUNOLOGY			English	Article							CONTACT HYPERSENSITIVITY RESPONSE; RECEPTOR ANTAGONIST; ELICITATION PHASE; LYMPHOID-TISSUE; IMMUNE EVENTS; INTERLEUKIN-1; DERMATITIS; INDUCTION; ALLERGY; NODES	It remains largely unclear how antigen-presenting cells (APCs) encounter effector or memory T cells efficiently in the periphery. Here we used a mouse contact hypersensitivity (CHS) model to show that upon epicutaneous antigen challenge, dendritic cells (DCs) formed clusters with effector T cells in dermal perivascular areas to promote in situ proliferation and activation of skin T cells in a manner dependent on antigen and the integrin LFA-1. We found that DCs accumulated in perivascular areas and that DC clustering was abrogated by depletion of macrophages. Treatment with interleukin 1 alpha (IL-1 alpha) induced production of the chemokine CXCL2 by dermal macrophages, and DC clustering was suppressed by blockade of either the receptor for IL-1 (IL-1R) or the receptor for CXCL2 (CXCR2). Our findings suggest that the dermal leukocyte cluster is an essential structure for elicitating acquired cutaneous immunity.	[Natsuaki, Yohei; Egawa, Gyohei; Nakamizo, Satoshi; Ono, Sachiko; Hanakawa, Sho; Kusuba, Nobuhiro; Otsuka, Atsushi; Kitoh, Akihiko; Honda, Tetsuya; Nakajima, Saeko; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Natsuaki, Yohei; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Fukuoka, Japan; [Okada, Takaharu] RIKEN Res Ctr Allergy & Immunol, Res Unit Immunodynam, Yokohama, Kanagawa, Japan; [Tsuchiya, Soken; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Kubo, Masato] RIKEN Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Chiba, Japan; [Ng, Lai Guan] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Fuentes, Judilyn; Guttman-Yassky, Emma] Mt Sinai Sch Med Ctr, Icahn Sch Med, Dept Dermatol, New York, NY USA	Kyoto University; Kurume University; RIKEN; Kumamoto University; National Institute of Health Sciences - Japan; Osaka University; Hyogo College of Medicine; Juntendo University; Tokyo University of Science; Chiba University; RIKEN; Tokyo University of Science; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Icahn School of Medicine at Mount Sinai	Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	kaba@kuhp.kyoto-u.ac.jp	Sugimoto, Yukihiko/AAV-6470-2021; Iwakura, Yoichiro/E-5457-2011; Okada, Takaharu/N-7931-2015; Hanakawa, Sho/GSO-1564-2022; Ng, Lai Guan/N-6980-2019; Ng, Lai Guan/E-5673-2011; Hashimoto, Takashi/H-6947-2019; Nakamizo, Satoshi/ABH-2121-2021; Nakajima, Saeko/AAB-1577-2021; Kubo, Masato/A-5918-2016; Ishii, Ken J/B-1685-2012; Natsuaki, Yohei/AAV-2054-2021; Kabashima, Kenji/G-2521-2014	Sugimoto, Yukihiko/0000-0001-6973-932X; Iwakura, Yoichiro/0000-0002-9934-5775; Hanakawa, Sho/0000-0002-0665-9602; Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Hashimoto, Takashi/0000-0002-0144-3255; Nakamizo, Satoshi/0000-0001-9332-0369; Ishii, Ken J/0000-0002-6728-3872; Natsuaki, Yohei/0000-0001-5721-5545; Egawa, Gyohei/0000-0002-6101-4719; Nakajima, Saeko/0000-0003-0831-1447; Kabashima, Kenji/0000-0002-0773-0554; Tsutsui, Hiroko/0000-0001-7928-4875; Otsuka, Atsushi/0000-0001-7365-947X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Yagita (Juntendo University) for the KBA neutralizing antibody to LFA-1; P. Bergstresser and J. Cyster for critical reading of our manuscript. Supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brandtzaeg P, 2008, MUCOSAL IMMUNOL, V1, P31, DOI 10.1038/mi.2007.9; Cattani F, 2006, EUR CYTOKINE NETW, V17, P42; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kish DD, 2012, J IMMUNOL, V188, P1761, DOI 10.4049/jimmunol.1100928; KONDO S, 1995, J INVEST DERMATOL, V105, P334, DOI 10.1111/1523-1747.ep12320329; Lee RT, 1997, J IMMUNOL, V159, P5084; Liao LJ, 2006, PEDIATR RES, V60, P299, DOI 10.1203/01.pdr.0000233058.08200.d6; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; SACKSTEIN R, 1988, J INVEST DERMATOL, V91, P423, DOI 10.1111/1523-1747.ep12476441; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Streilein JW, 1983, J INVEST DERMATOL S, V80, P12; Thyssen JP, 2009, BRIT J DERMATOL, V161, P1124, DOI 10.1111/j.1365-2133.2009.09325.x; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14	28	143	145	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1064	1069		10.1038/ni.2992	http://dx.doi.org/10.1038/ni.2992			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25240383	Green Published			2022-12-18	WOS:000343640700012
J	Vegran, F; Berger, H; Boidot, R; Mignot, G; Bruchard, M; Dosset, M; Chalmin, F; Rebe, C; Derangere, V; Ryffel, B; Kato, M; Prevost-Blondel, A; Ghiringhelli, F; Apetoh, L				Vegran, Frederique; Berger, Helene; Boidot, Romain; Mignot, Gregoire; Bruchard, Melanie; Dosset, Magalie; Chalmin, Fanny; Rebe, Cedric; Derangere, Valentin; Ryffel, Bernhard; Kato, Masashi; Prevost-Blondel, Armelle; Ghiringhelli, Francois; Apetoh, Lionel			The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of T(H)9 cells	NATURE IMMUNOLOGY			English	Article							T-CELLS; METASTATIC MELANOMA; IFN-GAMMA; IMMUNE-RESPONSES; MOUSE MODEL; FACTOR PU.1; TGF-BETA; ACTIVATION; IL-9; PHOSPHORYLATION	The T(H)9 subset of helper T cells was initially shown to contribute to the induction of autoimmune and allergic diseases, but subsequent evidence has suggested that these cells also exert antitumor activities. However, the molecular events that account for their effector properties are elusive. Here we found that the transcription factor IRF1 enhanced the effector function of T(H)9 cells and dictated their anticancer properties. Under T(H)9-skewing conditions, interleukin 1 beta (IL-1 beta) induced phosphorylation of the transcription factor STAT1 and subsequent expression of IRF1, which bound to the promoters of II9 and II21 and enhanced secretion of the cytokines IL-9 and IL-21 from T(H)9 cells. Furthermore, IL-1 beta-induced T(H)9 cells exerted potent anticancer functions in an IRF1- and IL-21-dependent manner. Our findings thus identify IRF1 as a target for controlling the function of T(H)9 cells.	[Vegran, Frederique; Berger, Helene; Mignot, Gregoire; Bruchard, Melanie; Dosset, Magalie; Chalmin, Fanny; Rebe, Cedric; Derangere, Valentin; Ghiringhelli, Francois; Apetoh, Lionel] INSERM, U866, Dijon, France; [Vegran, Frederique; Berger, Helene; Mignot, Gregoire; Bruchard, Melanie; Dosset, Magalie; Chalmin, Fanny; Rebe, Cedric; Derangere, Valentin; Ghiringhelli, Francois; Apetoh, Lionel] Univ Bourgogne, Fac Med, Dijon, France; [Boidot, Romain; Rebe, Cedric; Ghiringhelli, Francois; Apetoh, Lionel] Ctr Georges Francois Leclerc, Dijon, France; [Ryffel, Bernhard] CNRS, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Orleans, UMR7355, Orleans, France; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi 4648601, Japan; [Prevost-Blondel, Armelle] CNRS, UMR 8104, Paris, France; [Prevost-Blondel, Armelle] INSERM, U1016, Paris, France; [Prevost-Blondel, Armelle] Paris Descartes Univ, Cochin Inst, Paris, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; Nagoya University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ghiringhelli, F (corresponding author), INSERM, U866, Dijon, France.	fghiringhelli@cgfl.fr; lionel.apetoh@inserm.fr	Bruchard, Melanie/E-6508-2017; DOSSET, Magalie/AAX-2144-2020; Prevost-Blondel, Armelle/N-7643-2017; VEGRAN, Frederique/O-9986-2018; REBE, Cédric/AAD-4316-2019; KATO, Masashi/I-7250-2014; Dosset, Magalie/AAP-9086-2020; Apetoh, Lionel/AIC-2384-2022; Apetoh, Lionel/G-3310-2014; VEGRAN, Frédérique/H-4792-2017; Mignot, Grégoire/R-4976-2017	Bruchard, Melanie/0000-0003-0004-2887; DOSSET, Magalie/0000-0002-3531-4371; VEGRAN, Frederique/0000-0002-4377-1441; REBE, Cédric/0000-0001-8831-145X; Apetoh, Lionel/0000-0002-2774-438X; Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; Prevost-Blondel, Armelle/0000-0002-7268-5905; Chalmin, Fanny/0000-0002-0855-9453; ghiringhelli, francois/0000-0002-5465-8305	French National Research Agency [ANR-11-LABX-0021, ANR-13-JSV3-0001]; Ligue nationale contre le cancer; Fondation de France; Institut National du Cancer; Association pour la recherche sur le cancer; Conseil Regional de Bourgogne/INSERM; Centre National de la Recherche Scientifique; Fonds Europeen de Developpement Economique et Regional; Le Studium, Orleans; Fondation pour la Recherche Medicale; Fondation pour l'aide a la Recherche sur la Sclerose en Plaques; Ligue Regionale contre le cancer Comite Grand-Est; European Commission [PCIG10-GA-2011-303719]	French National Research Agency(French National Research Agency (ANR)); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Conseil Regional de Bourgogne/INSERM(Region Bourgogne-Franche-Comte); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fonds Europeen de Developpement Economique et Regional; Le Studium, Orleans; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour l'aide a la Recherche sur la Sclerose en Plaques(Fondation pour la Recherche Medicale); Ligue Regionale contre le cancer Comite Grand-Est; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank J.C. Renauld (Universite catholique de Louvain) and V. Kuchroo (Brigham and Women's Hospital) for Il9r<SUP>-/-</SUP> mice and Il21r<SUP>-/-</SUP> mice; B. Ryffel (Universite d'Orleans) for Ticam1<SUP>-/-</SUP>, Myd88<SUP>-/-</SUP>, Il1r1<SUP>-/-</SUP> and Ifng<SUP>-/-</SUP> mice; A. Prevost-Blondel (Cochin Institute) for MT-ret mice; J.D. Rosenblatt (University of Miami Miller School of Medicine) for B16-OVA cells; and R. Vile (Mayo Clinic) for LLC-OVA cells. Supported by the French National Research Agency ("Investissements d'Avenir" program; ANR-11-LABX-0021), the Ligue nationale contre le cancer (F.G. and F.V.), the Fondation de France (L.A.), the Institut National du Cancer (F.G.), the Association pour la recherche sur le cancer (L.A., F.G., G.M. and A.P.-B.), the Conseil Regional de Bourgogne/INSERM (H.B.), the Centre National de la Recherche Scientifique, Fonds Europeen de Developpement Economique et Regional, Le Studium, Orleans and Fondation pour la Recherche Medicale (F.G. and B.R.), the French National Research Agency (ANR-13-JSV3-0001 to L.A.), the Fondation pour l'aide a la Recherche sur la Sclerose en Plaques (L.A. and M.D.), the Ligue Regionale contre le cancer Comite Grand-Est (L.A.) and the European Commission (PCIG10-GA-2011-303719 to L.A.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Elser B, 2002, IMMUNITY, V17, P703, DOI 10.1016/S1074-7613(02)00471-5; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Frederiksen KS, 2008, CANCER IMMUNOL IMMUN, V57, P1439, DOI 10.1007/s00262-008-0479-4; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horka H, 2012, J IMMUNOL, V188, P2669, DOI 10.4049/jimmunol.1100529; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kara EE, 2013, J IMMUNOL, V191, P1110, DOI 10.4049/jimmunol.1203089; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lengagne R, 2004, CANCER RES, V64, P1496, DOI 10.1158/0008-5472.CAN-03-2828; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu AG, 2012, J BIOL CHEM, V287, P16132, DOI 10.1074/jbc.M111.310102; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nizamutdinova IT, 2009, J AGR FOOD CHEM, V57, P7324, DOI 10.1021/jf900856z; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Petrella TM, 2012, J CLIN ONCOL, V30, P3396, DOI 10.1200/JCO.2011.40.0655; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	50	143	151	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					758	+		10.1038/ni.2925	http://dx.doi.org/10.1038/ni.2925			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24973819				2022-12-18	WOS:000339323000011
J	Turner, M; Galloway, A; Vigorito, E				Turner, Martin; Galloway, Alison; Vigorito, Elena			Noncoding RNA and its associated proteins as regulatory elements of the immune system	NATURE IMMUNOLOGY			English	Review							T-CELL RESPONSES; MESSENGER-RNA; BINDING PROTEINS; ALTERNATIVE POLYADENYLATION; STRESS GRANULES; GROWTH ARREST; MICRORNA; GENE; DEGRADATION; STABILITY	The rapid changes in gene expression that accompany developmental transitions, stress responses and proliferation are controlled by signal-mediated coordination of transcriptional and post-transcriptional mechanisms. In recent years, understanding of the mechanics of these processes and the contexts in which they are employed during hematopoiesis and immune challenge has increased. An important aspect of this progress is recognition of the importance of RNA-binding proteins and noncoding RNAs. These have roles in the development and function of the immune system and in pathogen life cycles, and they represent an important aspect of intracellular immunity.	[Turner, Martin; Galloway, Alison; Vigorito, Elena] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England.	martin.turner@babraham.ac.uk	; Turner, Martin/N-9976-2014	Galloway, Alison/0000-0001-8780-0382; Turner, Martin/0000-0002-3801-9896	Biotechnology and Biological Sciences Research Council; Medical Research Council; Leukaemia and Lymphoma Research; BBSRC [BBS/E/B/000C0409, BB/J00152X/1, BBS/E/B/000C0407] Funding Source: UKRI; MRC [G1001781, G0700287] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0409, BB/J00152X/1, BBS/E/B/0000M983] Funding Source: researchfish; Medical Research Council [G0700287, G1001781] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Linterman, P. Katsilds, R. Newman and L. Webb for advice and comments on the manuscript. Supported by the Biotechnology and Biological Sciences Research Council, the Medical Research Council (M.T. and E.V.) and Leukaemia and Lymphoma Research (A.G.).	Akira S, 2013, COLD SH Q B, V78, P51, DOI 10.1101/sqb.2013.78.019877; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Aucher A, 2013, J IMMUNOL, V191, P6250, DOI 10.4049/jimmunol.1301728; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Cano F, 2010, BIOCHEM SOC T, V38, P1621, DOI 10.1042/BST0381621; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen CY, 2012, BIOINFORMATICS, V28, P3178, DOI 10.1093/bioinformatics/bts623; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Heissmeyer V, 2013, IMMUNOL REV, V253, P273, DOI 10.1111/imr.12056; Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019; Liu SF, 2013, P NATL ACAD SCI USA, V110, P19083, DOI 10.1073/pnas.1316208110; Madhani HD, 2013, CELL, V155, P744, DOI 10.1016/j.cell.2013.10.003; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Maruyama T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004822; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Minagawa K, 2014, J IMMUNOL, V192, P1512, DOI 10.4049/jimmunol.1301619; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Nagaike T, 2011, RNA BIOL, V8, P964, DOI 10.4161/rna.8.6.17210; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Ramachandran S, 2012, WIRES RNA, V3, P286, DOI 10.1002/wrna.115; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Saletore Y, 2013, RNA BIOL, V10, P342, DOI 10.4161/rna.23812; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Scott DD, 2013, BBA-GENE REGUL MECH, V1829, P654, DOI 10.1016/j.bbagrm.2013.01.009; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Simarro M, 2012, IMMUNOL LETT, V146, P8, DOI 10.1016/j.imlet.2012.04.001; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869; Turner M, 2012, J IMMUNOL, V189, P3, DOI 10.4049/jimmunol.1201339; Turner M, 2012, CURR OPIN IMMUNOL, V24, P160, DOI 10.1016/j.coi.2012.01.011; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Venigalla RKC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00398; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	116	143	152	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					484	491		10.1038/ni.2887	http://dx.doi.org/10.1038/ni.2887			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840979				2022-12-18	WOS:000336419300002
J	Bachelerie, F; Graham, GJ; Locati, M; Mantovani, A; Murphy, PM; Nibbs, R; Rot, A; Sozzani, S; Thelen, M				Bachelerie, Francoise; Graham, Gerard J.; Locati, Massimo; Mantovani, Alberto; Murphy, Philip M.; Nibbs, Robert; Rot, Antal; Sozzani, Silvano; Thelen, Marcus			New nomenclature for atypical chemokine receptors	NATURE IMMUNOLOGY			English	Letter							BETA-ARRESTIN; INFLAMMATION; MIGRATION		[Bachelerie, Francoise] Univ Paris 11, INSERM, UMR S996, Lab Excellence Res Medicat & Innovat Therapeut, Clamart, France; [Graham, Gerard J.; Nibbs, Robert] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Biomed Res Ctr, Glasgow, Lanark, Scotland; [Locati, Massimo; Mantovani, Alberto] Univ Milan, Milan, Italy; [Locati, Massimo; Mantovani, Alberto; Sozzani, Silvano] Humanitas Clin & Res Inst, Rozzano, Italy; [Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Rot, Antal] Univ Birmingham, MRC, Ctr Immune Regulat, Inst Biomed Res,Sch Infect & Immun, Birmingham, W Midlands, England; [Sozzani, Silvano] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Thelen, Marcus] Inst Res Biomed, Bellinzona, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Dundee; University of Glasgow; University of Milan; IRCCS Humanitas Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Birmingham; University of Brescia; Universita della Svizzera Italiana	Bachelerie, F (corresponding author), Univ Paris 11, INSERM, UMR S996, Lab Excellence Res Medicat & Innovat Therapeut, Clamart, France.	alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Locati, Massimo/ABF-6807-2021; BACHELERIE, FRANCOISE/F-8823-2013; Sozzani, Silvano/C-1447-2009; Locati, Massimo/H-8404-2015	Mantovani, Alberto/0000-0001-5578-236X; BACHELERIE, FRANCOISE/0000-0002-0399-3277; Graham, Gerard/0000-0002-7801-204X; Sozzani, Silvano/0000-0002-3144-8743; Nibbs, Robert/0000-0002-8150-0044; Rot, Antal/0000-0002-9730-6166; Locati, Massimo/0000-0003-3077-590X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER; MRC [G0802838, G0901113] Funding Source: UKRI; Medical Research Council [G0901113, G0802838] Funding Source: Medline; Wellcome Trust [099251] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Bunting MD, 2013, BLOOD, V121, P118, DOI 10.1182/blood-2012-06-434886; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; Del Prete A, 2013, EUR J IMMUNOL, V43, P1418, DOI 10.1002/eji.201243179; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Watts AO, 2013, J BIOL CHEM, V288, P7169, DOI 10.1074/jbc.M112.406108	16	143	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					207	208		10.1038/ni.2812	http://dx.doi.org/10.1038/ni.2812			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549061				2022-12-18	WOS:000331683100001
J	Schwickert, TA; Tagoh, H; Gultekin, S; Dakic, A; Axelsson, E; Minnich, M; Ebert, A; Werner, B; Roth, M; Cimmino, L; Dickins, RA; Zuber, J; Jaritz, M; Busslinger, M				Schwickert, Tanja A.; Tagoh, Hiromi; Gueltekin, Sinan; Dakic, Aleksandar; Axelsson, Elin; Minnich, Martina; Ebert, Anja; Werner, Barbara; Roth, Mareike; Cimmino, Luisa; Dickins, Ross A.; Zuber, Johannes; Jaritz, Markus; Busslinger, Meinrad			Stage-specific control of early B cell development by the transcription factor Ikaros	NATURE IMMUNOLOGY			English	Article							DNA-BINDING PROTEINS; LYMPHOBLASTIC-LEUKEMIA; EXCHANGE FACTOR; AIOLOS; GENE; REPRESSION; RECEPTOR; LINEAGE; CYCLE; RAC	The transcription factor Ikaros is an essential regulator of lymphopoiesis. Here we studied its B cell-specific function by conditional inactivation of the gene encoding Ikaros (Ikzf1) in pro-B cells. B cell development was arrested at an aberrant 'pro-B cell' stage characterized by increased cell adhesion and loss of signaling via the pre-B cell signaling complex (pre-BCR). Ikaros activated genes encoding signal transducers of the pre-BCR and repressed genes involved in the downregulation of pre-BCR signaling and upregulation of the integrin signaling pathway. Unexpectedly, derepression of expression of the transcription factor Aiolos did not compensate for the loss of Ikaros in pro-B cells. Ikaros induced or suppressed active chromatin at regulatory elements of activated or repressed target genes. Notably, binding of Ikaros and expression of its target genes were dynamically regulated at distinct stages of early B lymphopoiesis.	[Schwickert, Tanja A.; Tagoh, Hiromi; Gueltekin, Sinan; Dakic, Aleksandar; Axelsson, Elin; Minnich, Martina; Ebert, Anja; Werner, Barbara; Roth, Mareike; Zuber, Johannes; Jaritz, Markus; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Cimmino, Luisa; Dickins, Ross A.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Royal Melbourne Hospital; Walter & Eliza Hall Institute	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria.	busslinger@imp.ac.at	Dickins, Ross A/K-2852-2012; Busslinger, Meinrad J./J-1249-2016; Zuber, Johannes/E-7517-2011; Tagoh, Hiromi/B-2954-2009	Dickins, Ross A/0000-0003-4112-5304; Busslinger, Meinrad J./0000-0002-9111-9351; Zuber, Johannes/0000-0001-8810-6835; Tagoh, Hiromi/0000-0001-9905-6992; Axelsson, Elin/0000-0003-4382-1880; Schwickert, Tanja/0000-0002-3371-2376; Jaritz, Markus/0000-0002-9326-2047	Boehringer Ingelheim; European Community's Seventh Framework Programme (European Research Council Advanced Grant) [291740-LymphoControl]; Austrian GEN-AU initiative (Bundesminsterium far Bildung und Wissenschaft); European Molecular Biology Organization	Boehringer Ingelheim(Boehringer Ingelheim); European Community's Seventh Framework Programme (European Research Council Advanced Grant); Austrian GEN-AU initiative (Bundesminsterium far Bildung und Wissenschaft); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank G. Schmauss, T. Lendl and G. Stengl for sorting cells by flow cytometry; C. Theussl and J. Wojciechowski for blastocyst injection; B. Vilagos for the EBF1 ChIP-Seq data; K. Georgopoulos (Harvard University) for the Ikzf1<SUP>+/-</SUP> mouse and mouse mAb 4E9 to Ikaros; H. Karasuyama (Tokyo Medical and Dental University) for the antibody to CD79b; and A. Sommer and his team at the Campus Science Support Facilities for Illumina sequencing. Supported by Boehringer Ingelheim, the European Community's Seventh Framework Programme (European Research Council Advanced Grant 291740-LymphoControl), the Austrian GEN-AU initiative (financed by the Bundesminsterium far Bildung und Wissenschaft) and the European Molecular Biology Organization (T.A.S.).	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cai DP, 2003, CANCER RES, V63, P6802; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Dupuis A, 2013, LEUKEMIA, V27, P503, DOI 10.1038/leu.2012.204; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Fuxa M, 2007, J IMMUNOL, V178, P8221, DOI 10.4049/jimmunol.178.12.8221-a; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Karnowski A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003568; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Ma SB, 2010, MOL CELL BIOL, V30, P4149, DOI 10.1128/MCB.00224-10; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nagata K, 1997, IMMUNITY, V7, P559, DOI 10.1016/S1074-7613(00)80377-5; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; PASTERIS NG, 1994, CELL, V79, P669; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	47	143	146	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					283	293		10.1038/ni.2828	http://dx.doi.org/10.1038/ni.2828			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24509509	Green Accepted			2022-12-18	WOS:000331683100014
J	Yuk, JM; Shin, DM; Lee, HM; Kim, JJ; Kim, SW; Jin, HS; Yang, CS; Park, KA; Chanda, D; Kim, DK; Huang, SM; Lee, SK; Lee, CH; Kim, JM; Song, CH; Lee, SY; Hur, GM; Moore, DD; Choi, HS; Jo, EK				Yuk, Jae-Min; Shin, Dong-Min; Lee, Hye-Mi; Kim, Jwa-Jin; Kim, Sun-Woong; Jin, Hyo Sun; Yang, Chul-Su; Park, Kyeong Ah; Chanda, Dipanjan; Kim, Don-Kyu; Huang, Song Mei; Lee, Sang Ki; Lee, Chul-Ho; Kim, Jin-Man; Song, Chang-Hwa; Lee, Soo Young; Hur, Gang Min; Moore, David D.; Choi, Hueng-Sik; Jo, Eun-Kyeong			The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors	NATURE IMMUNOLOGY			English	Article							SMALL HETERODIMER PARTNER; MACROPHAGE-STIMULATING PROTEIN; HEPATOCYTE GROWTH-FACTOR; ACUTE LUNG INJURY; FACTOR-KAPPA-B; IMMUNE-RESPONSE; TYROSINE KINASE; GLUCOCORTICOID-RECEPTOR; MOLECULAR-MECHANISMS; DNA-BINDING	The orphan nuclear receptor SHP (small heterodimer partner) is a transcriptional corepressor that regulates hepatic metabolic pathways. Here we identified a role for SHP as an intrinsic negative regulator of Toll-like receptor (TLR)-triggered inflammatory responses. SHP-deficient mice were more susceptible to endotoxin-induced sepsis. SHP had dual regulatory functions in a canonical transcription factor NF-kappa B signaling pathway, acting as both a repressor of transactivation of the NF-kappa B subunit p65 and an inhibitor of polyubiquitination of the adaptor TRAF6. SHP-mediated inhibition of signaling via the TLR was mimicked by macrophage-stimulating protein (MSP), a strong inducer of SHP expression, via an AMP-activated protein kinase-dependent signaling pathway. Our data identify a previously unrecognized role for SHP in the regulation of TLR signaling.	[Chanda, Dipanjan; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju, South Korea; [Yuk, Jae-Min; Shin, Dong-Min; Lee, Hye-Mi; Kim, Jwa-Jin; Kim, Sun-Woong; Jin, Hyo Sun; Yang, Chul-Su; Song, Chang-Hwa; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon, South Korea; [Yuk, Jae-Min; Shin, Dong-Min; Lee, Hye-Mi; Kim, Jwa-Jin; Jin, Hyo Sun; Yang, Chul-Su; Park, Kyeong Ah; Huang, Song Mei; Kim, Jin-Man; Hur, Gang Min; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea; [Park, Kyeong Ah; Hur, Gang Min] Chungnam Natl Univ, Sch Med, Dept Pharmacol, Taejon, South Korea; [Huang, Song Mei; Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Lee, Sang Ki] Chungnam Natl Univ, Dept Sports Sci, Coll Nat Sci, Taejon, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon, South Korea; [Lee, Soo Young] Ewha Womans Univ, Dept Bioinspired Sci, Coll Life Sci, Seoul, South Korea; [Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Chonnam National University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Baylor College of Medicine	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju, South Korea.	hsc@chonnam.ac.kr; hayoungj@cnu.ac.kr	Chanda, Dipanjan/AAU-3996-2021; Hur, Gang-min/ABF-9263-2021; Song, Chang-Hwa/AAD-7917-2022; Yang, Chul-Su/J-3833-2013	Chanda, Dipanjan/0000-0003-0685-187X; Hur, Gang-min/0000-0003-4870-6574; Song, Chang-Hwa/0000-0002-9490-0573; Lee, Sang Ki/0000-0001-8507-564X; KIM, JIN MAN/0000-0003-0905-9730; Yuk, Jae-Min/0000-0002-0630-9194; Eun-Kyeong, Jo/0000-0001-7191-0587	National Research Foundation of Korea (Korean Ministry of Education, Science and Technology through the Infection Signaling Network Research Center at Chungnam National University) [2011-0006228]; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100588]; Korean Ministry of Education, Science and Technology (National Creative Research Initiatives) [20110018305]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Research Foundation of Korea (Korean Ministry of Education, Science and Technology through the Infection Signaling Network Research Center at Chungnam National University)(National Research Foundation of Korea); Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Ministry of Education, Science and Technology (National Creative Research Initiatives)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S.-Y. Choi for critical reading of manuscript; D.-H. Choi for technical assistance; E. Junn (University of New Jersey) for reagents; and J.-S. Kim and J.-W. Jang for support with total-body irradiation of mice for bone marrow transplantation. Supported by the National Research Foundation of Korea (Korean Ministry of Education, Science and Technology through the Infection Signaling Network Research Center (2011-0006228) at Chungnam National University), the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100588) and the Korean Ministry of Education, Science and Technology (National Creative Research Initiatives Grant 20110018305).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; BEZERRA JA, 1993, HEPATOLOGY, V18, P394, DOI 10.1016/0270-9139(93)90024-H; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chen YQ, 1998, J IMMUNOL, V161, P4950; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; HAN S, 1991, BIOCHEMISTRY-US, V30, P9768, DOI 10.1021/bi00104a029; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Imperatore F, 2004, INTENS CARE MED, V30, P1175, DOI 10.1007/s00134-003-2138-8; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lam IPY, 2009, AM J PHYSIOL-GASTR L, V297, pG90, DOI 10.1152/ajpgi.00094.2009; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu QP, 1999, J IMMUNOL, V163, P6606; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ray M, 2010, J IMMUNOL, V185, P7309, DOI 10.4049/jimmunol.1000095; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang MH, 1996, J CLIN INVEST, V97, P720, DOI 10.1172/JCI118470; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	49	143	146	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					742	U143		10.1038/ni.2064	http://dx.doi.org/10.1038/ni.2064			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21725320				2022-12-18	WOS:000292870700012
J	Hayakawa, S; Shiratori, S; Yamato, H; Kameyama, T; Kitatsuji, C; Kashigi, F; Goto, S; Kameoka, S; Fujikura, D; Yamada, T; Mizutani, T; Kazumata, M; Sato, M; Tanaka, J; Asaka, M; Ohba, Y; Miyazaki, T; Imamura, M; Takaoka, A				Hayakawa, Sumio; Shiratori, Souichi; Yamato, Hiroaki; Kameyama, Takeshi; Kitatsuji, Chihiro; Kashigi, Fumi; Goto, Showhey; Kameoka, Shoichiro; Fujikura, Daisuke; Yamada, Taisho; Mizutani, Tatsuaki; Kazumata, Mika; Sato, Maiko; Tanaka, Junji; Asaka, Masahiro; Ohba, Yusuke; Miyazaki, Tadaaki; Imamura, Masahiro; Takaoka, Akinori			ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE; CYTOSOLIC DNA; 5'-TRIPHOSPHATE RNA; UBIQUITIN LIGASE; ADAPTER PROTEIN; INNATE IMMUNITY; RECOGNITION; VIRUS; SENSOR	The poly(ADP-ribose) polymerases (PARPs) participate in many biological and pathological processes. Here we report that the PARP-13 shorter isoform (ZAPS), rather than the full-length protein (ZAP), was selectively induced by 5'-triphosphate-modified RNA (3pRNA) and functioned as a potent stimulator of interferon responses in human cells mediated by the RNA helicase RIG-I. ZAPS associated with RIG-I to promote the oligomerization and ATPase activity of RIG-I, which led to robust activation of IRF3 and NF-kappa B transcription factors. Disruption of the gene encoding ZAPS resulted in impaired induction of interferon-alpha (IFN-alpha), IFN-beta and other cytokines after viral infection. These results indicate that ZAPS is a key regulator of RIG-I signaling during the innate antiviral immune response, which suggests its possible use as a therapeutic target for viral control.	[Hayakawa, Sumio; Shiratori, Souichi; Yamato, Hiroaki; Kameyama, Takeshi; Kitatsuji, Chihiro; Kashigi, Fumi; Goto, Showhey; Kameoka, Shoichiro; Yamada, Taisho; Kazumata, Mika; Sato, Maiko; Takaoka, Akinori] Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Shiratori, Souichi; Tanaka, Junji; Imamura, Masahiro] Hokkaido Univ, Dept Hematol & Oncol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Yamato, Hiroaki; Asaka, Masahiro] Hokkaido Univ, Dept Gastroenterol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke; Miyazaki, Tadaaki] Hokkaido Univ, Dept Bioresources, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Mizutani, Tatsuaki; Ohba, Yusuke] Hokkaido Univ, Lab Pathophysiol & Signal Transduct, Grad Sch Med, Sapporo, Hokkaido, Japan; [Takaoka, Akinori] Hokkaido Univ, Res Ctr Infect Associated Canc, Inst Med Genet, Sapporo, Hokkaido, Japan; [Kashigi, Fumi; Goto, Showhey; Kameoka, Shoichiro] Hokkaido Univ, Dept Chem, Grad Sch Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Takaoka, A (corresponding author), Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido, Japan.	takaoka@igm.hokudai.ac.jp	Yamada, Taisho/GPP-5936-2022; Tanaka, Junji/A-4098-2012; Ohba, Yusuke/E-7944-2011; Miyazaki, Tadaaki/D-9368-2012; Asaka, Masahiro/A-5948-2012; Mizutani, Tatsuaki/AAA-5044-2021	Mizutani, Tatsuaki/0000-0002-4323-4347; da he, hong ming/0000-0002-4643-8302; Yamada, Taisho/0000-0002-2584-9583	Ministry of Education, Culture, Sports, Science and Technology of Japan; IRYO HOJIN SHADAN JIKOKAI; Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Kato Memorial Bioscience Foundation; Yasuda Medical Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); IRYO HOJIN SHADAN JIKOKAI; Astellas Foundation for Research on Metabolic Disorders; Kanae Foundation for the Promotion of Medical Science; Kato Memorial Bioscience Foundation; Yasuda Medical Foundation	We thank T. Fujita (Kyoto University) for the luciferase reporter plasmids p-55C1BLuc and p-125Luc; J. Miyazaki (Osaka University) for the pCAGGS vector; A. Miyawaki (RIKEN) for the Venus vector; H. Kida (Hokkaido University) for NDV; A. Iwai, H. Higashi and J. Hamada for technical help; M. Yamane for the purification of human primary CD14<SUP>+</SUP> monocytes; and S. Tamura and T. Moriyama for advice on recombinant protein purification. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists (A) to S. H., Young Scientists (S) to A. T.) and Scientific Research in Priority Areas (A. T.), IRYO HOJIN SHADAN JIKOKAI (H. Tanaka & N. Takayanagi) (A. T.), the Astellas Foundation for Research on Metabolic Disorders (A. T.), the Kanae Foundation for the Promotion of Medical Science (A. T.), the Kato Memorial Bioscience Foundation (A. T.) and the Yasuda Medical Foundation (A.T.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bowzard JB, 2009, CYTOKINE GROWTH F R, V20, P1, DOI 10.1016/j.cytogfr.2009.01.001; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Juszczynski P, 2006, MOL CELL BIOL, V26, P5348, DOI 10.1128/MCB.02351-05; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kofler J, 2006, J CEREBR BLOOD F MET, V26, P135, DOI 10.1038/sj.jcbfm.9600173; Kutsch S, 2008, IMMUNOBIOLOGY, V213, P353, DOI 10.1016/j.imbio.2007.10.011; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohsaki E, 2004, J VIROL, V78, P9936, DOI 10.1128/JVI.78.18.9936-9946.2004; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tempera I, 2010, J VIROL, V84, P4988, DOI 10.1128/JVI.02333-09; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044	55	143	154	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					37	U56		10.1038/ni.1963	http://dx.doi.org/10.1038/ni.1963			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21102435	Green Submitted			2022-12-18	WOS:000285465100011
J	Takamatsu, H; Takegahara, N; Nakagawa, Y; Tomura, M; Taniguchi, M; Friedel, RH; Rayburn, H; Tessier-Lavigne, M; Yoshida, Y; Okuno, T; Mizui, M; Kang, S; Nojima, S; Tsujimura, T; Nakatsuji, Y; Katayama, I; Toyofuku, T; Kikutani, H; Kumanogoh, A				Takamatsu, Hyota; Takegahara, Noriko; Nakagawa, Yukinobu; Tomura, Michio; Taniguchi, Masahiko; Friedel, Roland H.; Rayburn, Helen; Tessier-Lavigne, Marc; Yoshida, Yutaka; Okuno, Tatsusada; Mizui, Masayuki; Kang, Sujin; Nojima, Satoshi; Tsujimura, Tohru; Nakatsuji, Yuji; Katayama, Ichiro; Toyofuku, Toshihiko; Kikutani, Hitoshi; Kumanogoh, Atsushi			Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II	NATURE IMMUNOLOGY			English	Article							LEUKOCYTE MIGRATION; LANGERHANS CELLS; NODES; PLEXIN-A1; INTEGRIN; ROLES; ACTIN; SKIN; MORPHOGENESIS; RECEPTORS	The recirculation of leukocytes is essential for proper immune responses. However, the molecular mechanisms that regulate the entry of leukocytes into the lymphatics remain unclear. Here we show that plexin-A1, a principal receptor component for class III and class VI semaphorins, was crucially involved in the entry of dendritic cells (DCs) into the lymphatics. Additionally, we show that the semaphorin Sema3A, but not Sema6C or Sema6D, was required for DC transmigration and that Sema3A produced by the lymphatics promoted actomyosin contraction at the trailing edge of migrating DCs. Our findings not only demonstrate that semaphorin signals are involved in DC trafficking but also identify a previously unknown mechanism that induces actomyosin contraction as these cells pass through narrow gaps.	[Takamatsu, Hyota; Takegahara, Noriko; Nakagawa, Yukinobu; Okuno, Tatsusada; Kang, Sujin; Nojima, Satoshi; Toyofuku, Toshihiko; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 565, Japan; [Takamatsu, Hyota; Takegahara, Noriko; Nakagawa, Yukinobu; Okuno, Tatsusada; Mizui, Masayuki; Kang, Sujin; Nojima, Satoshi; Toyofuku, Toshihiko; Kikutani, Hitoshi; Kumanogoh, Atsushi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Nakagawa, Yukinobu; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 565, Japan; [Tomura, Michio] RIKEN, Brain Sci Inst, Adv Technol Dev Ctr, Lab Cell Funct & Dynam, Wako, Saitama, Japan; [Taniguchi, Masahiko] Sapporo Med Univ, Sch Med, Dept Biochem, Canc Res Inst, Sapporo, Hokkaido, Japan; [Friedel, Roland H.] Helmholtz Ctr Munich, Inst Dev Genet, Neuherberg, Germany; [Rayburn, Helen] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Mizui, Masayuki; Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 565, Japan; [Nojima, Satoshi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 565, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan; [Nakatsuji, Yuji] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 565, Japan	Osaka University; Osaka University; Osaka University; RIKEN; Sapporo Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University; Roche Holding; Genentech; Cincinnati Children's Hospital Medical Center; Osaka University; Osaka University; Hyogo College of Medicine; Osaka University	Kumanogoh, A (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 565, Japan.	kumanogo@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021; Mizui, Masayuki/AAD-1432-2019; Kumanogoh, Atsushi/C-7354-2009	Mizui, Masayuki/0000-0003-2543-8108; Nakagawa, Yukinobu/0000-0002-8247-0385; Friedel, Roland/0000-0002-7513-3604	Japan Society for the Promotion of Science; US National Institutes of Health [R01NS065048]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare; National Institute of Biomedical Innovation; Japan Science and Technology Agency; Uehara Memorial Foundation; Takeda Scientific Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Scientific Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D.D. Ginty and A.L. Kolodkin (Howard Hughes Medical Institute) for neuropilin-1-mutant mice; W. R. Heath (University of Melbourne) for OT-II-transgenic mice; and T. Yazawa for technical support. Supported by the Japan Society for the Promotion of Science (Research Fellowships for Young Scientists to H. T.), the US National Institutes of Health (R01NS065048 to Y.Y.), the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (A. K.), the Target Protein Research Program of the Japan Science and Technology Agency (T. T. and A. K.), the Uehara Memorial Foundation (A. K.) and the Takeda Scientific Foundation (T. T., N.T. and A. K.).	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown JA, 2009, MOL BIOL CELL, V20, P1167, DOI 10.1091/mbc.E08-01-0065; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lombardi ML, 2007, J CELL SCI, V120, P1624, DOI 10.1242/jcs.002527; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith LA, 2007, BIOPHYS J, V92, pL58, DOI 10.1529/biophysj.106.102822; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032	50	143	153	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					594	U60		10.1038/ni.1885	http://dx.doi.org/10.1038/ni.1885			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20512151	Green Accepted			2022-12-18	WOS:000278926400015
J	El Chamy, L; Leclerc, V; Caldelari, I; Reichhart, JM				El Chamy, Laure; Leclerc, Vincent; Caldelari, Isabelle; Reichhart, Jean-Marc			Sensing of 'danger signals' and pathogen-associated molecular patterns defines binary signaling pathways 'upstream' of Toll	NATURE IMMUNOLOGY			English	Article							SPATZLE-PROCESSING ENZYME; DROSOPHILA TOLL; RECOGNITION RECEPTOR; SERINE PROTEASES; ACTIVATION; IMMUNITY; DEFENSE; GENE; PGRP; INFECTIONS	In drosophila, molecular determinants from fungi and Gram-positive bacteria are detected by circulating pattern-recognition receptors. Published findings suggest that such pattern-recognition receptors activate as-yet-unidentified serine-protease cascades that culminate in the cleavage of Spatzle, the endogenous Toll receptor ligand, and trigger the immune response. We demonstrate here that the protease Grass defines a common activation cascade for the detection of fungi and Gram-positive bacteria mediated by pattern-recognition receptors. The serine protease Persephone, shown before to be specific for fungal detection in a cascade activated by secreted fungal proteases, was also required for the sensing of proteases elicited by bacteria in the hemolymph. Hence, Persephone defines a parallel proteolytic cascade activated by 'danger signals' such as abnormal proteolytic activities.	[El Chamy, Laure; Leclerc, Vincent; Caldelari, Isabelle; Reichhart, Jean-Marc] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Reichhart, JM (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, F-67084 Strasbourg, France.	jm.reichhart@ibmc.u-strasbg.fr		Laure, El Chamy/0000-0003-2293-5088	French Research Ministry; Association pour la Recherche contre le Cancer; Centre National de la Recherche Scientifique; National Institutes of Health [5PO1-AI044220-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	French Research Ministry(Ministry of Research, France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We dedicate this work to the memory of A. Killinc, who found the original Pasteur mutation. We thank L. Gutmann (Institut National de la Sante et de la Recherche Medicale U872) for E. faecalis peptidoglycan and A. Meunier, S. Ozkan and R. Walther for technical help. Supported by the French Research Ministry (L. E. C.), Association pour la Recherche contre le Cancer (L. E. C.), Centre National de la Recherche Scientifique and the National Institutes of Health (5PO1-AI044220-09).	Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; BRAND AH, 1993, DEVELOPMENT, V118, P401; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Green C, 2000, GENETICS, V156, P1117; Hoebe K, 2006, ADV IMMUNOL, V91, P175, DOI 10.1016/S0065-2776(06)91005-0; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiggins FM, 2007, J EVOLUTION BIOL, V20, P965, DOI 10.1111/j.1420-9101.2007.01305.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Mulinari S, 2006, FEBS LETT, V580, P5406, DOI 10.1016/j.febslet.2006.09.009; Pelte N, 2006, INSECT BIOCHEM MOLEC, V36, P37, DOI 10.1016/j.ibmb.2005.10.004; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Royet J, 2004, MOL IMMUNOL, V41, P1063, DOI 10.1016/j.molimm.2004.06.009; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	36	143	148	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1165	1170		10.1038/ni.1643	http://dx.doi.org/10.1038/ni.1643			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18724373	Green Accepted			2022-12-18	WOS:000259315600015
J	Mitoma, J; Bao, XF; Petryanik, B; Schaerli, P; Gauguet, JM; Yu, SY; Kawashima, H; Saito, H; Ohtsubo, K; Marth, JD; Khoo, KH; von Andrian, UH; Lowe, JB; Fukuda, M				Mitoma, Junya; Bao, Xingfeng; Petryanik, Bronislawa; Schaerli, Patrick; Gauguet, Jean-Marc; Yu, Shin-Yi; Kawashima, Hiroto; Saito, Hideo; Ohtsubo, Kazuaki; Marth, Jamey D.; Khoo, Kay-Hooi; von Andrian, Ulrich H.; Lowe, John B.; Fukuda, Minoru			Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; CORE-2 BRANCHING BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; SIALYL-LEWIS-X; P-SELECTIN; GLYCOPROTEIN LIGAND-1; TYROSINE SULFATION; PROTEIN EPITOPES; O-GLYCANS; NODES; IDENTIFICATION	Lymphocyte homing is mediated by specific interaction between L-selectin on lymphocytes and the carbohydrate ligand 6-sulfo sialyl Lewis X on high endothelial venules. Here we generated mice lacking both core 1 extension and core 2 branching enzymes to assess the functions of O-glycan-borne L-selectin ligands in vivo. Mutant mice maintained robust lymphocyte homing, yet they lacked O-glycan L-selectin ligands. Biochemical analyses identified a class of N-glycans bearing the 6-sulfo sialyl Lewis X L-selectin ligand in high endothelial venules. These N-glycans supported the binding of L-selectin to high endothelial venules in vitro and contributed in vivo to O-glycan-independent lymphocyte homing in wild-type and mutant mice. Our results demonstrate the critical function of N-glycan-linked 6-sulfo sialyl Lewis X in L-selectin-dependent lymphocyte homing and recruitment.	Burke Med Res Inst, Glycobiol Program, Canc Res Ctr, La Jolla, CA 92037 USA; Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Case Western Reserve University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Academia Sinica - Taiwan; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Fukuda, M (corresponding author), Burke Med Res Inst, Glycobiol Program, Canc Res Ctr, La Jolla, CA 92037 USA.	minoru@burnham.org	Khoo, Kay-Hooi/E-1989-2019; von Andrian, Ulrich H/A-5775-2008	Khoo, Kay-Hooi/0000-0003-2906-406X; YU, Shin-Yi/0000-0003-0197-9575	NATIONAL CANCER INSTITUTE [R01CA048737, P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663, R01AI069259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA71932, CA48737] Funding Source: Medline; NIAID NIH HHS [AI061663, AI069259] Funding Source: Medline; NIAMS NIH HHS [AR42689] Funding Source: Medline; NIDDK NIH HHS [DK48247] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Kanamori A, 2002, J BIOL CHEM, V277, P32578, DOI 10.1074/jbc.M204400200; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; LEY K, 1993, BLOOD, V82, P1632; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitoma J, 2006, METHOD ENZYMOL, V416, P293, DOI 10.1016/S0076-6879(06)16019-X; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Ohmori K, 2006, BLOOD, V107, P3197, DOI 10.1182/blood-2005-05-2185; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Rosen SD, 2005, AM J PATHOL, V166, P935, DOI 10.1016/S0002-9440(10)62313-9; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; van Zante A, 2003, J EXP MED, V198, P1289, DOI 10.1084/jem.20030057; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	53	143	147	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					409	418		10.1038/ni1442	http://dx.doi.org/10.1038/ni1442			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17334369				2022-12-18	WOS:000245075900016
J	Prinz, I; Sansoni, A; Kissenpfennig, A; Ardouin, L; Malissen, M; Malissen, B				Prinz, Immo; Sansoni, Amandine; Kissenpfennig, Adrien; Ardouin, Laurence; Malissen, Marie; Malissen, Bernard			Visualization of the earliest steps of gamma delta T cell development in the adult thymus	NATURE IMMUNOLOGY			English	Article							COMPLEX CLASS-I; RECEPTOR-BETA; TCR REPERTOIRE; DEFICIENT MICE; IL-7 RECEPTOR; ALPHA-CHAIN; DIFFERENTIATION; EXPRESSION; THYMOCYTES; GENE	The checkpoint in gamma delta cell development that controls successful T cell receptor (TCR) gene rearrangements remains poorly characterized. Using mice expressing a reporter gene 'knocked into' the Tcrd constant region gene, we have characterized many of the events that mark the life of early gamma delta cells in the adult thymus. We identify the developmental stage during which the Tcrd locus 'opens' in early T cell progenitors and show that a single checkpoint controls gamma delta cell development during the penultimate CD4(-)CD8(-) stage. Passage through this checkpoint required the assembly of gamma delta TCR heterodimers on the cell surface and signaling via the Lat adaptor protein. In addition, we show that gamma delta selection triggered a phase of sustained proliferation similar to that induced by the pre-TCR.	Univ Mediterranee, Ctr Immunol Marseille Luminy, INSERM, U631,Case 906, F-13288 Marseille, France; CNRS, UMR 6102, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Malissen, B (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, INSERM, U631,Case 906, F-13288 Marseille, France.	bernardm@ciml.univ-mrs.fr	BATAILLE, Laurence/AAA-5535-2021; Prinz, Immo/A-3026-2010; Malissen, Bernard/AAK-4659-2020	BATAILLE, Laurence/0000-0001-7770-2041; Prinz, Immo/0000-0002-8789-9578; Kissenpfennig, Adrien/0000-0002-9633-3111; Malissen, Bernard/0000-0003-1340-9342; Malissen, Marie/0000-0003-2331-1445				Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; Ardouin L, 1998, J EXP MED, V187, P105, DOI 10.1084/jem.187.1.105; Azuara V, 2001, EUR J IMMUNOL, V31, P205, DOI 10.1002/1521-4141(200101)31:1<205::AID-IMMU205>3.3.CO;2-#; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BLUESTONE JA, 1991, IMMUNOL REV, V120, P5, DOI 10.1111/j.1600-065X.1991.tb00585.x; Boucontet L, 2005, J IMMUNOL, V174, P3912, DOI 10.4049/jimmunol.174.7.3912; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; Carabana J, 2005, J IMMUNOL, V174, P4144, DOI 10.4049/jimmunol.174.7.4144; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; CROMPTON T, 1994, EUR J IMMUNOL, V24, P1903, DOI 10.1002/eji.1830240828; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang J, 1999, J EXP MED, V190, P973, DOI 10.1084/jem.190.7.973; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Krotkova A, 2004, J IMMUNOL, V173, P25, DOI 10.4049/jimmunol.173.1.25; Laurent J, 2004, INT IMMUNOL, V16, P1069, DOI 10.1093/intimm/dxh108; Lees RK, 2001, EUR J IMMUNOL, V31, P2901, DOI 10.1002/1521-4141(2001010)31:10<2901::AID-IMMU2901>3.0.CO;2-#; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Malissen B, 1999, ADV IMMUNOL, V72, P103, DOI 10.1016/S0065-2776(08)60018-8; Malissen M, 1997, J EXP MED, V186, P1277, DOI 10.1084/jem.186.8.1277; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2005, CURR OPIN IMMUNOL, V17, P108, DOI 10.1016/j.coi.2005.01.009; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prinz I, 2004, GASTROENTEROLOGY, V126, P170, DOI 10.1053/j.gastro.2003.10.062; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shortman K, 1990, Semin Immunol, V2, P3; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Vasseur F, 2001, EUR J IMMUNOL, V31, P3038, DOI 10.1002/1521-4141(2001010)31:10<3038::AID-IMMU3038>3.0.CO;2-3; Vicari AP, 1996, EUR J IMMUNOL, V26, P1424, DOI 10.1002/eji.1830260704; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; ZORBAS M, 1993, EUR J IMMUNOL, V23, P1655, DOI 10.1002/eji.1830230739	52	143	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					995	1003		10.1038/ni1371	http://dx.doi.org/10.1038/ni1371			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16878135	Green Published			2022-12-18	WOS:000239942300019
J	Winau, F; Schwierzeck, V; Hurwitz, R; Remmel, N; Sieling, PA; Modlin, RL; Porcelli, SA; Brinkmann, V; Sugita, M; Sandhoff, K; Kaufmann, SHE; Schaible, UE				Winau, F; Schwierzeck, V; Hurwitz, R; Remmel, N; Sieling, PA; Modlin, RL; Porcelli, SA; Brinkmann, V; Sugita, M; Sandhoff, K; Kaufmann, SHE; Schaible, UE			Saposin C is required for lipid presentation by human CD1b	NATURE IMMUNOLOGY			English	Article							T-CELL RECOGNITION; SPHINGOLIPID ACTIVATOR PROTEINS; ANTIGEN-PRESENTING MOLECULES; STRUCTURAL REQUIREMENTS; LIPOGLYCAN ANTIGENS; CYTOPLASMIC TAIL; TRAFFICKING; GLUCOSYLCERAMIDE; MYCOBACTERIA; DEGRADATION	Lipids from Mycobacterium tuberculosis are presented through CD1 proteins to T lymphocytes in humans, but the accessory molecules required for antigen loading and presentation remain unidentified. Here we show that fibroblasts deficient in sphingolipid activator proteins (SAPs) transfected with CD1b failed to activate lipid-specific T cells. However, the T cell response was restored when fibroblasts were reconstituted with SAP-C but not other SAPs. Lipid antigen and SAP-C colocalized in lysosomal compartments, and liposome assays showed that SAP-C efficiently extracts antigen from membranes. Coprecipitation demonstrated direct molecular interaction between SAP-C and CD1b. We propose a model in which SAP-C exposes lipid antigens from intralysosomal membranes for loading onto CD1b. Thus, SAP-C represents a missing link in antigen presentation of lipids through CD1b to human T cells.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Cent Core Facil Prot Biochem, D-10117 Berlin, Germany; Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; Max Planck Inst Infect Biol, Cent Core Facil Microscopy, D-10117 Berlin, Germany; Nippon Med Coll, Dept Microbiol & Immunol, Bunkyo Ku, Tokyo 1138602, Japan	Max Planck Society; Max Planck Society; University of Bonn; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yeshiva University; Max Planck Society; Nippon Medical School	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Schumannstr 21-22, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Schwierzeck, Vera/AAL-3028-2020; Modlin, Robert L/M-7941-2014; Kaufmann, Stefan HE/I-5454-2014	Schwierzeck, Vera/0000-0003-4254-3700; Modlin, Robert L/0000-0003-4720-031X; Kaufmann, Stefan HE/0000-0001-9866-8268; Sugita, Masahiko/0000-0001-5511-1304				Brennan PJ, 1997, BIOCHEM SOC T, V25, P188, DOI 10.1042/bst0250188; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Ham D, 2003, CELL BIOL INT, V27, P675, DOI 10.1016/S1065-6995(03)00124-0; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Joyce S, 2003, CURR OPIN IMMUNOL, V15, P95, DOI 10.1016/S0952-7915(02)00012-2; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; Ochoa MT, 2001, NAT MED, V7, P174, DOI 10.1038/84620; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; Vielhaber G, 1996, J BIOL CHEM, V271, P32438, DOI 10.1074/jbc.271.50.32438; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271	34	143	154	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					169	174		10.1038/ni1035	http://dx.doi.org/10.1038/ni1035			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14716313				2022-12-18	WOS:000188512000012
J	Dorfman, JR; Stefanova, I; Yasutomo, K; Germain, RN				Dorfman, JR; Stefanova, I; Yasutomo, K; Germain, RN			CD4(+) T cell survival is not directly linked to self-MHC-induced TCR signaling	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; MUTANT MICE; TYROSINE PHOSPHORYLATION; PERIPHERAL SELECTION; ANTIGEN PRESENTATION; DEFICIENT MICE; IN-VIVO; THYMOCYTES	T cell receptor (TCR) signaling triggered by recognition of self-major histocompatibility complex (MHC) ligands has been proposed to maintain the viability of naive T cells and to provoke their proliferation in T cell-deficient hosts. Consistent with this, the partially phosphorylated state of TCR zeta chains in naive CD4(+) and CD8(+) T tells in vivo was found to be actively maintained by TCR interactions with specific peptide-containing MHC molecules,TCR ligand-dependent phosphorylation of TCR zeta was lost within one day of cell transfer into MHC-deficient hosts, yet the survival of transferred CD4(+) lymphocytes was the same in recipients with or without MHC class II expression for one month. Thus, despite clear evidence for TCR signaling in nonactivated naive T cells, these data argue against the concept that such signaling plays a predominant role in determining lymphocyte lifespan.	NIH, Lymphocyte Biol Sect, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Germain, RN (corresponding author), NIH, Lymphocyte Biol Sect, Immunol Lab, Bldg 10,Room 11N311, Bethesda, MD 20892 USA.		Germain, Ronald N./Z-1945-2019; Dorfman, Jeffrey R/B-4854-2011; Dorfman, Jeffrey R/M-4218-2017; Germain, Ronald/ABE-7090-2020	Dorfman, Jeffrey R/0000-0001-9938-8911; Yasutomo, Koji/0000-0003-0411-2037	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000403, Z01AI000403] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Beutner U, 1998, INT IMMUNOL, V10, P305, DOI 10.1093/intimm/10.3.305; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; KIESELOW P, 1995, J EXP MED, V181, P1975; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Lee IH, 1999, J EXP MED, V190, P1263, DOI 10.1084/jem.190.9.1263; Ljunggren HG, 1996, IMMUNOL REV, V151, P123, DOI 10.1111/j.1600-065X.1996.tb00706.x; LJUNGGREN HG, 1995, EUR J IMMUNOL, V25, P174, DOI 10.1002/eji.1830250129; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mary F, 1999, EUR J IMMUNOL, V29, P3887, DOI 10.1002/(SICI)1521-4141(199912)29:12<3887::AID-IMMU3887>3.0.CO;2-A; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mostaghel EA, 1998, J IMMUNOL, V161, P6559; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Muranski P, 2000, J IMMUNOL, V164, P3087, DOI 10.4049/jimmunol.164.6.3087; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; Peterson DA, 1999, J IMMUNOL, V162, P3117; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Riberdy JM, 1998, P NATL ACAD SCI USA, V95, P4493, DOI 10.1073/pnas.95.8.4493; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Saparov A, 1999, INT IMMUNOL, V11, P1253, DOI 10.1093/intimm/11.8.1253; Schmitt S, 1997, EUR J IMMUNOL, V27, P2139, DOI 10.1002/eji.1830270904; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shores EW, 1997, J EXP MED, V185, P893, DOI 10.1084/jem.185.5.893; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smyth LA, 1998, P NATL ACAD SCI USA, V95, P8193, DOI 10.1073/pnas.95.14.8193; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; YASUTOMO K, 2000, IN PRESS J IMMUNOL; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	64	143	146	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					329	335		10.1038/79783	http://dx.doi.org/10.1038/79783			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017105				2022-12-18	WOS:000089869700016
J	Amsen, D; van Gisbergen, KPJM; Hombrink, P; van Lier, RAW				Amsen, Derk; van Gisbergen, Klaas P. J. M.; Hombrink, Pleun; van Lier, Rene A. W.			Tissue-resident memory T cells at the center of immunity to solid tumors	NATURE IMMUNOLOGY			English	Review							LYTIC GRANULE POLARIZATION; INFILTRATING LYMPHOCYTES; DENDRITIC CELLS; TGF-BETA; NONLYMPHOID TISSUES; CYTOTOXIC FUNCTION; LOCAL ANTIGEN; CUTTING EDGE; RM CELLS; CD103	Immune responses in tissues are constrained by the physiological properties of the tissue involved. Tissue-resident memory T cells (T-RM cells) are a recently discovered lineage of T cells specialized for life and function within tissues. Emerging evidence has shown that T-RM cells have a special role in the control of solid tumors. A high frequency of T-RM cells in tumors correlates with favorable disease progression in patients with cancer, and studies of mice have shown that T-RM cells are necessary for optimal immunological control of solid tumors. Here we describe what defines T-RM cells as a separate lineage and how these cells are generated. Furthermore, we discuss the properties that allow T-RM cells to operate in normal and transformed tissues, as well as implications for the treatment of patients with cancer.	[Amsen, Derk; van Gisbergen, Klaas P. J. M.; Hombrink, Pleun; van Lier, Rene A. W.] Univ Amsterdam, Acad Med Ctr, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Amsen, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hematopoiesis, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	d.amsen@sanquin.nl		van Gisbergen, Klaas/0000-0003-3623-7555	LSBR; NWO Vidi grant; NWO Veni grant	LSBR; NWO Vidi grant(Netherlands Organization for Scientific Research (NWO)); NWO Veni grant	This work was supported by an LSBR fellowship and an NWO Vidi grant to K.J.P.M.v.G. and by an NWO Veni grant to P.H.	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Backer RA, 2014, NAT IMMUNOL, V15, P1143, DOI 10.1038/ni.3027; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Becht E, 2016, CURR OPIN IMMUNOL, V39, P7, DOI 10.1016/j.coi.2015.11.009; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Boddupalli CS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88955; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Boutet M, 2016, CANCER RES, V76, P1757, DOI 10.1158/0008-5472.CAN-15-1545; Braga FAV, 2015, EUR J IMMUNOL, V45, P2945, DOI 10.1002/eji.201545650; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Dadi S, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0244-3; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Dalgleish AG, 2011, VACCINE, V29, P8501, DOI 10.1016/j.vaccine.2011.09.012; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Foppen MHG, 2015, MOL ONCOL, V9, P1918, DOI 10.1016/j.molonc.2015.10.018; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gabriely G, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1738; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gauthier L, 2017, CANCER RES, V77, P7072, DOI 10.1158/0008-5472.CAN-17-1487; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Glasner A, 2018, IMMUNITY, V48, P107, DOI 10.1016/j.immuni.2017.12.007; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jouanneau E, 2014, CANCER IMMUNOL IMMUN, V63, P911, DOI 10.1007/s00262-014-1559-2; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Koh J, 2017, ONCOTARGET, V8, P13762, DOI 10.18632/oncotarget.14632; Komdeur FL, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1338230; Komdeur FL, 2016, ONCOTARGET, V7, P75130, DOI 10.18632/oncotarget.12077; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Le Floc'h A, 2011, CANCER RES, V71, P328, DOI 10.1158/0008-5472.CAN-10-2457; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mlecnik B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007240; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Murray T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00573; Muschaweckh A, 2016, J EXP MED, V213, P3075, DOI 10.1084/jem.20160888; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nizard M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15221; Nizard M, 2016, CLIN CANCER RES, V22, P530, DOI 10.1158/1078-0432.CCR-15-2364; Oja AE, 2018, MUCOSAL IMMUNOL, V11, P654, DOI 10.1038/mi.2017.94; Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Quinn E, 2003, EUR J CANCER, V39, P469, DOI 10.1016/S0959-8049(02)00633-0; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reuben A, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0013-8; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sandoval F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004888; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Sierra RA, 2014, CANCER IMMUNOL RES, V2, P800, DOI 10.1158/2326-6066.CIR-14-0021; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stelma F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06352-3; Sun YY, 2016, CLIN CANCER RES, V22, P657, DOI 10.1158/1078-0432.CCR-15-0234; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Tsukumo S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00101; van Gisbergen KPJM, 2012, NAT IMMUNOL, V13, P864, DOI 10.1038/ni.2393; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wang B, 2015, J UROLOGY, V194, P556, DOI 10.1016/j.juro.2015.02.2941; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Wang ZQ, 2016, CLIN CANCER RES, V22, P6290, DOI 10.1158/1078-0432.CCR-16-0732; Webb JR, 2015, CANCER IMMUNOL RES, V3, P926, DOI 10.1158/2326-6066.CIR-14-0239; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877; Workel HH, 2016, EUR J CANCER, V60, P1, DOI 10.1016/j.ejca.2016.02.026; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Wu TC, 2014, CANCER IMMUNOL RES, V2, P487, DOI 10.1158/2326-6066.CIR-13-0217; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	124	142	147	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					538	546		10.1038/s41590-018-0114-2	http://dx.doi.org/10.1038/s41590-018-0114-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777219				2022-12-18	WOS:000433041500020
J	Arvey, A; van der Veeken, J; Samstein, RM; Feng, YQ; Stamatoyannopoulos, JA; Rudensky, AY				Arvey, Aaron; van der Veeken, Joris; Samstein, Robert M.; Feng, Yongqiang; Stamatoyannopoulos, John A.; Rudensky, Alexander Y.			Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells	NATURE IMMUNOLOGY			English	Article							EZH2 SUPPRESSES METHYLATION; ENHANCER LANDSCAPE; TARGET GENES; STEM-CELLS; DIFFERENTIATION; PHOSPHORYLATION; GENOME; STIMULATION; ACTIVATION; EXPRESSION	The transcription factor Foxp3 is indispensable for the ability of regulatory T cells (T-reg cells) to suppress fatal inflammation. Here we characterized the role of Foxp3 in chromatin remodeling and the regulation of gene expression in actively suppressive T-reg cells in an inflammatory setting. Although genome-wide occupancy of regulatory elements in DNA by Foxp3 was similar in resting T-reg cells and those activated in vivo, Foxp3-bound enhancer elements in the DNA were poised for repression only in activated T-reg cells. Following activation, Foxp3-bound sites showed diminished accessibility of chromatin and selective deposition of histone H3 trimethylated at Lys27 (H3K27me3), which was associated with recruitment of the histone methyltransferase Ezh2 and downregulation of the expression of nearby genes. Thus, Foxp3 poises its targets for repression by facilitating the formation of repressive chromatin in T-reg cells upon their activation in response to inflammatory cues.	[Arvey, Aaron; van der Veeken, Joris; Samstein, Robert M.; Feng, Yongqiang; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Arvey, Aaron; van der Veeken, Joris; Samstein, Robert M.; Feng, Yongqiang; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org	Feng, Yongqiang/N-2731-2018	Feng, Yongqiang/0000-0002-2320-5063; Samstein, Robert/0000-0001-6860-2401; van der Veeken, Joris/0000-0001-7299-2174; Arvey, Aaron/0000-0002-8789-0290	Cancer Research Institute; US National Institutes of Health [DK091963, 5R37AI034206, GM07739]; Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Cancer Research Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Loeb, S. Josefowicz and S. Hemmers for discussions. Supported by the Cancer Research Institute (J.v.d.V), the US National Institutes of Health (DK091963 to R.M.S.; 5R37AI034206 to A.Y.R.; and GM07739 to R.M.S.), the Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center (A.Y.R.) and the Howard Hughes Medical Institute (A.Y.R.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Camperio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048303; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	45	142	151	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					580	587		10.1038/ni.2868	http://dx.doi.org/10.1038/ni.2868			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24728351	Green Accepted			2022-12-18	WOS:000336419300015
J	Jojic, V; Shay, T; Sylvia, K; Zuk, O; Sun, X; Kang, J; Regev, A; Koller, D				Jojic, Vladimir; Shay, Tal; Sylvia, Katelyn; Zuk, Or; Sun, Xin; Kang, Joonsoo; Regev, Aviv; Koller, Daphne		Immunological Genome Project Conso	Identification of transcriptional regulators in the mouse immune system	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; T-CELLS; DIFFERENTIAL EXPRESSION; LINEAGE COMMITMENT; GENE-EXPRESSION; HEMATOPOIESIS; DIVERSITY; PROFILES; NETWORKS	The differentiation of hematopoietic stem cells into cells of the immune system has been studied extensively in mammals, but the transcriptional circuitry that controls it is still only partially understood. Here, the Immunological Genome Project gene-expression profiles across mouse immune lineages allowed us to systematically analyze these circuits. To analyze this data set we developed Ontogenet, an algorithm for reconstructing lineage-specific regulation from gene-expression profiles across lineages. Using Ontogenet, we found differentiation stage-specific regulators of mouse hematopoiesis and identified many known hematopoietic regulators and 175 previously unknown candidate regulators, as well as their target genes and the cell types in which they act. Among the previously unknown regulators, we emphasize the role of ETV5 in the differentiation of gamma delta T cells. As the transcriptional programs of human and mouse cells are highly conserved, it is likely that many lessons learned from the mouse model apply to humans.	[Jojic, Vladimir] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Shay, Tal; Zuk, Or; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA USA; [Sylvia, Katelyn; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA	Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	aregev@broadinstitute.org; koller@cs.stanford.edu	Heng, Tracy/AAR-5712-2021; Heng, Tracy/B-9847-2015; Shay, Tal/J-4028-2016; Gautier, Emmanuel L./E-2259-2017; Gazit, Roi/J-3352-2017	Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; Shay, Tal/0000-0003-0755-1350; Gautier, Emmanuel L./0000-0003-2976-7566; Kim, Charles/0000-0001-6474-8227; Fletcher, Anne/0000-0003-1534-1142; Miller, Jennifer/0000-0002-3591-369X; Tata, Nageswara Rao/0000-0002-9928-5944; Monach, Paul/0000-0003-4937-0515; Dustin, Michael/0000-0003-4983-6389; Rothamel, Katherine/0000-0001-9896-485X; kang, joonsoo/0000-0001-8419-7995; Gazit, Roi/0000-0002-0548-2147; Malhotra, Deepali/0000-0002-8215-7639	National Institute of Allergy and Infectious Diseases [R24 AI072073]; US National Institutes of Health [U54- CA149145, 149644.0103]; Burroughs Wellcome Fund; Klarman Cell Observatory; Howard Hughes Medical Institute; Merkin Foundation for Stem Cell Research at the Broad Institute; National Science Foundation [DBI- 0345474]; NATIONAL CANCER INSTITUTE [U54CA149145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073, R01AI101301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Klarman Cell Observatory; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Merkin Foundation for Stem Cell Research at the Broad Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the ImmGen core team (including M. Painter and S. Davis) for help with data generation and processing; eBioscience, Affymetrix and Expression Analysis for support of ImmGen; L. Gaffney for help with figure preparation and layout of the lineage tree; S. Hart for initial layout of the lineage tree; and A. Liberzon (Molecular Signatures Database) for the positional gene sets for mouse. Supported by National Institute of Allergy and Infectious Diseases (R24 AI072073 to the ImmGen Consortium), the US National Institutes of Health (A R.; and U54- CA149145 and 149644.0103 to V.J. and D.K.), the Burroughs Wellcome Fund (A.R.), the Klarman Cell Observatory (A.R.), the Howard Hughes Medical Institute (A.R.), the Merkin Foundation for Stem Cell Research at the Broad Institute (A.R.) and the National Science Foundation (DBI- 0345474 to V.J. and D.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Boyd S, 2004, CONVEX OPTIMIZATION; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kishi H, 2000, BLOOD, V95, P3845; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P91, DOI 10.1016/j.bbrc.2012.02.120; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Neumann M, 2000, BLOOD, V95, P277; Ng SSM, 2011, FEBS LETT, V585, P1331, DOI 10.1016/j.febslet.2011.04.001; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Outram SV, 2008, CELL CYCLE, V7, P2047, DOI 10.4161/cc.7.13.6234; Pierre M, 2009, EXP HEMATOL, V37, P1038, DOI 10.1016/j.exphem.2009.05.011; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang TH, 2009, BLOOD, V113, P2906, DOI 10.1182/blood-2008-08-176354; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	142	142	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					633	+		10.1038/ni.2587	http://dx.doi.org/10.1038/ni.2587			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23624555	Green Accepted, Green Submitted			2022-12-18	WOS:000319107600016
J	Siggers, T; Chang, AB; Teixeira, A; Wong, D; Williams, KJ; Ahmed, B; Ragoussis, J; Udalova, IA; Smale, ST; Bulyk, ML				Siggers, Trevor; Chang, Abraham B.; Teixeira, Ana; Wong, Daniel; Williams, Kevin J.; Ahmed, Bilal; Ragoussis, Jiannis; Udalova, Irina A.; Smale, Stephen T.; Bulyk, Martha L.			Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappa B family DNA binding	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION-FACTOR-BINDING; ACTIVATION; MICROARRAYS; MOTIFS; CELLS; SEQUENCE; INNATE; SITES; RECOGNITION; MODULATION	The unique DNA-binding properties of distinct NF-kappa B dimers influence the selective regulation of NF-kappa B target genes. To more thoroughly investigate these dimer-specific differences, we combined protein-binding microarrays and surface plasmon resonance to evaluate DNA sites recognized by eight different NF-kappa B dimers. We observed three distinct binding-specificity classes and clarified mechanisms by which dimers might regulate distinct sets of genes. We identified many new nontraditional NF-kappa B binding site (kappa B site) sequences and highlight the plasticity of NF-kappa B dimers in recognizing kappa B sites with a single consensus half-site. This study provides a database that can be used in efforts to identify NF-kappa B target sites and uncover gene regulatory circuitry.	[Siggers, Trevor; Ahmed, Bilal; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Chang, Abraham B.; Williams, Kevin J.; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Chang, Abraham B.; Williams, Kevin J.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Teixeira, Ana; Wong, Daniel; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ahmed, Bilal; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Udalova, Irina A.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London, England; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Imperial College London; University of Oxford; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu	Ragoussis, Ioannis/AAD-9790-2022; Chang, Anne/F-2066-2013	Chang, Anne/0000-0002-1331-3706; Udalova, Irina/0000-0002-6716-2528; Ragoussis, Ioannis/0000-0002-8515-0934	US National Institutes of Health (NIH) [R01 HG003985]; HFSP [RGY0085/2005-C]; NIH [R01 AI073868, T32 CA009120]; FP7 Collaborative Project [222008]; UK Medical Research Council; Wellcome Trust [075491/Z/04]; i2b2/HST Summer Institute in Bioinformatics and Integrative Genomics NIH [U54 LM008748]; MRC [G0700818] Funding Source: UKRI; Medical Research Council [G0700818] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009120] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073868] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7 Collaborative Project; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); i2b2/HST Summer Institute in Bioinformatics and Integrative Genomics NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by US National Institutes of Health (NIH) grant R01 HG003985 to M.L.B., HFSP grant RGY0085/2005-C to M.L.B., NIH grant R01 AI073868 to S.T.S., FP7 Collaborative Project Model-In grant 222008 to J.R. and I.U., support from the UK Medical Research Council to J.R. and I.U. and support from Wellcome Trust grant 075491/Z/04 to J.R.A.C. was funded by NIH grant T32 CA009120, and B.A. was funded by the i2b2/HST Summer Institute in Bioinformatics and Integrative Genomics NIH grant U54 LM008748. We thank G. Natoli, M. Pasparakis and L. Giorgetti for helpful discussions.	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Britanova LV, 2008, BIOCHEM BIOPH RES CO, V365, P583, DOI 10.1016/j.bbrc.2007.10.200; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Chen YQ, 2000, STRUCT FOLD DES, V8, P419, DOI 10.1016/S0969-2126(00)00123-4; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Field S, 2007, ADV BIOCHEM ENG BIOT, V104, P87, DOI 10.1007/10_2006_035; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gordan R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1166; GRILLI M, 1993, INT REV CYTOL, V143, P1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; MAUXION F, 1991, P NATL ACAD SCI USA, V88, P2141, DOI 10.1073/pnas.88.6.2141; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	46	142	147	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					95	U123		10.1038/ni.2151	http://dx.doi.org/10.1038/ni.2151			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22101729	Green Submitted, Green Accepted			2022-12-18	WOS:000298412800016
J	Verschoor, A; Neuenhahn, M; Navarini, AA; Graef, P; Plaumann, A; Seidlmeier, A; Nieswandt, B; Massberg, S; Zinkernagel, RM; Hengartner, H; Busch, DH				Verschoor, Admar; Neuenhahn, Michael; Navarini, Alexander A.; Graef, Patricia; Plaumann, Ann; Seidlmeier, Amelie; Nieswandt, Bernhard; Massberg, Steffen; Zinkernagel, Rolf M.; Hengartner, Hans; Busch, Dirk H.			A platelet-mediated system for shuttling blood-borne bacteria to CD8 alpha(+) dendritic cells depends on glycoprotein GPIb and complement C3	NATURE IMMUNOLOGY			English	Article							LISTERIA-MONOCYTOGENES; MARGINAL ZONE; IMMUNE-RESPONSES; T-CELLS; RECEPTOR; PHAGOCYTOSIS; CD8(+); MACROPHAGES; PROTEIN; MICE	The acquisition of pathogen-derived antigen by dendritic cells (DCs) is a key event in the generation of cytotoxic CD8(+) T cell responses. In mice, the intracellular bacterium Listeria monocytogenes is directed from the blood to splenic CD8 alpha(+) DCs. We report that L. monocytogenes rapidly associated with platelets in the bloodstream in a manner dependent on GPIb and complement C3. Platelet association targeted a small but immunologically important portion of L. monocytogenes to splenic CD8 alpha(+) DCs, diverting bacteria from swift clearance by other, less immunogenic phagocytes. Thus, an effective balance is established between maintaining sterility of the circulation and induction of antibacterial immunity by DCs. Other Gram-positive bacteria also were rapidly tagged by platelets, revealing a broadly active shuttling mechanism for systemic bacteria.	[Verschoor, Admar; Neuenhahn, Michael; Graef, Patricia; Plaumann, Ann; Seidlmeier, Amelie; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Verschoor, Admar; Neuenhahn, Michael; Graef, Patricia; Plaumann, Ann; Seidlmeier, Amelie; Busch, Dirk H.] Tech Univ Munich, Inst Adv Study, Focus Grp, Clin Cell Proc & Purificat, Munich, Germany; [Verschoor, Admar; Navarini, Alexander A.; Zinkernagel, Rolf M.; Hengartner, Hans] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Verschoor, Admar; Busch, Dirk H.] Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Clin Cooperat Grp Antigen Specif Immunotherapy, Helmholtz Zentrum Munchen & Immune Monitoring, Munich, Germany; [Nieswandt, Bernhard] Univ Hosp, Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Massberg, Steffen] Tech Univ Munich, Deutsch Herzzentrum, Klin Herz & Kreislauferkrankungen, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.	admar.verschoor@mikrobio.med.tum.de; dirk.busch@mikrobio.med.tum.de	Massberg, Steffen/AAN-6054-2021; Navarini, Alexander/C-5504-2014	Navarini, Alexander/0000-0001-7059-632X	German Research Foundation [SFB 914, SFB 576]; Swiss National Foundation [3100AO-100779/2, 3100AO-100068/2]; German Center for Infection Research (DZIF); European Commission	German Research Foundation(German Research Foundation (DFG)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); German Center for Infection Research (DZIF); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank S. Gordon, P. Lachmann and H. Wagner for input; M. Botto (Imperial College, London) for C1qa<SUP>-/-</SUP> mice; M. Carroll (Harvard Medical School) for C3<SUP>-/-</SUP> and C4b<SUP>-/-</SUP> mice; C. Gerard (Harvard Medical School) for C3ar<SUP>-/-</SUP> mice; F. Petry (Johannes Gutenberg University of Mainz, Germany) for C1qa<SUP>-/-</SUP> mice; M. van der Linden (University Hospital Aachen, Germany) for Streptococcus strains; S. Feihl and V. Greifenberg for bacterial typing; L. Henkel, M. Schiemann and K. Wild for flow cytometry cell sorting; K. Mink, S. Vieweg and A. Wanisch for experimental assistance; and L. Layland for support preparing the manuscript. Supported by the German Research Foundation SFB 914 (TP-B4 to A. V. and D. H. B.) and SFB 576 (TP-A8 to D. H. B.), the Swiss National Foundation (3100AO-100779/2 and 3100AO-100068/2 to H. H. and R.M.Z.), the German Center for Infection Research (DZIF; D. H. B.) and the European Commission (Marie Curie Fellowship to A.V.).	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Alexander JJ, 2001, J BIOL CHEM, V276, P32129, DOI 10.1074/jbc.M101299200; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; COSGROVE LJ, 1987, IMMUNOL CELL BIOL, V65, P453, DOI 10.1038/icb.1987.54; CROIZE J, 1993, INFECT IMMUN, V61, P5134, DOI 10.1128/IAI.61.12.5134-5139.1993; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; DREVETS DA, 1991, INFECT IMMUN, V59, P2645, DOI 10.1128/IAI.59.8.2645-2652.1991; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Fischer MB, 1996, J IMMUNOL, V157, P549; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Ford I, 1997, PLATELETS, V8, P285; Ford I, 1997, BRIT J HAEMATOL, V97, P737, DOI 10.1046/j.1365-2141.1997.1342950.x; Gregory SH, 2002, J IMMUNOL, V168, P308, DOI 10.4049/jimmunol.168.1.308; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kanaji T, 2002, BLOOD, V100, P2102, DOI 10.1182/blood-2002-03-0997; Kim DD, 2008, BLOOD, V112, P1109, DOI 10.1182/blood-2008-01-134304; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mollenkopf H, 2001, BIOL CHEM, V382, P521, DOI 10.1515/BC.2001.066; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakayama Y, 2009, J IMMUNOL, V183, P2921, DOI 10.4049/jimmunol.0801191; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Neuenhahn M, 2010, METHODS MOL BIOL, V595, P319, DOI 10.1007/978-1-60761-421-0_21; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Reinicke AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007210; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; SKAMENE E, 1977, IMMUNOLOGY, V33, P851; Staib Caroline, 2004, Methods Mol Biol, V269, P77; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Verschoor A, 2001, J IMMUNOL, V167, P2446, DOI 10.4049/jimmunol.167.5.2446; VIK DP, 1987, J IMMUNOL, V138, P254; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	50	142	146	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1194	U86		10.1038/ni.2140	http://dx.doi.org/10.1038/ni.2140			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22037602				2022-12-18	WOS:000297202700014
J	Stumhofer, JS; Tait, ED; Quinn, WJ; Hosken, N; Spudy, B; Goenka, R; Fielding, CA; O'Hara, AC; Chen, Y; Jones, ML; Saris, CJM; Rose-John, S; Cua, DJ; Jones, SA; Elloso, MM; Grotzinger, J; Cancro, MP; Levin, SD; Hunter, CA				Stumhofer, Jason S.; Tait, Elia D.; Quinn, William J., III; Hosken, Nancy; Spudy, Bjoern; Goenka, Radhika; Fielding, Ceri A.; O'Hara, Aisling C.; Chen, Yi; Jones, Michael L.; Saris, Christiaan J. M.; Rose-John, Stefan; Cua, Daniel J.; Jones, Simon A.; Elloso, Merle M.; Groetzinger, Joachim; Cancro, Michael P.; Levin, Steven D.; Hunter, Christopher A.			A role for IL-27p28 as an antagonist of gp130-mediated signaling	NATURE IMMUNOLOGY			English	Article							LEUKEMIA INHIBITORY FACTOR; CELL-STIMULATING FACTOR-3; TRANSGENIC MICE; T-CELLS; B-CELLS; KOREAN POPULATION; JAK/STAT PATHWAY; HELPER-CELLS; TH17 CELLS; IN-VIVO	The heterodimeric cytokine interleukin 27 (IL-27) signals through the IL-27R alpha subunit of its receptor, combined with gp130, a common receptor chain used by several cytokines, including IL-6. Notably, the IL-27 subunits p28 (IL-27p28) and EBI3 are not always expressed together, which suggests that they may have unique functions. Here we show that IL-27p28, independently of EBI3, antagonized cytokine signaling through gp130 and IL-6-mediated production of IL-17 and IL-10. Similarly, the ability to generate antibody responses was dependent on the activity of gp130-signaling cytokines. Mice transgenic for expression of IL-27p28 showed a substantial defect in the formation of germinal centers and antibody production. Thus, IL-27p28, as a natural antagonist of gp130-mediated signaling, may be useful as a therapeutic for managing inflammation mediated by cytokines that signal through gp130.	[Stumhofer, Jason S.; Tait, Elia D.; O'Hara, Aisling C.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Quinn, William J., III; Goenka, Radhika; Cancro, Michael P.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Hosken, Nancy; Levin, Steven D.] Zymogenet Inc, Dept Immunol, Seattle, WA 98105 USA; [Spudy, Bjoern; Rose-John, Stefan; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Fielding, Ceri A.; Jones, Simon A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Chen, Yi; Cua, Daniel J.] DNAX Discovery Res, Merck Res Labs, Palo Alto, CA USA; [Jones, Michael L.] Shenandoah Biotechnol, Warwick, PA USA; [Saris, Christiaan J. M.] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA USA; [Elloso, Merle M.] Centocor Res & Dev, Radnor, PA USA	University of Pennsylvania; University of Pennsylvania; Zymogenet Inc.; University of Kiel; Cardiff University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Amgen; Johnson & Johnson; Johnson & Johnson USA	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Quinn, William/K-1889-2019; Hunter, Christopher/H-1970-2011; Fielding, Ceri A/F-5638-2014; Rose-John, Stefan/A-7998-2010; Jones, Simon Arnett/Q-7017-2018	Fielding, Ceri A/0000-0002-5817-3153; Rose-John, Stefan/0000-0002-7519-3279; Tait Wojno, Elia/0000-0003-2822-296X; Hall, Aisling/0000-0001-8198-3245; Jones, Simon Arnett/0000-0001-7297-9711; Hosken, Nancy/0000-0003-2680-3533; Quinn, William/0000-0002-3642-584X; Cancro, Michael/0000-0002-8659-3227	US National Institutes for Health [AI-042334, AI-054488, 1-T32-AI-055428, 2-T32-AI-007532-11]; Abramson Cancer Center (Center for Digestive Diseases); State of Pennsylvania; Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB415, B5, SFB415, B7]; Cluster of Excellence 'Inflammation at Interfaces'; Marie Lowe Cancer Center of the University of Pennsylvania; Versus Arthritis [18286] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, P01AI043620, R01AI054488, R01AI042334, T32AI007532] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center (Center for Digestive Diseases); State of Pennsylvania; Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Cluster of Excellence 'Inflammation at Interfaces'; Marie Lowe Cancer Center of the University of Pennsylvania; Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Gorman for generating the IL-27 and IL-27p28 minicircles. Supported by the US National Institutes for Health (AI-042334 to C. A. H.; AI-054488 to M.P.C.; 1-T32-AI-055428 to J.S.S. and W.J.Q. III; and 2-T32-AI-007532-11 to E.D.T.), the Abramson Cancer Center (Center for Digestive Diseases), the state of Pennsylvania, the Deutsche Forschungsgemeinschaft (Bonn, Germany; SFB415, B5 to S.R-J., and SFB415, B7 to J.G. and B.S.), the Cluster of Excellence 'Inflammation at Interfaces' and the Marie Lowe Cancer Center of the University of Pennsylvania (C.A.H.).	ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Benigni F, 1996, BLOOD, V87, P1851, DOI 10.1182/blood.V87.5.1851.bloodjournal8751851; Brakenhoff JPJ, 1996, FEBS LETT, V395, P235, DOI 10.1016/0014-5793(96)00974-X; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chae SC, 2007, J HUM GENET, V52, P355, DOI 10.1007/s10038-007-0123-8; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; FATTORI E, 1994, BLOOD, V83, P2570; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; HANGOC G, 1993, BLOOD, V81, P965; Heinzel FP, 1997, J IMMUNOL, V158, P4381; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hogan BLM, 1994, MANIPULATING MOUSE E; Howlett M, 2009, BBA-MOL CELL RES, V1793, P1623, DOI 10.1016/j.bbamcr.2009.07.009; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; JACK RS, 1977, EUR J IMMUNOL, V7, P559, DOI 10.1002/eji.1830070813; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kumanogoh A, 1997, P NATL ACAD SCI USA, V94, P2478, DOI 10.1073/pnas.94.6.2478; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Li CS, 2009, J GASTROEN HEPATOL, V24, P1692, DOI 10.1111/j.1440-1746.2009.05901.x; Liu JG, 2007, J EXP MED, V204, P141, DOI 10.1084/jem.20061440; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; METCALF D, 1990, BLOOD, V76, P50; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; MURAGUCHI A, 1981, J IMMUNOL, V127, P412; MURAGUCHI A, 1988, J EXP MED, V167, P332, DOI 10.1084/jem.167.2.332; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Scheller J, 2005, BIOCHEM BIOPH RES CO, V326, P724, DOI 10.1016/j.bbrc.2004.11.098; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Senaldi G, 2002, J IMMUNOL, V168, P5690, DOI 10.4049/jimmunol.168.11.5690; SHEN MM, 1994, EMBO J, V13, P1375, DOI 10.1002/j.1460-2075.1994.tb06391.x; Shimozato O, 2009, IMMUNOLOGY, V128, pe816, DOI 10.1111/j.1365-2567.2009.03088.x; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; TAKATSUKI F, 1988, J IMMUNOL, V141, P3072; Timmermann A, 2000, FEBS LETT, V468, P120, DOI 10.1016/S0014-5793(00)01205-9; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	59	142	152	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1119	U118		10.1038/ni.1957	http://dx.doi.org/10.1038/ni.1957			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21057510	Green Accepted			2022-12-18	WOS:000284262200011
J	Ackerman, AL; Kyritsis, C; Tampe, R; Cresswell, P				Ackerman, AL; Kyritsis, C; Tampe, R; Cresswell, P			Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells	NATURE IMMUNOLOGY			English	Article							CLASS-I; MONOCLONAL-ANTIBODY; T-CELLS; TRANSPORT; DIFFERENTIATION; PROTEIN; LOCALIZATION; COMPARTMENT; ACTIVATION; PHAGOSOMES	In dendritic cells (DCs), peptides derived from internalized particulate substrates are efficiently cross-presented by major histocompatibility complex (MHC) class I molecules. Exogenous soluble antigens are also presented by DCs but with substantially lower efficiency. Here we show that particulate and soluble antigens use different transport pathways. Particulate antigens have been shown to access peripheral endoplasmic reticulum (ER)-like phagosomes that are competent for cross-presentation, whereas we show here that soluble proteins that escape proteolysis enter the lumen of the ER. From there, they may be translocated into the cytosol by the pathway established for ER-associated degradation and their derived peptides may be transported back into the ER for binding by MHC class I molecules. MHC class I presentation involving the constitutive retrograde transport of soluble proteins to the ER by DCs may facilitate DC tolerance to components of their extracellular environment.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA; Goethe Univ Frankfurt, Inst Biochem, D-60439 Frankfurt, Germany	Howard Hughes Medical Institute; Yale University; Goethe University Frankfurt	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunol Sect, 333 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Ackerman, Anne/ABG-8182-2020; Ackerman, A. Lenore/AAP-9844-2021; Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160	NIAID NIH HHS [F31 AI101347] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; BERGER AE, 1982, HYBRIDOMA, V1, P87, DOI 10.1089/hyb.1.1982.1.87; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Cannon KS, 2001, EMBO J, V20, P2443, DOI 10.1093/emboj/20.10.2443; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gredmark S, 2003, J VIROL, V77, P10943, DOI 10.1128/JVI.77.20.10943-10956.2003; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; PARHAM P, 1979, J IMMUNOL, V123, P342; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; St Louis DC, 1999, J IMMUNOL, V162, P3237; Steinman RM, 2001, MT SINAI J MED, V68, P160; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0	44	142	148	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					107	113		10.1038/ni1147	http://dx.doi.org/10.1038/ni1147			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15592474				2022-12-18	WOS:000225888500024
J	Gordon, J; Wilson, VA; Blair, NF; Sheridan, J; Farley, A; Wilson, L; Manley, NR; Blackburn, CC				Gordon, J; Wilson, VA; Blair, NF; Sheridan, J; Farley, A; Wilson, L; Manley, NR; Blackburn, CC			Functional evidence for a single endodermal origin for the thymic epithelium	NATURE IMMUNOLOGY			English	Article							CELL DIFFERENTIATION; NUDE-MICE; POSTNATAL THYMUS; STROMAL CELLS; MOUSE EMBRYO; NEURAL CREST; EXPRESSION; GENE; ORGANOGENESIS; MICROENVIRONMENT	T cell development depends critically on several distinct thymic epithelial cell types that are organized into two main compartments: cortex and medulla. The prevailing hypothesis suggests that these derive from ectoderm and endoderm, respectively. Here we show that lineage analysis provides no evidence for an ectodermal contribution to the thymic rudiment. We further demonstrate, via ectopic transplantation, that isolated pharyngeal endoderm can generate a functional thymus containing organized cortical and medullary regions and that this capacity is not potentiated by the presence of pharyngeal ectoderm. These data establish that the cortical and medullary thymic epithelial compartments derive from a single germ layer, the endoderm, thus refuting the 'dual-origin' model of thymic epithelial ontogeny.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Edinburgh, Div Biomed & Clin Lab Sci, Edinburgh EH8 9XD, Midlothian, Scotland; Univ Georgia, Dept Genet, Athens, GA 30602 USA	University of Edinburgh; University of Edinburgh; University System of Georgia; University of Georgia	Blackburn, CC (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	c.blackburn@ed.ac.uk	Wilson, Valerie A/H-5427-2011; Blackburn, Clare/AAM-7954-2020; Blackburn, Clare/B-2847-2009	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; FARLEY, ALISON/0000-0002-9609-8983; , Val/0000-0003-4182-5159; Sheridan, Julie/0000-0002-1478-3662	NICHD NIH HHS [HD035920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035920] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; AUERBACH R, 1960, DEV BIOL, V2, P271, DOI 10.1016/0012-1606(60)90009-9; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; CORDIER AC, 1975, SCAND J IMMUNOL, V4, P193, DOI 10.1111/j.1365-3083.1975.tb02616.x; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Imami N, 1992, Dev Immunol, V2, P161, DOI 10.1155/1992/18016; Ishii Y, 2001, DEV BIOL, V236, P344, DOI 10.1006/dbio.2001.0318; JANEWAY CA, 2001, IMMUNOBIOLOGY IMMUNE, P230; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Moore-Scott BA, 2003, GENESIS, V35, P164, DOI 10.1002/gene.10179; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; PARHAM P, 2003, IMMUNE SYSTEM, P107; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Prockop SE, 2002, J IMMUNOL, V169, P4354, DOI 10.4049/jimmunol.169.8.4354; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; SMITH C, 1965, AM J ANAT, V116, P611, DOI 10.1002/aja.1001160307; Su DM, 2001, DEV BIOL, V236, P316, DOI 10.1006/dbio.2001.0342; VANEWIJK W, 1982, EUR J IMMUNOL, V12, P262, DOI 10.1002/eji.1830120403; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393	45	142	149	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					546	553		10.1038/ni1064	http://dx.doi.org/10.1038/ni1064			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15098031				2022-12-18	WOS:000221101100020
J	Xu, YY; Banerjee, D; Huelsken, J; Birchmeier, W; Sen, JM				Xu, YY; Banerjee, D; Huelsken, J; Birchmeier, W; Sen, JM			Deletion of beta-catenin impairs T cell development	NATURE IMMUNOLOGY			English	Article							DIFFERENTIATION; EXPRESSION; SIGNALS; REARRANGEMENT; SURVIVAL; CHAIN	T cells encounter two main checkpoints during development in the thymus. These checkpoints are critically dependent on signals derived from the thymic microenvironment as well as from the pre-T cell receptor (pre-TCR) and the TCR. Here we show that T cell-specific deletion of beta-catenin impaired T cell development at the beta-selection checkpoint, leading to a substantial decrease in splenic T cells. In addition, beta-catenin also seemed to be a target of TCR-CD3 signals in thymocytes and mature T cells. These data indicate that beta-catenin-mediated signals are required for normal T cell development.	Dana Farber Canc Inst, Boston, MA 02115 USA; Brandeis Univ, Rosenstiel Ctr Biomed Res, Waltham, MA 02540 USA; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Brandeis University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Harvard Medical School	Sen, JM (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	jyoti_sen@dfci.harvard.edu	Huelsken, Joerg/AAC-9581-2021	Huelsken, Joerg/0000-0003-3105-9606				Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; Di Santo JP, 1999, J EXP MED, V189, P563, DOI 10.1084/jem.189.3.563; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; Muller KM, 1997, IMMUNITY, V6, P257, DOI 10.1016/S1074-7613(00)80328-3; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; MULROY TM, 2003, INT IMMUNOL, V15, P1; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Petrie HT, 2002, IMMUNOL REV, V189, P8, DOI 10.1034/j.1600-065X.2002.18902.x; Petrie HT, 2000, J IMMUNOL, V165, P3094, DOI 10.4049/jimmunol.165.6.3094; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Sellin JH, 2001, CANCER RES, V61, P2899; Sen J, 2001, CELL MOL BIOL, V47, P197; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xu YY, 2003, EUR J IMMUNOL, V33, P12, DOI 10.1002/immu.200390002; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	35	142	148	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1177	1182		10.1038/ni1008	http://dx.doi.org/10.1038/ni1008			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14608382				2022-12-18	WOS:000186769500010
J	Weinmann, AS; Mitchell, DM; Sanjabi, S; Bradley, MN; Hoffmann, A; Liou, HC; Smale, ST				Weinmann, AS; Mitchell, DM; Sanjabi, S; Bradley, MN; Hoffmann, A; Liou, HC; Smale, ST			Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-2; KAPPA-B; ADAPTIVE IMMUNITY; C/EBP-BETA; ACTIVATION; INTERLEUKIN-12; TRANSCRIPTION; LIPOPROTEINS; CBP/P300; GENES	Lipopolysaccharide (LPS) induction of the gene encoding interleukin 12 p40 requires remodeling of a promoter-encompassing nucleosome and the Toll-like receptor (TLR)-mediated activation of a c-Re1-containing complex. Analysis of TLR4-mutant mice revealed that remodeling requires TLR signaling. However, Re1 proteins and other proteins required for transcription of an integrated p40 promoter were insufficient for remodeling. c-Re1 was also unnecessary for remodeling, as remodeling was observed in c-Re1(-/-) macrophages, which lack p40 transcripts. These results suggest that remodeling requires TLR signaling pathways that diverge from the c-Re1 activation pathways. The factors that stimulate remodeling may represent, therefore, newly identified targets of TLR signaling and of agents that regulate inflammatory responses and T(H)1 development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Cornell Univ, Coll Med, Dept Med, Div Immunol, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology; Cornell University	Smale, ST (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645	NIAID NIH HHS [AI07323] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; De Maeyer Edward, 1998, P491; GORDON S, 1999, FUNDAMENTAL IMMUNOLO, P533; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Sutterwala FS, 1999, J LEUKOCYTE BIOL, V65, P543, DOI 10.1002/jlb.65.5.543; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Yang RB, 1999, J IMMUNOL, V163, P639; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	30	142	145	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					51	57		10.1038/83168	http://dx.doi.org/10.1038/83168			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135578				2022-12-18	WOS:000166261500014
J	Pollizzi, KN; Sun, IH; Patel, CH; Lo, YC; Oh, MH; Waickman, AT; Tam, AJ; Blosser, RL; Wen, JY; Delgoffe, GM; Powell, JD				Pollizzi, Kristen N.; Sun, Im-Hong; Patel, Chirag H.; Lo, Ying-Chun; Oh, Min-Hee; Waickman, Adam T.; Tam, Ada J.; Blosser, Richard L.; Wen, Jiayu; Delgoffe, Greg M.; Powell, Jonathan D.			Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation	NATURE IMMUNOLOGY			English	Article							AMINO-ACID-TRANSPORT; EARLY SPECIFICATION; MEMORY; EFFECTOR; ACTIVATION; METABOLISM; RAGULATOR; MECHANISM; IMMUNITY; GENE	The asymmetric partitioning of fate-determining proteins has been shown to contribute to the generation of CD8(+) effector and memory T cell precursors. Here we demonstrate the asymmetric partitioning of mTORC1 activity after the activation of naive CD8(+) T cells. This results in the generation of two daughter T cells, one of which shows increased mTORC1 activity, increased glycolytic activity and increased expression of effector molecules. The other daughter T cell has relatively low mTORC1 activity and increased lipid metabolism, expresses increased amounts of anti-apoptotic molecules and subsequently displays enhanced long-term survival. Mechanistically, we demonstrate a link between T cell antigen receptor (TCR)-induced asymmetric expression of amino acid transporters and RagC-mediated translocation of mTOR to the lysosomes. Overall, our data provide important insight into how mTORC1-mediated metabolic reprogramming affects the fate decisions of T cells.	[Pollizzi, Kristen N.; Sun, Im-Hong; Patel, Chirag H.; Lo, Ying-Chun; Oh, Min-Hee; Waickman, Adam T.; Tam, Ada J.; Blosser, Richard L.; Wen, Jiayu; Delgoffe, Greg M.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21205 USA; [Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Pollizzi, Kristen N.] MedImmune LLC, Dept Res Oncol, Gaithersburg, MD USA; [Lo, Ying-Chun] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Waickman, Adam T.] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; AstraZeneca; Medimmune; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21205 USA.	poweljo@jhmi.edu	Waickman, Adam/AHB-5028-2022; Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135; Sun, Im Hong/0000-0003-0288-2062; Waickman, Adam/0000-0002-4536-6714; Oh, Min-Hee/0000-0003-1581-4288	NIH [AI072677, AI77610, AI091481, S10 OD016374, S10 RR024550]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI072677, R01AI091481, R01AI077610, T32AI007247] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Powell lab and C. Gamper for critical discussion of the manuscript; B. Smith and T. Stephens for their technical support in microscopy studies; M. Gambello (Emory University, Atlanta, Georgia, USA) for Tsc2<SUP>loxP</SUP> mice; and P. Worley (Johns Hopkins University, Baltimore, Maryland, USA) for Rheb<SUP>loxP</SUP> mice. This work was supported by the NIH (grants AI072677, AI77610 and AI091481 to J.D.P., and grants S10 OD016374 and S10 RR024550 to the JHUSOM Microscope Facility).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Metz PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19182; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Pollizzi KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121710; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	39	141	146	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					704	+		10.1038/ni.3438	http://dx.doi.org/10.1038/ni.3438			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27064374	Green Accepted			2022-12-18	WOS:000376162200015
J	Apostolidis, SA; Rodriguez-Rodriguez, N; Suarez-Fueyo, A; Dioufa, N; Ozcan, E; Crispin, JC; Tsokos, MG; Tsokos, GC				Apostolidis, Sokratis A.; Rodriguez-Rodriguez, Noe; Suarez-Fueyo, Abel; Dioufa, Nikolina; Ozcan, Esra; Crispin, Jose C.; Tsokos, Maria G.; Tsokos, George C.			Phosphatase PP2A is requisite for the function of regulatory T cells	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REG CELLS; TUMOR-SUPPRESSOR; SCURFY MOUSE; PROTEIN; 2A; DIFFERENTIATION; DISEASE; CERAMIDE; FOXP3	Homeostasis of the immune system depends on the proper function of regulatory T cells (T-reg cells). Compromised suppressive activity of T-reg cells leads to autoimmune disease and graft rejection and promotes anti-tumor immunity. Here we report a previously unrecognized requirement for the serine-threonine phosphatase PP2A in the function of T-reg cells. T-reg cells exhibited high PP2A activity, and T-reg cell-specific ablation of the PP2A complex resulted in a severe, multi-organ, lymphoproliferative autoimmune disorder. Mass spectrometry revealed that PP2A associated with components of the mTOR metabolic-checkpoint kinase pathway and suppressed the activity of the mTORC1 complex. In the absence of PP2A, T-reg cells altered their metabolic and cytokine profile and were unable to suppress effector immune responses. Therefore, PP2A is required for the function of T-reg cells and the prevention of autoimmunity.	[Apostolidis, Sokratis A.; Rodriguez-Rodriguez, Noe; Suarez-Fueyo, Abel; Dioufa, Nikolina; Ozcan, Esra; Crispin, Jose C.; Tsokos, Maria G.; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Crispín, José/I-4919-2019; Suarez Fueyo, Abel/E-5746-2017; Suarez-Fueyo, Abel/D-1691-2013	tsokos, george C/0000-0001-9589-2360; Crispín, José/0000-0002-7590-3621; Suarez-Fueyo, Abel/0000-0002-8696-0197; Rodriguez-Rodriguez, Noe/0000-0001-7825-5634	US National Institutes of Health [R01 AI068787]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Seth for advice on the use of the Seahorse XF24 flux analyzer; J. Bielawski and J. Pierce for advice and technical assistance in studies of ceramide species by mass spectrometry; and A. Rao (La Jolla Institute for Allergy and Immunology) for the MSCV-FOXP3-IRES-Thy1.1 plasmid (initially generated at Harvard Medical School and the University of Colorado at Boulder). Supported by the US National Institutes of Health (R01 AI068787 to G.C.T.) and the Arthritis Foundation (S.A.A.).	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; RCore Team, 2022, R LANG ENV STAT COMP; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Trotta R, 2007, J EXP MED, V204, P2397, DOI 10.1084/jem.20070419; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xie L, 2013, CELL REP, V3, P678, DOI 10.1016/j.celrep.2013.01.029; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	55	141	148	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					556	+		10.1038/ni.3390	http://dx.doi.org/10.1038/ni.3390			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26974206	Green Accepted, Green Submitted			2022-12-18	WOS:000374323100015
J	Rivera, A; Siracusa, MC; Yap, GS; Gause, WC				Rivera, Amariliz; Siracusa, Mark C.; Yap, George S.; Gause, William C.			Innate cell communication kick-starts pathogen-specific immunity	NATURE IMMUNOLOGY			English	Review							ALTERNATIVELY ACTIVATED MACROPHAGES; MAST-CELLS; TYPE-2 IMMUNITY; NK CELLS; BONE-MARROW; T-CELLS; MONOCYTE EMIGRATION; GENE-EXPRESSION; DENDRITIC CELLS; LYMPHOID-CELLS	Innate cells are responsible for the rapid recognition of infection and mediate essential mechanisms of pathogen elimination, and also facilitate adaptive immune responses. We review here the numerous intricate interactions among innate cells that initiate protective immunity. The efficient eradication of pathogens depends on the coordinated actions of multiple cells, including innate cells and epithelial cells. Rather than acting as isolated effector cells, innate cells are in constant communication with other responding cells of the immune system, locally and distally. These interactions are critically important for the efficient control of primary infections as well for the development of 'trained' innate cells that facilitate the rapid elimination of homologous or heterologous infections.	[Rivera, Amariliz; Siracusa, Mark C.; Yap, George S.; Gause, William C.] Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07102 USA; [Rivera, Amariliz] Rutgers State Univ, Dept Pediat, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Newark, NJ 07102 USA; [Siracusa, Mark C.; Yap, George S.; Gause, William C.] Rutgers State Univ, Dept Med, New Jersey Med Sch, Rutgers,Biomed & Hlth Sci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gause, WC (corresponding author), Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07102 USA.; Gause, WC (corresponding author), Rutgers State Univ, Dept Med, New Jersey Med Sch, Rutgers,Biomed & Hlth Sci, Newark, NJ 07102 USA.	gausewc@njms.rutgers.edu			US National Institutes of Health [R01AI114647-01A1, R21CA167238-01A1, K22 AI110573-01, 1R01AI123224, R01AI083405, 1R01AI107588]; Amelior Foundation (Gause laboratory); NATIONAL CANCER INSTITUTE [R21CA167238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083405, K22AI110573, R01AI123224, R01AI107588, R01AI114647] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amelior Foundation (Gause laboratory); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (R01AI114647-01A1 and R21CA167238-01A1 to A.R.; K22 AI110573-01 and 1R01AI123224 to M.C.S.; R01AI083405 to G.S.Y.; and 1R01AI107588 to W.C.G.) and the Amelior Foundation (Gause laboratory).	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607; Bieren JEV, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003771; Bouchery T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7970; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chen L, 2015, MUCOSAL IMMUNOL, V8, P390, DOI 10.1038/mi.2014.77; Chiu C, 2015, NAT IMMUNOL, V16, P18, DOI 10.1038/ni.3056; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Espinosa V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003940; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Giacomin PR, 2012, J IMMUNOL, V189, P4371, DOI 10.4049/jimmunol.1200691; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Herbst T, 2012, P NATL ACAD SCI USA, V109, P14954, DOI 10.1073/pnas.1117584109; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hogan SP, 2013, CURR OPIN GASTROEN, V29, P7, DOI 10.1097/MOG.0b013e32835ab29a; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Jenkins MR, 2015, J EXP MED, V212, P307, DOI 10.1084/jem.20140964; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Kang YH, 2013, IMMUNITY, V38, P408, DOI 10.1016/j.immuni.2013.02.015; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Lang PA, 2009, BLOOD, V113, P1045, DOI 10.1182/blood-2007-10-117861; Lantz CS, 2008, LAB INVEST, V88, P1134, DOI 10.1038/labinvest.2008.88; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Murray PJ, 2015, CELL METAB, V22, P190, DOI 10.1016/j.cmet.2015.06.014; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Netea MG, 2015, NAT IMMUNOL, V16, P675, DOI 10.1038/ni.3178; Netea MG, 2014, J INNATE IMMUN, V6, P117, DOI 10.1159/000357283; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; OGILVIE BM, 1978, EXP PARASITOL, V46, P20, DOI 10.1016/0014-4894(78)90153-4; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ohnmacht C, 2010, J IMMUNOL, V184, P344, DOI 10.4049/jimmunol.0901841; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Randolph GJ, 2014, IMMUNOL REV, V262, P5, DOI 10.1111/imr.12232; Riise RE, 2015, J IMMUNOL, V195, P1121, DOI 10.4049/jimmunol.1500709; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Seo SU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9010; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Svensson L, 2005, MICROBES INFECT, V7, P720, DOI 10.1016/j.micinf.2005.01.010; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Urban JF, 2000, J IMMUNOL, V164, P2046, DOI 10.4049/jimmunol.164.4.2046; van Panhuys N, 2011, J IMMUNOL, V186, P2719, DOI 10.4049/jimmunol.1000940; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yap GS, 2012, IMMUNITY, V36, P904, DOI 10.1016/j.immuni.2012.06.007; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Yousefi S, 2015, ALLERGY, V70, P1184, DOI 10.1111/all.12662; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	106	141	149	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					356	363		10.1038/ni.3375	http://dx.doi.org/10.1038/ni.3375			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002843	Green Accepted			2022-12-18	WOS:000372508000007
J	Binstadt, BA; Patel, PR; Alencar, H; Nigrovic, PA; Lee, DM; Mahmood, U; Weissleder, R; Mathis, D; Benoist, C				Binstadt, BA; Patel, PR; Alencar, H; Nigrovic, PA; Lee, DM; Mahmood, U; Weissleder, R; Mathis, D; Benoist, C			Particularities of the vasculature can promote the organ specificity of autoimmune attack	NATURE IMMUNOLOGY			English	Article							MAST-CELLS; INDUCED ARTHRITIS; ARTHUS REACTION; DEFICIENT MICE; INFLAMMATORY RESPONSES; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; IMMUNE-COMPLEXES; INNATE IMMUNE; DOMINANT ROLE	How certain autoimmune diseases target specific organs remains obscure. In the 'K/BxN' arthritis model, autoantibodies to a ubiquitous antigen elicit joint-restricted pathology. Here we have used intravital imaging to demonstrate that transfer of arthritogenic antibodies caused macromolecular vasopermeability localized to sites destined to develop arthritis, augmenting its severity. Vasopermeability depended on mast cells, neutrophils and Fc gamma RIII but not complement, tumor necrosis factor or interleukin 1. Unexpectedly, radioresistant FcR gamma-expressing cells in an organ distant from the joint were required. Histamine and serotonin were critical, and systemic administration of these vasoactive amines recapitulated the joint localization of immune complex-triggered vasopermeability. We propose that regionally distinct vascular properties 'interface' with immune effector pathways to foster organ-specific autoimmune damage, perhaps explaining why arthritis accompanies many human infectious and autoimmune disorders.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02115 USA; Childrens Hosp, Rheumatol Program, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Mathis, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cbdm@joslin.harvard.edu; cbdm@joslin.harvard.edu	Binstadt, Bryce/N-1305-2013	Binstadt, Bryce/0000-0003-3127-3856; /0000-0003-0828-4143; Mahmood, Umar/0000-0001-7414-6123	NATIONAL CANCER INSTITUTE [R24CA092782, R01CA091007, P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046580] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA92782, P50 CA86355, R33 CA91007] Funding Source: Medline; NIAID NIH HHS [P01 AI54904] Funding Source: Medline; NIAMS NIH HHS [R01 AR046580] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Baumann U, 2001, J IMMUNOL, V167, P1022, DOI 10.4049/jimmunol.167.2.1022; Benjamim CF, 2005, J IMMUNOL, V174, P1616, DOI 10.4049/jimmunol.174.3.1616; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Geba GP, 1996, J IMMUNOL, V157, P557; GOULET JL, 1994, P NATL ACAD SCI USA, V91, P12852, DOI 10.1073/pnas.91.26.12852; HANG L, 1982, J EXP MED, V155, P1690, DOI 10.1084/jem.155.6.1690; Harbuz MS, 1996, BRIT J RHEUMATOL, V35, P112; HAYASHI H, 1964, BRIT J EXP PATHOL, V45, P419; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Huang Q, 1999, NAT BIOTECHNOL, V17, P1033, DOI 10.1038/13736; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; KATZ HR, 1992, J IMMUNOL, V148, P868; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KNIGHT AD, 1984, Q J EXP PHYSIOL CMS, V69, P271, DOI 10.1113/expphysiol.1984.sp002805; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lovdal T, 2000, J CELL SCI, V113, P3255; Lovdal T, 2001, CELL BIOL INT, V25, P821, DOI 10.1006/cbir.2001.0761; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; MAJNO G, 1987, AM J PATHOL, V128, P210; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; Mangialaio S, 1999, ARTHRITIS RHEUM, V42, P2517, DOI 10.1002/1529-0131(199912)42:12<2517::AID-ANR3>3.0.CO;2-W; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Moriyama M, 2005, J EXP MED, V202, P217, DOI 10.1084/jem.20050248; Oono T, 2001, J CLIN INVEST, V108, P1589, DOI 10.1172/JCI13256; POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001; RAMOS BF, 1992, J PHARMACOL EXP THER, V262, P559; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Weissleder R, 2001, BIOCONJUGATE CHEM, V12, P213, DOI 10.1021/bc000091p; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	49	141	145	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					284	292		10.1038/ni1306	http://dx.doi.org/10.1038/ni1306			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16444258				2022-12-18	WOS:000235360400013
J	Woo, M; Hakem, R; Furlonger, C; Hakem, A; Duncan, GS; Sasaki, T; Bouchard, D; Lu, LW; Wu, GE; Paige, CJ; Mak, TW				Woo, M; Hakem, R; Furlonger, C; Hakem, A; Duncan, GS; Sasaki, T; Bouchard, D; Lu, LW; Wu, GE; Paige, CJ; Mak, TW			Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity	NATURE IMMUNOLOGY			English	Article							DEPENDENT KINASES; APOPTOTIC PATHWAYS; CDK INHIBITORS; IN-VIVO; P21; ACTIVATION; PROTEIN; DEATH; PCNA; CLEAVAGE	Caspases are important for apoptosis but are also involved in mammalian cell survival and cell division. Here we report that caspase-3 is a negative regulator of B cell cycling. Mice deficient in caspase-3 (Casp3(-/-) mice) have increased numbers of splenic B cells that show normal apoptosis but enhanced proliferation in vivo and hyperproliferation after mitogenic stimulation in vitro. Cdkn1a encodes p21 (also called Waf1 or Cip1), a cyclin-dependent kinase (CDK) inhibitor. Although expression of p21 was increased, CDK activities and proliferating cell nuclear antigen (PCNA) were increased in Casp3(-/-) B cells. Using Casp3(-/-) Cdkn1a(-/-) mice, we show that the hyperproliferation of Casp3(-/-) B cells is abolished when Cdkn1a is also deleted. Our genetic and biochemical data demonstrate that caspase-3 is essential in the regulation of B cell homeostasis.	Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Ontario Canc Inst, Toronto, ON M5G 2N9, Canada; Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M2C 2T2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2N9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2N9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Mak, TW (corresponding author), Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada.		wu, ge/ABE-3285-2020; Duncan, Gordon/AIE-7011-2022; Lu, Liwei/C-4357-2009	Hakem, Razqallah/0000-0001-5948-7931; Lu, Liwei/0000-0002-8634-0967; Sasaki, Takehiko/0000-0003-1837-3748				Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Barboule N, 1998, INT J CANCER, V76, P891, DOI 10.1002/(SICI)1097-0215(19980610)76:6<891::AID-IJC20>3.0.CO;2-4; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Chau BN, 2002, NAT CELL BIOL, V4, P757, DOI 10.1038/ncb853; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Deng C, 1995, CELL, V25, P675; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erber R, 1997, INT J CANCER, V74, P383, DOI 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fulcher DA, 1999, IMMUNOL CELL BIOL, V77, P559, DOI 10.1046/j.1440-1711.1999.00870.x; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HARPER JW, 1993, CELL, V75, P805; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KINCADE PW, 1981, J IMMUNOL, V127, P2262; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Lipponen P, 1998, EUR UROL, V34, P237, DOI 10.1159/000019721; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Park JA, 1998, EUR J BIOCHEM, V257, P242, DOI 10.1046/j.1432-1327.1998.2570242.x; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Ray RJ, 1998, J IMMUNOL, V160, P5886; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WASEEM NH, 1992, EMBO J, V11, P5111, DOI 10.1002/j.1460-2075.1992.tb05618.x; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Woo M, 2000, CELL RES, V10, P267, DOI 10.1038/sj.cr.7290054; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	41	141	143	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					1016	1022		10.1038/ni976	http://dx.doi.org/10.1038/ni976			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12970760				2022-12-18	WOS:000185590100018
J	Kassiotis, G; Garcia, S; Simpson, E; Stockinger, B				Kassiotis, G; Garcia, S; Simpson, E; Stockinger, B			Impairment of immunological memory in the absence of MHC despite survival of memory T cells	NATURE IMMUNOLOGY			English	Article							CLASS-II MOLECULES; POSITIVE SELECTION; EFFECTOR FUNCTIONS; DENDRITIC CELLS; LIFE-SPAN; B-CELLS; IN-VIVO; PROLIFERATION; LYMPHOCYTES; NAIVE	The mechanisms by which immunological memory is maintained after infection or vaccination are still a matter of debate. Long-term survival of memory T cells does not require major histocompatibility complex (MHC) contact. We show here that compared with memory CD4(+) T cells that maintain contact with MHC class II, memory CD4(+) T cells deprived of MHC class II contact show distinct functional defects upon antigen re-encounter. Thus, in contrast to their survival, maintenance of the typical quality of memory T cells crucially depends on MHC-derived signals.	Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Transplantat Biol Grp, London W12 0NN, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research	Stockinger, B (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Transplantat Biol Grp, London W12 0NN, England.			Stockinger, Brigitta/0000-0001-8781-336X; Garcia, Sylvie/0000-0002-7655-8911; Kassiotis, George/0000-0002-8457-2633; Simpson, Elizabeth/0000-0002-2118-3139				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Barthlott T, 2001, EUR J IMMUNOL, V31, P3595, DOI 10.1002/1521-4141(200112)31:12<3595::AID-IMMU3595>3.0.CO;2-S; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; CROFT M, 1994, J IMMUNOL, V152, P2675; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kundig TM, 1996, IMMUNOL REV, V150, P63, DOI 10.1111/j.1600-065X.1996.tb00696.x; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Oxenius A, 1998, ADV IMMUNOL, V70, P313, DOI 10.1016/S0065-2776(08)60390-9; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	50	141	156	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					244	250		10.1038/ni766	http://dx.doi.org/10.1038/ni766			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11836529				2022-12-18	WOS:000174074000012
J	Verma, V; Shrimalim, RK; Ahmadm, S; Dai, WJ; Wang, H; Lu, SM; Nandrelm, R; Gaur, P; Lopez, J; Sade-Feldman, M; Yizhak, K; Bjorgaard, SL; Flaherty, KT; Wargo, JA; Boland, GM; Sullivan, RJ; Getz, G; Hammond, SA; Tan, M; Qi, JJ; Wong, P; Merghoub, T; Wolchok, J; Hacohen, N; Janik, JE; Mkrtichyan, M; Gupta, S; Khleif, SN				Verma, Vivek; Shrimalim, Rajeev K.; Ahmadm, Shamim; Dai, Winjie; Wang, Hua; Lu, Sumin; Nandrelm, Rahul; Gaur, Pankaj; Lopez, Jose; Sade-Feldman, Moshe; Yizhak, Keren; Bjorgaard, Stacey L.; Flaherty, Keith T.; Wargo, Jennifer A.; Boland, Genevieve M.; Sullivan, Ryan J.; Getz, Gad; Hammond, Scott A.; Tan, Ming; Qi, Jingjing; Wong, Phillip; Merghoub, Taha; Wolchok, Jedd; Hacohen, Nir; Janik, John E.; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.			PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance	NATURE IMMUNOLOGY			English	Article							T-CELLS; ACQUIRED-RESISTANCE; CANCER; IMMUNOTHERAPY; EXPRESSION; VACCINE; ACTIVATION; ANTIGEN; TUMORS; MECHANISM	Understanding resistance to antibody to programmed cell death protein 1 (PD-1; anti-PD-1) is crucial for the development of reversal strategies. In anti-PD-1-resistant models, simultaneous anti-PD-1 and vaccine therapy reversed resistance, while PD-1 blockade before antigen priming abolished therapeutic outcomes. This was due to induction of dysfunctional PD-1(+)CD38(hi) CD8(+) cells by PD-1 blockade in suboptimally primed CD8 cell conditions induced by tumors. This results in erroneous T cell receptor signaling and unresponsiveness to antigenic restimulation. On the other hand, PD-1 blockade of optimally primed CD8 cells prevented the induction of dysfunctional CD8 cells, reversing resistance. Depleting PD-1(+)CD38(+) CD8(+) cells enhanced therapeutic outcomes. Furthermore, non-responding patients showed more PD-1(+)CD38(+)CD8(+) cells in tumor and blood than responders. In conclusion, the status of CD8(+) T cell priming is a major contributor to anti-PD-1 therapeutic resistance. PD-1 blockade in unprimed or suboptimally primed CD8 cells induces resistance through the induction of PD-1(+)CD38(hi) CD8(+) cells that is reversed by optimal priming. PD-1(+)CD38(h)(i) CD8(+) cells serve as a predictive and therapeutic biomarker for anti-PD-1 treatment. Sequencing of anti-PD-1 and vaccine is crucial for successful therapy.	[Verma, Vivek; Shrimalim, Rajeev K.; Ahmadm, Shamim; Dai, Winjie; Wang, Hua; Lu, Sumin; Nandrelm, Rahul; Gaur, Pankaj; Janik, John E.; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA; [Sade-Feldman, Moshe; Bjorgaard, Stacey L.; Flaherty, Keith T.; Sullivan, Ryan J.; Getz, Gad; Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Canc Ctr, Boston, MA 02114 USA; [Sade-Feldman, Moshe; Yizhak, Keren; Bjorgaard, Stacey L.; Getz, Gad; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Boland, Genevieve M.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hammond, Scott A.] MedImmune LLC, Gaithersburg, MD USA; [Tan, Ming] Georgetown Univ, Dept Biostat Bioinformat & Biomath, Washington, DC USA; [Qi, Jingjing; Wong, Phillip; Merghoub, Taha; Wolchok, Jedd] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Merghoub, Taha; Wolchok, Jedd] Weill Cornell Med & Grad Sch, New York, NY USA; [Verma, Vivek; Nandrelm, Rahul; Gaur, Pankaj; Lopez, Jose; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Shrimalim, Rajeev K.] Univ Texas MD Anderson Canc Ctr, Therapeut Discovery, Houston, TX 77030 USA; [Ahmadm, Shamim] Five Prime Therapeut Inc, San Francisco, CA USA; [Janik, John E.] Incyte Inc, Wilmington, DE USA; [Mkrtichyan, Mikayel] A2 Biotherapeut, Agoura Hills, CA USA	University System of Georgia; Augusta University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; AstraZeneca; Medimmune; Georgetown University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Georgetown University; University of Texas System; UTMD Anderson Cancer Center; Incyte	Khleif, SN (corresponding author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.; Khleif, SN (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	snk48@georgetown.edu	Verma, Vivek/AFL-8809-2022; Merghoub, Taha/ABD-8362-2021; Gupta, Seema/AAK-9898-2020; Qi, Jingjing/AAP-8561-2021; Qi, Jingjing/AAL-7378-2021; Boland, Genevieve/AAP-2767-2021; Gaur, Pankaj/AAG-2765-2020	Verma, Vivek/0000-0001-8129-4140; Gupta, Seema/0000-0003-0106-595X; Qi, Jingjing/0000-0002-9368-1882; Gaur, Pankaj/0000-0002-9718-3565	Georgia Cancer Center, Augusta University; Ludwig Center for Cancer Immunotherapy; National Institutes of Health (NIH)/National Cancer Institute (NCI) Cancer Center Support grant [P30 CA008748, NIH/NCI R01 CA056821]; Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Virginia B. Squiers Foundation; Cancer Research Institute; Adelson Medical Research Foundation; NIH/NCI [R01CA208756]; Lombardi Comprehensive Cancer Center support grant [P30 CA 051008]; NATIONAL CANCER INSTITUTE [R01CA208756, R01CA056821] Funding Source: NIH RePORTER	Georgia Cancer Center, Augusta University; Ludwig Center for Cancer Immunotherapy; National Institutes of Health (NIH)/National Cancer Institute (NCI) Cancer Center Support grant; Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Virginia B. Squiers Foundation; Cancer Research Institute; Adelson Medical Research Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lombardi Comprehensive Cancer Center support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the Georgia Cancer Center, Augusta University internal support grant to S.N.K. We acknowledge the Lombardi Comprehensive Cancer Center support grant to the Biostatistics and Bioinformatics shared service (P30 CA 051008). We acknowledge the Ludwig Center for Cancer Immunotherapy for financial support for the Immune Monitoring Core Facility at the MSKCC. This research was funded in part through the National Institutes of Health (NIH)/National Cancer Institute (NCI) Cancer Center Support grant no. P30 CA008748, grant no. NIH/NCI R01 CA056821, the Swim Across America, Ludwig Institute for Cancer Research, Parker Institute for Cancer Immunotherapy and Virginia B. Squiers Foundation to J.W. and T.M. The research related to the human tumor samples was supported by the Cancer Research Institute (N.H.), Adelson Medical Research Foundation (N.H.) and NIH/NCI grant no. R01CA208756 (N.H.). We thank R. Ibrahim, Parker Institute for Cancer Immunotherapy, for reviewing the manuscript.	Abu Eid R, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1005448; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Banerjea Ayan, 2005, World J Surg Oncol, V3, P26, DOI 10.1186/1477-7819-3-26; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Buchwald ZS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00612; Chatterjee S, 2018, CELL METAB, V27, P85, DOI 10.1016/j.cmet.2017.10.006; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eroglu Z, 2018, NATURE, V553, P347, DOI 10.1038/nature25187; Frey AB, 2008, IMMUNOL REV, V222, P192, DOI 10.1111/j.1600-065X.2008.00606.x; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Karyampudi L, 2014, CANCER RES, V74, P2974, DOI 10.1158/0008-5472.CAN-13-2564; Kleponis J, 2015, CANCER BIOL MED, V12, P201, DOI 10.7497/j.issn.2095-3941.2015.0046; Kyi C, 2014, FEBS LETT, V588, P368, DOI 10.1016/j.febslet.2013.10.015; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee J., 2015, FOR IMMUNOPATHOL DIS, P7; Li YQ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0539-x; Lin KY, 1996, CANCER RES, V56, P21; Lohman BL, 1998, J VIROL, V72, P7815, DOI 10.1128/JVI.72.10.7815-7821.1998; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Mkrtichyan M, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-15; Mkrtichyan M, 2012, J IMMUNOL, V189, P2338, DOI 10.4049/jimmunol.1103085; Mkrtichyan M, 2011, EUR J IMMUNOL, V41, P2977, DOI 10.1002/eji.201141639; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pageon SV, 2016, P NATL ACAD SCI USA, V113, pE5454, DOI 10.1073/pnas.1607436113; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Patsoukis N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00330; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Poltorak M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-4; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shrimali RK, 2017, CANCER IMMUNOL RES, V5, P755, DOI 10.1158/2326-6066.CIR-17-0292; Soares KC, 2015, J IMMUNOTHER, V38, P1, DOI 10.1097/CJI.0000000000000062; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Vandeven NA, 2016, J ONCOL PRACT, V12, P649, DOI 10.1200/JOP.2016.014498; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vonderheide RH, 2018, CANCER CELL, V33, P563, DOI 10.1016/j.ccell.2018.03.008; Vonderheide RH, 2017, CLIN CANCER RES, V23, P2640, DOI 10.1158/1078-0432.CCR-16-2569; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	55	140	146	17	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1231	+		10.1038/s41590-019-0441-y	http://dx.doi.org/10.1038/s41590-019-0441-y			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31358999	Green Accepted			2022-12-18	WOS:000482212600022
J	Mohammed, J; Beura, LK; Bobr, A; Astry, B; Chicoine, B; Kashem, SW; Welty, NE; Igyarto, BZ; Wijeyesinghe, S; Thompson, EA; Matte, C; Bartholin, L; Kaplan, A; Sheppard, D; Bridges, AG; Shlomchik, WD; Masopust, D; Kaplan, DH				Mohammed, Javed; Beura, Lalit K.; Bobr, Aleh; Astry, Brian; Chicoine, Brian; Kashem, Sakeen W.; Welty, Nathan E.; Igyarto, Botond Z.; Wijeyesinghe, Sathi; Thompson, Emily A.; Matte, Catherine; Bartholin, Laurent; Kaplan, Alesia; Sheppard, Dean; Bridges, Alina G.; Shlomchik, Warren D.; Masopust, David; Kaplan, Daniel H.			Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-beta	NATURE IMMUNOLOGY			English	Article							LANGERHANS CELLS; DENDRITIC CELLS; STEADY-STATE; AUTOCRINE/PARACRINE TGF-BETA-1; INTEGRIN ALPHA(V)BETA(6); INTESTINAL EPITHELIUM; SKIN; TISSUE; EXPRESSION; DISTINCT	Cells of the immune system that reside in barrier epithelia provide a first line of defense against pathogens. Langerhans cells (LCs) and CD8(+) tissue-resident memory T cells (TRM cells) require active transforming growth factor-beta 1 (TGF-beta) for epidermal residence. Here we found that integrins alpha(v)beta(6) and alpha(v)beta(8) were expressed in non-overlapping patterns by keratinocytes (KCs) and maintained the epidermal residence of LCs and TRM cells by activating latent TGF-beta. Similarly, the residence of dendritic cells and TRM cells in the small intestine epithelium also required alpha v beta(6). Treatment of the skin with ultraviolet irradiation decreased integrin expression on KCs and reduced the availability of active TGF-beta, which resulted in LC migration. Our data demonstrated that regulated activation of TGF-beta by stromal cells was able to directly control epithelial residence of cells of the immune system through a novel mechanism of intercellular communication.	[Mohammed, Javed; Astry, Brian; Chicoine, Brian; Kashem, Sakeen W.; Welty, Nathan E.; Igyarto, Botond Z.; Wijeyesinghe, Sathi; Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Thompson, Emily A.; Masopust, David] Univ Minnesota, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN USA; [Bobr, Aleh; Bridges, Alina G.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Matte, Catherine] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Matte, Catherine] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Bartholin, Laurent] CNRS, INSERM, Ctr Rech Cancerol Lyon, U1052,UMR5286, Lyon, France; [Kaplan, Alesia] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Sheppard, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Shlomchik, Warren D.] Univ Pittsburgh, Dept Med, Canc Ctr Inst, Pittsburgh, PA USA; [Shlomchik, Warren D.] Univ Pittsburgh, Canc Ctr Inst, Dept Immunol, Pittsburgh, PA USA; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA; [Kaplan, Daniel H.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA.; Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	dankaplan@pitt.edu	, Alaska/AFJ-1849-2022; , Alaska/AAF-4514-2022; Beura, Lalit/W-6281-2019; Bartholin, Laurent/Q-6655-2017; Chicoine, Brian/AAM-9970-2021; masopust, david/B-5027-2008	Bartholin, Laurent/0000-0002-5637-3223; Welty, Nathan/0000-0001-6192-4117; Bobr, Aleh/0000-0003-1597-8071; Wijeyesinghe, Sathi/0000-0002-8819-2654; Kashem, Sakeen/0000-0002-2594-2884; Igyarto, Botond/0000-0002-9770-800X	US National Institutes of Health [AR060744, A1084913]; Dermatology Foundation; American Skin Association; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI084913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; American Skin Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Sheppard (University of California, San Francisco) for Itgb6<SUP>-/-</SUP> and Itgb8<SUP>loxP</SUP> mice and the isotype-matched control antibody ADWA-21; A. Glick, N. Blazanin and A. Ravindran for technical assistance with mouse KC culture; S. Violette (Biogen Idec) for antibody clones 6.3g9 and ch2A1 (both specific for alpha<INF>v</INF>beta<INF>6</INF>); J. Mitchell for technical assistance with confocal and epifluorescence microscopy; T. Martin, J. Motl and P. Champoux for technical assistance with flow cytometry and cell sorting; D. Rifkin and M. Vassallo for providing detailed protocols of an in vitro latent TGF-beta-activation assay; the Research Animal Resources staff at the University of Minnesota for animal care; the Mayo Clinic division of Biostatistics and Bioinformatics for assistance in searching control and losartan-treated skin samples; and M. Jenkins for critical reading of the manuscript. Supported by the US National Institutes of Health (AR060744 to D.H.K., A1084913 to D.M.), the Dermatology Foundation (J.M.) and the American Skin Association (J.M.).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; Bertolini Marta, 2015, J Investig Dermatol Symp Proc, V17, P9, DOI 10.1038/jidsymp.2015.31; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Harberts E, 2015, J IMMUNOL, V194, P3127, DOI 10.4049/jimmunol.1402583; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; King JK, 2015, J IMMUNOL, V195, P464, DOI 10.4049/jimmunol.1402735; Knight PA, 2002, AM J PATHOL, V161, P771, DOI 10.1016/S0002-9440(10)64236-8; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Obhrai JS, 2008, J INVEST DERMATOL, V128, P1950, DOI 10.1038/jid.2008.52; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	49	140	143	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					414	+		10.1038/ni.3396	http://dx.doi.org/10.1038/ni.3396			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	26901152	Green Accepted			2022-12-18	WOS:000372508000015
J	Marks, BR; Nowyhed, HN; Choi, JY; Poholek, AC; Odegard, JM; Flavell, RA; Craft, J				Marks, Benjamin R.; Nowyhed, Heba N.; Choi, Jin-Young; Poholek, Amanda C.; Odegard, Jared M.; Flavell, Richard A.; Craft, Joe			Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TGF-BETA; AUTOIMMUNE ENCEPHALOMYELITIS; CUTTING EDGE; TH17 CELLS; NKT CELLS; DIFFERENTIATION; LINEAGE; DISEASE; ANTIGEN	Interleukin 17 (IL-17)-producing CD4(+) helper T cells (T-H-17 cells) share a developmental relationship with Foxp3(+) regulatory T cells (T-reg cells). Here we show that a T-H-17 population differentiates in the thymus in a manner influenced by recognition of self antigen and by the cytokines IL-6 and transforming growth factor-beta (TGF-beta). Like previously described T-H-17 cells, the T-H-17 cells that developed in the thymus expressed the transcription factor ROR gamma t and the IL-23 receptor. These cells also expressed alpha(4)beta(1) integrins and the chemokine receptor CCR6 and were recruited to the lung, gut and liver. In the liver, these cells secreted IL-22 in response to self antigen and mediated host protection during inflammation. Thus, T-H-17 cells, like T-reg cells, can be selected by self antigens in the thymus.	[Marks, Benjamin R.; Nowyhed, Heba N.; Odegard, Jared M.; Flavell, Richard A.; Craft, Joe] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Choi, Jin-Young; Craft, Joe] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [Poholek, Amanda C.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA.	joseph.craft@yale.edu			US National Institutes of Heath [AR40072, AR44076, AI56219, AR053495, 5T32GM07205]; Arthritis Foundation; Rheuminations; Connecticut chapter of the Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI056219, R01AI056219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, P30AR053495, R01AR044076, R01AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	US National Institutes of Heath; Arthritis Foundation; Rheuminations; Connecticut chapter of the Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hedrick (University of California, San Diego) and S. Oehan (University Hospital, Zurich) for AND- and PCC-transgenic mice; F. Alt (The Children's Hospital and Harvard Medical School) and D. Schatz (Yale University School of Medicine) for RAG2:GFP mice; H. van Santen, D. Mathis and C. Benoist (Joslin Diabetes Center and Harvard Medical School) for TA. TIM mice; L. Bockenstedt (Yale University School of Medicine) for CD1d-deficient mice; E. Marks and other members of the Craft laboratory for discussions; L. Zenewicz and E. Espluges for advice; and R. Medzhitov and S. Kaech for critical reading of the manuscript. Supported by the US National Institutes of Heath (AR40072, AR44076, AI56219 and AR053495; and 5T32GM07205 to B. R. M.), the Arthritis Foundation, Rheuminations and the Connecticut chapter of the Lupus Foundation.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Betti M, 2006, ANN ONCOL, V17, P235; Bowman EP, 2006, CURR OPIN INFECT DIS, V19, P245, DOI 10.1097/01.qco.0000224818.42729.67; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oehen S, 1996, J EXP MED, V183, P2617, DOI 10.1084/jem.183.6.2617; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	53	140	142	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1125	U108		10.1038/ni.1783	http://dx.doi.org/10.1038/ni.1783			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19734905	Green Accepted			2022-12-18	WOS:000270006900017
J	Noguchi, E; Homma, Y; Kang, XY; Netea, MG; Ma, XJ				Noguchi, Eiichiro; Homma, Yoichiro; Kang, Xiaoyan; Netea, Mihai G.; Ma, Xiaojing			A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; INTERLEUKIN-10-DEFICIENT MICE; 3020INSC MUTATION; COLITIS; PROTEINS; IL-10; AUTOANTIBODIES; IDENTIFICATION	A common mutation in the gene encoding the cytoplasmic sensor Nod2, involving a frameshift insertion at nucleotide 3020 (3020insC), is strongly associated with Crohn's disease. How 3020insC contributes to this disease is a controversial issue. Clinical studies have identified defective production of interleukin 10 (IL-10) in patients with Crohn's disease who bear the 3020insC mutation, which suggests that 3020insC may be a loss-of-function mutation. However, here we found that 3020insC Nod2 mutant protein actively inhibited IL10 transcription. The 3020insC Nod2 mutant suppressed IL10 transcription by blocking phosphorylation of the nuclear ribonucleoprotein hnRNP-A1 via the mitogen-activated protein kinase p38. We confirmed impairment in phosphorylation of hnRNP-A1 and binding of hnRNP-A1 to the IL10 locus in peripheral blood mononuclear cells from patients with Crohn's disease who bear the 3020insC mutation and have lower production of IL-10.	[Kang, Xiaoyan; Ma, Xiaojing] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Noguchi, Eiichiro; Homma, Yoichiro] Tokyo Womens Med Univ, Dept Surg 2, Tokyo, Japan; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med 463, NL-6525 ED Nijmegen, Netherlands	Cornell University; Tokyo Women's Medical University; Radboud University Nijmegen	Ma, XJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	xim2002@med.cornell.edu	Netea, Mihai/N-5155-2014		Broad Medical Research Program [IBD-210R2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072149] Funding Source: NIH RePORTER	Broad Medical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. J. Murray (St. Jude Children's Research Hospital) for Nod2-knockout and control littermate mice; E. Pamer (Memorial Sloan-Kettering Cancer Center) for RICK-knockout (RIP2-knockout) and control mice; J. M. Park (Harvard University School of Medicine) for mice with conditional knockout of p38 alpha; and G. Nunez (University of Michigan) for the mouse Nod2 expression vector and mouse 2939insC Nod2. Supported by the Broad Medical Research Program (IBD-210R2 to X. M.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Caporali R, 2005, AUTOIMMUNITY, V38, P25, DOI 10.1080/08916930400022590; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones DA, 2004, J INVEST DERMATOL, V123, P93, DOI 10.1111/j.0022-202X.2004.22709.x; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kramer M, 2006, J LEUKOCYTE BIOL, V79, P860, DOI 10.1189/jlb.0805484; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Netea MG, 2005, NETH J MED, V63, P305; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Steiner G, 1996, MOL BIOL REP, V23, P167, DOI 10.1007/BF00351165; van der Linde K, 2003, AM J GASTROENTEROL, V98, P613, DOI 10.1016/S0002-9270(02)06009-4; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067	36	140	142	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					471	479		10.1038/ni.1722	http://dx.doi.org/10.1038/ni.1722			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19349988	Green Accepted			2022-12-18	WOS:000265394400008
J	Kabashima, K; Murata, T; Tanaka, H; Matsuoka, T; Sakata, D; Yoshida, N; Katagiri, K; Kinashi, T; Tanaka, T; Miyasaka, M; Nagai, H; Ushikubi, F; Narumiya, S				Kabashima, K; Murata, T; Tanaka, H; Matsuoka, T; Sakata, D; Yoshida, N; Katagiri, K; Kinashi, T; Tanaka, T; Miyasaka, M; Nagai, H; Ushikubi, F; Narumiya, S			Thromboxane A(2) modulates interaction of dendritic cells and T cells and regulates acquired immunity	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; CONTACT HYPERSENSITIVITY; POLYMORPHONUCLEAR LEUKOCYTES; ARACHIDONIC-ACID; HUMAN TISSUES; CUTTING EDGE; MACROPHAGES; RECEPTOR; ACTIVATION; EXPRESSION	Physical interaction of T cells and dendritic cells (DCs) is essential for T cell proliferation and differentiation, but it has been unclear how this interaction is regulated physiologically. Here we show that DCs produce thromboxane A(2) (TXA(2)), whereas naive T cells express the thromboxane receptor (TP). In vitro, a TP agonist enhances random cell movement (chemokinesis) of naive but not memory T cells, impairs DC-T cell adhesion, and inhibits DC-dependent proliferation of T cells. In vivo, immune responses to foreign antigens are enhanced in TP-deficient mice, which also develop marked lymphadenopathy with age. Similar immune responses were seen in wild-type mice treated with a TP antagonist during the sensitization period. Thus, TXA(2)-TP signaling modulates acquired immunity by negatively regulating DC-T cell interactions.	Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Dermatol, Kyoto 6068501, Japan; Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5028585, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1088339, Japan; Kyoto Univ, Fac Med, Dept Mol Immunol & Allergy, Kyoto 6068501, Japan; Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan	Kyoto University; Kyoto University; Gifu Pharmaceutical University; University of Tokyo; Kyoto University; Osaka University; Asahikawa Medical College	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan.		Miyasaka, Masayuki/AAM-6343-2020; Tanaka, Toshiyuki/D-1193-2010; Kabashima, Kenji/G-2521-2014	Tanaka, Toshiyuki/0000-0003-3659-9994; Murata, Takahiko/0000-0003-0132-5424; Kabashima, Kenji/0000-0002-0773-0554				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; ALLEN PM, 1984, J IMMUNOL, V132, P1077; Bleijs DA, 2001, TRENDS IMMUNOL, V22, P457, DOI 10.1016/S1471-4906(01)01974-3; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; BRUNE K, 1978, NATURE, V274, P261, DOI 10.1038/274261a0; CIFONE MG, 1987, INT J TISSUE REACT, V9, P51; CONTI P, 1986, PROSTAGLANDINS, V32, P111, DOI 10.1016/0090-6980(86)90151-6; Daniel TO, 1999, CANCER RES, V59, P4574; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; FITZGERALD GA, 1987, FASEB J, V46, P154; GOLDSTEIN IM, 1978, J EXP MED, V148, P787, DOI 10.1084/jem.148.3.787; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HANASAKI K, 1988, THROMB RES, V50, P365, DOI 10.1016/0049-3848(88)90266-6; INABA K, 1987, J EXP MED, V165, P1403, DOI 10.1084/jem.165.5.1403; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; KOUZAN S, 1988, AM REV RESPIR DIS, V137, P38, DOI 10.1164/ajrccm/137.1.38; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; KURIMOTO I, 1993, J INVEST DERMATOL, V101, P132, DOI 10.1111/1523-1747.ep12363616; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LOMBARDPLATLET S, 1993, IMMUNOLOGY, V80, P566; Mitsuhashi M, 2001, J IMMUNOL, V166, P617, DOI 10.4049/jimmunol.166.1.617; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MORINELLI TA, 1989, J PHARMACOL EXP THER, V251, P557; MUROTA SI, 1978, BIOCHIM BIOPHYS ACTA, V528, P507; Nagai H, 2000, BRIT J PHARMACOL, V129, P299, DOI 10.1038/sj.bjp.0703054; NAMBA T, 1992, BIOCHEM BIOPH RES CO, V184, P1197, DOI 10.1016/S0006-291X(05)80009-9; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NUSING R, 1990, EICOSANOIDS, V3, P175; NUSING R, 1992, VIRCHOWS ARCH A, V421, P249, DOI 10.1007/BF01611182; OGLETREE ML, 1987, FED PROC, V46, P133; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Sun LK, 2001, INFLAMM RES, V50, P496, DOI 10.1007/PL00000224; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; TONE Y, 1994, FEBS LETT, V340, P241, DOI 10.1016/0014-5793(94)80146-0; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; USHIKUBI F, 1993, J EXP MED, V178, P1825, DOI 10.1084/jem.178.5.1825; Wrenger S, 2000, J BIOL CHEM, V275, P22180, DOI 10.1074/jbc.M002338200; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; YONG K, 1990, BLOOD REV, V4, P211, DOI 10.1016/0268-960X(90)90001-9; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	46	140	144	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					694	701		10.1038/ni943	http://dx.doi.org/10.1038/ni943			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12778172				2022-12-18	WOS:000183952500018
J	Stevenson, PG; May, JS; Smith, XG; Marques, S; Adler, H; Koszinowski, UH; Simas, JP; Efstathiou, S				Stevenson, PG; May, JS; Smith, XG; Marques, S; Adler, H; Koszinowski, UH; Simas, JP; Efstathiou, S			K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus	NATURE IMMUNOLOGY			English	Article							MURINE GAMMAHERPESVIRUS INFECTION; CHEMOKINE BINDING-PROTEIN; GENE-EXPRESSION; HOST RESPONSE; IN-VIVO; B-CELLS; GENOME; PERSISTENCE; MICE; IDENTIFICATION	The murine gamma-herpesvirus-68 (MHV-68) K3 protein, like that of the Kaposi's sarcoma-associated herpesvirus, down-regulates major histocompatibility complex (MHC) class I expression. However, how this contributes to viral replication in vivo is unclear. After intranasal MHV-68 infection, K3 was transcribed both during acute lytic infection in the lung and during latency establishment in lymphoid tissue. K3-deficient viruses were not cleared more rapidly from the lung, but the number of latently infected spleen cells was reduced and the frequency of virus-specific CD8(+) cytotoxic T lymphocytes (CTLs) was increased. CTL depletion reversed the viral latency deficit. Thus, a major function of K3 appears to be CTL evasion during viral latency expansion.	Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; Univ Lisbon, Fac Med, Microbiol Lab, P-1649028 Lisbon, Portugal; Univ Munich, Max Von Pettenkofer Inst, Munich, Germany	University of Cambridge; Universidade de Lisboa; University of Munich	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Tennis Court Rd, Cambridge CB2 1QP, England.		Stevenson, Philip/F-6651-2011; Simas, J Pedro/M-5157-2013; Stevenson, Philip g/F-9688-2014	Simas, J Pedro/0000-0001-6982-9253; Stevenson, Philip g/0000-0002-3520-5060; Marques, Sofia/0000-0003-1467-1529				Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bowden RJ, 1997, J GEN VIROL, V78, P1675, DOI 10.1099/0022-1317-78-7-1675; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Brune W, 1999, NAT BIOTECHNOL, V17, P360, DOI 10.1038/7914; Coppola MA, 1999, J IMMUNOL, V163, P1481; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Doherty PC, 2001, PHILOS T R SOC B, V356, P581, DOI 10.1098/rstb.2000.0786; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; Hengel H, 1999, IMMUNOL REV, V168, P167, DOI 10.1111/j.1600-065X.1999.tb01291.x; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Liu LZ, 1999, J IMMUNOL, V163, P868; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Means RE, 2002, EMBO J, V21, P1638, DOI 10.1093/emboj/21.7.1638; Nicholas J, 1997, J VIROL, V71, P1963, DOI 10.1128/JVI.71.3.1963-1974.1997; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Pasquetto V, 2000, J VIROL, V74, P9792, DOI 10.1128/JVI.74.20.9792-9796.2000; Posavad CM, 1998, NAT MED, V4, P381, DOI 10.1038/nm0498-381; Rochford R, 2001, J VIROL, V75, P4955, DOI 10.1128/JVI.75.11.4955-4963.2001; Selvakumar R, 1997, J VIROL, V71, P5540, DOI 10.1128/JVI.71.7.5540-5548.1997; Simas JP, 1999, J GEN VIROL, V80, P75, DOI 10.1099/0022-1317-80-1-75; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 1999, J GEN VIROL, V80, P477, DOI 10.1099/0022-1317-80-2-477; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1998, J VIROL, V72, P943, DOI 10.1128/JVI.72.2.943-949.1998; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; van Berkel V, 2002, J CLIN INVEST, V109, P905, DOI 10.1172/JCI14358; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996	39	140	144	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					733	740		10.1038/ni818	http://dx.doi.org/10.1038/ni818			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12101398				2022-12-18	WOS:000177118500012
J	Halstead, ES; Mueller, YM; Altman, JD; Katsikis, PD				Halstead, ES; Mueller, YM; Altman, JD; Katsikis, PD			In vivo stimulation of CD137 broadens primary antiviral CD8(+) T cell responses	NATURE IMMUNOLOGY			English	Article							ANTI-4-1BB MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUS INFECTION; 4-1BB LIGAND; IMMUNE-RESPONSE; VIRAL-INFECTION; CO-STIMULATION; COSTIMULATORY MOLECULE; MICE LACKING; IN-VIVO; ACTIVATION	Given the key role CD8(+) T cells play in controlling viral infection, strategies to enhance these responses may have important clinical applications. We found that in vivo CD137 stimulation with an agonistic monoclonal antibody enhanced the primary CD8(+) T cell response to influenza type A viral infection in mice. Stimulation of CD137 increased the absolute number of CD8(+) T cells to influenza epitopes in the lungs of infected animals, preferentially expanded CD8(+) T cells that recognized nondominant epitopes and greatly enhanced direct ex vivo cytotoxicity. CD137 stimulation also restored the CD8(+) T cell response to the immunodominant influenza epitope in CD28(-/-) mice. Thus, in vivo CD137 stimulation enhances and broadens the CD8(+) T cell response to influenza virus and can restore the CD8(+) T cell response when CD28 costimulation is absent. This suggests that CD137 stimulation may be useful as a strategy to enhance the CD8(+) T cell response to viruses.	Med Coll Penn & Hahnemann Univ, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Drexel University; Emory University	Katsikis, PD (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Microbiol & Immunol, 3300 Henry Ave, Philadelphia, PA 19129 USA.			Mueller, Yvonne/0000-0002-4654-7509; Katsikis, Peter/0000-0001-7690-5218; Halstead, E. Scott/0000-0002-1167-0363	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI046719, R01AI046719] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46719] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Baumgarth N, 1997, J IMMUNOL, V159, P1182; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Cooper D, 2002, EUR J IMMUNOL, V32, P521, DOI 10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO;2-X; DALY K, 1995, J VIROL, V69, P7416, DOI 10.1128/JVI.69.12.7416-7422.1995; DEBENEDETTE MA, 1995, J EXP MED, V181, P985, DOI 10.1084/jem.181.3.985; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; DeBenedette MA, 1997, J IMMUNOL, V158, P551; Doyle AG, 1999, J EXP MED, V190, P1081, DOI 10.1084/jem.190.8.1081; Ebata T, 2001, EUR J IMMUNOL, V31, P1410, DOI 10.1002/1521-4141(200105)31:5<1410::AID-IMMU1410>3.0.CO;2-H; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Hong HJ, 2000, J IMMUNOTHER, V23, P613, DOI 10.1097/00002371-200011000-00002; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Hurtado JC, 1997, J IMMUNOL, V158, P2600; HURTADO JC, 1995, J IMMUNOL, V155, P3360; Johnston JV, 1996, J EXP MED, V183, P791, DOI 10.1084/jem.183.3.791; Kim YJ, 1998, EUR J IMMUNOL, V28, P881, DOI 10.1002/(SICI)1521-4141(199803)28:03<881::AID-IMMU881>3.0.CO;2-0; Lumsden JM, 2000, J IMMUNOL, V164, P79, DOI 10.4049/jimmunol.164.1.79; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 1998, CELL IMMUNOL, V190, P167, DOI 10.1006/cimm.1998.1396; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murtaza A, 1999, INT IMMUNOL, V11, P407, DOI 10.1093/intimm/11.3.407; Oukka M, 1996, J IMMUNOL, V157, P3039; Pardigon N, 1998, INT IMMUNOL, V10, P619, DOI 10.1093/intimm/10.5.619; POLLOK KE, 1995, EUR J IMMUNOL, V25, P488, DOI 10.1002/eji.1830250227; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Takahashi C, 1999, J IMMUNOL, V162, P5037; Tan JT, 1999, J IMMUNOL, V163, P4859; Tan JT, 2000, J IMMUNOL, V164, P2320, DOI 10.4049/jimmunol.164.5.2320; Vitiello A, 1996, J IMMUNOL, V157, P5555; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zhang J, 1999, J IMMUNOL, V162, P3819; Zhu GF, 2001, J IMMUNOL, V167, P2671, DOI 10.4049/jimmunol.167.5.2671	44	140	145	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					536	541		10.1038/ni798	http://dx.doi.org/10.1038/ni798			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12021777	Bronze			2022-12-18	WOS:000175874700012
J	Walker, BD; Korber, BT				Walker, BD; Korber, BT			Immune control of HIV: the obstacles of HLA and viral diversity	NATURE IMMUNOLOGY			English	Editorial Material							T-LYMPHOCYTE RESPONSES; VIRUS; IDENTIFICATION; CD8(+); RECOMBINANT; INFECTION; ANCESTOR; VIREMIA; CELLS		Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02114 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory	Walker, BD (corresponding author), Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA.	bwalker@helix.mgh.harvard.edu		Korber, Bette/0000-0002-2026-5757				Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Goulder PJR, 2000, J VIROL, V74, P5679, DOI 10.1128/JVI.74.12.5679-5690.2000; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jin X, 2000, AIDS RES HUM RETROV, V16, P67, DOI 10.1089/088922200309610; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; KAUL R, 1999, HIV MOL IMMUNOLOGY 4, P35; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KORBER B, 2000, HIV MOL IMMUNOLOGY 2, P1; Kuiken CL, 1999, EVOLUTION OF HIV, P432; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Lukashov VV, 1997, J VIROL, V71, P6332, DOI 10.1128/JVI.71.9.6332-6338.1997; MCCUTCHAN FE, 1992, AIDS RES HUM RETROV, V8, P1887, DOI 10.1089/aid.1992.8.1887; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Pikora CA, 1997, J EXP MED, V185, P1153, DOI 10.1084/jem.185.7.1153; Ray SC, 1998, AIDS RES HUM RETROV, V14, P3, DOI 10.1089/aid.1998.14.3; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sipsas NV, 1997, J CLIN INVEST, V99, P752, DOI 10.1172/JCI119221; Vidal N, 2000, AIDS RES HUM RETROV, V16, P2059, DOI 10.1089/088922200750054800; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	27	140	144	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					473	475		10.1038/88656	http://dx.doi.org/10.1038/88656			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376327				2022-12-18	WOS:000169078000004
J	Gong, K; Cheng, AM; Akk, AM; Albereola-Ila, J; Gong, GQ; Pawson, T; Chan, AC				Gong, K; Cheng, AM; Akk, AM; Albereola-Ila, J; Gong, GQ; Pawson, T; Chan, AC			Disruption of T cell signaling networks and development by Grb2 haploid insufficiency	NATURE IMMUNOLOGY			English	Article							REGULATE NUCLEAR FACTOR; NEGATIVE SELECTION; MAP KINASE; ANTIGEN RECEPTOR; ADAPTER PROTEIN; SH3-SH2-SH3 PROTEIN; ACTIVATION; RAS; LAT; JNK	The developmental processes of positive and negative selection in the thymus shape the T cell antigen receptor (TCR) repertoire and require the integration of multiple signaling networks. These networks involve the efficient assembly of macromolecular complexes and ave mediated by multimodular adaptor proteins that permit the functional integration of distinct signaling molecules. We show here that decreased expression of the adaptor protein Grb2 in Grb2(+/-) mice weakens TCR-induced c-Jun N-terminal kinase (JNK) and p38, but not extracellular signal-regulated kinase (ERK), activation. In turn, this selective effect decreases the ability of thymocytes to undergo negative, but not positive, selection. We also show that there are differences in the signaling thresholds of the three mitogen-activated protein kinase (MAPK) families. These differences may provide a mechanism by which quantitative differences in signal strength can alter the balance of downstream signaling pathways to induce the qualitatively distinct biological outcomes of proliferation, differentiation or apoptosis.	Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol,Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, Div Rheumatol,Ctr Immunol, St Louis, MO 63110 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); California Institute of Technology; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Chan, AC (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	achan@im.wustl.edu	Pawson, Tony J/E-4578-2013	alberola-ila, Jose/0000-0003-2439-553X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045072, P01AI047330] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47330, R01 AI045072, R01 AI045072-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ANDO A, 1994, EMBO J, V13, P3033, DOI 10.1002/j.1460-2075.1994.tb06602.x; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Faris M, 1996, J BIOL CHEM, V271, P27366, DOI 10.1074/jbc.271.44.27366; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Grossman Z, 1996, P NATL ACAD SCI USA, V93, P14747, DOI 10.1073/pnas.93.25.14747; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; KHARBANDA S, 1995, P NATL ACAD SCI USA, V92, P6132, DOI 10.1073/pnas.92.13.6132; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Love PE, 2000, IMMUNITY, V12, P591, DOI 10.1016/S1074-7613(00)80210-1; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pomerance M, 1998, J BIOL CHEM, V273, P24301, DOI 10.1074/jbc.273.38.24301; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SHI YF, 1991, J IMMUNOL, V146, P3340; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	59	140	140	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					29	36		10.1038/83134	http://dx.doi.org/10.1038/83134			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135575				2022-12-18	WOS:000166261500011
